PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	McEvoy, SP; Stevenson, MR; McCartt, AT; Woodward, M; Haworth, C; Palamara, P; Cercarelli, R				McEvoy, SP; Stevenson, MR; McCartt, AT; Woodward, M; Haworth, C; Palamara, P; Cercarelli, R			Role of mobile phones in motor vehicle crashes resulting in hospital attendance: a case-crossover study	BRITISH MEDICAL JOURNAL			English	Article							DRIVER BEHAVIOR; TELEPHONES; COLLISIONS; ATTENTION; TIME; RISK	Objectives To explore the effect of drivers' use of mobile (cell) phones on road safety. Design A case-crossover study. Setting Perth, Western Australia. Participants 456 drivers aged >= 17 who owned or used mobile phones and had been involved in road crashes necessitating hospital attendance between April 2002 and July 2004. Main outcome measure Driver's use of mobile phone at estimated time of crash and on trips at the same time of day in the week before the crash. Interviews with drivers in hospital and phone company's records of phone use. Results Driver's use of a mobile phone up to 10 minutes before a crash was associated with a fourfold increased likelihood of crashing (odds ratio 4.1,95% confidence interval 2.2 to 7.7, P < 0.001). Risk was raised irrespective of whether or not a hands-free device was used (hands-free: 3.8, 1.8 to 8.0, P < 0.001; hand held: 4.9, 1.6 to 15.5, P = 0.003). Increased risk was similar in men and women and in drivers aged >= 30 and < 30 years. A third (n = 21) of calls before crashes and on trips during the previous week were reportedly on hand held phones. Conclusions When drivers use a mobile phone there is an increased likelihood of a crash resulting in injury. Using a hands-free phone is not any safer.	Univ Sydney, George Inst Int Hlth, Sydney, NSW 2050, Australia; Insurance Inst Highway Safety, Arlington, VA USA; Univ Western Australia, Injury Res Ctr, Crawley, WA 6009, Australia	University of Sydney; University of Western Australia	McEvoy, SP (corresponding author), Univ Sydney, George Inst Int Hlth, POB M201, Sydney, NSW 2050, Australia.	smcevoy@thegeorgeinstitute.org	Woodward, Mark/L-6817-2017; stevenson, mark/AAE-9706-2019; Woodward, Mark/D-8492-2015	stevenson, mark/0000-0003-3166-5876; Palamara, Peter/0000-0001-8163-3333; Woodward, Mark/0000-0001-9800-5296; McEvoy, Suzanne/0000-0002-9804-4276				ALM H, 1995, ACCIDENT ANAL PREV, V27, P707, DOI 10.1016/0001-4575(95)00026-V; ALM H, 1994, ACCIDENT ANAL PREV, V26, P441, DOI 10.1016/0001-4575(94)90035-3; BROOKHUIS KA, 1991, ACCIDENT ANAL PREV, V23, P309, DOI 10.1016/0001-4575(91)90008-S; Consiglio W, 2003, ACCIDENT ANAL PREV, V35, P495, DOI 10.1016/S0001-4575(02)00027-1; GLASSBRENNER D, 2002, DRIVER CELL PHONE US; GLASSBRENNER D, 2005, DRIVER CELL PHONE US; Goodman M.J., 1999, TRANSPORT HUM FACTOR, V1, P3, DOI [10.1207/sthf0101_2, DOI 10.1207/STHF0101_2]; Haigney D., 2000, TRANSPORT RES F-TRAF, V3, P113, DOI [10.1016/S1369-8478(00)00020-6, DOI 10.1016/S1369-8478(00)00020-6]; Horberry T., 2001, TRANSP RES F, V4, P213; Johal S, 2005, J PUBLIC HEALTH-UK, V27, P112, DOI 10.1093/pubmed/fdh213; Laberge-Nadeau C, 2003, ACCIDENT ANAL PREV, V35, P649, DOI 10.1016/S0001-4575(02)00043-X; Maclure M, 1997, NEW ENGL J MED, V336, P501, DOI 10.1056/NEJM199702133360709; Matthews R, 2003, ACCIDENT ANAL PREV, V35, P451, DOI 10.1016/S0001-4575(02)00023-4; McCartt AT, 2004, INJURY PREV, V10, P11, DOI 10.1136/ip.2003.003731; MCCARTT AT, 2005, EFFECTS WASHINGTON D; MCKNIGHT AJ, 1993, ACCIDENT ANAL PREV, V25, P259, DOI 10.1016/0001-4575(93)90020-W; MIRTLEMAN MA, 1995, AM J EPIDEMIOL, V142, P91; Redelmeier DA, 1997, NEW ENGL J MED, V336, P453, DOI 10.1056/NEJM199702133360701; Royal D., 2003, NATL SURVEY DISTRACT; Strayer DL, 2003, J EXP PSYCHOL-APPL, V9, P23, DOI 10.1037/1076-898X.9.1.23; Sullman MJM, 2004, TRANSPORT RES F-TRAF, V7, P95, DOI 10.1016/j.trf.2004.03.001; Taylor DM, 2003, MED J AUSTRALIA, V179, P140, DOI 10.5694/j.1326-5377.2003.tb05472.x; Wikman AS, 1998, ERGONOMICS, V41, P358, DOI 10.1080/001401398187080; Wilson Jean, 2003, Traffic Inj Prev, V4, P45, DOI 10.1080/15389580309851; Woodward M., 2013, EPIDEMIOLOGY STUDY D	25	327	330	0	35	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 20	2005	331	7514					428	430A		10.1136/bmj.38537.397512.55	http://dx.doi.org/10.1136/bmj.38537.397512.55			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	958WB	16012176	Green Published, Bronze			2022-12-28	WOS:000231477800014
J	Gazzard, B				Gazzard, B			Antiretroviral therapy for HIV: medical miracles do happen	LANCET			English	Editorial Material									Chelsea & Westminster Hosp, Dept HIV, London SW10 9NH, England	Imperial College London	Gazzard, B (corresponding author), Chelsea & Westminster Hosp, Dept HIV, London SW10 9NH, England.	eileen.witney@chelwest.nhs.uk						Beck EJ, 2004, AIDS, V18, P2411; Havlir D V, 1998, AIDS, V12 Suppl A, pS165; Keenan PA, 2005, POSTGRAD MED, V117, P47, DOI 10.3810/pgm.2005.03.1600; Ruxin J, 2005, LANCET, V365, P618, DOI 10.1016/S0140-6736(05)70806-0; SELIGMANN M, 1994, LANCET, V343, P871; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5	6	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2005	366	9483					346	347		10.1016/S0140-6736(05)67002-X	http://dx.doi.org/10.1016/S0140-6736(05)67002-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	950IB	16054922				2022-12-28	WOS:000230849700005
J	Park, SK; Nguyen, MD; Fischer, A; Luke, MPS; Affar, EB; Dieffenbach, PB; Tseng, HC; Shi, Y; Tsai, LH				Park, SK; Nguyen, MD; Fischer, A; Luke, MPS; Affar, EB; Dieffenbach, PB; Tseng, HC; Shi, Y; Tsai, LH			Par-4 links dopamine signaling and depression	CELL			English	Article							PROSTATE APOPTOSIS RESPONSE-4; ELEMENT-BINDING PROTEIN; NUCLEUS-ACCUMBENS; NEURONAL DEGENERATION; HUNTINGTONS-DISEASE; AFFECTIVE-DISORDERS; MAJOR DEPRESSION; MOUSE MODEL; RECEPTOR; ANTIDEPRESSANT	Prostate apoptosis response 4 (Par-4) is a leucine zipper containing protein that plays a role in apoptosis. Although Par-4 is expressed in neurons, its physiological role in the nervous system is unknown. Here we identify Par-4 as a regulatory component in dopamine signaling. Par-4 directly interacts with the dopamine D2 receptor (D2DR) via the calmodulin binding motif in the third cytoplasmic loop. Calmodulin can effectively compete with Par-4 binding in a Ca2+- dependent manner, providing a route for Ca2+-mediated downregulation of D2DR efficacy. To examine the importance of the Par-4/D2DR interaction in dopamine signaling in vivo, we used a mutant mouse lacking the D2DR interaction domain of Par-4, Par-4 Delta LZ Primary neurons from Par-4 Delta LZ embryos exhibit an enhanced dopamine-cAMP-CREB signaling pathway, indicating an impairment in dopamine signaling in these cells. Remarkably, Par-4 Delta LZ mice display significantly increased depression-like behaviors. Collectively, these results provide evidence that Par-4 constitutes a molecular link between impaired dopamine signaling and depression.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT)	Tsai, LH (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	li-huei_tsai@hms.harvard.edu		Fischer, Andre/0000-0001-8546-1161				American Psychiatric Association, 2000, DIAGNOSTIC STAT MANU, V4th ed., P345; BALDESSARINI RJ, 1989, J CLIN PSYCHIAT, V50, P117; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Bieberich E, 2003, J CELL BIOL, V162, P469, DOI 10.1083/jcb.200212067; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; Bofill-Cardona E, 2000, J BIOL CHEM, V275, P32672, DOI 10.1074/jbc.M002780200; Bowden C, 1997, BRAIN RES, V769, P135, DOI 10.1016/S0006-8993(97)00692-6; BUNNEY WE, 1965, ARCH GEN PSYCHIAT, V13, P483; BUNZOW JR, 1988, NATURE, V336, P783, DOI 10.1038/336783a0; Burn DJ, 2002, EUR J NEUROL, V9, P44, DOI 10.1046/j.1468-1331.9.s3.6.x; Cheema SK, 2003, J BIOL CHEM, V278, P19995, DOI 10.1074/jbc.M205865200; Chen ACH, 2001, BIOL PSYCHIAT, V49, P753, DOI 10.1016/S0006-3223(00)01114-8; COPPEN ALEC, 1967, BRIT J PSYCHIAT, V113, P1237, DOI 10.1192/bjp.113.504.1237; DECAMILLI P, 1979, NATURE, V278, P252, DOI 10.1038/278252a0; DELAY J, 1952, Ann Med Psychol (Paris), V110, P689; Diaz-Meco MT, 1999, J BIOL CHEM, V274, P19606, DOI 10.1074/jbc.274.28.19606; DiazMeco MT, 1996, CELL, V86, P777, DOI 10.1016/S0092-8674(00)80152-X; Dowlatshahi D, 1998, LANCET, V352, P1754, DOI 10.1016/S0140-6736(05)79827-5; Duan WZ, 1999, ANN NEUROL, V46, P587, DOI 10.1002/1531-8249(199910)46:4<587::AID-ANA6>3.0.CO;2-M; Duan WZ, 1999, J NEUROCHEM, V72, P2312, DOI 10.1046/j.1471-4159.1999.0722312.x; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; El Yacoubi M, 2003, P NATL ACAD SCI USA, V100, P6227, DOI 10.1073/pnas.1034823100; FISHBURN CS, 1995, J BIOL CHEM, V270, P29819; Fuller R W, 1995, Prog Drug Res, V45, P167; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GREENBERG PE, 1993, J CLIN PSYCHIAT, V54, P405; Guo Q, 1998, NAT MED, V4, P957, DOI 10.1038/nm0898-957; HERSCH SM, 1995, J NEUROSCI, V15, P5222; JARVIE KR, 1989, J BIOCHEM-TOKYO, V106, P17, DOI 10.1093/oxfordjournals.jbchem.a122809; Johnstone RW, 1996, MOL CELL BIOL, V16, P6945; Jones SR, 1998, J NEUROSCI, V18, P1979; KINNEY JL, 1985, CLIN PHARMACY, V4, P625; KUHN R, 1958, AM J PSYCHIAT, V115, P459, DOI 10.1176/ajp.115.5.459; Leonard B E, 1978, Acta Psychiatr Belg, V78, P770; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Maj J, 1996, EUR J PHARMACOL, V304, P49, DOI 10.1016/0014-2999(96)00123-9; Manier DH, 2002, J NEURAL TRANSM, V109, P91, DOI 10.1007/s702-002-8239-6; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Murer MG, 2002, CELL MOL NEUROBIOL, V22, P611, DOI 10.1023/A:1021840504342; Nader K, 1997, ANNU REV PSYCHOL, V48, P85, DOI 10.1146/annurev.psych.48.1.85; Nestler EJ, 2001, AM J ADDICTION, V10, P201, DOI 10.1080/105504901750532094; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Newton SS, 2002, J NEUROSCI, V22, P10883; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; Ouimet CC, 1998, BRAIN RES, V808, P8, DOI 10.1016/S0006-8993(98)00724-0; Pedersen WA, 2000, FASEB J, V14, P913, DOI 10.1096/fasebj.14.7.913; Pliakas AM, 2001, J NEUROSCI, V21, P7397, DOI 10.1523/JNEUROSCI.21-18-07397.2001; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SCHILDKRAUT JJ, 1965, J PSYCHIAT RES, V3, P213, DOI 10.1016/0022-3956(65)90003-8; Scott L, 2002, P NATL ACAD SCI USA, V99, P1661, DOI 10.1073/pnas.032654599; SELLS SF, 1994, CELL GROWTH DIFFER, V5, P457; SOKOLOFF P, 1992, EUR J PHARM-MOLEC PH, V225, P331, DOI 10.1016/0922-4106(92)90107-7; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Viggiano D, 2003, NEUROSCI BIOBEHAV R, V27, P623, DOI 10.1016/j.neubiorev.2003.08.006; Willner Paul, 1995, P921; Wong ML, 2001, NAT REV NEUROSCI, V2, P343, DOI 10.1038/35072566	60	104	115	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 29	2005	122	2					275	287		10.1016/j.cell.2005.05.031	http://dx.doi.org/10.1016/j.cell.2005.05.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	951CR	16051151	Bronze			2022-12-28	WOS:000230907000014
J	Waters, AP				Waters, AP			Plasmodium's sticky fingers	CELL			English	Editorial Material							FALCIPARUM; RECEPTOR; INVASION; EBA-175; ANTIBODIES; FAMILY; DOMAIN		Leiden Univ, Ctr Med, Ctr Infect Dis, Dept Parasitol,Malaria Grp, NL-2333 ZA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Waters, AP (corresponding author), Leiden Univ, Ctr Med, Ctr Infect Dis, Dept Parasitol,Malaria Grp, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.		Waters, Andy P/C-9377-2009	Waters, Andy P/0000-0001-8900-2982				Adams JH, 2001, TRENDS PARASITOL, V17, P297, DOI 10.1016/S1471-4922(01)01948-1; ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; CHOEN S, 1970, NATURE, V225, P732, DOI 10.1038/225732a0; Gaur D, 2004, INT J PARASITOL, V34, P1413, DOI 10.1016/j.ijpara.2004.10.010; Gilberger TW, 2003, J CELL BIOL, V162, P317, DOI 10.1083/jcb.200301046; Jakobsen PH, 1998, INFECT IMMUN, V66, P4203; Lobo CA, 2003, BLOOD, V101, P4628, DOI 10.1182/blood-2002-10-3076; Mayer DCG, 2004, P NATL ACAD SCI USA, V101, P2518, DOI 10.1073/pnas.0307318101; Narum DL, 2000, INFECT IMMUN, V68, P1964, DOI 10.1128/IAI.68.4.1964-1966.2000; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033	10	0	0	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 29	2005	122	2					149	151		10.1016/j.cell.2005.07.008	http://dx.doi.org/10.1016/j.cell.2005.07.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	951CR	16051139	Bronze			2022-12-28	WOS:000230907000002
J	Padma, TV				Padma, TV			Ayurveda	NATURE			English	Article																			0	29	29	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2005	436	7050					486	486		10.1038/436486a	http://dx.doi.org/10.1038/436486a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049472				2022-12-28	WOS:000230788800041
J	Horton, R				Horton, R			A dismal and dangerous verdict against Roy Meadow	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Horton, R (corresponding author), Lancet, London NW1 7BY, England.							CRAFT A, 2004, RCPCH NEWSLETTER AUT, P2; Kmietowicz Z, 2004, BRIT MED J, V328, P601, DOI 10.1136/bmj.328.7440.601; LAMING, 2003, VICTORIA CLIMBIE INQ, P284; Moore A, 2005, ARCH DIS CHILD, V90, P687, DOI 10.1136/adc.2004.068460; SMITH J, 2004, SHIPMAN INQUIRY; Ward L., 2005, GUARDIAN        0714, P9; 2005, TIMES LOND      0704, P22	7	7	7	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 23	2005	366	9482					277	278		10.1016/S0140-6736(05)66965-6	http://dx.doi.org/10.1016/S0140-6736(05)66965-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RJ	16039319				2022-12-28	WOS:000230733100010
J	Szocska, MK; Rethelyi, JM; Normand, C				Szocska, MK; Rethelyi, JM; Normand, C			Managing healthcare reform in Hungary: challenges and opportunities	BRITISH MEDICAL JOURNAL			English	Article									Semmelweis Univ, Hlth Serv Management Training Ctr, H-1125 Budapest, Hungary; Univ Dublin Trinity Coll, Fac Hlth Sci, Dublin 2, Ireland	Semmelweis University; Trinity College Dublin	Szocska, MK (corresponding author), Semmelweis Univ, Hlth Serv Management Training Ctr, Kutvolgyi Ut 2, H-1125 Budapest, Hungary.	szocska@emk.sote.hu		/0000-0003-0648-9778; Normand, Charles/0000-0002-0885-5754; Rethelyi, Janos/0000-0002-3641-012X				BEER M, 2000, HARVARD BUS REV, V47, P127; Healy J., 2001, Eurohealth, V7, P2; Lavis JN, 2004, LANCET, V364, P1615, DOI 10.1016/S0140-6736(04)17317-0; SZOCSKA M, 2004, SURVEY MOST FREQUENT; SZOCSKA M, 1999, SURVEY SENIOR HUNGAR; SZOCSKA MK, 2004, SURVEY CENTRAL E EUR	6	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 23	2005	331	7510					231	233		10.1136/bmj.331.7510.231	http://dx.doi.org/10.1136/bmj.331.7510.231			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951EA	16037469	Bronze, Green Published			2022-12-28	WOS:000230910700038
J	Dodd, AN; Salathia, N; Hall, A; Kevei, E; Toth, R; Nagy, F; Hibberd, JM; Millar, AJ; Webb, AAR				Dodd, AN; Salathia, N; Hall, A; Kevei, E; Toth, R; Nagy, F; Hibberd, JM; Millar, AJ; Webb, AAR			Plant circadian clocks increase photosynthesis, growth, survival, and competitive advantage	SCIENCE			English	Article							RECIPROCAL REGULATION; STOMATAL CONDUCTANCE; ELEVATED CO2; ARABIDOPSIS; TRANSCRIPTION; RHYTHMS; FITNESS; OSCILLATIONS; ASSIMILATION; RESPONSES	Circadian clocks are believed to confer an advantage to plants, but the nature of that advantage has been unknown. We show that a substantial photosynthetic advantage is conferred by correct matching of the circadian clock period with that of the external tight-dark cycle. In wild type and in long- and short-circadian period mutants of Arabidopsis thaliana, plants with a clock period matched to the environment contain more chlorophyll, fix more carbon, grow faster, and survive better than plants with circadian periods differing from their environment. This explains why plants gain advantage from circadian control.	Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; Hungarian Acad Sci, Biol Res Ctr, Inst Plant Biol, H-6701 Szeged, Hungary	University of Cambridge; University of Warwick; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Webb, AAR (corresponding author), Univ Cambridge, Dept Plant Sci, Downing St, Cambridge CB2 3EA, England.	alex.webb@plantsci.cam.ac.uk	Hall, Anthony/D-2844-2009; Jansen, Heiko T./A-5770-2008; Nagy, Ferenc/D-3532-2015; Millar, Andrew J/G-2423-2012; Kevei, Eva/J-4828-2016	Hall, Anthony/0000-0002-1806-020X; Jansen, Heiko T./0000-0003-0178-396X; Nagy, Ferenc/0000-0002-6157-9269; Millar, Andrew J/0000-0003-1756-3654; Kevei, Eva/0000-0002-0560-9208; Toth, Reka/0000-0003-4099-5359; Webb, Alex/0000-0003-0261-4375; Salathia, Neeraj/0000-0002-1235-2439	Biotechnology and Biological Sciences Research Council [P19207] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Arntz AM, 2000, ECOLOGY, V81, P2567, DOI 10.1890/0012-9658(2000)081[2567:FFTFVI]2.0.CO;2; Curtis PS, 1998, OECOLOGIA, V113, P299, DOI 10.1007/s004420050381; Dodd AN, 2004, NEW PHYTOL, V162, P63, DOI 10.1111/j.1469-8137.2004.01005.x; Green RM, 2002, PLANT PHYSIOL, V129, P576, DOI 10.1104/pp.004374; Griffiths H, 1999, PHYSIOLOGICAL PLANT ECOLOGY, P415; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hayama R, 2003, CURR OPIN PLANT BIOL, V6, P13, DOI 10.1016/S1369-5266(02)00011-0; HENNESSEY TL, 1991, PLANT PHYSIOL, V96, P831, DOI 10.1104/pp.96.3.831; HIGHKIN HR, 1954, PLANT PHYSIOL, V29, P301, DOI 10.1104/pp.29.3.301; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Michael TP, 2003, SCIENCE, V302, P1049, DOI 10.1126/science.1082971; Millar, 1998, BIOL RHYTHMS PHOTOPE, P1; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; MitchellOlds T, 1996, EVOLUTION, V50, P140, DOI 10.1111/j.1558-5646.1996.tb04480.x; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Prombona A, 2004, PLANT SCI, V167, P117, DOI 10.1016/j.plantsci.2004.03.006; Roden LC, 2002, P NATL ACAD SCI USA, V99, P13313, DOI 10.1073/pnas.192365599; SALATHIA N, UNPUB; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Somers DE, 2004, PLANT CELL, V16, P769, DOI 10.1105/tpc.016808; Somers DE, 1998, DEVELOPMENT, V125, P485; Wang ZY, 1997, PLANT CELL, V9, P491, DOI 10.1105/tpc.9.4.491; Ward JK, 2004, ECOL LETT, V7, P427, DOI 10.1111/j.1461-0248.2004.00589.x; WITHROW AP, 1949, PLANT PHYSIOL, V24, P657, DOI 10.1104/pp.24.4.657; Woelfle MA, 2004, CURR BIOL, V14, P1481, DOI 10.1016/j.cub.2004.08.023; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; Yanovsky MJ, 2001, CURR OPIN PLANT BIOL, V4, P429, DOI 10.1016/S1369-5266(00)00196-5; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	30	995	1048	10	358	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2005	309	5734					630	633		10.1126/science.1115581	http://dx.doi.org/10.1126/science.1115581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040710				2022-12-28	WOS:000230735200054
J	Ash, C; Jasny, BR				Ash, C; Jasny, BR			Trypanosomatid genomes - Introduction	SCIENCE			English	Editorial Material																			0	10	11	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2005	309	5733					399	400		10.1126/science.309.5733.399	http://dx.doi.org/10.1126/science.309.5733.399			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020722				2022-12-28	WOS:000230574900032
J	Gourine, AV; Llaudet, E; Dale, N; Spyer, KM				Gourine, AV; Llaudet, E; Dale, N; Spyer, KM			ATP is a mediator of chemosensory transduction in the central nervous system	NATURE			English	Article							P2X(2) RECEPTOR SUBUNIT; RESPIRATORY CONTROL; SENSORY NEURONS; PAIN; MICE; RELEASE; RAT	Extracellular signalling by the purine nucleotide ATP has long been associated with sensory function(1-8). In the periphery, ATP mediates nociception(3-5), mechanosensitivity(3,6), thermal sensitivity(7) and O-2 chemosensitivity(8). These processes share a common mechanism that involves the release of ATP to excite afferent fibres via activation of ionotropic P2X and/or metabotropic P2Y receptors. Chemosensors located in the brainstem are crucial for the maintenance of physiological levels of blood gases through the regulation of breathing(9-11). Here we show that an increase in p(CO 2) in the arterial blood triggers the immediate release of ATP from three chemosensitive regions located on the ventral surface of the medulla oblongata. Blockade of ATP receptors at these sites diminishes the chemosensory control of breathing, suggesting that ATP release constitutes a key step in central chemosensory transduction. These new data suggest that ATP, a phylogenetically ancient, unique and simple molecule, has been widely used in the evolution of afferent systems to mediate distinct forms of sensory transduction not only in the periphery but also within the central nervous system.	UCL Royal Free & UCL Med Sch, Dept Physiol, London NW3 2PF, England; Univ Warwick, Dept Biol Sci, Warwick Biosensor Grp, Coventry CV4 7AL, W Midlands, England	University of London; University College London; University of Warwick	Gourine, AV (corresponding author), UCL Royal Free & UCL Med Sch, Dept Physiol, Rowland Hill St, London NW3 2PF, England.	a.gourine@medsch.ucl.ac.uk	Dale, Nicholas/C-7772-2011	Dale, Nicholas/0000-0003-2196-2949; Llaudet, Enrique/0000-0003-1136-0602	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		CHEN CC, 1995, NATURE, V377, P428, DOI 10.1038/377428a0; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Cook SP, 2002, PAIN, V95, P41, DOI 10.1016/S0304-3959(01)00372-4; Cook SP, 1997, NATURE, V387, P505, DOI 10.1038/387505a0; Feldman JL, 2003, ANNU REV NEUROSCI, V26, P239, DOI 10.1146/annurev.neuro.26.041002.131103; Gourine AV, 2003, J PHYSIOL-LONDON, V552, P197, DOI 10.1113/jphysiol.2003.045294; Kawai A, 1996, J PHYSIOL-LONDON, V492, P277, DOI 10.1113/jphysiol.1996.sp021308; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; Llaudet E, 2005, ANAL CHEM, V77, P3267, DOI 10.1021/ac048106q; Llaudet E, 2003, BIOSENS BIOELECTRON, V18, P43, DOI 10.1016/S0956-5663(02)00106-9; LOESCHCKE HH, 1982, J PHYSIOL-LONDON, V332, P1; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; Richter DW, 2001, TRENDS NEUROSCI, V24, P464, DOI 10.1016/S0166-2236(00)01867-1; Rong WF, 2003, J NEUROSCI, V23, P11315; Souslova V, 2000, NATURE, V407, P1015, DOI 10.1038/35039526; Vlaskovska M, 2001, J NEUROSCI, V21, P5670, DOI 10.1523/JNEUROSCI.21-15-05670.2001	16	400	405	4	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					108	111		10.1038/nature03690	http://dx.doi.org/10.1038/nature03690			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001070				2022-12-28	WOS:000230296600048
J	Long, SB; Campbell, EB; MacKinnon, R				Long, SB; Campbell, EB; MacKinnon, R			Voltage sensor of kv1.2: Structural basis of electromechanical coupling	SCIENCE			English	Article							SHAKER K+ CHANNEL; POTASSIUM-CHANNEL; CHARGE MOVEMENT; GATING CHARGE; ION CHANNELS; S4 SEGMENT; ACTIVATION GATE; PORE DOMAIN; PERSPECTIVE; MEMBRANE	Voltage-dependent ion channels contain voltage sensors that allow them to switch between nonconductive and conductive states over the narrow range of a few hundredths of a volt. We investigated the mechanism by which these channels sense cell membrane voltage by determining the x-ray crystal structure of a mammalian Shaker family potassium ion (K+) channel. The voltage-dependent K+ channel Kv1.2 grew three-dimensional crystals, with an internal arrangement that left the voltage sensors in an apparently native conformation, allowing us to reach three important conclusions. First, the voltage sensors are essentially independent domains inside the membrane. Second, they perform mechanical work on the pore through the S4-S5 linker helices, which are positioned to constrict or dilate the S6 inner helices of the pore. Third, in the open conformation, two of the four conserved Arg residues on S4 are on a lipid-facing surface and two are buried in the voltage sensor. The structure offers a simple picture of how membrane voltage influences the open probability of the channel.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.	mackinn@rockefeller.edu			NIGMS NIH HHS [GM43949] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bezanilla F, 2002, J GEN PHYSIOL, V120, P465, DOI 10.1085/jgp.20028660; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; Elinder F, 2001, BIOPHYS J, V80, P1802, DOI 10.1016/S0006-3495(01)76150-4; Elliott DJS, 2004, EMBO J, V23, P4717, DOI 10.1038/sj.emboj.7600484; Gandhi CS, 2003, NEURON, V40, P515, DOI 10.1016/S0896-6273(03)00646-9; Gandhi CS, 2002, J GEN PHYSIOL, V120, P455, DOI 10.1085/jgp.20028678; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Gonzalez C, 2005, P NATL ACAD SCI USA, V102, P5020, DOI 10.1073/pnas.0501051102; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; Hessa T, 2005, SCIENCE, V307, P1427, DOI 10.1126/science.1109176; Horn R, 2002, J GEN PHYSIOL, V120, P449, DOI 10.1085/jgp.20028658; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Laine M, 2004, FEBS LETT, V564, P257, DOI 10.1016/S0014-5793(04)00273-X; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Lee HC, 2003, NEURON, V40, P527, DOI 10.1016/S0896-6273(03)00636-6; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; MacKinnon R, 2004, SCIENCE, V306, P1304, DOI 10.1126/science.1105528; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; RUTA V, 2005, THESIS ROCKEFELLER U; Schoppa NE, 1998, J GEN PHYSIOL, V111, P295, DOI 10.1085/jgp.111.2.295; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Sukhareva M, 2003, J GEN PHYSIOL, V122, P541, DOI 10.1085/jgp.200308905; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253	43	769	782	2	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2005	309	5736					903	908		10.1126/science.1116270	http://dx.doi.org/10.1126/science.1116270			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953SS	16002579				2022-12-28	WOS:000231101400037
J	Fink, JN				Fink, JN			Underdiagnosis of right-brain stroke	LANCET			English	Editorial Material							WARNING SIGNS; HEMISPHERE; KNOWLEDGE		Christchurch Hosp, Acute Stroke Unit, Christchurch 8001, New Zealand; Christchurch Sch Med & Hlth Sci, Dept Med, Christchurch 8001, New Zealand	Christchurch Hospital New Zealand; University of Otago	Fink, JN (corresponding author), Christchurch Hosp, Acute Stroke Unit, Christchurch 8001, New Zealand.	john.fink@chmeds.ac.nz						*AM STROK ASS, 2005, HEART DIS STROK STAT; Fink JN, 2002, STROKE, V33, P954, DOI 10.1161/01.STR.0000013069.24300.1D; Foerch C, 2005, LANCET, V366, P392, DOI 10.1016/S0140-6736(05)67024-9; LIBMAN RB, 1995, ARCH NEUROL-CHICAGO, V52, P1119, DOI 10.1001/archneur.1995.00540350113023; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Schneider AT, 2003, JAMA-J AM MED ASSOC, V289, P343, DOI 10.1001/jama.289.3.343; Silver FL, 2003, STROKE, V34, P1965, DOI 10.1161/01.STR.0000083175.01126.62; *STROK UN TRIAL CO, 2002, COCHRANE DB SYST REV, V1; Warach S, 2004, NEUROLOGY, V62, P359, DOI 10.1212/WNL.62.3.359; Ween JE, 1996, NEUROLOGY, V47, P388, DOI 10.1212/WNL.47.2.388; Woo D, 1999, STROKE, V30, P2355, DOI 10.1161/01.STR.30.11.2355; Yoon SS, 2001, STROKE, V32, P1926, DOI 10.1161/01.STR.32.8.1926	12	16	16	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2005	366	9483					349	351		10.1016/S0140-6736(05)67004-3	http://dx.doi.org/10.1016/S0140-6736(05)67004-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	950IB	16054924				2022-12-28	WOS:000230849700007
J	Kapadia, S				Kapadia, S			Spot diagnosis or misdiagnosis?	LANCET			English	Editorial Material									Sir Ganga Ram Hosp, Dept Vasc Surg, New Delhi, India		Kapadia, S (corresponding author), Sir Ganga Ram Hosp, Dept Vasc Surg, New Delhi, India.	drsumit_k@rediffmaff.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2005	366	9483					425	425		10.1016/S0140-6736(05)67026-2	http://dx.doi.org/10.1016/S0140-6736(05)67026-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	950IB	16054944				2022-12-28	WOS:000230849700031
J	Mann, J				Mann, J			The Indo-Mediterranean diet revisited	LANCET			English	Editorial Material							DISEASE		Univ Otago, Dept Human Nutr, Dunedin, New Zealand; Univ Otago, Dept Med, Dunedin, New Zealand	University of Otago; University of Otago	Mann, J (corresponding author), Univ Otago, Dept Human Nutr, Dunedin, New Zealand.	jim.mann@stonebow.otago.ac.nz						Berry EM, 2005, LANCET, V366, P366, DOI 10.1016/S0140-6736(05)67015-8; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; DELORGERIL M, 1994, LANCET, V343, P1454, DOI 10.1016/S0140-6736(94)92580-1; Singh RB, 2002, LANCET, V360, P1455, DOI 10.1016/S0140-6736(02)11472-3; Soman CR, 2005, LANCET, V366, P365, DOI 10.1016/S0140-6736(05)67014-6; Trichopoulou A, 2005, BMJ-BRIT MED J, V330, P991, DOI 10.1136/bmj.38415.644155.8F	6	12	12	1	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 30	2005	366	9483					353	354		10.1016/S0140-6736(05)67005-5	http://dx.doi.org/10.1016/S0140-6736(05)67005-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	950IB	16054926				2022-12-28	WOS:000230849700009
J	Tubman, M; Majumdar, SR; Lee, D; Friesen, C; Klassen, TP				Tubman, M; Majumdar, SR; Lee, D; Friesen, C; Klassen, TP			Best practices for safe handling of products containing concentrated potassium	BMJ-BRITISH MEDICAL JOURNAL			English	Review									Alberta Res Ctr Child Hlth Evidence, Edmonton, AB T6G 2J3, Canada; Univ Alberta, Dept Med, Walter C Mackenzie Hlth Sci Ctr, Edmonton, AB T6G 2B7, Canada	University of Alberta	Klassen, TP (corresponding author), Alberta Res Ctr Child Hlth Evidence, Room 9419 4th Floor,Aberhart Ctr 1,11402 Univ Ave, Edmonton, AB T6G 2J3, Canada.	terry.klassen@ualberta.ca		Klassen, Terry/0000-0002-5309-7091; Friesen, Carol/0000-0001-6437-9126				[Anonymous], 2001, INT J QUAL HEALTH C, V13, P339; Bates DW, 1998, JAMA-J AM MED ASSOC, V279, P1216, DOI 10.1001/jama.279.15.1216; Bates DW, 1999, J AM MED INFORM ASSN, V6, P313, DOI 10.1136/jamia.1999.00660313; COHEN MR, 1997, HOSP PHARM, V32, P998; *HLTH QUAL CONTR A, 2002, REV BEST PRACT HANDL; *I SAF MED, 2004, PRACT MED SAF AL ISM; *I SAF MED PRACT C, 2004, ISMP CAN SAF B, P4; Kohn L.T., 2000, TO ERR IS HUMAN BUIL; Leape LL, 2002, JAMA-J AM MED ASSOC, V288, P501, DOI 10.1001/jama.288.4.501; *MASS COAL PREV ME, MHA BEST PRACT REC R; Miller LK, 2001, COMPENDIUM SUGGESTED; *NAT PAT SAF AG, 2002, PAT SAF AL; Newman TB, 2003, BRIT MED J, V327, P1424, DOI 10.1136/bmj.327.7429.1424; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; *SAF QUAL COUNC AU, 2003, MED AL INTR POT CHLO; SHOJANIA K, 2001, AHRQ PUBLICATION; Smith J., 2004, BUILDING SAFER NHS P; *WISC PAT SAF I IN, 2002, MAX PAT SAF MED USE; 2004, MED ALERT POTASSIUM	19	14	18	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2005	331	7511					274	277		10.1136/bmj.331.7511.274	http://dx.doi.org/10.1136/bmj.331.7511.274			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953FJ	16052020	Green Published			2022-12-28	WOS:000231061700021
J	White, C				White, C			Suspected research fraud: difficulties of getting at the truth	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; INDIAN EXPERIMENT; MEDITERRANEAN DIET; CHOLESTEROL LEVELS; CONTROLLED TRIAL; ADDING FRUITS; PRUDENT DIET; RISK-FACTORS; POPULATIONS					cwhite@bmjgroup.com						Al-Marzouki S, 2005, BMJ-BRIT MED J, V331, P267, DOI 10.1136/bmj.331.7511.267; Hu FB, 2003, NEW ENGL J MED, V348, P2595, DOI 10.1056/NEJMp030069; HUTH EJ, 1988, BRIT MED J, V296, P400; LOCK S, 1993, FRAUD MISCONDUCT BIO; Ramos EJB, 2005, NUTRITION, V21, P269, DOI 10.1016/j.nut.2004.06.021; RICE RD, 1998, BRIT MED J, V317, P1152; SINGH RB, 1992, BRIT MED J, V304, P1015, DOI 10.1136/bmj.304.6833.1015; Singh RB, 1997, CARDIOVASC DRUG THER, V11, P485, DOI 10.1023/A:1007757724505; SINGH RB, 1992, AM J CARDIOL, V69, P879, DOI 10.1016/0002-9149(92)90786-X; SINGH RB, 1994, CARDIOVASC DRUG THER, V8, P659, DOI 10.1007/BF00877420; SINGH RB, 1991, NUTRITION, V7, P125; Singh RB, 1999, INT J CARDIOL, V69, P139, DOI 10.1016/S0167-5273(99)00010-8; SINGH RB, 1991, NUTRITION, V7, P210; SINGH RB, 1992, CARDIOLOGY, V80, P283, DOI 10.1159/000175014; SINGH RB, 1995, INT J CARDIOL, V47, P245, DOI 10.1016/0167-5273(94)02186-M; SINGH RB, 1990, NUTRITION, V6, P297; Singh RB, 1998, INT J CARDIOL, V65, P81, DOI 10.1016/S0167-5273(98)00099-0; SINGH RB, 1992, AM J CARDIOL, V70, P869, DOI 10.1016/0002-9149(92)90729-I; SINGH RB, 1992, AM J CARDIOL, V70, P1287, DOI 10.1016/0002-9149(92)90763-O; Singh RB, 2002, LANCET, V360, P1455, DOI 10.1016/S0140-6736(02)11472-3; SINGH RB, 1993, J AM COLL NUTR, V12, P255; Singh RB, 1996, MAGNESIUM RES, V9, P299; Smith R, 2005, BMJ-BRIT MED J, V331, P288, DOI 10.1136/bmj.331.7511.288; Soman CR, 2000, INT J CARDIOL, V74, P243, DOI 10.1016/S0167-5273(00)00280-1	24	87	90	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2005	331	7511					281	288		10.1136/bmj.331.7511.281	http://dx.doi.org/10.1136/bmj.331.7511.281			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953FJ	16052022	Green Published			2022-12-28	WOS:000231061700023
J	Beaulieu, JM; Sotnikova, TD; Marion, S; Lefkowitz, RJ; Gainetdinov, RR; Caron, MG				Beaulieu, JM; Sotnikova, TD; Marion, S; Lefkowitz, RJ; Gainetdinov, RR; Caron, MG			An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior	CELL			English	Article							PROTEIN-KINASE-B; BETA-ARRESTIN; REWARDING PROPERTIES; SYNTHASE KINASE-3; PHOSPHATASE 2A; MICE LACKING; RECEPTOR; ACTIVATION; PHOSPHORYLATION; COCAINE	Dopamine plays an important role in the etiology of schizophrenia, and D2 class dopamine receptors are the best-established target of antipsychotic drugs. Here we show that D2 class-receptor-mediated Akt regulation involves the formation of signaling complexes containing beta-arrestin 2, PP2A, and Akt. beta-arrestin 2 deficiency in mice results in reduction of dopamine-dependent behaviors, loss of Akt regulation by dopamine in the striatum, and disruption of the dopamine-dependent interaction of Akt with its negative regulator, protein phosphatase 2A. Importantly, canonical cAMP-mediated dopamine-receptor signaling is not inhibited in the absence of beta-arrestin 2. These results demonstrate that, apart from its classical function in receptor desensitization, beta-arrestin 2 also acts as a signaling intermediate through a kinase/phosphatase scaffold. Furthermore, this function of beta-arrestin 2 is important for the expression of dopamine-associated behaviors, thus implicating beta-arrestin 2 as a positive mediator of dopaminergic synaptic transmission and a potential pharmacological target for dopamine-related psychiatric disorders.	Duke Univ, Med Ctr, Inst Genome Sci & Policy, Ctr Model Human Dis,Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute	Caron, MG (corresponding author), Duke Univ, Med Ctr, Inst Genome Sci & Policy, Ctr Model Human Dis,Dept Cell Biol, Durham, NC 27710 USA.	caron002@mc.duke.edu	Beaulieu, Jean-Martin/A-7598-2008; soler, martha maricel m gomez/L-6025-2014; Gainetdinov, Raul R/G-5875-2011; Lefkowitz, Robert/AAW-2649-2021; Sotnikova, Tatyana D/T-9992-2017	Beaulieu, Jean-Martin/0000-0002-0446-7447; soler, martha maricel m gomez/0000-0002-4412-8108; Gainetdinov, Raul R/0000-0003-2951-6038; Marion, Sebastien/0000-0002-3302-3845	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH040159, P30MH040159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013511] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-13511] Funding Source: Medline; NIMH NIH HHS [MH-40159] Funding Source: Medline; NINDS NIH HHS [NS-19576] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Bohn LM, 2003, J NEUROSCI, V23, P10265; Brami-Cherrier K, 2002, J NEUROSCI, V22, P8911; Carlsson A, 2001, SCIENCE, V294, P1021, DOI 10.1126/science.1066969; Chalecka-Franaszek E, 1999, P NATL ACAD SCI USA, V96, P8745, DOI 10.1073/pnas.96.15.8745; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cyr M, 2003, P NATL ACAD SCI USA, V100, P11035, DOI 10.1073/pnas.1831768100; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Fienberg AA, 1998, SCIENCE, V281, P838, DOI 10.1126/science.281.5378.838; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Gainetdinov RR, 2003, NEURON, V38, P291, DOI 10.1016/S0896-6273(03)00192-2; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Goel R, 2002, J BIOL CHEM, V277, P18640, DOI 10.1074/jbc.M108995200; Gould TD, 2004, INT J NEUROPSYCHOPH, V7, P387, DOI 10.1017/S1461145704004535; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Ikeda M, 2004, BIOL PSYCHIAT, V56, P698, DOI 10.1016/j.biopsych.2004.07.023; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; JESSELL TM, 1993, CELL, V72, P1, DOI 10.1016/S0092-8674(05)80025-X; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Kang UG, 2004, FEBS LETT, V560, P115, DOI 10.1016/S0014-5793(04)00082-1; Krupnick JG, 1997, J BIOL CHEM, V272, P15011, DOI 10.1074/jbc.272.23.15011; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Li LK, 2003, MOL CELL BIOL, V23, P9389, DOI 10.1128/MCB.23.24.9389-9404.2003; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; McCluskey Adam, 2001, Mini-Reviews in Medicinal Chemistry, V1, P43, DOI 10.2174/1389557013407205; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nair VD, 2003, J BIOL CHEM, V278, P47053, DOI 10.1074/jbc.M303364200; Nally RE, 2003, NEUROPSYCHOPHARMACOL, V28, P2055, DOI 10.1038/sj.npp.1300259; Nishi A, 1997, J NEUROSCI, V17, P8147; Povsic TJ, 2003, J BIOL CHEM, V278, P51334, DOI 10.1074/jbc.M309968200; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; SNYDER SH, 1976, AM J PSYCHIAT, V133, P197; Ugi S, 2004, MOL CELL BIOL, V24, P8778, DOI 10.1128/MCB.24.19.8778-8789.2004; UNWIN N, 1993, CELL, V72, P31, DOI 10.1016/S0092-8674(05)80026-1; Valjent E, 2000, J NEUROSCI, V20, P8701; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; Wang YM, 1997, NEURON, V19, P1285, DOI 10.1016/S0896-6273(00)80419-5; WILCOX RE, 1980, PHARMACOL BIOCHEM BE, V12, P29, DOI 10.1016/0091-3057(80)90411-6; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	51	767	796	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 29	2005	122	2					261	273		10.1016/j.cell.2005.05.012	http://dx.doi.org/10.1016/j.cell.2005.05.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	951CR	16051150	Bronze			2022-12-28	WOS:000230907000013
J	Avinun-Kalish, M; Heiblum, M; Zarchin, O; Mahalu, D; Umansky, V				Avinun-Kalish, M; Heiblum, M; Zarchin, O; Mahalu, D; Umansky, V			Crossover from 'mesoscopic' to 'universal' phase for electron transmission in quantum dots	NATURE			English	Article							SCATTERING	The measurement of phase in coherent electron systems-that is, 'mesoscopic' systems such as quantum dots-can yield information about fundamental transport properties that is not readily apparent from conductance measurements. Phase measurements on relatively large quantum dots(1) recently revealed that the phase evolution for electrons traversing the dots exhibits a 'universal' behaviour, independent of dot size, shape, and electron occupancy(2,3). Specifically, for quantum dots in the Coulomb blockade regime, the transmission phase increases monotonically by pi throughout each conductance peak; in the conductance valleys, the phase returns sharply to its starting value. The expected mesoscopic features in the phase evolution-related to the dot's shape, spin degeneracy or to exchange effects-have not been observed, and there is at present no satisfactory explanation for the observed universality in phase behaviour(4). Here we report the results of phase measurements on a series of small quantum dots, having occupancies of between only 1-20 electrons, where the phase behaviour for electron transmission should in principle be easier to interpret. In contrast to the universal behaviour observed thus far only in the larger dots, we see clear mesoscopic features in the phase measurements when the dot occupancy is less than similar to 10 electrons. As the occupancy increases, the manner of phase evolution changes and universal behaviour is recovered for some 14 electrons or more. The identification of a transition from the expected mesoscopic behaviour to universal phase evolution should help to direct and constrain theoretical models for the latter.	Weizmann Inst Sci, Braun Ctr Submicron Res, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Heiblum, M (corresponding author), Weizmann Inst Sci, Braun Ctr Submicron Res, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel.	heiblum@wisemail.weizmann.ac.il	Umansky, Vladimir/P-1334-2019; heiblum, moty/Q-1193-2019	Umansky, Vladimir/0000-0001-5727-2064; 				AHARONOV Y, 1959, PHYS REV, V115, P485, DOI 10.1103/PhysRev.115.485; Aharony A, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.115311; ARONOV AG, 1987, REV MOD PHYS, V59, P755, DOI 10.1103/RevModPhys.59.755; Ashcroft N., 1976, SOLID STATE PHYS; Breit G, 1936, PHYS REV, V49, P0519, DOI 10.1103/PhysRev.49.519; BUTTIKER M, 1986, PHYS REV LETT, V57, P1761, DOI 10.1103/PhysRevLett.57.1761; Entin-Wohlman O, 2002, J LOW TEMP PHYS, V126, P1251, DOI 10.1023/A:1013887801723; FIELD M, 1993, PHYS REV LETT, V70, P1311, DOI 10.1103/PhysRevLett.70.1311; Hackenbroich G, 1996, PHYS REV LETT, V76, P110, DOI 10.1103/PhysRevLett.76.110; Hackenbroich G, 2001, PHYS REP, V343, P464, DOI 10.1016/S0370-1573(00)00084-3; Ji Y, 2000, SCIENCE, V290, P779, DOI 10.1126/science.290.5492.779; Kouwenhoven LP, 1998, PHYSICA B, V249, P191, DOI 10.1016/S0921-4526(98)00096-9; KYRIAKIDIS J, 2004, PHYS REV LETT, V93; Lee HW, 1999, PHYS REV LETT, V82, P2358, DOI 10.1103/PhysRevLett.82.2358; Oreg Y, 1997, PHYS REV B, V55, P13726, DOI 10.1103/PhysRevB.55.13726; OREG Y, 2002, NANOPHYSICS BIOELECT, pCH5; Schuster R, 1997, NATURE, V385, P417, DOI 10.1038/385417a0; Silva A, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.195316; Silvestrov PG, 2000, PHYS REV LETT, V85, P2565, DOI 10.1103/PhysRevLett.85.2565; Silvestrov PG, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.035309; Sprinzak D, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.176805; Weidenmuller HA, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.245322; Yacoby A, 1996, PHYS REV B, V53, P9583, DOI 10.1103/PhysRevB.53.9583; Yeyati AL, 2000, PHYS REV B, V62, P7307, DOI 10.1103/PhysRevB.62.7307; ZUMBUHL DM, 2002, PHYS REV B, V66	26	140	142	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					529	533		10.1038/nature03899	http://dx.doi.org/10.1038/nature03899			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049482	Green Submitted			2022-12-28	WOS:000230788800055
J	Buchanan, JDR; Cowburn, RP; Jausovec, AV; Petit, D; Seem, P; Xiong, G; Atkinson, D; Fenton, K; Allwood, DA; Bryan, MT				Buchanan, JDR; Cowburn, RP; Jausovec, AV; Petit, D; Seem, P; Xiong, G; Atkinson, D; Fenton, K; Allwood, DA; Bryan, MT			Fingerprinting' documents and packaging	NATURE			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London SW7 2BW, England; Univ Durham, Dept Phys, Durham DH1 3LE, England; Univ Sheffield, Dept Mat Engn, Sheffield S1 3JD, S Yorkshire, England	Imperial College London; Durham University; University of Sheffield	Buchanan, JDR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London SW7 2BW, England.	r.cowburn@imperial.ac.uk	Cowburn, Russell/D-5820-2015	Cowburn, Russell/0000-0003-0867-8900; Atkinson, Del/0000-0002-9438-7407				Briers JD, 1999, J BIOMED OPT, V4, P164, DOI 10.1117/1.429903; GOODMAN JW, 1984, TOPICS APPL PHYS LAS, V9; INDECK RS, 1993, IEEE T MAGN, V29, P4095, DOI 10.1109/20.281401; Leonard LC, 1998, OPT LASER ENG, V30, P433, DOI 10.1016/S0143-8166(98)00036-0; Pappu R, 2002, SCIENCE, V297, P2026, DOI 10.1126/science.1074376; Seo YB, 1999, J PULP PAP SCI, V25, P321; Sjodahl M, 2004, OPT LASER ENG, V42, P193, DOI 10.1016/j.optlaseng.2003.08.004; Smith J. R., 1999, P 2 WORKSH AUT ID AD, P79; van Renesse R. L., 1995, European Convention on Security and Detection (Conf. Publ. No.408), P45, DOI 10.1049/cp:19950467	9	144	175	3	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					475	475		10.1038/436475a	http://dx.doi.org/10.1038/436475a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049465				2022-12-28	WOS:000230788800032
J	Sengupta, S; Eavarone, D; Capila, I; Zhao, GL; Watson, N; Kiziltepe, T; Sasisekharan, R				Sengupta, S; Eavarone, D; Capila, I; Zhao, GL; Watson, N; Kiziltepe, T; Sasisekharan, R			Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system	NATURE			English	Article							ANGIOGENESIS INHIBITORS; ANTIANGIOGENIC THERAPY; HYPOXIA; VASCULATURE; GROWTH	In the continuing search for effective treatments for cancer, the emerging model is the combination of traditional chemotherapy with anti-angiogenesis agents(1) that inhibit blood vessel growth. However, the implementation of this strategy has faced two major obstacles. First, the long-term shutdown of tumour blood vessels by the anti-angiogenesis agent can prevent the tumour from receiving a therapeutic concentration of the chemotherapy agent. Second, inhibiting blood supply drives the intra-tumoural accumulation of hypoxia-inducible factor-1 alpha (HIF1-alpha); overexpression of HIF1-alpha is correlated with increased tumour invasiveness and resistance to chemotherapy(2-5). Here we report the disease-driven engineering of a drug delivery system, a 'nanocell', which overcomes these barriers unique to solid tumours. The nanocell comprises a nuclear nanoparticle within an extranuclear pegylated-lipid envelope, and is preferentially taken up by the tumour. The nanocell enables a temporal release of two drugs: the outer envelope first releases an anti-angiogenesis agent, causing a vascular shutdown; the inner nanoparticle, which is trapped inside the tumour, then releases a chemotherapy agent. This focal release within a tumour results in improved therapeutic index with reduced toxicity. The technology can be extended to additional agents, so as to target multiple signalling pathways or distinct tumour compartments, enabling the model of an 'integrative' approach in cancer therapy.	MIT, Biol Engn Div, Cambridge, MA 02139 USA; MIT, Dept Chem, Cambridge, MA 02139 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Sasisekharan, R (corresponding author), MIT, Biol Engn Div, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rams@MIT.edu						Allen TM, 2002, NAT REV CANCER, V2, P750, DOI 10.1038/nrc903; Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121; Blagosklonny MV, 2004, CANCER CELL, V5, P13, DOI 10.1016/S1535-6108(03)00336-2; Chabner B.A, 1996, GOODMAN GILMANS PHAR; Hanahan D, 2000, J CLIN INVEST, V105, P1045, DOI 10.1172/JCI9872; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Kieran MW, 2003, NAT MED, V9, P1104, DOI 10.1038/nm0903-1104a; MIKLOS AG, 1994, BIOMATERIALS, V15, P55; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Rofstad EK, 2002, CANCER RES, V62, P1847; Semenza GL, 2000, J CLIN INVEST, V106, P809, DOI 10.1172/JCI11223; Sengupta S, 2004, FASEB J, V18, P1565, DOI 10.1096/fj.04-1934fje; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Tozer GM, 2002, INT J EXP PATHOL, V83, P21, DOI 10.1046/j.1365-2613.2002.00211.x; Tran J, 2002, P NATL ACAD SCI USA, V99, P4349, DOI 10.1073/pnas.072586399; Yoo HS, 1999, PHARMACEUT RES, V16, P1114, DOI 10.1023/A:1018908421434; Yu JL, 2002, SCIENCE, V295, P1526, DOI 10.1126/science.1068327; YUAN F, 1995, CANCER RES, V55, P3752	21	762	813	8	342	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					568	572		10.1038/nature03794	http://dx.doi.org/10.1038/nature03794			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049491				2022-12-28	WOS:000230788800064
J	Egues, JC				Egues, JC			Fingerprinting spin qubits	SCIENCE			English	Editorial Material							QUANTUM COMPUTATION; ELECTRON-SPIN; INJECTION		Univ Sao Paulo, Inst Phys Sao Carlos, Dept Phys & Informat, BR-13560970 Sao Carlos, SP, Brazil	Universidade de Sao Paulo	Egues, JC (corresponding author), Univ Sao Paulo, Inst Phys Sao Carlos, Dept Phys & Informat, BR-13560970 Sao Carlos, SP, Brazil.	egues@if.sc.usp.br	Egues, Jose Carlos/I-5791-2012	Egues, Jose Carlos/0000-0003-0856-3599				Awschalom DD, 2002, NANOSCI TECHNOL, P147; Beenakker CWJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.020501; Cerletti V, 2005, NANOTECHNOLOGY, V16, pR27, DOI 10.1088/0957-4484/16/4/R01; Egues JC, 1998, PHYS REV LETT, V80, P4578, DOI 10.1103/PhysRevLett.80.4578; Elzerman JM, 2004, NATURE, V430, P431, DOI 10.1039/nature02693; Elzerman JM, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.161308; Engel HA, 2005, SCIENCE, V309, P586, DOI 10.1126/science.1113203; Fiederling R, 1999, NATURE, V402, P787, DOI 10.1038/45502; FIELD M, 1993, PHYS REV LETT, V70, P1311, DOI 10.1103/PhysRevLett.70.1311; Folk JA, 2003, SCIENCE, V299, P679, DOI 10.1126/science.1078419; Hayashi T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.226804; Kikkawa JM, 1999, NATURE, V397, P139, DOI 10.1038/16420; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Kroutvar M, 2004, NATURE, V432, P81, DOI 10.1038/nature03008; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Ohno Y, 1999, NATURE, V402, P790, DOI 10.1038/45509	18	5	5	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2005	309	5734					565	567		10.1126/science.1115256	http://dx.doi.org/10.1126/science.1115256			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040695				2022-12-28	WOS:000230735200033
J	Lin, JF; Struzhkin, VV; Jacobsen, SD; Hu, MY; Chow, P; Kung, J; Liu, HZ; Mao, HK; Hemley, RJ				Lin, JF; Struzhkin, VV; Jacobsen, SD; Hu, MY; Chow, P; Kung, J; Liu, HZ; Mao, HK; Hemley, RJ			Spin transition of iron in magnesiowustite in the Earth's lower mantle	NATURE			English	Article							POST-PEROVSKITE PHASE; EQUATION-OF-STATE; THERMODYNAMIC PARAMETERS; SILICATE PEROVSKITE; HIGH-PRESSURE; TEMPERATURE; HETEROGENEITY; OXIDES	Iron is the most abundant transition-metal element in the mantle and therefore plays an important role in the geochemistry and geodynamics of the Earth's interior(1-11). Pressure-induced electronic spin transitions of iron occur in magnesiowustite, silicate perovskite and post-perovskite(1-4,8,10,11). Here we have studied the spin states of iron in magnesiowustite and the isolated effects of the electronic transitions on the elasticity of magnesiowustite with in situ X-ray emission spectroscopy and X-ray diffraction to pressures of the lowermost mantle. An observed high-spin to low-spin transition of iron in magnesiowustite results in an abnormal compressional behaviour between the high-spin and the low-spin states. The high-pressure, low-spin state exhibits a much higher bulk modulus and bulk sound velocity than the low-pressure, high-spin state; the bulk modulus jumps by similar to 35 per cent and bulk sound velocity increases by similar to 15 per cent across the transition in (Mg-0.83, Fe-0.17) O. Although no significant density change is observed across the electronic transition, the jump in the sound velocities and the bulk modulus across the transition provides an additional explanation for the seismic wave heterogeneity in the lowermost mantle(12-21). The transition also affects current interpretations of the geophysical and geochemical models using extrapolated or calculated thermal equation-of-state data without considering the effects of the electronic transition(5,6,22,23).	Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; Carnegie Inst Sci, HPCAT, Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; SUNY Stony Brook, Inst Mineral Phys, Stony Brook, NY 11794 USA	Carnegie Institution for Science; Carnegie Institution for Science; United States Department of Energy (DOE); Argonne National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Lin, JF (corresponding author), Lawrence Livermore Natl Lab, 7000 East Ave, Livermore, CA 94550 USA.	j.lin@gl.ciw.edu	Lin, Jung-Fu/B-4917-2011; Hu, Michael Y./C-7571-2013; Jacobsen, Steven/F-3443-2013; Liu, Haozhe/A-9462-2009; Struzhkin, Viktor V/J-9847-2013; Liu, Haozhe/E-6169-2011	Lin, Jung-Fu/0000-0002-0163-5329; Hu, Michael Y./0000-0002-3718-7169; Jacobsen, Steven/0000-0002-9746-958X; Liu, Haozhe/0000-0001-5720-2031; Struzhkin, Viktor V/0000-0002-3468-0548; 				Andrault D, 2001, J GEOPHYS RES-SOL EA, V106, P2079, DOI 10.1029/2000JB900362; Badro J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.205504; Badro J, 2003, SCIENCE, V300, P789, DOI 10.1126/science.1081311; Badro J, 2004, SCIENCE, V305, P383, DOI 10.1126/science.1098840; BIRCH F, 1986, J GEOPHYS RES-SOLID, V91, P4949, DOI 10.1029/JB091iB05p04949; BROWN JM, 1981, GEOPHYS J ROY ASTR S, V66, P579, DOI 10.1111/j.1365-246X.1981.tb04891.x; Burns RG., 1993, MINERALOGICAL APPL C, P7, DOI [10.1017/CBO9780511524899, DOI 10.1017/CBO9780511524899]; Cohen RE, 1997, SCIENCE, V275, P654, DOI 10.1126/science.275.5300.654; Garnero EJ, 2000, ANNU REV EARTH PL SC, V28, P509, DOI 10.1146/annurev.earth.28.1.509; HOLMES NC, 1989, J APPL PHYS, V66, P2962, DOI 10.1063/1.344177; Jackson I, 1998, GEOPHYS J INT, V134, P291, DOI 10.1046/j.1365-246x.1998.00560.x; Jacobsen SD, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000490; Karato S, 2001, J GEOPHYS RES-SOL EA, V106, P21771, DOI 10.1029/2001JB000214; Kellogg LH, 1999, SCIENCE, V283, P1881, DOI 10.1126/science.283.5409.1881; Kesson SE, 2002, PHYS EARTH PLANET IN, V131, P295, DOI 10.1016/S0031-9201(02)00063-8; Lay T, 2004, PHYS EARTH PLANET IN, V146, P441, DOI 10.1016/j.pepi.2004.04.004; Li J, 2004, P NATL ACAD SCI USA, V101, P14027, DOI 10.1073/pnas.0405804101; Lin JF, 2003, P NATL ACAD SCI USA, V100, P4405, DOI 10.1073/pnas.252782399; Mao HK, 1997, SCIENCE, V278, P2098, DOI 10.1126/science.278.5346.2098; Masters G., 2000, EARTHS DEEP INTERIOR, V117, P63, DOI DOI 10.1029/GM117P0063; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; Oganov AR, 2004, NATURE, V430, P445, DOI 10.1038/nature02701; SHANNON RD, 1969, ACTA CRYSTALL B-STRU, VB 25, P925, DOI 10.1107/S0567740869003220; Sherman D. M., 1988, STRUCTURAL MAGNETIC, P113; SHERMAN DM, 1995, GEOPHYS RES LETT, V22, P1001, DOI 10.1029/94GL03010; SHERMAN DM, 1991, J GEOPHYS RES-SOLID, V96, P14299, DOI 10.1029/91JB01202; Speziale S, 2001, J GEOPHYS RES-SOL EA, V106, P515, DOI 10.1029/2000JB900318; Stacey FD, 2001, GEOPHYS J INT, V146, P143, DOI 10.1046/j.1365-246X.2001.00437.x; Su WJ, 1997, PHYS EARTH PLANET IN, V100, P135, DOI 10.1016/S0031-9201(96)03236-0; Tsuchiya T, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020278; van der Hilst RD, 1999, SCIENCE, V283, P1885, DOI 10.1126/science.283.5409.1885; VINET P, 1987, J GEOPHYS RES-SOLID, V92, P9319, DOI 10.1029/JB092iB09p09319	32	272	284	0	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					377	380		10.1038/nature03825	http://dx.doi.org/10.1038/nature03825			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034415				2022-12-28	WOS:000230623400039
J	Luby, SP; Agboatwalla, M; Feikin, DR; Painter, J; Billhimer, W; Altaf, A; Hoekstra, RM				Luby, SP; Agboatwalla, M; Feikin, DR; Painter, J; Billhimer, W; Altaf, A; Hoekstra, RM			Effect of handwashing on child health: a randomised controlled trial	LANCET			English	Article; Proceedings Paper	3rd International Conference on Emerging Infectious Diseases	FEB 29-MAR 03, 2004	Atlanta, GA	Ctr Dis Control & Prevent, Amer Soc Microbiol, Assoc Public Hlth Labs, Council State & Territorial Epidemiologists, WHO			RISK-FACTORS; RESPIRATORY-INFECTIONS; INTEGRATED MANAGEMENT; PNEUMONIA; DIARRHEA; ILLNESS; SOAP; CARE; TRANSMISSION; BANGLADESH	Background More than 3.5 million children aged less than 5 years die from diarrhoea and acute lower respiratory-tract infection every year. We undertook a randomised controlled trial to assess the effect of handwashing promotion with soap on the incidence of acute respiratory infection, impetigo, and diarrhoea. Methods In adjoining squatter settlements in Karachi, Pakistan, we randomly assigned 25 neighbourhoods to handwashing promotion; 11 neighbourhoods (306 households) were randomised as controls. In neighbourhoods with handwashing promotion, 300 households each were assigned to antibacterial soap containing 1.2% triclocarban and to plain soap. Fieldworkers visited households weekly for 1 year to encourage handwashing by residents in soap households and to record symptoms in all households. Primary study outcomes were diarrhoea, impetigo, and acute respiratory-tract infections (ie, the number of new episodes of illness per person-weeks at risk). Pneumonia was defined according to the WHO clinical case definition. Analysis was by intention to treat. Findings Children younger than 5 years in households that received plain soap and handwashing promotion had a 50% lower incidence of pneumonia than controls (95% Cl -65% to -34%). Also compared with controls, children younger than 15 years in households with plain soap had a 53% lower incidence of diarrhoea (-65% to -41%) and a 34% lower incidence of impetigo (-52% to -16%). Incidence of disease did not differ significantly between households given plain soap compared with those given antibacterial soap. Interpretation Handwashing with soap prevents the two clinical syndromes that cause the largest number of childhood deaths globally-namely, diarrhoea and acute lower respiratory infections. Handwashing with daily bathing also prevents impetigo.	Ctr Dis Control & Prevent, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Hlth Oriented Prevent Educ, Karachi, Pakistan; Aga Khan Univ, Karachi, Pakistan; Procter & Gamble Co, Cincinnati, OH USA	Centers for Disease Control & Prevention - USA; Aga Khan University; Procter & Gamble	Luby, SP (corresponding author), Ctr Dis Control & Prevent, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA.	sluby@icddrb.org		Luby, Stephen/0000-0001-5385-899X; Hoekstra, Robert Michael/0000-0002-0340-8015				ADEGBOLA RA, 1994, PEDIATR INFECT DIS J, V13, P975, DOI 10.1097/00006454-199411000-00008; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Broor S, 2001, Indian Pediatr, V38, P1361; Capeding M R, 1994, Southeast Asian J Trop Med Public Health, V25, P684; Carabin H, 1999, EPIDEMIOLOGY, V10, P219, DOI 10.1097/00001648-199905000-00005; Fonseca W, 1996, B WORLD HEALTH ORGAN, V74, P199; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; GWALTNEY JM, 1978, ANN INTERN MED, V88, P463, DOI 10.7326/0003-4819-88-4-463; HALL CB, 1980, J INFECT DIS, V141, P98, DOI 10.1093/infdis/141.1.98; HAN AM, 1989, T ROY SOC TROP MED H, V83, P128, DOI 10.1016/0035-9203(89)90737-2; HEINZE JE, 1988, EPIDEMIOL INFECT, V101, P135, DOI 10.1017/S0950268800029290; Kahigwa E, 2002, T ROY SOC TROP MED H, V96, P162, DOI 10.1016/S0035-9203(02)90290-7; KALTENTHALER E, 1991, J TROP MED HYG, V94, P358; Kelly JM, 2001, AM J PUBLIC HEALTH, V91, P1617, DOI 10.2105/AJPH.91.10.1617; Koopman LP, 2001, PEDIATRICS, V108, P943, DOI 10.1542/peds.108.4.943; KORPPI M, 1989, PEDIATR INFECT DIS J, V8, P687, DOI 10.1097/00006454-198910000-00005; KORPPI M, 1990, SCAND J INFECT DIS, V22, P307, DOI 10.3109/00365549009027052; LEEDER SR, 1976, BRIT J PREV SOC MED, V30, P203; LOWBURY EJL, 1964, BMJ-BRIT MED J, V2, P230, DOI 10.1136/bmj.2.5403.230; Luby S, 2002, AM J TROP MED HYG, V67, P430, DOI 10.4269/ajtmh.2002.67.430; Luby SP, 2004, AM J TROP MED HYG, V71, P420, DOI 10.4269/ajtmh.2004.71.420; Luby SP, 2004, JAMA-J AM MED ASSOC, V291, P2547, DOI 10.1001/jama.291.21.2547; Marsh D, 1995, HEALTH POLICY PLANN, V10, P395, DOI 10.1093/heapol/10.4.395; Master D, 1997, Fam Med, V29, P336; Nafstad P, 1996, AM J PUBLIC HEALTH, V86, P1456, DOI 10.2105/AJPH.86.10.1456; Niffenegger J P, 1997, J Pediatr Health Care, V11, P26, DOI 10.1016/S0891-5245(97)90141-3; O'Brien KL, 2000, CLIN INFECT DIS, V30, P784, DOI 10.1086/313772; Perkins BA, 1997, B WORLD HEALTH ORGAN, V75, P33; Roberts L, 2000, PEDIATRICS, V105, P738, DOI 10.1542/peds.105.4.738; Ryan MAK, 2001, AM J PREV MED, V21, P79, DOI 10.1016/S0749-3797(01)00323-3; SELWYN BJ, 1990, REV INFECT DIS, V12, pS870; Shahid NS, 1996, J DIARRHOEAL DIS RES, V14, P85; STANTON BF, 1987, AM J EPIDEMIOL, V125, P292, DOI 10.1093/oxfordjournals.aje.a114529; Vejar L, 2000, REV MED CHILE, V128, P627; VELLA V, 1992, J BIOSOC SCI, V24, P103, DOI 10.1017/S0021932000006842; VERWEIJ PE, 1991, T ROY SOC TROP MED H, V85, P681, DOI 10.1016/0035-9203(91)90395-F; VICTORA CG, 1989, INT J EPIDEMIOL, V18, P918, DOI 10.1093/ije/18.4.918; West TE, 1999, B WORLD HEALTH ORGAN, V77, P144; *WHO, 2005, WORLD HLTH REP 2005, P190; ZAMAN S, 1993, ACTA PAEDIATR, V82, P63, DOI 10.1111/j.1651-2227.1993.tb12907.x	40	434	454	3	51	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2005	366	9481					225	233		10.1016/S0140-6736(05)66912-7	http://dx.doi.org/10.1016/S0140-6736(05)66912-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	945RG	16023513				2022-12-28	WOS:000230519200031
J	Berti, A; Bottini, G; Gandola, M; Pia, L; Smania, N; Stracciari, A; Castiglioni, I; Vallar, G; Paulesu, E				Berti, A; Bottini, G; Gandola, M; Pia, L; Smania, N; Stracciari, A; Castiglioni, I; Vallar, G; Paulesu, E			Shared cortical anatomy for motor, awareness and motor control	SCIENCE			English	Article							UNILATERAL NEGLECT; RIGHT-HEMISPHERE; ANOSOGNOSIA; HEMIPLEGIA; METAANALYSIS; IMAGERY; LESIONS; SYSTEM	In everyday life, the successful monitoring of behavior requires continuous updating of the effectiveness of motor acts; one crucial step is becoming aware of the movements one. is performing. We studied the anatomical distribution of lesions in right-brain-damaged hemiplegic patients, who obstinately denied their motor impairment, claiming that they could move their paralyzed limbs. Denial was associated with lesions in areas related to the programming of motor acts, particularly Brodmann's premotor areas 6 and 44, motor area 4, and the somatosensory cortex. This association suggests that monitoring systems may be implemented within the same cortical network that is responsible for the primary function that has to be monitored.	Univ Turin, Dept Psychol, I-10123 Turin, Italy; Univ Turin, Ctr Cognit Sci, I-10123 Turin, Italy; Univ Pavia, Dept Psychol, I-27100 Pavia, Italy; GB Rossi Univ Hosp, Rehabil Unit, I-37134 Verona, Italy; St Orsola Marcello Malpighi Hosp, Neurol Unit, I-40138 Bologna, Italy; CNR, Bioimaging & Mol Physiol Inst, I-20090 Milan, Italy; Univ Milano Bicocca, Dept Psychol, I-20126 Milan, Italy	University of Turin; University of Turin; University of Pavia; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Consiglio Nazionale delle Ricerche (CNR); University of Milano-Bicocca	Berti, A (corresponding author), Univ Turin, Dept Psychol, Via Po 14, I-10123 Turin, Italy.	berti@psych.unito.it	Gandola, Martina/GVR-2848-2022; Pia, Lorenzo/R-5263-2016; Gandola, Martina/AAC-1405-2019; Vallar, Giuseppe/K-8443-2012; Castiglioni, Isabella/AAC-4949-2022; PAULESU, ERALDO/C-2737-2017	Pia, Lorenzo/0000-0002-0360-3152; Gandola, Martina/0000-0002-0537-586X; Vallar, Giuseppe/0000-0001-7015-0117; Castiglioni, Isabella/0000-0001-7191-5417; PAULESU, ERALDO/0000-0002-9224-754X; stracciari, andrea/0000-0002-7058-4772; BOTTINI, GABRIELLA/0000-0003-4683-6420				Babinski J, 1914, REV NEUROL-FRANCE, V27, P845; Berti A, 1996, J Int Neuropsychol Soc, V2, P426; BERTI A, 1992, J COGNITIVE NEUROSCI, V4, P345, DOI 10.1162/jocn.1992.4.4.345; BISIACH E, 1986, NEUROPSYCHOLOGIA, V24, P471, DOI 10.1016/0028-3932(86)90092-8; Bisiach E., 1999, HDB CLIN EXPT NEUROP, P479; BISIACH E, 1995, COGNITIVE NEUROSCIEN, P1131; Bisiach E., 1991, AWARENESS DEFICIT BR, P17; BOTTINI G, 1995, NATURE, V376, P778, DOI 10.1038/376778a0; Dauriac-Le Masson V, 2002, REV NEUROL-FRANCE, V158, P427; Frith CD, 2000, PHILOS T R SOC B, V355, P1771, DOI 10.1098/rstb.2000.0734; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Jackson PL, 2004, CURR OPIN NEUROBIOL, V14, P259, DOI 10.1016/j.conb.2004.01.020; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; McGuire PK, 1996, BRIT J PSYCHIAT, V169, P148, DOI 10.1192/bjp.169.2.148; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Ossola, 1998, COGNITIVE NEUROPSYCH, V3, P21, DOI DOI 10.1080/135468098396233; Pia L, 2004, CORTEX, V40, P367, DOI 10.1016/S0010-9452(08)70131-X; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Roth R, 1996, NEUROREPORT, V7, P1280, DOI 10.1097/00001756-199605170-00012; Small M, 1996, EUR NEUROL, V36, P353, DOI 10.1159/000117293; Tanji J, 1996, CURR OPIN NEUROBIOL, V6, P782, DOI 10.1016/S0959-4388(96)80028-6; VALLAR G, 1986, NEUROPSYCHOLOGIA, V24, P609, DOI 10.1016/0028-3932(86)90001-1	24	249	249	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					488	491		10.1126/science.1110625	http://dx.doi.org/10.1126/science.1110625			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020740				2022-12-28	WOS:000230574900053
J	Dupuy, AJ; Akagi, K; Largaespada, DA; Copeland, NG; Jenkins, NA				Dupuy, AJ; Akagi, K; Largaespada, DA; Copeland, NG; Jenkins, NA			Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system	NATURE			English	Article							CHROMOSOMAL TRANSPOSITION; MLV INTEGRATION; HUMAN-CELLS; GENE; MOUSE; DROSOPHILA; GENOME; MICE; DISRUPTION; EXPRESSION	Transposons have provided important genetic tools for functional genomic screens in lower eukaryotes but have proven less useful in higher eukaryotes because of their low transposition frequency. Here we show that Sleeping Beauty (SB), a member of the Tc1/mariner class of transposons, can be mobilized in mouse somatic cells at frequencies high enough to induce embryonic death and cancer in wild-type mice. Tumours are aggressive, with some animals developing two or even three different types of cancer within a few months of birth. The tumours result from SB insertional mutagenesis of cancer genes, thus facilitating the identification of genes and pathways that induce disease. SB transposition can easily be controlled to mutagenize any target tissue and can therefore, in principle, be used to induce many of the cancers affecting humans, including those for which little is known about the aetiology. The uses of SB are also not restricted to the mouse and could potentially be used for forward genetic screens in any higher eukaryote in which transgenesis is possible.	NCI, Ctr Canc Res, Mouse Canc Genet Program, Frederick, MD 21702 USA; Univ Minnesota, Ctr Canc, Dept Genet Cell Biol & Dev, Arnold & Mabel Beckman Ctr Transposon Res, Minneapolis, MN 55455 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Minnesota System; University of Minnesota Twin Cities	Jenkins, NA (corresponding author), NCI, Ctr Canc Res, Mouse Canc Genet Program, Frederick, MD 21702 USA.	jenkins@ncifcrf.gov	Largaespada, David/C-9832-2014; Wilson, Matthew H/K-3193-2013	Dupuy, Adam/0000-0002-8561-4911	DIVISION OF BASIC SCIENCES - NCI [Z01BC010556] Funding Source: NIH RePORTER	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; Beverly LJ, 2003, CANCER CELL, V3, P551, DOI 10.1016/S1535-6108(03)00137-5; Carlson CM, 2003, GENETICS, V165, P243; Cui ZB, 2002, J MOL BIOL, V318, P1221, DOI 10.1016/S0022-2836(02)00237-1; Dupuy AJ, 2001, GENESIS, V30, P82, DOI 10.1002/gene.1037; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Fischer SEJ, 2001, P NATL ACAD SCI USA, V98, P6759, DOI 10.1073/pnas.121569298; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Geurts AM, 2003, MOL THER, V8, P108, DOI 10.1016/S1525-0016(03)00099-6; Grabher C, 2003, GENE, V322, P57, DOI 10.1016/j.gene.2003.09.009; Horie K, 2003, MOL CELL BIOL, V23, P9189, DOI 10.1128/MCB.23.24.9189-9207.2003; Horie K, 2001, P NATL ACAD SCI USA, V98, P9191, DOI 10.1073/pnas.161071798; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Luo GB, 1998, P NATL ACAD SCI USA, V95, P10769, DOI 10.1073/pnas.95.18.10769; OSBORNE BI, 1995, CURR OPIN CELL BIOL, V7, P406, DOI 10.1016/0955-0674(95)80097-2; Plasterk RHA, 1996, CURR TOP MICROBIOL, V204, P125; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SPRADLING AC, 1995, P NATL ACAD SCI USA, V92, P10824, DOI 10.1073/pnas.92.24.10824; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Yant SR, 2005, MOL CELL BIOL, V25, P2085, DOI 10.1128/MCB.25.6.2085-2094.2005	24	394	417	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					221	226		10.1038/nature03691	http://dx.doi.org/10.1038/nature03691			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015321				2022-12-28	WOS:000230459500032
J	Dagotto, E				Dagotto, E			Complexity in strongly correlated electronic systems	SCIENCE			English	Review							PHASE-SEPARATION; SUPERCONDUCTIVITY; PHYSICS; STATE; SPIN; EXCITATIONS; SYMMETRY; STRIPES; CHARGE	A wide variety of experimental results and theoretical investigations in recent years have convincingly demonstrated that several transition metal oxides and other materials have dominant states that are not spatially homogeneous. This occurs in cases in which several physical interactions-spin, charge, lattice, and/or orbital-are simultaneously active. This phenomenon causes interesting effects, such as colossal magnetoresistance, and it also appears crucial to understand the high-temperature superconductors. The spontaneous emergence of electronic nanometer-scale structures in transition metal oxides, and the existence of many competing states, are properties often associated with complex matter where nonlinearities dominate, such as soft materials and biological systems. This electronic complexity could have potential consequences for applications of correlated electronic materials, because not only charge (semiconducting electronic), or charge and spin (spintronics) are of relevance, but in addition the lattice and orbital degrees of freedom are active, leading to giant responses to small perturbations. Moreover, several metallic and insulating phases compete, increasing the potential for novel behavior.	Univ Tennessee, Dept Phys, Knoxville, TN 37996 USA; Oak Ridge Natl Lab, Condensed Matter Sci Div, Oak Ridge, TN 37831 USA	University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory	Dagotto, E (corresponding author), Univ Tennessee, Dept Phys, Knoxville, TN 37996 USA.							Ahn CH, 2003, NATURE, V424, P1015, DOI 10.1038/nature01878; Ahn KH, 2004, NATURE, V428, P401, DOI 10.1038/nature02364; Akahoshi D, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.177203; Aliaga H, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.104405; Alvarez G, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.014514; ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; Blinc R, 1999, PHYS REV LETT, V83, P424, DOI 10.1103/PhysRevLett.83.424; Bogdanovich S, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.236401; Bozovic I, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.157002; Burgy J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.097202; Burgy J, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.277202; Byczuk K, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.056404; Dagotto E, 2001, PHYS REP, V344, P1, DOI 10.1016/S0370-1573(00)00121-6; Dagotto E, 1996, SCIENCE, V271, P618, DOI 10.1126/science.271.5249.618; Dagotto E, 2002, NANOSCALE PHASE SEPA; Deac IG, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.172408; Dobrosavljevic V, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.016402; Frauenfelder H, 1999, REV MOD PHYS, V71, pS419, DOI 10.1103/RevModPhys.71.S419; Goldenfeld N, 1999, SCIENCE, V284, P87, DOI 10.1126/science.284.5411.87; Gruner G., 1994, DENSITY WAVES SOLIDS; Hanaguri T, 2004, NATURE, V430, P1001, DOI 10.1038/nature02861; Hayden SM, 2004, NATURE, V429, P531, DOI 10.1038/nature02576; Homes CC, 2004, NATURE, V430, P539, DOI 10.1038/nature02673; HOMES CC, CONDMAT0410719; Horowitz CJ, 2004, PHYS REV C, V69, DOI 10.1103/PhysRevC.69.045804; Hueso L, 2004, NATURE, V427, P301, DOI 10.1038/427301a; Kimura T, 2003, NATURE, V426, P55, DOI 10.1038/nature02018; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Kohsaka Y, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.097004; Kuhns PL, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.127202; Lang KM, 2002, NATURE, V415, P412, DOI 10.1038/415412a; Laughlin RB, 2000, P NATL ACAD SCI USA, V97, P28, DOI 10.1073/pnas.97.1.28; Levy P, 2003, APPL PHYS LETT, V83, P5247, DOI 10.1063/1.1635663; Limelette P, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.016401; Liu SQ, 2000, APPL PHYS LETT, V76, P2749, DOI 10.1063/1.126464; Louca D, 1997, PHYS REV B, V56, pR8475, DOI 10.1103/PhysRevB.56.R8475; Mackenzie AP, 2003, REV MOD PHYS, V75, P657, DOI 10.1103/RevModPhys.75.657; Mahendiran R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.286602; Mathur N, 2003, PHYS TODAY, V56, P25, DOI 10.1063/1.1554133; Milward GC, 2005, NATURE, V433, P607, DOI 10.1038/nature03300; MIRANDA E, IN PRESS REP PROG PH; Mitchell JF, 2001, J PHYS CHEM B, V105, P10731, DOI 10.1021/jp011419u; Miyagawa K, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.017003; Moreo A, 1999, SCIENCE, V283, P2034, DOI 10.1126/science.283.5410.2034; Motome Y, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.167204; Nakatsuji S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.146401; Nakatsuji S, 2000, PHYS REV LETT, V84, P2666, DOI 10.1103/PhysRevLett.84.2666; Rho H, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.127401; Rozenberg MJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.178302; Sacanell J, 2004, PHYSICA B, V354, P43, DOI 10.1016/j.physb.2004.09.017; Sachdev S., 1999, QUANTUM PHASE TRANSI; Salamon MB, 2001, REV MOD PHYS, V73, P583, DOI 10.1103/RevModPhys.73.583; Sanna S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.207001; SANNA S, CONDMAT0403608; Sasaki T, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.060505; Schmalian J, 2000, PHYS REV LETT, V85, P836, DOI 10.1103/PhysRevLett.85.836; Schmalian J, 2005, MRS BULL, V30, P433, DOI 10.1557/mrs2005.119; Sidorov VA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.157004; Sorella S, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.117002; Stojkovic BP, 1999, PHYS REV LETT, V82, P4679, DOI 10.1103/PhysRevLett.82.4679; Tokura Y, 2000, SCIENCE, V288, P462, DOI 10.1126/science.288.5465.462; Tomioka Y, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.014432; Tranquada JM, 2004, NATURE, V429, P534, DOI 10.1038/nature02574; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Uehara M, 1999, NATURE, V399, P560, DOI 10.1038/21142; Vershinin M, 2004, SCIENCE, V303, P1995, DOI 10.1126/science.1093384; Vicsek T, 2002, NATURE, V418, P131, DOI 10.1038/418131a; White SR, 1998, PHYS REV LETT, V80, P1272, DOI 10.1103/PhysRevLett.80.1272; Witten TA, 1999, REV MOD PHYS, V71, pS367, DOI 10.1103/RevModPhys.71.S367; Yamada H, 2004, SCIENCE, V305, P646, DOI 10.1126/science.1098867; Yunoki S, 1998, PHYS REV LETT, V80, P845, DOI 10.1103/PhysRevLett.80.845; Zaanen J, 2000, NATURE, V404, P714, DOI 10.1038/35008176; Zhang SC, 1997, SCIENCE, V275, P1089, DOI 10.1126/science.275.5303.1089; Zhu JX, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.057004	77	1529	1545	14	573	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2005	309	5732					257	262		10.1126/science.1107559	http://dx.doi.org/10.1126/science.1107559			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002608	Green Submitted			2022-12-28	WOS:000230449800032
J	Pascal, AA; Liu, ZF; Broess, K; van Oort, B; van Amerongen, H; Wang, C; Horton, P; Robert, B; Chang, WR; Ruban, A				Pascal, AA; Liu, ZF; Broess, K; van Oort, B; van Amerongen, H; Wang, C; Horton, P; Robert, B; Chang, WR; Ruban, A			Molecular basis of photoprotection and control of photosynthetic light-harvesting	NATURE			English	Article							CHLOROPHYLL-PROTEIN COMPLEX; TIME-RESOLVED FLUORESCENCE; GREEN PLANTS; EXCITATION-ENERGY; BINDING; LHCII; MECHANISM; XANTHOPHYLLS; ZEAXANTHIN; MEMBRANES	In order to maximize their use of light energy in photosynthesis, plants have molecules that act as light-harvesting antennae, which collect light quanta and deliver them to the reaction centres, where energy conversion into a chemical form takes place. The functioning of the antenna responds to the extreme changes in the intensity of sunlight encountered in nature(1-3). In shade, light is efficiently harvested in photosynthesis. However, in full sunlight, much of the energy absorbed is not needed and there are vitally important switches to specific antenna states, which safely dissipate the excess energy as heat(2,3). This is essential for plant survival(4), because it provides protection against the potential photo-damage of the photosynthetic membrane(5). But whereas the features that establish high photosynthetic efficiency have been highlighted(6), almost nothing is known about the molecular nature of the dissipative states. Recently, the atomic structure of the major plant light-harvesting antenna protein, LHCII, has been determined by X-ray crystallography(7). Here we demonstrate that this is the structure of a dissipative state of LHCII. We present a spectroscopic analysis of this crystal form, and identify the specific changes in configuration of its pigment population that give LHCII the intrinsic capability to regulate energy flow. This provides a molecular basis for understanding the control of photosynthetic light-harvesting.	Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; CNRS, URA 2096, Serv Biophys Fonct Membranaires, F-91191 Gif Sur Yvette, France; CEA Saclay, DBJC, F-91191 Gif Sur Yvette, France; Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; Univ Wageningen & Res Ctr, Biophys Lab, NL-6700 ET Wageningen, Netherlands	University of Sheffield; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Chinese Academy of Sciences; Institute of Biophysics, CAS; Wageningen University & Research	Horton, P (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	p.horton@sheffield.ac.uk; robert@dsvidf.cea.fr	Horton, Peter/A-3958-2012; Robert, Bruno/D-1264-2012; van Oort, Bart/C-4674-2008; van Amerongen, Herbert/J-9483-2016; pascal, andrew a/B-6186-2014	Horton, Peter/0000-0002-6095-1460; Robert, Bruno/0000-0001-5999-4538; van Oort, Bart/0000-0002-5470-1545; van Amerongen, Herbert/0000-0002-9783-2895; pascal, andrew a/0000-0002-1844-6065; liu, zhen feng/0000-0001-5502-9474				BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; Barzda V, 2001, BIOPHYS J, V81, P538, DOI 10.1016/S0006-3495(01)75720-7; BEDDARD GS, 1976, NATURE, V260, P366, DOI 10.1038/260366a0; Croce R, 1999, FEBS LETT, V456, P1, DOI 10.1016/S0014-5793(99)00907-2; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; Finazzi G, 2004, P NATL ACAD SCI USA, V101, P12375, DOI 10.1073/pnas.0404798101; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Horton P, 2005, J EXP BOT, V56, P365, DOI 10.1093/jxb/eri023; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; HORTON P, 1991, FEBS LETT, V292, P1, DOI 10.1016/0014-5793(91)80819-O; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; MULLET JE, 1980, BIOCHIM BIOPHYS ACTA, V589, P100, DOI 10.1016/0005-2728(80)90135-8; MULLINEAUX CW, 1993, BIOCHIM BIOPHYS ACTA, V1141, P23, DOI 10.1016/0005-2728(93)90184-H; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Remelli R, 1999, J BIOL CHEM, V274, P33510, DOI 10.1074/jbc.274.47.33510; Robert B, 2004, TRENDS PLANT SCI, V9, P385, DOI 10.1016/j.tplants.2004.06.006; Ruban AV, 2000, FEBS LETT, V477, P181, DOI 10.1016/S0014-5793(00)01799-3; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P30, DOI 10.1016/0005-2728(92)90061-6; RUBAN AV, 1995, BIOCHEMISTRY-US, V34, P2333, DOI 10.1021/bi00007a029; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; van Amerongen H, 2001, J PHYS CHEM B, V105, P604, DOI 10.1021/jp0028406; Wentworth M, 2003, J BIOL CHEM, V278, P21845, DOI 10.1074/jbc.M302586200	29	506	521	9	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					134	137		10.1038/nature03795	http://dx.doi.org/10.1038/nature03795			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001075				2022-12-28	WOS:000230296600053
J	Marketon, MM; DePaolo, RW; DeBord, KL; Jabri, B; Schneewind, O				Marketon, MM; DePaolo, RW; DeBord, KL; Jabri, B; Schneewind, O			Plague bacteria target immune cells during infection	SCIENCE			English	Article							YERSINIA YOP PROTEINS; V-ANTIGEN; III SECRETION; BETA-LACTAMASE; BUBONIC PLAGUE; HELA-CELLS; PESTIS; TRANSLOCATION; ENTEROCOLITICA; CYTOSOL	The plague is caused by the bacterium Yersinia pestis. Plague bacteria are thought to inject effector Yop proteins into host cells via the type III pathway. The identity of the host cells targeted for injection during plague infection is unknown. We found, using Yop beta-lactamase hybrids and fluorescent staining of live cells from plague-infected animals, that Y. pestis selected immune cells for injection. In vivo, dendritic cells, macrophages, and neutrophils were injected most frequently, whereas B and T lymphocytes were rarely selected. Thus, it appears that Y. pestis disables these cell populations to annihilate host immune responses during plague.	Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Schneewind, O (corresponding author), Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA.	oschnee@bsd.uchicago.edu		DePaolo, William/0000-0002-3880-4544	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER; NIAID NIH HHS [U54 AI057153-01, U54 AI057153-02, U54 AI057153, 1-U54-AI-057153] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLAOUI A, 1994, J BACTERIOL, V176, P4534, DOI 10.1128/JB.176.15.4534-4542.1994; Anderson GW, 1996, INFECT IMMUN, V64, P4580, DOI 10.1128/IAI.64.11.4580-4585.1996; BRUBAKER RR, 1969, J BACTERIOL, V98, P1404, DOI 10.1128/JB.98.3.1404-1406.1969; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Cheng LW, 1997, MOL MICROBIOL, V24, P757, DOI 10.1046/j.1365-2958.1997.3831750.x; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077; Day JB, 2003, MOL MICROBIOL, V47, P807, DOI 10.1046/j.1365-2958.2003.03343.x; HAKANSSON S, 1993, INFECT IMMUN, V61, P71; Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x; Lee VT, 2000, J BIOL CHEM, V275, P36869, DOI 10.1074/jbc.M002467200; Lee VT, 1998, MOL MICROBIOL, V28, P593, DOI 10.1046/j.1365-2958.1998.00822.x; PERRY RD, 1986, INFECT IMMUN, V54, P428, DOI 10.1128/IAI.54.2.428-434.1986; Philipovskiy AV, 2005, INFECT IMMUN, V73, P1532, DOI 10.1128/IAI.73.3.1532-1542.2005; ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x; Sebbane F, 2005, AM J PATHOL, V166, P1427, DOI 10.1016/S0002-9440(10)62360-7; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; UNE T, 1984, J IMMUNOL, V133, P2226; Zlokarnik G, 1998, SCIENCE, V279, P84, DOI 10.1126/science.279.5347.84	19	265	276	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2005	309	5741					1739	1741		10.1126/science.1114580	http://dx.doi.org/10.1126/science.1114580			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16051750	Green Accepted			2022-12-28	WOS:000231836700049
J	Ryan, JM; Mahoney, PF; Macnab, C				Ryan, JM; Mahoney, PF; Macnab, C			ABC of conflict and disaster - Conflict recovery and intervening in hospitals	BRITISH MEDICAL JOURNAL			English	Review									UCL, London WC1E 6BT, England; Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; Royal Ctr Def Med, Acad Dept Mil Emergency Med, Birmingham, W Midlands, England; UCL, Leonard Cheshire Ctr Conflict Recovery, London WC1E 6BT, England	University of London; University College London; Uniformed Services University of the Health Sciences - USA; Royal Centre for Defence Medicine; University of London; University College London	Ryan, JM (corresponding author), UCL, London WC1E 6BT, England.							[Anonymous], 1997, REF HLTH APPR EM SIT; FLEGGSON M, 2003, HLTH EXCHANGE    FEB, P8; HAYWARDKARLSSON J, 1998, HOSP WAR WOUNDED; Ignatieff M., 1998, WARRIORS HONOR ETHNI; KEGLEY C, 1999, WORLD POLITICS TREND; PERRIN P, 1996, WAR PUBLIC HLTH; Redmond T, 1999, BMJ-BRIT MED J, V319, P1652, DOI 10.1136/bmj.319.7225.1652; Ryan JM, 2003, J ROY SOC MED, V96, P56, DOI 10.1258/jrsm.96.2.56; RYAN JM, 2002, HLTH EXCHANGE    FEB, P5	9	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 30	2005	331	7511					278	280		10.1136/bmj.331.7511.278	http://dx.doi.org/10.1136/bmj.331.7511.278			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953FJ	16052021	Green Published			2022-12-28	WOS:000231061700022
J	Butler, D				Butler, D			Parasitology - Triple genome triumph	NATURE			English	Editorial Material																		[Anonymous], 2005, SCIENCE, V309, P436; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; 2005, SCIENCE, V309, P416	3	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					337	337		10.1038/436337b	http://dx.doi.org/10.1038/436337b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034405				2022-12-28	WOS:000230623400028
J	Croce, CM; Calin, GA				Croce, CM; Calin, GA			miRNAs, cancer, and stem cell division	CELL			English	Editorial Material							EXPRESSION; MICRORNAS; BIOGENESIS; RNA	MicroRNAs (miRNAs) are known to regulate the expression of genes involved in the control of development, proliferation, apoptosis, and the stress response. As a cluster of recent Nature papers now show, altered expression of specific miRNA genes contributes to the initiation and progression of cancer.	Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Croce, CM (corresponding author), Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.		Young, Richard A/F-6495-2012; Calin, George/E-9390-2011; ravegnini, gloria/K-1330-2016	Young, Richard A/0000-0001-8855-8647; ravegnini, gloria/0000-0002-7774-402X; Calin, George/0000-0001-6704-5615				Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; McManus MT, 2003, SEMIN CANCER BIOL, V13, P253, DOI 10.1016/S1044-579X(03)00038-5; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677	10	1169	1286	3	97	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 15	2005	122	1					6	7		10.1016/j.cell.2005.06.036	http://dx.doi.org/10.1016/j.cell.2005.06.036			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	950EC	16009126	Bronze			2022-12-28	WOS:000230839400004
J	Mazmanian, SK; Liu, CH; Tzianabos, AO; Kasper, DL				Mazmanian, SK; Liu, CH; Tzianabos, AO; Kasper, DL			An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system	CELL			English	Article							REGULATORY T-CELLS; DENDRITIC CELLS; CAPSULAR POLYSACCHARIDE; INTESTINAL MICROFLORA; BACTEROIDES-FRAGILIS; GUT MICROFLORA; COLONIZATION; RESPONSES; INTERLEUKIN-12; PROTECTION	The mammalian gastrointestinal tract harbors a complex ecosystem consisting of countless bacteria in homeostasis with the host immune system. Shaped by evolution, this partnership has potential for symbiotic benefit. However, the identities of bacterial molecules mediating symbiosis remain undefined. Here we show that, during colonization of animals with the ubiquitous gut microorganism Bacteroides fragilis, a bacterial polysaccharide (PSA) directs the cellular and physical maturation of the developing immune system. Comparison with germ-free animals reveals that the immunomodulatory activities of PSA during B. fragilis colonization include correcting systemic T cell deficiencies and T(H)1/T(H)2 imbalances and directing lymphoid organogenesis. A PSA mutant of B. fragilis does not restore these immunologic functions. PSA presented by intestinal dendritic cells activates CD4(+) T cells and elicits appropriate cytokine production. These findings provide a molecular basis for host-bacterial symbiosis and reveal the archetypal molecule of commensal bacteria that mediates development of the host immune system.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA; So Med Univ, Nanfang Hosp, Inst Mol Biol, Guangzhou 510515, Peoples R China; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Southern Medical University - China; Harvard University; Harvard Medical School	Mazmanian, SK (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA.	smazmanian@rics.bwh.harvard.edu; dennis_kasper@hms.harvard.edu	Mazmanian, Sarkis/ABD-7729-2021	Mazmanian, Sarkis/0000-0003-2713-1513	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039576] Funding Source: NIH RePORTER; NIAID NIH HHS [R01AI039576] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adkins B, 2000, Int Rev Immunol, V19, P157, DOI 10.3109/08830180009088503; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bjorksten B, 1999, CLIN EXP ALLERGY, V29, P342, DOI 10.1046/j.1365-2222.1999.00560.x; Bowman LM, 2001, INFECT IMMUN, V69, P3719, DOI 10.1128/IAI.69.6.3719-3727.2001; Brubaker JO, 1999, J IMMUNOL, V162, P2235; Cash HL, 2005, ASM NEWS, V71, P77; Cobb BA, 2004, CELL, V117, P677, DOI 10.1016/j.cell.2004.05.001; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Coyne MJ, 2001, INFECT IMMUN, V69, P4342, DOI 10.1128/IAI.69.7.4342-4350.2001; Dobber R, 1992, Dev Immunol, V2, P141, DOI 10.1155/1992/57057; Falkow S, 2004, NAT REV MICROBIOL, V2, P67, DOI 10.1038/nrmicro799; Groux H, 2004, SEMIN IMMUNOL, V16, P99, DOI 10.1016/j.smim.2003.12.004; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Heufler C, 1996, EUR J IMMUNOL, V26, P659, DOI 10.1002/eji.1830260323; Hooper LV, 1998, BIOESSAYS, V20, P336, DOI 10.1002/(SICI)1521-1878(199804)20:4&lt;336::AID-BIES10&gt;3.0.CO;2-3; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2004, TRENDS MICROBIOL, V12, P129, DOI 10.1016/j.tim.2004.01.001; Hooper LV, 2000, CURR OPIN MICROBIOL, V3, P79, DOI 10.1016/S1369-5274(99)00055-7; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Infante A J, 1999, Int Rev Immunol, V18, P83, DOI 10.3109/08830189909043020; Janeway CA, 2001, IMMUNOBIOLOGY; Kalka-Moll WM, 2002, J IMMUNOL, V169, P6149, DOI 10.4049/jimmunol.169.11.6149; Kalliomaki M, 2001, J ALLERGY CLIN IMMUN, V107, P129, DOI 10.1067/mai.2001.111237; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kidd Parris, 2003, Altern Med Rev, V8, P223; Kirjavainen PV, 1999, ANN MED, V31, P288, DOI 10.3109/07853899908995892; Kirjavainen PV, 2001, FEMS IMMUNOL MED MIC, V32, P1, DOI 10.1111/j.1574-695X.2001.tb00526.x; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; KONONEN E, 1992, ORAL MICROBIOL IMMUN, V7, P273, DOI 10.1111/j.1399-302X.1992.tb00587.x; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Malhotra V, 1992, Indian J Chest Dis Allied Sci, V34, P117; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Morelli AE, 2003, IMMUNOL REV, V196, P125, DOI 10.1046/j.1600-065X.2003.00079.x; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Neurath MF, 2002, NAT MED, V8, P567, DOI 10.1038/nm0602-567; Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008; PEREIRA P, 1986, EUR J IMMUNOL, V16, P685, DOI 10.1002/eji.1830160616; Prescott SL, 1998, J IMMUNOL, V160, P4730; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rastall RA, 2004, J NUTR, V134, p2022S, DOI 10.1093/jn/134.8.2022S; Rescigno M, 2001, IMMUNOBIOLOGY, V204, P572, DOI 10.1078/0171-2985-00094; Rook Graham A W, 2002, Biologist (London), V49, P145; Sheikh Aziz, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P232, DOI 10.1097/01.moo.0000122311.13359.30; Shi HN, 2004, CAN J GASTROENTEROL, V18, P493, DOI 10.1155/2004/690421; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Thery C, 2001, CURR OPIN IMMUNOL, V13, P45, DOI 10.1016/S0952-7915(00)00180-1; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Tzianabos AO, 2000, J BIOL CHEM, V275, P6733, DOI 10.1074/jbc.275.10.6733; TZIANABOS AO, 1993, SCIENCE, V262, P416, DOI 10.1126/science.8211161; TZIANABOS AO, 1992, J BIOL CHEM, V267, P18230; TZIANABOS AO, 1994, INFECT IMMUN, V62, P4881, DOI 10.1128/IAI.62.11.4881-4886.1994; Tzianabos AO, 1999, J IMMUNOL, V163, P893; Tzianabos AO, 2002, CURR OPIN MICROBIOL, V5, P92, DOI 10.1016/S1369-5274(02)00292-8; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; von Hertzen LC, 2004, ALLERGY, V59, P124, DOI 10.1046/j.1398-9995.2003.00433.x; Wills-Karp M, 2001, NAT REV IMMUNOL, V1, P69, DOI 10.1038/35095579; Wilson JD., HARRISONS PRINCIPLES, V1994, P472; Yamanaka T, 2003, J IMMUNOL, V170, P816, DOI 10.4049/jimmunol.170.2.816; Zhang GX, 1997, MUSCLE NERVE, V20, P543, DOI 10.1002/(SICI)1097-4598(199705)20:5<543::AID-MUS2>3.3.CO;2-I; Zou LH, 2004, CANCER RES, V64, P8451, DOI 10.1158/0008-5472.CAN-04-1987	65	1843	2014	38	365	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 15	2005	122	1					107	118		10.1016/j.cell.2005.05.007	http://dx.doi.org/10.1016/j.cell.2005.05.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	950EC	16009137	Bronze			2022-12-28	WOS:000230839400015
J	Schekman, R				Schekman, R			Peroxisomes: Another branch of the secretory pathway?	CELL			English	Editorial Material							ENDOPLASMIC-RETICULUM	The question of whether new peroxisomes form autonomously has been a subject of debate for more than 30 years. In this issue of Cell, Hoepfner et al. (2005) present the most compelling evidence to date in support of a role for the endoplasmic reticulum in the creation of peroxisomes.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Schekman, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.							Elgersma Y, 1997, EMBO J, V16, P7326, DOI 10.1093/emboj/16.24.7326; Geuze HJ, 2003, MOL BIOL CELL, V14, P2900, DOI 10.1091/mbc.E02-11-0734; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; SANTOS MJ, 1988, SCIENCE, V239, P1536, DOI 10.1126/science.3281254; South ST, 2000, J CELL BIOL, V149, P1345, DOI 10.1083/jcb.149.7.1345; South ST, 2001, P NATL ACAD SCI USA, V98, P12027, DOI 10.1073/pnas.221289498; Titorenko VI, 1997, MOL CELL BIOL, V17, P5210, DOI 10.1128/MCB.17.9.5210; Titorenko VI, 1998, MOL CELL BIOL, V18, P2789, DOI 10.1128/MCB.18.5.2789; Titorenko VI, 2000, J CELL BIOL, V150, P881, DOI 10.1083/jcb.150.4.881	10	23	23	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 15	2005	122	1					1	2		10.1016/j.cell.2005.06.033	http://dx.doi.org/10.1016/j.cell.2005.06.033			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	950EC	16009123	Bronze			2022-12-28	WOS:000230839400001
J	Curley, MAQ; Hibberd, PL; Fineman, LD; Wypij, D; Shih, MC; Thompson, J; Grant, MJC; Barr, FE; Cvijanovich, NZ; Sorce, L; Luckett, PM; Matthay, MA; Arnold, JH				Curley, MAQ; Hibberd, PL; Fineman, LD; Wypij, D; Shih, MC; Thompson, J; Grant, MJC; Barr, FE; Cvijanovich, NZ; Sorce, L; Luckett, PM; Matthay, MA; Arnold, JH			Effect of prone positioning on clinical outcomes in children with acute lung injury - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY-DISTRESS-SYNDROME; PEDIATRIC INTENSIVE-CARE; HIGH TIDAL VOLUME; OXYGENATION; FAILURE; INFANTS; VENTILATION; PRESSURES; MECHANICS; PULMONARY	Context In uncontrolled clinical studies, prone positioning appeared to be safe and to improve oxygenation in pediatric patients with acute lung injury. However, the effect of prone positioning on clinical outcomes in children is not known. Objective To test the hypothesis that at the end of 28 days infants and children with acute lung injury treated with prone positioning would have more ventilator-free days than those treated with supine positioning. Design, Setting, and Patients Multicenter, randomized, controlled clinical trial conducted from August 28, 2001, to April 23, 2004, of 102 pediatric. patients from 7 US pediatric intensive care units aged 2 weeks to 18 years who were treated with supine vs prone positioning. Randomization was concealed and group assignment was not blinded. Intervention Patients were randomized to either supine or prone positioning within 48 hours of meeting acute lung injury criteria, with those patients in the prone group being positioned within 4 hours of randomization and remaining prone for 20 hours each day during the acute phase of their illness for a maximum of 7 days, after which they were positioned supine. Both groups were treated using lung protective ventilator and sedation protocols, extubation readiness testing, and hemodynamic, nutrition, and skin care guidelines. Main Outcome Measure Ventilator-free days to day 28. Results The trial was stopped at the planned interim analysis on the basis of the pre-specified futility stopping rule. There were no differences in the number of ventilator-free days between the 2 groups (mean [SD], 15.8 [8.5] supine vs 15.6 [8.6] prone; mean difference, -0.2 days; 95% Cl, -3.6 to 3.2; P=.91). After controlling for age, Pediatric Risk of Mortality III score, direct vs indirect acute lung injury, and mode of mechanical ventilation at enrollment, the adjusted difference in ventilator-free days was 0.3 days (95% Cl, -3.0 to 3.5; P=.87). There were no differences in the secondary end points, including proportion alive and ventilator-free on day 28 (P=.45), mortality from all causes (P>.99), the time to recovery of lung injury (P=.78), organ-failure-free days (P=.88), and cognitive impairment (P=.16) or overall functional health (P=.12) at hospital discharge or on day 28. Conclusion Prone positioning does not significantly reduce ventilator-free days or improve other clinical outcomes in pediatric patients with acute lung injury.	Childrens Hosp, Med Surg Intens Care Unit, Boston, MA 02115 USA; Tufts New England Med Ctr, Boston, MA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Primary Childrens Med Ctr, Salt Lake City, UT 84103 USA; Vanderbilt Childrens Hosp, Nashville, TN USA; Childrens Hosp Oakland, Oakland, CA USA; Childrens Mem Hosp, Chicago, IL 60614 USA; Childrens Med Ctr, Dallas, TX 75235 USA	Harvard University; Boston Children's Hospital; Tufts Medical Center; University of California System; University of California San Francisco; Vanderbilt University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Ann & Robert H. Lurie Children's Hospital of Chicago	Curley, MAQ (corresponding author), Childrens Hosp, Med Surg Intens Care Unit, 300 Longwood Ave, Boston, MA 02115 USA.	martha.curley@childrens.harvard.edu	Curley, Martha A/F-3579-2016	Curley, Martha A/0000-0001-5228-6694; Sorce, Lauren/0000-0002-5460-0664; Wypij, David/0000-0001-8367-8711; Hibberd, Patricia/0000-0002-7455-8117	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR005336] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00054, M01 RR000064, RR00064, M01 RR000054] Funding Source: Medline; NINR NIH HHS [R01 NR005336, R01NR05336] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Broccard AF, 1997, CRIT CARE MED, V25, P16, DOI 10.1097/00003246-199701000-00007; Brower RG, 2004, NEW ENGL J MED, V351, P327; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; BRYAN AC, 1974, AM REV RESPIR DIS, V110, P143; Casado-Flores J, 2002, INTENS CARE MED, V28, P1792, DOI 10.1007/s00134-002-1527-8; Chatte G, 1997, AM J RESP CRIT CARE, V155, P473, DOI 10.1164/ajrccm.155.2.9032181; Curley M A, 1999, Am J Crit Care, V8, P397; Curley M A, 1998, Am J Crit Care, V7, P335; Curley MAQ, 2000, CHEST, V118, P156, DOI 10.1378/chest.118.1.156; Curley Martha A Q, 2005, Pediatr Crit Care Med, V6, pS150, DOI 10.1097/01.PCC.0000161582.63265.B6; DREYFUSS D, 1988, AM REV RESPIR DIS, V137, P1159, DOI 10.1164/ajrccm/137.5.1159; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Fridrich P, 1996, ANESTH ANALG, V83, P1206, DOI 10.1097/00000539-199612000-00013; Gattinoni L, 2001, NEW ENGL J MED, V345, P568, DOI 10.1056/NEJMoa010043; Gattinoni L, 1998, AM J RESP CRIT CARE, V158, P3, DOI 10.1164/ajrccm.158.1.9708031; Guerin C, 2004, JAMA-J AM MED ASSOC, V292, P2379, DOI 10.1001/jama.292.19.2379; LAMM WJE, 1994, AM J RESP CRIT CARE, V150, P184, DOI 10.1164/ajrccm.150.1.8025748; Leteurtre S, 2003, LANCET, V362, P192, DOI 10.1016/S0140-6736(03)13908-6; MURDOCH IA, 1994, ACTA PAEDIATR, V83, P1043, DOI 10.1111/j.1651-2227.1994.tb12981.x; MUSCEDERE JG, 1994, AM J RESP CRIT CARE, V149, P1327, DOI 10.1164/ajrccm.149.5.8173774; *NAT PRESS ULC ADV, 1989, DECUBITUS, V2, P24; *NPUAP, STAG 1 ASS DARKL PIG; Numa AH, 1997, AM J RESP CRIT CARE, V156, P1185, DOI 10.1164/ajrccm.156.4.9601042; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; PAPASTAMELOS C, 1995, J APPL PHYSIOL, V78, P179, DOI 10.1152/jappl.1995.78.1.179; Pelosi P, 1998, AM J RESP CRIT CARE, V157, P387, DOI 10.1164/ajrccm.157.2.97-04023; Plotz FB, 2004, INTENS CARE MED, V30, P1865, DOI 10.1007/s00134-004-2363-9; Pollack MM, 1997, J PEDIATR-US, V131, P575, DOI 10.1016/S0022-3476(97)70065-9; Randolph AG, 2003, AM J RESP CRIT CARE, V167, P1334, DOI 10.1164/rccm.200210-1175OC; Randolph AG, 2002, JAMA-J AM MED ASSOC, V288, P2561, DOI 10.1001/jama.288.20.2561; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; Spragg RG, 2004, NEW ENGL J MED, V351, P884, DOI 10.1056/NEJMoa033181; Taylor RW, 2004, JAMA-J AM MED ASSOC, V291, P1603, DOI 10.1001/jama.291.13.1603; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806	35	200	224	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2005	294	2					229	237		10.1001/jama.294.2.229	http://dx.doi.org/10.1001/jama.294.2.229			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944DO	16014597	Green Accepted			2022-12-28	WOS:000230406100027
J	Carapetis, JR; McDonald, M; Wilson, NJ				Carapetis, JR; McDonald, M; Wilson, NJ			Acute rheumatic fever	LANCET			English	Review							BENZATHINE PENICILLIN-G; GROUP-A STREPTOCOCCI; CELL ALLOANTIGEN D8/17; HEART-DISEASE; FOLLOW-UP; ECHOCARDIOGRAPHIC DIAGNOSIS; SYDENHAMS CHOREA; CLASS-I; DOPPLER-ECHOCARDIOGRAPHY; MOLECULAR EPIDEMIOLOGY	Acute rheumatic fever (ARF) and its chronic sequela, rheumatic heart disease (RHD), have become rare in most affluent populations, but remain unchecked in developing countries and in some poor, mainly indigenous populations in wealthy countries. More than a century of research, mainly in North America and Europe, has improved our understanding of ARF and RHD. However, whether traditional views need to be updated in view of the epidemiological shift of the past 50 years is still to be established, and improved data from developing countries are needed. Doctors who work in populations with a high incidence of ARF are adapting existing diagnostic guidelines to increase their sensitivity. Group A streptococcal vaccines are still years away from being available and, even if the obstacles of serotype coverage and safety can be overcome, their cost could make them inaccessible to the populations that need them most. New approaches to primary prevention are needed given the limitations of primary prophylaxis as a population-based strategy. The most effective approach for control of ARF and RHD is secondary prophylaxis, which is best delivered as part of a coordinated control programme.	Univ Melbourne, Ctr Int Child Hlth, Dept Paediat, Melbourne, Vic, Australia; Murdoch Childrens Res Inst, Melbourne, Vic, Australia; Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT, Australia; Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; Starship & Green Lane Hosp, Dept Cardiol, Auckland, New Zealand	University of Melbourne; Murdoch Children's Research Institute; Charles Darwin University; Menzies School of Health Research; University of Melbourne; Starship Children's Hospital	Carapetis, JR (corresponding author), Royal Childrens Hosp, Parkville, Vic 3052, Australia.	jonathan.carapetis@rch.org.au	Carapetis, Jonathan R/H-8933-2014	Carapetis, Jonathan R/0000-0002-1182-9792				ABERNETHY M, 1994, AUST NZ J MED, V24, P530, DOI 10.1111/j.1445-5994.1994.tb01753.x; AGARWAL AK, 1995, J ROY SOC HEALTH, V115, P303, DOI 10.1177/146642409511500509; Agarwal P K, 1998, J Assoc Physicians India, V46, P937; ALBERT DA, 1995, MEDICINE, V74, P1, DOI 10.1097/00005792-199501000-00001; ALEISSA A, 1993, BRIT J CLIN PRACT, V47, P14; *AM AC PED COMM IN, 2003, GROUP A STREPT INF R, P573; *AM HEART ASS, 1984, CIRCULATION, V69, pA203; Amir J, 1998, PEDIATR INFECT DIS J, V17, P890, DOI 10.1097/00006454-199810000-00008; [Anonymous], 1965, CIRCULATION, V32, P664, DOI DOI 10.1161/01.CIR.32.4.664; BAKER M, 2000, COMP EPIDEMIOLOGY PO, P545; Bass JW, 1996, PEDIATRICS, V97, P960; Batzloff MR, 2004, CURR DRUG TARGETS, V5, P57, DOI 10.2174/1389450043490721; BENDOV I, 1980, SEMIN ARTHRITIS RHEU, V10, P100, DOI 10.1016/0049-0172(80)90003-7; Berdeli A, 2004, CLIN BIOCHEM, V37, P925, DOI 10.1016/j.clinbiochem.2004.06.007; Bessen DE, 1996, J INFECT DIS, V173, P896, DOI 10.1093/infdis/173.4.896; Bessen DE, 2000, J INFECT DIS, V182, P1109, DOI 10.1086/315842; BESSEN DE, 1995, J INFECT DIS, V172, P1608, DOI 10.1093/infdis/172.6.1608; Bhatnagar A, 1999, CLIN EXP IMMUNOL, V116, P100; Bishop W, 1996, AUST NZ J MED, V26, P241, DOI 10.1111/j.1445-5994.1996.tb00898.x; Bisno A.L., 1980, STREPTOCOCCAL DISEAS, P789; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; BISNO AL, 1991, NEW ENGL J MED, V325, P783, DOI 10.1056/NEJM199109123251106; Bisno AL, 2002, CLIN INFECT DIS, V35, P113, DOI 10.1086/340949; BLAND EF, 1951, CIRCULATION, V4, P836, DOI 10.1161/01.CIR.4.6.836; Block SL, 2003, CLIN PEDIATR, V42, P663, DOI 10.1177/000992280304200801; Brandt ER, 1998, LANCET, V351, P1860, DOI 10.1016/S0140-6736(05)78806-1; BYWATERS EG, 1961, BRIT MED J, V1, P1628, DOI 10.1136/bmj.1.5240.1628; CARAPETIS J, 1995, J CLIN MICROBIOL, V33, P1471, DOI 10.1128/JCM.33.6.1471-1472.1995; Carapetis JR, 1996, MED J AUSTRALIA, V164, P146, DOI 10.5694/j.1326-5377.1996.tb122012.x; Carapetis JR, 1997, PEDIATR INFECT DIS J, V16, P494, DOI 10.1097/00006454-199705000-00008; Carapetis JR, 2001, ARCH DIS CHILD, V85, P223, DOI 10.1136/adc.85.3.223; Carapetis JR, 2000, EPIDEMIOL INFECT, V124, P239, DOI 10.1017/S0950268800003514; Carapetis JR, 1999, ARCH DIS CHILD, V80, P353, DOI 10.1136/adc.80.4.353; CARAPETIS JR, 2004, OXFORD TXB MED, P1050; CARAPETIS JR, 2004, WHOFCHCAH0507, P1; CARAPETIS JR, 2000, STREPTOCOCCI STREPTO, P155; CARP C, 1999, WHO WHF UNESCO JOINT, P1; CARTER M E, 1962, Br Med J, V1, P965; CATANZARO FJ, 1958, NEW ENGL J MED, V259, P51, DOI 10.1056/NEJM195807102590201; *CENTR AUSTR RHD S, 2002, CENTR AUSTR RHEUM HE, P1; Cernay J, 1993, Cesk Pediatr, V48, P79; CHEADLE WB, 1889, LANCET, V1, P821; Chou HT, 2004, AM HEART J, V148, P181, DOI 10.1016/j.ahj.2004.03.032; Chun L T, 1992, Hawaii Med J, V51, P206; CHUN LT, 1984, AM J DIS CHILD, V138, P476, DOI 10.1001/archpedi.1984.02140430052013; CILLIERS AM, 2003, COCHRANE DB SYST REV, V2; Coburn AF, 1935, J CLIN INVEST, V14, P755, DOI 10.1172/JCI100723; *COMB RHEUM FEV ST, 1965, NEW ENGL J MED, V272, P63; Cotrim C, 1994, Rev Port Cardiol, V13, P581; COULEHAN JL, 1982, PUBLIC HEALTH REP, V97, P73; COUZOS S, 2003, ABORIGINAL PRIMARY H, P281; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Cunningham MW, 2004, MOL IMMUNOL, V40, P1121, DOI 10.1016/j.molimm.2003.11.023; Cunningham MW, 2003, FRONT BIOSCI, V8, pS533, DOI 10.2741/1067; DAJANI AS, 1992, JAMA-J AM MED ASSOC, V268, P2069, DOI 10.1001/jama.1992.03490150121036; Danchin MH, 2002, MED J AUSTRALIA, V177, P512, DOI 10.5694/j.1326-5377.2002.tb04925.x; DAOUD AS, 1990, NEUROLOGY, V40, P1140, DOI 10.1212/WNL.40.7.1140; DECUNTO CL, 1988, PEDIATR INFECT DIS J, V7, P683, DOI 10.1097/00006454-198810000-00002; DENNY FW, 1950, JAMA-J AM MED ASSOC, V143, P151, DOI 10.1001/jama.1950.02910370001001; Dey N, 2005, CLIN INFECT DIS, V40, P46, DOI 10.1086/426443; DISCIASCIO G, 1980, AM HEART J, V99, P635, DOI 10.1016/0002-8703(80)90739-5; Donadi EA, 2000, J NEUROL, V247, P122, DOI 10.1007/s004150050027; DORFMAN A, 1961, PEDIATRICS, V27, P692; DUDDING BA, 1968, J EXP MED, V128, P1081, DOI 10.1084/jem.128.5.1081; Eltohami EA, 1997, ANGIOLOGY, V48, P481, DOI 10.1177/000331979704800602; ESHEL G, 1993, EUR J PEDIATR, V152, P645, DOI 10.1007/BF01955239; ESSOP MR, 1993, J AM COLL CARDIOL, V22, P826, DOI 10.1016/0735-1097(93)90197-9; Feder HM, 1999, PEDIATRICS, V103, P47, DOI 10.1542/peds.103.1.47; FELDMAN BM, 1993, J PEDIATR-US, V123, P84, DOI 10.1016/S0022-3476(05)81544-6; FIELD B, 2004, RHEUMATIC HEART DIS; Figueroa F, 2002, J AUTOIMMUN, V19, P233, DOI 10.1006/jaut.2002.0620; Figueroa FE, 2001, HEART, V85, P407, DOI 10.1136/heart.85.4.407; Folomeeva O M, 1996, Vestn Ross Akad Med Nauk, P21; Galvin JE, 2000, J CLIN INVEST, V106, P217, DOI 10.1172/JCI7132; Galvin JE, 2002, AM J PATHOL, V160, P297, DOI 10.1016/S0002-9440(10)64373-8; Gardiner DL, 1996, J CLIN MICROBIOL, V34, P1448, DOI 10.1128/JCM.34.6.1448-1452.1996; GAUSCH LJ, 1962, AM J MED SCI, V244, P290; Genel F, 2002, BRAIN DEV-JPN, V24, P73, DOI 10.1016/S0387-7604(01)00404-1; Gentles TL, 2001, J AM COLL CARDIOL, V37, P201, DOI 10.1016/S0735-1097(00)01058-5; GIBOFSKY A, 1991, J RHEUMATOL, V18, P1; GINSBURG CM, 1982, PEDIATRICS, V69, P452; GOLDSTEI.I, 1967, NATURE, V213, P44, DOI 10.1038/213044a0; GORDIS L, 1969, J CHRON DIS, V21, P655, DOI 10.1016/0021-9681(69)90037-X; GROVER A, 1993, B WORLD HEALTH ORGAN, V71, P59; Guedez Y, 1999, CIRCULATION, V99, P2784, DOI 10.1161/01.CIR.99.21.2784; Guilherme L, 2004, INT ARCH ALLERGY IMM, V134, P56, DOI 10.1159/000077915; Guilherme L, 2001, INFECT IMMUN, V69, P5345, DOI 10.1128/IAI.69.9.5345-5351.2001; GUILHERME L, 1995, CIRCULATION, V92, P415, DOI 10.1161/01.CIR.92.3.415; Haidan A, 2000, LANCET, V356, P1167, DOI 10.1016/S0140-6736(00)02765-3; Harel L, 2002, CLIN GENET, V61, P293, DOI 10.1034/j.1399-0004.2002.610409.x; Hasab A. A., 1997, Eastern Mediterranean Health Journal, V3, P17; Hashkes PJ, 2003, J PEDIATR-US, V143, P399, DOI 10.1067/S0022-3476(03)00388-3; HERDY GVH, 1992, BRAZ J MED BIOL RES, V25, P789; Hernandez-Pacheco G, 2003, INT J CARDIOL, V92, P49, DOI 10.1016/S0167-5273(03)00040-8; Hilario MOE, 2000, J RHEUMATOL, V27, P1082; Hu MC, 2002, INFECT IMMUN, V70, P2171, DOI 10.1128/IAI.70.4.2171-2177.2002; ILLINGWORTH RS, 1957, LANCET, V2, P653; Jones TD, 1944, J AMER MED ASSOC, V126, P481, DOI 10.1001/jama.1944.02850430015005; Kalia A, 2003, FEMS MICROBIOL LETT, V219, P291, DOI 10.1016/S0378-1097(03)00022-3; Kalia A, 2002, INFECT IMMUN, V70, P1971, DOI 10.1128/IAI.70.4.1971-1983.2002; Kalia A, 2001, INFECT IMMUN, V69, P4858, DOI 10.1128/IAI.69.8.4858-4869.2001; Kamblock J, 2003, EUR HEART J, V24, P855, DOI 10.1016/S0195-668X(02)00825-4; KAPLAN EL, 1970, J CLIN INVEST, V49, P1405, DOI 10.1172/JCI106358; KAPLAN EL, 1974, J PEDIATR-US, V84, P21, DOI 10.1016/S0022-3476(74)80548-2; Kaplan EL, 1995, B WORLD HEALTH ORGAN, V73, P583; Kaur S, 1998, INT J CARDIOL, V64, P9, DOI 10.1016/S0167-5273(98)00009-6; KAYEMBA KS, 1993, PEDIATRIE, V48, P823; Kechrid A, 1997, ADV EXP MED BIOL, V418, P121; KEMENY E, 1994, CLIN IMMUNOL IMMUNOP, V72, P35, DOI 10.1006/clin.1994.1104; KERMANI S, 2001, SITUATION EPIDEMIOLO; KHANNA AK, 1989, J CLIN INVEST, V83, P1710, DOI 10.1172/JCI114071; Kotloff KL, 2004, PEDIATR INFECT DIS J, V23, P765, DOI 10.1097/01.inf.0000136296.98686.c5; Kotloff KL, 2004, JAMA-J AM MED ASSOC, V292, P709, DOI 10.1001/jama.292.6.709; Kumar D, 2001, MOL CELL BIOCHEM, V218, P21, DOI 10.1023/A:1007204208281; Kumar R, 1997, Indian Heart J, V49, P282; Kumar Rajesh, 2002, Indian Heart J, V54, P54; Kuttner AG, 1941, J CLIN INVEST, V20, P273, DOI 10.1172/JCI101220; Lan AJ, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.2.e19; Lanna CCD, 2003, CARDIOL YOUNG, V13, P431, DOI 10.1017/S104795110300091X; Lawrence G, 2005, B WORLD HEALTH ORGAN, V83, P34; LENNON D, 2000, STREPTOCOCCI STREPTO, P503; LENNON DR, 2002, 42 INT C ANT AG CHEM, pG1481; LIONET P, 2001, P 2 INT CARD C S PAC; LOPEZ ESL, 2001, ARCH CARDIOLOGICA ME, V71, P127; LOPEZ R, 2000, RF RHD COMPREHENSIVE; LUE HC, 1994, J PEDIATR-US, V125, P812, DOI 10.1016/S0022-3476(94)70082-6; Lymbury RS, 2003, J AUTOIMMUN, V20, P211, DOI 10.1016/S0896-8411(03)00026-X; MAJEED HA, 1992, J CLIN EPIDEMIOL, V45, P871, DOI 10.1016/0895-4356(92)90070-4; MANYEMBA J, 2002, COCHRANE DB SYST REV, V3; MARKOWITZ M, 1957, PEDIATRICS, V19, P201; Markowitz M, 1998, PEDIATRICS, V102, P272; MARKOWITZ M, 1999, RHEUMATIC FEVER, P299; MARTIN D, 1997, RECENT ADV MICROBIOL, P1; MARTIN DR, 1994, PEDIATR INFECT DIS J, V13, P264, DOI 10.1097/00006454-199404000-00004; MASSELL BF, 1988, NEW ENGL J MED, V318, P280, DOI 10.1056/NEJM198802043180504; McDonald M, 2004, LANCET INFECT DIS, V4, P240, DOI 10.1016/S1473-3099(04)00975-2; McGregor KF, 2004, J INFECT DIS, V189, P717, DOI 10.1086/381452; MEIRA ZMA, 1993, J PEDIATR-US, V123, P156; MEIRA ZMA, 1995, ARQ BRAS CARDIOL, V65, P331; MICHAUD C, 1999, RHEUMATIC FEVER, P485; Minich LD, 1997, CLIN CARDIOL, V20, P924, DOI 10.1002/clc.4960201105; MORTIMER EA, 1959, NEW ENGL J MED, V260, P101, DOI 10.1056/NEJM195901152600301; Mota CC, 2001, CARDIOL YOUNG, V11, P251, DOI 10.1017/S1047951101000257; Myo Thet Htoon, 1992, Asia Pac J Public Health, V6, P188; Narula J, 2001, LANCET, V358, P2000, DOI 10.1016/S0140-6736(01)06993-8; NOAH PK, 1994, J TROP PEDIATRICS, V40, P94, DOI 10.1093/tropej/40.2.94; Omar A, 1995, Med J Malaysia, V50, P125; Ozkutlu S, 2001, CARDIOL YOUNG, V11, P255, DOI 10.1017/S1047951101000269; Padmavati S, 2001, Indian Heart J, V53, P35; Pena J, 2002, ARQ NEURO-PSIQUIAT, V60, P374, DOI 10.1590/S0004-282X2002000300006; Peyramond D, 1996, SCAND J INFECT DIS, V28, P497, DOI 10.3109/00365549609037947; PHIBBS B, 1958, JAMA-J AM MED ASSOC, V166, P1113, DOI 10.1001/jama.1958.02990100001001; POTTER EV, 1978, J PEDIATR-US, V92, P325, DOI 10.1016/S0022-3476(78)80036-5; Pruksakorn S, 2000, J CLIN MICROBIOL, V38, P1250, DOI 10.1128/JCM.38.3.1250-1254.2000; QUINN RW, 1989, REV INFECT DIS, V11, P928; RAMMELKAMP C, 1961, YALE J BIOL MED, V34, P386; RAMMELKAMP C H Jr, 1955, Harvey Lect, V51, P113; Regmi P R, 1997, Indian Heart J, V49, P518; Richmond P, 1998, J TROP PEDIATRICS, V44, P148, DOI 10.1093/tropej/44.3.148; Roberts S, 2001, J INFECT DIS, V183, P507, DOI 10.1086/318076; Robertson KA, 2004, EUR HEART J, V25, P527; RUTSTEIN DD, 1956, CIRCULATION, V13, P617, DOI 10.1161/01.CIR.13.4.617; RUTSTEIN DD, 1965, CIRCULATION, V32, P457; SANYAL SK, 1974, CIRCULATION, V49, P7, DOI 10.1161/01.CIR.49.1.7; Schafranski MD, 2004, CLIN EXP IMMUNOL, V138, P521, DOI 10.1111/j.1365-2249.2004.02645.x; SHIFFMAN RN, 1995, ARCH PEDIAT ADOL MED, V149, P727, DOI 10.1001/archpedi.1995.02170200017002; Shulman ST, 2002, CURR OPIN RHEUMATOL, V14, P562, DOI 10.1097/00002281-200209000-00014; SHVARTZMAN P, 1993, BRIT MED J, V306, P1170, DOI 10.1136/bmj.306.6886.1170; Simonini G, 2004, SEMIN ARTHRITIS RHEU, V34, P553, DOI 10.1016/j.semarthrit.2004.04.001; SMITH SC, 1992, P NATL ACAD SCI USA, V89, P9131, DOI 10.1073/pnas.89.19.9131; SPAGNUOL.M, 1971, NEW ENGL J MED, V285, P641, DOI 10.1056/NEJM197109162851201; Steer AC, 1999, ARCH DIS CHILD, V81, P373, DOI 10.1136/adc.81.4.372d; Stollerman GH, 1997, LANCET, V349, P935, DOI 10.1016/S0140-6736(96)06364-7; STOLLERMAN GH, 1955, NEW ENGL J MED, V252, P787, DOI 10.1056/NEJM195505122521901; Stollerman GH, 2001, CLIN INFECT DIS, V33, P806, DOI 10.1086/322665; STOLLERMAN GH, 1991, CLIN IMMUNOL IMMUNOP, V61, P131, DOI 10.1016/S0090-1229(05)80019-4; SWEDO SE, 1994, JAMA-J AM MED ASSOC, V272, P1788, DOI 10.1001/jama.272.22.1788; TANEJA V, 1989, CIRCULATION, V80, P335, DOI 10.1161/01.CIR.80.2.335; Tani LY, 2003, PEDIATRICS, V112, P1065, DOI 10.1542/peds.112.5.1065; TAPLIN D, 1991, LANCET, V337, P1016, DOI 10.1016/0140-6736(91)92669-S; TARAN LM, 1947, AM J MED, V2, P285, DOI 10.1016/0002-9343(47)90234-9; THORNLEY C, 2000, STREPTOCOCCI STREPTO, P541; TOMPKINS DG, 1972, CIRCULATION, V45, P543, DOI 10.1161/01.CIR.45.3.543; Uziel Y, 2000, J PEDIATR-US, V137, P269, DOI 10.1067/mpd.2000.107158; VANBUYNDER PG, 1992, MED J AUSTRALIA, V156, P537, DOI 10.5694/j.1326-5377.1992.tb121414.x; Vasan RS, 1996, CIRCULATION, V94, P73, DOI 10.1161/01.CIR.94.1.73; Veasy LG, 2004, PEDIATRICS, V113, pE168, DOI 10.1542/peds.113.3.e168; VEASY LG, 1994, J PEDIATR-US, V124, P9, DOI 10.1016/S0022-3476(94)70247-0; Veasy LG, 2001, LANCET, V357, P1994, DOI 10.1016/S0140-6736(00)05134-5; VEASY LG, 1987, NEW ENGL J MED, V316, P421, DOI 10.1056/NEJM198702193160801; Visentainer JEL, 2000, J RHEUMATOL, V27, P1518; Voss LM, 2001, CIRCULATION, V103, P401; WANNAMAKER LW, 1970, NEW ENGL J MED, V282, P23, DOI 10.1056/NEJM197001082820206; WANNAMAKER LW, 1973, CIRCULATION, V48, P9, DOI 10.1161/01.CIR.48.1.9; Weisz JL, 2004, CLIN DIAGN LAB IMMUN, V11, P330, DOI 10.1128/CDLI.11.2.330-336.2004; *WHO, 2004, WHO EXP CONS GEN 29; WIDDOWSON JP, 1971, J HYG-CAMB, V69, P553, DOI 10.1017/S0022172400021823; Williams RV, 2002, CARDIOL YOUNG, V12, P519, DOI 10.1017/S104795110200094X; Wilson MG, 1943, J PEDIATR-US, V22, P468, DOI 10.1016/S0022-3476(43)80097-4; WILSON NJ, 1995, INT J CARDIOL, V50, P1, DOI 10.1016/0167-5273(95)02325-Q; WOOD HF, 1964, ANN INTERN MED, V60, P31, DOI 10.7326/0003-4819-60-2-31; Zaman MM, 1998, INT J CARDIOL, V66, P17, DOI 10.1016/S0167-5273(98)00140-5	202	382	393	0	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2005	366	9480					155	168		10.1016/S0140-6736(05)66874-2	http://dx.doi.org/10.1016/S0140-6736(05)66874-2			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	943JH	16005340				2022-12-28	WOS:000230349200036
J	Al-Marzouki, S; Evans, S; Marshall, T; Roberts, I				Al-Marzouki, S; Evans, S; Marshall, T; Roberts, I			Are these data real? Statistical methods for the detection of data fabrication in clinical trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FRAUD	Objectives 16 test the application of statistical methods to detect data fabrication in a clinical trial Setting Data from two clinical trials: a trial of a dietary intervention for cardiovascular disease and a trial of a drug intervention for the same problem. Outcome measures Baseline comparisons of means and variances of cardiovascular risk factors; digit preference overall and its pattern by group. Results In the dietary intervention trial, variances for 16 of the 22 variables available at baseline were significally different, and 10 significant differences were seen in means for these variables. Some of these P values were extraordinarily small. Distributions of the final recorded digit were significantly different between the intervention and the control group at baseline for 14/22 variables in the dietary trial. In the drug trial, only five variables were available, and no significant differences between the groups for baseline values in means or variances or digit preference were seen. Conclusions Several statistical features of the data from the dietary trial are so strongly suggestive of data fabrication that no other explanation is likely.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Med Stat Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Evans, S (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Med Stat Unit, London WC1E 7HT, England.	stephen.evans@Lshtm.ac.uk	Al-Marzouki, Sanaa/C-6082-2013; Kriyenko, Olek/AAV-1346-2021	Evans, Stephen/0000-0002-1474-2596				Altman DG, 1991, PRACTICAL STAT MED R, P122; Berry G, 1994, STAT METHODS MED RES, P386; Buyse M, 1999, STAT MED, V18, P3435, DOI 10.1002/(SICI)1097-0258(19991230)18:24<3435::AID-SIM365>3.3.CO;2-F; Evans S, 2001, FRAUD MISCONDUCT MED, P186; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; Taylor RN, 2002, DRUG INF J, V36, P115, DOI 10.1177/009286150203600115	6	77	79	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2005	331	7511					267	270		10.1136/bmj.331.7511.267	http://dx.doi.org/10.1136/bmj.331.7511.267			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953FJ	16052019	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000231061700019
J	Almroth, L; Elmusharaf, S; El Hadi, N; Obeid, A; El Sheikh, MAA; Elfadil, SM; Bergstrom, S				Almroth, L; Elmusharaf, S; El Hadi, N; Obeid, A; El Sheikh, MAA; Elfadil, SM; Bergstrom, S			Primary infertility after genital mutilation in girlhood in Sudan: a case-control study	LANCET			English	Article							SUB-SAHARAN AFRICA; FEMALE CIRCUMCISION; HEALTH CONSEQUENCES; SCHISTOSOMIASIS; TUBERCULOSIS	Background In theory, infections that arise after female genital mutilation (FGM) in childhood might ascend to the internal genitalia, causing inflammation and scarring and subsequent tubal-factor infertility. Our aim was to investigate this possible association between FGM and primary infertility. Methods We did a hospital-based case-control study in Khartoum, Sudan, to which we enrolled women (n=99) with primary infertility not caused by hormonal or iatrogenic factors (previous abdominal surgery), or the result of malefactor infertility. These women underwent diagnostic laparoscopy. Our controls were primigravidae women (n=180) recruited from antenatal care. We used exact conditional logistic regression, stratifying for age and controlling for socioeconomic status, level of education, gonorrhoea, and chlamydia, to compare these groups with respect to FGM. Findings Of the 99 infertile women examined, 48 had adnexal pathology indicative of previous inflammation. After controlling for covariates, these women had a significantly higher risk than controls of having undergone the most extensive form of FGM, involving the labia majora (odds ratio 4.69, 95% CI 1.49-19.7). Among women with primary infertility, both those with tubal pathology and those with normal laparoscopy findings were at a higher risk than controls of extensive FGM, both with borderline significance (p=0.054 and p=0.055, respectively). The anatomical extent of FGM, rather than whether or not the vulva had been sutured or closed, was associated with primary infertility. Interpretation Our findings indicate a positive association between the anatomical extent of FGM and primary infertility. Laparoscopic postinflammatory adnexal changes are not the only explanation for this association, since cases without such pathology were also affected. The association between FGM and primary infertility is highly relevant for preventive work against this ancient practice.	Karolinska Inst, Div Int Hlth, SE-17176 Stockholm, Sweden; Univ Khartoum, Dept Obstet & Gynaecol, Khartoum, Sudan	Karolinska Institutet; University of Khartoum	Almroth, L (corresponding author), Karolinska Inst, Div Int Hlth, SE-17176 Stockholm, Sweden.	L.Almroth@telia.com						Aliyu MH, 2004, INT J FERTIL WOMEN M, V49, P123; Almroth L, 2001, INT J GYNECOL OBSTET, V74, P179, DOI 10.1016/S0020-7292(01)00392-7; BALK D, 2000, FEMALE CIRCUMCISION; BODDY J, 1982, AM ETHNOL, V9, P682, DOI 10.1525/ae.1982.9.4.02a00040; DESILVA S, 1989, EUR J OBSTET GYN R B, V32, P233, DOI 10.1016/0028-2243(89)90041-5; ELDAREER AA, 1983, TROP DOCT, V13, P41, DOI 10.1177/004947558301300114; Gruenbaum Ellen, 1982, MED ANTHR NEWSLETTER, V13, P4; Inhorn M C, 1993, Med Anthropol, V15, P217; Jahromi BN, 2001, INT J GYNECOL OBSTET, V75, P269, DOI 10.1016/S0020-7292(01)00494-5; Jones H, 1999, STUD FAMILY PLANN, V30, P219, DOI 10.1111/j.1728-4465.1999.00219.x; LARSEN U, 1994, POP STUD-J DEMOG, V48, P459, DOI 10.1080/0032472031000147976; Larsen U, 2002, J BIOSOC SCI, V34, P363, DOI 10.1017/S0021932002003632; Larsen U, 2000, INT J EPIDEMIOL, V29, P285, DOI 10.1093/ije/29.2.285; LARSEN UM, 1989, REPROD SOCIAL ORG SU; Lenzi E, 1970, Acta Eur Fertil, V2, P47; Morison L, 2001, TROP MED INT HEALTH, V6, P643, DOI 10.1046/j.1365-3156.2001.00749.x; NELSON WE, 2000, NELSON TXB PEDIAT, P1660; Obermeyer CM, 2003, MED ANTHROPOL Q, V17, P394, DOI 10.1525/maq.2003.17.3.394; Okonofua FE, 2002, BJOG-INT J OBSTET GY, V109, P1089, DOI 10.1111/j.1471-0528.2002.01550.x; Poggensee G, 1998, AM J TROP MED HYG, V59, P782, DOI 10.4269/ajtmh.1998.59.782; Poggensee G, 2001, ACTA TROP, V79, P193, DOI 10.1016/S0001-706X(01)00086-9; Rahman A, 2000, FEMALE GENITAL MUTIL; REIMANN K, 1987, GENITOURIN MED, V63, P250; RUSHWAN H, 1980, AM J OBSTET GYNECOL, V138, P877, DOI 10.1016/0002-9378(80)91076-5; Shandall A A, 1967, Sudan Med J, V5, P178; Talle A., 1993, CARVED FLESH CAST SE; Verzin J, 1975, TROPICAL DOCTOR, V5, P163; WHO Technical Working Group, 1996, FEM GEN MUT; World Health Organization, 1998, FEMALE GENITAL MUTIL; Yount KM, 2004, ADV GEND RES, V8, P199, DOI 10.1016/S1529-2126(04)08007-5; ZAKI AM, 1966, J OBSTET GYN BR COMM, V73, P302; 1991, SUDAN DEMOGRAPHIC HL	32	76	76	1	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 30	2005	366	9483					385	391		10.1016/S0140-6736(05)67023-7	http://dx.doi.org/10.1016/S0140-6736(05)67023-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	950IB	16054938				2022-12-28	WOS:000230849700025
J	Wawersik, M; Milutinovich, A; Casper, AL; Matunis, E; Williams, B; Van Doren, M				Wawersik, M; Milutinovich, A; Casper, AL; Matunis, E; Williams, B; Van Doren, M			Somatic control of germline sexual development is mediated by the JAK/STAT pathway	NATURE			English	Article							CELL SELF-RENEWAL; DROSOPHILA EMBRYOS; SIGNALING PATHWAY; PROTEIN; STAT; GENE; ACTIVATION; EXPRESSION; DIMORPHISM; MUTATIONS	Germ cells must develop along distinct male or female paths to produce the sperm or eggs required for sexual reproduction. In both mouse and Drosophila, the sexual identity of germ cells is influenced by the sex of the surrounding somatic tissue (for example, refs 1, 2, reviewed in refs 3, 4); however, little is known about how the soma controls germline sex determination. Here we show that the janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway provides a sex-specific signal from the soma to the germ line in Drosophila embryonic gonads. The somatic gonad expresses a JAK/STAT ligand, unpaired (upd), in a male-specific manner, and activates the JAK/STAT pathway in male germ cells at the time of gonad formation. Furthermore, the JAK/STAT pathway is necessary for male-specific germ cell behaviour during early gonad development, and is sufficient to activate aspects of male germ cell behaviour in female germ cells. Our findings provide direct evidence that the JAK/STAT pathway mediates a key signal from the somatic gonad that regulates male germline sexual development.	Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Van Doren, M (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	vandoren@jhu.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD046619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063023, F32GM066562] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD046619] Funding Source: Medline; NIGMS NIH HHS [R01 GM063023, F32 GM066562, T32 GM007231] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; Boyle M, 1997, DEVELOPMENT, V124, P971; Callus BA, 2002, ONCOGENE, V21, P4812, DOI 10.1038/sj.onc.1205618; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; DeFalco TJ, 2003, DEV CELL, V5, P205, DOI 10.1016/S1534-5807(03)00204-1; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Hou SX, 2002, DEV CELL, V3, P765, DOI 10.1016/S1534-5807(02)00376-3; Ichiba M, 1998, J BIOL CHEM, V273, P6132, DOI 10.1074/jbc.273.11.6132; Janzer B, 2001, MECH DEVELOP, V100, P3, DOI 10.1016/S0925-4773(00)00529-3; Jinks TM, 2000, MOL CELL, V5, P581, DOI 10.1016/S1097-2765(00)80451-7; Kerkis J, 1931, GENETICS, V16, P0212; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Li JH, 2003, DEV CELL, V5, P787, DOI 10.1016/S1534-5807(03)00328-9; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; MCLAREN A, 1981, J REPROD FERTIL, V61, P461, DOI 10.1530/jrf.0.0610461; Moore LA, 1998, DEVELOPMENT, V125, P667; NAGOSHI RN, 1990, GENE DEV, V4, P89, DOI 10.1101/gad.4.1.89; Oliver B, 2002, INT REV CYTOL, V219, P1; PATEL NH, 1994, DROSOPHILA MELANOGAS, P445; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; SCHUPBACH T, 1982, DEV BIOL, V89, P117, DOI 10.1016/0012-1606(82)90300-1; Sefton L, 2000, NATURE, V405, P970, DOI 10.1038/35016119; Sonnenblick B. P., 1941, P NATL ACAD SCI USA, V26, P373; Staab S, 1996, DEVELOPMENT, V122, P4065; STEINMANNZWICKY M, 1989, SXL CELL, V57, P157; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Van Doren M, 1998, NATURE, V396, P466, DOI 10.1038/24871; Zhang N, 1997, NATURE, V385, P64, DOI 10.1038/385064a0	30	97	100	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					563	567		10.1038/nature03849	http://dx.doi.org/10.1038/nature03849			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049490	Green Accepted			2022-12-28	WOS:000230788800063
J	Cox, TM; Jack, N; Lofthouse, S; Watling, J; Haines, J; Warren, MJ				Cox, TM; Jack, N; Lofthouse, S; Watling, J; Haines, J; Warren, MJ			King George III and porphyria: an elemental hypothesis and investigation	LANCET			English	Editorial Material							ARSENIC TOXICITY	In 1969 it was proposed that the episodic madness suffered by King George III (1738-1820) resulted from an acute hereditary porphyria, variegate porphyria, caused by deficiency of protoporphyrinogen oxidase. The diagnosis was based on the historical archive and a contentious claim that living members of the House of Hanover were affected with the condition. A re-examination of the medical evidence and the appearance of new historical material have suggested that porphyria did indeed exist in the Royal Houses of Europe. We report the analysis of hair obtained from George III. Although no genomic DNA could be obtained, metal analysis revealed high concentrations of arsenic. Since arsenic interferes with haem metabolism, it might have contributed to the King's unusually severe and prolonged bouts of illness. We have identified sources of arsenic in the context of the medication George III received from physicians.	Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England; Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; Harwell Sci, Didcot, Oxon, England; Curtin Univ Technol, Perth, WA 6001, Australia	University of Kent; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Curtin University	Warren, MJ (corresponding author), Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England.	m.j.warren@kent.ac.uk		Warren, Martin/0000-0002-6028-6456	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Anderson K.E., 2001, METABOLIC MOL BASES, P2961; Apostoli P, 2002, AM J IND MED, V42, P180, DOI 10.1002/ajim.10123; GRENVILLE WW, 1853, MEMOIRS COURT CABINE; GREVEILLE RF, 1930, DIARIES COLONEL HON, P107; Guttmacher MS, 1941, AM LAST KING INTERPR; HINDMARSH JT, 1986, CRC CR REV CL LAB SC, V23, P315, DOI 10.3109/10408368609167122; HUGHES GS, 1983, SOUTHERN MED J, V76, P1027, DOI 10.1097/00007611-198308000-00022; Hunter Richard, 1969, GEORGE III MAD BUSIN; MACALPINE I, 1966, BMJ-BRIT MED J, V1, P65, DOI 10.1136/bmj.1.5479.65; MACALPINE I, 1968, BMJ-BRIT MED J, V1, P7, DOI 10.1136/bmj.1.5583.7; Ratnaike RN, 2003, POSTGRAD MED J, V79, P391, DOI 10.1136/pmj.79.933.391; Ray N. N., 1855, AM J INSANITY, V12, P1; ROHL JC, 1998, PURPLE SECRET GENES; ROHL JCG, 1994, JUGEND KAISERS 1859; TAYLOR AS, 1849, POISONS RELATION MED; VIGNE R, 1986, J ROY COLL PHYS LOND, V20, P222; Wang JP, 2002, CELL MOL BIOL, V48, P835; WOODS JS, 1989, TOXICOL APPL PHARM, V97, P183, DOI 10.1016/0041-008X(89)90067-7	18	24	26	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2005	366	9482					332	335		10.1016/S0140-6736(05)66991-7	http://dx.doi.org/10.1016/S0140-6736(05)66991-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RJ	16039338				2022-12-28	WOS:000230733100034
J	Wanner, C; Krane, V; Marz, W; Olschewski, M; Mann, JFE; Ruf, G; Ritz, E				Wanner, C; Krane, V; Marz, W; Olschewski, M; Mann, JFE; Ruf, G; Ritz, E		German Diabetes Dialysis Study Inv	Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOVASCULAR-DISEASE; CLINICAL-TRIALS; CHOLESTEROL; DEATH; MORTALITY; IMPACT	Background: Statins reduce the incidence of cardiovascular events in persons with type 2 diabetes mellitus. However, the benefit of statins in such patients receiving hemodialysis, who are at high risk for cardiovascular disease and death, has not been examined. Methods: We conducted a multicenter, randomized, double-blind, prospective study of 1255 subjects with type 2 diabetes mellitus receiving maintenance hemodialysis who were randomly assigned to receive 20 mg of atorvastatin per day or matching placebo. The primary end point was a composite of death from cardiac causes, nonfatal myocardial infarction, and stroke. Secondary end points included death from all causes and all cardiac and cerebrovascular events combined. Results: After four weeks of treatment, the median level of low-density lipoprotein cholesterol was reduced by 42 percent among patients receiving atorvastatin, and among those receiving placebo it was reduced by 1.3 percent. During a median follow-up period of four years, 469 patients (37 percent) reached the primary end point, of whom 226 were assigned to atorvastatin and 243 to placebo (relative risk, 0.92; 95 percent confidence interval, 0.77 to 1.10; P=0.37). Atorvastatin had no significant effect on the individual components of the primary end point, except that the relative risk of fatal stroke among those receiving the drug was 2.03 (95 percent confidence interval, 1.05 to 3.93; P=0.04). Atorvastatin reduced the rate of all cardiac events combined (relative risk, 0.82; 95 percent confidence interval, 0.68 to 0.99; P=0.03, nominally significant) but not all cerebrovascular events combined (relative risk, 1.12; 95 percent confidence interval, 0.81 to 1.55; P=0.49) or total mortality (relative risk, 0.93; 95 percent confidence interval, 0.79 to 1.08; P=0.33). Conclusions: Atorvastatin had no statistically significant effect on the composite primary end point of cardiovascular death, nonfatal myocardial infarction, and stroke in patients with diabetes receiving hemodialysis.	Univ Wurzburg, Dept Med, Div Nephrol, Wurzburg, Germany; Univ Gen Hosp, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; Univ Hosp Freiburg, Dept Med Biometr & Stat, Freiburg, Germany; Schwabing Gen Hosp, Munich, Germany; Pfizer, Dept Clin Res, Karlsruhe, Germany; Heidelberg Univ, Dept Med, D-6900 Heidelberg, Germany	University of Wurzburg; University of Freiburg; Pfizer; Ruprecht Karls University Heidelberg	Wanner, C (corresponding author), Univ Hosp, Dept Med, Div Nephrol, Josef Schneider Str 2, D-97080 Wurzburg, Germany.	wanner_c@medizin.uni-wuerzburg.de	Mann, Johannes/AAI-8803-2020					Amann K, 1998, J AM SOC NEPHROL, V9, P1018; Armitage J, 2004, CURR OPIN LIPIDOL, V15, P439, DOI 10.1097/01.mol.0000137219.31407.16; Baigent C, 2000, LANCET, V356, P147, DOI 10.1016/S0140-6736(00)02456-9; Cheung BMY, 2004, BRIT J CLIN PHARMACO, V57, P640, DOI 10.1111/j.1365-2125.2003.02060.x; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; Iseki K, 2002, KIDNEY INT, V61, P1887, DOI 10.1046/j.1523-1755.2002.00324.x; KOCH M, 1993, DIABETOLOGIA, V36, P1113, DOI 10.1007/BF02374508; Koch M, 1997, J AM SOC NEPHROL, V8, P1889; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lins RL, 2003, NEPHROL DIAL TRANSPL, V18, P967, DOI 10.1093/ndt/gfg048; Mason NA, 2005, AM J KIDNEY DIS, V45, P119, DOI 10.1053/j.ajkd.2004.09.025; *NATI DIAB DIG KID, 2003, REN DAT SYST USRDS 2; NAUCK M, 1995, CLIN CHEM, V41, P1761; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; PEDERSEN TR, 1994, LANCET, V344, P1383; Prichard SS, 2003, J AM SOC NEPHROL, V14, pS315, DOI 10.1097/01.ASN.0000081698.10331.83; Schulgen G, 2005, CONTEMP CLIN TRIALS, V26, P386, DOI 10.1016/j.cct.2005.01.010; Schwenger V, 2003, DEUT MED WOCHENSCHR, V128, P1216; Seliger SL, 2002, KIDNEY INT, V61, P297, DOI 10.1046/j.1523-1755.2002.00109.x; Takayama F, 1998, CELL MOL BIOL, V44, P1101; Tonelli M, 2004, CIRCULATION, V110, P1557, DOI 10.1161/01.CIR.0000143892.84582.60; TSCHOPE W, 1993, NEPHRON, V64, P354, DOI 10.1159/000187353; Wanner C, 1999, KIDNEY INT, V56, pS222, DOI 10.1046/j.1523-1755.1999.07158.x; Wanner C, 2004, KIDNEY BLOOD PRESS R, V27, P259, DOI 10.1159/000080241	29	1906	1967	1	78	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2005	353	3					238	248		10.1056/NEJMoa043545	http://dx.doi.org/10.1056/NEJMoa043545			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YH	16034009	Bronze			2022-12-28	WOS:000230608700004
J	Hatcher, S				Hatcher, S			Commentary: Why stop at antidepressants?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Auckland, Dept Psychol Med, Auckland 1, New Zealand	University of Auckland	Hatcher, S (corresponding author), Univ Auckland, Dept Psychol Med, PB92019, Auckland 1, New Zealand.	s.hatcher@auckland.ac.nz		Hatcher, Simon/0000-0003-3117-2350				Black N, 1996, BRIT MED J, V312, P1215; Gilbody SM, 2000, PSYCHOL MED, V30, P253, DOI 10.1017/S0033291700001732; Moncrieff J, 2005, BMJ-BRIT MED J, V331, P155, DOI 10.1136/bmj.331.7509.155; Parker G, 2004, AUST NZ J PSYCHIAT, V38, P408, DOI 10.1111/j.1440-1614.2004.01386.x; Safer DJ, 2002, J NERV MENT DIS, V190, P583, DOI 10.1097/00005053-200209000-00002	5	1	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 16	2005	331	7509					158	158		10.1136/bmj.331.7509.158	http://dx.doi.org/10.1136/bmj.331.7509.158			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	947GV	16020859	Green Published			2022-12-28	WOS:000230632300023
J	El-Sayed, NM; Myler, PJ; Blandin, G; Berriman, M; Crabtree, J; Aggarwal, G; Caler, E; Renauld, H; Worthey, EA; Hertz-Fowler, C; Ghedin, E; Peacock, C; Bartholomeu, DC; Haas, BJ; Tran, AN; Wortman, JR; Alsmark, UCM; Angiuoli, S; Anupama, A; Badger, J; Bringaud, F; Cadag, E; Carlton, JM; Cerqueira, GC; Creasy, T; Delcher, AL; Djikeng, A; Embley, TM; Hauser, C; Ivens, AC; Kummerfeld, SK; Pereira-Leal, JB; Nilsson, D; Peterson, J; Salzberg, SL; Shallom, J; Silva, JC; Sundaram, J; Westenberger, S; White, O; Metville, SE; Donelson, JE; Andersson, B; Stuart, KD; Hall, N				El-Sayed, NM; Myler, PJ; Blandin, G; Berriman, M; Crabtree, J; Aggarwal, G; Caler, E; Renauld, H; Worthey, EA; Hertz-Fowler, C; Ghedin, E; Peacock, C; Bartholomeu, DC; Haas, BJ; Tran, AN; Wortman, JR; Alsmark, UCM; Angiuoli, S; Anupama, A; Badger, J; Bringaud, F; Cadag, E; Carlton, JM; Cerqueira, GC; Creasy, T; Delcher, AL; Djikeng, A; Embley, TM; Hauser, C; Ivens, AC; Kummerfeld, SK; Pereira-Leal, JB; Nilsson, D; Peterson, J; Salzberg, SL; Shallom, J; Silva, JC; Sundaram, J; Westenberger, S; White, O; Metville, SE; Donelson, JE; Andersson, B; Stuart, KD; Hall, N			Comparative genomics of trypanosomatid parasitic protozoa	SCIENCE			English	Article							HOST-CELL INVASION; LEISHMANIA-MAJOR; MOLECULAR PHYLOGENY; BRUCEI; CRUZI; GENE; TRANSCRIPTION; EVOLUTION; PROTEIN; LIFE	A comparison of gene content and genome architecture of Trypanosoma brucei, Trypanosoma cruzi, and Leishmania major, three related pathogens with different life cycles and disease pathology,. revealed a conserved core proteome of about 6200 genes in large syntenic polycistronic gene clusters. Many, species-specific genes, especially large surface antigen families, occur at nonsyntenic chromosome-internal and subtelomeric regions. Retroelements, structural RNAs, and gene family expansion are often associated with syntenic discontinuities that-along with gene divergence, acquisition and loss, and rearrangement within the syntenic regions-have shaped the genomes of each parasite. Contrary to recent reports, our analyses reveal no evidence that these species are descended from an ancestor that contained a photosynthetic endosymbiont.	Inst Genom Res, Rockville, MD 20850 USA; George Washington Univ, Dept Microbiol & Trop Med, Washington, DC 20052 USA; Seattle Biomed Res Inst, Seattle, WA 98109 USA; Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA; Univ Washington, Div Biomed & Hlth Informat, Seattle, WA 98195 USA; Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; Karolinska Inst, Ctr Genom & Bioinformat, S-17177 Stockholm, Sweden; Univ Newcastle Upon Tyne, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Bordeaux 2, Lab Genom Fonct Trypanosomatides, CNRS, UMR 5162, F-33076 Bordeaux, France; Univ Fed Minas Gerais, Dept Bioquim & Imunol, BR-31270901 Belo Horizonte, MG, Brazil; MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	J. Craig Venter Institute; George Washington University; Center for Infectious Disease Research; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Wellcome Trust Sanger Institute; Karolinska Institutet; Newcastle University - UK; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Universidade Federal de Minas Gerais; MRC Laboratory Molecular Biology; University of Cambridge; University of Iowa	El-Sayed, NM (corresponding author), Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	neisayed@tigr.org; peter.myler@sbri.org; nhali@tigr.org	Myler, Peter John/AAR-9535-2021; Donelson, John E/F-5795-2010; Berriman, Matthew/A-7618-2011; Silva, Joana/GYQ-9526-2022; El-Sayed, Najib M.A./K-7266-2015; Pereira-Leal, Jose/C-5616-2012; Angiuoli, Samuel V/H-7340-2014; Nilsson, Daniel/B-8365-2009; Hall, Neil/A-8717-2013; Andersson, Bjorn/G-9832-2013; Alsmark, Cecilia/AAO-1330-2021; Cerqueira, Gustavo/AAV-7398-2020; Holetz, Fabíola Barbieri/A-5592-2013; Salzberg, Steven/Q-6514-2019; Bartholomeu, Daniella C./J-4714-2015; Salzberg, Steven L/F-6162-2011; Blandin, Gaelle/N-9745-2013; Ghedin, Elodie/Y-5654-2019; Silva, Joana/GVT-6441-2022	Berriman, Matthew/0000-0002-9581-0377; El-Sayed, Najib M.A./0000-0001-7970-3312; Nilsson, Daniel/0000-0001-5831-385X; Hall, Neil/0000-0002-7995-3810; Andersson, Bjorn/0000-0002-4624-0259; Cerqueira, Gustavo/0000-0002-7692-3886; Salzberg, Steven/0000-0002-8859-7432; Bartholomeu, Daniella C./0000-0003-0974-7357; Salzberg, Steven L/0000-0002-8859-7432; Blandin, Gaelle/0000-0003-2790-9524; Ghedin, Elodie/0000-0002-1515-725X; Myler, Peter/0000-0002-0056-0513; Hall, Neil/0000-0003-2808-0009; Kummerfeld, Sarah/0000-0002-0089-2358; Ivens, Al/0000-0002-0112-3876; Embley, Thomas Martin/0000-0002-1484-340X; Hertz-Fowler, Christiane/0000-0002-0729-6479; Angiuoli, Samuel/0000-0001-9525-4350; Pereira Leal, Jose/0000-0002-3111-7119; Djikeng, Appolinaire/0000-0001-9271-3419; Wortman, Jennifer/0000-0002-8713-1227	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI040599, U01AI045038, R01AI043062, U01AI045039, U01AI043062, U01AI045061] Funding Source: NIH RePORTER; NIAID NIH HHS [AI45038, U01 AI045038, U01 AI045039, U01 AI040599, AI45061, AI045039, U01 AI043062, R01 AI043062] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission)		Aerts S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-34; Armengol L, 2003, HUM MOL GENET, V12, P2201, DOI 10.1093/hmg/ddg223; Bailey JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r23; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Burleigh BA, 1998, CURR OPIN MICROBIOL, V1, P461, DOI 10.1016/S1369-5274(98)80066-0; Caler EV, 1998, EMBO J, V17, P4975, DOI 10.1093/emboj/17.17.4975; Carlton J, 2005, CURR ISSUES MOL BIOL, V7, P23; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Douzery EJP, 2004, P NATL ACAD SCI USA, V101, P15386, DOI 10.1073/pnas.0403984101; DRAGON EA, 1987, MOL CELL BIOL, V7, P1271, DOI 10.1128/MCB.7.3.1271; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Falcone FH, 2001, J IMMUNOL, V167, P5348, DOI 10.4049/jimmunol.167.9.5348; Gibson W, 1999, ADV PARASIT, V43, P1, DOI 10.1016/S0065-308X(08)60240-7; Haag J, 1998, MOL BIOCHEM PARASIT, V91, P37, DOI 10.1016/S0166-6851(97)00185-0; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hannaert V, 2003, P NATL ACAD SCI USA, V100, P1067, DOI 10.1073/pnas.0335769100; Higo H, 1997, INT J PARASITOL, V27, P1369, DOI 10.1016/S0020-7519(97)00097-0; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; LANGFORD CK, 1992, MOL BIOCHEM PARASIT, V55, P51, DOI 10.1016/0166-6851(92)90126-5; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Lukes J, 1997, J MOL EVOL, V44, P521, DOI 10.1007/PL00006176; Martinez-Calvillo S, 2003, MOL CELL, V11, P1291, DOI 10.1016/S1097-2765(03)00143-6; McDonagh PD, 2000, NUCLEIC ACIDS RES, V28, P2800, DOI 10.1093/nar/28.14.2800; MOTTRAM JC, 1989, MOL BIOCHEM PARASIT, V37, P115, DOI 10.1016/0166-6851(89)90108-4; Nilsson D, 2005, EXP PARASITOL, V109, P143, DOI 10.1016/j.exppara.2004.12.004; O'Brien SJ, 1999, SCIENCE, V286, P458, DOI 10.1126/science.286.5439.458; Overath P, 2001, INT J PARASITOL, V31, P468, DOI 10.1016/S0020-7519(01)00152-7; Pays E, 2004, CURR OPIN MICROBIOL, V7, P369, DOI 10.1016/j.mib.2004.05.001; SALMON D, 1994, CELL, V78, P75, DOI 10.1016/0092-8674(94)90574-6; Shi HF, 2004, MOL CELL BIOL, V24, P420, DOI 10.1128/MCB.24.1.420-427.2004; Stevens J R, 1999, Cad Saude Publica, V15, P673, DOI 10.1590/S0102-311X1999000400002; Stevens JR, 1999, PARASITOLOGY, V118, P107, DOI 10.1017/S0031182098003473; Stevens JR, 2001, ADV PARASIT, V48, P1, DOI 10.1016/S0065-308X(01)48003-1; Ullu E, 2004, CELL MICROBIOL, V6, P509, DOI 10.1111/j.1462-5822.2004.00399.x; Worthey EA, 2003, NUCLEIC ACIDS RES, V31, P4201, DOI 10.1093/nar/gkg469; Wright ADG, 1999, MOL BIOCHEM PARASIT, V99, P69, DOI 10.1016/S0166-6851(98)00184-4; Zhang JZ, 2000, TRENDS GENET, V16, P107, DOI 10.1016/S0168-9525(99)01922-8	39	582	615	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					404	409		10.1126/science.1112181	http://dx.doi.org/10.1126/science.1112181			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020724				2022-12-28	WOS:000230574900034
J	Andrews, NC; Anupindi, S; Harris, NL; Buie, TM; Badizadegan, K				Andrews, NC; Anupindi, S; Harris, NL; Buie, TM; Badizadegan, K			Case 21-2005: A four-week-old male infant with jaundice and thrombocytopenia - Neonatal giant-cell hepatitis with bridging fibrosis and early regenerative nodules, with iron deposition in hepatocytes and Kupffer cells (consistent with - but not diagnostic of - neonatal hemochromatosis).	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DELTA(4)-3-OXOSTEROID 5-BETA-REDUCTASE; LIVER-FAILURE; INBORN ERROR; GENE; MUTATIONS		Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Andrews, NC (corresponding author), Childrens Hosp, Dept Pediat, Boston, MA 02115 USA.			Andrews, Nancy/0000-0003-0243-4462				Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Fellman V, 2002, BLOOD CELL MOL DIS, V29, P444, DOI 10.1006/bcmd.2002.0582; FIENBERG R, 1960, AM J CLIN PATHOL, V33, P480, DOI 10.1093/ajcp/33.6.480; Flynn DM, 2003, ARCH DIS CHILD-FETAL, V88, pF124, DOI 10.1136/fn.88.2.F124; Kelly AL, 2001, J MED GENET, V38, P599, DOI 10.1136/jmg.38.9.599; KERSHISNIK MM, 1992, HUM PATHOL, V23, P1075, DOI 10.1016/0046-8177(92)90272-5; Knisely AS, 2003, GASTROENTEROL CLIN N, V32, P877, DOI 10.1016/S0889-8553(03)00050-5; Krahenbuhl S, 1999, J HEPATOL, V31, P550, DOI 10.1016/S0168-8278(99)80050-6; LAURENDEAU T, 1961, ARCH PATHOL, V72, P410; Lemonde HA, 2003, GUT, V52, P1494, DOI 10.1136/gut.52.10.1494; Morris S, 2004, PEDIATR NEPHROL, V19, P341, DOI 10.1007/s00467-003-1319-6; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Parizhskaya M, 1999, PEDIATR DEVEL PATHOL, V2, P360, DOI 10.1007/s100249900135; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; ROSENTHAL P, 2001, LIVER DIS CHILDREN, P239; SCHOENLEBE J, 1993, AM J DIS CHILD, V147, P1072, DOI 10.1001/archpedi.1993.02160340058014; SHNEIDER BL, 1994, J PEDIATR-US, V124, P234, DOI 10.1016/S0022-3476(94)70310-8; Siafakas CG, 1997, J PEDIATR GASTR NUTR, V25, P321, DOI 10.1097/00005176-199709000-00015; Sigurdsson L, 1998, J PEDIATR GASTR NUTR, V26, P85, DOI 10.1097/00005176-199801000-00015; Verloes A, 1997, AM J MED GENET, V68, P391, DOI 10.1002/(SICI)1096-8628(19970211)68:4<391::AID-AJMG3>3.0.CO;2-P; Whitington PF, 2004, LANCET, V364, P1690, DOI 10.1016/S0140-6736(04)17356-X	22	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2005	353	2					189	198		10.1056/NEJMcpc059016	http://dx.doi.org/10.1056/NEJMcpc059016			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944OP	16014889				2022-12-28	WOS:000230438800012
J	Sinkins, SP; Walker, T; Lynd, AR; Steven, AR; Makepeace, BL; Godfray, HCJ; Parkhill, J				Sinkins, SP; Walker, T; Lynd, AR; Steven, AR; Makepeace, BL; Godfray, HCJ; Parkhill, J			Wolbachia variability and host effects on crossing type in Culex mosquitoes	NATURE			English	Article							CYTOPLASMIC INCOMPATIBILITY; BACTERIOPHAGE-WO; PIPIENS L; POPULATIONS; DROSOPHILA; TRANSMISSION; ENDOSYMBIONT; ARTHROPODS; RESISTANCE; EVOLUTION	Wolbachia is a common maternally inherited bacterial symbiont able to induce crossing sterilities known as cytoplasmic incompatibility (CI) in insects(1,2). Wolbachia-modified sperm are unable to complete fertilization of uninfected ova, but a rescue function allows infected eggs to develop normally. By providing a reproductive advantage to infected females, Wolbachia can rapidly invade uninfected populations(3), and this could provide a mechanism for driving transgenes through pest populations(4,5). CI can also occur between Wolbachia-infected populations and is usually associated with the presence of different Wolbachia strains(1). In the Culex pipiens mosquito group ( including the filariasis vector C. quinquefasciatus) a very unusual degree of complexity of Wolbachia-induced crossing-types has been reported, with partial or complete CI that can be unidirectional or bidirectional(6-11), yet no Wolbachia strain variation was found(11). Here we show variation between incompatible Culex strains in two Wolbachia ankyrin repeat-encoding genes associated with a prophage region, one of which is sex-specifically expressed in some strains, and also a direct effect of the host nuclear genome on CI rescue.	Univ Oxford, Dept Zool, Oxford OX1 3SY, England; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Dept Biol Sci, Ascot SL5 7PY, Berks, England; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Oxford; Liverpool School of Tropical Medicine; University of Liverpool; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Wellcome Trust Sanger Institute	Sinkins, SP (corresponding author), Univ Oxford, Dept Zool, Peter Medawar Bldg,S Parks Rd, Oxford OX1 3SY, England.	steven.sinkins@zoo.ox.ac.uk	Walker, Thomas/B-9198-2014; Lynd, Amy/C-8938-2013; Parkhill, Julian/G-4703-2011; Walker, Thomas/F-6572-2013; Lynd, Amy/AAE-9640-2020	Walker, Thomas/0000-0002-3545-012X; Parkhill, Julian/0000-0002-7069-5958; Walker, Thomas/0000-0003-4475-5395; Lynd, Amy/0000-0001-6054-0525	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARR AR, 1980, NATURE, V283, P71, DOI 10.1038/283071a0; Callaini G, 1997, J CELL SCI, V110, P271; Caturegli P, 2000, INFECT IMMUN, V68, P5277, DOI 10.1128/IAI.68.9.5277-5283.2000; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Dobson SL, 2003, TRENDS PARASITOL, V19, P128, DOI 10.1016/S1471-4922(03)00002-3; Elfring LK, 1997, MOL BIOL CELL, V8, P583, DOI 10.1091/mbc.8.4.583; Guillemaud T, 1997, P ROY SOC B-BIOL SCI, V264, P245, DOI 10.1098/rspb.1997.0035; IRVINGBELL RJ, 1983, J MED ENTOMOL, V20, P44, DOI 10.1093/jmedent/20.1.44; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; Laven H, 1967, GENETICS INSECT VECT, P251; MAGNIN M, 1987, GENETICA, V74, P125, DOI 10.1007/BF00055223; Masui S, 2000, J MOL EVOL, V51, P491, DOI 10.1007/s002390010112; Masui S, 2001, BIOCHEM BIOPH RES CO, V283, P1099, DOI 10.1006/bbrc.2001.4906; Olson KE, 1996, SCIENCE, V272, P884, DOI 10.1126/science.272.5263.884; ONEILL SL, 1992, MED VET ENTOMOL, V6, P209, DOI 10.1111/j.1365-2915.1992.tb00608.x; ONeill SL, 1997, INFLUENTIAL PASSENGE; RAYMOND M, 1991, NATURE, V350, P151, DOI 10.1038/350151a0; ROUSSET F, 1991, J EVOLUTION BIOL, V4, P69, DOI 10.1046/j.1420-9101.1991.4010069.x; Sanogo YO, 2004, INSECT MOL BIOL, V13, P365, DOI 10.1111/j.0962-1075.2004.00498.x; Sinkins SP, 2004, P ROY SOC B-BIOL SCI, V271, P1421, DOI 10.1098/rspb.2004.2740; Sinkins SP, 2000, INSECT TRANSGENESIS, P271; Song She-Wu, 2002, Acta Entomologica Sinica, V45, P705; Tram U, 2002, SCIENCE, V296, P1124, DOI 10.1126/science.1070536; TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0; TURELLI M, 1994, EVOLUTION, V48, P1500, DOI 10.1111/j.1558-5646.1994.tb02192.x; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; WILLIAMS EH, 1993, J INVERTEBR PATHOL, V61, P206, DOI 10.1006/jipa.1993.1037; WRIGHT JD, 1978, J ULTRA MOL STRUCT R, V63, P79, DOI 10.1016/S0022-5320(78)80046-X; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	30	113	121	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2005	436	7048					257	260		10.1038/nature03629	http://dx.doi.org/10.1038/nature03629			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015330				2022-12-28	WOS:000230459500041
J	Ioannidis, JPA				Ioannidis, JPA			Contradicted and initially stronger effects in highly cited clinical research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CORONARY-HEART-DISEASE; LEFT-VENTRICULAR DYSFUNCTION; COLONY-STIMULATING FACTOR; IMMUNODEFICIENCY-VIRUS-INFECTION; CONVERTING ENZYME-INHIBITORS; ACUTE MYOCARDIAL-INFARCTION; HUMAN MONOCLONAL-ANTIBODY; ESTROGEN PLUS PROGESTIN; VITAMIN-E CONSUMPTION; TRANS-RETINOIC ACID	Context Controversy and uncertainty ensue when the results of clinical research on the effectiveness of interventions are subsequently contradicted. Controversies are most prominent when high-impact research is involved. Objectives To understand how frequently highly cited studies are contradicted or find effects that are stronger than in other similar studies and to discern whether specific characteristics are associated with such refutation over time. Design All original clinical research studies published in 3 major general clinical journals or high-impact-factor specialty journals in 1990-2003 and cited more than 1000 times in the literature were examined. Main Outcome Measure The results of highly cited articles were compared against subsequent studies of comparable or larger sample size and similar or better controlled designs. The same analysis was also performed comparatively for matched studies that were not so highly cited. Results Of 49 highly cited original clinical research studies, 45 claimed that the intervention was effective. Of these, 7 (16%) were contradicted by subsequent studies, 7 others (16%) had found effects that were stronger than those of subsequent studies, 20 (44%) were replicated, and 11 (24%) remained largely unchallenged. Five of 6 highly-cited nonrandomized studies had been contradicted or had found stronger effects vs 9 of 39 randomized controlled trials (P=.008). Among randomized trials, studies with contradicted or stronger effects were smaller (P=.009) than replicated or unchallenged studies although there was no statistically significant difference in their early or overall citation impact. Matched control studies did not have a significantly different share of refuted results than highly cited studies, but they included more studies with "negative" results. Conclusions Contradiction and initially stronger effects are not unusual in highly cited research of clinical interventions and their outcomes. The extent to which high citations may provoke contradictions and vice versa needs more study. Controversies are most common with highly cited nonrandomized studies, but even the most highly cited randomized trials may be challenged and refuted over time, especially small ones.	Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; Tufts Univ New England Med Ctr, Dept Med, Inst Clin Res & Hlth Policy Studies, Boston, MA USA	University of Ioannina; Tufts Medical Center	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece.	jioannid@cc.uoi.gr	Ioannidis, John P. A./G-9836-2011					Adachi JD, 2000, J RHEUMATOL, V27, P2424; Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Anand SS, 1999, JAMA-J AM MED ASSOC, V282, P2058, DOI 10.1001/jama.282.21.2058; Anderson JW, 2004, J AM COLL NUTR, V23, P5, DOI 10.1080/07315724.2004.10719338; [Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A; [Anonymous], 1991, JAMA, V265, P3255; Benavente O, 1998, BMJ-BRIT MED J, V317, P1477, DOI 10.1136/bmj.317.7171.1477; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Bhasin S, 1996, NEW ENGL J MED, V335, P1, DOI 10.1056/NEJM199607043350101; BRADLEY JD, 1991, NEW ENGL J MED, V325, P87, DOI 10.1056/NEJM199107113250203; Brisinda G, 1999, NEW ENGL J MED, V341, P65, DOI 10.1056/NEJM199907083410201; Brophy JM, 2001, ANN INTERN MED, V134, P550, DOI 10.7326/0003-4819-134-7-200104030-00008; Brophy JM, 2003, ANN INTERN MED, V138, P777, DOI 10.7326/0003-4819-138-10-200305200-00005; BROWN G, 1990, NEW ENGL J MED, V323, P1289, DOI 10.1056/NEJM199011083231901; Budman DR, 1998, J NATL CANCER I, V90, P1205, DOI 10.1093/jnci/90.16.1205; CALIFF RM, 1994, NEW ENGL J MED, V330, P956, DOI 10.1056/nejm199404073301402; Cappelleri JC, 1996, JAMA-J AM MED ASSOC, V276, P1332, DOI 10.1001/jama.276.16.1332; CASTAIGNE S, 1990, BLOOD, V76, P1704; Citron ML, 2003, J CLIN ONCOL, V21, P1431, DOI 10.1200/JCO.2003.09.081; COHN JN, 1991, NEW ENGL J MED, V325, P303, DOI 10.1056/NEJM199108013250502; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; CRAWFORD J, 1991, NEW ENGL J MED, V325, P164, DOI 10.1056/NEJM199107183250305; CREERY D, 2003, CLIN EVID, V10, P457; Cucherat M, 2003, COCHRANE DB SYST REV, V3; Cuzick J, 2003, LANCET, V361, P296, DOI 10.1016/S0140-6736(03)12342-2; De Angelis C, 2004, NEW ENGL J MED, V351, P1250, DOI 10.1056/NEJMe048225; DICKERSIN K, 1993, ANN NY ACAD SCI, V703, P135, DOI 10.1111/j.1749-6632.1993.tb26343.x; Dickersin K, 2002, JAMA-J AM MED ASSOC, V287, P2772, DOI 10.1001/jama.287.21.2772; Diegoli MSC, 1998, INT J GYNECOL OBSTET, V62, P63, DOI 10.1016/S0020-7292(98)00035-6; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Dundar Y, 2003, QJM-INT J MED, V96, P103, DOI 10.1093/qjmed/hcg016; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; FAWZI WW, 1993, JAMA-J AM MED ASSOC, V269, P898, DOI 10.1001/jama.269.7.898; Fine PEM, 1996, LANCET, V348, P17, DOI 10.1016/S0140-6736(96)02166-6; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; FREEMAN EW, 1995, JAMA-J AM MED ASSOC, V274, P51, DOI 10.1001/jama.274.1.51; Gallo C, 1998, LANCET, V352, P17; GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450; Gill S, 2004, J CLIN ONCOL, V22, P1797, DOI 10.1200/JCO.2004.09.059; Giorgi A, 1999, J Sci Med Sport, V2, P341, DOI 10.1016/S1440-2440(99)80007-3; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; GranthamMcGregor SM, 1997, AM J CLIN NUTR, V66, P247, DOI 10.1093/ajcn/66.2.247; GRANTHAMMCGREGOR SM, 1991, LANCET, V338, P1, DOI 10.1016/0140-6736(91)90001-6; GREEN DM, 1991, NEW ENGL J MED, V325, P141, DOI 10.1056/NEJM199107183250301; GREENBERG ER, 1994, NEW ENGL J MED, V331, P141, DOI 10.1056/NEJM199407213310301; GRINES CL, 1993, NEW ENGL J MED, V328, P673, DOI 10.1056/NEJM199303113281001; Gulick RM, 1998, JAMA-J AM MED ASSOC, V280, P35, DOI 10.1001/jama.280.1.35; Hacke W, 2004, LANCET, V363, P768; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; HOOD WB, 2004, COCHRANE DB SYST REV, V2; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; HUNTER DJ, 1993, NEW ENGL J MED, V329, P234, DOI 10.1056/NEJM199307223290403; HUSSEY GD, 1990, NEW ENGL J MED, V323, P160, DOI 10.1056/NEJM199007193230304; Huxley RR, 2003, EUR J CLIN NUTR, V57, P904, DOI 10.1038/sj.ejcn.1601624; Institute for Scientific Information, WEB KNOWL; IOANNIDIS JPA, 1995, ANN INTERN MED, V122, P856, DOI 10.7326/0003-4819-122-11-199506010-00009; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P1089, DOI 10.1001/jama.279.14.1089; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; JAIN JK, 1994, NEW ENGL J MED, V331, P290, DOI 10.1056/NEJM199408043310502; JENKINS DJA, 1993, NEW ENGL J MED, V329, P21, DOI 10.1056/NEJM199307013290104; Kaplan LD, 1997, NEW ENGL J MED, V336, P1641, DOI 10.1056/NEJM199706053362304; Karvouni E, 2003, J AM COLL CARDIOL, V41, P26, DOI 10.1016/S0735-1097(02)02666-9; Kjaergard LL, 2001, BMJ-BRIT MED J, V323, P1151, DOI 10.1136/bmj.323.7322.1151; KLASSEN TP, 1994, NEW ENGL J MED, V331, P285, DOI 10.1056/NEJM199408043310501; Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lechat P, 1999, LANCET, V353, P9; LeLorier J, 1997, NEW ENGL J MED, V337, P536, DOI 10.1056/NEJM199708213370806; LEVINE AM, 1991, JAMA-J AM MED ASSOC, V266, P84, DOI 10.1001/jama.266.1.84; Levine RJ, 1997, NEW ENGL J MED, V337, P69, DOI 10.1056/NEJM199707103370201; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; LOPRINZI CL, 1994, NEW ENGL J MED, V331, P347, DOI 10.1056/NEJM199408113310602; Lyman GH, 2002, AM J MED, V112, P406, DOI 10.1016/S0002-9343(02)01036-7; MAGGIONI AP, 1992, NEW ENGL J MED, V327, P1, DOI 10.1056/NEJM199207023270101; Makhlouf A M, 2003, J Obstet Gynaecol, V23, P407; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Martin DF, 1999, NEW ENGL J MED, V340, P1063, DOI 10.1056/NEJM199904083401402; MCCLOSKEY RV, 1994, ANN INTERN MED, V121, P1, DOI 10.7326/0003-4819-121-1-199407010-00001; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Meduri GU, 1998, JAMA-J AM MED ASSOC, V280, P159, DOI 10.1001/jama.280.2.159; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; MOERTEL CG, 1990, NEW ENGL J MED, V322, P352, DOI 10.1056/NEJM199002083220602; MOFENSON LM, 1991, NEW ENGL J MED, V325, P73, DOI 10.1056/NEJM199107113250201; Musch DC, 1997, NEW ENGL J MED, V337, P83, DOI 10.1056/NEJM199707103370203; Nallamothu BK, 2004, AM J MED, V117, P938, DOI 10.1016/j.amjmed.2004.06.046; NEGRIN RS, 1990, BLOOD, V76, P36; Nelson R, 2004, DIS COLON RECTUM, V47, P422, DOI 10.1007/s10350-003-0079-5; Nieman DC, 2002, J AM COLL NUTR, V21, P344, DOI 10.1080/07315724.2002.10719233; OCONNELL M, 1994, NEW ENGL J MED, V331, P502, DOI 10.1056/NEJM199408253310803; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Ossenkoppele GJ, 1999, LEUKEMIA, V13, P1207, DOI 10.1038/sj.leu.2401478; PACKER M, 1993, NEW ENGL J MED, V329, P1, DOI 10.1056/NEJM199307013290101; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; PEDERSEN TR, 1994, LANCET, V344, P1383; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; PONSONBY AL, 1993, NEW ENGL J MED, V329, P377, DOI 10.1056/NEJM199308053290601; Poynard T, 2002, ANN INTERN MED, V136, P888, DOI 10.7326/0003-4819-136-12-200206180-00010; Poynard T, 1998, LANCET, V352, P1426, DOI 10.1016/S0140-6736(98)07124-4; Rantala H, 1997, J PEDIATR-US, V131, P922, DOI 10.1016/S0022-3476(97)70045-3; Rice GPA, 2000, NEUROLOGY, V54, P1145, DOI 10.1212/WNL.54.5.1145; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004; Rodrigues EJ, 2003, AM J MED, V115, P473, DOI 10.1016/S0002-9343(03)00435-2; ROSMAN NP, 1993, NEW ENGL J MED, V329, P79, DOI 10.1056/NEJM199307083290202; ROSS DA, 1993, LANCET, V342, P7, DOI 10.1016/0140-6736(93)91879-Q; ROSSAINT R, 1993, NEW ENGL J MED, V328, P399, DOI 10.1056/NEJM199302113280605; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; RUSSELL K, 2004, COCHRANE DB SYST REV, V1; Saag MS, 1999, CLIN INFECT DIS, V28, P291, DOI 10.1086/515110; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; SINGH SN, 1995, NEW ENGL J MED, V333, P77, DOI 10.1056/NEJM199507133330201; SIPE JC, 1994, LANCET, V344, P9, DOI 10.1016/S0140-6736(94)91046-4; SMITH DW, 1991, NEW ENGL J MED, V325, P24, DOI 10.1056/NEJM199107043250105; SMITH P, 1990, NEW ENGL J MED, V323, P147, DOI 10.1056/NEJM199007193230302; Sokol J, 2003, COCHRANE DB SYST REV, V1; SPECTOR SA, 1994, NEW ENGL J MED, V331, P1181, DOI 10.1056/NEJM199411033311802; Staessen JA, 2000, LANCET, V355, P865, DOI 10.1016/S0140-6736(99)07330-4; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; Stefanick ML, 1998, NEW ENGL J MED, V339, P12, DOI 10.1056/NEJM199807023390103; Stegeman CA, 1996, NEW ENGL J MED, V335, P16, DOI 10.1056/NEJM199607043350103; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; Stepniewska K, 2001, T ROY SOC TROP MED H, V95, P637, DOI 10.1016/S0035-9203(01)90104-X; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; SUAREZ FL, 1995, NEW ENGL J MED, V333, P1, DOI 10.1056/NEJM199507063330101; Tallman MS, 1997, NEW ENGL J MED, V337, P1021, DOI 10.1056/NEJM199710093371501; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Tepel M, 2000, NEW ENGL J MED, V343, P180, DOI 10.1056/NEJM200007203430304; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Topol EJ, 1998, LANCET, V352, P87, DOI 10.1016/S0140-6736(98)85010-1; Topol EJ, 1997, NEW ENGL J MED, V336, P1689; Torp-Pedersen C, 1999, LANCET, V354, P9, DOI 10.1016/S0140-6736(98)09374-X; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; vanderHorst CM, 1997, NEW ENGL J MED, V337, P15, DOI 10.1056/NEJM199707033370103; vanHensbroek MB, 1996, NEW ENGL J MED, V335, P69, DOI 10.1056/NEJM199607113350201; Ventre K., 2004, COCHRANE DB SYST REV, V4; Veronesi U, 1998, LANCET, V352, P93; Veronesi U, 1999, J NATL CANCER I, V91, P1847, DOI 10.1093/jnci/91.21.1847; VOLBERDING PA, 1990, NEW ENGL J MED, V322, P941, DOI 10.1056/NEJM199004053221401; Waldo AL, 1996, LANCET, V348, P7, DOI 10.1016/S0140-6736(96)02149-6; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; WATTS NB, 1990, NEW ENGL J MED, V323, P73, DOI 10.1056/NEJM199007123230201; Wheatley K, 2003, CONTROL CLIN TRIALS, V24, P66, DOI 10.1016/S0197-2456(02)00273-8; WILLIAMSRUSSO P, 1995, JAMA-J AM MED ASSOC, V274, P44, DOI 10.1001/jama.274.1.44; WINTERKORN JMS, 1993, NEW ENGL J MED, V329, P396, DOI 10.1056/NEJM199308053290604; Yazdanpanah Y, 2004, BMJ-BRIT MED J, V328, P249, DOI 10.1136/bmj.37995.435787.A6; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; Yusuf S, 2000, NEW ENGL J MED, V342, P145; ZIEGLER EJ, 1991, NEW ENGL J MED, V324, P429, DOI 10.1056/NEJM199102143240701; COCHRANE REV HDB	164	948	966	2	99	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2005	294	2					218	228		10.1001/jama.294.2.218	http://dx.doi.org/10.1001/jama.294.2.218			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944DO	16014596	Bronze			2022-12-28	WOS:000230406100026
J	Grimes, DA; Hubacher, D; Nanda, K; Schulz, KF; Moher, D; Altman, DG				Grimes, DA; Hubacher, D; Nanda, K; Schulz, KF; Moher, D; Altman, DG			The Good Clinical Practice guideline: a bronze standard for clinical research	LANCET			English	Editorial Material							METHODOLOGICAL QUALITY; CONSENSUS CONFERENCES; TRIALS; INDUSTRY		Family Hlth Int, Res Triangle Pk, NC 27709 USA; Childrens Hosp Eastern Ontario, Res Inst, Chalmers Res Grp, Ottawa, ON K1H 8L1, Canada; Inst Hlth Sci, Ctr Stat Med, Oxford, England	University of Ottawa; Children's Hospital of Eastern Ontario; University of Oxford	Grimes, DA (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.	dgrimes@fhi.org		Moher, David/0000-0003-2434-4206; Nanda, Kavita/0000-0001-7650-2929				Abraham J, 2001, HEALTH RISK SOC, V3, P113, DOI 10.1080/713670172; *AC MED SCI, EUR CLIN TRIAL DIR; [Anonymous], 2003, LANCET, V361, P2167; [Anonymous], INT C HARM TECHN REQ; [Anonymous], 2000, INT C HARM TECHN REQ; Blumberg N, 1999, ARCH PATHOL LAB MED, V123, P580; Buyse M, 1999, STAT MED, V18, P3435, DOI 10.1002/(SICI)1097-0258(19991230)18:24<3435::AID-SIM365>3.3.CO;2-F; Dixon J R Jr, 1998, Qual Assur, V6, P65; Dormont J, 2000, Rev Prat, V50, P856; Micieli G, 2002, STROKE, V33, P1341, DOI 10.1161/01.STR.0000013663.27776.DB; Peto R, 1997, CONTROL CLIN TRIALS, V18, P1, DOI 10.1016/S0197-2456(96)00225-5; RAMSCH KD, 1993, METHOD FIND EXP CLIN, V15, P237; Sauerland S, 2000, SURG ENDOSC-ULTRAS, V14, P908, DOI 10.1007/s004640000283; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; SCHWARZ RP, 1991, CONTROL CLIN TRIALS, V12, P753, DOI 10.1016/0197-2456(91)90038-N; Scottish Intercollegiate Guidelines Network, 2001, SIGN 50 GUID DEV HDB; Shaneyfelt TM, 1999, JAMA-J AM MED ASSOC, V281, P1900, DOI 10.1001/jama.281.20.1900; Shekelle PG, 1999, BRIT MED J, V318, P593, DOI 10.1136/bmj.318.7183.593; Shekelle PG, 2001, JAMA-J AM MED ASSOC, V286, P1461, DOI 10.1001/jama.286.12.1461; Sniderman AD, 1999, LANCET, V354, P327, DOI 10.1016/S0140-6736(98)11185-6; Wermeling DP, 1999, AM J HEALTH-SYST PH, V56, P252, DOI 10.1093/ajhp/56.3.252; WOOLF SH, 1992, ARCH INTERN MED, V152, P946, DOI 10.1001/archinte.152.5.946	22	99	104	1	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 9	2005	366	9480					172	174		10.1016/S0140-6736(05)66875-4	http://dx.doi.org/10.1016/S0140-6736(05)66875-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	943JH	16005342				2022-12-28	WOS:000230349200038
J	Lattimer, V; Turnbull, J; Burgess, A; Surridge, H; Gerard, K; Lathlean, J; Smith, H; George, S				Lattimer, V; Turnbull, J; Burgess, A; Surridge, H; Gerard, K; Lathlean, J; Smith, H; George, S			Effect of introduction of integrated out of hours care in England: observational study	BRITISH MEDICAL JOURNAL			English	Article							DEMAND	Objectives To quantify service integration achieved in the national exemplar programme for single call access to out of hours care through NHS Direct, and its effect on the wider health system. Design Observational before and after study of demand, activity, and trends in the use. of other health services. Participants 34 general practice cooperatives with NHS Direct partners (exemplars): four were case exemplars; 10 control cooperatives. Setting England. Main outcome measures Extent of integration; changes in demand, activity, mid trends in emergency ambulance transports; attendances at emergency departments, minor injuries units, and NHS walk-in centres; and emergency admissions to hospital in the first year. Results Of 31 distinct exemplars, 21 (68%) integrated all out of hours call management. Nine (29%) achieved single call access for all patients. In the only case exemplar where direct comparison was possible, a higher proportion of telephone calls were handled by cooperative nurses before integration than by NHS Direct afterwards (2622/6687 (39%) v 2092/7086 (30%): P < 0.0001). Other case exemplars did not achieve 30%. A small but significant downturn in overall demand for care seen in two case exemplars was also seen in the control cooperatives. The number of emergency ambulance transports increased in three of the four case exemplars after integration, reaching statistical significance in two (5%, - 0.02% to 10%, P = 0.06; 6%, 1% to 12%, P = 0.02; 7%, 3% to 12%, P = 0.001). This was always accompanied by a significant reduction in the number of calls to the integrated service. Conclusion Most exemplars achieved integration of call management but not single call access for patients. Most patients made at least two telephone calls to contact NHS Direct, and then waited for a nurse to call back. Evidence for transfer of demand from case exemplars to 999 ambulance services may be amenable to change, but NHS Direct may not have sufficient capacity to support national implementation of the programme.	Univ Southampton, Sch Nursing & Midwifery, Hlth Serv Res Grp, Southampton S016 1BJ, Hants, England; Univ Southampton, Sch Med, Community Clin Sci Div, Southampton SO9 5NH, Hants, England; Brighton & Sussex Med Sch, Dept Publ Hlth & Primary Care, Brighton, E Sussex, England	University of Southampton; University of Southampton; University of Brighton; University of Sussex	Lattimer, V (corresponding author), Univ Southampton, Sch Nursing & Midwifery, Hlth Serv Res Grp, Southampton S016 1BJ, Hants, England.	v.a.lattimer@soton.ac.uk	Smith, Helen E/M-2449-2016	Smith, Helen E/0000-0003-1883-6124; Turnbull, Joanne/0000-0002-5006-4438; Surridge, Heidi/0000-0001-6927-119X				*DEP HLTH, 2001, IMPL OUT OF HOURS RE; Department of Health, 2000, RAIS STAND PAT NEW P; Lattimer V, 1998, BMJ-BRIT MED J, V317, P1054; Munro J, 2000, BRIT MED J, V321, P150, DOI 10.1136/bmj.321.7254.150; Salisbury C, 2000, BRIT MED J, V320, P618, DOI 10.1136/bmj.320.7235.618	5	14	14	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 9	2005	331	7508					81	84		10.1136/bmj.331.7508.81	http://dx.doi.org/10.1136/bmj.331.7508.81			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945XR	16002882	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000230536800014
J	Masle, J; Gilmore, SR; Farquhar, GD				Masle, J; Gilmore, SR; Farquhar, GD			The ERECTA gene regulates plant transpiration efficiency in Arabidopsis	NATURE			English	Article							RECEPTOR-LIKE KINASE; CARBON-ISOTOPE DISCRIMINATION; WATER-USE EFFICIENCY; RESISTANCE; TRAITS; LEAVES; CO2; THALIANA; GROWTH; WHEAT	Assimilation of carbon by plants incurs water costs. In the many parts of the world where water is in short supply, plant transpiration efficiency, the ratio of carbon fixation to water loss, is critical to plant survival, crop yield and vegetation dynamics(1). When challenged by variations in their environment, plants often seem to coordinate photosynthesis and transpiration(2), but significant genetic variation in transpiration efficiency has been identified both between and within species(3,4). This has allowed plant breeders to develop effective selection programmes for the improved transpiration efficiency of crops(5), after it was demonstrated that carbon isotopic discrimination, Delta, of plant matter was a reliable and sensitive marker negatively related to variation in transpiration efficiency(3,4,6). However, little is known of the genetic controls of transpiration efficiency. Here we report the isolation of a gene that regulates transpiration efficiency, ERECTA. We show that ERECTA, a putative leucine-rich repeat receptor-like kinase (LRR-RLK)(7,8) known for its effects on inflorescence development(7,9), is a major contributor to a locus for Delta on Arabidopsis chromosome 2. Mechanisms include, but are not limited to, effects on stomatal density, epidermal cell expansion, mesophyll cell proliferation and cell - cell contact.	Australian Natl Univ, Res Sch Biol Sci, Environm Biol Grp, Canberra, ACT 2601, Australia	Australian National University	Masle, J (corresponding author), Australian Natl Univ, Res Sch Biol Sci, Environm Biol Grp, Canberra, ACT 2601, Australia.	josette.masle@anu.edu.au	FARQUHAR, GRAHAM D/A-3722-2008; Masle, Josette/D-1289-2009	Farquhar, Graham/0000-0002-7065-1971				Basten CJ, 2000, QTL CARTOGRAPHER; Bowman J., 1994, ARABIDOPSIS ATLAS MO, V102, P117; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Douglas SJ, 2002, PLANT CELL, V14, P547, DOI 10.1105/tpc.010391; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; FARQUHAR GD, 1978, PLANT PHYSIOL, V61, P1000, DOI 10.1104/pp.61.6.1000; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; FARQUHAR GD, 1982, OECOLOGIA, V52, P121, DOI 10.1007/BF00349020; Godiard L, 2003, PLANT J, V36, P353, DOI 10.1046/j.1365-313X.2003.01877.x; LANDER ES, 1989, GENETICS, V121, P185; Lease KA, 2001, NEW PHYTOL, V151, P133, DOI 10.1046/j.1469-8137.2001.00150.x; LISTER C, 1993, PLANT J, V4, P745, DOI 10.1046/j.1365-313X.1993.04040745.x; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; MARTIN B, 1989, SCIENCE, V243, P1725, DOI 10.1126/science.243.4899.1725; MASLE J, 1993, PLANT PHYSIOL, V103, P1075, DOI 10.1104/pp.103.4.1075; MASLE J, 1993, PERSPECTIVES PLANT C, P371; Nadeau Jeanette A, 2002, Arabidopsis Book, V1, pe0066, DOI 10.1199/tab.0066; Rebetzke GJ, 2002, CROP SCI, V42, P739, DOI 10.2135/cropsci2002.0739; Shpak ED, 2004, DEVELOPMENT, V131, P1491, DOI 10.1242/dev.01028; Shpak ED, 2003, PLANT CELL, V15, P1095, DOI 10.1105/tpc.010413; Thumma BR, 2001, J EXP BOT, V52, P203, DOI 10.1093/jexbot/52.355.203; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; VONCAEMMERER S, 1981, PLANTA, V153, P376, DOI 10.1007/BF00384257; WONG SC, 1979, NATURE, V282, P424, DOI 10.1038/282424a0; Xu L, 2003, DEVELOPMENT, V130, P4097, DOI 10.1242/dev.00622; Yokoyama R, 1998, PLANT J, V15, P301, DOI 10.1046/j.1365-313X.1998.00203.x; ZENG ZB, 1994, GENETICS, V136, P1457; ZHU Y, 1998, PLANT PHYSIOL, V116, P1603	29	388	428	19	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 11	2005	436	7052					866	870		10.1038/nature03835	http://dx.doi.org/10.1038/nature03835			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953XG	16007076				2022-12-28	WOS:000231116500050
J	Dichgans, M; Freilinger, T; Eckstein, G; Babini, E; Lorenz-Depiereux, B; Biskup, S; Ferrari, MD; Herzog, J; van den Maagdenberg, AMJM; Pusch, M; Strom, TM				Dichgans, M; Freilinger, T; Eckstein, G; Babini, E; Lorenz-Depiereux, B; Biskup, S; Ferrari, MD; Herzog, J; van den Maagdenberg, AMJM; Pusch, M; Strom, TM			Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine	LANCET			English	Article							SEVERE MYOCLONIC EPILEPSY; FEBRILE SEIZURES; HIPPOCAMPAL-FORMATION; SPREADING DEPRESSION; GENERALIZED EPILEPSY; SUBUNIT; GENE; MECHANISMS; TYPE-2; AURA	Background Familial hemiplegic migraine is an autosomal dominant severe subtype of migraine with aura characterised by some degree of hemiparesis during the attacks. So far, mutations in two genes regulating ion translocation-CACNA1A and ATP1A2-have been identified in pedigrees with this disease. Methods To identify additional genes for familial hemiplegic migraine, we did a genome-wide linkage analysis of two disease pedigrees without mutations in CACNA1A and ATP1A2. Ion channel genes in the candidate interval were analysed for mutations, and the functional consequences of the recorded sequence alteration were determined. Findings We identified a novel locus for familial hemiplegic migraine on chromosome 2q24. Sequencing of candidate genes in this region revealed a heterozygous missense mutation (Gln1489Lys) in the neuronal voltage-gated sodium channel gene SCN1A, mutations of which have been associated with epilepsy. This same mutation was present in three families with familial hemiplegic migraine. It results in a charge-altering aminoacid exchange in the so-called hinged-lid domain of the protein, which is critical for fast inactivation of the channel. Whole-cell recordings in transiently transfected tsA201 cells expressing the highly homologous SCN5A sodium channel showed that the mutation induces a two-fold to four-fold accelerated recovery from fast inactivation without altering any of the other channel parameters investigated. Interpretation Dysfunction of the neuronal sodium channel SCN1A can cause familial hemiplegic migraine. Our findings have implications for the understanding of migraine aura. Moreover, our study reinforces the molecular links between migraine and epilepsy, two common paroxysmal disorders.	Univ Munich, Klinikum Grosshadern, Dept Neurol, D-81377 Munich, Germany; GSF Natl Res Ctr Environm & Hlth, Inst Human Genet, Munich, Germany; CNR, Ist Biofis, Genoa, Italy; Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-8000 Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Technical University of Munich	Dichgans, M (corresponding author), Marchioninistr 15, D-81377 Munich, Germany.	martin.dichgans@med.uni-muenchen.de	Ferrari, Michel D./ABE-3758-2021; Dichgans, Martin/HCH-3247-2022	Ferrari, Michel D./0000-0001-9691-9449; Dichgans, Martin/0000-0002-0654-387X; Pusch, Michael/0000-0002-8644-8847	Telethon [GGP04018] Funding Source: Medline	Telethon(Fondazione Telethon)		BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; Bowyer SM, 2001, ANN NEUROL, V50, P582, DOI 10.1002/ana.1293; Ceulemans BPGM, 2004, PEDIATR NEUROL, V30, P236, DOI 10.1016/j.pediatrneurol.2003.10.012; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Ducros A, 1997, ANN NEUROL, V42, P885, DOI 10.1002/ana.410420610; Ducros A, 2002, LANCET NEUROL, V1, P285, DOI 10.1016/S1474-4422(02)00134-5; Ducros A, 2001, NEW ENGL J MED, V345, P17, DOI 10.1056/NEJM200107053450103; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Goldin AL, 2003, CURR OPIN NEUROBIOL, V13, P284, DOI 10.1016/S0959-4388(03)00065-5; Goldin AL, 1999, ANN NY ACAD SCI, V868, P38, DOI 10.1111/j.1749-6632.1999.tb11272.x; GRAFSTEIN B, 1956, J NEUROPHYSIOL, V19, P154, DOI 10.1152/jn.1956.19.2.154; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Kors EE, 2004, NEUROLOGY, V63, P1136, DOI 10.1212/01.WNL.0000138571.48593.FC; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Lossin C, 2002, NEURON, V34, P877, DOI 10.1016/S0896-6273(02)00714-6; Lossin C, 2003, J NEUROSCI, V23, P11289; Marconi R, 2003, ANN NEUROL, V53, P376, DOI 10.1002/ana.10464; Moskowitz MA, 2004, ANN NEUROL, V55, P276, DOI 10.1002/ana.20035; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; PATTON DE, 1992, P NATL ACAD SCI USA, V89, P10905, DOI 10.1073/pnas.89.22.10905; Pietrobon D, 2003, NAT REV NEUROSCI, V4, P386, DOI 10.1038/nrn1102; Rhodes TH, 2004, P NATL ACAD SCI USA, V101, P11147, DOI 10.1073/pnas.0402482101; Segall L, 2004, J BIOL CHEM, V279, P43692, DOI 10.1074/jbc.M407471200; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; SOMJEN GG, 1985, J NEUROPHYSIOL, V53, P1098, DOI 10.1152/jn.1985.53.4.1098; Spampanato J, 2004, J NEUROSCI, V24, P10022, DOI 10.1523/JNEUROSCI.2034-04.2004; Spampanato J, 2003, NEUROSCIENCE, V116, P37, DOI 10.1016/S0306-4522(02)00698-X; Spampanato J, 2001, J NEUROSCI, V21, P7481, DOI 10.1523/JNEUROSCI.21-19-07481.2001; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Thomsen LL, 2002, BRAIN, V125, P1379, DOI 10.1093/brain/awf132; Ulrich V, 1999, ANN NEUROL, V45, P242, DOI 10.1002/1531-8249(199902)45:2<242::AID-ANA15>3.0.CO;2-1; van den Maagdenberg AMJM, 2004, NEURON, V41, P701, DOI 10.1016/S0896-6273(04)00085-6; VANHARREVELD A, 1959, J NEUROCHEM, V3, P300; Vanmolkot KRJ, 2003, ANN NEUROL, V54, P360, DOI 10.1002/ana.10674; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Whitaker WRJ, 2000, J COMP NEUROL, V422, P123, DOI 10.1002/(SICI)1096-9861(20000619)422:1<123::AID-CNE8>3.0.CO;2-X	41	549	575	0	44	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2005	366	9483					371	377		10.1016/S0140-6736(05)66786-4	http://dx.doi.org/10.1016/S0140-6736(05)66786-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	950IB	16054936				2022-12-28	WOS:000230849700023
J	Shaaban, LM; Harbison, S				Shaaban, LM; Harbison, S			Reaching the tipping point against female genital mutilation	LANCET			English	Editorial Material									US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA	United States Agency for International Development (USAID)	Shaaban, LM (corresponding author), US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA.	lshaaban@usaid.gov						Almroth L, 2005, LANCET, V366, P385, DOI 10.1016/S0140-6736(05)67023-7; Askew Ian, 2004, MEDICALIZATION FEMAL; CEDPA-Egypt, 1999, POS DEV APPR FEM GEN; Chege J, 2001, ASSESSMENT ALTERNATI; Diop N., 2004, TOSTAN PROGRAM EVALU, DOI 10.31899/rh2.1002; DIOP NJ, 2004, EXPERIENCE COMMUNITY; Jones H, 1999, STUD FAMILY PLANN, V30, P219, DOI 10.1111/j.1728-4465.1999.00219.x; *POP COUNC, 2000, MAL FGC EXC PERS DES; Shell-Duncan B, 2001, SOC SCI MED, V52, P1013, DOI 10.1016/S0277-9536(00)00208-2; *WHO, 2000, 241 WHO; *WHO, 1999, FEM GEN MUT; YODER PS, 2004, 7 DHS	12	14	14	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 30	2005	366	9483					347	349		10.1016/S0140-6736(05)67003-1	http://dx.doi.org/10.1016/S0140-6736(05)67003-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	950IB	16054923				2022-12-28	WOS:000230849700006
J	Hinchliffe, P; Sazanov, LA				Hinchliffe, P; Sazanov, LA			Organization of iron-sulfur clusters in respiratory complex I	SCIENCE			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; QUINONE OXIDOREDUCTASE; 3-DIMENSIONAL STRUCTURE; ELECTRON-TRANSFER; MEMBRANE DOMAIN; SUBUNIT; DEHYDROGENASE; EXPRESSION; MECHANISM; BACTERIAL	Complex I of respiratory chains plays a central role in bioenergetics and is implicated in many human neurodegenerative diseases. An understanding of its mechanism requires a knowledge of the organization of redox centers. The arrangement of iron-sulfur clusters in the hydrophilic domain of complex I from Thermus thermophilus has been determined with the use of x-ray crystatiography. One binuclear and six tetranuclear clusters are arranged, maximally 14 angstroms apart, in an 84-angstrom-long electron transfer chain. The binuclear cluster N1a and the tetranuclear cluster N7 are not in this pathway. Cluster N1a may play a role in the prevention of oxidative damage. The structure provides a framework for the interpretation of the large amounts of data accumulated on complex I.	MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Sazanov, LA (corresponding author), MRC, Dunn Human Nutr Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.	sazanov@mrc-dunn.cam.ac.uk	Sazanov, Leonid A/ABF-2125-2021	Sazanov, Leonid A/0000-0002-0977-7989; Hinchliffe, Philip/0000-0001-8611-4743				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; BELOGRUDOV G, 1994, BIOCHEMISTRY-US, V33, P4571, DOI 10.1021/bi00181a018; Finel M, 1998, BBA-BIOENERGETICS, V1364, P112, DOI 10.1016/S0005-2728(98)00022-X; Friedrich T, 1998, BBA-BIOENERGETICS, V1364, P134, DOI 10.1016/S0005-2728(98)00024-3; Friedrich T, 2001, J BIOENERG BIOMEMBR, V33, P169, DOI 10.1023/A:1010722717257; Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6; Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668; Guenebaut V, 1997, J MOL BIOL, V265, P409, DOI 10.1006/jmbi.1996.0753; Guenebaut V, 1998, J MOL BIOL, V276, P105, DOI 10.1006/jmbi.1997.1518; Holt PJ, 2003, J BIOL CHEM, V278, P43114, DOI 10.1074/jbc.M308247200; LEIF H, 1995, EUR J BIOCHEM, V230, P538, DOI 10.1111/j.1432-1033.1995.tb20594.x; Mamedova AA, 2004, J BIOL CHEM, V279, P23830, DOI 10.1074/jbc.M401539200; Nakamaru-Ogiso E, 2005, J BIOL CHEM, V280, P301, DOI 10.1074/jbc.M410377200; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Page CC, 2003, CURR OPIN CHEM BIOL, V7, P551, DOI 10.1016/j.cbpa.2003.08.005; Peng GH, 2003, BIOCHEMISTRY-US, V42, P3032, DOI 10.1021/bi026876v; Rasmussen T, 2001, BIOCHEMISTRY-US, V40, P6124, DOI 10.1021/bi0026977; Sazanov LA, 2000, BIOCHEMISTRY-US, V39, P7229, DOI 10.1021/bi000335t; Schapira AHV, 1998, BBA-BIOENERGETICS, V1364, P261, DOI 10.1016/S0005-2728(98)00032-2; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; Yano T, 1996, J BIOL CHEM, V271, P5907, DOI 10.1074/jbc.271.10.5907; Yano T, 1999, J BIOL CHEM, V274, P28598, DOI 10.1074/jbc.274.40.28598; Yano T, 2005, BIOCHEMISTRY-US, V44, P1744, DOI 10.1021/bi048132i; Yano T, 2003, J BIOL CHEM, V278, P15514, DOI 10.1074/jbc.M212275200; Zickermann V, 2003, J BIOL CHEM, V278, P29072, DOI 10.1074/jbc.M302713200	29	148	156	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2005	309	5735					771	774		10.1126/science.1113988	http://dx.doi.org/10.1126/science.1113988			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051796				2022-12-28	WOS:000230938200050
J	Ramamoorthi, N; Narasimhan, S; Pal, U; Bao, FK; Yang, XFF; Fish, D; Anguita, J; Norgard, MV; Kantor, FS; Anderson, JF; Koski, RA; Fikrig, E				Ramamoorthi, N; Narasimhan, S; Pal, U; Bao, FK; Yang, XFF; Fish, D; Anguita, J; Norgard, MV; Kantor, FS; Anderson, JF; Koski, RA; Fikrig, E			The Lyme disease agent exploits a tick protein to infect the mammalian host	NATURE			English	Article							BORRELIA-BURGDORFERI; MICE; SPIROCHETE; IMMUNITY; DISSEMINATION; INHIBITION; ANTIBODIES; ARTHRITIS; IXODIDAE; ACARI	The Lyme disease agent, Borrelia burgdorferi, is maintained in a tick-mouse cycle(1,2). Here we show that B. burgdorferi usurps a tick salivary protein, Salp15 (ref. 3), to facilitate the infection of mice. The level of salp15 expression was selectively enhanced by the presence of B. burgdorferi in Ixodes scapularis, first indicating that spirochaetes might use Salp15 during transmission. Salp15 was then shown to adhere to the spirochaete, both in vitro and in vivo, and specifically interacted with B. burgdorferi outer surface protein C. The binding of Salp15 protected B. burgdorferi from antibody-mediated killing in vitro and provided spirochaetes with a marked advantage when they were inoculated into naive mice or animals previously infected with B. burgdorferi. Moreover, RNA interference-mediated repression of salp15 in I. scapularis drastically reduced the capacity of tick-borne spirochaetes to infect mice. These results show the capacity of a pathogen to use a secreted arthropod protein to help it colonize the mammalian host.	Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Internal Med, Sect Allergy & Immunol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Univ Texas, SW Med Ctr, Dept Microbiol, Dallas, TX 75390 USA; Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA; Connecticut Agr Expt Stn, Dept Entomol, New Haven, CT 06504 USA; L2 Diagnost, New Haven, CT 06511 USA	Yale University; Yale University; Yale University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of North Carolina; University of North Carolina Charlotte; Connecticut Agricultural Experiment Station	Fikrig, E (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, 333 Cedar St, New Haven, CT 06520 USA.	erol.fikrig@yale.edu	Anguita, Juan/D-5432-2011; Pal, Utpal/I-5265-2015; Yang, X. Frank/F-3266-2010	Anguita, Juan/0000-0003-2061-7182; 	NIAID NIH HHS [R01 AI053064-05, R01 AI053064] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053064] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anguita J, 2002, IMMUNITY, V16, P849, DOI 10.1016/S1074-7613(02)00325-4; BARTHOLD SW, 1990, J INFECT DIS, V162, P133, DOI 10.1093/infdis/162.1.133; BRUNET LR, 1995, INFECT IMMUN, V63, P3030, DOI 10.1128/IAI.63.8.3030-3036.1995; Bunikis J, 2004, J INFECT DIS, V189, P1515, DOI 10.1086/382594; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Coleman JL, 1997, CELL, V89, P1111, DOI 10.1016/S0092-8674(00)80298-6; Das S, 2001, J INFECT DIS, V184, P1056, DOI 10.1086/323351; de Silva AM, 1998, J INFECT DIS, V177, P395, DOI 10.1086/514200; Fikrig E, 1997, J IMMUNOL, V159, P5682; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; MALAWISTA SE, 1994, J INFECT DIS, V170, P1312, DOI 10.1093/infdis/170.5.1312; McKisic MD, 2000, INFECT IMMUN, V68, P5190, DOI 10.1128/IAI.68.9.5190-5197.2000; Nagamune K, 2004, J EXP MED, V199, P1445, DOI 10.1084/jem.20030635; Narasimhan S, 2004, P NATL ACAD SCI USA, V101, P1141, DOI 10.1073/pnas.0307669100; Nazario S, 1998, AM J TROP MED HYG, V58, P780, DOI 10.4269/ajtmh.1998.58.780; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Pal U, 2001, J IMMUNOL, V166, P7398, DOI 10.4049/jimmunol.166.12.7398; PIESMAN J, 1993, J MED ENTOMOL, V30, P199, DOI 10.1093/jmedent/30.1.199; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; RIBEIRO JMC, 1987, J MED ENTOMOL, V24, P201, DOI 10.1093/jmedent/24.2.201; SADZIENE A, 1993, J INFECT DIS, V167, P165, DOI 10.1093/infdis/167.1.165; SAUER JR, 1995, ANNU REV ENTOMOL, V40, P245, DOI 10.1146/annurev.en.40.010195.001333; Schwan TG, 2000, J CLIN MICROBIOL, V38, P382; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; Steere AC, 2004, NAT REV IMMUNOL, V4, P143, DOI 10.1038/nri1267; Wikel SK, 1996, ANNU REV ENTOMOL, V41, P1, DOI 10.1146/annurev.en.41.010196.000245; Wooten RM, 2002, J IMMUNOL, V168, P348, DOI 10.4049/jimmunol.168.1.348; Zeidner NS, 2002, J PARASITOL, V88, P1276, DOI 10.1645/0022-3395(2002)088[1276:COBSWT]2.0.CO;2	28	355	371	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					573	577		10.1038/nature03812	http://dx.doi.org/10.1038/nature03812			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049492	Green Accepted			2022-12-28	WOS:000230788800065
J	Marusic, A				Marusic, A			Commentary: Ethics in health care and research in European transition countries: reality and future prospects	BRITISH MEDICAL JOURNAL			English	Editorial Material									Croatian Med Journal, HR-10000 Zagreb, Croatia		Marusic, A (corresponding author), Croatian Med Journal, Salata 3, HR-10000 Zagreb, Croatia.	marusica@mef.hr	Marusic, Ana/E-7683-2013	Marusic, Ana/0000-0001-6272-0917				Borovecki A, 2005, BMJ-BRIT MED J, V331, P227, DOI 10.1136/bmj.331.7510.227; Bosnjak D, 2000, LANCET, V356, P1349, DOI 10.1016/S0140-6736(00)02829-4; Hrabak M, 2004, MED EDUC, V38, P276, DOI 10.1111/j.1365-2923.2004.01766.x; Magnus JR, 2002, J ECON EDUC, V33, P125, DOI 10.1080/00220480209596462; Soler M, 2001, NATURE, V411, P132, DOI 10.1038/35075637	5	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 23	2005	331	7510					230	230		10.1136/bmj.331.7510.230	http://dx.doi.org/10.1136/bmj.331.7510.230			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951EA	16037468	Bronze, Green Published			2022-12-28	WOS:000230910700037
J	Rieping, W; Habeck, M; Nilges, M				Rieping, W; Habeck, M; Nilges, M			Inferential structure determination	SCIENCE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; MACROMOLECULAR STRUCTURE DETERMINATION; MODEL-FREE APPROACH; NMR-SPECTROSCOPY; MONTE-CARLO; RELAXATION; CRYSTALLOGRAPHY; SPECTRIN; DOMAIN	Macromolecular structures calculated from nuclear magnetic resonance data are not fully determined by experimental data but depend on subjective choices in data treatment and parameter settings. This makes it difficult to objectively judge the precision of the structures. We used Bayesian inference to derive a probability distribution that represents the unknown structure and its precision. This probability distribution also determines additional unknowns, such as theory parameters, that previously had to be chosen empirically. We implemented this approach by using Markov chain, Monte Carlo techniques. Our method provides an objective figure of merit and improves structural quality.	Inst Pasteur, CNRS, URA 2185, Untie Bioinformat Struct, F-75724 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Nilges, M (corresponding author), Inst Pasteur, CNRS, URA 2185, Untie Bioinformat Struct, 25-28 Rue Docteur Roux, F-75724 Paris, France.	nilges@pasteur.fr	Nilges, Michael/E-4803-2011	Nilges, Michael/0000-0002-1451-8092; Habeck, Michael/0000-0002-2188-5667				Adams PD, 1997, P NATL ACAD SCI USA, V94, P5018, DOI 10.1073/pnas.94.10.5018; ALTMAN RB, 1989, METHOD ENZYMOL, V177, P218; Andrec M, 1999, J MAGN RESON, V139, P408, DOI 10.1006/jmre.1999.1839; Bricogne G, 1997, METHOD ENZYMOL, V276, P361, DOI 10.1016/S0076-6879(97)76069-5; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1993, SCIENCE, V261, P328, DOI 10.1126/science.8332897; BRUNGER AT, 1993, Q REV BIOPHYS, V26, P49, DOI 10.1017/S0033583500003966; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN MH, 2002, MONTE CARLO METHODS; COX RT, 1946, AM J PHYS, V14, P1, DOI 10.1119/1.1990764; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Habeck M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018105; Jaynes E.T., 2003, PROBABILITY THEORY L; KARPLUS M, 1963, J AM CHEM SOC, V85, P2870, DOI 10.1021/ja00901a059; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; MACURA S, 1980, MOL PHYS, V41, P95, DOI 10.1080/00268978000102601; Mal TK, 1998, J BIOMOL NMR, V12, P259, DOI 10.1023/A:1008238009056; Nilges M, 1998, PROG NUCL MAG RES SP, V32, P107, DOI 10.1016/S0079-6565(97)00025-3; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; NOBLE MEM, 1993, EMBO J, V12, P2617, DOI 10.1002/j.1460-2075.1993.tb05922.x; RIEPING W, UNPUB; SWENDSEN RH, 1986, PHYS REV LETT, V57, P2607, DOI 10.1103/PhysRevLett.57.2607	24	253	259	4	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2005	309	5732					303	306		10.1126/science.1110428	http://dx.doi.org/10.1126/science.1110428			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002620				2022-12-28	WOS:000230449800046
J	Margulies, M; Egholm, M; Altman, WE; Attiya, S; Bader, JS; Bemben, LA; Berka, J; Braverman, MS; Chen, YJ; Chen, ZT; Dewell, SB; Du, L; Fierro, JM; Gomes, XV; Godwin, BC; He, W; Helgesen, S; Ho, CH; Irzyk, GP; Jando, SC; Alenquer, MLI; Jarvie, TP; Jirage, KB; Kim, JB; Knight, JR; Lanza, JR; Leamon, JH; Lefkowitz, SM; Lei, M; Li, J; Lohman, KL; Lu, H; Makhijani, VB; McDade, KE; McKenna, MP; Myers, EW; Nickerson, E; Nobile, JR; Plant, R; Puc, BP; Ronan, MT; Roth, GT; Sarkis, GJ; Simons, JF; Simpson, JW; Srinivasan, M; Tartaro, KR; Tomasz, A; Vogt, KA; Volkmer, GA; Wang, SH; Wang, Y; Weiner, MP; Yu, PG; Begley, RF; Rothberg, JM				Margulies, M; Egholm, M; Altman, WE; Attiya, S; Bader, JS; Bemben, LA; Berka, J; Braverman, MS; Chen, YJ; Chen, ZT; Dewell, SB; Du, L; Fierro, JM; Gomes, XV; Godwin, BC; He, W; Helgesen, S; Ho, CH; Irzyk, GP; Jando, SC; Alenquer, MLI; Jarvie, TP; Jirage, KB; Kim, JB; Knight, JR; Lanza, JR; Leamon, JH; Lefkowitz, SM; Lei, M; Li, J; Lohman, KL; Lu, H; Makhijani, VB; McDade, KE; McKenna, MP; Myers, EW; Nickerson, E; Nobile, JR; Plant, R; Puc, BP; Ronan, MT; Roth, GT; Sarkis, GJ; Simons, JF; Simpson, JW; Srinivasan, M; Tartaro, KR; Tomasz, A; Vogt, KA; Volkmer, GA; Wang, SH; Wang, Y; Weiner, MP; Yu, PG; Begley, RF; Rothberg, JM			Genome sequencing in microfabricated high-density picolitre reactors	NATURE			English	Article							PYROPHOSPHATE; MOLECULES; EVOLUTION	The proliferation of large-scale DNA-sequencing projects in recent years has driven a search for alternative methods to reduce time and cost. Here we describe a scalable, highly parallel sequencing system with raw throughput significantly greater than that of state-of-the-art capillary electrophoresis instruments. The apparatus uses a novel fibre-optic slide of individual wells and is able to sequence 25 million bases, at 99% or better accuracy, in one four-hour run. To achieve an approximately 100-fold increase in throughput over current Sanger sequencing technology, we have developed an emulsion method for DNA amplification and an instrument for sequencing by synthesis using a pyrosequencing protocol optimized for solid support and picolitre-scale volumes. Here we show the utility, throughput, accuracy and robustness of this system by shotgun sequencing and de novo assembly of the Mycoplasma genitalium genome with 96% coverage at 99.96% accuracy in one run of the machine.	Life Sci Corp 454, Branford, CT 06405 USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA; Rothberg Inst Childhood Dis, Guilford, CT 06437 USA	University of California System; University of California Berkeley; Rockefeller University	Rothberg, JM (corresponding author), Life Sci Corp 454, 20 Commercial St, Branford, CT 06405 USA.	jrothberg@454.com	Bader, Joel/A-1818-2009; chen, qi/C-8585-2011	Bader, Joel/0000-0002-6020-4625; Tomasz, Alexander/0000-0003-1520-1983	NHGRI NIH HHS [R01 HG003562-02, P01 HG003022-020002] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG003022, R01HG003562] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BAINS W, 1988, J THEOR BIOL, V135, P303, DOI 10.1016/S0022-5193(88)80246-7; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FAGIN B, 1993, COMPUT APPL BIOSCI, V9, P221; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Ghadessy FJ, 2001, P NATL ACAD SCI USA, V98, P4552, DOI 10.1073/pnas.071052198; JACOBSON KB, 1991, GENET ANAL-BIOMOL E, V8, P223, DOI 10.1016/1050-3862(91)90032-M; JETT JH, 1989, J BIOMOL STRUCT DYN, V7, P301, DOI 10.1080/07391102.1989.10507773; LANDER E S, 1988, Genomics, V2, P231; Leamon JH, 2003, ELECTROPHORESIS, V24, P3769, DOI 10.1002/elps.200305646; Mehta K, 1993, Biomed Sci Instrum, V29, P507; MOORE GE, 1965, ELECTRONICS, V38, P8; Myers E W, 1995, J Comput Biol, V2, P275, DOI 10.1089/cmb.1995.2.275; NYREN P, 1993, ANAL BIOCHEM, V208, P171, DOI 10.1006/abio.1993.1024; OGAWA T, 2005, INCREASED PRODUCTIVI; PROBER JM, 1987, SCIENCE, V238, P336, DOI 10.1126/science.2443975; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217	22	5468	6635	26	1010	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					376	380		10.1038/nature03959	http://dx.doi.org/10.1038/nature03959			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16056220	hybrid, Green Accepted			2022-12-28	WOS:000231849100045
J	Crump, JA; Otieno, PO; Slutsker, L; Keswick, BH; Rosen, DH; Hoekstra, RM; Vulule, JM; Luby, SP				Crump, JA; Otieno, PO; Slutsker, L; Keswick, BH; Rosen, DH; Hoekstra, RM; Vulule, JM; Luby, SP			Household based treatment of drinking water with flocculant-disinfectant for preventing diarrhoea in areas with turbid source water in rural western Kenya: cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TREATED BED NETS; MALARIA TRANSMISSION; SAFE STORAGE; MORTALITY; INTERVENTION; EPIDEMIOLOGY; EFFICACY; STRATEGY; CHILDREN; QUALITY	Objective To compare the effect on prevalence of diarrhoea and mortality of household based treatment of drinking water with flocculant-disinfectant, sodium hypochlorite, and standard practices in areas with turbid water source in Africa. Design Cluster randomised controlled trial over 20 weeks. Setting Family compounds, each containing several houses, in rural western Kenya. Participants 6650 people in 605 family compounds. Intervention Water treatment: flocculant-disinfectant, sodium hypochlorite, and usual practice (control). Main outcome measures Prevalence of diarrhoea and all cause mortality. Escherichia coli concentration, free residual chlorine concentration, and turbidity in household drinking water as surrogates for effectiveness of water treatment. Results In children < 2 years old, compared with those in the control compounds, the absolute difference in prevalence of diarrhoea was -25% in the flocculant-disinfectant arm (95% confidence interval -40 to -5) and -17% in the sodium hypochlorite arm (-34 to 4). In all age groups compared with control, the absolute difference in prevalence was - 19% in the flocculant-disinfectant arm (-34 to -2) and - 26% in the sodium hypochlorite arm (-39 to -9). There were significantly fewer deaths in the intervention compounds than in the control compounds (relative risk of death 0.58, P = 0.036). Fourteen per cent of water samples from control compounds had E coli concentrations < I CFU/100 ml compared with 82% in flocculant-disinfectant and 78% in sodium hypochlorite compounds. The mean turbidity of drinking water was 8 nephelometric turbidity units (NTU) in flocculant-disinfectant households, compared with 55 NTU in the two other compounds (P < 0.001). Conclusions In areas of turbid water, flocculant-disinfectant was associated with a significant reduction in diarrhoea among children < 2 years. This health benefit, combined with a significant reduction in turbidity, suggests that flocculant-disinfectant is well suited to areas with highly contaminated and turbid water.	Ctr Dis Control & Prevent, Foodborne & Diarrhoeal Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Kisumu, Kenya; Procter & Gamble Co, Hlth Sci Inst, Mason, OH 45040 USA; Ctr Dis Control & Prevent, Biostat & Informat Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Kenya Govt Med Res Ctr, Ctr Vector Biol Control & Res, Kisumu, Kenya	Centers for Disease Control & Prevention - USA; Procter & Gamble; Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute	Crump, JA (corresponding author), Ctr Dis Control & Prevent, Foodborne & Diarrhoeal Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, 1600 Clifton Rd,MS A-38, Atlanta, GA 30333 USA.	jcrump@cdc.gov	Crump, John A./AAZ-6412-2020; Crump, John A./AAZ-6289-2020	Crump, John A./0000-0002-4529-102X; Crump, John A./0000-0002-4529-102X; Hoekstra, Robert Michael/0000-0002-0340-8015				[Anonymous], 1999, WORLD HLTH REPORT 19; Bloland PB, 1999, AM J TROP MED HYG, V60, P635, DOI 10.4269/ajtmh.1999.60.635; Brooks JT, 2003, AM J TROP MED HYG, V68, P671, DOI 10.4269/ajtmh.2003.68.671; Clasen TF, 2004, TROP MED INT HEALTH, V9, P187, DOI 10.1046/j.1365-3156.2003.01191.x; Crump JA, 2004, J APPL MICROBIOL, V97, P225, DOI 10.1111/j.1365-2672.2004.02309.x; KILLEWO J Z J, 1989, Journal of Diarrhoeal Diseases Research, V7, P21; Makutsa P, 2001, AM J PUBLIC HEALTH, V91, P1571, DOI 10.2105/AJPH.91.10.1571; Meinhardt PL, 1996, EPIDEMIOL REV, V18, P118, DOI 10.1093/oxfordjournals.epirev.a017920; Meltzer MI, 2003, AM J TROP MED HYG, V68, P149, DOI 10.4269/ajtmh.2003.68.149; Mintz E, 2001, AM J PUBLIC HEALTH, V91, P1565, DOI 10.2105/AJPH.91.10.1565; MINTZ ED, 1995, JAMA-J AM MED ASSOC, V273, P948, DOI 10.1001/jama.273.12.948; Morris SS, 1996, AM J EPIDEMIOL, V144, P582, DOI 10.1093/oxfordjournals.aje.a008968; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P23, DOI 10.4269/ajtmh.2003.68.23; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P3, DOI 10.4269/ajtmh.2003.68.3; Quick RE, 1999, EPIDEMIOL INFECT, V122, P83, DOI 10.1017/S0950268898001782; Quick RE, 2002, AM J TROP MED HYG, V66, P584, DOI 10.4269/ajtmh.2002.66.584; Rangel Josefa M., 2003, Journal of Water and Health, V1, P15; Reller ME, 2003, AM J TROP MED HYG, V69, P411, DOI 10.4269/ajtmh.2003.69.411; Semenza JC, 1998, AM J TROP MED HYG, V59, P941, DOI 10.4269/ajtmh.1998.59.941; Shapiro RL, 1999, AM J TROP MED HYG, V60, P271, DOI 10.4269/ajtmh.1999.60.271; Shapiro RL, 2001, J INFECT DIS, V183, P1701, DOI 10.1086/320710; Souter Philip F., 2003, Journal of Water and Health, V1, P73; STANTON B, 1992, SOC SCI MED, V35, P1405, DOI 10.1016/0277-9536(92)90044-Q; *UN DEV PROGR, 2003, HUM DEV REP 2005	24	89	89	0	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 3	2005	331	7515					478	481		10.1136/bmj.38512.618681.E0	http://dx.doi.org/10.1136/bmj.38512.618681.E0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	963RA	16046440	Green Published			2022-12-28	WOS:000231820400013
J	Smith, R				Smith, R			Investigating the previous studies of a fraudulent author	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRACE-ELEMENT SUPPLEMENTATION; ELDERLY SUBJECTS; VITAMIN		UnitedHlth Europe, London SW1P 1SB, England		Smith, R (corresponding author), UnitedHlth Europe, London SW1P 1SB, England.	richardswsmith@yahoo.co.uk						Carpenter KJ, 2003, LANCET, V361, P2247, DOI 10.1016/S0140-6736(03)13755-5; CHANDRA RK, 1992, LANCET, V340, P1124, DOI 10.1016/0140-6736(92)93151-C; Chandra RK, 2001, NUTRITION, V17, P709, DOI 10.1016/S0899-9007(01)00610-4; LOCK S, 1988, BRIT MED J, V297, P1531, DOI 10.1136/bmj.297.6662.1531; Lock S, 2001, FRAUD MISCONDUCT BIO; Martinson BC, 2005, NATURE, V435, P737, DOI 10.1038/435737a; PAYNE D, 2005, SCIENTIST       0303; Ramos EJB, 2005, NUTRITION, V21, P269, DOI 10.1016/j.nut.2004.06.021; RENNIE D, 2001, FRAUD MISCONDUCT BIO; SMITH AM, 2000, J R COLL PHYS EDI S7, V30, P22; WELLS F, 2001, FRAUD MISCONDUCT BIO; White C, 2005, BMJ-BRIT MED J, V331, P281, DOI 10.1136/bmj.331.7511.281; White C, 2004, BRIT MED J, V328, P67, DOI 10.1136/bmj.328.7431.67	13	51	52	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2005	331	7511					288	291		10.1136/bmj.331.7511.288	http://dx.doi.org/10.1136/bmj.331.7511.288			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953FJ	16052023	Green Published			2022-12-28	WOS:000231061700024
J	Bostwick, KS; Prum, RO				Bostwick, KS; Prum, RO			Courting bird sings with stridulating wing feathers	SCIENCE			English	Article							PIPRIDAE; AVES		Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA; Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; Yale Univ, Peabody Museum Nat Hist, New Haven, CT 06520 USA	Cornell University; Yale University; Yale University	Bostwick, KS (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA.	ksb6@cornell.edu		Prum, Richard/0000-0002-4741-7132				Bennet-Clark H.C., 1989, P227; Bostwick KS, 2000, AUK, V117, P465, DOI 10.1642/0004-8038(2000)117[0465:DBMSAE]2.0.CO;2; Bostwick KS, 2003, J EXP BIOL, V206, P3693, DOI 10.1242/jeb.00598; Darwin C., 1871, P475; Fletcher N. H., 1992, ACOUSTIC SYSTEMS BIO; Prum RO, 1998, ANIM BEHAV, V55, P977, DOI 10.1006/anbe.1997.0647	6	53	53	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2005	309	5735					736	736		10.1126/science.1111701	http://dx.doi.org/10.1126/science.1111701			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051789				2022-12-28	WOS:000230938200039
J	Campbell, CT; Peden, CHF				Campbell, CT; Peden, CHF			Chemistry - Oxygen vacancies and catalysis on ceria surfaces	SCIENCE			English	Editorial Material							GAS-SHIFT REACTION; MICROSCOPIC OBSERVATIONS; TIO2(110); HYDROGEN; BEHAVIOR; AU		Univ Washington, Dept Chem, Seattle, WA 98195 USA; Pacific NW Natl Lab, Inst Interfacial Catalysis, Richland, WA 99352 USA	University of Washington; University of Washington Seattle; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Campbell, CT (corresponding author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.	campbell@chem.washington.edu		Peden, Charles/0000-0001-6754-9928				Bunluesin T, 1998, APPL CATAL B-ENVIRON, V15, P107, DOI 10.1016/S0926-3373(97)00040-4; Deluga GA, 2004, SCIENCE, V303, P993, DOI 10.1126/science.1093045; Diebold U, 2005, SURF SCI, V578, P1, DOI 10.1016/j.susc.2005.01.029; Esch F, 2005, SCIENCE, V309, P752, DOI 10.1126/science.1111568; Farrauto R, 2003, ANNU REV MATER RES, V33, P1, DOI 10.1146/annurev.matsci.33.022802.091348; Fu Q, 2003, SCIENCE, V301, P935, DOI 10.1126/science.1085721; Giordano L, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.075417; Gritschneder S, 2005, NANOTECHNOLOGY, V16, pS41, DOI 10.1088/0957-4484/16/3/008; Henderson MA, 2003, J AM CHEM SOC, V125, P14974, DOI 10.1021/ja037764+; Henderson MA, 1999, J PHYS CHEM B, V103, P5328, DOI 10.1021/jp990655q; Honkala K, 2005, SCIENCE, V307, P555, DOI 10.1126/science.1106435; Kim YD, 2002, J PHYS CHEM B, V106, P6827, DOI 10.1021/jp0205766; Lee S, 2005, SURF SCI, V578, P5, DOI 10.1016/j.susc.2005.01.017; LU G, 1995, J PHYS CHEM-US, V99, P7626, DOI 10.1021/j100019a049; Namai Y, 2003, CATAL TODAY, V85, P79, DOI 10.1016/S0920-5861(03)00377-8; Namai Y, 2003, J PHYS CHEM B, V107, P11666, DOI 10.1021/jp030142q; Reuter K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.116105; SANDER M, 1994, SURF SCI, V302, pL263, DOI 10.1016/0039-6028(94)91086-3; Schaub R, 2003, SCIENCE, V299, P377, DOI 10.1126/science.1078962; Uetsuka H, 2004, J PHYS CHEM B, V108, P10621, DOI 10.1021/jp0484027; Wahlstrom E, 2004, SCIENCE, V303, P511, DOI 10.1126/science.1093425; Wheeler C, 2004, J CATAL, V223, P191, DOI 10.1016/j.jcat.2004.01.002	22	932	963	29	879	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2005	309	5735					713	714		10.1126/science.1113955	http://dx.doi.org/10.1126/science.1113955			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051777				2022-12-28	WOS:000230938200030
J	Huseby, ES; White, J; Crawford, F; Vass, T; Becker, D; Pinilla, C; Marrack, P; Kappler, JW				Huseby, ES; White, J; Crawford, F; Vass, T; Becker, D; Pinilla, C; Marrack, P; Kappler, JW			How the T cell repertoire becomes peptide and MHC specific	CELL			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; NEGATIVE SELECTION; POSITIVE SELECTION; CRYSTAL-STRUCTURES; THYMIC SELECTION; TRANSGENIC MICE; ANTIGEN; TOLERANCE; RECEPTOR; RESTRICTION	T cells bearing up T cell receptors (TCRs) recognize antigens in the form of peptides bound to class I or class II major histocompatibility proteins (MHC). TCRs on mature T cells are usually very specific for both peptide and MHC class and allele. They are picked out from a precursor population in the thymus by MHC-driven positive and negative selection. Here we show that the pool of T cells initially positively selected in the thymus contains many T cells that are very crossreactive for peptide and MHC and that subsequent negative selection establishes the MHC-restriction and peptide specificity of peripheral T cells. Our results also suggest that germline-encoded TCR variable elements have an inherent predisposition to react with features shared by all MHC proteins.	Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Denver, CO 80206 USA; Natl Jewish Med & Res Ctr, Integrated Dept Immunol, Denver, CO 80206 USA; Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA; Univ Colorado, Ctr Hlth Sci, Dept Biochem & Mol Genet, Denver, CO 80206 USA; Univ Colorado, Ctr Hlth Sci, Dept Med, Denver, CO 80206 USA; Univ Colorado, Ctr Hlth Sci, Dept Pharmacol, Denver, CO 80206 USA	Howard Hughes Medical Institute; National Jewish Health; National Jewish Health; Torrey Pines Institute for Molecular Studies, California; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Marrack, P (corresponding author), Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Denver, CO 80206 USA.	marrackp@njc.org	Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687	NCI NIH HHS [CA-046934] Funding Source: Medline; NIAID NIH HHS [AI-17134, AI-18785, AI-22295, AI-52225] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI017134, R01AI052225, R01AI018785, R37AI018785, R56AI017134, P01AI022295, R37AI017134] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; BLACKMAN M, 1986, CELL, V47, P349, DOI 10.1016/0092-8674(86)90591-X; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Crawford F, 2004, PLOS BIOL, V2, P523, DOI 10.1371/journal.pbio.0020090; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Housset D, 2003, TRENDS IMMUNOL, V24, P429, DOI 10.1016/S1471-4906(03)00180-7; Huseby ES, 2003, P NATL ACAD SCI USA, V100, P11565, DOI 10.1073/pnas.1934636100; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Huseby ES, 2001, IMMUNITY, V14, P471, DOI 10.1016/S1074-7613(01)00127-3; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KATZ DH, 1975, J EXP MED, V141, P263, DOI 10.1084/jem.141.1.263; KIRBERG J, 1994, J EXP MED, V180, P25, DOI 10.1084/jem.180.1.25; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Krogsgaard M, 2005, NAT IMMUNOL, V6, P239, DOI 10.1038/ni1173; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8820, DOI 10.1073/pnas.132272099; MACDONALD HR, 1988, NATURE, V336, P471, DOI 10.1038/336471a0; Mathis D, 2004, IMMUNITY, V20, P509, DOI 10.1016/S1074-7613(04)00111-6; MATZINGER P, 1993, IMMUNOL REV, V135, P81, DOI 10.1111/j.1600-065X.1993.tb00645.x; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; PINILLA C, 1992, BIOTECHNIQUES, V13, P901; Robinson J, 2003, NUCLEIC ACIDS RES, V31, P311, DOI [10.1093/nar/gkg070, 10.1093/nar/GKG070]; SCHILHAM MW, 1986, J IMMUNOL, V137, P2748; SCOTT B, 1989, NATURE, V338, P591, DOI 10.1038/338591a0; Sim BC, 1996, SCIENCE, V273, P963, DOI 10.1126/science.273.5277.963; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; UNANUE ER, 1984, ANNU REV IMMUNOL, V2, P395, DOI 10.1146/annurev.iy.02.040184.002143; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; Wise M, 1999, EUR J IMMUNOL, V29, P156, DOI 10.1002/(SICI)1521-4141(199901)29:01<156::AID-IMMU156>3.0.CO;2-K; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	38	233	239	3	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 29	2005	122	2					247	260		10.1016/j.cell.2005.05.013	http://dx.doi.org/10.1016/j.cell.2005.05.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	951CR	16051149	Bronze			2022-12-28	WOS:000230907000012
J	Drake, JJ; Testa, P				Drake, JJ; Testa, P			The 'solar model problem' solved by the abundance of neon in nearby stars	NATURE			English	Article							GAMMA-RAY SPECTROSCOPY; CORONAL ABUNDANCES; HELIOSEISMOLOGY; ELEMENTS; CAPELLA; CHANDRA; PLASMA; RATIO; IONS	The interior structure of the Sun can be studied with great accuracy using observations of its oscillations, similar to seismology of the Earth. Precise agreement between helioseismological measurements and predictions of theoretical solar models(1) has been a triumph of modern astrophysics. A recent downward revision by 25-35 per cent of the solar abundances of light elements such as C, N, O and Ne (ref. 2) has, however, broken this accordance: models adopting the new abundances incorrectly predict the depth of the convection zone, the depth profiles of sound speed and density, and the helium abundance(1,3). The discrepancies are far beyond the uncertainties in either the data or the model predictions(4). Here we report neon-to-oxygen ratios measured in a sample of nearby solar-like stars, using their X-ray spectra. The abundance ratios are all very similar and substantially larger than the recently revised solar value. The neon abundance in the Sun is quite poorly determined. If the Ne/O abundance in these stars is adopted for the Sun, the models are brought back into agreement with helioseismology measurements(5,6).	Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; MIT, MIT Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Massachusetts Institute of Technology (MIT)	Drake, JJ (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	jdrake@cfa.harvard.edu						ACTON LW, 1975, ASTROPHYS J, V195, pL93, DOI 10.1086/181718; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Antia HM, 2005, ASTROPHYS J, V620, pL129, DOI 10.1086/428652; Asplund M, 2000, ASTRON ASTROPHYS, V359, P743; ASPLUND M, 2004, SOLAR CHEM COMPOSITI; Audard M, 2003, ASTRON ASTROPHYS, V398, P1137, DOI 10.1051/0004-6361:20021737; Bahcall JN, 2005, ASTROPHYS J, V618, P1049, DOI 10.1086/426070; Bahcall JN, 2004, ASTROPHYS J, V614, P464, DOI 10.1086/423027; Bahcall JN, 2005, ASTROPHYS J, V621, pL85, DOI 10.1086/428929; BAHCALL JN, 2005, WHAT IS NEON ABUNDAN; Basu S, 2004, ASTROPHYS J, V606, pL85, DOI 10.1086/421110; Canizares CR, 2000, ASTROPHYS J, V539, pL41, DOI 10.1086/312823; Drake JJ, 2003, ADV SPACE RES-SERIES, V32, P945, DOI 10.1016/S0273-1177(03)00296-5; Drake JJ, 2001, ASTROPHYS J, V548, pL81, DOI 10.1086/318933; Feldman U, 2000, PHYS SCRIPTA, V61, P222, DOI 10.1238/Physica.Regular.061a00222; Frisch PC, 2003, ASTROPHYS J, V594, P844, DOI 10.1086/376689; GARCIAALVAREZ D, 2004, ASTRON ASTROPHYS SOC, V8; Grevesse N, 1998, SPACE SCI REV, V85, P161, DOI 10.1023/A:1005161325181; Gudel M, 2004, ASTRON ASTROPHYS REV, V12, P71, DOI 10.1007/s00159-004-0023-2; Henry RBC, 1999, PUBL ASTRON SOC PAC, V111, P919, DOI 10.1086/316403; Kashyap V., 2000, B ASTRON SOC INDIA, V28; Mazzotta P, 1998, ASTRON ASTROPHYS SUP, V133, P403, DOI 10.1051/aas:1998330; MEYER JP, 1985, ASTROPHYS J SUPPL S, V57, P151, DOI 10.1086/191000; MURPHY RJ, 1991, ASTROPHYS J, V371, P793, DOI 10.1086/169944; Ness JU, 2003, ASTROPHYS J, V598, P1277, DOI 10.1086/379059; RAMATY R, 1995, ASTROPHYS J, V455, pL193, DOI 10.1086/309841; Sanz-Forcada J, 2004, ASTRON ASTROPHYS, V416, P281, DOI 10.1051/0004-6361:20034466; Schmelz JT, 1996, ASTROPHYS J, V473, P519, DOI 10.1086/178164; SCHMELZ JT, 1993, ASTROPHYS J, V408, P373, DOI 10.1086/172594; Young PR, 2003, ASTROPHYS J SUPPL S, V144, P135, DOI 10.1086/344365	30	175	177	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2005	436	7050					525	528		10.1038/nature03803	http://dx.doi.org/10.1038/nature03803			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049481				2022-12-28	WOS:000230788800054
J	Jayaraman, KS				Jayaraman, KS			Biotech boom	NATURE			English	Article																			0	11	12	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2005	436	7050					480	483		10.1038/436480a	http://dx.doi.org/10.1038/436480a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049469				2022-12-28	WOS:000230788800038
J	Jayaraman, KS				Jayaraman, KS			Among the best	NATURE			English	Article																			0	5	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2005	436	7050					492	495		10.1038/436492a	http://dx.doi.org/10.1038/436492a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049476				2022-12-28	WOS:000230788800046
J	Chiou, PY; Ohta, AT; Wu, MC				Chiou, PY; Ohta, AT; Wu, MC			Massively parallel manipulation of single cells and microparticles using optical images	NATURE			English	Article							TRAVELING-WAVE DIELECTROPHORESIS; SEPARATION; BACTERIA; BEAMS; CHIP	The ability to manipulate biological cells and micrometre-scale particles plays an important role in many biological and colloidal science applications. However, conventional manipulation techniques - including optical tweezers(1-6), electrokinetic forces (electrophoresis(7,8), dielectrophoresis(9), travelling-wave dielectrophoresis(10,11)), magnetic tweezers(12,13), acoustic traps(14) and hydrodynamic flows(15-17) - cannot achieve high resolution and high throughput at the same time. Optical tweezers offer high resolution for trapping single particles, but have a limited manipulation area owing to tight focusing requirements; on the other hand, electrokinetic forces and other mechanisms provide high throughput, but lack the flexibility or the spatial resolution necessary for controlling individual cells. Here we present an optical image-driven dielectrophoresis technique that permits high-resolution patterning of electric fields on a photoconductive surface for manipulating single particles. It requires 100,000 times less optical intensity than optical tweezers. Using an incoherent light source ( a light-emitting diode or a halogen lamp) and a digital micromirror spatial light modulator, we have demonstrated parallel manipulation of 15,000 particle traps on a 1.3 x 1.0 mm(2) area. With direct optical imaging control, multiple manipulation functions are combined to achieve complex, multi-step manipulation protocols.	Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Berkeley Sensor & Actuator Ctr, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Wu, MC (corresponding author), Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA.	wu@eecs.berkeley.edu	Chiou, Pei-Yu/D-5496-2011; Wu, Ming C/J-9906-2012	Wu, Ming C/0000-0003-4808-6686; Ohta, Aaron/0000-0003-3789-897X				ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0; BECKER FF, 1995, P NATL ACAD SCI USA, V92, P860, DOI 10.1073/pnas.92.3.860; Cabrera CR, 2001, ELECTROPHORESIS, V22, P355, DOI 10.1002/1522-2683(200101)22:2<355::AID-ELPS355>3.0.CO;2-C; Curtis JE, 2002, OPT COMMUN, V207, P169, DOI 10.1016/S0030-4018(02)01524-9; Garces-Chavez V, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1843283; Gascoyne P, 2002, LAB CHIP, V2, P70, DOI [10.1039/b110990c, 10.1039/b110090c]; Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935; Hayward RC, 2000, NATURE, V404, P56, DOI 10.1038/35003530; HERTZ HM, 1995, J APPL PHYS, V78, P4845, DOI 10.1063/1.359770; Hughes MP, 2002, ELECTROPHORESIS, V23, P2569, DOI 10.1002/1522-2683(200208)23:16<2569::AID-ELPS2569>3.0.CO;2-M; KESSLER JO, 1985, NATURE, V313, P218, DOI 10.1038/313218a0; Kremser L, 2004, ELECTROPHORESIS, V25, P2282, DOI 10.1002/elps.200305868; Krupke R, 2003, SCIENCE, V301, P344, DOI 10.1126/science.1086534; Lee GB, 2001, J MICROMECH MICROENG, V11, P654, DOI 10.1088/0960-1317/11/6/306; Lee H, 2004, APPL PHYS LETT, V85, P1063, DOI 10.1063/1.1776339; MacDonald MP, 2003, NATURE, V426, P421, DOI 10.1038/nature02144; Manaresi N, 2003, IEEE J SOLID-ST CIRC, V38, P2297, DOI 10.1109/JSSC.2003.819171; McGloin D, 2003, OPT COMMUN, V225, P215, DOI 10.1016/j.optcom.2003.07.032; Morgan H, 1997, J MICROMECH MICROENG, V7, P65, DOI 10.1088/0960-1317/7/2/004; Ozkan M, 2002, SENSOR MATER, V14, P189; PAI DM, 1993, REV MOD PHYS, V65, P163, DOI 10.1103/RevModPhys.65.163; Pethig R, 2003, IEEE ENG MED BIOL, V22, P43, DOI 10.1109/MEMB.2003.1266046; SCHWARZ R, 1993, APPL PHYS LETT, V63, P1083, DOI 10.1063/1.109840; Sundararajan N, 2004, J MICROELECTROMECH S, V13, P559, DOI 10.1109/JMEMS.2004.832196; Yan J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011905; Yang J, 2000, BIOPHYS J, V78, P2680, DOI 10.1016/S0006-3495(00)76812-3	26	1058	1154	19	578	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					370	372		10.1038/nature03831	http://dx.doi.org/10.1038/nature03831			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034413				2022-12-28	WOS:000230623400037
J	Kinet, JP				Kinet, JP			A new strategy to counter allergy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECEPTOR		Harvard Univ, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Kinet, JP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.							Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Rivera J, 2002, CURR OPIN IMMUNOL, V14, P688, DOI 10.1016/S0952-7915(02)00396-5; SHU D, 2005, NAT MED, V11, P446; Siraganian RP, 2003, CURR OPIN IMMUNOL, V15, P639, DOI 10.1016/j.coi.2003.09.010	5	7	8	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2005	353	3					310	312		10.1056/NEJMcibr051440	http://dx.doi.org/10.1056/NEJMcibr051440			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YH	16034020				2022-12-28	WOS:000230608700016
J	Makinoshima, H; Glickman, MS				Makinoshima, H; Glickman, MS			Regulation of Mycobacterium tuberculosis cell envelope composition and virulence by intramembrane proteolysis	NATURE			English	Article							STRESS-RESPONSE; BOVIS BCG; BIOSYNTHESIS; CLEAVAGE; MICE; IDENTIFICATION; SURVIVAL; PATHWAY; RSEA	Mycobacterium tuberculosis infection is a continuing global health crisis that kills 2 million people each year(1). Although the structurally diverse lipids of the M. tuberculosis cell envelope each have non-redundant roles in virulence or persistence(2-7), the molecular mechanisms regulating cell envelope composition in M. tuberculosis are undefined. In higher eukaryotes, membrane composition is controlled by site two protease (S2P)-mediated cleavage of sterol regulatory element binding proteins(8,9), membrane-bound transcription factors that control lipid biosynthesis. S2P is the founding member of a widely distributed family of membrane metalloproteases(10,11) that cleave substrate proteins within transmembrane segments(12). Here we show that a previously uncharacterized M. tuberculosis S2P homologue (Rv2869c) regulates M. tuberculosis cell envelope composition, growth in vivo and persistence in vivo. These results establish that regulated intramembrane proteolysis is a conserved mechanism controlling membrane composition in prokaryotes and show that this proteolysis is a proximal regulator of cell envelope virulence determinants in M. tuberculosis.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Immunol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Div Infect Dis, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Glickman, MS (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Immunol, 1275 York Ave, New York, NY 10021 USA.	glickmam@mskcc.org		Glickman, Michael S/0000-0001-7918-5164	NIAID NIH HHS [R01 AI053417, R01 AI080619] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053417, R01AI080619] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902; Altincicek B, 2001, J BACTERIOL, V183, P2411, DOI 10.1128/JB.183.8.2411-2416.2001; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Chen JC, 2005, MOL MICROBIOL, V55, P1085, DOI 10.1111/j.1365-2958.2004.04443.x; Cohen-Gonsaud M, 2005, NAT STRUCT MOL BIOL, V12, P270, DOI 10.1038/nsmb905; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; CUTTING S, 1991, J MOL BIOL, V221, P1237; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Duncan EA, 1998, J BIOL CHEM, V273, P17801, DOI 10.1074/jbc.273.28.17801; Gao LY, 2003, MOL MICROBIOL, V49, P1547, DOI 10.1046/j.1365-2958.2003.03667.x; Gilleron M, 2003, J BIOL CHEM, V278, P29880, DOI 10.1074/jbc.M303446200; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Glickman MS, 2001, CELL, V104, P477, DOI 10.1016/S0092-8674(01)00236-7; Hingley-Wilson SM, 2003, NAT IMMUNOL, V4, P949, DOI 10.1038/ni981; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Kanehara K, 2002, GENE DEV, V16, P2147, DOI 10.1101/gad.1002302; Kremer L, 2002, BIOCHEM J, V363, P437, DOI 10.1042/0264-6021:3630437; Kuzuyama T, 2000, J BIOL CHEM, V275, P19928, DOI 10.1074/jbc.M001820200; Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Rhoades E, 2003, MOL MICROBIOL, V48, P875, DOI 10.1046/j.1365-2958.2003.03473.x; Rudner DZ, 1999, P NATL ACAD SCI USA, V96, P14765, DOI 10.1073/pnas.96.26.14765; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; Schobel S, 2004, MOL MICROBIOL, V52, P1091, DOI 10.1111/j.1365-2958.2004.04031.x; Vergne I, 2004, MOL BIOL CELL, V15, P751, DOI 10.1091/mbc.E03-05-0307; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; *WHO, 2004, GLOB TUB CONTR SURV	30	90	97	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					406	409		10.1038/nature03713	http://dx.doi.org/10.1038/nature03713			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034419	Green Accepted			2022-12-28	WOS:000230623400045
J	Tripati, A; Backman, J; Elderfield, H; Ferretti, P				Tripati, A; Backman, J; Elderfield, H; Ferretti, P			Eocene bipolar glaciation associated with global carbon cycle changes	NATURE			English	Article							SEA-SURFACE TEMPERATURES; SOUTHERN-OCEAN; ISOTOPE STRATIGRAPHY; ATMOSPHERIC CO2; COASTAL-PLAIN; LEVEL HISTORY; ANTARCTICA; MG/CA; SEQUENCES; OXYGEN	The transition from the extreme global warmth of the early Eocene 'greenhouse' climate similar to 55 million years ago to the present glaciated state is one of the most prominent changes in Earth's climatic evolution. It is widely accepted that large ice sheets first appeared on Antarctica similar to 34 million years ago, coincident with decreasing atmospheric carbon dioxide concentrations and a deepening of the calcite compensation depth in the world's oceans, and that glaciation in the Northern Hemisphere began much later, between 10 and 6 million years ago. Here we present records of sediment and foraminiferal geochemistry covering the greenhouse - icehouse climate transition. We report evidence for synchronous deepening and subsequent oscillations in the calcite compensation depth in the tropical Pacific and South Atlantic oceans from similar to 42 million years ago, with a permanent deepening 34 million years ago. The most prominent variations in the calcite compensation depth coincide with changes in seawater oxygen isotope ratios of up to 1.5 per mil, suggesting a lowering of global sea level through significant storage of ice in both hemispheres by at least 100 to 125 metres. Variations in benthic carbon isotope ratios of up to similar to 1.4 per mil occurred at the same time, indicating large changes in carbon cycling. We suggest that the greenhouse - icehouse transition was closely coupled to the evolution of atmospheric carbon dioxide, and that negative carbon cycle feedbacks may have prevented the permanent establishment of large ice sheets earlier than 34 million years ago.	Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Univ Stockholm, Dept Geol & Geochem, S-10691 Stockholm, Sweden	University of Cambridge; Stockholm University	Tripati, A (corresponding author), Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England.	atri02@esc.cam.ac.uk	Tripati, Aradhna/C-9419-2011	Tripati, Aradhna/0000-0002-1695-1754; FERRETTI, Patrizia/0000-0002-4814-3655	Natural Environment Research Council [NE/C510583/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ADAMS CG, 1990, PALAEOGEOGR PALAEOCL, V77, P289; ARCHER D, 1994, NATURE, V367, P260, DOI 10.1038/367260a0; Billups K, 2003, EARTH PLANET SC LETT, V209, P181, DOI 10.1016/S0012-821X(03)00067-0; Bohaty SM, 2003, GEOLOGY, V31, P1017, DOI 10.1130/G19800.1; Broecker W.S., 1982, TRACERS SEA; Browning JV, 1996, GEOLOGY, V24, P639, DOI 10.1130/0091-7613(1996)024<0639:GIOLTM>2.3.CO;2; Coxall HK, 2005, NATURE, V433, P53, DOI 10.1038/nature03135; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; DELAZZER A, 1998, SPACE FORUM, V3, P137; DiesterHaass L, 1996, GEOLOGY, V24, P163, DOI 10.1130/0091-7613(1996)024<0163:EOTITS>2.3.CO;2; Ehrmann W, 1998, PALAEOGEOGR PALAEOCL, V139, P213, DOI 10.1016/S0031-0182(97)00138-7; Freeman KH, 1992, GLOBAL BIOGEOCHEM CY, V6, P185, DOI 10.1029/92GB00190; Heath G. R., 1975, GEOL SOC AM MEM, V143, P1, DOI [10.1130/MEM143-p1, DOI 10.1130/MEM143-P1]; Huber M, 2003, SCIENCE, V299, P877, DOI 10.1126/science.1078766; Kump L. R., 1997, TECTONIC UPLIFT CLIM, P399, DOI [DOI 10.1007/978-1-4615-5935-1, DOI 10.1007/978-1-4615-5935-1_18]; Lear CH, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001039; Lear CH, 2002, GEOCHIM COSMOCHIM AC, V66, P3375, DOI 10.1016/S0016-7037(02)00941-9; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; LYLE M, 2002, P OCEAN DRILLING PRO, V199, P1, DOI DOI 10.2973/ODP.PROC.IR.199.104.2002; Marchitto TM, 2000, PALEOCEANOGRAPHY, V15, P299, DOI 10.1029/1999PA000420; Martin PA, 2002, EARTH PLANET SC LETT, V198, P193, DOI 10.1016/S0012-821X(02)00472-7; McArthur JM, 2001, J GEOL, V109, P155, DOI 10.1086/319243; Miller KG, 1987, PALEOCEANOGRAPHY, V2, P1, DOI 10.1029/PA002i001p00001; Miller KG, 1998, REV GEOPHYS, V36, P569, DOI 10.1029/98RG01624; Miller KG, 2004, GEOL SOC AM BULL, V116, P368, DOI 10.1130/B25279.1; Opdyke BN, 1988, PALEOCEANOGRAPHY, V3, P685, DOI 10.1029/PA003i006p00685; PALIKE H, 2003, ODP LEG 199 POSTCR M; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; Pearson PN, 2001, NATURE, V413, P481, DOI 10.1038/35097000; PETERSON LS, 1990, P OCEAN DRILLING PRO, V0115; ROBERT C, 1992, MAR GEOL, V103, P99, DOI 10.1016/0025-3227(92)90010-F; Royer DL, 2001, SCIENCE, V292, P2310, DOI 10.1126/science.292.5525.2310; SHACKLETON NJ, 1984, INITIAL REP DEEP SEA, V81, P599, DOI 10.2973/dsdp.proc.81.116.1984; Shipboard Scientific Party, 2004, Proceedings of the Ocean Drilling Program Initial Reports, V208, P1; Shipboard Scientific Party, 2005, 302 IODP SHIPB SCI P; Thunell R., 1986, TERMINAL EOCENE EVEN, P363, DOI [10.1016/s0920-5446(08)70140-7, DOI 10.1016/S0920-5446(08)70140-7]; Tripati A, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000605; Tripati AK, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000937; VANDENBERG MD, 2004, PALEOCEANOGRAPHY, V19, DOI DOI 10.1029/2003PA000928; Wade BS, 2002, GEOLOGY, V30, P1011, DOI 10.1130/0091-7613(2002)030<1011:MERCIE>2.0.CO;2; WILKINSON BH, 1989, AM J SCI, V289, P1158, DOI 10.2475/ajs.289.10.1158; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; ZACHOS JC, 1992, GEOLOGY, V20, P569, DOI 10.1130/0091-7613(1992)020<0569:EOISEO>2.3.CO;2; ZACHOS JC, 1994, PALEOCEANOGRAPHY, V9, P353, DOI 10.1029/93PA03266	44	209	226	1	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					341	346		10.1038/nature03874	http://dx.doi.org/10.1038/nature03874			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034408				2022-12-28	WOS:000230623400032
J	Busby, A; Ritvanen, A; Dolk, H; Armstrong, N; De Walle, H; Riano-Galan, I; Gatt, M; McDonnell, R; Nelen, V; Stone, D				Busby, A; Ritvanen, A; Dolk, H; Armstrong, N; De Walle, H; Riano-Galan, I; Gatt, M; McDonnell, R; Nelen, V; Stone, D			Survey of informed consent for registration of congenital anomalies in Europe	BMJ-BRITISH MEDICAL JOURNAL			English	Article							THREAT		Univ Ulster, Eurocat Cent Registry, Newtownabbey BT37 0QB, North Ireland; Eurocat Cent Registry, London WC1E 7HT, England; Finnish Register Congenital Malformat, Helsinki, Finland; Hlth & Social Serv No Ireland, R&D Off, Belfast BT2 8BS, Antrim, North Ireland; Univ Groningen, No Netherlands Registry, Groningen, Netherlands; Registry Congenital Defects Asturias, Oviedo, Spain; Univ Malta, Malta Congenital Anomalies Registry, Msida, Malta; Eastern Hlth Board, Dublin Registry, Dublin 8, Ireland; Prov Inst Hyg, Antwerp Registry, Antwerp, Belgium; Yorkhill Hosp, Glasgow Registry, Glasgow G3 8SJ, Lanark, Scotland	Ulster University; University of Groningen; University of Malta	Dolk, H (corresponding author), Univ Ulster, Eurocat Cent Registry, Newtownabbey BT37 0QB, North Ireland.	h.dolk@ulster.ac.uk	Riano-Galan, Isolina/AAL-7394-2020	Riano-Galan, Isolina/0000-0003-2125-5101; Armstrong, Nicola/0000-0001-7036-3649				BUSBY AL, INFORMED CONSENT CON; Jacobsen SJ, 1999, MAYO CLIN PROC, V74, P330, DOI 10.4065/74.4.330; Melton LJ, 1997, NEW ENGL J MED, V337, P1466, DOI 10.1056/NEJM199711133372012; Tu JV, 2004, NEW ENGL J MED, V350, P1414, DOI 10.1056/NEJMsa031697; Verity C, 2002, BRIT MED J, V324, P1210, DOI 10.1136/bmj.324.7347.1210	5	6	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 16	2005	331	7509					140	141		10.1136/bmj.331.7509.140	http://dx.doi.org/10.1136/bmj.331.7509.140			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	947GV	16020855	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000230632300016
J	Berriman, M; Ghedin, E; Hertz-Fowler, C; Blandin, G; Renauld, H; Bartholomeu, DC; Lennard, NJ; Caler, E; Hamlin, NE; Haas, B; Bohme, W; Hannick, L; Aslett, MA; Shallom, J; Marcello, L; Hou, LH; Wickstead, B; Alsmark, UCM; Arrowsmith, C; Atkin, RJ; Barron, AJ; Bringaud, F; Brooks, K; Carrington, M; Cherevach, I; Chillingworth, TJ; Churcher, C; Clark, LN; Corton, CH; Cronin, A; Davies, RM; Doggett, J; Djikeng, A; Feldblyum, T; Field, MC; Fraser, A; Goodhead, I; Hance, Z; Harper, D; Harris, BR; Hauser, H; Hostetter, J; Ivens, A; Jagels, K; Johnson, D; Johnson, J; Jones, K; Kerhornou, AX; Koo, H; Larke, N; Landfear, S; Larkin, C; Leech, V; Line, A; Lord, A; MacLeod, A; Mooney, PJ; Moule, S; Martin, DMA; Morgan, GW; Mungall, K; Norbertczak, H; Ormond, D; Pai, G; Peacock, CS; Peterson, J; Quail, MA; Rabbinowitsch, E; Rajandream, MA; Reitter, C; Salzberg, SL; Sanders, M; Schobel, S; Sharp, S; Simmonds, M; Simpson, AJ; Talton, L; Turner, CMR; Tait, A; Tivey, AR; Van Aken, S; Walker, D; Wanless, D; Wang, SL; White, B; White, O; Whitehead, S; Woodward, J; Wortman, J; Adams, MD; Embley, TM; Gull, K; Ullu, E; Barry, JD; Fairlamb, AH; Opperdoes, F; Barret, BG; Donelson, JE; Hall, N; Fraser, CM; Melville, SE; El-Sayed, NM				Berriman, M; Ghedin, E; Hertz-Fowler, C; Blandin, G; Renauld, H; Bartholomeu, DC; Lennard, NJ; Caler, E; Hamlin, NE; Haas, B; Bohme, W; Hannick, L; Aslett, MA; Shallom, J; Marcello, L; Hou, LH; Wickstead, B; Alsmark, UCM; Arrowsmith, C; Atkin, RJ; Barron, AJ; Bringaud, F; Brooks, K; Carrington, M; Cherevach, I; Chillingworth, TJ; Churcher, C; Clark, LN; Corton, CH; Cronin, A; Davies, RM; Doggett, J; Djikeng, A; Feldblyum, T; Field, MC; Fraser, A; Goodhead, I; Hance, Z; Harper, D; Harris, BR; Hauser, H; Hostetter, J; Ivens, A; Jagels, K; Johnson, D; Johnson, J; Jones, K; Kerhornou, AX; Koo, H; Larke, N; Landfear, S; Larkin, C; Leech, V; Line, A; Lord, A; MacLeod, A; Mooney, PJ; Moule, S; Martin, DMA; Morgan, GW; Mungall, K; Norbertczak, H; Ormond, D; Pai, G; Peacock, CS; Peterson, J; Quail, MA; Rabbinowitsch, E; Rajandream, MA; Reitter, C; Salzberg, SL; Sanders, M; Schobel, S; Sharp, S; Simmonds, M; Simpson, AJ; Talton, L; Turner, CMR; Tait, A; Tivey, AR; Van Aken, S; Walker, D; Wanless, D; Wang, SL; White, B; White, O; Whitehead, S; Woodward, J; Wortman, J; Adams, MD; Embley, TM; Gull, K; Ullu, E; Barry, JD; Fairlamb, AH; Opperdoes, F; Barret, BG; Donelson, JE; Hall, N; Fraser, CM; Melville, SE; El-Sayed, NM			The genome of the African trypanosome Trypanosoma brucei	SCIENCE			English	Article							ANTIGENIC VARIATION; LEISHMANIA-DONOVANI; PARASITIC PROTOZOA; SLEEPING SICKNESS; DRUG TARGET; CHEMOTHERAPY; METABOLISM; TELOMERES; SEQUENCE; GENES	African trypanosomes cause human sleeping sickness and livestock trypanosomiasis in sub-Saharan Africa. We present the sequence and analysis of the 11 megabase-sized chromosomes of Trypanosoma brucei. The 26-megabase genome contains 9068 predicted genes, including similar to 900 pseudogenes and similar to 1700 T. brucei-specific genes. Large subteiomeric arrays contain an archive of 806 variant surface glycoprotein (VSG) genes used by the parasite to evade the mammalian immune system. Most VSG genes are pseudogenes, which may be used to generate expressed mosaic genes by ectopic recombination. Comparisons of the cytoskeleton and endocytic trafficking systems with those of humans and other eukaryotic organisms reveal major differences. A comparison of metabolic pathways encoded by the genomes; of T. brucei, T. cruzi, and Leishmania major reveals the least overall metabolic capability in T. brucei and the greatest in L. major. Horizontal transfer of genes of, bacterial. origin has contributed to some of the metabolic differences in these, parasites, and a number of novel potential drug targets have been identified.	Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; Inst Genome Res, Rockville, MD 20850 USA; George Washington Univ, Dept Microbiol & Trop Med, Washington, DC 20052 USA; Univ Glasgow, Wellcome Ctr Mol Parasitol, Glasgow G11 6NU, Lanark, Scotland; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ Newcastle Upon Tyne, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Bordeaux 2, CNRS, UMR 5162, Lab Genom Fonct Trypanosomatides, F-33076 Bordeaux, France; Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; Oregon Hlth Sci Univ, Portland, OR 97239 USA; Univ Dundee, Sch Life Sci, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AY, England; Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Christian de Duve Inst Cellular Pathol, B-1200 Brussels, Belgium; Catholic Univ Louvain, B-1200 Brussels, Belgium; Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	Wellcome Trust Sanger Institute; J. Craig Venter Institute; George Washington University; University of Glasgow; University of Oxford; Newcastle University - UK; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; University of Cambridge; University of Cambridge; Oregon Health & Science University; University of Dundee; Imperial College London; University of Glasgow; Case Western Reserve University; Yale University; Universite Catholique Louvain; University of Iowa	Berriman, M (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, England.	neisayed@tigr.org	Quail, michael/ABE-6131-2020; Carrington, Mark/N-4892-2018; Salzberg, Steven/Q-6514-2019; Peacock, Christopher/A-4052-2012; Martin, David/C-2984-2009; Blandin, Gaelle/N-9745-2013; El-Sayed, Najib M.A./K-7266-2015; Hall, Neil/A-8717-2013; Carrington, Mark/N-3653-2019; Opperdoes, Frederik R/C-8897-2018; Opperdoes, Fred/N-9922-2019; Field, Mark/AAD-6455-2021; Fairlamb, Alan/A-5272-2009; Berriman, Matthew/A-7618-2011; Ghedin, Elodie/Y-5654-2019; Alsmark, Cecilia/AAO-1330-2021; Simpson, Amelia/HGB-1823-2022; Donelson, John E/F-5795-2010; Goodhead, Ian/ABC-9200-2020; Salzberg, Steven L/F-6162-2011; Bartholomeu, Daniella C./J-4714-2015	Carrington, Mark/0000-0002-6435-7266; Salzberg, Steven/0000-0002-8859-7432; Blandin, Gaelle/0000-0003-2790-9524; El-Sayed, Najib M.A./0000-0001-7970-3312; Hall, Neil/0000-0002-7995-3810; Carrington, Mark/0000-0002-6435-7266; Opperdoes, Frederik R/0000-0003-1984-3764; Opperdoes, Fred/0000-0003-1984-3764; Fairlamb, Alan/0000-0001-5134-0329; Berriman, Matthew/0000-0002-9581-0377; Ghedin, Elodie/0000-0002-1515-725X; Salzberg, Steven L/0000-0002-8859-7432; Bartholomeu, Daniella C./0000-0003-0974-7357; Ivens, Al/0000-0002-0112-3876; Djikeng, Appolinaire/0000-0001-9271-3419; Embley, Thomas Martin/0000-0002-1484-340X; MARCELLO, LUCIO/0000-0003-2252-1870; Davies, Robert/0000-0002-9983-1378; Field, Mark/0000-0002-4866-2885; Harper, David/0000-0002-8313-3516; Schobel, Seth/0000-0002-8967-257X; Hertz-Fowler, Christiane/0000-0002-0729-6479; Kerhornou, Arnaud/0000-0002-2890-295X; Wickstead, Bill/0000-0002-4620-9091; Goodhead, Ian/0000-0002-3110-9442; Bohme, Ulrike/0000-0002-0248-5924; Hannick, Linda/0000-0002-8018-8466; Hall, Neil/0000-0003-2808-0009; Fraser, Claire/0000-0003-1462-2428; Wortman, Jennifer/0000-0002-8713-1227; Martin, David/0000-0002-8732-204X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043062, U01AI043062] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43062, U01 AI043062, R01 AI043062] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ackers JP, 2005, MOL BIOCHEM PARASIT, V141, P89, DOI 10.1016/j.molbiopara.2005.01.017; Arkhipova IR, 2001, P NATL ACAD SCI USA, V98, P14497, DOI 10.1073/pnas.231494798; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Barry JD, 2003, INT J PARASITOL, V33, P29, DOI 10.1016/S0020-7519(02)00247-3; Becker M, 2004, GENOME RES, V14, P2319, DOI 10.1101/gr.2955304; Besteiro S, 2002, J BIOL CHEM, V277, P38001, DOI 10.1074/jbc.M201759200; Borst P, 2002, CELL, V109, P5, DOI 10.1016/S0092-8674(02)00711-0; Bringaud F, 2002, EUKARYOT CELL, V1, P137, DOI 10.1128/EC.1.1.137-151.2002; CARRINGTON M, 1991, J MOL BIOL, V221, P823, DOI 10.1016/0022-2836(91)80178-W; CAZZULO JJ, 1992, FASEB J, V6, P3153, DOI 10.1096/fasebj.6.13.1397837; Comini MA, 2004, FREE RADICAL BIO MED, V36, P1289, DOI 10.1016/j.freeradbiomed.2004.02.008; CRAIG A, 2003, ANTIGENIC VARIATION, P464; DREW ME, 1995, MOL CELL BIOL, V15, P5508; El Sawalhy A, 1998, J PARASITOL, V84, P469, DOI 10.2307/3284707; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; El-Sayed NMA, 2003, NUCLEIC ACIDS RES, V31, P4856, DOI 10.1093/nar/gkg673; Fairlamb AH, 2003, TRENDS PARASITOL, V19, P488, DOI 10.1016/j.pt.2003.09.002; Ferguson MAJ, 2000, P NATL ACAD SCI USA, V97, P10673, DOI 10.1073/pnas.97.20.10673; Field MC, 2004, TRAFFIC, V5, P905, DOI 10.1111/j.1600-0854.2004.00234.x; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gazit V, 2003, BEHAV BRAIN RES, V143, P1, DOI 10.1016/S0166-4328(03)00075-5; Ginger ML, 2001, J BIOL CHEM, V276, P11674, DOI 10.1074/jbc.M006850200; Hall N, 2003, NUCLEIC ACIDS RES, V31, P4864, DOI 10.1093/nar/gkg674; Huynh TT, 2003, J BIOL CHEM, V278, P39794, DOI 10.1074/jbc.M306306200; Irsch T, 2004, J BIOL CHEM, V279, P22209, DOI 10.1074/jbc.M401240200; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; KAMPER SM, 1992, MOL BIOCHEM PARASIT, V53, P33, DOI 10.1016/0166-6851(92)90004-4; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Landfear SM, 2004, EUKARYOT CELL, V3, P245, DOI 10.1128/EC.3.2.245-254.2004; Li F, 1998, EXP PARASITOL, V88, P255, DOI 10.1006/expr.1998.4237; LINSTEAD DJ, 1977, J GEN MICROBIOL, V101, P243, DOI 10.1099/00221287-101-2-243; LIU AYC, 1983, J MOL BIOL, V167, P57, DOI 10.1016/S0022-2836(83)80034-5; Lowell JE, 2004, J CELL SCI, V117, P5937, DOI 10.1242/jcs.01515; Melville SE, 1998, MOL BIOCHEM PARASIT, V94, P155, DOI 10.1016/S0166-6851(98)00054-1; Nihei C, 2002, BBA-MOL BASIS DIS, V1587, P234, DOI 10.1016/S0925-4439(02)00086-8; Ogbadoyi E, 2000, CHROMOSOMA, V108, P501, DOI 10.1007/s004120050402; Overath P, 2004, MOL MICROBIOL, V53, P735, DOI 10.1111/j.1365-2958.2004.04224.x; Pays E, 2004, CURR OPIN MICROBIOL, V7, P369, DOI 10.1016/j.mib.2004.05.001; Pereira CA, 2002, J EUKARYOT MICROBIOL, V49, P82, DOI 10.1111/j.1550-7408.2002.tb00346.x; Price HP, 2005, J CELL SCI, V118, P831, DOI 10.1242/jcs.01624; Roberts SC, 2004, J BIOL CHEM, V279, P23668, DOI 10.1074/jbc.M402042200; Roper JR, 2002, P NATL ACAD SCI USA, V99, P5884, DOI 10.1073/pnas.092669999; ROTH C, 1989, P NATL ACAD SCI USA, V86, P9375, DOI 10.1073/pnas.86.23.9375; Steenkamp DJ, 2002, ANTIOXID REDOX SIGN, V4, P105, DOI 10.1089/152308602753625906; STEIGER RF, 1977, J PROTOZOOL, V24, P437, DOI 10.1111/j.1550-7408.1977.tb04771.x; TURNER CMR, 1989, PARASITOLOGY, V99, P67, DOI 10.1017/S0031182000061035; Urbina JA, 2003, TRENDS PARASITOL, V19, P495, DOI 10.1016/j.pt.2003.09.001; Van Hellemond JJ, 1998, P NATL ACAD SCI USA, V95, P3036, DOI 10.1073/pnas.95.6.3036; VANDERPLOEG LH, 1982, NUCLEIC ACIDS RES, V10, P9505; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Vickers TJ, 2004, P NATL ACAD SCI USA, V101, P13186, DOI 10.1073/pnas.0402918101; Wickstead B, 2004, GENOME RES, V14, P1014, DOI 10.1101/gr.2227704; World Health Organization, 2004, WORLD HLTH REP 2004; Wyllie S, 2004, J BIOL CHEM, V279, P39925, DOI 10.1074/jbc.M405635200	55	1270	1375	3	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					416	422		10.1126/science.1112642	http://dx.doi.org/10.1126/science.1112642			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020726				2022-12-28	WOS:000230574900036
J	Perez-Morga, D; Vanhollebeke, B; Paturiaux-Hanocq, F; Nolan, DP; Lins, L; Homble, F; Vanhamme, L; Tebabi, P; Pays, A; Poelvoorde, P; Jacquet, A; Brasseur, R; Pays, E				Perez-Morga, D; Vanhollebeke, B; Paturiaux-Hanocq, F; Nolan, DP; Lins, L; Homble, F; Vanhamme, L; Tebabi, P; Pays, A; Poelvoorde, P; Jacquet, A; Brasseur, R; Pays, E			Apolipoprotein L-1 promotes trypanosome lysis by forming pores in lysosomal membranes	SCIENCE			English	Article							HIGH-DENSITY-LIPOPROTEIN; L GENE-CLUSTER; LYTIC FACTOR; HUMAN-SERUM; LIPID-MEMBRANES; COLICIN-A; L-I; BRUCEI; IDENTIFICATION; TISSUE	Apolipoprotein L-I is the trypanolytic factor of human serum. Here we show that this protein contains a membrane pore-forming domain functionally similar to that of bacteria[ colicins, flanked by a membrane-addressing domain. In lipid bilayer membranes, apolipoprotein L-I formed anion channels. In Trypanosoma brucei, apolipoprotein L-I was targeted to the lysosomal membrane and triggered depolarization of this membrane, continuous influx of chloride, and subsequent osmotic swelling of the lysosome until the trypanosome lysed.	Univ Libre Bruxelles, IBMM, Mol Parasitol Lab, B-6041 Gosselies, Belgium; Univ Dublin Trinity Coll, Dept Biochem, Dublin 2, Ireland; Univ Gembloux, Ctr Biophys Mol Numer, Gembloux, Belgium; Univ Libre Bruxelles, B-1050 Brussels, Belgium; Univ Libre Bruxelles, IBMM, Lab Appl Genet, B-6041 Gosselies, Belgium	Universite Libre de Bruxelles; Trinity College Dublin; University of Liege; Universite Libre de Bruxelles; Universite Libre de Bruxelles	Pays, E (corresponding author), Univ Libre Bruxelles, IBMM, Mol Parasitol Lab, 12 Rue Profs Jeener & Brachet, B-6041 Gosselies, Belgium.	epays@ulb.ac.be	LINS, LAURENCE/Y-1661-2019; Homble, Fabrice/AAH-3780-2020; Jacquet, Alain/T-8611-2019; Jacquet, Alain/GQI-0546-2022	LINS, LAURENCE/0000-0001-7772-6748; Homble, Fabrice/0000-0001-6031-136X; Jacquet, Alain/0000-0002-0980-9741; Jacquet, Alain/0000-0002-0980-9741; Perez-Morga, David/0000-0002-7168-1865; Nolan, Derek/0000-0002-3742-4304; Vanhollebeke, Benoit/0000-0002-0353-365X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Duchateau PN, 2001, J LIPID RES, V42, P620; Duchateau PN, 1997, J BIOL CHEM, V272, P25576, DOI 10.1074/jbc.272.41.25576; Duche D, 2002, BIOCHIMIE, V84, P455, DOI 10.1016/S0300-9084(02)01424-4; FUKS B, 1994, BIOPHYS J, V66, P1404, DOI 10.1016/S0006-3495(94)80931-2; Green HP, 2003, J BIOL CHEM, V278, P422, DOI 10.1074/jbc.M207215200; GRINVALD A, 1984, NATURE, V308, P848, DOI 10.1038/308848a0; HAGER KM, 1994, J CELL BIOL, V126, P155, DOI 10.1083/jcb.126.1.155; Kienker PK, 2003, J GEN PHYSIOL, V122, P161, DOI 10.1085/jgp.200308852; Lazebnik Y, 2001, CURR BIOL, V11, pR767, DOI 10.1016/S0960-9822(01)00465-1; Maget-Dana R, 1999, BBA-BIOMEMBRANES, V1462, P109, DOI 10.1016/S0005-2736(99)00203-5; Monajemi H, 2002, GENOMICS, V79, P539, DOI 10.1006/geno.2002.6729; MORLON J, 1983, J MOL BIOL, V170, P271, DOI 10.1016/S0022-2836(83)80148-X; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nardi A, 2001, J MOL BIOL, V307, P1293, DOI 10.1006/jmbi.2001.4524; Nolan DP, 2000, EUR J BIOCHEM, V267, P4615, DOI 10.1046/j.1432-1327.2000.01477.x; Page NM, 2001, GENOMICS, V74, P71, DOI 10.1006/geno.2001.6534; Poelvoorde P, 2004, MOL BIOCHEM PARASIT, V134, P155, DOI 10.1016/j.molbiopara.2003.11.006; RIFKIN MR, 1984, EXP PARASITOL, V58, P81, DOI 10.1016/0014-4894(84)90023-7; RIFKIN MR, 1991, J LIPID RES, V32, P639; Shimamura M, 2001, MOL BIOCHEM PARASIT, V115, P227, DOI 10.1016/S0166-6851(01)00292-4; Vanderheyden N, 2000, BIOCHEM J, V346, P53, DOI 10.1042/0264-6021:3460053; Vanhamme L, 2004, INT J PARASITOL, V34, P887, DOI 10.1016/j.ijpara.2004.04.008; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461	23	237	244	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					469	472		10.1126/science.1114566	http://dx.doi.org/10.1126/science.1114566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020735				2022-12-28	WOS:000230574900048
J	Sato, H; Hirata, N; Koketsu, K; Okaya, D; Abe, S; Kobayashi, R; Matsubara, M; Iwasaki, T; Ito, T; Ikawa, T; Kawanaka, T; Kasahara, K; Harder, S				Sato, H; Hirata, N; Koketsu, K; Okaya, D; Abe, S; Kobayashi, R; Matsubara, M; Iwasaki, T; Ito, T; Ikawa, T; Kawanaka, T; Kasahara, K; Harder, S			Earthquage source fault beneath Tokyo	SCIENCE			English	Article							BARBADOS RIDGE DECOLLEMENT; PHILIPPINE SEA PLATE; GROUND MOTION; 1923 KANTO; JAPAN; SLIP; SANRIKU; MODEL; ZONE	Devastating earthquakes occur on a megathrust fault that underlies the Tokyo, metropolitan region. We identify this fault with use of deep seismic reflection profiling to be the upper surface of the Philippine Sea plate. The depth to the top of this plate, 4 to 26 kilometers, is much shallower than previous estimates based on the distribution of seismicity. This shallower plate geometry changes the location of maximum finite slip of the 1923 Kanto earthquake and will affect estimations of strong ground motion for seismic hazards analysis within the Tokyo region.	Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan; Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; JDI Inc, Bunkyo Ku, Tokyo 1120012, Japan; Natl Res Inst Earth Sci & Disaster Prevent, Tsukuba, Ibaraki 3050006, Japan; Chiba Univ, Dept Earth Sci, Chiba 2638522, Japan; Univ Texas, Dept Geol Sci, El Paso, TX 79968 USA	University of Tokyo; University of Southern California; National Research Institute for Earth Science & Disaster Resilience; Chiba University; University of Texas System; University of Texas El Paso	Sato, H (corresponding author), Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.							Bangs NLB, 1999, J GEOPHYS RES-SOL EA, V104, P20399, DOI 10.1029/1999JB900133; Bilek SL, 1998, SCIENCE, V281, P1175, DOI 10.1126/science.281.5380.1175; Furumura T, 2000, PURE APPL GEOPHYS, V157, P2047, DOI 10.1007/PL00001074; Hayakawa T, 2002, PHYS EARTH PLANET IN, V132, P89, DOI 10.1016/S0031-9201(02)00046-8; ISHIDA M, 1992, J GEOPHYS RES-SOL EA, V97, P489, DOI 10.1029/91JB02567; KASAHARA K, 1985, REP NATL RES CENT DI, V35, P33; Kobayashi R, 2005, EARTH PLANETS SPACE, V57, P261, DOI 10.1186/BF03352562; Kodaira S, 2000, J GEOPHYS RES-SOL EA, V105, P5887, DOI 10.1029/1999JB900394; Kodaira S, 2004, SCIENCE, V304, P1295, DOI 10.1126/science.1096535; Kodaira S, 2002, GEOPHYS J INT, V149, P815, DOI 10.1046/j.1365-246X.2002.01691.x; Koketsu K, 2000, SCIENCE, V288, P1237, DOI 10.1126/science.288.5469.1237; Matsu'ura M., 1980, Journal of Physics of the Earth, V28, P119, DOI 10.4294/jpe1952.28.119; MATSUBARA M, UNPUB J GEOPHYS RES; Matsuzawa T, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014632; Nakanishi A, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002574; Nedimovic MR, 2003, NATURE, V424, P416, DOI 10.1038/nature01840; NOGUCHI S, 1998, B EARTHQ RES I TOKYO, V73, P73; OKADA Y, 2001, EARTH MON, V34, P94; Ozawa S, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016665; Sagiya T, 2004, PURE APPL GEOPHYS, V161, P2327, DOI 10.1007/s0024-004-2566-6; SENO T, 1993, J GEOPHYS RES-SOL EA, V98, P17941, DOI 10.1029/93JB00782; SHIPLEY TH, 1994, GEOLOGY, V22, P411, DOI 10.1130/0091-7613(1994)022<0411:SIDDNB>2.3.CO;2; Taira A, 1989, EVOLUTION PACIFIC OC, P100; TAKEMURA M, 2003, GREAT KANTO EARTHQUA; WALD DJ, 1995, B SEISMOL SOC AM, V85, P159; Wessel P, 1991, EOS T AM GEOPHYS UN, V72, P445, DOI [10.1029/90EO00319, DOI 10.1029/90EO00319, DOI 10.1029/90E000319]; Yamanaka Y, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002683	27	80	83	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					462	464		10.1126/science.1110489	http://dx.doi.org/10.1126/science.1110489			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020734				2022-12-28	WOS:000230574900045
J	Wilman, RJ; Gerssen, J; Bower, RG; Morris, SL; Bacon, R; de Zeeuw, PT; Davies, RL				Wilman, RJ; Gerssen, J; Bower, RG; Morris, SL; Bacon, R; de Zeeuw, PT; Davies, RL			The discovery of a galaxy-wide superwind from a young massive galaxy at redshift z approximate to 3	NATURE			English	Article							LY-ALPHA; LUMINOSITY; RADIATION; EMISSION; MATTER	High-velocity galactic outflows, driven by intense bursts of star formation and black hole accretion, are processes invoked by current theories of galaxy formation(1) to terminate star formation in the most massive galaxies and to deposit heavy elements in the intergalactic medium. From existing observational evidence(2,3) ( for high-redshift galaxies) it is unclear whether such outflows are localized to regions of intense star formation just a few kiloparsecs in extent, or whether they instead have a significant impact on the entire galaxy and its surroundings. Here we present two-dimensional spectroscopy of a star-forming galaxy(4) at redshift z = 3.09 ( seen 11.5 gigayears ago, when the Universe was 20 per cent of its current age): its spatially extended Ly alpha line emission appears to be absorbed by HI in a foreground screen covering the entire galaxy, with a lateral extent of at least 100 kpc and remarkable velocity coherence. This screen was ejected from the galaxy during a starburst several 10(8) years earlier and has subsequently swept up gas from the surrounding intergalactic medium and cooled. This demonstrates the galaxy-wide impact of high-redshift superwinds.	Univ Durham, Dept Phys, Durham DH1 3LE, England; CRAL Observ, F-69230 St Genis Laval, France; Leiden Observ, NL-2333 CA Leiden, Netherlands; Univ Oxford, Oxford OX1 3RH, England	Durham University; Leiden University; Leiden University - Excl LUMC; University of Oxford	Wilman, RJ (corresponding author), Univ Durham, Dept Phys, South Rd, Durham DH1 3LE, England.	r.j.wilman@durham.ac.uk	Morris, Simon L/G-7981-2011	Morris, Simon L/0000-0003-4866-110X; Bower, Richard/0000-0002-5215-6010; Wilman, Richard/0000-0002-6196-612X				Adelberger KL, 2003, ASTROPHYS J, V584, P45, DOI 10.1086/345660; Bacon R, 2001, MON NOT R ASTRON SOC, V326, P23, DOI 10.1046/j.1365-8711.2001.04612.x; Basu-Zych A, 2004, ASTROPHYS J, V615, pL85, DOI 10.1086/426390; Binette L, 2000, ASTRON ASTROPHYS, V356, P23; Boissier S, 2003, MON NOT R ASTRON SOC, V338, P131, DOI 10.1046/j.1365-8711.2003.06023.x; Bower RG, 2004, MON NOT R ASTRON SOC, V351, P63, DOI 10.1111/j.1365-2966.2004.07783.x; CHAPMAN S, 2001, APJ, V548, P17; Chapman SC, 2004, ASTROPHYS J, V606, P85, DOI 10.1086/382778; Dave R, 1999, ASTROPHYS J, V511, P521, DOI 10.1086/306722; Fardal MA, 2001, ASTROPHYS J, V562, P605, DOI 10.1086/323519; Mas-Hesse JM, 2003, ASTROPHYS J, V598, P858, DOI 10.1086/379116; NEUFELD DA, 1990, ASTROPHYS J, V350, P216, DOI 10.1086/168375; Pettini M, 2002, ASTROPHYS J, V569, P742, DOI 10.1086/339355; Rocca-Volmerange B, 2004, ASTRON ASTROPHYS, V415, P931, DOI 10.1051/0004-6361:20031717; SCHAYE J, 2001, ASTROPHYS J, V559, P1; Steidel CC, 2000, ASTROPHYS J, V532, P170, DOI 10.1086/308568; STEIDEL CC, 1993, ASTROPHYS SPACE SC L, V188, P263; SUTHERLAND RS, 1993, ASTROPHYS J SUPPL S, V88, P253, DOI 10.1086/191823; Taniguchi Y, 2000, ASTROPHYS J, V532, pL13, DOI 10.1086/312557; Tenorio-Tagle G, 1999, MON NOT R ASTRON SOC, V309, P332, DOI 10.1046/j.1365-8711.1999.02809.x	23	98	98	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					227	229		10.1038/nature03718	http://dx.doi.org/10.1038/nature03718			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015322	Green Accepted			2022-12-28	WOS:000230459500033
J	Pape, L; Ehrich, JHH; Zivicnjak, M; Offner, G				Pape, L; Ehrich, JHH; Zivicnjak, M; Offner, G			Growth in children after kidney transplantation with living related donor graft or cadaveric graft	LANCET			English	Article							RENAL-TRANSPLANTATION; HEIGHT	The extent to which growth after renal transplantation differs between children with a living related donor graft (LRD) and those with a cadaveric donor graft (CAD) is unclear. We retrospectively studied growth in the 5 years after transplantation in 30 boys who received LRD and 21 who received CAD. Height was similar in both groups after transplantation but was greater in LRD than in CAD recipients during follow-up. LRD recipients were taller at all ages, and had greater growth velocity in infancy and during puberty. Glomerular filtration rate (GFR) was higher immediately after transplantation in LRD than in CAD recipients, but did not differ between the groups during follow-up. GFR and other factors did not affect height 5 years after transplantation. These findings support use of LRD as the preferred option in children.	Hannover Med Sch, Dept Paediat Nephrol, D-30625 Hannover, Germany	Hannover Medical School	Pape, L (corresponding author), Hannover Med Sch, Dept Paediat Nephrol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	larspape@t-online.de	Pape, Lars/AAF-1477-2021; Zivicnjak, Miroslav/HHS-4915-2022	Pape, Lars/0000-0002-3635-6418; 				Maxwell H, 1998, J PEDIATR-US, V133, P435, DOI 10.1016/S0022-3476(98)70283-5; Ninik A, 2002, PEDIATR TRANSPLANT, V6, P219, DOI 10.1034/j.1399-3046.2002.01084.x; Nissel R, 2004, KIDNEY INT, V66, P792, DOI 10.1111/j.1523-1755.2004.00805.x; Prader A, 1989, Helv Paediatr Acta Suppl, V52, P1; SCHWARTZ GJ, 1987, PEDIATR CLIN N AM, V34, P571; Vats A, 2002, AM J TRANSPLANT, V2, P939, DOI 10.1034/j.1600-6143.2002.21010.x	6	39	40	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 9	2005	366	9480					151	153		10.1016/S0140-6736(05)66872-9	http://dx.doi.org/10.1016/S0140-6736(05)66872-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	943JH	16005338				2022-12-28	WOS:000230349200034
J	Currey, JD				Currey, JD			Materials science - Hierarchies in biomineral structures	SCIENCE			English	Editorial Material							FRACTURE; BONE		Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England	University of York - UK	Currey, JD (corresponding author), Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England.	jdc1@york.ac.uk						Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; CURREY JD, 1976, J MATER SCI, V11, P1615, DOI 10.1007/BF00737517; Deshpande VS, 2001, ACTA MATER, V49, P1035, DOI 10.1016/S1359-6454(00)00379-7; Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100; JACOBS CR, 1995, J BIOMECH, V28, P449, DOI 10.1016/0021-9290(94)00087-K; Kamat S, 2004, ACTA MATER, V52, P2395, DOI 10.1016/j.actamat.2004.01.030; Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1; Wang RZ, 1997, PHILOS T R SOC B, V352, P469, DOI 10.1098/rstb.1997.0034	8	146	148	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2005	309	5732					253	254		10.1126/science.1113954	http://dx.doi.org/10.1126/science.1113954			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002605				2022-12-28	WOS:000230449800029
J	Foerch, C; Misselwitz, B; Sitzer, M; Berger, K; Steinmetz, H; Neumann-Haefelin, T				Foerch, C; Misselwitz, B; Sitzer, M; Berger, K; Steinmetz, H; Neumann-Haefelin, T		Arbetisgrp Schlanganfall Hessen	Difference in recognition of right and left hemispheric stroke	LANCET			English	Article								Symptoms of cerebrovascular events differ depending on the hemisphere in which the lesion arises, thereby affecting disease recognition and management. We aimed to establish whether left and right hemispheric strokes are unequally distributed in inpatients. We obtained data from a large hospital-based stroke registry in Germany. 11 328 patients (56%) had left hemispheric events and 8769 (44%) had right-sided lesions (p<0.0001). Age, stroke severity, and time from symptom onset to admission were significantly associated with left hemispheric stroke, suggesting a selection effect. Difficulties in recognition of symptoms due to right hemispheric stroke challenge efforts to optimise stroke management, particularly in the critical early hours of stroke.	Goethe Univ Frankfurt, Dept Neurol, D-60528 Frankfurt, Germany; Geschaeftsstelle Qual Sicherung Hessen, Eschborn, Germany; Univ Munster, Inst Epidemiol & Social Med, Munster, Germany	Goethe University Frankfurt; University of Munster	Foerch, C (corresponding author), Goethe Univ Frankfurt, Dept Neurol, Schleusenweg 2-16, D-60528 Frankfurt, Germany.	foerch@em.uni-frankfurt.de	Neumann-Haefelin, Tobias/AAC-3915-2020					ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; BROTT T, 1994, STROKE, V25, P1122, DOI 10.1161/01.STR.25.6.1122; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Hernandez SAR, 2003, HYPERTENSION, V42, P56, DOI 10.1161/01.HYP.0000077983.66161.6F; vanLatum JC, 1996, NEUROLOGY, V46, P159; Woo D, 1999, STROKE, V30, P2355, DOI 10.1161/01.STR.30.11.2355	7	115	119	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2005	366	9483					392	393		10.1016/S0140-6736(05)67024-9	http://dx.doi.org/10.1016/S0140-6736(05)67024-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	950IB	16054939				2022-12-28	WOS:000230849700026
J	Kocer, A; Walko, M; Meijberg, W; Feringa, BL				Kocer, A; Walko, M; Meijberg, W; Feringa, BL			A light-actuated nanovalve derived from a channel protein	SCIENCE			English	Article							MECHANOSENSITIVE ION-CHANNEL; ESCHERICHIA-COLI-CELLS; OSMOTIC DOWNSHOCK; LARGE-CONDUCTANCE; GATING MECHANISM; SINGLE RESIDUE; MSCL; ACTIVATION; MUTATIONS	Toward the realization of nanoscale device control, we report a molecular valve embedded in a membrane that can be opened by illumination with long-wavelength ultraviolet (366 nanometers) tight and then resealed by visible irradiation. The valve consists of a channel protein, the mechanosensitive channel of large conductance (MscL) from Escherichia coli, modified by attachment of synthetic compounds that undergo tight-induced charge separation to reversibly open and close a 3-nanometer pore. The system is compatible with a classical encapsulation system, the liposome, and external photochemical control over transport through the channel is achieved.	BiOMaDe Technol Fdn, NL-9747 AG Groningen, Netherlands; Univ Groningen, Stratingh Inst, Dept Organ & Mol Inorgan Chem, NL-9747 AG Groningen, Netherlands; Univ Groningen, Ctr Mat Sci, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen	Feringa, BL (corresponding author), BiOMaDe Technol Fdn, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	meijberg@biomade.nl; B.L.Feringa@rug.nt	Feringa, Ben L./C-1665-2013; Kocer, A/M-6371-2013					Ajouz B, 1998, J BIOL CHEM, V273, P26670, DOI 10.1074/jbc.273.41.26670; Alfimov MV, 2003, J PHOTOCH PHOTOBIO A, V158, P183, DOI 10.1016/S1010-6030(03)00033-9; Anishkin A, 2005, J GEN PHYSIOL, V125, P155, DOI 10.1085/jgp.200409118; Berrier C, 2000, J BACTERIOL, V182, P248, DOI 10.1128/JB.182.1.248-251.2000; Bertarelli C, 2004, ADV FUNCT MATER, V14, P357, DOI 10.1002/adfm.200304414; Blount P, 1996, P NATL ACAD SCI USA, V93, P11652, DOI 10.1073/pnas.93.21.11652; Blount P, 1997, J BIOL CHEM, V272, P32150, DOI 10.1074/jbc.272.51.32150; Bochet CG, 2002, J CHEM SOC PERK T 1, P125, DOI 10.1039/b009522m; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Cruickshank CC, 1997, BIOPHYS J, V73, P1925, DOI 10.1016/S0006-3495(97)78223-7; Feringa B. L., 2001, MOL SWITCHES; Folgering JHA, 2004, LANGMUIR, V20, P6985, DOI 10.1021/la048942v; Gullingsrud J, 2003, BIOPHYS J, V85, P2087, DOI 10.1016/S0006-3495(03)74637-2; Hase CC, 1997, J MEMBRANE BIOL, V157, P17, DOI 10.1007/s002329900212; Ichimura K, 2000, SCIENCE, V288, P1624, DOI 10.1126/science.288.5471.1624; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; New R.R.C., 1990, LIPOSOMES PRACTICAL, P105; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Perozo E, 2001, J GEN PHYSIOL, V118, P193, DOI 10.1085/jgp.118.2.193; Perozo E, 2002, NATURE, V418, P942, DOI 10.1038/nature00992; Reinhard R, 1998, J ORG CHEM, V63, P2434, DOI 10.1021/jo961861m; Sukharev S, 2004, TRENDS NEUROSCI, V27, P345, DOI 10.1016/j.tins.2004.04.006; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; Sukhareva M, 2003, J GEN PHYSIOL, V122, P541, DOI 10.1085/jgp.200308905; Willner I, 1996, ANGEW CHEM INT EDIT, V35, P367, DOI 10.1002/anie.199603671; Yoshimura K, 1999, BIOPHYS J, V77, P1960, DOI 10.1016/S0006-3495(99)77037-2; Yoshimura K, 2001, BIOPHYS J, V80, P2198, DOI 10.1016/S0006-3495(01)76192-9	27	410	423	2	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2005	309	5735					755	758		10.1126/science.1114760	http://dx.doi.org/10.1126/science.1114760			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051792				2022-12-28	WOS:000230938200045
J	Nishida, A; Fukui, K				Nishida, A; Fukui, K			Transcatheter treatment of thromboembolism in the superior mesenteric artery	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Ureshino Med Ctr, Saga 8430393, Japan		Nishida, A (corresponding author), Ureshino Med Ctr, Saga 8430393, Japan.								0	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2005	353	4					E4	E4		10.1056/NEJMicm040977	http://dx.doi.org/10.1056/NEJMicm040977			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949JW	16049204				2022-12-28	WOS:000230782800014
J	Eathiraj, S; Pan, XJ; Ritacco, C; Lambright, DG				Eathiraj, S; Pan, XJ; Ritacco, C; Lambright, DG			Structural basis of family-wide Rab GTPase recognition by rabenosyn-5	NATURE			English	Article							ENDOCYTIC COMPARTMENTS; MEMBRANE TRAFFICKING; BINDING-PROTEINS; EARLY ENDOSOMES; TRANS-GOLGI; SPECIFICITY; EFFECTOR; COMPLEX; LOCALIZATION; DISSOCIATION	Rab GTPases regulate all stages of membrane trafficking, including vesicle budding, cargo sorting, transport, tethering and fusion(1,2). In the inactive (GDP-bound) conformation, accessory factors facilitate the targeting of Rab GTPases to intracellular compartments(3-8). After nucleotide exchange to the active (GTP-bound) conformation, Rab GTPases interact with functionally diverse effectors including lipid kinases, motor proteins and tethering complexes. How effectors distinguish between homologous Rab GTPases represents an unresolved problem with respect to the specificity of vesicular trafficking. Using a structural proteomic approach, we have determined the specificity and structural basis underlying the interaction of the multivalent effector rabenosyn-5 with the Rab family. The results demonstrate that even the structurally similar effector domains in rabenosyn-5 can achieve highly selective recognition of distinct subsets of Rab GTPases exclusively through interactions with the switch and interswitch regions. The observed specificity is determined at a family-wide level by structural diversity in the active conformation, which governs the spatial disposition of critical conserved recognition determinants, and by a small number of both positive and negative sequence determinants that allow further discrimination between Rab GTPases with similar switch conformations.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Lambright, DG (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	David.Lambright@umassmed.edu			NIAID NIH HHS [P30 AI042845] Funding Source: Medline; NIGMS NIH HHS [R01 GM056324] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056324] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Calero M, 2003, MOL BIOL CELL, V14, P1852, DOI 10.1091/mbc.E02-11-0707; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Chen D, 1996, GENE, V174, P129, DOI 10.1016/0378-1119(96)00509-4; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Fouraux MA, 2004, MOL BIOL CELL, V15, P611, DOI 10.1091/mbc.E03-05-0343; Fukuda M, 2003, J BIOL CHEM, V278, P15373, DOI 10.1074/jbc.M212341200; Heo WD, 2003, CELL, V113, P315; Junutula JR, 2004, MOL BIOL CELL, V15, P2218, DOI 10.1091/mbc.E03-10-0777; Kauppi M, 2002, J CELL SCI, V115, P899; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; Merithew E, 2001, J BIOL CHEM, V276, P13982, DOI 10.1074/jbc.M009771200; Mesa R, 2001, J CELL SCI, V114, P4041; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Pfeffer SR, 2005, J BIOL CHEM, V280, P15485, DOI 10.1074/jbc.R500003200; Rak A, 2004, CELL, V117, P749, DOI 10.1016/j.cell.2004.05.017; Rak A, 2003, SCIENCE, V302, P646, DOI 10.1126/science.1087761; Rodriguez-Gabin AG, 2001, J NEUROSCI RES, V66, P1149, DOI 10.1002/jnr.1253.abs; Seabra MC, 2004, CURR OPIN CELL BIOL, V16, P451, DOI 10.1016/j.ceb.2004.06.014; Simpson JC, 2004, J CELL SCI, V117, P6297, DOI 10.1242/jcs.01560; Sivars U, 2003, NATURE, V425, P856, DOI 10.1038/nature02057; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vitale G, 1998, EMBO J, V17, P1941, DOI 10.1093/emboj/17.7.1941; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhu GY, 2004, NAT STRUCT MOL BIOL, V11, P975, DOI 10.1038/nsmb832	30	170	184	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					415	419		10.1038/nature03798	http://dx.doi.org/10.1038/nature03798			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034420	Green Accepted			2022-12-28	WOS:000230623400047
J	Steinbrook, R				Steinbrook, R			The controversy over Guidant's implantable defibrillators	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SUDDEN-DEATH											Gornick CC, 2005, HEART RHYTHM, V2, P681, DOI 10.1016/j.hrthm.2005.05.014; GORSETT A, 2005, URGENT MED DEVICE SA; Maron BJ, 2000, NEW ENGL J MED, V342, P365, DOI 10.1056/NEJM200002103420601; MEIER B, 2005, NY TIMES        0524	4	39	39	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2005	353	3					221	224		10.1056/NEJMp058158	http://dx.doi.org/10.1056/NEJMp058158			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YH	16034006				2022-12-28	WOS:000230608700001
J	Weinstein, RA; Siegel, JD; Brennan, PJ				Weinstein, RA; Siegel, JD; Brennan, PJ			Infection-control report cards - Securing patient safety	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									John H Stroger Cook Cty Hosp, Chicago, IL 60612 USA; Rush Univ, Med Ctr, Chicago, IL 60612 USA; Univ Texas, SW Med Ctr, Dallas, TX USA; Childrens Med Ctr, Infect Control Comm, Dallas, TX 75235 USA; Univ Penn, Sch Med & Hlth Syst, Philadelphia, PA 19104 USA	John H Stroger Junior Hospital Cook County; Rush University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania	Weinstein, RA (corresponding author), John H Stroger Cook Cty Hosp, Chicago, IL 60612 USA.							*I HEALTHC IMPR, 100K LIV CAMP; McKibben L, 2005, AM J INFECT CONTROL, V33, P217, DOI 10.1016/j.ajic.2005.04.001	2	26	29	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2005	353	3					225	227		10.1056/NEJMp058073	http://dx.doi.org/10.1056/NEJMp058073			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YH	16034007				2022-12-28	WOS:000230608700002
J	Roy, CL; Poon, EG; Karson, AS; Ladak-Merchant, Z; Johnson, RE; Maviglia, SM; Gandhi, TK				Roy, CL; Poon, EG; Karson, AS; Ladak-Merchant, Z; Johnson, RE; Maviglia, SM; Gandhi, TK			Patient safety concerns arising from test results that return after hospital discharge	ANNALS OF INTERNAL MEDICINE			English	Article							FOLLOW-UP; CARE; IMPLEMENTATION; OUTCOMES; SERVICE	Background: Failure to relay information about test results pending when patients are discharged from the hospital may pose an important patient-safety problem. Few data are available on the epidemiology of test results pending at discharge or on physician awareness of these results. Objective: To determine the prevalence, characteristics, and physician awareness of potentially actionable laboratory and radiologic test results returning after hospital discharge. Design: Cross-sectional study. Setting: Two tertiary care academic hospitals. Patients: 2644 consecutive patients discharged from hospitalist services from February to June 2004. Measurements: The main outcomes were the prevalence and characteristics of potentially actionable test results returning after hospital discharge, awareness of these results by inpatient and primary care physicians, and satisfaction of inpatient physicians with current systems for follow-up on test results. The authors prospectively collected data on test results pending at the time of discharge and, as results returned after discharge, surveyed hospitalists, junior residents, and primary care physicians about those results that were potentially actionable according to a physician-reviewer. Results: A total of 1095 patients (41%) had 2033 test results return after discharge. Of these results, 191 (9.4% [95% CI, 8.0% to 11.0%]) were potentially actionable. Surveys were sent regarding 155 results, and 105 responses were returned. Of the 105 results in the surveys with responses, physicians had been unaware of 65 (61.6% [CI, 51.3% to 70.9%]); of these 65, they agreed with physician-reviewers that 24 (37.1% [CI, 25.7% to 50.2%]) were actionable and 8 (12.6% [CI, 6.4% to 23.3%]) required urgent action. Inpatient physicians were dissatisfied with their systems for following up on test results returning after discharge. Limitations: The authors were unable to determine whether physicians' lack of awareness of test results returning after discharge Conclusions: Many patients are discharged from hospitals with test results still pending, and physicians are often unaware of potentially actionable test results returning after discharge. Further work is needed to design better follow-up systems for test results returning after hospital discharge.	Brigham & Womens Hosp, Boston, MA 02115 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Roy, CL (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	croy@partners.org		Poon, Eric/0000-0002-7251-5842				*AG HEALTHC RES QU, PAT FACT SHEET 20 TI; Auerbach AD, 2002, ANN INTERN MED, V137, P859, DOI 10.7326/0003-4819-137-11-200212030-00006; Coleman EA, 2004, ANN INTERN MED, V141, P533, DOI 10.7326/0003-4819-141-7-200410050-00009; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; Goldman L, 2001, AM J MED, V111, P36, DOI 10.1016/S0002-9343(01)00968-8; *HARV RISK MAN FDN, 2000, FORUM, V20, P2; *I HEALTHC IMPR, 2004, INN SER; Meltzer D, 2002, ANN INTERN MED, V137, P866, DOI 10.7326/0003-4819-137-11-200212030-00007; Moore C, 2003, J GEN INTERN MED, V18, P646, DOI 10.1046/j.1525-1497.2003.20722.x; Murff HJ, 2003, INT J MED INFORM, V71, P137, DOI 10.1016/S1386-5056(03)00133-3; Pantilat SZ, 2001, AM J MED, V111, P15, DOI 10.1016/S0002-9343(01)00964-0; Poon EG, 2004, ARCH INTERN MED, V164, P2223, DOI 10.1001/archinte.164.20.2223; Poon EG, 2003, J BIOMED INFORM, V36, P80, DOI 10.1016/S1532-0464(03)00061-3; POON EG, 2004, MEDINFO, P1815; van Walraven C, 2002, J GEN INTERN MED, V17, P186, DOI 10.1046/j.1525-1497.2002.10741.x; van Walraven C, 2002, CAN FAM PHYSICIAN, V48, P737; Wachter RM, 2002, JAMA-J AM MED ASSOC, V287, P487, DOI 10.1001/jama.287.4.487	17	283	284	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2005	143	2					121	128		10.7326/0003-4819-143-2-200507190-00011	http://dx.doi.org/10.7326/0003-4819-143-2-200507190-00011			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YG	16027454				2022-12-28	WOS:000230608600005
J	Ricard, P				Ricard, P			Historical keywords - Gene	LANCET			English	Editorial Material									UCL, Wellcome Trust Ctr Hist Med, London, England	University of London; University College London	Ricard, P (corresponding author), UCL, Wellcome Trust Ctr Hist Med, London, England.	p.ricard@ucl.ac.uk							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 16	2005	366	9481					197	197		10.1016/S0140-6736(05)66894-8	http://dx.doi.org/10.1016/S0140-6736(05)66894-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945RG	16023498				2022-12-28	WOS:000230519200013
J	Sakaba, T; Stein, A; Jahn, R; Neher, E				Sakaba, T; Stein, A; Jahn, R; Neher, E			Distinct kinetic changes in neurotransmitter release after SNARE protein cleavage	SCIENCE			English	Article							SYNAPTIC TRANSMISSION; BOTULINUM TOXIN; VESICLE FUSION; EXOCYTOSIS; CA2+; CALYX; NEUROEXOCYTOSIS; PROBABILITY; SENSITIVITY; MODULATION	Neurotransmitter release is triggered by calcium ions and depends critically on the correct function of three types of SNARE [soluble N-ethylmaleimide-sensitive factor attachment protein (SNAP) receptor] proteins. With use of the large calyx of Held presynaptic terminal from rats, we found that cleavage of different SNARE proteins by clostridial neurotoxins caused distinct kinetic changes in neurotransmitter release. When elevating calcium ion concentration directly at the presynaptic terminal with the use of caged calcium, cleavage of SNAP-25 by botulinum toxin A (BoNT/A) produced a strong reduction in the calcium sensitivity for release, whereas cleavage of syntaxin using BoNT/C1 and synaptobrevin using tetanus toxin (TeNT) produced an all-or-nothing block without changing the kinetics of remaining vesicles, When stimulating release by calcium influx through channels, a difference between BoNT/C1 and TeNT emerged, which suggests that cleavage of synaptobrevin modifies the coupling between channels and release-competent vesicles.	Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Neher, E (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany.	tsakaba@gwdg.de; eneher@gwdg.de	Neher, Erwin/A-2109-2013; Stein, Alexander/I-4950-2012	Stein, Alexander/0000-0002-2696-0611; Jahn, Reinhard/0000-0003-1542-3498; Sakaba, Takeshi/0000-0003-0688-7717				Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Capogna M, 1997, J NEUROSCI, V17, P7190; Chen XM, 2001, EMBO REP, V2, P68, DOI 10.1093/embo-reports/kve005; CULLCANDY SG, 1976, J PHYSIOL-LONDON, V260, P177, DOI 10.1113/jphysiol.1976.sp011510; Deak F, 2004, NAT CELL BIOL, V6, P1102, DOI 10.1038/ncb1185; Finley MFA, 2002, J NEUROSCI, V22, P1266, DOI 10.1523/JNEUROSCI.22-04-01266.2002; Humeau Y, 2000, BIOCHIMIE, V82, P427, DOI 10.1016/S0300-9084(00)00216-9; Jarvis SE, 2001, TRENDS PHARMACOL SCI, V22, P519, DOI 10.1016/S0165-6147(00)01800-9; Lou XL, 2005, NATURE, V435, P497, DOI 10.1038/nature03568; Neher E, 2001, J NEUROSCI, V21, P444, DOI 10.1523/JNEUROSCI.21-02-00444.2001; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; NEHER E, 2002, SOC NEUR ABSTR, V32; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Stewart BA, 2000, P NATL ACAD SCI USA, V97, P13955, DOI 10.1073/pnas.250491397; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Young SM, 2005, P NATL ACAD SCI USA, V102, P2614, DOI 10.1073/pnas.0409656102; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	26	108	116	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					491	494		10.1126/science.1112645	http://dx.doi.org/10.1126/science.1112645			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020741	Green Published			2022-12-28	WOS:000230574900054
J	Matsuda, R; Kitaura, R; Kitagawa, S; Kubota, Y; Belosludov, RV; Kobayashi, TC; Sakamoto, H; Chiba, T; Takata, M; Kawazoe, Y; Mita, Y				Matsuda, R; Kitaura, R; Kitagawa, S; Kubota, Y; Belosludov, RV; Kobayashi, TC; Sakamoto, H; Chiba, T; Takata, M; Kawazoe, Y; Mita, Y			Highly controlled acetylene accommodation in a metal-organic microporous material	NATURE			English	Article							COORDINATION POLYMERS; CHARGE-DENSITY; ADSORPTION; MOLECULES; CRYSTALS; DESIGN; DIFFRACTION; FRAMEWORKS; CATALYSIS; NETWORK	Metal - organic microporous materials(1-4) (MOMs) have attracted wide scientific attention owing to their unusual structure and properties, as well as commercial interest due to their potential applications in storage(5-9), separation(10,11) and heterogeneous catalysis(12,13). One of the advantages of MOMs compared to other microporous materials, such as activated carbons, is their ability to exhibit a variety of pore surface properties such as hydrophilicity and chirality, as a result of the controlled incorporation of organic functional groups into the pore walls(11,13-15). This capability means that the pore surfaces of MOMs could be designed to adsorb specific molecules; but few design strategies for the adsorption of small molecules have been established so far. Here we report high levels of selective sorption of acetylene molecules as compared to a very similar molecule, carbon dioxide, onto the functionalized surface of a MOM. The acetylene molecules are held at a periodic distance from one another by hydrogen bonding between two non-coordinated oxygen atoms in the nanoscale pore wall of the MOM and the two hydrogen atoms of the acetylene molecule. This permits the stable storage of acetylene at a density 200 times the safe compression limit of free acetylene at room temperature.	Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto 6158510, Japan; Osaka Prefecture Univ, Grad Sch Sci, Dept Phys Sci, Osaka 5900035, Japan; Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; Okayama Univ, Fac Sci, Dept Phys, Okayama 7008530, Japan; Japan Synchrotron Radiat Res Inst SPring8, Sayo, Hyogo 6795198, Japan; Japan Sci & Technol Agcy, CREST, Tokyo, Japan; Osaka Univ, Grad Sch Engn Sci, Dept Mat Engn, Div Mat Phys, Osaka 5608531, Japan	Kyoto University; Osaka Metropolitan University; Tohoku University; Okayama University; Japan Synchrotron Radiation Research Institute; Japan Science & Technology Agency (JST); Osaka University	Kitagawa, S (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto 6158510, Japan.	kitagawa@sbchem.kyoto-u.ac.jp	Kawazoe, Yoshiyuki/C-2998-2011; Matsuda, Ryotaro/AGA-6072-2022; Kitagawa, Susumu/AAB-1753-2019; Belosludov, Rodion/A-1748-2013; KOBAYASHI, Tatsuo/B-1527-2011; Kubota, Yoshiki/M-4574-2019; Sakamoto, Hirotoshi/K-2516-2017; Kitaura, Ryo/B-8123-2008	Matsuda, Ryotaro/0000-0002-7665-6212; Kitagawa, Susumu/0000-0001-6956-9543; Sakamoto, Hirotoshi/0000-0002-0873-1321; Belosludov, Rodion/0000-0003-4661-9194; Kitaura, Ryo/0000-0001-8108-109X				Bradshaw D, 2004, J AM CHEM SOC, V126, P6106, DOI 10.1021/ja0316420; Budavari S., MERCK INDEX; Bulow, 2001, STUD SURF SCI CATAL, V135, P2952; Chae HK, 2004, NATURE, V427, P523, DOI 10.1038/nature02311; Chien J.C.W., 1984, POLYACETYLENE CHEM P; Eddaoudi M, 2002, SCIENCE, V295, P469, DOI 10.1126/science.1067208; Ferey G, 2003, CHEM COMMUN, P2976, DOI 10.1039/b308903g; ITO M, 1970, SPECTROCHIM ACTA A-M, VA 26, P695, DOI 10.1016/0584-8539(70)80115-5; Kesanli B, 2003, COORDIN CHEM REV, V246, P305, DOI 10.1016/j.cct.2003.08.004; Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610; Kitaura R, 2002, SCIENCE, V298, P2358, DOI 10.1126/science.1078481; Kondo M, 1999, ANGEW CHEM INT EDIT, V38, P140, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<140::AID-ANIE140>3.0.CO;2-9; Kosal ME, 2002, NAT MATER, V1, P118, DOI 10.1038/nmat730; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Li D, 2000, J PHYS CHEM B, V104, P8940, DOI 10.1021/jp000660q; Maji TK, 2004, ANGEW CHEM INT EDIT, V43, P3269, DOI 10.1002/anie.200453923; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.16.1746; Moulton B, 2001, CHEM REV, V101, P1629, DOI 10.1021/cr9900432; Nishibori E, 2001, J PHYS CHEM SOLIDS, V62, P2095, DOI 10.1016/S0022-3697(01)00164-0; Ohmori O, 2004, CHEM COMMUN, P1586, DOI 10.1039/b406114b; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; Radhakrishnan R, 2000, J CHEM PHYS, V112, P11048, DOI 10.1063/1.481745; Schuth F., 2002, HDB POROUS SOLIDS, V2, P1190; Seki K, 2002, J PHYS CHEM B, V106, P1380, DOI 10.1021/jp0130416; Seo JS, 2000, NATURE, V404, P982, DOI 10.1038/35010088; Stang P. J., 1995, MODERN ACETYLENE CHE; TAKATA M, 1995, NATURE, V377, P46, DOI 10.1038/377046a0; Takata M, 2001, Z KRISTALLOGR, V216, P71, DOI 10.1524/zkri.216.2.71.20335; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650; Zhao XB, 2004, SCIENCE, V306, P1012, DOI 10.1126/science.1101982	30	1225	1255	22	478	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2005	436	7048					238	241		10.1038/nature03852	http://dx.doi.org/10.1038/nature03852			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015325				2022-12-28	WOS:000230459500036
J	Leung, WC; Lao, TT				Leung, WC; Lao, TT			Rapid aneuploidy testing, traditional karyotyping, or both?	LANCET			English	Editorial Material							IN-SITU HYBRIDIZATION; CHROMOSOME-SPECIFIC PROBES; PRENATAL-DIAGNOSIS; DOWN-SYNDROME; QF-PCR; FISH; SAMPLES; RISK		Univ Hong Kong, Queen Mary Hosp, Dept Obstet & Gynaecol, Div Maternal Fetal Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Leung, WC (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Obstet & Gynaecol, Div Maternal Fetal Med, Hong Kong, Hong Kong, Peoples R China.	leungwc65@hotmail.com						CAINE A, 2005, LANCET; Cirigliano V, 2004, MOL HUM REPROD, V10, P839, DOI 10.1093/molehr/gah108; Donaghue C, 2003, PRENATAL DIAG, V23, P201, DOI 10.1002/pd.569; Evans MI, 1999, HUM REPROD, V14, P1213, DOI 10.1093/humrep/14.5.1213; GRIMSHAW GM, 2003, HLTH TECHNOL ASSESS, V7; Homer J, 2003, PRENATAL DIAG, V23, P566, DOI 10.1002/pd.642; Leung WC, 2004, PRENATAL DIAG, V24, P790, DOI 10.1002/pd.985; Leung WC, 2003, OBSTET GYNECOL, V101, P856, DOI 10.1016/S0029-7844(03)00222-9; Leung WC, 2001, PRENATAL DIAG, V21, P327; Lewin P, 2000, PRENATAL DIAG, V20, P1; Ryall RG, 2001, PRENATAL DIAG, V21, P553; Thein ATA, 2000, PRENATAL DIAG, V20, P275, DOI 10.1002/(SICI)1097-0223(200004)20:4<275::AID-PD799>3.0.CO;2-Z; Thilaganathan B, 2000, BRIT J OBSTET GYNAEC, V107, P262, DOI 10.1111/j.1471-0528.2000.tb11698.x; WARBURTON D, 1991, AM J HUM GENET, V49, P995; Witters I, 2002, PRENATAL DIAG, V22, P29, DOI 10.1002/pd.225	15	27	32	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 9	2005	366	9480					97	98		10.1016/S0140-6736(05)66791-8	http://dx.doi.org/10.1016/S0140-6736(05)66791-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	943JH	16005312				2022-12-28	WOS:000230349200004
J	Pelkmans, L; Zerial, M				Pelkmans, L; Zerial, M			Kinase-regulated quantal assemblies and kiss-and-run recycling of caveolae	NATURE			English	Article							ENDOCYTOSIS; INTERNALIZATION; DYNAMIN; TRAFFICKING; TRANSPORT; RELEASE; DOMAINS; PATHWAY	A functional genomics approach has revealed that caveolae/raft-mediated endocytosis is subject to regulation by a large number of kinases(1). Here we explore the role of some of these kinases in caveolae dynamics. We discover that caveolae operate using principles different from classical membrane trafficking. First, each caveolar coat contains a set number (one 'quantum') of caveolin-1 molecules. Second, caveolae are either stored as in stationary multi-caveolar structures at the plasma membrane, or undergo continuous cycles of fission and fusion with the plasma membrane in a small volume beneath the surface, without disassembling the caveolar coat. Third, a switch mechanism shifts caveolae from this localized cycle to long-range cytoplasmic transport. We have identified six kinases that regulate different steps of the caveolar cycle. Our observations reveal new principles in caveolae trafficking and suggest that the dynamic properties of caveolae and their transport competence are regulated by different kinases operating at several levels.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Pelkmans, L (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	pelkmans@mpi-cbg.de		Pelkmans, Lucas/0000-0002-6754-9730				AXELROD D, 1984, ANNU REV BIOPHYS BIO, V13, P247, DOI 10.1146/annurev.bb.13.060184.001335; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Frolov VA, 2003, P NATL ACAD SCI USA, V100, P8698, DOI 10.1073/pnas.1432962100; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; KATZ B, 1971, SCIENCE, V173, P123, DOI 10.1126/science.173.3992.123; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Minshall RD, 2000, J CELL BIOL, V150, P1057, DOI 10.1083/jcb.150.5.1057; Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; PARTON RG, 1994, J HISTOCHEM CYTOCHEM, V42, P155, DOI 10.1177/42.2.8288861; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pelkmans L, 2003, CURR OPIN CELL BIOL, V15, P414, DOI 10.1016/S0955-0674(03)00081-4; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Ryan TA, 1997, NATURE, V388, P478, DOI 10.1038/41335; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Shajahan AN, 2004, J BIOL CHEM, V279, P20392, DOI 10.1074/jbc.M308710200; Sharma DK, 2004, MOL BIOL CELL, V15, P3114, DOI 10.1091/mbc.E04-03-0189; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; Toomre D, 2000, J CELL BIOL, V149, P33, DOI 10.1083/jcb.149.1.33	22	274	279	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					128	133		10.1038/nature03866	http://dx.doi.org/10.1038/nature03866			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001074				2022-12-28	WOS:000230296600052
J	Rese, A; Balabanova, D; Danishevski, K; McKee, M; Sheaff, R				Rese, A; Balabanova, D; Danishevski, K; McKee, M; Sheaff, R			Iniplementing general practice in Russia: getting beyond the first steps	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH-CARE REFORM; SATISFACTION; ESTONIA; SYSTEM; FEDERATION		Univ London London Sch Hyg & Trop Med, Hlth Syst Dev Programme, London WC1E 7HT, England; All Russia Assoc Gen Practitioners, Moscow 119881, Russia; Moscow Med Acad, Moscow 109507, Russia; Univ London London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1E 7HT, England; Univ Manchester, Natl Primary Care Resource & Dev Ctr, Manchester M13 9PL, Lancs, England	University of London; London School of Hygiene & Tropical Medicine; Sechenov First Moscow State Medical University; University of London; London School of Hygiene & Tropical Medicine; University of Manchester	Balabanova, D (corresponding author), Univ London London Sch Hyg & Trop Med, Hlth Syst Dev Programme, Keppel St, London WC1E 7HT, England.	clina.balabanova@lshtm.ac.uk	Sheaff, Rod/N-2404-2019; McKee, Marc D/E-2187-2011; Reze, Andrey/B-2871-2018; Sheaff, Rod/I-5187-2013; Mckee, Martin/E-6673-2018	Sheaff, Rod/0000-0002-7984-2627; McKee, Marc D/0000-0001-8349-965X; Reze, Andrey/0000-0002-2337-7420; Sheaff, Rod/0000-0002-7984-2627; Mckee, Martin/0000-0002-0121-9683				ABZALOVA R, 1998, REFORM PRIMARY HLTH; Boerma W., 2003, PROFILES GEN PRACTIC; Chernichovsky D, 1999, J HEALTH POLIT POLIC, V24, P115, DOI 10.1215/03616878-24-1-115; CURTIS S, 1995, SOC SCI MED, V40, P755, DOI 10.1016/0277-9536(94)00137-I; Earl-Slater A, 1996, J Manag Med, V10, P13, DOI 10.1108/02689239610117780; *GOSK, 2002, POP CENS RUSS FED; *GOV RUSS FED, 1993, BAS LEG HLTH PROT RU; Kersnik J, 2000, INT J QUAL HEALTH C, V12, P143, DOI 10.1093/intqhc/12.2.143; Kersnik J, 2001, HEALTH POLICY, V57, P155, DOI 10.1016/S0168-8510(01)00118-X; Koppel A, 2003, SOC SCI MED, V56, P2461, DOI 10.1016/S0277-9536(02)00280-0; Lember M, 2002, INT J HEALTH PLAN M, V17, P41, DOI 10.1002/hpm.651; Lovkyte L, 2001, Cah Sociol Demogr Med, V41, P347; McEuen Mark, 2004, PILOT PROCESS CASE S; *MIN HLTH, 2003, IND HLTH HLTH CAR; ORLOVA GG, 1992, TERAPEVT ARKH, V64, P114; Polluste K, 2004, CROAT MED J, V45, P582; Reamy J, 2001, Cah Sociol Demogr Med, V41, P327; Ryan M, 1996, BRIT J GEN PRACT, V46, P487; SHARBAROVA Z, 2001, PRIMARY HLTH CARE NI; Shchepin O P, 2001, Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med, P11; SHEAFF R, 1990, NHS PRIVATE SECTOR I, P33; SHEIMAN I, 1995, HEALTH POLICY, V32, P167, DOI 10.1016/0168-8510(95)00734-A; Somanathan A., 2019, STRENGTHENING INTEGR; TISHUK EA, 2003, PROBL SOTSIALNOI GIG, V2, P28	24	30	31	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2005	331	7510					204	207		10.1136/bmj.331.7510.204	http://dx.doi.org/10.1136/bmj.331.7510.204			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951EA	16037457	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000230910700026
J	Chou, S; Hollander, H; Schaefer, PW; Harris, NL; Singhal, A; Daskalakis, DC; Hedley-Whyte, ET				Chou, S; Hollander, H; Schaefer, PW; Harris, NL; Singhal, A; Daskalakis, DC; Hedley-Whyte, ET			Case 22-2005: An 81-year-old man with cough, fever, and altered mental status - Encephalomyelitis due to West Nile virus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ENCEPHALITIS; INFECTION; DIAGNOSIS; PATHOLOGY; ASSAY		Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Chou, S (corresponding author), Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA.		Schaefer, Pamela/AAA-1323-2019; Hedley-Whyte, E Tessa/AAJ-9975-2021	Hedley-Whyte, E Tessa/0000-0002-1687-8905				Bilbao JM, 2003, J NEUROPATH EXP NEUR, V62, P538; Carroll KC, 2000, J CLIN VIROL, V19, P149, DOI 10.1016/S1386-6532(00)00115-3; Cinque P, 2003, J CLIN VIROL, V26, P1, DOI 10.1016/S1386-6532(02)00173-7; Domingues RB, 1998, J NEUROL SCI, V157, P148, DOI 10.1016/S0022-510X(98)00069-0; Glaser CA, 2003, CLIN INFECT DIS, V36, P731, DOI 10.1086/367841; Guarner J, 2004, HUM PATHOL, V35, P983, DOI 10.1016/j.humpath.2004.04.008; Haley M, 2003, CLIN INFECT DIS, V37, pE88, DOI 10.1086/377172; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Kleinschmidt-Demasters BK, 2001, BRAIN PATHOL, V11, P440, DOI 10.1111/j.1750-3639.2001.tb00413.x; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; MISBAH SA, 1992, J CLIN IMMUNOL, V12, P266, DOI 10.1007/BF00918150; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; Pepperell C, 2003, CAN MED ASSOC J, V168, P1399; Petersen LR, 2002, NEW ENGL J MED, V347, P1225, DOI 10.1056/NEJMo020128; Rudge P, 1996, BRAIN, V119, P1, DOI 10.1093/brain/119.1.1; Sampson BA, 2000, HUM PATHOL, V31, P527, DOI 10.1053/hp.2000.8047; Sampson BA, 2003, HUM PATHOL, V34, P628, DOI 10.1016/S0046-8177(03)00203-X; Solomon T, 2003, CLIN INFECT DIS, V36, pE140, DOI 10.1086/374936; 1999, MMWR MORB MORTAL WKL, V48, P845	19	9	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2005	353	3					287	295		10.1056/NEJMcpc059017	http://dx.doi.org/10.1056/NEJMcpc059017			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YH	16034015				2022-12-28	WOS:000230608700011
J	Picollo, A; Pusch, M				Picollo, A; Pusch, M			Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5	NATURE			English	Article							DENTS-DISEASE; CHANNEL; ACIDIFICATION; ENDOCYTOSIS; DISRUPTION; ENDOSOMES; INHIBITOR; VESICLES; FUSION; CELLS	ClC-4 and ClC-5 are members of the CLC gene family(1), with ClC-5 mutated in Dent's disease(2), a nephropathy associated with low-molecular-mass proteinuria and eventual renal failure. ClC-5 has been proposed to be an electrically shunting Cl- channel in early endosomes, facilitating intraluminal acidification(3,4). Motivated by the discovery that certain bacterial CLC proteins are secondary active Cl-/H+ antiporters(5), we hypothesized that mammalian CLC proteins might not be classical Cl- ion channels but might exhibit Cl-- coupled proton transport activity. Here we report that ClC-4 and ClC-5 carry a substantial amount of protons across the plasma membrane when activated by positive voltages, as revealed by measurements of pH close to the cell surface. Both proteins are able to extrude protons against their electrochemical gradient, demonstrating secondary active transport. H+, but not Cl-, transport was abolished when a pore glutamate was mutated to alanine (E211A). ClC-0, ClC-2 and ClC-Ka proteins showed no significant proton transport. The muscle channel ClC-1 exhibited a small H+ transport that might be physiologically relevant. For ClC-5, we estimated that Cl- and H+ transport contribute about equally to the total charge movement, raising the possibility that the coupled Cl-/H+ transport of ClC-4 and ClC-5 is of significant magnitude in vivo.	CNR, Ist Biofis, I-16149 Genoa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Pusch, M (corresponding author), CNR, Ist Biofis, Via Marini 6, I-16149 Genoa, Italy.	pusch@ge.ibf.cnr.it	Picollo, Alessandra/G-1709-2014; Picollo, Alessandra/O-1696-2016; Picollo, Alessandra/AAC-7529-2022	Picollo, Alessandra/0000-0003-2980-7951; Pusch, Michael/0000-0002-8644-8847	Telethon [GGP04018] Funding Source: Medline	Telethon(Fondazione Telethon)		Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; BAUER CK, 1991, P NATL ACAD SCI USA, V88, P11052, DOI 10.1073/pnas.88.24.11052; Bayer MJ, 2003, J CELL BIOL, V162, P211, DOI 10.1083/jcb.200212004; Chandy G, 2001, AM J PHYSIOL-CELL PH, V281, pC908, DOI 10.1152/ajpcell.2001.281.3.C908; Chen TY, 2005, ANNU REV PHYSIOL, V67, P809, DOI 10.1146/annurev.physiol.67.032003.153012; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Estevez R, 2003, NEURON, V38, P47, DOI 10.1016/S0896-6273(03)00168-5; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; GRUNDER S, 1992, NATURE, V360, P759, DOI 10.1038/360759a0; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Hara-Chikuma M, 2005, BIOCHEM BIOPH RES CO, V329, P941, DOI 10.1016/j.bbrc.2005.02.060; Hebeisen S, 2003, BIOPHYS J, V84, P2306, DOI 10.1016/S0006-3495(03)75036-X; Holroyd C, 1999, MOL BIOL CELL, V10, P3035, DOI 10.1091/mbc.10.9.3035; Jentsch TJ, 2005, ANNU REV PHYSIOL, V67, P779, DOI 10.1146/annurev.physiol.67.032003.153245; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; Li XH, 2000, J BIOL CHEM, V275, P35994, DOI 10.1074/jbc.M002712200; Lin YW, 1999, J GEN PHYSIOL, V114, P1, DOI 10.1085/jgp.114.1.1; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Saviane C, 1999, J GEN PHYSIOL, V113, P457, DOI 10.1085/jgp.113.3.457; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Traverso S, 2003, J GEN PHYSIOL, V122, P295, DOI 10.1085/jgp.200308784; TSAI TD, 1995, AM J PHYSIOL-CELL PH, V268, pC1173, DOI 10.1152/ajpcell.1995.268.5.C1173; VANDYKE RW, 1994, AM J PHYSIOL, V266, pC81, DOI 10.1152/ajpcell.1994.266.1.C81; Wang SS, 2000, HUM MOL GENET, V9, P2937, DOI 10.1093/hmg/9.20.2937; Weinreich F, 2001, J BIOL CHEM, V276, P2347, DOI 10.1074/jbc.M005733200	30	373	388	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					420	423		10.1038/nature03720	http://dx.doi.org/10.1038/nature03720			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034421				2022-12-28	WOS:000230623400048
J	Service, GJ; Thompson, GB; Service, FJ; Andrews, JC; Collazo-Clavell, ML; Lloyd, RV				Service, GJ; Thompson, GB; Service, FJ; Andrews, JC; Collazo-Clavell, ML; Lloyd, RV			Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLUCAGON-LIKE PEPTIDE-1; NONINSULINOMA PANCREATOGENOUS HYPOGLYCEMIA; REACTIVE HYPOGLYCEMIA; BARIATRIC SURGERY; OBESITY; GASTRECTOMY; APOPTOSIS; CELLS; GLP-1	We describe six patients (five women and one man; median age, 47 years; range, 39 to 54) with postprandial symptoms of neuroglycopenia owing to endogenous hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass surgery. Except for equivocal evidence in one patient, there was no radiologic evidence of insulinoma. Selective arterial calcium-stimulation tests, positive in each patient, were used to guide partial pancreatectomy. Nesidioblastosis was identified in resected specimens from each patient, and multiple insulinomas were identified in one. Hypoglycemic symptoms diminished postoperatively. We speculate that hyperfunction of pancreatic islets did not lead to obesity but that beta-cell trophic factors may have increased as a result of gastric bypass.	Mayo Clin & Mayo Fdn, Div Metab Endocrinol & Nutr, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Surg, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Radiol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Pathol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Service, GJ (corresponding author), Mayo Clin & Mayo Fdn, Div Metab Endocrinol & Nutr, 200 1st St SW, Rochester, MN 55905 USA.	service.john@mayo.edu			PHS HHS [32385] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ANDREASEN JJ, 1994, DIGESTION, V55, P221, DOI 10.1159/000201151; Brubaker PL, 2004, ENDOCRINOLOGY, V145, P2653, DOI 10.1210/en.2004-0015; De Leon DD, 2003, DIABETES, V52, P365, DOI 10.2337/diabetes.52.2.365; FABIO B, 2003, ENDOCRINE, V22, P19; Farilla L, 2003, ENDOCRINOLOGY, V144, P5149, DOI 10.1210/en.2003-0323; Gebhard B, 2001, DIGEST DIS SCI, V46, P1915, DOI 10.1023/A:1010635131228; KAO PC, 1992, ANN CLIN LAB SCI, V22, P307; List JF, 2004, AM J PHYSIOL-ENDOC M, V286, pE875, DOI 10.1152/ajpendo.00007.2004; Lloyd RV, 1996, ENDOCR PATHOL, V7, P145, DOI 10.1007/BF02739974; Magni F, 2000, ANAL BIOCHEM, V282, P136, DOI 10.1006/abio.2000.4597; Manson JE, 2004, ARCH INTERN MED, V164, P249, DOI 10.1001/archinte.164.3.249; MIHOLIC J, 1991, DIGEST DIS SCI, V36, P1361, DOI 10.1007/BF01296800; Monteforte MJ, 2000, OBES SURG, V10, P391, DOI 10.1381/096089200321594246; Moura MRL, 2004, ANAL BIOANAL CHEM, V378, P499, DOI 10.1007/s00216-003-2248-8; Sacks DB, 1999, TIETZ TXB CLIN CHEM, V3, P750; Service FJ, 1999, ENDOCRIN METAB CLIN, V28, P501, DOI 10.1016/S0889-8529(05)70085-2; Service FJ, 1999, J CLIN ENDOCR METAB, V84, P1582, DOI 10.1210/jc.84.5.1582; SIGSTAD H, 1970, Acta Medica Scandinavica, V188, P479; SOLCIA E, 1997, ATLAS TUMOR PATHOL, P120; Steinbrook R, 2004, NEW ENGL J MED, V350, P1075, DOI 10.1056/NEJMp048029; Thompson GB, 2000, SURGERY, V128, P937, DOI 10.1067/msy.2000.110243; THREATTE GA, 1996, CLIN DIAGNOSIS MANAG, P194; Zagury L, 2004, OBES SURG, V14, P120, DOI 10.1381/096089204772787419; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7; Zhou J, 1999, DIABETES, V48, P2358, DOI 10.2337/diabetes.48.12.2358	25	504	538	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2005	353	3					249	254		10.1056/NEJMoa043690	http://dx.doi.org/10.1056/NEJMoa043690			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YH	16034010	Bronze			2022-12-28	WOS:000230608700005
J	Song, IS; Zuckerman, B; Weinberger, AJ; Becklin, EE				Song, IS; Zuckerman, B; Weinberger, AJ; Becklin, EE			Extreme collisions between planetesimals as the origin of warm dust around a Sun-like star	NATURE			English	Article							SILICATE; DEBRIS; SPECTROSCOPY; SPECTRA; PLANETS; SEARCH; COMETS; DISKS	The slow but persistent collisions between asteroids in our Solar System generate a tenuous cloud of dust known as the zodiacal light ( because of the light the dust reflects). In the young Solar System, such collisions were more common and the dust production rate should have been many times larger(1). Yet copious dust in the zodiacal region around stars much younger than the Sun has rarely been found(2). Dust is known to orbit around several hundred main-sequence stars(3), but this dust is cold and comes from a Kuiper-belt analogous region out beyond the orbit of Neptune. Despite many searches, only a few main-sequence stars reveal warm (> 120 K) dust analogous to zodiacal dust near the Earth(3-5). Signs of planet formation ( in the form of collisions between bodies) in the regions of stars corresponding to the orbits of the terrestrial planets in our Solar System have therefore been elusive. Here we report an exceptionally large amount of warm, small, silicate dust particles around the solar-type star BD+20 307 ( HIP 8920, SAO75016). The composition and quantity of dust could be explained by recent frequent or huge collisions between asteroids or other 'planetesimals' whose orbits are being perturbed by a nearby planet.	Gemini Observ, Hilo, HI 96720 USA; Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Ctr Astrobiol, Los Angeles, CA 90095 USA; Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Carnegie Institution for Science	Song, IS (corresponding author), Gemini Observ, 670 N Aohoku Pl, Hilo, HI 96720 USA.	song@gemini.edu	Song, Inseok/GSI-5721-2022	Song, Inseok/0000-0002-5815-7372; Weinberger, Alycia/0000-0001-6654-7859				AUMANN HH, 1991, ASTROPHYS J, V368, P264, DOI 10.1086/169690; Chen CH, 2001, ASTROPHYS J, V560, pL171, DOI 10.1086/324057; Cutispoto G, 2003, ASTRON ASTROPHYS, V397, P987, DOI 10.1051/0004-6361:20021562; Cutri R. M., 2003, 2MASS ALL SKY CATALO; Gaidos EJ, 1999, ASTROPHYS J, V510, pL131, DOI 10.1086/311819; Haisch KE, 2001, ASTROPHYS J, V553, pL153, DOI 10.1086/320685; Hallenbeck SL, 2000, ASTROPHYS J, V535, P247, DOI 10.1086/308810; HANNER MS, 1994, ASTROPHYS J, V425, P274, DOI 10.1086/173984; Hauschildt PH, 1999, ASTROPHYS J, V512, P377, DOI 10.1086/306745; Hayward TL, 2000, ASTROPHYS J, V538, P428, DOI 10.1086/309117; KENYON SJ, 2005, IN PRESS ASTROPHYS J; Koike C, 2003, ASTRON ASTROPHYS, V399, P1101, DOI 10.1051/0004-6361:20021831; Laureijs RJ, 2002, ASTRON ASTROPHYS, V387, P285, DOI 10.1051/0004-6361:20020366; Li AG, 2001, ASTROPHYS J, V554, P778, DOI 10.1086/323147; Nesvorny D, 2003, ASTROPHYS J, V591, P486, DOI 10.1086/374807; Perryman MAC, 1997, ASTRON ASTROPHYS, V323, pL49; Rieke GH, 2005, ASTROPHYS J, V620, P1010, DOI 10.1086/426937; Sitko ML, 2004, ASTROPHYS J, V612, P576, DOI 10.1086/421991; STENCEL RE, 1991, ASTROPHYS J SUPPL S, V75, P905, DOI 10.1086/191553; Telesco CM, 2005, NATURE, V433, P133, DOI 10.1038/nature03255; WHITELOCK PA, 1991, MON NOT R ASTRON SOC, V250, P638, DOI 10.1093/mnras/250.3.638; Zuckerman B, 2004, ANNU REV ASTRON ASTR, V42, P685, DOI 10.1146/annurev.astro.42.053102.134111; Zuckerman B, 2004, ASTROPHYS J, V603, P738, DOI 10.1086/381700; ZUCKERMAN B, 1995, NATURE, V373, P494, DOI 10.1038/373494a0; Zuckerman B, 2001, ANNU REV ASTRON ASTR, V39, P549, DOI 10.1146/annurev.astro.39.1.549	28	112	113	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					363	365		10.1038/nature03853	http://dx.doi.org/10.1038/nature03853			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034411				2022-12-28	WOS:000230623400035
J	Beers, TC				Beers, TC			The first generations of stars	SCIENCE			English	Editorial Material									Michigan State Univ, E Lansing, MI 48824 USA; Joint Inst Nucl Astrophys, E Lansing, MI 48824 USA	Michigan State University	Beers, TC (corresponding author), Michigan State Univ, E Lansing, MI 48824 USA.	beers@pa.msu.edu	Beers, Timothy/D-1193-2019					BEERS TC, ANN REV ASTRON ASTRO; Frebel A, 2005, NATURE, V434, P871, DOI 10.1038/nature03455; Heger A, 2002, ASTROPHYS J, V567, P532, DOI 10.1086/338487; Iwamoto N, 2005, SCIENCE, V309, P451, DOI 10.1126/science.1112997; Umeda H, 2002, ASTROPHYS J, V565, P385, DOI 10.1086/323946	6	3	3	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					390	391		10.1126/science.1114671	http://dx.doi.org/10.1126/science.1114671			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020719				2022-12-28	WOS:000230574900029
J	Blais, JM; Kimpe, LE; McMahon, D; Keatley, BE; Mattory, ML; Douglas, MSV; Smol, JP				Blais, JM; Kimpe, LE; McMahon, D; Keatley, BE; Mattory, ML; Douglas, MSV; Smol, JP			Arctic seabirds transport marine-derived contaminants	SCIENCE			English	Article							POLLUTANTS; SALMON; LAKE		Univ Ottawa, Dept Biol, Ctr Adv Res Environm Genom, Ottawa, ON K1N 6N5, Canada; Queens Univ, Dept Biol, Paleoecol Environm Assessment & Res Lab, Kingston, ON K7L 3N6, Canada; Environm Canada, Canadian Wildlife Serv, Iqaluit, NU X0A 0H0, Canada; Univ Toronto, Dept Geol, Toronto, ON M5S 3B1, Canada	University of Ottawa; Queens University - Canada; Environment & Climate Change Canada; Canadian Wildlife Service; University of Toronto	Blais, JM (corresponding author), Univ Ottawa, Dept Biol, Ctr Adv Res Environm Genom, Ottawa, ON K1N 6N5, Canada.	jblais@science.uottawa.ca	Blais, Jules/AAV-2321-2020; Bond, Alexander L/A-3786-2010; Smol, John P/A-8838-2015	Blais, Jules/0000-0002-7188-3598; Smol, John/0000-0002-2499-6696				Evenset A, 2004, SCI TOTAL ENVIRON, V318, P125, DOI 10.1016/S0048-9697(03)00365-6; Ewald G, 1998, ARCTIC, V51, P40; HOBSON KA, 1993, MAR ECOL PROG SER, V95, P7, DOI 10.3354/meps095007; Kendall C, 1998, ISOTOPE TRACERS IN CATCHMENT HYDROLOGY, P519; Krummel EM, 2003, NATURE, V425, P255, DOI 10.1038/425255a; Mallory M.L., 2004, 109 CAN WILDL SERV	6	190	199	2	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2005	309	5733					445	445		10.1126/science.1112658	http://dx.doi.org/10.1126/science.1112658			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020729				2022-12-28	WOS:000230574900039
J	Sontheimer, EJ; Carthew, RW				Sontheimer, EJ; Carthew, RW			Silence from within: Endogenous siRNAs and miRNAs	CELL			English	Review							TRANS-ACTING SIRNAS; MESSENGER-RNAS; DROSOPHILA; MICRORNA; ARABIDOPSIS; GENES	Although eukaryotic cells use RNA silencing to defend against transposons and pathogens, they also employ these pathways to regulate the expression of their own genes. Recent results have uncovered new examples of RNA silencing in controlling endogenous gene expression and have revealed novel mechanisms of downregulation. Bioinformatic analyses indicate that target genes in vertebrate species may number in the thousands.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Sontheimer, EJ (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA.	erik@northwestern.edu		Sontheimer, Erik/0000-0002-0881-0310	NIGMS NIH HHS [R01 GM068743, R01 GM077581] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068743, R01GM077581] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin AA, 2004, MOL CELL BIOL, V24, P6742, DOI 10.1128/MCB.24.15.6742-6750.2004; Bao N, 2004, DEV CELL, V7, P653, DOI 10.1016/j.devcel.2004.10.003; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Mochizuki K, 2004, GENE DEV, V18, P2068, DOI 10.1101/gad.1219904; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104	20	217	242	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 15	2005	122	1					9	12		10.1016/j.cell.2005.06.030	http://dx.doi.org/10.1016/j.cell.2005.06.030			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	950EC	16009127	Bronze			2022-12-28	WOS:000230839400005
J	Takahashi, F; Matsushima, M; Honkura, Y				Takahashi, F; Matsushima, M; Honkura, Y			Simulations of a quasi-Taylor state geomagnetic field including polarity reversals on the Earth Simulator	SCIENCE			English	Article							INNER-CORE; DYNAMO	High-resolution, low-viscosity geodynamo simulations have been carried out on the Earth Simulator, one of the fastest supercomputers, in a dynamic regime similar to that of Earth's core, that is, in a quasi-Taylor state. Our dynamo models exhibit features of the geodynamo not only in spatial and temporal characteristics but also in dynamics. Polarity reversals occurred when magnetic flux patches at high latitudes moved poleward and disappeared; patches with reversed field at low and mid-latitudes then moved poleward.	Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Kanagawa, Japan; Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 152, Japan	Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Tokyo Institute of Technology	Takahashi, F (corresponding author), Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, 3-1-1 Yoshinodai, Kanagawa, Japan.	futoshi@stp.isas.jaxa.jp	Takahashi, Futoshi/P-4390-2019; Matsushima, Masaki/C-9260-2015; Honkura, Yoshimori/V-8169-2019; Takahashi, Futoshi/D-6062-2013	Takahashi, Futoshi/0000-0002-7371-9783; Matsushima, Masaki/0000-0001-8198-343X; Takahashi, Futoshi/0000-0002-7371-9783				Clement BM, 2004, NATURE, V428, P637, DOI 10.1038/nature02459; Coe RS, 2000, PHILOS T R SOC A, V358, P1141, DOI 10.1098/rsta.2000.0578; Constable C, 2000, PHYS EARTH PLANET IN, V118, P181, DOI 10.1016/S0031-9201(99)00139-9; Dumberry M, 2003, PHYS EARTH PLANET IN, V140, P29, DOI 10.1016/j.pepi.2003.07.012; Glatzmaier GA, 1996, SCIENCE, V274, P1887, DOI 10.1126/science.274.5294.1887; Glatzmaier GA, 1999, NATURE, V401, P885, DOI 10.1038/44776; GLATZMAIER GA, 1995, NATURE, V377, P203, DOI 10.1038/377203a0; GLATZMAIER GA, 1995, PHYS EARTH PLANET IN, V91, P63, DOI 10.1016/0031-9201(95)03049-3; Grote E, 2000, GEOPHYS RES LETT, V27, P2001, DOI 10.1029/1999GL011155; Hongre L, 1998, PHYS EARTH PLANET IN, V106, P311, DOI 10.1016/S0031-9201(97)00115-5; HULOT G, 1994, PHYS EARTH PLANET IN, V82, P167, DOI 10.1016/0031-9201(94)90070-1; Jackson A, 2000, PHILOS T ROY SOC A, V358, P957, DOI 10.1098/rsta.2000.0569; Kono M, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000102; Kono M, 2001, PHYS EARTH PLANET IN, V128, P13, DOI 10.1016/S0031-9201(01)00274-6; Kuang WL, 1997, NATURE, V389, P371, DOI 10.1038/38712; Kutzner C, 2002, PHYS EARTH PLANET IN, V131, P29, DOI 10.1016/S0031-9201(02)00016-X; Li JH, 2002, SCIENCE, V295, P1887, DOI 10.1126/science.1066959; Olsen N, 2000, GEOPHYS RES LETT, V27, P3607, DOI 10.1029/2000GL011930; Roberts PH, 2000, REV MOD PHYS, V72, P1081, DOI 10.1103/RevModPhys.72.1081; Sarson GR, 1998, GEOPHYS ASTRO FLUID, V88, P225, DOI 10.1080/03091929808245475; Sarson GR, 1999, PHYS EARTH PLANET IN, V111, P3, DOI 10.1016/S0031-9201(98)00142-3; Takahashi F, 2003, PHYS EARTH PLANET IN, V140, P53, DOI 10.1016/j.pepi.2003.07.009; Takahashi F, 2001, PHYS EARTH PLANET IN, V128, P149, DOI 10.1016/S0031-9201(01)00283-7; TAYLOR JB, 1963, PROC R SOC LON SER-A, V274, P274, DOI 10.1098/rspa.1963.0130; Wicht J, 2002, PHYS EARTH PLANET IN, V132, P281, DOI 10.1016/S0031-9201(02)00078-X	25	77	79	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					459	461		10.1126/science.1111831	http://dx.doi.org/10.1126/science.1111831			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020733				2022-12-28	WOS:000230574900044
J	Lin, SC; van Keken, PE				Lin, SC; van Keken, PE			Multiple volcanic episodes of flood basalts caused by thermochemical mantle plumes	NATURE			English	Article							OCEANIC-CRUST; EVOLUTION; SEPARATION; SYSTEM	The hypothesis that a single mushroom-like mantle plume head can generate a large igneous province within a few million years has been widely accepted(1). The Siberian Traps at the Permian Triassic boundary(2) and the Deccan Traps at the Cretaceous Tertiary boundary(3) were probably erupted within one million years. These large eruptions have been linked to mass extinctions. But recent geochronological data(4-11) reveal more than one pulse of major eruptions with diverse magma flux within several flood basalts extending over tens of million years. This observation indicates that the processes leading to large igneous provinces are more complicated than the purely thermal, single-stage plume model suggests. Here we present numerical experiments to demonstrate that the entrainment of a dense eclogite-derived material at the base of the mantle by thermal plumes can develop secondary instabilities due to the interaction between thermal and compositional buoyancy forces. The characteristic timescales of the development of the secondary instabilities and the variation of the plume strength are compatible with the observations. Such a process may contribute to multiple episodes of large igneous provinces.	Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Lin, SC (corresponding author), Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA.	skylin@umich.edu						BERCOVICI D, 1994, SCIENCE, V266, P1367, DOI 10.1126/science.266.5189.1367; CAMPBELL IH, 1990, EARTH PLANET SC LETT, V99, P79, DOI 10.1016/0012-821X(90)90072-6; Coffin MF, 2002, J PETROL, V43, P1121, DOI 10.1093/petrology/43.7.1121; COURTILLOT V, 1988, NATURE, V333, P843, DOI 10.1038/333843a0; Farnetani CG, 1997, GEOPHYS RES LETT, V24, P1583, DOI 10.1029/97GL01548; Fitton JG, 2004, GEOL SOC SPEC PUBL, V229, P151, DOI 10.1144/GSL.SP.2004.229.01.10; Hieronymus CF, 1999, NATURE, V397, P604, DOI 10.1038/17584; IRIFUNE T, 1993, EARTH PLANET SC LETT, V117, P101, DOI 10.1016/0012-821X(93)90120-X; Leitch AM, 2001, J GEOPHYS RES-SOL EA, V106, P2047, DOI 10.1029/2000JB900307; Morgan W.J., 1981, SEA VOLUME 7 OCEANIC, V7, P443; Neal C.R., 1997, GEOPH MONOG SERIES, V100, P183; O'Connor JM, 2000, NATURE, V408, P954, DOI 10.1038/35050066; OCONNOR JM, 1990, J GEOPHYS RES-SOLID, V95, P17475, DOI 10.1029/JB095iB11p17475; OLSON P, 1987, NATURE, V327, P409, DOI 10.1038/327409a0; Ono S, 2001, EARTH PLANET SC LETT, V190, P57, DOI 10.1016/S0012-821X(01)00375-2; RENNE PR, 1995, SCIENCE, V269, P1413, DOI 10.1126/science.269.5229.1413; Revillon S, 2000, J PETROL, V41, P1127, DOI 10.1093/petrology/41.7.1127; Rudnick RL, 2000, SCIENCE, V287, P278, DOI 10.1126/science.287.5451.278; Stewart K, 1996, EARTH PLANET SC LETT, V143, P95, DOI 10.1016/0012-821X(96)00132-X; Tomlinson KY, 2001, GEOL S AM S, P341; van Keken PE, 1998, EARTH PLANET SC LETT, V156, P19, DOI 10.1016/S0012-821X(98)00023-5; vanderHilst RD, 1997, NATURE, V386, P578, DOI 10.1038/386578a0; vanKeken P, 1997, EARTH PLANET SC LETT, V148, P1, DOI 10.1016/S0012-821X(97)00042-3; vanKeken PE, 1997, J GEOPHYS RES-SOL EA, V102, P22477, DOI 10.1029/97JB01353; vanKeken PE, 1996, GEOPHYS RES LETT, V23, P1821, DOI 10.1029/96GL01594	25	72	77	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					250	252		10.1038/nature03697	http://dx.doi.org/10.1038/nature03697			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015328	Green Published			2022-12-28	WOS:000230459500039
J	Birnbaum, KM; Boca, A; Miller, R; Boozer, AD; Northup, TE; Kimble, HJ				Birnbaum, KM; Boca, A; Miller, R; Boozer, AD; Northup, TE; Kimble, HJ			Photon blockade in an optical cavity with one trapped atom	NATURE			English	Article							STRONGLY INTERACTING PHOTONS; NONLINEAR CAVITY; SINGLE-ATOM; QUANTUM; RADIATION	At low temperatures, sufficiently small metallic(1) and semiconductor(2) devices exhibit the 'Coulomb blockade' effect, in which charge transport through the device occurs on an electron-by-electron basis(3). For example, a single electron on a metallic island can block the flow of another electron if the charging energy of the island greatly exceeds the thermal energy. The analogous effect of 'photon blockade' has been proposed for the transport of light through an optical system; this involves photon-photon interactions in a nonlinear optical cavity(4-13). Here we report observations of photon blockade for the light transmitted by an optical cavity containing one trapped atom, in the regime of strong atom cavity coupling(14). Excitation of the atom-cavity system by a first photon blocks the transmission of a second photon, thereby converting an incident poissonian stream of photons into a subpoissonian, anti-bunched stream. This is confirmed by measurements of the photon statistics of the transmitted field. Our observations of photon blockade represent an advance over traditional nonlinear optics and laser physics, into a regime with dynamical processes involving atoms and photons taken one-by-one.	CALTECH, Norman Bridge Lab Phys 12 23, Pasadena, CA 91125 USA	California Institute of Technology	Kimble, HJ (corresponding author), CALTECH, Norman Bridge Lab Phys 12 23, Pasadena, CA 91125 USA.	hjkimble@caltech.edu	Northup, Tracy E./N-1439-2017	Northup, Tracy E./0000-0002-1071-2218				Boca A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.233603; Brecha RJ, 1999, PHYS REV A, V59, P2392, DOI 10.1103/PhysRevA.59.2392; CARMICHAEL HJ, 1985, PHYS REV LETT, V55, P2790, DOI 10.1103/PhysRevLett.55.2790; CARMICHAEL HJ, 1991, OPT COMMUN, V82, P73, DOI 10.1016/0030-4018(91)90194-I; DIEDRICH F, 1987, PHYS REV LETT, V58, P203, DOI 10.1103/PhysRevLett.58.203; FULTON TA, 1987, PHYS REV LETT, V59, P109, DOI 10.1103/PhysRevLett.59.109; Grangier P, 1998, PHYS REV LETT, V81, P2833, DOI 10.1103/PhysRevLett.81.2833; Hood C. J., 2000, THESIS CALTECH; Imamoglu A, 1997, PHYS REV LETT, V79, P1467, DOI 10.1103/PhysRevLett.79.1467; JAYNES ET, 1963, P IEEE, V51, P89, DOI 10.1109/PROC.1963.1664; KASTNER MA, 1992, REV MOD PHYS, V64, P849, DOI 10.1103/RevModPhys.64.849; Kim J, 1999, NATURE, V397, P500, DOI 10.1038/17295; Kimble HJ, 1998, PHYS SCRIPTA, VT76, P127, DOI 10.1238/Physica.Topical.076a00127; KIMBLE HJ, 1977, PHYS REV LETT, V39, P691, DOI 10.1103/PhysRevLett.39.691; Likharev KK, 1999, P IEEE, V87, P606, DOI 10.1109/5.752518; Mandel L, 1995, OPTICAL COHERENCE QU; McKeever J, 2004, SCIENCE, V303, P1992, DOI 10.1126/science.1095232; McKeever J, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.133602; Rebic S, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.063804; Rebic S, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.043806; Rebic S, 1999, J OPT B-QUANTUM S O, V1, P490, DOI 10.1088/1464-4266/1/4/322; Smolyaninov II, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.187402; TIAN L, 1992, PHYS REV A, V46, pR6801, DOI 10.1103/PhysRevA.46.R6801; Werner M. J., 1999, PHYS REV A, V61	24	940	953	6	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					87	90		10.1038/nature03804	http://dx.doi.org/10.1038/nature03804			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001065	Green Submitted, Green Accepted			2022-12-28	WOS:000230296600043
J	Tolia, NH; Enemark, EJ; Sim, BKL; Joshua-Tor, L				Tolia, NH; Enemark, EJ; Sim, BKL; Joshua-Tor, L			Structural basis for the EBA-175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum	CELL			English	Article							BINDING ANTIGEN; MEROZOITE PROTEINS; RECEPTOR; ACID; EXPRESSION; GENES; VIVAX; PROGRAM; SURFACE; FAMILY	Erythrocyte binding antigen 175 (EBA-175) is a P. falciparum protein that binds the major glycoprotein found on human erythrocytes, glycophorin A, during invasion. Here we present the crystal structure of the erythrocyte binding domain of EBA-175, RII, which has been established as a vaccine candidate. Binding sites for the heavily sialylated receptor glycophorin A are proposed based on a complex of RII with a glycan that contains the essential components required for binding. The dimeric organization of RII displays two prominent channels that contain four of the six observed glycan binding sites. Each monomer consists of two Duffy binding-like (DBL) domains (F1 and F2). F2 more prominently lines the channels and makes the majority of the glycan contacts, underscoring its role in cytoadherence and in antigenic variation in malaria. Our studies provide insight into the mechanism of erythrocyte invasion by the malaria parasite and aid in rational drug design and vaccines.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA; Prot Potential, Gaithersburg, MD 20878 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory	Sim, BKL (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	ksim@protpot.com; leemor@cshl.edu	Tolia, Niraj H/D-2332-2014; Enemark, Eric/N-8086-2018	Tolia, Niraj H/0000-0002-2689-1337; Joshua-Tor, Leemor/0000-0001-8185-8049				ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Blair PL, 2002, MOL BIOCHEM PARASIT, V122, P35, DOI 10.1016/S0166-6851(02)00067-1; Breman JG, 2001, AM J TROP MED HYG, V64, pIV, DOI 10.4269/ajtmh.2001.64.iv; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAMUS D, 1985, SCIENCE, V230, P553, DOI 10.1126/science.3901257; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Duraisingh MT, 2003, P NATL ACAD SCI USA, V100, P4796, DOI 10.1073/pnas.0730883100; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gilberger TW, 2003, J CELL BIOL, V162, P317, DOI 10.1083/jcb.200301046; Gilberger TW, 2003, J BIOL CHEM, V278, P14480, DOI 10.1074/jbc.M211446200; Gowda DC, 1999, PARASITOL TODAY, V15, P147, DOI 10.1016/S0169-4758(99)01412-X; Guzman F, 2002, LIFE SCI, V71, P2773, DOI 10.1016/S0024-3205(02)02108-2; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Jones TR, 2001, J INFECT DIS, V183, P303, DOI 10.1086/317933; Kaneko O, 2002, MOL BIOCHEM PARASIT, V121, P275, DOI 10.1016/S0166-6851(02)00042-7; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P1878, DOI 10.1107/S0907444999010495; KLOTZ FW, 1992, MOL BIOCHEM PARASIT, V51, P49, DOI 10.1016/0166-6851(92)90199-T; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Liang H, 1997, MOL BIOCHEM PARASIT, V84, P241, DOI 10.1016/S0166-6851(96)02791-0; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; MARCHESI VT, 1972, P NATL ACAD SCI USA, V69, P1445, DOI 10.1073/pnas.69.6.1445; Mayer DCG, 2001, P NATL ACAD SCI USA, V98, P5222, DOI 10.1073/pnas.081075398; Mayor A, 2005, BLOOD, V105, P2557, DOI 10.1182/blood-2004-05-1722; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Narum DL, 2002, MOL BIOCHEM PARASIT, V119, P159, DOI 10.1016/S0166-6851(01)00428-5; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; ORLANDI PA, 1992, J CELL BIOL, V116, P901, DOI 10.1083/jcb.116.4.901; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; Rayner JC, 2000, P NATL ACAD SCI USA, V97, P9648, DOI 10.1073/pnas.160469097; Reed MB, 2000, P NATL ACAD SCI USA, V97, P7509, DOI 10.1073/pnas.97.13.7509; Rodriguez LE, 2000, PARASITOLOGY, V120, P225, DOI 10.1017/S003118209900551X; SHELDRICK GM, 1993, ACTA CRYSTALLOGR D, V49, P18, DOI 10.1107/S0907444992007364; SIM BKL, 1990, J CELL BIOL, V111, P1877, DOI 10.1083/jcb.111.5.1877; Sim BKL, 2001, MOL MED, V7, P247, DOI 10.1007/BF03401844; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Taylor HM, 2002, INFECT IMMUN, V70, P5779, DOI 10.1128/IAI.70.10.5779-5789.2002; TEWILLIGER TC, 2000, ACTA CRYSTALLOGR D, V56, P965; Thompson JK, 2001, MOL MICROBIOL, V41, P47, DOI 10.1046/j.1365-2958.2001.02484.x; Triglia T, 2005, MOL MICROBIOL, V55, P162, DOI 10.1111/j.1365-2958.2004.04388.x; Triglia T, 2001, MOL BIOCHEM PARASIT, V116, P55, DOI 10.1016/S0166-6851(01)00303-6; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400	59	251	255	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 29	2005	122	2					183	193		10.1016/j.cell.2005.05.033	http://dx.doi.org/10.1016/j.cell.2005.05.033			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	951CR	16051144	Bronze			2022-12-28	WOS:000230907000007
J	Burdyga, T; Wray, S				Burdyga, T; Wray, S			Action potential refractory period in ureter smooth muscle is set by Ca sparks and BK channels	NATURE			English	Article							GUINEA-PIG URETER; CA2+-ACTIVATED K+ CHANNELS; SARCOPLASMIC-RETICULUM; CALCIUM SPARKS; INTRACELLULAR CA2+; CURRENTS; CELLS; RYANODINE; RELEASE; RAT	In excitable tissues the refractory period is a critical control mechanism preventing hyperactivity and undesirable tetani, by preventing subsequent stimuli eliciting action potentials and Ca2+ entry. In ureteric smooth muscle, peristaltic waves that occur as invading pacemaker potentials produce long-lasting action potentials (300-800 ms) and extraordinarily long ( more than 10 s) refractory periods(1-6), which prevent urine reflux and kidney damage(2). For smooth muscles neither the mechanisms underlying the refractory period nor the link between excitability and refractoriness are properly understood. Here we show that a negative feedback process, which depends on Ca2+ loading the sarcoplasmic reticulum (SR) during the action potential and on the subsequent activation of local releases of Ca2+ from the SR (sparks(7)), stimulating plasmalemmal Ca2+-sensitive K+ (BK) channels, determines the refractory period of the action potential. As sparks gradually reduce the Ca2+ load in the SR, electrical inhibition is released, the refractory period is terminated and peristaltic contractions occur again. The refractory period can be manipulated, for example from 10 s to 100 s, by altering the Ca2+ content of the SR or release mechanism or by inhibiting BK channels. This insight into the control of excitability and hence function provides a focus for therapies directed at pathologies of smooth muscle.	Univ Liverpool, Dept Physiol, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Burdyga, T (corresponding author), Univ Liverpool, Dept Physiol, Liverpool L69 3BX, Merseyside, England.	burdyga@liv.ac.uk	wray, susan/B-1197-2009	Wray, Susan/0000-0002-0086-1359; Burdyga, Theodor/0000-0002-6312-1550				BENHAM CD, 1986, J PHYSIOL-LONDON, V381, P385, DOI 10.1113/jphysiol.1986.sp016333; Bogdanov KY, 2001, CIRC RES, V88, P1254, DOI 10.1161/hh1201.092095; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Burdyga T, 1997, PFLUG ARCH EUR J PHY, V435, P182, DOI 10.1007/s004240050499; Burdyga TV, 1998, BBA-MOL CELL RES, V1402, P109, DOI 10.1016/S0167-4889(97)00149-3; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Cheranov SY, 2002, J PHYSIOL-LONDON, V544, P71, DOI 10.1113/jphysiol.2002.025197; Cuthbert A W, 1965, J Physiol, V180, P225; Exintaris B, 1999, UROL RES, V27, P319; Gordienko DV, 2001, CELL CALCIUM, V29, P13, DOI 10.1054/ceca.2000.0180; Heppner TJ, 1997, AM J PHYSIOL-CELL PH, V273, pC110; Hove-Madsen L, 2004, CIRCULATION, V110, P1358, DOI 10.1161/01.CIR.0000141296.59876.87; IMAIZUMI Y, 1989, J PHYSIOL-LONDON, V411, P131, DOI 10.1113/jphysiol.1989.sp017565; Kotlikoff MI, 2003, PROG BIOPHYS MOL BIO, V83, P171, DOI 10.1016/S0079-6107(03)00056-7; KURIYAMA H, 1967, J PHYSIOL-LONDON, V191, P225, DOI 10.1113/jphysiol.1967.sp008247; LANG RJ, 1989, J PHYSIOL-LONDON, V412, P375, DOI 10.1113/jphysiol.1989.sp017622; MAGGI CA, 1994, N-S ARCH PHARMACOL, V349, P510, DOI 10.1007/BF00169141; MAGGI CA, 1995, BRIT J PHARMACOL, V114, P127, DOI 10.1111/j.1476-5381.1995.tb14916.x; Matthew A, 2004, J SOC GYNECOL INVEST, V11, P207, DOI 10.1016/j.jsgi.2003.10.009; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Shabir S, 2004, J PHYSIOL-LONDON, V560, P839, DOI 10.1113/jphysiol.2004.070615; Weiss R. M., 1986, CAMPBELLS UROLOGY, P94; Wellman GC, 2001, AM J PHYSIOL-CELL PH, V281, pC1029, DOI 10.1152/ajpcell.2001.281.3.C1029; WEMYSSHOLDEN GD, 1993, BRIT J UROL, V71, P156, DOI 10.1111/j.1464-410X.1993.tb15909.x; ZhuGe RH, 2004, AM J PHYSIOL-CELL PH, V287, pC1577, DOI 10.1152/ajpcell.00153.2004; Zima AV, 2004, J PHYSIOL-LONDON, V555, P607, DOI 10.1113/jphysiol.2003.058529	26	75	78	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2005	436	7050					559	562		10.1038/nature03834	http://dx.doi.org/10.1038/nature03834			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049489				2022-12-28	WOS:000230788800062
J	Carulla, N; Caddy, GL; Hall, DR; Zurdo, J; Gairi, M; Feliz, M; Giralt, E; Robinson, CV; Dobson, CM				Carulla, N; Caddy, GL; Hall, DR; Zurdo, J; Gairi, M; Feliz, M; Giralt, E; Robinson, CV; Dobson, CM			Molecular recycling within amyloid fibrils	NATURE			English	Article							PROTEIN AGGREGATION; CORE; MICROSCOPY; RESISTANT; POSSESS; PRIONS; MODEL	Amyloid fibrils are thread-like protein aggregates with a core region formed from repetitive arrays of beta-sheets oriented parallel to the fibril axis(1,2). Such structures were first recognized in clinical disorders(1,3), but more recently have also been linked to a variety of non-pathogenic phenomena ranging from the transfer of genetic information to synaptic changes associated with memory(4-7). The observation that many proteins can convert into similar structures in vitro has suggested that this ability is a generic feature of polypeptide chains(1,8). Here we have probed the nature of the amyloid structure by monitoring hydrogen/deuterium exchange in fibrils formed from an SH3 domain(9-12) using a combination of nuclear magnetic resonance spectroscopy and electrospray ionization mass spectrometry. The results reveal that under the conditions used in this study, exchange is dominated by a mechanism of dissociation and re-association that results in the recycling of molecules within the fibril population. This insight into the dynamic nature of amyloid fibrils, and the ability to determine the parameters that define this behaviour, have important implications for the design of therapeutic strategies directed against amyloid disease.	Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; Serv Cient Tecn, Barcelona 08028, Spain; Inst Recerca Biomed Barcelona, Barcelona 08028, Spain; Univ Barcelona, Dept Quim Organ, E-08028 Barcelona, Spain	University of Cambridge; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona	Dobson, CM (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	cvr24@cam.ac.uk; cmd44@cam.ac.uk	giralt, ernest/N-1669-2014; Gairi, Margarida/E-9800-2016; Hall, Damien/AGY-5341-2022; Feliz, Miguel/F-3792-2016; Zurdo, Jesús/C-3110-2015; Hall, Damien/D-9927-2012	giralt, ernest/0000-0001-8381-1797; Gairi, Margarida/0000-0003-3560-5897; Hall, Damien/0000-0003-1538-7618; Feliz, Miguel/0000-0002-7676-3309; Zurdo, Jesús/0000-0001-5186-8633; Hall, Damien/0000-0003-1538-7618; Carulla, Natalia/0000-0002-3787-978X; robinson, carol/0000-0001-7829-5505	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; de Laureto PP, 2003, J MOL BIOL, V334, P129, DOI 10.1016/j.jmb.2003.09.024; Dobson CM, 2004, SCIENCE, V304, P1259, DOI 10.1126/science.1093078; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Englander SW, 2001, NAT STRUCT BIOL, V8, P741, DOI 10.1038/nsb0901-741; Goldsbury C, 1999, J MOL BIOL, V285, P33, DOI 10.1006/jmbi.1998.2299; Hall D, 2004, J MOL BIOL, V336, P775, DOI 10.1016/j.jmb.2003.12.004; Hamada D, 2004, TRENDS BIOTECHNOL, V22, P93, DOI 10.1016/j.tibtech.2003.12.003; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Jimenez JL, 1999, EMBO J, V18, P815, DOI 10.1093/emboj/18.4.815; Kelly JW, 2003, J CELL BIOL, V161, P461, DOI 10.1083/jcb.200304074; Kheterpal I, 2003, BIOCHEMISTRY-US, V42, P14092, DOI 10.1021/bi0357816; Kheterpal I, 2000, P NATL ACAD SCI USA, V97, P13597, DOI 10.1073/pnas.250288897; MacPhee CE, 2004, CURR OPIN SOLID ST M, V8, P141, DOI 10.1016/j.cossms.2004.01.010; MIRANKER A, 1993, SCIENCE, V262, P896, DOI 10.1126/science.8235611; Olofsson A, 2004, J BIOL CHEM, V279, P5699, DOI 10.1074/jbc.M310605200; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Ventura S, 2004, P NATL ACAD SCI USA, V101, P7258, DOI 10.1073/pnas.0308249101; Wickner RB, 2004, GENE DEV, V18, P470, DOI 10.1101/gad.1177104; Yamaguchi KI, 2004, J MOL BIOL, V338, P559, DOI 10.1016/j.jmb.2004.02.067; Zurdo J, 2001, J MOL BIOL, V311, P325, DOI 10.1006/jmbi.2001.4858; Zurdo J, 2001, J AM CHEM SOC, V123, P8141, DOI 10.1021/ja016229b	30	288	288	0	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					554	558		10.1038/nature03986	http://dx.doi.org/10.1038/nature03986			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049488				2022-12-28	WOS:000230788800061
J	D'Amico, AV; Renshaw, AA; Sussman, B; Chen, MH				D'Amico, AV; Renshaw, AA; Sussman, B; Chen, MH			Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							III RANDOMIZED TRIAL; RADICAL PROSTATECTOMY; ANDROGEN SUPPRESSION; ANTIGEN LEVELS; TRENDS	Context Men with localized prostate cancer and a preoperative prostate-specific antigen (PSA) velocity greater than 2.0 ng/mL per year experience a 10-fold increase in prostate cancer-specific mortality despite surgery. Objective To assess whether a greater than 2.0-ng/mL increase in PSA level during the year prior to diagnosis was significantly associated with prostate cancer-specific mortality following radiation therapy (RT). Design, Setting, and Patients Between January 1, 1989, and December 1, 2002, 358 men treated with RT for localized prostate cancer formed the study cohort (median age at treatment, 71.2 (range, 43.2-83.5] years). A Cox regression multivariable analysis was used to evaluate whether a PSA velocity greater than 2.0 ng/mL per year was significantly associated with prostate cancer-specific mortality and all-cause mortality after controlling for prognostic factors available at diagnosis. Main Outcome Measure Time to prostate cancer-specific mortality for the 125 men with low-risk prostate cancer (clinical tumor category T1c or T2a and PSA level <10.0 ng/mL and Gleason score :56) and the 233 men with higher-risk disease, stratified by the PSA velocity. Results A PSA velocity greater than 2.0 ng/mL per year was significantly associated with a shorter time to prostate cancer-specific mortality (adjusted hazard ratio [HR], 12.0; 95% confidence interval [CI], 3.0-54.0; P=.001) and all-cause mortality (adjusted HR, 2.1; 95% Cl, 1.3-3.6; P=.005) when compared with men whose PSA velocity was 2.0 ng/mL per year or less. Men presenting with low-risk disease and a PSA velocity greater than 2.0 ng/mL per year had a 7-year estimate of prostate cancer-specific mortality of 19% (95% Cl, 2%-39%) compared with 0% for men whose PSA velocity was 2.0 ng/mL per year or less. The corresponding values for men with higher-risk disease were 24% (95% Cl, 12%-37%) and 4% (95% Cl, 0%-11%), respectively. Conclusions A greater than 2.0-ng/mL increase in PSA level during the year prior to diagnosis is associated with a significantly higher risk of death due to prostate cancer following RT despite having low-risk disease. Such men who are planning to undergo RT and are in good health could be considered for RT combined with androgen suppression therapy because this approach improves survival in men with higher-risk disease.	Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA 02215 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02215 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Univ Connecticut, Dept Stat, Storrs, CT 06269 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; University of Connecticut	D'Amico, AV (corresponding author), Brigham & Womens Hosp, Dept Radiat Oncol, 75 Francis St,L-2 Level, Boston, MA 02215 USA.	adamico@lroc.harvard.edu						Andriole GL, 2004, UROL ONCOL-SEMIN ORI, V22, P358, DOI 10.1016/j.urolonc.2004.04.013; Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4; CARTER HB, 1992, JAMA-J AM MED ASSOC, V267, P2215, DOI 10.1001/jama.267.16.2215; CATALONA WJ, 1993, JAMA-J AM MED ASSOC, V270, P948, DOI 10.1001/jama.270.8.948; Cooperberg MR, 2004, J CLIN ONCOL, V22, P2141, DOI 10.1200/JCO.2004.10.062; Cooperberg MR, 2003, J UROLOGY, V170, pS21, DOI 10.1097/01.ju.0000095025.03331.c6; Cox JD, 1999, J CLIN ONCOL, V17, P1155; D'Amico AV, 2002, J CLIN ONCOL, V20, P4567, DOI 10.1200/JCO.2002.03.061; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; D'Amico AV, 2003, J NATL CANCER I, V95, P1376, DOI 10.1093/jnci/djg043; D'Amico AV, 2004, JAMA-J AM MED ASSOC, V292, P821, DOI 10.1001/jama.292.7.821; D'Amico AV, 2004, NEW ENGL J MED, V351, P125, DOI 10.1056/NEJMoa032975; GAYNOR JJ, 1993, J AM STAT ASSOC, V88, P400, DOI 10.2307/2290318; Goluboff ET, 1997, J UROLOGY, V158, P1876, DOI 10.1016/S0022-5347(01)64154-5; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KLEIN JP, 1977, SURVIVAL ANAL TECHNI; PARTIN AW, 2004, P 2004 ANN M AM UR A; Pollack A, 2002, INT J RADIAT ONCOL, V53, P1097, DOI 10.1016/S0360-3016(02)02829-8; Roach M, 2003, J CLIN ONCOL, V21, P1904, DOI 10.1200/JCO.2003.05.004; Roobol MJ, 2003, BJU INT, V92, P117, DOI 10.1111/j.1464-410X.2003.4698x.x; Wilt T J, 1997, Oncology (Williston Park), V11, P1133; ZIETMAN AL, 2004, P 46 ANN M AM SOC TH	22	250	257	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2005	294	4					440	447		10.1001/jama.294.4.440	http://dx.doi.org/10.1001/jama.294.4.440			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RM	16046650				2022-12-28	WOS:000230733400018
J	Adams, PC				Adams, PC			Screening for haemochromatosis - producing or preventing illness?	LANCET			English	Editorial Material							HEREDITARY HEMOCHROMATOSIS; C282Y HOMOZYGOTES; POPULATION; PREVALENCE; MUTATION		London Hlth Sci Ctr, London, ON N6A 5A5, Canada	London Health Sciences Centre	Adams, PC (corresponding author), London Hlth Sci Ctr, London, ON N6A 5A5, Canada.	padams@uwo.ca		Adams, Paul/0000-0002-9921-2956				Adams PC, 2005, NEW ENGL J MED, V352, P1769, DOI 10.1056/NEJMoa041534; Adams PC, 2004, HEPATOLOGY, V40, p232A; Andersen RV, 2004, BLOOD, V103, P2914, DOI 10.1182/blood-2003-10-3564; Asberg A, 2001, SCAND J GASTROENTERO, V36, P1108; Beaton M, 2002, HEPATOLOGY, V36, P673, DOI 10.1053/jhep.2002.35343; Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; Bulaj ZJ, 2000, NEW ENGL J MED, V343, P1529, DOI 10.1056/NEJM200011233432104; Gleeson F, 2004, EUR J GASTROEN HEPAT, V16, P859, DOI 10.1097/00042737-200409000-00008; Green MJ, 2003, ANN INTERN MED, V138, P571, DOI 10.7326/0003-4819-138-7-200304010-00013; Power TE, 2001, GENET TEST, V5, P107, DOI 10.1089/109065701753145556; Shaheen NJ, 2003, AM J GASTROENTEROL, V98, P1175, DOI 10.1016/S0002-9270(03)00109-6; Smith BN, 1997, HEPATOLOGY, V25, P1439, DOI 10.1002/hep.510250622; Stave GM, 1999, AM J PREV MED, V16, P303, DOI 10.1016/S0749-3797(99)00018-5	13	7	7	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 23	2005	366	9482					269	271		10.1016/S0140-6736(05)66384-2	http://dx.doi.org/10.1016/S0140-6736(05)66384-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RJ	16039315				2022-12-28	WOS:000230733100006
J	Burazeri, G; Civljak, M; Ilakovac, V; Jankovic, S; Majica-Kovacevic, T; Nedera, O; Roshi, E; Sava, V; Simunovic, V; Marusic, A; Marusic, M				Burazeri, G; Civljak, M; Ilakovac, V; Jankovic, S; Majica-Kovacevic, T; Nedera, O; Roshi, E; Sava, V; Simunovic, V; Marusic, A; Marusic, M			Survey of attitudes and knowledge about science in medical students in southeast Europe	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Dept Med Sociol & Hlth Econ, Zagreb 41001, Croatia; Tirana Univ, Fac Med, Dept Publ Hlth, Tirana, Albania; Josip Juraj Strossmayer Univ Osijek, Sch Med, Dept Med Stat & Med Informat, Osijek, Croatia; Kragujevac Clin Hosp Ctr, Inst Pharmacol, Kragujevac, Serbia Monteneg; Split Univ, Sch Med, Split, Croatia; State Med & Pharm Univ, Sch Publ Hlth, Kishinev, Moldova; Ctr Publ Hlth & Management, Hlth Policy Div, Res & Training Dept, Kishinev, Moldova; Mostar Univ, Sch Med, Mostar, Bosnia & Herceg	University of Zagreb; University of Tirana (UT); University of JJ Strossmayer Osijek; University of Split; Nicolae Testemitanu State University of Medicine & Pharmacy; University of Mostar	Marusic, A (corresponding author), Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Dept Med Sociol & Hlth Econ, Zagreb 41001, Croatia.	marusica@mef.hr	Kovacevic, Tanja/D-5934-2017; Jankovic, Slobodan/Q-4607-2016; Marusic, Ana/E-7683-2013; Burazeri, Genc/Q-8860-2019; Roshi, Professor Enver Envi/AFN-4125-2022; Marusic, Matko/E-1834-2017; Ilakovac, Vesna/N-9884-2016	Kovacevic, Tanja/0000-0003-4252-9415; Jankovic, Slobodan/0000-0002-1519-8828; Marusic, Ana/0000-0001-6272-0917; Roshi, Professor Enver Envi/0000-0002-4257-7583; Marusic, Matko/0000-0001-5562-1777; Ilakovac, Vesna/0000-0002-2560-8800				Garner P, 2004, BRIT MED J, V329, P1036, DOI 10.1136/bmj.329.7473.1036; Hrabak M, 2004, MED EDUC, V38, P276, DOI 10.1111/j.1365-2923.2004.01766.x; Hren D, 2004, MED EDUC, V38, P81, DOI 10.1111/j.1365-2923.2004.01735.x; Marusic A, 2003, ACAD MED, V78, P1235, DOI 10.1097/00001888-200312000-00007	4	18	18	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2005	331	7510					195	196		10.1136/bmj.331.7510.195	http://dx.doi.org/10.1136/bmj.331.7510.195			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951EA	16037454	Green Published			2022-12-28	WOS:000230910700023
J	Kralikova, E; Podmaniczky, E; Stypulkowska-Misiurewicz, H; Kavcova, E; Veryga, A; Muller, T				Kralikova, E; Podmaniczky, E; Stypulkowska-Misiurewicz, H; Kavcova, E; Veryga, A; Muller, T			Commentary: Making the transition to action	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MORTALITY; TOBACCO		BMA, Tobacco Control Resource Ctr, Edinburgh EH2 1LL, Midlothian, Scotland; Charles Univ Prague, Inst Hyg & Epidemiol, Prague, Czech Republic; Hungarian Med Chamber, Int Relat Comm, Budapest, Hungary; Polish Chamber Phys & Dentists, Warsaw, Poland; Martin Fac Hosp, Dept TB & Resp Dis, Martin, Slovakia; Kaunas Univ, Dept Prevent Med, Kaunas, Lithuania	Charles University Prague; Kaunas University of Technology	Muller, T (corresponding author), BMA, Tobacco Control Resource Ctr, Edinburgh EH2 1LL, Midlothian, Scotland.	tmuller@bma.org.uk	Kralikova, Eva/B-9308-2012	Kralikova, Eva/0000-0003-0190-926X; Stypulkowska-Misiurewicz, Hanna/0000-0001-7548-380X				ASPECT Consortium, 2004, TOB HLTH EUR UN PRES; Boyle P, 2005, ANN ONCOL, V16, P481, DOI 10.1093/annonc/mdi098; Didkowska J, 2005, BMJ-BRIT MED J, V331, P189, DOI 10.1136/bmj.331.7510.189; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Gilmore AB, 2004, TOB CONTROL, V13, P136, DOI 10.1136/tc.2002.002667	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2005	331	7510					191	192		10.1136/bmj.331.7510.191	http://dx.doi.org/10.1136/bmj.331.7510.191			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951EA	16037451	Bronze, Green Published			2022-12-28	WOS:000230910700020
J	Rubinoff, D; Haines, WP				Rubinoff, D; Haines, WP			Web-spinning caterpillar stalks snails	SCIENCE			English	Article									Univ Hawaii, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA	University of Hawaii System	Rubinoff, D (corresponding author), Univ Hawaii, Dept Plant & Environm Protect Sci, 310 Gilmore Hall,3050 Maile Way, Honolulu, HI 96822 USA.	rubinoff@hawaii.edu						GILLESPIE RG, 1992, NATURE, V355, P212, DOI 10.1038/355212b0; KRISTENSEN NP, 1999, LEIPDOPTERA MOTHS BU, pCH2; MONTGOMERY SL, 1982, ENTOMOL GEN, V8, P27; Pierce Naomi E., 1995, Journal of the Lepidopterists' Society, V49, P412; Zimmerman EC, 1948, INSECTS HAWAII, V2; Zimmerman EC, 1978, MICROLEPIDOPTERA 2, V9, P883	6	22	24	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2005	309	5734					575	575		10.1126/science.1110397	http://dx.doi.org/10.1126/science.1110397			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040699				2022-12-28	WOS:000230735200037
J	Cyranoski, D				Cyranoski, D			Malaysia plans 'red book' in its attempts to go green	NATURE			English	News Item								Malaysia is one of the most biologically diverse countries in the world, yet in recent decades has been accused of clearing rainforests and draining peat swamps in order to grow palm trees for the production of palm oil. The international Convention on Biological Diversity has been pressurizing Malaysia to implement conservation strategies. Whilst the new government is said to be in favor, the resources might not yet be in place.											0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 21	2005	436	7049					313	313		10.1038/436313b	http://dx.doi.org/10.1038/436313b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034382	Bronze			2022-12-28	WOS:000230623400008
J	Fohlisch, A; Feulner, P; Hennies, F; Fink, A; Menzel, D; Sanchez-Portal, D; Echenique, PM; Wurth, W				Fohlisch, A; Feulner, P; Hennies, F; Fink, A; Menzel, D; Sanchez-Portal, D; Echenique, PM; Wurth, W			Direct observation of electron dynamics in the attosecond domain	NATURE			English	Article							RESONANT CHARGE-TRANSFER; TIME SCALES; SPECTROSCOPY; MOLECULES; ADSORBATES; HOLE	Dynamical processes are commonly investigated using laser pump - probe experiments, with a pump pulse exciting the system of interest and a second probe pulse tracking its temporal evolution as a function of the delay between the pulses(1-6). Because the time resolution attainable in such experiments depends on the temporal definition of the laser pulses, pulse compression to 200 attoseconds ( 1 as = 10(-18) s) is a promising recent development. These ultrafast pulses have been fully characterized(7), and used to directly measure light waves(8) and electronic relaxation in free atoms(2-4). But attosecond pulses can only be realized in the extreme ultraviolet and X-ray regime; in contrast, the optical laser pulses typically used for experiments on complex systems last several femtoseconds ( 1 fs = 10(-15) s)(1,5,6). Here we monitor the dynamics of ultrafast electron transfer - a process important in photo- and electrochemistry and used in solid-state solar cells, molecular electronics and single-electron devices - on attosecond timescales using core-hole spectroscopy. We push the method, which uses the lifetime of a core electron hole as an internal reference clock for following dynamic processes(9-19), into the attosecond regime by focusing on short-lived holes with initial and final states in the same electronic shell. This allows us to show that electron transfer from an adsorbed sulphur atom to a ruthenium surface proceeds in about 320 as.	Univ Hamburg, Inst Expt Phys, D-22761 Hamburg, Germany; Tech Univ Munich, Phys Dept E20, D-85747 Garching, Germany; Univ Basque Country, DIPC, Ctr Mixto CSIC UPV EHU Unidad Fis Mat, Donostia San Sebastian 20080, Spain; Univ Basque Country, Dept Fis Mat, Donostia San Sebastian 20080, Spain	University of Hamburg; Technical University of Munich; University of Basque Country; University of Basque Country	Wurth, W (corresponding author), Univ Hamburg, Inst Expt Phys, Luruper Chaussee 149, D-22761 Hamburg, Germany.	wilfried.wurth@desy.de	Echenique, Pedro Miguel/AAB-3348-2019; Sanchez-Portal, Daniel/E-5858-2010; Hennies, Franz/A-4643-2009	Sanchez-Portal, Daniel/0000-0001-6860-8790; Hennies, Franz/0000-0003-3904-1937; Alexander, Fohlisch/0000-0003-4126-8233; Menzel, Dietrich/0000-0002-7188-8532				Baltuska A, 2003, NATURE, V421, P611, DOI 10.1038/nature01414; BJORNEHOLM O, 1992, PHYS REV LETT, V68, P1892, DOI 10.1103/PhysRevLett.68.1892; Bjorneholm O, 1997, PHYS REV LETT, V79, P3150, DOI 10.1103/PhysRevLett.79.3150; Borisov AG, 1999, PHYS REV B, V59, P10935, DOI 10.1103/PhysRevB.59.10935; Bruhwiler PA, 2002, REV MOD PHYS, V74, P703, DOI 10.1103/RevModPhys.74.703; COVILLE M, 1991, PHYS REV A, V43, P6053, DOI 10.1103/PhysRevA.43.6053; Drescher M, 2002, NATURE, V419, P803, DOI 10.1038/nature01143; Feifel R, 2000, PHYS REV LETT, V85, P3133, DOI 10.1103/PhysRevLett.85.3133; Fohlisch A, 2003, CHEM PHYS, V289, P107, DOI 10.1016/S0301-0104(02)00939-4; Goulielmakis E, 2004, SCIENCE, V305, P1267, DOI 10.1126/science.1100866; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Jurgens D, 1997, SURF SCI, V381, P174, DOI 10.1016/S0039-6028(97)00087-3; Keller C, 1998, PHYS REV B, V57, P11951, DOI 10.1103/PhysRevB.57.11951; Keller C, 2004, APPL PHYS A-MATER, V78, P125, DOI 10.1007/s00339-003-2309-z; Keller C, 1998, PHYS REV LETT, V80, P1774, DOI 10.1103/PhysRevLett.80.1774; Kienberger R, 2004, NATURE, V427, P817, DOI 10.1038/nature02277; KRAUSE MO, 1979, J PHYS CHEM REF DATA, V8, P329, DOI 10.1063/1.555595; OHNO M, 1994, PHYS REV B, V50, P2566, DOI 10.1103/PhysRevB.50.2566; Petek H, 1997, PROG SURF SCI, V56, P239, DOI 10.1016/S0079-6816(98)00002-1; SanchezPortal D, 1997, INT J QUANTUM CHEM, V65, P453, DOI 10.1002/(SICI)1097-461X(1997)65:5<453::AID-QUA9>3.0.CO;2-V; Schnadt J, 2002, NATURE, V418, P620, DOI 10.1038/nature00952; SCHWENNICKE C, 1994, SURF SCI, V316, P81, DOI 10.1016/0039-6028(94)91130-4; Soler JM, 2002, J PHYS-CONDENS MAT, V14, P2745, DOI 10.1088/0953-8984/14/11/302; Steinmeyer G, 1999, SCIENCE, V286, P1507, DOI 10.1126/science.286.5444.1507; Wurth W, 2000, CHEM PHYS, V251, P141, DOI 10.1016/S0301-0104(99)00305-5; Zewail AH, 2000, J PHYS CHEM A, V104, P5660, DOI 10.1021/jp001460h	26	263	263	3	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 21	2005	436	7049					373	376		10.1038/nature03833	http://dx.doi.org/10.1038/nature03833			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034414				2022-12-28	WOS:000230623400038
J	Lichtenstein, AH; Russell, RM				Lichtenstein, AH; Russell, RM			Essential nutrients: Food or supplements? Where should the emphasis be?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CORONARY-HEART-DISEASE; LONG-TERM SUPPLEMENTATION; BETA-CAROTENE SUPPLEMENTS; VITAMIN-E SUPPLEMENTATION; CARDIOVASCULAR-DISEASE; ALPHA-TOCOPHEROL; ARTERY-DISEASE; LUNG-CANCER; MYOCARDIAL-INFARCTION; ANTIOXIDANT VITAMINS	The consumption of adequate levels and proper balance of essential nutrients is critical for maintaining health. The identification, isolation, and purification of nutrients in the early 20th century raised the possibility that optimal health outcomes could be realized through nutrient supplementation. Recent attempts using this approach for cardiovascular disease and lung cancer have been disappointing, as demonstrated with vitamin E and beta carotene. Moreover, previously unrecognized risks caused by nutrient toxicity and nutrient interactions have surfaced during intervention studies. The most promising data in the area of nutrition and positive health outcomes relate to dietary patterns, not nutrient supplements. These data suggest that other factors in food or the relative presence of some foods and the absence of other foods are more important than the level of individual nutrients consumed. Finally, unknown are the implications on public health behavior of shifting the emphasis away from food toward nutrient supplements. Notwithstanding the justification for targeting recommendations for nutrient supplements to certain segments of the population (eg, the elderly), there are insufficient data to justify an alteration in public health policy from one that emphasizes food and diet to one that emphasizes nutrient supplements.	Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA	Tufts University; United States Department of Agriculture (USDA)	Lichtenstein, AH (corresponding author), Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, 711 Washington St, Boston, MA 02111 USA.	alice.lichtenstein@tufts.edu						Al-Delaimy WK, 2004, STROKE, V35, P1259, DOI 10.1161/01.STR.0000127813.12854.9c; Alberts DS, 2000, NEW ENGL J MED, V342, P1156, DOI 10.1056/NEJM200004203421602; Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; *AM AC PED DENT, 2004, PEDIAT DENT S, V26, P87; [Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Bazzano LA, 2002, STROKE, V33, P1183, DOI 10.1161/01.STR.0000014607.90464.88; BLANK S, 1995, AM J PUBLIC HEALTH, V85, P656, DOI 10.2105/AJPH.85.5.656; Boaz M, 2000, LANCET, V356, P1213, DOI 10.1016/S0140-6736(00)02783-5; Boileau TWM, 2003, JNCI-J NATL CANCER I, V95, P1578, DOI 10.1093/jnci/djg081; Braam L, 2004, J AM DIET ASSOC, V104, P1410, DOI 10.1016/j.jada.2004.06.021; Brilakis ES, 2002, ATHEROSCLEROSIS, V165, P375, DOI 10.1016/S0021-9150(02)00303-9; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; Brown BG, 2002, ARTERIOSCL THROM VAS, V22, P1535, DOI 10.1161/01.ATV.0000034706.24149.95; BROWN ED, 1989, AM J CLIN NUTR, V49, P1258, DOI 10.1093/ajcn/49.6.1258; Brown MJ, 2004, AM J CLIN NUTR, V80, P396, DOI 10.1093/ajcn/80.2.396; CARPENTER TO, 1987, J PEDIATR-US, V111, P507, DOI 10.1016/S0022-3476(87)80109-9; CARTER EGA, 1982, AM J CLIN NUTR, V36, P855, DOI 10.1093/ajcn/36.5.855; Carter H, 2004, Morbidity and Mortality Weekly Report, V53, P847; Castenmiller JJM, 1999, J NUTR, V129, P349, DOI 10.1093/jn/129.2.349; Chung HY, 2004, J NUTR, V134, P1887, DOI 10.1093/jn/134.8.1887; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; CORRIGAN JJ, 1981, AM J CLIN NUTR, V34, P1701, DOI 10.1093/ajcn/34.9.1701; DAWSON DW, 1984, BRIT MED J, V288, P675, DOI 10.1136/bmj.288.6418.675; Dhar M, 2003, NEW ENGL J MED, V348, P2204, DOI 10.1056/NEJMoa022639; DISLER PB, 1975, GUT, V16, P193, DOI 10.1136/gut.16.3.193; Dragsted LO, 2004, AM J CLIN NUTR, V79, P1060; Eidelman RS, 2004, ARCH INTERN MED, V164, P1552, DOI 10.1001/archinte.164.14.1552; Eikelboom JW, 1999, ANN INTERN MED, V131, P363, DOI 10.7326/0003-4819-131-5-199909070-00008; Erkkila AT, 2005, EUR J CLIN NUTR, V59, P196, DOI 10.1038/sj.ejcn.1602058; Feskanich D, 2002, JAMA-J AM MED ASSOC, V287, P47, DOI 10.1001/jama.287.1.47; Fletcher RH, 2002, JAMA-J AM MED ASSOC, V287, P3127, DOI 10.1001/jama.287.23.3127; Gibbons RJ, 2003, CIRCULATION, V107, P149, DOI 10.1161/01.CIR.0000047041.66447.29; Girelli D, 2003, J NUTR, V133, P1281; Greenberg ER, 1996, JAMA-J AM MED ASSOC, V275, P699, DOI 10.1001/jama.275.9.699; Greger JL, 1999, J NUTR, V129, p1434S, DOI 10.1093/jn/129.7.1434S; HALLBERG L, 1991, AM J CLIN NUTR, V53, P112, DOI 10.1093/ajcn/53.1.112; Hannon-Fletcher MP, 2004, AM J CLIN NUTR, V80, P911, DOI 10.1093/ajcn/80.4.911; HARKER LA, 1974, NEW ENGL J MED, V291, P537, DOI 10.1056/NEJM197409122911101; HARKER LA, 1976, J CLIN INVEST, V58, P731, DOI 10.1172/JCI108520; Haskell MJ, 2004, AM J CLIN NUTR, V80, P705; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; Herbert V, 1998, JAMA-J AM MED ASSOC, V279, P505; Hodis HN, 2002, CIRCULATION, V106, P1453, DOI 10.1161/01.CIR.0000029092.99946.08; Hu FB, 2000, AM J CLIN NUTR, V72, P912; Huang HY, 2003, J NUTR, V133, P3137, DOI 10.1093/jn/133.10.3137; Hung J, 2003, BRIT MED J, V326, P131, DOI 10.1136/bmj.326.7381.131; *I MED, 1997, DIET REF INT CALC VI; *I MED, 2001, DIET REF INT ZINC; *I MED, 1998, DIET REF INT B12; Institute of Medicine, 1994, SHOULD REC DIET ALL; JACOBUS CH, 1992, NEW ENGL J MED, V326, P1173, DOI 10.1056/NEJM199204303261801; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Jasti S, 2003, J NUTR, V133, p2010S, DOI 10.1093/jn/133.6.2010S; JIALAL I, 1992, J LIPID RES, V33, P899; Katz DL, 2004, J AM COLL NUTR, V23, P397, DOI 10.1080/07315724.2004.10719384; KOPLAN JP, 1986, AM J PUBLIC HEALTH, V76, P287, DOI 10.2105/AJPH.76.3.287; KOSTIC D, 1995, AM J CLIN NUTR, V62, P604, DOI 10.1093/ajcn/62.3.604; Kris-Etherton PM, 2004, CIRCULATION, V110, P637, DOI 10.1161/01.CIR.0000137822.39831.F1; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Kruger WD, 2000, MOL GENET METAB, V70, P53, DOI 10.1006/mgme.2000.2993; Lampe JW, 1999, AM J CLIN NUTR, V70, p475S, DOI 10.1093/ajcn/70.3.475s; Lange H, 2004, NEW ENGL J MED, V350, P2673, DOI 10.1056/NEJMoa032845; Law MR, 1998, EUR J CLIN NUTR, V52, P549, DOI 10.1038/sj.ejcn.1600603; LEVY AS, 1987, J AM DIET ASSOC, V87, P754; Livny O, 2003, EUR J NUTR, V42, P338, DOI 10.1007/s00394-003-0430-6; Lonn E, 2002, DIABETES CARE, V25, P1919, DOI 10.2337/diacare.25.11.1919; Lonn E, 2005, JAMA-J AM MED ASSOC, V293, P1338, DOI 10.1001/jama.293.11.1338; Lu QJ, 2003, BIOMED ENVIRON SCI, V16, P237; MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134; Malinow MR, 1999, CIRCULATION, V99, P178, DOI 10.1161/01.CIR.99.1.178; Mayne ST, 1996, FASEB J, V10, P690, DOI 10.1096/fasebj.10.7.8635686; MCCAY PB, 1985, ANNU REV NUTR, V5, P323, DOI 10.1146/annurev.nu.05.070185.001543; Meydani SN, 2004, JAMA-J AM MED ASSOC, V292, P828, DOI 10.1001/jama.292.7.828; Michaud DS, 2000, AM J CLIN NUTR, V72, P990; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Milman N, 2004, ANN HEMATOL, V83, P423, DOI 10.1007/s00277-003-0830-y; Molldrem KL, 2004, AM J CLIN NUTR, V80, P131; Morris CD, 2003, ANN INTERN MED, V139, P56, DOI 10.7326/0003-4819-139-1-200307010-00014; Morris MC, 2005, ARCH NEUROL-CHICAGO, V62, P641, DOI 10.1001/archneur.62.4.641; Ness AR, 1997, INT J EPIDEMIOL, V26, P1, DOI 10.1093/ije/26.1.1; Odeberg JM, 2003, EUR J PHARM SCI, V19, P299, DOI 10.1016/S0928-0987(03)00135-0; Olmedilla B, 2002, CLIN SCI, V102, P447, DOI 10.1042/CS20010159; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Ordovas JM, 2004, ANNU REV GENOM HUM G, V5, P71, DOI 10.1146/annurev.genom.5.061903.180008; Osganian SK, 2003, J AM COLL CARDIOL, V42, P246, DOI 10.1016/S0735-1097(03)00575-8; Osganian SK, 2003, AM J CLIN NUTR, V77, P1390, DOI 10.1093/ajcn/77.6.1390; Pallast EG, 1999, AM J CLIN NUTR, V69, P1273; Pan MH, 2004, J CLIN INVEST, V113, P1277, DOI 10.1172/JCI200419197; PELLETIER DL, 1997, FAMILY EC NUTR REV, V10, P32; PETO R, 1981, NATURE, V290, P201, DOI 10.1038/290201a0; Rapola JM, 1997, LANCET, V349, P1715, DOI 10.1016/S0140-6736(97)01234-8; REAVEN PD, 1993, ARTERIOSCLER THROMB, V13, P590, DOI 10.1161/01.ATV.13.4.590; REINHOLD JG, 1974, J NUTR, V104, P976, DOI 10.1093/jn/104.8.976; RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004; Roodenburg AJC, 2000, AM J CLIN NUTR, V71, P1187; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Sanderson P, 2003, BRIT J NUTR, V90, P473, DOI 10.1079/BJN2003889; Schatzkin A, 2000, NEW ENGL J MED, V342, P1149, DOI 10.1056/NEJM200004203421601; Shekelle PG, 2004, J GEN INTERN MED, V19, P380, DOI 10.1111/j.1525-1497.2004.30090.x; Sies H, 1998, P SOC EXP BIOL MED, V218, P121, DOI 10.3181/00379727-218-44285a; SLESINSKI MJ, 1995, J AM DIET ASSOC, V95, P921, DOI 10.1016/S0002-8223(95)00255-3; SOLOMONS NW, 1982, J AM DIET ASSOC, V80, P115; STAHL W, 1992, J NUTR, V122, P2161, DOI 10.1093/jn/122.11.2161; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; Steinmetz KA, 1996, J AM DIET ASSOC, V96, P1027, DOI 10.1016/S0002-8223(96)00273-8; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; Strandhagen E, 2000, EUR J CLIN NUTR, V54, P337, DOI 10.1038/sj.ejcn.1600959; Tang G, 1999, AM J CLIN NUTR, V70, P1069; Teucher B, 2004, INT J VITAM NUTR RES, V74, P403, DOI 10.1024/0300-9831.74.6.403; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; US Department of Health and Human Services and USDA, 2005, DIET GUID AM 2005; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Virtamo J, 1998, ARCH INTERN MED, V158, P668, DOI 10.1001/archinte.158.6.668; Voutilainen S, 2004, AM J CLIN NUTR, V80, P317, DOI 10.1093/ajcn/80.2.317; Wang XD, 1999, J NATL CANCER I, V91, P60, DOI 10.1093/jnci/91.1.60; Willcox JK, 2003, CRIT REV FOOD SCI, V43, P1, DOI 10.1080/10408690390826437; Yeum KJ, 2004, ARCH BIOCHEM BIOPHYS, V430, P97, DOI 10.1016/j.abb.2004.03.006; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; YUZBASIYANGURKAN V, 1992, J LAB CLIN MED, V120, P380; Ziegler RG, 1996, CANCER CAUSE CONTROL, V7, P157, DOI 10.1007/BF00115646; 1983, MMWR MORB MORTAL WKL, V32, P305	124	74	79	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2005	294	3					351	358		10.1001/jama.294.3.351	http://dx.doi.org/10.1001/jama.294.3.351			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YL	16030280				2022-12-28	WOS:000230609100020
J	Moncrieff, J; Kirsch, I				Moncrieff, J; Kirsch, I			Efficacy of antidepressants in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DRUG-ADMINISTRATION DATABASE; RANDOMIZED CONTROLLED-TRIALS; SEROTONIN REUPTAKE INHIBITORS; SUICIDE RISK; CLINICAL-TRIALS; MAJOR DEPRESSION; SYMPTOM REDUCTION; UNITED-STATES; PLACEBO; METAANALYSIS		UCL, Dept Mental Hlth Sci, London W1N 8AA, England; Univ Plymouth, Sch Hlth & Social Work, Plymouth PL4 8AA, Devon, England	University of London; University College London; University of Plymouth	Moncrieff, J (corresponding author), UCL, Dept Mental Hlth Sci, Mortimer St, London W1N 8AA, England.	j.moncrieff@ucl.ac.uk	Kirsch, Irving/P-9316-2019					*AG HLTH CAR POL R, 1999, TREATM DEPR NEW PHAR; ANGST J, 1993, CLIN NEUROPHARMACOL, V16, pS55; Antonuccio DO, 1999, PSYCHOTHER PSYCHOSOM, V68, P3, DOI 10.1159/000012304; Bech P, 2000, BRIT J PSYCHIAT, V176, P421, DOI 10.1192/bjp.176.5.421; Bollini P, 1999, BRIT J PSYCHIAT, V174, P297, DOI 10.1192/bjp.174.4.297; BRUGHA TS, 1992, ACTA PSYCHIAT SCAND, V86, P5, DOI 10.1111/j.1600-0447.1992.tb03218.x; DRAPER BM, 2003, BMJ RAPID RESPONSES; ELKIN I, 1989, ARCH GEN PSYCHIAT, V46, P971; Fergusson D, 2005, BMJ-BRIT MED J, V330, P396, DOI 10.1136/bmj.330.7488.396; FOMBONNE E, 1994, ACTA PSYCHIAT SCAND, V90, P145, DOI 10.1111/j.1600-0447.1994.tb01571.x; Goldberg D, 1998, BRIT J GEN PRACT, V48, P1840; Greenberg R. P., 1997, PLACEBO PANACEA PUTT, P115; Grunebaum MF, 2004, J CLIN PSYCHIAT, V65, P1456, DOI 10.4088/JCP.v65n1103; Gunnell D, 2004, BRIT MED J, V329, P34, DOI 10.1136/bmj.329.7456.34; Gunnell D, 2005, BMJ-BRIT MED J, V330, P385, DOI 10.1136/bmj.330.7488.385; Hall WD, 2003, BRIT MED J, V326, P1008, DOI 10.1136/bmj.326.7397.1008; JOYCE PR, 1989, ARCH GEN PSYCHIAT, V46, P89; Khan A, 2003, AM J PSYCHIAT, V160, P790, DOI 10.1176/appi.ajp.160.4.790; Khan A, 2000, ARCH GEN PSYCHIAT, V57, P311, DOI 10.1001/archpsyc.57.4.311; Khan A, 2002, J CLIN PSYCHOPHARM, V22, P40, DOI 10.1097/00004714-200202000-00007; Khan A, 2001, INT J NEUROPSYCHOPH, V4, P113, DOI 10.1017/S1461145701002322; Kirsch I, 2003, COMPLEMENT THER MED, V11, P193, DOI 10.1016/S0965-2299(03)00109-2; KIRSCH I, 2002, PREV TREAT, P5; KUHN R, 1958, AM J PSYCHIAT, V115, P459, DOI 10.1176/ajp.115.5.459; *MED RES COUNC, 1965, BMJ-BRIT MED J, V1, P881; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Middleton H, 2005, BMJ-BRIT MED J, V330, P267, DOI 10.1136/bmj.330.7486.267; Moncrieff J, 2003, INT J METH PSYCH RES, V12, P117, DOI 10.1002/mpr.148; Moncrieff J, 2001, J NERV MENT DIS, V189, P288, DOI 10.1097/00005053-200105000-00003; MURPHY GE, 1980, ARCH GEN PSYCHIAT, V37, P519; *NAT I CLIN EXC, 2004, 23 NICE; PAYKEL ES, 1988, J AFFECT DISORDERS, V14, P83, DOI 10.1016/0165-0327(88)90075-4; RASKIN A, 1970, ARCH GEN PSYCHIAT, V23, P164; Ronalds G, 1997, BRIT J PSYCHIAT, V171, P427, DOI 10.1192/bjp.171.5.427; Storosum JG, 2001, AM J PSYCHIAT, V158, P1271, DOI 10.1176/appi.ajp.158.8.1271; Tuma TA, 2000, BRIT J PSYCHIAT, V176, P224, DOI 10.1192/bjp.176.3.224; WALSH D, 2004, BMJ RAPID RESPONSES	37	190	196	0	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 16	2005	331	7509					155	157		10.1136/bmj.331.7509.155	http://dx.doi.org/10.1136/bmj.331.7509.155			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	947GV	16020858	Green Submitted, Green Published			2022-12-28	WOS:000230632300022
J	Atwood, JA; Weatherly, DB; Minning, TA; Bundy, B; Cavola, C; Opperdoes, FR; Orlando, R; Tarleton, RL				Atwood, JA; Weatherly, DB; Minning, TA; Bundy, B; Cavola, C; Opperdoes, FR; Orlando, R; Tarleton, RL			The Trypanosoma cruzi proteome	SCIENCE			English	Article							GENE-EXPRESSION; RHODNIUS-PROLIXUS; DNA-MICROARRAY; LIFE-CYCLE; TRYPOMASTIGOTE; HISTIDINE; PROTEINS; BRUCEI; GENOME	To complement the sequencing of the three kinetoplastid genomes reported in this issue, we have undertaken a whole-organism, proteomic analysis of the four life-cycle stages of Trypanosoma cruzi. Peptides mapping to 2784 proteins in 1168 protein groups from the annotated T. cruzi genome were identified across the four life-cycte stages. Protein products were identified from >1000 genes annotated as "hypothetical" in the sequenced genome, including members of a newly defined gene family annotated, as mucin-associated surface proteins. The four parasite stages appear to use distinct energy sources, including histidine for stages present in the insect vectors and fatty acids by intracellular amastigotes.	Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; Catholic Univ Louvain, Brussels, Belgium; Christian de Duve Inst Cellular Pathol, Trop Dis Res Unit, Brussels, Belgium; Christian de Duve Inst Cellular Pathol, Biochem Lab, Brussels, Belgium	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Universite Catholique Louvain	Tarleton, RL (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.	tarleton@cb.uga.edu	Opperdoes, Fred/N-9922-2019; Tarleton, Rick/AES-8572-2022; Opperdoes, Frederik R/C-8897-2018	Opperdoes, Fred/0000-0003-1984-3764; Opperdoes, Frederik R/0000-0003-1984-3764; Tarleton, Rick/0000-0002-9589-5243	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044979] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI044979] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akopyants NS, 2001, MOL BIOCHEM PARASIT, V113, P337, DOI 10.1016/S0166-6851(01)00227-4; Almeida R, 2004, MOL BIOCHEM PARASIT, V136, P87, DOI 10.1016/j.molbiopara.2004.03.004; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Diehl S, 2002, MOL BIOCHEM PARASIT, V123, P115, DOI 10.1016/S0166-6851(02)00138-X; Duncan R, 2004, TRENDS PARASITOL, V20, P211, DOI 10.1016/j.pt.2004.02.008; ELSAYED NMA, 2005, SCIENCE, V309; EVANS DA, 1972, J PROTOZOOL, V19, P686, DOI 10.1111/j.1550-7408.1972.tb03561.x; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Frasch ACC, 2000, PARASITOL TODAY, V16, P282, DOI 10.1016/S0169-4758(00)01698-7; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; HARINGTON JS, 1961, PARASITOLOGY, V51, P309, DOI 10.1017/S0031182000070554; HARINGTON JS, 1956, NATURE, V178, P268, DOI 10.1038/178268a0; LOW HP, 1997, MOL BIOCHEM PARASIT, V160, P1817; Martin D, 2004, IMMUNOL REV, V201, P304, DOI 10.1111/j.0105-2896.2004.00183.x; Martinez-Calvillo S, 2003, MOL CELL, V11, P1291, DOI 10.1016/S1097-2765(03)00143-6; Minning TA, 2003, MOL BIOCHEM PARASIT, V131, P55, DOI 10.1016/S0166-6851(03)00189-0; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Resing KA, 2004, ANAL CHEM, V76, P3556, DOI 10.1021/ac035229m; TOMLINSON S, 1995, PARASITOLOGY, V110, P547, DOI 10.1017/S0031182000065264; Torres C, 2004, MOL MICROBIOL, V54, P632, DOI 10.1111/j.1365-2958.2004.04304.x; Vickery HB, 1942, J BIOL CHEM, V144, P719; Weatherly DB, 2005, MOL CELL PROTEOMICS, V4, P762, DOI 10.1074/mcp.M400215-MCP200; Wilkinson SR, 2002, P NATL ACAD SCI USA, V99, P13453, DOI 10.1073/pnas.202422899; Worthey EA, 2003, NUCLEIC ACIDS RES, V31, P4201, DOI 10.1093/nar/gkg469	24	323	335	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					473	476		10.1126/science.1110289	http://dx.doi.org/10.1126/science.1110289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020736				2022-12-28	WOS:000230574900049
J	Ivens, AC; Peacock, CS; Worthey, EA; Murphy, L; Aggarwal, G; Berriman, M; Sisk, E; Rajandream, MA; Adlem, E; Aert, R; Anupama, A; Apostolou, Z; Attipoe, P; Bason, N; Bauser, C; Beck, A; Beverley, SM; Bianchettin, G; Borzym, K; Bothe, G; Bruschi, CV; Collins, M; Cadag, E; Ciarloni, L; Clayton, C; Coulson, RMR; Cronin, A; Cruz, AK; Davies, RM; De Gaudenzi, J; Dobson, DE; Duesterhoeft, A; Fazelina, G; Fosker, N; Frasch, AC; Fraser, A; Fuchs, M; Gabel, C; Goble, A; Goffeau, A; Harris, D; Hertz-Fowler, C; Hilbert, H; Horn, D; Huang, YT; Klages, S; Knights, A; Kube, M; Larke, N; Litvin, L; Lord, A; Louie, T; Marra, M; Masuy, D; Matthews, K; Michaeli, S; Mottram, JC; Muller-Auer, S; Munden, H; Nelson, S; Norbertczak, H; Oliver, K; O'Neil, S; Pentony, M; Pohl, TM; Price, C; Purnelle, B; Quail, MA; Rabbinowitsch, E; Reinhardt, R; Rieger, M; Rinta, J; Robben, J; Robertson, L; Ruiz, JC; Rutter, S; Saunders, D; Schafer, M; Schein, J; Schwartz, DC; Seeger, K; Seyler, A; Sharp, S; Shin, H; Sivam, D; Squares, R; Squares, S; Tosato, V; Vogt, C; Volckaert, G; Wambutt, R; Warren, T; Wedler, H; Woodward, J; Zhou, SG; Zimmermann, W; Smith, DF; Blackwell, JM; Stuart, KD; Barrell, B; Myler, PJ				Ivens, AC; Peacock, CS; Worthey, EA; Murphy, L; Aggarwal, G; Berriman, M; Sisk, E; Rajandream, MA; Adlem, E; Aert, R; Anupama, A; Apostolou, Z; Attipoe, P; Bason, N; Bauser, C; Beck, A; Beverley, SM; Bianchettin, G; Borzym, K; Bothe, G; Bruschi, CV; Collins, M; Cadag, E; Ciarloni, L; Clayton, C; Coulson, RMR; Cronin, A; Cruz, AK; Davies, RM; De Gaudenzi, J; Dobson, DE; Duesterhoeft, A; Fazelina, G; Fosker, N; Frasch, AC; Fraser, A; Fuchs, M; Gabel, C; Goble, A; Goffeau, A; Harris, D; Hertz-Fowler, C; Hilbert, H; Horn, D; Huang, YT; Klages, S; Knights, A; Kube, M; Larke, N; Litvin, L; Lord, A; Louie, T; Marra, M; Masuy, D; Matthews, K; Michaeli, S; Mottram, JC; Muller-Auer, S; Munden, H; Nelson, S; Norbertczak, H; Oliver, K; O'Neil, S; Pentony, M; Pohl, TM; Price, C; Purnelle, B; Quail, MA; Rabbinowitsch, E; Reinhardt, R; Rieger, M; Rinta, J; Robben, J; Robertson, L; Ruiz, JC; Rutter, S; Saunders, D; Schafer, M; Schein, J; Schwartz, DC; Seeger, K; Seyler, A; Sharp, S; Shin, H; Sivam, D; Squares, R; Squares, S; Tosato, V; Vogt, C; Volckaert, G; Wambutt, R; Warren, T; Wedler, H; Woodward, J; Zhou, SG; Zimmermann, W; Smith, DF; Blackwell, JM; Stuart, KD; Barrell, B; Myler, PJ			The genome of the kinetoplastid parasite, Leishmania major	SCIENCE			English	Article							FAMILY ENCODING AMASTIN; PRE-MESSENGER-RNA; TRYPANOSOMA-BRUCEI; FRIEDLIN CHROMOSOME-1; AFRICAN TRYPANOSOME; GENE; TRANSCRIPTION; CRUZI; DIFFERENTIATION; SEQUENCE	Leishmania species cause a spectrum of human diseases in tropical and subtropical regions of the world. We have sequenced the 36 chromosomes of the 32.8-megabase haploid genome of Leishmania major (Friedlin strain) and predict 911 RNA genes, 39 pseudogenes, and 8272 protein-coding genes, of which 36% can be ascribed a putative function. These include genes involved in host-pathogen interactions, such as proteolytic enzymes, and extensive machinery for synthesis of complex surface glycoconjugates. The organization of protein-coding genes into long strand-specific, polycistronic clusters and lack of general transcription factors in the L. major, Trypanosoma brucei, and Trypanosoma cruzi (Tritryp) genomes suggest that the mechanisms regulating RNA polymerase II-directed transcription are distinct from those operating in other eukaryotes, although the trypanosomatids appear capable of chromatin remodeling. Abundant RNA-binding proteins are encoded in the Tritryp genomes, consistent with active posttranscriptional regulation of gene expression.	Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; Seattle Biomed Res Inst, Seattle, WA 98109 USA; Katholieke Univ Leuven, Lab Gene Technol, B-3001 Louvain, Belgium; GENOTYPE GmbH, D-69259 Wilhelmsfeld, Germany; GATC Biotech AG, D-78467 Constance, Germany; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Univ Trieste, Dept Biol, Genom Grp, Genet Lab, I-34148 Trieste, Italy; Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; Zentrum Mol Biol, D-69120 Heidelberg, Germany; European Mol Biol Lab, European Bioinformat Inst, Cambridge CB10 1SD, England; Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, BR-14049900 Ribeirao Preto, SP, Brazil; Univ San Martin, Inst Invest Biotecnol, INTECH, RA-1650 Buenos Aires, DF, Argentina; Consejo Nacl Invest Cient & Tecn, Natl Res Council, RA-1650 Buenos Aires, DF, Argentina; QIAGEN GmbH, D-40724 Hilden, Germany; Catholic Univ Louvain, Inst Sci Vie, Unite Biochim Physiol, B-1348 Louvain, Belgium; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; British Columbia Canc Agcy, Genome Sci Ctr, Genome Sequence Ctr, Vancouver, BC V5Z 4E6, Canada; Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh EH9 3JT, Midlothian, Scotland; Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel; Univ Glasgow, Wellcome Ctr Mol Parasitol, Glasgow G11 6NU, Lanark, Scotland; Univ Wisconsin, UW Biotechnol Ctr, Lab Mol & Computat Genom, Madison, WI 53706 USA; Agowa GmbH, D-12489 Berlin, Germany; Univ York, Dept Biol, Immunol & Infect Unit, York YO10 5YW, N Yorkshire, England; Cambridge Inst Med Res, Cambridge CB2 2XY, England; Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA; Univ Washington, Dept Biomed & Hlth Informat, Seattle, WA 98195 USA	Wellcome Trust Sanger Institute; Center for Infectious Disease Research; KU Leuven; Max Planck Society; Washington University (WUSTL); University of Trieste; International Center for Genetic Engineering & Biotechnology (ICGEB); Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Universidade de Sao Paulo; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); QIAGEN GmbH; Universite Catholique Louvain; University of London; London School of Hygiene & Tropical Medicine; British Columbia Cancer Agency; University of Edinburgh; Bar Ilan University; University of Glasgow; University of Wisconsin System; University of Wisconsin Madison; University of York - UK; University of Cambridge; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ivens, AC (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	aticat@sanger.ac.uk; peter.myler@sbri.org	Zhou, Shiguo/B-3832-2011; Quail, michael/ABE-6131-2020; Myler, Peter John/AAR-9535-2021; Michaeli, Shulamit/AAC-8255-2022; Ruiz, Jeronimo/D-2511-2011; Clayton, Christine/K-7700-2019; Berriman, Matthew/A-7618-2011; Blackwell, Jenefer M/H-3015-2015; Peacock, Christopher/A-4052-2012; Marra, Marco A/B-5987-2008; Schein, Jacquie E/G-3674-2015; Cruz, Angela Kaysel/N-8445-2014	Zhou, Shiguo/0000-0001-7421-2506; Berriman, Matthew/0000-0002-9581-0377; Marra, Marco A/0000-0001-7146-7175; Cruz, Angela Kaysel/0000-0002-4260-4713; Schofield, Ellen/0000-0003-0648-1418; Ciarloni, Laura/0000-0003-4185-016X; Reinhardt, Richard/0000-0001-9376-2132; Frasch, Alberto Carlos/0000-0001-7532-653X; Myler, Peter/0000-0002-0056-0513; Davies, Robert/0000-0002-9983-1378; Ivens, Al/0000-0002-0112-3876; Matthews FRS FMedSci FRSE, Professor Keith/0000-0003-0309-9184; Hertz-Fowler, Christiane/0000-0002-0729-6479; Beverley, Stephen/0000-0001-5319-0811; Clayton, Christine/0000-0002-6384-0731; Horn, David/0000-0001-5173-9284; /0000-0002-1361-9721; Mottram, Jeremy/0000-0001-5574-3766; Murphy, Lee/0000-0001-6467-7449	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI040599, R01AI040599, R01AI053667] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI053667, R01 AI040599] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission)		ALEXANDER J, 1992, ADV PARASIT, V31, P175, DOI 10.1016/S0065-308X(08)60022-6; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Besteiro S, 2004, MOL MICROBIOL, V54, P1224, DOI 10.1111/j.1365-2958.2004.04355.x; Britto C, 1998, GENE, V222, P107, DOI 10.1016/S0378-1119(98)00472-7; Burleigh BA, 2002, CELL MICROBIOL, V4, P701, DOI 10.1046/j.1462-5822.2002.00226.x; Chiurillo MA, 2000, EXP PARASITOL, V94, P248, DOI 10.1006/expr.2000.4499; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Couvreur B, 2002, MOL BIOL EVOL, V19, P2110, DOI 10.1093/oxfordjournals.molbev.a004036; Denny PW, 2004, MOL MICROBIOL, V52, P313, DOI 10.1111/j.1365-2958.2003.03975.x; Dobson DE, 2003, J BIOL CHEM, V278, P15523, DOI 10.1074/jbc.M301568200; DOBSON DE, UNPUB; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; El-Sayed NMA, 2003, NUCLEIC ACIDS RES, V31, P4856, DOI 10.1093/nar/gkg673; Estevez AM, 2001, EMBO J, V20, P3831, DOI 10.1093/emboj/20.14.3831; EVERS R, 1989, CELL, V56, P585, DOI 10.1016/0092-8674(89)90581-3; Falcone FH, 2001, J IMMUNOL, V167, P5348, DOI 10.4049/jimmunol.167.9.5348; Garami A, 2001, EMBO J, V20, P3657, DOI 10.1093/emboj/20.14.3657; Geiduschek EP, 2000, NAT STRUCT BIOL, V7, P437, DOI 10.1038/75820; Hall N, 2003, NUCLEIC ACIDS RES, V31, P4864, DOI 10.1093/nar/gkg674; Huang Y, 2001, NUCLEIC ACIDS RES, V29, P2675, DOI 10.1093/nar/29.13.2675; Ingram AK, 2002, MOL MICROBIOL, V45, P89, DOI 10.1046/j.1365-2958.2002.03018.x; Juttner S, 1998, J IMMUNOL, V161, P2383; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; Liu L, 2003, J BIOL CHEM, V278, P18271, DOI 10.1074/jbc.M209215200; Mair G, 2000, RNA, V6, P163, DOI 10.1017/S135583820099229X; Martinez-Calvillo S, 2003, MOL CELL, V11, P1291, DOI 10.1016/S1097-2765(03)00143-6; Martinez-Calvillo S, 2004, EUKARYOT CELL, V3, P506, DOI 10.1128/EC.3.2.506-517.2004; MATTHEWS KR, 1994, GENE DEV, V8, P491, DOI 10.1101/gad.8.4.491; Myler PJ, 1999, P NATL ACAD SCI USA, V96, P2902, DOI 10.1073/pnas.96.6.2902; Numata O, 2000, J BIOCHEM, V127, P51, DOI 10.1093/oxfordjournals.jbchem.a022583; Obado SO, 2005, GENOME RES, V15, P36, DOI 10.1101/gr.2895105; Ravel C, 1999, NUCLEIC ACIDS RES, V27, P2473, DOI 10.1093/nar/27.12.2473; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Rochette A, 2005, MOL BIOCHEM PARASIT, V140, P205, DOI 10.1016/j.molbiopara.2005.01.006; Ruan JP, 2004, MOL CELL BIOL, V24, P9610, DOI 10.1128/MCB.24.21.9610-9618.2004; Santos CC, 2005, J CELL SCI, V118, P901, DOI 10.1242/jcs.01677; Sunkin SM, 2000, MOL BIOCHEM PARASIT, V109, P1, DOI 10.1016/S0166-6851(00)00215-2; TEIXEIRA SMR, 1994, J BIOL CHEM, V269, P20509; Tosato V, 2001, CURR GENET, V40, P186, DOI 10.1007/s002940100246; ULLU E, COMMUNICATION; van Leeuwen F, 2003, CELL, V112, P591, DOI 10.1016/S0092-8674(03)00152-1; Vickers TJ, 2004, J BIOL CHEM, V279, P49003, DOI 10.1074/jbc.M407958200; Wang CC, 2003, J BIOL CHEM, V278, P15800, DOI 10.1074/jbc.M300195200; *WHO TDR, SPEC PROGR RES TRAIN; Wincker P, 1996, NUCLEIC ACIDS RES, V24, P1688, DOI 10.1093/nar/24.9.1688; Worthey EA, 2003, NUCLEIC ACIDS RES, V31, P4201, DOI 10.1093/nar/gkg469; Yao CQ, 2003, MOL BIOCHEM PARASIT, V132, P1, DOI 10.1016/S0166-6851(03)00211-1; Zangger H, 2002, CELL DEATH DIFFER, V9, P1126, DOI 10.1038/sj.cdd.4401071; Zhang K, 2005, MOL MICROBIOL, V55, P1566, DOI 10.1111/j.1365-2958.2005.04493.x; Zhou SG, 2004, MOL BIOCHEM PARASIT, V138, P97, DOI 10.1016/j.molbiopara.2004.08.002; Zurita M, 2003, TRENDS GENET, V19, P578, DOI 10.1016/j.tig.2003.08.005	52	1078	1170	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					436	442		10.1126/science.1112680	http://dx.doi.org/10.1126/science.1112680			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020728	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000230574900038
J	Caro, G; Bourdon, B; Wood, BJ; Corgne, A				Caro, G; Bourdon, B; Wood, BJ; Corgne, A			Trace-element fractionation in Hadean mantle generated by melt segregation from a magma ocean	NATURE			English	Article							LU-HF; EARLY DIFFERENTIATION; EARTHS MANTLE; EVOLUTION; GPA; CONSTRAINTS; SYSTEMATICS; CHONDRITES; PERIDOTITE; CRUST	Calculations of the energetics of terrestrial accretion indicate that the Earth was extensively molten in its early history(1). Examination of early Archaean rocks from West Greenland (3.6 - 3.8 Gyr old) using short-lived Sm-146 - Nd-142 chronometry indicates that an episode of mantle differentiation took place close to the end of accretion (4.46 +/- 0.11 Gyr ago)(2-4). This has produced a chemically depleted mantle with an Sm/Nd ratio higher than the chondritic value. In contrast, application of Lu-176 - Hf-176 systematics to 3.6 - 3.8-Gyr-old zircons from West Greenland indicates derivation from a mantle source with a chondritic Lu/Hf ratio(5-7). Although an early Sm/Nd fractionation could be explained by basaltic crust formation(8), magma ocean crystallization(2) or formation of continental crust, the absence of coeval Lu/Hf fractionation is in sharp contrast with the well-known covariant behaviour of Sm/Nd and Lu/Hf ratios in crustal formation processes(5). Here we show using mineral - melt partitioning data for high-pressure mantle minerals that the observed Nd and Hf signatures could have been produced by segregation of melt from a crystallizing magma ocean at upper-mantle pressures early in Earth's history. This residual melt would have risen buoyantly and ultimately formed the earliest terrestrial protocrust.	CNRS, IPGP, Lab Geochim & Cosmochim, F-75252 Paris, France; Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; Carnegie Inst Washington, Geophys Lab, Washington, DC 20015 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Bristol; Carnegie Institution for Science	Caro, G (corresponding author), CNRS, IPGP, Lab Geochim & Cosmochim, 4 Pl Jussieu, F-75252 Paris, France.	caro@ipgp.jussieu.fr	Corgne, Alexandre/C-6115-2009; Wood, Bernard J/E-8173-2010; Corgne, Alexandre/AAB-5961-2021; Bourdon, Bernard/A-3303-2008	Wood, Bernard J/0000-0003-1038-7301; Corgne, Alexandre/0000-0001-9640-6977; 				Abe Y, 1997, PHYS EARTH PLANET IN, V100, P27, DOI 10.1016/S0031-9201(96)03229-3; Amelin Y, 2000, GEOCHIM COSMOCHIM AC, V64, P4205, DOI 10.1016/S0016-7037(00)00493-2; Bizzarro M, 2003, NATURE, V421, P931, DOI 10.1038/nature01421; BlichertToft J, 1997, EARTH PLANET SC LETT, V148, P243, DOI 10.1016/S0012-821X(97)00040-X; Caro G, 2003, NATURE, V423, P428, DOI 10.1038/nature01668; CARO G, UNPUB GEOCHIM COSMOC; CHASE CG, 1988, EARTH PLANET SC LETT, V91, P66, DOI 10.1016/0012-821X(88)90151-3; Corgne A, 2005, GEOCHIM COSMOCHIM AC, V69, P485, DOI 10.1016/j.gca.2004.06.041; Corgne A, 2004, PHYS EARTH PLANET IN, V143, P407, DOI 10.1016/j.pepi.2003.08.012; Corgne A, 2005, CONTRIB MINERAL PETR, V149, P85, DOI 10.1007/s00410-004-0638-3; Draper DS, 2003, PHYS EARTH PLANET IN, V139, P149, DOI 10.1016/S0031-9201(03)00150-X; HARPER CL, 1992, NATURE, V360, P728, DOI 10.1038/360728a0; Hirose K, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000597; Ito E, 2004, PHYS EARTH PLANET IN, V143, P397, DOI 10.1016/j.pepi.2003.09.016; KATO T, 1988, EARTH PLANET SC LETT, V89, P123, DOI 10.1016/0012-821X(88)90038-6; Kesson SE, 1998, NATURE, V393, P252, DOI 10.1038/30466; Patchett PJ, 2004, EARTH PLANET SC LETT, V222, P29, DOI 10.1016/j.epsl.2004.02.030; Ringwood A. E., 1970, PHYS EARTH PLANET IN, V3, P109, DOI DOI 10.1016/0031-9201(70)90047-6; Salters VJM, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000597; Salters VJM, 1999, EARTH PLANET SC LETT, V166, P15, DOI 10.1016/S0012-821X(98)00271-4; Scherer E, 2001, SCIENCE, V293, P683, DOI 10.1126/science.1061372; Soderlund U, 2004, EARTH PLANET SC LETT, V219, P311, DOI 10.1016/S0012-821X(04)00012-3; SOLOMATOV VS, 1993, J GEOPHYS RES-PLANET, V98, P5391, DOI 10.1029/92JE02579; TONKS WB, 1993, J GEOPHYS RES-PLANET, V98, P5319, DOI 10.1029/92JE02726; Tronnes RG, 2002, EARTH PLANET SC LETT, V197, P117, DOI 10.1016/S0012-821X(02)00466-1; Vervoort JD, 1999, GEOCHIM COSMOCHIM AC, V63, P533, DOI 10.1016/S0016-7037(98)00274-9; Walter MJ, 2004, GEOCHIM COSMOCHIM AC, V68, P4267, DOI 10.1016/j.gca.2004.03.014; Wood BJ, 2000, EARTH PLANET SC LETT, V174, P341, DOI 10.1016/S0012-821X(99)00273-3; ZHANG JZ, 1994, J GEOPHYS RES-SOL EA, V99, P17729, DOI 10.1029/94JB01406	29	98	99	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2005	436	7048					246	249		10.1038/nature03827	http://dx.doi.org/10.1038/nature03827			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015327				2022-12-28	WOS:000230459500038
J	Habif, TP				Habif, TP			Pseudomonas cellulitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Dartmouth Coll, Sch Med, Hanover, NH 03755 USA	Dartmouth College	Habif, TP (corresponding author), Dartmouth Coll, Sch Med, Hanover, NH 03755 USA.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2005	353	2					E2	E2		10.1056/NEJMicm040605	http://dx.doi.org/10.1056/NEJMicm040605			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944OP	16014878				2022-12-28	WOS:000230438800011
J	Zuo, Y; Yang, G; Kwon, E; Gan, WB				Zuo, Y; Yang, G; Kwon, E; Gan, WB			Long-term sensory deprivation prevents dendritic spine loss in primary somatosensory cortex	NATURE			English	Article							VISUAL-CORTEX; NMDA RECEPTOR; CEREBRAL-CORTEX; SYNAPTIC PLASTICITY; OCULAR DOMINANCE; DIVERSE REGIONS; ADULT CORTEX; SYNAPSES; SYNAPTOGENESIS; POTENTIATION	A substantial decrease in the number of synapses occurs in the mammalian brain from the late postnatal period until the end of life(1-5). Although experience plays an important role in modifying synaptic connectivity(6-17), its effect on this nearly lifelong synapse loss remains unknown. Here we used transcranial two-photon microscopy to visualize postsynaptic dendritic spines in layer I of the barrel cortex in transgenic mice expressing yellow fluorescent protein. We show that in young adolescent mice, long-term sensory deprivation through whisker trimming prevents net spine loss by preferentially reducing the rate of ongoing spine elimination, not by increasing the rate of spine formation. This effect of deprivation diminishes as animals mature but still persists in adulthood. Restoring sensory experience after adolescent deprivation accelerates spine elimination. Similar to sensory manipulation, the rate of spine elimination decreases after chronic blockade of NMDA (N-methyl-D-aspartate) receptors with the antagonist MK801, and accelerates after drug withdrawal. These studies of spine dynamics in the primary somatosensory cortex suggest that experience plays an important role in the net loss of synapses over most of an animal's lifespan, particularly during adolescence.	NYU, Sch Med, Skirball Inst,Dept Physiol & Neurosci, Mol Neurobiol Program, New York, NY 10016 USA	New York University	Zuo, Y (corresponding author), NYU, Sch Med, Skirball Inst,Dept Physiol & Neurosci, Mol Neurobiol Program, 540 1st Ave, New York, NY 10016 USA.			Yang, Guang/0000-0002-5739-9126; Zuo, Yi/0000-0001-9020-0003				BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; Bock J, 1999, P NATL ACAD SCI USA, V96, P2485, DOI 10.1073/pnas.96.5.2485; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CHANGEUX JP, 1976, NATURE, V264, P705, DOI 10.1038/264705a0; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Grossman AW, 2002, PROG BRAIN RES, V138, P91, DOI 10.1016/S0079-6123(02)38073-7; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; MARKUS EJ, 1987, EXP NEUROL, V96, P262, DOI 10.1016/0014-4886(87)90045-8; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MICHEVA KD, 1995, P NATL ACAD SCI USA, V92, P11834, DOI 10.1073/pnas.92.25.11834; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Sadaka Y, 2003, J COMP NEUROL, V457, P75, DOI 10.1002/cne.10518; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; VALVERDE F, 1971, BRAIN RES, V33, P1, DOI 10.1016/0006-8993(71)90302-7; Winkelmann E, 1977, J Hirnforsch, V18, P21; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	30	326	333	3	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2005	436	7048					261	265		10.1038/nature03715	http://dx.doi.org/10.1038/nature03715			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015331				2022-12-28	WOS:000230459500042
J	McNamee, D				McNamee, D			What's maths got to do with it?	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		McNamee, D (corresponding author), The Lancet, London NW1 7BY, England.							*MANCH I MATH SCI, 2005, NEXT GENERATION UK M; TURNER R, 2005, W MAIL          0702	2	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 9	2005	366	9480					108	108		10.1016/S0140-6736(05)66847-X	http://dx.doi.org/10.1016/S0140-6736(05)66847-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	943JH	16005319				2022-12-28	WOS:000230349200011
J	Cardillo, M; Mace, GM; Jones, KE; Bielby, J; Bininda-Emonds, ORP; Sechrest, W; Orme, CDL; Purvis, A				Cardillo, M; Mace, GM; Jones, KE; Bielby, J; Bininda-Emonds, ORP; Sechrest, W; Orme, CDL; Purvis, A			Multiple causes of high extinction risk in large mammal species	SCIENCE			English	Article							BODY-SIZE; CONSERVATION BIOLOGY; POPULATION-DENSITY; SELECTIVITY; HISTORY; LIFE	Many large animal species have a high risk of extinction. This is usually thought to result simply from the way that species traits associated with vulnerability, such as low reproductive rates, scale with body size. In a broad-scale analysis of extinction risk in mammals, we find two additional patterns in the size selectivity of extinction risk. First, impacts of both intrinsic and environmental factors increase sharply above a threshold body mass around 3 kilograms. Second, whereas extinction risk in smaller species is driven by environmental factors, in larger species it is driven by a combination of environmental factors and intrinsic traits. Thus, the disadvantages of large size are greater than generally recognized, and future loss of large mammal biodiversity could be far more rapid than expected.	Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot SL5 7PY, Berks, England; Zool Soc London, Inst Zool, London NW1 4RY, England; Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; Tech Univ Munich, Lehrstuhl Tierzucht, D-85354 Freising Weihenstephan, Germany	Imperial College London; Zoological Society of London; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Virginia; Technical University of Munich	Cardillo, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biol, Silwood Pk, Ascot SL5 7PY, Berks, England.	m.cardillo@imperial.ac.uk	Cardillo, Marcel/C-9396-2009; Purvis, Andy/A-7529-2008; Mace, Georgina M/I-3072-2016; Bielby, Jon/D-5051-2011; Jones, Kate/Y-3317-2019; Bininda-Emonds, Olaf/P-6718-2019; Bininda-Emonds, Olaf R.P:/C-5405-2008; Jones, Kate E/G-4768-2010	Cardillo, Marcel/0000-0001-9855-0817; Purvis, Andy/0000-0002-8609-6204; Mace, Georgina M/0000-0001-8965-5211; Jones, Kate/0000-0001-5231-3293; Bininda-Emonds, Olaf R.P:/0000-0003-4432-224X; Jones, Kate E/0000-0001-5231-3293; Bielby, Jon/0000-0003-4586-0429	Natural Environment Research Council [NE/B503492/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Balmford A, 1996, TRENDS ECOL EVOL, V11, P193, DOI 10.1016/0169-5347(96)10026-4; Bennett PM, 1997, P ROY SOC B-BIOL SCI, V264, P401, DOI 10.1098/rspb.1997.0057; Bodmer RE, 1997, CONSERV BIOL, V11, P460, DOI 10.1046/j.1523-1739.1997.96022.x; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Cardillo M, 2001, CONSERV BIOL, V15, P1435, DOI 10.1046/j.1523-1739.2001.00286.x; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; FENSCHEL T, 1974, OECOLOGIA, V14, P317; Fisher DO, 2004, TRENDS ECOL EVOL, V19, P391, DOI 10.1016/j.tree.2004.05.004; *IUCN, 2003, IUCN RED LIST THREAT; Jernvall J, 1998, P NATL ACAD SCI USA, V95, P11279, DOI 10.1073/pnas.95.19.11279; Jerozolimski A, 2003, BIOL CONSERV, V111, P415, DOI 10.1016/S0006-3207(02)00310-5; Johnson CN, 2002, P ROY SOC B-BIOL SCI, V269, P2221, DOI 10.1098/rspb.2002.2130; Jones KE, 2003, AM NAT, V161, P601, DOI 10.1086/368289; Lawton John H., 1995, P147; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; Martin P. S., 1967, P75; McKinney ML, 1998, ANIM CONSERV, V1, P159, DOI 10.1111/j.1469-1795.1998.tb00024.x; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; Peres CA, 2001, CONSERV BIOL, V15, P1490, DOI 10.1046/j.1523-1739.2001.01089.x; Pimm S.L., 1991, BALANCE NATURE; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Raup D.M., 1993, EXTINCTION BAD GENES; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126	27	814	847	14	398	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 19	2005	309	5738					1239	1241		10.1126/science.1116030	http://dx.doi.org/10.1126/science.1116030			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957TE	16037416	Green Submitted			2022-12-28	WOS:000231395400045
J	Carette, S; Fehlings, MG				Carette, S; Fehlings, MG			Cervical radiculopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DORSAL-ROOT-GANGLIA; NERVE ROOT; RADICULAR PAIN; INTERVERTEBRAL DISC; NITRIC-OXIDE; MATRIX METALLOPROTEINASES; NONOPERATIVE MANAGEMENT; CONSERVATIVE TREATMENT; CLINICAL-EVALUATION; NECK PAIN		Univ Hlth Network, Toronto Western Hosp, Div Rheumatol, Toronto, ON M5T 2A8, Canada; Univ Hlth Network, Toronto Western Hosp, Div Neurosurg, Toronto, ON M5T 2A8, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Dept Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Carette, S (corresponding author), Univ Hlth Network, Toronto Western Hosp, Div Rheumatol, EW1-422,399 Bathurst St, Toronto, ON M5T 2A8, Canada.	simon.carette@uhn.on.ca		Fehlings, Michael/0000-0002-5722-6364				Bigos S.J., 1994, AHPCR PUBLICATION; Bogduk Nikolai, 2003, Phys Med Rehabil Clin N Am, V14, P455, DOI 10.1016/S1047-9651(03)00041-X; BROWN BM, 1988, AM J ROENTGENOL, V151, P1205, DOI 10.2214/ajr.151.6.1205; Bush K, 1997, SPINE, V22, P183, DOI 10.1097/00007632-199701150-00009; Bush K, 1996, Eur Spine J, V5, P319, DOI 10.1007/BF00304347; Casha S, 2003, J NEUROSURG, V99, P264, DOI 10.3171/spi.2003.99.3.0264; CICALA RS, 1989, CLIN J PAIN, V5, P143, DOI 10.1097/00002508-198906000-00003; Colachis S C Jr, 1965, Arch Phys Med Rehabil, V46, P815; Cruz-Martinez A, 2002, J PERIPHER NERV SYST, V7, P198, DOI 10.1046/j.1529-8027.2002.02025.x; DAVIDSON RI, 1981, SPINE, V6, P441, DOI 10.1097/00007632-198109000-00004; DWYER A, 1990, SPINE, V15, P453; Edwards CC, 2002, SPINE, V27, P1168, DOI 10.1097/00007632-200206010-00007; Fouyas IP, 2002, SPINE, V27, P736, DOI 10.1097/00007632-200204010-00011; Furusawa N, 2001, SPINE, V26, P1110, DOI 10.1097/00007632-200105150-00004; Grubb SA, 2000, SPINE, V25, P1382, DOI 10.1097/00007632-200006010-00010; Hacker RJ, 2000, SPINE, V25, P2646, DOI 10.1097/00007632-200010150-00017; Han Jay J, 2003, Phys Med Rehabil Clin N Am, V14, P549, DOI 10.1016/S1047-9651(03)00036-6; Heckmann JG, 1999, J SPINAL DISORD, V12, P396; Honet Joseph C, 2003, Phys Med Rehabil Clin N Am, V14, P473, DOI 10.1016/S1047-9651(03)00039-1; HOWE JF, 1977, PAIN, V3, P25, DOI 10.1016/0304-3959(77)90033-1; Kadanka Z, 2000, EUR SPINE J, V9, P538, DOI 10.1007/s005860000132; KANG JD, 1995, SPINE, V20, P2373, DOI 10.1097/00007632-199511001-00001; Kang JD, 1997, SPINE, V22, P1065, DOI 10.1097/00007632-199705150-00003; Lafuente J, 2005, J BONE JOINT SURG BR, V87B, P508, DOI 10.1302/0301-620X.87B4; LARSSON EM, 1989, ACTA RADIOL, V30, P233; MAIGNE JY, 1994, SPINE, V19, P189, DOI 10.1097/00007632-199401001-00013; Matsumoto M, 2001, SPINE, V26, P1592, DOI 10.1097/00007632-200107150-00021; Mink Jerrold H, 2003, Phys Med Rehabil Clin N Am, V14, P493, DOI 10.1016/S1047-9651(03)00035-4; Misamore GW, 1996, J BONE JOINT SURG AM, V78A, P1405, DOI 10.2106/00004623-199609000-00018; Miyamoto H, 2002, SPINE, V27, P2477, DOI 10.1097/00007632-200211150-00011; Mochida K, 1998, SPINE, V23, P990, DOI 10.1097/00007632-199805010-00005; MODIC MT, 1986, RADIOLOGY, V161, P753, DOI 10.1148/radiology.161.3.3786728; Persson LCG, 1997, SPINE, V22, P751, DOI 10.1097/00007632-199704010-00007; PYHTINEN J, 1993, NEURORADIOLOGY, V35, P596, DOI 10.1007/BF00588403; RADHAKRISHNAN K, 1994, BRAIN, V117, P325, DOI 10.1093/brain/117.2.325; Rao R, 2002, J BONE JOINT SURG AM, V84A, P1872, DOI 10.2106/00004623-200210000-00021; Rathmell JP, 2004, ANESTHESIOLOGY, V100, P1595, DOI 10.1097/00000542-200406000-00035; Redford JB, 1995, PHYS MED REHABIL, V9, P709; Saal JS, 1996, SPINE, V21, P1877, DOI 10.1097/00007632-199608150-00008; Salemi G, 1996, ACTA NEUROL SCAND, V93, P184; Sampath P, 1999, SPINE, V24, P591, DOI 10.1097/00007632-199903150-00021; SCOTTI G, 1983, AM J NEURORADIOL, V4, P601; Shelerud Randy A, 2002, Phys Med Rehabil Clin N Am, V13, P645, DOI 10.1016/S1047-9651(02)00012-8; Slipman CW, 2000, ARCH PHYS MED REHAB, V81, P741, DOI 10.1016/S0003-9993(00)90104-7; Slipman CW, 1998, SPINE, V23, P2235, DOI 10.1097/00007632-199810150-00019; Song XJ, 1999, J NEUROPHYSIOL, V82, P3347, DOI 10.1152/jn.1999.82.6.3347; Spurling RG, 1944, SURG GYNECOL OBSTET, V78, P350; Sugawara O, 1996, SPINE, V21, P2089, DOI 10.1097/00007632-199609150-00006; Swezey RL, 1999, AM J PHYS MED REHAB, V78, P30, DOI 10.1097/00002060-199901000-00008; TERESI LM, 1987, RADIOLOGY, V164, P83, DOI 10.1148/radiology.164.1.3588931; Vallee JN, 2001, RADIOLOGY, V218, P886, DOI 10.1148/radiology.218.3.r01mr17886; VANDERHEIJDEN GJMG, 1995, PHYS THER, V75, P93, DOI 10.1093/ptj/75.2.93; Wainner RS, 2003, SPINE, V28, P52, DOI 10.1097/00007632-200301010-00014; Wainner RS, 2000, J ORTHOP SPORT PHYS, V30, P728; Wolff Michael W, 2002, Phys Med Rehabil Clin N Am, V13, P589, DOI 10.1016/S1047-9651(02)00008-6	55	219	226	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2005	353	4					392	399		10.1056/NEJMcp043887	http://dx.doi.org/10.1056/NEJMcp043887			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949JW	16049211				2022-12-28	WOS:000230782800012
J	Mandavilli, A				Mandavilli, A			India	NATURE			English	Editorial Material																			0	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2005	436	7050					477	477		10.1038/436477a	http://dx.doi.org/10.1038/436477a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049467				2022-12-28	WOS:000230788800036
J	Didkowska, J; Manczuk, M; McNeill, A; Powles, J; Zatonski, W				Didkowska, J; Manczuk, M; McNeill, A; Powles, J; Zatonski, W			Lung cancer mortality at ages 35-54 in the European Union: ecological study of evolving tobacco epidemics	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Ctr Canc, Inst Oncol, Canc Epidemiol & Prevent Div, PL-02781 Warsaw, Poland; UCL, London WC1E 6BT, England; Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England	Maria Sklodowska-Curie National Research Institute of Oncology; University of London; University College London; University of Cambridge	Zatonski, W (corresponding author), Ctr Canc, Inst Oncol, Canc Epidemiol & Prevent Div, 5 Roentgena Str, PL-02781 Warsaw, Poland.	canepid@coi.waw.pl	Manczuk, Marta/S-5900-2016; Manczuk, Marta/GPK-8403-2022	Manczuk, Marta/0000-0002-4319-6424; Manczuk, Marta/0000-0002-4319-6424; McNeill, Ann/0000-0002-6223-4000; Powles, John/0000-0002-0766-7989				Brennan P, 2002, BRIT J CANCER, V87, P43, DOI 10.1038/sj.bjc.6600352; LOPEZ AD, 1994, TOB CONTROL, V3, P243; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Peto R, 1994, MORTALITY SMOKING DE; [No title captured]	5	34	36	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2005	331	7510					189	191		10.1136/bmj.331.7510.189	http://dx.doi.org/10.1136/bmj.331.7510.189			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951EA	16037450	Green Published, Bronze			2022-12-28	WOS:000230910700019
J	Gulis, G; Korcova, J; Letanovsky, P; Marcinkova, D				Gulis, G; Korcova, J; Letanovsky, P; Marcinkova, D			Transition and public health in the Slovak republic	BRITISH MEDICAL JOURNAL			English	Article									Univ So Denmark, Inst Publ Hlth, Unit Hlth Promot Res, DK-6700 Esbjerg, Denmark; Trnava Univ, Fac Hlth Care & Social Work, Dept Hyg & Epidemiol, Trnava, Slovakia; Minist Hlth, Bratislava, Slovakia	University of Southern Denmark; University of Trnava	Gulis, G (corresponding author), Univ So Denmark, Inst Publ Hlth, Unit Hlth Promot Res, Niels Bohrsvej 9-10, DK-6700 Esbjerg, Denmark.	ggulis@health.sdu.dk	Gulis, Gabriel/E-4505-2013	Gulis, Gabriel/0000-0002-8174-4591				*AG PODP VED TECHN, CELK PODP PROJ ROK 2; [Anonymous], EUR HLTH ALL DAT; DALGHREN G, 1995, EUR HLTH POL C OPP F, V2; GULIS G, 2004, MED MONITOR, V2, P33; Lessof S, 2004, HLTH SYSTEMS TRANSIT; Nosikov A., 2003, EUROHIS DEV COMMON I; Wardle J, 2004, INT J BEHAV MED, V11, P27, DOI 10.1207/s15327558ijbm1101_4	7	4	5	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 23	2005	331	7510					213	215		10.1136/bmj.331.7510.213	http://dx.doi.org/10.1136/bmj.331.7510.213			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951EA	16037460	Bronze, Green Published			2022-12-28	WOS:000230910700029
J	Kern, J; Strnad, M; Coric, T; Vuletic, S				Kern, J; Strnad, M; Coric, T; Vuletic, S			Cardiovascular risk factors in Croatia: struggling to provide the evidence for developing policy recommendations	BRITISH MEDICAL JOURNAL			English	Article							MEDITERRANEAN DIET; SURVIVAL		Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Zagreb 10000, Croatia; Croatian Publ Hlth Inst, Social Med Serv, Zagreb 10000, Croatia	University of Zagreb	Kern, J (corresponding author), Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Rockefellerova 4, Zagreb 10000, Croatia.	jkern@snz.hr	, jkern@snz.hr/AAR-8708-2021	KERN, JOSIPA/0000-0002-0896-3018				Bautista Marita C, 2005, Prog Cardiovasc Nurs, V20, P70, DOI 10.1111/j.0889-7204.2005.04558.x; BELAND Y, 2004, P AM STAT ASS M SURV; *CROAT CENTR BUR S, 2004, STAT YB 2004; Kern Josipa, 2004, Med Arh, V58, P351; McKee M, 2004, BRIT MED J, V329, P1355, DOI 10.1136/bmj.329.7479.1355; Trichopoulou A, 2005, ARCH INTERN MED, V165, P929, DOI 10.1001/archinte.165.8.929; Trichopoulou A, 2005, BMJ-BRIT MED J, V330, P991, DOI 10.1136/bmj.38415.644155.8F	7	47	52	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 23	2005	331	7510					208	210		10.1136/bmj.331.7510.208	http://dx.doi.org/10.1136/bmj.331.7510.208			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951EA	16037458	Green Published, Bronze			2022-12-28	WOS:000230910700027
J	Fox, LP; Grossman, ME				Fox, LP; Grossman, ME			Paget's disease of the breast	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Yale Univ, Sch Med, New Haven, CT 06520 USA; Columbia Univ, Med Ctr, New York, NY 10032 USA	Yale University; Columbia University	Fox, LP (corresponding author), Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06520 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2005	353	3					E3	E3		10.1056/NEJMicm040532	http://dx.doi.org/10.1056/NEJMicm040532			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YH	16034005				2022-12-28	WOS:000230608700010
J	Reichhardt, T				Reichhardt, T			Pumping up the volume	NATURE			English	News Item																			0	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 21	2005	436	7049					326	327		10.1038/436326a	http://dx.doi.org/10.1038/436326a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034390				2022-12-28	WOS:000230623400015
J	Lucic, V; Baumeister, W				Lucic, V; Baumeister, W			Monte Carlo places strong odds on ectopic release	SCIENCE			English	Editorial Material									Max Planck Inst Biochem, Dept Biol Struct, D-82152 Martinsried, Germany	Max Planck Society	Lucic, V (corresponding author), Max Planck Inst Biochem, Dept Biol Struct, D-82152 Martinsried, Germany.	baumeist@biochem.mpg.de	Lucic, Vladan/AAA-8128-2020	Lucic, Vladan/0000-0003-3698-7436				Al-Amoudi A, 2004, J STRUCT BIOL, V148, P131, DOI 10.1016/j.jsb.2004.03.010; BARTOL TM, 1991, BIOPHYS J, V59, P1290, DOI 10.1016/S0006-3495(91)82344-X; Coggan JS, 2005, SCIENCE, V309, P446, DOI 10.1126/science.1108239; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; Zhang ZW, 1996, NEURON, V17, P1231, DOI 10.1016/S0896-6273(00)80253-6	8	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					387	388		10.1126/science.1115632	http://dx.doi.org/10.1126/science.1115632			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020717				2022-12-28	WOS:000230574900027
J	Gohle, C; Udem, T; Herrmann, M; Rauschenberger, J; Holzwarth, R; Schuessler, HA; Krausz, F; Hansch, TW				Gohle, C; Udem, T; Herrmann, M; Rauschenberger, J; Holzwarth, R; Schuessler, HA; Krausz, F; Hansch, TW			A frequency comb in the extreme ultraviolet	NATURE			English	Article							FEMTOSECOND PULSE AMPLIFICATION; PASSIVE OPTICAL CAVITY; HARMONIC-GENERATION; SPECTROSCOPY; LASER; LIGHT; STABILIZATION; HG-199(+); METROLOGY; GASES	Since 1998, the interaction of precision spectroscopy and ultrafast laser science has led to several notable accomplishments. Femtosecond laser optical frequency 'combs' ( evenly spaced spectral lines) have revolutionized the measurement of optical frequencies(1,2) and enabled optical atomic clocks(3). The same comb techniques have been used to control the waveform of ultrafast laser pulses, which permitted the generation of single attosecond pulses(4), and have been used in a recently demonstrated 'oscilloscope' for light waves(5). Here we demonstrate intra-cavity high harmonic generation in the extreme ultraviolet, which promises to lead to another joint frontier of precision spectroscopy and ultrafast science. We have generated coherent extreme ultraviolet radiation at a repetition frequency of more than 100 MHz, a 1,000-fold improvement over previous experiments(6). At such a repetition rate, the mode spacing of the frequency comb, which is expected to survive the high harmonic generation process, is large enough for high resolution spectroscopy. Additionally, there may be many other applications of such a quasi-continuous compact and coherent extreme ultraviolet source, including extreme ultraviolet holography, microscopy, nanolithography and X-ray atomic clocks.	Max Planck Inst Quantum Opt, D-85748 Garching, Germany; Univ Munich, Dept Phys, D-85748 Garching, Germany	Max Planck Society; University of Munich	Gohle, C (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	ctg@mpq.mpg.de	Hädrich, Steffen/B-4331-2008; Rauschenberger, Jens/C-4078-2011; Herrmann, Maximilian/B-2315-2008; schuessler, hans/AAF-5725-2020	Gohle, Christoph/0000-0002-4616-4292				BAKLANOV YV, 1977, APPL PHYS, V12, P97, DOI 10.1007/BF00900075; Baltuska A, 2003, NATURE, V421, P611, DOI 10.1038/nature01414; Bellini M, 1998, PHYS REV LETT, V81, P297, DOI 10.1103/PhysRevLett.81.297; Constant E, 1999, PHYS REV LETT, V82, P1668, DOI 10.1103/PhysRevLett.82.1668; Cundiff ST, 2003, REV MOD PHYS, V75, P325, DOI 10.1103/RevModPhys.75.325; Diddams SA, 2001, SCIENCE, V293, P825, DOI 10.1126/science.1061171; ECKSTEIN JN, 1978, J OPT SOC AM, V68, P646; Fernandez A, 2004, OPT LETT, V29, P1366, DOI 10.1364/OL.29.001366; Fischer M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.230802; Goulielmakis E, 2004, SCIENCE, V305, P1267, DOI 10.1126/science.1100866; HANSCH TW, 1980, OPT COMMUN, V35, P441, DOI 10.1016/0030-4018(80)90069-3; Jones RJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.193201; Jones RJ, 2004, OPT LETT, V29, P2812, DOI 10.1364/OL.29.002812; Jones RJ, 2002, OPT LETT, V27, P1848, DOI 10.1364/OL.27.001848; Lindner F, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.013814; LOPEZMARTENS R, PHYS REV LETT, V94; Marian A, 2004, SCIENCE, V306, P2063, DOI 10.1126/science.1105660; Petersen JC, 2003, OPT EXPRESS, V11, P2975, DOI 10.1364/OE.11.002975; POLZIK ES, 1991, OPT LETT, V16, P1400, DOI 10.1364/OL.16.001400; Rafac RJ, 2000, PHYS REV LETT, V85, P2462, DOI 10.1103/PhysRevLett.85.2462; Reichert J, 1999, OPT COMMUN, V172, P59, DOI 10.1016/S0030-4018(99)00491-5; Schoof A, 2001, OPT LETT, V26, P1562, DOI 10.1364/OL.26.001562; Seres J, 2005, NATURE, V433, P596, DOI 10.1038/433596a; Snadden MJ, 1996, OPT COMMUN, V125, P70, DOI 10.1016/0030-4018(95)00711-3; STRICKLAND D, 1985, OPT COMMUN, V56, P219, DOI 10.1016/0030-4018(85)90120-8; Thorpe MJ, 2005, OPT EXPRESS, V13, P882, DOI 10.1364/OPEX.13.000882; Udem T, 2002, NATURE, V416, P233, DOI 10.1038/416233a; WAHLSTROM CG, 1993, PHYS REV A, V48, P4709, DOI 10.1103/PhysRevA.48.4709; Witte S, 2005, SCIENCE, V307, P400, DOI 10.1126/science.1106612; YANOVSKY VP, 1994, OPT LETT, V19, P1952, DOI 10.1364/OL.19.001952	30	451	467	2	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					234	237		10.1038/nature03851	http://dx.doi.org/10.1038/nature03851			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015324				2022-12-28	WOS:000230459500035
J	Masumoto, H; Hawke, D; Kobayashi, R; Verreault, A				Masumoto, H; Hawke, D; Kobayashi, R; Verreault, A			A role for cell-cycle-regulated histone H3 lysine 56 acetylation in the DNA damage response	NATURE			English	Article							NUCLEOSOME CORE PARTICLE; REPLICATION FORKS; H4; COMPLEXES; MECHANISM; REPAIR; H2A	DNA breaks are extremely harmful lesions that need to be repaired efficiently throughout the genome. However, the packaging of DNA into nucleosomes is a significant barrier to DNA repair, and the mechanisms of repair in the context of chromatin are poorly understood(1). Here we show that lysine 56 (K56) acetylation is an abundant modification of newly synthesized histone H3 molecules that are incorporated into chromosomes during S phase. Defects in the acetylation of K56 in histone H3 result in sensitivity to genotoxic agents that cause DNA strand breaks during replication. In the absence of DNA damage, the acetylation of histone H3 K56 largely disappears in G2. In contrast, cells with DNA breaks maintain high levels of acetylation, and the persistence of the modification is dependent on DNA damage checkpoint proteins. We suggest that the acetylation of histone H3 K56 creates a favourable chromatin environment for DNA repair and that a key component of the DNA damage response is to preserve this acetylation.	Canc Res UK, London Res Inst, Clare Hall Labs, Chromosome Dynam Lab, S Mimms EN6 3LD, Herts, England; Univ Texas, MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA	Cancer Research UK; University of Texas System; UTMD Anderson Cancer Center	Verreault, A (corresponding author), Canc Res UK, London Res Inst, Clare Hall Labs, Chromosome Dynam Lab, Blanche Lane, S Mimms EN6 3LD, Herts, England.	alain.verreault@cancer.org.uk		Hawke, David/0000-0002-6102-7843				Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9; HSIANG YH, 1989, CANCER RES, V49, P5077; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Nitiss JL, 1996, MOL PHARMACOL, V50, P1095; NORTON VG, 1989, CELL, V57, P449, DOI 10.1016/0092-8674(89)90920-3; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; Pommier Y, 2003, MUTAT RES-FUND MOL M, V532, P173, DOI 10.1016/j.mrfmmm.2003.08.016; Redon C, 2003, EMBO REP, V4, P678, DOI 10.1038/sj.embor.embor871; Sklenar Amy R., 2004, BMC Biochemistry, V5, P11, DOI 10.1186/1471-2091-5-11; SOGO JM, 1986, J MOL BIOL, V189, P189, DOI 10.1016/0022-2836(86)90390-6; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Wechser MA, 1997, EMBO J, V16, P2086, DOI 10.1093/emboj/16.8.2086; Ye JX, 2005, MOL CELL, V18, P123, DOI 10.1016/j.molcel.2005.02.031	21	473	478	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					294	298		10.1038/nature03714	http://dx.doi.org/10.1038/nature03714			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015338				2022-12-28	WOS:000230459500049
J	Shepherd, FA; Pereira, JR; Ciuleanu, T; Tan, EH; Hirsh, V; Thongprasert, S; Campos, D; Maoleekoonpiroj, S; Smylie, M; Martins, R; van Kooten, M; Dediu, M; Findlay, B; Tu, DS; Johnston, D; Bezjak, A; Clark, G; Santabarbara, P; Seymour, L				Shepherd, FA; Pereira, JR; Ciuleanu, T; Tan, EH; Hirsh, V; Thongprasert, S; Campos, D; Maoleekoonpiroj, S; Smylie, M; Martins, R; van Kooten, M; Dediu, M; Findlay, B; Tu, DS; Johnston, D; Bezjak, A; Clark, G; Santabarbara, P; Seymour, L		Natl Canc Inst Canada Clin Trials	Erlotinib in previously treated non-small-cell lung cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GROWTH-FACTOR RECEPTOR; PHASE-III TRIAL; GEFITINIB; MUTATIONS; DOCETAXEL; PLATINUM; RESPONSIVENESS; SENSITIVITY; COMBINATION; EXPRESSION	BACKGROUND We conducted a randomized, placebo-controlled, double-blind trial to determine whether the epidermal growth factor receptor inhibitor erlotinib prolongs survival in non - small-cell lung cancer after the failure of first-line or second-line chemotherapy. METHODS Patients with stage IIIB or IV non - small-cell lung cancer, with performance status from 0 to 3, were eligible if they had received one or two prior chemotherapy regimens. The patients were stratified according to center, performance status, response to prior chemotherapy, number of prior regimens, and prior platinum-based therapy and were randomly assigned in a 2: 1 ratio to receive oral erlotinib, at a dose of 150 mg daily, or placebo. RESULTS The median age of the 731 patients who underwent randomization was 61.4 years; 49 percent had received two prior chemotherapy regimens, and 93 percent had received platinum-based chemotherapy. The response rate was 8.9 percent in the erlotinib group and less than 1 percent in the placebo group (P< 0.001); the median duration of the response was 7.9 months and 3.7 months, respectively. Progression-free survival was 2.2 months and 1.8 months, respectively ( hazard ratio, 0.61, adjusted for stratification categories; P< 0.001). Overall survival was 6.7 months and 4.7 months, respectively ( hazard ratio, 0.70; P< 0.001), in favor of erlotinib. Five percent of patients discontinued erlotinib because of toxic effects. CONCLUSIONS Erlotinib can prolong survival in patients with non - small-cell lung cancer after first-line or second-line chemotherapy.	Univ Hlth Network, Dept Med Oncol & Hematol, Princess Margaret Site, Toronto, ON, Canada; Univ Hlth Network, Dept Radiat Oncol, Toronto, ON, Canada; Univ Toronto, Toronto, ON, Canada; Inst Canc Arnaldo Vieira de Carvalho, Sao Paulo, Brazil; Oncol Inst Ion Chiricuta, Cluj Napoca, Romania; Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore; McGill Univ, Dept Oncol, Montreal, PQ, Canada; Chiang Mai Univ, Fac Med, Chiang Mai 50000, Thailand; Confidence Med Ctr, San Isidro, Argentina; Pramongkutklao Hosp, Bangkok, Thailand; Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; Inst Nacl Canc, Rio De Janeiro, Brazil; Inst Med Alexander Fleming, Buenos Aires, DF, Argentina; Inst Oncol, Bucharest, Romania; Hop Hotel Dieu, Hlth Sci Hosp, St Catharines, ON, Canada; Natl Canc Inst Canada Clin Trials Grp, Kingston, ON, Canada; OSI Pharmaceut, Boulder, CO USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Oncology Institute Prof. Dr. Ion Chiricuta; National Cancer Centre Singapore (NCCS); McGill University; Chiang Mai University; Phramongkutklao Hospital; University of Alberta; National Cancer Institute (Inca); Institute of Oncology "Prof. Dr. Al Trestioreanu"; Queens University - Canada; Canadian Cancer Trials Group; Astellas Pharmaceuticals; OSI Pharmaceuticals	Shepherd, FA (corresponding author), Univ Hlth Network, Dept Med Oncol & Hematol, Princess Margaret Site, Toronto, ON, Canada.		Ciuleanu, Tudor-Eliade/ABH-8452-2020; Ciuleanu, Tudor Eliade/C-3996-2011; Dediu, Mircea/AAN-3089-2020	Ciuleanu, Tudor Eliade/0000-0003-0958-5597				ALBERTI W, 1995, BRIT MED J, V311, P899; Brabender J, 2001, CLIN CANCER RES, V7, P1850; Fontanini G, 1998, CLIN CANCER RES, V4, P241; Fossella, 2004, J CLIN ONCOL, V22, P209, DOI 10.1200/JCO.2004.10.966; Fossella FV, 2000, J CLIN ONCOL, V18, P2354, DOI 10.1200/JCO.2000.18.12.2354; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; GATZEMEIER U, 2004, P AN M AM SOC CLIN, V23, P617; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Grunwald V, 2003, JNCI-J NATL CANCER I, V95, P851, DOI 10.1093/jnci/95.12.851; Han SW, 2005, J CLIN ONCOL, V23, P2493, DOI 10.1200/JCO.2005.01.388; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; HERBST RS, 2004, P AN M AM SOC CLIN, V23, P617; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Huang SF, 2004, CLIN CANCER RES, V10, P8195, DOI 10.1158/1078-0432.CCR-04-1245; Inoue A, 2003, LANCET, V361, P137, DOI 10.1016/S0140-6736(03)12190-3; Isomura M, 2004, J CLIN ONCOL, V22, p200S; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Massarelli E, 2003, LUNG CANCER-J IASLC, V39, P55, DOI 10.1016/S0169-5002(02)00308-2; Miller VA, 2004, J CLIN ONCOL, V22, P1103, DOI 10.1200/JCO.2004.08.158; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Perez-Soler R, 2004, J CLIN ONCOL, V22, P3238, DOI 10.1200/JCO.2004.11.057; Perez-Soler Roman, 2003, Oncology (Williston Park), V17, P23; Pfister DG, 2004, J CLIN ONCOL, V22, P330, DOI 10.1200/JCO.2004.09.053; RUSCH V, 1993, CANCER RES, V53, P2379; Rusch V, 1997, CLIN CANCER RES, V3, P515; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095, DOI 10.1200/JCO.2000.18.10.2095; SHEPHERD FA, 2001, CLASSIC PAP CURR COM, V6, P87; Sridhar SS, 2003, LANCET ONCOL, V4, P397, DOI 10.1016/S1470-2045(03)01137-9; THATCHER N, 2005, P 96 ANN M AM ASS CA, P4; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Tu D., 2003, ENCY BIOPHARMACEUTIC, P614	37	4510	4752	2	308	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2005	353	2					123	132		10.1056/NEJMoa050753	http://dx.doi.org/10.1056/NEJMoa050753			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944OP	16014882	Bronze			2022-12-28	WOS:000230438800004
J	Sithinamsuwan, P; Chairangsaris, P				Sithinamsuwan, P; Chairangsaris, P			Gnathostomiasis - Neuroimaging of larval migration	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Pramongkutklao Hosp, Bangkok 10400, Thailand	Phramongkutklao Hospital	Sithinamsuwan, P (corresponding author), Pramongkutklao Hosp, Bangkok 10400, Thailand.								0	17	18	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2005	353	2					188	188		10.1056/NEJMicm040795	http://dx.doi.org/10.1056/NEJMicm040795			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944OP	16014888				2022-12-28	WOS:000230438800010
J	Clark, J				Clark, J		Int Campaign Revitalise Acad Med	Five futures for academic medicine: the ICRAM scenarios	BRITISH MEDICAL JOURNAL			English	Article									BMJ, London WC1H 9JR, England		Clark, J (corresponding author), BMJ, London WC1H 9JR, England.	jclark@bmj.com	Ward, Robyn L/I-2313-2013	Ward, Robyn L/0000-0002-6877-8906; Clark, Jocalyn/0000-0002-8014-3989	MRC [G84/6404] Funding Source: UKRI; Medical Research Council [G84/6404] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abbasi K, 2002, BRIT MED J, V325, P1472, DOI 10.1136/bmj.325.7378.1472; *AC MED SCI, 2002, CLIN AC MED JEOP REC; *AC MED SCI, 2003, STRENGTH CLIN RES; *AM ASS MED COLL A, 2004, ED DOCT PROV HIGH QU; [Anonymous], 2004, CAN MED ASSOC J, V170, P309; *ASS AC HLTH CTR, 2002, CHAL AC MED LEAD FOL; Awasthi S, 2005, PLOS MED, V2, P606, DOI 10.1371/journal.pmed.0020207; Bhutta Z, 2003, BMJ-BRIT MED J, V327, P1000, DOI 10.1136/bmj.327.7422.1000; Clark J, 2004, BMJ-BRIT MED J, V329, P751, DOI 10.1136/bmj.329.7469.751; Committee on the Roles of Academic Health Centers in the 21st Century, 2003, AC HLTH CTR LEAD CHA; Commonwealth Fund Task Force on Academic Health Centers, 2003, ENV FUT AC HLTH CTR; Davis Ged, 2002, SCENARIOS TOOL 21 CE; DONALDSON L, 2003, STATE PUBLIC HLTH AN, P36; *FOR AC MED, 2004, CLIN AC MED WAY FORW; The International Campaign to Revitalise Academic Medicine, 2005, FUT AC MED 5 SCEN 20; *UNAIDS, 2005, AIDS AFR 3 SCEN 2025; WACK P, 1985, HARVARD BUS REV, V63, P139; 2002, DEEPER NEWS, V7	18	53	54	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 9	2005	331	7508					101	104		10.1136/bmj.331.7508.101	http://dx.doi.org/10.1136/bmj.331.7508.101			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945XR	16002886	Green Published			2022-12-28	WOS:000230536800020
J	Hegerl, GC; Bindoff, NL				Hegerl, GC; Bindoff, NL			Ocean science - Warming the world's oceans	SCIENCE			English	Editorial Material							CLIMATE SYSTEM		Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA; Univ Tasmania, IASOS, Hobart, Tas 7001, Australia; Univ Tasmania, CSIRO Marine Res, Hobart, Tas 7001, Australia	Duke University; University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania	Hegerl, GC (corresponding author), Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA.	hegerl@duke.edu; n.bindoff@utas.edu.au	Bindoff, Nathaniel L/C-8050-2011	Bindoff, Nathaniel L/0000-0001-5662-9519; Hegerl, Gabriele/0000-0002-4159-1295				Antonov JI, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023112; Barnett T, 2005, J CLIMATE, V18, P1291, DOI 10.1175/JCLI3329.1; Barnett TP, 2005, SCIENCE, V309, P284, DOI 10.1126/science.1112418; Cubasch U., 2001, PROJECTIONS FUTURE C, P525; Forest CE, 2002, SCIENCE, V295, P113, DOI 10.1126/science.1064419; Levitus S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021592; Mitchell JFB, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P695; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; SCHLITZER R, 2003, EWOCE ELECT ATLAS WO	9	30	30	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2005	309	5732					254	255		10.1126/science.1114456	http://dx.doi.org/10.1126/science.1114456			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002606				2022-12-28	WOS:000230449800030
J	Riedel, IH; Kruse, K; Howard, J				Riedel, IH; Kruse, K; Howard, J			A self-organized vortex array of hydrodynamically entrained sperm cells	SCIENCE			English	Article							MOTILITY; MICROTUBULES; SPERMATOZOA	Many patterns in biological systems depend on the exchange of chemical signals between cells. We report a spatiotemporal pattern mediated by hydrodynamic interactions. At planar surfaces, spermatozoa self-organized into dynamic vortices resembling quantized rotating waves. These vortices formed an array with local hexagonal order. Introducing an order parameter that quantifies cooperativity, we found that the array appeared only above a critical sperm density. Using a model, we estimated the hydrodynamic interaction force between spermatozoa to be similar to 0.03 piconewtons. Thus, large-scale coordination of cells can be regulated hydrodynamically, and chemical signals are not required.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Max Planck Inst Phys Complex Syst, D-01187 Dresden, Germany	Max Planck Society; Max Planck Society	Riedel, IH (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	riedel@mpi-cbg.de; howard@mpi-cbg.de	Kruse, Karsten/GOG-8298-2022; Howard, Jonathon/D-4229-2011; Howard, Jonathon/J-7492-2016; Riedel-Kruse, Ingmar/B-8818-2008	Kruse, Karsten/0000-0001-8665-2349; Howard, Jonathon/0000-0003-0086-1196; Howard, Jonathon/0000-0003-0086-1196; Riedel-Kruse, Ingmar/0000-0002-6068-5561				[Anonymous], 1987, FLUID MECH-SOV RES; Berg, 2018, RANDOM WALKS BIOL; Darnton N, 2004, BIOPHYS J, V86, P1863, DOI 10.1016/S0006-3495(04)74253-8; Dombrowski C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098103; FAUCI LJ, 1995, B MATH BIOL, V57, P679, DOI 10.1007/bf02461846; Gibbons I.R., 1981, Journal of Cell Biology, V91, P107; GRAY J, 1955, J EXP BIOL, V32, P802; Gray J., 1928, CILIARY MOVEMENT; Gueron S, 1998, BIOPHYS J, V74, P1658, DOI 10.1016/S0006-3495(98)77879-8; HOELLDOBLER B, 1990, ANTS; Howard J., 2001, MECH MOTOR PROTEINS; Lenz P, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.108104; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; Moore H, 2002, NATURE, V418, P174, DOI 10.1038/nature00832; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; OKAMOTO K, 1994, J EXP BIOL, V192, P61; PRIGOGINE I, 1967, J CHEM PHYS, V46, P3542, DOI 10.1063/1.1841255; Sleigh M.A., 1974, CILIA FLAGELLA; Strogatz S., 2000, NONLINEAR DYNAMICS C; TAYLOR G, 1951, PROC R SOC LON SER-A, V209, P447, DOI 10.1098/rspa.1951.0218; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Woolley DM, 2003, REPRODUCTION, V126, P259, DOI 10.1530/rep.0.1260259; Wu XL, 2000, PHYS REV LETT, V84, P3017, DOI 10.1103/PhysRevLett.84.3017; Zahn K, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.115502; Zahn K, 1999, PHYS REV LETT, V82, P2721, DOI 10.1103/PhysRevLett.82.2721	26	393	393	5	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2005	309	5732					300	303		10.1126/science.1110329	http://dx.doi.org/10.1126/science.1110329			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002619				2022-12-28	WOS:000230449800045
J	Schalch, T; Duda, S; Sargent, DF; Richmond, TJ				Schalch, T; Duda, S; Sargent, DF; Richmond, TJ			X-ray structure of a tetranucleosome and its implications for the chromatin fibre	NATURE			English	Article							HIGHER-ORDER STRUCTURE; NUCLEOSOME CORE; REPEAT LENGTH; LINKER LENGTH; IN-SITU; DIAMETER; DNA; ORGANIZATION; FILAMENT; RIBBON	DNA in eukaryotic chromosomes is organized in arrays of nucleosomes compacted into chromatin fibres. This higher-order structure of nucleosomes is the substrate for DNA replication, recombination, transcription and repair. Although the structure of the nucleosome core is known at near-atomic resolution(1), even the most fundamental information about the organization of nucleosomes in the fibre is controversial. Here we report the crystal structure of an oligonucleosome (a compact tetranucleosome) at 9 angstrom resolution, solved by molecular replacement using the nucleosome core structure. The structure shows that linker DNA zigzags back and forth between two stacks of nucleosome cores, which forma truncated two-start helix, and does not follow a path compatible with a one-start solenoidal helix(2). The length of linker DNA is most probably buffered by stretching of the DNA contained in the nucleosome cores. We have built continuous fibre models by successively stacking tetranucleosomes one on another. The resulting models are nearly fully compacted and most closely resemble the previously described crossed-linker model(3). They suggest that the interfaces between nucleosomes along a single helix start are polymorphic.	ETH Honggerberg, ETH Zurich, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Richmond, TJ (corresponding author), ETH Honggerberg, ETH Zurich, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	richmond@mol.biol.ethz.ch	Schalch, Thomas/E-7507-2010; Schalch, Thomas/A-6007-2014	Schalch, Thomas/0000-0002-0758-3013				ALLAN J, 1984, J CELL BIOL, V98, P1320, DOI 10.1083/jcb.98.4.1320; ATHEY BD, 1990, J CELL BIOL, V111, P795, DOI 10.1083/jcb.111.3.795; BLANK TA, 1995, J MOL BIOL, V252, P305, DOI 10.1006/jmbi.1995.0498; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUTLER PJG, 1980, J MOL BIOL, V140, P505, DOI 10.1016/0022-2836(80)90268-5; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; FINCH JT, 1976, P NATL ACAD SCI USA, V73, P1897, DOI 10.1073/pnas.73.6.1897; GERCHMAN SE, 1987, P NATL ACAD SCI USA, V84, P7802, DOI 10.1073/pnas.84.22.7802; GRAZIANO V, 1994, NATURE, V368, P351, DOI 10.1038/368351a0; HOROWITZ RA, 1994, J CELL BIOL, V125, P1, DOI 10.1083/jcb.125.1.1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Korber P, 2004, J BIOL CHEM, V279, P35113, DOI 10.1074/jbc.M405446200; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; MCGHEE JD, 1983, CELL, V33, P831, DOI 10.1016/0092-8674(83)90025-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OUDET P, 1975, CELL, V4, P281, DOI 10.1016/0092-8674(75)90149-X; PEHRSON JR, 1989, P NATL ACAD SCI USA, V86, P9149, DOI 10.1073/pnas.86.23.9149; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; RIS H, 1979, CELL BIOL COMPREHENS, P268; SEN D, 1986, BIOCHEMISTRY-US, V25, P3441, DOI 10.1021/bi00359a052; THOMA F, 1977, CELL, V12, P101, DOI 10.1016/0092-8674(77)90188-X; THOMAS JO, 1976, FEBS LETT, V66, P274, DOI 10.1016/0014-5793(76)80521-2; WIDOM J, 1985, CELL, V43, P207, DOI 10.1016/0092-8674(85)90025-X; WIDOM J, 1985, EMBO J, V4, P3189, DOI 10.1002/j.1460-2075.1985.tb04064.x; WILLIAMS SP, 1986, BIOPHYS J, V49, P233, DOI 10.1016/S0006-3495(86)83637-2; WOODCOCK CL, 1994, J CELL BIOL, V125, P11, DOI 10.1083/jcb.125.1.11; WOODCOCK CLF, 1984, J CELL BIOL, V99, P42, DOI 10.1083/jcb.99.1.42	30	558	583	3	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					138	141		10.1038/nature03686	http://dx.doi.org/10.1038/nature03686			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001076				2022-12-28	WOS:000230296600054
J	Elliott, C				Elliott, C			Should journals publish industry-funded bioethics articles?	LANCET			English	Editorial Material							CONFLICT-OF-INTEREST; ASSOCIATION; EDUCATION; ETHICS; TRIALS		Univ Minnesota, Ctr Bioeth, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Elliott, C (corresponding author), Univ Minnesota, Ctr Bioeth, Minneapolis, MN 55455 USA.	ellio023@tc.umn.edu						Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Angell M., 2004, TRUTH DRUG CO; [Anonymous], WASHINGTON POST; Beauchamp TL, 2002, J MED PHILOS, V27, P547, DOI 10.1076/jmep.27.5.547.10320; Brody B, 2002, HASTINGS CENT REP, V32, P14; Burton B, 2003, BRIT MED J, V326, P1205, DOI 10.1136/bmj.326.7400.1205; Charney DS, 2002, ARCH GEN PSYCHIAT, V59, P262, DOI 10.1001/archpsyc.59.3.262; CHREN MM, 1994, JAMA-J AM MED ASSOC, V271, P684, DOI 10.1001/jama.271.9.684; *CTR SCI PUBL INT, CSPL CALLS PREV DISC; Drazen JM, 2002, NEW ENGL J MED, V346, P1901, DOI 10.1056/NEJMe020074; HANNERS D, 1998, DOCUMENTS INDICATE T; HENSLEY S, 2003, WALL STREET J   0114, pD5; Jansen LA, 2003, HASTINGS CENT REP, V33, P40, DOI 10.2307/3528379; KASSIRER J, 2004, ON TAKE; Katz D, 2003, AM J BIOETHICS, V3, P39, DOI 10.1162/15265160360706552; Krimsky S, 2001, SCI ENG ETHICS, V7, P205, DOI 10.1007/s11948-001-0041-7; Lanza RP, 2000, JAMA-J AM MED ASSOC, V284, P3175, DOI 10.1001/jama.284.24.3175; Lebacqz K, 1999, HASTINGS CENT REP, V29, P31; Lemmens T, 2000, MILBANK Q, V78, P547, DOI 10.1111/1468-0009.00185; Moynihan R, 2003, BRIT MED J, V326, P1163, DOI 10.1136/bmj.326.7400.1163; OKIE S, 2001, WASHINGTON POST 0830; Payer L., 1992, DIS MONGERS DOCTORS; Relman AS, 2001, JAMA-J AM MED ASSOC, V285, P2009, DOI 10.1001/jama.285.15.2009; SCHROEDER M, 2004, WALL STREET J   1210, pB1; Singer PA, 2001, SCIENCE, V294, P87, DOI 10.1126/science.1062633; Stolberg S G, 2001, N Y Times Web, pA16; WEIL J, 2004, WALL STREET J   0331, pC3; *WORK GROUP ADV CO, REP NIH BLUE RIBB PA; 2005, PERSPECT BIOL MED S1, V48	30	15	15	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2005	366	9483					422	424		10.1016/S0140-6736(05)66794-3	http://dx.doi.org/10.1016/S0140-6736(05)66794-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	950IB	16054943				2022-12-28	WOS:000230849700030
J	Olsson, A; Ebert, JP; Banaji, MR; Phelps, EA				Olsson, A; Ebert, JP; Banaji, MR; Phelps, EA			The role of social groups in the persistence of learned fear	SCIENCE			English	Article							ELECTRODERMAL RESPONSES; RELEVANT STIMULI; PREPAREDNESS; AMYGDALA; ACTIVATION; FACES	Classical fear conditioning investigates how animals learn to associate environmental stimuli with an aversive event. We examined how the mechanisms of fear conditioning apply when humans learn to associate social ingroup and outgroup members with a fearful event, with the goal of advancing our understanding of basic learning theory and social group interaction. Primates more readily associate stimuli from certain fear-relevant natural categories, such as snakes, with a negative outcome relative to stimuli from fear-irrelevant categories, such as birds. We assessed whether this bias in fear conditioning extends to social groups defined by race. Our results indicate that individuals from a racial group other than one's own are more readily associated with an aversive stimulus than individuals of one's own race, among both white and black Americans. This prepared fear response might be reduced by close, positive interracial contact.	NYU, Dept Psychol, New York, NY 10003 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	New York University; New York University; Harvard University	Phelps, EA (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	tiz.phelps@nyu.edu			NIMH NIH HHS [1RO1MH57672, 5R01MH068447] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068447, R01MH057672] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		COOK EW, 1986, J ABNORM PSYCHOL, V95, P195, DOI 10.1037/0021-843X.95.3.195; Cunningham WA, 2004, PSYCHOL SCI, V15, P806, DOI 10.1111/j.0956-7976.2004.00760.x; Dimberg U, 1996, MOTIV EMOTION, V20, P149, DOI 10.1007/BF02253869; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; HAMILTON DL, 1976, J EXP SOC PSYCHOL, V12, P392, DOI 10.1016/S0022-1031(76)80006-6; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; Hart AJ, 2000, NEUROREPORT, V11, P2351, DOI 10.1097/00001756-200008030-00004; HUGDAHL K, 1977, BEHAV RES THER, V15, P345, DOI 10.1016/0005-7967(77)90066-3; HUGDAHL K, 1989, BEHAV RES THER, V27, P269, DOI 10.1016/0005-7967(89)90046-6; HUGDAHL K, 1977, J EXP PSYCHOL-HUM L, V3, P608, DOI 10.1037/0278-7393.3.5.608; KATZ D, 1933, J ABNORM SOC PSYCHOL, V28, P282; Kunda Z, 1997, J PERS SOC PSYCHOL, V72, P965, DOI 10.1037/0022-3514.72.5.965; MANSON JH, 1991, CURR ANTHROPOL, V32, P369, DOI 10.1086/203974; MINEKA S, 1984, J ABNORM PSYCHOL, V93, P355, DOI 10.1037/0021-843X.93.4.355; Molnar S, 1998, HUMAN VARIATION RACE; OHMAN A, 1986, PSYCHOPHYSIOLOGY, V23, P123, DOI 10.1111/j.1469-8986.1986.tb00608.x; OHMAN A, 1993, J ABNORM PSYCHOL, V102, P121; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; OHMAN A, 1976, J EXPT PSYCHOL GEN, V103, P313; Olsson A, 2004, PSYCHOL SCI, V15, P822, DOI 10.1111/j.0956-7976.2004.00762.x; Pavlov I.P., 1927, CONDITIONED REFLEXES; PETTIGREW TF, IN PRESS J PERS SOC; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; SELIGMAN ME, 1970, PSYCHOL REV, V77, P406, DOI 10.1037/h0029790; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; WORD CO, 1974, J EXP SOC PSYCHOL, V10, P109, DOI 10.1016/0022-1031(74)90059-6	27	209	211	0	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2005	309	5735					785	787		10.1126/science.1113551	http://dx.doi.org/10.1126/science.1113551			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	951NU	16051800				2022-12-28	WOS:000230938200054
J	Schmidt, PO; Rosenband, T; Langer, C; Itano, WM; Bergquist, JC; Wineland, DJ				Schmidt, PO; Rosenband, T; Langer, C; Itano, WM; Bergquist, JC; Wineland, DJ			Spectroscopy using quantum logic	SCIENCE			English	Article							LASER FREQUENCY STANDARD; TRAPPED IONS; TRANSITION; STATES	We present a general technique for precision spectroscopy of atoms that lack suitable transitions for efficient laser cooling, internal state preparation, and detection. In our implementation with trapped atomic ions, an auxiliary "logic" ion provides sympathetic laser cooling, state initialization, and detection for a simultaneously trapped "spectroscopy" ion. Detection is achieved by applying a mapping operation to each ion, which results in a coherent transfer of the spectroscopy ion's internal state onto the logic ion, where it is then measured with high efficiency. Experimental realization, by using (9)Be(+) as the logic ion and (27)Al(+) as the spectroscopy ion, indicates the feasibility of applying this technique to make accurate optical clocks based on single ions.	Natl Inst Stand & Technol, Div Time & Frequency, Boulder, CO 80305 USA	National Institute of Standards & Technology (NIST) - USA	Schmidt, PO (corresponding author), Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria.	piet.schmidt@uibk.ac.at	Itano, Wayne/AAV-8781-2020; Schmidt, Piet/F-6384-2011	Schmidt, Piet/0000-0003-0773-5889				Charron E, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.077901; CIRAC JI, 1995, PHYS REV LETT, V74, P4091, DOI 10.1103/PhysRevLett.74.4091; DEHMELT HG, 1982, IEEE T INSTRUM MEAS, V31, P83, DOI 10.1109/TIM.1982.6312526; Diddams SA, 2004, SCIENCE, V306, P1318, DOI 10.1126/science.1102330; Eckert K, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.042317; GILL P, 2002, P 6 S FREQ STAND MET, P12703; HERRMANN M, UNPUB; ITANO WM, UNPUB; Karshenboim S. G., 2004, LECT NOTES PHYS, V648; LARSON DJ, 1986, PHYS REV LETT, V57, P70, DOI 10.1103/PhysRevLett.57.70; Meekhof DM, 1996, PHYS REV LETT, V76, P1796, DOI 10.1103/PhysRevLett.76.1796; Morigi G, 2001, EUR PHYS J D, V13, P261, DOI 10.1007/s100530170275; Roth B, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.053001; Rowe MA, 2002, QUANTUM INF COMPUT, V2, P257; Trabert E, 1999, J PHYS B-AT MOL OPT, V32, P537, DOI 10.1088/0953-4075/32/2/031; Wineland D. J., 2002, P 6 S FREQ STAND MET, P361; WINELAND DJ, 1979, PHYS REV A, V20, P1521, DOI 10.1103/PhysRevA.20.1521; Young BC, 1999, PHYS REV LETT, V82, P3799, DOI 10.1103/PhysRevLett.82.3799; YU N, 1992, P NATL ACAD SCI USA, V89, P7289, DOI 10.1073/pnas.89.16.7289	22	425	431	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2005	309	5735					749	752		10.1126/science.1114375	http://dx.doi.org/10.1126/science.1114375			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051790	Green Published			2022-12-28	WOS:000230938200043
J	Padma, TV				Padma, TV			India's drug tests	NATURE			English	Article																		Jayaraman KS, 2001, NATURE, V412, P466, DOI 10.1038/35087715	1	7	8	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2005	436	7050					485	485		10.1038/436485a	http://dx.doi.org/10.1038/436485a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049471				2022-12-28	WOS:000230788800040
J	Rychert, CA; Fischer, KM; Rondenay, S				Rychert, CA; Fischer, KM; Rondenay, S			A sharp lithosphere-asthenosphere boundary imaged beneath eastern North America	NATURE			English	Article							UPPER-MANTLE; VELOCITY; PROFILE; EVOLUTION; EURASIA; WATER	Plate tectonic theory hinges on the concept of a relatively rigid lithosphere moving over a weaker asthenosphere, yet the nature of the lithosphere-asthenosphere boundary remains poorly understood. The gradient in seismic velocity that occurs at this boundary is central to constraining the physical and chemical properties that create differences in mechanical strength between the two layers. For example, if the lithosphere is simply a thermal boundary layer that is more rigid owing to colder temperatures, mantle flow models(1,2) indicate that the velocity gradient at its base would occur over tens of kilometres. In contrast, if the asthenosphere is weak owing to volatile enrichment(3-6) or the presence of partial melt(7), the lithosphere-asthenosphere boundary could occur over a much smaller depth range. Here we use converted seismic phases in eastern North America to image a very sharp seismic velocity gradient at the base of the lithosphere-a 3-11 per cent drop in shear-wave velocity over a depth range of 11 km or less at 90-110 km depth. Such a strong, sharp boundary cannot be reconciled with a purely thermal gradient, but could be explained by an asthenosphere that contains a few per cent partial melt7 or that is enriched in volatiles relative to the lithosphere(3-6).	Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Brown University; Massachusetts Institute of Technology (MIT)	Rychert, CA (corresponding author), Brown Univ, Dept Geol Sci, Box 1846, Providence, RI 02912 USA.	Catherine_Rychert@Brown.edu	Rondenay, Stéphane/B-9764-2013	Rondenay, Stéphane/0000-0003-0805-249X; Rychert, Catherine/0000-0001-5071-793X				Abramovitz T, 1997, TECTONOPHYSICS, V269, P1; ANDERSON DL, 1989, THEORY EARTH; Bostock MG, 1998, J GEOPHYS RES-SOL EA, V103, P21183, DOI 10.1029/98JB01069; Collins JA, 2001, GEOPHYS RES LETT, V28, P49, DOI 10.1029/2000GL011638; Dueker K., 2001, GSA TODAY, V11, P4, DOI DOI 10.1130/1052-5173(2001)011<0004:TSPL0T>2.0.C0;2; Fouch MJ, 2000, J GEOPHYS RES-SOL EA, V105, P6255, DOI 10.1029/1999JB900372; Gaherty JB, 1999, PHYS EARTH PLANET IN, V110, P21, DOI 10.1016/S0031-9201(98)00132-0; Hammond WC, 2000, J GEOPHYS RES-SOL EA, V105, P10987, DOI 10.1029/2000JB900042; Hatcher Jr R.D., 1989, APPALACHIAN OUACHITA, V2, P511, DOI [10.1130/DNAG-GNA-F2.511, DOI 10.1130/DNAG-GNA-F2.511]; Heaman LM, 2000, EARTH PLANET SC LETT, V178, P253, DOI 10.1016/S0012-821X(00)00079-0; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; Hirth G., 2000, GEOCHEM GEOPHY GEOSY, V1, DOI [10.1029/2000GC000048, DOI 10.1029/2000GC000048]; Jackson I, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB001225; Karato S, 1998, EARTH PLANET SC LETT, V157, P193, DOI 10.1016/S0012-821X(98)00034-X; King SD, 2000, SCIENCE, V290, P1137, DOI 10.1126/science.290.5494.1137; Lee CTA, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2003JB002413; LI A, 2003, J GEOPHYS RES, V108, DOI DOI 10.1029/2002JB02259; Li AB, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000190; Li X, 2000, NATURE, V405, P938, DOI 10.1038/35016054; Li XQ, 2004, NATURE, V427, P827, DOI 10.1038/nature02349; Menke W, 2002, GEOPHYS J INT, V149, P413, DOI 10.1046/j.1365-246X.2002.01652.x; Morozova EA, 1999, J GEOPHYS RES-SOL EA, V104, P20329, DOI 10.1029/1999JB900142; REVENAUGH J, 1991, J GEOPHYS RES-SOL EA, V96, P19781, DOI 10.1029/91JB01487; Ryberg T, 1996, B SEISMOL SOC AM, V86, P857; SHEARER PM, 1991, J GEOPHYS RES-SOL EA, V96, P18147, DOI 10.1029/91JB01592; Steer DN, 1998, TECTONOPHYSICS, V286, P111, DOI 10.1016/S0040-1951(97)00258-8; Steer DN, 1998, TECTONICS, V17, P143, DOI 10.1029/97TC03056; Thybo H, 1997, SCIENCE, V275, P1626, DOI 10.1126/science.275.5306.1626; van der Lee S, 2002, EARTH PLANET SC LETT, V203, P15, DOI 10.1016/S0012-821X(02)00846-4; ZARANEK SE, 2004, EOS, V85	30	155	158	3	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					542	545		10.1038/nature03904	http://dx.doi.org/10.1038/nature03904			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049485				2022-12-28	WOS:000230788800058
J	Wright, AA; Katz, IT				Wright, AA; Katz, IT			Bar coding for patient safety	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ADVERSE DRUG EVENTS; HOSPITALIZED-PATIENTS		Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Wright, AA (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.		Wright, Alexi/T-5793-2019	Katz, Ingrid/0000-0002-3014-238X				Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; POON EG, 2005, SOC GEN INT MED 28 A; Rothschild JM, 2005, CRIT CARE MED, V33, P533, DOI 10.1097/01.ccm.0000155912.73313.cd	5	38	39	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2005	353	4					329	331		10.1056/NEJMp058101	http://dx.doi.org/10.1056/NEJMp058101			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949JW	16049205				2022-12-28	WOS:000230782800001
J	Nathan, N; Borel, T; Djibo, A; Evans, D; Djibo, S; Corty, JF; Guillerm, M; Alberti, KP; Pinoges, L; Guerin, PJ; Legros, D				Nathan, N; Borel, T; Djibo, A; Evans, D; Djibo, S; Corty, JF; Guillerm, M; Alberti, KP; Pinoges, L; Guerin, PJ; Legros, D			Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study	LANCET			English	Article							ACUTE BACTERIAL-MENINGITIS; SHORT-TERM TREATMENT; ANTIBIOTIC-RESISTANCE; SWISS MULTICENTER; CHILDREN; AFRICA; TRIAL; MONOTHERAPY; INJECTION; NIGERIA	Background in sub-Saharan Africa in the 1990s, more than 600 000 people had epidemic meningococcal meningitis, of whom 10% died. The current recommended treatment by WHO is short-course long-acting oily chloramphenicol. Continuation of the production of this drug is uncertain, so simple alternatives need to be found. We assessed whether the efficacy of single-dose treatment of ceftriaxone was non-inferior to that of oily chloramphenicol for epidemic meningococcal meningitis. Methods In 2003, we undertook a randomised, open-label, non-inferiority trial in nine health-care facilities in Niger. Participants with suspected disease who were older than 2 months were randomly assigned to receive either chloramphenicol or ceftriaxone. Primary outcome was treatment failure (defined as death or clinical failure) at 72 h, measured with intention-to-treat and per-protocol analyses. Findings Of 510 individuals with suspected disease, 247 received ceftriaxone, 256 received chloramphenicol, and seven were lost to follow-up. The treatment failure rate at 72 h for the intention-to-treat analysis was 9% (22 patients) for both drug groups (risk difference 0.3%, 90% CI -3.8 to 4.5). Case fatality rates and clinical failure rates were equivalent in both treatment groups (14 [6%] ceftriaxone vs 12 [5%] chloramphenicol). Results were also similar for both treatment groups in individuals with confirmed meningitis caused by Neisseria meningitidis. No adverse side-effects were reported. Interpretation Single-dose ceftriaxone provides an alternative treatment for epidemic meningococcal meningitis-its efficacy, ease of use, and low cost favour its use. National and international health partners should consider ceftriaxone as an alternative first-line treatment to chloramphenicol for epidemic meningococcal meningitis.	Epicentre, F-75011 Paris, France; Minist Sante Publ & Lutte Endemies, Niamey, Niger; CERMES, Niamey, Niger; MSF, Paris, France	Doctors Without Borders	Guerin, PJ (corresponding author), Epicentre, 8 Rue St Sabin, F-75011 Paris, France.	philippe.guerin@epicentre.msf.org	Guerin, Philippe/AAH-8873-2021	Guerin, Philippe/0000-0002-6008-2963				BARAFF LJ, 1993, PEDIATR INFECT DIS J, V12, P389, DOI 10.1097/00006454-199305000-00008; Benbachir M, 2001, ANTIMICROB AGENTS CH, V45, P627, DOI 10.1128/AAC.45.2.627-629.2001; Bernardino L, 2003, LANCET, V361, P1564, DOI 10.1016/S0140-6736(03)13204-7; CADOZ M, 1982, PATHOL BIOL, V30, P522; COMNOUGUE C, 1987, REV EPIDEMIOL SANTE, V35, P416; DELSIGNORE R, 1983, CHEMOTHERAPY, V29, P157, DOI 10.1159/000238191; Duke T, 2003, ARCH DIS CHILD, V88, P536, DOI 10.1136/adc.88.6.536; ELFILALI KM, 1993, EUR J CLIN MICROBIOL, V12, P766, DOI 10.1007/BF02098465; GARRAFFO R, 1995, LETT INFECT, P8; GREENWOOD BM, 1979, T ROY SOC TROP MED H, V73, P557, DOI 10.1016/0035-9203(79)90052-X; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P536, DOI 10.1016/0035-9203(87)90397-X; HOHL P, 1990, INFECTION, V18, P78, DOI 10.1007/BF01641419; Karstaedt AS, 2000, PEDIATR INFECT DIS J, V19, P454, DOI 10.1097/00006454-200005000-00012; KAVALIOTIS J, 1989, CHEMOTHERAPY, V35, P296, DOI 10.1159/000238685; Lewis RF, 1998, LANCET, V352, P823, DOI 10.1016/S0140-6736(05)60723-4; MARTIN E, 1990, INFECTION, V18, P70, DOI 10.1007/BF01641418; Mohammed I, 2000, T ROY SOC TROP MED H, V94, P265, DOI 10.1016/S0035-9203(00)90316-X; Molesworth AM, 2002, T ROY SOC TROP MED H, V96, P242, DOI 10.1016/S0035-9203(02)90089-1; Molyneux EM, 2002, LANCET, V360, P211, DOI 10.1016/S0140-6736(02)09458-8; Mwangi I, 2002, PEDIATR INFECT DIS J, V21, P1042, DOI 10.1097/00006454-200211000-00013; PECOUL B, 1991, LANCET, V338, P862, DOI 10.1016/0140-6736(91)91511-R; Peltola H, 2001, CLIN INFECT DIS, V32, P64, DOI 10.1086/317534; PUDDICOMBE JB, 1984, T ROY SOC TROP MED H, V78, P399, DOI 10.1016/0035-9203(84)90132-9; Rey M, 1976, MED MALADIES INFECT, V6, P120; Roine I, 2000, PEDIATR INFECT DIS J, V19, P219, DOI 10.1097/00006454-200003000-00009; SALIOU F, 1977, MED TROP, V37, P141; Santaniello-Newton A, 2000, EPIDEMIOL INFECT, V124, P75, DOI 10.1017/S0950268899003398; SCHAAD UB, 1990, NEW ENGL J MED, V322, P141, DOI 10.1056/NEJM199001183220301; Scholz H, 1998, CHEMOTHERAPY, V44, P142, DOI 10.1159/000007106; Tondella MLC, 2001, EMERG INFECT DIS, V7, P163, DOI 10.3201/eid0701.010130; VARAINE F, 1998, 8 INT C INF DIS BOST; WALI SS, 1979, T ROY SOC TROP MED H, V73, P698, DOI 10.1016/0035-9203(79)90024-5; WHO, 1997, ANT SUPP THER BACT M; *WHO, 1995, CONTROL EPIDEMIC MEN; World Health Organization, 2000, WHO REP GLOB SURV EP	35	65	65	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2005	366	9482					308	313		10.1016/S0140-6736(05)66792-X	http://dx.doi.org/10.1016/S0140-6736(05)66792-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RJ	16039333				2022-12-28	WOS:000230733100029
J	Polluste, K; Mannik, G; Axelsson, R				Polluste, K; Mannik, G; Axelsson, R			Public health reforms in Estonia: impact on the health of the population	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRANSITION		Univ Tartu, Dept Publ Hlth, EE-50411 Tartu, Estonia; Nord Sch Publ Hlth, Gothenburg, Sweden	University of Tartu	Polluste, K (corresponding author), Univ Tartu, Dept Publ Hlth, Ravila 19, EE-50411 Tartu, Estonia.	kaja.polluste@ut.ee	Põlluste, Kaja/G-6597-2016	Põlluste, Kaja/0000-0002-8871-1397				Block MAG, 1997, HEALTH POLICY, V42, P187, DOI 10.1016/S0168-8510(97)00072-9; *EST CTR HLTH ED P, 1996, HLTH PROM ESTON; Kaasik T, 1998, SOC SCI MED, V47, P1589, DOI 10.1016/S0277-9536(98)00221-4; KASMEL A, 2003, HLTH BEHAV ESTONIAN; Kohler L, 2002, EUR J PUBLIC HEALTH, V12, P152, DOI 10.1093/eurpub/12.2.152; Leinsalu M, 2003, INT J EPIDEMIOL, V32, P1081, DOI 10.1093/ije/dyg192; Lindsay M, 2002, B WORLD HEALTH ORGAN, V80, P519; LIPAND A, 1995, HLTH BEHAV ESTONIAN; LIPAND A, 1992, HLTH BEHAV ESTONIAN; Liu YL, 1998, HEALTH POLICY, V44, P103, DOI 10.1016/S0168-8510(98)00010-4; McKee M, 2004, BRIT MED J, V329, P1428, DOI 10.1136/bmj.329.7480.1428; McKee M, 2001, BRIT MED J, V323, P1051, DOI 10.1136/bmj.323.7320.1051; McKee M, 2000, J EPIDEMIOL COMMUN H, V54, P361, DOI 10.1136/jech.54.5.361; *MIN SOC AFF, 2000, EST HLTH STAT 1992 1; *MIN SOC AFF, 2003, EST HLTH STAT 2000 2; POLLUSTE K, 1998, PUBLIC HLTH ESTONIA; Saava A, 2000, EUR J PUBLIC HEALTH, V10, P164, DOI 10.1093/eurpub/10.3.164; SALTMAN R. B., 2002, EUROPEAN OBSERVATORY; Varnik A, 2005, BRIT MED J, V330, P176, DOI 10.1136/bmj.38328.454294.55; *WORLD BANK, 1995, 13297EE WORLD BANK; 1994, WHO WORLD BANK SEM 2	21	9	9	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2005	331	7510					210	213		10.1136/bmj.331.7510.210	http://dx.doi.org/10.1136/bmj.331.7510.210			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	951EA	16037459	Bronze, Green Published			2022-12-28	WOS:000230910700028
J	Goodacre, S; Sutton, AJ; Sampson, FC				Goodacre, S; Sutton, AJ; Sampson, FC			Meta-analysis: The value of clinical assessment in the diagnosis of deep venous thrombosis	ANNALS OF INTERNAL MEDICINE			English	Review							D-DIMER ASSAY; VEIN THROMBOSIS; IMPEDANCE PLETHYSMOGRAPHY; EMERGENCY-DEPARTMENT; PHYSICAL-EXAMINATION; HOSPITALIZED-PATIENTS; PREDICTIVE-VALUE; LOWER-LIMBS; MODEL; PROBABILITY	Background: Clinical assessment of suspected deep venous thrombosis (DVT) should be based on systematically evaluated evidence. Purpose: To determine whether clinical findings, risk scores, and physicians, empirical judgments affect the likelihood of detecting DVT on definitive testing. Data Sources: MEDLINE, EMBASE, CINAHL, Web of Science, Cochrane Database of Systematic Reviews, Cochrane Controlled Trials Register, Database of Reviews of Effectiveness, ACP Journal Club, and citation lists (1966 to January 2005). Study Selection: Cohort studies published in English, French, Spanish, or Italian that compared clinical assessment with a reference standard. Data Extraction: The authors extracted standardized data, including setting, exclusions, population characteristics, reference standard, and results, and assessed quality against validated criteria. Data Synthesis: The authors combined data by using random-effects meta-analysis and, if appropriate, used meta-regression to identify covariates that predicted diagnostic accuracy. Only malignancy (likelihood ratio [LR], 2.71), previous DVT (LR, 2.25), recent immobilization (LR, 1.98), difference in calf diameter (LR, 1.80), and recent surgery (LR, 1.76) were useful for ruling in DVT, while only absence of calf swelling (LR, 0.67) or difference in calf diameter (LR, 0.57) was useful for ruling out DVT. The Wells clinical score was more valuable than the individual characteristics; it stratified patients into groups with high (LR, 5.2), intermediate, and low (LR, 0.25) probability of DVT, The Wells score seemed able to stratify patients by risk only for proximal DVT, and it performed better in cohorts that were younger or excluded patients with previous thromboembolism. Limitations: Pooled estimates were subject to substantial heterogeneity. This may limit extrapolation between observers and settings. Only published studies were included, so findings may be subject to publication bias. Conclusion: individual clinical features are of limited value in diagnosing DVT. Overall assessment of clinical probability by using the Wells score is more useful.	Univ Sheffield, Med Care Res Unit, Sheffield S1 4DA, S Yorkshire, England; Univ Leicester, Leicester, Leics, England	University of Sheffield; University of Leicester	Goodacre, S (corresponding author), Univ Sheffield, Med Care Res Unit, Regent Court,30 Regent St, Sheffield S1 4DA, S Yorkshire, England.	s.goodacre@sheffield.ac.uk		Sampson, Fiona/0000-0003-2321-0302; Goodacre, Steve/0000-0003-0803-8444; Sutton, Alexander/0000-0002-8934-9940				Anand SS, 1998, JAMA-J AM MED ASSOC, V279, P1094, DOI 10.1001/jama.279.14.1094; Anderson DR, 1999, ARCH INTERN MED, V159, P477, DOI 10.1001/archinte.159.5.477; Armstrong PA, 1998, AM J SURG, V176, P226, DOI 10.1016/S0002-9610(98)00125-1; Arrive L, 2002, J RADIOL, V83, P337; Aschwanden M, 1999, J VASC SURG, V30, P929, DOI 10.1016/S0741-5214(99)70019-4; Bates SM, 2001, ARCH INTERN MED, V161, P447, DOI 10.1001/archinte.161.3.447; Blattler Werner, 2004, Eur J Intern Med, V15, P305, DOI 10.1016/j.ejim.2004.06.001; Borg JY, 1997, THROMB HAEMOSTASIS, V77, P602; Bounameaux H, 1999, THROMB HAEMOSTASIS, P172; Bozic M, 2002, THROMB RES, V108, P107, DOI 10.1016/S0049-3848(03)00007-0; BRIET E, 1983, NETH J MED, V26, P29; Bucek RA, 2001, THROMB RES, V103, P17, DOI 10.1016/S0049-3848(00)00367-4; CEI M, 2002, INTERNISTA, V10, P3; Chan L, 2000, AM J EMERG MED, V18, P342, DOI 10.1016/S0735-6757(00)90136-0; Constans J, 2003, AM J MED, V115, P436, DOI 10.1016/S0002-9343(03)00432-7; Constans J, 2001, THROMB HAEMOSTASIS, V86, P985; COOPERMAN M, 1979, AM J SURG, V137, P252, DOI 10.1016/0002-9610(79)90157-0; Cornuz J, 2002, AM J MED, V112, P198, DOI 10.1016/S0002-9343(01)01110-X; CRANLEY JJ, 1976, ARCH SURG-CHICAGO, V111, P34; Criado E, 1997, SURGERY, V122, P578, DOI 10.1016/S0039-6060(97)90131-8; Crippa L, 1997, THROMB HAEMOSTASIS, pPD647; DAngelo A, 1996, THROMB HAEMOSTASIS, V75, P412; Deeks~ JJ, 2001, SYSTEMATIC REV HLTH; Diamond PT, 1997, AM J PHYS MED REHAB, V76, P49, DOI 10.1097/00002060-199701000-00009; Donada C, 1990, Minerva Med, V81, P61; Dryjski M, 2001, J VASC SURG, V34, P1010, DOI 10.1067/mva.2001.119889; FRIC M, 1985, COR VASA, V27, P346; Funfsinn N, 2001, BLOOD COAGUL FIBRIN, V12, P165, DOI 10.1097/00001721-200104000-00001; Ginsberg JS, 1997, ARCH INTERN MED, V157, P1077, DOI 10.1001/archinte.157.10.1077; Glover JL, 1996, SURGERY, V120, P725, DOI 10.1016/S0039-6060(96)80023-7; Haeger K, 1968, Zentralbl Phlebol, V7, P212; Hellmich M, 1998, MED DECIS MAKING, V18, P436, DOI 10.1177/0272989X9801800412; HILL SL, 1995, AM J SURG, V170, P201, DOI 10.1016/S0002-9610(99)80286-4; Ilkhanipour K, 2004, J EMERG MED, V27, P233, DOI 10.1016/j.jemermed.2004.04.010; Johanning JM, 2002, J VASC SURG, V36, P877, DOI 10.1067/mva.2002.129247; Kahn SR, 1998, ARCH INTERN MED, V158, P2315, DOI 10.1001/archinte.158.21.2315; Kahn SR, 1999, THROMB HAEMOSTASIS, V81, P353; KIIL J, 1979, ACTA RADIOL DIAGN, V20, P292, DOI 10.1177/028418517902000202; Kilroy DA, 2003, EMERG MED J, V20, P29, DOI 10.1136/emj.20.1.29; Kraaijenhagen RA, 2002, ARCH INTERN MED, V162, P907, DOI 10.1001/archinte.162.8.907; KRAHENBUHL B, 1987, THROMB HAEMOSTASIS, V58, P382; Lambert PC, 2002, J CLIN EPIDEMIOL, V55, P86, DOI 10.1016/S0895-4356(01)00414-0; LANDEFELD CS, 1990, AM J MED, V88, P382, DOI 10.1016/0002-9343(90)90493-W; Lee Y. M., 2002, Hong Kong Medical Journal, V8, P9; Lennox AF, 1999, J VASC SURG, V30, P794, DOI 10.1016/S0741-5214(99)70003-0; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; LINDQVIST R, 1977, ACTA MED SCAND, V201, P435; LUCCHI M, 1993, J MAL VASCUL, V18, P303; Mattos MA, 1996, SURGERY, V120, P730; Miron MJ, 2000, J INTERN MED, V247, P249, DOI 10.1046/j.1365-2796.2000.00605.x; MOLLOY W, 1982, IRISH MED J, V75, P119; Motykie GD, 2000, INT ANGIOL, V19, P47; NYPAVER TJ, 1993, J VASC SURG, V18, P821, DOI 10.1016/0741-5214(93)90337-L; ODONNELL TF, 1980, SURG GYNECOL OBSTET, V150, P69; Oger E, 1997, RESPIRATION, V64, P326; Oudega R, 2005, FAM PRACT, V22, P86, DOI 10.1093/fampra/cmh718; Pini M, 1984, Recenti Prog Med, V75, P650; Prandoni P, 1988, Ann Ital Med Int, V3, P93; RICHARDS KL, 1976, ARCH INTERN MED, V136, P1091, DOI 10.1001/archinte.136.10.1091; Ruiz-Gimenez N, 2004, THROMB HAEMOSTASIS, V91, P1237, DOI 10.1160/TH03-02-0080; Ruiz-Gimenez N, 2002, MED CLIN-BARCELONA, V118, P529, DOI 10.1016/S0025-7753(02)72441-X; SACKETT DL, 1992, JAMA-J AM MED ASSOC, V267, P2638, DOI 10.1001/jama.267.19.2638; SANDLER DA, 1984, LANCET, V2, P716; *SAS I INC, SAS SOFTW VERS 8 4 U; Shields GP, 2002, ACAD EMERG MED, V9, P561, DOI 10.1111/j.1553-2712.2002.tb02292.x; Siragusa S, 2002, BLOOD, V100, p503A; Spiegelhalter D., 2000, WINBUGS VERSION 1 4; Tick LW, 2002, AM J MED, V113, P630, DOI 10.1016/S0002-9343(02)01347-5; Trujillo-Santos AJ, 2000, MED CLIN-BARCELONA, V114, P46, DOI 10.1016/S0025-7753(00)71185-7; VACCARO P, 1987, ANGIOLOGY, V38, P232, DOI 10.1177/000331978703800305; *VER STEER COMM, 2003, VEN THROMB REG REP; VINE HS, 1981, AM J ROENTGENOL, V136, P167, DOI 10.2214/ajr.136.1.167; Walsh K, 2002, POSTGRAD MED J, V78, P742, DOI 10.1136/pmj.78.926.742; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; Wells PS, 1997, THROMB HAEMOSTASIS, pO2403; Wells PS, 1999, THROMB HAEMOSTASIS, V81, P493; Wells PS, 1998, J INTERN MED, V243, P15; WELLS PS, 1995, LANCET, V345, P1326, DOI 10.1016/S0140-6736(95)92535-X; Wells PS, 1997, LANCET, V350, P1795, DOI 10.1016/S0140-6736(97)08140-3; Wijeyaratne S. M., 2002, Ceylon Medical Journal, V47, P16; WOJCIECHOWSKI J, 1982, ACTA THERMOGRAPHICA, V7, P1; Zambon G, 1987, Minerva Cardioangiol, V35, P133; ZAMORA J, 2004, METADISC VERSION BET	83	140	158	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2005	143	2					129	139		10.7326/0003-4819-143-2-200507190-00012	http://dx.doi.org/10.7326/0003-4819-143-2-200507190-00012			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YG	16027455				2022-12-28	WOS:000230608600006
J	Hobbs, CJ				Hobbs, CJ			Abdominal injury due to child abuse	LANCET			English	Editorial Material							TRAUMA		St Jamess Univ Hosp, Leeds LS9 7TF, W Yorkshire, England	Saint James's University Hospital; University of Leeds	Hobbs, CJ (corresponding author), St Jamess Univ Hosp, Leeds LS9 7TF, W Yorkshire, England.	chris.hobbs@leedsth.nhs.uk						Arkovitz MS, 1997, J TRAUMA, V42, P49, DOI 10.1097/00005373-199701000-00009; Barnes PM, 2005, LANCET, V366, P234, DOI 10.1016/S0140-6736(05)66913-9; CASE MES, 1983, J FORENSIC SCI, V28, P496; COANT PN, 1992, PEDIATRICS, V89, P274; COOPER A, 1988, J TRAUMA, V28, P1483, DOI 10.1097/00005373-198810000-00015; HAMILTON A, 1985, ULSTER MED J, V54, P221; HOBBS CJ, 1990, ARCH DIS CHILD, V65, P423, DOI 10.1136/adc.65.4.423; Hobbs CJ, 2001, PHYS SIGNS CHILD ABU; Huntimer CM, 2000, PEDIATRICS, V106, P301, DOI 10.1542/peds.106.2.301; KLEINMAN PK, 1986, RADIOLOGY, V160, P747, DOI 10.1148/radiology.160.3.3488562; Ludwig S, 2001, CHILD ABUSE MED DIAG	11	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 16	2005	366	9481					187	188		10.1016/S0140-6736(05)66887-0	http://dx.doi.org/10.1016/S0140-6736(05)66887-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	945RG	16023494				2022-12-28	WOS:000230519200008
J	Rohaly, G; Chemnitz, J; Dehde, S; Nunez, AM; Heukeshoven, J; Deppert, W; Dornreiter, I				Rohaly, G; Chemnitz, J; Dehde, S; Nunez, AM; Heukeshoven, J; Deppert, W; Dornreiter, I			A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint	CELL			English	Article							ALTERNATIVELY SPLICED FORM; DNA-DAMAGE; ACTIVATION; CELLS; RNA; RECRUITMENT; EXPRESSION; MUTANTS; BINDING; CANCER	The archetypal human tumor suppressor p53 is considered to have unique transactivation properties. The assumption is based on the fact that additionally identified human p53 isoforms lack transcriptional activity. However, we provide evidence for the existence of an alternatively spliced p53 isoform (Delta p53) that exerts its transcriptional activity independent from p53. In contrast to p53, Delta p53 transactivates the endogenous p21 and 14-3-3 sigma but not the mdm2, bax, and PIG3 promoter. Cell cycle studies showed that Delta p53 displays its differential transcriptional activity only in damaged S phase cells. Upon activation of the ATR-intra-S phase checkpoint, Ap53, but not p53, transactivates the Cdk inhibitor p21. Induction of p21 results in downregulation of cyclin A-Cdk activity and accordingly attenuation of S phase progression. Data demonstrate that the Delta p53-p21-cyclin A-Cdk pathway is crucial to facilitate uncoupling of repair and replication events, indicating that Delta p53 is an essential element of the ATR-intra-S phase checkpoint.	Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-20251 Hamburg, Germany	Heinrich Pette Institute; University of Hamburg	Dornreiter, I (corresponding author), Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, Martinistr 52, D-20251 Hamburg, Germany.	irene.dornreiter@hpi.uni-hamburg.de						Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; ARAI N, 1986, MOL CELL BIOL, V6, P3232, DOI 10.1128/MCB.6.9.3232; Aurelio ON, 2000, MOL CELL BIOL, V20, P770, DOI 10.1128/MCB.20.3.770-778.2000; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; BARTEV NA, 2004, NAT REV MOL CELL BIO, V5, P792; Baus F, 2003, EMBO J, V22, P3992, DOI 10.1093/emboj/cdg387; Chehab NH, 2000, GENE DEV, V14, P278; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cooley BC, 2001, ARCH BIOCHEM BIOPHYS, V390, P71, DOI 10.1006/abbi.2001.2347; Dehde S, 2001, MOL CELL BIOL, V21, P2581, DOI 10.1128/MCB.21.7.2581-2593.2001; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Ghosh A, 2004, MOL CELL BIOL, V24, P7987, DOI 10.1128/MCB.24.18.7987-7997.2004; Gottifredi V, 2001, P NATL ACAD SCI USA, V98, P1036, DOI 10.1073/pnas.021282898; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Kong XT, 2001, J BIOL CHEM, V276, P32990, DOI 10.1074/jbc.M103681200; KULESZMARTIN MF, 1994, MOL CELL BIOL, V14, P1698, DOI 10.1128/MCB.14.3.1698; OLIVE PL, 1992, J NATL CANCER I, V84, P707, DOI 10.1093/jnci/84.9.707; Rehberger PA, 1997, CELL GROWTH DIFFER, V8, P851; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WATERMAN JLF, 1995, EMBO J, V14, P512, DOI 10.1002/j.1460-2075.1995.tb07027.x; WILL K, 1995, NUCLEIC ACIDS RES, V23, P4023, DOI 10.1093/nar/23.20.4023	26	118	121	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 15	2005	122	1					21	32		10.1016/j.cell.2005.04.032	http://dx.doi.org/10.1016/j.cell.2005.04.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	950EC	16009130	Bronze			2022-12-28	WOS:000230839400008
J	Chen, H; Smith, GJD; Zhang, SY; Qin, K; Wang, J; Li, KS; Webster, RG; Peiris, JSM; Guan, Y				Chen, H; Smith, GJD; Zhang, SY; Qin, K; Wang, J; Li, KS; Webster, RG; Peiris, JSM; Guan, Y			H5N1 virus outbreak in migratory waterfowl	NATURE			English	Editorial Material							INFLUENZA		Shantou Univ Med Coll, Joint Influenza Res Ctr SUMC & HKU, Shantou 515031, Peoples R China; Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Chinese Acad Sci, Inst Zool, Beijing 100080, Peoples R China; St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38105 USA	University of Hong Kong; Chinese Academy of Sciences; Institute of Zoology, CAS; St Jude Children's Research Hospital	Chen, H (corresponding author), Shantou Univ Med Coll, Joint Influenza Res Ctr SUMC & HKU, Shantou 515031, Peoples R China.	yguan@hkucc.hku.hk	Zhang, Shuyi/B-5117-2011; Chen, Honglin/C-4224-2009; Peiris, Joseph Sriyal Malik/C-4380-2009	Chen, Honglin/0000-0001-5108-8338; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Smith, Gavin JD/0000-0001-5031-468X; Li, Kangsheng/0000-0002-6981-9263; Guan, Yi/0000-0001-6057-9243				CLEMENTS JF, 2000, BIRDS WORLDS CHECKLI; Ellis TM, 2004, AVIAN PATHOL, V33, P492, DOI 10.1080/03079450400003601; *FOOD AGR ORG UN, 2005, AV INFL DIS EM B, V30; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; *WHO, 2005, INT COUNTR CONS INFL	6	588	687	4	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					191	192		10.1038/nature03974	http://dx.doi.org/10.1038/nature03974			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16007072				2022-12-28	WOS:000230459500026
J	Konacki, M				Konacki, M			An extrasolar giant planet in a close triple-star system	NATURE			English	Article							PRECISION RADIAL-VELOCITIES; IODINE ABSORPTION CELL; BINARY-SYSTEMS; PROTOPLANETARY DISKS; MULTIPLICITY; COMPANION; ORBITS	Hot Jupiters are gas-giant planets orbiting with periods of 3 - 9 days around Sun-like stars. They are believed to form in a disk of gas and condensed matter at or beyond similar to 2.7 astronomical units (AU - the Sun - Earth distance) from their parent star(1,2). At such distances, there exists a sufficient amount of solid material to produce a core capable of capturing enough gas to form a giant planet. Subsequently, they migrate inward to their present close orbits(3). Here I report the detection of an unusual hot Jupiter orbiting the primary star of a triple stellar system, HD 188753. The planet has an orbital period of 3.35 days and a minimum mass of 1.14 times that of Jupiter. The primary star's mass is 1.06 times that of the Sun, 1.06 M-.. The secondary star, itself a binary stellar system, orbits the primary at an average distance of 12.3 AU with an eccentricity of 0.50. The mass of the secondary pair is 1.63 M-.. Such a close and massive secondary would have truncated a disk around the primary to a radius of only similar to 1.3 AU ( ref. 4) and might have heated it up to temperatures high enough to prohibit giant-planet formation(5,6), leaving the origin of this planet unclear.	CALTECH, Div Geol & Planetary Sci MC 150 21, Pasadena, CA 91125 USA	California Institute of Technology	Konacki, M (corresponding author), CALTECH, Div Geol & Planetary Sci MC 150 21, Pasadena, CA 91125 USA.	maciej@gps.caltech.edu	Konacki, Maciej/A-1220-2007	Konacki, Maciej/0000-0003-3400-1610				ARTYMOWICZ P, 1994, ASTROPHYS J, V421, P651, DOI 10.1086/173679; Boss AP, 2002, EARTH PLANET SC LETT, V202, P513, DOI 10.1016/S0012-821X(02)00808-7; Cutri R. M., 2003, 2MASS ALL SKY CATALO; DUQUENNOY A, 1991, ASTRON ASTROPHYS, V248, P485; DVORAK R, 1984, CELESTIAL MECH, V34, P369, DOI 10.1007/BF01235815; Eggenberger A, 2004, ASTRON ASTROPHYS, V417, P353, DOI 10.1051/0004-6361:20034164; Els SG, 2001, ASTRON ASTROPHYS, V370, pL1, DOI 10.1051/0004-6361:20010298; Girardi L, 2000, ASTRON ASTROPHYS SUP, V141, P371, DOI 10.1051/aas:2000126; GRIFFIN RF, 1977, OBSERVATORY, V97, P15; Hatzes AP, 2003, ASTROPHYS J, V599, P1383, DOI 10.1086/379281; Holman MJ, 1999, ASTRON J, V117, P621, DOI 10.1086/300695; Hough G. W., 1899, ASTRON NACHR, V149, P65; Kley W, 2001, IAU SYMP, P511; Konacki M, 2005, ASTROPHYS J, V626, P431, DOI 10.1086/429880; Konacki M, 2003, ASTROPHYS J, V597, P1076, DOI 10.1086/378561; Kornet K, 2004, ASTRON ASTROPHYS, V417, P151, DOI 10.1051/0004-6361:20034036; MARCY GW, 1992, PUBL ASTRON SOC PAC, V104, P270, DOI 10.1086/132989; Nelson AF, 2000, ASTROPHYS J, V537, pL65, DOI 10.1086/312752; Pichardo B, 2005, MON NOT R ASTRON SOC, V359, P521, DOI 10.1111/j.1365-2966.2005.08905.x; Sasselov DD, 2000, ASTROPHYS J, V528, P995, DOI 10.1086/308209; SCHNEIDER J, 2005, EXTRASOLAR PLANET EN; SIMON M, 1995, ASTROPHYS J, V443, P625, DOI 10.1086/175554; Soderhjelm S, 1999, ASTRON ASTROPHYS, V341, P121; Trilling DE, 1998, ASTROPHYS J, V500, P428, DOI 10.1086/305711; VOGT S, 1994, P SOC PHOTO-OPT INS, V2198, P362, DOI 10.1117/12.176725; WUCHTERL G, 1996, BAAS, V28, P1108; Zucker S, 2004, ASTRON ASTROPHYS, V426, P695, DOI 10.1051/0004-6361:20040384; Zucker S, 2002, ASTROPHYS J, V568, pL113, DOI 10.1086/340373; [No title captured]	30	58	58	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					230	233		10.1038/nature03856	http://dx.doi.org/10.1038/nature03856			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015323				2022-12-28	WOS:000230459500034
J	Pluchino, S; Zanotti, L; Rossi, B; Brambilla, E; Ottoboni, L; Salani, G; Martinello, M; Cattalini, A; Bergami, A; Furlan, R; Comi, G; Constantin, G; Martino, G				Pluchino, S; Zanotti, L; Rossi, B; Brambilla, E; Ottoboni, L; Salani, G; Martinello, M; Cattalini, A; Bergami, A; Furlan, R; Comi, G; Constantin, G; Martino, G			Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism	NATURE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; NITRIC-OXIDE; APOPTOSIS; BRAIN; INDUCTION; TRANSPLANTATION; EXPRESSION; MIGRATION	In degenerative disorders of the central nervous system (CNS), transplantation of neural multipotent ( stem) precursor cells (NPCs) is aimed at replacing damaged neural cells(1,2). Here we show that in CNS inflammation, NPCs are able to promote neuroprotection by maintaining undifferentiated features and exerting unexpected immune-like functions. In a mouse model of chronic CNS inflammation, systemically injected adult syngeneic NPCs use constitutively activated integrins and functional chemokine receptors to selectively enter the inflamed CNS. These undifferentiated cells survive repeated episodes of CNS inflammation by accumulating within perivascular areas where reactive astrocytes, inflamed endothelial cells and encephalitogenic T cells produce neurogenic and gliogenic regulators. In perivascular CNS areas, surviving adult NPCs induce apoptosis of blood-borne CNS-infiltrating encephalitogenic T cells, thus protecting against chronic neural tissue loss as well as disease-related disability. These results indicate that undifferentiated adult NPCs have relevant therapeutic potential in chronic inflammatory CNS disorders because they display immune-like functions that promote long-lasting neuroprotection.	Vita Salute Univ, Hosp San Raffaele, Neuroimmunol Unit DIBIT, I-20132 Milan, Italy; Vita Salute Univ, Hosp San Raffaele, Dept Neurol, I-20132 Milan, Italy; Vita Salute Univ, Hosp San Raffaele, Dept Neurophysiol, I-20132 Milan, Italy; Univ Verona, Dept Pathol, Sect Gen Pathol, I-37134 Verona, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Verona	Martino, G (corresponding author), Vita Salute Univ, Hosp San Raffaele, Neuroimmunol Unit DIBIT, Via Olgettina 58, I-20132 Milan, Italy.	martino.gianvito@hsr.it	Pluchino, Stefano/AAE-9037-2019; Ottoboni, Linda/AAC-4508-2022; Cattalini, Alessandro/K-4722-2016; martino, gianvito/AAL-2682-2020; Furlan, Roberto/N-5224-2019; Zanotti, Lucia/AAB-1484-2020; BRAMBILLA, ELENA/AAN-3742-2020; Martinello, Marianna/AAE-3863-2021; Furlan, Roberto/J-9177-2016	Pluchino, Stefano/0000-0002-6267-9472; Ottoboni, Linda/0000-0001-5412-7785; Cattalini, Alessandro/0000-0002-9833-6869; martino, gianvito/0000-0003-1295-9131; Furlan, Roberto/0000-0001-7376-9425; BRAMBILLA, ELENA/0000-0003-1399-2128; Furlan, Roberto/0000-0001-7376-9425; ROSSI, Barbara/0000-0003-4711-1528; cattalini, alessandro/0000-0001-7585-1780; Constantin, Gabriela/0000-0001-8978-3539; Martinello, Marianna/0000-0001-9811-6308				Akiyama Y, 2001, EXP NEUROL, V167, P27, DOI 10.1006/exnr.2000.7539; Alt C, 2002, EUR J IMMUNOL, V32, P2133, DOI 10.1002/1521-4141(200208)32:8<2133::AID-IMMU2133>3.0.CO;2-W; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Chu K, 2003, NEUROSCI LETT, V343, P129, DOI 10.1016/S0304-3940(03)00174-5; Constantin G, 1999, J IMMUNOL, V162, P1144; Constantin G, 1997, J IMMUNOL METHODS, V203, P35, DOI 10.1016/S0022-1759(97)00009-4; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; Fukuda S, 2003, J NEUROSCI, V23, P9357; Furlan R, 2001, J IMMUNOL, V167, P1821, DOI 10.4049/jimmunol.167.3.1821; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Karpus WJ, 1997, J LEUKOCYTE BIOL, V62, P681, DOI 10.1002/jlb.62.5.681; Lazarini F, 2000, EUR J NEUROSCI, V12, P117, DOI 10.1046/j.1460-9568.2000.00894.x; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Marsden VS, 2003, ANNU REV IMMUNOL, V21, P71, DOI 10.1146/annurev.immunol.21.120601.141029; MCRAE BL, 1992, J NEUROIMMUNOL, V38, P229, DOI 10.1016/0165-5728(92)90016-E; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Pender MP, 2001, GLIA, V36, P137, DOI 10.1002/glia.1103; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Ricci-Vitiani L, 2004, J EXP MED, V200, P1257, DOI 10.1084/jem.20040921; Schere-Levy C, 2003, EXP CELL RES, V282, P35, DOI 10.1006/excr.2002.5666; Tarrant TK, 1999, J EXP MED, V189, P219, DOI 10.1084/jem.189.2.219; Vandenbark AA, 2000, INT IMMUNOL, V12, P57, DOI 10.1093/intimm/12.1.57; Weishaupt A, 2000, J IMMUNOL, V165, P7157, DOI 10.4049/jimmunol.165.12.7157; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Zhang XH, 1997, J EXP MED, V185, P1837, DOI 10.1084/jem.185.10.1837	27	606	634	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					266	271		10.1038/nature03889	http://dx.doi.org/10.1038/nature03889			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015332				2022-12-28	WOS:000230459500043
J	Miller, GH; Fogel, ML; Magee, JW; Gagan, MK; Clarke, SJ; Johnson, BJ				Miller, GH; Fogel, ML; Magee, JW; Gagan, MK; Clarke, SJ; Johnson, BJ			Ecosystem collapse in pleistocene Australia and a human role in megafaunal extinction	SCIENCE			English	Article							HUMAN OCCUPATION; NORTHERN AUSTRALIA; CLIMATIC-CHANGE; CONTINENT; TURNOVER; MONSOON; RECORD; CARBON; AGES	Most of Australia's largest mammals became extinct 50,000 to 45,000 years ago, shortly after humans colonized the continent. Without exceptional climate change at that time, a human cause is inferred, but a mechanism remains elusive. A 140,000-year record of dietary delta(13)C documents a permanent reduction in food sources available to the Australian emu, beginning about the time of human colonization; a change replicated at three widely separated sites and in the marsupial wombat. We speculate that human firing of landscapes rapidly converted a drought-adapted mosaic of trees, shrubs, and nutritious grasslands to the modern fire-adapted desert scrub. Animals that could adapt survived; those that could not, became extinct.	Univ Colorado, INSTAAR & Geol Sci, Boulder, CO 80309 USA; Carnegie Inst Washington, Geophys Lab, Washington, DC 20015 USA; Australian Natl Univ, Res Sch Earth Sci, Dept Earth & Marine Sci, Canberra, ACT 0200, Australia; Charles Sturt Univ, Wagga Wagga, NSW 2678, Australia; Bates Coll, Dept Geol, Lewiston, ME 04240 USA	University of Colorado System; University of Colorado Boulder; Carnegie Institution for Science; Australian National University; Charles Sturt University	Miller, GH (corresponding author), Univ Colorado, INSTAAR & Geol Sci, Boulder, CO 80309 USA.		Gagan, Michael/L-5014-2018; Fogel, Marilyn L/M-2395-2015	Gagan, Michael/0000-0002-8279-323X; Fogel, Marilyn L/0000-0002-1176-3818				Barrett DJ, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001860; Bowler JM, 2003, NATURE, V421, P837, DOI 10.1038/nature01383; Hesse PP, 2004, QUATERN INT, V118, P87, DOI 10.1016/S1040-6182(03)00132-0; HOBSON KA, 1995, CONDOR, V97, P752, DOI 10.2307/1369183; Johnson BJ, 1999, SCIENCE, V284, P1150, DOI 10.1126/science.284.5417.1150; Johnson BJ, 1998, GEOCHIM COSMOCHIM AC, V62, P2451, DOI 10.1016/S0016-7037(98)00175-6; Johnson CN, 2004, AUSTRAL ECOL, V29, P553, DOI 10.1111/j.1442-9993.2004.01389.x; KERSHAW AP, 1986, NATURE, V322, P47, DOI 10.1038/322047a0; Kershaw P, 2003, FRESHWATER BIOL, V48, P1274, DOI 10.1046/j.1365-2427.2003.01085.x; Koch P.L., 1994, P63; Magee JW, 2004, GEOLOGY, V32, P885, DOI 10.1130/G20672.1; Miller GH, 1999, SCIENCE, V283, P205, DOI 10.1126/science.283.5399.205; Miller GH, 2000, PERSPECTIVES AMINO A, P161; O'Connell JF, 2004, J ARCHAEOL SCI, V31, P835, DOI 10.1016/j.jas.2003.11.005; Roberts R, 1998, NATURE, V393, P358, DOI 10.1038/30718; Roberts RG, 2001, SCIENCE, V292, P1888, DOI 10.1126/science.1060264; ROBERTS RG, 1990, NATURE, V345, P153, DOI 10.1038/345153a0; Turney CSM, 2001, J QUATERNARY SCI, V16, P767, DOI 10.1002/jqs.643; Turney CSM, 2001, QUATERNARY RES, V55, P3, DOI 10.1006/qres.2000.2195; van der Kaars S, 2002, REV PALAEOBOT PALYNO, V120, P17, DOI 10.1016/S0034-6667(02)00075-1	20	260	269	0	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2005	309	5732					287	290		10.1126/science.1111288	http://dx.doi.org/10.1126/science.1111288			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002615				2022-12-28	WOS:000230449800041
J	Pal, SK; Itkis, ME; Tham, FS; Reed, RW; Oakley, RT; Haddon, RC				Pal, SK; Itkis, ME; Tham, FS; Reed, RW; Oakley, RT; Haddon, RC			Resonating valence-bond ground state in a phenalenyl-based neutral radical conductor	SCIENCE			English	Article							TRIANGULAR LATTICE ANTIFERROMAGNETS; MOLECULAR CONDUCTORS; OPTICAL-TRANSITIONS; PHYSICAL-PROPERTIES; CRYSTAL-STRUCTURE; ASSOCIATION; COMPLEX; NATIO2; LINIO2; S=1/2	An organic material composed of neutral free radicals based on the spiro-biphenalenyl system exhibits a room temperature conductivity of 0.3 siemens per centimeter and a high-symmetry crystal structure. It displays the temperature-independent Pauli paramagnetism characteristic of a metal with a magnetic susceptibility that implies a density of states at the Fermi level of 15.5 states per electron volt per mote. Extended Huckel calculations indicate that the solid is a three-dimensional organic metal with a band width of similar to 0.5 electron volts. However, the compound shows activated conductivity (activation energy, 0.054 electron volts) and an optical energy gap of 0.34 electron volts. We argue that these apparently contradictory properties are best resolved in terms of the resonating valence-bond ground state originally suggested by Pauling, but with the modifications introduced by Anderson.	Univ Calif Riverside, Dept Chem & Chem Environm, Riverside, CA 92521 USA; Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada	University of California System; University of California Riverside; University of Waterloo	Haddon, RC (corresponding author), Univ Calif Riverside, Dept Chem & Chem Environm, Riverside, CA 92521 USA.	haddon@ucr.edu	Haddon, Robert C/A-2528-2008	Haddon, Robert C/0000-0002-7903-5139				ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; Chi X, 2001, J AM CHEM SOC, V123, P4041, DOI 10.1021/ja0039785; Chi X, 1999, J AM CHEM SOC, V121, P10395, DOI 10.1021/ja992040c; FAZEKAS P, 1974, PHILOS MAG, V30, P423, DOI 10.1080/14786439808206568; Ganesan V, 2003, J AM CHEM SOC, V125, P2559, DOI 10.1021/ja0211611; Goto K, 1999, J AM CHEM SOC, V121, P1619, DOI 10.1021/ja9836242; HADDON RC, 1994, ADV MATER, V6, P316, DOI 10.1002/adma.19940060415; HADDON RC, 1986, TETRAHEDRON, V42, P6293, DOI 10.1016/S0040-4020(01)88092-3; HIRAKAWA K, 1985, J PHYS SOC JPN, V54, P3526, DOI 10.1143/JPSJ.54.3526; Huang JS, 2003, J AM CHEM SOC, V125, P13334, DOI 10.1021/ja038038+; Itkis ME, 2002, SCIENCE, V296, P1443, DOI 10.1126/science.1071372; Lu JM, 2003, J AM CHEM SOC, V125, P12161, DOI 10.1021/ja0364928; Murata T, 2004, ANGEW CHEM INT EDIT, V43, P6343, DOI 10.1002/anie.200460801; Pal SK, 2004, J AM CHEM SOC, V126, P1478, DOI 10.1021/ja037864f; PAULING L, 1948, NATURE, V161, P1019, DOI 10.1038/1611019b0; Powell BJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047004; Small D, 2004, J AM CHEM SOC, V126, P13850, DOI 10.1021/ja046770i; YAMADA I, 1985, J PHYS SOC JPN, V54, P3571, DOI 10.1143/JPSJ.54.3571	19	232	234	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2005	309	5732					281	284		10.1126/science.1112446	http://dx.doi.org/10.1126/science.1112446			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002614				2022-12-28	WOS:000230449800039
J	Lamming, DW; Latorre-Esteves, M; Medvedik, O; Wong, SN; Tsang, FA; Wang, C; Lin, SJ; Sinclair, DA				Lamming, DW; Latorre-Esteves, M; Medvedik, O; Wong, SN; Tsang, FA; Wang, C; Lin, SJ; Sinclair, DA			HST2 mediates SIR2-independent life-span extension by catorie restriction	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; DEACETYLASE ACTIVITY; PROTEIN SIR2; GENE FAMILY; YEAST; NAD; LONGEVITY; NICOTINAMIDE; REQUIREMENT	Calorie restriction (CR) extends the life span of numerous species, from yeast to rodents. Yeast Sir2 is a nicotinamide adenine dinucleotide (NAD+)dependent histone deacetylase that has been proposed to mediate the effects of CR. However, this hypothesis has been challenged by the observation that CR can extend yeast life span in the absence of Sir2. Here, we show that Sir2-independent life-span extension is mediated by Hst2, a Sir2 homolog that promotes the stability of repetitive ribosomal DNA, the same mechanism by which Sir2 extends life span. These findings demonstrate that the maintenance of DNA stability is critical for yeast life-span extension by CR and suggest that, in higher organisms, multiple members of the Sir2 family may regulate life span in response to diet.	Harvard Univ, Sch Med, Dept Pathol, Paul F Glenn Labs Biol Mech Aging, Boston, MA 02115 USA; Univ Calif Davis, Ctr Genet & Dev, Davis, CA 95616 USA; Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA	Harvard University; Harvard Medical School; University of California System; University of California Davis; University of California System; University of California Davis	Lin, SJ (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Paul F Glenn Labs Biol Mech Aging, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	slin@ucdavis.edu; david_sindair@hms.harvard.edu	Lamming, Dudley/O-7191-2015; Latorre-Esteves, Magda/GMW-6353-2022	Lamming, Dudley/0000-0002-0079-4467; Sinclair, David/0000-0002-9936-436X	NIA NIH HHS [R01 AG024351] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG024351] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Falcon AA, 2003, J BIOL CHEM, V278, P41607, DOI 10.1074/jbc.M307025200; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Houthoofd K, 2003, EXP GERONTOL, V38, P947, DOI 10.1016/S0531-5565(03)00161-X; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jiang JC, 2002, EXP GERONTOL, V37, P1023, DOI 10.1016/S0531-5565(02)00064-5; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2005, MECH AGEING DEV, V126, P491, DOI 10.1016/j.mad.2004.10.007; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; KENNEDY BK, 1995, CELL, V80, P485, DOI 10.1016/0092-8674(95)90499-9; Kobayashi T, 1998, GENE DEV, V12, P3821, DOI 10.1101/gad.12.24.3821; Landry J, 2000, BIOCHEM BIOPH RES CO, V278, P685, DOI 10.1006/bbrc.2000.3854; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Perrod S, 2001, EMBO J, V20, P197, DOI 10.1093/emboj/20.1.197; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789	30	180	191	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2005	309	5742					1861	1864		10.1126/science.1113611	http://dx.doi.org/10.1126/science.1113611			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965ZN	16051752				2022-12-28	WOS:000231989500051
J	Emanuel, K				Emanuel, K			Increasing destructiveness of tropical cyclones over the past 30 years	NATURE			English	Article							HURRICANE INTENSITY; UNITED-STATES; EL-NINO; CLIMATE; FREQUENCY; DAMAGES; TRENDS	Theory(1) and modelling(2) predict that hurricane intensity should increase with increasing global mean temperatures, but work on the detection of trends in hurricane activity has focused mostly on their frequency(3,4) and shows no trend. Here I define an index of the potential destructiveness of hurricanes based on the total dissipation of power, integrated over the lifetime of the cyclone, and show that this index has increased markedly since the mid-1970s. This trend is due to both longer storm lifetimes and greater storm intensities. I find that the record of net hurricane power dissipation is highly correlated with tropical sea surface temperature, reflecting well-documented climate signals, including multi-decadal oscillations in the North Atlantic and North Pacific, and global warming. My results suggest that future warming may lead to an upward trend in tropical cyclone destructive potential, and - taking into account an increasing coastal population a substantial increase in hurricane-related losses in the twenty-first century.	MIT, Program Atmospheres Oceans & Climate, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Emanuel, K (corresponding author), MIT, Program Atmospheres Oceans & Climate, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	emanuel@texmex.mit.edu						Bister M, 1998, METEOROL ATMOS PHYS, V65, P233, DOI 10.1007/BF01030791; CAMARGO SJ, IN PRESS J CLIN; Chan JCL, 1996, GEOPHYS RES LETT, V23, P2765, DOI 10.1029/96GL02637; Emanuel K, 2000, MON WEATHER REV, V128, P1139, DOI 10.1175/1520-0493(2000)128<1139:ASAOTC>2.0.CO;2; Emanuel K, 2001, J GEOPHYS RES-ATMOS, V106, P14771, DOI 10.1029/2000JD900641; Emanuel K., 1998, WEATHER, V54, P107; EMANUEL KA, 1987, NATURE, V326, P483, DOI 10.1038/326483a0; Goldenberg SB, 2001, SCIENCE, V293, P474, DOI 10.1126/science.1060040; GRAY WM, 1984, MON WEATHER REV, V112, P1649, DOI 10.1175/1520-0493(1984)112<1649:ASHFPI>2.0.CO;2; Henderson-Sellers A, 1998, B AM METEOROL SOC, V79, P19, DOI 10.1175/1520-0477(1998)079<0019:TCAGCC>2.0.CO;2; Knutson TR, 2004, J CLIMATE, V17, P3477, DOI [10.1175/1520-0442(2004)017<3477:IOCWOS>2.0.CO;2, 10.1175/1520-0442(2004)017&lt;3477:IOCWOS&gt;2.0.CO;2]; Landsea CW, 1996, GEOPHYS RES LETT, V23, P1697, DOI 10.1029/96GL01029; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Mallen KJ, 2005, J ATMOS SCI, V62, P408, DOI 10.1175/JAS-3377.1; Pielke RA, 1998, WEATHER FORECAST, V13, P621, DOI 10.1175/1520-0434(1998)013<0621:NHDITU>2.0.CO;2; Pielke RA, 1999, B AM METEOROL SOC, V80, P2027, DOI 10.1175/1520-0477(1999)080<2027:LNAENO>2.0.CO;2; Pielke RA, 2003, NAT HAZARDS REV, V4, P101, DOI 10.1061/(ASCE)1527-6988(2003)4:3(101); Powell MD, 2003, NATURE, V422, P279, DOI 10.1038/nature01481; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Saunders MA, 1997, GEOPHYS RES LETT, V24, P1255, DOI 10.1029/97GL01164; Southern R L, 1979, AUST METEOROL MAG, V27, P175; WEATHERFORD CL, 1988, MON WEATHER REV, V116, P1032, DOI 10.1175/1520-0493(1988)116<1032:TSARBA>2.0.CO;2	22	2329	2496	43	758	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2005	436	7051					686	688		10.1038/nature03906	http://dx.doi.org/10.1038/nature03906			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951XA	16056221				2022-12-28	WOS:000230964500040
J	Horton, R				Horton, R			Expression of concern: Indo-Mediterranean Diet Heart Study	LANCET			English	Editorial Material							INTERNATIONAL COLLABORATION; DISEASE; TRIAL		The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							*INT COMM MED J ED, UN REQ MAN SUBM BIOM; Lucas AO, 2005, B WORLD HEALTH ORGAN, V83, P482; SINGH RB, 1992, BRIT MED J, V304, P1015, DOI 10.1136/bmj.304.6833.1015; Singh RB, 2002, LANCET, V360, P1455, DOI 10.1016/S0140-6736(02)11472-3; Swingler GH, 2005, B WORLD HEALTH ORGAN, V83, P511	5	48	49	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 30	2005	366	9483					354	356		10.1016/S0140-6736(05)67006-7	http://dx.doi.org/10.1016/S0140-6736(05)67006-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	950IB	16054927				2022-12-28	WOS:000230849700010
J	Krantz, BA; Melnyk, RA; Zhang, S; Juris, SJ; Lacy, DB; Wu, ZY; Finkelstein, A; Collier, RJ				Krantz, BA; Melnyk, RA; Zhang, S; Juris, SJ; Lacy, DB; Wu, ZY; Finkelstein, A; Collier, RJ			A phenylalanine clamp catalyzes protein translocation through the anthrax toxin pore	SCIENCE			English	Article							PROTECTIVE ANTIGEN CHANNEL; POTASSIUM CHANNEL; LETHAL; MUTATIONS; BILAYERS; RECEPTOR; BLOCK	The protective antigen component of anthrax toxin forms a homoheptameric pore in the endosomal membrane, creating a narrow passageway for the enzymatic components of the toxin to enter the cytosol. We found that, during conversion of the heptameric precursor to the pore, the seven phenylalanine-427 residues converged within the lumen, generating a radially symmetric heptad of solvent-exposed aromatic rings. This "phi-clamp" structure was required for protein translocation and comprised the major conductance-blocking site for hydrophobic drugs and mode[ cations. We conclude that the clamp serves a chaperone-like function, interacting with hydrophobic sequences presented by the protein substrate as it unfolds during translocation.	Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA	Harvard University; Harvard Medical School; Yeshiva University; Albert Einstein College of Medicine	Collier, RJ (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, 200 Longwood Ave, Boston, MA 02115 USA.	jcollier@hms.harvard.edu	Lacy, D. Borden/AFQ-2203-2022; Melnyk, Roman/GQA-9908-2022	Collier, R John/0000-0002-2427-4239; Lacy, Borden/0000-0003-2273-8121; Krantz, Bryan/0000-0002-4911-5824	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI062204, R37AI022021, R01AI022021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029210, R01GM029210] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI022021, AI022021, F32 AI062204, F32 AI062204-01, AI062204] Funding Source: Medline; NIGMS NIH HHS [R37 GM029210, GM29210] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benson EL, 1998, BIOCHEMISTRY-US, V37, P3941, DOI 10.1021/bi972657b; BLAUSTEIN RO, 1989, P NATL ACAD SCI USA, V86, P2209, DOI 10.1073/pnas.86.7.2209; BLAUSTEIN RO, 1990, J GEN PHYSIOL, V96, P905, DOI 10.1085/jgp.96.5.905; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; HILLE B, 1968, J GEN PHYSIOL, V51, P199, DOI 10.1085/jgp.51.2.199; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Krantz BA, 2004, J MOL BIOL, V344, P739, DOI 10.1016/j.jmb.2004.09.067; KRANTZ BA, UNPUB; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; Miller CJ, 1999, BIOCHEMISTRY-US, V38, P10432, DOI 10.1021/bi990792d; Mourez M, 2003, P NATL ACAD SCI USA, V100, P13803, DOI 10.1073/pnas.2436299100; Nassi S, 2002, BIOCHEMISTRY-US, V41, P1445, DOI 10.1021/bi0119518; Orlik F, 2005, BIOPHYS J, V88, P1715, DOI 10.1529/biophysj.104.050336; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; Sellman BR, 2001, J BIOL CHEM, V276, P8371, DOI 10.1074/jbc.M008309200; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; WESSON L, 1992, PROTEIN SCI, V1, P227; Zacharias N, 2002, TRENDS PHARMACOL SCI, V23, P281, DOI 10.1016/S0165-6147(02)02027-8; Zhang S, 2004, P NATL ACAD SCI USA, V101, P16756, DOI 10.1073/pnas.0405754101; Zhang S, 2004, BIOPHYS J, V87, P3842, DOI 10.1529/biophysj.104.050864; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	24	232	241	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2005	309	5735					777	781		10.1126/science.1113380	http://dx.doi.org/10.1126/science.1113380			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051798	Green Accepted			2022-12-28	WOS:000230938200052
J	Remy, JJ; Hobert, O				Remy, JJ; Hobert, O			An interneural chemoreceptor required for olfactory imprinting in C-elegans	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; NERVOUS-SYSTEM; RECEPTORS; GENES; NEURONS	Animals alter their behavioral patterns in an experience-dependent manner. Olfactory imprinting is a process in which the exposure of animals to olfactory cues during specific and restricted time windows leaves a permanent memory ("olfactory imprint") that shapes the animal's behavior upon encountering the olfactory cues at later times. We found that Caenorhabditis elegans displays olfactory imprinting behavior that is mediated by a single pair of interneurons. To function in olfactory imprinting, this interneuron pair must express a G protein-coupled chemoreceptor family member encoded by the Sra-11 gene. Our study provides insights into the cellular and molecular basis of olfactory imprinting and reveals a function for a chemosensory receptor family member in interneurons.	Inst Dev Biol, CNRS, UMR 6156, Lab NMDA, F-13288 Marseille, France; Columbia Univ, Med Ctr, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys,Howard Hughes Med Inst, New York, NY 10032 USA	Centre National de la Recherche Scientifique (CNRS); Columbia University; Howard Hughes Medical Institute	Remy, JJ (corresponding author), Inst Dev Biol, CNRS, UMR 6156, Lab NMDA, F-13288 Marseille, France.	remy@ibdm.univ-mrs.fr; or38@columbia.edu		Hobert, Oliver/0000-0002-7634-2854	NINDS NIH HHS [NS039996-05] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039996, R37NS039996] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Hobert O, 2003, J NEUROBIOL, V54, P203, DOI 10.1002/neu.10168; Hudson Robyn, 1993, Current Opinion in Neurobiology, V3, P548, DOI 10.1016/0959-4388(93)90054-3; Sullivan RM, 2003, ANN NY ACAD SCI, V1008, P122, DOI 10.1196/annals.1301.013; TRENT C, 1982, THESIS MIT; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; TSALIK EL, 2003, THESIS COLUMBIA U; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	12	65	72	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2005	309	5735					787	790		10.1126/science.1114209	http://dx.doi.org/10.1126/science.1114209			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051801				2022-12-28	WOS:000230938200055
J	Jha, AK; Li, ZH; Orav, EJ; Epstein, AM				Jha, AK; Li, ZH; Orav, EJ; Epstein, AM			Care in US hospitals - The Hospital Quality Alliance Program.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; OF-CARE; MEDICARE BENEFICIARIES; MYOCARDIAL-INFARCTION; GUIDELINES; MANAGEMENT; MORTALITY; OUTCOMES; ADULTS	Background: The Hospital Quality Alliance (HQA) is the first initiative that routinely reports data on hospitals' performance nationally. Heretofore, such data have been unavailable. Methods: We used data collected by the Centers for Medicare and Medicaid Services on 10 indicators of the quality of care for acute myocardial infarction, congestive heart failure, and pneumonia. The main outcome measures were hospitals' performance with respect to each indicator and summary scores for each clinical condition. Predictors of a high level of performance were determined with the use of multivariable linear regression. Results: A total of 3558 hospitals reported data on at least one stable measure (defined as information obtained from discharge data from at least 25 patients) during the first half of 2004. Median performance scores (expressed as the percentage of patients who satisfied the criterion) were at least 90 percent for 5 of the 10 measures but lower for the other 5. Performance varied moderately among large hospital-referral regions, with the top-ranked regions scoring 12 percentage points (for acute myocardial infarction) to 23 percentage points (for pneumonia) higher than the bottom-ranked regions. A high quality of care for acute myocardial infarction predicted a high quality of care for congestive heart failure but was only marginally better than chance at predicting a high quality of care for pneumonia. Characteristics associated with small but significant increases in performance included being an academic hospital, being in the Northeast or Midwest, and being a not-for-profit hospital. Conclusions: Analysis of data from the new HQA national reporting system shows that performance varies among hospitals and across indicators. Given this variation and small differences based on hospitals' characteristics, performance reporting will probably need to include numerous clinical conditions from a broad range of hospitals.	Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA; Boston Vet Affairs Healthcare Syst, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Jha, AK (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	ajha@hsph.harvard.edu						Allison JJ, 2000, JAMA-J AM MED ASSOC, V284, P1256, DOI 10.1001/jama.284.10.1256; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Ayanian JZ, 2002, MILBANK Q, V80, P569, DOI 10.1111/1468-0009.00023; Bradley EH, 2001, JAMA-J AM MED ASSOC, V285, P2604, DOI 10.1001/jama.285.20.2604; Devereaux PJ, 2002, JAMA-J AM MED ASSOC, V288, P2449, DOI 10.1001/jama.288.19.2449; DEVEREAUX PJ, 2004, JAMA-J AM MED ASSOC, V291, P186; Friend JAR, 2001, THORAX, V56, P1, DOI 10.1136/thorax.56.1.1; Galvin R, 2002, NEW ENGL J MED, V347, P939, DOI 10.1056/NEJMsb012850; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Jencks SF, 2002, JAMA-J AM MED ASSOC, V289, P2649; Mandell LA, 2003, CLIN INFECT DIS, V37, P1405, DOI 10.1086/380488; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; Milstein A, 2000, Eff Clin Pract, V3, P313; MILSTEIN A, 2001, EFF CLIN PRACT, V4, P94; *NAT COMM QUAL ASS, 2005, HEDIS 2005, V2; Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010; Sloan FA, 2003, MED CARE, V41, P1193, DOI 10.1097/01.MLR.0000088569.50763.15; Wennberg JE, 1999, DARTMOUTH ATLAS HLTH; Williams SC, 2005, NEW ENGL J MED, V353, P255, DOI 10.1056/NEJMsa043778	22	372	374	1	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2005	353	3					265	274		10.1056/NEJMsa051249	http://dx.doi.org/10.1056/NEJMsa051249			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YH	16034012				2022-12-28	WOS:000230608700007
J	Beek, CA; Richard, H; Tu, JV; Pilote, L				Beek, CA; Richard, H; Tu, JV; Pilote, L			Administrative data feedback for effective cardiac treatment - AFFECT, a cluster randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; QUALITY-OF-CARE; COOPERATIVE CARDIOVASCULAR PROJECT; SECONDARY PREVENTION; CANADIAN PROVINCES; IMPROVING QUALITY; MEDICARE PATIENTS; IMPROVEMENT; HOSPITALS; MORTALITY	Context Hospital report cards are increasingly being implemented for quality improvement despite lack of strong evidence to support their use. Objective To determine whether hospital report cards constructed using linked hospital and prescription administrative databases are effective for improving quality of care for acute myocardial infarction (AMI). Design The Administrative Data Feedback for Effective Cardiac Treatment (AFFECT) study, a cluster randomized trial. Setting and Patients Patients with AMI who were admitted to 76 acute care hospitals in Quebec that treated at least 30 AMI patients per year between April 1, 1999, and March 31, 2003. Intervention Hospitals were randomly assigned to receive rapid (immediate; n = 38 hospitals and 2533 patients) or delayed (14 months; n = 38 hospitals and 3142 patients) confidential feedback on quality indicators constructed using administrative data. Main Outcome Measures Quality indicators pertaining to processes of care and outcomes of patients admitted between 4 and 10 months after randomization. The primary indicator was the proportion of elderly survivors of AMI at each study hospital who filled a prescription for a beta-blocker within 30 days after discharge. Results At follow-up, adjusted prescription rates within 30 days after discharge were similar in the early vs late groups (for beta-blockers, odds ratio [OR], 1.06; 95% confidence interval [CI], 0.82-1.37; for angiotensin-converting enzyme inhibitors, OR, 1.17; 95% Cl, 0.90-1.52; for lipid-lowering drugs, OR, 1.14; 95% Cl, 0.86-1.50; and for aspirin, OR, 1.05; 95% Cl, 0.84-1.33). In addition, adjusted mortality was similar in both groups, as were length of in-hospital stay, physician visits after discharge, waiting times for invasive cardiac procedures, and readmissions for cardiac complications. Conclusions Feedback based on one-time, confidential report cards constructed using administrative data is not an effective strategy for quality improvement regarding care of patients with AMI. A need exists for further studies to rigorously evaluate the effectiveness of more intensive report card interventions.	McGill Univ, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ H3G 1A4, Canada; Univ Toronto, Summybrook & Womens Coll Hlth Sci Ctr, Inst Clin Evaluat Sci, Toronto, ON, Canada; Univ Toronto, Summybrook & Womens Coll Hlth Sci Ctr, Div Gen Internal Med, Toronto, ON, Canada	McGill University; University of Toronto; University of Toronto	Pilote, L (corresponding author), McGill Univ, Ctr Hlth, Div Clin Epidemiol, 1650 Cedar Ave,Suite L10-421, Montreal, PQ H3G 1A4, Canada.	louise.pilote@mcgill.ca		Pilote, Louise/0000-0002-6159-0628; Tu, Jack/0000-0003-0111-722X				Allison JJ, 2000, JAMA-J AM MED ASSOC, V284, P1256, DOI 10.1001/jama.284.10.1256; AYANIAN JZ, 1994, NEW ENGL J MED, V331, P1136, DOI 10.1056/NEJM199410273311707; Barron HV, 1998, J AM COLL CARDIOL, V32, P360, DOI 10.1016/S0735-1097(98)00225-3; Bentley J M, 1998, Jt Comm J Qual Improv, V24, P40; Bradley EH, 2004, QUAL SAF HEALTH CARE, V13, P26, DOI 10.1136/qhc.13.1.26; Bradley EH, 2001, JAMA-J AM MED ASSOC, V285, P2604, DOI 10.1001/jama.285.20.2604; *COOP CARD PROJ BE, 1998, JOINT COMM J QUAL IM, V24, P480; Dans P E, 1998, Jt Comm J Qual Improv, V24, P21; Ghali WA, 1997, JAMA-J AM MED ASSOC, V277, P379, DOI 10.1001/jama.277.5.379; HALABI AR, 2001, CAN J CARDIOL, V17, pC152; Horbar JD, 2004, BMJ-BRIT MED J, V329, P1004, DOI 10.1136/bmj.329.7473.1004; *I CLIN EV SCI, 2004, QUAL CARD CAR ONT; Kiefe CI, 2001, JAMA-J AM MED ASSOC, V285, P2871, DOI 10.1001/jama.285.22.2871; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; LaBresh KA, 2004, ARCH INTERN MED, V164, P203, DOI 10.1001/archinte.164.2.203; Levy AR, 1999, CAN J CARDIOL, V15, P1277; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; Marshall MN, 2000, JAMA-J AM MED ASSOC, V283, P1866, DOI 10.1001/jama.283.14.1866; Mehta RH, 2002, JAMA-J AM MED ASSOC, V287, P1269, DOI 10.1001/jama.287.10.1269; Mehta RH, 2004, J AM COLL CARDIOL, V43, P2166, DOI 10.1016/j.jacc.2003.08.067; OBRIEN MAT, 2001, COCHRANE DATABASE SY, P259; Ornstein S, 2004, ANN INTERN MED, V141, P523, DOI 10.7326/0003-4819-141-7-200410050-00008; Pilote L, 2004, CAN J CARDIOL, V20, P491; Pilote L, 2000, CAN MED ASSOC J, V163, P31; Pilote L, 2004, CAN J CARDIOL, V20, P61; Rainwater J A, 1998, Jt Comm J Qual Improv, V24, P31; Ramsay S, 2002, LANCET, V359, P329, DOI 10.1016/S0140-6736(02)07563-3; Romano PS, 1999, MED CARE, V37, P295, DOI 10.1097/00005650-199903000-00009; TAMBLYN R, 1995, J CLIN EPIDEMIOL, V48, P999, DOI 10.1016/0895-4356(94)00234-H; Thomas J W, 1998, Jt Comm J Qual Improv, V24, P50; TOPOL EJ, 1994, ANN INTERN MED, V120, P65, DOI 10.7326/0003-4819-120-1-199401010-00011; Tran CTT, 2003, CAN J CARDIOL, V19, P38; Tu JV, 2001, J AM COLL CARDIOL, V37, P992, DOI 10.1016/S0735-1097(01)01109-3; Tu JV, 2003, CAN J CARDIOL, V19, P893; Tu JV, 2001, CAN MED ASSOC J, V164, P1709; TU JV, 1999, CARDIOVASCULAR HLTH, P199; 2005, FED REG, V70, P13397	38	43	45	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2005	294	3					309	317		10.1001/jama.294.3.309	http://dx.doi.org/10.1001/jama.294.3.309			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YL	16030275	Bronze			2022-12-28	WOS:000230609100015
J	Rosen, RC				Rosen, RC			Reproductive health problems in ageing men	LANCET			English	Editorial Material							URINARY-TRACT SYMPTOMS; BENIGN PROSTATIC HYPERPLASIA; RANDOMIZED CONTROLLED-TRIAL; ERECTILE DYSFUNCTION; SEXUAL DYSFUNCTION; POPULATION; PREVALENCE		Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Rosen, RC (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA.	rosen@umdnj.edu						Araujo AB, 1998, PSYCHOSOM MED, V60, P458, DOI 10.1097/00006842-199807000-00011; Bacon CG, 2003, ANN INTERN MED, V139, P161, DOI 10.7326/0003-4819-139-3-200308050-00005; Brookes ST, 2002, BRIT MED J, V324, P1059, DOI 10.1136/bmj.324.7345.1059; Esposito K, 2004, JAMA-J AM MED ASSOC, V291, P2978, DOI 10.1001/jama.291.24.2978; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; HOPPS CV, 2003, J UROL S4, V169, P168; Kaiser DR, 2004, J AM COLL CARDIOL, V43, P179, DOI 10.1016/j.jacc.2003.07.042; Kirby M, 2001, INT J CLIN PRACT, V55, P614; MAATMAN TJ, 1987, UROLOGY, V29, P589, DOI 10.1016/0090-4295(87)90097-5; McVary KT, 2003, BJU INT, V91, P770, DOI 10.1046/j.1464-410X.2003.04252.x; Narayan P, 2001, UROLOGY, V57, P466, DOI 10.1016/S0090-4295(00)01042-6; Nicolosi A, 2003, INT J IMPOT RES, V15, P253, DOI 10.1038/sj.ijir.3901010; Rosen R, 2003, EUR UROL, V44, P637, DOI 10.1016/j.eururo.2003.08.015; Rosen RC, 2004, CURR MED RES OPIN, V20, P607, DOI 10.1185/030079904125003467	14	14	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 16	2005	366	9481					183	185		10.1016/S0140-6736(05)66885-7	http://dx.doi.org/10.1016/S0140-6736(05)66885-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	945RG	16023492				2022-12-28	WOS:000230519200006
J	Filipowicz, W				Filipowicz, W			RNAi: The nuts and bolts of the RISC machine	CELL			English	Review							DOUBLE-STRANDED-RNA; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SLICER ACTIVITY; PIWI PROTEIN; PAZ DOMAIN; RECOGNITION; ARGONAUTE2; DROSOPHILA; CLEAVAGE	Research on RNA interference and microRNA pathways continues to accelerate. Combinations of biochemical, genetic, and structural approaches are providing new insights into the mechanism by which small, 21 nt long RNAs find their way into the RISC effector complexes and how the RISCs execute their mission of RNA-guided posttranscriptional gene silencing.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Filipowicz, W (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.	filipowi@fmi.ch						Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Scadden ADJ, 2005, NAT STRUCT MOL BIOL, V12, P489, DOI 10.1038/nsmb936; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017	20	385	421	2	58	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 15	2005	122	1					17	20		10.1016/j.cell.2005.06.023	http://dx.doi.org/10.1016/j.cell.2005.06.023			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	950EC	16009129	Bronze			2022-12-28	WOS:000230839400007
J	Dagan, R; Leventhal, A; Anis, E; Slater, P; Ashur, Y; Shouval, D				Dagan, R; Leventhal, A; Anis, E; Slater, P; Ashur, Y; Shouval, D			Incidence of hepatitis A in Israel following universal immunization of toddlers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMMUNITY-WIDE OUTBREAK; VIRAL-HEPATITIS; RISK-FACTORS; VACCINATION; IMMUNOGENICITY; EPIDEMIOLOGY; SURVEILLANCE; TRANSMISSION; PROTECTION; PROGRAM	Context In Israel, the mean annual incidence of hepatitis A disease was 50.4 per 100 000 during 1993-1998. A 2-dose universal hepatitis A immunization program aimed at children aged 18 and 24 months (without a catch-up campaign) was started in 1999. Objective To observe the impact of toddlers-only universal vaccination on hepatitis A virus disease in Israel. Design and Setting Ongoing passive national surveillance of hepatitis A cases in Israel has been conducted since 1993 by the Ministry of Health. An active surveillance program in the Jerusalem district in 1999-2003 provided validation for the passive program. Main Outcome Measure Incidence of reported hepatitis A disease, 1993-2004. Results Overall vaccine coverage in Israel in 2001-2002 was 90% for the first dose and 85% for the second dose. A decline in disease rates was observed before 1999 among the Jewish but not the non-Jewish population. After initiation of the program, a sharp decrease in disease rates was observed in both populations. The annual incidence of 2.2 to 2.5 per 100000 during 2002-2004 represents a 95% or greater reduction for each year with respect to the mean incidence during 1993-1998 (P<.001). For children aged 1 through 4 years, a 98.2% reduction in disease was observed in 2002-2004, compared with the prevaccination period (P<.001). However, a sharp decline was also observed in all other age groups (84.3% [<1 year], 96.5% [5-9 years], 95.2% [10-14 years], 91.3% [15-44 years], 90.6% [45-64 years], and 77.3% [ >= 65 years]). Among the Jewish population in the Jerusalem district, in whom the active surveillance program was successfully conducted, a more than 90% reduction of disease was demonstrated. Of the 433 cases reported nationwide in 2002-2004 in whom vaccination status could be ascertained, 424 (97.9%) received no vaccine and none received 2 doses. Conclusion This universal toddlers-only immunization program in Israel demonstrated not only high effectiveness of hepatitis A vaccination but also marked herd protection, challenging the need for catch-up hepatitis A vaccination programs.	Soroka Univ Med Ctr, Pediat Infect Dis Unit, IL-84101 Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; Minist Hlth, Publ Hlth Serv, Jerusalem, Israel; Minist Hlth, Dept Infect Dis, Jerusalem, Israel; Minist Hlth, Dept Epidemiol, Jerusalem, Israel; Hadassah Hebrew Univ, Liver Unit, Jerusalem, Israel	Ben Gurion University; Soroka Medical Center; Ben Gurion University; Hebrew University of Jerusalem; Hadassah University Medical Center	Dagan, R (corresponding author), Soroka Univ Med Ctr, Pediat Infect Dis Unit, POB 151, IL-84101 Beer Sheva, Israel.	rdagan@bgu.ac.il	Shouval, Daniel/U-2779-2017	Shouval, Daniel/0000-0002-0512-6513				Allard R, 2001, J EPIDEMIOL COMMUN H, V55, P251, DOI 10.1136/jech.55.4.251; ALTER MJ, 1987, AM J EPIDEMIOL, V125, P133, DOI 10.1093/oxfordjournals.aje.a114496; Andre Francis, 2002, Expert Rev Vaccines, V1, P9, DOI 10.1586/14760584.1.1.9; Anis Emilia, 2000, Harefuah, V138, P177; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; Armstrong GL, 2002, PEDIATRICS, V109, P839, DOI 10.1542/peds.109.5.839; Averhoff F, 2001, JAMA-J AM MED ASSOC, V286, P2968, DOI 10.1001/jama.286.23.2968; BEHRENS RH, 1994, BRIT MED J, V309, P918, DOI 10.1136/bmj.309.6959.918; Bialek SR, 2004, AM J PUBLIC HEALTH, V94, P996, DOI 10.2105/AJPH.94.6.996; Bovier PA, 2002, J MED VIROL, V68, P489, DOI 10.1002/jmv.10244; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P600; CLEMENS R, 1995, J INFECT DIS, V171, pS44, DOI 10.1093/infdis/171.Supplement_1.S44; Craig AS, 2004, NEW ENGL J MED, V350, P476, DOI 10.1056/NEJMcp031540; Craig AS, 1998, CLIN INFECT DIS, V27, P531, DOI 10.1086/514700; FATTAL B, 1988, Harefuah, V115, P111; Ginsberg GM, 2001, J HEPATOL, V34, P92, DOI 10.1016/S0168-8278(00)00007-6; GREEN MS, 1989, REV INFECT DIS, V11, P464; Green MS, 2001, ISRAEL MED ASSOC J, V3, P347; GUST ID, 1992, VACCINE, V10, pS56, DOI 10.1016/0264-410X(92)90544-T; HADLER SC, 1980, NEW ENGL J MED, V302, P1222, DOI 10.1056/NEJM198005293022203; HADLER SC, 1991, VIRAL HEPATITIS AND LIVER DISEASE, P14; INNIS BL, 1994, JAMA-J AM MED ASSOC, V271, P1328, DOI 10.1001/jama.271.17.1328; *ISR CENTR BUR STA, 2003, STAT ABSTR ISR; *ISR CTR DIS CONTR, 1999, 7001 ISR MIN HLTH IS; *ISR MIN HLTH, 1999, REP INF COMP SERV DE; Jacobs RJ, 2003, PEDIATR INFECT DIS J, V22, P904, DOI 10.1097/01.inf.0000091295.53969.6a; Koff RS, 1999, NEW ENGL J MED, V340, P644, DOI 10.1056/NEJM199902253400810; LERMAN Y, 1999, HAREFUAH, V136, P514; Lerman Yehuda, 1999, Harefuah, V136, P441; LEVY BS, 1977, AM J EPIDEMIOL, V105, P127, DOI 10.1093/oxfordjournals.aje.a112364; McMahon BJ, 1996, ARCH PEDIAT ADOL MED, V150, P733, DOI 10.1001/archpedi.1996.02170320079014; Meyerhoff AS, 2001, J VIRAL HEPATITIS, V8, P454, DOI 10.1046/j.1365-2893.2001.00317.x; REISLER DM, 1970, AM J EPIDEMIOL, V92, P62, DOI 10.1093/oxfordjournals.aje.a121180; ROSENBLUM LS, 1991, J INFECT DIS, V164, P476, DOI 10.1093/infdis/164.3.476; SHOUVAL D, 1993, VACCINE, V11, pS9, DOI 10.1016/0264-410X(93)90151-M; Smith PF, 1997, EPIDEMIOL INFECT, V118, P243, DOI 10.1017/S0950268897007462; Staes CJ, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.4.e54; VANDAMME P, 1994, J MED VIROL, V44, P446, DOI 10.1002/jmv.1890440425; VOGT RL, 1983, AM J PUBLIC HEALTH, V73, P795, DOI 10.2105/AJPH.73.7.795; WERZBERGER A, 1992, NEW ENGL J MED, V327, P453, DOI 10.1056/NEJM199208133270702; Werzberger A, 2002, VACCINE, V20, P1699, DOI 10.1016/S0264-410X(02)00042-7; *WHO, 1998, B WORLD HEALTH ORGAN, V76, P94; Wiens BL, 1996, J MED VIROL, V49, P235, DOI 10.1002/(SICI)1096-9071(199607)49:3&lt;235::AID-JMV13&gt;3.0.CO;2-B; YAO G, 1990, VIRAL HEPATITIS LIVE; Zamir C, 2001, EUR J CLIN MICROBIOL, V20, P185, DOI 10.1007/s100960100461	45	168	180	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2005	294	2					202	210		10.1001/jama.294.2.202	http://dx.doi.org/10.1001/jama.294.2.202			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944DO	16014594				2022-12-28	WOS:000230406100024
J	Ezzati, M				Ezzati, M			Indoor air pollution and health in developing countries	LANCET			English	Editorial Material							BIRTH-WEIGHT; EXPOSURE; BIOMASS; PETROLEUM; SMOKE		Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Ezzati, M (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	mezzati@hsph.harvard.edu			NATIONAL INSTITUTE ON AGING [P01AG017625] Funding Source: NIH RePORTER; NIA NIH HHS [P01-AG17625] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AGARWAL B, 1983, WORLD DEV, V11, P359, DOI 10.1016/0305-750X(83)90047-5; Bailis R, 2005, SCIENCE, V308, P98, DOI 10.1126/science.1106881; Barnes D. F., 1994, WHAT MAKES PEOPLE CO; Boy E, 2002, ENVIRON HEALTH PERSP, V110, P109, DOI 10.1289/ehp.02110109; Ezzati M, 2004, ANNU REV ENV RESOUR, V29, P383, DOI 10.1146/annurev.energy.29.062103.121246; Ezzati M, 2001, LANCET, V358, P619, DOI 10.1016/S0140-6736(01)05777-4; International Energy Agency, 2002, WORLD EN OUTL 2002; Mishra V, 2004, ANN EPIDEMIOL, V14, P740, DOI 10.1016/j.annepidem.2004.01.009; Sinton JE, 2004, ENERGY SUSTAIN DEV, V8, P33, DOI [10.1016/S0973-0826(08)60465-2, DOI 10.1016/S0973-0826(08)60465-2]; Smith K.R., 2004, COMP QUANTIFICATION, V18, P1435; Smith KR, 2002, SCIENCE, V298, P1847, DOI 10.1126/science.298.5600.1847	11	93	97	0	22	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 9	2005	366	9480					104	106		10.1016/S0140-6736(05)66845-6	http://dx.doi.org/10.1016/S0140-6736(05)66845-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	943JH	16005317				2022-12-28	WOS:000230349200009
J	Kett, M				Kett, M			ABC of conflict and disaster - Displaced populations and long term humanitarian assistance	BRITISH MEDICAL JOURNAL			English	Review									UCL, Leonard Cheshire Ctr Conflict Recovery, London WC1E 6BT, England	University of London; University College London	Kett, M (corresponding author), UCL, Leonard Cheshire Ctr Conflict Recovery, London WC1E 6BT, England.		Kett, Maria/AAA-3421-2022	Kett, Maria/0000-0002-1975-7674				FAEN PW, 2003, FORCED MIGRATION REV, V17, P19; *GLOB IDP PROJ, INT DISPL GLOB OV TR; *MED SANS FRONT, 1997, REF HLTH APPROACH EM; RYAN J, 2002, CONFLICT CATASTROPHE	4	5	5	1	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 9	2005	331	7508					98	100		10.1136/bmj.331.7508.98	http://dx.doi.org/10.1136/bmj.331.7508.98			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945XR	16002885	Green Published			2022-12-28	WOS:000230536800019
J	Radisky, DC; Levy, DD; Littlepage, LE; Liu, H; Nelson, CM; Fata, JE; Leake, D; Godden, EL; Albertson, DG; Nieto, MA; Werb, Z; Bissell, MJ				Radisky, DC; Levy, DD; Littlepage, LE; Liu, H; Nelson, CM; Fata, JE; Leake, D; Godden, EL; Albertson, DG; Nieto, MA; Werb, Z; Bissell, MJ			Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability	NATURE			English	Article							MAMMARY EPITHELIAL-CELLS; OXIDATIVE STRESS; MATRIX METALLOPROTEINASES; SPLICE VARIANT; TUMOR; EXPRESSION; TRANSFORMATION; SUPPRESSION; PROGRESSION; TRANSITION	The tumour microenvironment can be a potent carcinogen, not only by facilitating cancer progression and activating dormant cancer cells, but also by stimulating tumour formation(1). We have previously investigated stromelysin-1/matrix metalloproteinase-3 (MMP-3), a stromal enzyme upregulated in many breast tumours(2), and found that MMP-3 can cause epithelial-mesenchymal transition (EMT) and malignant transformation in cultured cells(3-5), and genomically unstable mammary carcinomas in transgenic mice(3). Here we explain the molecular pathways by which MMP-3 exerts these effects: exposure of mouse mammary epithelial cells to MMP-3 induces the expression of an alternatively spliced form of Rac1, which causes an increase in cellular reactive oxygen species (ROS). The ROS stimulate the expression of the transcription factor Snail and EMT, and cause oxidative damage to DNA and genomic instability. These findings identify a previously undescribed pathway in which a component of the breast tumour microenvironment alters cellular structure in culture and tissue structure in vivo, leading to malignant transformation.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Dharmacon Inc, Lafayette, CO 80026 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; Inst Neurosci Alicante, Dept Dev Neurobiol, Alacant 03550, Spain	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Bissell, MJ (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA.	dcradisky@lbl.gov; mjbissell@lbl.gov	Radisky, Derek/B-6569-2018; Nelson, Celeste/AAT-7612-2021; Nieto, M. Angela/A-6531-2008	Radisky, Derek/0000-0002-1962-8784; Nelson, Celeste/0000-0001-9973-8870; Nieto, M. Angela/0000-0002-3538-840X	NATIONAL CANCER INSTITUTE [R01CA057621] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA057621-07, R01 CA057621] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fiegen D, 2004, J BIOL CHEM, V279, P4743, DOI 10.1074/jbc.M310281200; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; JOHNSON RK, 1976, CANCER RES, V36, P2720; Jordan P, 1999, ONCOGENE, V18, P6835, DOI 10.1038/sj.onc.1203233; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; Lochter A, 1997, J BIOL CHEM, V272, P5007, DOI 10.1074/jbc.272.8.5007; Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; Matos P, 2003, J BIOL CHEM, V278, P50442, DOI 10.1074/jbc.M308215200; Mori K, 2004, CANCER RES, V64, P7464, DOI 10.1158/0008-5472.CAN-04-1725; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Puri PL, 2002, NAT GENET, V32, P585, DOI 10.1038/ng1023; Samper E, 2003, AGING CELL, V2, P277, DOI 10.1046/j.1474-9728.2003.00062.x; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; Singh A, 2004, ONCOGENE, V23, P9369, DOI 10.1038/sj.onc.1208182; Snijders AM, 2003, ONCOGENE, V22, P4370, DOI 10.1038/sj.onc.1206482; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; Struthers L, 1998, ANAL BIOCHEM, V255, P20, DOI 10.1006/abio.1997.2354; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; WAHL GM, 1979, J BIOL CHEM, V254, P8679; Werner E, 2002, J CELL BIOL, V158, P357, DOI 10.1083/jcb.200111028	30	953	984	1	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					123	127		10.1038/nature03688	http://dx.doi.org/10.1038/nature03688			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001073	Green Accepted			2022-12-28	WOS:000230296600051
J	Sarda, P; Guillot, B				Sarda, P; Guillot, B			Breaking of Henry's law for noble gas and CO2 solubility in silicate melt under pressure	NATURE			English	Article							RIDGE POPPING ROCKS; ARGON SOLUBILITY; RARE-GASES; MANTLE; LIQUIDS; SYSTEMATICS; GLASSES; ASCENT; FLUIDS; CRESTS	Degassing of the Earth is still poorly understood, as is the large scatter in He/Ar ratios observed in mid-ocean ridge basalts. A possible explanation for such observations is that vesiculation occurs at great depths with noble-gas solubilities different from those measured at 1 bar (ref. 1). Here we develop a hard-sphere model for noble-gas solubility and find that, owing to melt compaction, solubility may decrease by several orders of magnitude when pressure increases, an effect subtly overbalanced by the compression of the fluid phase. Our results satisfactorily explain recent experimental data on argon solubility in silicate melts, where argon concentration increases almost linearly with pressure, then levels off at pressures of 50-100 kbar (refs 2-5). We also model vesiculation during magma ascent at ridges and find that noble-gas partitioning between melt and CO2 vesicles at depth differs significantly from that at low pressure. Starting at 10 kbar (similar to 35 km depth), several stages of vesiculation occur followed by vesicle loss, which explains the broad variability of He-Ar concentration data in mid-ocean ridge basalts. 'Popping rocks', exceptional samples with high vesicularity, may represent fully vesiculated ridge magma, whereas common samples would simply have lost such vesicles.	Univ Paris 11, Dept Sci Terre, Grp Geochim Gaz Rares, CNRS,UMR 8148,IDES, F-91405 Orsay, France; Univ Paris 06, CNRS, UMR 7600, Lab Phys Theor Mat Condensee, F-75252 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite	Sarda, P (corresponding author), Ecole Normale Super Lyon, CNRS, UMR 5570, Lab Sci Terre, F-69364 Lyon, France.	sarda@geophy.geol.u-psud.fr						AGEE CB, 1988, J GEOPHYS RES-SOLID, V93, P3437, DOI 10.1029/JB093iB04p03437; ALLEGRE CJ, 1987, EARTH PLANET SC LETT, V81, P127, DOI 10.1016/0012-821X(87)90151-8; ANDERSEN HC, 1971, PHYS REV A-GEN PHYS, V4, P1597, DOI 10.1103/PhysRevA.4.1597; Ballentine CJ, 2002, PHILOS T ROY SOC A, V360, P2611, DOI 10.1098/rsta.2002.1083; BOTTINGA Y, 1990, CHEM GEOL, V81, P255, DOI 10.1016/0009-2541(90)90050-H; BOTTINGA Y, 1983, B MINERAL, V106, P129, DOI 10.3406/bulmi.1983.7675; Burnard P, 1997, SCIENCE, V276, P568, DOI 10.1126/science.276.5312.568; CARNAHAN NF, 1969, J CHEM PHYS, V51, P635, DOI 10.1063/1.1672048; CARROLL MR, 1993, GEOCHIM COSMOCHIM AC, V57, P5039, DOI 10.1016/0016-7037(93)90606-W; CARROLL MR, 1994, CHEM GEOL, V117, P37, DOI 10.1016/0009-2541(94)90120-1; Chamorro-Perez E, 1998, NATURE, V393, P352, DOI 10.1038/30706; ChamorroPerez E, 1996, EARTH PLANET SC LETT, V145, P97, DOI 10.1016/S0012-821X(96)00188-4; Gaetani GA, 1998, GEOCHIM COSMOCHIM AC, V62, P2499, DOI 10.1016/S0016-7037(98)00172-0; GRAHAM D, 1991, EARTH PLANET SC LETT, V105, P568, DOI 10.1016/0012-821X(91)90194-M; Guillot B, 1996, J CHEM PHYS, V105, P255, DOI 10.1063/1.471871; JAMBON A, 1986, GEOCHIM COSMOCHIM AC, V50, P401, DOI 10.1016/0016-7037(86)90193-6; JAVOY M, 1991, EARTH PLANET SC LETT, V107, P598, DOI 10.1016/0012-821X(91)90104-P; KIRSTEN T, 1968, J GEOPHYS RES, V73, P2807, DOI 10.1029/JB073i008p02807; Moreira M, 1998, SCIENCE, V279, P1178, DOI 10.1126/science.279.5354.1178; Mourtada-Bonnefoi CC, 2004, EARTH PLANET SC LETT, V218, P521, DOI 10.1016/S0012-821X(03)00684-8; PAN V, 1991, GEOCHIM COSMOCHIM AC, V55, P1587, DOI 10.1016/0016-7037(91)90130-W; REISS H, 1960, J CHEM PHYS, V32, P119, DOI 10.1063/1.1700883; RIGDEN SM, 1984, SCIENCE, V226, P1071, DOI 10.1126/science.226.4678.1071; SARDA P, 1990, EARTH PLANET SC LETT, V97, P268, DOI 10.1016/0012-821X(90)90047-2; Sarda P, 2002, GEOCHIM COSMOCHIM AC, V66, P1449, DOI 10.1016/S0016-7037(01)00863-8; Schmidt BC, 2002, EARTH PLANET SC LETT, V195, P277, DOI 10.1016/S0012-821X(01)00584-2; Shibata T, 1998, GEOCHIM COSMOCHIM AC, V62, P1241, DOI 10.1016/S0016-7037(98)00046-5; SONG Y, 1989, J CHEM PHYS, V91, P7840, DOI 10.1063/1.457252; WHITE BS, 1989, AM MINERAL, V74, P513	29	32	32	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					95	98		10.1038/nature03636	http://dx.doi.org/10.1038/nature03636			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001067				2022-12-28	WOS:000230296600045
J	Grove, AS				Grove, AS			Efficiency in the health care industries - A view from the outside	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Intel Corp, Santa Clara, CA 95054 USA	Intel Corporation	Grove, AS (corresponding author), Intel Corp, 2200 Mission Coll Blvd, Santa Clara, CA 95054 USA.	Andy.Grove@intel.com						*AM ASS ADV SCI, 2004, NIH SOFTL TURNS HARD; Christensen C.M., 2013, INNOVATORS DILEMMA N; Cowan C, 2004, HEALTH CARE FINANC R, V25, P143; Elm JJ, 2005, ANN NEUROL, V57, P197, DOI 10.1002/ana.20361; GROVE AS, 1996, ONLY PARANOID SURVIV, P42; Leaf C, 2004, FORTUNE, V149, P76; *MANH RES, TAK PULS V 5 0 PHYS; Moore G., 1965, ELECTRONICS, V38, P114, DOI [DOI 10.1109/N-SSC.2006.4785860, DOI 10.1109/JPROC.1998.658762]; PEARL R, 2004, BETTER MED INFORMATI; Stead WW, 2005, J AM MED INFORM ASSN, V12, P113, DOI 10.1197/jamia.M1685; The Markle Foundation, 2003, PERS HLTH WORK GROUP; *US DEP HHS, 2004, CMS PUB, V3455	12	24	24	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2005	294	4					490	492		10.1001/jama.294.4.490	http://dx.doi.org/10.1001/jama.294.4.490			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RM	16046656				2022-12-28	WOS:000230733400025
J	Fatovic-Ferencic, S				Fatovic-Ferencic, S			Commentary: Bridging the gaps in biomedical research	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Croatian Acad Sci & Arts, Dept Hist & Philosophy Sci, Div Hist Med, Zagreb, Croatia	Croatian Academy of Sciences & Arts	Fatovic-Ferencic, S (corresponding author), Croatian Acad Sci & Arts, Dept Hist & Philosophy Sci, Div Hist Med, Zagreb, Croatia.	stella@hazu.hr						BENDAVID J, 1991, SCI GROWTH ESSAYS SO, P510; BURAZERI G, 2005, BRIT MED J, V331, P192; Soteriades ES, 2005, BRIT MED J, V331, P192, DOI 10.1136/bmj.331.7510.192	3	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2005	331	7510					194	195		10.1136/bmj.331.7510.194	http://dx.doi.org/10.1136/bmj.331.7510.194			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951EA	16037453	Green Published, Bronze			2022-12-28	WOS:000230910700022
J	Hall, W; Kimber, J				Hall, W; Kimber, J			Being realistic about benefits of supervised injecting facilities	LANCET			English	Editorial Material							DRUG CONSUMPTION FACILITIES		Univ Queensland, Inst Mol Biosci, Off Publ Policy & Eth, St Lucia, Qld 4072, Australia; Univ London Imperial Coll Sci Technol & Med, Ctr Drugs & Hlth Behav, London, England	University of Queensland; Imperial College London	Hall, W (corresponding author), Univ Queensland, Inst Mol Biosci, Off Publ Policy & Eth, St Lucia, Qld 4072, Australia.	w.hall@imb.uq.edu.au	Hall, Wayne D/A-3283-2008	Hall, Wayne D/0000-0003-1984-0096; Kimber, Jo/0000-0002-8608-7906				Dolan K, 2000, DRUG ALCOHOL REV, V19, P337, DOI 10.1080/713659379; FISCHER B, 2002, CAN J PUB HLTH, V13, P449; Hagan H, 2002, INT J DRUG POLICY, V13, P449; Hedrich D, 2004, EUROPEAN REPORT DRUG; Kimber J, 2003, DRUG ALCOHOL REV, V22, P227, DOI 10.1080/095952301000116951; *MED SUP INJ CTR E, 2003, FIN REP EV SYDN MED; STRATHDEE SA, 1997, AIDS, V11, P59; Wood E, 2004, CAN MED ASSOC J, V171, P731, DOI 10.1503/cmaj.1040774; Wood E, 2004, LANCET INFECT DIS, V4, P301, DOI 10.1016/S1473-3099(04)01006-0; Wood Evan, 2004, Harm Reduct J, V1, P9, DOI 10.1186/1477-7517-1-9	10	11	11	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 23	2005	366	9482					271	272		10.1016/S0140-6736(05)66476-8	http://dx.doi.org/10.1016/S0140-6736(05)66476-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RJ	16039316				2022-12-28	WOS:000230733100007
J	Ehrlich, PR; Kennedy, D				Ehrlich, PR; Kennedy, D			Millennium assessment of human behavior	SCIENCE			English	Editorial Material									Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Inst Int Studies, Stanford, CA 94305 USA	Stanford University; Stanford University	Ehrlich, PR (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	pre@stanford.edu						Brady H.E., 2003, BROOKINGS REV, V21, P16; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; Kirch PV, 1997, AM ANTHROPOL, V99, P30, DOI 10.1525/aa.1997.99.1.30	3	91	96	3	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2005	309	5734					562	563		10.1126/science.1113028	http://dx.doi.org/10.1126/science.1113028			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	948SE	16040693				2022-12-28	WOS:000230735200031
J	Leutgeb, S; Letugeb, JK; Barnes, CA; Moser, EI; McNaughton, BL; Moser, MB				Leutgeb, S; Letugeb, JK; Barnes, CA; Moser, EI; McNaughton, BL; Moser, MB			Independent codes for spatial and episodic memory in hippocampal neuronal ensembles	SCIENCE			English	Article							FREELY-MOVING RAT; PLACE CELLS; PATH-INTEGRATION; FIRING PATTERNS; UNIT-ACTIVITY; ENVIRONMENT; LOCATION; TASK; CA1; REPRESENTATION	Hippocampal neurons were recorded under conditions in which the recording chamber was varied but its location remained unchanged versus conditions in which an identical chamber was encountered in different places. Two forms of neuronal pattern separation occurred. In the variable cue-constant place condition, the firing rates of active cells varied, often over more than an order of magnitude, whereas the location of firing remained constant. In the variable place-constant cue condition, both location and rates changed, so that population vectors for a given location in the chamber were statistically independent. These independent encoding schemes may enable simultaneous representation of spatial and episodic memory information.	Norwegian Univ Sci & Technol, Med Tech Res Ctr, Ctr Biol Memory, N-7489 Trondheim, Norway; Univ Arizona, Arizona Res Labs, Div Neural Syst Memory & Aging, Tucson, AZ 85724 USA	Norwegian University of Science & Technology (NTNU); University of Arizona	McNaughton, BL (corresponding author), Norwegian Univ Sci & Technol, Med Tech Res Ctr, Ctr Biol Memory, N-7489 Trondheim, Norway.			Leutgeb, Jill/0000-0002-2014-842X				Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Bower MR, 2005, J NEUROSCI, V25, P1313, DOI 10.1523/JNEUROSCI.2901-04.2005; Cressant A, 2002, EXP BRAIN RES, V143, P470, DOI 10.1007/s00221-002-1013-0; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Gothard KM, 1996, J NEUROSCI, V16, P8027; Gothard KM, 1996, J NEUROSCI, V16, P823; Hollup SA, 2001, EUR J NEUROSCI, V13, P1197, DOI 10.1046/j.0953-816x.2001.01487.x; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; KNIERIM JJ, 1995, J NEUROSCI, V15, P1648, DOI 10.1523/JNEUROSCI.15-03-01648.1995; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Moita MAP, 2004, J NEUROSCI, V24, P7015, DOI 10.1523/JNEUROSCI.5492-03.2004; MULLER RU, 1987, J NEUROSCI, V7, P1935; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1978, EXP BRAIN RES, V31, P573; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Shapiro ML, 1997, HIPPOCAMPUS, V7, P624, DOI 10.1002/(SICI)1098-1063(1997)7:6<624::AID-HIPO5>3.0.CO;2-E; Skaggs WE, 1998, J NEUROSCI, V18, P8455; Tanila H, 1999, HIPPOCAMPUS, V9, P235, DOI 10.1002/(SICI)1098-1063(1999)9:3<235::AID-HIPO4>3.0.CO;2-3; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	30	525	532	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2005	309	5734					619	623		10.1126/science.1114037	http://dx.doi.org/10.1126/science.1114037			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040709				2022-12-28	WOS:000230735200051
J	Santen, RJ; Mansel, R				Santen, RJ; Mansel, R			Benign breast disorders	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ONCOLOGY TECHNOLOGY-ASSESSMENT; EVENING PRIMROSE OIL; CANCER RISK; MAMMOGRAPHIC DENSITIES; NIPPLE DISCHARGE; CONTROLLED-TRIAL; PREMENSTRUAL MASTALGIA; POSTMENOPAUSAL WOMEN; CYCLICAL MASTALGIA; AMERICAN-SOCIETY		Univ Virginia, Hlth Sci Ctr, Dept Med, Charlottesville, VA 22908 USA; Cardiff Univ, Dept Surg, Cardiff, Wales	University of Virginia; Cardiff University	Santen, RJ (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Med, POB 801416, Charlottesville, VA 22908 USA.	rjs5y@virginia.edu						Ader DN, 1997, AM J OBSTET GYNECOL, V177, P126, DOI 10.1016/S0002-9378(97)70450-2; Ader DN, 2001, J PSYCHOSOM OBST GYN, V22, P71, DOI 10.3109/01674820109049956; Allred DC, 2001, ENDOCR-RELAT CANCER, V8, P47, DOI 10.1677/erc.0.0080047; ALLRED DC, 2000, DIS BREAST, P355; Ambrogetti D, 1996, Radiol Med, V91, P198; [Anonymous], 1986, Arch Pathol Lab Med, V110, P171; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Barton MB, 1999, JAMA-J AM MED ASSOC, V282, P1270, DOI 10.1001/jama.282.13.1270; BELIEU RM, 1994, OBSTET GYN CLIN N AM, V21, P461; Blommers J, 2002, AM J OBSTET GYNECOL, V187, P1389, DOI 10.1067/mob.2002.127377a; BOONE CW, 1993, J CELL BIOCHEM, P14; Boyd NF, 1998, CANCER EPIDEM BIOMAR, V7, P1133; Boyd NF, 2000, EUR J CANCER PREV, V9, P15, DOI 10.1097/00008469-200002000-00003; Boyd NF, 2002, NEW ENGL J MED, V347, P886, DOI 10.1056/NEJMoa013390; Byrne C, 2001, CANCER CAUSE CONTROL, V12, P103, DOI 10.1023/A:1008935821885; Charreau I, 1993, Eur J Cancer Prev, V2, P147, DOI 10.1097/00008469-199303000-00007; Chlebowski RT, 2002, J CLIN ONCOL, V20, P3328, DOI 10.1200/JCO.2002.06.029; Chlebowski RT, 1999, J CLIN ONCOL, V17, P1939, DOI 10.1200/JCO.1999.17.6.1939; COSTANTINI L, 1993, RECENT DEV STUDY BEN, P227; Cuzick J, 2002, LANCET, V360, P817; Cuzick J, 2003, LANCET, V361, P296, DOI 10.1016/S0140-6736(03)12342-2; Dent DM, 1988, BR J CLIN PRACT S56, V42, P69; Dooley WC, 2001, J NATL CANCER I, V93, P1624, DOI 10.1093/jnci/93.21.1624; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; DUPONT WD, 1993, CANCER, V71, P1258, DOI 10.1002/1097-0142(19930215)71:4<1258::AID-CNCR2820710415>3.0.CO;2-I; Falkenberry SS, 2002, OBSTET GYN CLIN N AM, V29, P21, DOI 10.1016/S0889-8545(03)00049-4; FENTIMAN IS, 1986, LANCET, V1, P287; Flobbe K, 2003, ARCH INTERN MED, V163, P1194, DOI 10.1001/archinte.163.10.1194; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gail MH, 1999, J NATL CANCER I, V91, P1829, DOI 10.1093/jnci/91.21.1829; Gail MH, 2000, J NATL CANCER I, V92, P758, DOI 10.1093/jnci/92.9.758; GATELEY CA, 1992, J ROY SOC MED, V85, P12; Ginger MR, 2001, MOL ENDOCRINOL, V15, P1993, DOI 10.1210/me.15.11.1993; Goehring C, 1997, EPIDEMIOL REV, V19, P310, DOI 10.1093/oxfordjournals.epirev.a017960; Goodwin PJ, 1997, AM J OBSTET GYNECOL, V176, P998, DOI 10.1016/S0002-9378(97)70392-2; GOODWIN PJ, 1988, BRIT J SURG, V75, P837, DOI 10.1002/bjs.1800750904; Goyal A, 2005, BREAST J, V11, P41, DOI 10.1111/j.1075-122X.2005.21492.x; Groves AM, 1996, BREAST, V5, P96, DOI 10.1016/S0960-9776(96)90129-0; HAMED H, 1990, ANN ROY COLL SURG, V72, P221; Hankinson SE, 1998, JNCI-J NATL CANCER I, V90, P1292, DOI 10.1093/jnci/90.17.1292; Hartmann LC, 2005, NEW ENGL J MED, V353, P229, DOI 10.1056/NEJMoa044383; Hoogerbrugge N, 2003, J CLIN ONCOL, V21, P41, DOI 10.1200/JCO.2003.02.137; Houssami N, 2001, MED J AUSTRALIA, V174, P185, DOI 10.5694/j.1326-5377.2001.tb143215.x; HUGHES LE, 1987, LANCET, V2, P1316, DOI 10.1016/S0140-6736(87)91204-9; HUGHES LE, 1999, BENIGN BREAST DISORD; Hulka BS, 2001, MATURITAS, V38, P103, DOI 10.1016/S0378-5122(00)00196-1; Kessel B, 2000, OBSTET GYN CLIN N AM, V27, P625, DOI 10.1016/S0889-8545(05)70160-1; Khan SA, 2002, BREAST CANCER RES TR, V75, P147, DOI 10.1023/A:1019685829799; KOLLIAS J, 1997, RECENT DEV STUDY BEN, P119; Kuller LH, 1997, ENVIRON HEALTH PERSP, V105, P593, DOI 10.2307/3433376; Levine M, 2001, CAN MED ASSOC J, V164, P1681; LONDON SJ, 1992, JAMA-J AM MED ASSOC, V267, P1780; LOVE SM, 1982, NEW ENGL J MED, V307, P1010, DOI 10.1056/NEJM198210143071611; Lundin C, 1998, BREAST CANCER RES TR, V51, P1, DOI 10.1023/A:1006009531378; Mah PM, 2002, SEMIN REPROD MED, V20, P365, DOI 10.1055/s-2002-36709; Mansel RE, 2004, AM J OBSTET GYNECOL, V191, P1942, DOI 10.1016/j.ajog.2004.06.100; Mauvais-Javis P, 1988, CURRENT THERAPY ENDO, V3, P280; McTiernan A, 2001, CANCER EPIDEM BIOMAR, V10, P333; MESSINIS IE, 1988, ACTA OBSTET GYN SCAN, V67, P307; MICALE MA, 1994, HUM PATHOL, V25, P29, DOI 10.1016/0046-8177(94)90167-8; Millet AV, 2002, OBSTET GYNECOL SURV, V57, P451, DOI 10.1097/00006254-200207000-00022; Mokbel K, 2002, CURR MED RES OPIN, V18, P30, DOI 10.1185/030079902125000075; Morrow M, 1997, Oncology (Williston Park), V11, P877; Moy L, 2002, RADIOLOGY, V225, P176, DOI 10.1148/radiol.2251010999; O'Brien PMS, 1999, AM J OBSTET GYNECOL, V180, P18, DOI 10.1016/S0002-9378(99)70142-0; O'Connell P, 1998, JNCI-J NATL CANCER I, V90, P697, DOI 10.1093/jnci/90.9.697; OSBORNE MP, 2000, DIS BREAST, P1; Pappas SG, 2002, CANCER METAST REV, V21, P311, DOI 10.1023/A:1021219212638; PASHBY NL, 1981, BRIT J SURG, V68, P801; POTTEN CS, 1988, BRIT J CANCER, V58, P163, DOI 10.1038/bjc.1988.185; PREECE PE, 1976, LANCET, V2, P670; PREECE PE, 1982, CLIN USES ESSENTIAL, P147; Roger P, 2001, CANCER RES, V61, P2537; Rohan TE, 1999, EUR J CANCER PREV, V8, P123, DOI 10.1097/00008469-199904000-00006; RUSSO J, 2001, ENDOCRINOLOGY, P2181; SANDISON AT, 1962, NATL CANCER I MONOGR, V8, P1; SANTEN R, 2002, ENDOCRINOLOGY, P2189; SELTZER MH, 1970, SURG GYNECOL OBSTETR, V131, P519; Shaaban AM, 2002, AM J SURG PATHOL, V26, P421, DOI 10.1097/00000478-200204000-00003; Shetty MK, 2003, J ULTRAS MED, V22, P263, DOI 10.7863/jum.2003.22.3.263; Soo MS, 2001, AM J ROENTGENOL, V177, P1167, DOI 10.2214/ajr.177.5.1771167; Steinbrunn BS, 1997, POSTGRAD MED, V102, P183, DOI 10.3810/pgm.1997.11.369; Tan-Chiu E, 2003, J NATL CANCER I, V95, P302, DOI 10.1093/jnci/95.4.302; VENTA LA, 2000, DIS BREAST, P149; Wang JP, 2004, J NATL CANCER I, V96, P616, DOI 10.1093/jnci/djhs105; WETZIG NR, 1994, AUST NZ J SURG, V64, P329, DOI 10.1111/j.1445-2197.1994.tb02221.x; WILSON MC, 1976, BRIT MED J, V2, P90, DOI 10.1136/bmj.2.6027.90; WOLFE JN, 1987, AM J ROENTGENOL, V148, P1087, DOI 10.2214/ajr.148.6.1087; Zylstra S, 1999, CLIN OBSTET GYNECOL, V42, P234, DOI 10.1097/00003081-199906000-00008	90	173	187	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2005	353	3					275	285		10.1056/NEJMra035692	http://dx.doi.org/10.1056/NEJMra035692			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YH	16034013				2022-12-28	WOS:000230608700008
J	Ridker, PM; Rifai, N; Cook, NR; Bradwin, G; Buring, JE				Ridker, PM; Rifai, N; Cook, NR; Bradwin, G; Buring, JE			Non-HDL cholesterol, apolipoproteins A-I and B-100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; LOW-DOSE ASPIRIN; PRIMARY PREVENTION; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS RISK; STATIN THERAPY; PREDICTION; HEALTH; MEN	Context Current guidelines for cardiovascular risk detection are controversial with regard to the clinical utility of different lipid measures, non-high-density lipoprotein cholesterol (non-HDL-C), lipid ratios, apolipoproteins, and C-reactive protein (CRP). Objective To directly compare the clinical utility of total cholesterol, low-density lipoprotein cholesterol (LDL-C), HDL-C, non HDL-C, apolipoproteins A-I and B-100, high-sensitivity CRP, and the ratios of total cholesterol to HDL-C, LDL-C to HDL-C, apolipoprotein B-100 to apolipoprotein A-I, and apolipoprotein B-100 to HDL-C as predictors of future cardiovascular events in women. Design, Setting, and Participants Prospective cohort study of 15 632 initially healthy US women aged 45 years or older (interquartile range, 48-59 years) who were enrolled between November 1992 and July 1995. All participants were followed up over a 10-year period for the occurrence of future cardiovascular events. Main Outcome Measure Hazard ratios (HRs) and 95% confidence intervals (Cls) for first-ever major cardiovascular events (N = 464) according to baseline levels of each biomarker. Results After adjustment for age, smoking status, blood pressure, diabetes, and body mass index, the HRs for future cardiovascular events for those in the extreme quintiles were 1.62 (95% Cl, 1.17-2.25) for LDL-C, 1.75 (95% Cl, 1.30-2.38) for apolipoprotein A-I, 2.08 (95% Cl, 1.45-2.97) for total cholesterol, 2.32 (95% Cl, 1.643.33) for HDL-C, 2.50 (95% Cl, 1.68-3.72) for apolipoprotein B-100, 2.51 (95% Cl, 1.69-3.72) for non-HDL-C, and 2.98 (95% Cl, 1.90-4.67) for high-sensitivity CRP (P<.001 for trend across all quintiles). The HRs for the lipid ratios were 3.01 (95% Cl, 2.01-4.50) for apolipoprotein B-100 to apolipoprotein A-I, 3.18 (95% Cl, 2.12-4.75) for LDL-C to HDL-C, 3.56 (95% Cl, 2.31-5.47) for apolipoprotein 13100 to HDL-C, and 3.81 (95% Cl, 2.47-5.86) for the total cholesterol to HDL-C (P<.001 for trend across all quintiles). The correlation coefficients between high-sensitivity CRP and the lipid parameters ranged from -0.33 to 0.15, and the clinical cut points for CRP of less than 1, 1 to 3, and higher than 3 mg/L provided prognostic information on risk across increasing levels of each lipid measure and lipid ratio. Conclusions Non-HDL-C and the ratio of total cholesterol to HDL-C were as good as or better than apolipoprotein fractions in the prediction of future cardiovascular events. After adjustment for age, blood pressure, smoking, diabetes, and obesity, high-sensitivity CRP added prognostic information beyond that conveyed by all lipid measures.	Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA; Brigham & Womens Hosp, Donald W Reynolds Ctr Cardiovasc Res, Boston, MA 02215 USA; Brigham & Womens Hosp, Leducq Ctr Mol & Genet Epidemiol, Boston, MA 02215 USA; Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Div Cardiol, Boston, MA 02215 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Lab Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Ridker, PM (corresponding author), Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave E, Boston, MA 02215 USA.	pridker@partners.org						Ballantyne CM, 2004, CIRCULATION, V109, P837, DOI 10.1161/01.CIR.0000116763.91992.F1; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Freeman DJ, 2002, DIABETES, V51, P1596, DOI 10.2337/diabetes.51.5.1596; Gotto AM, 2000, CIRCULATION, V101, P477, DOI 10.1161/01.CIR.101.5.477; GROVER SA, 1995, JAMA-J AM MED ASSOC, V274, P801, DOI 10.1001/jama.274.10.801; HAINLINE A, 1982, MANUAL LAB OPERATION; KINOSIAN B, 1994, ANN INTERN MED, V121, P641, DOI 10.7326/0003-4819-121-9-199411010-00002; Koenig W, 2004, CIRCULATION, V109, P1349, DOI 10.1161/01.CIR.0000120707.98922.E3; Lamarche B, 1996, CIRCULATION, V94, P273, DOI 10.1161/01.CIR.94.3.273; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Miremadi S, 2002, CLIN CHEM, V48, P484; Moss AJ, 1999, CIRCULATION, V99, P2517, DOI 10.1161/01.CIR.99.19.2517; Natarajan S, 2003, AM J PREV MED, V25, P50, DOI 10.1016/S0749-3797(03)00092-8; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Ridker PM, 2005, J AM COLL CARDIOL, V45, P1644, DOI 10.1016/j.jacc.2005.02.080; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; RIFAI N, 1986, CLIN CHEM, V32, P957; Roberts WL, 2001, CLIN CHEM, V47, P418; Shai I, 2004, CIRCULATION, V110, P2824, DOI 10.1161/01.CIR.0000146339.57154.9B; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Sniderman AD, 2003, LANCET, V361, P777, DOI 10.1016/S0140-6736(03)12663-3; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P373, DOI 10.1056/NEJM199108083250601; Talmud PJ, 2002, ARTERIOSCL THROM VAS, V22, P1918, DOI 10.1161/01.ATV.0000035521.22199.C7; van Lennep JER, 2000, ARTERIOSCL THROM VAS, V20, P2408, DOI 10.1161/01.ATV.20.11.2408; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	36	545	562	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2005	294	3					326	333		10.1001/jama.294.3.326	http://dx.doi.org/10.1001/jama.294.3.326			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YL	16030277	Bronze			2022-12-28	WOS:000230609100017
J	McIntyre, J; Robertson, S; Norris, E; Appleton, R; Whitehouse, WP; Phillips, B; Martland, T; Berry, K; Collier, J; Smith, S; Choonara, L				McIntyre, J; Robertson, S; Norris, E; Appleton, R; Whitehouse, WP; Phillips, B; Martland, T; Berry, K; Collier, J; Smith, S; Choonara, L			Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial	LANCET			English	Article							CONVULSIVE STATUS EPILEPTICUS; ACUTE CHILDHOOD SEIZURES; INTRANASAL MIDAZOLAM; PROLONGED SEIZURES; LORAZEPAM; PHARMACOKINETICS; BENZODIAZEPINES; MANAGEMENT; ROUTES	Background Rectal diazepam and buccal midazolam are used for emergency treatment of acute febrile and afebrile (epileptic) seizures in children. We aimed to compare the safety and efficacy of these drugs. Methods A multicentre, randomised controlled trial was undertaken to compare buccal midazolam with rectal diazepam for emergency-room treatment of children aged 6 months and older presenting to hospital with active seizures and without intravenous access. The dose varied according to age from 2.5 to 10 mg. The primary endpoint was therapeutic success: cessation of seizures within 10 min and for at least 1 hour, without respiratory depression requiring intervention. Analysis was per protocol. Findings Consent was obtained for 219 separate episodes involving 177 patients, who had a median age of 3 years (IQR 1-5) at initial episode. Therapeutic success was 56% (61 of 109) for buccal midazolam and 27% (30 of 110) for rectal diazepam (percentage difference 29%, 95% CI 16-41). Analysing only initial episodes revealed a similar result. The rate of respiratory depression did not differ between groups. When Centre, age, known diagnosis of epilepsy, use of antiepileptic drugs, prior treatment, and length of seizure before treatment were adjusted for with logistic regression, buccal midazolam was more effective than rectal diazepam. Interpretation Buccal midazolam was more effective than rectal diazepam for children presenting to hospital with acute seizures and was not associated with an increased incidence of respiratory depression.	Univ Nottingham, Derbyshire Childrens Hosp, Acad Div Child Hlth, Derby DE22 3DT, England; Alder Hey Childrens Hosp, Emergency Dept, Liverpool L12 2AP, Merseyside, England; Alder Hey Childrens Hosp, Dept Paediat Neurol, Liverpool L12 2AP, Merseyside, England; Univ Nottingham, Dept Child Hlth, Nottingham NG7 2RD, England; Royal Manchester Childrens Hosp, Dept Paediat Neurol, Manchester M27 1HA, Lancs, England; Birmingham Childrens Hosp, Emergency Dept, Birmingham, W Midlands, England; Univ Nottingham, Sch Nursing, Nottingham NG7 2RD, England; Queens Med Ctr, Emergency Dept, Nottingham NG7 2UH, England	University of Nottingham; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Nottingham; Royal Manchester Children's Hospital; University of Birmingham; University of Nottingham; University of Nottingham	McIntyre, J (corresponding author), Univ Nottingham, Derbyshire Childrens Hosp, Acad Div Child Hlth, Uttoxeter Rd, Derby DE22 3DT, England.	john.mcintyre@nhs.net	Collier, Jacqueline/B-8203-2008; Whitehouse, William P/F-9065-2017	Collier, Jacqueline/0000-0003-0138-6569; Whitehouse, William P/0000-0001-5207-5731; Choonara, Imti/0000-0002-3069-6323				Alldredge BK, 2001, NEW ENGL J MED, V345, P631, DOI 10.1056/NEJMoa002141; Appleton R, 2000, ARCH DIS CHILD, V83, P415; APPLETON R, 1995, DEV MED CHILD NEUROL, V37, P682; Appleton R, 2002, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858; Chattopadhyay A, 1999, LANCET, V353, P1798, DOI 10.1016/S0140-6736(05)75898-0; Conroy S., 2000, PAEDIAT PERINAT DRUG, V4, P52; DIECKMANN RA, 1994, ANN EMERG MED, V23, P216, DOI 10.1016/S0196-0644(94)70034-6; Fisgin T, 2002, J CHILD NEUROL, V17, P123, DOI 10.1177/088307380201700206; Geldner G, 1997, PAEDIATR ANAESTH, V7, P103, DOI 10.1046/j.1460-9592.1997.d01-57.x; HOPPU K, 1981, ACTA PAEDIATR SCAND, V70, P369, DOI 10.1111/j.1651-2227.1981.tb16565.x; Jeannet P Y, 1999, Eur J Paediatr Neurol, V3, P73, DOI 10.1016/S1090-3798(99)80016-6; KNUDSEN FU, 1979, ARCH DIS CHILD, V54, P855, DOI 10.1136/adc.54.11.855; Kutlu NO, 2003, BRAIN DEV-JPN, V25, P275, DOI 10.1016/S0387-7604(02)00230-9; Lahat E, 1998, LANCET, V352, P620, DOI 10.1016/S0140-6736(05)79574-X; Lahat E, 2000, BRIT MED J, V321, P83, DOI 10.1136/bmj.321.7253.83; Lowenstein DH, 1998, NEW ENGL J MED, V338, P970, DOI 10.1056/NEJM199804023381407; Norris E, 1999, DEV MED CHILD NEUROL, V41, P340, DOI 10.1017/S0012162299000742; ORegan ME, 1996, DEV MED CHILD NEUROL, V38, P1037; Qureshi A, 2002, SEIZURE-EUR J EPILEP, V11, P141, DOI 10.1053/seiz.2001.0635; Rey E, 1999, CLIN PHARMACOKINET, V36, P409, DOI 10.2165/00003088-199936060-00003; Scheepers M, 1999, LANCET, V353, P1797, DOI 10.1016/S0140-6736(05)75897-9; Schwagmeier R, 1998, BRIT J CLIN PHARMACO, V46, P203, DOI 10.1046/j.1365-2125.1998.00781.x; Scott RC, 1998, ARCH DIS CHILD, V79, P73, DOI 10.1136/adc.79.1.73; Scott RC, 1999, LANCET, V353, P623, DOI 10.1016/S0140-6736(98)06425-3; Scott RC, 1998, EPILEPSIA, V39, P290, DOI 10.1111/j.1528-1157.1998.tb01375.x; SEIGLER R S, 1990, Journal of Emergency Medicine, V8, P155, DOI 10.1016/0736-4679(90)90225-K; SYKES RM, 1988, ANN TROP PAEDIATR, V8, P259, DOI 10.1080/02724936.1988.11748583; Wallace SJ, 1997, LANCET, V349, P222, DOI 10.1016/S0140-6736(05)64856-8	28	281	289	3	19	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 16	2005	366	9481					205	210		10.1016/S0140-6736(05)66909-7	http://dx.doi.org/10.1016/S0140-6736(05)66909-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945RG	16023510				2022-12-28	WOS:000230519200028
J	Darquie, B; Jones, MPA; Dingjan, J; Beugnon, J; Bergamini, S; Sortais, Y; Messin, G; Browaeys, A; Grangier, P				Darquie, B; Jones, MPA; Dingjan, J; Beugnon, J; Bergamini, S; Sortais, Y; Messin, G; Browaeys, A; Grangier, P			Controlled single-photon emission from a single trapped two-level atom	SCIENCE			English	Article							DETERMINISTIC QUANTUM TELEPORTATION; ENTANGLEMENT; GENERATION; CAVITY	By illuminating an individual rubidium atom stored in a tight optical tweezer with short resonant light pulses, we created an efficient triggered source of single photons with a well-defined polarization. The measured intensity correlation of the emitted tight pulses exhibits almost perfect antibunching. Such a source of high-rate, fully controlled single-photon pulses has many potential applications for quantum information processing.	Ctr Univ Orsay, Inst Opt, Lab Charles Fabry, UMR 8501, F-91403 Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay	Browaeys, A (corresponding author), Ctr Univ Orsay, Inst Opt, Lab Charles Fabry, UMR 8501, Batiment 503, F-91403 Orsay, France.	antoine.browaeys@iota.u-psud.fr	Beugnon, Jérôme/R-4691-2017; Jones, Matthew/C-2595-2009; Browaeys, Antoine/E-1547-2017	Jones, Matthew/0000-0003-1514-5977; Browaeys, Antoine/0000-0001-9941-8869; Bergamini, Silvia/0000-0002-3813-4253; Sortais, Yvan/0000-0002-9852-9783				Bergamini S, 2004, J OPT SOC AM B, V21, P1889, DOI 10.1364/JOSAB.21.001889; Blinov BB, 2004, NATURE, V428, P153, DOI 10.1038/nature02377; Chiaverini J, 2004, NATURE, V432, P602, DOI 10.1038/nature03074; Dowling JP, 2004, QUANTUM INF PROCESS, V3, P205, DOI 10.1007/s11128-004-9419-1; Duan LM, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.253601; GRANGIER P, 2004, NEW J PHYS, V6, P129; Grangier P., 2004, NEW J PHYS, V6, P85; Keller M, 2004, NATURE, V431, P1075, DOI 10.1038/nature02961; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Kuhn A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.067901; LIM YL, IN PRESS; Mandel O, 2003, NATURE, V425, P937, DOI 10.1038/nature02008; McKeever J, 2004, SCIENCE, V303, P1992, DOI 10.1126/science.1095232; Protsenko IE, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.062306; Schlosser N, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.023005; Schlosser N, 2001, NATURE, V411, P1024, DOI 10.1038/35082512; Simon C, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.110405; ZOLLER P, 2004, HOUCHES 2003 QUANTUM, P187	20	203	210	7	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					454	456		10.1126/science.1113394	http://dx.doi.org/10.1126/science.1113394			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020731	Green Submitted			2022-12-28	WOS:000230574900042
J	SantaCruz, K; Lewis, J; Spires, T; Paulson, J; Kotilinek, L; Ingelsson, M; Guimaraes, A; DeTure, M; Ramsden, M; McGowan, E; Forster, C; Yue, M; Orne, J; Janus, C; Mariash, A; Kuskowski, M; Hyman, B; Hutton, M; Ashe, KH				SantaCruz, K; Lewis, J; Spires, T; Paulson, J; Kotilinek, L; Ingelsson, M; Guimaraes, A; DeTure, M; Ramsden, M; McGowan, E; Forster, C; Yue, M; Orne, J; Janus, C; Mariash, A; Kuskowski, M; Hyman, B; Hutton, M; Ashe, KH			Tau suppression in a neurodegenerative mouse model improves memory function	SCIENCE			English	Article							PAIRED HELICAL FILAMENTS; NEUROFIBRILLARY TANGLES; ALZHEIMERS-DISEASE; PROTEIN-TAU; P301L TAU; A-BETA; ASSOCIATION; EXPRESSION; PATHOLOGY; PLAQUES	Neurofibrillary tangles (NFTs) are the most common intraneuronal inclusion in the brains of patients with neurodegenerative diseases and have been implicated in mediating, neuronal death and cognitive deficits. Here, we found that mice expressing a repressible human tau variant developed progressive age-related NFTs, neuronal loss, and behavioral impairments. After the suppression of transgenic tau, memory function recovered, and neuron numbers stabilized, but to our surprise, NFTs continued to accumulate. Thus, NFTs are not sufficient to cause cognitive decline or neuronal death in this model of tauopathy.	Univ Minnesota, Sch Med, Dept Neurol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Neurosci, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Grad Program Neurosci, Minneapolis, MN 55455 USA; Mayo Clin Jacksonville, Dept Neurosci, Jacksonville, FL 32224 USA; Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA 02129 USA; Minneapolis VA Hosp, Ctr Geriatr Res Educ & Clin, Minneapolis, MN 55417 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; Harvard University; Massachusetts General Hospital; Geriatric Research Education & Clinical Center	Ashe, KH (corresponding author), Univ Minnesota, Sch Med, Dept Neurol, Minneapolis, MN 55455 USA.	hsiao005@umn.edu	Spires-Jones, Tara/AAR-7697-2020	Spires-Jones, Tara/0000-0003-2530-0598	NIA NIH HHS [P01-AG15453, P50 AG005134, R01 AG026249, R01-AG26249, T31-AG00277, R01 AG026252, P01 AG015453, R01 AG008487, R01-AG08487] Funding Source: Medline; NINDS NIH HHS [R01 NS046355, R01-NS46355, R01 NS082672, R01 NS033249] Funding Source: Medline; PHS HHS [R01-026252] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082672, R01NS033249, R01NS046355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008487, P50AG005134, R01AG026249, P01AG015453, R01AG026252] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; BANCHER C, 1993, NEUROSCI LETT, V162, P179, DOI 10.1016/0304-3940(93)90590-H; Bennett DA, 2004, ARCH NEUROL-CHICAGO, V61, P378, DOI 10.1001/archneur.61.3.378; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Guillozet AL, 2003, ARCH NEUROL-CHICAGO, V60, P729, DOI 10.1001/archneur.60.5.729; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Lewis J M, UNPUB; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Spillantini MG, 1998, TRENDS NEUROSCI, V21, P428, DOI 10.1016/S0166-2236(98)01337-X; Tatebayashi Y, 2002, P NATL ACAD SCI USA, V99, P13896, DOI 10.1073/pnas.202205599; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002	26	1420	1498	2	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					476	481		10.1126/science.1113694	http://dx.doi.org/10.1126/science.1113694			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020737	Green Accepted			2022-12-28	WOS:000230574900050
J	O'Connor, PM; Claessens, LPAM				O'Connor, PM; Claessens, LPAM			Basic avian pulmonary design and flow-through ventilation in non-avian theropod dinosaurs	NATURE			English	Article							AIR-FLOW; PNEUMATICITY; MORPHOLOGY; ANATOMY; CHINA; LUNG	Birds are unique among living vertebrates in possessing pneumaticity of the postcranial skeleton, with invasion of bone by the pulmonary air-sac system(1-4). The avian respiratory system includes high-compliance air sacs that ventilate a dorsally fixed, non-expanding parabronchial lung(2,3,5,6). Caudally positioned abdominal and thoracic air sacs are critical components of the avian aspiration pump, facilitating flow-through ventilation of the lung and near-constant airflow during both inspiration and expiration, highlighting a design optimized for efficient gas exchange(2,5-8). Postcranial skeletal pneumaticity has also been reported in numerous extinct archosaurs including non-avian theropod dinosaurs and Archaeopteryx(9-12). However, the relationship between osseous pneumaticity and the evolution of the avian respiratory apparatus has long remained ambiguous. Here we report, on the basis of a comparative analysis of region-specific pneumaticity with extant birds, evidence for cervical and abdominal air-sac systems in non-avian theropods, along with thoracic skeletal prerequisites of an avian-style aspiration pump. The early acquisition of this system among theropods is demonstrated by examination of an exceptional new specimen of Majungatholus atopus, documenting these features in a taxon only distantly related to birds. Taken together, these specializations imply the existence of the basic avian pulmonary Bauplan in basal neotheropods, indicating that flow-through ventilation of the lung is not restricted to birds but is probably a general theropod characteristic.	Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA; Harvard Univ, Museum Comparat Zool, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	University System of Ohio; Ohio University; Harvard University	O'Connor, PM (corresponding author), Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, 228 Irvine Hall, Athens, OH 45701 USA.	oconnorp@ohiou.edu	Claessens, Leon P.A.M./F-5036-2012; OConnor, Patrick M/I-9383-2012	Claessens, Leon P.A.M./0000-0002-1873-6070; OConnor, Patrick M/0000-0002-6762-3806				[Anonymous], 1993, PNEUMATIC POSTCRANIA; BRACKENBURY JH, 1971, RESP PHYSIOL, V13, P319, DOI 10.1016/0034-5687(71)90036-3; Britt BB, 1998, NATURE, V395, P374, DOI 10.1038/26469; Chinsamy A, 2004, DINOSAURIA, 2ND EDITION, P643; Claessens LPAM, 2004, J VERTEBR PALEONTOL, V24, P89, DOI 10.1671/A1116-8; COVER MS, 1953, AM J VET RES, V14, P239; DUNCKER HR, 1989, LIFE SCI R, V45, P147; DUNCKER HR, 1971, ERGEBNISSE ANATOMIE, V0045, P00001; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Hunter J, 1774, PHILOS T ROY SOC LON, V64, P205; JENKINS FA, 1988, SCIENCE, V241, P1495, DOI 10.1126/science.241.4872.1495; KUETHE DO, 1988, J EXP BIOL, V136, P1; Maina JN, 2000, ANAT REC, V261, P25; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; O'Connor PM, 2004, J MORPHOL, V261, P141, DOI 10.1002/jmor.10190; OCONNOR PM, 2003, THESIS STONY BROOK U; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; Paul GS, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P463; PERRY SF, 1983, ADV ANAT EMBRYOL CEL, V79, P1; Perry SF, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P429; Ruben JA, 2003, PHYSIOL BIOCHEM ZOOL, V76, P141, DOI 10.1086/375425; Ruben JA, 1997, SCIENCE, V278, P1267, DOI 10.1126/science.278.5341.1267; Ruben JA, 1999, SCIENCE, V283, P514, DOI 10.1126/science.283.5401.514; Sampson SD, 1998, SCIENCE, V280, P1048, DOI 10.1126/science.280.5366.1048; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Wedel MJ, 2003, PALEOBIOLOGY, V29, P243, DOI 10.1666/0094-8373(2003)029<0243:VPASAT>2.0.CO;2; Xu X, 2004, NATURE, V431, P838, DOI 10.1038/nature02898; Xu X, 2004, NATURE, V431, P680, DOI 10.1038/nature02855; Zimmer K., 1935, Zoologica Stuttgart, V33, P1	30	152	158	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					253	256		10.1038/nature03716	http://dx.doi.org/10.1038/nature03716			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015329				2022-12-28	WOS:000230459500040
J	Sharifi, N; Gulley, JL; Dahut, WL				Sharifi, N; Gulley, JL; Dahut, WL			Androgen deprivation therapy for prostate cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							QUALITY-OF-LIFE; UNFAVORABLE-PROGNOSIS CARCINOMA; SUPPRESSION PLUS RADIATION; PREVENT BONE LOSS; MEGESTROL-ACETATE; HORMONAL-THERAPY; CONTROLLED-TRIAL; RADICAL PROSTATECTOMY; PILOT EVALUATION; ZOLEDRONIC ACID	Context Prostate cancer is the most common nonskin cancer and second most common cause of cancer mortality in US men. Androgen deprivation therapy (ADT), specifically surgical or medical castration, is the first line of treatment against advanced prostate cancer and is also used as an adjuvant to local treatment of high-risk disease. Objective To review systematically the evidence on the risks and benefits of ADT for prostate cancer as well as clinical management of its adverse effects. Evidence Acquisition We performed MEDLINE searches of English-language literature (1966 to March 2005) using the terms androgen deprivation therapy, hormone treatment, and prostate cancer. We reviewed bibliographies of literature to extract other relevant articles. Studies were selected based on clinical pertinence, with an emphasis on controlled study design. Evidence Synthesis Androgen deprivation therapy is effective for palliation in many patients with advanced prostate cancer and improves outcomes for high-risk patients treated with radiation therapy for localized disease. Although patients with increasing prostate-specific antigen levels after local treatment without metastatic disease frequently undergo ADT, the benefits of this strategy are not clear. Adverse effects of ADT include decreased libido, impotence, hot flashes, osteopenia with increased fracture risk, metabolic alterations, and changes in cognition and mood. Conclusions Androgen deprivation therapy has clear roles in the management of advanced prostate cancer and high-risk localized disease. The benefits of ADT in other settings need to be weighed carefully against substantial risks and adverse effects on quality of life.	NCI, Tumor Immunol & Biol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; NCI, Med Oncol Clin Res Unit, Bethesda, MD 20892 USA; NCI, Cytokine Mol Mech Sect, Mol Immunoregulat Lab, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gulley, JL (corresponding author), NCI, Tumor Immunol & Biol Lab, Ctr Canc Res, 10 Ctr Dr,8B09 MSC 1750, Bethesda, MD 20892 USA.	gul-leyj@mail.nih.gov	Gulley, James L/Y-7576-2019; Gulley, James L/K-4139-2016	Gulley, James L/0000-0002-6569-2912; Gulley, James L/0000-0002-6569-2912	NATIONAL CANCER INSTITUTE [Z01BC010666, ZIABC010666] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 1997, Br J Urol, V79, P235; Berruti A, 2002, J UROLOGY, V167, P2361, DOI 10.1016/S0022-5347(05)64985-3; Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502; Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4; Bubley GJ, 1999, J CLIN ONCOL, V17, P3461, DOI 10.1200/JCO.1999.17.11.3461; BYAR DP, 1973, CANCER, V32, P1126, DOI 10.1002/1097-0142(197311)32:5<1126::AID-CNCR2820320518>3.0.CO;2-C; Chen Allen C, 2004, Curr Oncol Rep, V6, P209, DOI 10.1007/s11912-004-0051-0; Crawford ED, 2003, UROLOGY, V61, P8, DOI 10.1016/S0090-4295(02)02394-4; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702; D'Amico AV, 2004, JAMA-J AM MED ASSOC, V292, P821, DOI 10.1001/jama.292.7.821; Dalesio O, 2000, LANCET, V355, P1491; DAWSON NA, 1995, J UROLOGY, V153, P1946, DOI 10.1016/S0022-5347(01)67365-8; Diamond TH, 2004, CANCER-AM CANCER SOC, V100, P892, DOI 10.1002/cncr.20056; Eisenberger MA, 1998, NEW ENGL J MED, V339, P1036, DOI 10.1056/NEJM199810083391504; Fowler FJ, 2002, CANCER-AM CANCER SOC, V95, P287, DOI 10.1002/cncr.10656; Green HJ, 2002, BJU INT, V90, P427, DOI 10.1046/j.1464-410X.2002.02917.x; Herr HW, 2000, J UROLOGY, V163, P1743, DOI 10.1016/S0022-5347(05)67533-7; Higano CS, 2004, UROL CLIN N AM, V31, P331, DOI 10.1016/j.ucl.2004.01.001; Higano CS, 2003, UROL ONCOL-SEMIN ORI, V21, P392, DOI 10.1016/S1078-1439(03)00143-1; Holzbeierlein JM, 2004, CURR OPIN UROL, V14, P177, DOI 10.1097/00042307-200405000-00007; Huggins C, 1941, CANCER RES, V1, P293; Huggins C, 1941, ARCH SURG-CHICAGO, V43, P209, DOI 10.1001/archsurg.1941.01210140043004; KUHN JM, 1989, NEW ENGL J MED, V321, P413, DOI 10.1056/NEJM198908173210701; Lawton CA, 2005, J CLIN ONCOL, V23, P800, DOI 10.1200/JCO.2005.08.141; Lawton CA, 2001, INT J RADIAT ONCOL, V49, P937, DOI 10.1016/S0360-3016(00)01516-9; Limonta P, 2001, EXPERT OPIN INV DRUG, V10, P709, DOI 10.1517/13543784.10.4.709; Loblaw DA, 2004, J CLIN ONCOL, V22, P2927, DOI 10.1200/jco.2004.04.579; LOPRINZI CL, 1994, NEW ENGL J MED, V331, P347, DOI 10.1056/NEJM199408113310602; Loprinzi CL, 2004, MAYO CLIN PROC, V79, P1247, DOI 10.4065/79.10.1247; McLeod DG, 2000, UROLOGY, V56, P713, DOI 10.1016/S0090-4295(00)00823-2; McLeod DG, 2003, UROLOGY, V61, P1, DOI 10.1016/S0090-4295(02)02392-0; Messing E, 2003, J UROLOGY, V169, P396; Messing EM, 1999, NEW ENGL J MED, V341, P1781, DOI 10.1056/NEJM199912093412401; Nishiyama T, 2005, J CLIN ENDOCR METAB, V90, P657, DOI 10.1210/jc.2004-1611; Oefelein MG, 2000, UROLOGY, V56, P1021, DOI 10.1016/S0090-4295(00)00793-7; Oh WK, 2002, UROLOGY, V60, P87, DOI 10.1016/S0090-4295(02)01581-9; Pilepich MV, 1997, J CLIN ONCOL, V15, P1013, DOI 10.1200/JCO.1997.15.3.1013; PILEPICH MV, 2003, P AM SOC CLIN ONC MA; Pirl WF, 2002, PSYCHO-ONCOLOGY, V11, P518, DOI 10.1002/pon.592; Potosky AL, 2001, J CLIN ONCOL, V19, P3750, DOI 10.1200/JCO.2001.19.17.3750; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Quella SK, 1999, J UROLOGY, V162, P98, DOI 10.1097/00005392-199907000-00024; Saad F, 2002, JNCI-J NATL CANCER I, V94, P1458, DOI 10.1093/jnci/94.19.1458; Salminen E, 2003, BRIT J CANCER, V89, P971, DOI 10.1038/sj.bjc.6601235; Salminen EK, 2005, CANCER-AM CANCER SOC, V103, P1381, DOI 10.1002/cncr.20962; Sartor O, 1999, SOUTHERN MED J, V92, P415, DOI 10.1097/00007611-199904000-00013; SCARDINO P, 2004, NATL COMPREHENSIVE C; Seidenfeld J, 2000, ANN INTERN MED, V132, P566, DOI 10.7326/0003-4819-132-7-200004040-00009; Shahinian VB, 2005, NEW ENGL J MED, V352, P154, DOI 10.1056/NEJMoa041943; Smith Matthew R, 2003, Clin Prostate Cancer, V2, P18, DOI 10.3816/CGC.2003.n.008; Smith MR, 2003, J UROLOGY, V169, P2008, DOI 10.1097/01.ju.0000063820.94994.95; Smith MR, 2002, J CLIN ENDOCR METAB, V87, P599, DOI 10.1210/jc.87.2.599; Smith MR, 2001, NEW ENGL J MED, V345, P948, DOI 10.1056/NEJMoa010845; Strum SB, 1997, BRIT J UROL, V79, P933, DOI 10.1046/j.1464-410X.1997.00234.x; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; TOLIS G, 1982, P NATL ACAD SCI-BIOL, V79, P1658, DOI 10.1073/pnas.79.5.1658; *VET ADM COOP UR R, 1967, SURG GYNECOL OBSTET, V124, P1011; Walsh PC, 2001, J UROLOGY, V166, P508, DOI 10.1016/S0022-5347(05)65972-1; YANNUCCI J, 2005, P AM SOC CLIN ONC MA	59	745	765	1	93	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2005	294	2					238	244		10.1001/jama.294.2.238	http://dx.doi.org/10.1001/jama.294.2.238			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944DO	16014598	Bronze			2022-12-28	WOS:000230406100028
J	Dennis, C				Dennis, C			Brown clouds cast a dark shadow	NATURE			English	News Item								In recent years China has seen increasing summer floods in the south and drought in the north. The likely culprit is air pollution, which has escalated withChina's rapid industrial growth. A blanket of aerosol particles over parts ofAsia is thought to be key factor in this change of climate. India is also a major contributor to clouds of black and organic carbon, sulfates and nitrates.											0	0	0	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 30	2005	435	7046					1154	1154						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	16021695				2022-12-28	WOS:000230140500011
J	Kaushal, R; Blumenthal, D; Poon, EG; Jha, AK; Franz, C; Middleton, B; Glaser, J; Kuperman, G; Christino, M; Fernandopulle, R; Newhouse, JP; Bates, DW				Kaushal, R; Blumenthal, D; Poon, EG; Jha, AK; Franz, C; Middleton, B; Glaser, J; Kuperman, G; Christino, M; Fernandopulle, R; Newhouse, JP; Bates, DW		Cost Natl Hlth Info Network Wkng Grp	The costs of a national health information network	ANNALS OF INTERNAL MEDICINE			English	Article							CONSENSUS; DELPHI; CARE	Background: The use of information technology may result in a safer and more efficient health care system. However, consensus does not exist about the structure or costs of a national health information network (NHIN). Objectives: To describe the potential structure and estimate the costs of an NHIN. Design: Cost estimates of an NHIN model developed by an expert panel. Setting: U.S. health care system. Measurements: An expert panel estimated the existing and the expected prevalence in 5 years of critical information technology functionalities. They then developed a model of an achievable NHIN by defining key providers, functionalities, and interoperability functions. By using these data and published cost estimates, the authors determined the cost of achieving this model NHIN in 5 years given the current state of information technology infrastructure. Results: To achieve an NHIN would cost $156 billion in capital investment over 5 years and $48 billion in annual operating costs. Approximately two thirds of the capital costs would be required for acquiring functionalities and one third for interoperability. ongoing costs would be more evenly divided between functionality and interoperability. If the current trajectory continues, the health care system will spend $24 billion on functionalities over the next 5 years or about one quarter of the cost for functionalities of a model NHIN. Limitations: Because of a lack of primary data, the authors relied on expert estimates. Conclusions: While an NHIN will be expensive, $156 billion is equivalent to 2% of annual health care spending for 5 years. Assessments such as this one may assist policymakers; in determining the level of investment that the United States should make in an NHIN.	Harvard Univ, Sch Publ Hlth, Massachusetts Gen Hosp, Inst Hlth Policy, Boston, MA 02120 USA; Eastern Res Grp Inc, Lexington, MA USA; Cornell Med Sch, New York, NY USA	Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts General Hospital; Cornell University	Kaushal, R (corresponding author), Harvard Univ, Sch Publ Hlth, Massachusetts Gen Hosp, Inst Hlth Policy, 1620 Tremont St, Boston, MA 02120 USA.	rkaushal@partners.org	Tao, Youyou/D-2367-2014; Greiver, Michelle/N-8764-2015; Newhouse, Joseph/AGJ-5632-2022; Middleton, Blackford/B-7304-2018	Greiver, Michelle/0000-0001-8957-0285; Middleton, Blackford/0000-0002-1819-1234; Kuperman, Gilad/0000-0002-4130-1577; Poon, Eric/0000-0002-7251-5842				BRAILER DJ, 2003, MOVING ELECT HLTH IN; BREWIN B, 2003, BRITAINS NATL HLTH S; Brooks Nicky, 2003, Br J Community Nurs, V8, P376; BUSH GW, 2004, STATE UNION ADD 0120; *COMM DAT STAND PA, 2001, KEY CAP EL HLTH REC; *COMM FUT HEALTHC, 2003, FED HLTH INV OTT ONT; *DARTM MED SCH CTR, 1999, DARTM ATL HLTH CAR U; FRIST W, 2004, WASHINGTON POST 0825, pA17; Glaser John P, 2003, J Healthc Inf Manag, V17, P42; Graham B, 2003, J CLIN EPIDEMIOL, V56, P1150, DOI 10.1016/S0895-4356(03)00211-7; HUNT DE, 2001, YOUR OFFICE STAFF FE; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; JOHNSTON J, 2003, VALUE COMPUTERIZED P; Kaushal R, 2003, MASSACHUSETTS MEMOS, P98; KAUSHAL R, 2005, IN PRESS HLTH AFF; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Levit K, 2004, HEALTH AFFAIR, V23, P147, DOI 10.1377/hlthaff.23.1.147; LUMPKIN J, 2002, COMMUNICATION   0227; Meijer R, 2003, INT J REHABIL RES, V26, P265, DOI 10.1097/00004356-200312000-00003; Overhage JM, 2001, J AM MED INFORM ASSN, V8, P361, DOI 10.1136/jamia.2001.0080361; PIZZIFERRI L, 2004, MED 2004 C 7 11 SEPT; THOMPSON TG, 2003, NAT HLTH INF INFR C; *US CENS BUR, 1997, EC CENS EST FIRM SIZ; US Census Bureau, COUNT BUS PATT; *US DEP HHS NAT CT, 2002, HLTH US 2002; Yasnoff WA, 2004, J AM MED INFORM ASSN, V11, P332, DOI 10.1197/jamia.M1616	27	71	72	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 2	2005	143	3					165	173		10.7326/0003-4819-143-3-200508020-00002	http://dx.doi.org/10.7326/0003-4819-143-3-200508020-00002			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	951TM	16061914				2022-12-28	WOS:000230953900001
J	Roy, PM; Colombe, I; Durieux, P; Chatellier, G; Sors, H; Meyer, G				Roy, PM; Colombe, I; Durieux, P; Chatellier, G; Sors, H; Meyer, G			Systematic review and meta-analysis of strategies for the diagnosis of suspected pulmonary embolism	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PLASMA D-DIMER; SPIRAL COMPUTED-TOMOGRAPHY; INTERMEDIATE PROBABILITY; LUNG-SCAN; CLINICAL-MODEL; HELICAL CT; WORK-UP; ANGIOGRAPHY; MANAGEMENT; TESTS	Objectives To assess the likelihood ratios of diagnostic strategies for pulmonary embolism and to determine their clinical application according to pretest probability. Data sources Medline, Embase, and Pascal Biomed and manual search for articles published from January 1990 to September 2003. Study selection Studies that evaluated diagnostic tests for confirmation or exclusion of pulmonary embolism. Data extracted Positive likelihood ratios for strategies that confirmed a diagnosis of pulmonary embolism and negative likelihood ratios for diagnostic strategies that excluded a diagnosis of pulmonary embolism. Data synthesis 48 of 1012 articles were included. Positive likelihood ratios for diagnostic tests were: high probability ventilation perfusion lung scan 18.3 (95% confidence interval 10.3 to 32.5), spiral computed tomography 24.1 (12.4 to 46.7), and ultrasonography of leg veins 16.2 (5.6 to 46.7). In patients with a moderate or high pretest probability, these findings were associated with a post-test probability of pulmonary embolism greater than 85%. Negative likelihood ratios were: normal or near normal appearance on lung scan 0.05 (0.03 to 0.10), a negative result on spiral computed tomography along with a negative result on ultrasonography 0.04 (0.03 to 0.06), and a D-dimer concentration < 500 mu g/l measured by quantitative enzyme linked immunosorbent assay 0.08 (0.04 to 0.18). In patients with a low or moderate pretest probability, these findings were associated with a post-test probability of pulmonary embolism below 5%. Spiral computed tomography alone, a low probability ventilation perfusion lung scan, magnetic resonance angiography, a quantitative latex D-dimer test, and haemagglutination D-dimers had higher negative likelihood ratios and can therefore only exclude pulmonary embolism in patients with a low pretest probability. Conclusions The accuracy of tests for suspected pulmonary embolism varies greatly, but it is possible to estimate the range of pretest probabilities over which each test or strategy can confirm or rule out pulmonary embolism.	CHU Angers, Emergency Dept, F-49033 Angers, France; Univ Paris 05, Assistance Publ Hop Paris, Hop Europeen Georges Pompidou, INSERM,U729,Dept Clin Epidemiol, Paris, France; Univ Paris 05, Dept Resp & Intens Care, Paris, France	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Meyer, G (corresponding author), Hop Europeen Georges Pompidou, Serv Pneumol Soins Intensifs, 20 Rue Leblanc, F-75015 Paris, France.	guy.meyer@hop.egp.ap-hop-paris.fr	Roy, Pierre-Marie/AAA-7737-2022; Colombet, Isabelle/J-8186-2017	Colombet, Isabelle/0000-0002-8721-1526				Agresti A, 1996, BIOMETRICS, V52, P1103, DOI 10.2307/2533072; Boonbaichaiyapruck Sarana, 1997, Journal of the Medical Association of Thailand, V80, P527; Bounameaux H, 1990, Blood Coagul Fibrinolysis, V1, P577, DOI 10.1097/00001721-199010000-00045; Bova C, 2003, AM J EMERG MED, V21, P180, DOI 10.1016/S0735-6757(02)42257-7; Christiansen F, 1996, ACTA RADIOL, V37, P14; Chunilal SD, 2003, JAMA-J AM MED ASSOC, V290, P2849, DOI 10.1001/jama.290.21.2849; de Groot MR, 1999, THROMB HAEMOSTASIS, V82, P1588; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; DerSimonian R, 1996, STAT MED, V15, P1237, DOI 10.1002/(SICI)1097-0258(19960630)15:12<1237::AID-SIM301>3.0.CO;2-N; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; Fedullo PF, 2003, NEW ENGL J MED, V349, P1247, DOI 10.1056/NEJMcp035442; Ferretti GR, 1997, RADIOLOGY, V205, P453, DOI 10.1148/radiology.205.2.9356628; GOLDHABER SZ, 1993, JAMA-J AM MED ASSOC, V270, P2819, DOI 10.1001/jama.270.23.2819; GRIST TM, 1993, RADIOLOGY, V189, P523, DOI 10.1148/radiology.189.2.8210385; Gupta A, 1999, RADIOLOGY, V210, P353, DOI 10.1148/radiology.210.2.r99fe53353; Heit JA, 1999, ARCH PATHOL LAB MED, V123, P235; Heit JA, 2000, THROMB HAEMOSTASIS, V83, P970; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HULL RD, 1991, ANN INTERN MED, V114, P142, DOI 10.7326/0003-4819-114-2-142; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P389, DOI 10.1001/jama.271.5.389; Kearon C, 2003, CAN MED ASSOC J, V168, P183; Kruip MJHA, 2003, ANN INTERN MED, V138, P941, DOI 10.7326/0003-4819-138-12-200306170-00005; Kruip MJHA, 2002, ARCH INTERN MED, V162, P1631, DOI 10.1001/archinte.162.14.1631; KRUIT WHJ, 1991, J INTERN MED, V230, P333, DOI 10.1111/j.1365-2796.1991.tb00453.x; Kutinsky I, 1999, ARCH INTERN MED, V159, P1569, DOI 10.1001/archinte.159.14.1569; Leclercq MGL, 2003, THROMB HAEMOSTASIS, V89, P97; LOUBEYRE P, 1994, AM J ROENTGENOL, V162, P1035, DOI 10.2214/ajr.162.5.8165977; Meaney JFM, 1997, NEW ENGL J MED, V336, P1422, DOI 10.1056/NEJM199705153362004; Miniati M, 2001, AM J MED, V110, P528, DOI 10.1016/S0002-9343(01)00693-3; Miniati M, 1996, AM J RESP CRIT CARE, V154, P1387, DOI 10.1164/ajrccm.154.5.8912753; Miron MJ, 1999, EUR RESPIR J, V13, P1365, DOI 10.1183/09031936.99.13613719; Musset D, 2002, LANCET, V360, P1914, DOI 10.1016/S0140-6736(02)11914-3; Nilsson T, 1998, EUR RADIOL, V8, P86, DOI 10.1007/s003300050344; Nilsson T, 2002, SCAND CARDIOVASC J, V36, P373, DOI 10.1080/140174302762659111; Ost D, 2001, AM J MED, V110, P16, DOI 10.1016/S0002-9343(00)00641-0; Perrier A, 2000, ARCH INTERN MED, V160, P512, DOI 10.1001/archinte.160.4.512; Perrier A, 1996, ARCH INTERN MED, V156, P531, DOI 10.1001/archinte.156.5.531; Perrier A, 2004, AM J MED, V116, P291, DOI 10.1016/j.amjmed.2003.09.041; Perrier A, 1997, AM J RESP CRIT CARE, V156, P492, DOI 10.1164/ajrccm.156.2.9702032; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; Perrin JM, 2001, AMBUL PEDIATR, V1, P1; Qanadli SD, 2000, RADIOLOGY, V217, P447, DOI 10.1148/radiology.217.2.r00nv01447; Quinn DA, 1999, AM J RESP CRIT CARE, V159, P1445, DOI 10.1164/ajrccm.159.5.9808094; QUINN RJ, 1994, RADIOLOGY, V190, P509, DOI 10.1148/radiology.190.2.8284407; RemyJardin M, 1996, RADIOLOGY, V200, P699, DOI 10.1148/radiology.200.3.8756918; REMYJARDIN M, 1992, RADIOLOGY, V185, P381, DOI 10.1148/radiology.185.2.1410342; Sackett DL, 2002, EVIDENCE BASE CLIN D, P19; Sijens PE, 2001, THROMB HAEMOSTASIS, V86, P1580; Sijens PE, 2000, THROMB HAEMOSTASIS, V84, P156; STEIN PD, 1992, CIRCULATION, V85, P462, DOI 10.1161/01.CIR.85.2.462; Stone E, 2003, INTERN MED J, V33, P74, DOI 10.1046/j.1445-5994.2003.00345.x; TEIGEN CL, 1995, RADIOLOGY, V194, P313, DOI 10.1148/radiology.194.2.7824704; Turkstra F, 1997, ANN INTERN MED, V126, P775, DOI 10.7326/0003-4819-126-10-199705150-00005; vanBeek EJR, 1997, ARCH INTERN MED, V157, P2593, DOI 10.1001/archinte.157.22.2593; vanBeek EJR, 1996, EUR RADIOL, V6, P415, DOI 10.1007/BF00182453; vanRossum AB, 1996, THORAX, V51, P23, DOI 10.1136/thx.51.1.23; VANSURIJEN MJ, 2003, ANN INTERN MED, V133, P307; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; Wallis JW, 2000, THROMB HAEMOSTASIS, V84, P925; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010	62	175	189	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2005	331	7511					259	263		10.1136/bmj.331.7511.259	http://dx.doi.org/10.1136/bmj.331.7511.259			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953FJ	16052017	Green Published, Bronze			2022-12-28	WOS:000231061700016
J	Basu, P				Basu, P			Vaccines on trial	NATURE			English	Article																			0	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2005	436	7050					484	484		10.1038/436484a	http://dx.doi.org/10.1038/436484a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049470				2022-12-28	WOS:000230788800039
J	Halamka, J				Halamka, J			Straight from the shoulder	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									CareGrp Healthcare Syst, Boston, MA USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Halamka, J (corresponding author), CareGrp Healthcare Syst, Boston, MA USA.							BONO S, ANAL TEXAS INSTRUMEN	1	11	11	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2005	353	4					331	333		10.1056/NEJMp058077	http://dx.doi.org/10.1056/NEJMp058077			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949JW	16049206				2022-12-28	WOS:000230782800002
J	Kagawa, F; Miyagawa, K; Kanoda, K				Kagawa, F; Miyagawa, K; Kanoda, K			Unconventional critical behaviour in a quasi-two-dimensional organic conductor	NATURE			English	Article							MEAN-FIELD THEORY; METAL-INSULATOR-TRANSITION; QUANTUM MOTT TRANSITION; CUPRATE SUPERCONDUCTORS; C-13 NMR; KAPPA-(ET)(2)CU<N(CN)(2)>BR; RELAXATION; SYSTEMS; STATE	Changing the interactions between particles in an ensemble-by varying the temperature or pressure, for example-can lead to phase transitions whose critical behaviour depends on the collective nature of the many-body system. Despite the diversity of ingredients, which include atoms, molecules, electrons and their spins, the collective behaviour can be grouped into several families (called 'universality classes') represented by canonical spin models(1). One kind of transition, the Mott transition(2), occurs when the repulsive Coulomb interaction between electrons is increased, causing wave-like electrons to behave as particles. In two dimensions, the attractive behaviour responsible for the superconductivity in high-transition temperature copper oxide(3,4) and organic(5-7) compounds appears near the Mott transition, but the universality class to which two-dimensional, repulsive electronic systems belongs remains unknown. Here we present an observation of the critical phenomena at the pressure-induced Mott transition in a quasi-two-dimensional organic conductor using conductance measurements as a probe. We find that the Mott transition in two dimensions is not consistent with known universality classes, as the observed collective behaviour has previously not been seen. This peculiarity must be involved in any emergent behaviour near the Mott transition in two dimensions.	Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Kanoda, K (corresponding author), Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan.	kanoda@ap.t.u-tokyo.ac.jp	Kanoda, Kazushi/ABA-8572-2021; Kagawa, Fumitaka/A-2824-2014	Kagawa, Fumitaka/0000-0002-1763-6799				CASTELLANI C, 1979, PHYS REV LETT, V43, P1957, DOI 10.1103/PhysRevLett.43.1957; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; DESOTO SM, 1995, PHYS REV B, V52, P10364, DOI 10.1103/PhysRevB.52.10364; Fournier D, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.127002; Georges A, 2004, AIP CONF PROC, V715, P3, DOI 10.1063/1.1800733; Georges A, 1996, REV MOD PHYS, V68, P13, DOI 10.1103/RevModPhys.68.13; Imada M, 2005, J PHYS SOC JPN, V74, P859, DOI 10.1143/JPSJ.74.859; Imada M, 2004, J PHYS SOC JPN, V73, P1851, DOI 10.1143/JPSJ.73.1851; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; KADANOFF LP, 1967, REV MOD PHYS, V39, P395, DOI 10.1103/RevModPhys.39.395; Kagawa F, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.064511; Kanoda K, 1996, PHYS REV B, V54, P76, DOI 10.1103/PhysRevB.54.76; Kanoda K, 1997, PHYSICA C, V282, P299, DOI 10.1016/S0921-4534(97)00266-9; Kino H, 1996, J PHYS SOC JPN, V65, P2158, DOI 10.1143/JPSJ.65.2158; Kotliar G, 2004, PHYS TODAY, V57, P53, DOI 10.1063/1.1712502; Kotliar G, 2000, PHYS REV LETT, V84, P5180, DOI 10.1103/PhysRevLett.84.5180; Lefebvre S, 2000, PHYS REV LETT, V85, P5420, DOI 10.1103/PhysRevLett.85.5420; Limelette P, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.016401; Limelette P, 2003, SCIENCE, V302, P89, DOI 10.1126/science.1088386; MAYAFFRE H, 1995, PHYS REV LETT, V75, P4122, DOI 10.1103/PhysRevLett.75.4122; McKenzie RH, 1997, SCIENCE, V278, P820, DOI 10.1126/science.278.5339.820; Miyagawa K, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.017003; Mott N.F., 1990, METAL INSULATOR TRAN; ONODA S, 2004, GINSBURG LANDAU THEO; WILLIAMS JM, 1990, INORG CHEM, V29, P3272, DOI 10.1021/ic00343a003	25	246	246	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					534	537		10.1038/nature03806	http://dx.doi.org/10.1038/nature03806			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049483	Green Submitted			2022-12-28	WOS:000230788800056
J	Pham, HH; Schrag, D; Hargraves, JL; Bach, PB				Pham, HH; Schrag, D; Hargraves, JL; Bach, PB			Delivery of preventive services to older adults by primary care physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ELDERLY MEDICARE BENEFICIARIES; FECAL OCCULT BLOOD; QUALITY-OF-CARE; HEALTH-CARE; CLAIMS DATA; UNITED-STATES; CANCER; BREAST; WOMEN; GUIDELINES	Context Rates of preventive services remain below national goals. Objective To identify characteristics of physicians and their practices that are associated with the quality of preventive care their patients receive. Design Cross-sectional analysis of data on US physician respondents to the 20002001 Community Tracking Study Physician Survey linked to claims data on Medicare beneficiaries they treated in 2001. Physician variables included training and qualifications and sex. Practice setting variables included practice type, size, sources of revenue, and access to information technology. Analyses were adjusted for patient demographics and comorbidity, as well as community characteristics. Setting and Participants Primary care delivered by 3660 physicians providing usual care to 24 581 Medicare beneficiaries aged 65 years and older. Main Outcome Measures Proportion of eligible beneficiaries receiving each of 6 preventive services: diabetic monitoring with hemoglobin A(1c) measurement or eye examinations, screening for colon or breast cancer, and vaccination for influenza or pneumococcus in 2001. Results Overall, the proportion of beneficiaries receiving services was below national goals. Physician and, more consistently, practice-level characteristics were both associated with differences in the delivery of services. The strongest associations were with practice type and the percentage of practice revenue derived from Medicaid. For instance, beneficiaries receiving usual care in practices with less than 6% of revenue from Medicaid were more likely than those with more than 15% of revenue derived from Medicaid to receive diabetic eye examinations (48.9% vs43%; P=.02), hemoglobin A(1c) monitoring (61.2% vs 48.4%; P<.001), mammograms (52.1% vs 38.9%; P<.001), colon cancer screening (10.0% vs 8.5%; P=.60), and influenza (50.2% vs 39.2%; P<001) and pneumococcal (8.2% vs 6.4%; P<001) vaccinations. Other variables associated with delivery of preventive services after adjustment for patient and geographic factors included obtaining usual health care from a physician who worked in group practices of 3 or more, who was a graduate of a US or Canadian medical school, or who reported availability of information technology to generate preventive care reminders or access treatment guidelines. Conclusions Delivery of routine preventive services is suboptimal for Medicare beneficiaries. However, patients treated within particular practice settings and by particular subgroups of physicians are at particular risk of low-quality care. Profiling these practices may help develop tailored interventions that can be directed to sites where the opportunities for quality improvement are greatest.	Ctr Studying Hlth Syst Change, Washington, DC 20024 USA; Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Hlth Outcomes Res Grp, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; Ctr Medicare & Medicaid Serv, Washington, DC USA; Univ Massachusetts, Sch Med, Dept Family Med & Community Hlth, Worcester, MA USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Centers for Medicare & Medicaid Services; University of Massachusetts System; University of Massachusetts Worcester	Pham, HH (corresponding author), Ctr Studying Hlth Syst Change, 600 Maryland Ave SW,Suite 550, Washington, DC 20024 USA.	mpham@hschange.org		Schrag, Deborah/0000-0002-4334-5717	NATIONAL CANCER INSTITUTE [R01CA090226] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA090226] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*AM CANC SOC, CANC DET GUID; Asch SM, 2000, JAMA-J AM MED ASSOC, V284, P2325, DOI 10.1001/jama.284.18.2325; Audet AMJ, 2005, HEALTH AFFAIR, V24, P843, DOI 10.1377/hlthaff.24.3.843; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Baldwin LM, 2002, MED CARE, V40, P82; Balkrishnan R, 2002, AM J MANAG CARE, V8, P332; Bonito AJ, 2004, AM J PREV MED, V27, P153, DOI 10.1016/j.amepre.2004.04.004; Bradley EH, 2004, JAMA-J AM MED ASSOC, V292, P1563, DOI 10.1001/jama.292.13.1563; Byers T, 1997, CA-CANCER J CLIN, V47, P154, DOI 10.3322/canjclin.47.3.154; Casalino LP, 2003, ARCH INTERN MED, V163, P1958, DOI 10.1001/archinte.163.16.1958; Chin MH, 2000, MED CARE, V38, P131, DOI 10.1097/00005650-200002000-00003; Collins JF, 2005, ANN INTERN MED, V142, P81, DOI 10.7326/0003-4819-142-2-200501180-00006; *CTR MED MED SERV, 2002, 2002 DAT COMP; *CTR MED MED SERV, MED FED HLTH CAR PRO; Dexter PR, 2001, NEW ENGL J MED, V345, P965, DOI 10.1056/NEJMsa010181; Epstein AM, 2004, NEW ENGL J MED, V351, P603, DOI 10.1056/NEJMe048181; Freeman JL, 2002, MED CARE, V40, P36; GANN P, 1993, ANN INTERN MED, V118, P893, DOI 10.7326/0003-4819-118-11-199306010-00011; GILLES RR, 2003, HLTH AFF MILLWOO JUL; Goldstein DE, 2004, DIABETES CARE, V27, P1761, DOI 10.2337/diacare.27.7.1761; Hebert PL, 2005, HEALTH SERV RES, V40, P517, DOI 10.1111/j.1475-6773.2005.0e371.x; *I MED COMM MON AC, 1993, ACC HLTH CAR AM; *I MED COMM UND EL, 2003, UN TREATM; Institute of Medicine (US) Committee on Quality of Health Care in America, 2001, CROSS QUAL CHASM; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Kerr EA, 2004, HEALTH AFFAIR, V23, P247, DOI 10.1377/hlthaff.23.3.247; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Koroukian SM, 2005, MED CARE, V43, P445, DOI 10.1097/01.mlr.0000160376.42562.79; LURIE N, 1993, NEW ENGL J MED, V329, P478, DOI 10.1056/NEJM199308123290707; McBean AM, 2005, AM J MANAG CARE, V11, P213; MCBEAN AM, 1991, ARCH INTERN MED, V151, P2009, DOI 10.1001/archinte.151.10.2009; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Mick SS, 1997, MED CARE RES REV, V54, P379, DOI 10.1177/107755879705400401; Miller RH, 2002, J HEALTH POLIT POLIC, V27, P401, DOI 10.1215/03616878-27-3-401; Nadel MR, 2005, ANN INTERN MED, V142, P86, DOI 10.7326/0003-4819-142-2-200501180-00007; O'Malley AS, 2003, J COMMUN HEALTH, V28, P185, DOI 10.1023/A:1022956223774; Randolph WM, 2002, HEALTH SERV RES, V37, P1643, DOI 10.1111/1475-6773.10912; Reschovsky J, 2001, MED CARE, V39, P254, DOI 10.1097/00005650-200103000-00006; RHEE SO, 1986, MED CARE, V24, P248, DOI 10.1097/00005650-198603000-00007; Salive ME, 1996, PREV MED, V25, P561, DOI 10.1006/pmed.1996.0090; Shah BV, 1996, SUDAAN USERS MANUAL; Sharp LK, 2002, ACAD MED, V77, P534, DOI 10.1097/00001888-200206000-00011; Shea S, 1996, J AM MED INFORM ASSN, V3, P399, DOI 10.1136/jamia.1996.97084513; Sloan FA, 2004, HEALTH SERV RES, V39, P1429, DOI 10.1111/j.1475-6773.2004.00297.x; *US PREV SERV TASK, IMM CHEM AD IMM REC; Van Harrison R, 2003, CANCER-AM CANCER SOC, V98, P1811, DOI 10.1002/cncr.11744; WEINER JP, 1995, JAMA-J AM MED ASSOC, V273, P1503, DOI 10.1001/jama.273.19.1503	47	217	219	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2005	294	4					473	481		10.1001/jama.294.4.473	http://dx.doi.org/10.1001/jama.294.4.473			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	948RM	16046654	Bronze			2022-12-28	WOS:000230733400022
J	Ashcroft, RE				Ashcroft, RE			Commentary: Ethics committees and countries in transition: a figleaf for structural violence?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, London W6 8RP, England	Imperial College London	Ashcroft, RE (corresponding author), Univ London Imperial Coll Sci Technol & Med, London W6 8RP, England.	r.ashcroft@imperial.ac.uk						Borovecki A, 2005, BMJ-BRIT MED J, V331, P227, DOI 10.1136/bmj.331.7510.227; Dwyer J, 2003, BIOETHICS, V17, P432, DOI 10.1111/1467-8519.00359; Farmer P, 2005, PATHOLOGIES POWER HL; *ROYAL COLL PHYS, 2005, ETH PRACT; Slowther A, 2004, BRIT MED J, V328, P950, DOI 10.1136/bmj.328.7445.950	5	9	9	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 23	2005	331	7510					229	230		10.1136/bmj.331.7510.229	http://dx.doi.org/10.1136/bmj.331.7510.229			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951EA	16037467	Bronze, Green Published			2022-12-28	WOS:000230910700036
J	Martin, R				Martin, R			Undue inducement in clinical research	LANCET			English	Editorial Material									Univ Hertfordshire, Ctr Res Primary & Community Care, Hatfield AL10 9AB, Herts, England	University of Hertfordshire	Martin, R (corresponding author), Univ Hertfordshire, Ctr Res Primary & Community Care, Hatfield AL10 9AB, Herts, England.	R.M.Martin@herts.ac.uk						Beauchamp TL, 2002, J MED PHILOS, V27, P547, DOI 10.1076/jmep.27.5.547.10320; Casarett D, 2002, J GEN INTERN MED, V17, P650; Emanuel EJ, 2005, LANCET, V366, P336, DOI 10.1016/S0140-6736(05)66992-9; Grady Christine, 2001, American Journal of Bioethics, V1, P40, DOI 10.1162/152651601300169031; Truman C., 2000, RES INEQUALITY, P24	5	10	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2005	366	9482					275	276		10.1016/S0140-6736(05)66964-4	http://dx.doi.org/10.1016/S0140-6736(05)66964-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RJ	16039318				2022-12-28	WOS:000230733100009
J	Zatonski, WA; Willett, W				Zatonski, WA; Willett, W			Changes in dietary fat and declining coronary heart disease in Poland: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK; MORTALITY		Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Ctr Canc, PL-02781 Warsaw, Poland; Inst Oncol, PL-02781 Warsaw, Poland	Harvard University; Harvard T.H. Chan School of Public Health; Maria Sklodowska-Curie National Research Institute of Oncology	Willett, W (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	walter.willett@channing.harvard.edu						DWYER T, 1980, INT J EPIDEMIOL, V9, P65, DOI 10.1093/ije/9.1.65; Hu FB, 1999, AM J CLIN NUTR, V70, P1001; Hu FB, 2002, JAMA-J AM MED ASSOC, V288, P2569, DOI 10.1001/jama.288.20.2569; Joshipura KJ, 2001, ANN INTERN MED, V134, P1106, DOI 10.7326/0003-4819-134-12-200106190-00010; Zatonski WA, 1998, BMJ-BRIT MED J, V316, P1047	5	107	112	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2005	331	7510					187	188		10.1136/bmj.331.7510.187	http://dx.doi.org/10.1136/bmj.331.7510.187			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951EA	16037448	Green Published, Bronze			2022-12-28	WOS:000230910700017
J	Roy, S; Asenov, A				Roy, S; Asenov, A			Where do the dopants go?	SCIENCE			English	Editorial Material							PARAMETER FLUCTUATIONS		Univ Glasgow, Dept Elect & Elect Engn, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Roy, S (corresponding author), Univ Glasgow, Dept Elect & Elect Engn, Glasgow G12 8QQ, Lanark, Scotland.	s.roy@elec.gla.ac.uk						BURNETT D, 1994, 1994 SYMPOSIUM ON VLSI TECHNOLOGY, P15, DOI 10.1109/VLSIT.1994.324400; Cheng B, 2005, SOLID STATE ELECTRON, V49, P740, DOI 10.1016/j.sse.2004.09.005; HOENEISEN B, 1972, SOLID STATE ELECTRON, V15, P819, DOI 10.1016/0038-1101(72)90103-7; Hon-Sum Wong, 1993, International Electron Devices Meeting 1993. Technical Digest (Cat. No.93CH3361-3), P705, DOI 10.1109/IEDM.1993.347215; KEYES RW, 1975, APPL PHYS, V8, P251, DOI 10.1007/BF00896619; MIZUNO T, 1994, IEEE T ELECTRON DEV, V41, P2216, DOI 10.1109/16.333844; Moore G., 1965, ELECTRONICS, V38, P114, DOI [DOI 10.1109/N-SSC.2006.4785860, DOI 10.1109/JPROC.1998.658762]; Semiconductor Industry Association, 2001, INT TECHN ROADM SEM; STEYAERT M, 1994, ELECTRON LETT, V30, P1546, DOI 10.1049/el:19940999; Stolk PA, 1998, IEEE T ELECTRON DEV, V45, P1960, DOI 10.1109/16.711362; Tang XH, 1997, IEEE T VLSI SYST, V5, P369, DOI 10.1109/92.645063; Wakabayashi H, 2003, 2003 IEEE INTERNATIONAL ELECTRON DEVICES MEETING, TECHNICAL DIGEST, P989; ZHOU JR, 1994, P 3 INT WORKSH COMP, P74	13	99	102	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					388	390		10.1126/science.1111104	http://dx.doi.org/10.1126/science.1111104			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020718				2022-12-28	WOS:000230574900028
J	Topol, EJ				Topol, EJ			Nesiritide - Not verified	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DECOMPENSATED HEART-FAILURE; INTRAVENOUS NESIRITIDE; RENAL-FUNCTION; RISK		Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Topol, EJ (corresponding author), Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA.			Topol, Eric/0000-0002-1478-4729				Colucci WS, 2000, NEW ENGL J MED, V343, P246, DOI 10.1056/NEJM200007273430403; Publication Committee for the VMAC Investigators, 2002, JAMA-J AM MED ASSOC, V287, P1531; Sackner-Bernstein JD, 2005, JAMA-J AM MED ASSOC, V293, P1900, DOI 10.1001/jama.293.15.1900; Sackner-Bernstein JD, 2005, CIRCULATION, V111, P1487, DOI 10.1161/01.CIR.0000159340.93220.E4; Teerlink JR, 2005, CIRCULATION, V111, P1459, DOI 10.1161/01.CIR.0000160874.48045.54; Young JB, 2002, JAMA-J AM MED ASSOC, V287, P1531, DOI 10.1001/jama.287.12.1531	6	79	82	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2005	353	2					113	116		10.1056/NEJMp058139	http://dx.doi.org/10.1056/NEJMp058139			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944OP	16014879	Bronze			2022-12-28	WOS:000230438800001
J	Vandergoes, MJ; Newnham, RM; Preusser, F; Hendy, CH; Lowell, TV; Fitzsimons, SJ; Hogg, AG; Kasper, HU; Schluchter, C				Vandergoes, MJ; Newnham, RM; Preusser, F; Hendy, CH; Lowell, TV; Fitzsimons, SJ; Hogg, AG; Kasper, HU; Schluchter, C			Regional insolation forcing of late Quaternary climate change in the Southern Hemisphere	NATURE			English	Article							NEW-ZEALAND; WESTLAND; RECORD; AGE; VEGETATION; SITE-594; ATLANTIC	In agreement with the Milankovitch orbital forcing hypothesis(1) it is often assumed that glacial - interglacial climate transitions occurred synchronously in the Northern and Southern hemispheres of the Earth. It is difficult to test this assumption, because of the paucity of long, continuous climate records from the Southern Hemisphere that have not been dated by tuning them to the presumed Northern Hemisphere signals(2). Here we present an independently dated terrestrial pollen record from a peat bog on South Island, New Zealand, to investigate global and local factors in Southern Hemisphere climate changes during the last two glacial - interglacial cycles. Our record largely corroborates the Milankovitch model of orbital forcing but also exhibits some differences: in particular, an earlier onset and longer duration of the Last Glacial Maximum. Our results suggest that Southern Hemisphere insolation may have been responsible for these differences in timing. Our findings question the validity of applying orbital tuning to Southern Hemisphere records and suggest an alternative mechanism to the bipolar seesaw for generating interhemispheric asynchrony in climate change.	Univ Maine, Climate Change Inst, Orono, ME 04469 USA; Univ Plymouth, Sch Geog, Plymouth PL4 8AA, Devon, England; Univ Bern, Inst Geol Sci, CH-3012 Bern, Switzerland; Univ Waikato, Radiocarbon Dating Lab, Hamilton, New Zealand; Univ Cincinnati, Dept Geol, Cincinnati, OH 45221 USA; Univ Otago, Dept Geog, Dunedin, New Zealand; Univ Cologne, Inst Geol, D-50674 Cologne, Germany	University of Maine System; University of Maine Orono; University of Plymouth; University of Bern; University of Waikato; University System of Ohio; University of Cincinnati; University of Otago; University of Cologne	Vandergoes, MJ (corresponding author), Univ Maine, Climate Change Inst, Orono, ME 04469 USA.	vandergoes@maine.edu	Newnham, Rewi M/F-1111-2011; Fitzsimons, Sean/C-4024-2009	Lowell, Thomas/0000-0001-7826-0636				Alley RB, 2002, QUATERNARY SCI REV, V21, P431, DOI 10.1016/S0277-3791(01)00072-5; Almond PC, 2001, NEW ZEAL J GEOL GEOP, V44, P1, DOI 10.1080/00288306.2001.9514917; BASSINOT FC, 1994, EARTH PLANET SC LETT, V126, P91, DOI 10.1016/0012-821X(94)90244-5; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Colhoun EA, 1999, QUATERN INT, V57-8, P5, DOI 10.1016/S1040-6182(98)00046-9; Denton GH, 1999, GEOGR ANN A, V81A, P107, DOI 10.1111/j.0435-3676.1999.00055.x; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Hellstrom J, 1998, QUATERNARY RES, V50, P167, DOI 10.1006/qres.1998.1991; Heusser CJ, 1999, GEOGR ANN A, V81A, P231, DOI 10.1111/1468-0459.00058; HEUSSER LE, 1994, QUATERNARY SCI REV, V13, P273, DOI 10.1016/0277-3791(94)90030-2; Imbrie J., 1993, GLOBAL CHANGES PERSP, P263; Knorr G, 2003, NATURE, V424, P532, DOI 10.1038/nature01855; Lamy F, 2004, SCIENCE, V304, P1959, DOI 10.1126/science.1097863; LOWELL TV, 1995, SCIENCE, V269, P1541, DOI 10.1126/science.269.5230.1541; Lynch-Stieglitz J, 2004, SCIENCE, V304, P1919, DOI 10.1126/science.1100374; MARTENS R., 1987, SPORT PSYCHOL, V1, P29, DOI [10.1123/tsp.1.1.29, DOI 10.1123/TSP.1.1.29]; NELSON CS, 1993, PALEOCEANOGRAPHY, V8, P435, DOI 10.1029/93PA01162; Newnham RM, 2000, GEOLOGY, V28, P759, DOI 10.1130/0091-7613(2000)028<0759:FRPROL>2.3.CO;2; Newnham RM, 2003, QUATERNARY SCI REV, V22, P289, DOI 10.1016/S0277-3791(02)00137-3; Pahnke K, 2003, SCIENCE, V301, P948, DOI 10.1126/science.1084451; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; SUGGATE RP, 1990, QUATERNARY SCI REV, V9, P175, DOI 10.1016/0277-3791(90)90017-5; SUGGATE RP, 1999, GEOLOGY KUMARA MOANA, pCH6; Turney CSM, 2003, GEOLOGY, V31, P223, DOI 10.1130/0091-7613(2003)031<0223:ACCBNZ>2.0.CO;2; Vandergoes MJ, 2003, RADIOCARBON, V45, P479, DOI 10.1017/S0033822200032823; Vandergoes MJ, 2003, QUATERNARY SCI REV, V22, P1461, DOI 10.1016/S0277-3791(03)00074-X; WARDIE P, 1979, PLANTS LANDSCAPES WE, pCH1; Williams PW, 1996, NEW ZEAL J GEOL GEOP, V39, P225, DOI 10.1080/00288306.1996.9514707; WILSON CJN, 1988, GEOL MAG, V125, P297, DOI 10.1017/S0016756800010232	29	109	114	1	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					242	245		10.1038/nature03826	http://dx.doi.org/10.1038/nature03826			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015326				2022-12-28	WOS:000230459500037
J	van den Born, BJH; Hulsman, CAA; Hoekstra, HBL; Schlingemann, RO; van Montfrans, GA				van den Born, BJH; Hulsman, CAA; Hoekstra, HBL; Schlingemann, RO; van Montfrans, GA			Value of routine funduscopy in patients with hypertension: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RETINAL MICROVASCULAR ABNORMALITIES; CORONARY-HEART-DISEASE; ATHEROSCLEROSIS RISK; HIGH PREVALENCE; BLOOD-PRESSURE; OLDER PERSONS; ARTERIOLAR; RETINOPATHY; MICROALBUMINURIA; HYPERTROPHY	Objective To evaluate the additional value of funduscopy in the routine management of patients with hypertension. Design Systematic review. Participants Adults aged 19 or more with hypertensive retinopathy. Data sources Medline, Embase, and the Cochrane Library from 1990. Review methods Studies were included that assessed hypertensive retinopathy with blinding for blood pressure and cardiovascular risk factors. Studies on observer agreement had to be assessed by two or more observers and expressed as a K statistic. Studies on the association between hypertensive retinopathy and hypertensive organ damage were carried out in patients with hypertension. The association between hypertensive retinopathy and cardiovascular risk was carried out in unselected normotensive and hypertensive people without diabetes mellitus. Results The assessment of microvascular changes in the retina is limited by large variation between observers. The positive and negative predictive values for the association between hypertensive retinopathy and blood pressure were low (47% to 72% and 32% to 67%, respectively). Associations between retinal microvascular changes and cardiovascular risk were inconsistent, except for retinopathy and stroke. The increased risk of stroke, however, was also present in normotensive people with retinopathy. These studies did not adjust for other indicators of hypertensive organ damage. Conclusion Evidence is lacking that routine funduscopy is of additional value in the management of hypertensive patients.	Acad Med Ctr, Dept Internal Med, NL-1100 DD Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van den Born, BJH (corresponding author), Acad Med Ctr, Dept Internal Med, PO 22660, NL-1100 DD Amsterdam, Netherlands.	b.j.vandenborn@amc.uva.nl	van den Born, Bert-Jan/E-4263-2017	van den Born, Bert-Jan H. (BJH)/0000-0003-0943-4393				BIESENBACH G, 1994, CLIN NEPHROL, V41, P211; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cifkova R, 2003, J Hypertens, V21, P1779; Couper DJ, 2002, AM J OPHTHALMOL, V133, P78, DOI 10.1016/S0002-9394(01)01315-0; Cuspidi C, 2004, BLOOD PRESSURE, V13, P25, DOI 10.1080/08037050310025753; DELEONARDIS V, 1992, INT J CARDIOL, V35, P95, DOI 10.1016/0167-5273(92)90060-G; Duncan BB, 2002, BRIT J OPHTHALMOL, V86, P1002, DOI 10.1136/bjo.86.9.1002; GILLUM RF, 1991, AM HEART J, V122, P262, DOI 10.1016/0002-8703(91)90796-K; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Ikram MK, 2004, INVEST OPHTH VIS SCI, V45, P2129, DOI 10.1167/iovs.03-1390; KLEIN R, 1994, ARCH OPHTHALMOL-CHIC, V112, P92, DOI 10.1001/archopht.1994.01090130102026; Klein R, 2000, ARTERIOSCL THROM VAS, V20, P1644, DOI 10.1161/01.ATV.20.6.1644; Klein R, 1992, Trans Am Ophthalmol Soc, V90, P561; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leung H, 2003, INVEST OPHTH VIS SCI, V44, P2900, DOI 10.1167/iovs.02-1114; Liao DP, 2004, STROKE, V35, P837, DOI 10.1161/01.STR.0000120310.43457.AD; Nakayama T, 1997, STROKE, V28, P45, DOI 10.1161/01.STR.28.1.45; Pontremoli R, 1997, HYPERTENSION, V30, P1135, DOI 10.1161/01.HYP.30.5.1135; Pose-Reino A., 1996, Blood Pressure, V5, P264, DOI 10.3109/08037059609078058; Saitoh M, 1998, INTERNAL MED, V37, P576, DOI 10.2169/internalmedicine.37.576; SHARP PS, 1995, HYPERTENSION, V25, P1322, DOI 10.1161/01.HYP.25.6.1322; Wang JJ, 2003, HYPERTENSION, V42, P534, DOI 10.1161/01.HYP.0000090122.38230.41; Wong TY, 2002, JAMA-J AM MED ASSOC, V288, P67, DOI 10.1001/jama.288.1.67; Wong TY, 2004, NEW ENGL J MED, V351, P2310, DOI 10.1056/NEJMra032865; Wong TY, 2004, AM J EPIDEMIOL, V159, P819, DOI 10.1093/aje/kwh119; Wong TY, 2003, OPHTHALMOLOGY, V110, P933, DOI 10.1016/S0161-6420(03)00084-8; Wong TY, 2003, OPHTHALMOLOGY, V110, P658, DOI 10.1016/S0161-6420(02)01931-0; Wong TY, 2003, HYPERTENSION, V41, P1086, DOI 10.1161/01.HYP.0000064181.63546.53; Wong TY, 2002, BRIT J OPHTHALMOL, V86, P1007, DOI 10.1136/bjo.86.9.1007; Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P1153, DOI 10.1001/jama.287.9.1153; Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5; Yu T, 1998, ARCH OPHTHALMOL-CHIC, V116, P83, DOI 10.1001/archopht.116.1.83	33	85	92	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 9	2005	331	7508					73	76A		10.1136/bmj.331.7508.73	http://dx.doi.org/10.1136/bmj.331.7508.73			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945XR	16002881	Green Published, Bronze			2022-12-28	WOS:000230536800012
J	Doh, YJ; van Dam, JA; Roest, AL; Bakkers, EPAM; Kouwenhoven, LP; De Franceschi, S				Doh, YJ; van Dam, JA; Roest, AL; Bakkers, EPAM; Kouwenhoven, LP; De Franceschi, S			Tunable supercurrent through semiconductor nanowires	SCIENCE			English	Article							FIELD-EFFECT TRANSISTORS; ENERGY-GAP STRUCTURE; JOSEPHSON-JUNCTIONS; INP NANOWIRES; STATE; FLUCTUATIONS; SILICON; PHYSICS	Nanoscale superconductor/semiconductor hybrid devices are assembled from indium arsenide semiconductor nanowires individually contacted by aluminum-based superconductor electrodes. Below 1 kelvin, the high transparency of the contacts gives rise to proximity-induced superconductivity. The nanowires form superconducting weak links operating as mesoscopic Josephson junctions with electrically tunable coupling. The supercurrent can be switched on/off by a gate voltage acting on the electron density in the nanowire. A variation in gate voltage induces universal fluctuations in the normal-state conductance, which are clearly correlated to critical current fluctuations. The alternating-current Josephson effect gives rise to Shapiro steps in the voltage-current characteristic under microwave irradiation.	Delft Univ Technol, Kavli Inst Nanosci, NL-2600 GA Delft, Netherlands; Philips Res Labs, NL-5656 AA Eindhoven, Netherlands	Delft University of Technology; Philips; Philips Research	Doh, YJ (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, POB 5046, NL-2600 GA Delft, Netherlands.		Doh, Yong-Joo/A-6523-2009	Doh, Yong-Joo/0000-0001-8203-5263				Al'tshuler B. L., 1987, Soviet Physics - JETP, V65, P343; ANDREEV AF, 1964, SOV PHYS JETP-USSR, V19, P1228; Bakkers EPAM, 2004, NAT MATER, V3, P769, DOI 10.1038/nmat1235; BEENAKKER CWJ, 1991, PHYS REV LETT, V67, P3836, DOI 10.1103/PhysRevLett.67.3836; Bjork MT, 2004, NANO LETT, V4, P1621, DOI 10.1021/nl049230s; Buitelaar MR, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.057005; Chrestin A, 1997, APPL PHYS LETT, V70, P3149, DOI 10.1063/1.119116; CLARK TD, 1980, J APPL PHYS, V51, P2736, DOI 10.1063/1.327935; De Franceschi S, 2003, APPL PHYS LETT, V83, P344, DOI 10.1063/1.1590426; de Gennes PG, 1964, REV MOD PHYS, V36, P216; FLENSBERG K, 1988, PHYS REV B, V38, P8707, DOI 10.1103/PhysRevB.38.8707; JOSEPHSON BD, 1962, PHYS LETT, V1, P251, DOI 10.1016/0031-9163(62)91369-0; KLEINSASSER AW, 1989, APPL PHYS LETT, V55, P1909, DOI 10.1063/1.102166; LEE PA, 1985, PHYS REV LETT, V55, P1622, DOI 10.1103/PhysRevLett.55.1622; Lieber CM, 2003, MRS BULL, V28, P486, DOI 10.1557/mrs2003.144; Makhlin Y, 2001, REV MOD PHYS, V73, P357, DOI 10.1103/RevModPhys.73.357; Martensson T, 2004, NANO LETT, V4, P1987, DOI 10.1021/nl0487267; NGUYEN C, 1990, APPL PHYS LETT, V57, P87; NISHINO T, 1985, IEEE ELECTR DEVICE L, V6, P297, DOI 10.1109/EDL.1985.26131; OCTAVIO M, 1983, PHYS REV B, V27, P6739, DOI 10.1103/PhysRevB.27.6739; Pannetier B, 2000, J LOW TEMP PHYS, V118, P599, DOI 10.1023/A:1004635226825; Samuelson L, 2004, PHYSICA E, V25, P313, DOI 10.1016/j.physe.2004.06.030; Scheer E, 2001, PHYS REV LETT, V86, P284, DOI 10.1103/PhysRevLett.86.284; Storcz MJ, 2003, APPL PHYS LETT, V83, P2387, DOI 10.1063/1.1612901; TAKAYANAGI H, 1985, PHYS REV LETT, V54, P2449, DOI 10.1103/PhysRevLett.54.2449; Tinkham M., 1996, INTRO SUPERCONDUCTIV, V2nd ed.; vanWees B, 1996, PHYS WORLD, V9, P41, DOI 10.1088/2058-7058/9/11/23; Yang PD, 2005, MRS BULL, V30, P85, DOI 10.1557/mrs2005.26; Zhong ZH, 2005, NANO LETT, V5, P1143, DOI 10.1021/nl050783s	29	398	400	3	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2005	309	5732					272	275		10.1126/science.1113523	http://dx.doi.org/10.1126/science.1113523			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002611	Green Submitted			2022-12-28	WOS:000230449800036
J	Yamashita, A; Singh, SK; Kawate, T; Jin, Y; Gouaux, E				Yamashita, A; Singh, SK; Kawate, T; Jin, Y; Gouaux, E			Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters	NATURE			English	Article							GAMMA-AMINOBUTYRIC-ACID; SEROTONIN TRANSPORTER; DOPAMINE TRANSPORTER; GABA TRANSPORTER; TRANSMEMBRANE DOMAIN; ION-BINDING; RAT-BRAIN; RESIDUES; PERMEATION; SUBSTRATE	Na+/Cl--dependent transporters terminate synaptic transmission by using electrochemical gradients to drive the uptake of neurotransmitters, including the biogenic amines, from the synapse to the cytoplasm of neurons and glia. These transporters are the targets of therapeutic and illicit compounds, and their dysfunction has been implicated in multiple diseases of the nervous system. Here we present the crystal structure of a bacterial homologue of these transporters from Aquifex aeolicus, in complex with its substrate, leucine, and two sodium ions. The protein core consists of the first ten of twelve transmembrane segments, with segments 1 - 5 related to 6 - 10 by a pseudo-two-fold axis in the membrane plane. Leucine and the sodium ions are bound within the protein core, halfway across the membrane bilayer, in an occluded site devoid of water. The leucine and ion binding sites are defined by partially unwound transmembrane helices, with main-chain atoms and helix dipoles having key roles in substrate and ion binding. The structure reveals the architecture of this important class of transporter, illuminates the determinants of substrate binding and ion selectivity, and defines the external and internal gates.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Gouaux, E (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 650 W 168th St, New York, NY 10032 USA.	jeg52@columbia.edu	Yamashita, Atsuko/H-5566-2017; Gouaux, Eric/Y-4370-2019	Yamashita, Atsuko/0000-0002-8001-4642; Gouaux, Eric/0000-0002-8549-2360				Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Androutsellis-Theotokis A, 2003, J BIOL CHEM, V278, P12703, DOI 10.1074/jbc.M206563200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARKER EL, 2000, PSYCHOPHARMACOLOGY 4; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Bismuth Y, 1997, J BIOL CHEM, V272, P16096, DOI 10.1074/jbc.272.26.16096; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao YW, 1998, J NEUROSCI, V18, P7739; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; Chen JG, 1998, J BIOL CHEM, V273, P12675, DOI 10.1074/jbc.273.20.12675; Chen NH, 2003, EUR J PHARMACOL, V479, P213, DOI 10.1016/j.ejphar.2003.08.070; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690; Hahn M. K., 2002, Pharmacogenomics Journal, V2, P217, DOI 10.1038/sj.tpj.6500106; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Hirai T, 2002, NAT STRUCT BIOL, V9, P597, DOI 10.1038/nsb821; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Just H, 2004, J BIOL CHEM, V279, P6650, DOI 10.1074/jbc.M306092200; KAVANAUGH MP, 1992, J BIOL CHEM, V267, P22007; KESHET GI, 1995, FEBS LETT, V371, P39, DOI 10.1016/0014-5793(95)00859-8; Krogsgaard-Larsen P, 2000, CURR PHARM DESIGN, V6, P1193, DOI 10.2174/1381612003399608; Loland CJ, 2004, J BIOL CHEM, V279, P3228, DOI 10.1074/jbc.M304755200; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Lopez-Corcuera B, 2001, J BIOL CHEM, V276, P43463, DOI 10.1074/jbc.M107438200; Mager S, 1996, J NEUROSCI, V16, P5405; Mari SA, 2004, CELL MOL LIFE SCI, V61, P243, DOI 10.1007/s00018-003-3367-2; Masson J, 1999, PHARMACOL REV, V51, P439; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Nelson N, 1998, J NEUROCHEM, V71, P1785; PANTANOWITZ S, 1993, J BIOL CHEM, V268, P3222; Penado KMY, 1998, J BIOL CHEM, V273, P28098, DOI 10.1074/jbc.273.43.28098; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Ponce J, 2000, J BIOL CHEM, V275, P13856, DOI 10.1074/jbc.275.18.13856; Richerson GB, 2004, ADV EXP MED BIOL, V548, P76; Roux MJ, 2000, NEURON, V25, P373, DOI 10.1016/S0896-6273(00)80901-0; Rudnick Gary, 2002, P25; Sato Y, 2004, J BIOL CHEM, V279, P22926, DOI 10.1074/jbc.M312194200; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Smicun Y, 1999, J BIOL CHEM, V274, P36058, DOI 10.1074/jbc.274.51.36058; Stephan MM, 1997, BIOCHEMISTRY-US, V36, P1322, DOI 10.1021/bi962150l; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Vanhatalo S, 1998, ANN MED, V30, P151; WANG JB, 1995, J NEUROCHEM, V64, P1416; Yernool D, 2003, BIOCHEMISTRY-US, V42, P12981, DOI 10.1021/bi030161q; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	50	1306	1322	2	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					215	223		10.1038/nature03978	http://dx.doi.org/10.1038/nature03978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16041361				2022-12-28	WOS:000231696900047
J	Long, SB; Campbell, EB; MacKinnon, R				Long, SB; Campbell, EB; MacKinnon, R			Crystal structure of a mammalian voltage-dependent Shaker family K+ channel	SCIENCE			English	Article							GATED POTASSIUM CHANNEL; BETA-SUBUNITS; ION CHANNELS; ACTIVATION GATE; MOLECULAR-BASIS; ALPHA-SUBUNITS; BOVINE BRAIN; INACTIVATION; DROSOPHILA; DOMAIN	Voltage-de pendent potassium ion (K+) channels (Kv channels) conduct K+ ions across the cell membrane in response to changes in the membrane voltage, thereby regulating neuronal excitability by modulating the shape and frequency of action potentials. Here we report the crystal structure, at a resolution of 2.9 angstroms, of a mammalian Kv channel, Kv1.2, which is a member of the Shaker K+ channel family. This structure is in complex with an oxido-reductase beta subunit of the kind that can regulate mammalian Kv channels in their native cell environment. The activation gate of the pore is open. Large side portals communicate between the pore and the cytoplasm. Electrostatic properties of the side portals and positions of the T1 domain and beta subunit are consistent with etectrophysiologicat studies of inactivation gating and with the possibility of K+ channel regulation by the beta subunit.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.	mackinn@rockefeller.edu			NCRR NIH HHS [RR00862] Funding Source: Medline; NIGMS NIH HHS [GM43949] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; CHOUINARD SW, 1995, P NATL ACAD SCI USA, V92, P6763, DOI 10.1073/pnas.92.15.6763; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P1; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; Heinemann SH, 1996, J PHYSIOL-LONDON, V493, P625, DOI 10.1113/jphysiol.1996.sp021409; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; MacKinnon R, 2004, ANGEW CHEM INT EDIT, V43, P4265, DOI 10.1002/anie.200400662; MCCORMACK K, 1995, FEBS LETT, V370, P32, DOI 10.1016/0014-5793(95)00785-8; MCCORMACK T, 1994, CELL, V79, P1133, DOI 10.1016/0092-8674(94)90004-3; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P977, DOI 10.1085/jgp.102.6.977; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P949, DOI 10.1085/jgp.102.6.949; Nagaya N, 1997, J BIOL CHEM, V272, P3022, DOI 10.1074/jbc.272.5.3022; Nakahira K, 1996, J BIOL CHEM, V271, P7084, DOI 10.1074/jbc.271.12.7084; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Parcej DN, 2003, J MOL BIOL, V333, P103, DOI 10.1016/j.jmb.2003.07.009; PARCEJ DN, 1992, BIOCHEMISTRY-US, V31, P11084, DOI 10.1021/bi00160a018; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; REHM H, 1988, P NATL ACAD SCI USA, V85, P4919, DOI 10.1073/pnas.85.13.4919; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; SCOTT VES, 1994, P NATL ACAD SCI USA, V91, P1637, DOI 10.1073/pnas.91.5.1637; Sesti F, 2003, NAT NEUROSCI, V6, P353, DOI 10.1038/nn1028; Sewing S, 1996, NEURON, V16, P455, DOI 10.1016/S0896-6273(00)80063-X; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Sokolova O, 2001, STRUCTURE, V9, P215, DOI 10.1016/S0969-2126(01)00578-0; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; Webster SM, 2004, NATURE, V428, P864, DOI 10.1038/nature02468; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Yu WF, 1996, NEURON, V16, P441, DOI 10.1016/S0896-6273(00)80062-8; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	54	1731	1791	6	245	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2005	309	5736					897	903		10.1126/science.1116269	http://dx.doi.org/10.1126/science.1116269			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953SS	16002581				2022-12-28	WOS:000231101400036
J	Robinson, BWS; Musk, AW; Lake, RA				Robinson, BWS; Musk, AW; Lake, RA			Malignant mesothelioma	LANCET			English	Review							LARGE-T-ANTIGEN; COMPARATIVE GENOMIC HYBRIDIZATION; ASBESTOS-INDUCED MESOTHELIOMAS; GENE-EXPRESSION RATIOS; GROWTH-FACTOR RECEPTOR; PLEURAL MESOTHELIOMA; PROGNOSTIC-FACTORS; PROTOONCOGENE EXPRESSION; CROCIDOLITE ASBESTOS; CONSECUTIVE PATIENTS	Malignant mesothelioma is an aggressive, treatment-resistant tumour, which is increasing in frequency throughout the world. Although the main risk factor is asbestos exposure, a virus, simian virus 40 (SV40), could have a role. Mesothelioma has an unusual molecular pathology with loss of tumour suppressor genes being the predominant pattern of lesions, especially the P16(INK4A), and P14(ARF), and NF2 genes, rather than the more common p53 and Rb tumour suppressor genes. Cytopathology of mesothelioma effusions or fine-needle aspirations are often sufficient to establish a diagnosis, but histopathology is also often required. Patients typically present with breathlessness and chest pain with pleural effusions. Median survival is now 12 months from diagnosis. Palliative chemotherapy is beneficial for mesothelioma patients with high performance status. The role of aggressive surgery remains controversial and growth factor receptor blockade is still unproven. Gene therapy and immunotherapy are used on an experimental basis only. Patterns identified from microarray studies could be useful for diagnosis as well as prognostication.	Univ Western Australia, Sch Med & Pharmacol, Sir Charles Gairdner Hosp, Tumour Immunol Grp, Nedlands, WA 6009, Australia; Sir Charles Gairdner Hosp, Sch Populat Hlth, Nedlands, WA 6009, Australia; Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA 6009, Australia; Sir Charles Gairdner Hosp, Western Australian Inst Med Res, Nedlands, WA 6009, Australia; Sir Charles Gairdner Hosp, Perth Mesothelioma Ctr, Nedlands, WA 6009, Australia	University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia	Robinson, BWS (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Sir Charles Gairdner Hosp, Tumour Immunol Grp, Nedlands, WA 6009, Australia.	bwsrobin@cyllene.uwa.edu.au	Robinson, Bruce/N-1900-2014					Abe K, 2002, INT J UROL, V9, P602, DOI 10.1046/j.1442-2042.2002.00521.x; Ahamad A, 2003, INT J RADIAT ONCOL, V55, P768, DOI 10.1016/S0360-3016(02)04151-2; ANDREWS PM, 1973, ANAT RECORD, V177, P409, DOI 10.1002/ar.1091770307; ARMSTRONG BK, 1984, MED J AUSTRALIA, V141, P86, DOI 10.5694/j.1326-5377.1984.tb132709.x; AULT JG, 1995, CANCER RES, V55, P792; Baldini Elizabeth H, 2004, Thorac Surg Clin, V14, P543; Balsara BR, 1999, CANCER RES, V59, P450; Barbanti-Brodano G, 2004, VIROLOGY, V318, P1, DOI 10.1016/j.virol.2003.09.004; BARIS I, 1987, INT J CANCER, V39, P10, DOI 10.1002/ijc.2910390104; BERGSAGEL DJ, 1992, NEW ENGL J MED, V326, P988, DOI 10.1056/NEJM199204093261504; Berry G, 2004, OCCUP ENVIRON MED, V61, DOI 10.1136/oem.2003.008128; Bjorkqvist AM, 1997, BRIT J CANCER, V75, P523, DOI 10.1038/bjc.1997.91; Bocchetta M, 2000, P NATL ACAD SCI USA, V97, P10214, DOI 10.1073/pnas.170207097; Boutin C, 1998, EUR RESPIR J, V12, P972, DOI 10.1183/09031936.98.12040972; BOUTIN C, 1993, CANCER, V72, P389, DOI 10.1002/1097-0142(19930715)72:2<389::AID-CNCR2820720213>3.0.CO;2-V; BOUTIN C, 1994, CANCER, V74, P2460, DOI 10.1002/1097-0142(19941101)74:9<2460::AID-CNCR2820740912>3.0.CO;2-N; Carbone M, 1997, NAT MED, V3, P908, DOI 10.1038/nm0897-908; Carroll Stephen J., 2002, ASBESTOS LITIGATION; Castagneto B, 2001, LUNG CANCER, V31, P303, DOI 10.1016/S0169-5002(00)00192-6; Chahininian AP, 2002, MESOTHELIOMA, P143; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Chang THT, 1997, ONCOGENE, V14, P2383, DOI 10.1038/sj.onc.1201196; Chapman SJ, 2003, CURR OPIN PULM MED, V9, P266, DOI 10.1097/00063198-200307000-00004; Chretien JB J, 1985, PLEURA HLTH DIS, P23; CHRISTMAS TI, 1993, EUR RESPIR REV, V3, P192; CICALA C, 1993, AM J PATHOL, V142, P1524; Comin CE, 1997, ULTRASTRUCT PATHOL, V21, P315, DOI 10.3109/01913129709021929; Curran D, 1998, J CLIN ONCOL, V16, P145, DOI 10.1200/JCO.1998.16.1.145; Davidson JA, 1998, J IMMUNOTHER, V21, P389, DOI 10.1097/00002371-199809000-00007; DAVIS MR, 1992, INT J CANCER, V52, P881, DOI 10.1002/ijc.2910520609; de Klerk NH, 1998, INT J CANCER, V75, P362, DOI 10.1002/(SICI)1097-0215(19980130)75:3&lt;362::AID-IJC6&gt;3.0.CO;2-0; de Klerk NH, 2002, MESOTHELIOMA, P339; deKlerk NH, 1996, AM J IND MED, V30, P579, DOI 10.1002/(SICI)1097-0274(199611)30:5<579::AID-AJIM5>3.0.CO;2-O; DEKLERK NH, 2004, MESOTHELIOMA SURVIVA; DeLuca A, 1997, NAT MED, V3, P913, DOI 10.1038/nm0897-913; Demant P, 2003, NAT REV GENET, V4, P721, DOI 10.1038/nrg1157; Di Muzio M, 2000, HUM PATHOL, V31, P1341; Engels EA, 2003, JNCI-J NATL CANCER I, V95, P532, DOI 10.1093/jnci/95.7.532; Finnerup Nanna B, 2002, Expert Opin Pharmacother, V3, P1411, DOI 10.1517/14656566.3.10.1411; Fleury-Feith J, 2003, ONCOGENE, V22, P3799, DOI 10.1038/sj.onc.1206593; Flores RM, 2003, J THORAC CARDIOV SUR, V126, P11, DOI 10.1016/s0022-5223(03)00207-1; Gazdar Adi F, 2003, Clin Lung Cancer, V5, P177, DOI 10.3816/CLC.2003.n.031; Goodglick LA, 1997, TOXICOL PATHOL, V25, P565, DOI 10.1177/019262339702500605; Gordon GJ, 2002, CANCER RES, V62, P4963; Gordon GJ, 2003, J NATL CANCER I, V95, P598, DOI 10.1093/jnci/95.8.598; GREENBERG AK, 2002, MESOTHELIOMA, P1; Hassan R, 2004, CLIN CANCER RES, V10, P3937, DOI 10.1158/1078-0432.CCR-03-0801; Herrick SE, 2004, INT J BIOCHEM CELL B, V36, P621, DOI 10.1016/j.biocel.2003.11.002; Hirano H, 2002, PATHOL INT, V52, P669, DOI 10.1046/j.1440-1827.2002.01404.x; Hodgson JT, 2000, ANN OCCUP HYG, V44, P565, DOI 10.1093/annhyg/44.8.565; Huncharek M, 1996, CANCER LETT, V102, P205, DOI 10.1016/0304-3835(96)04172-9; Illei PB, 2003, CLIN CANCER RES, V9, P2108; Jain KK, 2004, CURR OPIN DRUG DISC, V7, P285; Janne Pasi A, 2003, Clin Lung Cancer, V5, P98, DOI 10.3816/CLC.2003.n.023; KAMP DW, 1995, AM J PHYSIOL-LUNG C, V268, pL471, DOI 10.1152/ajplung.1995.268.3.L471; Kebapci M, 2003, EUR RADIOL, V13, P2620, DOI 10.1007/s00330-003-1851-6; Kindler H L, 2000, Curr Treat Options Oncol, V1, P313, DOI 10.1007/s11864-000-0047-4; Kindler HL, 2004, LUNG CANCER-J IASLC, V45, pS125, DOI 10.1016/j.lungcan.2004.04.022; KOERTEN HK, 1990, AM J PATHOL, V136, P141; KUCHARCZUK JC, 1995, ANN THORAC SURG, V60, P593, DOI 10.1016/0003-4975(95)00507-H; LEE YC, 2002, MESOTHELIOMA, V6, P111; LEIGH J, 2001, P INT C WORK INJ PRE, P102; Leigh J, 2002, MESOTHELIOMA, P55; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lumb PD, 2004, HISTOPATHOLOGY, V44, P345, DOI 10.1111/j.1365-2559.2004.01844.x; Manning CB, 2002, CANCER RES, V62, P4169; Marom EM, 2002, SEMIN ONCOL, V29, P26, DOI 10.1053/sonc.2002.30228; Marzo AL, 1997, CANCER RES, V57, P3200; Mukherjee S, 2000, CANCER GENE THER, V7, P663, DOI 10.1038/sj.cgt.7700133; MUKHERJEE S, 2002, MESOTHELIOMA, P325; Murthy SS, 1999, J CELL PHYSIOL, V180, P150, DOI 10.1002/(SICI)1097-4652(199908)180:2<150::AID-JCP2>3.0.CO;2-H; MUSK AW, 1995, CHEST, V108, P587, DOI 10.1378/chest.108.2.587; Musti M, 2002, CANCER GENET CYTOGEN, V138, P73, DOI 10.1016/S0165-4608(02)00575-7; Nguyen GK, 1999, DIAGN CYTOPATHOL, V21, P253, DOI 10.1002/(SICI)1097-0339(199910)21:4<253::AID-DC5>3.0.CO;2-N; Nowak AK, 2002, SEMIN ONCOL, V29, P82, DOI 10.1053/sonc.2002.30234; Nowak AK, 2002, BRIT J CANCER, V87, P491, DOI 10.1038/sj.bjc.6600505; O'Byrne KJ, 2004, LUNG CANCER-J IASLC, V45, pS45, DOI 10.1016/j.lungcan.2004.04.025; Pass HI, 1997, ANN SURG ONCOL, V4, P215, DOI 10.1007/BF02306613; PASS HI, 2002, MESOTHELIOMA, V13, P235; PELIN K, 1994, CARCINOGENESIS, V15, P2673, DOI 10.1093/carcin/15.11.2673; Peto J, 2000, NAT GENET, V26, P411, DOI 10.1038/82533; POTT F, 1987, EXP PATHOL-JENA, V32, P129, DOI 10.1016/S0232-1513(87)80044-0; Pylkkanen L, 2002, ONCOL REP, V9, P955; RABINOWITZ JG, 2002, MESOTHELIOMA, P201; Raetz EA, 2004, CANCER INVEST, V22, P312, DOI 10.1081/CNV-120030219; Ramos-Nino ME, 2003, CANCER RES, V63, P3539; ROBINSON BWS, 2004, AM J ONCOL REV, V3, P230; ROBINSON BWS, 1991, INTERFERONS CYTOKINE, V18, P5; Robinson M, 2000, JAVA REP, V5, P50; Roushdy-Hammady I, 2001, LANCET, V357, P444, DOI 10.1016/S0140-6736(00)04013-7; Rusch V W, 1999, Chest Surg Clin N Am, V9, P327; RUSCH VW, 1995, CHEST, V107, pS322, DOI 10.1378/chest.107.6_Supplement.322S; Saracci R, 2001, LANCET, V358, P1813, DOI 10.1016/S0140-6736(01)06816-7; Scholler N, 1999, P NATL ACAD SCI USA, V96, P11531, DOI 10.1073/pnas.96.20.11531; Scott B., 2000, TXB LUNG CANC, P273; Sebastien P, 1980, IARC Sci Publ, P237; SHAH N, 2001, SURVIVING ASBESTOS E, P14; SHATOS MA, 1987, ENVIRON RES, V44, P103, DOI 10.1016/S0013-9351(87)80090-7; Shivapurkar N, 2000, J CELL BIOCHEM, V76, P181; Singhal S, 2003, CLIN CANCER RES, V9, P3080; Sterman DH, 1998, HEMATOL ONCOL CLIN N, V12, P553, DOI 10.1016/S0889-8588(05)70008-3; STERRETT GF, 1987, ACTA CYTOL, V31, P185; Stewart DJ, 2004, ANN THORAC SURG, V78, P245, DOI 10.1016/j.athoracsur.2004.01.034; Sugarbaker DJ, 2004, J THORAC CARDIOV SUR, V128, P138, DOI 10.1016/j.jtcvs.2004.02.021; Tang P, 2001, ARCH PATHOL LAB MED, V125, P1598; Testa JR, 1998, CANCER RES, V58, P4505; Treasure T, 2004, LANCET, V364, P1183, DOI 10.1016/S0140-6736(04)17108-0; Vaslet CA, 2002, TOXICOL SCI, V68, P331, DOI 10.1093/toxsci/68.2.331; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; WAGNER J C, 1960, Br J Ind Med, V17, P260; Waller DA, 2004, LUNG CANCER, V45, pS81, DOI 10.1016/j.lungcan.2004.04.018; Wang ZY, 2004, RADIOGRAPHICS, V24, P105, DOI 10.1148/rg.241035058; Weber MA, 2004, INVEST RADIOL, V39, P554, DOI 10.1097/01.rli.0000131888.39636.c5; WEBSTER I, 1982, S AFR MED J, V61, P277; Weder W, 2004, J CLIN ONCOL, V22, P3451, DOI 10.1200/JCO.2004.10.071; WEITZMAN SA, 1984, ARCH BIOCHEM BIOPHYS, V228, P373, DOI 10.1016/0003-9861(84)90078-X; WHITAKER D, 1992, SEMIN DIAGN PATHOL, V9, P151; WHITAKER D, 1984, J PATHOL, V143, P147, DOI 10.1002/path.1711430303; Wolanski KD, 1998, CANCER, V82, P583, DOI 10.1002/(SICI)1097-0142(19980201)82:3<583::AID-CNCR22>3.0.CO;2-X; Zanella CL, 1996, CANCER RES, V56, P5334	120	589	606	3	60	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2005	366	9483					397	408		10.1016/S0140-6736(05)67025-0	http://dx.doi.org/10.1016/S0140-6736(05)67025-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	950IB	16054941				2022-12-28	WOS:000230849700028
J	Ou, GS; Blacque, OE; Snow, JJ; Leroux, MR; Scholey, JM				Ou, GS; Blacque, OE; Snow, JJ; Leroux, MR; Scholey, JM			Functional coordination of intraflagellar transport motors	NATURE			English	Article							CAENORHABDITIS-ELEGANS; CHEMOSENSORY NEURONS; C-ELEGANS; SENSORY CILIA; KINESIN-II; FLAGELLAR; PROTEIN; GENE; EXPRESSION; PARTICLES	Cilia have diverse roles in motility and sensory reception, and defects in cilia function contribute to ciliary diseases such as Bardet-Biedl syndrome (BBS). Intraflagellar transport (IFT) motors assemble and maintain cilia by transporting ciliary precursors, bound to protein complexes called IFT particles, from the base of the cilium to their site of incorporation at the distal tip(1-3). In Caenorhabditis elegans, this is accomplished by two IFT motors, kinesin-II and osmotic avoidance defective (OSM)-3 kinesin, which cooperate to form two sequential anterograde IFT pathways that build distinct parts of cilia(4-7). By observing the movement of fluorescent IFT motors and IFT particles along the cilia of numerous ciliary mutants, we identified three genes whose protein products mediate the functional coordination of these motors. The BBS proteins BBS-7 and BBS-8 are required to stabilize complexes of IFT particles containing both of the IFT motors, because IFT particles in bbs-7 and bbs-8 mutants break down into two subcomplexes, IFT-A and IFT-B, which are moved separately by kinesin-II and OSM-3 kinesin, respectively. A conserved ciliary protein, DYF-1, is specifically required for OSM-3 kinesin to dock onto and move IFT particles, because OSM-3 kinesin is inactive and intact IFT particles are moved by kinesin-II alone in dyf-1 mutants. These findings implicate BBS ciliary disease proteins and an OSM-3 kinesin activator in the formation of two IFT pathways that build functional cilia.	Univ Calif Davis, Ctr Genet & Dev, Sect Mol & Cellular Biol, Davis, CA 95616 USA; Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	University of California System; University of California Davis; Simon Fraser University	Scholey, JM (corresponding author), Univ Calif Davis, Ctr Genet & Dev, Sect Mol & Cellular Biol, Davis, CA 95616 USA.	jmscholey@ucdavis.edu	Blacque, Oliver/AAL-8860-2021	Blacque, Oliver/0000-0003-1598-2695				Awan A, 2004, CELL MOTIL CYTOSKEL, V58, P1, DOI 10.1002/cm.10170; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; Cole DG, 2003, TRAFFIC, V4, P435, DOI 10.1034/j.1600-0854.2003.t01-1-00103.x; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; COLE DG, 1993, NATURE, V366, P268, DOI 10.1038/366268a0; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; DERISO L, 1994, GENETICA, V94, P195, DOI 10.1007/BF01443433; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Mallik R, 2004, CURR BIOL, V14, pR971, DOI 10.1016/j.cub.2004.10.046; MESLAND DAM, 1980, J CELL BIOL, V84, P599, DOI 10.1083/jcb.84.3.599; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Mueller J, 2005, MOL BIOL CELL, V16, P1341, DOI 10.1091/mbc.E04-10-0931; Orozco JT, 1999, NATURE, V398, P674, DOI 10.1038/19448; Pan JM, 2005, LAB INVEST, V85, P452, DOI 10.1038/labinvest.3700253; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Scholey JM, 2004, BIOCHEM SOC T, V32, P682, DOI 10.1042/BST0320682; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; Signor D, 1999, J CELL BIOL, V147, P519, DOI 10.1083/jcb.147.3.519; Signor D, 1999, MOL BIOL CELL, V10, P345, DOI 10.1091/mbc.10.2.345; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; STARICH TA, 1995, GENETICS, V139, P171; Swoboda P, 2000, MOL CELL, V5, P411, DOI 10.1016/S1097-2765(00)80436-0; TABISH M, 1995, J MOL BIOL, V247, P377, DOI 10.1006/jmbi.1994.0146; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9	28	289	308	3	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					583	587		10.1038/nature03818	http://dx.doi.org/10.1038/nature03818			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049494				2022-12-28	WOS:000230788800067
J	Wang, D; Kennedy, S; Conte, D; Kim, JK; Gabel, HW; Kamath, RS; Mello, CC; Ruvkun, G				Wang, D; Kennedy, S; Conte, D; Kim, JK; Gabel, HW; Kamath, RS; Mello, CC; Ruvkun, G			Somatic misexpression of germline P granules and enhanced RNA interference in retinoblastoma pathway mutants	NATURE			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; VULVAL DEVELOPMENT; LIN-35 RB; COMPLEX; PROTEIN; GENE; DROSOPHILA; HOMOLOG; LINE	Caenorhabditis elegans homologues of the retinoblastoma (Rb) tumour suppressor complex specify cell lineage during development(1,2). Here we show that mutations in Rb pathway components enhance RNA interference (RNAi) and cause somatic cells to express genes and elaborate perinuclear structures normally limited to germline-specific P granules. Furthermore, particular gene inactivations that disrupt RNAi reverse the cell lineage transformations of Rb pathway mutants. These findings suggest that mutations in Rb pathway components cause cells to revert to patterns of gene expression normally restricted to germ cells. Rb may act by a similar mechanism to transform mammalian cells.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu		Kennedy, Scott/0000-0002-7974-8155				Black EP, 2003, CANCER RES, V63, P3716; Braas D, 2004, NUCLEIC ACIDS RES, V32, P4750, DOI 10.1093/nar/gkh808; Ceol CJ, 2001, MOL CELL, V7, P461, DOI 10.1016/S1097-2765(01)00194-0; Couteau F, 2002, EMBO REP, V3, P235, DOI 10.1093/embo-reports/kvf051; Debernardi S, 2002, BLOOD, V99, P275, DOI 10.1182/blood.V99.1.275; Fischer U, 1996, HUM GENET, V98, P625, DOI 10.1007/s004390050271; Fong YY, 2002, SCIENCE, V296, P2235, DOI 10.1126/science.1070790; Godbout R, 1998, J BIOL CHEM, V273, P21161, DOI 10.1074/jbc.273.33.21161; Hsieh J, 1999, GENE DEV, V13, P2958, DOI 10.1101/gad.13.22.2958; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Klymenko T, 2004, EMBO REP, V5, P373, DOI 10.1038/sj.embor.7400111; Lai A, 2001, MOL CELL BIOL, V21, P2918, DOI 10.1128/MCB.21.8.2918-2932.2001; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Linder B, 2001, EMBO REP, V2, P211, DOI 10.1093/embo-reports/kve039; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Myers TR, 2005, DEV CELL, V8, P117, DOI 10.1016/j.devcel.2004.11.015; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pitt JN, 2000, DEV BIOL, V219, P315, DOI 10.1006/dbio.2000.9607; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Robert VJP, 2005, GENE DEV, V19, P782, DOI 10.1101/gad.332305; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Streubel B, 2000, GENE CHROMOSOME CANC, V27, P380, DOI 10.1002/(SICI)1098-2264(200004)27:4<380::AID-GCC7>3.0.CO;2-#; Unhavaithaya Y, 2002, CELL, V111, P991, DOI 10.1016/S0092-8674(02)01202-3; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686	30	197	237	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					593	597		10.1038/nature04010	http://dx.doi.org/10.1038/nature04010			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049496				2022-12-28	WOS:000230788800069
J	Borovecki, A; ten Have, H; Oreskovic, S				Borovecki, A; ten Have, H; Oreskovic, S			Ethics and the structures of health care in the European countries in transition: hospital ethics committees in Croatia	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Zagreb 10000, Croatia; Radboud Univ Nijmegen, Univ Med Ctr, NL-6500 HB Nijmegen, Netherlands	University of Zagreb; Radboud University Nijmegen	Borovecki, A (corresponding author), Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Zagreb 10000, Croatia.	abor@mef.hr	Have, Henk ten/AAF-5188-2020; Borovecki, Ana/ABF-6921-2020	Oreskovic, Stjepan/0000-0002-9315-875X; Borovecki, Ana/0000-0001-8635-195X				Borovecki A, 2004, CAMB Q HEALTHC ETHIC, V13, P263; Drane J. F., 1994, CLIN BIOETHICS, P1; Emanuel LL, 2000, CAMB Q HEALTHC ETHIC, V9, P151, DOI 10.1017/S0963180100902032; Gefenas E, 2001, HEC Forum, V13, P381, DOI 10.1023/A:1014700703484; Glasa J, 2000, KENNEDY INST ETHIC J, V10, P165, DOI 10.1353/ken.2000.0012; Javashvili G, 2000, ETHICS COMMITTEES IN CENTRAL & EASTERN EUROPE, P179; McKee M, 2004, BRIT MED J, V329, P1355, DOI 10.1136/bmj.329.7479.1355; Meijburg HHV, 2001, J MED ETHICS, V27, pI36, DOI 10.1136/jme.27.suppl_1.i36; ORESKOVIC S, 1998, CROAT MED J, V3, P225; SIEGLER M, 1986, HASTINGS CENT REP, V16, P22, DOI 10.2307/3563271	10	26	26	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2005	331	7510					227	229		10.1136/bmj.331.7510.227	http://dx.doi.org/10.1136/bmj.331.7510.227			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	951EA	16037466	Green Published, Bronze			2022-12-28	WOS:000230910700035
J	Witt, C; Brinkhaus, B; Jena, S; Linde, K; Streng, A; Wagenpfeil, S; Hummelsberger, J; Walther, HU; Melchart, D; Willich, SN				Witt, C; Brinkhaus, B; Jena, S; Linde, K; Streng, A; Wagenpfeil, S; Hummelsberger, J; Walther, HU; Melchart, D; Willich, SN			Acupuncture in patients with osteoarthritis of the knee: a randomised trial	LANCET			English	Article							CLINICAL-TRIALS; RECOMMENDATIONS; FOLLOW; HIP; THERAPY; DESIGN; WOMAC; PAIN	Background Acupuncture is widely used by patients with effectiveness. We investigated the efficacy of acupuncture acupuncture in patients with osteoarthritis of the knee. chronic pain although there is little evidence of its compared with minimal acupuncture and with no acupuncture in patients with osteoarthritis of the knee. Methods Patients with chronic osteoarthritis of the knee (Kellgren grade <= 2) were randomly assigned to acupuncture (n=150), minimal acupuncture (superficial needling at non-acupuncture points; n=76), or a waiting list control (n=74). Specialised physicians, in 28 outpatient centres, administered acupuncture and minimal acupuncture in 12 sessions over 8 weeks. Patients completed standard questionnaires at baseline and after 8 weeks, 26 weeks, and 52 weeks. The primary outcome was the Western Ontario and McMaster Universities Osteoarthritis (WOMAC) index at the end of week 8 (adjusted for baseline score). All main analyses were by intention to treat. Results 294 patients were enrolled from March 6, 2002, to January 17, 2003; eight patients were lost to follow-up after randomisation, but were included in the final analysis. The mean baseline-adjusted WOMAC index at week 8 was 26.9 (SE 1.4) in the acupuncture group, 35.8 (1.9) in the minimal acupuncture group, and 49.6 (2.0) in the waiting list group (treatment difference acupuncture vs minimal acupuncture -8.8, [95% Cl -13.5 to -4.2], p=0.0002; acupuncture vs waiting list -22.7 [-27.5 to -17.9], p<0.0001). After 52 weeks the difference between the acupuncture and minimal acupuncture groups was no longer significant (p=0.08). Interpretation After 8 weeks of treatment, pain and joint function are improved more with acupuncture than with minimal acupuncture or no acupuncture in patients with osteoarthritis of the knee. However, this benefit decreases over time.	Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, D-10098 Berlin, Germany; Charite Univ Med Ctr, Ctr Musculoskeletal Surg, D-10098 Berlin, Germany; Tech Univ Munich, Ctr Complementary Med, Dept Internal Med 2, D-8000 Munich, Germany; Tech Univ Munich, Inst Med Stat & Epidemiol, D-8000 Munich, Germany; Univ Zurich Hosp, Dept Internal Med, Div Complementary Med, Zurich, Switzerland; Soc Med Sinensis, Int Soc Chinese Med, Munich, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Munich; Technical University of Munich; University of Zurich; University Zurich Hospital	Witt, C (corresponding author), Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, D-10098 Berlin, Germany.	claudia.witt@charite.de	Brinkhaus, Benno/AAU-2428-2021; Witt, Claudia M./AAX-2370-2021; Streng, Andrea/AAR-4986-2020	Brinkhaus, Benno/0000-0001-6290-744X; Witt, Claudia M./0000-0002-5440-7805; Streng, Andrea/0000-0003-2377-7106; Linde, Klaus/0000-0002-2902-970X				Altman R, 1996, OSTEOARTHR CARTILAGE, V4, P217, DOI 10.1016/S1063-4584(05)80101-3; Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905; Bellamy N, 1997, J RHEUMATOL, V24, P799; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Berman BM, 1999, RHEUMATOLOGY, V38, P346, DOI 10.1093/rheumatology/38.4.346; Brinkhaus B, 2003, FORSCH KOMP KLAS NAT, V10, P185, DOI 10.1159/000073474; BULLINGER M, 1998, SF36 FRAGEBOGEN GESU; CHRISTENSEN BV, 1992, ACTA ANAESTH SCAND, V36, P519, DOI 10.1111/j.1399-6576.1992.tb03511.x; Creamer P, 1997, LANCET, V350, P503, DOI 10.1016/S0140-6736(97)07226-7; Deadman P, 2001, MANUAL ACUPUNCTURE; DILLMANN U, 1994, SCHMERZ, P100; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Ezzo J, 2001, ARTHRITIS RHEUM, V44, P819, DOI 10.1002/1529-0131(200104)44:4<819::AID-ANR138>3.0.CO;2-P; Geissner E, 1996, SCHMERZEMPFINDUNGSSK; Hautzinger M., 1993, ALLGEMEINE DEPRESSIO; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kessler S, 1998, CLIN RHEUMATOL, V17, P205, DOI 10.1007/BF01451048; Linde K, 2004, J ALTERN COMPLEM MED, V10, P379, DOI 10.1089/107555304323062374; Melchart D, 2004, ARCH INTERN MED, V164, P104, DOI 10.1001/archinte.164.1.104; MOLSBERGER A, 1994, DER SCHMERZ, V8, P37; Nagel B, 2002, SCHMERZ, V16, P263, DOI 10.1007/s00482-002-0162-1; PETROU P, 1988, SCAND J ACUPUNCT, V3, P112; Sangdee Chaichan, 2002, BMC Complement Altern Med, V2, P3, DOI 10.1186/1472-6882-2-3; Stucki G, 1996, Z RHEUMATOL, V55, P40; Takeda W, 1994, Arthritis Care Res, V7, P118, DOI 10.1002/art.1790070304; Tillu Abhay, 2002, Acupunct Med, V20, P19; Tramer MR, 2000, PAIN, V85, P169, DOI 10.1016/S0304-3959(99)00267-5; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; VINCENT C, 1995, J ROY SOC MED, V88, P199; Vincent C, 1990, COMPLEMENT MED RES, V4, P8; WHITE AR, 2001, SURVEY ADVERSE EVENT, V1; Yamashita H, 2000, J ALTERN COMPLEM MED, V6, P345, DOI 10.1089/10755530050120718	32	412	440	2	109	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2005	366	9480					136	143		10.1016/S0140-6736(05)66871-7	http://dx.doi.org/10.1016/S0140-6736(05)66871-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	943JH	16005336				2022-12-28	WOS:000230349200032
J	Aizenberg, J; Weaver, JC; Thanawala, MS; Sundar, VC; Morse, DE; Fratzl, P				Aizenberg, J; Weaver, JC; Thanawala, MS; Sundar, VC; Morse, DE; Fratzl, P			Skeleton of Euplectella sp.: Structural hierarchy from the nanoscale to the macroscale	SCIENCE			English	Article							SPONGE; BONE; COMPOSITE; TOUGHNESS; BIOSILICA; FEATURES; DESIGN; FIBERS; MODEL	Structural materials in nature exhibit remarkable designs with building blocks, often hierarchically arranged from the nanometer to the macroscopic length scales. We report on the structural properties of biosilica observed in the hexactinellid sponge Euplectella sp. Consolidated, nanometer-scaled silica spheres are arranged in well-defined microscopic concentric rings glued together by organic matrix to form laminated spicules. The assembly of these spicules into bundles, effected by the laminated silica-based cement, results in the formation of a macroscopic cylindrical square-lattice cagelike structure reinforced by diagonal ridges. The ensuing design overcomes the brittleness of its constituent material, glass, and shows outstanding mechanical rigidity and stability. The mechanical benefits of each of seven identified hierarchical levels and their comparison with common mechanical engineering strategies are discussed.	Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA; Univ Calif Santa Barbara, Inst Collaborat Biotechnol, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Mat Res Lab, Santa Barbara, CA 93106 USA; Max Planck Inst Colloids & Interfaces, D-14424 Potsdam, Germany	Alcatel-Lucent; Lucent Technologies; AT&T; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Max Planck Society	Aizenberg, J (corresponding author), Bell Labs, Lucent Technol, 600 Mt Ave, Murray Hill, NJ 07974 USA.	jaizenberg@lucent.com	Weaver, James C./AAE-7870-2019; Fratzl, Peter/H-9095-2012	Fratzl, Peter/0000-0003-4437-7830				Aizenberg J, 2004, P NATL ACAD SCI USA, V101, P3358, DOI 10.1073/pnas.0307843101; Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361; Chai H, 2002, ACTA MATER, V50, P2613, DOI 10.1016/S1359-6454(02)00091-5; CLEGG WJ, 1990, NATURE, V347, P455, DOI 10.1038/347455a0; Currey JD, 1999, J EXP BIOL, V202, P3285; Deshpande VS, 2001, ACTA MATER, V49, P1035, DOI 10.1016/S1359-6454(00)00379-7; Evans AG, 2001, J MATER RES, V16, P2475, DOI 10.1557/JMR.2001.0339; Faber KT, 1997, ANNU REV MATER SCI, V27, P499, DOI 10.1146/annurev.matsci.27.1.499; Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g; Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100; Gibson L.J., 1988, CELLULAR SOLIDS STRU, DOI [10.1017/CBO9781139878326, DOI 10.1017/CBO9781139878326]; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; Hassenkam T, 2004, BONE, V35, P4, DOI 10.1016/j.bone.2004.02.024; Kamat S, 2000, NATURE, V405, P1036, DOI 10.1038/35016535; Keckes J, 2003, NAT MATER, V2, P810, DOI 10.1038/nmat1019; Kroger N, 2002, SCIENCE, V298, P584, DOI 10.1126/science.1076221; LEVI C, 1989, J MATER SCI LETT, V8, P337, DOI 10.1007/BF00725516; Lichtenegger H, 1999, J STRUCT BIOL, V128, P257, DOI 10.1006/jsbi.1999.4194; Lowenstam HA, 1989, BIOMINERALIZATION; Mayer G, 2002, EXP MECH, V42, P395, DOI 10.1007/BF02412144; MAYER G, 2004, CERAM B, V83, P9305; Perry CC, 2000, J BIOL INORG CHEM, V5, P537, DOI 10.1007/s007750000130; Porter AE, 2002, BIOMATERIALS, V23, P725, DOI 10.1016/S0142-9612(01)00177-6; Saito T, 2002, J ZOOL, V258, P521, DOI 10.1017/S0952836902001681; Sarikaya M, 2001, J MATER RES, V16, P1420, DOI 10.1557/JMR.2001.0198; SCHULZE FE, 1887, REPORT HEXACTINELLID, V21; Seshadri M, 2002, ACTA MATER, V50, P4477, DOI 10.1016/S1359-6454(02)00255-0; Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607; Sundar VC, 2003, NATURE, V424, P899, DOI 10.1038/424899a; Wainwright S.A., 1976, MECH DESIGN ORGANISM; Weaver JC, 2003, J STRUCT BIOL, V144, P271, DOI 10.1016/j.jsb.2003.09.031; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271	32	812	844	30	539	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2005	309	5732					275	278		10.1126/science.1112255	http://dx.doi.org/10.1126/science.1112255			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002612				2022-12-28	WOS:000230449800037
J	Carazo-Salas, RE; Antony, C; Nurse, P				Carazo-Salas, RE; Antony, C; Nurse, P			The kinesin Klp2 mediates polarization of interphase microtubules in fission yeast	SCIENCE			English	Article							POLE BODY; DYNAMICS; SPINDLE; END; NUCLEATION; CONTRIBUTE; MOVEMENT; MOTORS	Fission yeast (Schizosaccharomyces pombe) cells grow longitudinally in a manner dependent on a polarized distribution of their interphase microtubules. We found that this distribution required sliding of microtubules toward the cell center along preexisting microtubules. This sliding was mediated by the minus end-directed kinesin motor Klp2, which helped microtubules to become properly organized with plus ends predominantly oriented toward the cell ends and minus ends toward the cell center. Thus, interphase microtubules in the fission yeast require motor activities for their proper organization.	Canc Res UK, London Res Inst, Cell Cycle Lab, London WC2A 1PX, England; European Mol Biol Lab, D-69117 Heidelberg, Germany; Rockefeller Univ, New York, NY 10021 USA	Cancer Research UK; European Molecular Biology Laboratory (EMBL); Rockefeller University	Carazo-Salas, RE (corresponding author), Canc Res UK, London Res Inst, Cell Cycle Lab, 44 Lincolns Inn Fields, London WC2A 1PX, England.	carazo01@cancer.org.uk	antony, claude/K-5342-2013	Carazo-Salas, Rafael E/0000-0002-5943-3981				Behrens R, 2002, J CELL BIOL, V157, P783, DOI 10.1083/jcb.200112027; Brazer SCW, 2000, YEAST, V16, P149, DOI 10.1002/(SICI)1097-0061(20000130)16:2<149::AID-YEA514>3.0.CO;2-C; Browning H, 2003, NAT CELL BIOL, V5, P812, DOI 10.1038/ncb1034; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Busch KE, 2004, CURR BIOL, V14, P548, DOI 10.1016/j.cub.2004.03.029; Dammermann A, 2003, CURR BIOL, V13, pR614, DOI 10.1016/S0960-9822(03)00530-X; Ding R, 1997, MOL BIOL CELL, V8, P1461, DOI 10.1091/mbc.8.8.1461; Drummond DR, 2000, CURR BIOL, V10, P766, DOI 10.1016/S0960-9822(00)00570-4; Endow SA, 2000, NATURE, V406, P913, DOI 10.1038/35022617; Endow SA, 1999, EUR J BIOCHEM, V262, P12, DOI 10.1046/j.1432-1327.1999.00339.x; Hayles J, 2001, NAT REV MOL CELL BIO, V2, P647, DOI 10.1038/35089520; HEIDEMANN SR, 1991, METHOD ENZYMOL, V196, P469; Hyman A, 1998, J CELL SCI, V111, P2077; Keating TJ, 1999, BIOL CELL, V91, P321, DOI 10.1016/S0248-4900(99)80093-8; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; Paluh JL, 2000, MOL BIOL CELL, V11, P1225, DOI 10.1091/mbc.11.4.1225; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Rodionov VI, 1997, SCIENCE, V275, P215, DOI 10.1126/science.275.5297.215; Rusan NM, 2002, J CELL BIOL, V158, P997, DOI 10.1083/jcb.200204109; Sagolla MJ, 2003, J CELL SCI, V116, P4891, DOI 10.1242/jcs.00796; Sawin KE, 2004, CURR BIOL, V14, P763, DOI 10.1016/j.cub.2004.03.042; Sharp DJ, 1999, NAT CELL BIOL, V1, P51, DOI 10.1038/9025; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Troxell CL, 2001, MOL BIOL CELL, V12, P3476, DOI 10.1091/mbc.12.11.3476; Tulu US, 2003, CURR BIOL, V13, P1894, DOI 10.1016/j.cub.2003.10.002; West RR, 2001, MOL BIOL CELL, V12, P3919, DOI 10.1091/mbc.12.12.3919; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Yamamoto A, 1999, J CELL BIOL, V145, P1233, DOI 10.1083/jcb.145.6.1233	28	41	43	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2005	309	5732					297	300		10.1126/science.1113465	http://dx.doi.org/10.1126/science.1113465			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002618				2022-12-28	WOS:000230449800044
J	Worm, B; Sandow, M; Oschlies, A; Lotze, HK; Myers, RA				Worm, B; Sandow, M; Oschlies, A; Lotze, HK; Myers, RA			Global patterns of predator diversity in the open oceans	SCIENCE			English	Article							PACIFIC-OCEAN; CLIMATE; VARIABILITY; POPULATIONS; DYNAMICS; COLLAPSE; IMPACTS; HABITAT; DEPTH	The open oceans comprise most of the biosphere, yet patterns and trends of species diversity there are enigmatic. Here, we derive worldwide patterns of tuna and billfish diversity over the past 50 years, revealing distinct subtropical "hotspots" that appeared to hold generally for other predators and zooplankton. Diversity was positively correlated with thermal fronts and dissolved oxygen and a nonlinear function of temperature (similar to 25 degrees C optimum). Diversity declined between 10 and 50% in all. oceans, a trend that coincided with increased fishing pressure, superimposed on strong El Nino-Southern Oscillation-driven variability across the Pacific. We conclude that predator diversity shows a predictable yet eroding pattern signaling ecosystem-wide changes linked to climate and fishing.	Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada; Leibniz Inst Marine Sci, D-24105 Kiel, Germany; Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England	Dalhousie University; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; NERC National Oceanography Centre	Worm, B (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada.	bworm@dal.ca	Oschlies, Andreas/F-9749-2012	Oschlies, Andreas/0000-0002-8295-4013; Worm, Boris/0000-0002-5742-8716; Lotze, Heike/0000-0001-6258-1304				Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Bertrand A, 2002, CAN J FISH AQUAT SCI, V59, P1002, DOI 10.1139/F02-073; Blank JM, 2002, J EXP BIOL, V205, P1881; Block BA, 2002, OCEANOL ACTA, V25, P255, DOI 10.1016/S0399-1784(02)01212-4; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Cox SP, 2002, CAN J FISH AQUAT SCI, V59, P1736, DOI 10.1139/F02-138; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Etnoyer Peter, 2004, Oceanography, V17, P90; Ferraroli S, 2004, NATURE, V429, P521, DOI 10.1038/429521a; Gotelli N.J., 1996, NULL MODELS ECOLOGY; HANEY JC, 1986, MAR ECOL PROG SER, V28, P279, DOI 10.3354/meps028279; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hyrenbach KD, 2000, AQUAT CONSERV, V10, P437, DOI 10.1002/1099-0755(200011/12)10:6<437::AID-AQC425>3.3.CO;2-H; *IUCN, 2004, 10 YEAR HIGH SEAS MA; Lehodey P, 2003, FISH OCEANOGR, V12, P483, DOI 10.1046/j.1365-2419.2003.00244.x; Malakoff D, 2004, SCIENCE, V304, P1104, DOI 10.1126/science.304.5674.1104; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; Newman M, 2003, J CLIMATE, V16, P3853, DOI 10.1175/1520-0442(2003)016<3853:EVOTPD>2.0.CO;2; Oschlies A, 1998, NATURE, V394, P266, DOI 10.1038/28373; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Polovina JJ, 2001, PROG OCEANOGR, V49, P469, DOI 10.1016/S0079-6611(01)00036-2; Rutherford S, 1999, NATURE, V400, P749, DOI 10.1038/23449; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; Sund P.N., 1981, Oceanography and Marine Biology an Annual Review, V19, P443; Ward P, 2005, ECOLOGY, V86, P835, DOI 10.1890/03-0746; Ward P, 2005, CAN J FISH AQUAT SCI, V62, P1130, DOI 10.1139/F05-021; Worm B, 2004, NATURE, V429, P15, DOI 10.1038/429015a; Worm B, 2003, P NATL ACAD SCI USA, V100, P9884, DOI 10.1073/pnas.1333941100	29	241	253	2	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2005	309	5739					1365	1369		10.1126/science.1113399	http://dx.doi.org/10.1126/science.1113399			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TX	16051749	Green Accepted			2022-12-28	WOS:000231543300042
J	Marston, C; Meltzer, H; Majeed, A				Marston, C; Meltzer, H; Majeed, A			Impact on contraceptive practice of making emergency hormonal contraception available over the counter in Great Britain: repeated cross sectional surveys	BRITISH MEDICAL JOURNAL			English	Article							PLAN-B; SALES; FDA	Objective To examine the impact on contraceptive practice of making emergency hormonal contraception available over the counter. Design Analysis of data on contraceptive practice for women aged 16-49 years in the period 2000-2 from the Omnibus Survey, a multipurpose survey in which around 7600 adults living in private households are interviewed each year. Setting Private households in Great Britain. Main outcome measures Use of different types of contraception and rates of unprotected sex. Results After emergency hormonal contraception was made available over the counter, levels of use of different types of contraception by women aged 16-49 remained similar. No significant change occurred in the proportion of women using emergency hormonal contraception (8.4% in 2000,7.9% in 2001, 7.2% in 2002) or having unprotected sex. A change did, however, occur in where women obtained emergency hormonal contraception; a smaller proportion of women obtained emergency hormonal contraception from physicians and a greater proportion bought it over the counter. No significant change occurred in the proportion of women using more reliable methods of contraception, such as the oral contraceptive pill, or in the proportion of women using emergency hormonal contraception more than once during a year. Conclusions Making emergency hormonal contraception available over the counter does not seem to have led to an increase in its use, to an. increase in unprotected sex, or to a decrease in the use of more reliable methods of contraception.	Imperial Coll Fac Med, Dept Primary Care & Social Med, London W6 8RP, England; Off Natl Stat, London SW1V 2QQ, England	Imperial College London	Marston, C (corresponding author), Imperial Coll Fac Med, Dept Primary Care & Social Med, London W6 8RP, England.	c.marston@imperial.ac.uk	Meltzer, Herbert Y/E-8131-2013; Marston, Cicely A/T-3551-2017; Marston, Cicely/ABB-9376-2020	Marston, Cicely A/0000-0002-5529-4646; Majeed, Azeem/0000-0002-2357-9858				*AM LIF LEAG, ALLPRES J BROWN TEST; *AM LIF LEAG, ALL PRES J BROWN TES; Bissell P, 2003, SOC SCI MED, V57, P2367, DOI 10.1016/S0277-9536(03)00129-1; DAWE F, 2002, CONTRACEPTION SEXUAL; DAWE F, 2003, CONTRACEPTION SEXUAL; Drazen JM, 2004, NEW ENGL J MED, V350, P1561, DOI 10.1056/NEJMe048057; Fenichel RR, 2004, BMJ-BRIT MED J, V329, P182, DOI 10.1136/bmj.329.7459.182; Glasier A, 1998, NEW ENGL J MED, V339, P1, DOI 10.1056/NEJM199807023390101; Gold Melanie A, 2004, J Pediatr Adolesc Gynecol, V17, P87, DOI 10.1016/j.jpag.2003.11.018; Grimes DA, 2002, AM J OBSTET GYNECOL, V187, P1536, DOI 10.1067/mob.2002.128521; Harrison-Woolrych M, 2001, BRIT MED J, V322, P186; Jackson RA, 2003, OBSTET GYNECOL, V102, P8, DOI 10.1016/S0029-7844(03)00478-2; Kerins M, 2004, EMERG MED J, V21, P67, DOI 10.1136/emj.2003.007708; Mayor S, 2002, BRIT MED J, V324, P995; Nelson R, 2004, LANCET, V363, P1707, DOI 10.1016/S0140-6736(04)16290-9; Raine T, 2000, OBSTET GYNECOL, V96, P1, DOI 10.1016/S0029-7844(00)00830-9; Rothschild TJ, 2003, NEW ENGL J MED, V348, P82; Vastag B, 2004, JAMA-J AM MED ASSOC, V291, P2805, DOI 10.1001/jama.291.23.2805; Westhoff C, 2003, NEW ENGL J MED, V349, P1830, DOI 10.1056/NEJMcp031990; Williams C, 1996, BRIT MED J, V312, P463, DOI 10.1136/bmj.312.7029.463a	20	99	99	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 30	2005	331	7511					271	273		10.1136/bmj.38519.440266.8F	http://dx.doi.org/10.1136/bmj.38519.440266.8F			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953FJ	16009669	Green Published, Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000231061700020
J	Sugita, M; Shiba, Y				Sugita, M; Shiba, Y			Genetic tracing shows segregation of taste neuronal circuitries for bitter and sweet	SCIENCE			English	Article							PARABRACHIAL AREA; MAMMALIAN SWEET; PHA-L; RECEPTORS; RAT; PROJECTIONS; PATHWAYS; CORTEX; ORGANIZATION; CONNECTIONS	The recent discovery of mammalian bitter, sweet, and umami taste receptors indicates how the different taste qualities are encoded at the periphery. However, taste representations in the brain remain elusive. We used a genetic approach to visualize the neuronal circuitries of bitter and sweet tastes in mice to gain insight into how taste recognition is accomplished in the brain. By selectively expressing a transsynaptic tracer in either bitter- or sweet and/ or umami-responsive taste receptor cells, and by comparing the locations of the tracer-labeled neurons in the brain, our data revealed the potential neuronal bases that underlie discrimination of bitter versus sweet.	Hiroshima Univ, Grad Sch Biomed Sci, Dept Physiol & Oral Physiol, Minami Ku, Hiroshima 7348553, Japan	Hiroshima University	Sugita, M (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Physiol & Oral Physiol, Minami Ku, Kasumi 1-2-3, Hiroshima 7348553, Japan.	sugisan@hiroshima-u.ac.jp	Sugita, Makoto/E-9340-2018	Sugita, Makoto/0000-0002-3157-300X				Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; ALLEN GV, 1991, J COMP NEUROL, V311, P1, DOI 10.1002/cne.903110102; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; BERNARD JF, 1993, J COMP NEUROL, V329, P201, DOI 10.1002/cne.903290205; Bester H, 1999, J COMP NEUROL, V405, P421; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; HAMILTON RB, 1984, J COMP NEUROL, V222, P560, DOI 10.1002/cne.902220408; HERBERT H, 1990, J COMP NEUROL, V293, P540, DOI 10.1002/cne.902930404; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; NORGREN R, 1976, J COMP NEUROL, V166, P17, DOI 10.1002/cne.901660103; Norgren Ralph, 1995, P751; SUGITA M, UNPUB; Yee CL, 2003, J COMP NEUROL, V459, P15, DOI 10.1002/cne.10589; Yoshihara Y, 1999, NEURON, V22, P33, DOI 10.1016/S0896-6273(00)80676-5; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	21	71	75	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2005	309	5735					781	785		10.1126/science.1110787	http://dx.doi.org/10.1126/science.1110787			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051799				2022-12-28	WOS:000230938200053
J	Vagero, D; Leinsalu, M				Vagero, D; Leinsalu, M			Commentary: Health inequalities and social dynamics in Europe	BRITISH MEDICAL JOURNAL			English	Editorial Material									Stockholm Univ, Karolinska Inst, CHESS, SE-10691 Stockholm, Sweden; Sodertorn Univ Coll, Stockholm Ctr Hlth Soc Transit, SE-14189 Huddinge, Sweden	Karolinska Institutet; Stockholm University; Sodertorn University	Vagero, D (corresponding author), Stockholm Univ, Karolinska Inst, CHESS, SE-10691 Stockholm, Sweden.	denny.vagero@chess.su.se	Leinsalu, Mall/I-3768-2018	Leinsalu, Mall/0000-0003-4453-4760				Benach J., 2002, REDUCING INEQUALITIE, P262; Lawlor DA, 2005, BRIT MED J, V331, P183, DOI 10.1136/bmj.331.7510.183; Leinsalu M, 2003, INT J EPIDEMIOL, V32, P1081, DOI 10.1093/ije/dyg192; MARMOT MG, 1978, BRIT MED J, V2, P109; VAGERO D, 2005, ED DIFFERENCES MORTA	5	7	7	1	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 23	2005	331	7510					186	187		10.1136/bmj.331.7510.186	http://dx.doi.org/10.1136/bmj.331.7510.186			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951EA	16037447	Bronze, Green Published			2022-12-28	WOS:000230910700016
J	Hack, M; Taylor, HG; Drotar, D; Schluchter, M; Cartar, L; Andreias, L; Wilson-Costello, D; Klein, N				Hack, M; Taylor, HG; Drotar, D; Schluchter, M; Cartar, L; Andreias, L; Wilson-Costello, D; Klein, N			Chronic conditions, functional limitations, and special health care needs of school-aged children born with extremely low-birth-weight in the 1990s	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEONATAL RESEARCH NETWORK; IDENTIFYING CHILDREN; BRONCHOPULMONARY DYSPLASIA; OUTCOMES; DISABILITY; INFANTS; QUESTIONNAIRE; PREMATURITY; RETINOPATHY; DEFINITION	Context Information on the school-age functioning and special health care needs of extremely low-birth-weight (ELBW, <1000 g) children is necessary to plan for medical and educational services. Objective To examine neurosensory, developmental, and medical conditions together with the associated functional limitations and special health care needs of ELBW children compared with normal-birth-weight (NBW) term-born children (controls). Design, Setting, and Participants A follow-up study at age 8 years of a cohort of 219 ELBW children born 1992 to 1995 (92% of survivors) and 176 NBW controls of similar sociodemographic status conducted in Cleveland, Ohio. Main Outcome Measures Parent Questionnaire for Identifying Children with Chronic Conditions of 12 months or more and categorization of specific medical diagnoses and developmental disabilities based on examination of the children. Results In logistic regression analyses adjusting for sociodemographic status and sex, ELBW children had significantly more chronic conditions than NBW controls, including functional limitations (64% vs 20%, respectively; odds ratio [OR], 8.1; 95% confidence interval [CI], 5.0-13.1; P<.001), compensatory dependency needs (48% vs 23%, respectively; OR, 3.0; 95% Cl, 1.9-4.7; P<.001), and services above those routinely required by children (65% vs 27%, respectively; OR, 5.4; 95% Cl, 3.4-8.5; P<.001). These differences remained significant when the 36 ELBW children with neurosensory impairments were excluded. Specific diagnoses and disabilities for ELBW vs NBW children included cerebral palsy (14% vs 0%, respectively; P<.001), asthma (21% vs 9%; OR, 3.0; 95% Cl, 1.6-5.6; P=.001), vision of less than 20/200 (10% vs 3%; OR, 3.1; 95% Cl, 1.2-7.8; P=.02), low IQ of less than 85 (38% vs 14%; OR, 4.5; 95% Cl, 2.7-7.7; P<.001), limited academic skills (37% vs 15%; OR, 4.2; 95% Cl, 2.5-7.3; P<.001), poor motor skills (47% vs 10%; OR, 7.8; 95% Cl, 4.5-13.6; P<.001), and poor adaptive functioning (69% vs 34%; OR, 6.5; 95% Cl, 4.0-10.6; P<.001). Conclusion The ELBW survivors in school at age 8 years who were born in the 1990s have considerable long-term health and educational needs.	Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA	Case Western Reserve University	Hack, M (corresponding author), Univ Hosp Cleveland, Rainbow Babies & Childrens Hosp, Div Neonatol, Suite 3100,11100 Euclid Ave, Cleveland, OH 44106 USA.	mxh7@case.edu			NCRR NIH HHS [M01 RR00080] Funding Source: Medline; NICHD NIH HHS [R01 HD39756] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039756] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000080] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Anderson P, 2003, JAMA-J AM MED ASSOC, V289, P3264, DOI 10.1001/jama.289.24.3264; Berlin LJ, 1998, PREV MED, V27, P238, DOI 10.1006/pmed.1998.0282; Bethell CD, 2002, AMBUL PEDIATR, V2, P49, DOI 10.1367/1539-4409(2002)002<0049:COTCWS>2.0.CO;2; Bethell CD, 2002, AMBUL PEDIATR, V2, P38, DOI 10.1367/1539-4409(2002)002<0038:ICWSHC>2.0.CO;2; BRUININKSOSERET.R, 1978, TEST MOTOR PROFICIEN; Canty-Mitchell J, 2004, ARCH PSYCHIAT NURS, V18, P79, DOI 10.1016/j.apnu.2004.03.003; Emsley HCA, 1998, ARCH DIS CHILD-FETAL, V78, pF99, DOI 10.1136/fn.78.2.F99; Evans M, 1998, AM J EPIDEMIOL, V148, P460; Fanaroff AA, 2003, SEMIN PERINATOL, V27, P281, DOI 10.1016/S0146-0005(03)00055-7; Farooqi A, 2004, PEDIATR RES, V55, p504A; Freed GL, 2005, J PEDIATR-US, V146, P14, DOI 10.1016/j.jpeds.2004.08.054; HACK M, 1994, NEW ENGL J MED, V331, P753, DOI 10.1056/NEJM199409223311201; Hack M, 2000, PEDIATRICS, V106, P554, DOI 10.1542/peds.106.3.554; Halterman JS, 2000, PEDIATRICS, V105, P272; Health, 2005, MED BENEFITS, V22, P12; KAUFMAN AS, 1988, J CLIN CHILD PSYCHOL, V17, P359, DOI 10.1207/s15374424jccp1704_10; Lollar DJ, 2000, ARCH PHYS MED REHAB, V81, pS46, DOI 10.1053/apmr.2000.20624; Lorenz JM, 2001, PEDIATRICS, V108, P1269, DOI 10.1542/peds.108.6.1269; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; MARTIN JA, 2003, NATL VITAL STAT REPO, V52; McPherson M, 1998, PEDIATRICS, V102, P137, DOI 10.1542/peds.102.1.137; Msall ME, 2002, MENT RETARD DEV D R, V8, P258, DOI 10.1002/mrdd.10046; Newacheck PW, 2003, ARCH PEDIAT ADOL MED, V157, P244, DOI 10.1001/archpedi.157.3.244; NEWACHECK PW, 1986, AM J PUBLIC HEALTH, V76, P178, DOI 10.2105/AJPH.76.2.178; Newacheck PW, 2005, ARCH PEDIAT ADOL MED, V159, P10, DOI 10.1001/archpedi.159.1.10; O'Connor AR, 2002, PEDIATRICS, V109, P12, DOI 10.1542/peds.109.1.12; Schmidt B, 2003, JAMA-J AM MED ASSOC, V289, P1124, DOI 10.1001/jama.289.9.1124; Sparrow S.S., 2005, VINELAND 2 ADAPTIVE; Stein REK, 1999, ARCH PEDIAT ADOL MED, V153, P68; Stein REK, 1997, PEDIATRICS, V99, P513, DOI 10.1542/peds.99.4.513; Stein REK, 2004, AMBUL PEDIATR, V4, P365, DOI 10.1367/A03-193R.1; Stein REK, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.4.e61; STEIN REK, 1993, J PEDIATR-US, V122, P342, DOI 10.1016/S0022-3476(05)83414-6; US Census Bureau, 2000, CENS 2000; Vohr BR, 2000, PEDIATRICS, V105, P1216, DOI 10.1542/peds.105.6.1216; Wechsler D., 1991, WISC 3 WECHSLER INTE; Westbrook LE, 1998, PEDIATRICS, V101, P1025, DOI 10.1542/peds.101.6.1025; Wiebe RA, 1999, PEDIATRICS, V104; Williams TV, 2004, PEDIATRICS, V114, P384, DOI 10.1542/peds.114.2.384; Wilson-Costello D, 2005, PEDIATRICS, V115, P997, DOI 10.1542/peds.2004-0221; WOODCOCK R, 1989, WOODCOCKJOHNSON TEST; World Health Organisation (WHO), 2001, INT CLASS FUNCT DIS; Ziring PR, 2000, PEDIATRICS, V105, P448; Ziring PR, 1999, PEDIATRICS, V104, P978	44	358	371	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2005	294	3					318	325		10.1001/jama.294.3.318	http://dx.doi.org/10.1001/jama.294.3.318			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YL	16030276	Bronze			2022-12-28	WOS:000230609100016
J	Mahon, NG; Murphy, RT; MacRae, CA; Caforio, ALP; Elliott, PM; McKenna, WJ				Mahon, NG; Murphy, RT; MacRae, CA; Caforio, ALP; Elliott, PM; McKenna, WJ			Echocardiographic evaluation in asymptornatic relatives of patients with dilated cardiomyopathy reveals preclinical disease	ANNALS OF INTERNAL MEDICINE			English	Article							CONDUCTION-SYSTEM DISEASE; LAMIN A/C GENE; HEART-FAILURE; MUTATION; ASSOCIATION; GUIDELINES; ADULT; LOCUS; MAPS	Background: idiopathic dilated cardiomyopathy is often familial, and apparently healthy relatives may have latent, early, or undiagnosed established disease. Objective: To determine the prevalence and natural history of asymptomatic cardiac abnormalities among sampled relatives of unselected patients referred for management of dilated cardiomyopathy. Design: Prospective cohort study. Patients: 767 asymptomatic relatives of 189 consecutive unselected patients with dilated cardiomyopathy. Measurements: Clinical evaluation, including history, physical examination, electrocardiography, and echocardiography, was performed. Participants were classified in accordance with published echocardiographic criteria. Sampled relatives who did not have evidence of dilated cardiomyopathy at the initial evaluation were followed for a median of 57 months (range, 1 to 133 months). Results: Of the 767 patients evaluated, 592 (77.2%) were assessed as healthy, 35 (4.6% [95% CI, 3.7% to 7.6%]) had dilated cardiomyopathy, 119 (15.5% [CI, 12.5% to 18.8%]) had left ventricular enlargement without systolic dysfunction, and 21 (2.7% [CI, 1.9% to 4.9%]) had depressed fractional shortening without ventricular dilatation. At follow-up, progression to dilated cardiomyopathy occurred in 13 (10%) relatives with left ventricular enlargement or depressed fractional shortening versus 3 (1.3%) healthy relatives. In a multivariate model, only left ventricular enlargement or depressed fractional shortening independently predicted progression to dilated cardiomyopathy (hazard ratio, 10.0 [CI, 2.8 to 35.5]; P < 0.001). Limitations: Because relatives had to be willing to participate and be available geographically, selection bias may have occurred. Conclusion: Treatable asymptomatic dilated cardiomyopathy was identified in 4.6% of asymptomatic relatives. In addition, left ventricular enlargement and depressed fractional shortening were common in asymptomatic relatives of patients with dilated cardiomyopathy and were associated with a statistically significant medium-term risk for disease progression. Evaluation of relatives of patients with cardiomyopathy is recommended.	St George Hosp, Sch Med, London, England; Massachusetts Gen Hosp, Charlestown, MA USA; Univ Padua, Padua, Italy	St Georges University London; Harvard University; Massachusetts General Hospital; University of Padua	McKenna, WJ (corresponding author), Heart Hosp, Westmoreland St, London W1G 8PH, England.	william.mckenna@uclh.org	Caforio, Alida/AAC-3223-2019; Elliott, Perry/AAR-3430-2020; McKenna, William J/C-3243-2008	Elliott, Perry/0000-0003-3383-3984; McKenna, William J/0000-0001-7994-2460; Caforio, Alida Linda Patrizia/0000-0002-4901-5655	NHLBI NIH HHS [R01 HL075431] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075431] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arbustini E, 2000, J AM COLL CARDIOL, V35, P1760, DOI 10.1016/S0735-1097(00)00650-1; Baig MK, 1998, J AM COLL CARDIOL, V31, P195, DOI 10.1016/S0735-1097(97)00433-6; Bowles KR, 1996, J CLIN INVEST, V98, P1355, DOI 10.1172/JCI118922; Brodsky GL, 2000, CIRCULATION, V101, P473, DOI 10.1161/01.CIR.101.5.473; CAFORIO ALP, 1994, LANCET, V344, P773, DOI 10.1016/S0140-6736(94)92339-6; DURAND JB, 1995, CIRCULATION, V92, P3387, DOI 10.1161/01.CIR.92.12.3387; Fadic R, 1996, NEW ENGL J MED, V334, P362, DOI 10.1056/NEJM199602083340604; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Henderson R, 1999, J R STAT SOC B, V61, P367, DOI 10.1111/1467-9868.00182; HENRY WL, 1980, CIRCULATION, V62, P1054, DOI 10.1161/01.CIR.62.5.1054; Hunt SA, 2001, CIRCULATION, V104, P2996, DOI 10.1161/hc4901.102568; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; KASS S, 1994, NAT GENET, V7, P546, DOI 10.1038/ng0894-546; KEELING PJ, 1995, BRIT HEART J, V73, P417; KRAJINOVIC M, 1995, AM J HUM GENET, V57, P846; Li DX, 1999, CIRCULATION, V100, P461, DOI 10.1161/01.CIR.100.5.461; Li DX, 2001, CIRCULATION, V104, P2188, DOI 10.1161/hc4301.098285; McLeod RS, 2001, CAN J GASTROENTEROL, V15, P647, DOI 10.1155/2001/284746; Mestroni L, 1999, EUR HEART J, V20, P93, DOI 10.1053/euhj.1998.1145; Mestroni L, 1999, J AM COLL CARDIOL, V34, P181, DOI 10.1016/S0735-1097(99)00172-2; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; MUNTONI F, 1993, NEW ENGL J MED, V329, P921, DOI 10.1056/NEJM199309233291304; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; Olson TM, 1996, J CLIN INVEST, V97, P528, DOI 10.1172/JCI118445; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; OrtizLopez R, 1997, CIRCULATION, V95, P2434, DOI 10.1161/01.CIR.95.10.2434; *R FDN STAT COMP, 2003, LANG ENV STAT COMP; Rice JP, 2001, ADV GENET, V42, P69, DOI 10.1016/S0065-2660(01)42015-3; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Shaw T, 2002, LANCET, V360, P654, DOI 10.1016/S0140-6736(02)09879-3; Siu BL, 1999, CIRCULATION, V99, P1022, DOI 10.1161/01.CIR.99.8.1022; SUGRUE DD, 1992, ANN INTERN MED, V117, P117, DOI 10.7326/0003-4819-117-2-117; Tiret L, 2000, J AM COLL CARDIOL, V35, P29, DOI 10.1016/S0735-1097(99)00522-7; Towbin JA, 1998, CURR OPIN CELL BIOL, V10, P131, DOI 10.1016/S0955-0674(98)80096-3	34	104	104	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2005	143	2					108	115		10.7326/0003-4819-143-2-200507190-00009	http://dx.doi.org/10.7326/0003-4819-143-2-200507190-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YG	16027452				2022-12-28	WOS:000230608600003
J	Griffiths, MJD; Bonnet, D; Janes, SM				Griffiths, MJD; Bonnet, D; Janes, SM			Stem cells of the alveolar epithelium	LANCET			English	Review							MARROW-DERIVED CELLS; RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; BONE-MARROW; PROGENITOR CELLS; IN-VIVO; NUCLEAR TRANSPLANTATION; CIRCULATING FIBROCYTES; MOLECULAR PHENOTYPE; STROMAL CELLS	Elucidation of the biology of stem cells of the lung parenchyma could revolutionise treatment of patients with lung disorders such as cancer, acute respiratory distress syndrome, emphysema, and fibrotic lung disease. How close is this goal? Despite remarkable observations and ensuing advances, more questions than answers have been generated. Progenitors of the alveolar epithelium remain largely mysterious, so the prospect of isolating enough of these cells and delivering them effectively to cure disease remains remote. Similarly, the bone-marrow-derived cell that might most effectively engraft the lung remains unknown. If this mechanism is an important process for lung repair, why will the administration of additional cells be more effective? Finally, there is an issue of control of multipotent cells to avoid the generation of multiple teratomas, longevity of the graft, and possible immunological reactions to gene products inserted to replace a deficiency. The biology is exciting but not yet well enough understood to support therapeutic advances.	UCL, Rayne Inst, Ctr Resp Res, London WC1E 6JJ, England; UCL, Haematopoiet Stem Cell Lab, London WC1E 6JJ, England; Natl Heart & Lung Inst, Imperial Coll London, Crit Care Unit, London, England; Royal Brompton Hosp, London SW3 6LY, England	University of London; King's College London; University College London; University of London; University College London; Imperial College London; Royal Brompton Hospital	Janes, SM (corresponding author), UCL, Rayne Inst, Ctr Resp Res, 5 Univ St, London WC1E 6JJ, England.	s.janes@ucl.ac.uk		Griffiths, Mark/0000-0002-1615-1896				Abe S, 2004, AM J RESP CELL MOL, V30, P491, DOI 10.1165/rcmb.2003-0140OC; ADAMSON IYR, 1975, LAB INVEST, V32, P736; ADAMSON IYR, 1974, LAB INVEST, V30, P35; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ali NN, 2002, TISSUE ENG, V8, P541, DOI 10.1089/107632702760240463; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; ANDERSON WR, 1992, ULTRASTRUCT PATHOL, V16, P615, DOI 10.3109/01913129209023751; Anjos-Afonso F, 2004, J CELL SCI, V117, P5655, DOI 10.1242/jcs.01488; Asakura A, 2002, EXP HEMATOL, V30, P1339, DOI 10.1016/S0301-472X(02)00954-2; Bardales RH, 1996, AM J PATHOL, V149, P845; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Borthwick DW, 2001, AM J RESP CELL MOL, V24, P662, DOI 10.1165/ajrcmb.24.6.4217; BRODY JS, 1978, AM REV RESPIR DIS, V117, P307; BROERS JLV, 1993, AM J RESP CELL MOL, V9, P33, DOI 10.1165/ajrcmb/9.1.33; BRUCE WR, 1963, NATURE, V199, P79, DOI 10.1038/199079a0; Buckley S, 1998, AM J PHYSIOL-LUNG C, V274, pL714, DOI 10.1152/ajplung.1998.274.5.L714; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chesnutt AN, 1997, AM J RESP CRIT CARE, V156, P840, DOI 10.1164/ajrccm.156.3.9701124; Chien KR, 2004, NATURE, V428, P607, DOI 10.1038/nature02500; Christopherson KW, 2004, SCIENCE, V305, P1000, DOI 10.1126/science.1097071; Chuang PT, 2003, TRENDS CELL BIOL, V13, P86, DOI 10.1016/S0962-8924(02)00031-4; Crow S, 1999, INT J EAT DISORDER, V26, P97, DOI 10.1002/(SICI)1098-108X(199907)26:1<97::AID-EAT13>3.3.CO;2-4; Dahlin K, 2004, AM J RESP CELL MOL, V31, P309, DOI 10.1165/rcmb.2003-0423OC; Daley GQ, 2004, NEW ENGL J MED, V351, P627, DOI 10.1056/NEJMp048200; DANTO SI, 1995, AM J RESP CELL MOL, V12, P497, DOI 10.1165/ajrcmb.12.5.7742013; Dolgin JL, 2004, ISSUES LAW MED, V19, P203; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Dooner M, 2004, BLOOD CELL MOL DIS, V32, P47, DOI 10.1016/j.bcmd.2003.09.014; Drazen JM, 2003, NEW ENGL J MED, V349, P300, DOI 10.1056/NEJMe030059; Ehrhardt A, 2001, BRIT J CANCER, V84, P813, DOI 10.1054/bjoc.2000.1676; ENGELHARDT JF, 1995, DEVELOPMENT, V121, P2031; Epperly MW, 2003, AM J RESP CELL MOL, V29, P213, DOI 10.1165/rcmb.2002-0069OC; EVANS MJ, 1975, EXP MOL PATHOL, V22, P142, DOI 10.1016/0014-4800(75)90059-3; Fehrenbach H, 1999, EUR RESPIR J, V14, P534, DOI 10.1034/j.1399-3003.1999.14c10.x; Fortunel NO, 2003, SCIENCE, V302, P393; Frye M, 2003, DEVELOPMENT, V130, P2793, DOI 10.1242/dev.00462; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; GHIO AJ, 1989, AM REV RESPIR DIS, V139, P1158, DOI 10.1164/ajrccm/139.5.1158; Giangreco A, 2004, AM J PHYSIOL-LUNG C, V286, pL624, DOI 10.1152/ajplung.00149.2003; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; Glaser R, 2002, CIRCULATION, V106, P17, DOI 10.1161/01.CIR.0000021923.58307.8F; Goodell MA, 2003, CURR OPIN HEMATOL, V10, P208, DOI 10.1097/00062752-200305000-00003; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Grove JE, 2002, AM J RESP CELL MOL, V27, P645, DOI 10.1165/rcmb.2002-0056RC; Guinee D, 1997, AM J PATHOL, V151, P999; Guinee D, 1996, AM J PATHOL, V149, P531; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Harris RG, 2004, SCIENCE, V305, P90, DOI 10.1126/science.1098925; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Hatch Heather M., 2002, Cloning and Stem Cells, V4, P339, DOI 10.1089/153623002321025014; Hematti P, 2002, EXP HEMATOL, V30, P943, DOI 10.1016/S0301-472X(02)00873-1; Herzog EL, 2003, BLOOD, V102, P3483, DOI 10.1182/blood-2003-05-1664; Hochedlinger K, 2003, NEW ENGL J MED, V349, P275, DOI 10.1056/NEJMra035397; Hong KU, 2001, AM J RESP CELL MOL, V24, P671, DOI 10.1165/ajrcmb.24.6.4498; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; HRUBAN RH, 1993, AM J PATHOL, V142, P975; Ishizawa K, 2004, FEBS LETT, V556, P249, DOI 10.1016/S0014-5793(03)01399-1; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jaiswal S, 2003, P NATL ACAD SCI USA, V100, P10002, DOI 10.1073/pnas.1633833100; Janes SM, 2002, J PATHOL, V197, P479, DOI 10.1002/path.1156; JEFFERY PK, 2003, RESP MED, P51; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; KALINA M, 1993, EXP LUNG RES, V19, P153, DOI 10.3109/01902149309031717; KAPANCI Y, 1969, LAB INVEST, V20, P101; Kawase K, 2000, OSA TRENDS OPT PHOTO, V46, P39, DOI 10.1109/NLO.2000.883568; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kleeberger W, 2003, AM J PATHOL, V162, P1487, DOI 10.1016/S0002-9440(10)64281-2; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Korbling M, 2002, NEW ENGL J MED, V346, P738, DOI 10.1056/NEJMoa3461002; Kotton DN, 2001, DEVELOPMENT, V128, P5181; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Laflamme MA, 2002, CIRC RES, V90, P634, DOI 10.1161/01.RES.0000014822.62629.EB; Lagaaij EL, 2001, LANCET, V357, P33, DOI 10.1016/S0140-6736(00)03569-8; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Lambert JF, 2003, J EXP MED, V197, P1563, DOI 10.1084/jem.20030031; MARTIN C, 1995, CHEST, V107, P196, DOI 10.1378/chest.107.1.196; Massaro D, 2004, AM J PHYSIOL-LUNG C, V286, pL896, DOI 10.1152/ajplung.00333.2003; Meneghetti A, 1996, J HISTOCHEM CYTOCHEM, V44, P1173, DOI 10.1177/44.10.8813083; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Muller P, 2002, CIRCULATION, V106, P31, DOI 10.1161/01.CIR.0000022405.68464.CA; Okamoto R, 2002, NAT MED, V8, P1011, DOI 10.1038/nm755; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; PARK CH, 1971, JNCI-J NATL CANCER I, V46, P411; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Pearce DJ, 2004, BLOOD, V103, P2541, DOI 10.1182/blood-2003-09-3281; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; PINKERTON KE, 1993, AM J PATHOL, V142, P947; Poulsom R, 2002, J PATHOL, V197, P441, DOI 10.1002/path.1176; Poulsom R, 2001, J PATHOL, V195, P229, DOI 10.1002/path.976; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Qiao RL, 2003, AM J RESP CELL MOL, V29, P98, DOI 10.1165/rcmb.2002-0196OC; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Quan TE, 2004, INT J BIOCHEM CELL B, V36, P598, DOI 10.1016/j.biocel.2003.10.005; Quesenberry PJ, 2001, ANN NY ACAD SCI, V938, P54; Radisky DC, 2004, SCIENCE, V303, P775, DOI 10.1126/science.1094412; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reddy R, 2004, AM J PHYSIOL-LUNG C, V286, pL658, DOI 10.1152/ajplung.00159.2003; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Roufosse CA, 2004, INT J BIOCHEM CELL B, V36, P585, DOI 10.1016/j.biocel.2003.10.007; SAETTA M, 1985, AM REV RESPIR DIS, V131, P764; SAHEBJAMI H, 1981, AM REV RESPIR DIS, V124, P619; Shannon JM, 2004, ANNU REV PHYSIOL, V66, P625, DOI 10.1146/annurev.physiol.66.032102.135749; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Smith JR, 2004, STEM CELLS, V22, P823, DOI 10.1634/stemcells.22-5-823; Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100; STINSON SF, 1976, ARCH PATHOL LAB MED, V100, P147; STONER GD, 1978, LAB INVEST, V38, P685; Summer R, 2004, AM J PHYSIOL-LUNG C, V287, pL477, DOI 10.1152/ajplung.00020.2004; Suratt BT, 2003, AM J RESP CRIT CARE, V168, P318, DOI 10.1164/rccm.200301-145OC; Tauer CA, 2004, LANCET, V364, P209, DOI 10.1016/S0140-6736(04)16637-3; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Tesfaigzi J, 1998, INT J EXP PATHOL, V79, P303, DOI 10.1046/j.1365-2613.1998.720402.x; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Theise ND, 2003, SCIENCE, V299, p1317A, DOI 10.1126/science.1078412; Theise ND, 2002, EXP HEMATOL, V30, P1333, DOI 10.1016/S0301-472X(02)00931-1; Tomashefski JF, 2000, CLIN CHEST MED, V21, P435, DOI 10.1016/S0272-5231(05)70158-1; Uhal BD, 1997, AM J PHYSIOL-LUNG C, V272, pL1031, DOI 10.1152/ajplung.1997.272.6.L1031; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Vastag B, 2004, JAMA-J AM MED ASSOC, V291, P1185, DOI 10.1001/jama.291.10.1185; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wagers AJ, 2003, SCIENCE, V299, p1317B, DOI 10.1126/science.1079110; Wang HC, 2002, CRIT CARE MED, V30, P1528, DOI 10.1097/00003246-200207000-00022; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Williams MC, 2003, ANNU REV PHYSIOL, V65, P669, DOI 10.1146/annurev.physiol.65.092101.142446; Wuenschell CW, 1996, J HISTOCHEM CYTOCHEM, V44, P113, DOI 10.1177/44.2.8609367; Yamada M, 2004, J IMMUNOL, V172, P1266, DOI 10.4049/jimmunol.172.2.1266; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; YOUSEM SA, 1991, CHEST, V99, P275, DOI 10.1378/chest.99.2.275	136	100	111	1	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2005	366	9481					249	260		10.1016/S0140-6736(05)66916-4	http://dx.doi.org/10.1016/S0140-6736(05)66916-4			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945RG	16023517				2022-12-28	WOS:000230519200035
J	Horton, R				Horton, R			The Ellison Institute: monitoring health, challenging WHO	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Murray CJL, 2004, BMJ-BRIT MED J, V329, P1096, DOI 10.1136/bmj.329.7474.1096; World Health Organization, 2000, WORLD HLTH REP 2000	2	11	11	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 16	2005	366	9481					179	181		10.1016/S0140-6736(05)66883-3	http://dx.doi.org/10.1016/S0140-6736(05)66883-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945RG	16023490				2022-12-28	WOS:000230519200004
J	Wassenegger, M				Wassenegger, M			The role of the RNAi machinery in heterochromatin formation	CELL			English	Review							RETRACTED ARTICLE. SEE; DNA METHYLATION; HISTONE METHYLATION; METHYLTRANSFERASES; CELLS	Considerable effort has been devoted to the characterization of RNA interference (RNAi), a posttranscriptional gene silencing mechanism involving small RNA-containing effector complexes. Recent studies have revealed that components of the RNAi machinery are associated not only with target RNA cleavage and impairment of target RNA translation but also with the formation of heterochromatin. There is increasing evidence that RNA-mediated chromatin modifications play an important role in epigenetic transcriptional gene silencing.	RLP AgroSci GmbH, AlPlanta Inst Plant Res, D-67435 Neustadt, Germany		Wassenegger, M (corresponding author), RLP AgroSci GmbH, AlPlanta Inst Plant Res, Breitenweg 71, D-67435 Neustadt, Germany.	michael.wassenegger@agroscience.rip.de	Wassenegger, Michael/AAF-6507-2020	Wassenegger, Michael/0000-0002-7926-2454				Aufsatz W, 2002, EMBO J, V21, P6832, DOI 10.1093/emboj/cdf663; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Grewal SIS, 2004, CURR OPIN CELL BIOL, V16, P230, DOI 10.1016/j.ceb.2004.04.002; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Kawasaki H, 2004, NATURE, V431, P211, DOI 10.1038/nature02889; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Naumann K, 2005, EMBO J, V24, P1418, DOI 10.1038/sj.emboj.7600604; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Schramke V, 2003, SCIENCE, V301, P1069, DOI 10.1126/science.1086870; Sigova A, 2004, GENE DEV, V18, P2359, DOI 10.1101/gad.1218004; Sontheimer EJ, 2005, CELL, V122, P9, DOI 10.1016/j.cell.2005.06.030; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zemach A, 2005, PLANT CELL, V17, P1549, DOI 10.1105/tpc.105.031567; Zemach A, 2003, PLANT J, V34, P565, DOI 10.1046/j.1365-313X.2003.01756.x; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055	22	153	171	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 15	2005	122	1					13	16		10.1016/j.cell.2005.06.034	http://dx.doi.org/10.1016/j.cell.2005.06.034			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	950EC	16009128	Bronze			2022-12-28	WOS:000230839400006
J	Bundock, P; Hooykaas, P				Bundock, P; Hooykaas, P			An Arabidopsis hAT-like transposase is essential for plant development	NATURE			English	Article							DNA-BINDING DOMAIN; PROTEINS; ELEMENTS; FINGER; GENE; FHY3	A significant proportion of the genomes of higher plants and vertebrates consists of transposable elements and their derivatives. Autonomous DNA type transposons encode a transposase that enables them to mobilize to a new chromosomal position in the host genome by a cut-and-paste mechanism. As this is potentially mutagenic, the host limits transposition through epigenetic gene silencing and heterochromatin formation. Here we show that a transposase from Arabidopsis thaliana that we named DAYSLEEPER is essential for normal plant growth; it shares several characteristics with the hAT ( hobo, Activator, Tam3) family of transposases(1). DAYSLEEPER was isolated as a factor binding to a motif (Kubox1) present in the upstream region of the Arabidopsis DNA repair gene Ku70 ( refs 2, 3). This motif is also present in the upstream regions of many other plant genes. Plants lacking DAYSLEEPER or strongly overexpressing this gene do not develop in a normal manner. Furthermore, DAYSLEEPER overexpression results in the altered expression of many genes. Our data indicate that transposase-like genes can be essential for plant development and can also regulate global gene expression. Thus, transposases can become domesticated by the host to fulfil important cellular functions.	Leiden Univ, Inst Biol, NL-2333 AL Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Hooykaas, P (corresponding author), Leiden Univ, Inst Biol, Wassenaarseweg 64, NL-2333 AL Leiden, Netherlands.	hooykaas@rulbim.leidenuniv.nl	Hooykaas, Paul JJ/S-4256-2017	Hooykaas, Paul JJ/0000-0002-9736-6927				Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P421, DOI 10.1016/S0968-0004(00)01620-0; Bundock P, 2002, NUCLEIC ACIDS RES, V30, P3395, DOI 10.1093/nar/gkf445; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hudson ME, 2003, PLANT J, V34, P453, DOI 10.1046/j.1365-313X.2003.01741.x; Kempken F, 2001, CHROMOSOMA, V110, P1, DOI 10.1007/s004120000118; Kidwell MG, 2000, TRENDS ECOL EVOL, V15, P95, DOI 10.1016/S0169-5347(99)01817-0; KUNZE R, 1993, P NATL ACAD SCI USA, V90, P7094, DOI 10.1073/pnas.90.15.7094; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lundquist EA, 1996, DEVELOPMENT, V122, P1601; Mack AM, 2001, PLANT CELL, V13, P2319, DOI 10.1105/tpc.13.10.2319; Meijer AH, 1998, YEAST, V14, P1407, DOI 10.1002/(SICI)1097-0061(199811)14:15<1407::AID-YEA325>3.0.CO;2-M; Pardue ML, 2003, ANNU REV GENET, V37, P485, DOI 10.1146/annurev.genet.38.072902.093115; RHIA K, 2002, EMBO J, V21, P2819; Rubin E, 2001, GENETICS, V158, P949; Wang HY, 2002, EMBO J, V21, P1339, DOI 10.1093/emboj/21.6.1339	16	106	114	0	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					282	284		10.1038/nature03667	http://dx.doi.org/10.1038/nature03667			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015335				2022-12-28	WOS:000230459500046
J	Haskin, LA; Wang, A; Jolliff, BL; McSween, HY; Clark, BC; Des Marais, DJ; McLennan, SM; Tosca, NJ; Hurowitz, JA; Farmer, JD; Yen, A; Squyres, SW; Arvidson, RE; Klingelhofer, G; Schroder, C; de Souza, PA; Ming, DW; Gellert, R; Zipfel, J; Bruckner, J; Bell, JF; Herkenhoff, K; Christensen, PR; Ruff, S; Blaney, D; Gorevan, S; Cabrol, NA; Crumpler, L; Grant, J; Soderblom, L				Haskin, LA; Wang, A; Jolliff, BL; McSween, HY; Clark, BC; Des Marais, DJ; McLennan, SM; Tosca, NJ; Hurowitz, JA; Farmer, JD; Yen, A; Squyres, SW; Arvidson, RE; Klingelhofer, G; Schroder, C; de Souza, PA; Ming, DW; Gellert, R; Zipfel, J; Bruckner, J; Bell, JF; Herkenhoff, K; Christensen, PR; Ruff, S; Blaney, D; Gorevan, S; Cabrol, NA; Crumpler, L; Grant, J; Soderblom, L			Water alteration of rocks and soils on Mars at the Spirit rover site in Gusev crater	NATURE			English	Article							MINERALOGY; CHEMISTRY; DEPOSITS	Gusev crater was selected as the landing site for the Spirit rover because of the possibility that it once held a lake. Thus one of the rover's tasks was to search for evidence of lake sediments(1). However, the plains at the landing site were found to be covered by a regolith composed of olivine-rich basaltic rock and windblown 'global' dust(2). The analyses of three rock interiors exposed by the rock abrasion tool showed that they are similar to one another, consistent with having originated from a common lava flow(3-8). Here we report the investigation of soils, rock coatings and rock interiors by the Spirit rover from sol (martian day) 1 to sol 156, from its landing site to the base of the Columbia hills. The physical and chemical characteristics of the materials analysed provide evidence for limited but unequivocal interaction between water and the volcanic rocks of the Gusev plains. This evidence includes the softness of rock interiors that contain anomalously high concentrations of sulphur, chlorine and bromine relative to terrestrial basalts and martian meteorites(9); sulphur, chlorine and ferric iron enrichments in multilayer coatings on the light-toned rock Mazatzal; high bromine concentration in filled vugs and veins within the plains basalts; positive correlations between magnesium, sulphur and other salt components in trench soils; and decoupling of sulphur, chlorine and bromine concentrations in trench soils compared to Gusev surface soils, indicating chemical mobility and separation.	Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; Lockheed Martin Space Syst, Littleton, CO 80125 USA; NASA, Exobiol Branch, Ames Res Ctr, Moffett Field, CA 94035 USA; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Cornell Univ, Ithaca, NY 14853 USA; Johannes Gutenberg Univ Mainz, Inst Anorgan & Analyt Chem, D-55128 Mainz, Germany; Co Vale Rio Doce, BR-20030900 Rio De Janeiro, Brazil; NASA, Lyndon B Johnson Space Ctr, MC KR, Houston, TX 77058 USA; Max Planck Inst Chem, Abt Kosmochem, D-55128 Mainz, Germany; US Geol Survey, Flagstaff, AZ 86001 USA; Honeybee Robot, New York, NY 10012 USA; NASA, SETI Inst, Ames Res Ctr, Moffett Field, CA 94035 USA; NASA, Div Space Sci, Ames Res Ctr, Moffett Field, CA 94035 USA; New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA; Smithsonian Inst, Washington, DC 20024 USA	Washington University (WUSTL); University of Tennessee System; University of Tennessee Knoxville; Lockheed Martin; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Arizona State University; Arizona State University-Tempe; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Cornell University; Johannes Gutenberg University of Mainz; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Max Planck Society; United States Department of the Interior; United States Geological Survey; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Smithsonian Institution	Wang, A (corresponding author), Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA.	alianw@levee.wustl.edu	Hurowitz, Joel A/A-8862-2008; Blaney, Diana/M-1756-2019; de Souza, Paulo/W-2993-2019; Farmer, Jack D/B-9343-2019; Schröder, Christian/B-3870-2009; de Souza, Paulo A/B-8961-2008; de Souza, Paulo/P-7294-2019	Blaney, Diana/0000-0002-4267-7939; de Souza, Paulo/0000-0002-0091-8925; Schröder, Christian/0000-0002-7935-6039; de Souza, Paulo A/0000-0002-0091-8925; McLennan, Scott/0000-0003-4259-7178; Tosca, Nicholas/0000-0003-4415-4231				Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; BARTLETT PW, 2005, LUNAR PLANET SCI C, V36; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; CLARK BC, 1993, GEOCHIM COSMOCHIM AC, V57, P4575, DOI 10.1016/0016-7037(93)90183-W; CLARK BC, 1982, J GEOPHYS RES, V87, P59, DOI 10.1029/JB087iB12p10059; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; GOODING JL, 1992, ICARUS, V99, P28, DOI 10.1016/0019-1035(92)90168-7; GOODING JL, 1978, GEOPHYS RES LETT, V5, P727, DOI 10.1029/GL005i008p00727; Gorevan SP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002061; Govindaraju K., 1994, GEOSTANDARDS NEWSLET, V18, P1; Grant JA, 2004, SCIENCE, V305, P807, DOI 10.1126/science.1099849; Greeley R, 2004, SCIENCE, V305, P810, DOI 10.1126/science.1100108; Haskin LA, 2003, METEORIT PLANET SCI, V38, P13, DOI 10.1111/j.1945-5100.2003.tb01043.x; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.1100015; HUNTEN DM, 1979, J MOL EVOL, V14, P71, DOI 10.1007/BF01732369; Lide D. R., 2001, HDB CHEM PHYS, P4; McSween H.Y., 1998, PLANETARY MAT, V36; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; Morris RV, 2000, J GEOPHYS RES-PLANET, V105, P1757, DOI 10.1029/1999JE001059; MORRIS RV, 2005, LUNAR PLANET SCI C, V36; Richardson MI, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002367; SETTLE M, 1979, J GEOPHYS RES, V84, P8343, DOI 10.1029/JB084iB14p08343; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121; Wang AL, 1999, J GEOPHYS RES-PLANET, V104, P27067, DOI 10.1029/1999JE001071	27	194	197	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					66	69		10.1038/nature03640	http://dx.doi.org/10.1038/nature03640			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001063				2022-12-28	WOS:000230296600040
J	Vollbrecht, E; Springer, PS; Goh, L; Buckler, ES; Martienssen, R				Vollbrecht, E; Springer, PS; Goh, L; Buckler, ES; Martienssen, R			Architecture of floral branch systems in maize and related grasses	NATURE			English	Article							MERISTEM IDENTITY; GENE; SHOOT; EVOLUTION; MORPHOGENESIS; SELECTION; PATTERNS; ENCODES; TASSEL	The external appearance of flowering plants is determined to a large extent by the forms of flower-bearing branch systems, known as inflorescences, and their position in the overall structure of the plant. Branches and branching patterns are produced by tissues called shoot apical meristems. Thus, inflorescence architecture reflects meristem number, arrangement and activity, and the duration of meristem activity correlates with branch length. The inflorescences of maize, unlike those of related grasses such as rice and sorghum, predominantly lack long branches, giving rise to the tassel and familiar corncob. Here we report the isolation of the maize ramosa1 gene and show that it controls inflorescence architecture. Through its expression in a boundary domain near the nascent meristem base, ramosa1 imposes short branch identity as branch meristems are initiated. A second gene, ramosa2, acts through ramosa1 by regulating ramosa1 gene expression levels. ramosa1 encodes a transcription factor that appears to be absent in rice, is heterochronically expressed in sorghum, and may have played an important role in maize domestication and grass evolution.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Cornell Univ, Dept Plant Breeding, Ithaca, NY 14850 USA	Cold Spring Harbor Laboratory; Cornell University	Martienssen, R (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.org	Buckler, Edward/L-7651-2019; Buckler, Edward/GPS-4932-2022	Buckler, Edward/0000-0002-3100-371X; Vollbrecht, Erik/0000-0003-4919-1365				Bommert P, 2005, DEVELOPMENT, V132, P1235, DOI 10.1242/dev.01671; CHENG PC, 1983, AM J BOT, V70, P450, DOI 10.2307/2443252; Chuck G, 2002, SCIENCE, V298, P1238, DOI 10.1126/science.1076920; Chuck G, 1998, GENE DEV, V12, P1145, DOI 10.1101/gad.12.8.1145; Clifford H.T., 1986, GRASS SYSTEMATICS EV, P21; Collins GN, 1917, P NATL ACAD SCI USA, V3, P345, DOI 10.1073/pnas.3.5.345; DAWE RK, 1990, DEV BIOL, V142, P233, DOI 10.1016/0012-1606(90)90167-H; Doebley J, 2004, ANNU REV GENET, V38, P37, DOI 10.1146/annurev.genet.38.072902.092425; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; DOEBLEY J, 1993, GENETICS, V134, P559; Doust AN, 2002, AM J BOT, V89, P1203, DOI 10.3732/ajb.89.8.1203; EMERSON RA, 1935, CORNELL U AGR EXP ST, V180, P3; Gallavotti A, 2004, NATURE, V432, P630, DOI 10.1038/nature03148; Gernert WB, 1912, AM NAT, V46, P616, DOI 10.1086/279312; HUDSON RR, 1987, GENETICS, V116, P153; JACKSON D, 1994, DEVELOPMENT, V120, P405; KELLOGG E, 2000, GRASSES SYSTEMATICS; Kellogg EA, 2004, CURR OPIN PLANT BIOL, V7, P92, DOI 10.1016/j.pbi.2003.11.004; Kelly AL, 1997, INT DAIRY J, V7, P411, DOI 10.1016/S0958-6946(97)00038-1; Martienssen R, 1997, NATURE, V386, P443, DOI 10.1038/386443a0; MCCLINTOCK B, 1953, GENETICS, V38, P579; McSteen P, 2000, TRENDS PLANT SCI, V5, P61, DOI 10.1016/S1360-1385(99)01541-1; NICKERSON NORTON H., 1955, ANN MISSOURI BOT GARDEN, V42, P195, DOI 10.2307/2394655; POETHIG RS, 1990, SCIENCE, V250, P923, DOI 10.1126/science.250.4983.923; POSTLETHEWAIT SN, 1964, AM J BOT, V51, P238, DOI 10.2307/2440292; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; SAKAI H, 1995, NATURE, V378, P199, DOI 10.1038/378199a0; Sambrook J., 2001, MOL CLONING LAB MANU; Sussex IM, 2001, CURR OPIN PLANT BIOL, V4, P33, DOI 10.1016/S1369-5266(00)00132-1; Taguchi-Shiobara F, 2001, GENE DEV, V15, P2755, DOI 10.1101/gad.208501; Takatsuji H, 1999, PLANT MOL BIOL, V39, P1073, DOI 10.1023/A:1006184519697; Takeda T, 2003, PLANT J, V33, P513, DOI 10.1046/j.1365-313X.2003.01648.x; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Troll W, 1964, INFLORESZENZEN TYPOL; VEIT B, 1993, PLANT CELL, V5, P1205, DOI 10.1105/tpc.5.10.1205; Vollbrecht E, 2000, DEVELOPMENT, V127, P3161; Walsh J, 1999, PLANT J, V19, P489, DOI 10.1046/j.1365-313X.1999.00541.x; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Weberling F, 1989, MORPHOLOGY FLOWERS I; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Wilson LM, 2004, PLANT CELL, V16, P2719, DOI 10.1105/tpc.104.025700	42	238	275	4	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2005	436	7054					1119	1126		10.1038/nature03892	http://dx.doi.org/10.1038/nature03892			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958AK	16041362				2022-12-28	WOS:000231416600037
J	Aharonian, F; Akhperjanian, AG; Aye, KM; Bazer-Bachi, AR; Beilicke, M; Benbow, W; Berge, D; Berghaus, P; Bernlohr, K; Boisson, C; Bolz, O; Borrel, V; Braun, I; Breitling, F; Brown, AM; Gordo, JB; Chadwick, PM; Chounet, LM; Cornils, R; Costamante, L; Degrange, B; Dickinson, HJ; Djannati-Ataii, A; Drury, LO; Dubus, G; Emmanouiopoulos, D; Espigat, P; Feinstein, F; Fleury, P; Fontaine, G; Fuchs, Y; Funk, S; Gallant, YA; Giebels, B; Gillessen, S; Glicenstein, JF; Goret, P; Hadjichristidis, C; Hauser, M; Heinzelmann, G; Henri, G; Hermann, G; Hinton, JA; Hofmann, W; Holieran, M; Horns, D; Jacholkowska, A; de Jager, OC; Khelifi, B; Komin, N; Konopelko, A; Latham, IJ; Le Gallou, R; Lemiere, A; Lemoine-Goumard, M; Leroy, N; Lohse, T; Marcowith, A; Martin, JM; Martineau-Huynh, O; Masterson, C; McComb, TJL; de Naurois, M; Nolan, SJ; Noutsos, A; Orford, KJ; Osborne, JL; Ouchrif, M; Panter, M; Pelletier, G; Pita, S; Puhlhofer, G; Punch, M; Raubenheimer, BC; Raue, M; Raux, J; Rayner, SM; Reimer, A; Reimer, O; Ripken, J; Rob, L; Rolland, L; Rowell, G; Sahakian, V; Sauge, L; Schlenker, S; Schlickeiser, R; Schuster, C; Schwanke, U; Siewert, M; Sol, H; Spangler, D; Steenkamp, R; Stegmann, C; Tavernet, JP; Terrier, R; Theoret, CG; Tluczykont, M; Vasileiadis, G; Venter, C; Vincent, P; Volk, HJ; Wagner, SJ				Aharonian, F; Akhperjanian, AG; Aye, KM; Bazer-Bachi, AR; Beilicke, M; Benbow, W; Berge, D; Berghaus, P; Bernlohr, K; Boisson, C; Bolz, O; Borrel, V; Braun, I; Breitling, F; Brown, AM; Gordo, JB; Chadwick, PM; Chounet, LM; Cornils, R; Costamante, L; Degrange, B; Dickinson, HJ; Djannati-Ataii, A; Drury, LO; Dubus, G; Emmanouiopoulos, D; Espigat, P; Feinstein, F; Fleury, P; Fontaine, G; Fuchs, Y; Funk, S; Gallant, YA; Giebels, B; Gillessen, S; Glicenstein, JF; Goret, P; Hadjichristidis, C; Hauser, M; Heinzelmann, G; Henri, G; Hermann, G; Hinton, JA; Hofmann, W; Holieran, M; Horns, D; Jacholkowska, A; de Jager, OC; Khelifi, B; Komin, N; Konopelko, A; Latham, IJ; Le Gallou, R; Lemiere, A; Lemoine-Goumard, M; Leroy, N; Lohse, T; Marcowith, A; Martin, JM; Martineau-Huynh, O; Masterson, C; McComb, TJL; de Naurois, M; Nolan, SJ; Noutsos, A; Orford, KJ; Osborne, JL; Ouchrif, M; Panter, M; Pelletier, G; Pita, S; Puhlhofer, G; Punch, M; Raubenheimer, BC; Raue, M; Raux, J; Rayner, SM; Reimer, A; Reimer, O; Ripken, J; Rob, L; Rolland, L; Rowell, G; Sahakian, V; Sauge, L; Schlenker, S; Schlickeiser, R; Schuster, C; Schwanke, U; Siewert, M; Sol, H; Spangler, D; Steenkamp, R; Stegmann, C; Tavernet, JP; Terrier, R; Theoret, CG; Tluczykont, M; Vasileiadis, G; Venter, C; Vincent, P; Volk, HJ; Wagner, SJ			Discovery of very high energy gamma rays associated with an X-ray binary	SCIENCE			English	Article							STAR LSI &61-DEGREES-303; MICROQUASAR LS-5039; GALACTIC PLANE; SYSTEM; GALAXY; MODEL	X-ray binaries are composed of a normal star in orbit around a neutron star or stellar-mass black hole. Radio and x-ray observations have led to the presumption that some x-ray binaries called microquasars behave as scaled-down active galactic nuclei. Microquasars have resolved radio emission that is thought to arise from a relativistic outflow akin to active galactic nuclei jets, in which particles can be accelerated to large energies. Very high energy gamma-rays produced by the interactions of these particles have been observed from several active galactic nuclei. Using the High Energy Stereoscopic System, we find evidence for gamma-ray emission of >100 gigaelectron volts from a candidate microquasar, LS 5039, showing that particles are also accelerated to very high energies in these systems.	Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France; Max Planck Inst Kernphys, D-69029 Heidelberg, Germany; Yerevan Phys Inst, Yerevan 375036, Armenia; Univ Durham, Dept Phys, Durham DH1 3LE, England; UPS, CNRS, Ctr Etud Spatiale Rayonnements, F-31029 Toulouse, France; Univ Hamburg, Inst Expt Phys, D-22761 Hamburg, Germany; APC, CNRS, UMR 7164, F-75231 Paris, France; Humboldt Univ, Inst Phys, D-12489 Berlin, Germany; Observ Paris, CNRS, UMR 8102, LUTH,Sect Meudon, F-92195 Meudon, France; Univ Montpellier 2, CNRS, IN2P3, Lab Phys Theor & Astroparticules, F-34095 Montpellier, France; Dublin Inst Adv Studies, Dublin 2, Ireland; Landessternwarte Konigstuhl, D-69117 Heidelberg, Germany; Univ Grenoble 1, CNRS, INSU, Lab Astrophys Grenoble, F-38041 Grenoble, France; Ctr Etud Saclay, CEA, DSM, DAPNIA, F-91191 Gif Sur Yvette, France; NW Univ, Unit Space Phys, ZA-2520 Potchefstroom, South Africa; Univ Paris 06, CNRS, IN2P3, Phys Theor & Hautes Energies Lab, F-75252 Paris, France; Univ Paris 07, CNRS, IN2P3, Phys Theor & Hautes Energies Lab, F-75252 Paris, France; Ruhr Univ Bochum, Inst Theoret Phys, Lehrstuhl Weltraum & Astrophys 4, D-44780 Bochum, Germany; Charles Univ, Inst Nucl & Particle Phys, CR-18000 Prague, Czech Republic; Univ Namibia, Windhoek, Namibia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; Max Planck Society; Yerevan Physics Institute; Durham University; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Hamburg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; PSL Research University Paris; Universite Paris Cite; Observatoire de Paris; CEA; Humboldt University of Berlin; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Montpellier; Dublin Institute for Advanced Studies; Ruprecht Karls University Heidelberg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Universite Paris Saclay; North West University - South Africa; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Ruhr University Bochum; Charles University Prague; University of Namibia	de Naurois, M (corresponding author), Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France.	dubus@in2p3.fr; denauroi@in2p3.fr	Reimer, Olaf/A-3117-2013; Marcowith, Alexandre/ABH-1254-2020; Pühlhofer, Gerd/Q-2336-2018; Reimer, Anita/K-5822-2015; Fontaine, Gerard/D-6420-2014; Gordo, Javier Bussons/B-5572-2019; Aye, Klaus-Michael/D-2425-2009; Horns, Dieter/ABE-9516-2020; Berge, David/P-2179-2017; Drury, Luke O'C/B-1916-2017; White, Richard/AAF-4527-2019; Hadjichristidis, Christos/G-7284-2012; Horns, Dieter/C-9727-2011; Funk, Stefan/B-7629-2015; Funk, Stefan/AAI-1568-2021; Venter, Christo/E-6884-2011; Braun, Isabel V/C-9373-2012; Aye, Klaus-Michael/W-1271-2018; Komin, Nukri/J-6781-2015	Reimer, Olaf/0000-0001-6953-1385; Marcowith, Alexandre/0000-0002-3971-0910; Reimer, Anita/0000-0001-8604-7077; Fontaine, Gerard/0000-0002-6443-5025; Gordo, Javier Bussons/0000-0002-8275-592X; Horns, Dieter/0000-0003-1945-0119; Berge, David/0000-0002-2918-1824; Drury, Luke O'C/0000-0002-9257-2270; White, Richard/0000-0002-3356-0763; Hadjichristidis, Christos/0000-0002-5933-0755; Funk, Stefan/0000-0002-2012-0080; Funk, Stefan/0000-0002-2012-0080; Venter, Christo/0000-0002-2666-4812; Braun, Isabel V/0000-0002-9389-0502; Hinton, James/0000-0002-1031-7760; Benbow, Wystan/0000-0003-2098-170X; Aye, Klaus-Michael/0000-0002-4088-1928; Noutsos, Aristeidis/0000-0002-4151-3860; Punch, Michael/0000-0002-4710-2165; Brown, Anthony/0000-0003-0259-3148; Komin, Nukri/0000-0003-3280-0582; Chadwick, Paula/0000-0002-1468-2685; Bernlohr, Konrad/0000-0001-8065-3252; Dubus, Guillaume/0000-0002-5130-2514; Martineau-Huynh, Olivier/0000-0001-5334-8244; Rowell, Gavin/0000-0002-9516-1581; Hermann, German/0000-0002-4595-1032; Khelifi, Bruno/0000-0001-6876-5577				Aharonian F, 2005, SCIENCE, V307, P1938, DOI 10.1126/science.1108643; Aharonian F, 2004, ASTROPART PHYS, V22, P109, DOI 10.1016/j.astropartphys.2004.06.006; BEILICKE M, 2004, 8300 IAUC, P2; Bernlohr K, 2003, ASTROPART PHYS, V20, P111, DOI 10.1016/S0927-6505(03)00171-3; BIGNAMI GF, 1981, ASTROPHYS J, V247, pL85, DOI 10.1086/183595; Bosch-Ramon V, 2004, ASTRON ASTROPHYS, V417, P1075, DOI 10.1051/0004-6361:20035615; Clark JS, 2001, ASTRON ASTROPHYS, V376, P476, DOI 10.1051/0004-6361:20010919; Condon JJ, 1998, ASTRON J, V115, P1693, DOI 10.1086/300337; Corbel S, 2002, SCIENCE, V298, P196, DOI 10.1126/science.1075857; DENAUROIS M, 2003, 28 ICRC P, P2907; Funk S, 2004, ASTROPART PHYS, V22, P285, DOI 10.1016/j.astropartphys.2004.08.001; GOULD RJ, 1967, PHYS REV, V155, P1408, DOI 10.1103/PhysRev.155.1408; GREGORY PC, 1978, NATURE, V272, P704, DOI 10.1038/272704a0; Hartman RC, 1999, ASTROPHYS J SUPPL S, V123, P79, DOI 10.1086/313231; Hinton JA, 2004, NEW ASTRON REV, V48, P331, DOI 10.1016/j.newar.2003.12.004; HUTCHINGS JB, 1981, PUBL ASTRON SOC PAC, V93, P486, DOI 10.1086/130863; MARASCHI L, 1981, MON NOT R ASTRON SOC, V194, pP1, DOI 10.1093/mnras/194.1.1P; Marscher AP, 2002, NATURE, V417, P625, DOI 10.1038/nature00772; Marti J, 1998, ASTRON ASTROPHYS, V338, pL71; Martocchia A, 2005, ASTRON ASTROPHYS, V430, P245, DOI 10.1051/0004-6361:20041390; McSwain MV, 2004, ASTROPHYS J, V600, P927, DOI 10.1086/379892; MIRABEL IF, 1994, NATURE, V371, P46, DOI 10.1038/371046a0; Motch C, 1997, ASTRON ASTROPHYS, V323, P853; Paredes JM, 2000, SCIENCE, V288, P2340, DOI 10.1126/science.288.5475.2340; Piron F, 2001, ASTRON ASTROPHYS, V374, P895, DOI 10.1051/0004-6361:20010798; Ribo M, 2002, ASTRON ASTROPHYS, V384, P954, DOI 10.1051/0004-6361:20020093; Ribo M, 1999, ASTRON ASTROPHYS, V347, P518; TASKER NJ, 1994, ASTRON J, V107, P2115, DOI 10.1086/117022; TAYLOR AR, 1992, ASTROPHYS J, V395, P268, DOI 10.1086/171648; WEEKES TC, 1992, SPACE SCI REV, V59, P315, DOI 10.1007/BF00242089	30	270	271	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2005	309	5735					746	749		10.1126/science.1113764	http://dx.doi.org/10.1126/science.1113764			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16002580	Green Accepted, Green Submitted			2022-12-28	WOS:000230938200042
J	Giorgio, M; Migliaccio, E; Orsini, F; Paolucci, D; Moroni, M; Contursi, C; Pelliccia, G; Luzi, L; Minucci, S; Marcaccio, M; Pinton, P; Rizzuto, R; Bernardi, P; Paolucci, F; Pelicci, PG				Giorgio, M; Migliaccio, E; Orsini, F; Paolucci, D; Moroni, M; Contursi, C; Pelliccia, G; Luzi, L; Minucci, S; Marcaccio, M; Pinton, P; Rizzuto, R; Bernardi, P; Paolucci, F; Pelicci, PG			Electron transfer between cytochrome c and p66(Shc) generates reactive oxygen species that trigger mitochondrial apoptosis	CELL			English	Article							CELL-DEATH; SUPEROXIDE; MECHANISMS; OXIDANTS; DOMAIN; OUTER; PROBE	Reactive oxygen species (ROS) are potent inducers of oxidative damage and have been implicated in the regulation of specific cellular functions, including apoptosis. Mitochondrial ROS increase markedly after proapoptotic signals, though the biological significance and the underlying molecular mechanisms remain undetermined. P66(Shc) is a genetic determinant of life span in mammals, which regulates ROS metabolism and apoptosis. We report here that p66(Shc) is a redox enzyme that generates mitochondrial ROS (hydrogen peroxide) as signaling molecules for apoptosis. For this function, p66(Shc) utilizes reducing equivalents of the mitochondrial electron transfer chain through the oxidation of cytochrome c. Redox-defective mutants of p66(Shc) are unable to induce mitochondrial ROS generation and swelling in vitro or to mediate mitochondrial apoptosis in vivo. These data demonstrate the existence of alternative redox reactions of the mitochondrial electron transfer chain, which evolved to generate proapoptotic ROS in response to specific stress signals.	European Inst Oncol, Expt Oncol Dept, Milan, Italy; FIRC Inst Mol Oncol, Milan, Italy; Univ Bologna, G Ciamician Chem Dept, Bologna, Italy; Congenia Srt, Bologna, Italy; Univ Padua, Dept Biomed Sci, Padua, Italy; Univ Ferrara, Expt & Diagnost Med Dept, I-44100 Ferrara, Italy; Univ Milan, Dept Med & Surg, Milan, Italy	IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology; University of Bologna; University of Padua; University of Ferrara; University of Milan	Giorgio, M (corresponding author), European Inst Oncol, Expt Oncol Dept, Milan, Italy.	marco.giorgio@ifom-ieo-campus.it; piergiuseppe.pellici@ifom-ieo-campus.it	Luzi, Lucilla/K-4350-2018; Paolucci, Francesco/A-8708-2008; Minucci, Saverio/J-9669-2012; Bernardi, Paolo/C-3656-2008; Franzeck, Fabian C/B-5055-2011; Rizzuto, Rosario/B-6312-2008; Migliaccio, Enrica/AAQ-8880-2020; Pinton, Paolo/J-8025-2012; Giorgio, Marco/I-9425-2012; Pelicci, Pier Giuseppe/AAL-6572-2020	Luzi, Lucilla/0000-0002-8746-4179; Paolucci, Francesco/0000-0003-4614-8740; Bernardi, Paolo/0000-0001-9187-3736; Pinton, Paolo/0000-0001-7108-6508; Giorgio, Marco/0000-0002-5842-6042; Rizzuto, Rosario/0000-0001-7044-5097				Armstrong FA, 2002, J CHEM SOC DALTON, P661, DOI 10.1039/b108359g; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Becker LB, 2004, CARDIOVASC RES, V61, P461, DOI 10.1016/j.cardiores.2003.10.025; BERNARDI P, 1981, J BIOL CHEM, V256, P7187; Bernardi P, 2001, TRENDS BIOCHEM SCI, V26, P112, DOI 10.1016/S0968-0004(00)01745-X; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; Callegari A, 2004, J MATER CHEM, V14, P807, DOI 10.1039/b316806a; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chen XX, 2002, LANGMUIR, V18, P7009, DOI 10.1021/la0204794; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DIWAN JJ, 1988, BIOCHEM PHARMACOL, V37, P957, DOI 10.1016/0006-2952(88)90188-8; Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; MAYER M, 1994, P NATL ACAD SCI USA, V91, P7496, DOI 10.1073/pnas.91.16.7496; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Orsini F, 2004, J BIOL CHEM, V279, P25689, DOI 10.1074/jbc.M401844200; Pacini S, 2004, MOL CELL BIOL, V24, P1747, DOI 10.1128/MCB.24.4.1747-1757.2004; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Pelicci PG, 2004, J CLIN INVEST, V113, P4, DOI 10.1172/JCI200420750; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Sarti P, 2003, IUBMB LIFE, V55, P605, DOI 10.1080/15216540310001628726; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Trinei M, 2002, ONCOGENE, V21, P3872, DOI 10.1038/sj.onc.1205513; Ventura A, 2004, J BIOL CHEM, V279, P2299, DOI 10.1074/jbc.M307655200; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Zaccagnini G, 2004, CIRCULATION, V109, P2917, DOI 10.1161/01.CIR.0000129309.58874.0F; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zhen YJ, 1999, J BIOL CHEM, V274, P38032, DOI 10.1074/jbc.274.53.38032	36	866	908	7	89	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 29	2005	122	2					221	233		10.1016/j.cell.2005.05.011	http://dx.doi.org/10.1016/j.cell.2005.05.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	951CR	16051147	Bronze			2022-12-28	WOS:000230907000010
J	Lohani, S; Niven, R				Lohani, S; Niven, R			Bilateral pulmonary-artery aneurysms in Behcet's syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Wythenshawe Hosp, Manchester M23 9LT, Lancs, England	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Lohani, S (corresponding author), Wythenshawe Hosp, Manchester M23 9LT, Lancs, England.			Niven, Robert/0000-0003-2249-960X					0	4	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2005	353	4					400	400		10.1056/NEJMicm041070	http://dx.doi.org/10.1056/NEJMicm041070			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949JW	16049212				2022-12-28	WOS:000230782800013
J	Soteriades, ES; Falagas, ME				Soteriades, ES; Falagas, ME			Comparison of amount of biomedical research originating from the European Union and the United States	BRITISH MEDICAL JOURNAL			English	Article							JOURNALS	Objective To examine and compare the research productivity of the European Union, the four "candidate" countries (those currently waiting to join the EU), and the United States in several fields of biomedical sciences. Design A retrospective observational study-bibliometric analysis. Data sources Manuscripts published by authors from each country separately and from each group of countries for the period 1994 to 2004 and included in the Essential Science Indicators database of the Institute of Scientific Information. Main outcome measures Number of published articles and number of citations, adjusted for gross domestic product and population size. Results 1485 749 articles were published by authors from the EU compared with 1 56 805 from the US. The research productivity of the first 15 countries to join the EU, adjusted for population, was lower (76%) than that of the US-and even lower (66%) when the 10 newest EU countries were included in the analysis. Conclusion The newest EU members and die EU candidate countries need further help and resources to increase their productivity, thereby improving the productivity of the EU as a whole.	Alfa Inst Biomed Sci, Athens 15123, Greece; Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Alfa Institute Of Biomedical Sciences; Harvard University; Harvard T.H. Chan School of Public Health	Falagas, ME (corresponding author), Alfa Inst Biomed Sci, 9 Neapoleos St, Athens 15123, Greece.	m.falagas@aibs.gr						Auger Jean-Marie, 2004, Stud Health Technol Inform, V108, P81; MANFRASS K, 1992, INT MIGR REV, V26, P388, DOI 10.2307/2547064; Rosmarakis ES, 2005, INT J CARDIOL, V100, P443, DOI 10.1016/j.ijcard.2004.11.005; STOSSEL TP, 1990, NEW ENGL J MED, V322, P739, DOI 10.1056/NEJM199003153221106; Vergidis PI, 2005, EUR J CLIN MICROBIOL, V24, P342, DOI 10.1007/s10096-005-1306-x; *WORLD BANK, 2004, WORLD DEV IND; Zetterstrom R, 2002, ACTA PAEDIATR, V91, P1020, DOI 10.1080/080352502760311467; 1997, NATURE, V387, P537	8	60	63	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 23	2005	331	7510					192	194		10.1136/bmj.331.7510.192	http://dx.doi.org/10.1136/bmj.331.7510.192			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951EA	16037452	Green Published, Bronze			2022-12-28	WOS:000230910700021
J	Engel, HA; Loss, D				Engel, HA; Loss, D			Fermionic Bell-state Analyzer for spin qubits	SCIENCE			English	Article							QUANTUM DOTS; ELECTRON-SPIN; COMPUTATION	We propose a protocol and physical implementation for partial Bell-state measurements of Fermionic qubits, allowing for deterministic quantum computing in solid-state systems without the need for two-qubit gates. Our scheme consists of two spin qubits in a double quantum dot where the two dots have different Zeeman splittings and resonant tunneling between the dots is only allowed when the spins are antiparallel. This converts spin parity into charge information by means of a projective measurement and can be implemented with established technologies. This measurement-based qubit scheme greatly simplifies the experimental realization of scalable quantum computers in electronic nanostructures.	Harvard Univ, Dept Phys, Lyman Lab, Cambridge, MA 02138 USA; Univ Basel, Dept Phys & Astron, CH-4056 Basel, Switzerland	Harvard University; University of Basel	Engel, HA (corresponding author), Harvard Univ, Dept Phys, Lyman Lab, Cambridge, MA 02138 USA.		Loss, Daniel/A-3721-2008	Loss, Daniel/0000-0001-5176-3073				AWSCHALOM DD, 2002, SERIES NANOSCIENCE T; Beenakker CWJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.020501; Blum K., 2012, DENSITY MATRIX THEOR, V3rd; Clerk AA, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.165324; DiCarlo L, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.226801; Elzerman JM, 2004, NATURE, V430, P431, DOI 10.1039/nature02693; Elzerman JM, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.161308; Engel HA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.106804; FIELD M, 1993, PHYS REV LETT, V70, P1311, DOI 10.1103/PhysRevLett.70.1311; Fujisawa T, 1998, SCIENCE, V282, P932, DOI 10.1126/science.282.5390.932; Fujisawa T, 2002, NATURE, V419, P278, DOI 10.1038/nature00976; Guo GP, 2001, PHYS LETT A, V286, P401, DOI 10.1016/S0375-9601(01)00420-0; Hayashi T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.226804; Johnson AC, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.115333; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Kouwenhoven L. P., 1997, MESOSCOPIC ELECT T E, V345; Kouwenhoven LP, 2001, REP PROG PHYS, V64, P701, DOI 10.1088/0034-4885/64/6/201; Kroutvar M, 2004, NATURE, V432, P81, DOI 10.1038/nature03008; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Makhlin Y, 2000, PHYS REV LETT, V85, P4578, DOI 10.1103/PhysRevLett.85.4578; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Schleser R, 2004, APPL PHYS LETT, V85, P2005, DOI 10.1063/1.1784875; Uhlmann A, 2000, REP MATH PHYS, V45, P407, DOI 10.1016/S0034-4877(00)80007-5; van der Wiel WG, 2003, REV MOD PHYS, V75, P1, DOI 10.1103/RevModPhys.75.1; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389	27	86	88	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2005	309	5734					586	588		10.1126/science.1113203	http://dx.doi.org/10.1126/science.1113203			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040700				2022-12-28	WOS:000230735200040
J	Murdoch, W; Briggs, CJ; Swarbrick, S				Murdoch, W; Briggs, CJ; Swarbrick, S			Host suppression and stability in a parasitoid-host system: Experimental demonstration	SCIENCE			English	Article							CALIFORNIA RED SCALE; BIOLOGICAL-CONTROL; APHYTIS-MELINUS; POPULATION; MODELS; SIZE	We elucidate the mechanisms causing stability and severe resource suppression in a consumer-resource system. The consumer, the parasitoid Aphytis, rapidly controlled an experimentally induced outbreak of the resource, California red scale, an agricultural pest, and imposed a low, stable pest equilibrium. The results are well predicted by a mechanistic, independently parameterized model. The key mechanisms are widespread in nature: an invulnerable adult stage in the resource population and rapid consumer development. Stability in this biologically nondiverse agricultural system is a property of the local interaction between these two species, not of spatial processes or of the larger ecological community.	Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Santa Barbara; University of California System; University of California Berkeley	Murdoch, W (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	murdoch@lifesci.ucsb.edu	Briggs, Cheryl/F-7456-2013					DeBach P., 1971, BIOL CONTROL, P165, DOI DOI 10.1007/978-1-4615-6531-4_7; HASSELL MP, 1978, MONOGRAPHS POPULATIO, V13; LUCK RF, 1985, ECOLOGY, V66, P904, DOI 10.2307/1940553; May R.M., 1976, P49; MCNAIR JN, 1987, THEOR POPUL BIOL, V32, P383, DOI 10.1016/0040-5809(87)90056-6; MURDOCH WW, 1994, ECOLOGY, V75, P271, DOI 10.2307/1939533; Murdoch WW, 1996, AM NAT, V148, P807, DOI 10.1086/285957; MURDOCH WW, 1995, ECOLOGY, V76, P206, DOI 10.2307/1940642; Murdoch WW, 1996, AM NAT, V147, P424, DOI 10.1086/285859; MURDOCH WW, 1992, J ANIM ECOL, V61, P533, DOI 10.2307/5608; Murdoch WW, 2003, MONOGRAPHS POPULATIO; REEVE JD, 1986, J ANIM ECOL, V55, P1069, DOI 10.2307/4434; REEVE JD, 1985, J ANIM ECOL, V54, P797, DOI 10.2307/4379; Rosen D, 1979, SPECIES APHYTIS WORL; ROSENZWE.ML, 1971, SCIENCE, V171, P385, DOI 10.1126/science.171.3969.385; SMITH RH, 1974, THEOR POPUL BIOL, V6, P308, DOI 10.1016/0040-5809(74)90014-8	16	45	47	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2005	309	5734					610	613		10.1126/science.1114426	http://dx.doi.org/10.1126/science.1114426			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040706				2022-12-28	WOS:000230735200048
J	Burns, KEA; Chu, MWA; Novick, RJ; Fox, SA; Gallo, K; Martin, CM; Stitt, LW; Heidenheim, A; Myers, ML; Moist, L				Burns, KEA; Chu, MWA; Novick, RJ; Fox, SA; Gallo, K; Martin, CM; Stitt, LW; Heidenheim, A; Myers, ML; Moist, L			Perioperative n-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing CABG surgery - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ARTERY-BYPASS; CONTRAST-INDUCED NEPHROPATHY; III INHIBITOR ENOXIMONE; CARDIAC-SURGERY; CARDIOPULMONARY BYPASS; PROPHYLACTIC USE; MYOCARDIAL REVASCULARIZATION; METAANALYSIS; FAILURE; MORTALITY	Context Renal dysfunction is a complication of coronary artery bypass graft (CABG) surgery performed with cardiopulmonary bypass (CPB) that is associated with increased morbidity and mortality. N-acetylcysteine, an antioxidant and vasodilator, counteracts renal ischemia and hypoxia. Objective To determine whether perioperative intravenous (IV) N-acetylcysteine preserves renal function in high-risk patients undergoing CABG surgery with CPB compared with placebo. Design, Setting, and Patients Randomized, quadruple blind, placebo-controlled trial (October 2003-September 2004) in operating rooms and general intensive care units (ICUs) of 2 Ontario tertiary care centers. The 295 patients required elective or urgent CABG and had at least 1 of the following: preexisting renal dysfunction, at least 70 years old, diabetes mellitus, impaired left ventricular function, or undergoing concomitant valve or redo surgery Interventions Patients received 4 (2 intraoperative and 2 postoperative) doses of IV N-acetylcysteine (600 mg) (n = 148) or placebo (n = 147) over 24 hours. Main Outcome Measures The primary outcome was the proportion of patients developing postoperative renal dysfunction, defined by an increase in serum creatinine level greater than 0.5 mg/dL (44 mu mol/L) or a 25% increase from baseline within the first 5 postoperative days. Secondary outcomes included postoperative interventions and complications, the requirement for renal replacement therapy (RRT), adverse events, hospital mortality, and ICU and hospital length of stay. Results There was no difference in the proportion of patients with postoperative renal dysfunction (29.7% vs 29.0%, P=.89; relative risk [RR], 1.03 [95% confidence interval {CI}, 0.72-1.46]) in the N-acetylcysteine and placebo groups, respectively. We noted nonsignificant differences in postoperative interventions and complications, the need for RRT (0.7% vs 2.1 %; P=37), total (6.1% vs 9.6%; P=.26) and serious adverse events, hospital mortality (3.4% vs 2.7%; P>39), and ICU and hospital length of stay between the N-acetylcysteine and placebo groups. A post hoc subgroup analysis of patients (baseline creatinine level >1.4 mg/dL [120 mu mol/L]) showed a nonsignificant trend toward fewer patients experiencing postoperative renal dysfunction in the N-acetylcysteine group compared with the placebo group (25.0% vs 37.1 %; P=.29). Conclusions N-acetylcysteine did not prevent postoperative renal dysfunction, interventions, complications, or mortality in high-risk patients undergoing CABG surgery with CPB. Further research is required to identify CABG patients at risk for postoperative renal events, valid markers of renal dysfunction, and to establish renal thresholds associated with important clinical outcomes.	Univ Western Ontario, Div Crit Care Med, London, ON, Canada; Univ Western Ontario, Div Nephrol, London, ON, Canada; Univ Western Ontario, Div Cardiac Surg, London, ON, Canada; Univ Western Ontario, Dept Biostat, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Burns, KEA (corresponding author), Univ Toronto, St Michaels Hosp, Interdepartmental Div Crit Care, 30 Bond St,4-012 Bond Wing, Toronto, ON M5B 1W8, Canada.	burnske2@yahoo.ca	Moist, Louise/G-3334-2011; Martin, Claudio/G-3327-2011	Chu, Michael/0000-0002-9872-399X				ABE K, 1993, PROSTAG LEUKOTR ESS, V49, P627, DOI 10.1016/0952-3278(93)90170-2; Abramov D, 2000, ANN THORAC SURG, V70, P84, DOI 10.1016/S0003-4975(00)01249-2; Alonso A, 2004, AM J KIDNEY DIS, V43, P1, DOI 10.1053/j.ajkd.2003.09.009; Antunes PE, 2004, EUR J CARDIO-THORAC, V25, P597, DOI 10.1016/j.ejcts.2004.01.010; Baker CSR, 2003, J AM COLL CARDIOL, V41, P2114, DOI 10.1016/S0735-1097(03)00487-X; BAKRIS GL, 1990, AM J PHYSIOL, V258, pF115, DOI 10.1152/ajprenal.1990.258.1.F115; Baliga R, 1997, AM J KIDNEY DIS, V29, P465, DOI 10.1016/S0272-6386(97)90212-2; Bergman ASF, 2002, J CARDIOTHOR VASC AN, V16, P294, DOI 10.1053/jcan.2002.124136; Bertolissi M, 1996, J CARDIOTHOR VASC AN, V10, P238, DOI 10.1016/S1053-0770(96)80245-X; Birck R, 2003, LANCET, V362, P598, DOI 10.1016/S0140-6736(03)14189-X; Boldt J, 2004, ANESTH ANALG, V99, P1009, DOI [10.1213/01.ANE.0000132969.88550.96, 10.1213/01.ane.0000132969.88550.96]; Boldt J, 2002, INTENS CARE MED, V28, P1462, DOI 10.1007/s00134-002-1435-y; Boldt J, 2001, CRIT CARE MED, V29, P952, DOI 10.1097/00003246-200105000-00008; Bove T, 2004, J CARDIOTHOR VASC AN, V18, P442, DOI 10.1053/j.jvca.2004.05.021; Bucerius J, 2004, INTENS CARE MED, V30, P88, DOI 10.1007/s00134-003-1950-5; Caimmi PP, 2003, J CARDIOTHOR VASC AN, V17, P491, DOI 10.1016/S1053-0770(03)00155-1; CHATTAS MA, 1986, ANESTH ANALG, V65, pS57; Chertow GM, 1998, AM J MED, V104, P343, DOI 10.1016/S0002-9343(98)00058-8; Chertow GM, 1997, CIRCULATION, V95, P878; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; DiMari J, 1997, AM J PHYSIOL-RENAL, V272, pF292, DOI 10.1152/ajprenal.1997.272.3.F292; Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2; Guru V, 2004, CLIN NEPHROL, V62, P77; Hoffmann U, 2004, J AM SOC NEPHROL, V15, P407, DOI 10.1097/01.ASN.0000106780.14856.55; Isenbarger DW, 2003, AM J CARDIOL, V92, P1454, DOI 10.1016/j.amjcard.2003.08.059; Ivanov J, 1998, CIRCULATION, V97, P673, DOI 10.1161/01.CIR.97.7.673; Katz NM, 1998, AM J CARDIOL, V81, P1400, DOI 10.1016/S0002-9149(98)00211-2; Khachigian LM, 1997, AM J PATHOL, V151, P1225; Kulka PJ, 1996, CRIT CARE MED, V24, P947, DOI 10.1097/00003246-199606000-00012; Mangano CM, 1998, ANN INTERN MED, V128, P194, DOI 10.7326/0003-4819-128-3-199802010-00005; MCGRATH LB, 1990, ANN THORAC SURG, V49, P410, DOI 10.1016/0003-4975(90)90245-2; Misra D, 2004, CLIN CARDIOL, V27, P607, DOI 10.1002/clc.4960271106; Moshkovitz Y, 1997, EUR J CARDIO-THORAC, V12, P31, DOI 10.1016/S1010-7940(97)00129-2; Naylor CD, 1999, CARDIOVASCULAR HLTH, P189; PERRELLA MA, 1992, AM J PHYSIOL, V263, pR45, DOI 10.1152/ajpregu.1992.263.1.R45; Ranucci M, 2004, ANN THORAC SURG, V78, P1332, DOI 10.1016/j.athoracsur.2004.02.065; SMITH MS, 2003, PERIOPERATIVE ORGAN, P89; Tepel M, 2000, NEW ENGL J MED, V343, P180, DOI 10.1056/NEJM200007203430304; YOSHIOKA T, 1992, KIDNEY INT, V41, P1008, DOI 10.1038/ki.1992.153; Zanardo G, 1993, J Cardiothorac Vasc Anesth, V7, P711, DOI 10.1016/1053-0770(93)90057-R; ZANARDO G, 1994, J THORAC CARDIOV SUR, V107, P1489, DOI 10.1016/S0022-5223(94)70429-5; ZHANG H, 1995, EUR SURG RES, V27, P292, DOI 10.1159/000129412	42	151	153	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2005	294	3					342	350		10.1001/jama.294.3.342	http://dx.doi.org/10.1001/jama.294.3.342			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YL	16030279	Bronze			2022-12-28	WOS:000230609100019
J	Greene, M; Schill, K; Takahashi, S; Bateman-House, A; Beauchamp, T; Bok, H; Cheney, D; Coyle, J; Deacon, T; Dennett, D; Donovan, P; Flanagan, O; Goldman, S; Greely, H; Martin, L; Miller, E; Mueller, D; Siegel, A; Solter, D; Gearhart, J; McKhann, G; Faden, R				Greene, M; Schill, K; Takahashi, S; Bateman-House, A; Beauchamp, T; Bok, H; Cheney, D; Coyle, J; Deacon, T; Dennett, D; Donovan, P; Flanagan, O; Goldman, S; Greely, H; Martin, L; Miller, E; Mueller, D; Siegel, A; Solter, D; Gearhart, J; McKhann, G; Faden, R			Moral issues of human-non-human primate neural grafting	SCIENCE			English	Editorial Material							STEM-CELLS; CHIMPANZEES		Johns Hopkins Univ, Phoebe R Berman Bioeth Inst, Baltimore, MD 21218 USA; Univ Delaware, Newark, DE 19716 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; Columbia Univ, New York, NY 10027 USA; Georgetown Univ, Washington, DC 20057 USA; Univ Penn, Philadelphia, PA 19104 USA; Harvard Univ, Cambridge, MA 02138 USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; Tufts Univ, Medford, MA 02155 USA; Duke Univ, Durham, NC 27706 USA; Univ Rochester, Rochester, NY 14627 USA; Stanford Univ, Stanford, CA 94305 USA; MIT, Cambridge, MA 02139 USA; Univ Maryland, College Pk, MD 20742 USA; Max Planck Inst Immunobiol, Freiburg, Germany	Johns Hopkins University; University of Delaware; Case Western Reserve University; Johns Hopkins University; Columbia University; Georgetown University; University of Pennsylvania; Harvard University; University of California System; University of California Berkeley; Tufts University; Duke University; University of Rochester; Stanford University; Massachusetts Institute of Technology (MIT); University System of Maryland; University of Maryland College Park; Max Planck Society	Faden, R (corresponding author), Johns Hopkins Univ, Phoebe R Berman Bioeth Inst, Baltimore, MD 21218 USA.	rfaden@jhsph.edu	Miller, Earl K./AAE-8187-2019; Solter, Davor/Q-5476-2019; Bateman-House, Alison/AAP-6213-2021	Miller, Earl K./0000-0002-0582-6958; Bateman-House, Alison/0000-0001-6921-9666; Greene, Mark/0000-0001-9512-4943; Solter, Davor/0000-0002-8438-347X; Goldman, Steven/0000-0002-5498-4303				Brustle O, 1998, NAT BIOTECHNOL, V16, P1040, DOI 10.1038/3481; Fink JS, 2000, CELL TRANSPLANT, V9, P273, DOI 10.1177/096368970000900212; FUKUYAMA F, 2004, WASHINGTON POST 0215; Institute of Medicine and National Research Council, 2007, GUID HUM EMBR STEM C, DOI [10.17226/11870, DOI 10.17226/11153]; KANT I, 1998, CAMBRIDGE TEXTS HIST, P37; Karpowicz P, 2004, NAT MED, V10, P331, DOI 10.1038/nm0404-331; Long KD, 2001, P NATL ACAD SCI USA, V98, P5862, DOI 10.1073/pnas.091080098; MILL JS, UTILITARIANISM, P87; Ourednik V, 2001, SCIENCE, V293, P1820, DOI 10.1126/science.1060580; Oxnard CE, 2004, INT J PRIMATOL, V25, P1127, DOI 10.1023/B:IJOP.0000043355.96393.8b; Pau K-Y Francis, 2004, Reprod Biol Endocrinol, V2, P41, DOI 10.1186/1477-7827-2-41; Rakic P, 2004, NATURE, V427, P685, DOI 10.1038/427685a; Robert JS, 2004, BIOESSAYS, V26, P1005, DOI 10.1002/bies.20100; SINGER P, 1979, INQUIRY, V22, P145, DOI 10.1080/00201747908601869; TOMASELLO M, 1993, CHILD DEV, V64, P1688, DOI 10.1111/j.1467-8624.1993.tb04207.x; Tomasello M, 2003, TRENDS COGN SCI, V7, P153, DOI 10.1016/S1364-6613(03)00035-4	16	69	70	2	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					385	386		10.1126/science.1112207	http://dx.doi.org/10.1126/science.1112207			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020716				2022-12-28	WOS:000230574900026
J	Daniels, N				Daniels, N			Fair process in patient selection for antiretroviral treatment in WHO's goal of 3 by 5	LANCET			English	Article							AFRICA; TECHNOLOGIES; MEDICINE; CARE		Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Daniels, N (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	ndaniels@hsph.harvard.edu						Brock D., 1988, ORGAN SUBSTITUTION T, P86; Creese A, 2002, LANCET, V359, P1635, DOI 10.1016/S0140-6736(02)08595-1; DANIELS N, 1993, BIOETHICS, V7, P224, DOI 10.1111/j.1467-8519.1993.tb00288.x; Daniels N, 1997, PHILOS PUBLIC AFF, V26, P303, DOI 10.1111/j.1088-4963.1997.tb00082.x; Daniels N, 2002, SETTING LIMITS FAIRL; Gibson JL, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-14; Gilson L, 1997, HEALTH POLICY PLANN, V12, P273, DOI 10.1093/oxfordjournals.heapol.a018882; Ham C., 2003, REASONABLE RATIONING; KAMM FM, 1993, MORALITY MORTALITY, V1, P233; Marseille E, 2002, LANCET, V359, P1851, DOI 10.1016/S0140-6736(02)08705-6; Martin DK, 2003, J NEUROL NEUROSUR PS, V74, P1299, DOI 10.1136/jnnp.74.9.1299; Martin DK, 2002, HEALTH POLICY, V61, P279, DOI 10.1016/S0168-8510(01)00237-8; McCoy D, 2003, HLTH SECTOR RESPONSE; *NAT AIDS COMM MAL, EQ ACC ANT THER ART; Singer PA, 2000, BMJ-BRIT MED J, V321, P1316, DOI 10.1136/bmj.321.7272.1316; SONTAG D, 2004, NY TIMES        0425, pA1; *WHO JOINT UN PROG, 2004, CONS EQ ACC TREATM C; World Health Organization, 2004, GUID ETH EQ ACC HIV; World Health Organization, 2003, SCAL ANT THER RES LT	19	36	36	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 9	2005	366	9480					169	171		10.1016/S0140-6736(05)66518-X	http://dx.doi.org/10.1016/S0140-6736(05)66518-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	943JH	16005341				2022-12-28	WOS:000230349200037
J	Dekel, E; Alon, U				Dekel, E; Alon, U			Optimality and evolutionary tuning of the expression level of a protein	NATURE			English	Article							ADAPTIVE EVOLUTION; DIAUXIC GROWTH; OPERON; DYNAMICS; FITNESS; GLUCOSE; MODEL	Different proteins have different expression levels. It is unclear to what extent these expression levels are optimized to their environment. Evolutionary theories suggest that protein expression levels maximize fitness(1-11), but the fitness as a function of protein level has seldom been directly measured. To address this, we studied the lac system of Escherichia coli, which allows the cell to use the sugar lactose for growth(12). We experimentally measured the growth burden(13,14) due to production and maintenance of the Lac proteins (cost), as well as the growth advantage (benefit) conferred by the Lac proteins when lactose is present. The fitness function, given by the difference between the benefit and the cost, predicts that for each lactose environment there exists an optimal Lac expression level that maximizes growth rate. We then performed serial dilution evolution experiments at different lactose concentrations. In a few hundred generations, cells evolved to reach the predicted optimal expression levels. Thus, protein expression from the lac operon seems to be a solution of a cost-benefit optimization problem, and can be rapidly tuned by evolution to function optimally in new environments.	Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	urialon@weizmann.ac.il	Yang, Chen/G-1379-2010					Bremer H, 1996, ESCHERICHIA COLI SAL; Conant GC, 2003, NAT GENET, V34, P264, DOI 10.1038/ng1181; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Dekel E, 2005, PHYS BIOL, V2, P81, DOI 10.1088/1478-3975/2/2/001; DYKHUIZEN DE, 1987, GENETICS, V115, P25; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Endy D, 2000, P NATL ACAD SCI USA, V97, P5375, DOI 10.1073/pnas.090101397; Fay JC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r26; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; HARTL DL, 1984, ANNU REV GENET, V18, P31, DOI 10.1146/annurev.ge.18.120184.000335; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Heinrich R., 1996, REGULATION CELLULAR; Honisch C, 2004, GENOME RES, V14, P2495, DOI 10.1101/gr.2977704; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; KOCH AL, 1983, J MOL EVOL, V19, P455, DOI 10.1007/BF02102321; Kremling A, 2001, METAB ENG, V3, P362, DOI 10.1006/mben.2001.0199; Liebermeister W, 2004, BIOSYSTEMS, V76, P261, DOI 10.1016/j.biosystems.2004.05.022; M_uller-Hill B., 1996, LAC OPERON SHORT HIS; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; NGUYEN TNM, 1989, MOL BIOL EVOL, V6, P213; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Rosen R., 1967, OPTIMALITY PRINCIPLE; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Smith J. M., 1997, MAJOR TRANSITIONS EV; Stephanopoulos G, 2001, SCIENCE, V292, P2024, DOI 10.1126/science.1062556; Wong P, 1997, BIOTECHNOL PROGR, V13, P132, DOI 10.1021/bp970003o; Yildirim N, 2004, CHAOS, V14, P279, DOI 10.1063/1.1689451; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999	30	519	522	2	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					588	592		10.1038/nature03842	http://dx.doi.org/10.1038/nature03842			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049495				2022-12-28	WOS:000230788800068
J	Olson, LM; Tang, SS; Newacheck, PW				Olson, LM; Tang, SS; Newacheck, PW			Children in the United States with discontinuous health insurance coverage	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOW-INCOME CHILDREN; MEDICAL HOME; CARE	BACKGROUND: Estimates of the number of uninsured people in the United States usually exclude those with discontinuous coverage. The effects of gaps in insurance coverage for children on access to and use of ambulatory care are poorly understood. METHODS: We analyzed a sample of 26,955 children under 18 years of age from the 2000 and 2001 National Health Interview Surveys. Children with discontinuous health insurance coverage were compared with those who were uninsured all year and with those who had public or private full-year coverage. RESULTS: During the last 12 months before they were interviewed, 6.6 percent of children in the United States had no insurance and an additional 7.7 percent had gaps in insurance. Children who had full-year insurance coverage (private or public) had low rates of unmet health care needs and good access to care (delayed care, unmet medical care, and unfilled prescriptions were reported in <3 percent, and <5 percent had no usual place of care). Access to care was much worse for children who were uninsured for part of the year and for those who were uninsured for the full year (delayed care, 20.2 percent and 15.9 percent, respectively; unmet medical care, 13.4 percent and 12.6 percent, respectively; unfilled prescriptions, 9.9 percent and 10.0 percent, respectively; P<0.01 for all comparisons with children with full-year, private insurance coverage). In multivariate analyses adjusting for age, income, race or ethnic group, region, citizenship, family structure, parental employment, and health status, the differences in access to care persisted. As compared with the parents of children with full-year, private insurance, parents of children uninsured for the full year were far more likely to report delaying care (adjusted odds ratio, 12.65; 95 percent confidence interval, 9.45 to 16.94), as were parents of children uninsured for part of the year (adjusted odds ratio, 13.65; 95 percent confidence interval, 10.41 to 17.90). CONCLUSIONS: Children with gaps in health insurance coverage commonly do not seek medical care, including preventive visits, and do not get prescriptions filled. These findings are important for both research and policy and point to the need for more encompassing and sensitive measures of the situation of being uninsured.	Acad Amer Pediat, Dept Res, Elk Grove Village, IL 60007 USA; Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	American Academy of Pediatrics; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Olson, LM (corresponding author), Acad Amer Pediat, Dept Res, 141 NW Point Blvd, Elk Grove Village, IL 60007 USA.	lolson@aap.org						Aday L A, 1974, Health Serv Res, V9, P208; Aiken KD, 2004, AMBUL PEDIATR, V4, P237, DOI 10.1367/A03-103R.1; BHANDARI S, 2004, PEOPLE HLTH INSURANC; CHOLLET DJ, SURVEY SURVEYS WHAT; Czajka JL., 1998, COUNTING UNINSURED R; DEY AN, 2002, SUMMARY STAT US CHIL; *DIV HLTH INT STAT, 2003, 2001 NHIS SURV DESCR; *DIV HLTHINT STAT, 2002, 2000 NHIS SURV DESCR; *KAIS COMM MED UN, HLTH INS COV AM 2002; Kempe A, 2000, PEDIATRICS, V105, P1020, DOI 10.1542/peds.105.5.1020; KOGAN MD, 1995, JAMA-J AM MED ASSOC, V274, P1429, DOI 10.1001/jama.274.18.1429; Moriarity CL, 2000, DESIGN ESTIMATION NA; National Center for Health Statistics, NAT HLTH INT SURV NH; Shah BV, 1996, SUDAAN USERS MANUAL; Short PF, 2003, HEALTH AFFAIR, V22, P244, DOI 10.1377/hlthaff.22.6.244; Sia CJ, 2002, PEDIATRICS, V110, P184; Starfield B, 2004, PEDIATRICS, V113, P1493; Starfield B, 1998, PRIMARY CARE BALANCI; Tang SFS, 2003, PEDIATRICS, V112, pE168, DOI 10.1542/peds.112.2.e168	19	184	184	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2005	353	4					382	391		10.1056/NEJMsa043878	http://dx.doi.org/10.1056/NEJMsa043878			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	949JW	16049210				2022-12-28	WOS:000230782800011
J	Rhodes, T; Simic, M				Rhodes, T; Simic, M			Transition and the HIV risk environment	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BOSNIA; HEALTH; VIOLENCE; CROATIA; WAR		Univ London Imperial Coll Sci Technol & Med, Ctr Res Drugs & Hlth Behav, London W6 8RP, England	Imperial College London	Rhodes, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Res Drugs & Hlth Behav, London W6 8RP, England.	t.rhodes@imperial.ac.uk	Manzotti, Grazia/C-5985-2008; Rhodes, Tim/DNJ-9679-2022	Rhodes, Tim/0000-0003-2400-9838				ARGOVINO T, 1997, LANCET, V350, P1757; BARNETT T, 1999, EUR J DEV RES, V11, P200; Blankenship KM, 2000, AIDS, V14, pS11, DOI 10.1097/00002030-200006001-00003; Carballo M, 2004, J BIOSOC SCI, V36, P463, DOI 10.1017/S0021932004006753; CARBALLO M, 1998, 12 WORLD AIDS C GEN; DJILAS A, 1993, FOREIGN AFF, V72, P81, DOI 10.2307/20045624; Duff CH, 1999, J EPIDEMIOL COMMUN H, V53, P578, DOI 10.1136/jech.53.9.578; *EUR BANK REC DEV, 2001, TRANS REP EN TRANS; *EUR ROM RIGHTS CT, 2002, ROM FUND RIGHTS FORM; Farmer Paul, 1996, WOMEN POVERTY AIDS S; GODINHO J, 2004, HIV AIDS W BALKANS P; Gordy Eric D., 1999, CULTURE POWER SERBIA; Horton R, 1999, LANCET, V353, P2223, DOI 10.1016/S0140-6736(99)06043-2; McKEE M., 2002, INT J DRUG POLICY, V13, P453; *MIN SOC AFF REP S, 2003, POV RED STRAT PAP S; Olujic MB, 1998, MED ANTHROPOL Q, V12, P31, DOI 10.1525/maq.1998.12.1.31; Pedersen D, 2002, SOC SCI MED, V55, P175, DOI 10.1016/S0277-9536(01)00261-1; Poundstone KE, 2004, EPIDEMIOL REV, V26, P22, DOI 10.1093/epirev/mxh005; PYLE GF, 1998, CROAT MED J, V39, P3; Rhodes T, 1999, ADDICTION, V94, P1323, DOI 10.1046/j.1360-0443.1999.94913235.x; Rhodes T, 1999, AIDS, V13, pS259; Rhodes T., 2004, International Journal of Drug Policy, V15, P1, DOI 10.1016/j.drugpo.2003.09.001; Rhodes T., 2002, INT J DRUG POLICY, V13, P85, DOI [10.1016/S0955-3959(02)00007-5, DOI 10.1016/S0955-3959(02)00007-5]; *UN DEV PROGR, 2003, BUILD BLOCKS REF FEC; *UN DEV PROGR, 1997, HUM DEV REP YUG; WONG T, 2002, RAPID ASSESSMENT SER	26	148	149	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2005	331	7510					220	223		10.1136/bmj.331.7510.220	http://dx.doi.org/10.1136/bmj.331.7510.220			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	951EA	16037463	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000230910700032
J	Ceballos, G; Ehrlich, PR; Soberon, J; Salazar, I; Fay, JP				Ceballos, G; Ehrlich, PR; Soberon, J; Salazar, I; Fay, JP			Global mammal conservation: What must we manage?	SCIENCE			English	Article							HUMAN-POPULATION; BIODIVERSITY; EXTINCTION; HOTSPOTS	We present a global conservation analysis for an entire "flagship" taxon, [and mammals. A combination of rarity, anthropogenic impacts, and political endemism has put about a quarter of terrestrial mammal species, and a larger fraction of their populations, at risk of extinction. A new global database and complementarity analysis for selecting priority areas for conservation shows that similar to 11% of Earth's land surface should be managed for conservation to preserve at least 10% of terrestrial mammal geographic ranges. Different approaches, from protection (or establishment) of reserves to countryside biogeographic enhancement of human-dominated landscapes, will be required to approach this minimal goal.	Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; Stanford Univ, Dept Biol Sci, Ctr Conservat Biol, Stanford, CA 94305 USA; Comis Nacl Biodivers, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Stanford University	Ceballos, G (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Apdo Postal 70-275, Mexico City 04510, DF, Mexico.	gcebatto@miranda.ecologia.unam.mx	Soberon, Jorge/ABF-1306-2021	Soberon, Jorge/0000-0003-2160-4148				Balmford A, 2001, SCIENCE, V291, P2616, DOI 10.1126/science.291.5513.2616; Brooks TM, 2004, BIOSCIENCE, V54, P1081, DOI 10.1641/0006-3568(2004)054[1081:CPBTGP]2.0.CO;2; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Daily G.C., 1997, NATURES SERVICES SOC, V1; Daily GC, 2003, CONSERV BIOL, V17, P1814, DOI 10.1111/j.1523-1739.2003.00298.x; Duff A, 2004, MAMMALS WORLD CHECKL; Ehrlich A., 2004, ONE NINEVEH POLITICS; Ehrlich P.R., 1981, EXTINCTION; *ESRI, 2002, ESRI DAT MAPS 2002; Gaston KJ, 2003, P ROY SOC B-BIOL SCI, V270, P1293, DOI 10.1098/rspb.2002.2303; Hughes JB, 1997, SCIENCE, V278, P689, DOI 10.1126/science.278.5338.689; IUCN, 2003, 2003 IUCN RED LIST T; Kareiva P, 2003, AM SCI, V91, P344, DOI 10.1511/2003.26.869; Liu JG, 2003, NATURE, V421, P530, DOI 10.1038/nature01359; Long AJ, 1996, GLOBAL ECOL BIOGEOGR, V5, P281, DOI 10.2307/2997796; Luck GW, 2003, TRENDS ECOL EVOL, V18, P331, DOI 10.1016/S0169-5347(03)00100-9; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McKee JK, 2004, BIOL CONSERV, V115, P161, DOI 10.1016/S0006-3207(03)00099-5; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Possingham Hugh, 2000, P291, DOI 10.1007/0-387-22648-6_17; Ramankutty N, 1999, GLOBAL ECOL BIOGEOGR, V8, P381, DOI 10.1046/j.1365-2699.1999.00141.x; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wikramanayake E, 2004, CONSERV BIOL, V18, P839, DOI 10.1111/j.1523-1739.2004.00145.x; World Bank, 2004, WORLD DEV IND 2004	28	209	220	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2005	309	5734					603	607		10.1126/science.1114015	http://dx.doi.org/10.1126/science.1114015			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040704				2022-12-28	WOS:000230735200046
J	Anderson, GF				Anderson, GF			Medicare and chronic conditions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RISK-ADJUSTMENT; CHRONIC CARE		Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Hosp Finance & Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Anderson, GF (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Hosp Finance & Management, Baltimore, MD USA.							*AG HEALTHC RES QU, 2001, 2001 MED EXP PAN SUR; Anderson G, 2001, HEALTH AFFAIR, V20, P146, DOI 10.1377/hlthaff.20.6.146; Anderson GF, 2003, ARCH INTERN MED, V163, P437, DOI 10.1001/archinte.163.4.437; ANDERSON GF, 2004, DOUGHNUT HOLES PRICE; BERENSON RA, 2003, CONFRONTING BARRIERS; Congressional Budget Office, 2004, AN LIT DIS MAN PROGR; CORRIGAN J, 2003, LEADERSHIP EXAMPLE C; *CTR MED MED SERV, 2005, MED HLTH SUPP; Darer JD, 2004, ACAD MED, V79, P541, DOI 10.1097/00001888-200406000-00009; Frank RG, 2004, NEW ENGL J MED, V351, P1375, DOI 10.1056/NEJMp048158; Hwang W, 2001, HEALTH AFFAIR, V20, P267, DOI 10.1377/hlthaff.20.6.267; *J HOPK U, PARTN SOL BETT LIV P; Kuttner R, 1998, NEW ENGL J MED, V339, P1952, DOI 10.1056/NEJM199812243392625; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; THORPE KE, 2004, WHICH MED CONDITIONS; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; WILLIAMS RD, 2004, 10 NAT AC SOC I; Wu SY, 2000, PROJECTION CHRONIC I	18	94	94	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2005	353	3					305	309		10.1056/NEJMsb044133	http://dx.doi.org/10.1056/NEJMsb044133			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YH	16034019				2022-12-28	WOS:000230608700015
J	Wilson, JF				Wilson, JF			Gene therapy yields to RNA interference	ANNALS OF INTERNAL MEDICINE			English	News Item							MICE					jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Ge Q, 2004, P NATL ACAD SCI USA, V101, P8676, DOI 10.1073/pnas.0402486101; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Ling XY, 2005, CANCER RES, V65, P2532, DOI 10.1158/0008-5472.CAN-04-2425; Shankar P, 2005, JAMA-J AM MED ASSOC, V293, P1367, DOI 10.1001/jama.293.11.1367; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Zhang Y, 2004, CLIN CANCER RES, V10, P3667, DOI 10.1158/1078-0432.CCR-03-0740	8	2	4	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2005	143	2					161	164		10.7326/0003-4819-143-2-200507190-00033	http://dx.doi.org/10.7326/0003-4819-143-2-200507190-00033			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YG	16027472				2022-12-28	WOS:000230608600025
J	Pittet, D				Pittet, D			Clean hands reduce the burden of disease	LANCET			English	Editorial Material							HYGIENE		Hop Univ Geneve, Infect Control Programme, CH-1211 Geneva, Switzerland; Fac Med, CH-1211 Geneva, Switzerland; WHO, World Alliance Patient Safety, Global Patient Safety Challenge, Geneva, Switzerland	University of Geneva; University of Geneva; World Health Organization	Pittet, D (corresponding author), Hop Univ Geneve, Infect Control Programme, CH-1211 Geneva, Switzerland.	didier.pittet@hcuge.ch						Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; *I HEALTHC IMPR, 100K LIV CAMP SOM IS; Lee GM, 2005, PEDIATRICS, V115, P852, DOI 10.1542/peds.2004-0856; Luby S, 2001, Int J Infect Dis, V5, P144, DOI 10.1016/S1201-9712(01)90089-X; Luby SP, 2005, LANCET, V366, P225, DOI 10.1016/S0140-6736(05)66912-7; Luby SP, 2005, JAMA-J AM MED ASSOC, V291, P2547; Marsh D, 1995, HEALTH POLICY PLANN, V10, P395, DOI 10.1093/heapol/10.4.395; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; *ORLD ALL PAT SAF, 2005, GLOB PAT SAF CHALL 2; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 2004, J HOSP INFECT, V58, P1, DOI 10.1016/j.jhin.2004.06.002; Pittet D, 2004, ANN INTERN MED, V141, P1, DOI 10.7326/0003-4819-141-1-200407060-00008; Pittet D, 2001, LANCET, P9; Pittet D, 2004, INFECT CONT HOSP EP, V25, P264, DOI 10.1086/502389; *WHO, 2005, PAT SAF WORLD ALL PA; 2005, INT DECADE ACTION WA; BASIC SUPPORT I CHIL	18	27	28	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2005	366	9481					185	187		10.1016/S0140-6736(05)66886-9	http://dx.doi.org/10.1016/S0140-6736(05)66886-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945RG	16023493				2022-12-28	WOS:000230519200007
J	Fetler, L; Amigorena, S				Fetler, L; Amigorena, S			Brain under surveillance: The microglia patrol	SCIENCE			English	Editorial Material							IN-VIVO		Inst Curie, Lab Physicochim Curie, CNRS, UMR 168, F-75245 Paris, France; Inst Curie, INSERM, U365, F-75245 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Fetler, L (corresponding author), Inst Curie, Lab Physicochim Curie, CNRS, UMR 168, 26 Rue Ulm, F-75245 Paris, France.	luc.fetler@curie.fr; sebastian.amigorena@curie.fr	Fetler, luc/M-9034-2018	Amigorena, Sebastian/0000-0001-8583-8416				Backskai BJ, 2001, NAT MED, V7, P369, DOI 10.1038/85525; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	5	115	126	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					392	393		10.1126/science.1114852	http://dx.doi.org/10.1126/science.1114852			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020721				2022-12-28	WOS:000230574900031
J	Morel, CM; Acharya, T; Broun, D; Dang, AJ; Elias, C; Ganguly, NK; Gardner, CA; Gupta, RK; Haycock, J; Heher, AD; Hotez, PJ; Kettler, HE; Keusch, GT; Krattiger, AF; Kreutz, FT; Lall, S; Lee, K; Mahoney, R; Martinez-Palomo, A; Mashelkar, RA; Matlin, SA; Mzimba, M; Oehler, J; Ridley, RG; Pramilla, S; Singer, P; Yun, MY				Morel, CM; Acharya, T; Broun, D; Dang, AJ; Elias, C; Ganguly, NK; Gardner, CA; Gupta, RK; Haycock, J; Heher, AD; Hotez, PJ; Kettler, HE; Keusch, GT; Krattiger, AF; Kreutz, FT; Lall, S; Lee, K; Mahoney, R; Martinez-Palomo, A; Mashelkar, RA; Matlin, SA; Mzimba, M; Oehler, J; Ridley, RG; Pramilla, S; Singer, P; Yun, MY			Health innovation networks to help developing countries address neglected diseases	SCIENCE			English	Editorial Material								Gross inequities in disease burden between developed and developing countries are now the subject of intense global attention. Public and private donors have marshaled resources and created organizational structures to accelerate the development of new health products and to procure and distribute drugs and vaccines for the poor. Despite these encouraging efforts directed primarily from and funded by industrialized countries, sufficiency and sustainability remain enormous challenges because of the sheer magnitude of the problem. Here we highlight a complementary and increasingly important means to improve health equity: the growing ability of some developing countries to undertake health innovation.	Fiocruz MS, Ctr Technol Dev Hlth, BR-21040900 Rio De Janeiro, Brazil; Joint United Nations Programme HIV AIDS, New Delhi 110003, India; Org Pharmaceut Producers India, Peninsula Chambers, Bombay 400013, Maharashtra, India; Program Appropriate Technol Hlth, Seattle, WA 98107 USA; Indian Council Med Res, New Delhi 110029, India; Rockefeller Fdn, New York, NY 10018 USA; CSIR, Intellectual Property Management Div, New Delhi 110067, India; Mission United Kingdon United Nations, New York, NY 10017 USA; Univ Cape Town, Res & Innovat House, ZA-7701 Cape Town, South Africa; George Washington Univ, Dept Microbiol & Trop Med, Washington, DC 20037 USA; Bill & Melinda Gates Fdn, Seattle, WA 98102 USA; Boston Univ, Boston, MA 02118 USA; Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; Univ Fed Rio Grande do Sul, FK Biotecnol, BR-91501970 Porto Alegre, RS, Brazil; Univ Oxford, Oxford OX1 3LA, England; Seoul Natl Univ, Dept Econ, Seoul 151742, South Korea; Minist Hlth, Mexico City 01900, DF, Mexico; CSIR, New Delhi 110001, India; Global Forum Hlth Res, CH-1211 Geneva, Switzerland; S African Embassy, Dept Sci & Technol, B-1040 Brussels, Belgium; Concept Fdn, Klongluang 12120, Pathumthani, Thailand; WHO, Trop Dis Res Program, CH-1211 Geneva, Switzerland; Global Forum Hlth Res, Colombo 2, Sri Lanka; Univ Toronto, Toronto, ON M5G 1L4, Canada; Korea Inst Int Econ Policy, Seoul 137747, South Korea	Center for Technological Development in Health (CDTS); Fundacao Oswaldo Cruz; Indian Council of Medical Research (ICMR); Council of Scientific & Industrial Research (CSIR) - India; University of Cape Town; George Washington University; Bill & Melinda Gates Foundation; Boston University; Arizona State University; Arizona State University-Tempe; Universidade Federal do Rio Grande do Sul; University of Oxford; Seoul National University (SNU); Council of Scientific & Industrial Research (CSIR) - India; World Health Organization; University of Toronto; Korea Institute for International Economic Policy (KIEP)	Morel, CM (corresponding author), Fiocruz MS, Ctr Technol Dev Hlth, Ave Brasil 4365, BR-21040900 Rio De Janeiro, Brazil.	morel@fiocruz.br	Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019; Morel, Carlos/AHD-9349-2022; Lee, Keun/AAU-8046-2020	Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009; Lee, Keun/0000-0002-0403-6348; /0000-0001-5724-2965; Hotez, Peter/0000-0001-8770-1042				BALE HE, 2000, WG43 WHO CMH; Dahlman C.J., 1995, SOCIAL CAPABILITY LO, P82, DOI [10.1007/978-1-349-13512-7_5, DOI 10.1007/978-1-349-13512-7]; Edquist C., 2001, SYSTEMS INNOVATION D; Grace C, 2004, EFFECT CHANGING INTE; Hotez PJ, 2005, PLOS MED, V2, P187, DOI 10.1371/journal.pmed.0020067; *HOUS COMM, 2004, US SCI UK INT DEV PO; Juma C, 2001, INT J TECHNOL MANAGE, V22, P629, DOI 10.1504/IJTM.2001.002982; Kettler HE, 2001, B WORLD HEALTH ORGAN, V79, P742; King DA, 2004, NATURE, V430, P311, DOI 10.1038/430311a; LEVI GC, 2002, J ACQ IMMUN DEF SYND, V16, P2373; MASHELKAR RA, UNPUB; *MEX STAT HLTH RES, STRENGTH HLTH SYST; *MIN HLTH BRAZ, SCAL INT RESP AIDS B; Morel C., 2005, INNOVATION STRATEGY, V1, P1; *ORG PHARM PROD IN, 2003, OUTS OPP IND PHARM I, P24; Pereira JCR, 2004, REV SAUDE PUBL, V38, P1, DOI 10.1590/S0034-89102004000100001; Prahalad C.K., 2008, MCKINSEY BRIEFING NO, V36, P52; SAHA R, 2004, IP STRATEGY TODAY, V9, P23; THORSTEINSDOTTI.H, COMMUNICATION; *UN MILL PROJ UN D, 2004, INT REP TASK FORC 10; WIDDUS R, COMBATING DIS ASS PO; *WORLD BANK, 2005, WORLD DEV REP, pCH3; World Health Organization, 2001, MACR HLTH INV HLTH E; 2004, NAT BIOTECHNOL S, V22; 2002, FINANCIAL TIMES 0614; 2004, MONITORING FINANCIAL, V2, P14	26	129	133	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					401	404		10.1126/science.1115538	http://dx.doi.org/10.1126/science.1115538			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020723	Green Submitted, Green Published			2022-12-28	WOS:000230574900033
J	Loma-Sanner, I; Kang, EY; Sepehrdad, S; Goldstein, SL; Herman, MS; Accardo, PJ; Green, PHR; Roseman, B				Loma-Sanner, I; Kang, EY; Sepehrdad, S; Goldstein, SL; Herman, MS; Accardo, PJ; Green, PHR; Roseman, B			A floppy child with failure to thrive	LANCET			English	Editorial Material							CELIAC-DISEASE		Westchester Med Ctr, Dept Pediat, Valhalla, NY 10595 USA; New York Med Coll, Valhalla, NY 10595 USA; Westchester Celiac Sprue Support Grp, White Plains, NY USA; Virginia Commonwealth Univ, Richmond, VA USA; Coll Phys & Surg, New York, NY USA	Westchester Medical Center; New York Medical College; Virginia Commonwealth University	Loma-Sanner, I (corresponding author), Westchester Med Ctr, Dept Pediat, Valhalla, NY 10595 USA.	Ingrid_loma@nymc.edu						Chin RL, 2003, NEUROLOGY, V60, P1581, DOI 10.1212/01.WNL.0000063307.84039.C7; D'Amico MA, 2005, CLIN PEDIATR, V44, P249, DOI 10.1177/000992280504400309; Murray JA, 2003, CLIN GASTROENTEROL H, V1, P19, DOI 10.1053/jcgh.2003.50004; Polizzi A, 2000, J NEUROL NEUROSUR PS, V68, P104, DOI 10.1136/jnnp.68.1.104; Volta U, 2002, SCAND J GASTROENTERO, V37, P1276, DOI 10.1080/003655202761020542	5	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2005	366	9480					176	176		10.1016/S0140-6736(05)66877-8	http://dx.doi.org/10.1016/S0140-6736(05)66877-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	943JH	16005344				2022-12-28	WOS:000230349200040
J	Hosoya, T; Baccus, SA; Meister, M				Hosoya, T; Baccus, SA; Meister, M			Dynamic predictive coding by the retina	NATURE			English	Article							HUMAN VISUAL-SYSTEM; CONTRAST ADAPTATION; SALAMANDER RETINA; GANGLION-CELLS; TEMPORAL CONTRAST; NEURAL CODE; IMAGES; INHIBITION; ORIENTATION; STATISTICS	Retinal ganglion cells convey the visual image from the eye to the brain. They generally encode local differences in space and changes in time rather than the raw image intensity. This can be seen as a strategy of predictive coding, adapted through evolution to the average image statistics of the natural environment. Yet animals encounter many environments with visual statistics different from the average scene. Here we show that when this happens, the retina adjusts its processing dynamically. The spatio-temporal receptive fields of retinal ganglion cells change after a few seconds in a new environment. The changes are adaptive, in that the new receptive field improves predictive coding under the new image statistics. We show that a network model with plastic synapses can account for the large variety of observed adaptations.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Harvard University; Stanford University	Meister, M (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	meister@fas.harvard.edu	Hosoya, Toshihiko/Q-2514-2018	Hosoya, Toshihiko/0000-0001-8559-8344; Meister, Markus/0000-0003-2136-6506				Aizenman CD, 2000, PROG BRAIN RES, V124, P257; ATICK JJ, 1992, NEURAL COMPUT, V4, P196, DOI 10.1162/neco.1992.4.2.196; Baccus SA, 2004, NEURON, V42, P5, DOI 10.1016/S0896-6273(04)00187-4; BARLOW H, 1989, COMP NEUR S, P54; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; Bell CC, 2001, CURR OPIN NEUROBIOL, V11, P481, DOI 10.1016/S0959-4388(00)00238-5; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Blakemore C., 2010, VISION CODING EFFICI, P363, DOI 10.1017/cbo9780511626197.034; BLOOMFIELD SA, 1994, J NEUROPHYSIOL, V71, P1672, DOI 10.1152/jn.1994.71.5.1672; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Cook PB, 1998, J NEUROSCI, V18, P2301; Cook PB, 1998, NAT NEUROSCI, V1, P714, DOI 10.1038/3714; Cook PB, 2000, J NEUROSCI, V20, P806, DOI 10.1523/JNEUROSCI.20-02-00806.2000; DEVALOIS KK, 1977, VISION RES, V17, P1057, DOI 10.1016/0042-6989(77)90010-4; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P345, DOI 10.1088/0954-898X/6/3/003; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; Graham N.V.S, 1989, VISUAL PATTERN ANAL; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MOLLON JD, 1977, PERCEPTUAL WORLD, P71; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; Schnitzer MJ, 2003, NEURON, V37, P499, DOI 10.1016/S0896-6273(03)00004-7; Shapley R.M., 1984, PROG RETIN RES, V3, P263, DOI [DOI 10.1016/0278-4327(84)90011-7, 10.1016/0278-4327(84)90011-7]; Snippe HP, 2004, J VISION, V4, P1, DOI 10.1167/4.1.1; SNOWDEN RJ, 1992, NATURE, V355, P248, DOI 10.1038/355248a0; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; VANHATEREN JH, 1992, NATURE, V360, P68, DOI 10.1038/360068a0; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; YANG CY, 1991, J COMP NEUROL, V312, P19, DOI 10.1002/cne.903120103	38	312	321	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					71	77		10.1038/nature03689	http://dx.doi.org/10.1038/nature03689			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001064				2022-12-28	WOS:000230296600041
J	Imai, Y; Kuba, K; Rao, S; Huan, Y; Guo, F; Guan, B; Yang, P; Sarao, R; Wada, T; Leong-Poi, H; Crackower, MA; Fukamizu, A; Hui, CC; Hein, L; Uhlig, S; Slutsky, AS; Jiang, CY; Penninger, JM				Imai, Y; Kuba, K; Rao, S; Huan, Y; Guo, F; Guan, B; Yang, P; Sarao, R; Wada, T; Leong-Poi, H; Crackower, MA; Fukamizu, A; Hui, CC; Hein, L; Uhlig, S; Slutsky, AS; Jiang, CY; Penninger, JM			Angiotensin-converting enzyme 2 protects from severe acute lung failure	NATURE			English	Article							ACUTE RESPIRATORY SYNDROME; DISTRESS-SYNDROME; FUNCTIONAL RECEPTOR; SARS CORONAVIRUS; DEFICIENT MICE; HONG-KONG; EXPRESSION; IDENTIFICATION; REGULATOR; CLONING	Acute respiratory distress syndrome (ARDS), the most severe form of acute lung injury, is a devastating clinical syndrome with a high mortality rate (30-60%) (refs 1-3). Predisposing factors for ARDS are diverse(1,3) and include sepsis, aspiration, pneumonias and infections with the severe acute respiratory syndrome (SARS) corona-virus(4,5). At present, there are no effective drugs for improving the clinical outcome of ARDS(1-3). Angiotensin-converting enzyme (ACE) and ACE2 are homologues with different key functions in the renin-angiotensin system(6-8). ACE cleaves angiotensin I to generate angiotensin II, whereas ACE2 inactivates angiotensin II and is a negative regulator of the system. ACE2 has also recently been identified as a potential SARS virus receptor and is expressed in lungs(9,10). Here we report that ACE2 and the angiotensin II type 2 receptor (AT(2)) protect mice from severe acute lung injury induced by acid aspiration or sepsis. However, other components of the renin-angiotensin system, including ACE, angiotensin II and the angiotensin II type 1a receptor (AT(1)a), promote disease pathogenesis, induce lung oedemas and impair lung function. We show that mice deficient for Ace show markedly improved disease, and also that recombinant ACE2 can protect mice from severe acute lung injury. Our data identify a critical function for ACE2 in acute lung injury, pointing to a possible therapy for a syndrome affecting millions of people worldwide every year.	Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100005, Peoples R China; Peking Union Med Coll, Beijing 100005, Peoples R China; St Michaels Hosp, Dept Cardiol, Toronto, ON M5B 1W8, Canada; Merck Frosst Ctr Therapeut Res, Dept Biochem & Mol Biol, Montreal, PQ H3R 4P8, Canada; Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan; Hosp Sick Children, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1X8, Canada; Univ Freiburg, Dept Pharmacol, D-79104 Freiburg, Germany; Res Ctr Borstel, Div Pulm Pharmacol, D-23845 Borstel, Germany; Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; Univ Toronto, St Michaels Hosp, Interdepartmental Div Crit Care, Toronto, ON M5B 1W8, Canada	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Merck & Company; University of Tsukuba; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Freiburg; Forschungszentrum Borstel; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Penninger, JM (corresponding author), Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria.	Josef.penninger@imba.oeaw.ac.at	Imai, Yumiko/GXW-1144-2022; Uhlig, Stefan/A-7290-2014; Slutsky, Arthur S/A-6013-2008; fukamizu, akiyoshi/J-5350-2012; Slutsky, Arthur/M-3325-2019; Penninger, Josef/I-6860-2013	Uhlig, Stefan/0000-0003-2332-1280; Slutsky, Arthur S/0000-0002-6063-3876; fukamizu, akiyoshi/0000-0002-8786-6020; Rao, Shuan/0000-0002-5268-7006; Guo, Feng/0000-0002-4506-7618; Penninger, Josef/0000-0002-8194-3777				Boehm M, 2002, NEW ENGL J MED, V347, P1795, DOI 10.1056/NEJMcibr022472; CORVOL P, 1995, METHOD ENZYMOL, V248, P283; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; GASC JM, 1994, HYPERTENSION, V24, P531, DOI 10.1161/01.HYP.24.5.531; Goggel R, 2004, NAT MED, V10, P155, DOI 10.1038/nm977; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; HANSEN TN, 1985, J APPL PHYSIOL, V58, P812, DOI 10.1152/jappl.1985.58.3.812; HEIN L, 1995, NATURE, V377, P744, DOI 10.1038/377744a0; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182; Imai Y, 2003, JAMA-J AM MED ASSOC, V289, P2104, DOI 10.1001/jama.289.16.2104; INAGAMI T, 1995, ADV EXP MED BIOL, V377, P311; KREGE JH, 1995, NATURE, V375, P146, DOI 10.1038/375146a0; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Marshall RP, 2002, AM J RESP CRIT CARE, V166, P646, DOI 10.1164/rccm.2108086; Martin EL, 2003, AM J PHYSIOL-LUNG C, V285, pL1222, DOI 10.1152/ajplung.00141.2003; Nagase T, 2000, NAT IMMUNOL, V1, P42, DOI 10.1038/76897; Plante GE, 1996, CAN J PHYSIOL PHARM, V74, P824, DOI 10.1139/cjpp-74-7-824; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Roy BJ, 1996, AM J PHYSIOL-HEART C, V271, pH222, DOI 10.1152/ajpheart.1996.271.1.H222; Skeggs L T, 1980, Adv Exp Med Biol, V130, P1; SUGAYA T, 1995, J BIOL CHEM, V270, P18719, DOI 10.1074/jbc.270.32.18719; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; Vincent JL, 2003, CRIT CARE MED, V31, pS296, DOI 10.1097/01.CCM.0000057906.89552.8F; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806	30	1670	1818	13	182	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					112	116		10.1038/nature03712	http://dx.doi.org/10.1038/nature03712			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001071	Bronze, Green Published			2022-12-28	WOS:000230296600049
J	Holzapfel, C; Rubie, DC; Frost, DJ; Langenhorst, F				Holzapfel, C; Rubie, DC; Frost, DJ; Langenhorst, F			Fe-Mg interdiffusion in (Mg,Fe)SiO3 perovskite and lower mantle reequilibration	SCIENCE			English	Article							DIFFUSION; PHASE; DISCONTINUITY; CONSTRAINTS; MECHANISMS; PRESSURE; MGSIO3; RATES	Fe-Mg interdiffusion coefficients for (Mg,Fe)SiO3 perovskite have been measured at pressures of 22 to 26 gigapascals and temperatures between 1973 and 2273 kelvin. Perovskite Fe-Mg interdiffusion is as slow as Si self-diffusion and is orders of magnitude slower than Fe-Mg diffusion in other mantle minerals. Length scales over which chemical heterogeneities can homogenize, throughout the depth range of the lower mantle, are limited to a few meters even on time scales equivalent to the age of Earth. Heterogeneities can therefore only equilibrate chemically when they are stretched and thinned by intense deformation.	Univ Bayreuth, Bayer Geoinst, D-95440 Bayreuth, Germany; Univ Jena, Inst Geowissensch, D-07749 Jena, Germany	University of Bayreuth; Friedrich Schiller University of Jena	Holzapfel, C (corresponding author), Univ Saarland, Inst Werkstoffwissensch, Postfach 15 11 50, D-66041 Saarbrucken, Germany.	c.holzapfel@mx.uni-saarland.de	Frost, Daniel J/B-7526-2016	Frost, Daniel J/0000-0002-4443-8149; Langenhorst, Falko/0000-0003-4892-7713				Chakraborty S, 1997, J GEOPHYS RES-SOL EA, V102, P12317, DOI 10.1029/97JB00208; Chakraborty S, 1996, CONTRIB MINERAL PETR, V122, P406, DOI 10.1007/s004100050136; Chakraborty S, 1999, SCIENCE, V283, P362, DOI 10.1126/science.283.5400.362; Crank J., 1975, MATH DIFFUSION; Dohmen R, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015480; Frost DJ, 2004, NATURE, V428, P409, DOI 10.1038/nature02413; HASHIN Z, 1962, J APPL PHYS, V33, P3125, DOI 10.1063/1.1728579; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; Holzapfel C, 2003, PHYS EARTH PLANET IN, V139, P21, DOI 10.1016/S0031-9201(03)00142-0; HOLZAPFEL C, 2004, THESIS U COLOGNE; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; Nishiyama N, 2004, PHYS EARTH PLANET IN, V143, P185, DOI 10.1016/j.pepi.2003.08.010; Oganov AR, 2004, NATURE, V430, P445, DOI 10.1038/nature02701; Ono S, 2001, EARTH PLANET SC LETT, V190, P57, DOI 10.1016/S0012-821X(01)00375-2; Poirier J.-P., 2000, INTRO PHYS EARTHS IN; Shim SH, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019639; Solomatov VS, 2002, PHYS EARTH PLANET IN, V129, P265, DOI 10.1016/S0031-9201(01)00295-3; van Keken P. E., 2003, TREATISE GEOCHEMISTR, V2, P471; van Keken PE, 2002, ANNU REV EARTH PL SC, V30, P493, DOI 10.1146/annurev.earth.30.091201.141236; Van Orman JA, 2001, CONTRIB MINERAL PETR, V141, P687, DOI 10.1007/s004100100269; Van Orman JA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016343; WRIGHT K, 1993, J GEOPHYS RES-SOL EA, V98, P22245, DOI 10.1029/93JB01098; Yamazaki D, 2000, PHYS EARTH PLANET IN, V119, P299, DOI 10.1016/S0031-9201(00)00135-7	23	107	108	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2005	309	5741					1707	1710		10.1126/science.1111895	http://dx.doi.org/10.1126/science.1111895			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16051751				2022-12-28	WOS:000231836700039
J	Ihee, H; Lorenc, M; Kim, TK; Kong, QY; Cammarata, M; Lee, JH; Bratos, S; Wulff, M				Ihee, H; Lorenc, M; Kim, TK; Kong, QY; Cammarata, M; Lee, JH; Bratos, S; Wulff, M			Ultrafast x-ray diffraction of transient molecular structures in solution	SCIENCE			English	Article							RADICALS; CRYSTALLOGRAPHY	We report direct structural evidence of the bridged radical (CH(2)ICH(2)center dot) in a polar solution, obtained using time-resolved liquid-phase x-ray diffraction. This transient intermediate has long been hypothesized to explain stereochemical control in many association and/or dissociation reactions involving haloalkanes. Ultrashort optical pulses were used to dissociate an iodine atom from the haloethane molecule (C2H4I2) dissolved in methanol, and the diffraction of picosecond x-ray pulses from a synchrotron supports the following structural dynamics, with similar to 0.01 angstrom spatial resolution and similar to 100 picosecond time resolution: The loss of one iodine atom from C2H4I2 leads to the C-I-C triangular geometry of CH(2)ICH(2)center dot. This transient C2H4I then binds to an iodine atom to form a new species, the C2H4I-I isomer, which eventually decays into C2H4+I-2. Solvent dynamics were also extracted from the data, revealing a change in the solvent cage geometry, heating, and thermal expansion.	Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea; Korea Adv Inst Sci & Technol, Sch Mol Sci BK21, Taejon 305701, South Korea; European Synchrotron Radiat Facil, F-38043 Grenoble, France; Natl Inst Phys Matter, I-90123 Palermo, Italy; Dept Phys & Astron Sci, I-90123 Palermo, Italy; Univ Paris 06, Phys Theor Liquides Lab, F-75252 Paris, France	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); European Synchrotron Radiation Facility (ESRF); Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); UDICE-French Research Universities; Sorbonne Universite	Ihee, H (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea.	hyotcherl_ihee@kaist.ac.kr	Cammarata, Marco/C-2322-2008; Lorenc, Maciej/N-7594-2014; KIM, TAE KYU/A-8737-2016; Ihee, Hyotcherl/C-1614-2011	Cammarata, Marco/0000-0003-3013-1186; KIM, TAE KYU/0000-0002-9578-5722; 				ADITYA S, 1957, J AM CHEM SOC, V79, P2680, DOI 10.1021/ja01568a005; Allen M. P., 1989, COMPUTER SIMULATION; BECKWITH ALJ, 1980, REARRANGEMENTS GROUN, V1, P273; Bernardi F., 1988, J MOL STRUC-THEOCHEM, V180, P79; Bowles AJ, 1970, CHEM PHYS LETT, V5, P552, DOI 10.1016/0009-2614(70)85043-6; Bratos S, 2004, CHEM PHYS, V304, P245, DOI 10.1016/j.chemphys.2004.06.065; Dudek RC, 2001, J PHYS CHEM A, V105, P4167, DOI 10.1021/jp010122t; EDGE DJ, 1972, J AM CHEM SOC, V94, P6485, DOI 10.1021/ja00773a036; ENGELS B, 1986, J MOL STRUC-THEOCHEM, V138, P59; Fossey J, 1995, FREE RADICALS ORGANI; Gnanakaran S, 2001, J AM CHEM SOC, V123, P12886, DOI 10.1021/ja011088z; GOERING HL, 1952, J AM CHEM SOC, V74, P3588, DOI 10.1021/ja01134a035; Ihee H, 2001, SCIENCE, V291, P458, DOI 10.1126/science.291.5503.458; Ihee H, 1999, J PHYS CHEM A, V103, P6638, DOI 10.1021/jp990867n; Kochi J. K., 1973, FREE RADICALS, VII; Paul Maj S., 1984, CHEM COMMUN, P561; Plech A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.125505; Rasmusson M, 2002, J PHYS CHEM A, V106, P7090, DOI 10.1021/jp020720n; Rischel C, 1997, NATURE, V390, P490, DOI 10.1038/37317; Rose-Petruck C, 1999, NATURE, V398, P310, DOI 10.1038/18631; Ruan CY, 2004, SCIENCE, V304, P80, DOI 10.1126/science.1094818; Schotte F, 2003, SCIENCE, V300, P1944, DOI 10.1126/science.1078797; Siders CW, 1999, SCIENCE, V286, P1340, DOI 10.1126/science.286.5443.1340; Siwick BJ, 2003, SCIENCE, V302, P1382, DOI 10.1126/science.1090052; SKELL PS, 1963, J AM CHEM SOC, V85, P2849, DOI 10.1021/ja00901a038; THALER W, 1963, J AM CHEM SOC, V85, P2607, DOI 10.1021/ja00900a019; Tomov IV, 1999, J PHYS CHEM B, V103, P7081, DOI 10.1021/jp9908449; Vakhtin AB, 2003, J PHYS CHEM A, V107, P10055, DOI 10.1021/jp030230a	28	195	197	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 19	2005	309	5738					1223	1227		10.1126/science.1114782	http://dx.doi.org/10.1126/science.1114782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957TE	16020695				2022-12-28	WOS:000231395400040
J	Hickey, M; Davis, SR; Sturdee, DW				Hickey, M; Davis, SR; Sturdee, DW			Treatment of menopausal symptoms: what shall we do now?	LANCET			English	Review							HORMONE-REPLACEMENT THERAPY; ESTROGEN PLUS PROGESTIN; VENOUS THROMBOEMBOLIC DISEASE; HEALTHY POSTMENOPAUSAL WOMEN; CONJUGATED EQUINE ESTROGENS; MILD COGNITIVE IMPAIRMENT; CORONARY-HEART-DISEASE; LONG-TERM TREATMENT; BREAST-CANCER; HOT FLASHES	During the past few years, many women and doctors have revised their opinions of hormone replacement therapy (HRT) for menopausal symptoms, and a substantial number of individuals have discontinued its use because of concerns about side-effects. Numerous alternatives to HRT are promoted, and assessment of the quality of evidence about the safety and effectiveness of these compounds can be difficult. In this Review, we summarise the data from studies addressing the efficacy, risks, and benefits of frequently prescribed treatments, and offer evidence-based clinical guidelines for the management of menopausal symptoms. Although few comparative studies exist, oestrogen alone or combinations of oestrogen and progestagen are likely to be the most effective treatments for menopausal hot flushes and vaginal dryness. Tibolone is as effective as HRT, however, and might also improve libido. For those who wish to avoid hormonal treatments, there are few effective options. Selective serotonin reuptake inhibitors might be effective in the very short term (less than 12 weeks) and are well tolerated. There is not enough evidence that any of the complementary therapies available are any better than placebo for menopausal vasomotor symptoms, and few safety data exist.	Univ Western Australia, Sch Womens & Infants Hlth, King Edward Mem Hosp, Subiaco, WA 6008, Australia; Alfred Hosp, Monash Med Sch, Dept Med, Womens Hlth Programme, Prahran, Vic 3181, Australia; Heart England NHS Fdn Trust, Solihull Hosp, Dept Womens Hlth, Solihull, W Midlands, England	King Edward Memorial Hospital; University of Western Australia; Florey Institute of Neuroscience & Mental Health; Monash University; Heart of England NHS Foundation Trust	Hickey, M (corresponding author), Univ Western Australia, Sch Womens & Infants Hlth, King Edward Mem Hosp, Subiaco, WA 6008, Australia.	mhickey@obsgyn.uwa.edu.au	Davis, Susan D/GZL-2361-2022; Davis, Susan R/A-3111-2009; Sturdee, David/ABF-9792-2020	Davis, Susan R/0000-0002-2955-0415; Hickey, Martha/0000-0002-3941-082X				Aiello EJ, 2004, MENOPAUSE, V11, P382, DOI 10.1097/01.GME.0000113932.56832.27; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Anderson IM, 2000, J AFFECT DISORDERS, V58, P19, DOI 10.1016/S0165-0327(99)00092-0; ANDREWS H, 2004, J R COLL PHYS ED S13, V34, P2; ANTUNES CMF, 1979, NEW ENGL J MED, V300, P9, DOI 10.1056/NEJM197901043000103; ARCHER D, 2004, N AM MENOPAUSE SOC, V11, P589; ASLAKSEN K, 1982, ACTA OBSTET GYN SCAN, V61, P423, DOI 10.3109/00016348209156584; Bachmann GA, 1998, AM J OBSTET GYNECOL, V178, pS257, DOI 10.1016/S0002-9378(98)70558-7; Bagger YZ, 2004, BONE, V34, P728, DOI 10.1016/j.bone.2003.12.021; BAKER VL, 1994, OBSTET GYN CLIN N AM, V21, P271; Banks E, 2004, BMJ-BRIT MED J, V328, P1291, DOI 10.1136/bmj.328.7451.1291; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Barton DL, 1998, J CLIN ONCOL, V16, P495, DOI 10.1200/JCO.1998.16.2.495; Beral V, 2005, LANCET, V365, P1543, DOI 10.1016/S0140-6736(05)66455-0; Beral V, 2002, LANCET, V360, P942, DOI 10.1016/S0140-6736(02)11032-4; Beresford SAA, 1997, LANCET, V349, P458, DOI 10.1016/S0140-6736(96)07365-5; Biglia N, 2003, MATURITAS, V45, P29, DOI 10.1016/S0378-5122(03)00087-2; Bjarnason K, 1999, MATURITAS, V32, P161, DOI 10.1016/S0378-5122(99)00033-X; Bolego C, 2003, CURR DRUG TARGETS, V4, P77, DOI 10.2174/1389450033347000; Boothby LA, 2004, MENOPAUSE, V11, P356, DOI 10.1097/01.GME.0000094356.92081.EF; Borrelli F, 2002, EUR J CLIN PHARMACOL, V58, P235, DOI 10.1007/s00228-002-0457-2; Brown JS, 2001, OBSTET GYNECOL, V98, P1045, DOI 10.1016/S0029-7844(01)01630-1; Bruce D, 2004, CLIMACTERIC, V7, P261, DOI 10.1080/13697130410001713805; Burger HG, 2000, J CLIN ENDOCR METAB, V85, P2832, DOI 10.1210/jc.85.8.2832; Burkhardt MS, 2004, J ALZHEIMERS DIS, V6, P221; Bygdeman M, 1996, MATURITAS, V23, P259, DOI 10.1016/0378-5122(95)00955-8; CALLE EE, 1995, J NATL CANCER I, V87, P517, DOI 10.1093/jnci/87.7.517; Cardozo L, 1998, OBSTET GYNECOL, V92, P722, DOI 10.1016/S0029-7844(98)00175-6; Carlson MC, 2001, NEUROLOGY, V57, P2210, DOI 10.1212/WNL.57.12.2210; CAULEY JA, 1995, ANN INTERN MED, V122, P9, DOI 10.7326/0003-4819-122-1-199501010-00002; Cherry N, 2002, LANCET, V360, P2001; Clarke SC, 2002, BJOG-INT J OBSTET GY, V109, P1056, DOI 10.1111/j.1471-0528.2002.01544.x; COLDITZ GA, 1995, NEW ENGL J MED, V332, P1589, DOI 10.1056/NEJM199506153322401; Crisafulli A, 2004, MENOPAUSE, V11, P400, DOI 10.1097/01.GME.0000109314.11228.E5; CRITCHLEY H, 2004, P 47 RCOG STUD GROUP; CUMMINGS SR, 1989, ARCH INTERN MED, V149, P2445, DOI 10.1001/archinte.149.11.2445; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Cushman M, 2004, JAMA-J AM MED ASSOC, V292, P1573, DOI 10.1001/jama.292.13.1573; DAVID A, 1988, AM J OBSTET GYNECOL, V158, P1107, DOI 10.1016/0002-9378(88)90230-X; DAVIS SR, 1995, MATURITAS, V21, P227, DOI 10.1016/0378-5122(94)00898-H; Davis SR, 1999, RECENT PROG HORM RES, V54, P185; Dennerstein L, 2004, MENOPAUSE, V11, P563, DOI 10.1097/01.GME.0000113844.74462.F6; DENNERSTEIN L, 1978, BRIT J OBSTET GYNAEC, V85, P852, DOI 10.1111/j.1471-0528.1978.tb15842.x; Durna EM, 2002, MED J AUSTRALIA, V177, P347, DOI 10.5694/j.1326-5377.2002.tb04835.x; Espeland MA, 2004, JAMA-J AM MED ASSOC, V291, P2959, DOI 10.1001/jama.291.24.2959; Evans ML, 2005, OBSTET GYNECOL, V105, P161, DOI 10.1097/01.AOG.0000147840.06947.46; Farish E, 2000, Climacteric, V3, P125, DOI 10.3109/13697130009167614; Faure ED, 2002, MENOPAUSE, V9, P329, DOI 10.1097/00042192-200209000-00005; FELSON DT, 1993, NEW ENGL J MED, V329, P1141, DOI 10.1056/NEJM199310143291601; FREEDMAN RR, 1995, MENOPAUSE, V2, P211, DOI 10.1097/00042192-199502040-00005; Freedman RR, 2001, AM J HUM BIOL, V13, P453, DOI 10.1002/ajhb.1077; GOLDBERG RM, 1994, J CLIN ONCOL, V12, P155, DOI 10.1200/JCO.1994.12.1.155; Gomes MPV, 2004, ARCH INTERN MED, V164, P1965, DOI 10.1001/archinte.164.18.1965; Gompel A, 2000, EUR J CANCER, V36, pS76; Grady D, 2000, ANN INTERN MED, V132, P689, DOI 10.7326/0003-4819-132-9-200005020-00002; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; Grady D, 2003, OBSTET GYNECOL, V102, P1233, DOI 10.1016/j.obstetgynecol.2003.09.025; Green PK, 1996, CANCER CAUSE CONTROL, V7, P575, DOI 10.1007/BF00051699; Grodstein F, 1998, ANN INTERN MED, V128, P705, DOI 10.7326/0003-4819-128-9-199805010-00001; Grodstein F, 2004, OBSTET GYNECOL, V103, P254, DOI 10.1097/01.AOG.0000107290.33034.6f; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; Guttuso T, 2003, OBSTET GYNECOL, V101, P337, DOI 10.1016/S0029-7844(02)02712-6; Hammar M, 1998, BRIT J OBSTET GYNAEC, V105, P904, DOI 10.1111/j.1471-0528.1998.tb10237.x; HAMMOND MG, 1984, J CLIN ENDOCR METAB, V58, P1158, DOI 10.1210/jcem-58-6-1158; Harman SM, 2005, CLIMACTERIC, V8, P3, DOI 10.1080/13697130500042417; Haskell SG, 2004, J WOMENS HEALTH, V13, P438, DOI 10.1089/154099904323087132; HENDERSON BE, 1983, BRIT J CANCER, V47, P749, DOI 10.1038/bjc.1983.127; Hoda Daanish, 2003, Breast J, V9, P431, DOI 10.1046/j.1524-4741.2003.09526.x; Holmberg L, 2004, LANCET, V363, P453, DOI 10.1016/S0140-6736(04)15493-7; HORWITZ RI, 1978, NEW ENGL J MED, V299, P1089, DOI 10.1056/NEJM197811162992001; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Huntley A, 2003, MENOPAUSE, V10, P58, DOI 10.1097/01.GME.0000030262.75610.9B; Hyder SM, 2001, INT J CANCER, V92, P469, DOI 10.1002/ijc.1236; Irvin JH, 1996, J PSYCHOSOM OBST GYN, V17, P202, DOI 10.3109/01674829609025684; Kanis JA, 1997, OSTEOPOROSIS INT, V7, P108, DOI 10.1007/BF03194355; KHAN SA, 1994, BRIT J CLIN PRACT, V48, P240; KIEL DP, 1987, NEW ENGL J MED, V317, P1169, DOI 10.1056/NEJM198711053171901; Komesaroff P A, 2001, Climacteric, V4, P144; Krebs EE, 2004, OBSTET GYNECOL, V104, P824, DOI 10.1097/01.AOG.0000140688.71638.d3; KRONENBERG F, 1990, ANN NY ACAD SCI, V592, P52; KRONENBERG F, 1990, ANN NY ACAD SCI, V592, P123; Landgren MB, 2002, BJOG-INT J OBSTET GY, V109, P1109, DOI 10.1111/j.1471-0528.2002.02020.x; Laughlin GA, 2000, J CLIN ENDOCR METAB, V85, P645, DOI 10.1210/jc.85.2.645; Lawlor DA, 2003, J CLIN EPIDEMIOL, V56, P155; Lawton B, 2003, BRIT MED J, V327, P845, DOI 10.1136/bmj.327.7419.845; LEBHERZ TB, 1969, OBSTET GYNECOL, V33, P795; LeBlanc ES, 2001, JAMA-J AM MED ASSOC, V285, P1489, DOI 10.1001/jama.285.11.1489; Lemaitre RN, 2002, ARCH INTERN MED, V162, P1954, DOI 10.1001/archinte.162.17.1954; Leonetti HB, 1999, OBSTET GYNECOL, V94, P225, DOI 10.1016/S0029-7844(99)00266-5; Lethaby A., 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000402, DOI 10.1002/14651858.CD000402, 10.1002/14651858.CD000402.pub2]; Lindh-Astrand L, 2004, MATURITAS, V48, P97, DOI 10.1016/S0378-5122(03)00187-7; Lobo RA, 2003, FERTIL STERIL, V79, P1341, DOI 10.1016/S0015-0282(03)00358-3; Lokkegaard E, 2002, MATURITAS, V42, P209, DOI 10.1016/S0378-5122(02)00076-2; Lontos S, 2003, MED J AUSTRALIA, V179, P390, DOI 10.5694/j.1326-5377.2003.tb05606.x; Loprinzi CL, 2002, J CLIN ONCOL, V20, P1578, DOI 10.1200/JCO.20.6.1578; Loprinzi CL, 2000, LANCET, V356, P2059, DOI 10.1016/S0140-6736(00)03403-6; Loprinzi CL, 1998, J CLIN ONCOL, V16, P2377, DOI 10.1200/JCO.1998.16.7.2377; Lowe GDO, 2001, THROMB HAEMOSTASIS, V86, P550; MACLENNAN AH, 2002, COCHRANE DB SYST REV, V1; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; McBee WL, 1997, ENDOCRIN METAB CLIN, V26, P329, DOI 10.1016/S0889-8529(05)70250-4; Milner MH, 1996, OBSTET GYNECOL, V87, P593, DOI 10.1016/0029-7844(95)00468-8; MORRISON JC, 1980, AM J OBSTET GYNECOL, V138, P99, DOI 10.1016/0002-9378(80)90017-4; Mulnard RI, 2000, JAMA-J AM MED ASSOC, V283, P1007, DOI 10.1001/jama.283.8.1007; Munoz GH, 2003, MATURITAS, V44, pS59, DOI 10.1016/S0378-5122(02)00349-3; NACHTIGALL LE, 1994, FERTIL STERIL, V61, P178; Nachtigall LE, 2000, MENOPAUSE, V7, P243, DOI 10.1097/00042192-200007040-00006; Naftolin F, 2004, CLIMACTERIC, V7, P333, DOI 10.1080/13697130400014615; Naftolin F, 2004, FERTIL STERIL, V81, P1498, DOI 10.1016/j.fertnstert.2004.02.095; Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P872, DOI 10.1001/jama.288.7.872; PAGANINIHILL A, 1989, BRIT J CANCER, V59, P445, DOI 10.1038/bjc.1989.91; Palomba S, 2003, MATURITAS, V45, P267, DOI 10.1016/S0378-5122(03)00153-1; Pandya KJ, 2000, ANN INTERN MED, V132, P788, DOI 10.7326/0003-4819-132-10-200005160-00004; Pasqualini JR, 1996, J CLIN ENDOCR METAB, V81, P1460, DOI 10.1210/jc.81.4.1460; PATERSON MEL, 1982, BRIT J OBSTET GYNAEC, V89, P464, DOI 10.1111/j.1471-0528.1982.tb03638.x; Post MS, 2003, AM J OBSTET GYNECOL, V189, P1221, DOI 10.1067/S0002-9378(03)00599-4; Prestwood KM, 2003, JAMA-J AM MED ASSOC, V290, P1042, DOI 10.1001/jama.290.8.1042; Pukkala E, 2001, CANCER CAUSE CONTROL, V12, P111, DOI 10.1023/A:1008934919159; Raudaskoski T, 2002, BJOG-INT J OBSTET GY, V109, P136, DOI 10.1016/S1470-0328(02)01167-9; Riphagen F E, 2000, Climacteric, V3, P199, DOI 10.1080/13697130008500114; Ross RK, 2000, JNCI-J NATL CANCER I, V92, P328, DOI 10.1093/jnci/92.4.328; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Santoro NF, 2004, MENOPAUSE, V11, P11; Scarabin PY, 2003, LANCET, V362, P428, DOI 10.1016/S0140-6736(03)14066-4; Schairer C, 2000, JAMA-J AM MED ASSOC, V283, P485, DOI 10.1001/jama.283.4.485; SCHIFF I, 1980, JAMA-J AM MED ASSOC, V244, P1443, DOI 10.1001/jama.244.13.1443; Schindler DE, 2003, FRONT ECOL ENVIRON, V1, P31, DOI 10.1890/1540-9295(2003)001[0031:PSATEO]2.0.CO;2; Shanafelt TD, 2002, MAYO CLIN PROC, V77, P1207, DOI 10.4065/77.11.1207; Shifren JL, 2000, NEW ENGL J MED, V343, P682, DOI 10.1056/NEJM200009073431002; Shumaker SA, 2004, JAMA-J AM MED ASSOC, V291, P2947, DOI 10.1001/jama.291.24.2947; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Simpson E, 2000, TRENDS ENDOCRIN MET, V11, P184, DOI 10.1016/S1043-2760(00)00254-X; Slater CC, 2001, MENOPAUSE, V8, P200, DOI 10.1097/00042192-200105000-00009; SLOWINSKASRZEDNICKA J, 1992, J ENDOCRINOL INVEST, V15, P533, DOI 10.1007/BF03348801; Stearns V, 2003, JNCI-J NATL CANCER I, V95, P1758, DOI 10.1093/jnci/djg108; Stearns V, 2000, ANN ONCOL, V11, P17, DOI 10.1023/A:1008382706068; Stearns V, 2003, JAMA-J AM MED ASSOC, V289, P2827, DOI 10.1001/jama.289.21.2827; Stearns V, 2002, LANCET, V360, P1851, DOI 10.1016/S0140-6736(02)11774-0; Sturdee DW, 2004, CLIMACTERIC, V7, P404, DOI 10.1080/13697130400012270; STURDEE DW, 1978, BRIT MED J, V2, P79, DOI 10.1136/bmj.2.6130.79; Tice JA, 2003, JAMA-J AM MED ASSOC, V290, P207, DOI 10.1001/jama.290.2.207; TKINSON C, 2004, BREAST CANCER RES, V6, P2170; Unfer V, 2004, FERTIL STERIL, V82, P145, DOI 10.1016/j.fertnstert.2003.11.041; *US FDA, WITHDR GUID ESTR EST; van de Weijer PHM, 2002, MATURITAS, V42, P187, DOI 10.1016/S0378-5122(02)00080-4; Viscoli CM, 2001, NEW ENGL J MED, V345, P1243, DOI 10.1056/NEJMoa010534; Warren MP, 2004, AM J OBSTET GYNECOL, V190, P1141, DOI 10.1016/j.ajog.2003.09.033; Warren R, 2004, MATURITAS, V49, P67, DOI 10.1016/j.maturitas.2004.06.013; Weiderpass E, 1999, J NATL CANCER I, V91, P1131, DOI 10.1093/jnci/91.13.1131; Weitzner MA, 2002, J PAIN SYMPTOM MANAG, V23, P337, DOI 10.1016/S0885-3924(02)00379-2; Wells M, 2002, BMJ-BRIT MED J, V325, P239, DOI 10.1136/bmj.325.7358.239; *WHO, 1966, WHO TECHN REP SER, V7, P236; *WRIT GROUP CONS P, 2004, ADV MED PRACT REG US; Wyon Y, 2004, CLIMACTERIC, V7, P153, DOI 10.1080/13697130410001713814; ZUMOFF B, 1995, J CLIN ENDOCR METAB, V80, P1429, DOI 10.1210/jc.80.4.1429	155	90	96	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2005	366	9483					409	421		10.1016/S0140-6736(05)66519-1	http://dx.doi.org/10.1016/S0140-6736(05)66519-1			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	950IB	16054942				2022-12-28	WOS:000230849700029
J	Johnson, J; Bagley, J; Skaznik-Wikiel, M; Lee, HJ; Adams, GB; Niikura, Y; Tschudy, KS; Tilly, JC; Cortes, ML; Forkert, R; Spitzer, T; Iacomini, J; Scadden, DT; Tilly, JL				Johnson, J; Bagley, J; Skaznik-Wikiel, M; Lee, HJ; Adams, GB; Niikura, Y; Tschudy, KS; Tilly, JC; Cortes, ML; Forkert, R; Spitzer, T; Iacomini, J; Scadden, DT; Tilly, JL			Oocyte generation in adult mammalian ovaries by putative germ cells in bone marrow and peripheral blood	CELL			English	Article							HEMATOPOIETIC STEM-CELLS; MURINE HOMOLOG; PROPHASE I; MOUSE; EXPRESSION; GENE; MICE; FOLLICULOGENESIS; DEFICIENCY; PLASTICITY	It has been suggested that germline stem cells maintain oogenesis in postnatal mouse ovaries. Here we show that adult mouse ovaries rapidly generate hundreds of oocytes, despite a small premeiotic germ cell pool. In considering the possibility of an extragonadal source of germ cells, we show expression of germline markers in bone marrow (BM). Further, BM transplantation restores oocyte production in wild-type mice sterilized by chemotherapy, as well as in ataxia telangiectasia-mutated gene-deficient mice, which are otherwise incapable of making oocytes. Donor-derived oocytes are also observed in female mice following peripheral blood transplantation. Although the fertilizability and developmental competency of the BM and peripheral blood-derived oocytes remain to be established, their morphology, enclosure within follicles, and expression of germ-cell- and oocyte-specific markers collectively support that these cells are bona fide oocytes. These results identify BM as a potential source of germ cells that could sustain oocyte production in adulthood.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Vincent Ctr Reprod Biol,Vincent Obstetr & Gynecol, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med & Technol, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH Canc Ctr, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Tilly, JL (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Vincent Ctr Reprod Biol,Vincent Obstetr & Gynecol, Boston, MA 02114 USA.	jtilly@partners.org	Niikura, Yuichi/AAQ-5935-2020; Johnson, Johnson/HDL-9124-2022	Johnson, Joshua/0000-0002-6016-8089; Skaznik-Wikiel, Malgorzata/0000-0002-5248-6909	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024999, R01AG012279] Funding Source: NIH RePORTER; NIA NIH HHS [R01-AG012279, R01-AG024999] Funding Source: Medline; NICHD NIH HHS [L50 HD048367] Funding Source: Medline; NIEHS NIH HHS [R01-ES08430] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Allen E, 1923, AM J ANAT, V31, P439, DOI 10.1002/aja.1000310502; Barlow C, 1998, DEVELOPMENT, V125, P4007; Benson DA, 2004, NUCLEIC ACIDS RES, V32, pD23, DOI 10.1093/nar/gkh045; Brinster CJ, 2003, BIOL REPROD, V69, P412, DOI 10.1095/biolreprod.103.016519; Brinster RL, 2002, SCIENCE, V296, P2174, DOI 10.1126/science.1071607; Canning J, 2003, ENDOCRINOLOGY, V144, P9, DOI 10.1210/en.2002-220988; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Cohen PE, 2001, BIOESSAYS, V23, P996, DOI 10.1002/bies.1145; Cooke HJ, 1996, HUM MOL GENET, V5, P513, DOI 10.1093/hmg/5.4.513; Cooper R., 1993, METHODS TOXICOLOGY B, P45; Deng W, 2001, INT REV CYTOL, V203, P93; Di Giacomo M, 2005, P NATL ACAD SCI USA, V102, P737, DOI 10.1073/pnas.0406212102; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Erickson GF, 2000, TRENDS ENDOCRIN MET, V11, P193, DOI 10.1016/S1043-2760(00)00249-6; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; GOSDEN RG, 1983, BIOL REPROD, V28, P255, DOI 10.1095/biolreprod28.2.255; Gosden RG, 2004, HUM REPROD UPDATE, V10, P193, DOI 10.1093/humupd/dmh023; GREEN EL, 1970, INT J RADIAT BIOL RE, V17, P87, DOI 10.1080/09553007014550091; Grove JE, 2004, STEM CELLS, V22, P487, DOI 10.1634/stemcells.22-4-487; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Heike T, 2004, INT J HEMATOL, V79, P7, DOI 10.1007/BF02983527; Herzog EL, 2003, BLOOD, V102, P3483, DOI 10.1182/blood-2003-05-1664; HIRSHFIELD AN, 1991, INT REV CYTOL, V124, P43; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; LAWSON KA, 1994, CIBA F SYMP, V182, P68; MARANI E, 1986, ACTA MORPHOL NEER SC, V24, P103; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; MCGRATH SA, 1995, MOL ENDOCRINOL, V9, P131, DOI 10.1210/me.9.1.131; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Meirelles LD, 2003, BRIT J HAEMATOL, V123, P702, DOI 10.1046/j.1365-2141.2003.04669.x; Molyneaux K, 2004, INT J DEV BIOL, V48, P537, DOI 10.1387/ijdb.041833km; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Neto ED, 2000, P NATL ACAD SCI USA, V97, P3491; Noce T, 2001, CELL STRUCT FUNCT, V26, P131, DOI 10.1247/csf.26.131; OKADA S, 1991, BLOOD, V78, P1706; OKADA S, 1992, BLOOD, V80, P3044; Perez GI, 1999, NAT GENET, V21, P200, DOI 10.1038/5985; Perez GI, 1997, NAT MED, V3, P1228, DOI 10.1038/nm1197-1228; PETERS H, 1969, ACTA ENDOCRINOL-COP, V62, P98, DOI 10.1530/acta.0.0620098; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PHILPOTT CC, 1987, DEV BIOL, V121, P568, DOI 10.1016/0012-1606(87)90192-8; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; RICH IN, 1995, BLOOD, V86, P463, DOI 10.1182/blood.V86.2.463.bloodjournal862463; RICHARDSON SJ, 1987, J CLIN ENDOCR METAB, V65, P1231, DOI 10.1210/jcem-65-6-1231; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; SARMIENTO M, 1980, J IMMUNOL, V125, P2665; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; Sette C, 2000, INT J DEV BIOL, V44, P599; SHIROMIZU K, 1984, PEDIATR PHARMACOL, V4, P213; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SPANGRUDE GJ, 1990, EXP HEMATOL, V18, P920; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suzumori N, 2002, MECH DEVELOP, V111, P137, DOI 10.1016/S0925-4773(01)00620-7; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Tilly JL, 2001, NAT REV MOL CELL BIO, V2, P838, DOI 10.1038/35099086; Tilly Jonathan L, 2003, Reprod Biol Endocrinol, V1, P11, DOI 10.1186/1477-7827-1-11; VANDERIJN M, 1989, P NATL ACAD SCI USA, V86, P4634; Wognum AW, 2003, ARCH MED RES, V34, P461, DOI 10.1016/j.arcmed.2003.09.008; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; ZUCKERMAN S, 1951, RECENT PROG HORM RES, V6, P63; Zuckerman S., 1977, OVARY, V1, P41	65	516	564	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 29	2005	122	2					303	315		10.1016/j.cell.2005.06.031	http://dx.doi.org/10.1016/j.cell.2005.06.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	951CR	16051153	Bronze			2022-12-28	WOS:000230907000016
J	Kerner, MJ; Naylor, DJ; Ishihama, Y; Maier, T; Chang, HC; Stines, AP; Georgopoulos, C; Frishman, D; Hayer-Hartl, M; Mann, M; Hartl, FU				Kerner, MJ; Naylor, DJ; Ishihama, Y; Maier, T; Chang, HC; Stines, AP; Georgopoulos, C; Frishman, D; Hayer-Hartl, M; Mann, M; Hartl, FU			Proteome-wide analysis of chaperonin-dependent protein folding in Escherichia coli	CELL			English	Article							TRIGGER FACTOR; IN-VIVO; MOLECULAR CHAPERONES; CRYSTAL-STRUCTURE; POLYPEPTIDE FLUX; GROEL; DNAK; SYSTEM; CELL; INTERMEDIATE	The E. coli chaperonin GroEL and its cofactor GroES promote protein folding by sequestering nonnative polypeptides in a cage-like structure. Here we define the contribution of this system to protein folding across the entire E. coli proteome. Approximately 250 different proteins interact with GroEL, but most of these can utilize either GroEL or the upstream chaperones trigger factor (TF) and DnaK for folding. Obligate GroEL-dependence is limited to only similar to 85 substrates, including 13 essential proteins, and occupying more than 75% of GroEL capacity. These proteins appear to populate kinetically trapped intermediates during folding; they are stabilized by TF/DnaK against aggregation but reach native state only upon transfer to GroEL/GroES. Interestingly, substantially enriched among the GroEL substrates are proteins with (beta alpha)(8) TIM-barrel domains. We suggest that the chaperonin system may have facilitated the evolution of this fold into a versatile platform for the implementation of numerous enzymatic functions.	Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; Univ So Denmark, Ctr Expt Bioinformat, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; Ctr Med Univ Geneva, Dept Microbiol & Med Mol, CH-1211 Geneva, Switzerland; GSF Natl Res Ctr Environm & Hlth, Inst Bioinformat, D-85764 Neuherberg, Germany; Tech Univ Munich, Wissensch Zentrum Weihenstephan, Dept Genome Oriented Bioinformat, D-85354 Freising Weihenstephan, Germany	Max Planck Society; University of Southern Denmark; University of Geneva; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de	Hayer-Hartl, Manajit/V-8078-2017; Frishman, Dmitrij/AAT-7815-2020; Mann, Matthias/A-3454-2013; Hartl, F. Ulrich/Y-8206-2019; Ishihama, Yasushi/B-3101-2016	Hayer-Hartl, Manajit/0000-0001-8213-6742; Mann, Matthias/0000-0003-1292-4799; Ishihama, Yasushi/0000-0001-7714-203X; zhang, hong jun/0000-0003-0030-8323				Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Chaudhuri TK, 2001, CELL, V107, P235, DOI 10.1016/S0092-8674(01)00523-2; Chiti F, 2002, P NATL ACAD SCI USA, V99, P16419, DOI 10.1073/pnas.212527999; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Ellis RJ, 1996, FASEB J, V10, P20, DOI 10.1096/fasebj.10.1.8566542; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; Fenton WA, 2003, Q REV BIOPHYS, V36, P229, DOI 10.1017/S0033583503003883; Ferguson N, 1999, J MOL BIOL, V286, P1597, DOI 10.1006/jmbi.1998.2548; Figueiredo L, 2004, J BIOL CHEM, V279, P1090, DOI 10.1074/jbc.M310914200; Frishman D, 2003, NUCLEIC ACIDS RES, V31, P207, DOI 10.1093/nar/gkg005; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Genevaux P, 2004, EMBO REP, V5, P195, DOI 10.1038/sj.embor.7400067; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Gromiha MM, 2004, PROG BIOPHYS MOL BIO, V86, P235, DOI 10.1016/j.pbiomolbio.2003.09.003; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HORWICH AL, 1993, CELL, V74, P909, DOI 10.1016/0092-8674(93)90470-B; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Jewett AI, 2004, P NATL ACAD SCI USA, V101, P13192, DOI 10.1073/pnas.0400720101; Klunker D, 2003, J BIOL CHEM, V278, P33256, DOI 10.1074/jbc.M302018200; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Lin Z, 2004, MOL CELL, V16, P23, DOI 10.1016/j.molcel.2004.09.003; Lo Conte L, 2002, NUCLEIC ACIDS RES, V30, P264; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; McLennan N, 1998, NATURE, V392, P139, DOI 10.1038/32317; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Nobelmann B, 1996, J BACTERIOL, V178, P6790, DOI 10.1128/jb.178.23.6790-6795.1996; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Thirumalai D, 2003, P NATL ACAD SCI USA, V100, P11195, DOI 10.1073/pnas.2035072100; Ullers RS, 2004, P NATL ACAD SCI USA, V101, P7583, DOI 10.1073/pnas.0402398101; Vorderwulbecke S, 2004, FEBS LETT, V559, P181, DOI 10.1016/S0014-5793(04)00052-3; Wang JD, 2002, CELL, V111, P1027, DOI 10.1016/S0092-8674(02)01198-4; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944	40	481	489	0	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 29	2005	122	2					209	220		10.1016/j.cell.2005.05.028	http://dx.doi.org/10.1016/j.cell.2005.05.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	951CR	16051146	hybrid			2022-12-28	WOS:000230907000009
J	Schroeder, SA				Schroeder, SA			What to do with a patient who smokes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SMOKING-CESSATION; MENTAL-ILLNESS; HEALTH-CARE; TOBACCO; NICOTINE; MORTALITY; TRIAL	Despite the reality that smoking remains the most important preventable cause of death and disability, most clinicians underperform in helping smokers quit. Of the 46 million current smokers in the United States, 70% say they would like to quit, but only a small fraction are able to do so on their own because nicotine is so highly addictive. One third to one half of all smokers die prematurely. Reasons clinicians avoid helping smokers quit include time constraints, lack of expertise, lack of financial incentives, respect for a smoker's privacy, fear that a negative message might lose customers, pessimism because most smokers are unable to quit, stigma, and clinicians being smokers. The gold standard for cessation treatment is the 5 As (ask, advise, assess, assist, and arrange). Yet, only a minority of physicians know about these, and fewer put them to use. Acceptable shortcuts are asking, advising, and referring to a telephone "quit line" or an internal referral system. Successful treatment combines counseling with pharmacotherapy (nicotine replacement therapy with or without psychotropic medication such as bupropion). Nicotine replacement therapy comes in long-acting (patch) or short-acting (gum, lozenge, nasal spray, or inhaler) forms. Ways to counter clinicians' pessimism about cessation include the knowledge that most smokers require multiple quit attempts before they succeed, that rigorous studies show long-term quit rates of 14% to 20%, with 1 report as high as 35%, that cessation rates for users of telephone quit lines and integrated health care systems are comparable with those of individual clinicians, and that no other clinical intervention can offer such a large potential benefit.	Univ Calif San Francisco, Smoking Cessat Leadership Ctr, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Schroeder, SA (corresponding author), Univ Calif San Francisco, Smoking Cessat Leadership Ctr, 3333 Calif St,Suite 430, San Francisco, CA 94143 USA.	schroeder@medicine.ucsf.edu						[Anonymous], HLTH CONS SMOK REP S; Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P675, DOI 10.1164/rccm.2112096; BENOWITZ NL, 1994, J PHARMACOL EXP THER, V268, P296; Bentz CJ, 2000, TOB CONTROL, V9, P42; *CDCP, COMP CAUS ANN DEATHS; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P842; CORELLI RL, 2004, APPL THERAPEUTICS CL; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Filozof C, 2004, Obes Rev, V5, P95, DOI 10.1111/j.1467-789X.2004.00131.x; FIORE MC, 2000, TREATING TOBACCO USE; FIX B, 2004, FREE NRT PROGRAMS RE; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Goldstein MG, 1997, ARCH INTERN MED, V157, P1313, DOI 10.1001/archinte.157.12.1313; HENNINGFIELD JE, 1993, DRUG ALCOHOL DEPEN, V33, P23, DOI 10.1016/0376-8716(93)90030-T; HUGHES JR, 1991, ARCH GEN PSYCHIAT, V48, P52; HUGHES JR, 2000, COCHRANE DB SYST REV, V2, P31; HURT RD, IN PRESS VA VANGUARD; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; KAWACHI I, 1993, ANN INTERN MED, V119, P992, DOI 10.7326/0003-4819-119-10-199311150-00005; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; McAfee T, 1998, AM J PREV MED, V14, P46, DOI 10.1016/S0749-3797(97)00051-2; *NAT CTR CHRON DIS, 1990, DHHS PUBL; Niaura R, 2002, J CONSULT CLIN PSYCH, V70, P887, DOI 10.1037//0022-006X.70.4.887; Ossip-Klein DJ, 2003, AM J MED SCI, V326, P201, DOI 10.1097/00000441-200310000-00010; Perry DC, 1999, J PHARMACOL EXP THER, V289, P1545; Schroeder SA, 2004, NEW ENGL J MED, V350, P293, DOI 10.1056/NEJMsr031421; SILAGY C, 2000, COCHRANE DB SYST REV, V2, P146; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000165.pub3; Taylor DH, 2002, AM J PUBLIC HEALTH, V92, P990, DOI 10.2105/AJPH.92.6.990; Williams JM, 2004, ADDICT BEHAV, V29, P1067, DOI 10.1016/j.addbeh.2004.03.009; WILLIAMS SC, IN PRESS J HLTH OUTC; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Zhu SH, 2002, NEW ENGL J MED, V347, P1087, DOI 10.1056/NEJMsa020660; ZHU SH, IN PRESS VA VANGUARD; 2002, MMWR MORB MORTAL WKL, V51, P300; RX CHANGE CLIN ASSIS; 2004, MMWR MORB MORTAL WKL, V53, P1035	37	217	224	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2005	294	4					482	487		10.1001/jama.294.4.482	http://dx.doi.org/10.1001/jama.294.4.482			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	948RM	16046655				2022-12-28	WOS:000230733400023
J	Iqbal, MB; Sharma, R; Underwood, SR; Kaddoura, S				Iqbal, MB; Sharma, R; Underwood, SR; Kaddoura, S			Radioisotopes and airport security	LANCET			English	Editorial Material									Royal Brompton Hosp, Dept Nucl Med, London SW3 6NP, England; Royal Brompton Hosp, Dept Cardiol, London SW3 6NP, England	Royal Brompton Hospital; Royal Brompton Hospital	Underwood, SR (corresponding author), Royal Brompton Hosp, Dept Nucl Med, London SW3 6NP, England.	r.underwood@imperial.ac.uk		Underwood, Stephen Richard/0000-0002-5777-1442				ATKINS HL, 1977, J NUCL MED, V18, P133; LEVIN ME, 1988, NEW ENGL J MED, V319, P587; TOLTZIS RJ, 1986, NEW ENGL J MED, V315, P836; 2004, RSNA NEWS, V14, P6	4	13	13	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2005	366	9482					342	342		10.1016/S0140-6736(05)66994-2	http://dx.doi.org/10.1016/S0140-6736(05)66994-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RJ	16039341				2022-12-28	WOS:000230733100037
J	Mierzewski, P				Mierzewski, P			Commentary: Patients' empowerment: the East side story	BRITISH MEDICAL JOURNAL			English	Editorial Material									Council Europe, Directorate Gen Social Cohes 3, Dept Hlth, F-67075 Strasbourg, France; Council Europe, Directorate Gen Social Cohes 3, Partial Agreement Social & Publ Hlth Field, F-67075 Strasbourg, France		Mierzewski, P (corresponding author), Council Europe, Directorate Gen Social Cohes 3, Dept Hlth, F-67075 Strasbourg, France.	piotr.mierzewski@coe.int						Council of Europe, 2000, DEV STRUCT CIT PAT P; Francke R, 2001, BURGERBETEILIGUNG GE; Mastilica M, 2005, BMJ-BRIT MED J, V331, P223, DOI 10.1136/bmj.331.7510.223; SALTMAN RB, 2000, EUROHEALTH, V6, P22	4	3	3	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 23	2005	331	7510					226	227		10.1136/bmj.331.7510.226	http://dx.doi.org/10.1136/bmj.331.7510.226			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951EA	16037465	Green Published, Bronze			2022-12-28	WOS:000230910700034
J	Sibly, RM; Barker, D; Denham, MC; Hone, J; Pagel, M				Sibly, RM; Barker, D; Denham, MC; Hone, J; Pagel, M			On the regulation of populations of mammals, birds, fish, and insects	SCIENCE			English	Article							DENSITY-DEPENDENCE; GROWTH; HERBIVORES	A key unresolved question in population ecology concerns the relationship between a population's size and its growth rate. We estimated this relationship for 1780 time series of mammals, birds, fish, and insects. We found that rates of population growth are high at low population densities but, contrary to previous predictions, decline rapidly with increasing population size and then flatten out, for all four taxa. This produces a strongly concave relationship between a population's growth rate and its size. These findings have fundamental implications for our understanding of animals' lives, suggesting in particular that many animals in these taxa will be found living at densities above the carrying capacity of their environments.	Univ Reading, Sch Anim & Microbial Sci, Reading RG6 6AJ, Berks, England; GlaxoSmithKline Res & Dev Ltd, Stat Sci Europe, Harlow CM19 5AW, Essex, England; Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia	University of Reading; GlaxoSmithKline; University of Canberra	Sibly, RM (corresponding author), Univ Reading, Sch Anim & Microbial Sci, Reading RG6 6AJ, Berks, England.	r.m.sibly@reading.ac.uk	Barker, David JP/A-5671-2013	Sibly, Richard/0000-0001-6828-3543; Hone, Jim/0000-0002-8104-8852				ANDERSON R M, 1991; Bayliss P, 2002, PHILOS T ROY SOC B, V357, P1233, DOI 10.1098/rstb.2002.1124; Beissinger S. R., 2002, POPULATION VIABILITY; Caughley GJ, 1994, WILDLIFE ECOLOGY MAN; CluttonBrock TH, 1997, AM NAT, V149, P195, DOI 10.1086/285987; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; FOWLER CW, 1981, ECOLOGY, V62, P602, DOI 10.2307/1937727; GILPIN ME, 1973, P NATL ACAD SCI USA, V70, P3590, DOI 10.1073/pnas.70.12.3590; Halley J, 2002, OIKOS, V99, P518, DOI 10.1034/j.1600-0706.2002.11962.x; Jennings S., 2001, MARINE FISHERIES ECO; Krebs CJ, 2002, PHILOS T ROY SOC B, V357, P1211, DOI 10.1098/rstb.2002.1122; Lande R, 1997, ECOLOGY, V78, P1341; Lande R., 2003, OXFORD SERIES ECOLOG; Lindstrom J, 2002, ECOL LETT, V5, P338, DOI 10.1046/j.1461-0248.2002.00317.x; NERC Centre for Population Biology IC, 2010, GLOB POP DYN DAT; Pastorok R. A., 2002, ECOLOGICAL MODELING; Royama T., 1992, ANAL POPULATION ECOL; Saether BE, 1997, TRENDS ECOL EVOL, V12, P143, DOI 10.1016/S0169-5347(96)10068-9; Saether BE, 1996, OIKOS, V77, P217, DOI 10.2307/3546060; Saether BE, 2002, SCIENCE, V295, P2070; Shenk TM, 1998, ECOL MONOGR, V68, P445, DOI 10.1890/0012-9615(1998)068[0445:SVEODD]2.0.CO;2; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; Sinclair A.R.E., 1989, P197; Sinclair ARE, 2003, PHILOS T R SOC B, V358, P1729, DOI 10.1098/rstb.2003.1359; Sinclair ARE, 1996, FRONTIERS OF POPULATION ECOLOGY, P127; Sinclair ARE, 2002, PHILOS T ROY SOC B, V357, P1221, DOI 10.1098/rstb.2002.1123; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Tsoularis A, 2002, MATH BIOSCI, V179, P21, DOI 10.1016/S0025-5564(02)00096-2; Turchin P, 1999, OIKOS, V84, P153, DOI 10.2307/3546876; Turchin Peter, 2003, Monographs in Population Biology, V35, pi	30	305	316	4	210	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2005	309	5734					607	610		10.1126/science.1110760	http://dx.doi.org/10.1126/science.1110760			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040705				2022-12-28	WOS:000230735200047
J	Matsuoka, T; Ahlberg, PE; Kessaris, N; Iannarelli, P; Dennehy, U; Richardson, WD; McMahon, AP; Koentges, G				Matsuoka, T; Ahlberg, PE; Kessaris, N; Iannarelli, P; Dennehy, U; Richardson, WD; McMahon, AP; Koentges, G			Neural crest origins of the neck and shoulder	NATURE			English	Article							EXPRESSION; MUSCLES; GENES; EVOLUTION; MIGRATION; SUGGEST; GROWTH; FATE	The neck and shoulder region of vertebrates has undergone a complex evolutionary history. To identify its underlying mechanisms we map the destinations of embryonic neural crest and mesodermal stem cells using Cre- recombinase-mediated transgenesis. The single-cell resolution of this genetic labelling reveals cryptic cell boundaries traversing the seemingly homogeneous skeleton of the neck and shoulders. Within this assembly of bones and muscles we discern a precise code of connectivity that mesenchymal stem cells of both neural crest and mesodermal origin obey as they form muscle scaffolds. The neural crest anchors the head onto the anterior lining of the shoulder girdle, while a Hox-gene-controlled mesoderm links trunk muscles to the posterior neck and shoulder skeleton. The skeleton that we identify as neural crest-derived is specifically affected in human Klippel - Feil syndrome, Sprengel's deformity and Arnold - Chiari I/II malformation, providing insights into their likely aetiology. We identify genes involved in the cellular modularity of the neck and shoulder skeleton and propose a new method for determining skeletal homologies that is based on muscle attachments. This has allowed us to trace the whereabouts of the cleithrum, the major shoulder bone of extinct land vertebrate ancestors, which seems to survive as the scapular spine in living mammals.	UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; UCL, Lab Funct Genom, London WC1E 6BT, England; UCL, Dept Biol, London WC1E 6BT, England; Uppsala Univ, Dept Physiol & Dev Biol, Subdept Evolutionary Organismal Biol, S-75236 Uppsala, Sweden; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	University of London; University College London; University of London; University College London; University of London; University College London; Uppsala University; Harvard University	Koentges, G (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	g.koentges@ucl.ac.uk	Kessaris, Nicoletta/AAD-6774-2019; McMahon, Andrew P/ABE-7520-2020; Campbell, Chris/J-7596-2013; Richardson FMedSci FRS, William D/C-1762-2008	Kessaris, Nicoletta/0000-0003-1191-6009; Campbell, Chris/0000-0001-7749-8538; Ahlberg, Per/0000-0001-9054-2900; Richardson FMedSci FRS, William D/0000-0001-7261-2485	NINDS NIH HHS [R01 NS033642] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033642] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alvares LE, 2003, DEV CELL, V5, P379, DOI 10.1016/S1534-5807(03)00263-6; Barrow JR, 1999, DEVELOPMENT, V126, P5011; Baylies MK, 1998, CELL, V93, P921, DOI 10.1016/S0092-8674(00)81198-8; BURKE AC, 1995, DEVELOPMENT, V121, P333; Clack JA., 2005, J SYST PALAEONTOL, V2, P311, DOI [10.1017/S1477201904001506, DOI 10.1017/S1477201904001506]; Clarke RA, 1998, PEDIATR RADIOL, V28, P967, DOI 10.1007/s002470050511; CONDIE BG, 1994, NATURE, V370, P304, DOI 10.1038/370304a0; COULY GF, 1992, DEVELOPMENT, V114, P1; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; DIETRICH S, 1995, DEV BIOL, V167, P529, DOI 10.1006/dbio.1995.1047; Edgeworth FH, 1935, CRANIAL MUSCLES VERT; Ferguson CA, 2004, DEV BIOL, V269, P70, DOI 10.1016/j.ydbio.2004.01.013; Graham D. I., 2002, GREENFIELDS NEUROPAT; Hall BK, 2001, J EXP ZOOL, V289, P153, DOI 10.1002/1097-010X(20010215)289:3<153::AID-JEZ1>3.0.CO;2-O; HORWITZ AE, 1908, AM J ORTHOP SURG, V6, P260; Huang LF, 1997, DEV DYNAM, V210, P33, DOI 10.1002/(SICI)1097-0177(199709)210:1<33::AID-AJA4>3.0.CO;2-2; Huang RJ, 2000, ANAT EMBRYOL, V202, P375, DOI 10.1007/s004290000131; Huang RJ, 2000, DEVELOPMENT, V127, P3789; Jaekel O., 1918, Palaeontologische Zeitschrift Berlin, V2, P88; Janvier P., 1996, EARLY VERTEBRATES; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Johanson Z, 2003, J VERTEBR PALEONTOL, V23, P735, DOI 10.1671/2; Joyce W, 2003, J VERTEBR PALEONTOL, V23, p66A; Kjaer I, 1999, AM J MED GENET, V82, P6, DOI 10.1002/(SICI)1096-8628(19990101)82:1<6::AID-AJMG2>3.0.CO;2-#; Kontges G, 1996, DEVELOPMENT, V122, P3229; Le Douarin NM, 1999, NEURAL CREST, V2; LEBEDEV OA, 2005, ACTA U LATVIENSIS, V679, P79; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; Motta PJ, 2001, ENVIRON BIOL FISH, V60, P131, DOI 10.1023/A:1007649900712; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Peters H, 1999, DEVELOPMENT, V126, P5399; Prols F, 2004, DEV BIOL, V275, P315, DOI 10.1016/j.ydbio.2004.08.003; Reisz R.R., 1984, Journal of Vertebrate Paleontology, V4, P57; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; Schoch Rainer R., 1999, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V278, P1; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Selleri L, 2001, DEVELOPMENT, V128, P3543; Shearman RM, 2005, J MORPHOL, V264, P94, DOI 10.1002/jmor.10322; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Smith A, 1997, CURR BIOL, V7, P561, DOI 10.1016/S0960-9822(06)00255-7; SMITH MM, 1990, BIOL REV, V65, P277, DOI 10.1111/j.1469-185X.1990.tb01427.x; SMITH MM, 1993, EVOL BIOL, V27, P387; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sumida Stuart S., 1997, P353, DOI 10.1016/B978-012676460-4/50012-3; Takio Y, 2004, NATURE, V429, DOI 10.1038/nature02616; WINTERBOTTOM R, 1974, P ACAD NAT SCI PHILA, V125, P225; Zhang F, 1997, MECH DEVELOP, V67, P49, DOI 10.1016/S0925-4773(97)00104-4	50	340	353	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					347	355		10.1038/nature03837	http://dx.doi.org/10.1038/nature03837			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034409	Green Accepted			2022-12-28	WOS:000230623400033
J	Hahn, J; Maier, B; Haijema, BJ; Sheetz, M; Dubnau, D				Hahn, J; Maier, B; Haijema, BJ; Sheetz, M; Dubnau, D			Transformation proteins and DNA uptake localize to the cell poles in Bacillus subtilis	CELL			English	Article							BINDING-SITE; COMPETENCE; DIVISION; SPORULATION; EXPRESSION; MOVEMENT; PATTERNS; BACTERIA; DISTINCT; SEPTUM	The Gram-positive, rod-forming bacterium Bacillus subtilis efficiently binds and internalizes transforming DNA. The localization of several competence proteins, required for DNA uptake, has been studied using fluorescence microscopy. At least three proteins (ComGA, ComFA, and YwpH) are preferentially associated with the cell poles and appear to colocalize. This association is dynamic; the proteins accumulate at the poles as transformability develops and then delocalize as transformability wanes. DNA binding and uptake also occur preferentially at the cell poles, as shown using fluorescent DNA and in single-molecule experiments with laser tweezers. In addition to the prominent polar sites, the competence proteins also localize as foci in association with the lateral cell membrane, but this distribution does not exhibit the same temporal changes as the polar accumulation. The results suggest the regulated assembly and disassembly of a DNA-uptake machine at the cell poles.	Publ Hlth Res Inst, Newark, NJ 07103 USA; Columbia Univ, Dept Sci Biol, New York, NY 10027 USA	Columbia University	Dubnau, D (corresponding author), Publ Hlth Res Inst, 225 Warren St, Newark, NJ 07103 USA.	dubnau@phri.org	Maier, Berenike/B-2350-2016	Maier, Berenike/0000-0001-6971-9927	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043756, R01GM057720] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM57720, GM3677, R01 GM043756, R01 GM057720, GM43756] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBANO M, 1987, J BACTERIOL, V169, P3110, DOI 10.1128/jb.169.7.3110-3117.1987; ALBANO M, 1989, J BACTERIOL, V171, P5386, DOI 10.1128/jb.171.10.5386-5404.1989; Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; Berge M, 2003, MOL MICROBIOL, V50, P527, DOI 10.1046/j.1365-2958.2003.03702.x; Berka RM, 2002, MOL MICROBIOL, V43, P1331, DOI 10.1046/j.1365-2958.2002.02833.x; Campo N, 2004, MOL MICROBIOL, V53, P1583, DOI 10.1111/j.1365-2958.2004.04278.x; CHUNG YS, 1995, MOL MICROBIOL, V15, P543, DOI 10.1111/j.1365-2958.1995.tb02267.x; Chung YS, 1998, MOL MICROBIOL, V29, P905, DOI 10.1046/j.1365-2958.1998.00989.x; Chung YS, 1998, J BACTERIOL, V180, P41, DOI 10.1128/JB.180.1.41-45.1998; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Draskovic I, 2005, MOL MICROBIOL, V55, P881, DOI 10.1111/j.1365-2958.2004.04430.x; DRASKOVIC I, 2005, COMPETENCE GENETIC T; DUBNAU D, 1971, J MOL BIOL, V56, P209, DOI 10.1016/0022-2836(71)90460-8; DUBNAU D, 1972, J MOL BIOL, V64, P31, DOI 10.1016/0022-2836(72)90319-1; DUBNAU D, 2001, BACILLUS SUBTILIS IT, P453; Edwards DH, 1997, MOL MICROBIOL, V24, P905, DOI 10.1046/j.1365-2958.1997.3811764.x; HAHN J, 1987, J BACTERIOL, V169, P3104, DOI 10.1128/jb.169.7.3104-3109.1987; Haijema BJ, 2001, MOL MICROBIOL, V40, P52, DOI 10.1046/j.1365-2958.2001.02363.x; Hamoen LW, 2002, NUCLEIC ACIDS RES, V30, P5517, DOI 10.1093/nar/gkf698; HARRY EJ, 1995, J BACTERIOL, V177, P3386, DOI 10.1128/jb.177.12.3386-3393.1995; Hoa TT, 2002, MOL MICROBIOL, V43, P15, DOI 10.1046/j.1365-2958.2002.02727.x; INAMINE GS, 1995, J BACTERIOL, V177, P3045, DOI 10.1128/jb.177.11.3045-3051.1995; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kidane D, 2005, CELL, V122, P73, DOI 10.1016/j.cell.2005.04.036; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVIN PA, 1994, J BACTERIOL, V176, P1451, DOI 10.1128/jb.176.5.1451-1459.1994; Levin PA, 1997, MOL MICROBIOL, V25, P839; Levin PA, 1996, GENE DEV, V10, P478, DOI 10.1101/gad.10.4.478; LONDONOVALLEJO JA, 1994, MOL MICROBIOL, V13, P197, DOI 10.1111/j.1365-2958.1994.tb00415.x; LONDONOVALLEJO JA, 1994, J BACTERIOL, V176, P4642; Maier B, 2004, NAT STRUCT MOL BIOL, V11, P643, DOI 10.1038/nsmb783; Meima R, 2002, J BIOL CHEM, V277, P6994, DOI 10.1074/jbc.M111380200; Ogura M, 2002, J BACTERIOL, V184, P2344, DOI 10.1128/JB.184.9.2344-2351.2002; Provvedi R, 1999, MOL MICROBIOL, V31, P271, DOI 10.1046/j.1365-2958.1999.01170.x; SANSONETTI P, 2002, COMEA DNA RECEPTOR; Scheffers DJ, 2004, MOL MICROBIOL, V51, P749, DOI 10.1046/j.1365-2958.2003.03854.x; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; SINGH RN, 1972, J BACTERIOL, V110, P266, DOI 10.1128/JB.110.1.266-272.1972; Soufo HJD, 2004, EMBO REP, V5, P789, DOI 10.1038/sj.embor.7400209; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; Thanedar S, 2004, CURR BIOL, V14, P1167, DOI 10.1016/j.cub.2004.06.048	42	111	117	4	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 15	2005	122	1					59	71		10.1016/j.cell.2005.04.035	http://dx.doi.org/10.1016/j.cell.2005.04.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	950EC	16009133	Green Accepted, Bronze			2022-12-28	WOS:000230839400011
J	Hoepfner, D; Schildknegt, D; Braakman, I; Philippsen, P; Tabak, HF				Hoepfner, D; Schildknegt, D; Braakman, I; Philippsen, P; Tabak, HF			Contribution of the endoplasmic reticulum to peroxisome formation	CELL			English	Article							MEMBRANE-PROTEINS; BIOGENESIS; IMPORT; PEX19P; INHERITANCE; COMPONENTS; TRANSPORT; MULTIPLE; DYNAMICS; MODULES	How peroxisomes are formed in eukaryotic cells is unknown but important for insight into a variety of diseases. Both human and yeast cells lacking peroxisomes due to mutations in PEX3 or PEX19 genes regenerate the organelles upon reintroduction of the corresponding wild-type version. To evaluate how and from where new peroxisomes are formed, we followed the trafficking route of newly made YFP-tagged Pex3 and Pex19 proteins by real-time fluorescence microscopy in Saccharomyces cerevisiae. Remarkably, Pex3 (an integral membrane protein) could first be observed in the endoplasmic reticulum (ER), where it concentrates in foci that then bud off in a Pex19-dependent manner and mature into fully functional peroxisomes. Pex19 (a farnesylated, mostly cytosolic protein) enriches first at the Pex3 foci on the ER and then on the maturing peroxisomes. This trafficking route of Pex3-YFP is the same in wild-type cells. These results demonstrate that peroxisomes are generated from domains in the ER.	Univ Utrecht, Dept Cellular Prot Chem, NL-3548 CH Utrecht, Netherlands; Univ Basel, Bioctr, Lehrstuhl Angewandte Mikrobiol, CH-4056 Basel, Switzerland; Univ Utrecht, Med Ctr, Cell Biol Lab, NL-3584 CX Utrecht, Netherlands; Univ Utrecht, Acad Biomed Ctr, NL-3548 CL Utrecht, Netherlands	Utrecht University; University of Basel; Utrecht University; Utrecht University	Tabak, HF (corresponding author), Univ Utrecht, Dept Cellular Prot Chem, Padualaan 8, NL-3548 CH Utrecht, Netherlands.	h.f.tabak@chem.uu.nl		Braakman, Ineke/0000-0003-1592-4364				Alberts B., 2008, MOL BIOL CEL, V5th ed.; Bascom RA, 2003, MOL BIOL CELL, V14, P939, DOI 10.1091/mbc.E02-10-0633; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Daum G, 1997, PROG LIPID RES, V36, P103, DOI 10.1016/S0163-7827(97)00006-4; deDuve C, 1996, SCI AM, V274, P50, DOI 10.1038/scientificamerican0496-50; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; Fang Y, 2004, J CELL BIOL, V164, P863, DOI 10.1083/jcb.200311131; Fehrenbacher KL, 2002, MOL BIOL CELL, V13, P854, DOI 10.1091/mbc.01-04-0184; FELDHEIM D, 1992, MOL CELL BIOL, V12, P3288, DOI 10.1128/MCB.12.7.3288; Geuze HJ, 2003, MOL BIOL CELL, V14, P2900, DOI 10.1091/mbc.E02-11-0734; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gotte K, 1998, MOL CELL BIOL, V18, P616; Hettema EH, 2000, EMBO J, V19, P223, DOI 10.1093/emboj/19.2.223; Hettema EH, 1998, J CELL BIOL, V142, P421, DOI 10.1083/jcb.142.2.421; Hoepfner D, 2001, J CELL BIOL, V155, P979, DOI 10.1083/jcb.200107028; HOHFELD J, 1991, J CELL BIOL, V114, P1167, DOI 10.1083/jcb.114.6.1167; HUXLEY C, 1990, TRENDS GENET, V6, P236, DOI 10.1016/0168-9525(90)90190-H; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jones SC, 2004, HEALTH EDUC RES, V19, P1, DOI 10.1093/her/cyg002; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Lazarow PB, 2003, CURR OPIN CELL BIOL, V15, P489, DOI 10.1016/S0955-0674(03)00082-6; Lisenbee CS, 2003, TRAFFIC, V4, P491, DOI 10.1034/j.1600-0854.2003.00107.x; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marelli M, 2004, J CELL BIOL, V167, P1099, DOI 10.1083/jcb.200404119; Monosov EZ, 1996, J HISTOCHEM CYTOCHEM, V44, P581, DOI 10.1177/44.6.8666743; NOVIKOFF PM, 1972, J CELL BIOL, V53, P532, DOI 10.1083/jcb.53.2.532; Nunnari J, 1996, CELL, V84, P389, DOI 10.1016/S0092-8674(00)81283-0; Otte S, 2001, J CELL BIOL, V152, P503, DOI 10.1083/jcb.152.3.503; Phillips GN, 1997, CURR OPIN STRUC BIOL, V7, P821, DOI 10.1016/S0959-440X(97)80153-4; Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469; Rottensteiner H, 2004, MOL BIOL CELL, V15, P3406, DOI 10.1091/mbc.E04-03-0188; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; Schliebs W, 2004, CURR BIOL, V14, pR397, DOI 10.1016/j.cub.2004.05.017; Snyder WB, 2000, J CELL BIOL, V149, P1171, DOI 10.1083/jcb.149.6.1171; South ST, 2001, P NATL ACAD SCI USA, V98, P12027, DOI 10.1073/pnas.221289498; Subramani S, 1998, PHYSIOL REV, V78, P171, DOI 10.1152/physrev.1998.78.1.171; Tabak HF, 2003, TRAFFIC, V4, P512, DOI 10.1034/j.1600-0854.2003.00110.x; Titorenko VI, 1997, MOL CELL BIOL, V17, P5210, DOI 10.1128/MCB.17.9.5210; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; Voelker DR, 2000, BBA-MOL CELL BIOL L, V1486, P97, DOI 10.1016/S1388-1981(00)00051-2; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Warren G, 1996, CELL, V84, P395, DOI 10.1016/S0092-8674(00)81284-2; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	45	354	361	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 15	2005	122	1					85	95		10.1016/j.cell.2005.04.025	http://dx.doi.org/10.1016/j.cell.2005.04.025			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	950EC	16009135	Green Published, Bronze			2022-12-28	WOS:000230839400013
J	Carmeliet, P; Tessier-Lavigne, M				Carmeliet, P; Tessier-Lavigne, M			Common mechanisms of nerve and blood vessel wiring	NATURE			English	Review							ENDOTHELIAL GROWTH-FACTOR; COMMISSURAL AXON GUIDANCE; CARDIOVASCULAR DEVELOPMENT; VASCULAR MORPHOGENESIS; OPTIC CHIASM; IN-VIVO; LYMPHATIC VASCULATURE; SYMPATHETIC NEURONS; ANGIOGENIC MITOGEN; MULTIPLE ASPECTS	Blood vessels and nerve fibres course throughout the body in an orderly pattern, often alongside one another. Although superficially distinct, the mechanisms involved in wiring neural and vascular networks seem to share some deep similarities. The discovery of key axon guidance molecules over the past decade has shown that axons are guided to their targets by finely tuned codes of attractive and repulsive cues, and recent studies reveal that these cues also help blood vessels to navigate to their targets. Parallels have also emerged between the actions of growth factors that direct angiogenic sprouting and those that regulate axon terminal arborization.	Univ Louvain VIB, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium; Genentech Inc, Div Res, San Francisco, CA 94080 USA	Flanders Institute for Biotechnology (VIB); Roche Holding; Genentech	Carmeliet, P (corresponding author), Univ Louvain VIB, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium.	peter.carmeliet@med.kuleuven.be; marctl@gene.com	Xiao, Yang/B-5668-2012; Carmeliet, Peter/AAQ-5140-2020	Carmeliet, Peter/0000-0001-7961-1821				Adams RH, 2001, CELL, V104, P57, DOI 10.1016/S0092-8674(01)00191-X; Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; *AR, 2004, AR PARTS AN; Augustin HG, 2003, CELL TISSUE RES, V314, P25, DOI 10.1007/s00441-003-0770-9; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; Basile JR, 2004, CANCER RES, V64, P5212, DOI 10.1158/0008-5472.CAN-04-0126; Bedell VM, 2005, P NATL ACAD SCI USA, V102, P6373, DOI 10.1073/pnas.0408318102; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Charron F, 2005, DEVELOPMENT, V132, P2251, DOI 10.1242/dev.01830; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Corset V, 2000, NATURE, V407, P747, DOI 10.1038/35037600; Davies AM, 2000, CURR BIOL, V10, pR374, DOI 10.1016/S0960-9822(00)00480-2; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; DIAMOND J, 1992, J NEUROSCI, V12, P1454; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fujisawa H, 2004, J NEUROBIOL, V59, P24, DOI 10.1002/neu.10337; Fuller T, 2003, J CELL SCI, V116, P2461, DOI 10.1242/jcs.00426; Gallo G, 1998, J NEUROSCI, V18, P5403, DOI 10.1523/JNEUROSCI.18-14-05403.1998; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Glebova NO, 2004, J NEUROSCI, V24, P743, DOI 10.1523/JNEUROSCI.4523-03.2004; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Honma Y, 2002, NEURON, V35, P267, DOI 10.1016/S0896-6273(02)00774-2; HOYLE GW, 1993, NEURON, V10, P1019, DOI 10.1016/0896-6273(93)90051-R; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Keleman K, 2005, NAT NEUROSCI, V8, P156, DOI 10.1038/nn1388; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Kim S, 2004, TRENDS NEUROSCI, V27, P194, DOI 10.1016/j.tins.2004.02.011; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; LeCouter J, 2001, NATURE, V412, P877, DOI 10.1038/35091000; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; Miao HQ, 1999, J CELL BIOL, V146, P233, DOI 10.1083/jcb.146.1.233; Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2; Nakagawa S, 2000, NEURON, V25, P599, DOI 10.1016/S0896-6273(00)81063-6; Ogawa K, 2000, ONCOGENE, V19, P6043, DOI 10.1038/sj.onc.1204004; Oike Y, 2002, BLOOD, V100, P1326, DOI 10.1182/blood.V100.4.1326.h81602001326_1326_1333; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; PANDEY A, 1995, SCIENCE, V268, P567, DOI 10.1126/science.7536959; Park KW, 2004, P NATL ACAD SCI USA, V101, P16210, DOI 10.1073/pnas.0405984101; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; Ramon y Cajal S, 1890, ANAT ANZEIGER, V5, P609; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003; Schwarz Q, 2004, GENE DEV, V18, P2822, DOI 10.1101/gad.322904; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Shoji W, 2003, DEVELOPMENT, V130, P3227, DOI 10.1242/dev.00516; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Suchting S, 2004, FASEB J, V18, P121, DOI 10.1096/fj.04-1991fje; Takashima S, 2002, P NATL ACAD SCI USA, V99, P3657, DOI 10.1073/pnas.022017899; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; Vesalius Andreas, 1543, HUMANI CORPORIFABR; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; WESSELLS NK, 1978, EXP CELL RES, V115, P111, DOI 10.1016/0014-4827(78)90408-1; Williams SE, 2004, CURR OPIN NEUROBIOL, V14, P51, DOI 10.1016/j.conb.2004.01.010; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9; Yuan L, 2002, DEVELOPMENT, V129, P4797; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2	104	755	793	2	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					193	200		10.1038/nature03875	http://dx.doi.org/10.1038/nature03875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015319				2022-12-28	WOS:000230459500028
J	Krause, DS; Van Etten, RA				Krause, DS; Van Etten, RA			Tyrosine kinases as targets for cancer therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CELL LUNG-CANCER; ACUTE MYELOID-LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; ETV6-NTRK3 GENE FUSION; PHASE-II TRIAL; GROWTH-FACTOR; BCR-ABL; C-KIT; IMATINIB-MESYLATE; ACTIVATING MUTATIONS		Tufts Univ, New England Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; Tufts Univ, New England Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University	Van Etten, RA (corresponding author), Tufts Univ, New England Med Ctr, Mol Oncol Res Inst, 750 Washington St,Box 5609, Boston, MA 02111 USA.	rvanetten@tufts-nemc.org			NCI NIH HHS [CA90576] Funding Source: Medline; NHLBI NIH HHS [HL56949] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090576] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056949] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; Apperley JF, 2002, NEW ENGL J MED, V347, P481, DOI 10.1056/NEJMoa020150; Arteaga CL, 2004, CANCER CELL, V5, P525, DOI 10.1016/j.ccr.2004.05.028; Barber KE, 2004, LEUKEMIA, V18, P1153, DOI 10.1038/sj.leu.2403357; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Baselga J, 2002, J CLIN ONCOL, V20, P4292, DOI 10.1200/JCO.2002.03.100; Baxter EJ, 2002, HUM MOL GENET, V11, P1391, DOI 10.1093/hmg/11.12.1391; Boldrini L, 2004, CLIN CANCER RES, V10, P4101, DOI 10.1158/1078-0432.CCR-03-0664; Branford S, 2003, BLOOD, V102, P276, DOI 10.1182/blood-2002-09-2896; Casali PG, 2004, CANCER-AM CANCER SOC, V101, P2086, DOI 10.1002/cncr.20618; Cazzaniga G, 1999, BLOOD, V94, P4370, DOI 10.1182/blood.V94.12.4370.424k34_4370_4373; Charest A, 2003, GENE CHROMOSOME CANC, V37, P58, DOI 10.1002/gcc.10207; Chen J, 2004, P NATL ACAD SCI USA, V101, P14479, DOI 10.1073/pnas.0404438101; Chen LL, 2004, CANCER RES, V64, P5913, DOI 10.1158/0008-5472.CAN-04-0085; Chesi M, 1997, NAT GENET, V16, P260, DOI 10.1038/ng0797-260; Cools J, 2003, CANCER CELL, V3, P459, DOI 10.1016/S1535-6108(03)00108-9; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Cruz J, 2003, ONCOLOGY-BASEL, V65, P72, DOI 10.1159/000071207; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V345, P232; Eguchi M, 1999, BLOOD, V93, P1355, DOI 10.1182/blood.V93.4.1355; Estey EH, 2003, BLOOD, V102, p614A; *FDA, 2004, FDA STAT IR; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fiedler W, 2003, BLOOD, V102, P2763, DOI 10.1182/blood-2002-10-2998; Finn Richard S, 2003, Cancer Chemother Biol Response Modif, V21, P223; Frederick L, 2000, CANCER RES, V60, P1383; FURITSU T, 1993, J CLIN INVEST, V92, P1736, DOI 10.1172/JCI116761; Gari M, 1999, BRIT J HAEMATOL, V105, P894, DOI 10.1046/j.1365-2141.1999.01449.x; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Gilliland DG, 2002, CANCER CELL, V1, P417, DOI 10.1016/S1535-6108(02)00081-8; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; Golub TR, 1996, MOL CELL BIOL, V16, P4107; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Gotlib J, 2003, BLOOD, V102, p919A; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Graux C, 2004, NAT GENET, V36, P1084, DOI 10.1038/ng1425; GRECO A, 1992, ONCOGENE, V7, P237; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Gumireddy K, 2005, P NATL ACAD SCI USA, V102, P1992, DOI 10.1073/pnas.0408283102; Gumireddy K, 2005, P NATL ACAD SCI USA, V102, P5635, DOI 10.1073/pnas.0501595102; Han SW, 2005, J CLIN ONCOL, V23, P2493, DOI 10.1200/JCO.2005.01.388; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; HERMANSON M, 1992, CANCER RES, V52, P3213; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Holdhoff M, 2005, BLOOD CELL MOL DIS, V34, P181, DOI 10.1016/j.bcmd.2004.11.006; Hughes TP, 2003, NEW ENGL J MED, V349, P1423, DOI 10.1056/NEJMoa030513; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Johnson BE, 2003, CLIN CANCER RES, V9, P5880; Kemmer K, 2004, AM J PATHOL, V164, P305, DOI 10.1016/S0002-9440(10)63120-3; Kilic T, 2000, CANCER RES, V60, P5143; Kindler T, 2004, BLOOD, V103, P3644, DOI 10.1182/blood-2003-06-2071; Klion AD, 2003, BLOOD, V101, P4660, DOI 10.1182/blood-2003-01-0006; Knezevich SR, 1998, NAT GENET, V18, P184, DOI 10.1038/ng0298-184; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kottaridis PD, 2002, BLOOD, V100, P2393, DOI 10.1182/blood-2002-02-0420; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Kuno Y, 2001, BLOOD, V97, P1050, DOI 10.1182/blood.V97.4.1050; Kwak EL, 2005, P NATL ACAD SCI USA, V102, P7665, DOI 10.1073/pnas.0502860102; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Liu Q, 2000, EMBO J, V19, P1827, DOI 10.1093/emboj/19.8.1827; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Ma PC, 2003, CANCER RES, V63, P6272; Macdonald D, 2002, ACTA HAEMATOL-BASEL, V107, P101, DOI 10.1159/000046639; Magnusson MK, 2002, BLOOD, V100, P1088, DOI 10.1182/blood-2002-01-0165; McArthur G, 2004, SEMIN ONCOL, V31, P30, DOI 10.1053/j.seminoncol.2004.03.038; McGary EC, 2002, CLIN CANCER RES, V8, P3584; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Mitsudomi T, 2005, J CLIN ONCOL, V23, P2513, DOI 10.1200/JCO.2005.00.992; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nakao M, 1996, LEUKEMIA, V10, P1911; *NAT CANC I, 2005, HERC COMB CHEM IMPR; Nishida T, 1998, NAT GENET, V19, P323, DOI 10.1038/1209; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; O'Brien SG, 2002, BLOOD, V99, P3465, DOI 10.1182/blood.V99.9.3465; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pardanani A, 2003, BLOOD, V102, P3093, DOI 10.1182/blood-2003-05-1627; Pulford K, 2004, CELL MOL LIFE SCI, V61, P2939, DOI 10.1007/s00018-004-4275-9; Rich JN, 2004, J CLIN ONCOL, V22, P133, DOI 10.1200/JCO.2004.08.110; RIDGE SA, 1990, P NATL ACAD SCI USA, V87, P1377, DOI 10.1073/pnas.87.4.1377; Rothenberg ML, 2003, NAT REV CANCER, V3, P303, DOI 10.1038/nrc1047; Rowinsky EK, 2004, J CLIN ONCOL, V22, P3003, DOI 10.1200/JCO.2004.11.061; Rubin BP, 2001, CANCER RES, V61, P8118; Santoro M, 2004, CELL MOL LIFE SCI, V61, P2954, DOI 10.1007/s00018-004-4276-8; Schaefer KL, 2004, CANCER RES, V64, P3395, DOI 10.1158/0008-5472.CAN-03-0809; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Simon MP, 1997, NAT GENET, V15, P95, DOI 10.1038/ng0197-95; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Smith BD, 2004, BLOOD, V103, P3669, DOI 10.1182/blood-2003-11-3775; Smith KM, 2003, MOL CELL, V12, P27, DOI 10.1016/S1097-2765(03)00274-0; Smithey BE, 2002, AM J SURG PATHOL, V26, P486, DOI 10.1097/00000478-200204000-00011; SOMAN NR, 1991, P NATL ACAD SCI USA, V88, P4892, DOI 10.1073/pnas.88.11.4892; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Stone RM, 2005, BLOOD, V105, P54, DOI 10.1182/blood-2004-03-0891; Tamborini E, 2004, CLIN CANCER RES, V10, P938, DOI 10.1158/1078-0432.CCR-03-0059; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Van Etten RA, 2004, CANCER CELL, V6, P547, DOI 10.1016/j.ccr.2004.12.004; Van Etten RA, 2003, CURR BIOL, V13, pR608, DOI 10.1016/S0960-9822(03)00528-1; Wadleigh M, 2005, BLOOD, V105, P22, DOI 10.1182/blood-2003-11-3896; Wallenius V, 2000, AM J PATHOL, V156, P821, DOI 10.1016/S0002-9440(10)64950-4; Watanabe D, 2004, BRIT J HAEMATOL, V126, P726, DOI 10.1111/j.1365-2141.2004.05107.x; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Weisberg E, 2002, CANCER CELL, V1, P433, DOI 10.1016/S1535-6108(02)00069-7; Wong S, 2004, P NATL ACAD SCI USA, V101, P17456, DOI 10.1073/pnas.0407061101; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Zermati Y, 2003, ONCOGENE, V22, P660, DOI 10.1038/sj.onc.1206120; Zhao JM, 2002, GENE CHROMOSOME CANC, V34, P48, DOI 10.1002/gcc.10035; Zheng R, 2004, BLOOD, V103, P267, DOI 10.1182/blood-2003-06-1969; Zipfel PA, 2004, CURR BIOL, V14, P1222, DOI 10.1016/j.cub.2004.07.021	123	1034	1122	6	144	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2005	353	2					172	187		10.1056/NEJMra044389	http://dx.doi.org/10.1056/NEJMra044389			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944OP	16014887	Green Published			2022-12-28	WOS:000230438800009
J	Sergio, F; Newton, I; Marchesi, L				Sergio, F; Newton, I; Marchesi, L			Top predators and biodiversity	NATURE			English	Editorial Material							CONSERVATION		CSIC, Estac Biol Donana, Dept Conservat Biol, Seville 41013, Spain; Trento Museum Nat Sci, Raptor Conservat Res Unit, I-38100 Trento, Italy; Ctr Ecol & Hydrol, Huntingdon PE28 2LS, Cambs, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); UK Centre for Ecology & Hydrology (UKCEH)	Sergio, F (corresponding author), CSIC, Estac Biol Donana, Dept Conservat Biol, Seville 41013, Spain.	fsergio@ebd.csic.es	Newton, Ian/AAV-5830-2021; Sergio, Fabrizio/B-3952-2015	Newton, Ian/0000-0002-7757-4008; Sergio, Fabrizio/0000-0002-8024-1773				Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; [Anonymous], 2001, CARNIVORE CONSERVATI; Carroll C, 2001, ECOL APPL, V11, P961, DOI 10.1890/1051-0761(2001)011[0961:CAFSFC]2.0.CO;2; Entwistle A, 2000, PRIORITIES CONSERVAT; JEGGINS MD, 2000, LANDSCAPE ECOL, V15, P5; Kerr JT, 1997, CONSERV BIOL, V11, P1094, DOI 10.1046/j.1523-1739.1997.96089.x; MURPHY DD, 1992, ECOL APPL, V2, P3, DOI 10.2307/1941885; White PCL, 1997, BIOL CONSERV, V82, P345, DOI 10.1016/S0006-3207(97)00036-0	8	204	227	4	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2005	436	7048					192	192		10.1038/436192a	http://dx.doi.org/10.1038/436192a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015318	Bronze, Green Submitted			2022-12-28	WOS:000230459500027
J	Tsao, MS; Sakurada, A; Cutz, JC; Zhu, CQ; Kamel-Reid, S; Squire, J; Lorimer, I; Zhang, T; Liu, N; Daneshmand, M; Marrano, P; Santos, GD; Lagarde, A; Richardson, F; Seymour, L; Whitehead, M; Ding, KY; Pater, J; Shepherd, FA				Tsao, MS; Sakurada, A; Cutz, JC; Zhu, CQ; Kamel-Reid, S; Squire, J; Lorimer, I; Zhang, T; Liu, N; Daneshmand, M; Marrano, P; Santos, GD; Lagarde, A; Richardson, F; Seymour, L; Whitehead, M; Ding, KY; Pater, J; Shepherd, FA			Erlotinib in lung cancer - Molecular and clinical predictors of outcome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GROWTH-FACTOR-RECEPTOR; TYROSINE KINASE; POOR-PROGNOSIS; EGFR MUTATIONS; GENE-MUTATIONS; FACTOR-ALPHA; GEFITINIB; EXPRESSION; SENSITIVITY; OVEREXPRESSION	BACKGROUND A clinical trial that compared erlotinib with a placebo for non - small- cell lung cancer demonstrated a survival benefit for erlotinib. We used tumor- biopsy samples from participants in this trial to investigate whether responsiveness to erlotinib and its impact on survival were associated with expression by the tumor of epidermal growth factor receptor ( EGFR) and EGFR gene amplification and mutations. METHODS EGFR expression was evaluated immunohistochemically in non - small- cell lung cancer specimens from 325 of 731 patients in the trial; 197 samples were analyzed for EGFR mutations; and 221 samples were analyzed for the number of EGFR genes. RESULTS In univariate analyses, survival was longer in the erlotinib group than in the placebo group when EGFR was expressed ( hazard ratio for death, 0.68; P= 0.02) or there was a high number of copies of EGFR ( hazard ratio, 0.44; P= 0.008). In multivariate analyses, adenocarcinoma ( P= 0.01), never having smoked ( P< 0.001), and expression of EGFR ( P= 0.03) were associated with an objective response. In multivariate analysis, survival after treatment with erlotinib was not influenced by the status of EGFR expression, the number of EGFR copies, or EGFR mutation. CONCLUSIONS Among patients with non - small- cell lung cancer who receive erlotinib, the presence of an EGFR mutation may increase responsiveness to the agent, but it is not indicative of a survival benefit.	Univ Hlth Network, Toronto, ON, Canada; Univ Toronto, Ontario Canc Inst, Toronto, ON, Canada; Univ Ottawa, Ottawa Hlth Res Inst, Ottawa, ON, Canada; OSI Pharmaceut, Boulder, CO USA; Natl Canc Inst Canada Clin Trials Grp, Kingston, ON, Canada; Queens Univ, Kingston, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Ottawa; Ottawa Hospital Research Institute; Astellas Pharmaceuticals; OSI Pharmaceuticals; Queens University - Canada; Canadian Cancer Trials Group; Queens University - Canada	Tsao, MS (corresponding author), Univ Hlth Network, Princess Margaret Hosp Site, Toronto, ON, Canada.		Squire, Jeremy A/A-9352-2012; Tsao, Ming-Sound/M-3503-2017; Tsao, Ming Sound/AFQ-7332-2022; da Cunha Santos, Gilda/A-5851-2010	Squire, Jeremy A/0000-0002-9863-468X; Tsao, Ming Sound/0000-0002-9160-5405; Kamel-Reid, Suzanne/0000-0002-4386-0292; Zhu, ChangQi/0000-0002-9992-0258; da Cunha Santos, Gilda/0000-0001-5577-7464				Arteaga CL, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.35642; Brabender J, 2001, CLIN CANCER RES, V7, P1850; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Dancey JE, 2004, CANCER CELL, V5, P411, DOI 10.1016/S1535-6108(04)00122-9; Fontanini G, 1998, CLIN CANCER RES, V4, P241; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Han SW, 2005, J CLIN ONCOL, V23, P2493, DOI 10.1200/JCO.2005.01.388; Herbst RS, 2003, CLIN CANCER RES, V9, P5813; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Hsieh ETK, 2000, LUNG CANCER, V29, P151, DOI 10.1016/S0169-5002(00)00116-1; Huang SF, 2004, CLIN CANCER RES, V10, P8195, DOI 10.1158/1078-0432.CCR-04-1245; Isomura M, 2004, J CLIN ONCOL, V22, p200S; Janne PA, 2004, LUNG CANCER-J IASLC, V44, P221, DOI 10.1016/j.lungcan.2003.12.014; Kim KS, 2005, CLIN CANCER RES, V11, P2244, DOI 10.1158/1078-0432.CCR-04-2081; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marchetti A, 2005, J CLIN ONCOL, V23, P857, DOI 10.1200/JCO.2005.08.043; Meert AP, 2002, EUR RESPIR J, V20, P975, DOI 10.1183/09031936.02.00296502; Miller VA, 2004, J CLIN ONCOL, V22, P1103, DOI 10.1200/JCO.2004.08.158; Nagahara H, 2005, CLIN CANCER RES, V11, P1368, DOI 10.1158/1078-0432.CCR-04-1894; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Parra HS, 2004, BRIT J CANCER, V91, P208, DOI 10.1038/sj.bjc.6601923; Pedersen MW, 2001, ANN ONCOL, V12, P745, DOI 10.1023/A:1011177318162; Perez-Soler R, 2004, J CLIN ONCOL, V22, P3238, DOI 10.1200/JCO.2004.11.057; Rusch V, 1997, CLIN CANCER RES, V3, P515; SALOMON DS, 2001, SIGNAL, V2, P4; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Selvaggi G, 2004, ANN ONCOL, V15, P28, DOI 10.1093/annonc/mdh011; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Sridhar SS, 2003, LANCET ONCOL, V4, P397, DOI 10.1016/S1470-2045(03)01137-9; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Swinson DEB, 2004, BRIT J CANCER, V91, P1301, DOI 10.1038/sj.bjc.6602149; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tokumo M, 2005, CLIN CANCER RES, V11, P1167; VEALE D, 1993, BRIT J CANCER, V68, P162, DOI 10.1038/bjc.1993.306; Weber F, 2005, BRIT J CANCER, V92, P1922, DOI 10.1038/sj.bjc.6602557; Yang SH, 2005, CLIN CANCER RES, V11, P2106, DOI 10.1158/1078-0432.CCR-04-1853	41	1539	1619	1	66	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2005	353	2					133	144		10.1056/NEJMoa050736	http://dx.doi.org/10.1056/NEJMoa050736			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944OP	16014883	Bronze			2022-12-28	WOS:000230438800005
J	Caine, A; Maltby, AE; Parkin, CA; Waters, JJ; Crolla, JA				Caine, A; Maltby, AE; Parkin, CA; Waters, JJ; Crolla, JA		UK ACC	Prenatal detection of Down's syndrome by rapid aneuploidy testing for chromosomes 13,18, and 21 by FISH or PCR without a full karyotype: a cytogenetic risk assessment	LANCET			English	Article							IN-SITU HYBRIDIZATION; FETAL NUCHAL-TRANSLUCENCY; QF-PCR; DIAGNOSIS; EXPERIENCE; ULTRASOUND; TRISOMY; PROBES; 1ST	Background In 2004, the UK National Screening Committee (UKNSC) recommended that new screening programmes for Down's syndrome need not include karyotyping and can offer prenatal diagnosis for the syndrome with FISH (fluorescence in-situ hybridisation) or PCR as rapid diagnostic tests. The UKNSC also recommended that FISH or PCR tests should only include trisomies 13, 18, and 21. We undertook a retrospective cytogenetic audit to assess the probable clinical effect of these proposed policy changes. Methods 23 prenatal cytogenetic laboratories from the UK public sector submitted data for amniotic fluid or chorionic villus samples referred from April, 1999, to March, 2004. We obtained data for the details of all abnormal karyotypes by reason for referral and assessed the efficiency of FISH and PCR rapid tests for the detection of chromosome abnormalities. Findings Of 119 528 amniotic fluid and 23 077 chorionic villus samples, rapid aneuploidy testing replacement of karyotyping would have resulted in about one in 100 and one in 40 samples having an undetected abnormal karyotype, respectively. Of these missed results, 293 (30%) of 1006 amniotic fluid samples and 152 (45%) of 327 chorionic villus samples were associated with a substantial risk of an abnormal phenotypic outcome. Of 34 995 amniotic fluid and 3049 chorionic villus samples that had karyotyping and a rapid test on the same sample, none of the three technologies was completely reliable to detect an abnormal karyotype, but the best protocol for an interpretable result was PCR and karyotyping or FISH and karyotyping. Interpretation Replacement of full karyotyping with rapid testing for trisomies 13, 18, and 21 after a positive screen for Down's syndrome will result in substantial numbers of liveborn children with hitherto preventable mental or physical handicaps, and represents a substantial change in the outcome quality of prenatal testing offered to couples in the UK.	Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England; St James Univ Hosp, Reg Cytogenet Unit, Leeds LS9 7TF, W Yorkshire, England; Sheffield Childrens NHS Trust, Sheffield, S Yorkshire, England; City Hosp Nottingham, Ctr Med Genet, Nottingham, England; Great Ormond St Hosp Children, NE London Reg Cytogenet Lab, London WC1N 3JH, England	Salisbury District Hospital; Saint James's University Hospital; Sheffield Children's NHS Foundation Trust; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Crolla, JA (corresponding author), Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England.	john.crolla@salisbury.nhs.uk						Cirigliano V, 2004, MOL HUM REPROD, V10, P839, DOI 10.1093/molehr/gah108; Evans MI, 1999, HUM REPROD, V14, P1213, DOI 10.1093/humrep/14.5.1213; Grimshaw G M, 2003, Health Technol Assess, V7, P1; HADDOW JE, 1992, NEW ENGL J MED, V327, P588, DOI 10.1056/NEJM199208273270902; HASSOLD T, 1993, CURR OPIN GENET DEV, V3, P398, DOI 10.1016/0959-437X(93)90111-2; Hulten MA, 2003, REPRODUCTION, V126, P279, DOI 10.1530/reprod/126.3.279; KALOUSEK DK, 1987, HUM GENET, V77, P163, DOI 10.1007/BF00272385; Levett LJ, 2001, ULTRASOUND OBST GYN, V17, P115, DOI 10.1046/j.1469-0705.2001.00340.x; Lewin P, 2000, PRENATAL DIAG, V20, P1; Mann K, 2004, EUR J HUM GENET, V12, P907, DOI 10.1038/sj.ejhg.5201224; NICOLAIDES KH, 1992, BRIT MED J, V304, P867, DOI 10.1136/bmj.304.6831.867; Snijders RJM, 1998, LANCET, V352, P343, DOI 10.1016/S0140-6736(97)11280-6; Spencer K, 2003, BJOG-INT J OBSTET GY, V110, P281, DOI 10.1016/S1470-0328(03)02946-X; Thein ATA, 2000, PRENATAL DIAG, V20, P275, DOI 10.1002/(SICI)1097-0223(200004)20:4<275::AID-PD799>3.0.CO;2-Z; Thilaganathan B, 2000, BRIT J OBSTET GYNAEC, V107, P262, DOI 10.1111/j.1471-0528.2000.tb11698.x; United Kingdom Department of Health, 2003, OUR INH OUR FUT REAL; Verma L, 1998, LANCET, V352, P9, DOI 10.1016/S0140-6736(97)11090-X; Wald N J, 1997, J Med Screen, V4, P181; Wald NJ, 1999, NEW ENGL J MED, V341, P461, DOI 10.1056/NEJM199908123410701; WARBURTON D, 1991, AM J HUM GENET, V49, P995; WARD BE, 1993, AM J HUM GENET, V52, P854; WATSON MS, 2000, GENET MED, V2, P356	22	89	122	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2005	366	9480					123	128		10.1016/S0140-6736(05)66790-6	http://dx.doi.org/10.1016/S0140-6736(05)66790-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	943JH	16005334				2022-12-28	WOS:000230349200030
J	Dezawa, M; Ishikawa, H; Itokazu, Y; Yoshihara, T; Hoshino, M; Takeda, S; Ide, C; Nabeshima, Y				Dezawa, M; Ishikawa, H; Itokazu, Y; Yoshihara, T; Hoshino, M; Takeda, S; Ide, C; Nabeshima, Y			Bone marrow stromal cells generate muscle cells and repair muscle degeneration	SCIENCE			English	Article							STEM-CELLS; MYOGENIC SPECIFICATION; REGULATORY GENE; EXPRESSION; DIFFERENTIATION; REGENERATION; QUIESCENT	Bone marrow stromal cells (MSCs) have great potential as therapeutic agents. We report a method for inducing skeletal muscle lineage cells from human and rat general adherent MSCs with an efficiency of 89%. Induced cells differentiated into muscle fibers upon transplantation into degenerated muscles of rats and mdx-nude mice. The induced population contained Pax7-positive cells that contributed to subsequent regeneration of muscle upon repetitive damage without additional transplantation of cells. These MSCs represent a more ready supply of myogenic cells than do the rare myogenic stem cells normally found in muscle and bone marrow.	Kyoto Univ, Grad Sch Med, Dept Anat & Neurobiol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Sakyo Ku, Kyoto 6068501, Japan; Natl Ctr Neurol & Psychiat, Dept Mol Therapy, Tokyo 1878502, Japan	Kyoto University; Kyoto University; National Center for Neurology & Psychiatry - Japan	Dezawa, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Anat & Neurobiol, Sakyo Ku, Kyoto 6068501, Japan.	dezawa@anat2.med.kyoto-u.ac.jp	谭, 德华 德/D-1910-2009	Ishikawa, Hiroto/0000-0003-0760-7203				Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Bischoff R., 1994, MYOLOGY, VVolume 1, P97; BOBER E, 1991, J CELL BIOL, V113, P1255, DOI 10.1083/jcb.113.6.1255; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; DEZAWA M, UNPUB; Dreyfus PA, 2004, AM J PATHOL, V164, P773, DOI 10.1016/S0002-9440(10)63165-3; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Fukada S, 2002, J CELL SCI, V115, P1285; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Qu Z, 2000, GENE THER, V7, P428, DOI 10.1038/sj.gt.3301103; ROHWEDEL J, 1994, DEV BIOL, V164, P87, DOI 10.1006/dbio.1994.1182; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Suva D, 2004, J CELL PHYSIOL, V198, P110, DOI 10.1002/jcp.10396; Torrente Y, 2003, J CELL BIOL, V162, P511, DOI 10.1083/jcb.200210006; Wada MR, 2002, DEVELOPMENT, V129, P2987; Yoshida N, 1998, J CELL SCI, V111, P769	21	458	525	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2005	309	5732					314	317		10.1126/science.1110364	http://dx.doi.org/10.1126/science.1110364			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002622				2022-12-28	WOS:000230449800050
J	Safina, C; Rosenberg, AA; Myers, RA; Quinn, TJ; Collie, JS				Safina, C; Rosenberg, AA; Myers, RA; Quinn, TJ; Collie, JS			US ocean fish recovery: Staying the course	SCIENCE			English	Article							BLUEFIN TUNA; ATLANTIC COD; POPULATION; COLLAPSE		SUNY Stony Brook, Marine Sci Res Ctr, Stony Brook, NY 11794 USA; Univ New Hampshire, Coll Agr & Life Sci, Durham, NH 03824 USA; Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada; Univ Alaska, Sch Fisheries & Ocean Sci, Juneau Ctr, Juneau, AK 99801 USA; Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University System Of New Hampshire; University of New Hampshire; Dalhousie University; University of Rhode Island	Safina, C (corresponding author), SUNY Stony Brook, Marine Sci Res Ctr, Stony Brook, NY 11794 USA.	csafina@blueocean.org		Quinn II, Terrance/0000-0002-9502-8959				Ames EP, 2004, FISHERIES, V29, P10, DOI 10.1577/1548-8446(2004)29[10:ACSSIT]2.0.CO;2; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Berkeley SA, 2004, FISHERIES, V29, P23, DOI 10.1577/1548-8446(2004)29[23:FSVPOA]2.0.CO;2; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Friedland KD, 2003, CAN J FISH AQUAT SCI, V60, P563, DOI 10.1139/F03-047; Hauser L, 2002, P NATL ACAD SCI USA, V99, P11742, DOI 10.1073/pnas.172242899; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Hutchings JA, 2000, NATURE, V406, P882, DOI 10.1038/35022565; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Myers RA, 1999, CAN J FISH AQUAT SCI, V56, P2404, DOI 10.1139/cjfas-56-12-2404; Myers RA, 1997, FISH B-NOAA, V95, P762; Pauly D, 2003, SCIENCE, V302, P1359, DOI 10.1126/science.1088667; Quinn T.J., 1999, BIOL RES MANAG SER; Safina C, 2004, ISSUES SCI TECHNOL, V21, P37; SAFINA C, 1993, CONSERV BIOL, V7, P229, DOI 10.1046/j.1523-1739.1993.07020229.x; Silliman BR, 2002, P NATL ACAD SCI USA, V99, P10500, DOI 10.1073/pnas.162366599; Sissenwine MP, 1998, T AM FISH SOC, V127, P838, DOI 10.1577/1548-8659(1998)127<0838:ACOWAB>2.0.CO;2; Staneck RS, 1998, TRENDS ECOL EVOL, V13, P429, DOI 10.1016/S0169-5347(98)01494-3; [No title captured]; [No title captured]; [No title captured]; [No title captured]	24	46	48	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2005	309	5735					707	708		10.1126/science.1113725	http://dx.doi.org/10.1126/science.1113725			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051773				2022-12-28	WOS:000230938200026
J	Weinberger, LS; Burnett, JC; Toettcher, JE; Arkin, AP; Schaffer, DV				Weinberger, LS; Burnett, JC; Toettcher, JE; Arkin, AP; Schaffer, DV			Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity	CELL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; COUPLED CHEMICAL-REACTIONS; DNA METHYLATION; SINGLE-CELL; TRANSCRIPTIONAL ACTIVITY; LATENT INFECTION; TYPE-1; GENOME; INTEGRATION; VECTOR	HIV-1 Tat transactivation is vital for completion of the viral life cycle and has been implicated in determining proviral latency. We present an extensive experimental/computational study of an HIV-1 model vector (LTR-GFP-IRES-Tat) and show that stochastic fluctuations in Tat influence the viral latency decision. Low GFP/Tat expression was found to generate bifurcating phenotypes with clonal populations derived from single proviral integrations simultaneously exhibiting very high and near zero GFP expression. Although phenotypic bifurcation (PheB) was correlated with distinct genomic integration patterns, neither these patterns nor other extrinsic cellular factors (cell cycle/size, aneuploidy, chromatin silencing, etc.) explained PheB. Stochastic computational modeling successfully accounted for PheB and correctly predicted the dynamics of a Tat mutant that were subsequently confirmed by experiment. Thus, Tat stochastics appear sufficient to generate PheB (and potentially proviral latency), illustrating the importance of stochastic fluctuations in gene expression in a mammalian system.	Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Bioengn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Weinberger, LS (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	leor@princeton.edu; aparkin@lbl.gov	Arkin, Adam/M-9941-2019; Arkin, Adam P/A-6751-2008	Arkin, Adam/0000-0002-4999-2931; Arkin, Adam P/0000-0002-4999-2931; Burnett, John/0000-0002-8817-6064	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073058] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM73058] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arkin A, 1998, GENETICS, V149, P1633; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Brooks DG, 2001, NAT MED, V7, P459, DOI 10.1038/86531; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fields B. N., 2001, FIELDS VIROLOGY, V4; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; HANAHAN D, 1980, CELL, V21, P127, DOI 10.1016/0092-8674(80)90120-8; He Hongpeng, 2003, Briefings in Functional Genomics & Proteomics, V2, P234, DOI 10.1093/bfgp/2.3.234; Horie R, 1998, INT IMMUNOL, V10, P203, DOI 10.1093/intimm/10.2.203; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; JAENISCH R, 1982, J CELL BIOCHEM, V20, P331, DOI 10.1002/jcb.240200403; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; Kaehlcke K, 2003, MOL CELL, V12, P167, DOI 10.1016/S1097-2765(03)00245-4; KARN J, 2000, HIV SEQUENCE COMPEND, P2; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Kutsch O, 2002, J VIROL, V76, P8776, DOI 10.1128/JVI.76.17.8776-8786.2002; Lai K, 2004, BIOPHYS J, V86, P2748, DOI 10.1016/S0006-3495(04)74328-3; Lewinski MK, 2005, J VIROL, V79, P6610, DOI 10.1128/JVI.79.11.6610-6619.2005; Lin X, 2003, J VIROL, V77, P8227, DOI 10.1128/JVI.77.15.8227-8236.2003; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Nightingale S, 2004, MOL THER, V9, pS159; Okada M, 2002, J RHEUMATOL, V29, P1678; OTT M, 2004, NOVART FDN SYMP, V259, P223; Ott M., 2004, NOVART FDN SYMP, V259, P193; Ott Melanie, 2004, Novartis Found Symp, V259, P182; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Pion M, 2003, J VIROL, V77, P4025, DOI 10.1128/JVI.77.7.4025-4032.2003; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Reddehase MJ, 2002, J CLIN VIROL, V25, pS23; Reddy B, 1999, AIDS RES HUM RETROV, V15, P273, DOI 10.1089/088922299311457; REUTER G, 1992, BIOESSAYS, V14, P605, DOI 10.1002/bies.950140907; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Srivastava R, 2002, J THEOR BIOL, V218, P309, DOI 10.1006/jtbi.2002.3078; STEVENS SW, 1994, P NATL ACAD SCI USA, V91, P5557, DOI 10.1073/pnas.91.12.5557; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Sverdlov ED, 2000, BIOESSAYS, V22, P161, DOI 10.1002/(SICI)1521-1878(200002)22:2<161::AID-BIES7>3.0.CO;2-X; Wu Yuntao, 2004, Retrovirology, V1, P13, DOI 10.1186/1742-4690-1-13; Yik JHN, 2004, MOL CELL BIOL, V24, P5094, DOI 10.1128/MCB.24.12.5094-5105.2004	53	457	464	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 29	2005	122	2					169	182		10.1016/j.cell.2005.06.006	http://dx.doi.org/10.1016/j.cell.2005.06.006			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	951CR	16051143	Green Submitted, Bronze			2022-12-28	WOS:000230907000006
J	Muscheler, R; Joos, F; Muller, SA; Snowball, I				Muscheler, R; Joos, F; Muller, SA; Snowball, I			Climate - How unusual is today's solar activity?	NATURE			English	Letter							GEOMAGNETIC-FIELD INTENSITY; LAST; CALIBRATION; RECORD		Natl Ctr Atmospher Res, Climate & Global Dynam Div, Boulder, CO 80305 USA; Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; Lund Univ, GeoBiosphere Sci Ctr, S-22362 Lund, Sweden	National Center Atmospheric Research (NCAR) - USA; University of Bern; Lund University	Muscheler, R (corresponding author), Natl Ctr Atmospher Res, Climate & Global Dynam Div, Boulder, CO 80305 USA.	raimund@ucar.edu	Joos, Fortunat/B-4118-2018	Joos, Fortunat/0000-0002-9483-6030; Muscheler, Raimund/0000-0003-2772-3631; Snowball, Ian/0000-0002-6257-3088				Bard E, 2000, TELLUS B, V52, P985, DOI 10.1034/j.1600-0889.2000.d01-7.x; Beer J, 2000, SPACE SCI REV, V93, P107, DOI 10.1023/A:1026536226656; Francey RJ, 1999, TELLUS B, V51, P170, DOI 10.1034/j.1600-0889.1999.t01-1-00005.x; Gerber S, 2003, CLIM DYNAM, V20, P281, DOI 10.1007/s00382-002-0270-8; Hoyt DV, 1998, SOL PHYS, V179, P189, DOI 10.1023/A:1005007527816; Joos F, 1996, TELLUS B, V48, P397, DOI 10.1034/j.1600-0889.1996.t01-2-00006.x; Masarik J, 1999, J GEOPHYS RES-ATMOS, V104, P12099, DOI 10.1029/1998JD200091; McCormac FG, 2002, RADIOCARBON, V44, P641, DOI 10.1017/S0033822200032094; MCCRACKEN KG, 2003, P 28 INT COSM RAY C, P4117; Muscheler R, 2005, QUATERNARY SCI REV, V24, P1849, DOI 10.1016/j.quascirev.2005.01.012; SIEGENTHALER U, 1983, J GEOPHYS RES-OCEANS, V88, P3599, DOI 10.1029/JC088iC06p03599; Snowball I, 2004, EARTH PLANET SC LETT, V227, P361, DOI 10.1016/j.epsl.2004.09.017; Solanki SK, 2004, NATURE, V431, P1084, DOI 10.1038/nature02995; Stuiver M, 1998, RADIOCARBON, V40, P1127, DOI 10.1017/S0033822200019172; Yang S, 2000, GEOPHYS J INT, V140, P158, DOI 10.1046/j.1365-246x.2000.00011.x	15	52	53	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					E3	E4		10.1038/nature04045	http://dx.doi.org/10.1038/nature04045			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049429				2022-12-28	WOS:000230788800034
J	Tanabe, KK; Blaszkowsky, LS; Chung, RT; Blake, MA; Lauwers, GY				Tanabe, KK; Blaszkowsky, LS; Chung, RT; Blake, MA; Lauwers, GY			Case 23-2005: A 57-year-old man with a mass in the liver - Hepatocellular carcinoma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PERCUTANEOUS ETHANOL INJECTION; RANDOMIZED CONTROLLED TRIAL; 2ND PRIMARY TUMORS; HEPATITIS-B; POSTOPERATIVE RECURRENCE; INTRAHEPATIC RECURRENCE; PROGNOSTIC INDEX; RESECTION; SURVIVAL; CIRRHOSIS		Massachusetts Gen Hosp, Dept Surg Oncol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Hematol Oncol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Gastrointestinal Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Surg, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University	Tanabe, KK (corresponding author), Massachusetts Gen Hosp, Dept Surg Oncol, Boston, MA 02114 USA.							ARII S, 1992, CANCER, V69, P913, DOI 10.1002/1097-0142(19920215)69:4<913::AID-CNCR2820690413>3.0.CO;2-T; BELGHITI J, 1991, ANN SURG, V214, P114, DOI 10.1097/00000658-199108000-00004; Bilimoria MM, 2001, ARCH SURG-CHICAGO, V136, P528, DOI 10.1001/archsurg.136.5.528; Bouchard MJ, 2001, SCIENCE, V294, P2376, DOI 10.1126/science.294.5550.2376; CHEN MF, 1994, ARCH SURG-CHICAGO, V129, P738; Chevret S, 1999, J HEPATOL, V31, P133, DOI 10.1016/S0168-8278(99)80173-1; Chisari FV, 2000, AM J PATHOL, V156, P1117, DOI 10.1016/S0002-9440(10)64980-2; CHUN HG, 2003, P AN M AM SOC CLIN, V22, P350; Couinaud C, 1957, FOIE ETUDES ANATOMIQ; Donato F, 1998, INT J CANCER, V75, P347, DOI 10.1002/(SICI)1097-0215(19980130)75:3&lt;347::AID-IJC4&gt;3.0.CO;2-2; Greene FL, 2002, AJCC CANC STAGING MA, P131; HARATAKE J, 1993, CANCER, V72, P1178, DOI 10.1002/1097-0142(19930815)72:4<1178::AID-CNCR2820720408>3.0.CO;2-Q; Hu R, 2003, SURGERY, V133, P251, DOI 10.1067/msy.2003.102; Hui AM, 2000, J HEPATOL, V33, P975, DOI 10.1016/S0168-8278(00)80131-2; Iwatsuki S, 2000, J AM COLL SURGEONS, V191, P389, DOI 10.1016/S1072-7515(00)00688-8; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Lau WY, 1999, LANCET, V353, P797, DOI 10.1016/S0140-6736(98)06475-7; Lau WY, 1998, INT J RADIAT ONCOL, V40, P583, DOI 10.1016/S0360-3016(97)00818-3; Lauwers GY, 2002, AM J SURG PATHOL, V26, P25, DOI 10.1097/00000478-200201000-00003; LAUWERS GY, 2003, MALIGNANT LIVER TUMO; Lencioni RA, 2003, RADIOLOGY, V228, P235, DOI 10.1148/radiol.2281020718; Leung TWT, 2002, CANCER, V94, P1760, DOI 10.1002/cncr.10384; *LIV CANC STUD GRO, 1997, GEN RUL CLIN PATH ST, P5; LIVRAGHI T, 1995, RADIOLOGY, V197, P101, DOI 10.1148/radiology.197.1.7568806; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Llovet JM, 1999, HEPATOLOGY, V30, P1434, DOI 10.1002/hep.510300629; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; Lok ASF, 2001, HEPATOLOGY, V34, P1225, DOI 10.1053/jhep.2001.29401; Manghisi G, 1998, HEPATOLOGY, V28, P751; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Muto Y, 1999, NEW ENGL J MED, V340, P1046, DOI 10.1056/NEJM199904013401315; Muto Y, 1996, NEW ENGL J MED, V334, P1561, DOI 10.1056/NEJM199606133342402; NAGAO T, 1990, ANN SURG, V211, P28, DOI 10.1097/00000658-199001000-00005; Nakamoto Y, 1998, J EXP MED, V188, P341, DOI 10.1084/jem.188.2.341; Nzeako UC, 1996, AM J CLIN PATHOL, V105, P65; OKUDA K, 1985, CANCER, V56, P918, DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E; Patt YZ, 2004, CANCER, V101, P578, DOI 10.1002/cncr.20368; Semelka RC, 2001, J MAGN RESON IMAGING, V13, P397, DOI 10.1002/jmri.1057; Shiffman ML, 2002, LIVER TRANSPLANT, V8, P174, DOI 10.1053/jlts.2002.30981; Solmi L, 1996, AM J GASTROENTEROL, V91, P1189; VAUTHEY JN, 1995, AM J SURG, V169, P28, DOI 10.1016/S0002-9610(99)80106-8; Vauthey JN, 2002, J CLIN ONCOL, V20, P1527, DOI 10.1200/JCO.20.6.1527; Villeneuve JP, 2000, HEPATOLOGY, V31, P207, DOI 10.1002/hep.510310130; Wayne JD, 2002, ANN SURG, V235, P722, DOI 10.1097/00000658-200205000-00015; Yang HI, 2002, NEW ENGL J MED, V347, P168, DOI 10.1056/NEJMoa013215	47	1	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2005	353	4					401	410		10.1056/NEJMcpc059019	http://dx.doi.org/10.1056/NEJMcpc059019			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949JW	16049213				2022-12-28	WOS:000230782800015
J	Verma, I				Verma, I			Then and now	NATURE			English	Article									Salk Inst Biol Studies, La Jolla, CA 92037 USA	Salk Institute	Verma, I (corresponding author), Salk Inst Biol Studies, La Jolla, CA 92037 USA.								0	4	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2005	436	7050					478	479		10.1038/436478a	http://dx.doi.org/10.1038/436478a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049468				2022-12-28	WOS:000230788800037
J	Roos, KL				Roos, KL			Viral encephalitis transmitted from donor to organ recipients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							4 TRANSPLANT RECIPIENTS; RABIES VIRUS; TRANSMISSION		Indiana Univ, Sch Med, Dept Neurol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Roos, KL (corresponding author), Indiana Univ Hosp, 550 N Univ Blvd,Suite 4411, Indianapolis, IN 46202 USA.	kroos@iupui.edu						Burton EC, 2005, ARCH NEUROL-CHICAGO, V62, P873, DOI 10.1001/archneur.62.6.873; Hemachudha T., 2005, PRINCIPLES NEUROLOGI, P151; Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987; Roos KL, 2005, ARCH NEUROL-CHICAGO, V62, P855, DOI 10.1001/archneur.62.6.855; Srinivasan A, 2005, NEW ENGL J MED, V352, P1103, DOI 10.1056/NEJMoa043018	5	2	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2005	294	4					488	489		10.1001/jama.294.4.488	http://dx.doi.org/10.1001/jama.294.4.488			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RM	16050013				2022-12-28	WOS:000230733400024
J	Delatycki, MB; Allen, KJ; Nisselle, AE; Collins, V; Metcalfe, S; du Sart, D; Halliday, J; Aitken, MA; Macciocca, I; Hill, V; Wakefield, A; Ritchie, A; Gason, AA; Nicoll, AJ; Powell, LW; Williamson, R				Delatycki, MB; Allen, KJ; Nisselle, AE; Collins, V; Metcalfe, S; du Sart, D; Halliday, J; Aitken, MA; Macciocca, I; Hill, V; Wakefield, A; Ritchie, A; Gason, AA; Nicoll, AJ; Powell, LW; Williamson, R			Use of community genetic screening to prevent HFE-associated hereditary haemochromatosis	LANCET			English	Article							PENETRANCE	HFE-associated hereditary haemochromatosis is a recessive, iron-overload disorder that affects about one in 200 north Europeans and that can be easily prevented. However, genetic screening for this disease is controversial, and so we assessed whether such screening was suitable for communities. Cheek-brush screening for the Cys282Tyr HFE mutation was offered to individuals in the workplace. Outcomes were assessed by questionnaires before and after testing. 11307 individuals were screened. We recorded no increase in anxiety. in individuals who were homozygous for the Cys282Tyr mutation or non-homozygous. Self-reported tiredness before testing was significantly higher in homozygous participants than in non-homozygous participants (chi(2) test, p=0.029). Of the 47 homozygous individuals identified, 46 have taken steps to treat or prevent iron accumulation. Population genetic screening for HFE-associated hereditary haemochromatosis can be practicable and acceptable.	Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; Bruce Lefroy Ctr Genet Hlth Res, Parkville, Vic, Australia; Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; Royal Childrens Hosp, Dept Gastroenterol & Clin Nutr, Melbourne, Vic, Australia; Royal Melbourne Hosp, Dept Gastroenterol, Melbourne, Vic, Australia; Univ Queensland, Brisbane, Qld, Australia; Queensland Inst Med Res, Brisbane, Qld 4006, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; Royal Melbourne Hospital; University of Queensland; QIMR Berghofer Medical Research Institute	Allen, KJ (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	katie.allen@rch.org.au	halliday, jane/T-1476-2019; Delatycki, Martin B/A-5409-2013; , Amy/M-3622-2019; Allen, Katrina/I-4361-2018; Metcalfe, Sylvia A/B-5303-2014	, Amy/0000-0002-8908-5906; Allen, Katrina/0000-0002-1921-4493; 				Allen KJ, 2002, LANCET, V360, P412, DOI 10.1016/S0140-6736(02)09583-1; Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; Delatycki M, 2002, LANCET, V359, P1433, DOI 10.1016/S0140-6736(02)08369-1; Guyader D, 1998, GASTROENTEROLOGY, V115, P929, DOI 10.1016/S0016-5085(98)70265-3; McDonnell SM, 1999, AM J MED, V106, P619, DOI 10.1016/S0002-9343(99)00120-5; Nisselle AE, 2004, CLIN GENET, V65, P358, DOI 10.1111/j.1399-0004.2004.0239.x; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; Powell LW, 2004, HEPATOLOGY, V40, p574A	8	75	76	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2005	366	9482					314	316		10.1016/S0140-6736(05)63012-7	http://dx.doi.org/10.1016/S0140-6736(05)63012-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RJ	16039334				2022-12-28	WOS:000230733100030
J	Ice, RJ; Wildonger, J; Mann, RS; Hiebert, SW				Ice, RJ; Wildonger, J; Mann, RS; Hiebert, SW			Comment on "Nervy links protein kinase A to plexin-mediated semaphorin repulsion"	SCIENCE			English	Editorial Material							IDENTIFICATION; TARGET; ETO		Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Vanderbilt Univ, Sch Med, Dept Biochem, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA	Columbia University; Vanderbilt University	Ice, RJ (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 701 W 168th St,HHSC 1104, New York, NY 10032 USA.	rsm10@columbia.edu; Scott.Hieber@vanderbilt.edu			NCI NIH HHS [CA64140, R01 CA087379, CA87379] Funding Source: Medline; NIGMS NIH HHS [R01 GM058575] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amann JM, 2001, MOL CELL BIOL, V21, P6470, DOI 10.1128/MCB.21.19.6470-6483.2001; Asirvatham AL, 2004, J IMMUNOL, V173, P4806, DOI 10.4049/jimmunol.173.8.4806; Davis JN, 2003, GENE, V303, P1, DOI 10.1016/S0378-1119(02)01172-1; FEINSTEIN PG, 1995, GENETICS, V140, P573; Fukuyama T, 2001, ONCOGENE, V20, P6225, DOI 10.1038/sj.onc.1204794; Rossetti S, 2004, GENOMICS, V84, P1, DOI 10.1016/j.ygeno.2004.02.011; Schillace RV, 2002, J IMMUNOL, V168, P1590, DOI 10.4049/jimmunol.168.4.1590; Terman JR, 2004, SCIENCE, V303, P1204, DOI 10.1126/science.1092121	8	3	3	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2005	309	5734								10.1126/science.1108719	http://dx.doi.org/10.1126/science.1108719			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040690				2022-12-28	WOS:000230735200026
J	Shuster, DL; Weiss, BP				Shuster, DL; Weiss, BP			Martian surface paleotemperatures from thermochronology of meterorites	SCIENCE			English	Article							MAGNETIC-PROPERTIES; METEORITES; MARS; AGES; TEMPERATURE; DIFFUSION; NAKHLITES; EVOLUTION; ALH84001; ARGON	The temporal evolution of past martian surface temperatures is poorly known. We used thermochronology and published noble gas and petrographic data to constrain the temperature histories of the nakhlites and martian meteorite ALH84001. We found that the nakhlites have not been heated to more than 350 degrees C since they formed. Our calculations also suggest that for most of the past 4 billion years, ambient near-surface temperatures on Mars are unlikely to have been much higher than the present cold (<0 degrees C) state.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	Massachusetts Institute of Technology (MIT); California Institute of Technology	Weiss, BP (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 54-724, Cambridge, MA 02139 USA.	bpweiss@mit.edu	Shuster, David/A-4838-2011					Artemieva N, 2004, ICARUS, V171, P84, DOI 10.1016/j.icarus.2004.05.003; Bogard DD, 1999, METEORIT PLANET SCI, V34, P451, DOI 10.1111/j.1945-5100.1999.tb01353.x; Bridges JC, 2001, SPACE SCI REV, V96, P365, DOI 10.1023/A:1011965826553; BURGESS R, 2000, J C ABSTR, V5, P266; Carr M.H, 1996, WATER MARS; Collinson DW, 1997, METEORIT PLANET SCI, V32, P803, DOI 10.1111/j.1945-5100.1997.tb01571.x; Eugster O, 2002, METEORIT PLANET SCI, V37, P1345, DOI 10.1111/j.1945-5100.2002.tb01033.x; FANALE FP, 1982, ICARUS, V50, P381, DOI 10.1016/0019-1035(82)90131-2; Fechtig H., 1966, POTASSIUM ARGON DATI, P68, DOI DOI 10.1007/978-3-642-87895-4_4; FRITZ J, 2003, LUNAR PLANET SCI, V26; GANAPATHY R, 1969, GEOCHIM COSMOCHIM AC, V33, P775, DOI 10.1016/0016-7037(69)90026-X; Gilder SA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019844; Greenwood JP, 2001, METEORIT PLANET SCI, V36, P43, DOI 10.1111/j.1945-5100.2001.tb01809.x; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; Lentz RCF, 1999, METEORIT PLANET SCI, V34, P919, DOI 10.1111/j.1945-5100.1999.tb01410.x; Lovera OM, 2002, GEOCHIM COSMOCHIM AC, V66, P1237, DOI 10.1016/S0016-7037(01)00846-8; Marti K., 2004, ANTARCT METEORITE RE, V17, P117; McDougall I., 1999, GEOCHRONOLOGY THERMO, V2ed; MCSWEEN HY, 1998, PLANETARY MAT; MELOSH HJ, 1993, NATURE, V363, P498, DOI 10.1038/363498a0; MELOSH HJ, 1986, IMPACT CRATERING GEO; Meyer C., 2003, MARS METEORITE COMPE; Mikouchi T., 2003, ANT METEORIT RES, V16, P34; Min K, 2004, GEOLOGY, V32, P677, DOI 10.1130/G20510.1; MIN K, 2005, LUNAR PLANET SCI, V36; MURTY SVS, 2005, LUNAR PLANET SCI, V36; Nyquist LE, 2001, SPACE SCI REV, V96, P105, DOI 10.1023/A:1011993105172; Shuster DL, 2004, EARTH PLANET SC LETT, V217, P1, DOI 10.1016/S0012-821X(03)00595-8; Swindle TD, 2004, METEORIT PLANET SCI, V39, P755, DOI 10.1111/j.1945-5100.2004.tb00117.x; Terada K, 2003, METEORIT PLANET SCI, V38, P1697, DOI 10.1111/j.1945-5100.2003.tb00009.x; Weiss BP, 2002, EARTH PLANET SC LETT, V201, P465, DOI 10.1016/S0012-821X(02)00729-X; Weiss BP, 2000, SCIENCE, V290, P791, DOI 10.1126/science.290.5492.791; [No title captured]	34	81	81	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2005	309	5734					594	597		10.1126/science.1113077	http://dx.doi.org/10.1126/science.1113077			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040703				2022-12-28	WOS:000230735200043
J	Negrete, OA; Levroney, EL; Aguilar, HC; Bertolotti-Ciarlet, A; Nazarian, R; Tajyar, S; Lee, B				Negrete, OA; Levroney, EL; Aguilar, HC; Bertolotti-Ciarlet, A; Nazarian, R; Tajyar, S; Lee, B			EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus	NATURE			English	Article							ENDOTHELIAL-CELLS; HAMSTER MODEL; SMOOTH-MUSCLE; FUSION; HENDRA; ROLES; NEOVASCULARIZATION; GLYCOPROTEINS; ENCEPHALITIS; VACCINATION	Nipah virus (NiV) is an emergent paramyxovirus that causes fatal encephalitis in up to 70 per cent of infected patients(1), and there is evidence of human - to - human transmission(2). Endothelial syncytia, comprised of multinucleated giant-endothelial cells, are frequently found in NiV infections, and are mediated by the fusion ( F) and attachment ( G) envelope glycoproteins. Identification of the receptor for this virus will shed light on the pathobiology of NiV infection, and spur the rational development of effective therapeutics. Here we report that ephrinB2, the membrane-bound ligand for the EphB class of receptor tyrosine kinases (RTKs)(3), specifically binds to the attachment (G) glycoprotein of NiV. Soluble Fc-fusion proteins of ephrinB2, but not ephrinB1, effectively block NiV fusion and entry into permissive cell types. Moreover, transfection of ephrinB2 into non-permissive cells renders them permissive for NiV fusion and entry. EphrinB2 is expressed on endothelial cells and neurons(3,4), which is consistent with the known cellular tropism for NiV5. Significantly, we find that NiV-envelope-mediated infection of microvascular endothelial cells and primary cortical rat neurons is inhibited by soluble ephrinB2, but not by the related ephrinB1 protein. Cumulatively, our data show that ephrinB2 is a functional receptor for NiV.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, UCLA AIDS Inst, Los Angeles, CA 90095 USA; Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Pennsylvania	Lee, B (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA.	bleebhl@ucla.edu	Aguilar, Hector/AAD-6663-2022; Lee, Benhur/A-8554-2016	Lee, Benhur/0000-0003-0760-1709	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI059051] Funding Source: NIH RePORTER; NIAID NIH HHS [R21 AI059051] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bossart Katharine N, 2004, Methods Mol Biol, V269, P309; Bossart KN, 2002, J VIROL, V76, P11186, DOI 10.1128/JVI.76.22.11186-11198.2002; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Estus S, 1997, J NEUROSCI, V17, P7736; Field H, 2001, MICROBES INFECT, V3, P307, DOI 10.1016/S1286-4579(01)01384-3; Gale NW, 2001, DEV BIOL, V230, P151, DOI 10.1006/dbio.2000.0112; Guillaume V, 2004, J VIROL, V78, P834, DOI 10.1128/JVI.78.2.834-840.2004; Harcourt BH, 2000, VIROLOGY, V271, P334, DOI 10.1006/viro.2000.0340; Hooper P, 2001, MICROBES INFECT, V3, P315, DOI 10.1016/S1286-4579(01)01385-5; Hsu VP, 2004, EMERG INFECT DIS, V10, P2082, DOI 10.3201/eid1012.040701; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lam SK, 2003, ANTIVIR RES, V57, P113, DOI 10.1016/S0166-3542(02)00204-8; Liu J, 2002, MED RES REV, V22, P1, DOI 10.1002/med.1026; Noren NK, 2004, P NATL ACAD SCI USA, V101, P5583, DOI 10.1073/pnas.0401381101; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Parashar UD, 2000, J INFECT DIS, V181, P1755, DOI 10.1086/315457; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Rucker J, 1997, METHOD ENZYMOL, V288, P118; Shao R, 2004, BIOCHEM BIOPH RES CO, V321, P788, DOI 10.1016/j.bbrc.2004.07.033; Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Tamin A, 2002, VIROLOGY, V296, P190, DOI 10.1006/viro.2002.1418; Tollefsen S, 2003, SCAND J IMMUNOL, V57, P229, DOI 10.1046/j.1365-3083.2003.01218.x; Wong KT, 2003, AM J PATHOL, V163, P2127, DOI 10.1016/S0002-9440(10)63569-9; Wong KT, 2002, AM J PATHOL, V161, P2153, DOI 10.1016/S0002-9440(10)64493-8; 2004, HLTH SCI B, V2, P5	27	331	355	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					401	405		10.1038/nature03838	http://dx.doi.org/10.1038/nature03838			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16007075	Bronze			2022-12-28	WOS:000230623400044
J	Parkes, RJ; Webster, G; Cragg, BA; Weightman, AJ; Newberry, CJ; Ferdelman, TG; Kallmeyer, J; Jorgensen, BB; Aiello, IW; Fry, JC				Parkes, RJ; Webster, G; Cragg, BA; Weightman, AJ; Newberry, CJ; Ferdelman, TG; Kallmeyer, J; Jorgensen, BB; Aiello, IW; Fry, JC			Deep sub-seafloor prokaryotes stimulated at interfaces over geological time	NATURE			English	Article							SUBSEAFLOOR SEDIMENTS; MICROBIAL COMMUNITIES; BACTERIAL DIVERSITY; MARINE-SEDIMENTS; BIOSPHERE; METHANE; OXIDATION; SULFIDE; DENMARK; MARGIN	The sub-seafloor biosphere is the largest prokaryotic habitat on Earth(1) but also a habitat with the lowest metabolic rates(2). Modelled activity rates are very low, indicating that most prokaryotes may be inactive or have extraordinarily slow metabolism(2). Here we present results from two Pacific Ocean sites, margin and open ocean, both of which have deep, subsurface stimulation of prokaryotic processes associated with geochemical and/or sedimentary interfaces. At 90 m depth in the margin site, stimulation was such that prokaryote numbers were higher ( about 13-fold) and activity rates higher than or similar to near-surface values. Analysis of high-molecular-mass DNA confirmed the presence of viable prokaryotes and showed changes in biodiversity with depth that were coupled to geochemistry, including a marked community change at the 90-m interface. At the open ocean site, increases in numbers of prokaryotes at depth were more restricted but also corresponded to increased activity; however, this time they were associated with repeating layers of diatom-rich sediments ( about 9 Myr old). These results show that deep sedimentary prokaryotes can have high activity, have changing diversity associated with interfaces and are active over geological timescales.	Cardiff Univ, Sch Earth Ocean & Planetary Sci, Cardiff CF10 3YE, Wales; Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3TL, Wales; Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; Moss Landing Marine Labs, Moss Landing, CA 95039 USA	Cardiff University; Cardiff University; Max Planck Society; Moss Landing Marine Laboratories	Parkes, RJ (corresponding author), Cardiff Univ, Sch Earth Ocean & Planetary Sci, Main Bldg,Pk Pl, Cardiff CF10 3YE, Wales.	j.parkes@earth.cf.ac.uk	Webster, Gordon/A-1877-2008; Fry, John C/H-6081-2012; Weightman, Andrew/W-7659-2019; Weightman, Andrew/W-8681-2019; Kallmeyer, Jens/AAF-6906-2020; chen, qi/C-8585-2011; Cragg, Barry/D-2690-2009; Weightman, Andrew J/A-2970-2010; Kallmeyer, Jens/I-3554-2012; Jorgensen, Bo B/C-2214-2013; Parkes, Ronald/B-1731-2010; Ferdelman, Timothy G/A-3758-2013	Webster, Gordon/0000-0002-9530-7835; Weightman, Andrew/0000-0002-6671-2209; Kallmeyer, Jens/0000-0002-6440-1140; Weightman, Andrew J/0000-0002-6671-2209; Kallmeyer, Jens/0000-0002-6440-1140; Jorgensen, Bo B/0000-0001-9398-8027; Parkes, Ronald/0000-0001-9402-5943; Ferdelman, Timothy G/0000-0002-9701-3793				Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; CHAPELLE FH, 1990, APPL ENVIRON MICROB, V56, P1865, DOI 10.1128/AEM.56.6.1865-1874.1990; Coolen MJL, 2002, SCIENCE, V296, P2407, DOI 10.1126/science.1071893; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; D'Hondt S, 2002, SCIENCE, V295, P2067, DOI 10.1126/science.1064878; D'Hondt S.L., 2003, INITIAL REPORTS, V201, P1, DOI DOI 10.2973/ODP.PROC.IR.201.111.2003; Ibaraki M., 1990, Proceedings of the Ocean Drilling Program Scientific Results, V112, P239, DOI 10.2973/odp.proc.sr.112.197.1990; Inagaki F, 2003, APPL ENVIRON MICROB, V69, P7224, DOI 10.1128/AEM.69.12.7224-7235.2003; IVERSEN N, 1985, LIMNOL OCEANOGR, V30, P944, DOI 10.4319/lo.1985.30.5.0944; Kallmeyer J, 2004, LIMNOL OCEANOGR-METH, V2, P171, DOI 10.4319/lom.2004.2.171; Kemp PF, 2004, FEMS MICROBIOL ECOL, V47, P161, DOI 10.1016/S0168-6496(03)00257-5; Krumholz LR, 1997, NATURE, V386, P64, DOI 10.1038/386064a0; Leloup J, 2004, FEMS MICROBIOL ECOL, V47, P207, DOI 10.1016/S0168-6496(03)00262-9; LOVLEY DR, 1995, REV GEOPHYS, V33, P365, DOI 10.1029/95RG01305; Marchesi JR, 2001, FEMS MICROBIOL ECOL, V34, P221, DOI 10.1016/S0168-6496(00)00099-4; MCMAHON PB, 1992, J SEDIMENT PETROL, V62, P1; Mitterer RM, 2001, GEOPHYS RES LETT, V28, P3931, DOI 10.1029/2001GL013320; Newberry CJ, 2004, ENVIRON MICROBIOL, V6, P274, DOI 10.1111/j.1462-2920.2004.00568.x; Parkes RJ, 2000, HYDROGEOL J, V8, P11, DOI 10.1007/PL00010971; PARKES RJ, 1990, PHILOS T R SOC A, V331, P139, DOI 10.1098/rsta.1990.0061; PARKES RJ, 2004, MICROBIAL DIVERSITY, P120; Schippers A, 2005, NATURE, V433, P861, DOI 10.1038/nature03302; Teske A, 1996, APPL ENVIRON MICROB, V62, P1405, DOI 10.1128/AEM.62.4.1405-1415.1996; Webster G, 2004, APPL ENVIRON MICROB, V70, P5708, DOI 10.1128/AEM.70.9.5708-5713.2004; Webster G, 2003, J MICROBIOL METH, V55, P155, DOI 10.1016/S0167-7012(03)00140-4; Wellsbury P, 1997, NATURE, V388, P573, DOI 10.1038/41544; WELLSBURY P, 1993, FEMS MICROBIOL ECOL, V12, P87; Wellsbury P., 2000, PROC OCEAN DRILL SCI, V164, P379, DOI DOI 10.2973/ODP.PROC.SR.164.216.2000; WHELAN JK, 1990, P ODP SCI RESULTS, V112, P573; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	30	327	347	2	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 21	2005	436	7049					390	394		10.1038/nature03796	http://dx.doi.org/10.1038/nature03796			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034418	Green Accepted			2022-12-28	WOS:000230623400042
J	Palmer, I				Palmer, I			ABC of conflict and disaster - Psychological aspects of providing medical humanitarian aid	BRITISH MEDICAL JOURNAL			English	Review									Inst Psychiat, Div Psychol Med, London, England	University of London; King's College London	Palmer, I (corresponding author), Inst Psychiat, Div Psychol Med, London, England.							Basoglu M., 1992, TORTURE ITS CONSEQUE; BRACKEN PJ, 1988, RETHINKING TRAMA WAR; Palmer I., 2002, ADV PSYCHIAT TREATME, V8, P17; SUMMERFIELD D, 1997, PSYCHOL TRAUMA DEV A; *UN HIGH COMM REF, 1993, GUID EV CAR VICT TRA	5	11	11	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 16	2005	331	7509					152	154		10.1136/bmj.331.7509.152	http://dx.doi.org/10.1136/bmj.331.7509.152			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	947GV	16020857	Green Published			2022-12-28	WOS:000230632300021
J	Spaldin, NA; Fiebig, M				Spaldin, NA; Fiebig, M			The renaissance of magnetoelectric multiferroics	SCIENCE			English	Editorial Material									Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA; Max Born Inst, D-12489 Berlin, Germany	University of California System; University of California Santa Barbara; Max Born Institute for Nonlinear Optics & Short Term Spectroscopy	Spaldin, NA (corresponding author), Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA.	nicola@mrl.ucsb.edu; fiebig@mbi-berlin.de	Spaldin, Nicola A/A-1017-2010	Spaldin, Nicola A/0000-0003-0709-9499				Fiebig M, 2005, J PHYS D APPL PHYS, V38, pR123, DOI 10.1088/0022-3727/38/8/R01; Hill NA, 2000, J PHYS CHEM B, V104, P6694, DOI [10.1021/jp000114x, 10.1021/jpc00114x]; Kimura T, 2003, NATURE, V426, P55, DOI 10.1038/nature02018; Lottermoser T, 2004, NATURE, V430, P541, DOI 10.1038/nature02728; Schmid H., 1994, Ferroelectrics, V162, P317, DOI 10.1080/00150199408245120; Withers RL, 2001, FERROELECTRICS, V250, P47, DOI 10.1080/00150190108225030; Zheng H, 2004, SCIENCE, V303, P661, DOI 10.1126/science.1094207	7	2363	2429	15	675	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					391	392		10.1126/science.1113357	http://dx.doi.org/10.1126/science.1113357			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020720				2022-12-28	WOS:000230574900030
J	Vigny, C; Simons, WJF; Abu, S; Bamphenyu, R; Satirapod, C; Choosakul, N; Subarya, C; Socquet, A; Omar, K; Abidin, HZ; Ambrosius, BAC				Vigny, C; Simons, WJF; Abu, S; Bamphenyu, R; Satirapod, C; Choosakul, N; Subarya, C; Socquet, A; Omar, K; Abidin, HZ; Ambrosius, BAC			Insight into the 2004 Sumatra-Andaman earthquake from GPS measurements in southeast Asia	NATURE			English	Article							FAULT	Data collected at,60 Global Positioning System (GPS) sites in southeast Asia show the crustal deformation caused by the 26 December 2004 Sumatra - Andaman earthquake at an unprecedented large scale. Small but significant co-seismic jumps are clearly detected more than 3,000 km from the earthquake epicentre. The nearest sites, still more than 400 km away, show displacements of 10 cm or more. Here we show that the rupture plane for this earthquake must have been at least 1,000 km long and that non-homogeneous slip is required to fit the large displacement gradients revealed by the GPS measurements. Our kinematic analysis of the GPS recordings indicates that the centroid of released deformation is located at least 200 km north of the seismological epicentre. It also provides evidence that the rupture propagated northward sufficiently fast for stations in northern Thailand to have reached their final positions less than 10 min after the earthquake, hence ruling out the hypothesis of a silent slow aseismic rupture.	Ecole Normale Super, CNRS, Geol Lab, F-75231 Paris, France; Delft Univ Technol, DEOS, NL-2629 HS Delft, Netherlands; Dept Survey & Mapping Malaysia, Kuala Lumpur 50578, Malaysia; Royal Thai Survey Dept, Bangkok 10200, Thailand; Chulalongkorn Univ, Dept Survey Engn, Bangkok 10330, Thailand; Chulalongkorn Univ, Dept Geol, Bangkok 10330, Thailand; Natl Coordinat Agcy Surveys & Mapping BAKOSURTANA, Cibinong 16911, Indonesia; Univ Technol Malaysia, Johor Baharu 81310, Malaysia; Inst Technol Bandung, Bandung 40132, Indonesia	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Delft University of Technology; Chulalongkorn University; Chulalongkorn University; Universiti Teknologi Malaysia; Institute Technology of Bandung	Vigny, C (corresponding author), Ecole Normale Super, CNRS, Geol Lab, 24 Rue Lhomond, F-75231 Paris, France.	vigny@geologie.ens.fr	Socquet, Anne/A-5698-2011; Simons, Wim/AAP-9336-2021; Abidin, Hasanuddin Z./AAM-6900-2021	Socquet, Anne/0000-0002-9208-7136; Abidin, Hasanuddin Z./0000-0002-9276-9348				Altamimi Z, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000561; Bock Y, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000324; Feigl KL, 1999, COMPUT GEOSCI-UK, V25, P695, DOI 10.1016/S0098-3004(99)00003-5; Heki K, 1997, NATURE, V386, P595, DOI 10.1038/386595a0; LEDAIN AY, 1984, J GEOPHYS RES, V89, P453, DOI 10.1029/JB089iB01p00453; Marquez Azua B., 2002, Geophysical Research Letters, V29, P122, DOI 10.1029/2001GL014702; McCaffrey R., 2002, GEODYNAMICS, V30, P101, DOI 10.1029/030GD06; MCCAFFREY R, IN PRESS J GEOPHYS R; McCloskey J, 2005, NATURE, V434, P291, DOI 10.1038/434291a; Michel GW, 2001, EARTH PLANET SC LETT, V187, P239, DOI 10.1016/S0012-821X(01)00298-9; Nielsen C, 2004, MAR GEOL, V209, P303, DOI 10.1016/j.margeo.2004.05.001; OKADA Y, 1985, B SEISMOL SOC AM, V75, P1135; Ortiz M, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001941; Prawirodirdjo L, 1997, GEOPHYS RES LETT, V24, P2601, DOI 10.1029/97GL52691; Pubellier M, 2003, B SOC GEOL FR, V174, P561, DOI 10.2113/174.6.561; RUEGG JC, 2001, SEISMOL RES LETT, V72, P680; Scholz CH, 1998, NATURE, V391, P37, DOI 10.1038/34097; Sieh K, 2000, J GEOPHYS RES-SOL EA, V105, P28295, DOI 10.1029/2000JB900120; SIMONS W, UNPUB J GEOPHYS RES; SOCQUET A, UNPUB J GEOPHYS RES; Stein RS, 1999, NATURE, V402, P605, DOI 10.1038/45144; Vigny C, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000377; Zumberge JF, 1997, J GEOPHYS RES-SOL EA, V102, P5005, DOI 10.1029/96JB03860	23	258	276	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					201	206		10.1038/nature03937	http://dx.doi.org/10.1038/nature03937			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015320				2022-12-28	WOS:000230459500029
J	Wasley, A; Samandari, T; Bell, BP				Wasley, A; Samandari, T; Bell, BP			Incidence of hepatitis A in the United States in the era of vaccination	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EPIDEMIOLOGY	Context In the United States, hepatitis A is a frequently reported vaccine-preventable disease. Vaccination has been recommended for persons at increased risk since 1996. In 1999, it was recommended that children living in 11 states with the highest incidence of hepatitis A be routinely vaccinated, and that children living in 6 additional states, with incidence above the national average, be considered for routine vaccination. Objective To assess impact of the current vaccination strategy by evaluating trends in reported cases of hepatitis A since implementation. Design, Setting, and Cases A longitudinal analysis of characteristics of cases of hepatitis A reported in the United States since 1990 to the National Notifiable Diseases Surveillance System. Main Outcome Measure Incidence rates of reported cases of hepatitis A. Incidence rates in 2003 were compared with those for the prevaccination baseline period (1990-1997) overall and in the 17 states in which children should be routinely vaccinated or considered for routine vaccination (vaccinating states). Incidence rates in vaccinating states were also compared with those in the remaining states where there is no recommendation for statewide vaccination of children (nonvaccinating states). Results Between the baseline period (1990-1997) and 2003, overall hepatitis A rates declined 76% to 2.6 per 100 000, significantly lower than previous nadirs in 1983 (9.2/ 100000) and 1992 (9.1/100000). The rate in vaccinating states declined 88% to 2.5 per 100000 compared with 53% elsewhere (to 2.7/100 000). In 2003, cases from vaccinating states accounted for 33% of the national total vs 65% during the baseline period. Declines were greater among children aged 2 to 18 years (87%) than among persons older than age 18 years (69%); the proportion of cases in children dropped from 35% to 19%. Since 2001, rates in adults have been higher than among children, with the highest rates now among men aged 25 through 39 years. Conclusions Following implementation of routine hepatitis A vaccination of children, hepatitis A rates have declined to historic lows, accompanied by substantial changes in the epidemiologic profile. Greater decreases in the age groups and regions where routine vaccination of children is recommended likely reflect the results of implementation of this novel vaccination strategy. Continued monitoring is needed to verify that implementation continues to proceed and that low rates are sustained.	Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Epidemiol Program Off, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Wasley, A (corresponding author), Ctr Dis Control & Prevent, Div Viral Hepatitis, 1600 Clifton Rd NE,Mailstop G-37, Atlanta, GA 30333 USA.	awasley@cdc.gov						ALTER MJ, 1987, AM J EPIDEMIOL, V125, P133, DOI 10.1093/oxfordjournals.aje.a114496; AMON JJ, 2003, IN PRESS PEDIATRICS; ANDERSON RM, 1998, INFECT DIS HUMANS DY; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; ARMITAGE P, 1990, STAT INFERENCE STAT, P120; Armstrong GL, 2002, PEDIATRICS, V109, P839, DOI 10.1542/peds.109.5.839; Averhoff F, 2001, JAMA-J AM MED ASSOC, V286, P2968, DOI 10.1001/jama.286.23.2968; Bell BP, 1998, J INFECT DIS, V178, P1579, DOI 10.1086/314518; Bialek SR, 2004, AM J PUBLIC HEALTH, V94, P996, DOI 10.2105/AJPH.94.6.996; *CDCP, 2004, MMWR-MORBID MORTAL W, V51, P1; *CDCP, 2004, 59 CDCP US DEP HHS; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P141; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P1155; Cotter SM, 2003, J INFECT DIS, V187, P1235, DOI 10.1086/374057; DAGAN R, 2002, INF DIS SOC AM 40 AN; Dominguez A, 2003, VACCINE, V21, P698, DOI 10.1016/S0264-410X(02)00583-2; Doyle TJ, 2002, AM J EPIDEMIOL, V155, P866, DOI 10.1093/aje/155.9.866; Kann Laura, 1996, Morbidity and Mortality Weekly Report, V45, P1; Lopalco PL, 2000, VACCINE, V19, P470, DOI 10.1016/S0264-410X(00)00193-6; Samandari T, 2004, VACCINE, V22, P4342, DOI 10.1016/j.vaccine.2004.04.014; Staes CJ, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.4.e54; *US BUR CENS, STAT POP DAT	22	167	184	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2005	294	2					194	201		10.1001/jama.294.2.194	http://dx.doi.org/10.1001/jama.294.2.194			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944DO	16014593				2022-12-28	WOS:000230406100023
J	Clemens, J; Jodar, L				Clemens, J; Jodar, L			Hib vaccines for all the world's children?	LANCET			English	Editorial Material							DEVELOPING-COUNTRIES; B INFECTIONS; VACCINATION; DISEASE		Int Vaccine Inst, Seoul 151818, South Korea	International Vaccine Institute	Clemens, J (corresponding author), Int Vaccine Inst, Seoul 151818, South Korea.	jclemens@ivi.int						ADAMS WG, 1993, JAMA-J AM MED ASSOC, V269, P221, DOI 10.1001/jama.269.2.221; Adegbola RA, 2005, LANCET, V366, P144, DOI 10.1016/S0140-6736(05)66788-8; Clemens J, 2005, NAT MED, V11, pS12, DOI 10.1038/nm1225; Lagos R, 1996, PEDIATR INFECT DIS J, V15, P216, DOI 10.1097/00006454-199603000-00008; Landaverde M, 1999, Rev Panam Salud Publica, V5, P200, DOI 10.1590/S1020-49891999000300022; LAU YL, 1995, ACTA PAEDIATR, V84, P173, DOI 10.1111/j.1651-2227.1995.tb13604.x; Mahoney RT, 1999, VACCINE, V17, P646, DOI 10.1016/S0264-410X(98)00246-1; Martin JF, 2003, VACCINE, V21, P587, DOI 10.1016/S0264-410X(02)00564-9; Mitchell V, 2005, LANCET, V365, P936, DOI 10.1016/S0140-6736(05)71076-X; MURPHY TV, 1993, JAMA-J AM MED ASSOC, V269, P246, DOI 10.1001/jama.269.2.246; Peltola H, 2000, CLIN MICROBIOL REV, V13, P302, DOI 10.1128/CMR.13.2.302-317.2000; Wenger JD, 1999, VACCINE, V18, P736, DOI 10.1016/S0264-410X(99)00269-8	12	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 9	2005	366	9480					101	103		10.1016/S0140-6736(05)66789-X	http://dx.doi.org/10.1016/S0140-6736(05)66789-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	943JH	16005315				2022-12-28	WOS:000230349200007
J	Grisendi, S; Bernardi, R; Rossi, M; Cheng, K; Khandker, L; Manova, K; Pandolfi, PP				Grisendi, S; Bernardi, R; Rossi, M; Cheng, K; Khandker, L; Manova, K; Pandolfi, PP			Role of nucleophosmin in embryonic development and tumorigenesis	NATURE			English	Article							TUMOR-SUPPRESSOR PROTEIN; LEUKEMIA; GENE; NPM; CHROMOSOME-5; INHIBITION; FUSION; ARF	Nucleophosmin ( also known as NPM, B23, NO38) is a nucleolar protein directly implicated in cancer pathogenesis, as the NPM1 gene is found mutated and rearranged in a number of haematological disorders(1-5). Furthermore, the region of chromosome 5 to which NPM1 maps is deleted in a proportion of de novo human myelodysplastic syndromes (MDS)(6-9), and loss of chromosome 5 is extremely frequent in therapy-related MDS9,10. NPM is a multifunctional protein(11-15), and its role in oncogenesis is controversial as NPM has been attributed with both oncogenic and tumour suppressive functions(16-19). To study the function of Npm in vivo, we generated a hypomorphic Npm1 mutant series (Npm1(+/-) < Npm1(hy/ hy) < Npm1(-/-)) in mouse. Here we report that Npm is essential for embryonic development and the maintenance of genomic stability. Npm1(-/-) and Npm1(hy/hy) mutants have aberrant organogenesis and die between embryonic day E11.5 and E16.5 owing to severe anaemia resulting from defects in primitive haematopoiesis. We show that Npm1 inactivation leads to unrestricted centrosome duplication and genomic instability. We demonstrate that Npm is haploinsufficient in the control of genetic stability and that Npm1 heterozygosity accelerates oncogenesis both in vitro and in vivo. Notably, Npm1(+/-) mice develop a haematological syndrome with features of human MDS. Our findings uncover an essential developmental role for Npm and implicate its functional loss in tumorigenesis and MDS pathogenesis.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Med, Lab Cellular Immunobiol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Mol Cytol Core Facil, Dev Biol Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	p-pandolfi@ski.mskcc.org	Rossi, Marco/AAF-6413-2020; bernardi, rosa/B-1650-2013	Rossi, Marco/0000-0002-7258-475X; bernardi, rosa/0000-0002-3607-6336; Khandker, Luipa/0000-0001-6274-0520				Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Chung YJ, 2004, GENOME RES, V14, P188, DOI 10.1101/gr.1878804; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Giagounidis AAN, 2004, LEUKEMIA, V18, P113, DOI 10.1038/sj.leu.2403189; Grisendi S, 2005, NEW ENGL J MED, V352, P291, DOI 10.1056/NEJMe048337; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; KHAN SH, 1998, CANCER RES, V58, P369; Kondo T, 1997, ONCOGENE, V15, P1275, DOI 10.1038/sj.onc.1201286; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Lerch-Gaggl A, 2002, J BIOL CHEM, V277, P45347, DOI 10.1074/jbc.M208338200; Li J, 2004, J BIOL CHEM, V279, P41275, DOI 10.1074/jbc.C400297200; List Alan F, 2004, Hematology Am Soc Hematol Educ Program, P297; Mendes-da-Silva P, 2000, J CLIN PATHOL-MOL PA, V53, P184, DOI 10.1136/mp.53.4.184; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Olney HJ, 2002, BAS CLIN ON, V27, P89; Redner RL, 1996, BLOOD, V87, P882, DOI 10.1182/blood.V87.3.882.bloodjournal873882; Savkur RS, 1998, NUCLEIC ACIDS RES, V26, P4508, DOI 10.1093/nar/26.19.4508; Spike BT, 2004, EMBO J, V23, P4319, DOI 10.1038/sj.emboj.7600432; Stewart ZA, 1999, MOL CELL BIOL, V19, P205; VandenBerghe H, 1997, CANCER GENET CYTOGEN, V94, P1, DOI 10.1016/S0165-4608(96)00350-0; Westbrook CA, 2000, BRIT J HAEMATOL, V110, P847, DOI 10.1046/j.1365-2141.2000.02285.x; Wu MH, 2002, J BIOL CHEM, V277, P48234, DOI 10.1074/jbc.M206550200; YonedaKato N, 1996, ONCOGENE, V12, P265; Zhang H, 2004, J BIOL CHEM, V279, P35726, DOI 10.1074/jbc.M403264200	30	425	453	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2005	437	7055					147	153		10.1038/nature03915	http://dx.doi.org/10.1038/nature03915			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16007073				2022-12-28	WOS:000231560400059
J	Philips, JA; Rubin, EJ; Perrimon, N				Philips, JA; Rubin, EJ; Perrimon, N			Drosophila RNAi screen reveals CD36 family member required for mycobacterial infection	SCIENCE			English	Article							I SR-BI; RECEPTOR; PHAGOCYTOSIS; TUBERCULOSIS; PHAGOSOME; IDENTIFICATION; MACROPHAGES; VIRULENCE; PROTEINS; MODEL	Certain pathogens, such as Mycobacterium tuberculosis, survive within the hostile intracellular environment of a macrophage. To identify host factors required for mycobacterial entry and survival within macrophages, we performed a genome-wide RNA interference screen in Drosophila macrophage-like cells, using Mycobacterium fortuitum. We identified factors required for general phagocytosis, as well as those needed specifically for mycobacterial infection. One specific factor, Peste (Pes), is a CD36 family member required for uptake of mycobacteria, but not Escherichia coli or Staphylococcus aureus. Moreover, mammalian class B scavenger receptors (SRs) conferred uptake of bacteria into nonphagocytic cells, with SR-BI and SR-BII uniquely mediating uptake of M. fortuitum, which suggests a conserved role for class B SRs in pattern recognition and innate immunity.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard T.H. Chan School of Public Health	Philips, JA (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Louis Pasteur Ave, Boston, MA 02115 USA.	jphilips@partners.org; perrimon@receptor.med.harvard.edu	Eckhardt, Erik/G-1567-2010	Perrimon, Norbert/0000-0001-7542-472X; Rubin, Eric/0000-0001-5120-962X				Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Cirillo JD, 1997, INFECT IMMUN, V65, P3759, DOI 10.1128/IAI.65.9.3759-3767.1997; da Silva TRM, 2002, INFECT IMMUN, V70, P5628, DOI 10.1128/IAI.70.10.5628-5634.2002; Dionne MS, 2003, INFECT IMMUN, V71, P3540, DOI 10.1128/IAI.71.6.3540-3550.2003; El-Etr SH, 2001, INFECT IMMUN, V69, P7310, DOI 10.1128/IAI.69.12.7310-7317.2001; Fischer O, 2001, MED VET ENTOMOL, V15, P208, DOI 10.1046/j.1365-2915.2001.00292.x; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Griffith D E, 1996, Semin Respir Infect, V11, P301; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Husemann J, 2001, J NEUROIMMUNOL, V114, P142, DOI 10.1016/S0165-5728(01)00239-9; Kelley VA, 2003, MOL BIOL CELL, V14, P3366, DOI 10.1091/mbc.E02-12-0780; Mulcahy JV, 2004, BIOCHEM J, V377, P741, DOI 10.1042/bj20030307; Pearson AM, 2003, MICROBES INFECT, V5, P815, DOI 10.1016/S1286-4579(03)00157-6; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Rhainds D, 2004, INT J BIOCHEM CELL B, V36, P39, DOI 10.1016/S1357-2725(03)00173-0; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Zimmerli S, 1996, AM J RESP CELL MOL, V15, P760, DOI 10.1165/ajrcmb.15.6.8969271	20	275	289	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2005	309	5738					1251	1253		10.1126/science.1116006	http://dx.doi.org/10.1126/science.1116006			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957TE	16020694				2022-12-28	WOS:000231395400049
J	Blake, WJ; Collins, JJ				Blake, WJ; Collins, JJ			And the noise played on: Stochastic gene expression and HIV-1 infection	CELL			English	Editorial Material									Boston Univ, Ctr Biodynam, Boston, MA 02215 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Boston University; Boston University	Blake, WJ (corresponding author), Boston Univ, Ctr Biodynam, Boston, MA 02215 USA.							Arkin A, 1998, GENETICS, V149, P1633; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kramer BP, 2005, P NATL ACAD SCI USA, V102, P9517, DOI 10.1073/pnas.0500345102; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006	11	4	4	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 29	2005	122	2					147	149		10.1016/j.cell.2005.07.006	http://dx.doi.org/10.1016/j.cell.2005.07.006			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	951CR	16051138	Bronze			2022-12-28	WOS:000230907000001
J	Peik, E				Peik, E			Physics - Logical spectroscopy	SCIENCE			English	Editorial Material							FREQUENCY; ION; STANDARDS		Phys Tech Bundesanstalt, Time & Frequency Dept, D-38116 Braunschweig, Germany	Physikalisch-Technische Bundesanstalt (PTB)	Peik, E (corresponding author), Phys Tech Bundesanstalt, Time & Frequency Dept, D-38116 Braunschweig, Germany.	ekkehard.peik@ptb.de		Peik, Ekkehard/0000-0001-6309-2975				Becker T, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.051802; DEHMELT HG, 1982, IEEE T INSTRUM MEAS, V31, P83, DOI 10.1109/TIM.1982.6312526; Diddams SA, 2004, SCIENCE, V306, P1318, DOI 10.1126/science.1102330; Gill P, 2003, MEAS SCI TECHNOL, V14, P1174, DOI 10.1088/0957-0233/14/8/302; Margolis HS, 2004, SCIENCE, V306, P1355, DOI 10.1126/science.1105497; Schmidt PO, 2005, SCIENCE, V309, P749, DOI 10.1126/science.1114375; Wineland D. J., 2002, P 6 S FREQ STAND MET, P361	7	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2005	309	5735					710	711		10.1126/science.1116127	http://dx.doi.org/10.1126/science.1116127			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051775				2022-12-28	WOS:000230938200028
J	Weissmann, C				Weissmann, C			Birth of a prion: Spontaneous generation revisited	CELL			English	Review							STRAIN; TRANSMISSION; SCRAPIE; PRP		Scripps Florida, Jupiter, FL 33480 USA	State University System of Florida; University of Florida	Weissmann, C (corresponding author), Scripps Florida, 5353 Parkside Dr, Jupiter, FL 33480 USA.	charlesw@scripps.edu						Aguzzi A, 2003, ADV IMMUNOL, V81, P123, DOI 10.1016/S0065-2776(03)81004-0; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Bruce ME, 2003, BRIT MED BULL, V66, P99, DOI 10.1093/bmb/66.1.99; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Caughey B, 1999, MOL BIOTECHNOL, V13, P45, DOI 10.1385/MB:13:1:45; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Hill AF, 2003, TRENDS MICROBIOL, V11, P578, DOI 10.1016/j.tim.2003.10.007; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; KIMBERLIN RH, 1987, J GEN VIROL, V68, P1875, DOI 10.1099/0022-1317-68-7-1875; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Manson JC, 1999, EMBO J, V18, P6855, DOI 10.1093/emboj/18.23.6855; Perrier V, 2002, P NATL ACAD SCI USA, V99, P13079, DOI 10.1073/pnas.182425299; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Wickner RB, 2004, ANNU REV GENET, V38, P681, DOI 10.1146/annurev.genet.38.072902.092200	20	65	69	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 29	2005	122	2					165	168		10.1016/j.cell.2005.07.001	http://dx.doi.org/10.1016/j.cell.2005.07.001			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	951CR	16051142	Bronze			2022-12-28	WOS:000230907000005
J	Bayley, PJ; Frascino, JC; Squire, LR				Bayley, PJ; Frascino, JC; Squire, LR			Robust habit learning in the absence of awareness and independent of the medial temporal lobe	NATURE			English	Article							HIPPOCAMPAL-LESIONS; SEMANTIC KNOWLEDGE; BASAL GANGLIA; MEMORY; MONKEYS; PERFORMANCE; AMNESIA; DAMAGE; SYSTEMS; TASK	Habit memory is thought to involve slowly acquired associations between stimuli and responses and to depend on the basal ganglia(1). Habit memory has been well studied in experimental animals but is poorly understood in humans because of their strong tendency to acquire information as conscious ( declarative) knowledge. Here we show that humans have a robust capacity for gradual trial-and-error learning that operates outside awareness for what is learned and independently of the medial temporal lobe. We tested two patients with large medial temporal lobe lesions and no capacity for declarative memory. Both patients gradually acquired a standard eight-pair object discrimination task over many weeks but at the start of each session could not describe the task, the instructions or the objects. The acquired knowledge was rigidly organized, and performance collapsed when the task format was altered.	Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; Vet Affairs Med Ctr, San Diego, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Squire, LR (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	Lsquire@ucsd.edu			NIMH NIH HHS [R01 MH024600] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH024600] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amaral DG, 1990, HUMAN NERVOUS SYSTEM, P711; Bayley PJ, 2005, NEURON, V46, P799, DOI 10.1016/j.neuron.2005.04.034; Bayley PJ, 2005, HIPPOCAMPUS, V15, P273, DOI 10.1002/hipo.20057; Buffalo EA, 1998, BEHAV NEUROSCI, V112, P3, DOI 10.1037/0735-7044.112.1.3; CORRELL RE, 1965, J COMP PHYSIOL PSYCH, V60, P175, DOI 10.1037/h0022290; Driscoll I, 2004, BEHAV NEUROSCI, V118, P1427, DOI 10.1037/0735-7044.118.6.1427; Eichenbaum HE, 2001, CONDITIONING CONSCIO; Fernandez-Ruiz J, 2001, P NATL ACAD SCI USA, V98, P4196, DOI 10.1073/pnas.061022098; Gaffan D, 1996, SEMIN NEUROSCI, V8, P33, DOI 10.1006/smns.1996.0005; Gold JJ, 2005, HIPPOCAMPUS, V15, P79, DOI 10.1002/hipo.20032; HAYES KJ, 1953, J COMP PHYSIOL PSYCH, V46, P105, DOI 10.1037/h0055072; Hood KL, 1999, NEUROPSYCHOLOGIA, V37, P1375, DOI 10.1016/S0028-3932(99)00048-2; Hopkins RO, 2004, NEUROPSYCHOLOGIA, V42, P524, DOI 10.1016/j.neuropsychologia.2003.09.005; Insausti R, 1998, AM J NEURORADIOL, V19, P659; Knowlton B J, 1994, Learn Mem, V1, P106; Levy DA, 2004, P NATL ACAD SCI USA, V101, P6710, DOI 10.1073/pnas.0401679101; MALAMUT BL, 1984, BEHAV NEUROSCI, V98, P759, DOI 10.1037/0735-7044.98.5.759; Myers CE, 2003, J COGNITIVE NEUROSCI, V15, P185, DOI 10.1162/089892903321208123; Nosofsky R, 1999, TRENDS COGN SCI, V3, P125, DOI 10.1016/S1364-6613(99)01291-7; Petri HL, 1984, NEUROPSYCHOLOGY MEMO, P287; SCHACTER DL, 1994, MEMORY SYTEMS 1994; SHANKS DR, 1994, BEHAV BRAIN SCI, V17, P367, DOI 10.1017/S0140525X00035032; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; SQUIRE LR, 1988, BEHAV NEUROSCI, V102, P210, DOI 10.1037/0735-7044.102.2.210; Stefanacci L, 2000, J NEUROSCI, V20, P7024, DOI 10.1523/JNEUROSCI.20-18-07024.2000; Teng E, 2000, J NEUROSCI, V20, P3853, DOI 10.1523/JNEUROSCI.20-10-03853.2000; Wise SP, 1996, SEMIN NEUROSCI, V8, P39, DOI 10.1006/smns.1996.0006	29	117	120	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					550	553		10.1038/nature03857	http://dx.doi.org/10.1038/nature03857			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049487	Green Accepted			2022-12-28	WOS:000230788800060
J	Lloyd-Jones, DM; Evans, JC; Levy, D				Lloyd-Jones, DM; Evans, JC; Levy, D			Hypertension in adults across the age spectrum - Current outcomes and control in the community	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NUTRITION EXAMINATION SURVEY; BLOOD-PRESSURE CONTROL; UNITED-STATES; SYSTOLIC HYPERTENSION; ANTIHYPERTENSIVE DRUGS; RANDOMIZED-TRIAL; ACTIVE TREATMENT; ELDERLY-PATIENTS; NATIONAL-HEALTH; SWEDISH TRIAL	Context Data are sparse regarding current rates of hypertension treatment and control, and risks associated with hypertension, among persons older than 80 years. Objective To determine the prevalence of blood pressure stages, hypertension treatment and control, and cardiovascular risk among older patients with hypertension. Design, Setting, and Participants A community-based cohort study in which data were collected during all Framingham Heart Study examinations attended in the 1990s. Participants were pooled according to age: younger than 60 years, 60 to 79 years, or 80 years or older. There were 5296 participants who contributed 14458 person-examinations of observation, including 7135 hypertensive person-examinations (4919 treated). Main Outcome Measures Prevalence of hypertension, its treatment, and its control were compared across age groups. Risks for incident cardiovascular disease during follow-up of up to 6 years were estimated as multivariate-adjusted hazard ratios (HRs) and 95% confidence intervals (Cls) using Cox proportional hazards regression. Results Prevalence of hypertension and drug treatment increased with advancing age, whereas control rates were markedly lower in older women (systolic <140 and diastolic <90 mm Hg). For ages younger than 60 years, 60 to 79, and 80 years and older, respectively, control rates were 38%, 36%, and 38% in men (P=.30) and 38%, 28%, and 23% in women (P<.001). Relative risks for cardiovascular disease associated with increasing blood pressure stage did not decline with advancing age, and absolute risks increased markedly. Among participants 80 years of age or older, major cardiovascular events occurred in 9.5% of the normal blood pressure (referent) group, 19.8% of the prehypertension group (HR, 1.9; 95% Cl, 0.9-3.9), 20.3% of the stage 1 hypertension group (HR, 1.8; 95% Cl, 0.8-3.7), and 24.7% of the stage 2 or treated hypertension group (HR, 2.4; 95% Cl, 1.2-4.6). Conclusions Relative to current national guidelines, rates of blood pressure control in the community are low, especially among older Women with hypertension. Short-term risks for cardiovascular disease are substantial, indicating the need for greater efforts at safe, effective risk reduction among the oldest patients with hypertension.	Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Blood Inst, Framingham Heart Study, Framingham, MA USA	Northwestern University; Feinberg School of Medicine; Framingham Heart Study	Lloyd-Jones, DM (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Suite 1102, Chicago, IL 60611 USA.	dlj@northwestern.edu	Levy, Daniel/ABB-2752-2021; Lloyd-Jones, Donald M/C-5899-2009; Levy, Daniel/ABF-6873-2021	Levy, Daniel/0000-0003-1843-8724; Lloyd-Jones, Donald/0000-0003-0847-6110	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL004253] Funding Source: NIH RePORTER	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abbott RD, 1987, FRAMINGHAM STUDY EPI; AMERY A, 1986, J HYPERTENS, V4, pS642; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 1993, ARCH INTERN MED, V153, P154, DOI DOI 10.1001/archinte.1993.00410020010002; Bulpitt C, 2001, DRUG AGING, V18, P151, DOI 10.2165/00002512-200118030-00001; Bulpitt CJ, 2003, J HYPERTENS, V21, P2409, DOI 10.1097/00004872-200312000-00030; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Chaudhry SI, 2004, JAMA-J AM MED ASSOC, V292, P1074, DOI 10.1001/jama.292.9.1074; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COOPE J, 1986, BRIT MED J, V293, P1145, DOI 10.1136/bmj.293.6555.1145; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; DAHLOF B, 1991, LANCET, V338, P1281, DOI 10.1016/0140-6736(91)92589-T; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; Fields LE, 2004, HYPERTENSION, V44, P398, DOI 10.1161/01.HYP.0000142248.54761.56; Fischer MA, 2004, JAMA-J AM MED ASSOC, V291, P1850, DOI 10.1001/jama.291.15.1850; Franklin SS, 2001, HYPERTENSION, V37, P869, DOI 10.1161/01.HYP.37.3.869; Franklin SS, 1997, CIRCULATION, V96, P308; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Gueyffier F, 1999, LANCET, V353, P793, DOI 10.1016/S0140-6736(98)08127-6; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Hansson L, 1999, LANCET, V354, P1751, DOI 10.1016/S0140-6736(99)10327-1; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Liu LS, 1998, J HYPERTENS, V16, P1823, DOI 10.1097/00004872-199816120-00016; Lloyd-Jones DM, 2000, HYPERTENSION, V36, P594, DOI 10.1161/01.HYP.36.4.594; MANOLIO TA, 1995, ARCH INTERN MED, V155, P829, DOI 10.1001/archinte.155.8.829; Meyer J., 2001, AGE 2000 CENSUS 2000; PERRY HM, 1989, STROKE, V20, P4, DOI 10.1161/01.STR.20.1.4; Psaty BM, 2002, ARCH INTERN MED, V162, P2325, DOI 10.1001/archinte.162.20.2325; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Rhoads Caroline S, 2004, Am J Geriatr Cardiol, V13, P161, DOI 10.1111/j.1076-7460.2004.02124.x; SAS Institute Inc, 1999, SAS STAT US GUID VER; Siegel D, 1997, JAMA-J AM MED ASSOC, V278, P1745, DOI 10.1001/jama.278.21.1745; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; STAMLER J, 1993, ARCH INTERN MED, V153, P598, DOI 10.1001/archinte.153.5.598; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Xu KT, 2003, AM J MANAG CARE, V9, P529; 1997, ARCH INTERN MED, V157, P2413	42	418	447	1	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2005	294	4					466	472		10.1001/jama.294.4.466	http://dx.doi.org/10.1001/jama.294.4.466			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RM	16046653				2022-12-28	WOS:000230733400021
J	Barnes, PM; Norton, CM; Dunstan, FD; Kemp, AM; Yates, DW; Sibert, JR				Barnes, PM; Norton, CM; Dunstan, FD; Kemp, AM; Yates, DW; Sibert, JR			Abdominal injury due to child abuse	LANCET			English	Article								Diagnosis of abuse in children with internal abdominal injury is difficult because of limited published work. We aimed to ascertain the incidence of abdominal injury due to abuse in children age 0-14 years. 20 children (identified via the British Paediatric Surveillance Unit) had abdominal injuries due to abuse and 164 (identified via the Trauma Audit and Research Network) had injuries to the abdomen due to accident (112 by road-traffic accidents, 52 by falls). 16 abused children were younger than 5 years. Incidence of abdominal injury due to abuse was 2.33 cases per million children per year (95% CI 1.43-3.78) in children younger than 5 years. Six abused children died. 11 abused children had an injury to the gut (ten small bowel) compared with five (all age >5 years) who were injured by a fall (relative risk 5.72 [95% CI 2.27-14.4]; p=0.0002). We have shown that small-bowel injuries can arise accidentally as a result of falls and road-traffic accidents but they are significantly more common in abused children. Therefore, injuries to the small bowel in young children need special consideration, particularly if a minor fall is the explanation.	Cardiff Univ, Acad Ctr, Llandough Hosp, Dept Child Hlth, Penarth, S Glam, Wales; Cardiff Univ, Acad Ctr, Llandough Hosp, Dept Epidemiol Stat & Publ Hlth, Penarth, S Glam, Wales; Hope Hosp, Trauma Audit & Res Network, Salford M6 8HD, Lancs, England	Cardiff University; Cardiff University	Sibert, JR (corresponding author), Cardiff Univ, Acad Ctr, Llandough Hosp, Dept Child Hlth, Penarth, S Glam, Wales.	sibert@cardiff.ac.uk						COANT PN, 1992, PEDIATRICS, V89, P274; COOPER A, 1988, J TRAUMA, V28, P1483, DOI 10.1097/00005373-198810000-00015; Huntimer CM, 2000, PEDIATRICS, V106, P301, DOI 10.1542/peds.106.2.301; LEDBETTER DJ, 1988, ARCH SURG-CHICAGO, V123, P1101; Sibert JR, 2002, CHILD ABUSE NEGLECT, V26, P267, DOI 10.1016/S0145-2134(01)00324-6; Verity C, 2002, ARCH DIS CHILD, V87, P269, DOI 10.1136/adc.87.4.269	6	48	48	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2005	366	9481					234	235		10.1016/S0140-6736(05)66913-9	http://dx.doi.org/10.1016/S0140-6736(05)66913-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	945RG	16023514				2022-12-28	WOS:000230519200032
J	Arlotta, P; Macklis, JD				Arlotta, P; Macklis, JD			Archeo-cell biology: Carbon dating is not just for pots and dinosaurs	CELL			English	Editorial Material							SUBVENTRICULAR ZONE; ADULT MICE; NEUROGENESIS; PROLIFERATION; NEURONS; FOREBRAIN; NEOCORTEX; RAT	Defining the life span of specific human cell populations is limited by our inability to mark the exact time when cells are born in a way that can be detected over many years. In this issue of Cell, Spalding et al. (2005) describe a clever strategy for retrospectively birth dating human cells in vivo, based on their incorporation of C-14 during a peak in atmospheric levels of this isotope resulting from above-ground nuclear arms testing in the 1950s.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH HMS Ctr Nervous Syst Repair,Dept Neurosurg,Pr, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH HMS Ctr Nervous Syst Repair,Dept Neurol,Progr, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Arlotta, P (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH HMS Ctr Nervous Syst Repair,Dept Neurosurg,Pr, Boston, MA 02114 USA.							ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Chen JH, 2004, P NATL ACAD SCI USA, V101, P16357, DOI 10.1073/pnas.0406795101; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; KAPLAN MS, 1981, J COMP NEUROL, V195, P323, DOI 10.1002/cne.901950211; Kornack DR, 2001, SCIENCE, V294, P2127, DOI 10.1126/science.1065467; Kuhn HG, 1996, J NEUROSCI, V16, P2027; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Nowakowski R S, 2000, Science, V288, P771; Palmer TD, 1999, J NEUROSCI, V19, P8487; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028	13	4	4	1	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 15	2005	122	1					4	6		10.1016/j.cell.2005.06.037	http://dx.doi.org/10.1016/j.cell.2005.06.037			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	950EC	16009125	Bronze			2022-12-28	WOS:000230839400003
J	Bassermann, F; von Klitzing, C; Munch, S; Bai, RY; Kawaguchi, H; Morris, SW; Peschel, C; Duyster, J				Bassermann, F; von Klitzing, C; Munch, S; Bai, RY; Kawaguchi, H; Morris, SW; Peschel, C; Duyster, J			NIPA defines an SCF-type mammalian E3 ligase that regulates mitotic entry	CELL			English	Article							ANAPHASE-PROMOTING COMPLEX; F-BOX PROTEINS; UBIQUITIN-LIGASE; CYCLIN B1; S-PHASE; DEGRADATION; CELL; MITOSIS; PHOSPHORYLATION; LOCALIZATION	The regulated oscillation of protein expression is an essential mechanism of cell cycle control. The SCF class of E3 ubiquitin ligases is involved in this process by targeting cell cycle regulatory proteins for degradation by the proteasome, with the F-box subunit of the SCF specifically recruiting a given substrate to the SCF core. Here we identify NIPA (nuclear interaction partner of ALK) as a human F-box-containing protein that defines an SCF-type E3 ligase (SCFNIPA) controlling mitotic entry. Assembly of this SCF complex is regulated by cell-cycle-dependent phosphorylation of NIPA, which restricts substrate ubiquitination activity to interphase. We show nuclear cyclin B1 to be a substrate of SCF NIPA. Inactivation of NIPA by RNAi results in nuclear accumulation of cyclin B1 in interphase, activation of cyclin B1-Cdk1 kinase activity, and premature mitotic entry. Thus, SCFNIPA-based ubiquitination may regulate S-phase completion and mitotic entry in the mammalian cell cycle.	Tech Univ Munich, Dept Internal Med 3, D-81675 Munich, Germany; St Jude Childrens Res Hosp, Dept Pathol & Hematol Oncol, Memphis, TN 38105 USA	Technical University of Munich; University of Munich; St Jude Children's Research Hospital	Duyster, J (corresponding author), Tech Univ Munich, Dept Internal Med 3, D-81675 Munich, Germany.	justus.duyster@lrz.tum.de			NATIONAL CANCER INSTITUTE [R01CA069129] Funding Source: NIH RePORTER; NCI NIH HHS [CA 69129] Funding Source: Medline; PHS HHS [21765] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ayad NG, 2003, CELL, V113, P101, DOI 10.1016/S0092-8674(03)00232-0; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Bai RY, 2002, NAT CELL BIOL, V4, P181, DOI 10.1038/ncb753; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bassermann F, 2002, J BIOL CHEM, V277, P12437, DOI 10.1074/jbc.M112397200; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; DUYSTER J, 1995, P NATL ACAD SCI USA, V92, P1555, DOI 10.1073/pnas.92.5.1555; Duyster J, 2001, ONCOGENE, V20, P5623, DOI 10.1038/sj.onc.1204594; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Hagting A, 1999, CURR BIOL, V9, P680, DOI 10.1016/S0960-9822(99)80308-X; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Jackson PK, 2002, MOL CELL, V9, P923, DOI 10.1016/S1097-2765(02)00538-5; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Li J, 1997, P NATL ACAD SCI USA, V94, P502, DOI 10.1073/pnas.94.2.502; Michael WM, 1998, SCIENCE, V282, P1886, DOI 10.1126/science.282.5395.1886; MINSHULL J, 1989, CELL, V56, P947, DOI 10.1016/0092-8674(89)90628-4; Moore JD, 2003, SCIENCE, V300, P987, DOI 10.1126/science.1081418; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Ng RWM, 1998, FEBS LETT, V438, P183, DOI 10.1016/S0014-5793(98)01299-X; Ouyang T, 2003, J BIOL CHEM, V278, P30028, DOI 10.1074/jbc.M300883200; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5; Yamano H, 2000, MOL CELL, V6, P1377, DOI 10.1016/S1097-2765(00)00135-0; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2	33	61	66	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 15	2005	122	1					45	57		10.1016/j.cell.2005.04.034	http://dx.doi.org/10.1016/j.cell.2005.04.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	950EC	16009132	Bronze			2022-12-28	WOS:000230839400010
J	Sanada, K; Tsai, LH				Sanada, K; Tsai, LH			G protein beta gamma subunits and AGS3 control spindle orientation and asymmetric cell fate of cerebral cortical progenitors	CELL			English	Article							HETEROTRIMERIC G-PROTEINS; DEPENDENT ACTIVATION; RECEPTOR KINASE; DIVISION; NEUROGENESIS; NEURONS; NUMA; ORGANIZATION; INHERITANCE; EXPRESSION	Neurons in the developing mammalian brain are generated from progenitor cells in the proliferative ventricular zone, and control of progenitor division is essential to produce the correct number of neurons during neurogenesis. Here we establish that G beta gamma subunits of heterotrimeric G proteins are required for proper mitotic-spindle orientation of neural progenitors in the developing neocortex. Interfering with G beta gamma function in progenitors causes a shift in spindle orientation from apical-basal divisions to planar divisions. This results in hyperdifferentiation of progenitors into neurons as a consequence of both daughter cells adopting a neural fate instead of the normal asymmetric cell fates. Silencing AGS3, a nonreceptor activator of G beta gamma, results in defects similar to the impairment of G beta gamma, providing evidence that AGS3-G beta gamma signaling in progenitors regulates apical-basal division and asymmetric cell-fate decisions. Furthermore, our observations indicate that the cell-fate decision of daughter cells is coupled to mitotic-spindle orientation in progenitors.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Tsai, LH (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	li-huei_tsai@hms.harvard.edu	SANADA, YOSHIKADO/G-5014-2014	Sanada, Kamon/0000-0002-0280-8957	NINDS NIH HHS [NS37007] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037007] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Asano T, 2001, J NEUROCHEM, V79, P1129, DOI 10.1046/j.1471-4159.2001.00662.x; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Cai L, 2002, J NEUROSCI RES, V69, P731, DOI 10.1002/jnr.10398; Cayouette M, 2003, DEVELOPMENT, V130, P2329, DOI 10.1242/dev.00446; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; GAGLIO T, 1995, J CELL BIOL, V131, P693, DOI 10.1083/jcb.131.3.693; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Mandato CA, 2003, CURR BIOL, V13, P1096, DOI 10.1016/S0960-9822(03)00420-2; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mochizuki N, 1996, GENE, V181, P39, DOI 10.1016/S0378-1119(96)00456-8; Natochin M, 2000, J BIOL CHEM, V275, P40981, DOI 10.1074/jbc.M006478200; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Rajan P, 1998, J NEUROSCI, V18, P3620; RHYU MS, 1995, CELL, V82, P523, DOI 10.1016/0092-8674(95)90022-5; Roychowdhury S, 1997, J BIOL CHEM, V272, P31576, DOI 10.1074/jbc.272.50.31576; Sanada K, 2004, NEURON, V42, P197, DOI 10.1016/S0896-6273(04)00222-3; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Shen Q, 2002, DEVELOPMENT, V129, P4843; Shinohara H, 2004, J BIOL CHEM, V279, P41141, DOI 10.1074/jbc.M406721200; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Takahashi T, 1996, J NEUROSCI, V16, P6183; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; ZHONG W, 1996, NEURON, V17, P45	39	215	222	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 15	2005	122	1					119	131		10.1016/j.cell.2005.05.009	http://dx.doi.org/10.1016/j.cell.2005.05.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	950EC	16009138	Bronze			2022-12-28	WOS:000230839400016
J	Scheuring, S; Sturgis, JN				Scheuring, S; Sturgis, JN			Chromatic adaptation of photosynthetic membranes	SCIENCE			English	Article							LIGHT-HARVESTING COMPLEX; X-RAY-STRUCTURE; RHODOBACTER-SPHAEROIDES; CORE COMPLEX; CRYSTAL-STRUCTURE; RHODOSPIRILLUM-RUBRUM; NATIVE MEMBRANES; ELECTRON-DENSITY; RESOLUTION; LH2	Many biological membranes adapt in response to environmental conditions. We investigated how the composition and architecture of photosynthetic membranes of a bacterium change in response to light, using atomic force microscopy. Despite large modifications in the membrane composition, the local environment of core complexes remained unaltered, whereas specialized paracrystalline light-harvesting antenna domains grew under tow-light conditions. Thus, the protein mixture in the membrane shows eutectic behavior and can be mimicked by a simple model. Such structural adaptation ensures efficient photon capture under low-light conditions and prevents photodamage under high-light conditions.	Inst Curie, CNRS, Unite Mixte Rech 168, F-75231 Paris, France; CNRS, Unite Propre Rech 9027, Lab Indenierie Syst Macromol, Inst Biol Struct & Microbiol, F-13402 Marseille, France	UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)	Scheuring, S (corresponding author), Inst Curie, CNRS, Unite Mixte Rech 168, 11 Rue Pierre & Marie Curie, F-75231 Paris, France.	simon.scheuring@curie.fr	Sturgis, James/F-6051-2011; Sturgis, James/AAU-8103-2020; Scheuring, Simon/L-9843-2018	Scheuring, Simon/0000-0003-3534-069X; Sturgis, James/0000-0001-5125-7699				ALLEN JP, 1987, P NATL ACAD SCI USA, V84, P6162, DOI 10.1073/pnas.84.17.6162; Bahatyrova S, 2004, NATURE, V430, P1058, DOI 10.1038/nature02823; Berry EA, 2004, PHOTOSYNTH RES, V81, P251, DOI 10.1023/B:PRES.0000036888.18223.0e; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V723, P202, DOI 10.1016/0005-2728(83)90120-2; DEISENHOFER J, 1984, J MOL BIOL, V180, P385, DOI 10.1016/S0022-2836(84)80011-X; Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929; Fotiadis D, 2004, J BIOL CHEM, V279, P2063, DOI 10.1074/jbc.M310382200; Hartigan N, 2002, BIOPHYS J, V82, P963, DOI 10.1016/S0006-3495(02)75456-8; Jamieson SJ, 2002, EMBO J, V21, P3927, DOI 10.1093/emboj/cdf410; Joliot P, 2005, BBA-BIOENERGETICS, V1706, P204, DOI 10.1016/j.bbabio.2004.11.002; Jungas C, 1999, EMBO J, V18, P534, DOI 10.1093/emboj/18.3.534; Koepke J, 1996, STRUCTURE, V4, P581, DOI 10.1016/S0969-2126(96)00063-9; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; Noro MG, 2001, J CHEM PHYS, V114, P2477, DOI 10.1063/1.1338504; PANAGIOTOPOULOS AZ, 1995, GIBBS ENSEMBLE TECHN, V460; Papiz MZ, 2003, J MOL BIOL, V326, P1523, DOI 10.1016/S0022-2836(03)00024-X; Roszak AW, 2003, SCIENCE, V302, P1969, DOI 10.1126/science.1088892; Scheuring S, 2004, EMBO J, V23, P4127, DOI 10.1038/sj.emboj.7600429; Scheuring S, 2004, J BIOL CHEM, V279, P3620, DOI 10.1074/jbc.M310050200; Scheuring S, 2004, P NATL ACAD SCI USA, V101, P11293, DOI 10.1073/pnas.0404350101; Scheuring S, 2005, J BIOL CHEM, V280, P1426, DOI 10.1074/jbc.M411334200; Scheuring S, 2003, P NATL ACAD SCI USA, V100, P1690, DOI 10.1073/pnas.0437992100; Scheuring S, 2003, J MOL BIOL, V325, P569, DOI 10.1016/S0022-2836(02)01241-X; Scheuring S, 2001, EMBO J, V20, P3029, DOI 10.1093/emboj/20.12.3029; Siebert CA, 2004, EMBO J, V23, P690, DOI 10.1038/sj.emboj.7600092; STURGIS JN, 1988, PHOTOCHEM PHOTOBIOL, V48, P243, DOI 10.1111/j.1751-1097.1988.tb02817.x; Sturgis JN, 1996, ARCH MICROBIOL, V165, P235, DOI 10.1007/s002030050321; Walz T, 1998, J MOL BIOL, V282, P833, DOI 10.1006/jmbi.1998.2050	29	216	226	4	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					484	487		10.1126/science.1110879	http://dx.doi.org/10.1126/science.1110879			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020739				2022-12-28	WOS:000230574900052
J	Lerner, BH				Lerner, BH			Last-ditch medical therapy - Revisiting lobotomy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Univ, Med Ctr, New York, NY 10027 USA	Columbia University	Lerner, BH (corresponding author), Columbia Univ, Med Ctr, New York, NY 10027 USA.							Braslow Joel, 1997, MENTAL ILLS BODILY C, DOI 10.1525/9780520917934; El -Hai Jack, 2005, LOBOTOMIST MAVERICK; Laurence William L., 1937, NY TIMES        1128, P1; LAURENCE WL, 1937, NY TIMES        0607, P10; Pressman Jack, 1998, LAST RESORT PSYCHOSU; Valenstein E. S., 1986, GREAT DESPERATE CURE	6	14	14	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2005	353	2					119	121		10.1056/NEJMp048349	http://dx.doi.org/10.1056/NEJMp048349			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944OP	16014881	Green Published			2022-12-28	WOS:000230438800003
J	Huang, QS; Greening, G; Baker, MG; Grimwood, K; Hewitt, J; Hulston, D; van Duin, L; Fitzsimons, A; Garrett, N; Graham, D; Lennon, D; Shimizu, H; Miyamura, T; Pallansch, M				Huang, QS; Greening, G; Baker, MG; Grimwood, K; Hewitt, J; Hulston, D; van Duin, L; Fitzsimons, A; Garrett, N; Graham, D; Lennon, D; Shimizu, H; Miyamura, T; Pallansch, M			Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand	LANCET			English	Article							ERADICATION	On Feb 1, 2002, inactivated poliomyelitis vaccines replaced live-attenuated oral poliovirus vaccine (OPV) in New Zealand's immunisation schedule, allowing systematic monitoring of OPV virus circulation. Findings of paediatric-inpatient surveillance indicate that 7% of children excreted polioviruses before this switch, but none did so 1 month afterwards. Acute flaccid paralysis surveillance detected no poliovirus during and after the switch, whereas enterovirus surveillance detected poliovirus only once during the switch. Environmental surveillance identified polioviruses in sewage samples until May, 2002, after which they were detected infrequently. Intratypic differentiation and sequencing showed that all polioviruses were Sabin-like. Multiple surveillance methods hence showed that OPV strains did not persist for extended periods after a vaccine switch in a developed country with a temperate climate. Sequence homology with Sabin vaccine parent strains indicated that polioviruses detected more than 4 months after the switch were of recent origin, consistent with importation from OPV-using countries.	Inst Environm Sci & Res, Porirua, New Zealand; Univ Otago, Wellington Sch Med & Hlth Sci, Dept Paediat, Wellington, New Zealand; Auckland Univ Technol, Fac Hlth, Auckland, New Zealand; Waikato Hosp, Hamilton, New Zealand; Middlemore Hosp, S Auckland Clin Sch, Auckland 6, New Zealand; Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; Ctr Dis Control & Prevent, Enterovirus Sect, Natl Ctr Infect Dis, Atlanta, GA USA	Institute of Environmental Science & Research (ESR) - New Zealand; University of Otago; Auckland University of Technology; Waikato Hospital; National Institute of Infectious Diseases (NIID); Centers for Disease Control & Prevention - USA	Huang, QS (corresponding author), Inst Environm Sci & Res, POB 50348, Porirua, New Zealand.	Sue.Huang@esr.cri.nz	Grimwood, Keith/F-9334-2011; Shimizu, Hiroyuki/AAU-9621-2020	Shimizu, Hiroyuki/0000-0002-2987-2377; Huang, Q. Sue/0000-0002-3923-5195; Hewitt, Joanne/0000-0003-0370-6394; Garrett, Nick/0000-0001-9289-9743; Grimwood, Keith/0000-0003-3174-9834				Dowdle WR, 2003, REV MED VIROL, V13, P277, DOI 10.1002/rmv.401; Halsey NA, 2004, B WORLD HEALTH ORGAN, V82, P3; HEFFERNAN H, 1999, NZ PUBLIC HLTH REPOR, V6, P33; Huang QS, 2003, CLIN INFECT DIS, V37, P650, DOI 10.1086/376915; Lago PM, 1999, B WORLD HEALTH ORGAN, V77, P681; Wood DJ, 2000, B WORLD HEALTH ORGAN, V78, P347; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003	7	57	58	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2005	366	9483					394	396		10.1016/S0140-6736(05)66386-6	http://dx.doi.org/10.1016/S0140-6736(05)66386-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	950IB	16054940				2022-12-28	WOS:000230849700027
J	Aminetzach, YT; Macpherson, JM; Petrov, DA				Aminetzach, YT; Macpherson, JM; Petrov, DA			Pesticide resistance via transposition-mediated adaptive gene truncation in Drosophila	SCIENCE			English	Article							MELANOGASTER; POPULATION; ELEMENTS; LOCUS	To study adaptation, it is essential to identify multiple adaptive mutations and to characterize their molecular, phenotypic, selective, and ecological consequences. Here we describe a genomic screen for adaptive insertions of transposable elements in Drosophila. Using a pilot application of this screen, we have identified an adaptive transposable element insertion, which truncates a gene and apparently generates a functional protein in the process. The insertion of this transposable element confers increased resistance to an organophosphate pesticide and has spread in D. melanogaster recently.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Petrov, DA (corresponding author), Stanford Univ, Dept Biol Sci, 371 Serra Mall, Stanford, CA 94305 USA.	dpetrov@stanford.edu		Petrov, Dmitri/0000-0002-3664-9130				Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BENDER W, 1983, J MOL BIOL, V168, P17, DOI 10.1016/S0022-2836(83)80320-9; CHARLESWORTH B, 1989, ANNU REV GENET, V23, P251, DOI 10.1146/annurev.ge.23.120189.001343; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Kaminker JS, 2002, GENOME BIOL, V3, P0084, DOI DOI 10.1186/GB-2002-3-12-RFESEARCH84; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; MONTGOMERY E, 1987, GENET RES, V49, P31, DOI 10.1017/S0016672300026707; Petrov DA, 2003, MOL BIOL EVOL, V20, P880, DOI 10.1093/molbev/msg102; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Schlenke TA, 2004, P NATL ACAD SCI USA, V101, P1626, DOI 10.1073/pnas.0303793101; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Singh ND, 2005, GENETICS, V169, P709, DOI 10.1534/genetics.104.032250; Singh ND, 2004, MOL BIOL EVOL, V21, P670, DOI 10.1093/molbev/msh060; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P225, DOI 10.1146/annurev.genom.1.1.225	16	181	184	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2005	309	5735					764	767		10.1126/science.1112699	http://dx.doi.org/10.1126/science.1112699			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051794				2022-12-28	WOS:000230938200048
J	Lee, JT				Lee, JT			Regulation of X-chromosome counting by Tsix and Xite sequences	SCIENCE			English	Article							INACTIVATION CENTER; XIST GENE	In mammals, X-inactivation establishes X-chromosome dosage parity between mates and females. How X-chromosome counting regulates this process remains elusive, because neither the hypothesized inactivation "blocking factor" nor the required cis-elements have been defined. Here, a mouse knockout and transgenic analysis identified DNA sequences within the noncoding Tsix and Xite genes as numerators. Homozygous deficiency of Tsix resulted in "chaotic choice" and a variable number of inactive X's, whereas overdosage of TsixlXite inhibited X-inactivation. Thus, counting was affected by specific TsixlXite mutations, suggesting that counting is genetically separable from but molecularly coupled to choice. The mutations affect XX and XY cells differently, demonstrating that counting and choice are regulated not by one "blocking factor," but by both a "blocking" and a "competence" factor.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol,Howard Hughes Med Inst,Dept Genet, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute	Lee, JT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol,Howard Hughes Med Inst,Dept Genet, Boston, MA 02114 USA.	tee@molbio.mgh.harvard.edu			NIGMS NIH HHS [R01-GM58839] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058839] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Clerc P, 1998, NAT GENET, V19, P249, DOI 10.1038/924; Heard E, 1999, MOL CELL BIOL, V19, P3156; Lee JT, 1999, P NATL ACAD SCI USA, V96, P3836, DOI 10.1073/pnas.96.7.3836; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 2002, NAT GENET, V32, P195, DOI 10.1038/ng939; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; LYON MF, 1972, BIOL REV, V47, P1; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Morey C, 2004, EMBO J, V23, P594, DOI 10.1038/sj.emboj.7600071; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; RASTAN S, 1983, J EMBRYOL EXP MORPH, V78, P1; Stavropoulos N, 2005, MOL CELL BIOL, V25, P2757, DOI 10.1128/MCB.25.7.2757-2769.2005	14	114	120	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2005	309	5735					768	771		10.1126/science.1113673	http://dx.doi.org/10.1126/science.1113673			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051795				2022-12-28	WOS:000230938200049
J	Reinking, J; Lam, MMS; Pardee, K; Sampson, HM; Liu, SY; Yang, P; Williams, S; White, W; Lajoie, G; Edwards, A; Krause, HM				Reinking, J; Lam, MMS; Pardee, K; Sampson, HM; Liu, SY; Yang, P; Williams, S; White, W; Lajoie, G; Edwards, A; Krause, HM			The Drosophila nuclear receptor E75 contains heme and is gas responsive	CELL			English	Article							LIGAND-BINDING DOMAIN; NITRIC-OXIDE; CARBON-MONOXIDE; TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; PROTHORACICOTROPIC HORMONE; DEVELOPMENTAL EXPRESSION; CIRCADIAN TRANSCRIPTION; RHODOSPIRILLUM-RUBRUM; SUPERFAMILY MEMBERS	Nuclear receptors are a family of transcription factors with structurally conserved ligand binding domains that regulate their activity. Despite intensive efforts to identify ligands, most nuclear receptors are still "orphans." Here, we demonstrate that the ligand binding pocket of the Drosophila nuclear receptor E75 contains a heme prosthetic group. E75 absorption spectra, resistance to denaturants, and effects of site-directed mutagenesis indicate a single, coordinately bound heme molecule. A correlation between the levels of E75 expression and the levels of available heme suggest a possible role as a heme sensor. The oxidation state of the heme iron also determines whether E75 can interact with its heterodimer partner DHR3, suggesting an additional role as a redox sensor. Further, the E75-DHR3 interaction is also regulated by the binding of NO or CO to the heme center, suggesting that E75 may also function as a diatomic gas sensor. Possible mechanisms and roles for these interactions are discussed.	Charles H Best Inst, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Western Ontario, Siebens Drake Res Inst, London, ON N6A 5C1, Canada; GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA	University of Toronto; Western University (University of Western Ontario); GlaxoSmithKline	Krause, HM (corresponding author), Charles H Best Inst, Banting & Best Dept Med Res, 112 Coll St, Toronto, ON M5G 1L6, Canada.	h.krause@utoronto.ca		Edwards, Aled/0000-0002-4782-6016; Krause, Henry/0000-0002-6182-7074; Lam, Mandy/0000-0001-7984-9709; Williams, Shawn/0000-0001-8311-2638				Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Aono S, 1996, BIOCHEM BIOPH RES CO, V228, P752, DOI 10.1006/bbrc.1996.1727; Artinian LR, 2001, EXP NEUROL, V171, P293, DOI 10.1006/exnr.2001.7781; Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003; Bialecki M, 2002, DEV CELL, V3, P209, DOI 10.1016/S1534-5807(02)00204-6; Bicker G, 2001, CELL TISSUE RES, V303, P137, DOI 10.1007/s004410000321; Billas IML, 2001, J BIOL CHEM, V276, P7465, DOI 10.1074/jbc.M008926200; Brennan CA, 1998, DEVELOPMENT, V125, P2653; Buszczak M, 1999, DEVELOPMENT, V126, P4581; Chan SM, 1998, FEBS LETT, V436, P395, DOI 10.1016/S0014-5793(98)01148-X; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; D'Avino PP, 1998, DEVELOPMENT, V125, P1733; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Dubrovskaya VA, 2004, GENE, V340, P171, DOI 10.1016/j.gene.2004.07.022; EVANS LA, 1988, SCIENCE, V240, P1522, DOI 10.1126/science.2836951; Gevantman LH, 2004, CRC HDB CHEM PHYS; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Glass CK, 2000, GENE DEV, V14, P121; Hiruma K, 2004, DEV BIOL, V272, P510, DOI 10.1016/j.ydbio.2004.04.028; HORNER MA, 1995, DEV BIOL, V168, P490, DOI 10.1006/dbio.1995.1097; Ignarro LJ, 2000, NITRIC OXIDE BIOL PA; Jain R, 2003, J BIOL INORG CHEM, V8, P1, DOI 10.1007/s00775-002-0405-8; JINDRA M, 1994, EUR J BIOCHEM, V221, P665, DOI 10.1111/j.1432-1033.1994.tb18779.x; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kurokawa H, 2004, J BIOL CHEM, V279, P20186, DOI 10.1074/jbc.M314199200; Loo JA, 2000, INT J MASS SPECTROM, V200, P175, DOI 10.1016/S1387-3806(00)00298-0; LORENZ RT, 1991, LIPIDS, V26, P598, DOI 10.1007/BF02536423; Nakajima Y, 2004, FEBS LETT, V565, P122, DOI 10.1016/j.febslet.2004.03.083; Neill SJ, 2003, NEW PHYTOL, V159, P11, DOI 10.1046/j.1469-8137.2003.00804.x; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Orlicky SM, 2001, J BIOL CHEM, V276, P10097, DOI 10.1074/jbc.M003165200; PALLI SR, 1995, INSECT BIOCHEM MOLEC, V25, P697, DOI 10.1016/0965-1748(95)00008-J; Palli SR, 1997, DEV GENET, V20, P36, DOI 10.1002/(SICI)1520-6408(1997)20:1&lt;36::AID-DVG5&gt;3.0.CO;2-A; PARDEE K, 2004, SCI AGING KNOWLEDGE, pRE8, DOI DOI 10.1126/SAGEKE.2004.47.RE8; Potier N, 2003, PROTEIN SCI, V12, P725, DOI 10.1110/ps.0232503; POULOS TL, 1988, PHARMACEUT RES, V5, P67, DOI 10.1023/A:1015920931701; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Regulski M, 2004, CURR BIOL, V14, pR881, DOI 10.1016/j.cub.2004.09.068; Reynolds MF, 2000, BIOCHEMISTRY-US, V39, P388, DOI 10.1021/bi991378g; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Ryter SW, 2004, BIOESSAYS, V26, P270, DOI 10.1002/bies.20005; Sasakura Y, 2002, J BIOL CHEM, V277, P23821, DOI 10.1074/jbc.M202738200; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schwartz CJE, 2001, EMBO J, V20, P510, DOI 10.1093/emboj/20.3.510; SEGRAVES WA, 1990, GENE DEV, V4, P204, DOI 10.1101/gad.4.2.204; Shelver D, 1997, P NATL ACAD SCI USA, V94, P11216, DOI 10.1073/pnas.94.21.11216; Siaussat D, 2004, INSECT MOL BIOL, V13, P179, DOI 10.1111/j.0962-1075.2004.00475.x; Snyder SH, 2000, AM J PSYCHIAT, V157, P1738, DOI 10.1176/appi.ajp.157.11.1738; Stehlin C, 2001, EMBO J, V20, P5822, DOI 10.1093/emboj/20.21.5822; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Sullivan AA, 2003, MOL ENDOCRINOL, V17, P2125, DOI 10.1210/me.2002-0430; Swevers L, 2002, J BIOL CHEM, V277, P41637, DOI 10.1074/jbc.M203581200; Swevers L, 2002, INSECT BIOCHEM MOLEC, V32, P1643, DOI 10.1016/S0965-1748(02)00104-2; THUMMEL CS, 1995, CELL, V83, P871, DOI 10.1016/0092-8674(95)90203-1; Vafopoulou X, 1996, GEN COMP ENDOCR, V102, P123, DOI 10.1006/gcen.1996.0053; Vafopoulou X, 1996, P NATL ACAD SCI USA, V93, P3368, DOI 10.1073/pnas.93.8.3368; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5; Ward RE, 2003, DEV BIOL, V256, P389, DOI 10.1016/S0012-1606(02)00100-8; White KP, 1997, SCIENCE, V276, P114, DOI 10.1126/science.276.5309.114; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; YANG P, 2005, IN PRESS PROTEOMICS; Zhang RG, 2001, STRUCTURE, V9, P1095, DOI 10.1016/S0969-2126(01)00675-X; Zhang XH, 2004, EUR J BIOCHEM, V271, P1713, DOI 10.1111/j.1432-1033.2004.04077.x	67	201	214	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 29	2005	122	2					195	207		10.1016/j.cell.2005.07.005	http://dx.doi.org/10.1016/j.cell.2005.07.005			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	951CR	16051145	Bronze			2022-12-28	WOS:000230907000008
J	Araki, T; Enomoto, S; Furuno, K; Gando, Y; Ichimura, K; Ikeda, H; Inoue, K; Kishimoto, Y; Koga, M; Koseki, Y; Maeda, T; Mitsui, T; Motoki, M; Nakajima, K; Ogawa, H; Ogawa, M; Owada, K; Ricol, JS; Shimizu, I; Shirai, J; Suekane, F; Suzuki, A; Tada, K; Takeuchi, S; Tamae, K; Tsuda, Y; Watanabe, H; Busenitz, J; Classen, T; Djurcic, Z; Keefer, G; Leonard, D; Piepke, A; Yakushev, E; Berger, BE; Chan, YD; Decowski, MP; Dwyer, DA; Freedman, SJ; Fujikawa, BK; Goldman, J; Gray, F; Heeger, KM; Hsu, L; Lesko, KT; Luk, KB; Murayama, H; O'Donnell, T; Poon, AWP; Steiner, HM; Winslow, LA; Mauger, C; McKeown, RD; Vogel, P; Lane, CE; Miletic, T; Guillian, G; Learned, JG; Maricic, J; Matsuno, S; Pakvasa, S; Horton-Smith, GA; Dazeley, S; Hatakeyama, S; Rojas, A; Svoboda, R; Dieterle, BD; Detwiler, J; Gratta, G; Ishii, K; Tolich, N; Uchida, Y; Batygov, M; Bugg, W; Efremenko, Y; Kamyshkov, Y; Kozlov, A; Nakamura, Y; Karwowski, HJ; Markoff, DM; Nakamura, K; Rohm, RM; Tornow, W; Wendell, R; Chen, MJ; Wang, YF; Piquemal, F				Araki, T; Enomoto, S; Furuno, K; Gando, Y; Ichimura, K; Ikeda, H; Inoue, K; Kishimoto, Y; Koga, M; Koseki, Y; Maeda, T; Mitsui, T; Motoki, M; Nakajima, K; Ogawa, H; Ogawa, M; Owada, K; Ricol, JS; Shimizu, I; Shirai, J; Suekane, F; Suzuki, A; Tada, K; Takeuchi, S; Tamae, K; Tsuda, Y; Watanabe, H; Busenitz, J; Classen, T; Djurcic, Z; Keefer, G; Leonard, D; Piepke, A; Yakushev, E; Berger, BE; Chan, YD; Decowski, MP; Dwyer, DA; Freedman, SJ; Fujikawa, BK; Goldman, J; Gray, F; Heeger, KM; Hsu, L; Lesko, KT; Luk, KB; Murayama, H; O'Donnell, T; Poon, AWP; Steiner, HM; Winslow, LA; Mauger, C; McKeown, RD; Vogel, P; Lane, CE; Miletic, T; Guillian, G; Learned, JG; Maricic, J; Matsuno, S; Pakvasa, S; Horton-Smith, GA; Dazeley, S; Hatakeyama, S; Rojas, A; Svoboda, R; Dieterle, BD; Detwiler, J; Gratta, G; Ishii, K; Tolich, N; Uchida, Y; Batygov, M; Bugg, W; Efremenko, Y; Kamyshkov, Y; Kozlov, A; Nakamura, Y; Karwowski, HJ; Markoff, DM; Nakamura, K; Rohm, RM; Tornow, W; Wendell, R; Chen, MJ; Wang, YF; Piquemal, F			Experimental investigation of geologically produced antineutrinos with KamLAND	NATURE			English	Article							EARTH; GEOPHYSICS; OSCILLATIONS; TERRESTRIAL; NEUTRINOS; DECAY; FLUX	The detection of electron antineutrinos produced by natural radioactivity in the Earth could yield important geophysical information. The Kamioka liquid scintillator antineutrino detector (KamLAND) has the sensitivity to detect electron antineutrinos produced by the decay of U-238 and Th-232 within the Earth. Earth composition models suggest that the radiogenic power from these isotope decays is 16 TW, approximately half of the total measured heat dissipation rate from the Earth. Here we present results from a search for geoneutrinos with KamLAND. Assuming a Th/U mass concentration ratio of 3.9, the 90 per cent confidence interval for the total number of geoneutrinos detected is 4.5 to 54.2. This result is consistent with the central value of 19 predicted by geophysical models. Although our present data have limited statistical power, they nevertheless provide by direct means an upper limit (60 TW) for the radiogenic power of U and Th in the Earth, a quantity that is currently poorly constrained.	Tohoku Univ, Res Ctr Neutrino Sci, Sendai, Miyagi 9808578, Japan; Univ Alabama, Dept Phys & Astron, Tuscaloosa, AL 35487 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; CALTECH, WK Kellogg Radiat Lab, Pasadena, CA 91125 USA; Drexel Univ, Dept Phys, Philadelphia, PA 19104 USA; Univ Hawaii Manoa, Dept Phys & Astron, Honolulu, HI 96822 USA; Kansas State Univ, Dept Phys, Manhattan, KS 66506 USA; Louisiana State Univ, Dept Phys & Astron, Baton Rouge, LA 70803 USA; Univ New Mexico, Dept Phys, Albuquerque, NM 87131 USA; Stanford Univ, Dept Phys, Stanford, CA 94305 USA; Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA; Duke Univ, Dept Phys, Durham, NC 27008 USA; N Carolina State Univ, Dept Phys, Raleigh, NC 27695 USA; Univ N Carolina, Dept Phys, Chapel Hill, NC 27599 USA; Inst High Energy Phys, Beijing 100039, Peoples R China; CEN Bordeaux Gradignan, IN2P3, CNRS, F-33175 Gradignan, France; Univ Bordeaux 1, F-33175 Gradignan, France	Tohoku University; University of Alabama System; University of Alabama Tuscaloosa; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; California Institute of Technology; Drexel University; University of Hawaii System; University of Hawaii Manoa; Kansas State University; Louisiana State University System; Louisiana State University; University of New Mexico; Stanford University; University of Tennessee System; University of Tennessee Knoxville; Duke University; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Enomoto, S (corresponding author), Tohoku Univ, Res Ctr Neutrino Sci, Sendai, Miyagi 9808578, Japan.	sanshiro@awa.tohoku.ac.jp; nrtolich@lbl.gov	Lang, Ming/HIK-0758-2022; Murayama, Hitoshi/A-4286-2011; Horton-Smith, Glenn A./A-4409-2011; Kozlov, Alexandre/AAK-8368-2021; Decowski, Patrick/A-4341-2011; Poon, Alan/AAJ-5095-2020; Kamyshkov, Yuri A/J-7999-2016; Gando, Yoshihito/ABH-5373-2020; Якушев, Евгений/GWZ-2431-2022; MOTOKI, Masakazu/B-4212-2009; Fujikawa, Brian K./A-4330-2011; Kamyshkov, Yuri/N-4066-2019; Heeger, Karsten/A-9533-2011	Horton-Smith, Glenn A./0000-0001-9677-9167; Kozlov, Alexandre/0000-0002-6679-3985; Decowski, Patrick/0000-0002-1577-6229; Poon, Alan/0000-0003-2684-6402; Kamyshkov, Yuri A/0000-0002-3789-7152; MOTOKI, Masakazu/0000-0002-2379-9113; Fujikawa, Brian K./0000-0002-7001-717X; Kamyshkov, Yuri/0000-0002-3789-7152; dazeley, steven/0000-0002-7395-8119; Gray, Frederick/0000-0003-4073-8336; Lane, Charles/0000-0003-4329-5796; Vogel, Petr/0000-0003-0587-5466; Keefer, Gregory/0000-0003-1411-7106; Watanabe, Hiroko/0000-0002-2363-5637; Murayama, Hitoshi/0000-0001-5769-9471; Winslow, Lindley/0000-0002-9970-108X; Chen, Mingjun/0000-0003-0084-1312; Yakushev, Evgeny/0000-0001-9113-2858; Heeger, Karsten/0000-0002-4623-7543; Ichimura, Koichi/0000-0001-9783-5781; Wang, Yifang/0000-0001-8331-6980; Detwiler, Jason/0000-0002-9050-4610; Classen, Timothy/0000-0001-6386-041X				Ahmed SN, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.181301; APOSTOLAKIS J, 2003, GEANT DETECTOR DESCR; Araki T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.081801; AVILEZ C, 1981, PHYS REV D, V23, P1116, DOI 10.1103/PhysRevD.23.1116; BEHRENS H, 1969, LANDOLTBORNSTEIN GRO, V4; EDER G, 1966, NUCL PHYS, V78, P657, DOI 10.1016/0029-5582(66)90903-5; Eguchi K, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.021802; ENOMOTO S, 2005, THESIS TOHOKU U; Firestone RB, 1996, TABLE ISOTOPES; Hofmeister AM, 2005, TECTONOPHYSICS, V395, P159, DOI 10.1016/j.tecto.2004.09.006; JACKSON MJ, 1984, J GEOPHYS RES, V89, P103, DOI 10.1029/JB089iB12p10103; *KAMLAND COLL, 2005, DAT REL ACC 2ND KAML; KERR GW, 1968, NUCL PHYS A, VA110, P637, DOI 10.1016/0375-9474(68)90378-3; KOBAYASHI M, 1991, GEOPHYS RES LETT, V18, P633, DOI 10.1029/91GL00800; Kopeikin VI, 2001, PHYS ATOM NUCL+, V64, P849, DOI 10.1134/1.1378874; KRAUSS LM, 1984, NATURE, V310, P191, DOI 10.1038/310191a0; Mantovani F, 2004, PHYS REV D, V69, DOI 10.1103/PhysRevD.69.013001; MARX G, 1969, CZECH J PHYS, V19, P1471, DOI 10.1007/BF01698889; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; McKeown RD, 2004, PHYS REP, V394, P315, DOI 10.1016/j.physrep.2004.01.003; POLLACK HN, 1993, REV GEOPHYS, V31, P267, DOI 10.1029/93RG01249; Raghavan RS, 1998, PHYS REV LETT, V80, P635, DOI 10.1103/PhysRevLett.80.635; RICHTER FM, 1984, EARTH PLANET SC LETT, V68, P471, DOI 10.1016/0012-821X(84)90131-6; ROCHOLL A, 1993, EARTH PLANET SC LETT, V117, P265, DOI 10.1016/0012-821X(93)90132-S; Rothschild CG, 1998, GEOPHYS RES LETT, V25, P1083, DOI 10.1029/98GL50667; TOLICH N, 2005, THESIS STANFORD U; Vogel P, 1999, PHYS REV D, V60, DOI 10.1103/PhysRevD.60.053003; WALTON RB, 1957, PHYS REV, V107, P1065, DOI 10.1103/PhysRev.107.1065; WOLFENSTEIN L, 1978, PHYS REV D, V17, P2369, DOI 10.1103/PhysRevD.17.2369	29	276	284	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					499	503		10.1038/nature03980	http://dx.doi.org/10.1038/nature03980			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049478				2022-12-28	WOS:000230788800050
J	Ratnieks, F				Ratnieks, F			Outsmarted by ants	NATURE			English	Editorial Material									Univ Sheffield, Dept Anim & Plant Sci, Lab Apiculture & Social Insects, Sheffield S10 2TN, S Yorkshire, England; Inst Adv Study, D-14193 Berlin, Germany	University of Sheffield	Ratnieks, F (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Lab Apiculture & Social Insects, Sheffield S10 2TN, S Yorkshire, England.							Feynman R. P., 2005, DONT YOU HAVE TIME T; FEYNMAN RP, 1985, SURLEY YOURE JOKING; Jackson DE, 2004, NATURE, V432, P907, DOI 10.1038/nature03105	3	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2005	436	7050					465	465		10.1038/436465a	http://dx.doi.org/10.1038/436465a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049456	Bronze			2022-12-28	WOS:000230788800024
J	Sampson, W				Sampson, W			Studying herbal remedies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Santa Clara Valley Med Ctr, Div Oncol, San Jose, CA 95128 USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA	Santa Clara Valley Medical Center; Stanford University	Sampson, W (corresponding author), Santa Clara Valley Med Ctr, Div Oncol, San Jose, CA 95128 USA.							Atwood Kimball C 4th, 2004, MedGenMed, V6, P33; Melchart D., 2000, COCHRANE DB SYST REV; SKRABANEK P, 1986, LANCET, V1, P960; Taylor JA, 2003, JAMA-J AM MED ASSOC, V290, P2824, DOI 10.1001/jama.290.21.2824	4	27	28	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2005	353	4					337	339		10.1056/NEJMp058130	http://dx.doi.org/10.1056/NEJMp058130			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949JW	16049207				2022-12-28	WOS:000230782800005
J	Sur, M				Sur, M			Breathing life into biology	NATURE			English	Article									MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Sur, M (corresponding author), MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA.								0	4	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2005	436	7050					487	487		10.1038/436487a	http://dx.doi.org/10.1038/436487a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049473				2022-12-28	WOS:000230788800042
J	Mastilica, M; Kusec, S				Mastilica, M; Kusec, S			Croatian healthcare system in transition, from the perspective of users	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Dept Med Sociol, HR-10000 Zagreb, Croatia; Univ Zagreb, Andrija Stampar Sch Publ Hlth, Dept Educ Technol, Zagreb, Croatia	University of Zagreb; University of Zagreb	Mastilica, M (corresponding author), Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Dept Med Sociol, Rockefellerova 4, HR-10000 Zagreb, Croatia.	mmastil@snz.hr		Brangan, Sanja/0000-0002-6588-0091				BELAND Y, 2004, P AM STAT ASS M SURV; Chen MS, 1998, AM J PUBLIC HEALTH, V88, P1156, DOI 10.2105/AJPH.88.8.1156; HEBRANG A, 1994, CROAT MED J, V35, P130; Maarse H., 1995, ANTIDOTUM S, V1, P56; Mastilica M, 2002, CROAT MED J, V43, P417; Mastilica M, 1999, CROAT MED J, V40, P152; Mastilica M, 1998, Croat Med J, V39, P256; MASTILICA M, 1990, SOC SCI MED, V31, P405, DOI 10.1016/0277-9536(90)90287-3; Mastilica M., 1992, INT J HLTH SCI, V3, P195; Oreskovic S, 1997, COLLEGIUM ANTROPOL, V21, P595; Oreskovic Stjepan, 1995, Croatian Medical Journal, V36, P47; Saric M, 1993, J Public Health Policy, V14, P220, DOI 10.2307/3342966; SIXMA HJ, 1996, QUATE HLTH CARE SERV; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; Vienonen M, 1995, ANTIDOTUM S, V1, P107; *WHO, 1996, EUR HLTH CAR REF LJU	16	30	32	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2005	331	7510					223	226		10.1136/bmj.331.7510.223	http://dx.doi.org/10.1136/bmj.331.7510.223			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951EA	16037464	Bronze, Green Published			2022-12-28	WOS:000230910700033
J	Reilly, JJ				Reilly, JJ			Physical activity and obesity in childhood and adolescence	LANCET			English	Editorial Material									Univ Glasgow, Div Dev Med, Glasgow G3 8SJ, Lanark, Scotland	University of Glasgow	Reilly, JJ (corresponding author), Univ Glasgow, Div Dev Med, Glasgow G3 8SJ, Lanark, Scotland.	jjr2y@clinmed.gla.ac.uk						Butte NF, 2003, SCIENCE, V301; Fogelholm M, 2000, Obes Rev, V1, P95, DOI 10.1046/j.1467-789x.2000.00016.x; Gordon-Larsen P, 2004, AM J CLIN NUTR, V80, P569; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Kimm SYS, 2002, NEW ENGL J MED, V347, P709, DOI 10.1056/NEJMoa003277; KIMM SYS, 2005, LANCET, V365, P300; Montgomery C, 2004, AM J CLIN NUTR, V80, P591; Parsons TJ, 1999, INT J OBESITY, V23, pS1; REILLY JJ, IN PRESS CHILDHOOD O; REILLY JJ, IN PRESS NUTR ABSTR; Wareham NJ, 1998, INT J OBESITY, V22, pS30; Westerterp KR, 2001, NATURE, V410, P539, DOI 10.1038/35069142; Whitaker RC, 2003, ARCH PEDIAT ADOL MED, V157, P725, DOI 10.1001/archpedi.157.8.725	13	24	26	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2005	366	9482					268	269		10.1016/S0140-6736(05)66838-9	http://dx.doi.org/10.1016/S0140-6736(05)66838-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RJ	16039314				2022-12-28	WOS:000230733100005
J	Staiano, JJ; Savage, P; Stephenson, BM; Milling, MAP				Staiano, JJ; Savage, P; Stephenson, BM; Milling, MAP			Mesh mimics metastasis	LANCET			English	Editorial Material									Morriston Hosp, Welsh Ctr Burns & Plast Surg, Swansea SA6 6NL, W Glam, Wales; Velindre Hosp, Cardiff CF14 2TL, Wales; Royal Gwent Hosp, Newport NP20 9UB, Gwent, Wales	Morriston Hospital; Velindre Hospital; Royal Gwent Hospital	Staiano, JJ (corresponding author), Morriston Hosp, Welsh Ctr Burns & Plast Surg, Swansea SA6 6NL, W Glam, Wales.	jjstaiano@doctors.org.uk		Savage, Philip/0000-0002-4792-6869					0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 23	2005	366	9482					341	341		10.1016/S0140-6736(05)66993-0	http://dx.doi.org/10.1016/S0140-6736(05)66993-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RJ	16039340				2022-12-28	WOS:000230733100036
J	Reynolds, JD; Freckleton, RP				Reynolds, JD; Freckleton, RP			Population dynamics: Growing to extremes	SCIENCE			English	Editorial Material									Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of East Anglia; University of Oxford	Reynolds, JD (corresponding author), Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England.	reynolds@uea.ac.uk; robert.freckleton@zoology.oxford.ac.uk	Freckleton, Rob P/B-6455-2013; Reynolds, John D/L-6345-2015	Reynolds, John D/0000-0002-0459-0074; Freckleton, Robert/0000-0002-8338-864X				*IMP COLL LOND, 1999, GLOB POP DYN DAT; Royama T., 1992, ANAL POPULATION ECOL; Shenk TM, 1998, ECOL MONOGR, V68, P445, DOI 10.1890/0012-9615(1998)068[0445:SVEODD]2.0.CO;2; Sibly RM, 2005, SCIENCE, V309, P607, DOI 10.1126/science.1110760	4	22	22	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2005	309	5734					567	568		10.1126/science.1116268	http://dx.doi.org/10.1126/science.1116268			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040696				2022-12-28	WOS:000230735200034
J	Tulevski, GS; Myers, MB; Hybertsen, MS; Steigerwald, ML; Nuckolls, C				Tulevski, GS; Myers, MB; Hybertsen, MS; Steigerwald, ML; Nuckolls, C			Formation of catalytic metal-molecule contacts	SCIENCE			English	Article							SURFACE; BETA-MO2C; NITROGEN; RU(0001)	We describe a new strategy for the in situ growth of molecular wires predicated on the synthesis of a trifunctional "primed" contact formed from metal-carbon multiple bonds. The ruthenium-carbon it bond provides structural stability to the molecular linkages under ambient conditions, and density functional calculations indicate the formation of an efficient conduit for charge carriers to pass between the metal and the molecule. Moreover, the metal-carbon it bond provides a chemically reactive site from which a conjugated molecular wire can be grown in situ through an olefin metathesis reaction.	Columbia Univ, Dept Chem, New York, NY 10027 USA; Columbia Univ, Nanosci Ctr, New York, NY 10027 USA; Columbia Univ, Dept Appl Phys & Appl Math, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University	Steigerwald, ML (corresponding author), Columbia Univ, Dept Chem, New York, NY 10027 USA.	mls2064@columbia.edu; cn37@columbia.edu	Myers, Matthew Benjamin/B-8867-2015; Hybertsen, Mark S./AAX-3175-2021	Myers, Matthew Benjamin/0000-0002-5889-4196; Hybertsen, Mark S./0000-0003-3596-9754				Arnold R, 2001, LANGMUIR, V17, P4980, DOI 10.1021/la010202o; BIRCHEM T, 1995, SURF SCI, V334, pL701, DOI 10.1016/0039-6028(95)80020-4; Combes JR, 1999, LANGMUIR, V15, P7870, DOI 10.1021/la990495+; GAGNE MR, 1992, ORGANOMETALLICS, V11, P3933, DOI 10.1021/om00060a003; GEORGE PM, 1983, J AM CHEM SOC, V105, P1393, DOI 10.1021/ja00343a065; Gonze X, 2002, COMP MATER SCI, V25, P478, DOI 10.1016/S0927-0256(02)00325-7; Grubbs R. H., 2003, HDB OLEFIN METATHESI; Gunia M, 2004, J PHYS CHEM B, V108, P14025, DOI 10.1021/jp0401877; Jacobi K, 2000, PHYS STATUS SOLIDI A, V177, P37, DOI 10.1002/(SICI)1521-396X(200001)177:1<37::AID-PSSA37>3.0.CO;2-Y; Kaga Y., 1999, Surface Science Spectra, V6, P68, DOI 10.1116/1.1247890; Nitzan A, 2003, SCIENCE, V300, P1384, DOI 10.1126/science.1081572; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; *SCHROD LLC, 1991, JAG 5 0; Siaj M, 2005, SURF SCI, V579, P1, DOI 10.1016/j.susc.2005.01.021; Siaj M, 2004, J AM CHEM SOC, V126, P9514, DOI 10.1021/ja048640f; UMBACH E, 1984, SOLID STATE COMMUN, V51, P365, DOI 10.1016/0038-1098(84)90114-5; WASSERMAN SR, 1989, LANGMUIR, V5, P1074, DOI 10.1021/la00088a035; WULFMAN DS, 1988, SYNTHETIC COMMUN, V18, P2349, DOI 10.1080/00397918808082380; Zahidi E, 2001, NATURE, V409, P1023, DOI 10.1038/35059047; Zhong HC, 2001, J ELECTRON MATER, V30, P1493, DOI 10.1007/s11664-001-0164-2	20	66	68	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2005	309	5734					591	594		10.1126/science.1112767	http://dx.doi.org/10.1126/science.1112767			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040702				2022-12-28	WOS:000230735200042
J	Kidane, D; Graumann, PL				Kidane, D; Graumann, PL			Intracellular protein and DNA dynamics in competent Bacillus subtilis cells	CELL			English	Article							ESCHERICHIA-COLI RECA; SINGLE-STRANDED-DNA; SMC PROTEIN; TRANSFORMATION; RECOMBINATION; REPAIR; BINDING; LOCALIZATION; CONDENSATION; REPLICATION	We have found that two DNA repair/recombination proteins localize differentially to the cell poles in competent Bacillus subtilis cells. RecA protein colocalized with competence protein ComGA, and its polar localization largely depended on ComGA and ComK activity, while RecN oscillated between the poles in a minute time frame, independent of any competence factor. Oscillation of RecN arrested upon addition of external DNA, suggesting that an interaction with incoming single-stranded (ss) DNA favors the localization of RecN at the pole containing the competence machinery. In agreement with this model, purified RecN protein showed ATP-dependent binding to ssDNA. Addition of DNA resulted in the formation of RecA threads emanating from the competence machinery. Our data show that in competent bacteria there exists a specifically positioned and dynamic ssDNA binding apparatus that accepts ssDNA taken up through the polar competence machinery and processes ssDNA for recombination with chromosomal DNA via extended RecA filaments.	Univ Freiburg, Fachbereich Biol 2, Inst Mikrobiol, D-79104 Freiburg, Germany	University of Freiburg	Graumann, PL (corresponding author), Univ Freiburg, Fachbereich Biol 2, Inst Mikrobiol, Stefan Meier Str 19, D-79104 Freiburg, Germany.	peter.graumann@biologie.uni-freiburg.de		Graumann, Peter/0000-0002-8033-5171				Arnold DA, 2000, J BIOL CHEM, V275, P12261, DOI 10.1074/jbc.275.16.12261; Ayora S, 2004, P NATL ACAD SCI USA, V101, P452, DOI 10.1073/pnas.2533829100; Berka RM, 2002, MOL MICROBIOL, V43, P1331, DOI 10.1046/j.1365-2958.2002.02833.x; Bork JM, 2001, EMBO J, V20, P7313, DOI 10.1093/emboj/20.24.7313; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Chung YS, 1998, J BACTERIOL, V180, P41, DOI 10.1128/JB.180.1.41-45.1998; Cox MM, 2003, ANNU REV MICROBIOL, V57, P551, DOI 10.1146/annurev.micro.57.030502.090953; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; DUBNAU D, 1973, J BACTERIOL, V113, P1512, DOI 10.1128/JB.113.3.1512-1514.1973; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; DUBNAU D, 1971, J MOL BIOL, V56, P209, DOI 10.1016/0022-2836(71)90460-8; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9; Hahn J, 2005, CELL, V122, P59, DOI 10.1016/j.cell.2005.04.035; Haijema BJ, 2001, MOL MICROBIOL, V40, P52, DOI 10.1046/j.1365-2958.2001.02363.x; Hamoen LW, 2001, J BIOL CHEM, V276, P42901, DOI 10.1074/jbc.M104407200; Hirano M, 2002, EMBO J, V21, P5733, DOI 10.1093/emboj/cdf575; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; Kidane D, 2004, MOL MICROBIOL, V52, P1627, DOI 10.1111/j.1365-2958.2004.04102.x; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Lewis PJ, 1999, GENE, V227, P101, DOI 10.1016/S0378-1119(98)00580-0; LONDONOVALLEJO JA, 1994, J BACTERIOL, V176, P4642; Maier B, 2004, NAT STRUCT MOL BIOL, V11, P643, DOI 10.1038/nsmb783; Mascarenhas J, 2002, EMBO J, V21, P3108, DOI 10.1093/emboj/cdf314; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Provvedi R, 1999, MOL MICROBIOL, V31, P271, DOI 10.1046/j.1365-2958.1999.01170.x; Provvedi R, 2001, MOL MICROBIOL, V40, P634, DOI 10.1046/j.1365-2958.2001.02406.x; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Sanchez H, 2005, NUCLEIC ACIDS RES, V33, P2343, DOI 10.1093/nar/gki533; Sciochetti SA, 2001, J BACTERIOL, V183, P2963, DOI 10.1128/JB.183.9.2963-2968.2001; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Teleman AA, 1998, CURR BIOL, V8, P1102, DOI 10.1016/S0960-9822(98)70464-6; Volkov A, 2003, MOL CELL BIOL, V23, P5638, DOI 10.1128/MCB.23.16.5638-5650.2003; Webb BL, 1997, CELL, V91, P347, DOI 10.1016/S0092-8674(00)80418-3; Webb CD, 1997, CELL, V88, P667, DOI 10.1016/S0092-8674(00)81909-1; Xing X, 2004, J MOL BIOL, V342, P1471, DOI 10.1016/j.jmb.2004.07.091	38	82	84	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 15	2005	122	1					73	84		10.1016/j.cell.2005.04.036	http://dx.doi.org/10.1016/j.cell.2005.04.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	950EC	16009134	Bronze			2022-12-28	WOS:000230839400012
J	Kujoth, GC; Hiona, A; Pugh, TD; Someya, S; Panzer, K; Wohlgemuth, SE; Hofer, T; Seo, AY; Sullivan, R; Jobling, WA; Morrow, JD; Van Remmen, H; Sedivy, JM; Yamasoba, T; Tanokura, M; Weindruch, R; Leeuwenburgh, C; Prolla, TA				Kujoth, GC; Hiona, A; Pugh, TD; Someya, S; Panzer, K; Wohlgemuth, SE; Hofer, T; Seo, AY; Sullivan, R; Jobling, WA; Morrow, JD; Van Remmen, H; Sedivy, JM; Yamasoba, T; Tanokura, M; Weindruch, R; Leeuwenburgh, C; Prolla, TA			Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging	SCIENCE			English	Article							MICE; MUSCLE; AGE; ABNORMALITIES; DELETION; ATROPHY; HEARING	Mutations in mitochondrial DNA. (mtDNA) accumulate in tissues of mammalian species and have been hypothesized to contribute to aging. We show that mice expressing a proof reading-deficient version of the mitochondrial DNA polymerase gamma (POLG) accumulate mtDNA mutations and display features of accelerated aging. Accumulation of mtDNA mutations was not associated with increased markers of oxidative stress or a defect in cellular proliferation, but was correlated with the induction of apoptotic markers, particularly in tissues characterized by rapid cellular turnover. The levels of apoptotic markers were also found to increase during aging in normal mice. Thus, accumulation of mtDNA mutations that promote apoptosis may be a central mechanism driving mammalian aging.	Univ Wisconsin, Dept Genet & Med Genet, Madison, WI 53706 USA; Univ Florida, Coll Med, Dept Aging & Geriatr Res, Inst Aging,Biochem Aging Lab, Gainesville, FL 32610 USA; Univ Wisconsin, Dept Med, Madison, WI 53705 USA; Univ Wisconsin, Vet Adm Hosp, Madison, WI 53705 USA; Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; Brown Univ, Ctr Genom & Proteom, Providence, RI 02912 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78284 USA; Univ Texas, Hlth Sci Ctr, Barshop Inst Longev & Aging Studies, San Antonio, TX 78284 USA; Univ Tokyo, Dept Otolaryngol, Bunkyo Ku, Tokyo 1138657, Japan	University of Wisconsin System; University of Wisconsin Madison; State University System of Florida; University of Florida; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Tokyo; University of Wisconsin System; University of Wisconsin Madison; Brown University; Brown University; Vanderbilt University; Vanderbilt University; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Tokyo	Prolla, TA (corresponding author), Univ Wisconsin, Dept Genet & Med Genet, Madison, WI 53706 USA.	taprolla@wisc.edu		Tanokura, Masaru/0000-0001-5072-2480; Leeuwenburgh, Christiaan/0000-0003-0826-4257; Kujoth, Gregory/0000-0002-6636-2800	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017994, R01AG021042, R01AG021905, R01AG018922, R01AG016694, T32AG000213, R37AG016694] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00095] Funding Source: Medline; NIA NIH HHS [AG16694, AG21042, AG18922, AG021905, T32 AG00213, AG17994] Funding Source: Medline; NIDDK NIH HHS [DK48831] Funding Source: Medline; NIGMS NIH HHS [T32 GM07601] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aspnes LE, 1997, FASEB J, V11, P573, DOI 10.1096/fasebj.11.7.9212081; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; FLEMING JE, 1982, GERONTOLOGY, V28, P44, DOI 10.1159/000212510; Gratton Michael Anne, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P367, DOI 10.1097/00020840-200310000-00010; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Keithley EM, 2004, HEARING RES, V188, P21, DOI 10.1016/S0378-5955(03)00365-4; Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1; LEE CM, 1993, J GERONTOL, V48, P201; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Melov S, 1997, NUCLEIC ACIDS RES, V25, P974, DOI 10.1093/nar/25.5.974; Roberts LJ, 2002, CELL MOL LIFE SCI, V59, P808, DOI 10.1007/s00018-002-8469-8; Shelke RRJ, 2003, FASEB J, V17, P494, DOI 10.1096/fj.02-0803fje; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com; Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	23	1472	1567	5	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					481	484		10.1126/science.1112125	http://dx.doi.org/10.1126/science.1112125			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020738				2022-12-28	WOS:000230574900051
J	Raisz, LG				Raisz, LG			Screening for osteoporosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MINERAL DENSITY; X-RAY ABSORPTIOMETRY; HIP FRACTURE RISK; VERTEBRAL FRACTURES; POSTMENOPAUSAL WOMEN; CLINICAL-USE; WHITE WOMEN; TURNOVER; MASS; MEN		Univ Connecticut, Ctr Hlth, Musculoskeletal Inst, Farmington, CT 06030 USA	University of Connecticut	Raisz, LG (corresponding author), Univ Connecticut, Ctr Hlth, Musculoskeletal Inst, 263 Farmington Ave,MC-3805, Farmington, CT 06030 USA.	raisz@nso.uchc.edu						Barrett-Connor E, 2005, J BONE MINER RES, V20, P185, DOI 10.1359/JBMR.041007; Bates DW, 2002, JAMA-J AM MED ASSOC, V288, P1898, DOI 10.1001/jama.288.15.1898; Berg AO, 2002, ANN INTERN MED, V137, P526, DOI 10.7326/0003-4819-137-6-200209170-00014; Bilezikian JP, 2004, NEW ENGL J MED, V350, P1746, DOI 10.1056/NEJMcp032200; Birch K, 2005, BRIT MED J, V330, P244, DOI 10.1136/bmj.330.7485.244; Bischoff-Ferrari HA, 2004, JAMA-J AM MED ASSOC, V291, P1999, DOI 10.1001/jama.291.16.1999; Black DM, 2001, OSTEOPOROSIS INT, V12, P519, DOI 10.1007/s001980170072; Cadarette SM, 2004, OSTEOPOROSIS INT, V15, P361, DOI 10.1007/s00198-003-1552-7; Cauley JA, 2004, OSTEOPOROSIS INT, V15, P32, DOI 10.1007/s00198-003-1462-8; CHRISTIANSEN C, 1991, AM J MED, V90, P107; Clark MK, 2003, OSTEOPOROSIS INT, V14, P396, DOI 10.1007/s00198-003-1387-2; Cranney A, 2002, ENDOCR REV, V23, P570, DOI 10.1210/er.2001-9002; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Department of Health and Human Services, 2004, BON HLTH OST REP SUR; Elliot-Gibson V, 2004, OSTEOPOROSIS INT, V15, P767, DOI 10.1007/s00198-004-1675-5; Ensrud KE, 2003, J AM GERIATR SOC, V51, P1740, DOI 10.1046/j.1532-5415.2003.51558.x; Espallargues M, 2001, OSTEOPOROSIS INT, V12, P811, DOI 10.1007/s001980170031; Ferrar L, 2003, J BONE MINER RES, V18, P933, DOI 10.1359/jbmr.2003.18.5.933; Garnero P, 2003, J BONE MINER RES, V18, P1789, DOI 10.1359/jbmr.2003.18.10.1789; Genant HK, 1999, OSTEOPOROSIS INT, V10, P259, DOI 10.1007/s001980050224; GERDHEM P, IN PRESS OSTEOPOROS; HODGSON SF, 2004, ENDOCR PRACT, V10, P90; Hodgson Stephen F, 2003, Endocr Pract, V9, P544; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; HUI SL, 1988, J CLIN INVEST, V81, P1804, DOI 10.1172/JCI113523; Johnell O, 2004, J BONE MINER RES, V19, P764, DOI 10.1359/JBMR.040211; Johnell O, 2002, OSTEOPOROSIS INT, V13, P523, DOI 10.1007/s001980200068; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P581, DOI 10.1007/s00198-004-1780-5; Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Lang TF, 2002, BONE, V30, P247, DOI 10.1016/S8756-3282(01)00647-0; Leib ES, 2004, J CLIN DENSITOM, V7, P1, DOI 10.1385/JCD:7:1:1; Lindsay R, 2001, JAMA-J AM MED ASSOC, V285, P320, DOI 10.1001/jama.285.3.320; Maalouf NM, 2005, J CLIN ENDOCR METAB, V90, P2456, DOI 10.1210/jc.2004-1978; Melton LJ, 2005, J BONE MINER RES, V20, P487, DOI 10.1359/JBMR.041131; Melton LJ, 2003, J BONE MINER RES, V18, P312, DOI 10.1359/jbmr.2003.18.2.312; Miller KK, 2005, ARCH INTERN MED, V165, P561, DOI 10.1001/archinte.165.5.561; National Osteoporosis Foundation, 2003, PHYS GUID PREV TREAT; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Nevitt MC, 2005, J BONE MINER RES, V20, P131, DOI 10.1359/JBMR.041003; Pack AM, 2005, ANN NEUROL, V57, P252, DOI 10.1002/ana.20378; Picard D, 2004, J CLIN DENSITOM, V7, P111, DOI 10.1385/JCD:7:1:111; Sanders KM, 1998, J BONE MINER RES, V13, P1337, DOI 10.1359/jbmr.1998.13.8.1337; Schrager S, 2004, J WOMENS HEALTH, V13, P431, DOI 10.1089/154099904323087123; Schuit SCE, 2004, BONE, V34, P195, DOI 10.1016/j.bone.2003.10.001; Shahinian VB, 2005, NEW ENGL J MED, V352, P154, DOI 10.1056/NEJMoa041943; Silman AJ, 2003, OSTEOPOROSIS INT, V14, P213, DOI 10.1007/s00198-002-1364-1; Siminoski K, 2005, OSTEOPOROSIS INT, V16, P403, DOI 10.1007/s00198-004-1709-z; Solomon DH, 2003, AM J MED, V115, P398, DOI 10.1016/S0002-9343(03)00357-7; Stein E, 2003, ENDOCRIN METAB CLIN, V32, P115, DOI 10.1016/S0889-8529(02)00062-2; Stenson WF, 2005, ARCH INTERN MED, V165, P393, DOI 10.1001/archinte.165.4.393; Tannenbaum C, 2002, J CLIN ENDOCR METAB, V87, P4431, DOI 10.1210/jc.2002-020275; Taylor BC, 2004, J AM GERIATR SOC, V52, P1479, DOI 10.1111/j.1532-5415.2004.52410.x; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; van Staa TP, 2005, QJM-INT J MED, V98, P191, DOI 10.1093/qjmed/hci029	55	179	189	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2005	353	2					164	171		10.1056/NEJMcp042092	http://dx.doi.org/10.1056/NEJMcp042092			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944OP	16014886				2022-12-28	WOS:000230438800008
J	Garraway, LA; Widlund, HR; Rubin, MA; Getz, G; Berger, AJ; Ramaswamy, S; Beroukhim, R; Milner, DA; Granter, SR; Du, JY; Lee, C; Wagner, SN; Li, C; Golub, TR; Rimm, DL; Meyerson, ML; Fisher, DE; Sellers, WR				Garraway, LA; Widlund, HR; Rubin, MA; Getz, G; Berger, AJ; Ramaswamy, S; Beroukhim, R; Milner, DA; Granter, SR; Du, JY; Lee, C; Wagner, SN; Li, C; Golub, TR; Rimm, DL; Meyerson, ML; Fisher, DE; Sellers, WR			Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma	NATURE			English	Article							NUCLEOTIDE POLYMORPHISM ARRAYS; ANTICANCER DRUG SCREEN; CANCER-CELL LINES; HETEROZYGOSITY ANALYSIS; EXPRESSION PATTERNS; PROSTATE-CANCER; COPY NUMBER; MELANOCYTES; GENE; MICROPHTHALMIA	Systematic analyses of cancer genomes promise to unveil patterns of genetic alterations linked to the genesis and spread of human cancers. High-density single-nucleotide polymorphism (SNP) arrays enable detailed and genome-wide identification of both loss-of-heterozygosity events and copy-number alterations in cancer(1-5). Here, by integrating SNP array-based genetic maps with gene expression signatures derived from NCI60 cell lines, we identified the melanocyte master regulator MITF (microphthalmia-associated transcription factor) as the target of a novel melanoma amplification. We found that MITF amplification was more prevalent in metastatic disease and correlated with decreased overall patient survival. BRAF mutation and p16 inactivation accompanied MITF amplification in melanoma cell lines. Ectopic MITF expression in conjunction with the BRAF(V600E) mutant transformed primary human melanocytes, and thus MITF can function as a melanoma oncogene. Reduction of MITF activity sensitizes melanoma cells to chemotherapeutic agents. Targeting MITF in combination with BRAF or cyclin-dependent kinase inhibitors may offer a rational therapeutic avenue into melanoma, a highly chemotherapy-resistant neoplasm. Together, these data suggest that MITF represents a distinct class of 'lineage survival' or 'lineage addiction' oncogenes required for both tissue-specific cancer development and tumour progression.	Dana Farber Canc Inst, Dept Med Oncol, Pediat Oncol Biostat Sci & Melonam Program Med On, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Broad Inst Harvard, Cambridge, MA 02141 USA; MIT, Cambridge, MA 02141 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Dept Med, Charlestown, MA 02129 USA; Austrian Acad Sci, Ctr Mol Med, A-1090 Vienna, Austria; Med Univ Vienna, Dept Dermatol, DIAID, A-1090 Vienna, Austria	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Yale University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Austrian Academy of Sciences; Medical University of Vienna	Sellers, WR (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Pediat Oncol Biostat Sci & Melonam Program Med On, 44 Binney St, Boston, MA 02115 USA.	William_Sellers@dfci.harvard.edu	Milner, Danny/K-3568-2019; Meyerson, Matthew L/E-7123-2012	Widlund, Hans/0000-0002-7506-2447; Wagner, Stephan/0000-0003-4941-7029; Milner, Jr, Danny Arnold/0000-0002-6685-8208; Rimm, David/0000-0001-5820-4397; Rubin, Mark/0000-0002-8321-9950	NCI NIH HHS [T32 CA009172] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009172] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BERGER AJ, IN PRESS CANC RES; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Bignell GR, 2004, GENOME RES, V14, P287, DOI 10.1101/gr.2012304; Camp RL, 2003, CANCER RES, V63, P1445; Carreira S, 2005, NATURE, V433, P764, DOI 10.1038/nature03269; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chu W, 2000, ONCOGENE, V19, P395, DOI 10.1038/sj.onc.1203315; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; JAFARI M, 1995, J CANCER RES CLIN, V121, P23, DOI 10.1007/BF01202725; Kubo A, 1999, CLIN CANCER RES, V5, P4279; Lieberfarb ME, 2003, CANCER RES, V63, P4781; Lindblad-Toh K, 2000, NAT BIOTECHNOL, V18, P1001, DOI 10.1038/79269; Loercher AE, 2005, J CELL BIOL, V168, P35, DOI 10.1083/jcb.200410115; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Mei R, 2000, GENOME RES, V10, P1126, DOI 10.1101/gr.10.8.1126; Monks A, 1997, ANTI-CANCER DRUG DES, V12, P533; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; Price ER, 1998, J BIOL CHEM, V273, P17983, DOI 10.1074/jbc.273.29.17983; Roschke AV, 2003, CANCER RES, V63, P8634; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Rubin MA, 2004, CANCER RES, V64, P3814, DOI 10.1158/0008-5472.CAN-03-3881; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; STINSON SF, 1992, ANTICANCER RES, V12, P1035; Wu M, 2000, GENE DEV, V14, P301; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	29	1085	1127	2	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					117	122		10.1038/nature03664	http://dx.doi.org/10.1038/nature03664			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001072				2022-12-28	WOS:000230296600050
J	Saether, BE; Lande, R; Engen, S; Weimerskirch, H; Lillegard, M; Altwegg, R; Becker, PH; Bregnballe, T; Brommer, JE; McCleery, RH; Merila, J; Nyholm, E; Rendell, W; Robertson, RR; Tryjanowski, P; Visser, ME				Saether, BE; Lande, R; Engen, S; Weimerskirch, H; Lillegard, M; Altwegg, R; Becker, PH; Bregnballe, T; Brommer, JE; McCleery, RH; Merila, J; Nyholm, E; Rendell, W; Robertson, RR; Tryjanowski, P; Visser, ME			Generation time and temporal scaling of bird population dynamics	NATURE			English	Article							LIFE-HISTORY VARIATION; DENSITY-DEPENDENCE; CLIMATE; PARAMETERS; TRENDS	Theoretical studies have shown that variation in density regulation strongly influences population dynamics(1), yet our understanding of factors influencing the strength of density dependence in natural populations still is limited(2). Consequently, few general hypotheses have been advanced to explain the large differences between species in the magnitude of population fluctuations(3-6). One reason for this is that the detection of density regulation in population time series is complicated by time lags induced by the life history of species(7,8) that make it difficult to separate the relative contributions of intrinsic and extrinsic factors to the population dynamics. Here we use population time series for 23 bird species to estimate parameters of a stochastic density-dependent age-structured model. We show that both the strength of total density dependence in the life history and the magnitude of environmental stochasticity, including transient fluctuations in age structure, increase with generation time. These results indicate that the relationships between demographic and life-history traits in birds(9,10) translate into distinct population dynamical patterns that are apparent only on a scale of generations.	Norwegian Univ Sci & Technol, Dept Biol, N-7491 Trondheim, Norway; Univ Calif San Diego, Dept Biol 0116, La Jolla, CA 92093 USA; Norwegian Univ Sci & Technol, Dept Math Sci, N-7491 Trondheim, Norway; CNRS, CEBC, FR-79360 Villiers En Bois, France; Univ Victoria, Dept Biol, Victoria, BC V8W 3N5, Canada; Inst Vogelforsch Vogelwarte Helgoland, D-26386 Wilhelmshaven, Germany; Natl Environm Res Inst, Dept Coastal Zone Ecol, DK-8410 Ronde, Denmark; Univ Helsinki, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Umea Univ, Dept Ecol & Environm Sci, S-90187 Umea, Sweden; Loyalist Coll, Belleville, ON K8N 5B9, Canada; Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; Adam Mickiewicz Univ, Dept Behav Ecol, PL-61614 Poznan, Poland; Netherlands Inst Ecol, NL-6666 ZG Heteren, Netherlands	Norwegian University of Science & Technology (NTNU); University of California System; University of California San Diego; Norwegian University of Science & Technology (NTNU); Centre National de la Recherche Scientifique (CNRS); University of Victoria; Aarhus University; University of Helsinki; University of Oxford; Umea University; Queens University - Canada; Adam Mickiewicz University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Saether, BE (corresponding author), Norwegian Univ Sci & Technol, Dept Biol, N-7491 Trondheim, Norway.	bernt-erik.sather@bio.ntnu.no	Merila, Juha/A-4061-2008; Brommer, Jon E/C-3613-2008; Bregnballe, Thomas/L-1890-2013; Weimerskirch, Henri/F-5562-2013; Tryjanowski, Piotr/C-1367-2009; Visser, Marcel E/A-9151-2009; Weimerskirch, Henri/K-7306-2019	Merila, Juha/0000-0001-9614-0072; Brommer, Jon E/0000-0002-2435-2612; Visser, Marcel E/0000-0002-1456-1939; Weimerskirch, Henri/0000-0002-0457-586X; Bregnballe, Thomas/0000-0003-2867-478X				ARINO A, 1995, EVOL ECOL, V9, P429, DOI 10.1007/BF01237765; Barbraud C, 2003, P ROY SOC B-BIOL SCI, V270, P2111, DOI 10.1098/rspb.2003.2488; Bennett P. M., 2002, OX ECOL EV; BULMER MG, 1975, BIOMETRICS, V31, P901, DOI 10.2307/2529815; Charnov EL, 2000, EVOL ECOL RES, V2, P365; CHARNOV EL, 1995, EVOL ECOL, V9, P288, DOI 10.1007/BF01237774; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; CROXALL JP, 1991, BIRD POPULATION STUD, P272; De Valpine P, 2002, ECOL MONOGR, V72, P57, DOI 10.1890/0012-9615(2002)072[0057:FPMIPN]2.0.CO;2; DEKROON H, 1986, ECOLOGY, V67, P1427, DOI 10.2307/1938700; HANSKI I, 1990, PHILOS T R SOC B, V330, P141, DOI 10.1098/rstb.1990.0188; Holyoak M, 1996, OECOLOGIA, V108, P54, DOI 10.1007/BF00333214; Lande R, 2002, AM NAT, V159, P321, DOI 10.1086/338988; Lande R, 2002, POPULATION VIABILITY ANALYSIS, P18; Lande R., 2003, OXFORD SERIES ECOLOG; May R.M., 1973, STABILITY COMPLEXITY; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; Micol T, 2001, POLAR BIOL, V24, P175, DOI 10.1007/s003000000193; Newton I., 1998, POPULATION LIMITATIO; Nisbet R.M., 1997, STRUCTURED POPULATIO, V18, P89; Pimm S.L., 1991, BALANCE NATURE; Royama T., 1992, ANAL POPULATION ECOL; Saether BE, 2004, ADV ECOL RES, V35, P185, DOI 10.1016/S0065-2504(04)35009-9; Saether BE, 2004, AM NAT, V164, P793, DOI 10.1086/425371; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Shumway R.H., 1988, APPL STAT TIME SERIE; Sibly Richard M., 2003, P11, DOI 10.1017/CBO9780511615740.002; Thompson PM, 2001, NATURE, V413, P417, DOI 10.1038/35096558; Weimerskirch H, 2003, ANTARCT SCI, V15, P249, DOI 10.1017/S0954102003001202; Zeng Z, 1998, ECOLOGY, V79, P2193, DOI 10.1890/0012-9658(1998)079[2193:CPDITR]2.0.CO;2	30	135	139	0	71	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					99	102		10.1038/nature03666	http://dx.doi.org/10.1038/nature03666			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001068				2022-12-28	WOS:000230296600046
J	Higgins, LJ; Yan, F; Liu, PH; Liu, HW; Drennan, CL				Higgins, LJ; Yan, F; Liu, PH; Liu, HW; Drennan, CL			Structural insight into antibiotic fosfomycin biosynthesis by a mononuclear iron enzyme	NATURE			English	Article							(S)-2-HYDROXYPROPYLPHOSPHONIC ACID EPOXIDASE; SUBSTRATE; COMPLEX; CUPINS; TAUD	The biosynthetic pathway of the clinically important antibiotic fosfomycin uses enzymes that catalyse reactions without precedent in biology. Among these is hydroxypropylphosphonic acid epoxidase, which represents a new subfamily of non-haem mononuclear iron enzymes. Here we present six X-ray structures of this enzyme: the apoenzyme at 2.0 angstrom resolution; a native Fe(II)-bound form at 2.4 angstrom resolution; a tris( hydroxymethyl) aminomethane - Co( II)- enzyme complex structure at 1.8 angstrom resolution; a substrate - Co( II)- enzyme complex structure at 2.5 angstrom resolution; and two substrate - Fe( II)enzyme complexes at 2.1 and 2.3 angstrom resolution. These structural data lead us to suggest how this enzyme is able to recognize and respond to its substrate with a conformational change that protects the radical-based intermediates formed during catalysis. Comparisons with other family members suggest why substrate binding is able to prime iron for dioxygen binding in the absence of alpha-ketoglutarate ( a co-substrate required by many mononuclear iron enzymes), and how the unique epoxidation reaction of hydroxypropylphosphonic acid epoxidase may occur.	MIT, Dept Chem, Cambridge, MA 02139 USA; Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA	Massachusetts Institute of Technology (MIT); University of Texas System; University of Texas Austin	Higgins, LJ (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.							Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cassone M, 2004, MICROB DRUG RESIST, V10, P43, DOI 10.1089/107662904323047790; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; DeLano W.L, PYMOL MOL GRAPHICS S; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Dunwell JM, 1998, BIOTECHNOL GENET ENG, V15, P1; Guengerich FP, 2003, ARCH BIOCHEM BIOPHYS, V409, P59; HAMMERSCHMIDT F, 1991, J CHEM SOC P1, V8, P1993; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hegg EL, 1997, EUR J BIOCHEM, V250, P625, DOI 10.1111/j.1432-1033.1997.t01-1-00625.x; HIDAKA T, 1995, MOL GEN GENET, V249, P274, DOI 10.1007/BF00290527; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu PH, 2001, J AM CHEM SOC, V123, P4619, DOI 10.1021/ja004153y; Liu PH, 2004, J AM CHEM SOC, V126, P10306, DOI 10.1021/ja0475050; Liu PH, 2003, BIOCHEMISTRY-US, V42, P11577, DOI 10.1021/bi030140w; Lobel B, 2003, INT J ANTIMICROB AG, V22, pS85, DOI 10.1016/S0924-8579(03)00237-1; Nakazawa Hiroaki, 2003, Journal of Infection and Chemotherapy, V9, P304, DOI 10.1007/s10156-003-0266-2; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Roach PL, 1996, EUR J BIOCHEM, V242, P736, DOI 10.1111/j.1432-1033.1996.0736r.x; Roach PL, 1997, NATURE, V387, P827, DOI 10.1038/42990; ROACH PL, 1995, PROTEIN SCI, V4, P1007; Ryle MJ, 2003, BIOCHEMISTRY-US, V42, P1854, DOI 10.1021/bi026832m; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Valegard K, 2004, NAT STRUCT MOL BIOL, V11, P95, DOI 10.1038/nsmb712; Zhao ZB, 2002, ANGEW CHEM INT EDIT, V41, P4529, DOI 10.1002/1521-3773(20021202)41:23<4529::AID-ANIE4529>3.0.CO;2-2; Zhou J, 2001, J AM CHEM SOC, V123, P7388, DOI 10.1021/ja004025+	31	97	101	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 6	2005	437	7060					838	844		10.1038/nature03924	http://dx.doi.org/10.1038/nature03924			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	970VB	16015285				2022-12-28	WOS:000232338600036
J	Reisz, RR; Scott, D; Sues, HD; Evans, DC; Raath, MA				Reisz, RR; Scott, D; Sues, HD; Evans, DC; Raath, MA			Embryos of an Early Jurassic prosauropod dinosaur and their evolutionary significance	SCIENCE			English	Article							SAUROPOD DINOSAURS; LOCOMOTION	Articulated embryos from the Lower Jurassic Elliot Formation of South Africa are referable to the prosauropod Massospondylus carinatus and, together with other material, provide substantial insights into the ontogenetic development in this early dinosaur. The large forelimbs and head and the horizontally held neck indicate that the hatchlings were obligate quadrupeds. In contrast, adult Massospondylus were at least facultatively bipedal. This suggests that the quadrupedal gait of giant sauropods may have evolved by retardation of postnatal negative allometry of the forelimbs. Embryonic body proportions and an absence of well-developed teeth suggest that hatchlings of this dinosaur may have required parental care.	Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA; Univ Witwatersrand, Bernard Price Inst Palaeontol Res, ZA-2050 Wits, Johannesburg, South Africa	University of Toronto; University Toronto Mississauga; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Witwatersrand	Reisz, RR (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada.	rreisz@utm.utoronto.ca						BONAPARTE J F, 1979, Ameghiniana, V16, P173; Bonnan MF, 2003, J VERTEBR PALEONTOL, V23, P595, DOI 10.1671/A1108; Carrano MT, 2000, PALEOBIOLOGY, V26, P489, DOI 10.1666/0094-8373(2000)026<0489:HATEOD>2.0.CO;2; COOPER M R, 1981, Occasional Papers of the National Museums and Monuments of Rhodesia Series B Natural Sciences, V6, P689; Currie PJ, 2003, CAN J EARTH SCI, V40, P651, DOI 10.1139/E02-083; Ferguson M.W.J., 1985, Biology of Reptilia, V14, P329; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P232; KITCHING J W, 1984, Palaeontologia Africana, V25, P111; KITCHING J W, 1979, Palaeontologia Africana, V22, P41; Langer MC, 1999, CR ACAD SCI II A, V329, P511, DOI 10.1016/S1251-8050(00)80025-7; SERENO PC, 1991, MEMOIRS SOC VERTEBRA, V2, P1, DOI DOI 10.2307/3889336; Starck J.M., 1998, AVIAN GROWTH DEV EVO, P3; Starck J.M., 1998, AVIAN GROWTH DEV EVO, P59; Stevens KA, 1999, SCIENCE, V284, P798, DOI 10.1126/science.284.5415.798; Sues HD, 2004, ANN CARNEGIE MUS, V73, P239; WILSON JA, 1998, MEMOIR SOC VERTEBRAT, V5, P1, DOI DOI 10.2307/3889325; Yates Adam M., 2003, Journal of Systematic Palaeontology, V1, P1, DOI 10.1017/S1477201903001007; Yates AM, 2003, P ROY SOC B-BIOL SCI, V270, P1753, DOI 10.1098/rspb.2003.2417	18	102	113	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2005	309	5735					761	764		10.1126/science.1114942	http://dx.doi.org/10.1126/science.1114942			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051793	Green Submitted			2022-12-28	WOS:000230938200047
J	Bernays, EA; Singer, MS				Bernays, EA; Singer, MS			Taste alteration and endoparasites	NATURE			English	Editorial Material							PYRROLIZIDINE ALKALOIDS; POLYPHAGOUS CATERPILLAR; GALEAL SENSILLUM; FOOD QUALITY; SUBSTANCES; SELECTION; NEURON; PLANTS		Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; Univ Arizona, Arizona Res Labs, Div Neurobiol, Tucson, AZ 85721 USA; Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA	University of Arizona; University of Arizona; Wesleyan University	Bernays, EA (corresponding author), Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA.							Bernays EA, 2002, PHYSIOL ENTOMOL, V27, P312, DOI 10.1046/j.1365-3032.2002.00304.x; Bernays EA, 2002, J COMP PHYSIOL A, V188, P715, DOI 10.1007/s00359-002-0345-3; Bernays EA, 2000, J COMP PHYSIOL A, V186, P13, DOI 10.1007/s003590050002; Bezzerides A, 2004, P NATL ACAD SCI USA, V101, P9029, DOI 10.1073/pnas.0402480101; Bowers M. Deane, 1993, P331; Hartmann T, 2004, J CHEM ECOL, V30, P229, DOI 10.1023/B:JOEC.0000017975.16399.c3; Nishida R, 2002, ANNU REV ENTOMOL, V47, P57, DOI 10.1146/annurev.ento.47.091201.145121; ROTHSCHILD M, 1979, BIOL J LINN SOC, V12, P305, DOI 10.1111/j.1095-8312.1979.tb00062.x; SIMPSON SJ, 1991, APPETITE, V17, P141, DOI 10.1016/0195-6663(91)90069-5; Singer MS, 2004, ECOLOGY, V85, P2747, DOI 10.1890/03-0827; Singer MS, 2003, OIKOS, V100, P554, DOI 10.1034/j.1600-0706.2003.11720.x; Singer MS, 2004, AM NAT, V164, P423, DOI 10.1086/423152; Stireman JO, 2003, ECOLOGY, V84, P296, DOI 10.1890/0012-9658(2003)084[0296:DOPHAI]2.0.CO;2	13	63	65	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2005	436	7050					476	476		10.1038/436476a	http://dx.doi.org/10.1038/436476a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049466				2022-12-28	WOS:000230788800033
J	Mayor, S				Mayor, S			Coming home	NATURE			English	Article									Natl Ctr Biol Sci, Bangalore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Mayor, S (corresponding author), Natl Ctr Biol Sci, Bangalore, Karnataka, India.								0	5	5	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2005	436	7050					488	489		10.1038/436488a	http://dx.doi.org/10.1038/436488a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049474				2022-12-28	WOS:000230788800043
J	Turner, RB; Bauer, R; Woelkart, K; Hulsey, TC; Gangemi, JD				Turner, RB; Bauer, R; Woelkart, K; Hulsey, TC; Gangemi, JD			An evaluation of Echinacea angustifolia in experimental rhinovirus infections	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLEMASTINE FUMARATE; COMMON COLD; COMPLICATIONS; COMMUNITY; SEVERITY; CHILDREN; TRIAL; VIRUS	BACKGROUND: Echinacea has been widely used as an herbal remedy for the common cold, but efficacy studies have produced conflicting results, and there are a variety of echinacea products on the market with different phytochemical compositions. We evaluated the effect of chemically defined extracts from Echinacea angustifolia roots on rhinovirus infection. METHODS: Three preparations of echinacea, with distinct phytochemical profiles, were produced by extraction from E. angustifolia roots with supercritical carbon dioxide, 60 percent ethanol, or 20 percent ethanol. A total of 437 volunteers were randomly assigned to receive either prophylaxis (beginning seven days before the virus challenge) or treatment (beginning at the time of the challenge) either with one of these preparations or with placebo. The results for 399 volunteers who were challenged with rhinovirus type 39 and observed in a sequestered setting for five days were included in the data analysis. RESULTS: There were no statistically significant effects of the three echinacea extracts on rates of infection or severity of symptoms. Similarly, there were no significant effects of treatment on the volume of nasal secretions, on polymorphonuclear leukocyte or interleukin-8 concentrations in nasal-lavage specimens, or on quantitative-virus titer. CONCLUSIONS: The results of this study indicate that extracts of E. angustifolia root, either alone or in combination, do not have clinically significant effects on infection with a rhinovirus or on the clinical illness that results from it.	Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; Karl Franzens Univ Graz, Graz, Austria; Med Univ S Carolina, Charleston, SC 29425 USA; Clemson Univ, Clemson, SC USA	University of Virginia; University of Graz; Medical University of South Carolina; Clemson University	Turner, RB (corresponding author), Univ Virginia, Sch Med, POB 800386, Charlottesville, VA 22908 USA.	rbt2n@virginia.edu	Bauer, Rudolf/F-8468-2010	Bauer, Rudolf/0000-0002-0057-5547	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT001146] Funding Source: NIH RePORTER; NCCIH NIH HHS [R01 AT001146] Funding Source: Medline	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)		Barrett B, 2003, PHYTOMEDICINE, V10, P66, DOI 10.1078/094471103321648692; Bauer R, 2000, HERBS BOT TEAS, P45; DOE J, 1999, WHO MONOGRAPHS SELEC, V1, P125; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Gwaltney J.M., 1989, DIAGNOSTIC PROCEDURE, P579; Gwaltney JM, 1996, ANTIVIR RES, V29, P287, DOI 10.1016/0166-3542(95)00935-3; GWALTNEY JM, 1992, PROG MED VIROL, V39, P256; Gwaltney JM, 1996, CLIN INFECT DIS, V22, P656, DOI 10.1093/clinids/22.4.656; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Melchart D., 2000, COCHRANE DB SYST REV; Nicholson KG, 1996, BMJ-BRIT MED J, V313, P1119, DOI 10.1136/bmj.313.7065.1119; Pitkaranta A, 1998, J PEDIATR-US, V133, P390, DOI 10.1016/S0022-3476(98)70276-8; Rakes CP, 1999, AM J RESP CRIT CARE, V159, P785, DOI 10.1164/ajrccm.159.3.9801052; RAO SS, 1995, AM J RHINOL, V9, P49, DOI 10.2500/105065895781874114; Seemungal TAR, 2000, EUR RESPIR J, V16, P677, DOI 10.1034/j.1399-3003.2000.16d19.x; SMYTH AR, 1995, ARCH DIS CHILD, V73, P117, DOI 10.1136/adc.73.2.117; Turner RB, 1997, CLIN INFECT DIS, V25, P824, DOI 10.1086/515546; Turner RB, 1999, JAMA-J AM MED ASSOC, V281, P1797, DOI 10.1001/jama.281.19.1797; Turner RB, 1998, CLIN INFECT DIS, V26, P840, DOI 10.1086/513922; Turner RB, 1996, AM J RHINOL, V10, P167, DOI 10.2500/105065896781794888; WALD ER, 1991, PEDIATRICS, V87, P129; Winther B, 2002, PEDIATRICS, V109, P826, DOI 10.1542/peds.109.5.826; Wolkart K, 2004, PHARM BIOL, V42, P443, DOI 10.1080/13880200490894815; 2002, MED LETT DRUGS THER, V44, P29	24	136	144	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2005	353	4					341	348		10.1056/NEJMoa044441	http://dx.doi.org/10.1056/NEJMoa044441			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949JW	16049208	Bronze			2022-12-28	WOS:000230782800006
J	Childs, R; Srinivasan, R				Childs, R; Srinivasan, R			High-dose chemotherapy and allogeneic immunotherapy	LANCET			English	Editorial Material							METASTATIC BREAST-CANCER; STEM-CELL TRANSPLANTATION		NIH, Hematol Branch, Bethesda, MD 20892 USA; NIH, Urol Oncol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA	Childs, R (corresponding author), NIH, Hematol Branch, Bethesda, MD 20892 USA.	childsr@nih.gov			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002345, Z01HL002345] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bernard-Marty C, 2004, ONCOLOGIST, V9, P617, DOI 10.1634/theoncologist.9-6-617; Bishop MR, 2004, J CLIN ONCOL, V22, P3886, DOI 10.1200/JCO.2004.01.127; Bregni M, 2002, BLOOD, V99, P4234, DOI 10.1182/blood.V99.11.4234; Carella AM, 2005, LANCET, V366, P318, DOI 10.1016/S0140-6736(05)66989-9; Childs RW, 2004, ANNU REV MED, V55, P459, DOI 10.1146/annurev.med.55.091902.104511; Eibl B, 1996, BLOOD, V88, P1501, DOI 10.1182/blood.V88.4.1501.bloodjournal8841501; Ferlay J, 2001, GLOBOCAN 2000 CANC I; Gratwohl A, 2004, BONE MARROW TRANSPL, V34, P855, DOI 10.1038/sj.bmt.1704653; Maloney DG, 2003, BLOOD, V102, P3447, DOI 10.1182/blood-2002-09-2955; Nieto Y, 2000, BIOL BLOOD MARROW TR, V6, P476, DOI 10.1016/S1083-8791(00)70019-X; Riddell SR, 2003, BLOOD REV, V17, P153, DOI 10.1016/S0268-960X(03)00007-9; Stadtmauer EA, 2000, NEW ENGL J MED, V342, P1069, DOI 10.1056/NEJM200004133421501; Storb Rainer F, 2003, Hematology Am Soc Hematol Educ Program, P372; Ueno NT, 1998, J CLIN ONCOL, V16, P986, DOI 10.1200/JCO.1998.16.3.986	14	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 23	2005	366	9482					273	275		10.1016/S0140-6736(05)66963-2	http://dx.doi.org/10.1016/S0140-6736(05)66963-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RJ	16039317				2022-12-28	WOS:000230733100008
J	Fox, RI				Fox, RI			Sjogren's syndrome	LANCET			English	Review							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PRIMARY BILIARY-CIRRHOSIS; CONGENITAL HEART-BLOCK; SALIVARY-GLAND BIOPSY; NERVOUS-SYSTEM; DOUBLE-BLIND; FOLLOW-UP; GASTROINTESTINAL MANIFESTATIONS; CLINICAL-SIGNIFICANCE; RHEUMATOID-ARTHRITIS	Sjogren's syndrome is a chronic autoimmune disorder of the exocrine glands with associated lymphocytic infiltrates of the affected glands. Dryness of the mouth and eyes results from involvement of the salivary and lacrimal glands. The accessibility of these glands to biopsy enables study of the molecular biology of a tissue-specific autoimmune process. The exocrinopathy can be encountered alone (primary Sjogren's syndrome) or in the presence of another autoimmune disorder such as rheumatoid arthritis, systemic lupus erythematosus, or progressive systemic sclerosis. A new international consensus for diagnosis requires objective signs and symptoms of dryness including a characteristic appearance of a biopsy sample from a minor salivary gland or autoantibody such as anti-SS-A. Exclusions to the diagnosis include infections with HIV, human T-lymphotropic virus type 1, or hepatitis C virus. Therapy includes topical agents to improve moisture and decrease inflammation. Systemic therapy includes steroidal and non-steroidal anti-inflammatory agents, disease-modifying agents, and cytotoxic agents to address the extraglandular manifestations involving skin, lung, heart, kidneys, and nervous system (peripheral and central) and haematological and lymphoproliferative disorders. The most difficult challenge in diagnosis and therapy is patients with symptoms of fibromyalgia (arthralgia, myalgia, fatigue) and oral and ocular dryness in the presence of circulating antinuclear antibodies.	Scripps Mem Hosp & Res Fdn, Rheumatol Clin, La Jolla, CA 92037 USA		Fox, RI (corresponding author), Scripps Mem Hosp & Res Fdn, Rheumatol Clin, 9850 Genesee Ave,910, La Jolla, CA 92037 USA.	bobfox@adnc.com						ALEXANDER EL, 1986, ANN INTERN MED, V104, P323, DOI 10.7326/0003-4819-104-3-323; Allison PJ, 1999, ORAL ONCOL, V35, P138, DOI 10.1016/S1368-8375(98)00108-0; Andonopoulos AP, 1998, J RHEUMATOL, V25, P2385; Arnett F C, 1995, Int Rev Immunol, V12, P107, DOI 10.3109/08830189509056707; ARNETT FC, 1994, RHEUM DIS CLIN N AM, V20, P371; Barendregt PJ, 2001, ANN RHEUM DIS, V60, P876; BATTISTA G, 2003, RADIOL MED TORINO, V106, P452; Battista Giuseppe, 2003, Radiol Med, V106, P445; Belafsky Peter C, 2003, Curr Rheumatol Rep, V5, P297, DOI 10.1007/s11926-003-0008-6; Belin C, 1999, ANN MED INTERNE, V150, P598; Bergdahl J, 2001, ACTA ODONTOL SCAND, V59, P104, DOI 10.1080/000163501750157270; BERNSTEIN HN, 1991, ANN OPHTHALMOL, V23, P292; Beroukas D, 2002, LAB INVEST, V82, P203, DOI 10.1038/labinvest.3780412; Beroukas T, 2001, LANCET, V358, P1875, DOI 10.1016/S0140-6736(01)06900-8; BLOCH KJ, 1965, MEDICINE, V44, P187, DOI 10.1097/00005792-196505000-00001; Bolstad AI, 2003, ARTHRITIS RHEUM, V48, P174, DOI 10.1002/art.10734; BONAFEDE RP, 1995, J RHEUMATOL, V22, P133; Borda E, 1999, INT J CARDIOL, V70, P23, DOI 10.1016/S0167-5273(99)00041-8; Bowman SJ, 2004, SCAND J RHEUMATOL, V33, P39, DOI 10.1080/03009740310004676; Bowman SJ, 2002, SCAND J RHEUMATOL, V31, P23, DOI 10.1080/03009740232081788832; Chatterjee S, 2004, SCAND J RHEUMATOL, V33, P276, DOI 10.1080/03009740410005836; Christensen LB, 2001, ACTA ODONTOL SCAND, V59, P116; Cimaz R, 2003, EUR J PEDIATR, V162, P661, DOI 10.1007/s00431-003-1277-9; Cohen Y, 2003, CURR PHARM DESIGN, V9, P279, DOI 10.2174/1381612033392134; Collin P, 1997, SCAND J GASTROENTERO, V32, P108, DOI 10.3109/00365529709000179; Collin P, 1997, SCAND J GASTROENTERO, V32, P1129, DOI 10.3109/00365529709002992; CONSTANTOPOULOS SH, 1992, RHEUM DIS CLIN N AM, V18, P617; D'Arbonneau F, 2003, ARTHRIT RHEUM-ARTHR, V49, P804, DOI 10.1002/art.11460; DABADGAO S, 1995, CLIN EXP RHEUMATOL, V13, P509; Dafni UG, 1997, ANN RHEUM DIS, V56, P521, DOI 10.1136/ard.56.9.521; DALAVANGA YA, 1987, ANN RHEUM DIS, V46, P89, DOI 10.1136/ard.46.2.89; Daniels T E, 2000, J Calif Dent Assoc, V28, P933; DANIELS TE, 1984, ARTHRITIS RHEUM-US, V27, P147, DOI 10.1002/art.1780270205; DANIELS TE, 1992, RHEUM DIS CLIN N AM, V18, P571; Daniels TE, 2000, J RHEUMATOL, V27, P6; de Seze J, 2001, NEUROLOGY, V57, P1359, DOI 10.1212/WNL.57.8.1359; Deheinzelin D, 1996, AM J RESP CRIT CARE, V154, P794, DOI 10.1164/ajrccm.154.3.8810621; Delalande S, 2004, MEDICINE, V83, P280, DOI 10.1097/01.md.0000141099.53742.16; Feist E, 1999, ARTHRITIS RHEUM, V42, P697, DOI 10.1002/1529-0131(199904)42:4<697::AID-ANR12>3.0.CO;2-H; Fisher A, 1996, ANN NY ACAD SCI, V777, P189, DOI 10.1111/j.1749-6632.1996.tb34418.x; Fisher A, 1999, CNS DRUGS, V12, P197, DOI 10.2165/00023210-199912030-00004; FOX R, 1997, MED CLIN N AM, V17, P441; Fox R I, 1999, Curr Opin Rheumatol, V11, P364, DOI 10.1097/00002281-199909000-00007; Fox RI, 2000, EXPERT OPIN INV DRUG, V9, P2007, DOI 10.1517/13543784.9.9.2007; Fox RI, 1996, LUPUS, V5, pS31, DOI 10.1177/096120339600500108; FOX RI, 1986, SCAND J RHEUMATOL, P28; FOX RI, 1988, AM J MED, V85, P62, DOI 10.1016/0002-9343(88)90365-8; Fox RI, 2001, CLIN IMMUNOL, V101, P249, DOI 10.1006/clim.2001.5128; FOX RI, 2002, SCAND J RHEUMATOL S, P2; Fulop M, 2004, ARCH INTERN MED, V164, P905, DOI 10.1001/archinte.164.8.905; Gamron S, 2000, SCAND J RHEUMATOL, V29, P65; Grant IA, 1997, NEUROLOGY, V48, P855, DOI 10.1212/WNL.48.4.855; Gross Wolfgang L., 1999, Current Opinion in Rheumatology, V11, P41, DOI 10.1097/00002281-199901000-00007; Gyongyosi M, 1996, ANN RHEUM DIS, V55, P450, DOI 10.1136/ard.55.7.450; Illei GG, 2004, ARTHRITIS RHEUM, V50, P2048, DOI 10.1002/art.20345; Invernizzi P, 1998, CLIN EXP IMMUNOL, V114, P448; Isidor F, 1999, INT J ORAL MAX IMPL, V14, P736; Johnson EO, 1998, J RHEUMATOL, V25, P1508; Jonsson Roland, 2003, Curr Rheumatol Rep, V5, P311, DOI 10.1007/s11926-003-0010-z; JOSEPHS SF, 1988, LEUKEMIA, V2, P132; KAMEL OW, 1993, NEW ENGL J MED, V328, P1317, DOI 10.1056/NEJM199305063281806; KASSAN SS, 1978, ANN INTERN MED, V89, P888, DOI 10.7326/0003-4819-89-6-888; Khurshudian AV, 2003, ORAL SURG ORAL MED O, V95, P38, DOI 10.1067/moe.2003.30; Kim EA, 2002, RADIOGRAPHICS, V22, pS151, DOI 10.1148/radiographics.22.suppl_1.g02oc04s151; Konttinen YT, 2002, SCAND J RHEUMATOL, V31, P15; KONTTINEN YT, 1992, ARTHRITIS RHEUM, V35, P815, DOI 10.1002/art.1780350717; KRUIZE AA, 1993, ANN RHEUM DIS, V52, P360, DOI 10.1136/ard.52.5.360; Lass P, 2000, NUCL MED COMMUN, V21, P31, DOI 10.1097/00006231-200001000-00006; Leppilahti M, 2003, AM J MED, V115, P62, DOI 10.1016/S0002-9343(03)00257-2; LI JM, 1995, CLIN EXP IMMUNOL, V99, P316; Lightfoot RW, 1997, B RHEUM DIS, V46, P1; Lindvall B, 2002, J RHEUMATOL, V29, P717; Lwin CTT, 2003, SCAND J RHEUMATOL, V32, P33, DOI 10.1080/03009740310000373; Ma-Krupa W, 2004, J EXP MED, V199, P173, DOI 10.1084/jem.20030850; Manoussakis MN, 2004, ARTHRITIS RHEUM-US, V50, P882, DOI 10.1002/art.20093; MARRIETTE X, 2003, ARTH RHEUM, V48, pS19; MORGAN WS, 1953, AM J PATHOL, V29, P471; Nakamura H, 2000, LAB INVEST, V80, P1421, DOI 10.1038/labinvest.3780149; Nakamura H, 2000, J LAB CLIN MED, V135, P139, DOI 10.1067/mlc.2000.103429; Nishimagi E, 2001, INTERNAL MED, V40, P1059, DOI 10.2169/internalmedicine.40.1059; NISHIMORI I, 1993, J CLIN IMMUNOL, V13, P265, DOI 10.1007/BF00919385; Nishimura M, 2000, J Dermatol, V27, P450; Ogawa N, 2002, ARTHRITIS RHEUM-US, V46, P2730, DOI 10.1002/art.10577; Oxholm P, 1995, CLIN EXP RHEUMATOL, V13, P693; PEASE CT, 1993, BRIT J RHEUMATOL, V32, P609; Pender MP, 1999, J CLIN NEUROSCI, V6, P367, DOI 10.1016/S0967-5868(99)90026-7; PEREZE B, 1995, AM J MED, V99, P480, DOI 10.1016/S0002-9343(99)80223-X; Pflugfelder S C, 1996, Adv Dent Res, V10, P9; Pillemer SR, 2001, MAYO CLIN PROC, V76, P593; Press J, 1996, AM J MED, V100, P328, DOI 10.1016/S0002-9343(97)89492-2; Price EJ, 1998, J RHEUMATOL, V25, P896; Quismorio F P Jr, 1996, Curr Opin Pulm Med, V2, P424; Raderer M, 2001, ANN ONCOL, V12, P937, DOI 10.1023/A:1011122904602; Radfar L, 2002, ARTHRIT RHEUM-ARTHR, V47, P520, DOI 10.1002/art.10668; Ramos-Casals M, 2004, MEDICINE, V83, P96, DOI 10.1097/01.md.0000119465.24818.98; Robinson CP, 1996, CLIN IMMUNOL IMMUNOP, V79, P50, DOI 10.1006/clin.1996.0050; Roguedas AM, 2004, CLIN EXP RHEUMATOL, V22, P632; ROSLER DH, 1995, LUPUS, V4, P155, DOI 10.1177/096120339500400215; Royer B, 1997, BLOOD, V90, P766, DOI 10.1182/blood.V90.2.766; Salaffi F, 2000, J RHEUMATOL, V27, P1229; Salomonsson S, 2002, SCAND J IMMUNOL, V55, P336, DOI 10.1046/j.1365-3083.2002.01058.x; Sankar V, 2004, ARTHRITIS RHEUM-US, V50, P2240, DOI 10.1002/art.20299; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Sawalha Amr H, 2003, Curr Rheumatol Rep, V5, P324, DOI 10.1007/s11926-003-0012-x; SHEIKH SH, 1995, AM J GASTROENTEROL, V90, P9; Shibata S, 2004, INTERNAL MED, V43, P248, DOI 10.2169/internalmedicine.43.248; SIAMOPOULOS KC, 1994, NEPHROL DIAL TRANSPL, V9, P1176, DOI 10.1093/ndt/9.8.1176; SIMMONSOBRIEN E, 1995, MEDICINE, V74, P109, DOI 10.1097/00005792-199505000-00001; Skopouli FN, 1996, CLIN EXP RHEUMATOL, V14, P555; Soto-Rojas AE, 2002, ARCH MED RES, V33, P95, DOI 10.1016/S0188-4409(01)00371-X; SPEZIALETTI R, 1993, AM J MED, V95, P153, DOI 10.1016/0002-9343(93)90255-N; Steinfeld S, 2001, LAB INVEST, V81, P143, DOI 10.1038/labinvest.3780221; Steinfeld SD, 2001, ARTHRITIS RHEUM, V44, P2371, DOI 10.1002/1529-0131(200110)44:10<2371::AID-ART401>3.0.CO;2-W; Stern ME, 1998, ADV EXP MED BIOL, V438, P643; Swords R, 2004, AM J HEMATOL, V77, P103, DOI 10.1002/ajh.20135; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tan EM, 1997, ARTHRITIS RHEUM-US, V40, P1601, DOI 10.1002/art.1780400909; Tapinos NI, 1999, ADV EXP MED BIOL, V455, P127; Tektonidou MG, 2004, ANN RHEUM DIS, V63, P1159, DOI 10.1136/ard.2004.022624; Tensing EK, 2001, CLIN EXP RHEUMATOL, V19, P313; TISHLER M, 1995, CLIN EXP RHEUMATOL, V13, P497; Tishler M, 1997, CLIN EXP RHEUMATOL, V15, P71; Tonami H, 2001, J COMPUT ASSIST TOMO, V25, P262, DOI 10.1097/00004728-200103000-00020; Tsubota K, 2001, LANCET, V357, P688, DOI 10.1016/S0140-6736(00)04140-4; Uhlig T, 1999, ANN RHEUM DIS, V58, P415, DOI 10.1136/ard.58.7.415; Urban PP, 2001, J NEUROL SCI, V186, P59, DOI 10.1016/S0022-510X(01)00501-9; UTSET TO, 1994, J RHEUMATOL, V21, P2039; VANDAM AP, 1994, RHEUMATOL INT, V14, P57, DOI 10.1007/BF00300248; Vitali C, 2003, ANN RHEUM DIS, V62, P94, DOI 10.1136/ard.62.1.94; VITALI C, 1994, ANN RHEUM DIS, V53, P637, DOI 10.1136/ard.53.10.637; Vivino FB, 2002, J RHEUMATOL, V29, P938; von Mikulicz JH., 1892, BILLROTH GT BEITR CH, P610; Voulgarelis M, 1999, ARTHRITIS RHEUM-US, V42, P1765, DOI 10.1002/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V; WALLACE DJ, 1994, RHEUM DIS CLIN N AM, V20, P243; Wallace DJ, 2002, CURR OPIN RHEUMATOL, V14, P212, DOI 10.1097/00002281-200205000-00003; Xanthou G, 2001, ARTHRITIS RHEUM-US, V44, P408; Yousem DM, 2000, RADIOLOGY, V216, P19, DOI 10.1148/radiology.216.1.r00jl4519; Zandbelt MM, 2004, J RHEUMATOL, V31, P96; Zukowski TH, 1998, AM J GASTROENTEROL, V93, P958	139	1037	1091	6	143	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2005	366	9482					321	331		10.1016/S0140-6736(05)66990-5	http://dx.doi.org/10.1016/S0140-6736(05)66990-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RJ	16039337				2022-12-28	WOS:000230733100033
J	Birnie, A; Varma, S				Birnie, A; Varma, S			Adenocarcinoma of the breast in a man	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Queens Med Ctr, Nottingham NG7 2UH, England	University of Nottingham	Birnie, A (corresponding author), Queens Med Ctr, Nottingham NG7 2UH, England.								0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2005	353	3					286	286		10.1056/NEJMicm040548	http://dx.doi.org/10.1056/NEJMicm040548			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YH	16034014				2022-12-28	WOS:000230608700009
J	Perez-Gussinye, M; Watts, AB				Perez-Gussinye, M; Watts, AB			The long-term strength of Europe and its implications for plate-forming processes	NATURE			English	Article							FLEXURAL RIGIDITY; LITHOSPHERIC STRENGTH; ELASTIC THICKNESS; THERMAL EVOLUTION; ANOMALIES; AGE	Field-based geological studies show that continental deformation preferentially occurs in young tectonic provinces rather than in old cratons(1). This partitioning of deformation suggests that the cratons are stronger than surrounding younger Phanerozoic provinces. However, although Archaean and Phanerozoic lithosphere differ in their thickness(2-4) and composition(4,5), their relative strength is a matter of much debate. One proxy of strength is the effective elastic thickness of the lithosphere, T-e. Unfortunately, spatial variations in T-e are not well understood, as different methods yield different results. The differences are most apparent in cratons, where the 'Bouguer coherence' method yields large T-e values (> 60 km)(6-9) whereas the 'free-air admittance' method yields low values (< 25 km)(10). Here we present estimates of the variability of T-e in Europe using both methods. We show that when they are consistently formulated(11), both methods yield comparable T-e values that correlate with geology, and that the strength of old lithosphere (>= 1.5 Gyr old) is much larger ( mean T-e > 60 km) than that of younger lithosphere ( mean T-e < 30 km). We propose that this strength difference reflects changes in lithospheric plate structure ( thickness, geothermal gradient and composition) that result from mantle temperature and volatile content decrease through Earth's history.	Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England	University of Oxford	Perez-Gussinye, M (corresponding author), Inst Ciencies Terra Jaume Almera, Lluis Sole & Sabaris S-N, Barcelona 08028, Spain.	martap@earth.ox.ac.uk; mperez@ija.csic.es	Perez-Gussinye, Marta/R-1704-2016	Perez-Gussinye, Marta/0000-0003-4109-1810				Artemieva IM, 2001, J GEOPHYS RES-SOL EA, V106, P16387, DOI 10.1029/2000JB900439; Audet P, 2004, EARTH PLANET SC LETT, V226, P17, DOI 10.1016/j.epsl.2004.07.035; BECHTEL TD, 1990, NATURE, V343, P636, DOI 10.1038/343636a0; Boschi L, 2004, GEOPHYS J INT, V157, P293, DOI 10.1111/j.1365-246X.2004.02194.x; CHRISTENSEN NI, 1995, J GEOPHYS RES-SOL EA, V100, P9761, DOI 10.1029/95JB00259; Cloetingh S, 2005, QUATERNARY SCI REV, V24, P241, DOI 10.1016/j.quascirev.2004.06.015; Dixon JE, 2004, EARTH PLANET SC LETT, V222, P451, DOI 10.1016/j.epsl.2004.03.022; Djomani YHP, 1999, EARTH PLANET SC LETT, V174, P139, DOI 10.1016/S0012-821X(99)00260-5; Doin MP, 1997, J GEOPHYS RES-SOL EA, V102, P2771, DOI 10.1029/96JB03271; FORSYTH DW, 1985, J GEOPHYS RES-SOLID, V90, P2623, DOI 10.1029/JB090iB14p12623; Goodwin A., 1996, PRINCIPLES PRECAMBRI; GROTZINGER J, 1990, NATURE, V347, P64, DOI 10.1038/347064a0; Hartley R, 1996, EARTH PLANET SC LETT, V137, P1, DOI 10.1016/0012-821X(95)00185-F; JORDAN TH, 1978, NATURE, V274, P544, DOI 10.1038/274544a0; KOGAN MG, 1994, GEOPHYS RES LETT, V21, P2653, DOI 10.1029/94GL02550; LASKE G, 2000, REFERENCE EARTH MODE; Lenardic A, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001859; *M LIS WORK GROUP, 1997, GEOLOGY, V22, P617; MCBRIDE JH, 1996, GSA TODAY, V6, P1; MCCONNELL RB, 1972, GEOL SOC AM BULL, V83, P2549, DOI 10.1130/0016-7606(1972)83[2549:GDOTRS]2.0.CO;2; McKenzie D, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001766; Murphy JB, 2002, EARTH-SCI REV, V59, P77, DOI 10.1016/S0012-8252(02)00070-3; O'Reilly S.Y., 2001, GSA TODAY, V11, P4, DOI DOI 10.1130/1052-5173(2001)011<0004:ALFTCI>2.0.CO;2; PEARSON DG, 1995, NATURE, V374, P711, DOI 10.1038/374711a0; Perez-Gussinye M, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002788; POLET J, 1995, GEOLOGY, V23, P205, DOI 10.1130/0091-7613(1995)023<0205:DEOCAI>2.3.CO;2; POLLACK HN, 1986, EARTH PLANET SC LETT, V80, P175, DOI 10.1016/0012-821X(86)90031-2; Stewart J, 1997, J GEOPHYS RES-SOL EA, V102, P5327, DOI 10.1029/96JB03664; Swain CJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017070; USSAMI N, 1993, J GEOPHYS RES-SOL EA, V98, P2199, DOI 10.1029/92JB01398; Watts AB, 2003, EARTH PLANET SC LETT, V213, P113, DOI 10.1016/S0012-821X(03)00289-9; Wessel P, 1991, EOS T AM GEOPHYS UN, V72, P445, DOI [10.1029/90EO00319, DOI 10.1029/90EO00319, DOI 10.1029/90E000319]; Windley B.F., 1992, CONTINENT REVEALED E, P139	33	132	135	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					381	384		10.1038/nature03854	http://dx.doi.org/10.1038/nature03854			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034416				2022-12-28	WOS:000230623400040
J	Rutgers, LV; van der Borg, K; de Jong, AFM; Poole, I				Rutgers, LV; van der Borg, K; de Jong, AFM; Poole, I			Jewish inspiration of Christian catacombs	NATURE			English	Editorial Material									Univ Utrecht, Fac Theol, NL-3508 TC Utrecht, Netherlands; Univ Utrecht, AMS Facil Utrecht, Subatom Phys Dept, NL-3508 TA Utrecht, Netherlands; Natl Herbarium Nederland, Utrecht Univ Branch, NL-3585 CS Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University	Rutgers, LV (corresponding author), Univ Utrecht, Fac Theol, NL-3508 TC Utrecht, Netherlands.	lrutgers@theo.uu.nl	van der Borg, Klaas/K-1990-2019; van der Borg, Klaas/W-6101-2018	van der Borg, Klaas/0000-0002-5999-2804; van der Borg, Klaas/0000-0002-5999-2804				BARBERA M, 2003, BENI CULTUALLI EBRAI, P55; DECKERS JG, 1992, STUDI ANTICHITA CRIS, V48, P217; Fasola U, 1976, RIV ARCHEOLOGIA CRIS, V5, P7; FENAROLI L, 1967, GLI ALBERI ITALIA; Fiocchi Nicolai V., 1999, CHRISTIAN CATACOMBS; Fiocchi Nicolai V., 2001, STRUTTURE FUNERARI E; GUYON J, 1994, BOREAS, V17, P89; Pergola P., 1997, CATACOMBE ROMANE STO; Rutgers L., 2000, SUBTERRANEAN ROME; Rutgers Leonard V., 1998, HIDDEN HERITAGE DIAS; Rutgers LV, 2002, RADIOCARBON, V44, P541, DOI 10.1017/S0033822200031891; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; vanderBorg K, 1997, NUCL INSTRUM METH B, V123, P97, DOI 10.1016/S0168-583X(96)00713-6	13	11	11	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 21	2005	436	7049					339	339		10.1038/436339a	http://dx.doi.org/10.1038/436339a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034407	Bronze, Green Published			2022-12-28	WOS:000230623400029
J	Ingelsson, E; Sundstrom, J; Arnlov, J; Zethelius, B; Lind, L				Ingelsson, E; Sundstrom, J; Arnlov, J; Zethelius, B; Lind, L			Insulin resistance and risk of congestive heart failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIAC STRUCTURE; ANGIOTENSIN-II; GLUCOSE; POPULATION; HYPERINSULINEMIA; HYPERTENSION; PREDICTORS; ACTIVATION; IMPACT	Context Diabetes and obesity are established risk factors for-congestive heart failure (CHF) and are both associated with insulin resistance. Objective To explore if insulin resistance may predict CHF and may provide the link between obesity and CHF. Design, Setting, and Participants The Uppsala Longitudinal Study of Adult Men, a prospective, community-based, observational cohort in Uppsala, Sweden. We investigated 1187 elderly ( >= 70 years) men free from CHF and valvular disease at baseline between 1990 and 1995, with follow-up until the end of 2002. Variables reflecting insulin sensitivity (including euglycemic insulin clamp glucose disposal rate) and obesity were analyzed together with established risk factors (prior myocardial infarction, hypertension, diabetes, electrocardiographic left ventricular hypertrophy, smoking, and serum cholesterol level) as predictors of subsequent incidence of CHF, using Cox proportional hazards analyses. Main Outcome Measure First hospitalization for heart failure. Results One hundred four men developed CHF during a median follow-up of 8.9 (range, 0.01-11.4) years. In multivariable Cox proportional hazards models adjusted for established risk factors for CHF, increased risk of CHF was associated with a 1-SD increase in the 2-hour glucose value of an oral glucose tolerance test (hazard ratio [HR], 1.44; 95% confidence interval [CI], 1.08-1.93), fasting serum proinsulin level (HR, 1.29; 95% Cl, 1.02-1.64), body mass index (HR, 1.35; 95% Cl, 1.11-1.65), and waist circumference (HR, 1.36; 95% Cl, 1.10-1.69), whereas a 1-SD increase in clamp glucose disposal rate decreased the risk (HR, 0.66; 95% Cl, 0.51-0.86). When adding clamp glucose disposal rate to these models as a covariate, the obesity variables were no longer significant predictors of subsequent CHF. Conclusions Insulin resistance predicted CHF incidence independently of established risk factors including diabetes in our large community-based sample of elderly men. The previously described association between obesity and subsequent CHF may be mediated largely by insulin resistance.	Uppsala Univ, Dept Publ Hlth & Caring Sci, Sect Geriatr, SE-75125 Uppsala, Sweden; Uppsala Univ, Dept Med Sci, SE-75125 Uppsala, Sweden; AstraZeneca R&D, Molndal, Sweden	Uppsala University; Uppsala University; AstraZeneca	Ingelsson, E (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci, Sect Geriatr, Box 609, SE-75125 Uppsala, Sweden.	erik.ingelsson@pubcare.uu.se	Ärnlöv, Johan/AAF-2746-2019; Sundstrom, Johan/R-2139-2019; Sundström, Johan/A-6286-2009	Ärnlöv, Johan/0000-0002-6933-4637; Sundstrom, Johan/0000-0003-2247-8454; Sundström, Johan/0000-0003-2247-8454				ANDERSON EA, 1991, J CLIN INVEST, V87, P2246, DOI 10.1172/JCI115260; Arnlov J, 2001, AM HEART J, V142, P720, DOI 10.1067/mhj.2001.116957; ARNLOV J, IN PRESS NUTR METAB; Basta G, 2004, CARDIOVASC RES, V63, P582, DOI 10.1016/j.cardiores.2004.05.001; Bell DSH, 2003, DIABETES CARE, V26, P2433, DOI 10.2337/diacare.26.8.2433; Chen YT, 1999, AM J MED, V106, P605, DOI 10.1016/S0002-9343(99)00126-6; CLELAND JG, 1995, EUR HEART J, V16, P741; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DEFRONZO RA, 1975, J CLIN INVEST, V55, P845, DOI 10.1172/JCI107996; Devereux RB, 2000, CIRCULATION, V101, P2271, DOI 10.1161/01.CIR.101.19.2271; ERIKSSON H, 1989, EUR HEART J, V10, P647, DOI 10.1093/oxfordjournals.eurheartj.a059542; Ferrannini E, 1997, J CLIN INVEST, V100, P1166, DOI 10.1172/JCI119628; GABOURY CL, 1994, J CLIN INVEST, V94, P2295, DOI 10.1172/JCI117593; Gavin JR, 1999, DIABETES CARE, V22, pS5; Hammar N, 2001, INT J EPIDEMIOL, V30, pS30, DOI 10.1093/ije/30.suppl_1.S30; He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996; Hedstrand H, 1975, Ups J Med Sci Suppl, V19, P1; Holmang A, 1996, EUR J CLIN INVEST, V26, P973, DOI 10.1046/j.1365-2362.1996.2880577.x; INGELSSON E, IN PRESS EUR J HEART; Jyothirmayi, 1998, J Cardiovasc Pharmacol Ther, V3, P319, DOI 10.1177/107424849800300407; KANNEL WB, 1991, AM HEART J, V121, P951, DOI 10.1016/0002-8703(91)90225-7; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; LINDBLAD U, 1993, SCAND J SOC MED, V21, P3, DOI 10.1177/140349489302100102; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Paolisso G, 1999, AM J CARDIOL, V83, P1338, DOI 10.1016/S0002-9149(99)00097-1; POLLARE T, 1991, ARTERIOSCLER THROMB, V11, P1192, DOI 10.1161/01.ATV.11.5.1192; PRINEAS RJ, 1982, MINNESOTA CODE MANUA, P239; Rutter MK, 2003, CIRCULATION, V107, P448, DOI 10.1161/01.CIR.0000045671.62860.98; Sartori M, 2004, AM J HYPERTENS, V17, P604, DOI 10.1016/j.amjhyper.2004.02.017; SOBEY WJ, 1989, BIOCHEM J, V260, P535, DOI 10.1042/bj2600535; Sundstrom J, 2000, CIRCULATION, V101, P2595, DOI 10.1161/01.CIR.101.22.2595; Suskin N, 2000, EUR HEART J, V21, P1368, DOI 10.1053/euhj.1999.2043; Swan JW, 1997, J AM COLL CARDIOL, V30, P527, DOI 10.1016/S0735-1097(97)00185-X; Wong CY, 2004, CIRCULATION, V110, P3081, DOI 10.1161/01.CIR.0000147184.13872.0F; Zethelius B, 2004, DIABETES CARE, V27, P1433, DOI 10.2337/diacare.27.6.1433	37	394	411	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2005	294	3					334	341		10.1001/jama.294.3.334	http://dx.doi.org/10.1001/jama.294.3.334			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YL	16030278	Bronze			2022-12-28	WOS:000230609100018
J	Minassian, A; Chambers, J; Klein, JL				Minassian, A; Chambers, J; Klein, JL			A non-infectious cardiac vegetation	LANCET			English	Editorial Material							NONBACTERIAL THROMBOTIC ENDOCARDITIS		St Thomas Hosp, Dept Infect, London SE1 7EH, England; St Thomas Hosp, Ctr Cardiothorac, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust	Klein, JL (corresponding author), St Thomas Hosp, Dept Infect, London SE1 7EH, England.	john.klein@gstt.sthames.nhs.uk		Minassian, Angela/0000-0001-7832-9824				ANEESH B, 2002, STROKE, V33, P1267; Edoute Y, 1997, AM J MED, V102, P252, DOI 10.1016/S0002-9343(96)00457-3; Eiken PW, 2001, MAYO CLIN PROC, V76, P1204, DOI 10.4065/76.12.1204; Heiro M, 2000, ARCH INTERN MED, V160, P2781, DOI 10.1001/archinte.160.18.2781; LOPEZ JA, 1987, AM HEART J, V113, P773, DOI 10.1016/0002-8703(87)90719-8	5	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2005	366	9481					264	264		10.1016/S0140-6736(05)66918-8	http://dx.doi.org/10.1016/S0140-6736(05)66918-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945RG	16023519				2022-12-28	WOS:000230519200037
J	Carroll, JS; Liu, XS; Brodsky, AS; Li, W; Meyer, CA; Szary, AJ; Eeckhoute, J; Shao, WL; Hestermann, EV; Geistlinger, TR; Fox, EA; Silver, PA; Brown, M				Carroll, JS; Liu, XS; Brodsky, AS; Li, W; Meyer, CA; Szary, AJ; Eeckhoute, J; Shao, WL; Hestermann, EV; Geistlinger, TR; Fox, EA; Silver, PA; Brown, M			Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1	CELL			English	Article							BREAST-CANCER CELLS; BETA-GLOBIN LOCUS; TRANSCRIPTION FACTOR; CHROMATIN-IMMUNOPRECIPITATION; RESPONSIVE ELEMENT; GENE-EXPRESSION; ALPHA; ACTIVATION; IDENTIFICATION; MICROARRAY	Estrogen plays an essential physiologic role in reproduction and a pathologic one in breast cancer. The completion of the human genome has allowed the identification of the expressed regions of protein-coding genes; however, little is known concerning the organization of their cis-regulatory elements. We have mapped the association of the estrogen receptor (ER) with the complete nonrepetitive sequence of human chromosomes 21 and 22 by combining chromatin immunoprecipitation (ChIP) with tiled microarrays. ER binds selectively to a limited number of sites, the majority of which are distant from the transcription start sites of regulated genes. The unbiased sequence interrogation of the genuine chromatin binding sites suggests that direct ER binding requires the presence of Forkhead factor binding in close proximity. Furthermore, knockdown of FoxA1 expression blocks the association of ER with chromatin and estrogen-induced gene expression demonstrating the necessity of FoxA1 in mediating an estrogen response in breast cancer cells.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Sch Publ Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Furman Univ, Dept Biol, Greenville, SC 29613 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Brown, M (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	myles_brown@dfci.harvard.edu	Brown, Myles/B-6906-2008; Brown, Myles/AAX-5332-2021; Eeckhoute, Jerome/AAN-8219-2021; Li, Wei/A-8544-2009	Brown, Myles/0000-0002-8213-1658; Eeckhoute, Jerome/0000-0002-7222-9264; Carroll, Jason/0000-0003-3643-0080; Li, Wei/0000-0001-9931-5990	NATIONAL CANCER INSTITUTE [F32CA108380] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K22HG002488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T90DK070078] Funding Source: NIH RePORTER; NCI NIH HHS [F32 CA108380-02] Funding Source: Medline; NHGRI NIH HHS [K22 HG02488-01A1] Funding Source: Medline; NIDDK NIH HHS [T90 DK070078-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AUGEREAU P, 1994, MOL ENDOCRINOL, V8, P693, DOI 10.1210/me.8.6.693; Bajic VB, 2003, NUCLEIC ACIDS RES, V31, P3560, DOI 10.1093/nar/gkg570; Beck S, 1999, DNA CELL BIOL, V18, P157, DOI 10.1089/104454999315547; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; BERRY M, 1989, P NATL ACAD SCI USA, V86, P1218, DOI 10.1073/pnas.86.4.1218; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bourdeau V, 2004, MOL ENDOCRINOL, V18, P1411, DOI 10.1210/me.2003-0441; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bulger M, 2002, CURR OPIN GENET DEV, V12, P170, DOI 10.1016/S0959-437X(02)00283-6; Carroll JS, 2000, J BIOL CHEM, V275, P38221, DOI 10.1074/jbc.M004424200; CAVAILLES V, 1995, EMBO J, V14, P3741, DOI 10.1002/j.1460-2075.1995.tb00044.x; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DUBIK D, 1992, ONCOGENE, V7, P1587; Giamarchi C, 1999, ONCOGENE, V18, P533, DOI 10.1038/sj.onc.1202317; HALACHMI S, 1994, SCIENCE, V264, P1455, DOI 10.1126/science.8197458; Holmqvist PH, 2005, EXP CELL RES, V304, P593, DOI 10.1016/j.yexcr.2004.12.002; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Ikeda K, 2000, BIOCHEM BIOPH RES CO, V273, P654, DOI 10.1006/bbrc.2000.2920; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Katsanis N, 1998, HUM GENET, V102, P221, DOI 10.1007/s004390050682; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kuang SQ, 2004, CANCER RES, V64, P1875, DOI 10.1158/0008-5472.CAN-03-3745; Lacroix M, 2004, MOL CELL ENDOCRINOL, V219, P1, DOI 10.1016/j.mce.2004.02.021; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Pedram A, 2002, J BIOL CHEM, V277, P50768, DOI 10.1074/jbc.M210106200; Petz LN, 2002, ENDOCRINOLOGY, V143, P4583, DOI 10.1210/en.2002-220369; Porter W, 1996, MOL ENDOCRINOL, V10, P1371, DOI 10.1210/me.10.11.1371; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Robyr D, 2000, J BIOL CHEM, V275, P28291; Sawado T, 2003, GENE DEV, V17, P1009, DOI 10.1101/gad.1072303; Schiff R, 2000, J NATL CANCER I, V92, P1926, DOI 10.1093/jnci/92.23.1926; Schuur ER, 2001, J BIOL CHEM, V276, P33554, DOI 10.1074/jbc.M105555200; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Singh RJ, 1998, P NATL ACAD SCI USA, V95, P6675, DOI 10.1073/pnas.95.12.6675; TENG CT, 1992, MOL ENDOCRINOL, V6, P1969, DOI 10.1210/me.6.11.1969; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; UMAYAHARA Y, 1994, J BIOL CHEM, V269, P16433; Vyhlidal C, 2000, J MOL ENDOCRINOL, V24, P329, DOI 10.1677/jme.0.0240329; Wang DY, 2004, MOL ENDOCRINOL, V18, P402, DOI 10.1210/me.2003-0202; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; WEISZ A, 1990, NUCLEIC ACIDS RES, V18, P5097, DOI 10.1093/nar/18.17.5097	50	1044	1071	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 15	2005	122	1					33	43		10.1016/j.cell.2005.05.008	http://dx.doi.org/10.1016/j.cell.2005.05.008			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	950EC	16009131	Bronze			2022-12-28	WOS:000230839400009
J	Barna, M; Pandolfi, PP; Niswander, L				Barna, M; Pandolfi, PP; Niswander, L			Gli3 and Plzf cooperate in proximal limb patterning at early stages of limb development	NATURE			English	Article							VERTEBRATE LIMB; GENE-EXPRESSION; MOUSE LIMB; CHICK LIMB; DIFFERENTIATION; CHONDROGENESIS; ROLES; CONDENSATIONS; EVOLUTION; HEDGEHOG	The vertebrate limb initially develops as a bud of mesenchymal cells that subsequently aggregate in a proximal to distal (P - D) sequence to give rise to cartilage condensations that prefigure all limb skeletal components(1). Of the three cardinal limb axes, the mechanisms that lead to establishment and patterning of skeletal elements along the P - D axis are the least understood. Here we identify a genetic interaction between Gli3 (GLI-Kruppel family member 3) and Plzf ( promyelocytic leukaemia zinc finger, also known as Zbtb16 and Zfp145), which is required specifically at very early stages of limb development for all proximal cartilage condensations in the hindlimb ( femur, tibia, fibula). Notably, distal condensations comprising the foot are relatively unperturbed in Gli3(-/-); Plzf(-/-) mouse embryos. We demonstrate that the cooperative activity of Gli3 and Plzf establishes the correct temporal and spatial distribution of chondrocyte progenitors in the proximal limb-bud independently of known P - D patterning markers and overall limb-bud size. Moreover, the limb defects in Gli3(-/-); Plzf(-/-) embryos correlate with the transient death of a specific subset of proximal mesenchymal cells that express bone morphogenetic protein receptor, type 1B (Bmpr1b) at the onset of limb development. These findings suggest that the development of proximal and distal skeletal elements is distinctly regulated early during limb-bud formation. The initial division of the vertebrate limb into two distinct molecular domains is consistent with fossil evidence indicating that the upper and lower extremities of the limb have different evolutionary origins(2).	Sloan Kettering Inst, Dev Biol Program, New York, NY 10021 USA; Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10021 USA; Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Program Mol Biol, New York, NY 10021 USA; Univ Colorado, Hlth Sci Ctr, Howard Hughes Med Inst, Aurora, CO 80045 USA; Univ Colorado, Hlth Sci Ctr, Dept Pediat, Sect Dev Biol, Aurora, CO 80045 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Niswander, L (corresponding author), Sloan Kettering Inst, Dev Biol Program, New York, NY 10021 USA.	Lee.Niswander@uchsc.edu	Niswander, Lee/D-3976-2013	Niswander, Lee/0000-0002-9959-0594				Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; AVANTAGGIATO V, 1995, J NEUROSCI, V15, P4927; Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Boulet AM, 2004, DEVELOPMENT, V131, P299, DOI 10.1242/dev.00936; Buscher D, 1997, MECH DEVELOP, V62, P175, DOI 10.1016/S0925-4773(97)00656-4; Cohn MJ, 2002, BIOESSAYS, V24, P460, DOI 10.1002/bies.10088; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; Dudley AT, 2002, NATURE, V418, P539, DOI 10.1038/nature00945; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Masuya H, 1997, DEV BIOL, V182, P42, DOI 10.1006/dbio.1996.8457; Mercader N, 2000, DEVELOPMENT, V127, P3961; OSTER GF, 1988, EVOLUTION, V42, P862, DOI 10.1111/j.1558-5646.1988.tb02508.x; Pizette S, 2000, DEV BIOL, V219, P237, DOI 10.1006/dbio.2000.9610; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; SUMMERBELL D, 1974, J EMBRYOL EXP MORPH, V32, P651; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Wakamatsu Y, 1998, DEVELOPMENT, V125, P4205; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; WOLPERT L, 1979, J EMBRYOL EXP MORPH, V50, P175; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Yi SE, 2000, DEVELOPMENT, V127, P621; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	26	77	83	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					277	281		10.1038/nature03801	http://dx.doi.org/10.1038/nature03801			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015334				2022-12-28	WOS:000230459500045
J	Turner, CH				Turner, CH			The biomechanics of hip fracture	LANCET			English	Editorial Material									Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; Indiana Univ Purdue Univ, Dept Orthoped Surg, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Turner, CH (corresponding author), Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA.	turnerch@iupui.edu						CAMPBELL A J, 1981, Age and Ageing, V10, P264, DOI 10.1093/ageing/10.4.264; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; Mayhew PM, 2005, LANCET, V366, P129, DOI 10.1016/S0140-6736(05)66870-5; RECKER RR, 1989, P SOC EXP BIOL MED, V191, P272; TINETTI ME, 1989, NEW ENGL J MED, V320, P1055; YOSHIKAWA T, 1994, J BONE MINER RES, V9, P1053	6	20	23	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 9	2005	366	9480					98	99		10.1016/S0140-6736(05)66842-0	http://dx.doi.org/10.1016/S0140-6736(05)66842-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	943JH	16005313				2022-12-28	WOS:000230349200005
J	Nateri, AS; Spencer-Dene, B; Behrens, A				Nateri, AS; Spencer-Dene, B; Behrens, A			Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development	NATURE			English	Article							TERMINAL PHOSPHORYLATION; TARGET GENES; APC GENE; PROLIFERATION; AP-1; TRANSCRIPTION; REGENERATION; CARCINOMAS; EXPRESSION; PATHWAY	The proto-oncoprotein c-Jun is a component of the AP-1 transcription factor, the activity of which is augmented in many tumour types(1). An important mechanism in the stimulation of AP-1 function is amino-terminal phosphorylation of c-Jun by the c-Jun N-terminal kinases (JNKs)(2). Phosphorylated c-Jun is biologically more active, partially because it acquires the ability to interact with binding partners. Here we show that phosphorylated c-Jun interacts with the HMG-box transcription factor TCF4 to form a ternary complex containing c-Jun, TCF4 and beta-catenin. Chromatin immunoprecipitation assays revealed JNK-dependent c-Jun - TCF4 interaction on the c-jun promoter, and c-Jun and TCF4 cooperatively activated the c-jun promoter in reporter assays in a beta-catenin-dependent manner. In the Apc(Min) mouse model of intestinal cancer(6), genetic abrogation of c-Jun N-terminal phosphorylation(3) or gut-specific conditional c-jun inactivation(4,5) reduced tumour number and size and prolonged lifespan. Therefore, the phosphorylation-dependent interaction between c-Jun and TCF4 regulates intestinal tumorigenesis by integrating JNK and APC/beta-catenin, two distinct pathways activated by WNT signalling.	CR UK London Res Inst, Lincolns Inn Fields Labs, Mammalian Genet Lab, London WC2A 3PX, England; CR UK London Res Inst, Lincolns Inn Fields Labs, Expt Pathol Lab, London WC2A 3PX, England; Univ London Imperial Coll Sci Technol & Med, Dept Histopathol, London SW7 2AZ, England	Imperial College London	Behrens, A (corresponding author), CR UK London Res Inst, Lincolns Inn Fields Labs, Mammalian Genet Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	axel.behrens@cancer.org.uk		Behrens, Axel/0000-0002-1557-1143; Shams Nateri, Abdolrahman/0000-0002-6422-6813				Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Bogoyevitch MA, 2004, BBA-PROTEINS PROTEOM, V1697, P89, DOI 10.1016/j.bbapap.2003.11.016; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fodde R, 2002, EUR J CANCER, V38, P867, DOI 10.1016/S0959-8049(02)00040-0; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; MOSER AR, 1993, P NATL ACAD SCI USA, V90, P8977, DOI 10.1073/pnas.90.19.8977; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Staal FJT, 2004, J IMMUNOL, V172, P1099, DOI 10.4049/jimmunol.172.2.1099; STEIN B, 1992, PHOTOCHEM PHOTOBIOL, V55, P409, DOI 10.1111/j.1751-1097.1992.tb04255.x; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wada T, 2004, NAT CELL BIOL, V6, P215, DOI 10.1038/ncb1098; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2	24	285	300	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					281	285		10.1038/nature03914	http://dx.doi.org/10.1038/nature03914			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16007074				2022-12-28	WOS:000231696900061
J	Agaisse, H; Burrack, LS; Philips, JA; Rubin, EJ; Perrimon, N; Higgins, DE				Agaisse, H; Burrack, LS; Philips, JA; Rubin, EJ; Perrimon, N; Higgins, DE			Genome-wide RNAi screen for host factors required for intracellular bacterial infection	SCIENCE			English	Article							DROSOPHILA; PHAGOCYTOSIS; TIP60	Most studies of host-pathogen interactions have focused on pathogen-specific virulence determinants. Here, we report a genome-wide RNA interference screen to identify host factors required for intracellular bacterial pathogenesis. Using Drosophila cells and the cytosolic pathogen Listeria monocytogenes, we identified 305 double-stranded RNAs targeting a wide range of cellular functions that altered L. monocytogenes infection. Comparison to a similar screen with Mycobacterium fortuitum, a vacuolar pathogen, identified host factors that may play a general role in intracellular pathogenesis and factors that specifically affect access to the cytosol by L. monocytogenes.	Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Agaisse, H (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06519 USA.	herve.agaisse@yale.edu; dhiggins@hms.harvard.edu		Burrack, Laura/0000-0002-0821-0980; Rubin, Eric/0000-0001-5120-962X; Perrimon, Norbert/0000-0001-7542-472X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053669, R01AI048704] Funding Source: NIH RePORTER; NIAID NIH HHS [AI048704, AI053669] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Beauregard KE, 1997, J EXP MED, V186, P1159, DOI 10.1084/jem.186.7.1159; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Cheng LW, 2003, CELL MICROBIOL, V5, P875, DOI 10.1046/j.1462-5822.2003.00327.x; Creaven M, 1999, BIOCHEMISTRY-US, V38, P8826, DOI 10.1021/bi9907274; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Hild M, 2004, GENOME BIOL, V5; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Mansfield BE, 2003, CELL MICROBIOL, V5, P901, DOI 10.1046/j.1462-5822.2003.00329.x; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015	14	228	245	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2005	309	5738					1248	1251		10.1126/science.1116008	http://dx.doi.org/10.1126/science.1116008			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957TE	16020693				2022-12-28	WOS:000231395400048
J	Yasuda, S; Townsend, D; Michele, DE; Favre, EG; Day, SM; Metzger, JM				Yasuda, S; Townsend, D; Michele, DE; Favre, EG; Day, SM; Metzger, JM			Dystrophic heart failure blocked by membrane sealant poloxamer	NATURE			English	Article							MUSCULAR-DYSTROPHIES; SKELETAL-MUSCLE; CARDIOMYOPATHY; EXPRESSION; INJECTION; DISEASE; CELLS; MICE	Dystrophin deficiency causes Duchenne muscular dystrophy (DMD) in humans, an inherited and progressive disease of striated muscle deterioration that frequently involves pronounced cardiomyopathy(1). Heart failure is the second leading cause of fatalities in DMD1,2. Progress towards defining the molecular basis of disease in DMD has mostly come from studies on skeletal muscle, with comparatively little attention directed to cardiac muscle. The pathophysiological mechanisms involved in cardiac myocytes may differ significantly from skeletal myofibres; this is underscored by the presence of significant cardiac disease in patients with truncated or reduced levels of dystrophin but without skeletal muscle disease(3). Here we show that intact, isolated dystrophin-deficient cardiac myocytes have reduced compliance and increased susceptibility to stretch-mediated calcium overload, leading to cell contracture and death, and that application of the membrane sealant poloxamer 188 corrects these defects in vitro. In vivo administration of poloxamer 188 to dystrophic mice instantly improved ventricular geometry and blocked the development of acute cardiac failure during a dobutamine-mediated stress protocol. Once issues relating to optimal dosing and long-term effects of poloxamer 188 in humans have been resolved, chemical-based membrane sealants could represent a new therapeutic approach for preventing or reversing the progression of cardiomyopathy and heart failure in muscular dystrophy.	Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Metzger, JM (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	metzgerj@umich.edu						AdamsGraves P, 1997, BLOOD, V90, P2041, DOI 10.1182/blood.V90.5.2041; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Burger AJ, 2000, AM J CARDIOL, V86, P825, DOI 10.1016/S0002-9149(00)01100-0; Coutu P, 2004, CIRC RES, V94, P1235, DOI 10.1161/01.RES.0000126923.46786.FD; Danialou G, 2001, FASEB J, V15, P1655, DOI 10.1096/fj.01-0030fje; Davis DB, 2000, HUM MOL GENET, V9, P217, DOI 10.1093/hmg/9.2.217; Finsterer J, 2003, CARDIOLOGY, V99, P1, DOI 10.1159/000068446; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Jewell RC, 1997, J PHARM SCI, V86, P808, DOI 10.1021/js960491e; Lee RC, 1999, ANN NY ACAD SCI, V888, P266, DOI 10.1111/j.1749-6632.1999.tb07961.x; LEE RC, 1992, P NATL ACAD SCI USA, V89, P4524, DOI 10.1073/pnas.89.10.4524; Michele DE, 2002, CIRC RES, V91, P255, DOI 10.1161/01.RES.0000027530.58419.82; Muntoni F, 2003, CURR OPIN NEUROL, V16, P577, DOI 10.1097/00019052-200310000-00003; PASTERNAK C, 1995, J CELL BIOL, V128, P355, DOI 10.1083/jcb.128.3.355; RODRIGUEZ EK, 1992, AM J PHYSIOL, V263, pH293, DOI 10.1152/ajpheart.1992.263.1.H293; Squire S, 2002, HUM MOL GENET, V11, P3333, DOI 10.1093/hmg/11.26.3333; Straub V, 1997, CURR OPIN NEUROL, V10, P168, DOI 10.1097/00019052-199704000-00016; Togo T, 1999, J CELL SCI, V112, P719; Torrente Y, 2004, J CLIN INVEST, V114, P182, DOI 10.1172/JCI200420325; TURNER PR, 1991, J CELL BIOL, V115, P1701, DOI 10.1083/jcb.115.6.1701; Wu GH, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.028101; Yasuda SI, 2001, AM J PHYSIOL-HEART C, V281, pH1442, DOI 10.1152/ajpheart.2001.281.3.H1442; [No title captured]	25	233	247	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2005	436	7053					1025	1029		10.1038/nature03844	http://dx.doi.org/10.1038/nature03844			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955XQ	16025101	Green Published			2022-12-28	WOS:000231263900052
J	MacLennan, C; MacLennan, J				MacLennan, C; MacLennan, J			What threat from persistent vaccine-related poliovirus?	LANCET			English	Editorial Material							POLIOMYELITIS; EPIDEMIOLOGY		Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; Univ Birmingham, Div Immun & Infect, MRC, Ctr Immune Regulat, Birmingham, W Midlands, England; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Malawi; University of Birmingham; University of Oxford	MacLennan, C (corresponding author), Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.	cmaclennan@mlw.medcol.mw	MacLennan, Calman A/L-9343-2014	MacLennan, Calman A/0000-0001-9694-0846				Alexander JP, 1997, J INFECT DIS, V175, pS176, DOI 10.1093/infdis/175.Supplement_1.S176; Biologicals DoVa, 2003, GUID ENV SURV POL CI; Dowdle WR, 1997, J INFECT DIS, V175, pS286, DOI 10.1093/infdis/175.Supplement_1.S286; Halsey NA, 2004, B WORLD HEALTH ORGAN, V82, P3; Kew OM, 2004, B WORLD HEALTH ORGAN, V82, P16; Kew OM, 1995, SEMIN VIROL, V6, P401, DOI 10.1016/S1044-5773(05)80017-4; MacLennan C, 2004, LANCET, V363, P1509, DOI 10.1016/S0140-6736(04)16150-3; NATHANSON N, 1979, AM J EPIDEMIOL, V110, P672, DOI 10.1093/oxfordjournals.aje.a112848; SABIN AB, 1985, J INFECT DIS, V151, P420, DOI 10.1093/infdis/151.3.420; *WHO, 2003, WKLY EPIDEMIOL REC, V78, P241; *WHO, 2003, GLOB POL ER IN STRAT; *WHO, 2004, 115 WHO; *WHO, 2004, WKLY EPIDEMIOL REC, V5, P42; World Health Organization, 2004, POL LAB MAN, V4th	14	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2005	366	9483					351	353		10.1016/S0140-6736(05)66387-8	http://dx.doi.org/10.1016/S0140-6736(05)66387-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	950IB	16054925				2022-12-28	WOS:000230849700008
J	Bibb, JA				Bibb, JA			Decoding dopamine signaling	CELL			English	Editorial Material							ACTIVATION; RECEPTORS; NEURONS		Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Bibb, JA (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA.							Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Brami-Cherrier K, 2002, J NEUROSCI, V22, P8911; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Macey TA, 2004, MOL PHARMACOL, V66, P1635, DOI 10.1124/mol.104.001495; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Neve KA, 1997, DOPAMINE RECEPTORS; Park SK, 2005, CELL, V122, P275, DOI 10.1016/j.cell.2005.05.031; Rakhilin SV, 2004, SCIENCE, V306, P698, DOI 10.1126/science.1099961; Takeuchi Y, 2004, J NEUROCHEM, V90, P155, DOI 10.1111/j.1471-4159.2004.02476.x; Zou SW, 2005, J NEUROSCI, V25, P4385, DOI 10.1523/JNEUROSCI.5099-04.2005	11	40	44	1	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 29	2005	122	2					153	155		10.1016/j.cell.2005.07.011	http://dx.doi.org/10.1016/j.cell.2005.07.011			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	951CR	16051141	Bronze			2022-12-28	WOS:000230907000004
J	Choudhuri, K; Wiseman, D; Brown, MH; Gould, K; van der Merwe, PA				Choudhuri, K; Wiseman, D; Brown, MH; Gould, K; van der Merwe, PA			T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand	NATURE			English	Article							ANTIGEN RECOGNITION; SURFACE MOLECULES; ACTIVATION; ADHESION; COMPLEX; SYNAPSE; CD2	The binding of a T-cell antigen receptor (TCR) to peptide antigen presented by major histocompatibility antigens (pMHC) on antigen-presenting cells (APCs) is a central event in adaptive immune responses(1,2). The mechanism by which TCR-pMHC ligation initiates signalling, a process termed TCR triggering, remains controversial(3-5). It has been proposed(6-8) that TCR triggering is promoted by segregation at the T cell-APC interface of cell-surface molecules with small ectodomains (such as TCR-pMHC and accessory receptors) from molecules with large ectodomains (such as the receptor protein tyrosine phosphatases CD45 and CD148). Here we show that increasing the dimensions of the TCR-pMHC interaction by elongating the pMHC ectodomain greatly reduces TCR triggering without affecting TCR-pMHC ligation. A similar dependence on receptor-ligand complex dimensions was observed with artificial TCR-ligand systems that span the same dimensions as the TCR-pMHC complex. Interfaces between T cells and APCs expressing elongated pMHC showed an increased intermembrane separation distance and less depletion of CD45. These results show the importance of the small size of the TCR-pMHC complex and support a role for size-based segregation of cell-surface molecules in TCR triggering.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ London Imperial Coll Sci Technol & Med, Wright Fleming Inst, Dept Immunol, London W2 1PG, England	University of Oxford; Imperial College London	van der Merwe, PA (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	k.gould@imperial.ac.uk; anton.vandermerwe@path.ox.ac.uk	van der Merwe, P. Anton/F-8539-2011; Wiseman, David/D-7495-2014	Wiseman, David/0000-0002-8823-1422; Choudhuri, Kaushik/0000-0002-3911-027X; Gould, Keith/0000-0003-0913-5422	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Barclay A. N, 1997, LEUKOCYTE ANTIGEN FA; CHAN PY, 1992, MOL BIOL CELL, V3, P157, DOI 10.1091/mbc.3.2.157; Coombs D, 2004, BIOPHYS J, V86, P1408, DOI 10.1016/S0006-3495(04)74211-3; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; Davis DM, 1999, P NATL ACAD SCI USA, V96, P15062, DOI 10.1073/pnas.96.26.15062; Davis MM, 2002, CELL, V110, P285, DOI 10.1016/S0092-8674(02)00865-6; Davis MM, 2003, ANNU REV BIOCHEM, V72, P717, DOI 10.1146/annurev.biochem.72.121801.161625; Davis SJ, 2003, NAT IMMUNOL, V4, P217, DOI 10.1038/ni0303-217; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; DILLON SR, 1994, J IMMUNOL, V152, P1790; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Irles C, 2003, NAT IMMUNOL, V4, P189, DOI 10.1038/ni877; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lin J, 2003, J CELL BIOL, V162, P673, DOI 10.1083/jcb.200303040; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Trautmann A, 2003, TRENDS IMMUNOL, V24, P425, DOI 10.1016/S1471-4906(03)00182-0; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; van der Merwe PA, 2001, IMMUNITY, V14, P665, DOI 10.1016/S1074-7613(01)00155-8; WEISS A, 2003, FUNDAMENTAL IMMUNOLO, P321; Wild MK, 1999, J EXP MED, V190, P31, DOI 10.1084/jem.190.1.31; Yu YYL, 2002, J IMMUNOL, V168, P3145, DOI 10.4049/jimmunol.168.7.3145	30	246	257	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					578	582		10.1038/nature03843	http://dx.doi.org/10.1038/nature03843			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049493				2022-12-28	WOS:000230788800066
J	DeBell, D; Carter, R				DeBell, D; Carter, R			Impact of transition on public health in Ukraine: case study of the HIV/AIDS epidemic	BRITISH MEDICAL JOURNAL			English	Article									Anglia Polytech Univ, Inst Hlth & Social Care, Ctr Res Hlth & Social Care, Chelmsford CM1 1SQ, Essex, England; Every Child UK, London EC2A 3DR, England	Anglia Ruskin University	DeBell, D (corresponding author), Anglia Polytech Univ, Inst Hlth & Social Care, Ctr Res Hlth & Social Care, Chelmsford CM1 1SQ, Essex, England.	ddebell@compuserve.com						ADEYI O, 2003, FUNDING REQUIRED RES; Barnett T, 2000, SOC SCI MED, V51, P1387, DOI 10.1016/S0277-9536(00)00104-0; BARNETT T, 2004, REVERSING EPIDEMIC F; BASS E, 2003, IAVI REPORT, V7; *TRANSP INT, 2004, TRANSP INT CORR PERC; *UKR UNAIDS WHO, 2004, UNAIDS WHO EP FACT S; *UNAIDS, 4 UNAIDS; United Nations Development Programme, 2004, HUM DEV REP 2004 CUL; World Bank, 2004, WORLD DEV IND DAT	9	12	12	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 23	2005	331	7510					216	219		10.1136/bmj.331.7510.216	http://dx.doi.org/10.1136/bmj.331.7510.216			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951EA	16037461	Bronze, Green Published			2022-12-28	WOS:000230910700030
J	Novotny, TE				Novotny, TE			Commentary: HIV is not just a transitional problem	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Calif San Francisco, Inst Global Hlth, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Novotny, TE (corresponding author), Univ Calif San Francisco, Inst Global Hlth, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	tnovotny@psg.ucsf.edu						DeBell D, 2005, BRIT MED J, V331, P216, DOI 10.1136/bmj.331.7510.216; Rhodes T, 2005, BMJ-BRIT MED J, V331, P220, DOI 10.1136/bmj.331.7510.220; ROSENMOLLER M, IN PRESS EUROHEALTH; *UNAIDS WHO, AIDS EP UPD DEC 2004	4	0	0	1	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 23	2005	331	7510					219	219		10.1136/bmj.331.7510.219	http://dx.doi.org/10.1136/bmj.331.7510.219			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951EA	16037462	Green Published, Bronze			2022-12-28	WOS:000230910700031
J	Oliver, RTD; Mason, MD; Mead, GM; von der Maase, H; Rustin, GJS; Joffe, JK; de Wit, R; Aass, N; Graham, JD; Coleman, R; Kirk, SJ; Stenning, SP				Oliver, RTD; Mason, MD; Mead, GM; von der Maase, H; Rustin, GJS; Joffe, JK; de Wit, R; Aass, N; Graham, JD; Coleman, R; Kirk, SJ; Stenning, SP		MRC TE10 Collaborators; EORTC30982 Collaborators	Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial	LANCET			English	Article							GERM-CELL TUMORS; AGENT CARBOPLATIN; TESTICULAR SEMINOMA; MANAGEMENT; SURVEILLANCE; THERAPY; CANCER; CHEMOTHERAPY; EXPERIENCE; TESTIS	Background Adjuvant radiotherapy is effective treatment for stage I seminoma, but is associated with a risk of late non-germ-cell cancer and cardiovascular events. After good results in initial studies with one injection of carboplatin, we undertook a large randomised trial to compare the approaches of radiotherapy with chemotherapy in seminoma treatment. Methods Between 1996 and 2001, 1477 patients from 70 hospitals in 14 countries were randomly assigned to receive radiotherapy (para-aortic strip or dog-leg field; n=904) or one injection of carboplatin (n=573; dose based on the formula 7 X [glomerular filtration rate + 25] mg), at two trial centres in the UK and Belgium. The primary outcome measure was the relapse-free rate, with the trial powered to exclude absolute differences in 2-year rates of more than 3%. Analysis was by intention to treat and per protocol. This trial has been assigned the international Standard Randomised Controlled Trial Number ISRCTN27163214. Findings 885 and 560 patients received radiotherapy and carboplatin, respectively. With a median follow-up of 4 years (IQR 3.0-4-9), relapse-free survival rates for radiotherapy and carboplatin were similar (96.7% [95% Cl 95.3-97.7] vs 97.7% [96.0-98.6] at 2 years; 95.9% [94.4-97.1] vs 94.8% [92.5-96.4] at 3 years, respectively; hazard ratio 1.28 [90% Cl 0.85-1.93], p=0.32). At 2 years' follow-up, the absolute differences in relapse-free rates (radiotherapy-chemotherapy) were -1.0% (90% CI -2.5 to 0.5) by direct comparison of proportions, and 0.9% (-0.5 to 3.0) by a hazard-ratio-based approach. Patients given carboplatin were less lethargic and less likely to take time off work than those given radiotherapy. New, second primary testicular germ-cell tumours were reported in ten patients allocated irradiation (all after para-aortic strip field) and two allocated carboplatin (5-year event rate 1.96% [95% CI 1.0-3.8] vs 0.54% [0.1-2.1], p=0.04). One seminoma-related death occurred after radiotherapy and none after carboplatin. Interpretation This trial has shown the non-inferiority of carboplatin to radiotherapy in the treatment of stage I seminoma. Although the absence of disease-related deaths and preliminary data indicating fewer second primary testicular germ-cell tumours favour carboplatin use, these findings need to be confirmed beyond 4 years' follow-up.	St Barts & London Hosp, Dept Med Oncol, London EC1A 7BE, England; Velindre Hosp, Dept Clin Oncol, Cardiff, S Glam, Wales; Southampton Gen Hosp, Southampton SO9 4XY, Hants, England; Aarhus Univ Hosp, Dept Oncol, Aarhus, Denmark; Mt Vernon Hosp, Dept Radiotherapy, Northwood HA6 2RN, Middx, England; Cookridge Hosp, Leeds LS16 6QB, W Yorkshire, England; Erasmus MC, Dept Oncol, Rotterdam, Netherlands; Norwegian Radium Hosp, Oslo, Norway; Beatson Oncol Ctr, Glasgow, Lanark, Scotland; Weston Pk Hosp, Sheffield, S Yorkshire, England; MRC, Clin Trials Unit, Canc Div, London, England	University of London; Queen Mary University London; Velindre Hospital; University of Southampton; Aarhus University; Cookridge Hospital; Erasmus University Rotterdam; Erasmus MC; University of Oslo; Beatson Oncology Centre; Weston Park Hospital; Medical Research Council Clinical Trials Unit	Oliver, RTD (corresponding author), St Barts & London Hosp, Dept Med Oncol, London EC1A 7BE, England.	r.t.oliver@qmul.ac.uk	Mason, Malcolm D/H-6979-2013; Rustin, Gordon J. S./J-9763-2019	Graham, John/0000-0003-3381-9787				Aparicio J, 2004, J CLIN ONCOL, V22, p386S; Aparicio J, 2003, ANN ONCOL, V14, P867, DOI 10.1093/annonc/mdg241; Bajorin DF, 1998, J CLIN ONCOL, V16, P707, DOI 10.1200/JCO.1998.16.2.707; Bokemeyer C, 2004, BRIT J CANCER, V91, P683, DOI 10.1038/sj.bjc.6602020; Calvert AH, 2002, EUR J CANCER, V38, P11, DOI 10.1016/S0959-8049(01)00340-9; Christiansen HH, 1998, PERMAFROST PERIGLAC, V9, P1; Cullen MH, 1996, BRIT J CANCER, V74, P1487, DOI 10.1038/bjc.1996.570; Dieckmann KP, 2000, UROLOGY, V55, P102, DOI 10.1016/S0090-4295(99)00376-3; Fayers P, 1995, EORTC QLQC 30 SCORIN; Fossa SD, 1999, J CLIN ONCOL, V17, P1146, DOI 10.1200/JCO.1999.17.4.1146; Friedman Milton, 1944, S CLIN NORTH AM, V24, P1424; GIRLING DJ, 2003, CLIN TRIALS CANC PRI, P238; Jones WG, 2005, J CLIN ONCOL, V23, P1200, DOI 10.1200/JCO.2005.08.003; Krege S, 1997, EUR UROL, V31, P405; OLIVER RT, 2001, P AN M AM SOC CLIN, V20, pA196; OLIVER RTD, 1984, BRIT J UROL, V56, P729, DOI 10.1111/j.1464-410X.1984.tb06158.x; Oliver RTD, 2003, APMIS, V111, P86, DOI 10.1034/j.1600-0463.2003.11101121.x; OLIVER RTD, 1990, BRIT J UROL, V65, P61, DOI 10.1111/j.1464-410X.1990.tb14663.x; OLIVER RTD, 1987, INT J ANDROL, V10, P263, DOI 10.1111/j.1365-2605.1987.tb00192.x; OLIVER RTD, 1994, INT J RADIAT ONCOL, V29, P3, DOI 10.1016/0360-3016(94)90219-4; Oliver T, 2005, J CLIN ONCOL, V23, p395S; Reiter WJ, 1998, UROLOGY, V52, P117, DOI 10.1016/S0090-4295(98)00139-3; Reiter WJ, 2001, J CLIN ONCOL, V19, P101, DOI 10.1200/JCO.2001.19.1.101; Schmidberger H, 2001, INT J RADIAT ONCOL, V50, P857, DOI 10.1016/S0360-3016(01)01521-8; Steiner H, 2002, UROLOGY, V60, P324, DOI 10.1016/S0090-4295(02)01708-9; Travis LB, 1997, JNCI-J NATL CANCER I, V89, P1429, DOI 10.1093/jnci/89.19.1429; VANLEEUWEN FE, 1993, J CLIN ONCOL, V11, P2286; Wanderas EH, 1997, EUR J CANCER, V33, P244; Warde P, 2002, J CLIN ONCOL, V20, P4448, DOI 10.1200/JCO.2002.01.038; Zagars GK, 2004, J CLIN ONCOL, V22, P640, DOI 10.1200/JCO.2004.05.205; 1987, TMN CLASSIFICATION M	31	317	320	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2005	366	9482					293	300		10.1016/S0140-6736(05)66984-X	http://dx.doi.org/10.1016/S0140-6736(05)66984-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RJ	16039331				2022-12-28	WOS:000230733100027
J	Kraus, SD; Brown, MW; Caswell, H; Clark, CW; Fujiwara, M; Hamilton, PK; Kenney, RD; Knowlton, AR; Landry, S; Mayo, CA; McLellan, WA; Moore, MJ; Nowacek, DP; Pabst, DA; Read, AJ; Rolland, RM				Kraus, SD; Brown, MW; Caswell, H; Clark, CW; Fujiwara, M; Hamilton, PK; Kenney, RD; Knowlton, AR; Landry, S; Mayo, CA; McLellan, WA; Moore, MJ; Nowacek, DP; Pabst, DA; Read, AJ; Rolland, RM			North Atlantic right whales in crisis	SCIENCE			English	Editorial Material									New England Aquarium, Edgerton Res Lab, Boston, MA 02110 USA; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; Cornell Univ, Cornell Lab Ornithol, Ithaca, NY 14850 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA; Provincetown Ctr Coastal Studies, Provincetown, MA 02657 USA; Univ N Carolina, Wilmington, NC 28403 USA; Florida State Univ, Dept Oceanog, Tallahassee, FL 32306 USA; Duke Univ, Marine Lab, Beaufort, NC 28516 USA	Woods Hole Oceanographic Institution; Cornell University; University of California System; University of California Santa Barbara; University of Rhode Island; University of North Carolina; University of North Carolina Wilmington; State University System of Florida; Florida State University; Duke University	Kraus, SD (corresponding author), New England Aquarium, Edgerton Res Lab, Boston, MA 02110 USA.	skraus@neaq.org	Fujiwara, Masami/C-3115-2012; Moore, Michael/E-1707-2015; Read, Andrew/AAE-8386-2019	Fujiwara, Masami/0000-0002-9255-6043; Moore, Michael/0000-0003-3074-6631; Kraus, Scott/0000-0003-4367-6548; Caswell, Hal/0000-0003-4394-6894				Best Peter B., 2001, Journal of Cetacean Research and Management Special Issue, V2, P161; Caswell H, 1999, P NATL ACAD SCI USA, V96, P3308, DOI 10.1073/pnas.96.6.3308; Fujiwara M, 2001, NATURE, V414, P537, DOI 10.1038/35107054; FUJIWARA M, 2002, THESIS MIT; James MC, 2005, ECOL LETT, V8, P195, DOI 10.1111/j.1461-0248.2004.00710.x; Knowlton Amy R., 2001, Journal of Cetacean Research and Management Special Issue, V2, P193; Kraus Scott D., 2001, Journal of Cetacean Research and Management Special Issue, V2, P231; Moore Michael J., 2004, Journal of Cetacean Research and Management, V6, P199; Reeves Randall R., 2001, Journal of Cetacean Research and Management Special Issue, V2, P187; 2004, FED REG         0601, V69, P30857	10	229	239	0	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2005	309	5734					561	562		10.1126/science.1111200	http://dx.doi.org/10.1126/science.1111200			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040692				2022-12-28	WOS:000230735200030
J	Weinberg, DH				Weinberg, DH			Mapping the large-scale structure of the universe	SCIENCE			English	Editorial Material							DIGITAL SKY SURVEY; GALAXY REDSHIFT SURVEY		Ohio State Univ, Dept Astron, Columbus, OH 43210 USA	Ohio State University	Weinberg, DH (corresponding author), Ohio State Univ, Dept Astron, 140 W 18th Ave, Columbus, OH 43210 USA.	dhw@astronomy.ohio-state.edu						Bahcall NA, 2003, ASTROPHYS J, V585, P182, DOI 10.1086/345981; Colless M, 2001, MON NOT R ASTRON SOC, V328, P1039, DOI 10.1046/j.1365-8711.2001.04902.x; EISENSTEIN DJ, ASTROPH0501171; Seife C, 2003, SCIENCE, V302, P2038, DOI 10.1126/science.302.5653.2038; Sheldon ES, 2004, ASTRON J, V127, P2544, DOI 10.1086/383293; Tegmark M, 2004, ASTROPHYS J, V606, P702, DOI 10.1086/382125; TINKER JL, IN PRESS ASTROPHYS J; van den Bosch FC, 2003, MON NOT R ASTRON SOC, V340, P771, DOI 10.1046/j.1365-8711.2003.06335.x; van den Bosch FC, 2003, MON NOT R ASTRON SOC, V345, P923, DOI 10.1046/j.1365-8711.2003.07012.x; York DG, 2000, ASTRON J, V120, P1579, DOI 10.1086/301513; ZEHAVI I, ASTROPH0408569	12	5	5	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2005	309	5734					564	565		10.1126/science.1115128	http://dx.doi.org/10.1126/science.1115128			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040694	Green Submitted			2022-12-28	WOS:000230735200032
J	Yang, Q; Graham, TE; Mody, N; Preitner, F; Peroni, OD; Zabolotny, JM; Kotani, K; Quadro, L; Kahn, BB				Yang, Q; Graham, TE; Mody, N; Preitner, F; Peroni, OD; Zabolotny, JM; Kotani, K; Quadro, L; Kahn, BB			Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes	NATURE			English	Article							RETINOL-BINDING-PROTEIN; PROLIFERATOR-ACTIVATED RECEPTORS; GLUT4 GLUCOSE-TRANSPORTER; KNOCKOUT MICE; VITAMIN-A; PLASMA RETINOL; ADIPOSE-TISSUE; TRANSTHYRETIN; MUSCLE; ADIPOCYTES	In obesity and type 2 diabetes, expression of the GLUT4 glucose transporter is decreased selectively in adipocytes. Adipose-specific Glut4 ( also known as Slc2a4) knockout (adipose-Glut4(-/-)) mice show insulin resistance secondarily in muscle and liver. Here we show, using DNA arrays, that expression of retinol binding protein-4 (RBP4) is elevated in adipose tissue of adipose-Glut4(-/-) mice. We show that serum RBP4 levels are elevated in insulin-resistant mice and humans with obesity and type 2 diabetes. RBP4 levels are normalized by rosiglitazone, an insulin-sensitizing drug. Transgenic overexpression of human RBP4 or injection of recombinant RBP4 in normal mice causes insulin resistance. Conversely, genetic deletion of Rbp4 enhances insulin sensitivity. Fenretinide, a synthetic retinoid that increases urinary excretion of RBP4, normalizes serum RBP4 levels and improves insulin resistance and glucose intolerance in mice with obesity induced by a high-fat diet. Increasing serum RBP4 induces hepatic expression of the gluconeogenic enzyme phosphoenolpyruvate carboxykinase ( PEPCK) and impairs insulin signalling in muscle. Thus, RBP4 is an adipocyte-derived 'signal' that may contribute to the pathogenesis of type 2 diabetes. Lowering RBP4 could be a new strategy for treating type 2 diabetes.	Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Columbia Univ Coll Phys & Surg, Inst Canc Res, Dept Med, New York, NY 10032 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Columbia University	Kahn, BB (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.	bkahn@bidmc.harvard.edu	Mody, Nimesh/J-9602-2019	Mody, Nimesh/0000-0002-2215-7952	NIDDK NIH HHS [R01 DK043051] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abahusain MA, 1999, EUR J CLIN NUTR, V53, P630, DOI 10.1038/sj.ejcn.1600825; Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Anai M, 1999, DIABETES, V48, P158, DOI 10.2337/diabetes.48.1.158; Basualdo CG, 1997, J AM COLL NUTR, V16, P39, DOI 10.1080/07315724.1997.10718647; BERNI R, 1993, FASEB J, V7, P1179, DOI 10.1096/fasebj.7.12.8375617; BLANER WS, 1989, ENDOCR REV, V10, P308, DOI 10.1210/edrv-10-3-308; CARVALHO E, 2005, AM J PHYSL ENDOCRINO; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Christensen EI, 1999, J AM SOC NEPHROL, V10, P685; DeFronzo R. A., 1997, DIABETES REV, V5, P171; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; KAHN CR, 1989, MOL ENDOCRINOL, V3, P840, DOI 10.1210/mend-3-5-840; KATO M, 1985, P NATL ACAD SCI USA, V82, P2488, DOI 10.1073/pnas.82.8.2488; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kitamura T, 2003, ANNU REV PHYSIOL, V65, P313, DOI 10.1146/annurev.physiol.65.092101.142540; Kliewer SA, 2001, RECENT PROG HORM RES, V56, P239, DOI 10.1210/rp.56.1.239; Koistinen HA, 2001, DIABETES-METAB RES, V17, P391, DOI 10.1002/dmrr.222; Kotani K, 2004, J CLIN INVEST, V114, P1666, DOI 10.1172/JCI200421341; Kotani K, 2001, DIABETES, V50, pA274; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Malpeli G, 1996, BBA-PROTEIN STRUCT M, V1294, P48, DOI 10.1016/0167-4838(95)00264-2; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; MATARESE V, 1993, J BIOL CHEM, V268, P18859; Meigs JB, 2002, DIABETES, V51, P833, DOI 10.2337/diabetes.51.3.833; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minokoshi Y, 2003, J BIOL CHEM, V278, P33609, DOI 10.1074/jbc.R300019200; Monaco HL, 2000, BBA-PROTEIN STRUCT M, V1482, P65, DOI 10.1016/S0167-4838(00)00140-0; Mothe I, 1996, J BIOL CHEM, V271, P11222, DOI 10.1074/jbc.271.19.11222; National Research Council, 1995, NUTR REQ LAB AN, P92; Naylor HM, 1999, BIOCHEMISTRY-US, V38, P2647, DOI 10.1021/bi982291i; Nikoulina SE, 2000, DIABETES, V49, P263, DOI 10.2337/diabetes.49.2.263; Pagliassotti MJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE170, DOI 10.1152/ajpendo.2002.282.1.E170; PEDERSEN O, 1992, J CLIN INVEST, V89, P1964, DOI 10.1172/JCI115804; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Quadro L, 2002, J BIOL CHEM, V277, P30191, DOI 10.1074/jbc.M205046200; Rodondi N, 2002, ANN INTERN MED, V136, P582, DOI 10.7326/0003-4819-136-8-200204160-00007; SHEIKH MS, 1995, CARCINOGENESIS, V16, P2477, DOI 10.1093/carcin/16.10.2477; Shen Q, 2004, J BIOL CHEM, V279, P19721, DOI 10.1074/jbc.M311729200; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Shin DJ, 2002, MOL CELL ENDOCRINOL, V195, P39, DOI 10.1016/S0303-7207(02)00215-0; SIVAPRASADARAO A, 1988, BIOCHEM J, V255, P561; Tozzo E, 1997, ENDOCRINOLOGY, V138, P1604, DOI 10.1210/en.138.4.1604; TSUTSUMI C, 1992, J BIOL CHEM, V267, P1805; Um SJ, 2001, CANCER LETT, V174, P127, DOI 10.1016/S0304-3835(01)00697-8; Wang JC, 2000, J BIOL CHEM, V275, P14717, DOI 10.1074/jbc.275.19.14717; WANG TTY, 1993, GENE, V133, P291, DOI 10.1016/0378-1119(93)90654-L; Xie YS, 1998, PROTEIN EXPRES PURIF, V14, P31, DOI 10.1006/prep.1998.0944; ZOVICH DC, 1992, J BIOL CHEM, V267, P13884	50	1557	1714	5	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					356	362		10.1038/nature03711	http://dx.doi.org/10.1038/nature03711			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034410				2022-12-28	WOS:000230623400034
J	Priestley, RD; Ellison, CJ; Broadbelt, LJ; Torkelson, JM				Priestley, RD; Ellison, CJ; Broadbelt, LJ; Torkelson, JM			Structural relaxation of polymer glasses at surfaces, interfaces and in between	SCIENCE			English	Article							TRANSITION TEMPERATURE; FORMING LIQUIDS; FILMS; THIN; DYNAMICS; SCALE; FLUORESCENCE; CONFINEMENT; BEHAVIOR; BULK	We analyzed the glassy-state structural relaxation of polymers near surfaces and interfaces by monitoring fluorescence in multilayer films. Relative to that of bulk, the rate of structural relaxation of poly(methyl methacrylate) is reduced by a factor of 2 at a free surface and by a factor of 15 at a silica substrate interface; the latter exhibits a nearly complete arresting of relaxation. The distribution in relaxation rates extends more than 100 nanometers into the film interior, a distance greater than that over which surfaces and interfaces affect the glass transition temperature.	Northwestern Univ, Dept Biol & Chem Engn, Evanston, IL 60208 USA; Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Broadbelt, LJ (corresponding author), Northwestern Univ, Dept Biol & Chem Engn, Evanston, IL 60208 USA.	broadbelt@northwestern.edu; j-torkelson@northwestern.edu	Broadbelt, Linda/B-7640-2009; Torkelson, John M/B-7616-2009					ADAM G, 1965, J CHEM PHYS, V43, P139, DOI 10.1063/1.1696442; Alcoutlabi M, 2005, J PHYS-CONDENS MAT, V17, pR461, DOI 10.1088/0953-8984/17/15/R01; ANGELL CA, 1995, SCIENCE, V267, P1924, DOI 10.1126/science.267.5206.1924; Angell CA, 2000, J APPL PHYS, V88, P3113, DOI 10.1063/1.1286035; Ash BJ, 2002, MATER LETT, V55, P83, DOI 10.1016/S0167-577X(01)00626-7; Baljon ARC, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.255701; Berriot J, 2002, MACROMOLECULES, V35, P9756, DOI 10.1021/ma0212700; BRAUMAN JI, 1995, SCIENCE, V267, P1887, DOI 10.1126/science.267.5206.1887; de Gennes PG, 2000, EUR PHYS J E, V2, P201, DOI 10.1007/PL00013665; Debenedetti PG, 2001, NATURE, V410, P259, DOI 10.1038/35065704; Ellison CJ, 2003, NAT MATER, V2, P695, DOI 10.1038/nmat980; Ellison CJ, 2005, MACROMOLECULES, V38, P1767, DOI 10.1021/ma047846y; Ellison CJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.095702; Ellison CJ, 2002, EUR PHYS J E, V8, P155, DOI 10.1140/epje/i2001-10057-y; Forrest JA, 1996, PHYS REV LETT, V77, P2002, DOI 10.1103/PhysRevLett.77.2002; Frank CW, 1996, SCIENCE, V273, P912, DOI 10.1126/science.273.5277.912; GREINER R, 1984, RHEOL ACTA, V23, P378, DOI 10.1007/BF01329190; Huang Y, 2004, POLYMER, V45, P8377, DOI 10.1016/j.polymer.2004.10.019; HUTCHINSON JM, 1995, PROG POLYM SCI, V20, P703, DOI 10.1016/0079-6700(94)00001-I; JACKSON CL, 1991, J NON-CRYST SOLIDS, V131, P221, DOI 10.1016/0022-3093(91)90305-P; Jain TS, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.155505; Jerome B, 1997, NATURE, V386, P589, DOI 10.1038/386589a0; Kawana S, 2003, EUR PHYS J E, V10, P223, DOI 10.1140/epje/i2002-10111-4; KEDDIE JL, 1994, EUROPHYS LETT, V27, P59, DOI 10.1209/0295-5075/27/1/011; Long D, 2001, EUR PHYS J E, V4, P371, DOI 10.1007/s101890170120; Merabia S, 2004, EUR PHYS J E, V15, P189, DOI 10.1140/epje/i2004-10047-7; Novikov VN, 2004, NATURE, V431, P961, DOI 10.1038/nature02947; O'Connell PA, 2005, SCIENCE, V307, P1760, DOI 10.1126/science.1105658; Priestley RD, 2005, MACROMOLECULES, V38, P654, DOI 10.1021/ma047994o; Richardson H, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.051805; ROTH CB, 2005, SOFT MAT STRUCTURE D; ROYAL JS, 1993, MACROMOLECULES, V26, P5331, DOI 10.1021/ma00072a009; Simon SL, 2002, EUR PHYS J E, V8, P209, DOI 10.1140/epje/i2001-10072-0; Struik L. C. E., 1978, PHYS AGING AMORPHOUS; Torre R, 2004, NATURE, V428, P296, DOI 10.1038/nature02409; Varnik F, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.021507; Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627	38	598	606	3	303	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2005	309	5733					456	459		10.1126/science.1112217	http://dx.doi.org/10.1126/science.1112217			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020732				2022-12-28	WOS:000230574900043
J	Spalding, KL; Bhardwaj, RD; Buchholz, BA; Druid, H; Frisen, J				Spalding, KL; Bhardwaj, RD; Buchholz, BA; Druid, H; Frisen, J			Retrospective birth dating of cells in humans	CELL			English	Article							HIPPOCAMPAL NEUROGENESIS; MUTATION-RATE; ADULT MICE; STEM-CELL; DNA; NEOCORTEX; C-14; RADIOCARBON; LYMPHOCYTES; PRECURSORS	The generation of cells in the human body has been difficult to study, and our understanding of cell turnover is limited. Testing of nuclear weapons resulted in a dramatic global increase in the levels of the isotope C-14 in the atmosphere, followed by an exponential decrease after 1963. We show that the level of C-14 in genomic DNA closely parallels atmospheric levels and can be used to establish the time point when the DNA was synthesized and cells were born. We use this strategy to determine the age of cells in the cortex of the adult human brain and show that whereas nonneuronal cells are exchanged, occipital neurons are as old as the individual, supporting the view that postnatal neurogenesis does not take place in this region. Retrospective birth dating is a generally applicable strategy that can be used to measure cell turnover in man under physiological and pathological conditions.	Karolinska Inst, Dept Cell & Mol Biol, Med Nobel Inst, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Forens Med, SE-17177 Stockholm, Sweden; Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94551 USA	Karolinska Institutet; Karolinska Institutet; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Frisen, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Med Nobel Inst, SE-17177 Stockholm, Sweden.	jonas.frisen@cmb.ki.se	Buchholz, Bruce A/G-1356-2011; Slagboom, P. Eline/R-4790-2016; Spalding, Kirsty/CAF-4248-2022; spalding, kirsty/I-6046-2017; pirazzini, chiara/K-2258-2018; Castellani, Gastone c/L-3333-2017	Buchholz, Bruce A/0000-0002-9531-551X; Slagboom, P. Eline/0000-0002-2875-4723; Spalding, Kirsty/0000-0002-5189-7028; Castellani, Gastone c/0000-0003-4892-925X; Druid, Henrik/0000-0002-9198-023X	NCRR NIH HHS [P41 RR013461, RR13461] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013461] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bridges BA, 1997, BIOESSAYS, V19, P347, DOI 10.1002/bies.950190412; Brown TA, 1997, NUCL INSTRUM METH B, V123, P208, DOI 10.1016/S0168-583X(96)00676-3; Chen JH, 2004, P NATL ACAD SCI USA, V101, P16357, DOI 10.1073/pnas.0406795101; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Dayer AG, 2005, J CELL BIOL, V168, P415, DOI 10.1083/jcb.200407053; DEVRIES H, 1958, SCIENCE, V128, P1550, DOI 10.1126/science.128.3338.1550; Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Duman RS, 2004, BIOL PSYCHIAT, V56, P140, DOI 10.1016/j.biopsych.2004.02.033; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gould E, 2001, P NATL ACAD SCI USA, V98, P10910, DOI 10.1073/pnas.181354698; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; GREEN MHL, 1995, MUTAT RES-ENVIR MUTA, V334, P323, DOI 10.1016/0165-1161(95)90070-5; HARKNESS DD, 1972, NATURE, V240, P302, DOI 10.1038/240302a0; KAPLAN MS, 1981, J COMP NEUROL, V195, P323, DOI 10.1002/cne.901950211; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kornack DR, 2001, SCIENCE, V294, P2127, DOI 10.1126/science.1065467; Levin I, 2004, RADIOCARBON, V46, P1261, DOI 10.1017/S0033822200033130; LIBBY WF, 1964, SCIENCE, V146, P1171; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Love AH, 2003, ENVIRON SCI TECHNOL, V37, P4330, DOI 10.1021/es034278d; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Morley AA, 1996, MUTAT RES-FUND MOL M, V357, P167, DOI 10.1016/0027-5107(96)00096-6; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nouspikel T, 2002, DNA REPAIR, V1, P59, DOI 10.1016/S1568-7864(01)00005-2; Nowakowski R S, 2000, Science, V288, P771; NYDAL R, 1965, NATURE, V206, P1029, DOI 10.1038/2061029a0; Pawelczyk S, 2004, RADIOCARBON, V46, P701, DOI 10.1017/S003382220003575X; Rakic P, 2002, NAT REV NEUROSCI, V3, P65, DOI 10.1038/nrn700; Rakic P, 2002, J NEUROSCI, V22, P614, DOI 10.1523/JNEUROSCI.22-03-00614.2002; Reimer PJ, 2004, RADIOCARBON, V46, P1299; Richard Shambavi, 2002, Curr Hematol Rep, V1, P103; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; Sussman MA, 2004, ANNU REV PHYSIOL, V66, P29, DOI 10.1146/annurev.physiol.66.032102.140723; VOGEL JS, 1987, NUCL INSTRUM METH B, V29, P50, DOI 10.1016/0168-583X(87)90202-3; WANG L, 1994, NUCLEIC ACIDS RES, V22, P1774, DOI 10.1093/nar/22.9.1774; Wersto RP, 2001, CYTOMETRY, V46, P296, DOI 10.1002/cyto.1171	46	397	410	0	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 15	2005	122	1					133	143		10.1016/j.cell.2005.04.028	http://dx.doi.org/10.1016/j.cell.2005.04.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	950EC	16009139	Bronze			2022-12-28	WOS:000230839400017
J	Garrison, JL; Kunkel, EJ; Hegde, RS; Taunton, J				Garrison, JL; Kunkel, EJ; Hegde, RS; Taunton, J			A substrate-specific inhibitor of protein translocation into the endoplasmic reticulum	NATURE			English	Article							SIGNAL SEQUENCE RECOGNITION; ER MEMBRANE; NASCENT PREPROLACTIN; SEC PROTEINS; POLYPEPTIDE; TRANSPORT; COMPLEX; COMPONENTS; HUN-7293; PARTICLE	The segregation of secretory and membrane proteins to the mammalian endoplasmic reticulum is mediated by remarkably diverse signal sequences that have little or no homology with each other(1,2). Despite such sequence diversity, these signals are all recognized and interpreted by a highly conserved protein-conducting channel composed of the Sec61 complex(3,4). Signal recognition by Sec61 is essential for productive insertion of the nascent polypeptide into the translocation site(5), channel gating(6) and initiation of transport. Although subtle differences in these steps can be detected between different substrates(7,8), it is not known whether they can be exploited to modulate protein translocation selectively. Here we describe cotransin, a small molecule that inhibits protein translocation into the endoplasmic reticulum. Cotransin acts in a signal-sequence-discriminatory manner to prevent the stable insertion of select nascent chains into the Sec61 translocation channel. Thus, the range of substrates accommodated by the channel can be specifically and reversibly modulated by a cell-permeable small molecule that alters the interaction between signal sequences and the Sec61 complex.	NICHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA; Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA 94107 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94107 USA; Bioseek Inc, Burlingame, CA 94010 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hegde, RS (corresponding author), NICHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA.	hegder@mail.nih.gov; taunton@cmp.ucsf.edu		Hegde, Ramanujan/0000-0001-8338-852X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008752, ZIAHD008752] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Boger DL, 1999, J AM CHEM SOC, V121, P6197, DOI 10.1021/ja990918u; Chen Y, 2002, J AM CHEM SOC, V124, P5431, DOI 10.1021/ja020166v; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; FOSTER CA, 1994, JOURNAL OF DERMATOLOGY, VOL 21, NO 11, NOVEMBER 1994, P847, DOI 10.1111/j.1346-8138.1994.tb03300.x; GORLICH D, 1992, NATURE, V357, P47, DOI 10.1038/357047a0; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Kim SJ, 2002, DEV CELL, V2, P207, DOI 10.1016/S1534-5807(01)00120-4; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; Kunkel EJ, 2004, ASSAY DRUG DEV TECHN, V2, P431, DOI 10.1089/1540658041850607; KURZCHALIA TV, 1986, NATURE, V320, P634, DOI 10.1038/320634a0; LINDLEY IJD, 2004, Patent No. 20040086904; Lyman SK, 1997, CELL, V88, P85, DOI 10.1016/S0092-8674(00)81861-9; Mothes W, 1998, J CELL BIOL, V142, P355, DOI 10.1083/jcb.142.2.355; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; RANDALL LL, 1989, SCIENCE, V243, P1156, DOI 10.1126/science.2646712; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; Rutkowski DT, 2001, P NATL ACAD SCI USA, V98, P7823, DOI 10.1073/pnas.141125098; Tyedmers J, 2003, EMBO REP, V4, P505, DOI 10.1038/sj.embor.embor826; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Voigt S, 1996, J CELL BIOL, V134, P25, DOI 10.1083/jcb.134.1.25; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WOLIN SL, 1993, J CELL BIOL, V121, P1211, DOI 10.1083/jcb.121.6.1211	28	119	123	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					285	289		10.1038/nature03821	http://dx.doi.org/10.1038/nature03821			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015336				2022-12-28	WOS:000230459500047
J	Ortiz, Z				Ortiz, Z			Commentary: How far is the future?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACADEMIC MEDICINE		Natl Acad Med Buenos Aires, Epidemiol Res Ctr, Training & Res Dept, Buenos Aires, DF, Argentina	Buenos Aires National Academy of Medicine; IIE - Instituto de Investigaciones Epidemiologicas	Ortiz, Z (corresponding author), Natl Acad Med Buenos Aires, Epidemiol Res Ctr, Training & Res Dept, Pacheco de Melo 3081, Buenos Aires, DF, Argentina.	cie@epidermologia.anm.edu.ar						Clark J, 2005, BRIT MED J, V331, P101, DOI 10.1136/bmj.331.7508.101; Ioannidis JPA, 2004, BMJ-BRIT MED J, V329, P789; UN, MILL DEV GOALS; Wilkinson D, 2004, BMJ-BRIT MED J, V329, P787	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 9	2005	331	7508					106	107		10.1136/bmj.331.7508.106	http://dx.doi.org/10.1136/bmj.331.7508.106			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945XR	16002889	Green Published			2022-12-28	WOS:000230536800023
J	Imaizumi, T; Schultz, TF; Harmon, FG; Ho, LA; Kay, SA				Imaizumi, T; Schultz, TF; Harmon, FG; Ho, LA; Kay, SA			FKF1F-BOX protein mediates cyclic degradation of a repressor of CONSTANS in Arabidopsis	SCIENCE			English	Article							MOLECULAR-BASIS; COMPLEX; EXPRESSION; CLOCK; GENES; TIME; FKF1	The temporal control of CONSTANS (CO) expression and activity is a key mechanism in photoperiodic flowering in Arabidopsis. FLAVIN-BINDING, KELCH REPEAT, F-BOX 1 (FKF1) protein regulates CO transcription, although the molecular mechanism is unknown. We demonstrate here that FKF1 controls the stability of a Dof transcription factor, CYCLING DOF FACTOR 1 (CDF1). FKF1 physically interacts with CDF1, and CDF1 protein is more stable in fkf1 mutants. Plants with elevated levels of CDF1 flower late and have reduced expression of CO. CDF1 and CO are expressed in the same tissues, and CDF1 binds to the CO promoter. Thus, FKF1 controls daily CO expression in part by degrading CDF1, a repressor of CO transcription.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Kay, SA (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stevek@scripps.edu	Kay, Steve A/F-6025-2011	Kay, Steve A/0000-0002-0402-2878; Schultz, Thomas/0000-0001-9694-9920				An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Beerli RR, 1998, P NATL ACAD SCI USA, V95, P14628, DOI 10.1073/pnas.95.25.14628; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Garner WW., 1920, J AGR RES, VXVII, P553; Han LQ, 2004, PLANT J, V40, P291, DOI 10.1111/j.1365-313X.2004.02207.x; Hayama R, 2004, PLANT PHYSIOL, V135, P677, DOI 10.1104/pp.104.042614; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; IMAIZUMI T, UNPUB; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Takahashi N, 2004, PLANT CELL PHYSIOL, V45, P83, DOI 10.1093/pcp/pch009; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Vierstra RD, 2003, TRENDS PLANT SCI, V8, P135, DOI 10.1016/S1360-1385(03)00014-1; Yanagisawa S, 2002, TRENDS PLANT SCI, V7, P555, DOI 10.1016/S1360-1385(02)02362-2; Yanovsky MJ, 2003, NAT REV MOL CELL BIO, V4, P265, DOI 10.1038/nrm1077; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996	17	524	623	11	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2005	309	5732					293	297		10.1126/science.1110586	http://dx.doi.org/10.1126/science.1110586			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002617				2022-12-28	WOS:000230449800043
J	Orszag, JM; Orszag, PR				Orszag, JM; Orszag, PR			Individual accounts: Lessons from international experience	SCIENCE			English	Article									Watson Wyatt LLP, Surrey RH2 9PQ, England; Brookings Inst, Washington, DC 20036 USA	Brookings Institution	Orszag, JM (corresponding author), Watson Wyatt LLP, Surrey RH2 9PQ, England.	mike.orszag@watsonwyatt.com; porszag@brookings.edu						Bateman H., 2004, J PENSION EC FINANCE, V3, P63; Bateman H, 2001, FORCED SAVING MANDAT; Blundell R, 2004, NBER CONF R, P643; BROWN SJ, 1999, J FINANC, V54, P953; CARDINALE M, 2002, RU07 WATS WYATT WORL; Choi J.J., 2002, TAX POLICY EC, V16, P67, DOI DOI 10.1162/089286402760173467; COHEN N, 2005, AM PROSPECT     0111; DIMSON E, 2002, TRIJPH OPTIMISTS 101; DISNEY R, 1992, R40 IFS; Engstrom S., 2003, INT TAX PUBLIC FINAN, V2, P225; GALE WG, 2004, PRIVATE PENSIONS PUB; Madrian BC, 2001, Q J ECON, V116, P1149, DOI 10.1162/003355301753265543; MANKIW NG, 2005, SOCIAL SECURITY REFO; Mitchell O. S, 2004, PENSION DESIGN STRUC, P3, DOI DOI 10.1093/0199273391.003.0001; MUNNELL AH, 2004, COMING SHORT CHALLEN; MURTHI M., 2001, NEW IDEAS OLD AGE SE; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; PALMER E, 2002, COPING PENSION CRISI; Reno V. P., 2005, UNCHARTED WATERS PAY; SHILLER RJ, 2005, 11300 NAT BUR EC RES; Thaler RH, 2004, J POLIT ECON, V112, pS164, DOI 10.1086/380085; TURNER J, 2003, 60 AARP PUBL POL I	23	1	1	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2005	309	5732					250	251		10.1126/science.1113199	http://dx.doi.org/10.1126/science.1113199			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002603				2022-12-28	WOS:000230449800027
J	Melchart, D; Streng, A; Hoppe, A; Brinkhaus, B; Witt, C; Wagenpfeil, S; Pfaffenrath, V; Hammes, M; Hummelsberger, J; Irnich, D; Weidenhammer, W; Willich, SN; Linde, K				Melchart, D; Streng, A; Hoppe, A; Brinkhaus, B; Witt, C; Wagenpfeil, S; Pfaffenrath, V; Hammes, M; Hummelsberger, J; Irnich, D; Weidenhammer, W; Willich, SN; Linde, K			Acupuncture in patients with tension-type headache: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PLACEBO; MIGRAINE	Objective To investigate the effectiveness of acupuncture compared with minimal acupuncture and with no acupuncture in patients with tension-type headache. Design Three armed randomised controlled multicentre trial. Setting 28 outpatient centres in Germany. Participants 270 patients (74% women, mean age 43 (SD 13) years) with episodic or chronic tension-type headache. Interventions Acupuncture, minimal acupuncture (superficial needling at non-acupuncture points), or waiting list control. Acupuncture and minimal acupuncture were administered by specialised physicians and consisted of 12 sessions per patient over eight weeks. Main outcome measure Difference in numbers of days with headache between the four weeks before randomisation and weeks 9-12 after randomisation, as recorded by participants in headache diaries. Results The number of days with headache decreased by 7.2 (SD 6.5) days in the acupuncture group compared with 6.6 (SD 6.0) days in the minimal acupuncture group and 1.5 (SD 3.7) days in the waiting list group (difference: acupuncture v minimal acupuncture, 0.6 days, 95% confidence interval - 1.5 to 2.6 days, P = 0.58; acupuncture v waiting list, 5.7 days, 3.9 to 7.5 days, P < 0.00 1). The proportion of responders (at least 50% reduction in days with headache) was 46% in the acupuncture group, 35% in the minimal acupuncture group, and 4% in the waiting list group. Conclusions The acupuncture intervention investigated in this trial was more effective than no treatment but not significantly more effective than minimal acupuncture for the treatment of tension-type headache.	Tech Univ Munich, Dept Internal Med 2, Ctr Complementary Med Res, D-80801 Munich, Germany; Tech Univ Munich, Inst Med Stat & Epidemiol, D-8000 Munich, Germany; Tech Univ Munich, Dept Neurol, D-8000 Munich, Germany; Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany; Univ Munich, Dept Anesthesiol, Munich, Germany; Univ Zurich Hosp, Dept Internal Med, Div Complementary Med, Zurich, Switzerland	Technical University of Munich; Technical University of Munich; Technical University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich; University of Zurich; University Zurich Hospital	Linde, K (corresponding author), Tech Univ Munich, Dept Internal Med 2, Ctr Complementary Med Res, Kaiserstr 9, D-80801 Munich, Germany.	Klaus.Linde@lrz.tu-muenchen.de	Streng, Andrea/AAR-4986-2020; Witt, Claudia M./AAX-2370-2021; Brinkhaus, Benno/AAU-2428-2021	Streng, Andrea/0000-0003-2377-7106; Witt, Claudia M./0000-0002-5440-7805; Brinkhaus, Benno/0000-0001-6290-744X; Linde, Klaus/0000-0002-2902-970X				BOGAARDS MC, 1994, CLIN J PAIN, V10, P174, DOI 10.1097/00002508-199409000-00003; BULLINGER M, 1998, SF 36 FRAGEBOGEN GES; CARLSSON J, 1990, CEPHALALGIA, V10, P131, DOI 10.1046/j.1468-2982.1990.1003131.x; Dillmann U, 1994, Schmerz, V8, P100, DOI 10.1007/BF02530415; GEISSNER E, 1991, SCHMERUEMPFINDUNGS; HANSEN PE, 1985, CEPHALALGIA, V5, P137, DOI 10.1046/j.1468-2982.1985.0503137.x; Hautzinger M., 1991, ALLGEMEINE DEPRESSIO; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Irnich D, 2002, SCHMERZ, V16, P93, DOI 10.1007/s004820100094; Kaptchuk TJ, 2000, J CLIN EPIDEMIOL, V53, P786, DOI 10.1016/S0895-4356(00)00206-7; Kaptchuk TJ, 2002, ANN INTERN MED, V136, P817, DOI 10.7326/0003-4819-136-11-200206040-00011; Karst M, 2001, CEPHALALGIA, V21, P637, DOI 10.1046/j.1468-2982.2001.00198.x; Melchart D, 1999, CEPHALALGIA, V19, P779, DOI 10.1046/j.1468-2982.1999.1909779.x; Melchart D, 2003, FORSCH KOMP KLAS NAT, V10, P179, DOI 10.1159/000073473; Nagel B, 2002, SCHMERZ, V16, P263, DOI 10.1007/s00482-002-0162-1; Pfaffenrath V, 1998, SCHMERZ, V12, P156, DOI 10.1007/s004820050138; SCHOENEN J, 1995, CEPHALALGIA, V15, P165, DOI 10.1046/j.1468-2982.1995.015003165.x; Schwartz BS, 1998, JAMA-J AM MED ASSOC, V279, P381, DOI 10.1007/s11916-010-0146-2; TAVOLA T, 1992, PAIN, V48, P325, DOI 10.1016/0304-3959(92)90080-U; Vickers AJ, 2004, BRIT MED J, V328, P744, DOI 10.1136/bmj.38029.421863.EB; Vincent C, 1990, COMPLEMENT MED RES, V4, P8; Welch KMA, 1997, CEPHALALGIA, V17, P1, DOI 10.1046/j.1468-2982.1997.1701001.x; White AR, 2000, CEPHALALGIA, V20, P632, DOI 10.1046/j.1468-2982.2000.00097.x; Xue CCL, 2004, HEADACHE, V44, P333, DOI 10.1111/j.1526-4610.2004.04077.x	24	242	268	4	60	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 13	2005	331	7513					376	379		10.1136/bmj.38512.405440.8F	http://dx.doi.org/10.1136/bmj.38512.405440.8F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	956SK	16055451	Green Published			2022-12-28	WOS:000231319900013
J	Lenart, P; Bacher, CP; Daigle, N; Hand, AR; Eils, R; Terasaki, M; Ellenberg, J				Lenart, P; Bacher, CP; Daigle, N; Hand, AR; Eils, R; Terasaki, M; Ellenberg, J			A contractile nuclear actin network drives chromosome congression in oocytes	NATURE			English	Article							GERMINAL VESICLE BREAKDOWN; CYCLE-DEPENDENT CHANGES; XENOPUS EGG EXTRACTS; MICROTUBULE DYNAMICS; STARFISH OOCYTES; MITOTIC-SPINDLE; ENVELOPE BREAKDOWN; CYTOCHALASIN-B; MOUSE OOCYTES; F-ACTIN	Chromosome capture by microtubules is widely accepted as the universal mechanism of spindle assembly in dividing cells. However, the observed length of spindle microtubules and computer simulations of spindle assembly predict that chromosome capture is efficient in small cells, but may fail in cells with large nuclear volumes such as animal oocytes. Here we investigate chromosome congression during the first meiotic division in starfish oocytes. We show that microtubules are not sufficient for capturing chromosomes. Instead, chromosome congression requires actin polymerization. After nuclear envelope breakdown, we observe the formation of a filamentous actin mesh in the nuclear region, and find that contraction of this network delivers chromosomes to the microtubule spindle. We show that this mechanism is essential for preventing chromosome loss and aneuploidy of the egg - a leading cause of pregnancy loss and birth defects in humans.	European Mol Biol Lab, Gene Express & Cell Biol Programme, D-69117 Heidelberg, Germany; European Mol Biol Lab, Biophys Programme, D-69117 Heidelberg, Germany; German Canc Res Ctr, D-69120 Heidelberg, Germany; Univ Connecticut, Ctr Hlth, Dept Orthodont, Farmington, CT 06030 USA; Univ Connecticut, Ctr Hlth, Dept Oral & Maxillofacial Surg, Farmington, CT 06030 USA; Univ Connecticut, Ctr Hlth, Dept Pediat Dent, Farmington, CT 06030 USA; Univ Connecticut, Ctr Hlth, Dept Adv Gen Dent, Farmington, CT 06030 USA; Univ Connecticut, Ctr Hlth, Dept Physiol, Farmington, CT 06030 USA; Marine Biol Lab, Woods Hole, MA 02543 USA	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut; Marine Biological Laboratory - Woods Hole	Ellenberg, J (corresponding author), European Mol Biol Lab, Gene Express & Cell Biol Programme, Meyerhofstr 1, D-69117 Heidelberg, Germany.	jan.ellenberg@embl.de	Ellenberg, Jan/I-4688-2014; Eils, Roland/B-6121-2009	Ellenberg, Jan/0000-0001-5909-701X; Eils, Roland/0000-0002-0034-4036; Lenart, Peter/0000-0002-3927-248X				Bacher CP, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-45; BELMONT LD, 1990, CELL, V62, P579, DOI 10.1016/0092-8674(90)90022-7; Carazo-Salas RE, 2003, CURR BIOL, V13, P1728, DOI 10.1016/j.cub.2003.09.006; Faire K, 1999, J CELL SCI, V112, P4243; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; GARD DL, 1992, DEV BIOL, V151, P516, DOI 10.1016/0012-1606(92)90190-R; GARD DL, 1995, ZYGOTE, V3, P17, DOI 10.1017/S0967199400002331; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; Hand Arthur R., 1995, P205, DOI 10.1016/B978-012286230-4/50006-7; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; HeilChapdelaine RA, 1996, DEV BIOL, V177, P204, DOI 10.1006/dbio.1996.0156; Hinkle B, 2002, J CELL SCI, V115, P4685, DOI 10.1242/jcs.00136; HOLY TE, 1994, P NATL ACAD SCI USA, V91, P5682, DOI 10.1073/pnas.91.12.5682; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Lenart P, 2003, J CELL BIOL, V160, P1055, DOI 10.1083/jcb.200211076; LONGO FJ, 1985, DEV BIOL, V107, P382, DOI 10.1016/0012-1606(85)90320-3; Maro B, 2002, NAT CELL BIOL, V4, pE281, DOI 10.1038/ncb1202-e281; Miyazaki A, 2000, DEV BIOL, V218, P161, DOI 10.1006/dbio.1999.9577; Pang KM, 1998, CURR BIOL, V8, P405, DOI 10.1016/S0960-9822(98)70159-9; Peter M, 2001, NAT CELL BIOL, V3, P83, DOI 10.1038/35050607; Piehl M, 2003, MOL BIOL CELL, V14, P916, DOI 10.1091/mbc.E02-09-0607; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; RYABOVA LV, 1986, CELL DIFFER DEV, V19, P89, DOI 10.1016/0045-6039(86)90065-5; SPICER SS, 1952, J BIOL CHEM, V199, P289; STRICKER SA, 1991, DEV GROWTH DIFFER, V33, P163; Strickland L, 2004, METHOD CELL BIOL, V74, P371; Szent-Gy_orgyi A., 1951, CHEM MUSCULAR CONTRA, V2nd; TERASAKI M, 1994, J CELL SCI, V107, P1797; Tulu US, 2003, CURR BIOL, V13, P1894, DOI 10.1016/j.cub.2003.10.002; Visegrady B, 2004, FEBS LETT, V565, P163, DOI 10.1016/j.febslet.2004.03.096; Wassmann K, 2003, CURR BIOL, V13, P1596, DOI 10.1016/j.cub.2003.08.052; Waterman-Storer C, 2000, J CELL BIOL, V150, P361, DOI 10.1083/jcb.150.2.361; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019; Zhai Y, 1996, J CELL BIOL, V135, P201, DOI 10.1083/jcb.135.1.201; Zhang QY, 2004, DEV BIOL, V266, P190, DOI 10.1016/j.ydbio.2003.10.027	40	178	181	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2005	436	7052					812	818		10.1038/nature03810	http://dx.doi.org/10.1038/nature03810			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953XG	16015286				2022-12-28	WOS:000231116500037
J	Goadsby, PJ; Kullmann, DM				Goadsby, PJ; Kullmann, DM			Another migraine gene	LANCET			English	Editorial Material							FAMILIAL HEMIPLEGIC MIGRAINE; MUTATIONS; CHANNELS; BURDEN; AURA		UCL, Inst Neurol, Headache Grp, London WC1N 3BG, England; UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England	University of London; University College London; University of London; University College London	Goadsby, PJ (corresponding author), UCL, Inst Neurol, Headache Grp, London WC1N 3BG, England.	peterg@ion.ucl.ac.uk	Kullmann, Dimitri M/A-3162-2009; Goadsby, Peter J/B-2267-2009; Goadsby, Peter J/Z-1970-2019	Kullmann, Dimitri M/0000-0001-6696-3545; Goadsby, Peter J/0000-0003-3260-5904				Ambrosini A, 2005, NEUROLOGY, V64, pA132; Cao YQ, 2004, NEURON, V43, P387, DOI 10.1016/j.neuron.2004.07.014; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; DICHGANS D, 2005, LANCET, DOI DOI 10.1016/S0140-6736(05)66786-4; Ducros A, 2001, NEW ENGL J MED, V345, P17, DOI 10.1056/NEJM200107053450103; Goadsby PJ, 2003, NEUROLOGY, V60, P536, DOI 10.1212/01.WNL.0000052260.98503.26; Kaube H, 2000, NEUROLOGY, V55, P139, DOI 10.1212/WNL.55.1.139; Kors EE, 2004, CURR OPIN NEUROL, V17, P283, DOI 10.1097/00019052-200406000-00008; Kullmann DM, 2002, BRAIN, V125, P1177, DOI 10.1093/brain/awf130; Lance JW, 2005, MECH MANAGEMENT HEAD; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; LIPTON RB, 1994, NEUROLOGY, V44, P28; Lossin C, 2002, NEURON, V34, P877, DOI 10.1016/S0896-6273(02)00714-6; Menken M, 2000, ARCH NEUROL-CHICAGO, V57, P418, DOI 10.1001/archneur.57.3.418; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Ptacek L, 1998, AM J MED, V105, P58, DOI 10.1016/S0002-9343(98)00123-5; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Steiner TJ, 1999, CEPHALALGIA, V19, P305; Thomsen LL, 2003, NEUROLOGY, V60, P595, DOI 10.1212/01.WNL.0000046524.25369.7D; Tottene A, 2002, P NATL ACAD SCI USA, V99, P13284, DOI 10.1073/pnas.192242399; van den Maagdenberg AMJM, 2004, NEURON, V41, P701, DOI 10.1016/S0896-6273(04)00085-6; Vanmolkot KRJ, 2003, ANN NEUROL, V54, P360, DOI 10.1002/ana.10674	23	6	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2005	366	9483					345	346		10.1016/S0140-6736(05)66787-6	http://dx.doi.org/10.1016/S0140-6736(05)66787-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	950IB	16054921				2022-12-28	WOS:000230849700004
J	Sterne, JAC; Hernan, MA; Ledergerber, B; Tilling, K; Weber, R; Sendi, P; Rickenbach, M; Robins, JM; Egger, M				Sterne, JAC; Hernan, MA; Ledergerber, B; Tilling, K; Weber, R; Sendi, P; Rickenbach, M; Robins, JM; Egger, M		Swiss HIV Cohort Study	Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study	LANCET			English	Article							MARGINAL STRUCTURAL MODELS; IMMUNODEFICIENCY-VIRUS-INFECTION; SWISS HIV COHORT; COMBINATION THERAPIES; CLINICAL PROGRESSION; CONTROLLED-TRIAL; CELL COUNT; MORTALITY; SURVIVAL; METAANALYSIS	Background Evidence on the effectiveness of highly active antiretroviral therapy (HAART) for HIV-infected individuals is limited. Most clinical trials examined surrogate endpoints over short periods of follow-up and there has been no placebo-controlled randomised trial of HAART. Estimation of treatment effects in observational studies is problematic, because of confounding by indication. We aimed to use novel methodology to overcome this problem in the Swiss HIV Cohort Study. Methods Patients were included if they had been examined after January 1996, when HAART became available in Switzerland, were not on HAART, and were free of AIDS at baseline. Cox regression models were weighted to create a statistical population in which the probability of being treated at each time point was unrelated to prognostic factors. Results Low CD4 counts and increasing HIV-1 viral load were associated with increased probability of starting HAART. Overall hazard ratios were 0.14 (95% CI 0.07-0.29) for HAART compared with no treatment, and 0.49 (0.31-0.79) compared with dual therapy. Compared with no treatment, HAART became more beneficial with increasing time since initiation but was less beneficial for patients whose presumed mode of transmission was via intravenous drug use (hazard ratio 0.27, 0.12-0.61) than for other patients (0.08, 0.03-0.19). Interpretation Our results, which are appropriately controlled for confounding by indication, are consistent with reported declines in rates of AIDS and death in developed countries, and provide a context in which to consider adverse effects of HAART.	Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Univ Zurich, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; Univ Basel Hosp, Inst Clin Epidemiol, CH-4031 Basel, Switzerland; Univ Basel Hosp, Div Infect Dis, CH-4031 Basel, Switzerland; Swiss HIV Cohort Study, Ctr Data, Lausanne, Switzerland; Univ Bern, Dept Social & Prevent Med, Bern, Switzerland	University of Bristol; Harvard University; Harvard T.H. Chan School of Public Health; University of Zurich; University of Basel; University of Basel; University of Bern	Sterne, JAC (corresponding author), Univ Bristol, Dept Social Med, Canynge Hall,Whiteladies Rd, Bristol BS8 2PR, Avon, England.	jonathan.sterne@bristol.ac.uk	Sendi, Pedram/AAC-2067-2019; VALLET, Yannick/F-9979-2011; Tilling, Kate/AAY-1578-2021; Sterne, Jonathan/Z-3106-2019; Weber, Rainer/D-5175-2012; Ledergerber, Bruno/B-5656-2009; Sendi, Parham/R-3286-2018	Sterne, Jonathan/0000-0001-8496-6053; Ledergerber, Bruno/0000-0002-6881-4401; Egger, Matthias/0000-0001-7462-5132; Sendi, Parham/0000-0002-7347-6312; Tilling, Kate/0000-0002-1010-8926	NIAID NIH HHS [K08-AI-49392, AI32475, R37 AI032475] Funding Source: Medline; MRC [G0100221] Funding Source: UKRI; Medical Research Council [G0100221] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032475, K08AI049392, R37AI032475] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Babiker A, 2000, AIDS RES HUM RETROV, V16, P1123; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Choi HK, 2002, LANCET, V359, P1173, DOI 10.1016/S0140-6736(02)08213-2; Cole SR, 2003, AM J EPIDEMIOL, V158, P687, DOI 10.1093/aje/kwg206; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; Fewell Z, 2004, STATA J, V4, P402, DOI 10.1177/1536867X0400400403; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Gebhardt M, 1998, AIDS, V12, P1195, DOI 10.1097/00002030-199810000-00012; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hernan MA, 2001, J AM STAT ASSOC, V96, P440, DOI 10.1198/016214501753168154; Hirsch MS, 2002, NEW ENGL J MED, V347, P438, DOI 10.1056/NEJMe020072; Hogg RS, 1999, CAN MED ASSOC J, V160, P659; Hughes MD, 1998, AIDS, V12, P1823, DOI 10.1097/00002030-199814000-00014; Jordan R, 2002, BMJ-BRIT MED J, V324, P757, DOI 10.1136/bmj.324.7340.757; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; LEDERGERBER B, 1994, SOZ PRAVENTIV MED, V39, P387, DOI 10.1007/BF01299670; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Levin BR, 2001, EMERG INFECT DIS, V7, P505, DOI 10.3201/eid0707.017704; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; Marseille E, 2002, LANCET, V359, P1851, DOI 10.1016/S0140-6736(02)08705-6; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pezzotti P, 1999, AIDS, V13, P249, DOI 10.1097/00002030-199902040-00013; Phillips AN, 1999, AIDS, V13, P2075, DOI 10.1097/00002030-199910220-00010; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; SELWYN PA, 1989, AM J PUBLIC HEALTH, V79, P1358, DOI 10.2105/AJPH.79.10.1358; Vittinghoff E, 1999, J INFECT DIS, V179, P717, DOI 10.1086/314623; Walker AM, 1996, EPIDEMIOLOGY, V7, P335; Wood E, 2003, ANN INTERN MED, V139, P810, DOI 10.7326/0003-4819-139-10-200311180-00008	37	422	438	0	32	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 30	2005	366	9483					378	384		10.1016/S0140-6736(05)67022-5	http://dx.doi.org/10.1016/S0140-6736(05)67022-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	950IB	16054937				2022-12-28	WOS:000230849700024
J	Collins, CA; Olsen, I; Zammit, PS; Heslop, L; Petrie, A; Partridge, TA; Morgan, JE				Collins, CA; Olsen, I; Zammit, PS; Heslop, L; Petrie, A; Partridge, TA; Morgan, JE			Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche	CELL			English	Article							MYOGENIC SPECIFICATION; MOUSE MUSCLE; BONE-MARROW; REGENERATION; TRANSPLANTATION; EXPRESSION; PLASTICITY; FIBER; FATES	Satellite cells are situated beneath the basal lamina that surrounds each myofiber and function as myogenic precursors for muscle growth and repair. The source of satellite cell renewal is controversial and has been suggested to be a separate circulating or interstitial stem cell population. Here, we transplant single intact myofibers into radiation-ablated muscles and demonstrate that satellite cells are self-sufficient as a source of regeneration. As few as seven satellite cells associated with one transplanted myofiber can generate over 100 new myofibers containing thousands of myonuclei. Moreover, the transplanted satellite cells vigorously self-renew, expanding in number and repopulating the host muscle with new satellite cells. Following experimental injury, these cells proliferate extensively and regenerate large compact clusters of myofibers. Thus, within a normally stable tissue, the satellite cell exhibits archetypal stem cell properties and is competent to form the basal origin of adult muscle regeneration.	Hammersmith Hosp, Fac Med, Imperial Coll, MRC Clin Sci Ctr,Muscle Cell Biol Grp, London W12 0NN, England; UCL, Eastman Dent Inst, London WC1X 8LD, England; Hammersmith Hosp, Imperial Coll, Dubowitz Neuromuscular Ctr, Dept Paediat, London W12 0NN, England	Imperial College London; University of London; University College London; Imperial College London; University of London; University College London	Collins, CA (corresponding author), Hammersmith Hosp, Fac Med, Imperial Coll, MRC Clin Sci Ctr,Muscle Cell Biol Grp, Du Cane Rd, London W12 0NN, England.	charlotte.collins2@csc.mrc.ac.uk; terence.partridge@csc.mrc.ac.uk	Morgan, Jennifer/C-6475-2008; Zammit, peter/GXV-7746-2022	zammit, peter/0000-0001-9562-3072; Collins, Charlotte/0000-0002-8715-9035				Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Bin Cheung Y, 2002, STAT MED, V21, P1461, DOI 10.1002/sim.1088; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blaveri K, 1999, DEV DYNAM, V216, P244, DOI 10.1002/(SICI)1097-0177(199911)216:3<244::AID-DVDY3>3.0.CO;2-9; CARLSON BM, 1986, FASEB J, V45, P1456; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Gross JG, 1999, MUSCLE NERVE, V22, P174, DOI 10.1002/(SICI)1097-4598(199902)22:2<174::AID-MUS5>3.0.CO;2-S; Gross JG, 1999, CELL TISSUE RES, V298, P371, DOI 10.1007/s004419900062; Harris JB, 2003, TOXICON, V42, P933, DOI 10.1016/j.toxicon.2003.11.011; Heslop L, 2001, GENE THER, V8, P778, DOI 10.1038/sj.gt.3301463; Heslop L, 2000, J CELL SCI, V113, P2299; KELLY R, 1995, J CELL BIOL, V129, P383, DOI 10.1083/jcb.129.2.383; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; MORGAN JE, 1993, J NEUROL SCI, V115, P191, DOI 10.1016/0022-510X(93)90224-M; MOSS FP, 1971, ANAT REC, V170, P421, DOI 10.1002/ar.1091700405; Partridge TA, 2003, MUSCLE NERVE, V27, P133, DOI 10.1002/mus.10243; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Raff M, 2003, ANNU REV CELL DEV BI, V19, P1, DOI 10.1146/annurev.cellbio.19.111301.143037; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shefer G, 2004, J CELL SCI, V117, P5393, DOI 10.1242/jcs.01419; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; SNOW MH, 1978, CELL TISSUE RES, V186, P535; STUDITSKY AN, 1964, ANN NY ACAD SCI, V120, P789, DOI 10.1111/j.1749-6632.1964.tb34771.x; Tajbakhsh S, 1996, NATURE, V384, P266, DOI 10.1038/384266a0; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Yang JW, 1997, ANAT RECORD, V248, P40; Zammit PS, 2001, DIFFERENTIATION, V68, P193, DOI 10.1046/j.1432-0436.2001.680407.x; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Zammit PS, 2002, EXP CELL RES, V281, P39, DOI 10.1006/excr.2002.5653	33	961	1018	2	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 29	2005	122	2					289	301		10.1016/j.cell.2005.05.010	http://dx.doi.org/10.1016/j.cell.2005.05.010			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	951CR	16051152	Bronze			2022-12-28	WOS:000230907000015
J	Esch, F; Fabris, S; Zhou, L; Montini, T; Africh, C; Fornasiero, P; Comelli, G; Rosei, R				Esch, F; Fabris, S; Zhou, L; Montini, T; Africh, C; Fornasiero, P; Comelli, G; Rosei, R			Electron localization determines defect formation on ceria substrates	SCIENCE			English	Article							SURFACE OXYGEN-ATOMS; CEO2(111) SURFACES; MICROSCOPIC OBSERVATIONS; TIO2(110) SURFACE; OXIDE; OXIDATION; BEHAVIOR; DIFFUSION; CATALYSTS; VACANCIES	The high performance of ceria (CeO(2)) as an oxygen buffer and active support for noble metals in catalysis relies on an efficient supply of lattice oxygen at reaction sites governed by oxygen vacancy formation. We used high-resolution scanning tunneling microscopy and density functional calculations to unravel the local structure of surface and subsurface oxygen vacancies on the (111) surface. Electrons left behind by released oxygen localize on cerium ions. Clusters of more than two vacancies exclusively expose these reduced cerium ions, primarily by including subsurface vacancies, which therefore play a crucial role in the process of vacancy cluster formation. These results have implications for our understanding of oxidation processes on reducible rare-earth oxides.	INFM, Lab Nazl Tecnol Avanzate & Nanosci, I-34012 Trieste, Italy; SISSA, I-34014 Trieste, Italy; INFM, Democritos Natl Simulat Ctr, I-34014 Trieste, Italy; Leibniz Univ Hannover, Inst Phys Chem & Electrochem, D-30167 Hannover, Germany; Univ Trieste, Dept Chem, I-34127 Trieste, Italy; Univ Trieste, Consorzio Interuniv Nazl Sci & Tecnol Mat, I-34127 Trieste, Italy; Univ Trieste, CENMAT, I-34127 Trieste, Italy; Univ Trieste, Dept Phys, I-34127 Trieste, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); International School for Advanced Studies (SISSA); Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Leibniz University Hannover; University of Trieste; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie Molecolari (ISTM-CNR); University of Trieste; University of Trieste; University of Trieste	Esch, F (corresponding author), INFM, Lab Nazl Tecnol Avanzate & Nanosci, I-34012 Trieste, Italy.	friedrich.esch@elettra.trieste.it	Fabris, Stefano/B-6907-2008; Montini, Tiziano/G-3363-2011; Fornasiero, Paolo/J-5758-2019; Fornasiero, Paolo/B-7279-2011; Africh, Cristina/O-2976-2015; Esch, Friedrich/A-3678-2010	Fabris, Stefano/0000-0003-2562-8788; Montini, Tiziano/0000-0001-9515-566X; Fornasiero, Paolo/0000-0003-1082-9157; Fornasiero, Paolo/0000-0003-1082-9157; Africh, Cristina/0000-0002-1922-2557; Esch, Friedrich/0000-0001-7793-3341				Bernal S, 1999, CATAL TODAY, V50, P175, DOI 10.1016/S0920-5861(98)00503-3; Campbell CT, 2003, SCIENCE, V299, P357, DOI 10.1126/science.1081090; Chen MS, 2004, SCIENCE, V306, P252, DOI 10.1126/science.1102420; Cococcioni M, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.035105; Colon G, 1999, CATAL TODAY, V50, P271, DOI 10.1016/S0920-5861(98)00509-4; Deluga GA, 2004, SCIENCE, V303, P993, DOI 10.1126/science.1093045; Fabris S, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.041102; Fornasiero P, 1996, J CATAL, V164, P173, DOI 10.1006/jcat.1996.0373; Fu Q, 2003, SCIENCE, V301, P935, DOI 10.1126/science.1085721; Fukui K, 2002, APPL SURF SCI, V188, P252, DOI 10.1016/S0169-4332(01)00917-5; Liu ZP, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.196102; MARTINEZARIAS A, 1995, J CHEM SOC FARADAY T, V91, P1679, DOI 10.1039/ft9959101679; Mullins DR, 1998, SURF SCI, V409, P307, DOI 10.1016/S0039-6028(98)00257-X; Namai Y, 2003, CATAL TODAY, V85, P79, DOI 10.1016/S0920-5861(03)00377-8; Namai Y, 2003, J PHYS CHEM B, V107, P11666, DOI 10.1021/jp030142q; Norenberg H, 1999, SURF SCI, V424, pL352, DOI 10.1016/S0039-6028(99)00212-5; NORENBERG H, 1997, PHYS REV LETT, V79, P422; OTSUKA K, 1993, CHEM LETT, P1517, DOI 10.1246/cl.1993.1517; Park SD, 2000, NATURE, V404, P265, DOI 10.1038/35005040; Rao GR, 1996, J CATAL, V162, P1, DOI 10.1006/jcat.1996.0254; Rasmussen MD, 2004, J CHEM PHYS, V120, P988, DOI 10.1063/1.1631922; Schaub R, 2003, SCIENCE, V299, P377, DOI 10.1126/science.1078962; Trovarelli A., 2002, CATALYSIS CERIA RELA; Wahlstrom E, 2004, SCIENCE, V303, P511, DOI 10.1126/science.1093425; Wu LJ, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.125415; Yang ZX, 2004, J CHEM PHYS, V120, P7741, DOI 10.1063/1.1688316	26	1060	1094	35	861	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2005	309	5735					752	755		10.1126/science.1111568	http://dx.doi.org/10.1126/science.1111568			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051791				2022-12-28	WOS:000230938200044
J	Pyenson, ND; Pyenson, L				Pyenson, ND; Pyenson, L			Treating medieval manuscripts as fossils	SCIENCE			English	Letter							EVOLUTION; HISTORY		Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; Univ Louisiana Lafayette, Ctr Louisiana Studies, Lafayette, LA 70504 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Louisiana Lafayette	Pyenson, ND (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	pyenson@berkeley.edu						Crisp MD, 2005, TRENDS ECOL EVOL, V20, P122, DOI 10.1016/j.tree.2004.11.010; GOULD SJ, 1986, AM SCI, V74, P60; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Jablonski D, 2003, SCIENCE, V300, P1133, DOI 10.1126/science.1083246; Mace R, 2005, TRENDS ECOL EVOL, V20, P116, DOI 10.1016/j.tree.2004.12.002	5	3	3	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2005	309	5735					698	699						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051771				2022-12-28	WOS:000230938200019
J	Wu, LC; Estrada, O; Zaborina, O; Bains, M; Shen, L; Kohler, JE; Patel, N; Musch, MW; Chang, EB; Fu, YX; Jacobs, MA; Nishimura, MI; Hancock, REW; Turner, JR; Alverdy, JC				Wu, LC; Estrada, O; Zaborina, O; Bains, M; Shen, L; Kohler, JE; Patel, N; Musch, MW; Chang, EB; Fu, YX; Jacobs, MA; Nishimura, MI; Hancock, REW; Turner, JR; Alverdy, JC			Recognition of host immune activation by Pseudomonas aeruginosa	SCIENCE			English	Article							NECROSIS-FACTOR-ALPHA; ESCHERICHIA-COLI; EPITHELIAL-CELLS; PA-I; QUORUM; GENES; EXPRESSION; BACTERIA; CULTURE; BINDING	It is generally reasoned that lethal infections caused by opportunistic pathogens develop permissively by invading a host that is both physiologically stressed and immunologically compromised. However, an alternative hypothesis might be that opportunistic pathogens actively sense alterations in host immune function and respond by enhancing their virulence phenotype. We demonstrate that interferon-gamma binds to an outer membrane protein in Pseudomonas aeruginosa, OprF, resulting in the expression of a quorum-sensing dependent virulence determinant, the PA-1 lectin. These observations provide details of the mechanisms by which prokaryotic organisms are directly signaled by immune activation in their eukaryotic host.	Univ Chicago, Pritzker Sch Med, Dept Surg, Chicago, IL 60637 USA; Univ Chicago, Pritzker Sch Med, Dept Pathol, Chicago, IL 60637 USA; Univ Chicago, Pritzker Sch Med, Dept Med, Chicago, IL 60637 USA; Univ British Columbia, Dept Immunol & Microbiol, Vancouver, BC V6T 1Z4, Canada; Univ Washington, Dept Genome Sci & Med, Seattle, WA 98195 USA	University of Chicago; University of Chicago; University of Chicago; University of British Columbia; University of Washington; University of Washington Seattle	Alverdy, JC (corresponding author), Univ Chicago, Pritzker Sch Med, Dept Surg, Chicago, IL 60637 USA.	jaiverdy@surgery.bsd.uchicago.edu	Zaborina, Olga/AAQ-6977-2021; Kohler, Jonathan/C-7753-2009; Patel, Nachiket/J-8019-2019; Turner, Jerrold/H-1502-2019; Turner, Jerrold R/A-6895-2009; Hancock, Robert E. W./E-1145-2013; Shen, Le/E-7866-2010	Patel, Nachiket/0000-0002-5841-7568; Turner, Jerrold R/0000-0003-0627-9455; Hancock, Robert E. W./0000-0001-5989-8503; fu, yang-xin/0000-0001-8441-6617	NIDDK NIH HHS [R01DK68271, R01DK61931, DK-47722, DK-38510] Funding Source: Medline; NIGMS NIH HHS [2-RO1 GM062344-05] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038510, R01DK061931, R01DK068271, R01DK047722, R37DK047722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062344] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Azghani AO, 2002, MICROB PATHOGENESIS, V33, P109, DOI 10.1006/mpat.2002.0514; BAJOLETLAUDINAT O, 1994, INFECT IMMUN, V62, P4481, DOI 10.1128/IAI.62.10.4481-4487.1994; Diggle SP, 2003, MOL MICROBIOL, V50, P29, DOI 10.1046/j.1365-2958.2003.03672.x; Diggle SP, 2002, J BACTERIOL, V184, P2576, DOI 10.1128/JB.184.10.2576-2586.2002; Ikuta S, 2004, SHOCK, V21, P452, DOI 10.1097/00024382-200405000-00009; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Lau GW, 2004, INFECT IMMUN, V72, P4275, DOI 10.1128/IAI.72.7.4275-4278.2004; Laughlin RS, 2000, ANN SURG, V232, P133, DOI 10.1097/00000658-200007000-00019; LUO GY, 1993, INFECT IMMUN, V61, P830, DOI 10.1128/IAI.61.3.830-835.1993; MEKALANOS JJ, 1992, J BACTERIOL, V174, P1; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; PORAT R, 1991, SCIENCE, V254, P430, DOI 10.1126/science.1833820; SCHWARTZENTRUBER DJ, 1991, J IMMUNOL, V146, P3674; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Whiteley M, 1999, P NATL ACAD SCI USA, V96, P13904, DOI 10.1073/pnas.96.24.13904; Winzer K, 2000, J BACTERIOL, V182, P6401, DOI 10.1128/JB.182.22.6401-6411.2000; Wu LC, 2004, GASTROENTEROLOGY, V126, P488, DOI 10.1053/j.gastro.2003.11.011	19	238	249	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2005	309	5735					774	777		10.1126/science.1112422	http://dx.doi.org/10.1126/science.1112422			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051797				2022-12-28	WOS:000230938200051
J	Minn, AJ; Gupta, GP; Siegel, PM; Bos, PD; Shu, WP; Giri, DD; Viale, A; Olshen, AB; Gerald, WL; Massague, J				Minn, AJ; Gupta, GP; Siegel, PM; Bos, PD; Shu, WP; Giri, DD; Viale, A; Olshen, AB; Gerald, WL; Massague, J			Genes that mediate breast cancer metastasis to lung	NATURE			English	Article							EXPRESSION PROFILES; TUMOR PROGRESSION; METALLOPROTEINASES; SIGNATURE; MOLECULES; CARCINOMA; PROTEINS; SURVIVAL; NETWORK; GROWTH	By means of in vivo selection, transcriptomic analysis, functional verification and clinical validation, here we identify a set of genes that marks and mediates breast cancer metastasis to the lungs. Some of these genes serve dual functions, providing growth advantages both in the primary tumour and in the lung microenvironment. Others contribute to aggressive growth selectively in the lung. Many encode extracellular proteins and are of previously unknown relevance to cancer metastasis.	Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Genom Core Lab, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	j-massague@ski.mskcc.org	Gupta, Gaorav/AAL-4472-2021	Massague, Joan/0000-0001-9324-8408; Minn, Andy/0000-0003-1418-0906	NATIONAL CANCER INSTITUTE [P01CA094060] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA094060] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amatschek S, 2004, CANCER RES, V64, P844, DOI 10.1158/0008-5472.CAN-03-2361; Arun B, 2004, SEMIN ONCOL, V31, P22, DOI 10.1053/j.seminoncol.2004.03.042; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Davidson B, 2004, CLIN CANCER RES, V10, P7335, DOI 10.1158/1078-0432.CCR-04-0183; Desprez PY, 2003, J MAMMARY GLAND BIOL, V8, P225, DOI 10.1023/A:1025957025773; Duffy MJ, 2000, BREAST CANCER RES, V2, P252, DOI 10.1186/bcr65; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Framson PE, 2004, J CELL BIOCHEM, V92, P679, DOI 10.1002/jcb.20091; Heimann R, 2000, J CLIN ONCOL, V18, P591, DOI 10.1200/JCO.2000.18.3.591; Hynes RO, 2003, CELL, V113, P821, DOI 10.1016/S0092-8674(03)00468-9; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; O'Hanlon DM, 2002, EUR J CANCER, V38, P2252, DOI 10.1016/S0959-8049(02)00218-6; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Schairer C, 2004, JNCI-J NATL CANCER I, V96, P1311, DOI 10.1093/jnci/djh253; Shelly M, 1998, J BIOL CHEM, V273, P10496, DOI 10.1074/jbc.273.17.10496; Simon R, 2003, BRIT J CANCER, V89, P1599, DOI 10.1038/sj.bjc.6601326; Solomayer EF, 2000, BREAST CANCER RES TR, V59, P271, DOI 10.1023/A:1006308619659; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wood N, 2003, J EXP MED, V197, P703, DOI 10.1084/jem.20020906; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yokota J, 2000, CARCINOGENESIS, V21, P497, DOI 10.1093/carcin/21.3.497	33	2145	2278	4	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					518	524		10.1038/nature03799	http://dx.doi.org/10.1038/nature03799			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049480	Green Accepted			2022-12-28	WOS:000230788800053
J	Hall, LA				Hall, LA			Historical keywords - Sterilisation	LANCET			English	Editorial Material									Wellcome Lib Hist & Understanding Med, London, England		Hall, LA (corresponding author), Wellcome Lib Hist & Understanding Med, London, England.	l.hall@wellcome.ac.uk	Hall, Lesley/ABD-1649-2021	Hall, Lesley/0000-0002-9979-268X					0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 23	2005	366	9482					285	285		10.1016/S0140-6736(05)66970-X	http://dx.doi.org/10.1016/S0140-6736(05)66970-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RJ	16039321	Bronze			2022-12-28	WOS:000230733100013
J	Lawlor, DA; Harro, M; Wedderkopp, N; Andersen, LB; Sardinha, LB; Riddoch, CJ; Page, AS; Anderssen, SA; Froberg, K; Stansbie, D; Smith, GD				Lawlor, DA; Harro, M; Wedderkopp, N; Andersen, LB; Sardinha, LB; Riddoch, CJ; Page, AS; Anderssen, SA; Froberg, K; Stansbie, D; Smith, GD			Association of socioeconomic position with insulin resistance among children from Denmark, Estonia, and Portugal: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article							CAUSE-SPECIFIC MORTALITY; 11 EUROPEAN COUNTRIES; MIDDLE-AGED MEN; OCCUPATIONAL CLASS; EDUCATIONAL-LEVEL; INEQUALITIES; HEALTH; ADULTHOOD; CHILDHOOD; DISEASE	Objectives To examine the association between socioeconomic position and insulin resistance in children from three countriesin northern Europe (Denmark), eastern Europe (Estonia), and southern Europe (Portugal) that have different physical, economic, and cultural environments. Design Cross sectional study. Participants 3189 randomly selected schoolchildren aged 9 and 15 years from Denmark (n = 933), Estonia (n = 1103), and Portugal (n = 1153). Main outcome measure Insulin resistance (homoeostasis model assessment). Results Family income and parental education were inversely associated with insulin resistance in Danish children but were positively associated with insulin resistance in Estonian and Portuguese children. Among Danish children, insulin resistance was 24% lower (95% confidence interval - 38% to - 10%) in those whose fathers had the most education compared with those with the least education. The equivalent results were 15% (2% to 28%) higher for Estonia and 19% (2% to 36%) higher for Portugal. These associations remained after adjustment for a range of covariates: - 20% (- 36% to - 5%) for Denmark, 10% ( - 4% to 24%) for Estonia, and 18% ( -1% to 31%) for Portugal. Strong statistical evidence supported differences between the associations in Denmark and those in the other two countries in both unadjusted and adjusted models (all P < 0.03). Conclusions Among Danish children, those with the most educated and highest earning parents had least insulin resistance, whereas the opposite was true for children from Estonia and Portugal.	Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Univ Bristol, Dept Exercise & Hlth Sci, Bristol BS8 1TH, Avon, England; Estonian Natl Inst Hlth Dev, Tallinn, Estonia; Univ So Denmark, Inst Sports Sci & Clin Biomech, Odense, Denmark; Norwegian Univ Sport & Phys Educ, Dept Sports Med, Oslo, Norway; Univ Tecn Lisboa, Fac Human Movement, Lisbon, Portugal; Middlesex Univ, London Sport Inst, London N17 8HR, England; United Bristol Healthcare NHS Trust, Dept Clin Biochem, Bristol, Avon, England	University of Bristol; University of Bristol; University of Southern Denmark; Norwegian School of Sport Sciences; Universidade de Lisboa; Middlesex University	Lawlor, DA (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.	d.a.lawlor@bristol.ac.uk	Sardinha, Luís B./ABG-5389-2020; Wedderkopp, Niels/L-9810-2019; Davey Smith, George/A-7407-2013; Sardinha, Luís Bettencourt/F-2641-2013	Sardinha, Luís B./0000-0002-6230-6027; Davey Smith, George/0000-0002-1407-8314; Sardinha, Luís Bettencourt/0000-0002-6230-6027; Wedderkopp, Niels/0000-0002-9660-6618; Lawlor, Debbie A/0000-0002-6793-2262				Brandou F, 2005, J CLIN ENDOCR METAB, V90, P761, DOI 10.1210/jc.2004-0329; Galobardes B, 2004, EPIDEMIOL REV, V26, P7, DOI 10.1093/epirev/mxh008; Gunnell D, 2001, INT J EPIDEMIOL, V30, P221, DOI 10.1093/ije/30.2.221; HARRO M, 2005, IN PRESS J PUBLIC HL; KUNST A, 1997, CROSS NATL COMP SOCI; KUNST AE, 1994, AM J PUBLIC HEALTH, V84, P932, DOI 10.2105/AJPH.84.6.932; Kunst AE, 1999, AM J PUBLIC HEALTH, V89, P47, DOI 10.2105/AJPH.89.1.47; KUNST AE, 1995, J EPIDEMIOL COMMUN H, V49, P117, DOI 10.1136/jech.49.2.117; Kunst AE, 1998, BMJ-BRIT MED J, V316, P1636, DOI 10.1136/bmj.316.7145.1636; Lawlor DA, 2002, BRIT MED J, V325, P805, DOI 10.1136/bmj.325.7368.805; LAWLOR DA, 2005, IN PRESS DIABET MED; LECLERC A, 1990, INT J EPIDEMIOL, V19, P1001, DOI 10.1093/ije/19.4.1001; Leinsalu M, 2003, INT J EPIDEMIOL, V32, P1081, DOI 10.1093/ije/dyg192; Leon DA, 1998, BRIT MED J, V316, P1642; Mackenbach JP, 1997, LANCET, V349, P1655, DOI 10.1016/S0140-6736(96)07226-1; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Riddoch C, 2005, J PHYS ACT HEALTH, V2, P115, DOI DOI 10.1123/JPAH.2.1.115; Shkolnikov VM, 1998, SOC SCI MED, V47, P357, DOI 10.1016/S0277-9536(98)00096-3; Smith GD, 1997, LIFE COURSE APPROACH TO CHRONIC DISEASE EPIDEMIOLOGY, P242; SMITH GD, 2004, LIFE COURSE APPROACH, P77, DOI DOI 10.1093/ACPROF:OSO/9780198578154.001.0001; VAN DE, 2004, HEALTH ECON, V13, P609; Vodopivec M, 2002, INT J MANPOWER, V23, P77, DOI 10.1108/01437720210426885; Wannamethee SG, 1996, LANCET, V348, P1259, DOI 10.1016/S0140-6736(96)02465-8	24	46	47	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 23	2005	331	7510					183	186		10.1136/bmj.331.7510.183	http://dx.doi.org/10.1136/bmj.331.7510.183			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	951EA	16037446	Bronze, Green Published			2022-12-28	WOS:000230910700015
J	Heinsohn, R; Legge, S; Endler, JA				Heinsohn, R; Legge, S; Endler, JA			Extreme reversed sexual dichromatism in a bird without sex role reversal	SCIENCE			English	Article							COLOR PATTERNS; ECLECTUS PARROTS; SELECTION; COMPETITION; POPULATION; EVOLUTION; LIGHT; SIZE	Brilliant plumage is typical of mate birds, reflecting differential enhancement of mate traits when females are the limiting sex. Brighter females are thought to evolve exclusively in response to sex role reversal. The striking reversed plumage dichromatism of Eclectus roratus parrots does not fit this pattern. We quantify plumage color in this species and show that very different selection pressures are acting on males and females. Mate plumage reflects a compromise between the conflicting requirements for camouflage from predators while foraging and conspicuousness during display. Females are liberated from the need for camouflage but compete for rare nest hollows.	Australian Natl Univ, Ctr Resource & Environm Studies, Canberra, ACT 0200, Australia; Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; James Cook Univ N Queensland, Dept Zool & Trop Ecol, Townsville, Qld 4811, Australia	Australian National University; Australian National University; University of California System; University of California Santa Barbara; James Cook University	Heinsohn, R (corresponding author), Australian Natl Univ, Ctr Resource & Environm Studies, Canberra, ACT 0200, Australia.	Robert.Heinsohn@anu.edu.au	Legge, Sarah/GYE-1554-2022; Endler, John A/B-6659-2009; Legge, Sarah/AAB-7229-2019	Endler, John A/0000-0002-7557-7627; Legge, Sarah/0000-0001-6968-2781				ALMADA VC, 1995, ANIM BEHAV, V49, P1125, DOI 10.1006/anbe.1995.0142; AMUNDSEN T, IN PRESS AVIAN COLOR; Andersson Malte, 1994; BAKER RR, 1979, PHILOS T R SOC B, V287, P63, DOI 10.1098/rstb.1979.0053; BENNETT ATD, 1994, VISION RES, V34, P1471, DOI 10.1016/0042-6989(94)90149-X; CLUTTONBROCK TH, 1991, NATURE, V351, P58; Eens M, 2000, BEHAV PROCESS, V51, P135, DOI 10.1016/S0376-6357(00)00124-8; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; ENDLER JA, 1993, ECOL MONOGR, V63, P1, DOI 10.2307/2937121; ENDLER JA, 1991, VISION RES, V31, P587, DOI 10.1016/0042-6989(91)90109-I; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Endler JA, 1996, AM NAT, V148, P421, DOI 10.1086/285934; Forshaw J. M., 1989, PARROTS WORLD, P616; GRAFEN A, 2000, GUARDIAN        0309, P27; Heinsohn R, 2003, J ZOOL, V259, P197, DOI 10.1017/S0952836902003138; Heinsohn R, 2003, AUST J ZOOL, V51, P81, DOI 10.1071/ZO02003; JONES IL, 1993, NATURE, V362, P238, DOI 10.1038/362238a0; Juniper T, 1998, PARROTS GUIDE PARROT; Kemp A.C., 1995, HORNBILLS BUCEROTIFO, V1; Kokko H, 2001, ECOL LETT, V4, P159, DOI 10.1046/j.1461-0248.2001.00212.x; Kvarnemo C, 1996, TRENDS ECOL EVOL, V11, P404, DOI 10.1016/0169-5347(96)10056-2; Langmore NE, 1998, TRENDS ECOL EVOL, V13, P136, DOI 10.1016/S0169-5347(97)01241-X; Legge S, 2004, WILDLIFE RES, V31, P149, DOI 10.1071/WR03020; Szekely T, 2004, P NATL ACAD SCI USA, V101, P12224, DOI 10.1073/pnas.0404503101; Wallace A. R., 1889, DARWINISM	27	142	147	1	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2005	309	5734					617	619		10.1126/science.1112774	http://dx.doi.org/10.1126/science.1112774			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040708				2022-12-28	WOS:000230735200050
J	Murphy, WJ; Larkin, DM; Everts-van der Wind, A; Bourque, G; Tesler, G; Auvil, L; Beever, JE; Chowdhary, BP; Galibert, F; Gatzke, L; Hitte, C; Meyers, SN; Milan, D; Ostrander, EA; Pape, G; Parker, HG; Raudsepp, T; Rogatcheva, MB; Schook, LB; Skow, LC; Welge, M; Womack, JE; O'Brien, SJ; Pevzner, PA; Lewin, HA				Murphy, WJ; Larkin, DM; Everts-van der Wind, A; Bourque, G; Tesler, G; Auvil, L; Beever, JE; Chowdhary, BP; Galibert, F; Gatzke, L; Hitte, C; Meyers, SN; Milan, D; Ostrander, EA; Pape, G; Parker, HG; Raudsepp, T; Rogatcheva, MB; Schook, LB; Skow, LC; Welge, M; Womack, JE; O'Brien, SJ; Pevzner, PA; Lewin, HA			Dynamics of mammalian chromosome evolution inferred from multispecies comparative maps	SCIENCE			English	Article							HUMAN GENOME SEQUENCE; RADIATION HYBRID MAP; SEGMENTAL DUPLICATIONS; MOUSE GENOMES; CENTROMERE; REARRANGEMENTS; BREAKPOINT; RESOLUTION; INVERSION; REGION	The genome organizations of eight phylogenetically distinct species from five mammalian orders were compared in order to address fundamental questions relating to mammalian chromosomal evolution. Rates of chromosome evolution within mammalian orders were found to increase since the Cretaceous-Tertiary boundary. Nearly 20% of chromosome breakpoint regions were reused during mammalian evolution; these reuse sites are also enriched for centromeres. Analysis of gene content in and around evolutionary breakpoint regions revealed increased gene density relative to the genome-wide average. We found that segmental duplications populate the majority of primate-specific breakpoints and often flank inverted chromosome segments, implicating their role in chromosomal rearrangement.	Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77843 USA; SAIC Frederick Inc, Frederick, MD 21702 USA; NCI, Lab Genom Divers, Frederick, MD 21702 USA; Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; Univ Illinois, Natl Ctr Supercomp Applicat, Urbana, IL 61801 USA; Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; Genome Inst Singapore, Singapore 138672, Singapore; Univ Calif San Diego, Dept Math, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; Univ Rennes 1, CNRS, UMR6061, F-35043 Rennes, France; INRA, Lab Genet Cellulaire, F-31326 Castanet Tolosan, France; NHGRI, Bethesda, MD 20892 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of California System; University of California San Diego; University of California System; University of California San Diego; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; INRAE; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Murphy, WJ (corresponding author), Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA.	wmurphy@cvm.tamu.edu; h-lewin@uiuc.edu	Larkin, Denis/AAB-1633-2022; LEWIN, HARRIS/HGC-6543-2022; Bourque, Guillaume/AFR-2927-2022; Fiumefreddo, Andrea/T-2977-2019; Larkin, Denis/AAB-2249-2022; OBRIEN, STEPHEN/ABD-1346-2020; Parker, Heidi/C-6954-2008	Larkin, Denis/0000-0001-7859-6201; LEWIN, HARRIS/0000-0002-1043-7287; Bourque, Guillaume/0000-0002-3933-9656; Ostrander, Elaine/0000-0001-6075-9738; Parker, Heidi G./0000-0002-9707-6380; Schook, Lawrence/0000-0002-6580-8364; Skow, Loren/0000-0001-8998-359X; OBRIEN, STEPHEN/0000-0001-7857-0757; Hitte, Christophe/0000-0003-1714-437X	NATIONAL CANCER INSTITUTE [R01CA092167] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200325] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-12400, R01CA-92167] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amor DJ, 2004, P NATL ACAD SCI USA, V101, P6542, DOI 10.1073/pnas.0308637101; Amor DJ, 2002, AM J HUM GENET, V71, P695, DOI 10.1086/342730; [Anonymous], MITELMAN DATABASE CH; Armengol L, 2003, HUM MOL GENET, V12, P2201, DOI 10.1093/hmg/ddg223; Bailey JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r23; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Beck TW, 2005, IMMUNOGENETICS, V56, P702, DOI 10.1007/s00251-004-0742-6; Bourque G, 2004, GENOME RES, V14, P507, DOI 10.1101/gr.1975204; Bourque G, 2002, GENOME RES, V12, P26; Burt DW, 1999, NATURE, V402, P411, DOI 10.1038/46555; Chowdhary BP, 2003, GENOME RES, V13, P742, DOI 10.1101/gr.917503; Dennehey BK, 2004, GENOMICS, V83, P493, DOI 10.1016/j.ygeno.2003.08.017; Eder V, 2003, MOL BIOL EVOL, V20, P1506, DOI 10.1093/molbev/msg165; Everts-van der Wind A, 2004, GENOME RES, V14, P1424, DOI 10.1101/gr.2554404; Froenicke L, 2005, CYTOGENET GENOME RES, V108, P122, DOI 10.1159/000080810; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Guyon R, 2003, P NATL ACAD SCI USA, V100, P5296, DOI 10.1073/pnas.0831002100; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Larkin DM, 2003, GENOME RES, V13, P1966, DOI 10.1101/gr.1560203; Menotti-Raymond M, 2003, CYTOGENET GENOME RES, V102, P272, DOI 10.1159/000075762; MEYERS SN, IN PRESS GENOMICS; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Nash WG, 2001, CYTOGENET CELL GENET, V95, P210, DOI 10.1159/000059348; O'Brien SJ, 1999, SCIENCE, V286, P458, DOI 10.1126/science.286.5439.458; Pevzner P, 2003, P NATL ACAD SCI USA, V100, P7672, DOI 10.1073/pnas.1330369100; Samonte RV, 2002, NAT REV GENET, V3, P65, DOI 10.1038/nrg705; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yuhki N, 2003, GENOME RES, V13, P1169, DOI 10.1101/gr.976103; Zhao SY, 2004, GENOME RES, V14, P1851, DOI 10.1101/gr.2663304	31	419	433	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2005	309	5734					613	617		10.1126/science.1111387	http://dx.doi.org/10.1126/science.1111387			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040707				2022-12-28	WOS:000230735200049
J	Hartmann, LC; Sellers, TA; Frost, MH; Lingle, WL; Degnim, AC; Ghosh, K; Vierkant, RA; Maloney, SD; Pankratz, VS; Hillman, DW; Suman, VJ; Johnson, J; Blake, C; Tlsty, T; Vachon, CM; Melton, LJ; Visscher, DW				Hartmann, LC; Sellers, TA; Frost, MH; Lingle, WL; Degnim, AC; Ghosh, K; Vierkant, RA; Maloney, SD; Pankratz, VS; Hillman, DW; Suman, VJ; Johnson, J; Blake, C; Tlsty, T; Vachon, CM; Melton, LJ; Visscher, DW			Benign breast disease and the risk of breast cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WOMEN; OVEREXPRESSION; AMPLIFICATION; HYPERPLASIA; AGE; P53	Background: Benign breast disease is an important risk factor for breast cancer. We studied a large group of women with benign breast disease to obtain reliable estimates of this risk. Methods: We identified all women who received a diagnosis of benign breast disease at the Mayo Clinic between 1967 and 1991. Breast-cancer events were obtained from medical records and questionnaires. To estimate relative risks, we compared the number of observed breast cancers with the number expected on the basis of the rates of breast cancer in the Iowa Surveillance, Epidemiology, and End Results registry. Results: We followed 9087 women for a median of 15 years. The histologic findings were nonproliferative lesions in 67 percent of women, proliferative lesions without atypia in 30 percent, and atypical hyperplasia in 4 percent. To date, 707 breast cancers have developed. The relative risk of breast cancer for the cohort was 1.56 (95 percent confidence interval, 1.45 to 1.68), and this increased risk persisted for at least 25 years after biopsy. The relative risk associated with atypia was 4.24 (95 percent confidence interval, 3.26 to 5.41), as compared with a relative risk of 1.88 (95 percent confidence interval, 1.66 to 2.12) for proliferative changes without atypia and of 1.27 (95 percent confidence interval, 1.15 to 1.41) for nonproliferative lesions. The strength of the family history of breast cancer, available for 4808 women, was a risk factor that was independent of histologic findings. No increased risk was found among women with no family history and nonproliferative findings. In the first 10 years after the initial biopsy, an excess of cancers occurred in the same breast, especially in women with atypia. Conclusions: Risk factors for breast cancer after the diagnosis of benign breast disease include the histologic classification of a benign breast lesion and a family history of breast cancer.	Mayo Clin, Coll Med, Div Med Oncol, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Div Expt Pathol, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Div Gen Surg, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Div Gen Internal Med, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Div Biostat, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Div Epidemiol, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Div Anat Pathol, Rochester, MN 55905 USA; Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; Wayne State Univ, Detroit, MI USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Wayne State University; University of California System; University of California San Francisco	Hartmann, LC (corresponding author), Mayo Clin, Coll Med, Div Med Oncol, Rochester, MN 55905 USA.		Vierkant, Robert/AAP-4927-2020	Vierkant, Robert/0000-0001-6242-5221	NCI NIH HHS [R01 CA46332] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA046332] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 2009, SEER STAT DAT; BAIN LJ, 1992, INTRO PROBABILITY MA, P369; CARTER CL, 1988, AM J EPIDEMIOL, V128, P467, DOI 10.1093/oxfordjournals.aje.a114995; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; CONNOLLY JL, 1993, CANCER, V71, P1187, DOI 10.1002/1097-0142(19930215)71:4<1187::AID-CNCR2820710402>3.0.CO;2-V; Crawford YG, 2004, CANCER CELL, V5, P263, DOI 10.1016/S1535-6108(04)00023-6; DUPONT WD, 1993, CANCER, V71, P1258, DOI 10.1002/1097-0142(19930215)71:4<1258::AID-CNCR2820710415>3.0.CO;2-I; DUPONT WD, 1985, NEW ENGL J MED, V312, P146, DOI 10.1056/NEJM198501173120303; DUPONT WD, 1994, NEW ENGL J MED, V331, P10, DOI 10.1056/NEJM199407073310103; DUPONT WD, 1987, AM J EPIDEMIOL, V125, P769, DOI 10.1093/oxfordjournals.aje.a114594; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Fitzgibbons PL, 1998, ARCH PATHOL LAB MED, V122, P1053; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; JENSEN RA, 1989, CANCER, V64, P1977, DOI 10.1002/1097-0142(19891115)64:10<1977::AID-CNCR2820641002>3.0.CO;2-N; Kandel R, 2001, EUR J CANCER PREV, V10, P43, DOI 10.1097/00008469-200102000-00005; Kandel R, 2000, INT J CANCER, V87, P73, DOI 10.1002/1097-0215(20000701)87:1<73::AID-IJC11>3.0.CO;2-U; KRIEGER N, 1992, AM J EPIDEMIOL, V135, P619, DOI 10.1093/oxfordjournals.aje.a116341; Li JJ, 2004, P NATL ACAD SCI USA, V101, P18123, DOI 10.1073/pnas.0408273101; LONDON SJ, 1992, JAMA-J AM MED ASSOC, V267, P1780; Marshall LM, 1997, CANCER EPIDEM BIOMAR, V6, P297; Melton LJ, 1997, NEW ENGL J MED, V337, P1466, DOI 10.1056/NEJM199711133372012; Page DL, 2003, LANCET, V361, P1994; Page DL, 2003, LANCET, V361, P125, DOI 10.1016/S0140-6736(03)12230-1; PAGE DL, 1985, CANCER, V55, P2698, DOI 10.1002/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A; Rohan TE, 1998, JNCI-J NATL CANCER I, V90, P1262, DOI 10.1093/jnci/90.17.1262; Schnitt SJ, 2001, CLIN CANCER RES, V7, p4419S; Wang JP, 2004, J NATL CANCER I, V96, P616, DOI 10.1093/jnci/djhs105	27	569	613	3	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2005	353	3					229	237		10.1056/NEJMoa044383	http://dx.doi.org/10.1056/NEJMoa044383			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YH	16034008	Green Published			2022-12-28	WOS:000230608700003
J	Lukhtanov, VA; Kandul, NP; Plotkin, JB; Dantchenko, AV; Haig, D; Pierce, NE				Lukhtanov, VA; Kandul, NP; Plotkin, JB; Dantchenko, AV; Haig, D; Pierce, NE			Reinforcement of pre-zygotic isolation and karyotype evolution in Agrodiaetus butterflies	NATURE			English	Article							SEXUAL SELECTION; SPECIATION; PATTERNS; DRIVEN	The reinforcement model of evolution argues that natural selection enhances pre-zygotic isolation between divergent populations or species by selecting against unfit hybrids(1,2) or costly interspecific matings(3). Reinforcement is distinguished from other models that consider the formation of reproductive isolation to be a by-product of divergent evolution(4,5). Although theory has shown that reinforcement is a possible mechanism that can lead to speciation(6-8), empirical evidence has been sufficiently scarce to raise doubts about the importance of reinforcement in nature(6,9,10). Agrodiaetus butterflies ( Lepidoptera: Lycaenidae) exhibit unusual variability in chromosome number. Whereas their genitalia and other morphological characteristics are largely uniform, different species vary considerably in male wing colour, and provide a model system to study the role of reinforcement in speciation. Using comparative phylogenetic methods, we show that the sympatric distribution of 15 relatively young sister taxa of Agrodiaetus strongly correlates with differences in male wing colour, and that this pattern is most likely the result of reinforcement. We find little evidence supporting sympatric speciation: rather, in Agrodiaetus, karyotypic changes accumulate gradually in allopatry, prompting reinforcement when karyotypically divergent races come into contact.	Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; St Petersburg State Univ, Dept Entomol, St Petersburg 199034, Russia; Bauer Ctr Genom Res, Cambridge, MA 02138 USA	Harvard University; Saint Petersburg State University	Pierce, NE (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, 26 Oxford St, Cambridge, MA 02138 USA.	npierce@fas.harvard.edu	TATSUTA, HARUKI/F-2997-2010; Plotkin, Joshua B/E-6947-2013; Lukhtanov, Vladimir/C-6740-2008; Danchenko, Alexander/I-6660-2015	Lukhtanov, Vladimir/0000-0003-2856-2075; Danchenko, Alexander/0000-0002-4404-7287; Kandul, Nikolay/0000-0001-7347-5558				Barraclough TG, 2000, AM NAT, V155, P419, DOI 10.1086/303332; BERNARD GD, 1991, P NATL ACAD SCI USA, V88, P2783, DOI 10.1073/pnas.88.7.2783; BUTLIN RK, 1987, AM NAT, V130, P461, DOI 10.1086/284723; BUTLIN RK, 1995, TRENDS ECOL EVOL, V10, P432, DOI 10.1016/S0169-5347(00)89173-9; Coyne J.A., 2004, SPECIATION; COYNE JA, 1989, EVOLUTION, V43, P362, DOI [10.2307/2409213, 10.1111/j.1558-5646.1989.tb04233.x]; Coyne JA, 1997, EVOLUTION, V51, P295, DOI [10.1111/j.1558-5646.1997.tb02412.x, 10.2307/2410984]; Day T, 2000, EVOLUTION, V54, P715; de Lesse H., 1960, ANN SCI NAT ZOOL, V2, P1; Dobzhansky T, 1940, AM NAT, V74, P312, DOI 10.1086/280899; Drummmond B.A. III, 1984, P291; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fordyce JA, 2002, J EVOLUTION BIOL, V15, P871, DOI 10.1046/j.1420-9101.2002.00432.x; Hagen Wolfgang Ten, 2003, Nachrichten des Entomologischen Vereins Apollo, V23, P199; Jiggins CD, 2001, NATURE, V411, P302, DOI 10.1038/35077075; Kandul NP, 2004, SYST BIOL, V53, P278, DOI 10.1080/10635150490423692; Kirkpatrick M, 2002, AM NAT, V159, pS22, DOI 10.1086/338370; Lorkovic Z., 1990, P332; Lukhtanov VA, 2002, CHROMOSOME RES, V10, P5, DOI 10.1023/A:1014249607796; Marshall JL, 2002, TRENDS ECOL EVOL, V17, P558, DOI 10.1016/S0169-5347(02)02636-8; Mayr E, 1970, POPULATION SPECIES E; NOOR MA, 1995, NATURE, V375, P674, DOI 10.1038/375674a0; Noor MAF, 1999, HEREDITY, V83, P503, DOI 10.1038/sj.hdy.6886320; Nosil P, 2003, P ROY SOC B-BIOL SCI, V270, P1911, DOI 10.1098/rspb.2003.2457; Saetre GP, 1997, NATURE, V387, P589; Schurian K.G., 1980, Nachrichten des Entomologischen Vereins Apollo, V1, P21; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; TEMPLETON AR, 1981, ANNU REV ECOL SYST, V12, P23, DOI 10.1146/annurev.es.12.110181.000323; Turelli M, 2001, TRENDS ECOL EVOL, V16, P330, DOI 10.1016/S0169-5347(01)02177-2; VANEWRIGHT RI, 1993, PHILOS T R SOC B, V340, P197, DOI 10.1098/rstb.1993.0058	30	151	168	1	45	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					385	389		10.1038/nature03704	http://dx.doi.org/10.1038/nature03704			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034417				2022-12-28	WOS:000230623400041
J	Williams, SC; Schmaltz, SP; Morton, DJ; Koss, RG; Loeb, JM				Williams, SC; Schmaltz, SP; Morton, DJ; Koss, RG; Loeb, JM			Quality of care in US hospitals as reflected by standardized measures, 2002-2004	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYOCARDIAL-INFARCTION; PERFORMANCE REPORTS; IMPROVEMENT; GUIDELINES; ADULTS	Background: In July 2002, the Joint Commission on Accreditation of Healthcare Organizations implemented standardized performance measures that were designed to track the performance of accredited hospitals and encourage improvement in the quality of health care. Methods: We examined hospitals' performance on 18 standardized indicators of the quality of care for acute myocardial infarction, heart failure, and pneumonia. One measure assessed a clinical outcome (death in the hospital after acute myocardial infarction), and the other 17 measures assessed processes of care. Data were collected over a two-year period in more than 3000 accredited hospitals. All participating hospitals received quarterly feedback in the form of comparative reports throughout the study. Results: Descriptive analysis revealed a significant improvement (P<0.01) in the performance of U.S. hospitals on 15 of 18 measures, and no measure showed a significant deterioration. The magnitude of improvement ranged from 3 percent to 33 percent during the eight quarters studied. For 16 of the 17 process-of-care measures, hospitals with a low level of performance at baseline had greater improvements over the subsequent two years than hospitals with a high level of performance at baseline. Conclusions: Over a two-year period, we observed consistent improvement in measures reflecting the process of care for acute myocardial infarction, heart failure, and pneumonia. Both quantitative and qualitative research are needed to explore the reasons for these improvements.	Joint Commiss Accreditat Healthcare Org, Div Res, Oak Brook Terrace, IL 60181 USA		Williams, SC (corresponding author), Joint Commiss Accreditat Healthcare Org, Div Res, 1 Renaissance Blvd, Oak Brook Terrace, IL 60181 USA.	swilliams@jcaho.org						*AG HEALTHC RES QU, 2004 NAT HEALTHC QUA; *AM HOSP ASS, 2005, HEALTHC QUICK DISK 2; Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002; ANTMAN EM, 2005, J AM COLL CARDIOL, V45, P1376; Bartlett JG, 1998, CLIN INFECT DIS, V26, P811, DOI 10.1086/513953; Bradley EH, 2004, QUAL SAF HEALTH CARE, V13, P26, DOI 10.1136/qhc.13.1.26; Bradley EH, 2001, JAMA-J AM MED ASSOC, V285, P2604, DOI 10.1001/jama.285.20.2604; Braun BI, 1999, EVAL HEALTH PROF, V22, P283, DOI 10.1177/016327879902200301; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; CLAYTON D, 1987, BIOMETRICS, V43, P671, DOI 10.2307/2532003; Gibberd R, 2004, INT J QUAL HEALTH C, V16, pI37, DOI 10.1093/intqhc/mzh019; Hibbard JH, 2003, HEALTH AFFAIR, V22, P84, DOI 10.1377/hlthaff.22.2.84; Hunt SA, 2001, J AM COLL CARDIOL, V38, P2101, DOI 10.1016/S0735-1097(01)01683-7; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Jencks SF, 2002, JAMA-J AM MED ASSOC, V289, P2649; Jha AK, 2005, NEW ENGL J MED, V353, P265, DOI 10.1056/NEJMsa051249; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; *JOINT COMM ACCR H, COMPR REV DEV TEST N; *JOINT COMM ACCR H, PERF MEAS SYST REQ O; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; Marshall MN, 2000, JAMA-J AM MED ASSOC, V283, P1866, DOI 10.1001/jama.283.14.1866; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Palmer RH, 1998, INT J QUAL HEALTH C, V10, P477; SAS Institute, 2002, SAS STAT US GUID VER, VSixth; Schade Charles P, 2004, Jt Comm J Qual Saf, V30, P143; Schneider EC, 1996, NEW ENGL J MED, V335, P251, DOI 10.1056/NEJM199607253350406; Schneider EC, 1998, JAMA-J AM MED ASSOC, V279, P1638, DOI 10.1001/jama.279.20.1638; Watt Ann, 2003, J AHIMA, V74, P20; Winer BJ., 1970, STAT PRINCIPLES EXPT, V2nd	30	333	336	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2005	353	3					255	264		10.1056/NEJMsa043778	http://dx.doi.org/10.1056/NEJMsa043778			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YH	16034011				2022-12-28	WOS:000230608700006
J	Delanoue, R; Davis, I				Delanoue, R; Davis, I			Dynein anchors its mRNA cargo after apical transport in the Drosophila blastoderm embryo	CELL			English	Article							BICAUDAL-D PROTEIN; CYTOPLASMIC DYNEIN; BICOID RNA; XENOPUS OOCYTES; MOTOR COMPLEX; BUDDING YEAST; ANTERIOR POLE; LIGHT-CHAIN; KINESIN-I; F-ACTIN	Molecular motors actively transport many types of cargo along the cytoskeleton in a wide range of organisms. One class of cargo is localized mRNAs, which are transported by myosin on actin filaments or by kinesin and dynein on microtubules. How the cargo is kept at its final intracellular destination and whether the motors are recycled after completion of transport are poorly understood. Here, we use a new RNA anchoring assay in living Drosophila blastoderm embryos to show that apical anchoring of mRNA after completion of dynein transport does not depend on actin or on continuous active transport by the motor. Instead, apical anchoring of RNA requires microtubules and involves dynein as a static anchor that remains with the cargo at its final destination. We propose a general principle that could also apply to other dynein cargo and to some other molecular motors, whereby cargo transport and anchoring reside in the same molecule.	Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Davis, I (corresponding author), Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland.	ilan.davis@ed.ac.uk	Davis, Ilan/F-4975-2010; Delanoue, Renald/D-3093-2017; renald, delanoue/D-3109-2017	renald, delanoue/0000-0003-2479-4442; Davis, Ilan/0000-0002-5385-3053	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; Babu K, 2004, GENE DEV, V18, P138, DOI 10.1101/gad.282604; Beach DL, 1999, CURR BIOL, V9, P569, DOI 10.1016/S0960-9822(99)80260-7; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Bullock SL, 2004, DEVELOPMENT, V131, P4251, DOI 10.1242/dev.01289; Bullock SL, 2001, NATURE, V414, P611, DOI 10.1038/414611a; CALLAINI G, 1988, EXP CELL RES, V178, P415, DOI 10.1016/0014-4827(88)90410-7; DAVIS I, 1995, DEV BIOL, V170, P726, DOI 10.1006/dbio.1995.1251; DAVIS I, 1991, CELL, V67, P927, DOI 10.1016/0092-8674(91)90366-7; DAVIS I, 2000, PROTEIN LOCALISATION, P131; De Bor VV, 2004, CURR OPIN CELL BIOL, V16, P300, DOI 10.1016/j.ceb.2004.03.008; de Heredia ML, 2004, CURR OPIN CELL BIOL, V16, P80, DOI 10.1016/j.ceb.2003.11.002; Duncan JE, 2002, CURR BIOL, V12, P1982, DOI 10.1016/S0960-9822(02)01303-9; EDGAR BA, 1987, GENE DEV, V1, P1226, DOI 10.1101/gad.1.10.1226; ERDELYI M, 1995, NATURE, V377, P524, DOI 10.1038/377524a0; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; Foe VE, 2000, DEVELOPMENT, V127, P1767; Foe Victoria E., 1993, P149; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; Gepner J, 1996, GENETICS, V142, P865; Glotzer JB, 1997, CURR BIOL, V7, P326, DOI 10.1016/S0960-9822(06)00156-4; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Hoogenraad CC, 2001, EMBO J, V20, P4041, DOI 10.1093/emboj/20.15.4041; Jankovics F, 2002, CURR BIOL, V12, P2060, DOI 10.1016/S0960-9822(02)01256-3; Januschke J, 2002, CURR BIOL, V12, P1971, DOI 10.1016/S0960-9822(02)01302-7; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Lambert JD, 2002, NATURE, V420, P682, DOI 10.1038/nature01241; Latham VM, 2001, CURR BIOL, V11, P1010, DOI 10.1016/S0960-9822(01)00291-3; LI MG, 1994, J CELL BIOL, V126, P1475, DOI 10.1083/jcb.126.6.1475; MacDougall N, 2003, DEV CELL, V4, P307, DOI 10.1016/S1534-5807(03)00058-3; Mach JM, 1997, GENE DEV, V11, P423, DOI 10.1101/gad.11.4.423; Maddox PS, 2003, CURR BIOL, V13, P1423, DOI 10.1016/S0960-9822(03)00547-5; Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891; Megraw TL, 2002, J CELL SCI, V115, P4707, DOI 10.1242/jcs.00134; Miller KG, 2004, CELL, V116, P635, DOI 10.1016/S0092-8674(04)00213-2; Morris NR, 2003, CURR OPIN CELL BIOL, V15, P54, DOI 10.1016/S0955-0674(02)00004-2; Navarro C, 2004, NAT CELL BIOL, V6, P427, DOI 10.1038/ncb1122; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; Oh J, 2000, GENETICS, V154, P713; Palacios IM, 2002, DEVELOPMENT, V129, P5473, DOI 10.1242/dev.00119; Palacios IM, 2001, ANNU REV CELL DEV BI, V17, P569, DOI 10.1146/annurev.cellbio.17.1.569; Schnorrer F, 2000, NAT CELL BIOL, V2, P185, DOI 10.1038/35008601; Schnorrer F, 2002, DEV CELL, V3, P685, DOI 10.1016/S1534-5807(02)00301-5; Sharp DJ, 2000, NAT CELL BIOL, V2, P922, DOI 10.1038/35046574; Simmonds AJ, 2001, CELL, V105, P197, DOI 10.1016/S0092-8674(01)00311-7; Steffen W, 1997, MOL BIOL CELL, V8, P2077, DOI 10.1091/mbc.8.10.2077; STEPHENSON EC, 1988, GENE DEV, V2, P1655, DOI 10.1101/gad.2.12a.1655; STJOHNSTON D, 1989, DEVELOPMENT, V107, P13; SUNDELL CL, 1991, SCIENCE, V253, P1275, DOI 10.1126/science.1891715; SUTER B, 1991, CELL, V67, P917, DOI 10.1016/0092-8674(91)90365-6; Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015; Tekotte H, 2002, TRENDS GENET, V18, P636, DOI 10.1016/S0168-9525(02)02819-6; Tracey WD, 2000, GENETICS, V154, P273; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; VALE RD, 1989, CELL, V59, P915, DOI 10.1016/0092-8674(89)90614-4; Wagner C, 2001, J MOL BIOL, V313, P511, DOI 10.1006/jmbi.2001.5057; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; Wilkie GS, 2001, CELL, V105, P209, DOI 10.1016/S0092-8674(01)00312-9; YISRAELI JK, 1990, DEVELOPMENT, V108, P289	61	73	75	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 15	2005	122	1					97	106		10.1016/j.cell.2005.04.033	http://dx.doi.org/10.1016/j.cell.2005.04.033			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	950EC	16009136	Bronze			2022-12-28	WOS:000230839400014
J	El-Sayed, NM; Myler, PJ; Bartholomeu, DC; Nilsson, D; Aggarwal, G; Tran, AN; Ghedin, E; Worthey, EA; Delcher, AL; Blandin, G; Westenberger, SJ; Caler, E; Cerqueira, GC; Branche, C; Haas, B; Anupama, A; Arner, E; Aslund, L; Attipoe, P; Bontempi, E; Bringaud, F; Burton, P; Cadag, E; Campbell, DA; Carrington, M; Crabtree, J; Darban, H; da Silveira, JF; de Jong, P; Edwards, K; Englund, PT; Fazelina, G; Feldblyum, T; Ferella, M; Frasch, AC; Gull, K; Horn, D; Hou, LH; Huang, YT; Kindlund, E; Ktingbeil, M; Kluge, S; Koo, H; Lacerda, D; Levin, MJ; Lorenzi, H; Louie, T; Machado, CR; McCulloch, R; McKenna, A; Mizuno, Y; Mottram, JC; Nelson, S; Ochaya, S; Osoegawa, K; Pai, G; Parsons, M; Pentony, M; Pettersson, U; Pop, M; Ramirez, JL; Rinta, J; Robertson, L; Salzberg, SL; Sanchez, DO; Seyler, A; Sharma, R; Shetty, J; Simpson, AJ; Sisk, E; Tammi, MT; Tarteton, R; Teixeira, S; Van Aken, S; Vogt, C; Ward, PN; Wickstead, B; Wortman, J; White, O; Fraser, CM; Stuart, KD; Andersson, B				El-Sayed, NM; Myler, PJ; Bartholomeu, DC; Nilsson, D; Aggarwal, G; Tran, AN; Ghedin, E; Worthey, EA; Delcher, AL; Blandin, G; Westenberger, SJ; Caler, E; Cerqueira, GC; Branche, C; Haas, B; Anupama, A; Arner, E; Aslund, L; Attipoe, P; Bontempi, E; Bringaud, F; Burton, P; Cadag, E; Campbell, DA; Carrington, M; Crabtree, J; Darban, H; da Silveira, JF; de Jong, P; Edwards, K; Englund, PT; Fazelina, G; Feldblyum, T; Ferella, M; Frasch, AC; Gull, K; Horn, D; Hou, LH; Huang, YT; Kindlund, E; Ktingbeil, M; Kluge, S; Koo, H; Lacerda, D; Levin, MJ; Lorenzi, H; Louie, T; Machado, CR; McCulloch, R; McKenna, A; Mizuno, Y; Mottram, JC; Nelson, S; Ochaya, S; Osoegawa, K; Pai, G; Parsons, M; Pentony, M; Pettersson, U; Pop, M; Ramirez, JL; Rinta, J; Robertson, L; Salzberg, SL; Sanchez, DO; Seyler, A; Sharma, R; Shetty, J; Simpson, AJ; Sisk, E; Tammi, MT; Tarteton, R; Teixeira, S; Van Aken, S; Vogt, C; Ward, PN; Wickstead, B; Wortman, J; White, O; Fraser, CM; Stuart, KD; Andersson, B			The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease	SCIENCE			English	Article							MULTILOCUS ENZYME ELECTROPHORESIS; PARASITE PLASMODIUM-FALCIPARUM; AMPLIFIED POLYMORPHIC DNA; NON-LTR RETROTRANSPOSONS; RNA INTERFERENCE RNAI; CLONE CL BRENER; TRANS-SIALIDASE; PROTEIN-KINASE; AFRICAN TRYPANOSOMES; NUCLEOTIDE-SEQUENCE	Whole-genome sequencing of the protozoan pathogen Trypanosoma cruzi revealed that the diploid genome contains a predicted 22,570 proteins encoded by genes, of which 12,570 represent allelic pairs. Over 50% of the genome consists of repeated sequences, such as retrotransposons and genes for large, families of surface molecules, which include trans-sialidases, mucins, gp63s, and a large novel family (>1300 copies) of mucin-associated surface protein (MASP) genes. Analyses of the T. cruzi, T. brucei, and Leishmania major (Tritryp) genomes imply differences from other eukaryotes in DNA repair and initiation of replication and reflect their unusual mitochondrial DNA. Although the Tritryp lack several classes of signaling molecules, their kinomes contain a large and diverse set of protein kinases and phosphatases; their size and diversity imply previously unknown interactions and regulatory processes, which may be targets for intervention.	Inst Genome Res, Dept Parasite Genom, Rockville, MD 20850 USA; George Washington Univ, Dept Microbiol & Trop Med, Washington, DC 20052 USA; Seattle Biomed Res Inst, Seattle, WA 98109 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Pathobiol, Seattle, WA 98195 USA; Univ Washington, Dept Med Educ & Biomed Informat, Seattle, WA 98195 USA; Karolinska Inst, Ctr Genom & Bioinformat, S-17177 Stockholm, Sweden; Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; Univ Fed Minas Gerais, Dept Bioquim 7 Imunol, BR-31270901 Belo Horizonte, MG, Brazil; Uppsala Univ, Dept Genet & Pathol, SE-75185 Uppsala, Sweden; Adm Nacl Labs, Inst Nacl Parasitol Dr M Fatala Chaben, RA-1063 Buenos Aires, DF, Argentina; Inst Salud ANUS, RA-1063 Buenos Aires, DF, Argentina; Univ Bordeaux 2, CNRS, UMR 5162, LabGenom Fonct Trypanosomatides, F-33076 Bordeaux, France; Univ Glasgow, Wellcome Ctr Mol Parasitol, Glasgow G11 6NU, Lanark, Scotland; Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, BR-04023062 Sao Paulo, Brazil; Childrens Hosp, Oakland Res Inst, BACPAC Resources, Oakland, CA 94609 USA; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Natl Univ San Martin, Inst Invest Biotecnol, Inst Tecnol Chascomus, RA-1650 Buenos Aires, DF, Argentina; CNR, RA-1650 Buenos Aires, DF, Argentina; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; Fundacao Oswaldo Cruz, Rene Rachou Res Ctr CPqRR, Belo Horizonte, MG, Brazil; Univ Buenos Aires, Ctr Genom Aplicada, Sch Sci,CONICET,CYTED Project,Natl Res Council, Lab Mol Biol Chagas Dis,Inst Invest Ingn Genet &, RA-1428 Buenos Aires, DF, Argentina; Cent Univ Venezuela, Inst Expt Biol, Caracas 1041A, Venezuela; ADEA MCT, Caracas 1041A, Venezuela; Natl Univ Singapore, Dept Biol Sci & Biochem, Singapore 117548, Singapore; Univ Georgia, Dept Cellular Biol, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA	J. Craig Venter Institute; George Washington University; Center for Infectious Disease Research; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Karolinska Institutet; University of California System; University of California Los Angeles; Universidade Federal de Minas Gerais; Uppsala University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; University of Glasgow; University of Cambridge; Universidade Federal de Sao Paulo (UNIFESP); Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Johns Hopkins University; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of Massachusetts System; University of Massachusetts Amherst; Fundacao Oswaldo Cruz; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Central Venezuela; National University of Singapore; University System of Georgia; University of Georgia	El-Sayed, NM (corresponding author), Inst Genome Res, Dept Parasite Genom, Rockville, MD 20850 USA.	neisayed@tigr.org; peter.myler@sbri.org; bjorn.andersson@cgb.ki.se	Bartholomeu, Daniella C./J-4714-2015; Simpson, Amelia/HGB-1823-2022; Tammi, Martti T/C-1115-2008; da Silveira, Jose Franco/F-5390-2012; Arner, Erik/A-1895-2010; Sharma, Reuben/AAI-6444-2020; Machado, Carlos Renato/H-1043-2015; MACHADO, CARLOS/AAW-1492-2020; Salzberg, Steven/Q-6514-2019; Myler, Peter John/AAR-9535-2021; Blandin, Gaelle/N-9745-2013; Ghedin, Elodie/Y-5654-2019; TEIXEIRA, SANTUZA MR/I-8137-2013; El-Sayed, Najib M.A./K-7266-2015; Tarleton, Rick/AES-8572-2022; Ramirez, Jose Luis/AAE-3117-2021; Nilsson, Daniel/B-8365-2009; Andersson, Bjorn/G-9832-2013; Salzberg, Steven L/F-6162-2011; Carrington, Mark/N-4892-2018; Cerqueira, Gustavo/AAV-7398-2020; Carrington, Mark/N-3653-2019; Pop, Mihai/A-7987-2013	Bartholomeu, Daniella C./0000-0003-0974-7357; Arner, Erik/0000-0003-1225-4908; Machado, Carlos Renato/0000-0002-8724-3165; Salzberg, Steven/0000-0002-8859-7432; Blandin, Gaelle/0000-0003-2790-9524; Ghedin, Elodie/0000-0002-1515-725X; El-Sayed, Najib M.A./0000-0001-7970-3312; Nilsson, Daniel/0000-0001-5831-385X; Andersson, Bjorn/0000-0002-4624-0259; Salzberg, Steven L/0000-0002-8859-7432; Carrington, Mark/0000-0002-6435-7266; Cerqueira, Gustavo/0000-0002-7692-3886; Carrington, Mark/0000-0002-6435-7266; Pop, Mihai/0000-0001-9617-5304; sanchez, daniel/0000-0002-5427-7764; Tarleton, Rick/0000-0002-9589-5243; Wortman, Jennifer/0000-0002-8713-1227; Bontempi, Esteban/0000-0001-8182-2089; Ward, Pauline/0000-0001-9455-0983; Klingbeil, Michele/0000-0002-7236-8424; Wickstead, Bill/0000-0002-4620-9091; Frasch, Alberto Carlos/0000-0001-7532-653X; Horn, David/0000-0001-5173-9284; Lorenzi, Hernan/0000-0003-0910-7894; Mottram, Jeremy/0000-0001-5574-3766; Fraser, Claire/0000-0003-1462-2428; Myler, Peter/0000-0002-0056-0513; Parsons, Marilyn/0000-0003-3994-8096	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI045038, U01AI045061, R01AI031077, U01AI045039] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI031077, AI45061, AI045039, R01 AI031077-11, U01 AI045039, AI45038, U01 AI045038] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission)		Agusti R, 1998, MOL BIOCHEM PARASIT, V97, P123, DOI 10.1016/S0166-6851(98)00137-6; AKSOY S, 1987, EMBO J, V6, P3819, DOI 10.1002/j.1460-2075.1987.tb02718.x; Allen CL, 2001, EXP PARASITOL, V97, P173, DOI 10.1006/expr.2001.4600; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Beverley SM, 2003, NAT REV GENET, V4, P11, DOI 10.1038/nrg980; Bringaud F, 2004, MOL BIOL EVOL, V21, P520, DOI 10.1093/molbev/msh045; Bringaud F, 2002, EUKARYOT CELL, V1, P137, DOI 10.1128/EC.1.1.137-151.2002; Bringaud F, 2002, MOL BIOCHEM PARASIT, V124, P73, DOI 10.1016/S0166-6851(02)00167-6; Briones MRS, 1999, MOL BIOCHEM PARASIT, V104, P219, DOI 10.1016/S0166-6851(99)00155-3; Brisse S, 1998, MOL BIOCHEM PARASIT, V92, P253, DOI 10.1016/S0166-6851(98)00005-X; Brisse S, 2000, INT J PARASITOL, V30, P35, DOI 10.1016/S0020-7519(99)00168-X; Brisse S, 2003, INFECT GENET EVOL, V2, P173, DOI 10.1016/S1567-1348(02)00097-7; Buscaglia CA, 2004, J BIOL CHEM, V279, P15860, DOI 10.1074/jbc.M314051200; Campo V, 2004, MOL BIOCHEM PARASIT, V133, P81, DOI 10.1016/j.molbiopara.2003.09.006; CANO MI, 1995, MOL BIOCHEM PARASIT, V71, P273, DOI 10.1016/0166-6851(95)00066-A; Cano MIN, 1999, P NATL ACAD SCI USA, V96, P3616, DOI 10.1073/pnas.96.7.3616; Chiurillo MA, 1999, MOL BIOCHEM PARASIT, V100, P173, DOI 10.1016/S0166-6851(99)00047-X; CLARK CG, 1994, MOL BIOCHEM PARASIT, V66, P175, DOI 10.1016/0166-6851(94)90045-0; Conway C, 2002, J BIOL CHEM, V277, P21269, DOI 10.1074/jbc.M200550200; Cross M, 2002, MOL MICROBIOL, V46, P37, DOI 10.1046/j.1365-2958.2002.03144.x; DaRocha WD, 2004, MOL BIOCHEM PARASIT, V133, P175, DOI 10.1016/j.molbiopara.2003.10.005; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; Elias MCQB, 2005, MOL BIOCHEM PARASIT, V140, P221, DOI 10.1016/j.molbiopara.2004.12.016; Ferguson MAJ, 1997, PHILOS T ROY SOC B, V352, P1295, DOI 10.1098/rstb.1997.0113; Frasch ACC, 2000, PARASITOL TODAY, V16, P282, DOI 10.1016/S0169-4758(00)01698-7; Fujimura AE, 2001, INFECT IMMUN, V69, P5477, DOI 10.1128/IAI.69.9.5477-5486.2001; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gaunt MW, 2003, NATURE, V421, P936, DOI 10.1038/nature01438; Ghedin E, 2004, MOL BIOCHEM PARASIT, V134, P183, DOI 10.1016/j.molbiopara.2003.11.012; Grams J, 2002, J BIOL CHEM, V277, P16952, DOI 10.1074/jbc.M200662200; Hammarton Tansy C, 2003, Prog Cell Cycle Res, V5, P91; HASAN G, 1984, CELL, V37, P333, DOI 10.1016/0092-8674(84)90329-5; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; JENNI L, 1986, NATURE, V322, P173, DOI 10.1038/322173a0; Kelman LM, 2003, MOL MICROBIOL, V48, P605, DOI 10.1046/j.1365-2958.2003.03369.x; KIMMEL BE, 1987, MOL CELL BIOL, V7, P1465, DOI 10.1128/MCB.7.4.1465; Klingbeil MM, 2002, MOL CELL, V10, P175, DOI 10.1016/S1097-2765(02)00571-3; Liu Y, 2000, MOL CELL BIOL, V20, P8178, DOI 10.1128/MCB.20.21.8178-8184.2000; Machado CA, 2001, P NATL ACAD SCI USA, V98, P7396, DOI 10.1073/pnas.121187198; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Montagna G, 2002, EUR J BIOCHEM, V269, P2941, DOI 10.1046/j.1432-1033.2002.02968.x; Muller IB, 2002, MOL BIOL CELL, V13, P3787, DOI 10.1091/mbc.E02-02-0093; Olivares M, 2000, ELECTROPHORESIS, V21, P2973, DOI 10.1002/1522-2683(20000801)21:14&lt;2973::AID-ELPS2973&gt;3.0.CO;2-4; Pays E, 2004, CURR OPIN MICROBIOL, V7, P369, DOI 10.1016/j.mib.2004.05.001; Pedroso A, 2003, MOL BIOCHEM PARASIT, V129, P79, DOI 10.1016/S0166-6851(03)00096-3; Pena-Diaz J, 2004, J MOL BIOL, V342, P787, DOI 10.1016/j.jmb.2004.07.043; POLLEVICK GD, 1991, MOL BIOCHEM PARASIT, V47, P247, DOI 10.1016/0166-6851(91)90185-9; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Saxowsky TT, 2003, J BIOL CHEM, V278, P49095, DOI 10.1074/jbc.M308565200; Sinha KM, 2004, P NATL ACAD SCI USA, V101, P4361, DOI 10.1073/pnas.0305705101; Sturm NR, 2003, INT J PARASITOL, V33, P269, DOI 10.1016/S0020-7519(02)00264-3; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Turner CMR, 2004, PARASITOLOGY, V129, P445, DOI 10.1017/S0031182004005906; Vastenhouw NL, 2003, CURR BIOL, V13, P1311, DOI 10.1016/s0960-9822(03)00539-6; VILLANUEVA MS, 1991, MOL CELL BIOL, V11, P6139, DOI 10.1128/MCB.11.12.6139; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; WESTENBERGER SJ, IN PRESS GENETICS; Wiese M, 2003, EUKARYOT CELL, V2, P769, DOI 10.1128/EC.2.4.769-777.2003; WINCKER P, 1992, MOL BIOCHEM PARASIT, V55, P217, DOI 10.1016/0166-6851(92)90142-7; WOODWARD R, 1990, J CELL SCI, V95, P49; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Yao CQ, 2003, MOL BIOCHEM PARASIT, V132, P1, DOI 10.1016/S0166-6851(03)00211-1; Zingales B, 1997, ACTA TROP, V68, P159, DOI 10.1016/S0001-706X(97)00088-0; 1999, MEM I O CRUZ, V94, P429	67	1077	1161	2	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					409	415		10.1126/science.1112631	http://dx.doi.org/10.1126/science.1112631			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020725	Green Published			2022-12-28	WOS:000230574900035
J	[Anonymous]				[Anonymous]			The trypanosomatid genomes: Plates	SCIENCE			English	Article																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					423	435						13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020727				2022-12-28	WOS:000230574900037
J	Casarett, D; Karlawish, J; Morales, K; Crowley, R; Mirsch, T; Asch, DA				Casarett, D; Karlawish, J; Morales, K; Crowley, R; Mirsch, T; Asch, DA			Improving the use of hospice services in nursing homes - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-LIFE CARE; HEALTH-CARE; ADVANCE DIRECTIVES; END; COMPLETION; PATIENT; PAIN; PREFERENCES; MANAGEMENT; PHYSICIANS	Context Hospice care may improve the quality of end-of-life care for nursing home residents, but hospice is underutilized by this population, at least in part because physicians are not aware of their patients' preferences. Objective To determine whether it is possible to increase hospice utilization and improve the quality of end-of-life care by identifying residents whose goals and preferences are consistent with hospice care. Design, Setting, and Participants Randomized controlled trial (December 2003-December 2004) of nursing home residents and their surrogate decision makers (N=205) in 3 US nursing homes. Intervention A structured interview identified residents whose goals for care, treatment preferences, and palliative care needs made them appropriate for hospice care. These residents' physicians were notified and asked to authorize a hospice informational visit. Main Outcome Measures The primary outcome measures were (1) hospice enrollment within 30 days of the intervention and (2) families' ratings of the quality of care for residents who died during the 6-month follow-up period. Results Of the 205 residents in the study sample, 107 were randomly assigned to receive the intervention, and 98 received usual care. Intervention residents were more likely than usual care residents to enroll in hospice within 30 days (21/107 [20%] vs 1/98 [1%]; P<.001 [Fisher exact test]) and to enroll in hospice during the follow-up period (27/207 [25%] vs 6/98 [6%]; P<.001). Intervention residents had fewer acute care admissions (mean: 0.28 vs 0.49; P=.04 [Wilcoxon rank sum test]) and spent fewer days in an acute care setting (mean: 1.2 vs 3.0; P=.03 [Wilcoxon rank sum test]). Families of intervention residents rated the resident's care more highly than did families of usual care residents (mean on a scale of 1-5: 4.1 vs 2.5; P=.04 [Wilcoxon rank sum test]). Conclusion A simple communication intervention can increase rates of hospice referrals and families' ratings of end-of-life care and may also decrease utilization of acute care resources.	Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equity Res & Promot, Philadelphia, PA USA; Univ Penn, Div Geriatr Med, Philadelphia, PA 19104 USA; Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA; Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Temple Univ, Sch Law, Philadelphia, PA 19122 USA; Holy Redeemer Home Hlth & Hospice Care, Philadelphia, PA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Casarett, D (corresponding author), 3615 Chestnut St, Philadelphia, PA 19104 USA.	casarett@mail.med.upenn.edu		Asch, David/0000-0002-7970-286X				Baer WM, 2000, J AM GERIATR SOC, V48, P879, DOI 10.1111/j.1532-5415.2000.tb06883.x; Bernabei R, 1998, JAMA-J AM MED ASSOC, V279, P1877, DOI 10.1001/jama.279.23.1877; Boockvar K, 2004, ARCH INTERN MED, V164, P545, DOI 10.1001/archinte.164.5.545; Byock IR, 1996, J PAIN SYMPTOM MANAG, V11, P69, DOI 10.1016/0885-3924(95)00154-9; Casarett D, 2005, J AM GERIATR SOC, V53, P249, DOI 10.1111/j.1532-5415.2005.53110.x; Casarett DJ, 2004, J AM GERIATR SOC, V52, P1923, DOI 10.1111/j.1532-5415.2004.52520.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Christakis NA, 1998, ARCH INTERN MED, V158, P2389, DOI 10.1001/archinte.158.21.2389; Cohen-Mansfield J, 1999, J CLIN EPIDEMIOL, V52, P273, DOI 10.1016/S0895-4356(98)00156-5; *CTR MED MED SERV, LAST YEAR LIF STUD S; *CTR MED MED SERV, MDS QUAL IND RES REP; Daugherty CK, 2002, J CLIN ONCOL, V20, P2752, DOI 10.1200/JCO.2002.20.11.2752; Desbiens NA, 1998, J PAIN SYMPTOM MANAG, V16, P281, DOI 10.1016/S0885-3924(98)00092-X; Dexter PR, 1998, ANN INTERN MED, V128, P102, DOI 10.7326/0003-4819-128-2-199801150-00005; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hanson Laura C, 2002, J Palliat Med, V5, P117; Hanson LC, 1997, J AM GERIATR SOC, V45, P1339, DOI 10.1111/j.1532-5415.1997.tb02933.x; Happ MB, 2002, J AM GERIATR SOC, V50, P829, DOI 10.1046/j.1532-5415.2002.50207.x; HAUPT BJ, 2003, VITAL HLTH STAT 13, V154, P1; Hofmann JC, 1997, ANN INTERN MED, V127, P1, DOI 10.7326/0003-4819-127-1-199707010-00001; KANE RL, 1984, LANCET, V1, P890; KATZ S, 1976, MED CARE, V14, P116, DOI 10.1097/00005650-197605001-00018; KEAY TJ, 1994, J AM GERIATR SOC, V42, P853, DOI 10.1111/j.1532-5415.1994.tb06557.x; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Levy CR, 2004, J AM GERIATR SOC, V52, P1247, DOI 10.1111/j.1532-5415.2004.52352.x; Lilly CM, 2000, AM J MED, V109, P469, DOI 10.1016/S0002-9343(00)00524-6; McGorty EK, 2003, J EVAL CLIN PRACT, V9, P363, DOI 10.1046/j.1365-2753.2003.00406.x; Meier DE, 1996, ARCH INTERN MED, V156, P1227, DOI 10.1001/archinte.156.11.1227; Miller SC, 2003, J AM GERIATR SOC, V51, P798, DOI 10.1046/j.1365-2389.2003.51253.x; Miller SC, 2003, J PAIN SYMPTOM MANAG, V26, P791, DOI 10.1016/S0885-3924(03)00284-7; Miller SC, 2001, AM J MED, V111, P38, DOI 10.1016/S0002-9343(01)00747-1; Miller SC, 2002, J AM GERIATR SOC, V50, P507, DOI 10.1046/j.1532-5415.2002.50118.x; Miller Susan C, 2003, J Palliat Med, V6, P725, DOI 10.1089/109662103322515239; Mitchell SL, 2004, ARCH INTERN MED, V164, P321, DOI 10.1001/archinte.164.3.321; Molloy DW, 2000, JAMA-J AM MED ASSOC, V283, P1437, DOI 10.1001/jama.283.11.1437; MORRISON RS, 1995, JAMA-J AM MED ASSOC, V274, P478, DOI 10.1001/jama.274.6.478; *NAT HOSP PALL CAR, HSP FACTS FIG; PORTENOY RK, 1994, EUR J CANCER, V30A, P1326, DOI 10.1016/0959-8049(94)90182-1; REILLY BM, 1995, ARCH INTERN MED, V155, P2202, DOI 10.1001/archinte.155.20.2202; Richter K P, 1995, Arch Fam Med, V4, P609, DOI 10.1001/archfami.4.7.609; RICKERSON E, IN PRESS J AM GERIAT; RUBIN SM, 1994, JAMA-J AM MED ASSOC, V271, P209, DOI 10.1001/jama.271.3.209; SACHS GA, 1992, J AM GERIATR SOC, V40, P269, DOI 10.1111/j.1532-5415.1992.tb02081.x; SCULLY T, 2002, COMMUNICATION   0524; TENO J, BROWN ATLAS DYING US; Teno JM, 2001, J PAIN SYMPTOM MANAG, V22, P752, DOI 10.1016/S0885-3924(01)00331-1; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Tolle SW, 2000, NURS RES, V49, P310, DOI 10.1097/00006199-200011000-00003; Wenger NS, 2000, J AM GERIATR SOC, V48, pS44, DOI 10.1111/j.1532-5415.2000.tb03140.x; Wenger NS, 2001, JAMA-J AM MED ASSOC, V285, P2880, DOI 10.1001/jama.285.22.2880; Zerzan J, 2000, JAMA-J AM MED ASSOC, V284, P2489, DOI 10.1001/jama.284.19.2489	51	156	157	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2005	294	2					211	217		10.1001/jama.294.2.211	http://dx.doi.org/10.1001/jama.294.2.211			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944DO	16014595				2022-12-28	WOS:000230406100025
J	Leong, AL				Leong, AL			Commentary: Challenging the patience of patients	BRITISH MEDICAL JOURNAL			English	Editorial Material											Leong, AL (corresponding author), 1416 Tanglewood Dr, N Wales, PA 19454 USA.	AmyeLeong@aol.com						Clark J, 2005, BRIT MED J, V331, P101, DOI 10.1136/bmj.331.7508.101; Leong AL, 2004, B WORLD HEALTH ORGAN, V82, P115; 2004, ANN REPORT GLOBAL VO	3	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 9	2005	331	7508					107	107		10.1136/bmj.331.7508.107	http://dx.doi.org/10.1136/bmj.331.7508.107			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945XR	16002890	Green Published			2022-12-28	WOS:000230536800024
J	Hatano, T; Stopa, M; Tarucha, S				Hatano, T; Stopa, M; Tarucha, S			Single-electron delocalization in hybrid vertical-lateral double quantum dots	SCIENCE			English	Article							COULOMB-BLOCKADE; ARTIFICIAL MOLECULES; TRANSPORT	We used a hybrid vertical-lateral double-dot device, consisting of laterally coupled vertical quantum dots, to measure the interdot tunnel coupling. By using nonlinear transport measurements of "Coulomb diamonds," we showed that an inherent asymmetry in the capacitances of the component dots influences the diamond slopes, thereby allowing for the determination of the dot through which the electron has passed. We used this technique to prepare a delocalized one-electron state and Heitler-London (HL) two-electron state, and we showed that the interdot tunnel coupling, which determines whether HL is the ground state, is tunable. This implies that our device may be useful for implementing two-electron spin entanglement.	Japan Sci & Tedchnol Agcy, Int Cooperat Res Project, Quantum Spin Informat Project, Atsugi, Kanagawa 2430198, Japan; Harvard Univ, Ctr Nanoscale Syst, Cambridge, MA 02138 USA; Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1130033, Japan	Japan Science & Technology Agency (JST); Harvard University; University of Tokyo	Hatano, T (corresponding author), Japan Sci & Tedchnol Agcy, Int Cooperat Res Project, Quantum Spin Informat Project, Morinosato Wakamiya 3-1, Atsugi, Kanagawa 2430198, Japan.		Hatano, Tsuyoshi/B-3182-2013; Hatano, Tsuyoshi/E-8308-2019; Hatano, Tsuyoshi/AAM-2310-2020; TARUCHA, SEIGO/I-7030-2012	Hatano, Tsuyoshi/0000-0002-6173-6404; Hatano, Tsuyoshi/0000-0002-6173-6404; Hatano, Tsuyoshi/0000-0002-6173-6404; 				Amaha S, 2001, SOLID STATE COMMUN, V119, P183, DOI 10.1016/S0038-1098(01)00176-4; Austing DG, 1997, SEMICOND SCI TECH, V12, P631, DOI 10.1088/0268-1242/12/5/018; Blick RH, 1998, PHYS REV LETT, V80, P4032, DOI 10.1103/PhysRevLett.80.4032; Brodsky M, 2000, PHYS REV LETT, V85, P2356, DOI 10.1103/PhysRevLett.85.2356; Burkard G, 1999, PHYS REV B, V59, P2070, DOI 10.1103/PhysRevB.59.2070; Chan IH, 2004, NANOTECHNOLOGY, V15, P609, DOI 10.1088/0957-4484/15/5/035; DiCarlo L, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.226801; Elzerman JM, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.161308; Fulde P., 1995, ELECT CORRELATIONS M; Golden JM, 1996, PHYS REV B, V53, P3893, DOI 10.1103/PhysRevB.53.3893; Hatano T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.066806; Hatano T, 2004, PHYSICA E, V22, P534, DOI 10.1016/j.physe.2003.12.063; Holleitner AW, 2002, SCIENCE, V297, P70, DOI 10.1126/science.1071215; Livermore C, 1996, SCIENCE, V274, P1332, DOI 10.1126/science.274.5291.1332; Loss D, 2000, PHYS REV LETT, V84, P1035, DOI 10.1103/PhysRevLett.84.1035; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Matveev KA, 1996, PHYS REV B, V54, P5637, DOI 10.1103/PhysRevB.54.5637; Oosterkamp TH, 1998, NATURE, V395, P873, DOI 10.1038/27617; Pioro-Ladriere M, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.026803; Qin H, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.241302; Rontani M, 2001, SOLID STATE COMMUN, V119, P309, DOI 10.1016/S0038-1098(01)00226-5; van der Wiel WG, 2003, REV MOD PHYS, V75, P1, DOI 10.1103/RevModPhys.75.1	23	118	120	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2005	309	5732					268	271		10.1126/science.1111205	http://dx.doi.org/10.1126/science.1111205			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002610				2022-12-28	WOS:000230449800035
J	Troshin, PA; Avent, AG; Darwish, AD; Martsinovich, N; Abdul-Sada, AK; Street, JM; Taylor, R				Troshin, PA; Avent, AG; Darwish, AD; Martsinovich, N; Abdul-Sada, AK; Street, JM; Taylor, R			Isolation of two seven-membered ring C-58 fullerene derivatives: C58F17CF3 and C58F18	SCIENCE			English	Article							UNSYMMETRICAL C60ME5O3H; FRAGMENTATION; CARBON; C-36	Fluorination of C-60 at 550 degrees C leads to milligram quantities of two stable fullerene derivatives with 58-carbon cage structures: C58F18 and C58F17CF3. The compounds were characterized by mass spectrometry and fluorine nuclear magnetic resonance spectroscopy, and the data support a heptagonal ring in the framework. The resulting strain, which has hindered past attempts to prepare these smaller quasi-fullerenes, is mitigated here by hybridization change of some of the carbons in the pentagons from sp(2) to sp(3) because of fluorine addition. The loss of carbon from C-60 is believed to occur via sequential fluorine addition to a C-C single bond and an adjacent C=C bond, followed by loss of a :CF2 carbene.	Univ Sussex, Dept Chem, Brighton BN1 9QJ, E Sussex, England; Russian Acad Sci, Inst Problems Chem Phys, Chernogolovka 142432, Russia; Univ Southampton, Sch Chem, Southampton SO17 1BJ, Hants, England	University of Sussex; Russian Academy of Sciences; Institute of Problems of Chemical Physics of the Russian Academy of Sciences; University of Southampton	Taylor, R (corresponding author), Univ Sussex, Dept Chem, Brighton BN1 9QJ, E Sussex, England.	R.Taylor@sussex.ac.uk	Troshin, Pavel A/A-5128-2014	Troshin, Pavel A/0000-0001-9957-4140; Martsinovich, Natalia/0000-0001-9226-8175				Abdul-Sada AK, 1999, J CHEM SOC PERK T 2, P2659, DOI 10.1039/a907606i; Al-Matar H, 2000, CHEM COMMUN, P1071, DOI 10.1039/b002254n; Al-Matar H, 2001, ORG LETT, V3, P1669, DOI 10.1021/ol0100531; Al-Matar H, 2002, J CHEM SOC PERK T 2, P53, DOI 10.1039/b108292m; Avent AG, 2002, CHEM COMMUN, P2726, DOI 10.1039/b208670k; AVENT AG, 2004, RECENT ADV CHEM PHYS, V14, P249; BELLAMY LJ, 1975, INFRARED SPECTRA COM, P39; Boltalina OV, 2000, J CHEM SOC PERK T 2, P2410, DOI 10.1039/b006890j; Boltalina OV, 1996, CHEM COMMUN, P2549, DOI 10.1039/cc9960002549; BOLTALINA OV, 1997, RECENT ADV CHEM PHYS, V14, P257; Bottcher A, 2004, PHYS CHEM CHEM PHYS, V6, P5213, DOI 10.1039/b413464h; Darwish AD, 2001, J CHEM SOC PERK T 2, P1038, DOI 10.1039/b102713c; Darwish AD, 1997, FULLERENE SCI TECHN, V5, P705, DOI 10.1080/15363839708012227; Fowler PW, 2001, J CHEM SOC PERK T 2, P487, DOI 10.1039/b009370j; Hitchcock PB, 2005, ORG LETT, V7, P1975, DOI 10.1021/ol050441t; Jones R, 1998, SEMICONDUCT SEMIMET, V51, P287; KROTO HW, 1987, NATURE, V329, P529, DOI 10.1038/329529a0; Neretin IS, 2000, ANGEW CHEM INT EDIT, V39, P3273, DOI 10.1002/1521-3773(20000915)39:18<3273::AID-ANIE3273>3.0.CO;2-F; Piskoti C, 1998, NATURE, V393, P771, DOI 10.1038/31668; STONE AJ, 1986, CHEM PHYS LETT, V128, P501, DOI 10.1016/0009-2614(86)80661-3; Taylor R, 2001, CHEM-EUR J, V7, P4074, DOI 10.1002/1521-3765(20011001)7:19<4074::AID-CHEM4074>3.0.CO;2-U; TAYLOR R, 1992, INTERDISCIPL SCI REV, V17, P161; TAYLOR R, 1999, LECT NOTES FULLERENE, P126; Xie SY, 2004, SCIENCE, V304, P699, DOI 10.1126/science.1095567	24	136	143	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2005	309	5732					278	281		10.1126/science.1111904	http://dx.doi.org/10.1126/science.1111904			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	944SP	16002613				2022-12-28	WOS:000230449800038
J	Koppens, FHL; Folk, JA; Elzerman, JM; Hanson, R; van Beveren, LHW; Vink, IT; Tranitz, HP; Wegscheider, W; Kouwenhoven, LP; Vandersypen, LMK				Koppens, FHL; Folk, JA; Elzerman, JM; Hanson, R; van Beveren, LHW; Vink, IT; Tranitz, HP; Wegscheider, W; Kouwenhoven, LP; Vandersypen, LMK			Control and detection of singlet-triplet mixing in a random nuclear field	SCIENCE			English	Article							ELECTRON-SPIN; QUANTUM	We observed mixing between two-electron singlet and triplet states in a double quantum dot, caused by interactions with nuclear spins in the host semiconductor. This mixing was suppressed when we applied a small magnetic field or increased the interdot tunnel coupling and thereby the singlet-triplet splitting. Electron transport involving transitions between triplets and singlets in turn polarized the nuclei, resulting in marked bistabilities. We extract from the fluctuating nuclear field a [imitation on the time-averaged spin coherence time T*(2) of 25 nanoseconds. Control of the electron-nuclear interaction will therefore be crucial for the coherent manipulation of individual electron spins.	Delft Univ Technol, Kavli Inst Nanosci, NL-2600 GA Delft, Netherlands; Univ Regensburg, Inst Angew & Expt Phys, D-8400 Regensburg, Germany	Delft University of Technology; University of Regensburg	Vandersypen, LMK (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, POB 5046, NL-2600 GA Delft, Netherlands.	lieven@qt.tn.tudelft.nl	Wegscheider, Werner H/D-1493-2010; Folk, Joshua A/E-6287-2017; Hanson, Ronald/B-9555-2008; Elzerman, Jeroen M/J-3551-2012; Koppens, Frank/X-4422-2018; van Beveren, Laurens Willems/B-4301-2008	Folk, Joshua A/0000-0003-4455-5609; Elzerman, Jeroen M/0000-0002-4596-8483; Koppens, Frank/0000-0001-9764-6120; van Beveren, Laurens Willems/0000-0002-4404-0042				Bracker AS, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047402; Braun PF, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.116601; COLSH WA, 2004, PHYS REV B, V70; de Sousa R, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.033301; DOBERS M, 1988, PHYS REV LETT, V61, P1650, DOI 10.1103/PhysRevLett.61.1650; Elzerman JM, 2004, NATURE, V430, P431, DOI 10.1039/nature02693; Eto M, 2004, J PHYS SOC JPN, V73, P307, DOI 10.1143/JPSJ.73.307; Fujisawa T, 1998, SCIENCE, V282, P932, DOI 10.1126/science.282.5390.932; Gammon D, 1997, SCIENCE, V277, P85, DOI 10.1126/science.277.5322.85; Gammon D, 2001, PHYS REV LETT, V86, P5176, DOI 10.1103/PhysRevLett.86.5176; Huttel AK, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.073302; Johnson AC, 2005, NATURE, V435, P925, DOI 10.1038/nature03815; JOHNSON AC, 2004, CONDMAT0410679; JOURAVLEV ON, COMMUNICATION; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Khaetskii AV, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.186802; Kroutvar M, 2004, NATURE, V432, P81, DOI 10.1038/nature03008; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Meier F., 1984, OPTICAL ORIENTATION; Merkulov IA, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.205309; Ono K, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.256803; Ono K, 2002, SCIENCE, V297, P1313, DOI 10.1126/science.1070958; PAGET D, 1977, PHYS REV B, V15, P5780, DOI 10.1103/PhysRevB.15.5780; Schliemann J, 2003, J PHYS-CONDENS MAT, V15, pR1809, DOI 10.1088/0953-8984/15/50/R01; Taylor JM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.246802; van der Wiel WG, 2003, REV MOD PHYS, V75, P1, DOI 10.1103/RevModPhys.75.1	27	471	478	3	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2005	309	5739					1346	1350		10.1126/science.1113719	http://dx.doi.org/10.1126/science.1113719			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TX	16037418	Green Submitted			2022-12-28	WOS:000231543300036
J	Christensen, PR; McSween, HY; Bandfield, JL; Ruff, SW; Rogers, AD; Hamilton, VE; Gorelick, N; Wyatt, MB; Jakosky, BM; Kieffer, HH; Malin, MC; Moersch, JE				Christensen, PR; McSween, HY; Bandfield, JL; Ruff, SW; Rogers, AD; Hamilton, VE; Gorelick, N; Wyatt, MB; Jakosky, BM; Kieffer, HH; Malin, MC; Moersch, JE			Evidence for magmatic evolution and diversity on Mars from infrared observations	NATURE			English	Article							THERMAL EMISSION SPECTROMETER; MINI-TES EXPERIMENT; MARTIAN SURFACE; GUSEV CRATER; SPECTRAL EVIDENCE; MERIDIANI-PLANUM; ROCKS; MINERALOGY; SPECTROSCOPY; CHEMISTRY	Compositional mapping of Mars at the 100-metre scale with the Mars Odyssey Thermal Emission Imaging System (THEMIS) has revealed a wide diversity of igneous materials. Volcanic evolution produced compositions from low-silica basalts to high-silica dacite in the Syrtis Major caldera. The existence of dacite demonstrates that highly evolved lavas have been produced, at least locally, by magma evolution through fractional crystallization. Olivine basalts are observed on crater floors and in layers exposed in canyon walls up to 4.5 km beneath the surface. This vertical distribution suggests that olivine-rich lavas were emplaced at various times throughout the formation of the upper crust, with their growing inventory suggesting that such ultramafic (picritic) basalts may be relatively common. Quartz-bearing granitoid rocks have also been discovered, demonstrating that extreme differentiation has occurred. These observations show that the martian crust, while dominated by basalt, contains a diversity of igneous materials whose range in composition from picritic basalts to granitoids rivals that found on the Earth.	Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; Univ Hawaii, Inst Geophys & Planetol, Honolulu, HI 96822 USA; Univ Colorado, Boulder, CO 80309 USA; US Geol Survey, Carson City, NV 89703 USA; Malin Space Sci Syst, San Diego, CA 92191 USA	Arizona State University; Arizona State University-Tempe; University of Tennessee System; University of Tennessee Knoxville; University of Hawaii System; University of Colorado System; University of Colorado Boulder; United States Department of the Interior; United States Geological Survey	Christensen, PR (corresponding author), Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA.	phil.christensen@asu.edu	Rogers, Deanne/I-9737-2016; Moersch, Jeffrey E/F-7189-2010; Rogers, A. Deanne/ABE-8469-2021	Rogers, Deanne/0000-0002-4671-2551; Moersch, Jeffrey E/0000-0003-3433-9419; Rogers, A. Deanne/0000-0002-4671-2551; Bandfield, Joshua/0000-0003-3571-3716; Gorelick, Noel/0000-0002-5548-2436				ADAMS JB, 1986, J GEOPHYS RES-SOLID, V91, P8098, DOI 10.1029/JB091iB08p08098; Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Bandfield JL, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002290; Bandfield JL, 2003, ICARUS, V161, P47, DOI 10.1016/S0019-1035(02)00025-8; Barker F., 1979, TRONDHJEMITES DACITE, V6, P1; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23873, DOI 10.1029/2000JE001415; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9609, DOI 10.1029/1999JE001127; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9735, DOI 10.1029/1998JE000624; Christensen PR, 2004, SCIENCE, V306, P1733, DOI 10.1126/science.1104909; Christensen PR, 2003, SCIENCE, V300, P2056, DOI 10.1126/science.1080885; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23823, DOI 10.1029/2000JE001370; CLARK DB, 1992, GRANITOID ROCKS; Feely KC, 1999, J GEOPHYS RES-PLANET, V104, P24195, DOI 10.1029/1999JE001034; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; GILLESPIE AR, 1992, REMOTE SENS ENVIRON, V42, P137, DOI 10.1016/0034-4257(92)90097-4; Hamilton VE, 2000, J GEOPHYS RES-PLANET, V105, P9717, DOI 10.1029/1999JE001113; Hamilton VE, 2003, METEORIT PLANET SCI, V38, P871, DOI 10.1111/j.1945-5100.2003.tb00284.x; Hamilton VE, 2001, J GEOPHYS RES-PLANET, V106, P14733, DOI 10.1029/2000JE001353; HAMILTON VE, IN PRESS GEOLOGY; HAMILTON VE, 1982, LUNAR PLANET SCI, V34; HAMILTON VE, 2003, METEORIT PLANET SCI, V37, P59; Hoefen TM, 2003, SCIENCE, V302, P627, DOI 10.1126/science.1089647; Kieffer H. H., 1977, Journal of Geophysical Research, V82, P4249, DOI 10.1029/JS082i028p04249; KRAFT MD, 2004, LUNAR PLANET SCI, V35; McSween HY, 2002, METEORIT PLANET SCI, V37, P7, DOI 10.1111/j.1945-5100.2002.tb00793.x; McSween HY, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002175; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; MCSWEEN HY, 1994, METEORITICS, V29, P757, DOI 10.1111/j.1945-5100.1994.tb01092.x; Mellon MT, 2000, ICARUS, V148, P437, DOI 10.1006/icar.2000.6503; MICHALSKI JR, IN PRESS ICARUS; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; MUSTARD JF, 1995, SCIENCE, V267, P1623, DOI 10.1126/science.7886449; Presley MA, 1997, J GEOPHYS RES-PLANET, V102, P6551, DOI 10.1029/96JE03303; Ramsey MS, 1998, J GEOPHYS RES-SOL EA, V103, P577, DOI 10.1029/97JB02784; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; ROGERS AD, UNPUB J GEOPHYS RES; Ruff SW, 2004, ICARUS, V168, P131, DOI 10.1016/j.icarus.2003.11.003; RUFF SW, 2002, J GEOPHYS RES, V107, DOI DOI 10.1029/JE001580; RUFF SW, 2001, LUNAR PLANET SC, V32; SCHABER GG, 1982, J GEOPHYS RES, V87, P9852, DOI 10.1029/JB087iB12p09852; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; Smith MD, 2000, J GEOPHYS RES-PLANET, V105, P9589, DOI 10.1029/1999JE001105; SODERBLOM L. A., 1992, MARS, P557; Wyatt MB, 2002, NATURE, V417, P263, DOI 10.1038/417263a; Wyatt MB, 2004, GEOLOGY, V32, P645, DOI 10.1130/G20527.1; Wyatt MB, 2001, J GEOPHYS RES-PLANET, V106, P14711, DOI 10.1029/2000JE001356	48	156	159	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					504	509		10.1038/nature03639	http://dx.doi.org/10.1038/nature03639			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16007077				2022-12-28	WOS:000230788800051
J	Padma, TV				Padma, TV			Rivalry and red tape	NATURE			English	Article																			0	4	5	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2005	436	7050					490	491		10.1038/436490a	http://dx.doi.org/10.1038/436490a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049475				2022-12-28	WOS:000230788800045
J	Freedland, SJ; Humphreys, EB; Mangold, LA; Eisenberger, M; Dorey, FJ; Walsh, PC; Partin, AW				Freedland, SJ; Humphreys, EB; Mangold, LA; Eisenberger, M; Dorey, FJ; Walsh, PC; Partin, AW			Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTIGEN DOUBLING TIME; RADIATION-THERAPY; RETROPUBIC PROSTATECTOMY; HORMONAL-THERAPY; CONSECUTIVE PATIENTS; LOCAL RECURRENCE; FAILURE; PROGRESSION; SURVIVAL; DISEASE	Context The natural history of biochemical recurrence after radical prostatectomy can be long but variable. Better risk assessment models are needed to identify men who are at high risk for prostate cancer death early and who may benefit from aggressive salvage treatment and to identify men who are at low risk for prostate cancer death and can be safely observed. Objectives To define risk factors for prostate cancer death following radical prostatectomy and to develop tables to risk stratify for prostate cancer-specific survival. Design, Setting, and Patients Retrospective cohort study of 379 men who had undergone radical prostatectomy at an urban tertiary care hospital between 1982 and 2000 and who had a biochemical recurrence and after biochemical failure had at least 2 prostate-specific antigen (PSA) values at least 3 months apart in order to calculate PSA doubling time (PSADT). The mean (SD) follow-up after surgery was 10.3 (4.7) years and median follow-up was 10 years (range, 1-20 years). Main Outcome Measure Prostate cancer-specific mortality. Results Median survival had not been reached after 16 years of follow-up after biochemical recurrence. Prostate-specific doubling time (<3.0 vs 3.0-8.9 vs 9.0-14.9 vs >= 15.0 months), pathological Gleason score (<= 7 vs 8-10), and time from surgery to biochemical recurrence (<= 3 vs >3 years) were all significant risk factors for time to prostate-specific mortality. Using these 3 variables, tables were constructed to estimate the risk of prostate cancer-specific survival at year 15 after biochemical recurrence. Conclusion Clinical parameters (PSADT, pathological Gleason score, and time from surgery to biochemical recurrence) can help risk stratify patients for prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. These preliminary findings may serve as useful guides to patients and their physicians to identify patients at high risk for prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy to enroll them in early aggressive treatment trials. In addition, these preliminary findings highlight that survival in low-risk patients can be quite prolonged.	Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Urol, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA; Univ So Calif, Childrens Hosp Los Angeles, Keck Sch Med, Los Angeles, CA USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Children's Hospital Los Angeles; University of Southern California	Freedland, SJ (corresponding author), Johns Hopkins Univ Hosp, Dept Urol, Baltimore, MD 21287 USA.	sfreedl1@jhmi.edu	FENTON, MIRIAM C/B-6430-2011		NATIONAL CANCER INSTITUTE [P50CA058236] Funding Source: NIH RePORTER; NCI NIH HHS [P50CA58236] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albertsen PC, 2004, J UROLOGY, V171, P2221, DOI 10.1097/01.ju.0000124381.93689.b4; Amling CL, 2000, J UROLOGY, V164, P101, DOI 10.1016/S0022-5347(05)67457-5; Crawford ED, 2003, UROLOGY, V61, P8, DOI 10.1016/S0090-4295(02)02394-4; D'Amico AV, 2002, J CLIN ONCOL, V20, P4567, DOI 10.1200/JCO.2002.03.061; D'Amico AV, 2003, J NATL CANCER I, V95, P1376, DOI 10.1093/jnci/djg043; DAMICO AV, 1993, CANCER-AM CANCER SOC, V72, P2638, DOI 10.1002/1097-0142(19931101)72:9<2638::AID-CNCR2820720919>3.0.CO;2-N; DOREY FJ, 1987, STAT MED, V6, P679, DOI 10.1002/sim.4780060605; Han M, 2001, UROL CLIN N AM, V28, P555, DOI 10.1016/S0094-0143(05)70163-4; HANCOCK SL, 1995, J UROLOGY, V154, P1412, DOI 10.1016/S0022-5347(01)66879-4; Hanlon AL, 2004, INT J RADIAT ONCOL, V58, P43, DOI 10.1016/S0360-3016(03)01432-9; Hanlon AL, 2002, INT J RADIAT ONCOL, V53, P297, DOI 10.1016/S0360-3016(02)02717-7; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hull GW, 2002, J UROLOGY, V167, P528, DOI 10.1016/S0022-5347(01)69079-7; Iversen P, 2002, EUR UROL, V42, P204, DOI 10.1016/S0302-2838(02)00311-1; Kim-Sing C, 2004, INT J RADIAT ONCOL, V60, P463, DOI 10.1016/j.ijrobp.2004.03.004; Messing EM, 1999, NEW ENGL J MED, V341, P1781, DOI 10.1056/NEJM199912093412401; Moul JW, 2004, J UROLOGY, V171, P1141, DOI 10.1097/01.JU.0000113794.34810.D0; Okotie OT, 2004, J UROLOGY, V171, P2260, DOI 10.1097/01.ju.0000127734.01845.99; PARTIN AW, 1994, UROLOGY, V43, P649, DOI 10.1016/0090-4295(94)90180-5; Patel A, 1997, J UROLOGY, V158, P1441, DOI 10.1016/S0022-5347(01)64238-1; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Pinover WH, 2003, CANCER-AM CANCER SOC, V97, P1127, DOI 10.1002/cncr.11166; POLLACK A, 1994, CANCER, V74, P670, DOI 10.1002/1097-0142(19940715)74:2<670::AID-CNCR2820740220>3.0.CO;2-8; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Roberts SG, 2001, MAYO CLIN PROC, V76, P576; Roehl KA, 2004, J UROLOGY, V172, P910, DOI 10.1097/01.ju.0000134888.22332.bb; Sartor CI, 1997, INT J RADIAT ONCOL, V38, P941, DOI 10.1016/S0360-3016(97)00082-5; Swindle PW, 2003, UROL CLIN N AM, V30, P377, DOI 10.1016/S0094-0143(02)00176-3; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; TRAPASSO JG, 1994, J UROLOGY, V152, P1821, DOI 10.1016/S0022-5347(17)32394-7; Ward JF, 2003, J UROLOGY, V170, P1872, DOI 10.1097/01.ju.0000091876.13656.2e; Zagars GK, 1997, RADIOTHER ONCOL, V44, P213, DOI 10.1016/S0167-8140(97)00123-0	32	1042	1060	2	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2005	294	4					433	439		10.1001/jama.294.4.433	http://dx.doi.org/10.1001/jama.294.4.433			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RM	16046649	Bronze			2022-12-28	WOS:000230733400017
J	Burazeri, G; Roshi, E; Jewkes, R; Jordan, S; Bjegovic, V; Laaser, U				Burazeri, G; Roshi, E; Jewkes, R; Jordan, S; Bjegovic, V; Laaser, U			Factors associated with spousal physical violence in Albania: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article							INTIMATE PARTNER VIOLENCE; DOMESTIC VIOLENCE; WIFE ABUSE; WOMEN	Objective To describe the prevalence of intimate partner violence and associated factors among married women in Albania. Design Cross sectional study. Setting Tirana, the capital city of Albania. Participants A representative sample of 1039 married women aged 25-65 living in Tirana and recorded in the 2001 census. Methods Questionnaire on intimate partner violence and social and demographic characteristics of the women and their husbands. Main outcome measure Women's experience within the past year of being hit, slapped, kicked, or otherwise physically hurt by the husband. Results More than a third (37%,384/1039) of women had experienced violence. Risk was greatest among women aged 25-34 (odds ratio 1.47,95% Cl 1.04 to 2.09), women with tertiary education (3.70,2.04 to 6.67), women in white collar jobs (4.0,1.59 to 10.0), women with least educated husbands (5.01, 2.91 to 8.64), and women married to men raised in rural areas (3.31, 2.29 to 4.80). Women were at higher risk if they were more educated than their husbands (4.76, 2.56 to 9.09). Conclusions In transitional Albania, the risk of spousal violence is high, and more empowered women are at greater risk.	Univ Tirana, Fac Med, Dept Publ Hlth, Tirana, Albania; MRC, Gender & Hlth Res Unit, Pretoria, South Africa; Fed Ctr Hlth Educ, Unit Primary Prevent Addict, Cologne, Germany; Univ Belgrade, Sch Med, Sch Publ Hlth, Belgrade, Serbia Monteneg; Univ Bielefeld, Fac Hlth Sci, Sect Int Publ Hlth, D-4800 Bielefeld, Germany	University of Tirana (UT); University of Belgrade; University of Bielefeld	Burazeri, G (corresponding author), Univ Tirana, Fac Med, Dept Publ Hlth, St Dibres N-371, Tirana, Albania.	gburazeri@yahoo.com	Bjegovic-Mikanovic, Vesna/AAD-9847-2019; Roshi, Professor Enver Envi/AFN-4125-2022; Laaser, Ulrich/AAE-9755-2022; Laaser, Ulrich/ACH-6512-2022; Laaser, Ulrich/AAD-9790-2019; Burazeri, Genc/Q-8860-2019	Bjegovic-Mikanovic, Vesna/0000-0002-8299-6555; Roshi, Professor Enver Envi/0000-0002-4257-7583; Laaser, Ulrich/0000-0001-5889-4471; Jewkes, Rachel/0000-0002-4330-6267; Jordan, Susanne/0000-0003-0721-1604				Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Ellsberg M, 2002, LANCET, V359, P1599, DOI 10.1016/S0140-6736(02)08521-5; Ellsberg MC, 1999, AM J PUBLIC HEALTH, V89, P241, DOI 10.2105/AJPH.89.2.241; Hotaling G T, 1986, Violence Vict, V1, P101; Jewkes R, 2002, SOC SCI MED, V55, P1603, DOI 10.1016/S0277-9536(01)00294-5; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Kantor G K, 1994, Violence Vict, V9, P207; KANTOR GK, 1989, AM J DRUG ALCOHOL AB, V15, P173, DOI 10.3109/00952998909092719; Martin SL, 1999, AM J EPIDEMIOL, V150, P417, DOI 10.1093/oxfordjournals.aje.a010021; Schuler SR, 1996, SOC SCI MED, V43, P1729, DOI 10.1016/S0277-9536(96)00068-8; Sorenson SB, 1996, AM J PUBLIC HEALTH, V86, P35, DOI 10.2105/AJPH.86.1.35; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1	12	65	71	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 23	2005	331	7510					197	201		10.1136/bmj.331.7510.197	http://dx.doi.org/10.1136/bmj.331.7510.197			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	951EA	16037455	Bronze, Green Published			2022-12-28	WOS:000230910700024
J	Carella, AM; Beltrami, G; Corsetti, MT; Nati, S; Musto, P; Scalzulli, P; Gonella, R; Ballestrero, A; Patrone, F				Carella, AM; Beltrami, G; Corsetti, MT; Nati, S; Musto, P; Scalzulli, P; Gonella, R; Ballestrero, A; Patrone, F			Reduced intensity conditioning for allograft after cytoreductive autograft in metastatic breast cancer	LANCET			English	Article							TRANSPLANTATION	The benefits of allografiing noted in some malignant diseases might be safely extended to metastatic breast cancer by a combination of cytoreduction with high-dose chemotherapy (HDT) and autologous stem-cell transplant (ASCT) with graft-versus-tumour effect mediated by transplanted donor immune cells with nonmyeloablative allografting (reduced intensity conditioning transplantation, RICT). 17 patients with heavily pretreated disease were given tandem transplants. 13 patients sustained donor engraftment. Three had partial remission after HDT and ASCT and complete remission after RICT; they achieved full chimerism and all developed graft-versus-host disease (GVHD) before regression of cancer. Another patient did not respond to HDT and ASCT but had partial remission after RICT, giving an overall response rate of 24%. Five patients had grade H or higher acute GVHD and five had extensive chronic GVHD. No non-relapse-related deaths occurred during the first 100 days. Five patients (29%) were alive 90-2160 days (median 1320) after RICT. This two-step approach is feasible in patients with metastatic breast cancer.	Azienda Osped, Div Haematol, I-16132 Genoa, Italy; Clin Univ San Martino, I-16132 Genoa, Italy; IRCCS Casa Sollievo Sofferenza, Foggia, Italy; Univ Genoa, DIMI, Dept Internal Med, Genoa, Italy	University of Genoa; IRCCS AOU San Martino IST; IRCCS Casa Sollievo Della Sofferenza; University of Genoa	Carella, AM (corresponding author), Azienda Osped, Div Haematol, Largo R Benzi, I-16132 Genoa, Italy.	angelomichele.carella@hsanmartino.it	Gonella, Roberta/AAA-7517-2021; Scalzulli, Potito Rosario/AAA-6104-2021; Ballestrero, Alberto/K-7546-2016	Gonella, Roberta/0000-0001-7897-4102; Scalzulli, Potito Rosario/0000-0002-0253-0756; Ballestrero, Alberto/0000-0002-2601-7711; Musto, Pellegrino/0000-0003-3277-6594				Bishop MR, 2004, J CLIN ONCOL, V22, P3886, DOI 10.1200/JCO.2004.01.127; Childs RW, 1999, J CLIN ONCOL, V17, P2044, DOI 10.1200/JCO.1999.17.7.2044; Eibl B, 1996, BLOOD, V88, P1501, DOI 10.1182/blood.V88.4.1501.bloodjournal8841501; Slavin S, 2001, LANCET ONCOL, V2, P491, DOI 10.1016/S1470-2045(01)00455-7; Ueno NT, 2003, BLOOD, V102, P3829, DOI 10.1182/blood-2003-04-1022	5	42	44	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 23	2005	366	9482					318	320		10.1016/S0140-6736(05)66989-9	http://dx.doi.org/10.1016/S0140-6736(05)66989-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RJ	16039336				2022-12-28	WOS:000230733100032
J	Lock, K; McKee, M				Lock, K; McKee, M			Commentary: Will Europe's agricultural policy damage progress on cardiovascular disease?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Lock, K (corresponding author), Univ London London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, Keppel St, London WC1E 7HT, England.	karen.lock@lshtm.ac.uk	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683				Bobak M, 1997, J EPIDEMIOL COMMUN H, V51, P272, DOI 10.1136/jech.51.3.272; Lobstein T., 2004, EUROHEALTH, V10, P8; Lock K, 2004, EUROHEALTH, V10, P1; LOCK K, 2005, FRUIT VEGETABLES EUR	4	4	4	1	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 23	2005	331	7510					188	189		10.1136/bmj.331.7510.188	http://dx.doi.org/10.1136/bmj.331.7510.188			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951EA	16037449	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000230910700018
J	Warde, P; Gospodarowicz, M				Warde, P; Gospodarowicz, M			Adjuvant carboplatin in stage I seminoma	LANCET			English	Editorial Material							TESTICULAR SEMINOMA; SURVEILLANCE; CANCER; TUMORS		Univ Toronto, Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Warde, P (corresponding author), Univ Toronto, Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON M5G 2M9, Canada.	padraig.warde@rmp.uhn.on.ca		Warde, Padraig/0000-0002-4236-0026				APARICIO J, 2004, J CLIN ONCOL, V22, pS14; Choo R, 2005, INT J RADIAT ONCOL, V61, P736, DOI 10.1016/j.ijrobp.2004.06.209; Daugaard G, 2003, APMIS, V111, P76, DOI 10.1034/j.1600-0463.2003.11101111.x; Dieckmann KP, 1996, J CANCER RES CLIN, V122, P63, DOI 10.1007/BF01203075; Fitzgerald R, 2004, CLIN ONCOL-UK, V16, P158, DOI 10.1016/j.clon.2003.11.004; HORWICH A, 1992, BRIT J CANCER, V65, P775, DOI 10.1038/bjc.1992.164; Logue JP, 2003, INT J RADIAT ONCOL, V57, P1304, DOI 10.1016/S0360-3016(03)00754-5; McGlynn KA, 2003, CANCER, V97, P63, DOI 10.1002/cncr.11054; Oliver RTD, 2005, LANCET, V366, P293, DOI 10.1016/S0140-6736(05)66984-X; Travis LB, 1997, JNCI-J NATL CANCER I, V89, P1429, DOI 10.1093/jnci/89.19.1429; WARDE PR, 2005, J CLIN ONCOL, V23, P4520; Zagars GK, 2004, J CLIN ONCOL, V22, P640, DOI 10.1200/JCO.2004.05.205	12	9	9	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 23	2005	366	9482					267	268		10.1016/S0140-6736(05)66959-0	http://dx.doi.org/10.1016/S0140-6736(05)66959-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RJ	16039313				2022-12-28	WOS:000230733100004
J	Buzsaki, G				Buzsaki, G			Similar is different in hippocampal networks	SCIENCE			English	Editorial Material							ENVIRONMENT		Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu		Buzsaki, Gyorgy/0000-0002-3100-4800				Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gothard KM, 1996, J NEUROSCI, V16, P823; Lenck-Santini PP, 2005, HIPPOCAMPUS, V15, P356, DOI 10.1002/hipo.20060; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Skaggs WE, 1998, J NEUROSCI, V18, P8455; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905	8	5	5	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2005	309	5734					568	569		10.1126/science.1116376	http://dx.doi.org/10.1126/science.1116376			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040697				2022-12-28	WOS:000230735200035
J	Siaj, M; McBreen, PH				Siaj, M; McBreen, PH			Creating, varying, and growing single-site molecular contacts	SCIENCE			English	Article							OPENING METATHESIS POLYMERIZATION; OLEFIN METATHESIS; ACYCLIC OLEFINS; SURFACE; ALKYLIDENE; COMPLEXES; LAYERS	The known range of chemisorption bonds forms the toolbox for the design of electrical contacts in molecular electronics devices. Double-bond contacts to technologically relevant materials would be attractive for a number of reasons. They are truly single-site, bonding to a single surface atom. They obviate the need for a thiol linkage, and they may be amenable to further modification through olefin-metathesis methodologies. We report olefin-metathesis methods for establishing varying, and growing thermally stable double-bond contacts to molybdenum carbide, a conducting material.	Univ Laval, Dept Chim, Quebec City, PQ G1K 7P4, Canada	Laval University	McBreen, PH (corresponding author), Univ Laval, Dept Chim, Quebec City, PQ G1K 7P4, Canada.	peter.mcbreen@chm.ulaval.ca		Siaj, Mohamed/0000-0003-0499-4260				BRYAN JC, 1990, J AM CHEM SOC, V112, P2298, DOI 10.1021/ja00162a034; Buchmeiser MR, 2000, CHEM REV, V100, P1565, DOI 10.1021/cr990248a; GEORGE PM, 1983, J AM CHEM SOC, V105, P1393, DOI 10.1021/ja00343a065; HERISSON JL, 1971, MAKROMOLEKUL CHEM, V141, P161; Jennings GK, 2004, ADV MATER, V16, P1983, DOI 10.1002/adma.200400810; Kim NY, 2000, MACROMOLECULES, V33, P2793, DOI 10.1021/ma000046c; LECONTE M, 1979, J AM CHEM SOC, V101, P7296, DOI 10.1021/ja00518a027; Lei RZ, 2004, SURF SCI, V554, P125, DOI 10.1016/j.susc.2003.12.058; Martel R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.256805; Misewich JA, 2003, SCIENCE, V300, P783, DOI 10.1126/science.1081294; Morris LJ, 2001, ORGANOMETALLICS, V20, P2344, DOI 10.1021/om0100479; Petersen MA, 2004, J PHYS CHEM B, V108, P5909, DOI 10.1021/jp037880z; Rutenberg IM, 2004, J AM CHEM SOC, V126, P4062, DOI 10.1021/ja035773c; Siaj M, 2004, J AM CHEM SOC, V126, P9514, DOI 10.1021/ja048640f; Zahidi E, 2001, NATURE, V409, P1023, DOI 10.1038/35059047; Zhang Y, 1999, SCIENCE, V285, P1719, DOI 10.1126/science.285.5434.1719	16	41	41	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2005	309	5734					588	590		10.1126/science.1113667	http://dx.doi.org/10.1126/science.1113667			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040701				2022-12-28	WOS:000230735200041
J	Thomas, PC; Robinson, MS				Thomas, PC; Robinson, MS			Seismic resurfacing by a single impact on the asteroid 433 Eros	NATURE			English	Article							COLLISIONAL HISTORY; EJECTA; CRATERS; FEATURES; 433-EROS	Impact cratering creates a wide range of topography on small satellites and asteroids. The population of visible craters evolves with impacts, and because there are no competing endogenic processes to modify the surface, determining the various ways younger craters add to or subtract from the population is a fundamental aspect of small-body geology(1,2). Asteroid 433 Eros, the most closely studied small body, has regions of substantially different crater densities(3-5) that remain unexplained. Here we show that the formation of a relatively young crater ( 7.6 km in diameter) resulted in the removal of other craters as large as 0.5 km over nearly 40 per cent of the asteroid. Burial by ejecta cannot explain the observed pattern of crater removal. The limitation of reduced crater density to a zone within a particular straight-line distance through the asteroid from the centre of the large crater suggests degradation of the topography by seismic energy(6) released during the impact. Our observations indicate that the interior of Eros is sufficiently cohesive to transmit seismic energy over many kilometres, and the outer several tens of metres of the asteroid must be composed of relatively non-cohesive material.	Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA; Northwestern Univ, Ctr Planetary Sci, Evanston, IL USA	Cornell University; Northwestern University	Thomas, PC (corresponding author), Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA.	thomas@baritone.astro.cornell.edu	Robinson, Mark/ABI-6841-2020					[Anonymous], 1979, ICARUS, V37, P467, DOI 10.1016/0019-1035(79)90009-5; Asphaug E, 1996, ICARUS, V120, P158, DOI 10.1006/icar.1996.0043; ASPHAUG E, 1993, ICARUS, V101, P144, DOI 10.1006/icar.1993.1012; Barnouin-Jha O.S., 2001, LUNAR PLANET SCI, V32, P1786; BERTHOUD M, UNPUB ICARUS; BETHOUD M, 2001, B AM ASTRON SOC, V33, P1149; Chapman C.R, 2002, ASTEROIDS, VIII, P315; Chapman CR, 2002, ICARUS, V155, P104, DOI 10.1006/icar.2001.6744; Cheng AF, 2002, METEORIT PLANET SCI, V37, P1095, DOI 10.1111/j.1945-5100.2002.tb00880.x; Davis DR, 1999, ICARUS, V140, P49, DOI 10.1006/icar.1999.6123; DOBROVOLSKIS AR, 1980, ICARUS, V42, P422, DOI 10.1016/0019-1035(80)90105-0; Geissler P, 1996, ICARUS, V120, P140, DOI 10.1006/icar.1996.0042; GREENBERG R, 1994, ICARUS, V107, P84, DOI 10.1006/icar.1994.1008; Greenberg R, 1996, ICARUS, V120, P106, DOI 10.1006/icar.1996.0040; Housen KR, 1999, NATURE, V402, P155, DOI 10.1038/45985; HOUSTON WN, 1973, P LUNAR PLANET SCI C, V4, P2425; Korycansky DG, 2004, ICARUS, V171, P110, DOI 10.1016/j.icarus.2004.03.021; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; Nolan MC, 2001, ICARUS, V153, P1, DOI 10.1006/icar.2001.6660; Nolan MC, 1996, ICARUS, V124, P359, DOI 10.1006/icar.1996.0214; Prockter L, 2002, ICARUS, V155, P75, DOI 10.1006/icar.2001.6770; Richardson JE, 2004, SCIENCE, V306, P1526, DOI 10.1126/science.1104731; Robinson MS, 2002, METEORIT PLANET SCI, V37, P1651, DOI 10.1111/j.1945-5100.2002.tb01157.x; Sullivan R., 2002, ASTEROIDS, VIII, P331; Thomas PC, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014599; Thomas PC, 2002, ICARUS, V155, P18, DOI 10.1006/icar.2001.6755; Thomas PC, 2001, NATURE, V413, P394, DOI 10.1038/35096513; Thomas PC, 1998, ICARUS, V131, P78, DOI 10.1006/icar.1997.5858; Veverka J, 2001, SCIENCE, V292, P484, DOI 10.1126/science.1058651	29	53	53	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					366	369		10.1038/nature03855	http://dx.doi.org/10.1038/nature03855			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034412				2022-12-28	WOS:000230623400036
J	Wiznitzer, M				Wiznitzer, M			Buccal midazolam for seizures	LANCET			English	Editorial Material							RECTAL DIAZEPAM; INTRANASAL MIDAZOLAM; PROLONGED SEIZURES; STATUS EPILEPTICUS; CHILDREN; GEL		Rainbow Babies & Childrens Hosp, Div Pediat Neurol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital	Wiznitzer, M (corresponding author), Rainbow Babies & Childrens Hosp, Div Pediat Neurol, 2101 Adelbert Rd, Cleveland, OH 44106 USA.	mxwl2@cwru.edu						Dreifus FE, 1998, NEW ENGL J MED, V338, P1869, DOI 10.1056/NEJM199806253382602; Fisgin T, 2002, J CHILD NEUROL, V17, P123, DOI 10.1177/088307380201700206; Geldner G, 1997, PAEDIATR ANAESTH, V7, P103, DOI 10.1046/j.1460-9592.1997.d01-57.x; Goodkin HP, 2003, EPILEPSIA, V44, P1109, DOI 10.1046/j.1528-1157.2003.62402.x; Holmes GL, 1999, LANCET, V353, P608, DOI 10.1016/S0140-6736(98)00357-2; Jeannet P Y, 1999, Eur J Paediatr Neurol, V3, P73, DOI 10.1016/S1090-3798(99)80016-6; McIntyre J, 2005, LANCET, V366, P205, DOI 10.1016/S0140-6736(05)66909-7; Pellock JM, 2004, DRUG SAFETY, V27, P383, DOI 10.2165/00002018-200427060-00003; Scheepers M, 2000, SEIZURE-EUR J EPILEP, V9, P417, DOI 10.1053/seiz.2000.0425; Scott RC, 1999, LANCET, V353, P623, DOI 10.1016/S0140-6736(98)06425-3; Scott RC, 1998, EPILEPSIA, V39, P290, DOI 10.1111/j.1528-1157.1998.tb01375.x; TOWNE AR, 1994, EPILEPSIA, V35, P27, DOI 10.1111/j.1528-1157.1994.tb02908.x; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; WALTON NY, 1993, EPILEPSIA S1, V34, P54; Wilson MT, 2004, ARCH DIS CHILD, V89, P50, DOI 10.1136/adc.2002.019836	15	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2005	366	9481					182	183		10.1016/S0140-6736(05)66884-5	http://dx.doi.org/10.1016/S0140-6736(05)66884-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945RG	16023491				2022-12-28	WOS:000230519200005
J	Dagna, L; Broccolo, F; Paties, CT; Ferrarini, M; Sarmati, L; Praderio, L; Sabbadini, MG; Lusso, P; Malnati, MS				Dagna, L; Broccolo, F; Paties, CT; Ferrarini, M; Sarmati, L; Praderio, L; Sabbadini, MG; Lusso, P; Malnati, MS			A relapsing inflammatory syndrome and active human herpesvirus 8 infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; KAPOSIS-SARCOMA; DNA-SEQUENCES; CASTLEMANS-DISEASE; PERIPHERAL-BLOOD; INTERLEUKIN-6; HYPERPLASIA; PROGRESSION	We describe an immunocompetent 61-year-old woman who was negative for human immunodeficiency virus and who had recurrent human herpesvirus 8 (HHV-8) infection associated with a relapsing systemic inflammatory syndrome characterized by fever, lymphadenopathy, splenomegaly, edema, arthrosynovitis, and rash. Kaposi's sarcoma developed 10 months after the initial clinical presentation. A correlation was documented between the recurrent clinical manifestations and the HHV-8 load in plasma and peripheral-blood mononuclear cells. Histologic examination of an enlarged lymph node heavily infected with HHV-8 revealed an atypical lymphoproliferative disorder characterized by paracortical hyperplasia and collapsed primary and secondary follicles.	Univ Vita Salute San Raffaele Sch Med, Unit Human Virol, Labs DIBIT P2 P3, I-20132 Milan, Italy; Ist Sci San Raffaele, Unit Human Virol, I-20132 Milan, Italy; Ist Sci San Raffaele, Unit Rheumatol & Clin Immunol, I-20132 Milan, Italy; Ist Sci San Raffaele, Dept Pathol, I-20132 Milan, Italy; Ist Sci San Raffaele, Lab Tumor Immunol, I-20132 Milan, Italy; Univ Roma Tor Vergata, Dept Publ Hlth, Rome, Italy; Univ Cagliari, Dept Biomed Sci, Cagliari, Italy	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Rome Tor Vergata; University of Cagliari	Dagna, L (corresponding author), Univ Vita Salute San Raffaele Sch Med, Unit Human Virol, Labs DIBIT P2 P3, Via Olgettina 58, I-20132 Milan, Italy.	lorenzo.dagna@hsr.it	Dagna, Lorenzo/AAB-2790-2019; Broccolo, Francesco/K-4334-2016; Malnati, Mauro/AAN-4207-2020; Ferrarini, Marina/AAO-1548-2020	Broccolo, Francesco/0000-0002-9737-0459; Dagna, Lorenzo/0000-0002-7428-315X; Ferrarini, Marina/0000-0003-1015-9632; sarmati, loredana/0000-0003-1452-0333; Malnati, mauro/0000-0001-5355-1680				Andreoni M, 2002, JAMA-J AM MED ASSOC, V287, P1295, DOI 10.1001/jama.287.10.1295; Aoki Y, 1999, BLOOD, V93, P4034, DOI 10.1182/blood.V93.12.4034.412k38_4034_4043; BANDIERI E, 1995, BLOOD, V86, P832, DOI 10.1182/blood.V86.2.832.bloodjournal862832; BECK JT, 1994, NEW ENGL J MED, V330, P602, DOI 10.1056/NEJM199403033300904; Broccolo F, 2002, J CLIN MICROBIOL, V40, P4652, DOI 10.1128/JCM.40.12.4652-4658.2002; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHAN J, 1996, PATHOLOGY LYMPH NODE, P81; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; FRIZZERA G, 1983, AM J SURG PATHOL, V7, P211, DOI 10.1097/00000478-198304000-00001; Gao SJ, 1996, NAT MED, V2, P925, DOI 10.1038/nm0896-925; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; Luppi M, 2000, NEW ENGL J MED, V343, P1378, DOI 10.1056/NEJM200011093431905; Luppi M, 1996, BLOOD, V87, P3903, DOI 10.1182/blood.V87.9.3903.bloodjournal8793903; Mazzi R, 2001, AIDS, V15, P2061, DOI 10.1097/00002030-200110190-00026; MOORE PS, 1995, NEW ENGL J MED, V332, P1181, DOI 10.1056/NEJM199505043321801; Nicholas J, 1997, NAT MED, V3, P287, DOI 10.1038/nm0397-287; Oksenhendler E, 2000, BLOOD, V96, P2069, DOI 10.1182/blood.V96.6.2069.h8002069_2069_2073; Oksenhendler E, 1998, NEW ENGL J MED, V338, P1585, DOI 10.1056/NEJM199805283382204; Rezza G, 1999, J NATL CANCER I, V91, P1468, DOI 10.1093/jnci/91.17.1468; Scarpellini P, 2004, J CLIN MICROBIOL, V42, P3469, DOI 10.1128/JCM.42.8.3469-3474.2004; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Wang QJ, 2001, BLOOD, V97, P2366, DOI 10.1182/blood.V97.8.2366; WHITBY D, 1995, LANCET, V346, P799, DOI 10.1016/S0140-6736(95)91619-9; Wit FWNM, 1998, AIDS, V12, P218; YOSHIZAKI K, 1989, BLOOD, V74, P1360	25	21	23	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2005	353	2					156	163		10.1056/NEJMoa042850	http://dx.doi.org/10.1056/NEJMoa042850			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944OP	16014885				2022-12-28	WOS:000230438800007
J	Marra, J				Marra, J			When will we tame the oceans?	NATURE			English	Editorial Material							SUSTAINABILITY; AQUACULTURE; FISHERIES; FUTURE		Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Columbia University	Marra, J (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.							Baldwin K, 2000, MAR TECHNOL SOC J, V34, P53; Bromhead D, 2003, REV IMPACT FISH AGGR; Dalton R, 2005, NATURE, V435, P1014, DOI 10.1038/4351014b; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Goldburg R.J., 2001, MARINE AQUACULTURE U; GOUDEY CA, 1998, P OFFSH TECHN AQ, P193; *ICCAT, 1999, SCRS9921 ICCAT; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Pitcher TJ, 2001, ECOL APPL, V11, P601; Pitcher TJ, 2000, FISH FISH, V1, P99, DOI 10.1046/j.1467-2979.2000.00004.x; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014	14	51	52	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2005	436	7048					175	176		10.1038/436175a	http://dx.doi.org/10.1038/436175a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015306				2022-12-28	WOS:000230459500016
J	Adegbola, RA; Secka, O; Lahai, G; Lloyd-Evans, N; Njie, A; Usen, S; Oluwalana, C; Obaro, S; Weber, M; Corrah, T; Mulholland, K; McAdam, K; Greenwood, B; Milligan, PJM				Adegbola, RA; Secka, O; Lahai, G; Lloyd-Evans, N; Njie, A; Usen, S; Oluwalana, C; Obaro, S; Weber, M; Corrah, T; Mulholland, K; McAdam, K; Greenwood, B; Milligan, PJM			Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study	LANCET			English	Article							MENINGITIS; INFECTIONS; EPIDEMIOLOGY; PNEUMONIA; EFFICACY; CHILDREN; TRIAL	Background Routine immunisation of infants in The Gambia with a Haemophilus influenzae type b (Hib) polysaccharide-tetanus toxoid conjugate vaccine began in May, 1997. We investigated the effectiveness of the vaccine when delivered through the expanded programme on immunisation and the effect of national immunisation. on incidence of Hib disease. Methods Surveillance for Hib disease was maintained in the western half of The Gambia using standard methods with an emphasis on meningitis. We estimated vaccine efficacy using the case control method, and vaccine coverage and population denominators for incidence rates using a cluster sample survey. Prevalence of Hib carriage in a sample of 1-2-year old children attending health centres for vaccination was ascertained with oropharyngeal swabs plated onto antiserum agar. Findings Between May, 1997, and April, 2002, a total of 5984 children were examined for possible Hib infections. 49 children had Hib disease, 36 of whom had meningitis. The annual incidence rates of Hib meningitis before any use of the vaccine (1990-93) dropped from over 200 per 100 000 children aged younger than 1 year to none per 100 000 in 2002, and from 60 to no cases per 100 000 in children younger than 5 years. The prevalence of Hib carriage decreased from 12% to 0.25% (p<0.0001). Two doses of vaccine were needed for direct protection from Hib disease (vaccine efficacy 94%, 95% CI 62-99). Since most children received a protective dose after the age of greatest disease risk, indirect effects were important in reducing disease incidence. Interpretation The Gambian Hib immunisation programme reduced the occurrence of Hib disease despite irregular vaccine supply. The effect of the programme in The Gambia has important implications for the introduction of the vaccine into routine immunisation. programmes of other developing countries.	MRC Labs, Banjul, Gambia; Natl Hlth Lab, Banjul, Gambia; Dept State Hlth, Banjul, Gambia; Royal Childrens Hosp, Parkville, Vic 3052, Australia; London Sch Hyg & Trop Med, Dept Infect Dis, London WC1, England	MRC Laboratory Molecular Biology; Royal Children's Hospital Melbourne; University of London; London School of Hygiene & Tropical Medicine	Adegbola, RA (corresponding author), MRC Labs, POB 273, Banjul, Gambia.	radegbola@mrc.gm	Milligan, Paul/D-8985-2017	Milligan, Paul/0000-0003-3430-3395				ADAMS WG, 1993, JAMA-J AM MED ASSOC, V269, P221, DOI 10.1001/jama.269.2.221; Adegbola RA, 1996, ANN TROP PAEDIATR, V16, P103, DOI 10.1080/02724936.1996.11747812; Adegbola RA, 1998, J INFECT DIS, V177, P1758, DOI 10.1086/517440; Adegbola RA, 1999, LANCET, V354, P1091, DOI 10.1016/S0140-6736(99)03010-X; BAER M, 1995, LANCET, V345, P661, DOI 10.1016/S0140-6736(95)90570-7; BIJLMER HA, 1990, J INFECT DIS, V161, P1210, DOI 10.1093/infdis/161.6.1210; BIJLMER HA, 1991, VACCINE S, V9, P5; BULKOW LR, 1993, PEDIATR INFECT DIS J, V12, P484, DOI 10.1097/00006454-199306000-00006; COCHI SL, 1988, PEDIATRICS, V81, P166; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Dagan R, 1999, VACCINE, V17, P134, DOI 10.1016/S0264-410X(98)00165-0; DECKER MD, 1992, J PEDIATR-US, V120, P184, DOI 10.1016/S0022-3476(05)80424-X; Garner D, 2003, LANCET, V361, P395, DOI 10.1016/S0140-6736(03)12385-9; GIESECHE J, 1997, LANCET, V349, P670; Goetghebuer T, 2000, TROP MED INT HEALTH, V5, P207, DOI 10.1046/j.1365-3156.2000.00535.x; GREENWOOD B, 1992, J INFECT DIS, V165, pS26, DOI 10.1093/infdis/165-Supplement_1-S26; Jordens JZ, 1995, EUR J CLIN MICROBIOL, V14, P935, DOI 10.1007/BF01691374; Lagos R, 1998, PEDIATR INFECT DIS J, V17, pS139, DOI 10.1097/00006454-199809001-00010; Milligan P, 2004, INT J EPIDEMIOL, V33, P469, DOI 10.1093/ije/dyh096; Mulholland K, 1997, LANCET, V349, P1191, DOI 10.1016/S0140-6736(96)09267-7; PELTOLA H, 1992, LANCET, V340, P592, DOI 10.1016/0140-6736(92)92117-X; Ramsay ME, 2003, J INFECT DIS, V188, P481, DOI 10.1086/376997; WAGGONERFOUNTAIN LA, 1995, CLIN INFECT DIS, V21, P1322, DOI 10.1093/clinids/21.5.1322; Ward JJ, 1996, CLIN INFECT DIS, V22, P1077, DOI 10.1093/clinids/22.6.1077; Wenger JD, 1999, VACCINE, V18, P736, DOI 10.1016/S0264-410X(99)00269-8	25	219	225	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2005	366	9480					144	150		10.1016/S0140-6736(05)66788-8	http://dx.doi.org/10.1016/S0140-6736(05)66788-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	943JH	16005337				2022-12-28	WOS:000230349200033
J	Modlin, RL; Sieling, PA				Modlin, RL; Sieling, PA			Immunology - Now presenting: gamma delta T cells	SCIENCE			English	Editorial Material							INNATE IMMUNITY; ACTIVATION; ANTIGENS; BACTERIA		Univ Calif Los Angeles, David Geffen Sch Med, Div Dermatol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Modlin, RL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Dermatol, Los Angeles, CA 90095 USA.	rmodlin@mednet.ucla.edu	Modlin, Robert L/M-7941-2014	Modlin, Robert L/0000-0003-4720-031X				BARNES PF, 1993, INFECT IMMUN, V61, P197, DOI 10.1128/IAI.61.1.197-203.1993; Brandes M, 2003, BLOOD, V102, P3693, DOI 10.1182/blood-2003-04-1016; Brandes M, 2005, SCIENCE, V309, P264, DOI 10.1126/science.1110267; BRENNER MB, 1986, NATURE, V322, P145, DOI 10.1038/322145a0; Bukowski JF, 1999, IMMUNITY, V11, P57, DOI 10.1016/S1074-7613(00)80081-3; FOLLOWS GA, 1992, INFECT IMMUN, V60, P1229, DOI 10.1128/IAI.60.3.1229-1231.1992; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; Ismaili J, 2002, CLIN IMMUNOL, V103, P296, DOI 10.1006/clim.2002.5218; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; MORITA CT, 1995, IMMUNITY, V3, P495, DOI 10.1016/1074-7613(95)90178-7; MUNK ME, 1990, J IMMUNOL, V145, P2434; Shen Y, 2002, SCIENCE, V295, P2255, DOI 10.1126/science.1068819; Spada FM, 2000, J EXP MED, V191, P937, DOI 10.1084/jem.191.6.937; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0	14	14	16	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2005	309	5732					252	253		10.1126/science.1115264	http://dx.doi.org/10.1126/science.1115264			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002604				2022-12-28	WOS:000230449800028
J	Doval, HC; Grancelli, HO; Nul, D; Varini, S; Soifer, S; Ferrante, DC; Villalba, E; Silva, C; Paiva, P; Zambrano, C; Schwartzman, RA; Christen, AI; Ramos, S; Cerezo, G; Fernandez, A				Doval, HC; Grancelli, HO; Nul, D; Varini, S; Soifer, S; Ferrante, DC; Villalba, E; Silva, C; Paiva, P; Zambrano, C; Schwartzman, RA; Christen, AI; Ramos, S; Cerezo, G; Fernandez, A		GESICA Investigators	Randomised trial of telephone intervention in chronic heart failure: DIAL trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DISEASE MANAGEMENT; ELDERLY-PATIENTS; READMISSION; PROGRAM; SUPPORT; DESIGN	Objective To determine whether a centralised telephone intervention reduces the incidence of death or admissions for worsening heart failure in outpatients with chronic heart failure. Design Multicentre randomised controlled trial. Setting 51 centres in Argentina (public and private hospitals and ambulatory settings). Participants 1518 outpatients with stable chronic heart failure and optimal drug treatment randomised, stratified by attending cardiologist, to telephone intervention or usual care. Intervention Education, counselling, and monitoring by nurses through frequent telephone follow-up in addition to usual care, delivered from a single centre. Main outcome measure All cause mortality or admission to hospital for worsening heart failure. Results Complete follow-up was available in 99.5% of patients. The 758 patients in the usual care group were more likely to be admitted for worsening heart failure or to dic (235 events, 31%) than the 760 patients who received the telephone intervention (200 events, 26.3%) (relative risk reduction = 20%, 95% confidence interval 3 to 34, P = 0.026). This benefit was mostly due to a significant reduction in admissions for heart failure (relative risk reduction = 29%, P = 0.005). Mortality was similar in both groups. At the end of the study the intervention group had a better quality of life than the usual care group (mean total score on Minnesota living with heart failure questionnaire 30.6 v 35, P = 0.001). Conclusions This simple, centralised heart failure programme was effective in reducing the primary end point through a significant reduction in admissions to hospital for heart failure.	Fdn GESICA, Buenos Aires, DF, Argentina		Grancelli, HO (corresponding author), Fdn GESICA, Av Rivadavia 2358,PB4,C1034ACP, Buenos Aires, DF, Argentina.	gesica@advancedsl.com.ar						Berry C, 2001, EUR J HEART FAIL, V3, P283, DOI 10.1016/S1388-9842(01)00123-4; BOURASSA MG, 1993, J AM COLL CARDIOL, V22, pA14, DOI 10.1016/0735-1097(93)90456-B; Capomolla S, 2002, J AM COLL CARDIOL, V40, P1259, DOI 10.1016/S0735-1097(02)02140-X; Cline CMJ, 1998, HEART, V80, P442, DOI 10.1136/hrt.80.5.442; Cohen-Solal A, 2000, EUR HEART J, V21, P763, DOI 10.1053/euhj.1999.1762; COX DR, 1972, J R STAT SOC B, V34, P187; Croft JB, 1997, J AM GERIATR SOC, V45, P270, DOI 10.1111/j.1532-5415.1997.tb00939.x; Grancelli H, 2003, J CARD FAIL, V9, P172, DOI 10.1054/jcaf.2003.33; Jaarsma T, 1999, EUR HEART J, V20, P673, DOI 10.1053/euhj.1998.1341; Krumholz HM, 2000, AM HEART J, V139, P72, DOI 10.1016/S0002-8703(00)90311-9; McAlister FA, 2001, AM J MED, V110, P378, DOI 10.1016/S0002-9343(00)00743-9; Philbin EF, 1999, AM J MED, V107, P549, DOI 10.1016/S0002-9343(99)00309-5; Phillips CO, 2004, JAMA-J AM MED ASSOC, V291, P1358, DOI 10.1001/jama.291.11.1358; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Rich MW, 1999, J CARD FAIL, V5, P64, DOI 10.1016/S1071-9164(99)90026-X; Stewart S, 2002, EUR HEART J, V23, P1369, DOI 10.1053/euhj.2001.3114; THOM TJ, 1997, DIS MANAG HEALTH OUT, V1, P75; VINSON JM, 1990, J AM GERIATR SOC, V38, P1290, DOI 10.1111/j.1532-5415.1990.tb03450.x; ZELEN M, 1979, NEW ENGL J MED, V300, P1242, DOI 10.1056/NEJM197905313002203; 1998, MMWR, V47, P633	20	135	148	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 20	2005	331	7514					425	427		10.1136/bmj.38516.398067.E0	http://dx.doi.org/10.1136/bmj.38516.398067.E0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	958WB	16061499	Green Published, Bronze			2022-12-28	WOS:000231477800013
J	Braga, SS; Manni, R; Pedretti, RFE				Braga, SS; Manni, R; Pedretti, RFE			Laughter-induced syncope	LANCET			English	Editorial Material									IRCCS Fdn Salvatore Maugeri, Ist Sci Tradate, Dept Cardiol, I-21049 Tradate, Italy; IRCCS Fdn Ist Neurol Casimiro Mondino, Unit Sleep Med & Epilepsy, I-27100 Pavia, Italy	Istituti Clinici Scientifici Maugeri IRCCS; IRCCS Fondazione Casimiro Mondino	Braga, SS (corresponding author), IRCCS Fdn Salvatore Maugeri, Ist Sci Tradate, Dept Cardiol, Via Roncaccio 16, I-21049 Tradate, Italy.	ssarzibraga@fsm.it	manni, raffaele/AAB-8804-2019; braga, simona sarzi/AAC-1002-2020	braga, simona sarzi/0000-0001-5704-4109; Pedretti, Roberto/0000-0003-1789-8657				American Sleep Disorders Association International Classification of Sleep Disorders, 1997, INT CLASS SLEEP DIS; Cox SV, 1997, CATHETER CARDIO DIAG, V42, P242, DOI 10.1002/(SICI)1097-0304(199710)42:2<242::AID-CCD41>3.3.CO;2-5; PORTH CJM, 1984, HEART LUNG, V13, P507; Totah AR, 2002, SLEEP MED, V3, P77, DOI 10.1016/S1389-9457(01)00113-7; Vignatelli L, 2002, SLEEP, V25, P193, DOI 10.1093/sleep/25.2.193	5	18	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2005	366	9483					426	426		10.1016/S0140-6736(05)67027-4	http://dx.doi.org/10.1016/S0140-6736(05)67027-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	950IB	16054945				2022-12-28	WOS:000230849700032
J	Cui, W				Cui, W			Astronomy - Very energetic gamma rays from microblazars	SCIENCE			English	Editorial Material							DISCOVERY; EMISSION		Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Cui, W (corresponding author), Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA.	cui@physics.purdue.edu	Cui, Wei/Y-3279-2019	Cui, Wei/0000-0002-6324-5772				Aharonian F, 2005, SCIENCE, V309, P746, DOI 10.1126/science.1113764; Bernado MMK, 2002, ASTRON ASTROPHYS, V385, pL10, DOI 10.1051/0004-6361:20020251; Bosch-Ramon V, 2004, ASTRON ASTROPHYS, V417, P1075, DOI 10.1051/0004-6361:20035615; Mirabel IF, 1999, ANNU REV ASTRON ASTR, V37, P409, DOI 10.1146/annurev.astro.37.1.409; MIRABEL IF, 2002, SKY TELESCOPE    MAY, P32; Paredes JM, 2000, SCIENCE, V288, P2340, DOI 10.1126/science.288.5475.2340; Romero GE, 2003, ASTRON ASTROPHYS, V410, pL1, DOI [10.1051/0004-6361:20031314-1, 10.1051/0004-6361:20031314]; Weekes T C, 2003, VERY HIGH ENERGY GAM	8	3	3	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2005	309	5735					714	715		10.1126/science.1116381	http://dx.doi.org/10.1126/science.1116381			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051778				2022-12-28	WOS:000230938200031
J	Mervis, J				Mervis, J			Inside the pipeline: Pharma goes to work - Introduction	SCIENCE			English	Editorial Material																			0	3	3	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2005	309	5735					721	721		10.1126/science.309.5735.721	http://dx.doi.org/10.1126/science.309.5735.721			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051780				2022-12-28	WOS:000230938200032
J	Mayorga, E; Aufdenkampe, AK; Masiello, CA; Krusche, AV; Hedges, JI; Quay, PD; Richey, JE; Brown, TA				Mayorga, E; Aufdenkampe, AK; Masiello, CA; Krusche, AV; Hedges, JI; Quay, PD; Richey, JE; Brown, TA			Young organic matter as a source of carbon dioxide outgassing from Amazonian rivers	NATURE			English	Article							C-14; FRACTIONATION; GEOCHEMISTRY; RADIOCARBON; STREAM; AGE	Rivers are generally supersaturated with respect to carbon dioxide, resulting in large gas evasion fluxes that can be a significant component of regional net carbon budgets(1,2). Amazonian rivers were recently shown to outgas more than ten times the amount of carbon exported to the ocean in the form of total organic carbon or dissolved inorganic carbon(1). High carbon dioxide concentrations in rivers originate largely from in situ respiration of organic carbon(1-3), but little agreement exists about the sources or turnover times of this carbon(2,4,5). Here we present results of an extensive survey of the carbon isotope composition (C-13 and C-14) of dissolved inorganic carbon and three size-fractions of organic carbon across the Amazonian river system. We find that respiration of contemporary organic matter (less than five years old) originating on land and near rivers is the dominant source of excess carbon dioxide that drives outgassing in medium to large rivers, although we find that bulk organic carbon fractions transported by these rivers range from tens to thousands of years in age. We therefore suggest that a small, rapidly cycling pool of organic carbon is responsible for the large carbon fluxes from land to water to atmosphere in the humid tropics.	Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; Stroud Water Res Ctr, Avondale, PA 19311 USA; Rice Univ, Dept Earth Sci, Houston, TX 77005 USA; Univ Sao Paulo, CENA, Lab Ecol Isotop, BR-13400970 Piracicaba, SP, Brazil; Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94551 USA	University of Washington; University of Washington Seattle; Rice University; Universidade de Sao Paulo; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Mayorga, E (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	emiliomayorga@alum.mit.edu	Masiello, Caroline/A-2653-2011; Krusche, Alex V/H-8988-2012	Masiello, Caroline/0000-0003-2102-6229; Mayorga, Emilio/0000-0003-2574-4623; Krusche, Alex/0000-0001-7094-5577; Brown, Tom/0000-0001-9984-7647; Aufdenkampe, Anthony/0000-0002-5811-6458				Aufdenkampe AK, 2001, LIMNOL OCEANOGR, V46, P1921, DOI 10.4319/lo.2001.46.8.1921; AUFDENKAMPE AK, IN PRESS ORG GEOCHEM; Bernardes MC, 2004, ECOL APPL, V14, pS263; Clark I.D., 1997, ENV ISOTOPES HYDROGE, P328; Cole JJ, 2001, MAR FRESHWATER RES, V52, P101, DOI 10.1071/MF00084; Devol A. H., 2001, BIOGEOCHEMISTRY AMAZ, P275; GESCH DB, 1999, EOS, V80, P70; GIBBS RJ, 1967, GEOL SOC AM BULL, V78, P1203, DOI 10.1130/0016-7606(1967)78[1203:TGOTAR]2.0.CO;2; Grimm NB, 2003, OECOLOGIA, V137, P485, DOI 10.1007/s00442-003-1382-5; HEDGES JI, 1986, SCIENCE, V231, P1129, DOI 10.1126/science.231.4742.1129; Hedges JI, 2000, LIMNOL OCEANOGR, V45, P1449, DOI 10.4319/lo.2000.45.7.1449; HEDGES JI, 1986, LIMNOL OCEANOGR, V31, P717, DOI 10.4319/lo.1986.31.4.0717; Jones JB, 1998, ECOSYSTEMS, V1, P183; Kerrick DM, 2001, REV GEOPHYS, V39, P565, DOI 10.1029/2001RG000105; KORNER C, 1991, OECOLOGIA, V88, P30, DOI 10.1007/BF00328400; Levin I, 2000, RADIOCARBON, V42, P69, DOI 10.1017/S0033822200053066; Levin I, 2004, RADIOCARBON, V46, P1261, DOI 10.1017/S0033822200033130; MAYORGA E, IN PRESS J HYDROL; Melack J.M., 2001, BIOGEOCHEMISTRY AMAZ, P235; Mulholland PJ, 2001, FRESHWATER BIOL, V46, P1503, DOI 10.1046/j.1365-2427.2001.00773.x; QUAY PD, 1992, LIMNOL OCEANOGR, V37, P857, DOI 10.4319/lo.1992.37.4.0857; Randerson JT, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001876; Raymond PA, 2001, NATURE, V409, P497, DOI 10.1038/35054034; Raymond PA, 2003, ECOSYSTEMS, V6, P694, DOI 10.1007/s10021-002-0213-6; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; STALLARD RF, 1983, J GEOPHYS RES-OCEANS, V88, P9671, DOI 10.1029/JC088iC14p09671; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Trumbore S, 2000, ECOL APPL, V10, P399, DOI 10.1890/1051-0761(2000)010[0399:AOSOMA]2.0.CO;2; VOGEL JS, 1987, RADIOCARBON, V29, P323; ZHANG J, 1995, GEOCHIM COSMOCHIM AC, V59, P107, DOI 10.1016/0016-7037(95)91550-D	30	422	445	13	245	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					538	541		10.1038/nature03880	http://dx.doi.org/10.1038/nature03880			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049484	Green Submitted			2022-12-28	WOS:000230788800057
J	Schwarz, D; Matta, BM; Shakir-Botteri, NL; McPheron, BA				Schwarz, D; Matta, BM; Shakir-Botteri, NL; McPheron, BA			Host shift to an invasive plant triggers rapid animal hybrid speciation	NATURE			English	Article							APPLE MAGGOT FLY; RHAGOLETIS-POMONELLA; SYMPATRIC SPECIATION; HYBRIDIZATION; COMPILATION; EVOLUTION; ALLOZYMES; RADIATION; INFERENCE; LINKAGE	Speciation in animals is almost always envisioned as the split of an existing lineage into an ancestral and a derived species. An alternative speciation route is homoploid hybrid speciation(1) in which two ancestral taxa give rise to a third, derived, species by hybridization without a change in chromosome number. Although theoretically possible it has been regarded as rare(1) and hence of little importance in animals. On the basis of molecular and chromosomal evidence, hybridization is the best explanation for the origin of a handful of extant diploid bisexual animal taxa(2-6). Here we report the first case in which hybridization between two host-specific animals (tephritid fruitflies) is clearly associated with the shift to a new resource. Such a hybrid host shift presents an ecologically robust scenario for animal hybrid speciation because it offers a potential mechanism for reproductive isolation through differential adaptation to a new ecological niche(7). The necessary conditions for this mechanism of speciation(7) are common in parasitic animals, which represent much of animal diversity(8). The frequency of homoploid hybrid speciation in animals may therefore be higher than previously assumed.	Penn State Univ, Dept Entomol, University Pk, PA 16803 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Schwarz, D (corresponding author), Penn State Univ, Dept Entomol, 501 ASI Bldg, University Pk, PA 16803 USA.	dxs332@psu.edu	TATSUTA, HARUKI/F-2997-2010	McPheron, Bruce/0000-0001-9623-5100				Anderson EC, 2002, GENETICS, V160, P1217; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Berlocher SH, 2002, ANNU REV ENTOMOL, V47, P773, DOI 10.1146/annurev.ento.47.091201.145312; Berlocher SH, 2000, EVOLUTION, V54, P543, DOI 10.1111/j.0014-3820.2000.tb00057.x; Buerkle CA, 2000, HEREDITY, V84, P441, DOI 10.1046/j.1365-2540.2000.00680.x; Coyne J. A., 2004, SPECIATION, P337; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Falush D, 2003, GENETICS, V164, P1567; Feder JL, 2003, GENETICS, V163, P939; Feder JL, 1999, ENTOMOL EXP APPL, V90, P9, DOI 10.1023/A:1003512607608; FLOATE KD, 1993, AM NAT, V141, P651, DOI 10.1086/285497; Fonseca DM, 2004, SCIENCE, V303, P1535, DOI 10.1126/science.1094247; FOOTE RH, 1993, HDB FRUIT FLIES DIPT, P322; Hirai H, 2000, INT J PARASITOL, V30, P441, DOI 10.1016/S0020-7519(99)00186-1; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; MCPHERON BA, 1985, J HERED, V76, P218, DOI 10.1093/oxfordjournals.jhered.a110075; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Pialek J, 2001, MOL ECOL, V10, P613, DOI 10.1046/j.1365-294x.2001.01209.x; Price P. W., 1980, EVOLUTIONARY BIOL PA; REHDER A, 1947, MANUAL CULTIVATED TR, P852; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Roethele JB, 2001, ANN ENTOMOL SOC AM, V94, P936, DOI 10.1603/0013-8746(2001)094[0936:EFBSCO]2.0.CO;2; Salzburger W, 2002, MOL ECOL, V11, P619, DOI 10.1046/j.0962-1083.2001.01438.x; Schneider S., 2000, ARLEQUIN SOFTWARE PO; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; SHAW CR, 1970, BIOCHEM GENET, V4, P297, DOI 10.1007/BF00485780; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smith JJ, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P187; Taylor DJ, 1996, MOL PHYLOGENET EVOL, V5, P495, DOI 10.1006/mpev.1996.0045; *USDA, 2005, PLANTS DAT	30	186	192	0	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					546	549		10.1038/nature03800	http://dx.doi.org/10.1038/nature03800			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049486				2022-12-28	WOS:000230788800059
J	Alarcon, WA; Calvert, GM; Blondell, JM; Mehler, LN; Sievert, J; Propeck, M; Tibbetts, DS; Becker, A; Lackovic, M; Soileau, SB; Das, R; Beckman, J; Male, DP; Thomsen, CL; Stanbury, M				Alarcon, WA; Calvert, GM; Blondell, JM; Mehler, LN; Sievert, J; Propeck, M; Tibbetts, DS; Becker, A; Lackovic, M; Soileau, SB; Das, R; Beckman, J; Male, DP; Thomsen, CL; Stanbury, M			Acute illnesses associated with pesticide exposure at schools	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMMUNITIES	Context Pesticides continue to be used on school property, and some schools are at risk of pesticide drift exposure from neighboring farms, which leads to pesticide exposure among students and school employees. However, information on the magnitude of illnesses and risk factors associated with these pesticide exposures is not available. Objective To estimate the magnitude of and associated risk factors for pesticide-related illnesses at schools. Design, Setting, and Participants Analysis of surveillance data from 1998 to 2002 of 2593 persons with acute pesticide- related illnesses associated with exposure at schools. Nationwide information on pesticide- related illnesses is routinely collected by 3 national pesticide surveillance systems: the National Institute for Occupational Safety and Health's Sentinel Event Notification System for Occupational Risks pesticides program, the California Department of Pesticide Regulation, and the Toxic Exposure Surveillance System. Main Outcome Measures Incidence rates and severity of acute pesticide- related illnesses. Results Incidence rates for 1998-2002 were 7.4 cases per million children and 27.3 cases per million school employee full-time equivalents. The incidence rates among children increased significantly from 1998 to 2002. Illness of high severity was found in 3 cases (0.1 %), moderate severity in 275 cases (11 %), and low severity in 2315 cases (89%). Most illnesses were associated with insecticides (n=895, 35%), disinfectants (n=830, 32%), repellents (n=335,13%), or herbicides (n=279, 11 %). Among 406 cases with detailed information on the source of pesticide exposure, 281 (69%) were associated with pesticides used at schools and 125 (31 %) were associated with pesticide drift exposure from farmland. Conclusions Pesticide exposure at schools produces acute illnesses among school employees and students. To prevent pesticide- related illnesses at schools, implementation of integrated pest management programs in schools, practices to reduce pesticide drift, and adoption of pesticide spray buffer zones around schools are recommended.	NIOSH, US Ctr Dis Control & Prevent, Cincinnati, OH 45226 USA; US EPA, Off Pesticide Programs, Washington, DC 20460 USA; Calif Environm Protect Agcy, Dept Pesticide Regulat, Sacramento, CA USA; Texas Dept State Hlth Serv, Environm & Injury Epidemiol & Toxicol Branch, Austin, TX USA; Washington Dept Hlth, Pesticides & Surveillance Sect, Olympia, WA USA; Florida Dept Hlth, Bur Community Environm Hlth, Tallahassee, FL USA; Louisiana Dept Hlth & Hosp, Sect Environm Epidemiol & Toxicol, New Orleans, LA USA; Calif Dept Hlth Serv, Occupat Hlth Branch, Oakland, CA USA; Inst Publ Hlth, Oakland, CA USA; New York State Dept Hlth, Bur Occupat Hlth, Troy, NY USA; Oregon Dept Human Serv Hlth Serv, Portland, OR USA; Michigan Dept Community Hlth, Div Environm & Occupat Epidemiol, Lansing, MI USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); United States Environmental Protection Agency; California Environmental Protection Agency; Texas Department of State Health Services; Florida Department of Health; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; California Department of Health Care Services; Public Health Institute; MDHHS - Michigan Department of Health & Human Services	Alarcon, WA (corresponding author), NIOSH, US Ctr Dis Control & Prevent, 4676 Columbia Pkwy,Mail Stop R-17, Cincinnati, OH 45226 USA.	walarcon@cdc.gov	Alarcon, Walter/C-4470-2008	Alarcon, Walter/0000-0002-4907-4380; Becker, alan/0000-0001-6464-4444				*AM ASS POIS CONTR, TOX EXP SURV SYST TE; *AM ASS POIS CONTR, 2001, TOX EXP SURV SYST TE, P1; Ames RG, 2002, INT J TOXICOL, V21, P397, DOI 10.1080/10915810290096621; *CA DEP PEST REG, 2002, SCH INT PEST MAN PRO; *CA DEP PEST REG, PEST ILLN SURV PROGR; Calvert GM, 2003, AM J PUBLIC HEALTH, V93, P605, DOI 10.2105/AJPH.93.4.605; CALVERT GM, 2001, HDB PESTICIDE TOXICO, P603; *CDCP, SENSOR PEST ILLN INJ; Fenske RA, 2000, J EXPO ANAL ENV EPID, V10, P662, DOI 10.1038/sj.jea.7500116; Greene A, 2002, J ECON ENTOMOL, V95, P1, DOI 10.1603/0022-0493-95.1.1; Koch D, 2002, ENVIRON HEALTH PERSP, V110, P829, DOI 10.1289/ehp.02110829; Lu CS, 2000, ENVIRON RES, V84, P290, DOI 10.1006/enrs.2000.4076; *NAT CTR MAN SCI, 1997, LEAD FREE SOLD PROJ, P1; *NAT ENV ED TRAIN, PEST NAT STRAT HLTH; National Intelligent Transport System Architecture Focus Groups, 2003, NAT INT TRANSP SYST, P1; OWENS K, 2002, SCH STATE PESTICIDE; PIPER C, 2002, PESTIC YOU, V22, P11; Quandt SA, 2004, ENVIRON HEALTH PERSP, V112, P382, DOI 10.1289/ehp.6554; Reigart J. R., 1999, RECOGNITION MANAGEME; Reigart JR, 2001, PEDIATR CLIN N AM, V48, P1185, DOI 10.1016/S0031-3955(05)70368-0; *US BUR LAB STAT, 2003, CURR POP SURV 1998 2; *US CENS BUR, 2003, PRIM CHILD CAR ARR U; *US CENS BUR, 2003, NAT POP DAT POP EST; US Environmental Protection Agency, INT PEST MAN IPM SCH; *US EPA, RER EL DEC RED GLYPH; *US EPA, INT RER EL DEC DIAZ; *US EPA, MAL RER EL DOC ENV F; *US EPA, INT RER EL DEC CHLOR; US General Accounting Office, 1999, PEST US EFF ALT PEST; OHIO SCH PEST MANAGE; PESTICIDES SCH PESTI	31	59	64	1	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2005	294	4					455	465		10.1001/jama.294.4.455	http://dx.doi.org/10.1001/jama.294.4.455			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RM	16046652	Bronze			2022-12-28	WOS:000230733400020
J	Foley, JA; DeFries, R; Asner, GP; Barford, C; Bonan, G; Carpenter, SR; Chapin, FS; Coe, MT; Daily, GC; Gibbs, HK; Helkowski, JH; Holloway, T; Howard, EA; Kucharik, CJ; Monfreda, C; Patz, JA; Prentice, IC; Ramankutty, N; Snyder, PK				Foley, JA; DeFries, R; Asner, GP; Barford, C; Bonan, G; Carpenter, SR; Chapin, FS; Coe, MT; Daily, GC; Gibbs, HK; Helkowski, JH; Holloway, T; Howard, EA; Kucharik, CJ; Monfreda, C; Patz, JA; Prentice, IC; Ramankutty, N; Snyder, PK			Global consequences of land use	SCIENCE			English	Review							AGRICULTURAL INTENSIFICATION; HUMAN APPROPRIATION; CLIMATE; CARBON; WATER; NITROGEN; IMPACT; DEFORESTATION; VULNERABILITY; URBANIZATION	Land use has generally been considered a local environmental issue, but it is becoming a force of global importance. Worldwide changes to forests, farmlands, waterways, and air are being driven by the need to provide food, fiber, water, and shelter to more than six billion people. Global croplands, pastures, plantations, and urban areas have expanded in recent decades, accompanied by large increases in energy, water, and fertilizer consumption, along with considerable tosses of biodiversity. Such changes in land use have enabled humans to appropriate an increasing share of the planet's resources, but they also potentially undermine the capacity of ecosystems to sustain food production, maintain freshwater and forest resources, regulate climate and air quality, and ameliorate infectious diseases. We face the challenge of managing trade-offs between immediate human needs and maintaining the capacity of the biosphere to provide goods and services in the long term.	Univ Wisconsin, Ctr Sustainabil & Global Environm, Madison, WI 53726 USA; Univ Maryland, Dept Geog, College Pk, MD 20742 USA; Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; Carnegie Inst Washington, Dept Global Ecol, Stanford, CA 94305 USA; Natl Ctr Atmospher Res, Boulder, CO 80307 USA; Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA; Stanford Univ, Dept Biol Sci, Ctr Conservat Biol, Stanford, CA 94305 USA; Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; Univ Illinois, Dept Atmospher Sci, Urbana, IL 61801 USA	University of Wisconsin System; University of Wisconsin Madison; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Carnegie Institution for Science; National Center Atmospheric Research (NCAR) - USA; University of Wisconsin System; University of Wisconsin Madison; University of Alaska System; University of Alaska Fairbanks; Stanford University; University of Bristol; University of Illinois System; University of Illinois Urbana-Champaign	Foley, JA (corresponding author), Univ Wisconsin, Ctr Sustainabil & Global Environm, 1710 Univ Ave, Madison, WI 53726 USA.	jfoley@wisc.edu	Snyder, Peter/H-3063-2013; Ramirez, Aldo/AAI-1308-2021; Asner, Gregory/G-9268-2013; Carpenter, Stephen/AAQ-6404-2020; Ramankutty, Navin/AAM-6074-2020; Chapin, F Stuart/AAZ-3931-2020; Foley, Jonathan A/GRS-5522-2022	Asner, Gregory/0000-0001-7893-6421; Ramankutty, Navin/0000-0002-3737-5717; Chapin, F Stuart/0000-0002-2558-9910; Coe, Michael/0000-0002-7470-0697				[Anonymous], 2002, ECOLOGICAL CLIMATOLO; ASNER GP, 2004, ANN REV ENV RESOUR, V29; Bennett EM, 2001, BIOSCIENCE, V51, P227, DOI 10.1641/0006-3568(2001)051[0227:HIOEPA]2.0.CO;2; BONAN GB, 1992, NATURE, V359, P716, DOI 10.1038/359716a0; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; Cockburn A, 1999, INT J HEALTH SERV, V29, P459, DOI 10.2190/BC4C-Y1T9-23P8-U991; Costa MH, 2000, J CLIMATE, V13, P18, DOI [10.1175/1520-0442(2000)013<0018:CEODAD>2.0.CO;2, 10.1175/1520-0442(2000)013&lt;0018:CEODAD&gt;2.0.CO;2]; Costa MH, 2003, J HYDROL, V283, P206, DOI 10.1016/S0022-1694(03)00267-1; Costanza R, 2000, BIOSCIENCE, V50, P149, DOI 10.1641/0006-3568(2000)050[0149:MOEP]2.3.CO;2; Daily GC, 1997, NATURES SERVICES SOC, DOI DOI 10.12987/9780300188479-039; DEFRIES R, 2004, GEOPHYS MONOGRAPH SE, V153; DeFries RS, 2004, FRONT ECOL ENVIRON, V2, P249, DOI 10.1890/1540-9295(2004)002[0249:LCBHNA]2.0.CO;2; *ED STAFF, 1999, ENV HLTH PERSP, V107, P139; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; *FOOD AGR ORG, 2004, FAOSTAT DAT; Frink CR, 1999, P NATL ACAD SCI USA, V96, P1175, DOI 10.1073/pnas.96.4.1175; GIBBS HK, 2001, THESIS OHIO STAT U C; Gleick PH, 2003, ANNU REV ENV RESOUR, V28, P275, DOI 10.1146/annurev.energy.28.040202.122849; Guo ZW, 2000, ECOL APPL, V10, P925, DOI 10.1890/1051-0761(2000)010[0925:AAOESW]2.0.CO;2; Houghton R. A., 2001, ORNLCDIAC131; Kalnay E, 2003, NATURE, V423, P528, DOI 10.1038/nature01675; KAUPPI PE, 1992, SCIENCE, V256, P70, DOI 10.1126/science.256.5053.70; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Lal R, 2001, CLIMATIC CHANGE, V51, P35, DOI 10.1023/A:1017529816140; Mann CC, 1999, SCIENCE, V283, P310, DOI 10.1126/science.283.5400.310; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; Millenium Ecosystem Assessment, 2003, EC HUM WELLB FRAM AS; Mols CMM, 2002, J APPL ECOL, V39, P888, DOI 10.1046/j.1365-2664.2002.00761.x; Nabuurs GJ, 2003, GLOBAL CHANGE BIOL, V9, P152, DOI 10.1046/j.1365-2486.2003.00570.x; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877; Pielke RA, 2002, PHILOS T ROY SOC A, V360, P1705, DOI 10.1098/rsta.2002.1027; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Postel S, 1999, PILLAR SAND CAN MIRA; Postel SL, 1996, SCIENCE, V271, P785, DOI 10.1126/science.271.5250.785; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; RICKETTS TH, IN PRESS P NATL ACAD; Rose JB, 2001, ENVIRON HEALTH PERSP, V109, P211, DOI 10.2307/3435011; Rosegrant M.W., 2002, INT FOOD POLICY RES; Rosenberg NJ, 2001, CLIMATIC CHANGE, V51, P1, DOI 10.1023/A:1017599420258; Sahin V, 1996, J HYDROL, V178, P293, DOI 10.1016/0022-1694(95)02825-0; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; SHIKLOMANOV IA, 1998, UN COMPREHENSIVE ASS; SILLMAN S, 1995, J GEOPHYS RES-ATMOS, V100, P11497, DOI 10.1029/94JD02146; Snyder PK, 2004, CLIM DYNAM, V23, P279, DOI 10.1007/s00382-004-0430-0; Tilman D, 1998, NATURE, V396, P211, DOI 10.1038/24254; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Townsend AR, 2003, FRONT ECOL ENVIRON, V1, P240, DOI 10.2307/3868011; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; *US EPA, 2003, HEAT ISL EFF; VITOUSEK PM, 1986, BIOSCIENCE, V36, P368, DOI 10.2307/1310258; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; VITTOR AY, IN PRESS J AM TROP M; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Wackernagel M, 2002, P NATL ACAD SCI USA, V99, P9266, DOI 10.1073/pnas.142033699; Williams Michael, 1990, EARTH TRANSFORMED HU, P179; Wolfe ND, 2004, LANCET, V363, P932, DOI 10.1016/S0140-6736(04)15787-5; Wood S., 2000, PILOT ANAL GLOBAL EC; WU N, 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P436; Zhou LM, 2004, P NATL ACAD SCI USA, V101, P9540, DOI 10.1073/pnas.0400357101	62	7428	8043	479	8173	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2005	309	5734					570	574		10.1126/science.1111772	http://dx.doi.org/10.1126/science.1111772			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040698				2022-12-28	WOS:000230735200036
J	Rosen, AB; Hamel, MB; Weinstein, MC; Cutler, DM; Fendrick, AM; Vijan, S				Rosen, AB; Hamel, MB; Weinstein, MC; Cutler, DM; Fendrick, AM; Vijan, S			Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes	ANNALS OF INTERNAL MEDICINE			English	Article							PLACEBO-CONTROLLED TRIAL; CORONARY-HEART-DISEASE; PRESCRIPTION DRUGS; MYOCARDIAL-INFARCTION; NORMOALBUMINURIC PATIENTS; CARDIOVASCULAR EVENTS; RISK-FACTORS; HEALTH; NEPHROPATHY; MELLITUS	Background: Angiotensin-converting enzyme (ACE) inhibitors slow renal disease progression and reduce cardiac morbidity and mortality in patients with diabetes. Patients' out-of-pocket costs pose a barrier to using this effective therapy. Objective: To estimate the cost-effectiveness to Medicare of first-dollar coverage (no cost sharing) of ACE inhibitors for beneficiaries with diabetes. Design: Markov model with costs and benefits discounted at 3%. Data Sources: Published literature and Medicare claims data. Target Population: 65-year-old Medicare beneficiary with diabetes. Time Horizon: Lifetime. Perspective: Medicare and societal. Interventions: we evaluated Medicare first-dollar coverage of ACE inhibitors compared with current practice (no coverage) and the new Medicare drug benefit. Outcome Measures: Costs (2003 U.S. dollars), quality-adjusted life-years (QALYs), life-years, and incremental cost-effectiveness. Results of Base-Case Analysis: Compared with current practice, first-dollar coverage of ACE inhibitors saved both lives and money (0.23 QALYs gained and $1606 saved per Medicare beneficiary). Compared with the new Medicare drug benefit, first-dollar coverage remained a dominant strategy (0.15 QALYs gained, $922 saved). Results of Sensitivity Analysis: Results were most sensitive to our estimate of increase in ACE inhibitor use; however, if ACE inhibitor use increased by only 7.2% (from 40% to 47.2%), first-dollar coverage would remain life-saving at no net cost to Medicare. In analyses conducted from the societal perspective, benefits were similar and cost savings were larger. Limitations: Results depend on accuracy of the underlying data and assumptions. The effect of more generous drug coverage on medication adherence is uncertain. Conclusions: Medicare first-dollar coverage of ACE inhibitors for beneficiaries with diabetes appears to extend life and reduce Medicare program costs. A reduction in program costs may result in more money to spend on other health care needs of the elderly.	Univ Michigan, Div Gen Med, Ann Arbor, MI 48109 USA; Ann Arbor Vet Affairs Med Ctr, Ann Arbor, MI USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Harvard Univ, Cambridge, MA 02138 USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Rosen, AB (corresponding author), Univ Michigan, Div Gen Med, 300 N Ingalls,Suite 7E10, Ann Arbor, MI 48109 USA.	abrosen@umich.edu		Cutler, David/0000-0002-4949-8917	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000020] Funding Source: NIH RePORTER; AHRQ HHS [5 T32 HS00020-16] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Ahmad J, 1997, DIABETES CARE, V20, P1576, DOI 10.2337/diacare.20.10.1576; Arias Elizabeth, 2002, Natl Vital Stat Rep, V51, P1; Artz MB, 2002, AM J PUBLIC HEALTH, V92, P1257, DOI 10.2105/AJPH.92.8.1257; Bertoni AG, 2002, DIABETES CARE, V25, P471, DOI 10.2337/diacare.25.3.471; Brown GC, 2000, J DIABETES COMPLICAT, V14, P18, DOI 10.1016/S1056-8727(00)00061-1; Chaturvedi N, 2001, ANN INTERN MED, V134, P370, DOI 10.7326/0003-4819-134-5-200103060-00009; Chaturvedi N, 1998, LANCET, V351, P28, DOI 10.1016/S0140-6736(97)06209-0; Clark WF, 2000, CAN MED ASSOC J, V162, P195; *CTR MED MED SERV, 2003, MED MOD ACT; CULYER A, 2000, HDB HLTH EC, P119; Dunn EJ, 1999, QJM-INT J MED, V92, P443, DOI 10.1093/qjmed/92.8.443; Ellis JJ, 2004, J GEN INTERN MED, V19, P638, DOI 10.1111/j.1525-1497.2004.30516.x; Federman AD, 2001, JAMA-J AM MED ASSOC, V286, P1732, DOI 10.1001/jama.286.14.1732; Fendrick AM, 2001, AM J MANAG CARE, V7, P861; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Gerstein HC, 2000, LANCET, V355, P253; Golan L, 1999, ANN INTERN MED, V131, P660, DOI 10.7326/0003-4819-131-9-199911020-00005; Gold J A, 1996, Wis Med J, V95, P588; GOLD MR, 1996, COST EFFECTIVENESS; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; Gordian M E, 1998, Alaska Med, V40, P51; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hagihara A, 2001, HEALTH POLICY, V58, P231, DOI 10.1016/S0168-8510(01)00171-3; Haider A, 2000, Can J Clin Pharmacol, V7, P115; HARRIS BL, 1990, MED CARE, V28, P907, DOI 10.1097/00005650-199010000-00005; *HARV CTR RISK AN, 2003, COMPR TABL COST UT R; Herman WH, 2003, DIABETES CARE, V26, P683, DOI 10.2337/diacare.26.3.683; Hillen T, 2003, STROKE, V34, P1457, DOI 10.1161/01.STR.0000072985.24967.7F; Huskamp HA, 2003, NEW ENGL J MED, V349, P2224, DOI 10.1056/NEJMsa030954; Johnson RE, 1997, HEALTH SERV RES, V32, P103; JOHNSTON M, 1991, EC HLTH 1990, P46; Joyce GF, 2002, JAMA-J AM MED ASSOC, V288, P1733, DOI 10.1001/jama.288.14.1733; *KAIS FAM FDN, 2003, MED PRESCR DRUGS FA; *KAIS FAM FDN, 2004, PUBL KAIS FAM FDN; Kvetny J, 2001, QJM-INT J MED, V94, P89, DOI 10.1093/qjmed/94.2.89; Langa KM, 2002, J GERONTOL B-PSYCHOL, V57, pS177, DOI 10.1093/geronb/57.3.S177; LAWRENCE WF, 1995, AM J KIDNEY DIS, V25, P701, DOI 10.1016/0272-6386(95)90545-6; LEIBOWITZ A, 1985, SOC SCI MED, V21, P1063, DOI 10.1016/0277-9536(85)90161-3; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Malik RA, 1998, LANCET, V352, P1978, DOI 10.1016/S0140-6736(98)02478-7; Marre M, 2004, BRIT MED J, V328, P495, DOI 10.1136/bmj.37970.629537.0D; Mathias SD, 1997, STROKE, V28, P1888, DOI 10.1161/01.STR.28.10.1888; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; *NAT CTR HLTH STAT, 2004, NHANES 1999 200 PUB; Nathan DM, 1996, JAMA-J AM MED ASSOC, V276, P1409; National Center for Health Statistics, 2003, HLTH US 2003 CHARTB; NEWHOUSE JB, 2001, NATL BUREAU EC RES W, V8168; Niskanen L, 2001, DIABETES CARE, V24, P2091, DOI 10.2337/diacare.24.12.2091; O'Hare JP, 2000, DIABETES CARE, V23, P1823, DOI 10.2337/diacare.23.12.1823; OBRIEN B, 1989, J HEALTH ECON, V8, P109, DOI 10.1016/0167-6296(89)90011-8; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Phillips KA, 2000, JAMA-J AM MED ASSOC, V284, P2748, DOI 10.1001/jama.284.21.2748; Piette JD, 2004, MED CARE, V42, P102, DOI 10.1097/01.mlr.0000108742.26446.17; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Ravid M, 1998, ANN INTERN MED, V128, P982, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00004; Ravid M, 1996, ARCH INTERN MED, V156, P286, DOI 10.1001/archinte.156.3.286; REJA A, 1995, DIABETIC MED, V12, P307, DOI 10.1111/j.1464-5491.1995.tb00482.x; RETTENMAIER AJ, 2004, MEDICARE PRESCRIPTIO; Rodby RA, 1996, DIABETES CARE, V19, P1051, DOI 10.2337/diacare.19.10.1051; Rosen AB, 2004, J GEN INTERN MED, V19, P210; Rosen AB, 2004, J GEN INTERN MED, V19, P669, DOI 10.1111/j.1525-1497.2004.30264.x; Scarsi KK, 2000, ANN PHARMACOTHER, V34, P1002; Sisk JE, 1997, JAMA-J AM MED ASSOC, V278, P1333, DOI 10.1001/jama.278.16.1333; SMITH DG, 1993, INQUIRY-J HEALTH CAR, V30, P189; SOUMERAI SB, 1987, NEW ENGL J MED, V317, P550, DOI 10.1056/NEJM198708273170906; Stuart B, 1999, HEALTH AFFAIR, V18, P201, DOI 10.1377/hlthaff.18.2.201; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; TSEVAT J, 1993, MED DECIS MAKING, V13, P161, DOI 10.1177/0272989X9301300210; *US BUR LAB STAT, 2005, CONS PRIC IND ALL UR; *US REN DAT SYST, 2003, USRDS 2003 ANN DAT R; Valmadrid CT, 2000, ARCH INTERN MED, V160, P1093, DOI 10.1001/archinte.160.8.1093; VIBERTI G, 1994, JAMA-J AM MED ASSOC, V271, P275, DOI 10.1001/jama.271.4.275; Yusuf S, 2000, NEW ENGL J MED, V342, P145; 2003, 2003 DRUG TOPICS RED	76	104	106	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2005	143	2					89	99		10.7326/0003-4819-143-2-200507190-00007	http://dx.doi.org/10.7326/0003-4819-143-2-200507190-00007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	946YG	16027450				2022-12-28	WOS:000230608600001
J	Duerr, A; Hurst, S; Kourtis, AP; Rutenberg, N; Jamieson, DJ				Duerr, A; Hurst, S; Kourtis, AP; Rutenberg, N; Jamieson, DJ			Integrating family planning and prevention of mother-to-child HIV transmission in resource-limited settings	LANCET			English	Editorial Material							INFECTION; MORTALITY; WOMEN; CARE		Fred Hutchinson Canc Res Ctr, HIV Vaccine Trials Network, Seattle, WA 98109 USA; Ctr Dis Control & Prevent, Atlanta, GA USA; Assoc Sch Publ Hlth, Washington, DC USA; Populat Council, Washington, DC USA	Fred Hutchinson Cancer Center; Centers for Disease Control & Prevention - USA; Population Council	Duerr, A (corresponding author), Fred Hutchinson Canc Res Ctr, HIV Vaccine Trials Network, LE 500,POB 19024, Seattle, WA 98109 USA.	aduerr@hvtn.org		Jamieson, Denise/0000-0003-2597-1201; Hurst, Stacey/0000-0002-3338-9708; Kourtis, Athena/0000-0003-1585-1310				Brocklehurst P, 1998, BRIT J OBSTET GYNAEC, V105, P836, DOI 10.1111/j.1471-0528.1998.tb10227.x; *CENTR BUR STAT, 1999, KEN DEM HLTH SURV 19; *CENTR BUR STAT, 2003, ZAMB DEM HLTH SURV 2; Crampin AC, 2003, AIDS, V17, P389, DOI 10.1097/00002030-200302140-00013; Desgrees-du-Lou A, 2002, INT J STD AIDS, V13, P462, DOI 10.1258/09564620260079617; *FAM HLTH INT, 2004, NETWORK, V23, P16; FOSTER G, 1995, AIDS CARE, V7, P3, DOI 10.1080/09540129550126911; Kilewo C, 2001, J ACQ IMMUN DEF SYND, V28, P458, DOI 10.1097/00042560-200112150-00009; KING RWP, 1995, J ELECTROMAGNET WAVE, V9, P1, DOI 10.1163/156939395X00226; McIntyre J, 2003, BRIT MED BULL, V67, P127, DOI 10.1093/bmb/ldg012; Nakiyingi JS, 2003, AIDS, V17, P1827, DOI 10.1097/00002030-200308150-00012; Peck R, 2003, JAIDS-J ACQ IMM DEF, V33, P470, DOI 10.1097/00126334-200308010-00007; RYDER RW, 1994, AIDS, V8, P673, DOI 10.1097/00002030-199405000-00015; Sewankambo NK, 2000, AIDS, V14, P2391, DOI 10.1097/00002030-200010200-00021; Strachan M, 2004, ANAL FAMILY PLANNING; Sweat MD, 2004, AIDS, V18, P1661, DOI 10.1097/01.aids.0000131353.06784.8f; *UN POP FUND, 2004, NEW YORK CALL COMM L; *US DEP HHS, 2004, GUID US ANT AG HIV 1; WHO, 2004, MED EL CRIT CONTR US, V3; WHO, 2004, GLION CALL ACT FAM P; *WHO, 2003, AIDS EP UPD; World Health Organization, 2002, PREV HIV INF YOUNG C	22	38	38	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 16	2005	366	9481					261	263		10.1016/S0140-6736(05)66917-6	http://dx.doi.org/10.1016/S0140-6736(05)66917-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945RG	16023518				2022-12-28	WOS:000230519200036
J	Guleria, R; Mohan, A				Guleria, R; Mohan, A			Re-expansion pulmonary oedema	LANCET			English	Editorial Material									All India Inst Med Sci, Dept Med, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Guleria, R (corresponding author), All India Inst Med Sci, Dept Med, New Delhi 110029, India.	randeepg@hotmail.com							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2005	366	9481					236	236		10.1016/S0140-6736(05)66914-0	http://dx.doi.org/10.1016/S0140-6736(05)66914-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945RG	16023515				2022-12-28	WOS:000230519200033
J	Bellwood, P; White, P				Bellwood, P; White, P			Domesticated pigs in eastern Indonesia	SCIENCE			English	Letter									Australian Natl Univ, Sch Archaeol & Anthropol, Canberra, ACT 0200, Australia; Univ Sydney, Sch Philosoph & Hist Inquiry, Sydney, NSW 2006, Australia	Australian National University; University of Sydney	Bellwood, P (corresponding author), Australian Natl Univ, Sch Archaeol & Anthropol, Canberra, ACT 0200, Australia.			Dobney, Keith/0000-0001-9036-4681				Allen J, 2000, MOD QUAT RE, V16, P139; Bellwood P., 1998, MOD QUAT RE, P233; Flannery T.F., 1998, Australian Mammalogy, V20, P391; WHITE JP, 2004, VOYAGES DISCOVERY AR, P147	4	15	15	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2005	309	5733					381	381						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020714				2022-12-28	WOS:000230574900020
J	Coggan, JS; Bartol, TM; Esquenazi, E; Stiles, JR; Lamont, S; Martone, ME; Berg, DK; Ellisman, MH; Sejnowski, TJ				Coggan, JS; Bartol, TM; Esquenazi, E; Stiles, JR; Lamont, S; Martone, ME; Berg, DK; Ellisman, MH; Sejnowski, TJ			Evidence for ectopic neurotransmission at a neuronal synapse	SCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; CHICK CILIARY GANGLION; BUNGAROTOXIN BINDING-SITES; QUANTAL VARIABILITY; MULTIPLE CLASSES; MOLECULAR-FORMS; TRANSMISSION; LOCALIZATION; RECORDINGS; EXPRESSION	Neurotransmitter release is well known to occur at specialized synaptic regions that include presynaptic active zones and postsynaptic densities. At cholinergic synapses in the chick ciliary ganglion, however, membrane formations and physiological measurements suggest that release distant from postsynaptic densities can activate the predominantly extrasynaptic alpha 7 nicotinic receptor subtype. We explored such ectopic neurotransmission with a novel model synapse that combines Monte Carlo simulations with high-resolution serial electron microscopic tomography. Simulated synaptic activity is consistent with experimental recordings of miniature excitatory postsynaptic currents only when ectopic transmission is included in the model, broadening the possibilities for mechanisms of neuronal communication.	Salk Inst Biol Studies, Computat Neurobiol Lab, La Jolla, CA 92037 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; Carnegie Mellon Univ, Pittsburgh Supercomp Ctr, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA	Salk Institute; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Diego	Sejnowski, TJ (corresponding author), Salk Inst Biol Studies, Computat Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	terry@salk.edu	Sejnowski, Terrence/AAV-5558-2021	Coggan, Jay S/0000-0002-2270-1989	Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [RR04050, P41-RR06009, P41 RR004050, P41 RR006009] Funding Source: Medline; NIDCD NIH HHS [DC03192] Funding Source: Medline; NIGMS NIH HHS [P20-GM065805, P20 GM065805, GM068630, R01 GM068630] Funding Source: Medline; NINDS NIH HHS [NS12601, P01 NS044306, P01-NS044306, NS35469, R01 NS035469, R01 NS012601] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050, P41RR006009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM065805, R01GM068630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044306, R01NS035469, R01NS012601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003192] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ANGLISTER L, 1994, NEURON, V12, P783, DOI 10.1016/0896-6273(94)90331-X; BARTOL TM, 1991, BIOPHYS J, V59, P1290, DOI 10.1016/S0006-3495(91)82344-X; Bennett MR, 1997, BIOPHYS J, V72, P1595, DOI 10.1016/S0006-3495(97)78806-4; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Chang KT, 1999, J NEUROSCI, V19, P3701; Chang KT, 2001, NEURON, V32, P855, DOI 10.1016/S0896-6273(01)00516-5; CONROY WG, 1995, J BIOL CHEM, V270, P4424, DOI 10.1074/jbc.270.9.4424; COURAUD JY, 1980, J NEUROCHEM, V34, P1209, DOI 10.1111/j.1471-4159.1980.tb09961.x; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; FABER DS, 1992, SCIENCE, V258, P1494, DOI 10.1126/science.1279813; Franks KM, 2003, J NEUROSCI, V23, P3186; Franks KM, 2002, BIOPHYS J, V83, P2333, DOI 10.1016/S0006-3495(02)75248-X; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; Horch HLW, 1995, J NEUROSCI, V15, P7778; JACOB MH, 1983, J NEUROSCI, V3, P260; Kruk PJ, 1997, BIOPHYS J, V73, P2874, DOI 10.1016/S0006-3495(97)78316-4; Lenzi D, 1999, J NEUROSCI, V19, P119, DOI 10.1523/JNEUROSCI.19-01-00119.1999; Lorensen W.E., 1987, COMPUT GRAPH, V21, P163, DOI [10.1145/37401.37422, DOI 10.1145/37401.37422]; LORING RH, 1985, NEUROSCIENCE, V14, P645, DOI 10.1016/0306-4522(85)90316-1; MARGIOTTA JF, 1987, J NEUROSCI, V7, P3612; McNerney ME, 2000, J NEUROPHYSIOL, V84, P1314, DOI 10.1152/jn.2000.84.3.1314; Momiyama A, 2003, J PHYSIOL-LONDON, V549, P75, DOI 10.1113/jphysiol.2002.033472; Nguyen D, 2002, J COMP NEUROL, V448, P128, DOI 10.1002/cne.10237; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Shoop RD, 2001, J NEUROSCI, V21, P771, DOI 10.1523/JNEUROSCI.21-03-00771.2001; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Soto G E, 1994, Neuroimage, V1, P230, DOI 10.1006/nimg.1994.1008; Stiles JR, 2001, METH NE FRO NEUROSCI, P87; Stiles JR, 1999, BIOPHYS J, V77, P1177, DOI 10.1016/S0006-3495(99)76969-9; Stiles JR, 1996, P NATL ACAD SCI USA, V93, P5747, DOI 10.1073/pnas.93.12.5747; Taschenberger H, 2002, NEURON, V36, P1127, DOI 10.1016/S0896-6273(02)01137-6; Ullian EM, 1997, J NEUROSCI, V17, P7210; VIGNY M, 1978, EUR J BIOCHEM, V85, P317, DOI 10.1111/j.1432-1033.1978.tb12241.x; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zhang ZW, 1996, NEURON, V17, P1231, DOI 10.1016/S0896-6273(00)80253-6	36	138	154	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					446	451		10.1126/science.1108239	http://dx.doi.org/10.1126/science.1108239			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020730	Green Accepted			2022-12-28	WOS:000230574900040
J	Eynon, EE; Zenewicz, LA; Flavell, RA				Eynon, EE; Zenewicz, LA; Flavell, RA			Sugar-coated regulation of T cells	CELL			English	Editorial Material							POLYSACCHARIDE	The human gut is host to hundreds of different species of commensal bacteria that live in peaceful partnership with the host immune system. These commensal bacteria are far from neutral bystanders as they are intimately involved in the development of the immune system. Reporting in this issue of Cell, Kasper and colleagues (Mazmanian et al., 2005) reveal that a bacterial polysaccharide, PSA, produced by the commensal bacterium Bacteroides fragilis directs development of the immune system of the mouse host.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute	Eynon, EE (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA.			Zenewicz, Lauren/0000-0002-8787-5955				Brubaker JO, 1999, J IMMUNOL, V162, P2235; Cobb BA, 2004, CELL, V117, P677, DOI 10.1016/j.cell.2004.05.001; Hooper LV, 2004, TRENDS MICROBIOL, V12, P129, DOI 10.1016/j.tim.2004.01.001; Koropatnick TA, 2004, SCIENCE, V306, P1186, DOI 10.1126/science.1102218; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Tzianabos AO, 1999, J IMMUNOL, V163, P893; Wagner N, 1998, EUR J IMMUNOL, V28, P3832, DOI 10.1002/(SICI)1521-4141(199811)28:11<3832::AID-IMMU3832>3.0.CO;2-J	8	4	4	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 15	2005	122	1					2	4		10.1016/j.cell.2005.06.035	http://dx.doi.org/10.1016/j.cell.2005.06.035			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	950EC	16009124	Bronze			2022-12-28	WOS:000230839400002
J	Gewin, V				Gewin, V			Industry lured by the gains of going green	NATURE			English	Editorial Material																			0	15	18	3	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2005	436	7048					173	173		10.1038/436173a	http://dx.doi.org/10.1038/436173a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015302	Bronze			2022-12-28	WOS:000230459500012
J	Steinbrook, R				Steinbrook, R			Financial conflicts of interest and the Food and Drug Administration's Advisory Committees	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		*CTR SCI PUBL INT, 2005, CONFL INT COX 2 PAN; Food and Drug Administration U.S. Department of Health and Human Services, 2002, DRAFT GUID DISCL CON; *FOOD DRUG ADM, 2000, FDA GUID CONFL INT A; Harris G., 2005, NY TIMES 0225, pA1; Okie S, 2005, NEW ENGL J MED, V352, P1063, DOI 10.1056/NEJMp058003	5	32	33	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2005	353	2					116	118		10.1056/NEJMp058108	http://dx.doi.org/10.1056/NEJMp058108			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944OP	16014880				2022-12-28	WOS:000230438800002
J	Chong, KKL; Chan, WM				Chong, KKL; Chan, WM			Looking for the obvious	LANCET			English	Editorial Material									Chinese Univ Hong Kong, Hong Kong Eye Hosp, Dept Ophthalmol & Visual Sci, Kowloon, Hong Kong, Peoples R China	Chinese University of Hong Kong	Chan, WM (corresponding author), Chinese Univ Hong Kong, Hong Kong Eye Hosp, Dept Ophthalmol & Visual Sci, Kowloon, Hong Kong, Peoples R China.	cwm6373@netvigator.com	Chong, Kelvin Kam-Lung/K-4929-2016	CHONG, Kelvin Kam-lung/0000-0003-2587-1323					0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2005	366	9480					175	175		10.1016/S0140-6736(05)66876-6	http://dx.doi.org/10.1016/S0140-6736(05)66876-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	943JH	16005343				2022-12-28	WOS:000230349200039
J	Davies, SC				Davies, SC			Commentary: Universities have a vital role	BRITISH MEDICAL JOURNAL			English	Editorial Material									Dept Hlth, London SE1 6TE, England		Davies, SC (corresponding author), Dept Hlth, London SE1 6TE, England.	sally.davies@dh.gsi.gov.uk						Clark J, 2005, BRIT MED J, V331, P101, DOI 10.1136/bmj.331.7508.101; *COUNC HEADS MED S, 2004, CLIN AC STAFF LEV UK; *HARV MED SCH, HARV MED SCH ANN CTR; *INT VIRT MED SCH, IMPR HLTH SETT NEW S	4	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 9	2005	331	7508					105	105		10.1136/bmj.331.7508.105	http://dx.doi.org/10.1136/bmj.331.7508.105			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945XR	16002888	Green Published			2022-12-28	WOS:000230536800021
J	Moore, A; McQuay, H				Moore, A; McQuay, H			Acupuncture: not just needles?	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; OSTEOARTHRITIS; KNEE; THERAPY		Churchill Hosp, Oxford OX3 7LJ, England	University of Oxford	Moore, A (corresponding author), Churchill Hosp, Oxford OX3 7LJ, England.	andrew.moore@pru.ox.ac.uk						Berman BM, 2004, ANN INTERN MED, V141, P901, DOI 10.7326/0003-4819-141-12-200412210-00006; Ezzo J, 2001, ARTHRITIS RHEUM, V44, P819, DOI 10.1002/1529-0131(200104)44:4<819::AID-ANR138>3.0.CO;2-P; Lee H, 2005, PAIN, V114, P511, DOI 10.1016/j.pain.2005.02.011; Paterson C, 2005, BMJ-BRIT MED J, V330, P1202, DOI 10.1136/bmj.330.7501.1202; Vas J, 2004, BMJ-BRIT MED J, V329, P1216, DOI 10.1136/bmj.38238.601447.3A; Vickers AJ, 2004, HEALTH TECHNOL ASSES, V8, P1; Witt C, 2005, LANCET, V366, P136, DOI 10.1016/S0140-6736(05)66871-7	7	14	14	1	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 9	2005	366	9480					100	101		10.1016/S0140-6736(05)66843-2	http://dx.doi.org/10.1016/S0140-6736(05)66843-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	943JH	16005314				2022-12-28	WOS:000230349200006
J	Villanueva, T				Villanueva, T			Commentary: the future for medical education	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Lisbon, Hosp Santa Maria, P-1649035 Lisbon, Portugal	Universidade de Lisboa; Hospital Santa Maria	Villanueva, T (corresponding author), Univ Lisbon, Hosp Santa Maria, P-1649035 Lisbon, Portugal.	Tiago.villanueva@gmail.com	Villanueva, Tiago/AAC-3104-2020					Clark J, 2005, BRIT MED J, V331, P101, DOI 10.1136/bmj.331.7508.101; HWANG R, 2005, BRIT MED J, V13, P239; SPRY E, 2005, BRIT MED J, V13, P181	3	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 9	2005	331	7508					105	106		10.1136/bmj.331.7508.105-a	http://dx.doi.org/10.1136/bmj.331.7508.105-a			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945XR	16002887	Green Published			2022-12-28	WOS:000230536800022
J	Young, C; Horton, R				Young, C; Horton, R			Putting clinical trials into context	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Young, C (corresponding author), The Lancet, London NW1 7BY, England.							Chalmers I, 2005, CLIN TRIALS, V2, P229; Chalmers I, 2005, LANCET, V365, P469; De Angelis C, 2005, LANCET, V365, P1827, DOI 10.1016/S0140-6736(05)66588-9; Fergusson D, 2005, CLIN TRIALS, V2, P218, DOI 10.1191/1740774505cn085oa; GILBERT R, 2005, INT J EPIDEMIOL 0420; Gulmezoglu AM, 2005, LANCET, V365, P1829, DOI 10.1016/S0140-6736(05)66589-0; *J LIND LIB, 2005, 1 INT CLIN TRIALS DA; 2005, EUROPEAN CLIN RES IN	8	136	137	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 9	2005	366	9480					107	108		10.1016/S0140-6736(05)66846-8	http://dx.doi.org/10.1016/S0140-6736(05)66846-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	943JH	16005318				2022-12-28	WOS:000230349200010
J	Guo, FZ; Guo, AK				Guo, FZ; Guo, AK			Crossmodal interactions between olfactory and visual learning in Drosophila	SCIENCE			English	Article							FLIGHT; MELANOGASTER; INSIGHTS; REQUIRES; MEMORY; SMELLS; BRAIN	Different modalities of sensation interact in a synergistic or antagonistic manner during sensory perception, but whether there is also interaction during memory acquisition is largely unknown. In Drosophila reinforcement learning we found that conditioning with concurrent visual and olfactory cues reduced the threshold for unimodal memory retrieval. Furthermore, bimodal preconditioning followed by unimodal conditioning with either a visual or olfactory cue led to crossmodal memory transfer. Crossmodal memory acquisition in Drosophila may contribute significantly to learning in a natural environment.	Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurobiol, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Guo, AK (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurobiol, Inst Neurosci, Shanghai 200031, Peoples R China.	akguo@ion.ac.cn						Brembs B, 2001, J EXP BIOL, V204, P2849; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Davis RL, 2004, NEURON, V44, P31, DOI 10.1016/j.neuron.2004.09.008; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; Frye MA, 2004, J EXP BIOL, V207, P123, DOI 10.1242/jeb.00725; Frye MA, 2003, J EXP BIOL, V206, P843, DOI 10.1242/jeb.00175; Gottfried JA, 2003, NEURON, V39, P375, DOI 10.1016/S0896-6273(03)00392-1; GREENSPAN RJ, 1995, NEURON, V15, P747, DOI 10.1016/0896-6273(95)90165-5; Guo A, 1996, LEARN MEMORY, V3, P49, DOI 10.1101/lm.3.1.49; Hall G, 1996, ANIM LEARN BEHAV, V24, P233, DOI 10.3758/BF03198973; Heisenberg M, 2001, LEARN MEMORY, V8, P1, DOI 10.1101/lm.8.1.1; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; Srinivasan MV, 1998, NATURE, V396, P637, DOI 10.1038/25272; Stein BE., 1993, MERGING SENSES; Tang SM, 2004, SCIENCE, V305, P1020, DOI 10.1126/science.1099839; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; van Swinderen B, 2003, NAT NEUROSCI, V6, P579, DOI 10.1038/nn1054; Waddell S, 2001, TRENDS GENET, V17, P719, DOI 10.1016/S0168-9525(01)02526-4	18	88	101	4	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2005	309	5732					307	310		10.1126/science.1111280	http://dx.doi.org/10.1126/science.1111280			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002621				2022-12-28	WOS:000230449800047
J	Haddock, SHD; Dunn, CW; Pugh, PR; Schnitzler, CE				Haddock, SHD; Dunn, CW; Pugh, PR; Schnitzler, CE			Bioluminescent and red-fluorescent lures in a deep-sea siphonophore	SCIENCE			English	Article							MEDUSAE		Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Yale Univ, New Haven, CT 06520 USA; Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England	Monterey Bay Aquarium Research Institute; Yale University; NERC National Oceanography Centre	Haddock, SHD (corresponding author), Monterey Bay Aquarium Res Inst, 7700 Sandholdt Rd, Moss Landing, CA 95039 USA.	haddock@mbari.org	Schnitzler, Christine/G-8733-2013	Schnitzler, Christine/0000-0002-5001-6524; Dunn, Casey/0000-0003-0628-5150				BONNETT R, 1979, J MAR BIOL ASSOC UK, V59, P565, DOI 10.1017/S0025315400045574; DOUGLAS RH, 2002, BIOLUMINESCENCE CHEM, P391; Haddock SHD, 1999, MAR BIOL, V133, P571, DOI 10.1007/s002270050497; HERRING PJ, 1971, COMP BIOCHEM PHYSIOL, V39, P739, DOI 10.1016/0305-0491(71)90099-X; HERRING PJ, 1977, S ZOOL SOC LOND, V38, P127; Pugh P.R., 2001, Bulletin of the Natural History Museum Zoology Series, V67, P169; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079	7	75	79	0	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2005	309	5732					263	263		10.1126/science.1110441	http://dx.doi.org/10.1126/science.1110441			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002609				2022-12-28	WOS:000230449800033
J	Wolfe, CDA; Smeeton, NC; Coshall, C; Tilling, K; Rudd, AG				Wolfe, CDA; Smeeton, NC; Coshall, C; Tilling, K; Rudd, AG			Survival differences after stroke in a multiethnic population: follow-up study with the south London stroke register	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; PUBLICATION BIAS; ETHNIC-DIFFERENCES; PHARMACEUTICAL-INDUSTRY; CLINICAL-RESEARCH; ISCHEMIC-STROKE; RISK-FACTORS; ABSTRACTS; MORTALITY; BLACKS	Objectives To identify ethnic differences in survival after stroke and examine the factors that influence survival. Design Population based stroke register with follow-up. Settings South London stroke register. Participants 2321 patients with first stroke registered between January 1995 and December 2002. Main outcome measures Sociodemographic factors, risk factors for stroke and their management, severity of stroke, and acute service provision factors. Survival analysis with Kaplan-Meier curves, log rank test, and Cox's proportional hazard model with stratification. Results In univariable analyses of survival, outcome was better for black people than white people (median 33.7 v 20.0 months). After stratification by socioeconomic status, type of stroke, and Glasgow coma score, and adjustment for other potential confounders, being black was generally associated with better survival, taking into account the interaction between ethnicity and age, and ethnicity and prior Barthel score. Of the risk factors for stroke considered, current smoking (hazard ratio 1.21, 95% confidence interval 1.01 to 1.45, P = 0.044), untreated atrial fibrillation (1.36,1.08 to 1.72, P = 0.009), untreated diabetes (1.53, 1.05 to 2.22, P = 0.027), and treated diabetes (1.61, 1.27 to 2.03, P < 0.001) were associated with reduced survival. Conclusion In general, black patients in a south London population with first ever stroke are more likely to survive than white patients, the exceptions being in those aged < 65 and those with a prior Barthel score < 15. Some pre-stroke risk factors that have the potential to be modified, including the appropriate treatment of existing health problems, have a strong impact on survival.	Kings Coll London, Div Hlth & Social Care, London SE1 3QD, England; Dept Social Med, Bristol BS8 2PR, Avon, England; St Thomas Hosp, Dept Ageing & Hlth, London SE1 7EH, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Wolfe, CDA (corresponding author), Kings Coll London, Div Hlth & Social Care, London SE1 3QD, England.	charles.wolfe@kcl.ac.uk	Tilling, Kate/AAY-1578-2021	Wolfe, Charles/0000-0001-8264-0981; Smeeton, Nigel/0000-0001-9460-5411; Tilling, Kate/0000-0002-1010-8926				[Anonymous], 2001, STAT SQUARE 2 UNDERS; Balarajan R, 1995, Health Trends, V27, P114; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Bardy AH, 1998, BRIT J CLIN PHARMACO, V46, P147, DOI 10.1046/j.1365-2125.1998.00759.x; Bhopal R, 1997, BRIT MED J, V314, P1751, DOI 10.1136/bmj.314.7096.1751; Callaham ML, 1998, JAMA-J AM MED ASSOC, V280, P254, DOI 10.1001/jama.280.3.254; CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1401, DOI 10.1001/jama.263.10.1401; Cheng K, 1998, PEDIATR PULM, V26, P101, DOI 10.1002/(SICI)1099-0496(199808)26:2<101::AID-PPUL5>3.3.CO;2-C; Collett, 2003, MODELLING SURVIVAL D; Comstock RD, 2004, AM J EPIDEMIOL, V159, P611, DOI 10.1093/aje/kwh084; Daniels CE, 2002, ACAD MED, V77, P266, DOI 10.1097/00001888-200203000-00019; DEBELLEFEUILLE C, 1992, ANN ONCOL, V3, P187, DOI 10.1093/oxfordjournals.annonc.a058147; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3; DICKERSIN K, 1993, J CURR CLIN TRI 0428; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7; Evers JLH, 2000, HUM REPROD, V15, P2063, DOI 10.1093/humrep/15.10.2063; Gillum RF, 1999, STROKE, V30, P1711, DOI 10.1161/01.STR.30.8.1711; Gillum RF, 2003, J CLIN EPIDEMIOL, V56, P188, DOI 10.1016/S0895-4356(02)00535-8; Hajat C, 2004, STROKE, V35, P1562, DOI 10.1161/01.STR.0000131903.04708.b8; Hartmann A, 2001, NEUROLOGY, V57, P2000, DOI 10.1212/WNL.57.11.2000; HOWARD G, 1994, STROKE, V25, P2120, DOI 10.1161/01.STR.25.11.2120; HOWARD G, 1995, STROKE, V26, P1759, DOI 10.1161/01.STR.26.10.1759; Kaufman JS, 2001, AM J EPIDEMIOL, V154, P291, DOI 10.1093/aje/154.4.291; Klassen TP, 2002, ARCH PEDIAT ADOL MED, V156, P474, DOI 10.1001/archpedi.156.5.474; KOREN G, 1989, LANCET, V2, P1440; Krzyzanowska MK, 2003, JAMA-J AM MED ASSOC, V290, P495, DOI 10.1001/jama.290.4.495; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; McKevitt C, 2005, STROKE, V36, P315, DOI 10.1161/01.STR.0000152332.32267.19; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Misakian AL, 1998, JAMA-J AM MED ASSOC, V280, P250, DOI 10.1001/jama.280.3.250; Olson CM, 2002, JAMA-J AM MED ASSOC, V287, P2825, DOI 10.1001/jama.287.21.2825; Petticrew M, 1999, J EPIDEMIOL COMMUN H, V53, P442, DOI 10.1136/jech.53.7.442; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Sacco RL, 2001, STROKE, V32, P1725, DOI 10.1161/01.STR.32.8.1725; SCHERER RW, 1994, JAMA-J AM MED ASSOC, V272, P158, DOI 10.1001/jama.272.2.158; *SECR STAT HLTH, 1997, OUR HLTH NAT STRAT H; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Stewart JA, 1999, BRIT MED J, V318, P967, DOI 10.1136/bmj.318.7189.967; Tilling K, 2001, INT J EPIDEMIOL, V30, P1351, DOI 10.1093/ije/30.6.1351; Timmer Antje, 2002, BMC Med Res Methodol, V2, P7, DOI 10.1186/1471-2288-2-7; Weber EJ, 1998, JAMA-J AM MED ASSOC, V280, P257, DOI 10.1001/jama.280.3.257; Wolfe CDA, 2002, J NEUROL NEUROSUR PS, V72, P211, DOI 10.1136/jnnp.72.2.211; Zimpel T, 2000, FORSCH KOMP KLAS NAT, V7, P71, DOI 10.1159/000021324	45	50	50	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 20	2005	331	7514					431	433		10.1136/bmj.38510.458218.8F	http://dx.doi.org/10.1136/bmj.38510.458218.8F			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	958WB	16055452	Green Published, Bronze			2022-12-28	WOS:000231477800015
J	Flores, I; Cayuela, ML; Blasco, MA				Flores, I; Cayuela, ML; Blasco, MA			Effects of telomerase and telomere length on epidermal stem cell behavior	SCIENCE			English	Article							SELF-RENEWAL; MAMMALIAN TELOMERES; CANCER; MOUSE; SKIN; MICE; SENESCENCE; NICHE	A key process in organ homeostasis is the mobilization of stem cells out of their niches. We show through analysis of mouse models that telomere length, as well as the catalytic component of telomerase, Tert, are critical determinants in the mobilization of epidermal stem cells. Telomere shortening inhibited mobilization of stem cells out of their niche, impaired hair growth, and resulted in suppression of stem cell proliferative capacity in vitro. In contrast, Tert overexpression in the absence of changes in telomere length promoted stem cell mobilization, hair growth, and stem cell proliferation in vitro. The effects of telomeres and telomerase on stem cell biology anticipate their role in cancer and aging.	Spanish Natl Canc Ctr, Mol Oncol Program, Telomeres & Telomerase Grp, E-28029 Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Blasco, MA (corresponding author), Spanish Natl Canc Ctr, Mol Oncol Program, Telomeres & Telomerase Grp, Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.	mblasco@cnio.es	Flores, Ignacio/E-8304-2016; Blasco, Maria A./M-1694-2014	Flores, Ignacio/0000-0001-8789-6396; Blasco, Maria A./0000-0002-4211-233X				Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Bell DR, 2004, ONCOGENE, V23, P7290, DOI 10.1038/sj.onc.1207949; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blasco MA, 2003, EUR J CELL BIOL, V82, P441, DOI 10.1078/0171-9335-00335; Blasco MA, 2002, NAT REV CANCER, V2, P627, DOI 10.1038/nrc862; Blasco MA, 2003, CANCER LETT, V194, P183, DOI 10.1016/S0304-3835(02)00705-X; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Ferron S, 2004, DEVELOPMENT, V131, P4059, DOI 10.1242/dev.01215; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; Gonzalez-Suarez E, 2003, CANCER RES, V63, P7047; Gonzalez-Suarez E, 2002, MOL CELL BIOL, V22, P7291, DOI 10.1128/MCB.22.20.7291-7301.2002; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Harrington L, 2004, ONCOGENE, V23, P7283, DOI 10.1038/sj.onc.1207948; Harrington L, 2003, CANCER LETT, V194, P139, DOI 10.1016/S0304-3835(02)00701-2; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Perez-Losada J, 2003, NAT REV CANCER, V3, P434, DOI 10.1038/nrc1095; Samper E, 2002, BLOOD, V99, P2767, DOI 10.1182/blood.V99.8.2767; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Van Zant G, 2003, EXP HEMATOL, V31, P659, DOI 10.1016/S0301-472X(03)00088-2; WILSON C, 1994, DIFFERENTIATION, V55, P127, DOI 10.1046/j.1432-0436.1994.5520127.x	28	329	369	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2005	309	5738					1253	1256		10.1126/science.1115025	http://dx.doi.org/10.1126/science.1115025			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957TE	16037417				2022-12-28	WOS:000231395400050
J	Ohman, A				Ohman, A			Psychology - Conditioned fear of a face: A prelude to ethnic enmity?	SCIENCE			English	Editorial Material									Karolinska Inst, Dept Clin Neurosci, SE-17176 Stockholm, Sweden	Karolinska Institutet	Ohman, A (corresponding author), Ctr Adv Study Behav Sci, Stanford, CA 94305 USA.	arne.ohman@cns.ki.se						Critchley HD, 2002, NEURON, V33, P653, DOI 10.1016/S0896-6273(02)00588-3; Cunningham WA, 2004, PSYCHOL SCI, V15, P806, DOI 10.1111/j.0956-7976.2004.00760.x; ESTEVES F, 1994, PSYCHOPHYSIOLOGY, V31, P375, DOI 10.1111/j.1469-8986.1994.tb02446.x; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Morris JS, 2001, NEUROIMAGE, V14, P529, DOI 10.1006/nimg.2001.0891; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Olsson A, 2005, SCIENCE, V309, P785, DOI 10.1126/science.1113551; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; SELIGMAN ME, 1970, PSYCHOL REV, V77, P406, DOI 10.1037/h0029790; Wrangham Richard, 1996, DEMONIC MALES APES O	10	18	18	2	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2005	309	5735					711	+		10.1126/science.1116710	http://dx.doi.org/10.1126/science.1116710			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	951NU	16051776				2022-12-28	WOS:000230938200029
J	Schafmeier, T; Haase, A; Kaldi, K; Scholz, J; Fuchs, M; Brunner, M				Schafmeier, T; Haase, A; Kaldi, K; Scholz, J; Fuchs, M; Brunner, M			Transcriptional feedback of Neurospora circadian clock gene by phosphorylation-dependent inactivation of its transcription factor	CELL			English	Article							LIGHT SIGNAL-TRANSDUCTION; PROTEIN PHOSPHATASE 2A; CASEIN KINASE-II; WHITE COLLAR-1; CRASSA; FREQUENCY; DROSOPHILA; BINDING; COMPLEX; SYSTEM	The circadian clock protein Frequency (FRO) feedback-regulates its own expression by inhibiting its transcriptional activator, White Collar Complex (WCC). We present evidence that FRO regulates the bulk of WCC through modulation of its phosphorylation status rather than via direct complex formation. In the absence of FRO, WCC is hypophosphorylated and transcriptionally active, while WCC is hyperphosphorylated and transcriptionally inactive when FRO is expressed. The phosphorylation status of WCC changes rhythmically over a circadian cycle. Dephosphorylation and activation of WCC depend on protein phosphatase 2A (PP2A), and WCC is a substrate of PP2A in vitro. Hypophosphorylated WCC binds to the clock box of the frq promoter even in the presence of FRO, while binding of hyperphosphorylated WCC is compromised even when FRO is depleted. We propose that negative feedback in the circadian clock of Neurospora is mediated by FRO, which rhythmically promotes phosphorylation of WCC, functionally equivalent to a cyclin recruiting cyclin-dependent kinase to its targets.	Univ Heidelberg, Biochem Ctr, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Brunner, M (corresponding author), Univ Heidelberg, Biochem Ctr, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	michael.brunner@urz.uni-heidelberg.de	Káldi, Krisztina/X-4080-2019	Brunner, Michael/0000-0001-9798-3047; Kaldi, Krisztina/0000-0002-5724-0182				Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; ARONSON BD, 1994, P NATL ACAD SCI USA, V91, P7683, DOI 10.1073/pnas.91.16.7683; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; BellPedersen D, 1996, P NATL ACAD SCI USA, V93, P13096, DOI 10.1073/pnas.93.23.13096; Byrne M, 2004, J MOL BIOL, V335, P57, DOI 10.1016/j.jmb.2003.10.035; Carroll AS, 2002, TRENDS BIOCHEM SCI, V27, P87, DOI 10.1016/S0968-0004(01)02040-0; Cheng P, 2005, GENE DEV, V19, P234, DOI 10.1101/gad.1266805; Cheng P, 2003, J BIOL CHEM, V278, P3801, DOI 10.1074/jbc.M209592200; Cheng P, 2002, MOL CELL BIOL, V22, P517, DOI 10.1128/MCB.22.2.517-524.2002; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Correa A, 2003, P NATL ACAD SCI USA, V100, P13597, DOI 10.1073/pnas.2233734100; Denault DL, 2001, EMBO J, V20, P109, DOI 10.1093/emboj/20.1.109; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Froehlich AC, 2003, P NATL ACAD SCI USA, V100, P5914, DOI 10.1073/pnas.1030057100; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Gachon F, 2004, CHROMOSOMA, V113, P103, DOI 10.1007/s00412-004-0296-2; Gao ZH, 2002, P NATL ACAD SCI USA, V99, P1182, DOI 10.1073/pnas.032468199; GORI M, 2001, EMBO J, V20, P7074; He QY, 2005, J BIOL CHEM, V280, P17526, DOI 10.1074/jbc.M414010200; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Kim EY, 2002, NEURON, V34, P69, DOI 10.1016/S0896-6273(02)00639-6; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee C, 1999, MOL CELL BIOL, V19, P5316; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Lee K, 2003, GENETICS, V163, P103; Linden H, 1997, EMBO J, V16, P98, DOI 10.1093/emboj/16.1.98; Luo CH, 1998, EMBO J, V17, P1228, DOI 10.1093/emboj/17.5.1228; Merrow M, 2001, EMBO J, V20, P307, DOI 10.1093/emboj/20.3.307; Nawathean P, 2004, MOL CELL, V13, P213, DOI 10.1016/S1097-2765(03)00503-3; Nowrousian M, 2003, GENETICS, V164, P923; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Roenneberg T, 2003, CURR BIOL, V13, pR198, DOI 10.1016/S0960-9822(03)00124-6; Sanada K, 2002, J BIOL CHEM, V277, P267, DOI 10.1074/jbc.M107850200; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Schwerdtfeger C, 2000, EUR J BIOCHEM, V267, P414, DOI 10.1046/j.1432-1327.2000.01016.x; Stanewsky R, 2003, J NEUROBIOL, V54, P111, DOI 10.1002/neu.10164; Swiatek W, 2004, J BIOL CHEM, V279, P13011, DOI 10.1074/jbc.M304682200; Talora C, 1999, EMBO J, V18, P4961, DOI 10.1093/emboj/18.18.4961; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Yang YH, 2004, GENE DEV, V18, P255, DOI 10.1101/gad.1152604; Yang YH, 2003, MOL CELL BIOL, V23, P6221, DOI 10.1128/MCB.23.17.6221-6228.2003; Yang YH, 2002, GENE DEV, V16, P994, DOI 10.1101/gad.965102; Yang YH, 2001, J BIOL CHEM, V276, P41064, DOI 10.1074/jbc.M106905200; Yatzkan E, 1999, MOL MICROBIOL, V31, P197, DOI 10.1046/j.1365-2958.1999.01161.x; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zhu H, 2001, GENETICS, V157, P1057	49	188	193	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 29	2005	122	2					235	246		10.1016/j.cell.2005.05.032	http://dx.doi.org/10.1016/j.cell.2005.05.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	951CR	16051148	Bronze			2022-12-28	WOS:000230907000011
J	Thummel, CS				Thummel, CS			Powered by gas - A ligand for a fruit fly nuclear receptor	CELL			English	Editorial Material							METAMORPHOSIS		Univ Utah, Sch Med, Howard Hughes Med Inst, Dept Human Genet, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Thummel, CS (corresponding author), Univ Utah, Sch Med, Howard Hughes Med Inst, Dept Human Genet, Salt Lake City, UT 84112 USA.							Bialecki M, 2002, DEV CELL, V3, P209, DOI 10.1016/S1534-5807(02)00204-6; Champlin DT, 2000, DEVELOPMENT, V127, P3543; Kingan TG, 1997, J EXP BIOL, V200, P3245; Maglich JM, 2001, GENOME BIOL, V2; Maniere G, 2003, J ENDOCRINOL, V177, P35, DOI 10.1677/joe.0.1770035; PARDEE K, 2004, SCI AGING KNOWLEDGE, pRE8, DOI DOI 10.1126/SAGEKE.2004.47.RE8; Pierceall WE, 1999, MOL CELL ENDOCRINOL, V150, P73, DOI 10.1016/S0303-7207(99)00022-2; Regulski M, 2004, CURR BIOL, V14, pR881, DOI 10.1016/j.cub.2004.09.068; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; White KP, 1997, SCIENCE, V276, P114, DOI 10.1126/science.276.5309.114	10	7	7	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 29	2005	122	2					151	153		10.1016/j.cell.2005.07.007	http://dx.doi.org/10.1016/j.cell.2005.07.007			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	951CR	16051140	Bronze			2022-12-28	WOS:000230907000003
J	von Heijne, G				von Heijne, G			Microbiology - Translocation of anthrax toxin: Lord of the rings	SCIENCE			English	Editorial Material							CHANNEL		Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden	Stockholm University	von Heijne, G (corresponding author), Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	gunnar@dbb.su.se	von Heijne, Gunnar/AAH-9389-2019; von Heijne, Gunnar/F-5576-2011	von Heijne, Gunnar/0000-0002-4490-8569				Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Fenton WA, 2003, Q REV BIOPHYS, V36, P229, DOI 10.1017/S0033583503003883; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Krantz BA, 2004, J MOL BIOL, V344, P739, DOI 10.1016/j.jmb.2004.09.067; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218	6	5	5	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2005	309	5735					709	710		10.1126/science.1116630	http://dx.doi.org/10.1126/science.1116630			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051774				2022-12-28	WOS:000230938200027
J	Lindenauer, PK; Pekow, P; Wang, KJ; Mamidi, DK; Gutierrez, B; Benjamin, EM				Lindenauer, PK; Pekow, P; Wang, KJ; Mamidi, DK; Gutierrez, B; Benjamin, EM			Perioperative beta-blocker therapy and mortality after major noncardiac surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	26th Annual Meeting of the Society-of-General-Internal-Medicine	APR 30-MAY 03, 2003	VANCOUVER, CANADA	Soc Gen Internal Med			POSTOPERATIVE MYOCARDIAL-INFARCTION; CARDIAC RISK; CARDIOVASCULAR MORBIDITY; ADRENERGIC-BLOCKADE; ADMINISTRATIVE DATA; VASCULAR-SURGERY; EVENTS; INDEX; QUALITY; PROGRAM	BACKGROUND: Despite limited evidence from randomized trials, perioperative treatment with beta-blockers is now widely advocated. We assessed the use of perioperative beta-blockers and their association with in-hospital mortality in routine clinical practice. METHODS: We conducted a retrospective cohort study of patients 18 years of age or older who underwent major noncardiac surgery in 2000 and 2001 at 329 hospitals throughout the United States. We used propensity-score matching to adjust for differences between patients who received perioperative beta-blockers and those who did not receive such therapy and compared in-hospital mortality using multivariable logistic modeling. RESULTS: Of 782,969 patients, 663,635 (85 percent) had no recorded contraindications to beta-blockers, 122,338 of whom (18 percent) received such treatment during the first two hospital days, including 14 percent of patients with a Revised Cardiac Risk Index (RCRI) score of 0 and 44 percent with a score of 4 or higher. The relationship between perioperative beta-blocker treatment and the risk of death varied directly with cardiac risk; among the 580,665 patients with an RCRI score of 0 or 1, treatment was associated with no benefit and possible harm, whereas among the patients with an RCRI score of 2, 3, or 4 or more, the adjusted odds ratios for death in the hospital were 0.88 (95 percent confidence interval, 0.80 to 0.98), 0.71 (95 percent confidence interval, 0.63 to 0.80), and 0.58 (95 percent confidence interval, 0.50 to 0.67), respectively. CONCLUSIONS: Perioperative beta-blocker therapy is associated with a reduced risk of in-hospital death among high-risk, but not low-risk, patients undergoing major noncardiac surgery. Patient safety may be enhanced by increasing the use of beta-blockers in high-risk patients.	Baystate Med Ctr, Div Healthcare Qual, Springfield, MA 01199 USA; Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA; Premier Inc, Premier Healthcare Informat, Charlotte, NC USA	Baystate Medical Center; Tufts University; University of Massachusetts System; University of Massachusetts Amherst	Lindenauer, PK (corresponding author), Baystate Med Ctr, Div Healthcare Qual, 759 Chestnut St P-5928, Springfield, MA 01199 USA.	Peter.Lindenauer@bhs.org		MAMIDI, DHEERESH/0000-0003-2058-5002				Auerbach AD, 2002, JAMA-J AM MED ASSOC, V287, P1435, DOI 10.1001/jama.287.11.1435; Best WR, 2002, J AM COLL SURGEONS, V194, P257, DOI 10.1016/S1072-7515(01)01183-8; Cohn SL, 2003, MED CLIN N AM, V87, P111, DOI 10.1016/S0025-7125(02)00143-8; DETSKY AS, 1986, ARCH INTERN MED, V146, P2131, DOI 10.1001/archinte.146.11.2131; Devereaux PJ, 2004, CAN MED ASSOC J, V171, P245, DOI 10.1503/cmaj.1031619; EAGLE KA, 1989, ANN INTERN MED, V110, P859, DOI 10.7326/0003-4819-110-11-859; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fleisher LA, 2001, NEW ENGL J MED, V345, P1677, DOI 10.1056/NEJMcp002842; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; Grayburn PA, 2003, ANN INTERN MED, V138, P506, DOI 10.7326/0003-4819-138-6-200303180-00017; HALL MJ, 2000, ADV DATA VITAL HLTH, V329; Juul AB, 2004, AM HEART J, V147, P677, DOI 10.1016/j.ahj.2003.10.030; JUUL AB, 2004, AM HEART ASS SCI SES; Khuri SF, 1998, ANN SURG, V228, P491, DOI 10.1097/00000658-199810000-00006; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Lindenauer PK, 2004, ARCH INTERN MED, V164, P762, DOI 10.1001/archinte.164.7.762; Mangano DT, 1997, NEW ENGL J MED, V336, P1039; Mangano DT, 1996, NEW ENGL J MED, V335, P1713, DOI 10.1056/NEJM199612053352301; *NAT QUAL FOR, 2003, PUBL NAT QUAL FOR; Nettleman MD, 1997, AM J MED, V103, P357, DOI 10.1016/S0002-9343(97)00162-9; Parsons, 2001, P 26 ANN SAS US GROU; Poldermans D, 1999, NEW ENGL J MED, V341, P1789, DOI 10.1056/NEJM199912093412402; Quan HD, 2002, MED CARE, V40, P675, DOI 10.1097/00005650-200208000-00007; Selzman CH, 2001, ARCH SURG-CHICAGO, V136, P286, DOI 10.1001/archsurg.136.3.286; SHOJANIA K, 2001, AHRQ PUBLICATION; WROBLEWSKI F, 1952, JAMA-J AM MED ASSOC, V150, P1212, DOI 10.1001/jama.1952.63680120015010f; YANG H, 2004, CAN J ANAESTH, V51, pA7	27	597	613	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2005	353	4					349	361		10.1056/NEJMoa041895	http://dx.doi.org/10.1056/NEJMoa041895			13	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949JW	16049209	Green Published			2022-12-28	WOS:000230782800007
J	Sieburth, D; Ch'ng, Q; Dybbs, M; Tavazoie, M; Kennedy, S; Wang, D; Dupuy, D; Rual, JF; Hill, DE; Vidal, M; Ruvkun, G; Kaplan, JM				Sieburth, D; Ch'ng, Q; Dybbs, M; Tavazoie, M; Kennedy, S; Wang, D; Dupuy, D; Rual, JF; Hill, DE; Vidal, M; Ruvkun, G; Kaplan, JM			Systematic analysis of genes required for synapse structure and function	NATURE			English	Article							CAENORHABDITIS-ELEGANS; PROTEIN; KINASE; ACTIN; RELEASE; TRANSMISSION; UNC-13; BETA; UBIQUITINATION; INTERFERENCE	Chemical synapses are complex structures that mediate rapid intercellular signalling in the nervous system. Proteomic studies suggest that several hundred proteins will be found at synaptic specializations. Here we describe a systematic screen to identify genes required for the function or development of Caenorhabditis elegans neuromuscular junctions. A total of 185 genes were identified in an RNA interference screen for decreased acetylcholine secretion; 132 of these genes had not previously been implicated in synaptic transmission. Functional profiles for these genes were determined by comparing secretion defects observed after RNA interference under a variety of conditions. Hierarchical clustering identified groups of functionally related genes, including those involved in the synaptic vesicle cycle, neuropeptide signalling and responsiveness to phorbol esters. Twenty-four genes encoded proteins that were localized to presynaptic specializations. Loss-of-function mutations in 12 genes caused defects in presynaptic structure.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA; Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Kaplan, JM (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	kaplan@molbio.mgh.harvard.edu	Ch'ng, QueeLim/C-5348-2009; Hill, David E/B-6617-2011	Ch'ng, QueeLim/0000-0003-1941-3828; Rual, Jean-Francois/0000-0003-4465-8819; Kennedy, Scott/0000-0002-7974-8155; Dupuy, Denis/0000-0002-4781-5595	NIDDK NIH HHS [R01 DK070147] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070147] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; Bloom O, 2003, J CELL BIOL, V161, P737, DOI 10.1083/jcb.200212140; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; Colbert HA, 1997, J NEUROSCI, V17, P8259; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Dunaevsky A, 2000, J NEUROSCI, V20, P6007, DOI 10.1523/JNEUROSCI.20-16-06007.2000; Fuchs F, 2005, MOL BIOL CELL, V16, P153, DOI 10.1091/mbc.E04-05-0413; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Grant SGN, 2003, CURR OPIN NEUROBIOL, V13, P577, DOI 10.1016/j.conb.2003.09.016; Greener T, 2000, J BIOL CHEM, V275, P1365, DOI 10.1074/jbc.275.2.1365; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Jacob TC, 2003, J NEUROSCI, V23, P2122; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kass J, 2001, J NEUROSCI, V21, P9265, DOI 10.1523/JNEUROSCI.21-23-09265.2001; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kohn RE, 2000, MOL BIOL CELL, V11, P3441, DOI 10.1091/mbc.11.10.3441; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Lindberg I, 1998, DNA CELL BIOL, V17, P727, DOI 10.1089/dna.1998.17.727; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Muly EC, 2004, J COMP NEUROL, V469, P185, DOI 10.1002/cne.11001; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; NGUYEN M, 1995, GENETICS, V140, P527; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Oliver CJ, 2002, MOL CELL BIOL, V22, P4690, DOI 10.1128/MCB.22.13.4690-4701.2002; Paganoni S, 2003, J NEUROSCI RES, V73, P429, DOI 10.1002/jnr.10674; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Renden R, 2001, NEURON, V31, P421, DOI 10.1016/S0896-6273(01)00382-8; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Robatzek M, 2000, GENETICS, V156, P1069; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Sone M, 2000, DEVELOPMENT, V127, P4157; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zahn TR, 2004, TRAFFIC, V5, P544, DOI 10.1111/j.1600-0854.2004.00195.x; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022	54	280	351	1	28	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					510	517		10.1038/nature03809	http://dx.doi.org/10.1038/nature03809			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049479				2022-12-28	WOS:000230788800052
J	Emanuel, EJ; Currie, XE; Herman, A				Emanuel, EJ; Currie, XE; Herman, A		Project Phidisa	Undue inducement in clinical research in developing countries: is it a worry?	LANCET			English	Editorial Material							ETHICS; CONSENT		NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA; S African Natl Def Force, Project Phidisa, Pretoria, Gauteng, South Africa; Med Univ S Africa, Natl Sch Publ Hlth, Pretoria, Gauteng, South Africa	National Institutes of Health (NIH) - USA; Sefako Makgatho Health Sciences University	Emanuel, EJ (corresponding author), NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, Bldg 10,Room 1C118, Bethesda, MD 20892 USA.	eemanuel@nih.gov						Berkley S, 2003, LANCET, V362, P992, DOI 10.1016/S0140-6736(03)14371-1; CHRISTAKIS NA, 1988, HASTINGS CENT REP, V18, P31, DOI 10.2307/3562201; Council for International Organizations of Medical Sciences WHO, 2002, INT ETH GUID BIOM RE; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Emanuel EJ, 2004, J LAW MED ETHICS, V32, P100, DOI 10.1111/j.1748-720X.2004.tb00453.x; Emanuel EJ, 2004, J INFECT DIS, V189, P930, DOI 10.1086/381709; Faden R., 1986, HIST THEORY INFORMED, P337; Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593; Grant RW, 2002, ECON PHILOS, V18, P111, DOI 10.1017/S0266267102001104; HARRIS J, 1992, WONDERWOMAN SUPERMAN, P116; LAFRANIERE S, 2000, WASHINGTON POST 1219; Lemmens Trudo, 1999, Account Res, V7, P3, DOI 10.1080/08989629908573939; LEVINE RJ, 1988, ETHICS REGULATION CL, P82; Macklin Ruth, 1981, IRB, V3, P1, DOI 10.2307/3564136; McNeill P, 1997, BIOETHICS, V11, P390, DOI 10.1111/1467-8519.00079; Newton Lisa H, 1982, IRB, V4, P4, DOI 10.2307/3564325; Pace C, 2005, AM J PUBLIC HEALTH, V95, P1184, DOI 10.2105/AJPH.2004.053082; PACE C, WHAT WE DONT KNOW IN; Pace CA, 2005, LANCET, V365, P11, DOI 10.1016/S0140-6736(04)17679-4; Participants 2001 Conference Ethical, 2004, HASTINGS CENT REP, V34, P17; Shah S, 2004, JAMA-J AM MED ASSOC, V291, P476, DOI 10.1001/jama.291.4.476; WERTHEIMER A, 1989, COERCION, P3; WERTHEIMER A, 1996, EXPLOITATION, P3; Wilkinson M, 1997, BIOETHICS, V11, P373, DOI 10.1111/1467-8519.00078; [No title captured]	25	82	86	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2005	366	9482					336	340		10.1016/S0140-6736(05)66992-9	http://dx.doi.org/10.1016/S0140-6736(05)66992-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	948RJ	16039339				2022-12-28	WOS:000230733100035
J	Jerolmack, DJ; Mohrig, D				Jerolmack, DJ; Mohrig, D			Palaeoclimatology - Formation of Precambrian sediment ripples	NATURE			English	Editorial Material							WAVES		MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Jerolmack, DJ (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	douglasj@mit.edu	Mohrig, David/O-1758-2013	Mohrig, David/0000-0003-1828-4526				Allen PA, 2005, NATURE, V433, P123, DOI 10.1038/nature03176; Ardhuin F, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000986; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; KOMAR PD, 1973, J SEDIMENT PETROL, V43, P1101	4	8	8	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					E1	E1		10.1038/nature04025	http://dx.doi.org/10.1038/nature04025			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034374	Bronze			2022-12-28	WOS:000230623400030
J	Scheel, O; Zdebik, AA; Lourdel, S; Jentsch, TJ				Scheel, O; Zdebik, AA; Lourdel, S; Jentsch, TJ			Voltage-dependent electrogenic chloride/proton exchange by endosomal CLC proteins	NATURE			English	Article							MOLECULAR-BASIS; DENTS-DISEASE; CHANNELS; LEADS; ACIDIFICATION; SELECTIVITY; MOUSE; DISRUPTION; CLONING; MODEL	Eukaryotic members of the CLC gene family function as plasma membrane chloride channels, or may provide neutralizing anion currents for V-type H+-ATPases that acidify compartments of the endosomal/lysosomal pathway(1). Loss-of-function mutations in the endosomal protein ClC-5 impair renal endocytosis(2) and lead to kidney stones(3), whereas loss of function of the endosomal/ lysosomal protein ClC-7 entails osteopetrosis(4) and lysosomal storage disease(5). Vesicular CLCs have been thought to be Cl- channels, in particular because ClC-4 and ClC-5 mediate plasma membrane Cl- currents upon heterologous expression(6,7). Here we show that these two mainly endosomal CLC proteins instead function as electrogenic Cl-/H+ exchangers ( also called antiporters), resembling the transport activity of the bacterial protein ClC-e1 ( ref. 8), the crystal structure of which has already been determined(9). Neutralization of a critical glutamate residue not only abolished the steep voltage-dependence of transport(7), but also eliminated the coupling of anion flux to proton counter-transport. ClC-4 and ClC-5 may still compensate the charge accumulation by endosomal proton pumps, but are expected to couple directly vesicular pH gradients to Cl- gradients.	Univ Hamburg, ZMNH, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Jentsch, TJ (corresponding author), Univ Hamburg, ZMNH, Zentrum Mol Neurobiol, Falkenried 94, D-20246 Hamburg, Germany.	Jentsch@zmnh.uni-hamburg.de		Jentsch, Thomas/0000-0002-3509-2553; Lourdel, Stephane/0000-0002-3626-7650				Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Davis-Kaplan SR, 1998, P NATL ACAD SCI USA, V95, P13641, DOI 10.1073/pnas.95.23.13641; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Fahlke C, 1997, NATURE, V390, P529, DOI 10.1038/37391; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; Gunther W, 2003, PFLUG ARCH EUR J PHY, V445, P456, DOI 10.1007/s00424-002-0950-6; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Hara-Chikuma M, 2005, BIOCHEM BIOPH RES CO, V329, P941, DOI 10.1016/j.bbrc.2005.02.060; Jentsch TJ, 2005, ANNU REV PHYSIOL, V67, P779, DOI 10.1146/annurev.physiol.67.032003.153245; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Li XH, 2002, AM J PHYSIOL-CELL PH, V282, pC1483, DOI 10.1152/ajpcell.00504.2001; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; MYERS VB, 1972, BIOCHIM BIOPHYS ACTA, V274, P313, DOI 10.1016/0005-2736(72)90179-4; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Poet M, 2001, EMBO J, V20, P5595, DOI 10.1093/emboj/20.20.5595; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Soleimani M, 2001, AM J PHYSIOL-RENAL, V280, pF356, DOI 10.1152/ajprenal.2001.280.2.F356; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Traverso S, 2003, J GEN PHYSIOL, V122, P295, DOI 10.1085/jgp.200308784; Waldegger S, 2000, J BIOL CHEM, V275, P24527, DOI 10.1074/jbc.M001987200; Yoshikawa M, 2002, GENES CELLS, V7, P597, DOI 10.1046/j.1365-2443.2002.00539.x	26	386	400	3	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					424	427		10.1038/nature03860	http://dx.doi.org/10.1038/nature03860			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034422				2022-12-28	WOS:000230623400049
J	Tulsky, JA				Tulsky, JA			Beyond advance directives. Importance of communication skills at the end of life	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE-CARE-UNIT; SERIOUSLY ILL; DECISION-MAKING; CANCER-PATIENTS; CARDIOPULMONARY-RESUSCITATION; SUSTAINING TREATMENT; FAMILY SATISFACTION; PATIENT PREFERENCES; PHYSICIANS; SURVIVAL	Patients and their families struggle with myriad choices concerning medical treatments that frequently precede death. Advance directives have been proposed as a tool to facilitate end-of-life decision making, yet frequently fail to achieve this goal. In the context of the case of a man with metastatic cancer for whom an advance directive was unable to prevent a traumatic death, I review the challenges in creating and implementing advance directives, discuss factors that can affect clear decision making; including trust, uncertainty, emotion, hope, and the presence of multiple medical providers; and offer practical suggestions for physicians. Advance care planning remains a useful tool for approaching conversations with patients about the end of life. However, such planning should occur within a framework that emphasizes responding to patient and family emotions and focuses more on goals for care and less on specific treatments.	Duke Univ, Med Ctr, Ctr Palliat Care, Durham, NC 27705 USA; Vet Affairs Med Ctr, Ctr Palliat Care, Durham, NC USA; Vet Affairs Med Ctr, Dept Med, Durham, NC USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA)	Tulsky, JA (corresponding author), Duke Univ, Med Ctr, Ctr Palliat Care, Hock Plaza,2424 Erwin Rd,Suite 1105, Durham, NC 27705 USA.	jtulsky@duke.edu			NCI NIH HHS [R01 CA100387] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA100387] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abbott KH, 2001, CRIT CARE MED, V29, P197, DOI 10.1097/00003246-200101000-00040; Arnold RM, 2003, CRIT CARE MED, V31, pS347, DOI 10.1097/01.CCM.0000065123.23736.12; Arora NK, 2003, SOC SCI MED, V57, P791, DOI 10.1016/S0277-9536(02)00449-5; Back AL, 2005, JAMA-J AM MED ASSOC, V293, P1374, DOI 10.1001/jama.293.11.1374; Back Anthony L, 2003, Ann Intern Med, V138, P439; Baker DW, 2003, J GEN INTERN MED, V18, P343, DOI 10.1046/j.1525-1497.2003.20522.x; Baker R, 2000, J AM GERIATR SOC, V48, pS61, DOI 10.1111/j.1532-5415.2000.tb03143.x; BEDELL SE, 1983, NEW ENGL J MED, V309, P569, DOI 10.1056/NEJM198309083091001; BOHNER G, 1994, EUR J SOC PSYCHOL, V24, P207, DOI 10.1002/ejsp.2420240115; Breen CM, 2001, J GEN INTERN MED, V16, P283, DOI 10.1046/j.1525-1497.2001.00419.x; BRETT AS, 1991, JAMA-J AM MED ASSOC, V266, P825, DOI 10.1001/jama.266.6.825; Bricker Leslie J, 2003, J Palliat Med, V6, P511, DOI 10.1089/109662103322144880; Bruera E, 2001, J CLIN ONCOL, V19, P2883, DOI 10.1200/JCO.2001.19.11.2883; Butow PN, 2002, SUPPORT CARE CANCER, V10, P161, DOI 10.1007/s005200100290; Butow PN, 2002, PSYCHO-ONCOLOGY, V11, P47, DOI 10.1002/pon.556; Christakis Nicholas, 1999, DEATH FORETOLD PROPH; Covinsky KE, 2000, J AM GERIATR SOC, V48, pS187, DOI 10.1111/j.1532-5415.2000.tb03131.x; DANIS M, 1994, ANN INTERN MED, V120, P567, DOI 10.7326/0003-4819-120-7-199404010-00006; DANIS M, 1991, NEW ENGL J MED, V324, P882, DOI 10.1056/NEJM199103283241304; Ditto PH, 2001, ARCH INTERN MED, V161, P421, DOI 10.1001/archinte.161.3.421; Eden O. B., 1994, Palliative Medicine, V8, P105, DOI 10.1177/026921639400800203; Eliasson AH, 1999, ARCH INTERN MED, V159, P2213, DOI 10.1001/archinte.159.18.2213; ENDE J, 1989, J GEN INTERN MED, V4, P23, DOI 10.1007/BF02596485; Fogarty LA, 1999, J CLIN ONCOL, V17, P371, DOI 10.1200/JCO.1999.17.1.371; FORD S, 1994, BRIT J CANCER, V70, P767, DOI 10.1038/bjc.1994.393; Ford S, 1996, SOC SCI MED, V42, P1511, DOI 10.1016/0277-9536(95)00265-0; Gattellari M, 2002, J CLIN ONCOL, V20, P503, DOI 10.1200/JCO.20.2.503; Gattellari M, 2001, SOC SCI MED, V52, P1865, DOI 10.1016/S0277-9536(00)00303-8; GOOD MJD, 1990, CULT MED PSYCHIAT, V14, P59; Gordon GH, 2000, PATIENT EDUC COUNS, V40, P59, DOI 10.1016/S0738-3991(99)00069-5; Hanson LC, 1997, ANN INTERN MED, V126, P381, DOI 10.7326/0003-4819-126-5-199703010-00007; Heaven CM, 1997, PALLIATIVE MED, V11, P283, DOI 10.1177/026921639701100404; Henman MJ, 2002, PSYCHO-ONCOLOGY, V11, P295, DOI 10.1002/pon.566; HERTH K, 1990, J ADV NURS, V15, P1250, DOI 10.1111/j.1365-2648.1990.tb01740.x; Heyland DK, 2003, J CRIT CARE, V18, P3, DOI 10.1053/jcrc.2003.YJCRC2; Hofmann JC, 1997, ANN INTERN MED, V127, P1, DOI 10.7326/0003-4819-127-1-199707010-00001; Keating NL, 2004, ARCH INTERN MED, V164, P1015, DOI 10.1001/archinte.164.9.1015; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Koopmeiners L, 1997, Oncol Nurs Forum, V24, P1507; Kreitler S, 1999, CANCER INVEST, V17, P514, DOI 10.3109/07357909909032861; Lamont EB, 2001, ANN INTERN MED, V134, P1096, DOI 10.7326/0003-4819-134-12-200106190-00009; Lee MA, 2000, J AM GERIATR SOC, V48, P1219, DOI 10.1111/j.1532-5415.2000.tb02594.x; Levine LJ, 1997, SOC COGNITION, V15, P157, DOI 10.1521/soco.1997.15.3.157; Levinson W, 2000, JAMA-J AM MED ASSOC, V284, P1021, DOI 10.1001/jama.284.8.1021; Lilly CM, 2000, AM J MED, V109, P469, DOI 10.1016/S0002-9343(00)00524-6; Lo B, 1999, ANN INTERN MED, V130, P744, DOI 10.7326/0003-4819-130-9-199905040-00015; Lo B, 2004, ARCH INTERN MED, V164, P1501, DOI 10.1001/archinte.164.14.1501; Maguire P, 1999, EUR J CANCER, V35, P1415, DOI 10.1016/S0959-8049(99)00178-1; McDonagh JR, 2004, CRIT CARE MED, V32, P1484, DOI 10.1097/01.CCM.0000127262.16690.65; Mishler EG, 1984, DISCOURSE MED DIALEC; Molloy DW, 2000, JAMA-J AM MED ASSOC, V283, P1437, DOI 10.1001/jama.283.11.1437; MURPHY DJ, 1994, NEW ENGL J MED, V330, P545, DOI 10.1056/NEJM199402243300807; Pochard F, 2001, CRIT CARE MED, V29, P1893, DOI 10.1097/00003246-200110000-00007; Quill TE, 1996, ANN INTERN MED, V125, P763, DOI 10.7326/0003-4819-125-9-199611010-00010; Rabow MW, 2004, JAMA-J AM MED ASSOC, V291, P483, DOI 10.1001/jama.291.4.483; ROSENBERG M, 1993, ARCH INTERN MED, V153, P1370, DOI 10.1001/archinte.153.11.1370; Rosenfeld KE, 1996, ARCH INTERN MED, V156, P1558, DOI 10.1001/archinte.156.14.1558; Schneiderman LJ, 2003, JAMA-J AM MED ASSOC, V290, P1166, DOI 10.1001/jama.290.9.1166; SELL L, 1993, RESP MED, V87, P61, DOI 10.1016/S0954-6111(05)80315-4; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011; Tarrant C, 2003, BRIT J GEN PRACT, V53, P798; Teno J, 1997, J AM GERIATR SOC, V45, P500, DOI 10.1111/j.1532-5415.1997.tb05178.x; Tolle SW, 1998, J AM GERIATR SOC, V46, P1097, DOI 10.1111/j.1532-5415.1998.tb06647.x; Tulsky JA, 1998, ANN INTERN MED, V129, P441, DOI 10.7326/0003-4819-129-6-199809150-00003; Tulsky James A, 2002, J Palliat Med, V5, P339, DOI 10.1089/109662102320135225; Waisel DB, 2002, J CLIN ANESTH, V14, P467, DOI 10.1016/S0952-8180(02)00401-4; WALKER RM, 1991, JAMA-J AM MED ASSOC, V266, P2407, DOI 10.1001/jama.266.17.2407; Wallace SK, 2002, SUPPORT CARE CANCER, V10, P425, DOI 10.1007/s00520-002-0353-4; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; Wenrich MD, 2001, ARCH INTERN MED, V161, P868, DOI 10.1001/archinte.161.6.868; Yates J L, 1997, J Aging Soc Policy, V9, P29	72	264	267	1	50	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2005	294	3					359	365		10.1001/jama.294.3.359	http://dx.doi.org/10.1001/jama.294.3.359			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	946YL	16030281				2022-12-28	WOS:000230609100021
J	Ford, ES; Ajani, UA; Mokdad, AH				Ford, ES; Ajani, UA; Mokdad, AH			Brief communication: The prevalence of high intake of vitamin E from the use of supplements among US adults	ANNALS OF INTERNAL MEDICINE			English	Article							ALPHA-TOCOPHEROL; GAMMA-TOCOPHEROL; CARDIOVASCULAR-DISEASE; METAANALYSIS; PREVENTION	Background: People who consume at least 400 IU of vitamin E per day from supplements may be at slightly increased risk for premature mortality. Objective: To estimate the percentage of U.S. adults age 20 years or older who consume at least 400 IU of vitamin E per day through the use of vitamins, minerals, or other dietary supplements. Design: Cross-sectional analysis. Setting: The 1999-2000 National Health and Nutrition Examination Survey. Patients: Representative sample of the civilian, noninstitutionalized U.S. population. Measurements: Participants answered questions about the use of vitamins, minerals, or other dietary supplements. Results: Among 4609 adults, 11.3% (95% CI, 9.7% to 13.1%) consumed at least 400 IU of vitamin E per day from supplements. Such intake increased with age, was about equal for men and women, and was more common among white persons (14.1%; CI, 11.9% to 16.7%) than African-American (3.7% [CI, 2.6% to 5.2%]) or Mexican-American persons (3.9% [CI, 2.8% to 5.4%]). The median dietary intake of vitamin E was 8.8 IU per day. Limitations: information about vitamin E intake was self-reported. Conclusions: The use of vitamin E supplements in dosages of at least 400 IU per day is common among U.S. adults.	Ctr Dis Control & Prevent, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Ford, ES (corresponding author), Ctr Dis Control & Prevent, 470 Buford Highway,MS K66, Atlanta, GA 30341 USA.		Mokdad, Ali H./AAD-1232-2022	Mokdad, Ali H./0000-0002-4994-3339				Briefel RR, 2004, ANNU REV NUTR, V24, P401, DOI 10.1146/annurev.nutr.23.011702.073349; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, NHANES 1999 2000 PUB; HANDELMAN GJ, 1985, J NUTR, V115, P807, DOI 10.1093/jn/115.6.807; Hensley Kenneth, 2004, Free Radic Biol Med, V36, P1; Huang HY, 2003, J NUTR, V133, P3137, DOI 10.1093/jn/133.10.3137; Lonn E, 2005, JAMA-J AM MED ASSOC, V293, P1338, DOI 10.1001/jama.293.11.1338; Maras JE, 2004, J AM DIET ASSOC, V104, P567, DOI 10.1016/j.jada.2004.01.004; Millen AE, 2004, J AM DIET ASSOC, V104, P942, DOI 10.1016/j.jada.2004.03.022; Miller ER, 2005, ANN INTERN MED, V143, P156, DOI 10.7326/0003-4819-143-2-200507190-00029; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Muntwyler J, 2002, ARCH INTERN MED, V162, P1472, DOI 10.1001/archinte.162.13.1472; *RES TRIANGL I, 2002, SUDAAN US MAN REL 8; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Vivekananthan DP, 2003, LANCET, V361, P2017, DOI 10.1016/S0140-6736(03)13637-9	15	45	47	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2005	143	2					116	120		10.7326/0003-4819-143-2-200507190-00010	http://dx.doi.org/10.7326/0003-4819-143-2-200507190-00010			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YG	16027453				2022-12-28	WOS:000230608600004
J	Krucoff, MW; Crater, SW; Gallup, D; Blankenship, JC; Cuffe, M; Guarneri, M; Krieger, RA; Kshettry, VR; Morris, K; Oz, M; Pichard, A; Sketch, MH; Koenig, HG; Mark, D; Lee, KL				Krucoff, MW; Crater, SW; Gallup, D; Blankenship, JC; Cuffe, M; Guarneri, M; Krieger, RA; Kshettry, VR; Morris, K; Oz, M; Pichard, A; Sketch, MH; Koenig, HG; Mark, D; Lee, KL			Music, imagery, touch, and prayer as adjuncts to interventional cardiac care: the Monitoring and Actualisation of Noetic Trainings (MANTRA) II randomised study	LANCET			English	Article							INTERCESSORY PRAYER; PERCUTANEOUS INTERVENTION; CORONARY; RELIGION; UNIT; THERAPIES; OUTCOMES	Background Data from a pilot study suggested that noetic therapies-healing practices that are not mediated by tangible elements-can reduce preprocedural distress and might affect outcomes in patients undergoing percutaneous coronary intervention. We undertook a multicentre, prospective trial of two such practices: intercessory prayer and music, imagery, and touch (MIT) therapy. Methods 748 patients undergoing percutaneous coronary intervention or elective catheterisation in nine USA centres were assigned in a 2 X 2 factorial randomisation either off-site prayer by established congregations of various religions or no off-site prayer (double-blinded) and MIT therapy or none (unmasked). The primary endpoint was combined in-hospital major adverse cardiovascular events and 6-month readmission or death. Prespecified secondary endpoints were 6-month major adverse cardiovascular events, 6-month death or readmission, and 6-month mortality. Findings 371 patients were assigned prayer and 377 no prayer; 374 were assigned MIT therapy and 374 no MIT therapy. The factorial distribution was: standard care only, 192; prayer only, 182; MIT therapy only, 185; and both prayer and MIT therapy, 189. No significant difference was found for the primary composite endpoint in any treatment comparison. Mortality at 6 months was lower with MIT therapy than with no MIT therapy (hazard ratio 0.35 (95% CI 0.15-0.82, p=0.016). Interpretation Neither masked prayer nor MIT therapy significantly improved clinical outcome after elective catheterisation or percutaneous coronary intervention.	Duke Clin Res Inst, Durham, NC 27705 USA; Geisinger Med Ctr, Danville, PA 17822 USA; Duke Univ, Med Ctr, Durham, NC USA; Scripps Ctr Integrat Med, San Diego, CA USA; Florida Cardiovasc Grp Res, Atlantis, FL USA; Minneapolis Heart Inst, Minneapolis, MN USA; Columbia Univ, Coll Phys & Surg, New York, NY USA; Washington Hosp Ctr, Washington, DC 20010 USA; Vet Affairs Med Ctr, Dept Med Cardiol, Durham, NC USA; Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Durham, NC USA	Duke University; Geisinger Medical Center; Duke University; Minneapolis Heart Institute Foundation; Columbia University; MedStar Washington Hospital Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Krucoff, MW (corresponding author), Duke Clin Res Inst, 508 Fulton St,Room A3006, Durham, NC 27705 USA.	kruco001@mc.duke.edu	Blankenship, James/AAX-4084-2020; Koenig, Harold G/F-7379-2011	Blankenship, James/0000-0003-4966-533X; Mark, Daniel/0000-0001-6340-8087				Astin JA, 2000, ANN INTERN MED, V132, P903, DOI 10.7326/0003-4819-132-11-200006060-00009; Aviles JM, 2001, MAYO CLIN PROC, V76, P1192, DOI 10.4065/76.12.1192; Bally Kathy, 2003, Crit Care Nurse, V23, P50; BENSON H, 1990, RELAXATION RESPONSE; Brummett BH, 1998, PSYCHOSOM MED, V60, P707, DOI 10.1097/00006842-199811000-00008; BYRD RC, 1988, SOUTHERN MED J, V81, P826, DOI 10.1097/00007611-198807000-00005; Cha KY, 2001, J REPROD MED, V46, P781; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Dossey L., 1993, HEALING WORDS POWER; Dusek JA, 2003, ALTERN THER HEALTH M, V9, pA44; Ernst E, 2003, WIEN KLIN WOCHENSCHR, V115, P241, DOI 10.1007/BF03040322; Grunberg Gregory E, 2003, Cardiol Rev, V11, P309, DOI 10.1097/01.crd.0000089947.20354.d5; GUZZETTA CE, 1989, HEART LUNG, V18, P609; Harris WS, 1999, ARCH INTERN MED, V159, P2273, DOI 10.1001/archinte.159.19.2273; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jiang W, 2001, ARCH INTERN MED, V161, P1849, DOI 10.1001/archinte.161.15.1849; JOSEPHSON BD, 1991, FOUND PHYS, V21, P197, DOI 10.1007/BF01889532; Joy W. B, 1979, JOYS WAY MAP TRANSFO; Koenig H, 1997, AM J PSYCHIAT, V154, P885; Koenig HG., 1997, IS RELIG GOOD YOUR H; Krucoff MW, 2001, AM HEART J, V142, P760, DOI 10.1067/mhj.2001.119138; LEVIN JS, 1994, SOC SCI MED, V38, P1475, DOI 10.1016/0277-9536(94)90109-0; MENTGEN DHK, 1996, HEALING TOUCH RESOUR; ROBERTS L, 2000, COCHRANE DB SYST REV, V2; Seskevich JE, 2004, NURS RES, V53, P116, DOI 10.1097/00006199-200403000-00007; Sloan RP, 1999, LANCET, V353, P664, DOI 10.1016/S0140-6736(98)07376-0; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; STRAUS S, 2001, NAT CTR COMPL ALT ME; ZIMMERMAN LM, 1988, HEART LUNG, V17, P560	29	93	94	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2005	366	9481					211	217		10.1016/S0140-6736(05)66910-3	http://dx.doi.org/10.1016/S0140-6736(05)66910-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	945RG	16023511				2022-12-28	WOS:000230519200029
J	Yabroff, KR; Kerner, JF				Yabroff, KR; Kerner, JF			Variations in surgery for early-stage breast cancer: what are we measuring?	LANCET			English	Editorial Material							OLDER WOMEN; GEOGRAPHIC-VARIATION; MASTECTOMY; RADIATION; THERAPY; CARE		NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yabroff, KR (corresponding author), NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA.	yabroffr@mail.nih.gov		Kerner, Jon/0000-0002-8792-3830; Yabroff, K. Robin/0000-0003-0644-5572				BallardBarbash R, 1996, JNCI-J NATL CANCER I, V88, P716, DOI 10.1093/jnci/88.11.716; Caldon LJM, 2005, BRIT J CANCER, V92, P55, DOI 10.1038/sj.bjc.6602264; Charles C, 1999, SOC SCI MED, V49, P651, DOI 10.1016/S0277-9536(99)00145-8; FARROW DC, 1992, NEW ENGL J MED, V326, P1097, DOI 10.1056/NEJM199204233261701; FISHER B, 1985, NEW ENGL J MED, V312, P665, DOI 10.1056/NEJM198503143121101; HALL WH, 1991, JAMA-J AM MED ASSOC, V265, P391; Hebert-Croteau N, 2000, EPIDEMIOL REV, V22, P228, DOI 10.1093/oxfordjournals.epirev.a018035; Hewitt M, 1999, ENSURING QUALITY CAN; Keating NL, 2003, J CLIN ONCOL, V21, P4532, DOI 10.1200/JCO.2003.05.131; Lantz PM, 2002, HEALTH SERV RES, V37, P417, DOI 10.1111/1475-6773.030; Liang WH, 2002, J CLIN ONCOL, V20, P1008, DOI 10.1200/JCO.20.4.1008; Lipscomb Joseph, 2004, J Natl Cancer Inst Monogr, P178; Mandelblatt JS, 1999, CANCER-AM CANCER SOC, V86, P2378, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2378::AID-CNCR28>3.3.CO;2-C; Mandelblatt JS, 2001, MED CARE, V39, P228, DOI 10.1097/00005650-200103000-00004; Morris AD, 1997, CANCER J, V3, P6; NATTINGER AB, 1992, NEW ENGL J MED, V326, P1102, DOI 10.1056/NEJM199204233261702	16	4	4	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 16	2005	366	9481					188	190		10.1016/S0140-6736(05)66888-2	http://dx.doi.org/10.1016/S0140-6736(05)66888-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	945RG	16023495				2022-12-28	WOS:000230519200009
J	Collier, LS; Carlson, CM; Ravimohan, S; Dupuy, AJ; Largaespada, DA				Collier, LS; Carlson, CM; Ravimohan, S; Dupuy, AJ; Largaespada, DA			Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse	NATURE			English	Article							SLEEPING-BEAUTY; EXPRESSION; GENOME; CELLS; FISH; MICE	Retroviruses, acting as somatic cell insertional mutagens, have been widely used to identify cancer genes in the haematopoietic system and mammary gland(1,2). An insertional mutagen for use in other mouse somatic cells would facilitate the identification of genes involved in tumour formation in a wider variety of tissues. Here we report the ability of the Sleeping Beauty transposon to act as a somatic insertional mutagen to identify genes involved in solid tumour formation. A Sleeping Beauty transposon, engineered to elicit loss-of-function or gain-of-function mutations, transposed in all somatic tissues tested and accelerated tumour formation in mice predisposed to cancer. Cloning transposon insertion sites from these tumours revealed the presence of common integration sites, at known and candidate cancer genes, similar to those observed in retroviral mutagenesis screens. Sleeping Beauty is a new tool for unbiased, forward genetic screens for cancer genes in vivo.	Univ Minnesota Twin Cities, Ctr Canc, Arnold & Mabel Beckman Ctr Transposon Res, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Largaespada, DA (corresponding author), Univ Minnesota Twin Cities, Ctr Canc, Arnold & Mabel Beckman Ctr Transposon Res, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	larga002@umn.edu	Wilson, Matthew H/K-3193-2013; Largaespada, David/C-9832-2014	Dupuy, Adam/0000-0002-8561-4911				Abdallah B, 1996, HUM GENE THER, V7, P1947, DOI 10.1089/hum.1996.7.16-1947; Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Carlson CM, 2003, GENETICS, V165, P243; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Dupuy AJ, 2001, GENESIS, V30, P82, DOI 10.1002/gene.1037; Fischer SEJ, 2001, P NATL ACAD SCI USA, V98, P6759, DOI 10.1073/pnas.121569298; Geurts AM, 2003, MOL THER, V8, P108, DOI 10.1016/S1525-0016(03)00099-6; HAWLEY RG, 1994, GENE THER, V1, P136; HEIDECKER G, 1990, MOL CELL BIOL, V10, P2503, DOI 10.1128/MCB.10.6.2503; Horie K, 2003, MOL CELL BIOL, V23, P9189, DOI 10.1128/MCB.23.24.9189-9207.2003; Horie K, 2001, P NATL ACAD SCI USA, V98, P9191, DOI 10.1073/pnas.161071798; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Johansson FK, 2004, P NATL ACAD SCI USA, V101, P11334, DOI 10.1073/pnas.0402716101; Jonkers J, 1996, BBA-REV CANCER, V1287, P29, DOI 10.1016/0304-419X(95)00020-G; Kamijo T, 1999, CANCER RES, V59, P2217; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Lund AH, 2002, NAT GENET, V32, P160, DOI 10.1038/ng956; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Montini E, 2002, MOL THER, V6, P759, DOI 10.1006/mthe.2002.0812; Neil JC, 2002, CANCER CELL, V2, P253, DOI 10.1016/S1535-6108(02)00158-7; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Seidel C, 2005, INT J CANCER, V114, P442, DOI 10.1002/ijc.20707; Vigdal TJ, 2002, J MOL BIOL, V323, P441, DOI 10.1016/S0022-2836(02)00991-9; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Yant SR, 2000, NAT GENET, V25, P35, DOI 10.1038/75568	27	327	345	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					272	276		10.1038/nature03681	http://dx.doi.org/10.1038/nature03681			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015333				2022-12-28	WOS:000230459500044
J	Toff, WD; Camm, J; Skehan, JD				Toff, WD; Camm, J; Skehan, JD		UKPACE Trial Investigators	Single-chamber versus dual-chamber pacing for high-grade atrioventricular block	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ATRIAL-FIBRILLATION; CANADIAN TRIAL; PACEMAKERS; SURVIVAL; LIFE	BACKGROUND In the treatment of atrioventricular block, dual-chamber cardiac pacing is thought to confer a clinical benefit as compared with single-chamber ventricular pacing, but the supporting evidence is mainly from retrospective studies. Uncertainty persists regarding the true benefits of dual-chamber pacing, particularly in the elderly, in whom it is used less often than in younger patients. METHODS In a multicenter, randomized, parallel-group trial, 2021 patients 70 years of age or older who were undergoing their first pacemaker implant for high-grade atrioventricular block were randomly assigned to receive a single-chamber ventricular pacemaker ( 1009 patients) or a dual-chamber pacemaker ( 1012 patients). In the single-chamber group, patients were randomly assigned to receive either fixed-rate pacing ( 504 patients) or rate-adaptive pacing ( 505 patients). The primary outcome was death from all causes. Secondary outcomes included atrial fibrillation, heart failure, and a composite of stroke, transient ischemic attack, or other thromboembolism. RESULTS The median follow-up period was 4.6 years for mortality and 3 years for other cardiovascular events. The mean annual mortality rate was 7.2 percent in the single-chamber group and 7.4 percent in the dual-chamber group ( hazard ratio, 0.96; 95 percent confidence interval, 0.83 to 1.11). We found no significant differences between the group with single-chamber pacing and that with dual-chamber pacing in the rates of atrial fibrillation, heart failure, or a composite of stroke, transient ischemic attack, or other thromboembolism. CONCLUSIONS In elderly patients with high-grade atrioventricular block, the pacing mode does not influence the rate of death from all causes during the first five years or the incidence of cardiovascular events during the first three years after implantation of a pacemaker.	Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; Glenfield Gen Hosp, Univ Hosp Leicester NHS Trust, Dept Cardiol, Leicester LE3 9QP, Leics, England; St Georges Univ London, Div Cardiac & Vasc Sci, London, England	University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; St Georges University London	Toff, WD (corresponding author), Univ Leicester, Glenfield Gen Hosp, Dept Cardiovasc Sci, Clin Sci Wing, Groby Rd, Leicester LE3 9QP, Leics, England.	atw.toff@le.ac.uk		Toff, William/0000-0001-5631-4496				BOON NA, 1987, BRIT HEART J, V58, P34; CLARKE M, 1991, BRIT HEART J, V66, P185; Connolly SJ, 2000, NEW ENGL J MED, V342, P1385, DOI 10.1056/NEJM200005113421902; COX DR, 1972, J R STAT SOC B, V34, P187; Gregoratos G, 1998, J AM COLL CARDIOL, V31, P1175; Jahangir A, 1999, J AM COLL CARDIOL, V33, P1208, DOI 10.1016/S0735-1097(99)00005-4; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kerr CR, 2004, CIRCULATION, V109, P357, DOI 10.1161/01.CIR.0000109490.72104.EE; KRUSE I, 1982, CIRCULATION, V65, P846, DOI 10.1161/01.CIR.65.5.846; LAMAS GA, 1995, CIRCULATION, V91, P1063, DOI 10.1161/01.CIR.91.4.1063; Lamas GA, 1998, NEW ENGL J MED, V338, P1097, DOI 10.1056/NEJM199804163381602; LAU CP, 1990, PACE, V13, P1832, DOI 10.1111/j.1540-8159.1990.tb06899.x; PAYNE GE, 1994, BRIT HEART J, V72, P102; PETCH MC, 1993, BRIT MED J, V307, P215, DOI 10.1136/bmj.307.6898.215; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Skanes AC, 2001, J AM COLL CARDIOL, V38, P167, DOI 10.1016/S0735-1097(01)01326-2; Sweeney MO, 2003, CIRCULATION, V107, P2932, DOI 10.1161/01.CIR.0000072769.17295.B1; Tang Chuen Y., 2000, Cardiology Clinics, V18, P1, DOI 10.1016/S0733-8651(05)70124-7; Toff WD, 1997, HEART, V78, P221, DOI 10.1136/hrt.78.3.221; Wilkoff BL, 2002, JAMA-J AM MED ASSOC, V288, P3115	20	241	268	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2005	353	2					145	155		10.1056/NEJMoa042283	http://dx.doi.org/10.1056/NEJMoa042283			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944OP	16014884	Green Published, Green Submitted			2022-12-28	WOS:000230438800006
J	Ockene, JK; Barad, DH; Cochrane, BB; Larson, JC; Gass, M; Wassertheil-Smoller, S; Manson, JE; Barnabei, VM; Lane, DS; Brzyski, RG; Rosal, MC; Wylie-Rosett, J; Hays, J				Ockene, JK; Barad, DH; Cochrane, BB; Larson, JC; Gass, M; Wassertheil-Smoller, S; Manson, JE; Barnabei, VM; Lane, DS; Brzyski, RG; Rosal, MC; Wylie-Rosett, J; Hays, J			Symptom experience after discontinuing use of estrogen plus progestin	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HORMONE REPLACEMENT THERAPY; POSTMENOPAUSAL WOMEN; ATTITUDES; TRIALS; KNEE	Context Little is known about women's experiences after stopping menopausal hormone therapy. Objective To describe women's symptoms and management strategies after stopping the intervention in a large estrogen plus progestin trial. Design, Setting, and Participants Cross-sectional survey of 8405 women (89.9%; N = 9351) at 40 clinical centers who were still taking study pills (conjugated equine estrogens plus medroxyprogesterone [CEE + MPA] or placebo) when the estrogen plus progestin intervention (Women's Health Initiative) was stopped. Surveys were mailed 8 to 12 months after the stop date. Logistic regression was used to model vasomotor symptoms and pain or stiffness symptoms as functions of former treatment and baseline symptoms, adjusted for appropriate covariates. Main Outcome Measures Symptoms (vasomotor or pain and stiffness) and management strategies. Results Respondents' mean (SD) age at trial stop date was 69.1 (6.7) years. They averaged 5.7 years of taking study pills. Moderate or severe vasomotor symptoms after discontinuing study pill use were reported by 21.2% of former CEE + MPA and 4.8% of placebo group respondents overall and by 55.5% and 21.3%, respectively, with these symptoms at baseline (randomization). Compared with respondents in the former placebo group, moderate or severe vasomotor symptoms (adjusted odds ratio [AOR] 5.82; 95% confidence interval [CI], 4.92-6.89) and pain or stiffness symptoms (AOR, 2.16; 95% Cl, 1.95-2.40) were more likely in respondents in the former CEE + MPA group. Both vasomotor symptoms (AOR, 5.36; 95% Cl, 4.51-6.38) and pain or stiffness symptoms (AOR, 3.21; 95% Cl, 2.90-3.56) also were more likely in women with these symptoms at baseline. Women reported a wide range of strategies to manage symptoms. Conclusions More than half of the women with vasomotor symptoms at randomization to active CEE + MPA also reported these symptoms after discontinuing use of the study pills. However, these participants did not include women who were unwilling to be randomized or who had stopped taking the study pills earlier. These findings should be considered when advising women to treat menopausal symptoms with hormone therapy for as short duration as possible. Investigation of alternative strategies to manage menopausal symptoms is warranted.	Univ Massachusetts, Sch Med, Div Prevent & Behav Med, Worcester, MA 01655 USA; Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; Univ Cincinnati, Coll Med, Dept Obstet & Gynecol, Cincinnati, OH 45267 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med, Boston, MA USA; Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA; SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA; Univ Texas, Hlth Sci Ctr, Dept Obstet & Gynecol, San Antonio, TX 78284 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA	University of Massachusetts System; University of Massachusetts Worcester; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Fred Hutchinson Cancer Center; University System of Ohio; University of Cincinnati; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Medical College of Wisconsin; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Texas System; University of Texas Health San Antonio; Baylor College of Medicine	Ockene, JK (corresponding author), Univ Massachusetts, Sch Med, Div Prevent & Behav Med, 55 Lake Ave N, Worcester, MA 01655 USA.	Judith.Ockene@umassmed.edu	Barad, David/AAF-4332-2021	Barnabei, Vanessa/0000-0002-9650-0143; Hays-Grudo, Jennifer/0000-0002-8107-1243				*AM COLL OBST GYN, 2004, OBSTET GYNECOL, V104, pS62; *AM COLL OBST GYN, QUEST ANSW HORM THER; Avis NE, 2001, SOC SCI MED, V52, P345, DOI 10.1016/S0277-9536(00)00147-7; BARNABEI V, IN PRESS OBSTET GYNE; Barnabei VM, 2002, OBSTET GYNECOL, V100, P1209, DOI 10.1016/S0029-7844(02)02369-4; BARRETTCONNOR E, 2002, BEST CLIN PRACTICES; Blumel JE, 2004, MENOPAUSE, V11, P57, DOI 10.1097/01.GME.0000075503.60230.61; Collins D, 2003, QUAL LIFE RES, V12, P229, DOI 10.1023/A:1023254226592; Conboy L, 2001, MATURITAS, V38, P129, DOI 10.1016/S0378-5122(00)00211-5; Drennan J, 2003, J ADV NURS, V42, P57, DOI 10.1046/j.1365-2648.2003.02579.x; *FOOD DRUG ADM, FDA UPD HORM THER IN; Freedman L, 1996, CONTROL CLIN TRIALS, V17, P509, DOI 10.1016/S0197-2456(96)00016-5; Gordon FT, 1996, HORM BEHAV, V30, P244, DOI 10.1006/hbeh.1996.0029; Gordon S, 2004, OBSTET GYNECOL, V103, P267, DOI 10.1097/01.AOG.0000110247.98588.ff; Grady D, 2003, OBSTET GYNECOL, V102, P1233, DOI 10.1016/j.obstetgynecol.2003.09.025; Greendale GA, 1998, OBSTET GYNECOL, V92, P982, DOI 10.1016/S0029-7844(98)00305-6; Hammar M, 1999, MATURITAS, V31, P117, DOI 10.1016/S0378-5122(98)00101-7; HANNAN MT, 1990, ARTHRITIS RHEUM-US, V33, P525, DOI 10.1002/art.1780330410; Hays J, 2003, NEW ENGL J MED, V348, P1839, DOI 10.1056/NEJMoa030311; Hays J, 2003, ANN EPIDEMIOL, V13, pS18, DOI 10.1016/S1047-2797(03)00042-5; Hersh AL, 2004, JAMA-J AM MED ASSOC, V291, P47, DOI 10.1001/jama.291.1.47; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Matthews KA, 1997, AM PSYCHOL, V52, P101, DOI 10.1037/0003-066X.52.2.101; *N AM MEN SOC, 2003, MEN GUID; *N AM MEN SOC, ESTR PROG US PER POS; National Institute of Aging, 2001, MEN ON WOM STOR EV W; Nevitt MC, 2001, ARTHRITIS RHEUM-US, V44, P811, DOI 10.1002/1529-0131(200104)44:4<811::AID-ANR137>3.0.CO;2-F; Newton KM, 2002, OBSTET GYNECOL, V100, P18, DOI 10.1016/S0029-7844(02)02005-7; Reginster JY, 2003, OSTEOARTHR CARTILAGE, V11, P87, DOI 10.1053/joca.2002.0872; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; ROTHERT M, 1994, EXP GERONTOL, V29, P463, DOI 10.1016/0531-5565(94)90026-4; Santoro NF, 2004, MENOPAUSE, V11, P11; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stefanick ML, 2003, ANN EPIDEMIOL, V13, pS78, DOI 10.1016/S1047-2797(03)00045-0; Will Constance I, 2003, J Holist Nurs, V21, P368, DOI 10.1177/0898010103258605; Zethraeus N, 1997, BRIT J OBSTET GYNAEC, V104, P1191, DOI 10.1111/j.1471-0528.1997.tb10945.x	36	131	134	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2005	294	2					183	193		10.1001/jama.294.2.183	http://dx.doi.org/10.1001/jama.294.2.183			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944DO	16014592	Bronze			2022-12-28	WOS:000230406100022
J	Mayhew, PM; Thomas, CD; Clement, JG; Loveridge, N; Beck, TJ; Bonfield, W; Burgoyne, CJ; Reeve, J				Mayhew, PM; Thomas, CD; Clement, JG; Loveridge, N; Beck, TJ; Bonfield, W; Burgoyne, CJ; Reeve, J			Relation between age, femoral neck cortical stability, and hip fracture risk	LANCET			English	Article							X-RAY ABSORPTIOMETRY; OSTEOPOROTIC FRACTURES; COMPUTED-TOMOGRAPHY; DISTAL FOREARM; BONE TISSUE; STRENGTH; FEMUR; MECHANISM; EVOLUTION; POROSITY	Background Hip fracture risk rises 100 to 1000-fold over 60 years of ageing. Loss of resistance to bending is not a major feature of normal ageing of the femoral neck. Another cause of fragility is local buckling or elastic instability. Bones adapt to their local experience of mechanical loading. The suggestion that bipedalism allows thinning of the underloaded superolateral. femoral neck cortex arises from the failure of walking to transmit much mechanical load to this region. We aimed to measure whether elastic instability increases greatly with age since it might trigger hip fracture in a sideways fall. Methods We measured with computed tomography the distribution of bone in the mid-femoral neck of 77 proximal femurs from people who died suddenly aged 20-95 years. We then calculated the critical stress, from the geometric properties and density of the cortical zone most highly loaded in a sideways fall, as a threshold for elastic instability. Findings With normal ageing, this thin cortical zone in the upper femoral neck became substantially thinner. Relative to mean values at age 60 years, female cortical thickness declined by 6.4% (SD 1.1) per decade (p<0.0001), and critical stress by 13.2% (4.3) per decade (p=0.004) in the superoposterior octant compressed most in a sideways fall. Similar, but significantly smaller, effects were evident in men (p=0.004). This thinning compromised the capacity of the femur to absorb energy independently of osteoporosis. Patients with hip fracture had further reduced stability. Interpretation As women age, hip fragility increases because underloading of the superolateral cortex leads to atrophic thinning. Because walking does not sufficiently load the upper femoral neck, the fragile zones in healthy bones may need strengthening, for example with more well targeted exercise.	Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; Univ Cambridge, Dept Mat Sci, Cambridge, England; Univ Cambridge, Dept Engn, Cambridge, England; Univ Melbourne, Sch Dent Sci, Parkville, Vic 3052, Australia; Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA	University of Cambridge; University of Cambridge; University of Cambridge; University of Melbourne; Johns Hopkins University	Reeve, J (corresponding author), Addenbrookes Hosp, Dept Med, Box 157, Cambridge CB2 2QQ, England.	jr357@cam.ac.uk	Thomas, Christopher DL/B-1117-2008; Reeve, Jonathan/C-7551-2012; clement, john G/C-9303-2013	Thomas, Christopher DL/0000-0001-7668-4259; Reeve, Jonathan/0000-0002-4364-2682; clement, john/0000-0001-5348-5898; Loveridge, Nigel/0000-0002-5550-7584				ADEBAJO AO, 1991, AGE AGEING, V20, P435, DOI 10.1093/ageing/20.6.435; Aspray TJ, 1996, J BONE MINER RES, V11, P1019; Beck TJ, 2000, J BONE MINER RES, V15, P2297, DOI 10.1359/jbmr.2000.15.12.2297; Bell KL, 1999, BONE, V24, P57, DOI 10.1016/S8756-3282(98)00143-4; Bell KL, 2000, BONE, V27, P297, DOI 10.1016/S8756-3282(00)00318-5; BURSTEIN AH, 1976, J BONE JOINT SURG AM, V58, P82, DOI 10.2106/00004623-197658010-00015; CARTER DR, 1977, J BONE JOINT SURG AM, V59, P954, DOI 10.2106/00004623-197759070-00021; COUPLAND C, 1993, J EPIDEMIOL COMMUN H, V47, P441, DOI 10.1136/jech.47.6.441; Crabtree N, 2001, J BONE MINER RES, V16, P1318, DOI 10.1359/jbmr.2001.16.7.1318; Crabtree NJ, 2002, OSTEOPOROSIS INT, V13, P48, DOI 10.1007/s198-002-8337-y; *GAL GAL LINC, 1638, DISC DIM MAT INT DUE; Hangartner TN, 1996, J BONE MINER RES, V11, P1518, DOI 10.1002/jbmr.5650111019; Kaptoge S, 2003, BONE, V32, P561, DOI 10.1016/S8756-3282(03)00055-3; Kaptoge S, 2003, OSTEOPOROSIS INT, V14, P941, DOI 10.1007/s00198-003-1484-2; LOTZ JC, 1995, OSTEOPOROSIS INT, V5, P252, DOI 10.1007/BF01774015; LOVEJOY CO, 1988, SCI AM, V259, P118, DOI 10.1038/scientificamerican1188-118; Loveridge N, 2004, BONE, V35, P929, DOI 10.1016/j.bone.2004.05.025; Mayhew P, 2004, BONE, V34, P352, DOI 10.1016/j.bone.2003.11.012; MELTON LJ, 1990, CALCIFIED TISSUE INT, V46, P285; Mosley JR, 1997, BONE, V20, P191, DOI 10.1016/S8756-3282(96)00385-7; NEVITT MC, 1993, J AM GERIATR SOC, V41, P1226, DOI 10.1111/j.1532-5415.1993.tb07307.x; Noble BS, 2003, AM J PHYSIOL-CELL PH, V284, pC934, DOI 10.1152/ajpcell.00234.2002; ONeill TW, 1995, J EPIDEMIOL COMMUN H, V49, P597, DOI 10.1136/jech.49.6.597; POWER J, 2004, OSTEOPOROS INT  1126; ROBINOVITCH SN, 1991, J BIOMECH ENG-T ASME, V113, P366, DOI 10.1115/1.2895414; Thomas CDL, 2000, J ANAT, V196, P463, DOI 10.1046/j.1469-7580.2000.19630463.x; TIMOSHENKO SP, 1979, THEORY ELASTIC STABI; Van Rietbergen B, 2003, J BONE MINER RES, V18, P1781, DOI 10.1359/jbmr.2003.18.10.1781; VANBUSKIRK WC, 1989, BONE MECH, P43; Vashishth D, 2003, J BIOMECH, V36, P121, DOI 10.1016/S0021-9290(02)00319-6; WAND JS, 1990, CLIN ORTHOP RELAT R, V278, P88; Yan L, 1999, BONE, V24, P151, DOI 10.1016/S8756-3282(98)00168-9; YOSHIKAWA T, 1994, J BONE MINER RES, V9, P1053; Zioupos P, 1998, BONE, V22, P57, DOI 10.1016/S8756-3282(97)00228-7	34	307	315	2	29	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2005	366	9480					129	135		10.1016/S0140-6736(05)66870-5	http://dx.doi.org/10.1016/S0140-6736(05)66870-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	943JH	16005335				2022-12-28	WOS:000230349200031
J	Midgley, AK				Midgley, AK			"Choose and book" does not solve any problems	BRITISH MEDICAL JOURNAL			English	Letter												amidgley2@defoam.net						de Kare-Silver N, 2005, BMJ-BRIT MED J, V330, P1093, DOI 10.1136/bmj.330.7499.1093	1	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 30	2005	331	7511					294	294		10.1136/bmj.331.7511.294-b	http://dx.doi.org/10.1136/bmj.331.7511.294-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953FJ	16052028	Green Published			2022-12-28	WOS:000231061700031
J	Mandavilli, A				Mandavilli, A			The coming epidemic	NATURE			English	Article																			0	6	6	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2005	436	7050					496	498		10.1038/436496a	http://dx.doi.org/10.1038/436496a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049477				2022-12-28	WOS:000230788800049
J	Babaev, A; Frederick, PD; Pasta, DJ; Every, N; Sichrovsky, T; Hochman, JS				Babaev, A; Frederick, PD; Pasta, DJ; Every, N; Sichrovsky, T; Hochman, JS		NRMI Investigators	Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COOPERATIVE CARDIOVASCULAR PROJECT; PERCUTANEOUS CORONARY INTERVENTION; EARLY REVASCULARIZATION; NATIONAL REGISTRY; TRIAL REGISTRY; MEDICARE PATIENTS; TEMPORAL TRENDS; GUIDELINES; QUALITY; CARE	Context Early mechanical revascularization in patients with acute myocardial infarction (AMI) complicated by cardiogenic shock is a therapeutic strategy that reduces mortality. It has been a class I recommendation in guidelines from the American College of Cardiology and the American Heart Association since 1999 for patients younger than 75 years. However, little is known about implementation of these guidelines in practice. Objectives To assess trends in early revascularization and mortality for patients with cardiogenic shock complicating AMI and to determine whether the national guidelines affect revascularization rates. Design, Setting, and Patients Prospective, observational study of 293 633 patients with ST-elevation myocardial infarction (25311 [8.6%] had cardiogenic shock; 7356 [29%] had cardiogenic shock at hospital presentation) enrolled in the National Registry of Myocardial Infarction (NRMI) from January 1995 to May 2004 at 775 US hospitals with revascularization capability (defined as the capability to perform cardiac catheterization, percutaneous coronary intervention [PCI], and open-heart surgery). Main Outcome Measures Management patterns and in-hospital mortality rates. Results There was an increase in primary PCI rates from 27.4% to 54.4% (P<.001) in hospitals with revascularization capability that paralleled the change in PC[ for ST-elevation myocardial infarction. There was no significant change in rates of immediate coronary artery bypass graft surgery (from 2.1% to 3.2%). Propensity-adjusted multivariable analyses demonstrated that primary PCI was associated with a decreased odds of death during hospitalization (odds ratio, 0.46; 95% confidence interval, 0.40-0.53). There were no differences in the rates of change in revascularization rates based on the date when the guidelines were released regardless of patient age. Overall in-hospital cardiogenic shock mortality decreased from 60.3% in 1995 to 47.9% in 2004 (P<.001). Conclusions The use of PCI for patients with cardiogenic shock was associated with improved survival in a large group of hospitals with revascularization capability. The American College of Cardiology and American Heart Association guidelines had no detectable temporal impact on revascularization rates. These findings support the need for increased adherence to these guidelines.	NYU, Sch Med, Cardiovasc Clin Res Ctr, New York, NY 10016 USA; Ovat Res Grp, Seattle, WA USA; Ovat Res Grp, San Francisco, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ Washington, Sch Med, Dept Cardiol, Seattle, WA USA; St Lukes Roosevelt Hosp, Div Cardiol, New York, NY USA	New York University; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; Mount Sinai St. Luke's; Mount Sinai West	Hochman, JS (corresponding author), NYU, Sch Med, Cardiovasc Clin Res Ctr, 530 1st Ave,HCC 1173, New York, NY 10016 USA.	judith.hochman@med.nyu.edu		Frederick, Paul/0000-0002-7936-5488; Hochman, Judith/0000-0002-5889-5981; Pasta, David/0000-0003-2637-9293				Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002; Becker RC, 1996, J AM COLL CARDIOL, V27, P1321, DOI 10.1016/0735-1097(96)00008-3; Curry SJ, 2000, CHEST, V118, p40S, DOI 10.1378/chest.118.2_suppl.40S; Dauerman HL, 2001, AM J CARDIOL, V87, P844, DOI 10.1016/S0002-9149(00)01524-1; Dzavik V, 2005, AM HEART J, V149, P1128, DOI 10.1016/j.ahj.2005.03.045; Dzavik V, 2003, EUR HEART J, V24, P828, DOI 10.1016/S0195-668X(02)00844-8; Eagle KA, 2002, LANCET, V359, P373, DOI 10.1016/S0140-6736(02)07595-5; ELLERBECK EF, 1995, JAMA-J AM MED ASSOC, V273, P1509, DOI 10.1001/jama.273.19.1509; Goldberg RJ, 1999, NEW ENGL J MED, V340, P1162, DOI 10.1056/NEJM199904153401504; GUNNAR RM, 1990, J AM COLL CARDIOL, V16, P249, DOI 10.1016/0735-1097(90)90575-A; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Hochman JS, 2001, JAMA-J AM MED ASSOC, V285, P190, DOI 10.1001/jama.285.2.190; Hochman JS, 2000, J AM COLL CARDIOL, V36, P1063, DOI 10.1016/S0735-1097(00)00879-2; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; Mehta RH, 2002, JAMA-J AM MED ASSOC, V287, P1269, DOI 10.1001/jama.287.10.1269; Moscucci M, 2005, J AM COLL CARDIOL, V45, P1759, DOI 10.1016/j.jacc.2005.01.055; ROGERS WJ, 1994, CIRCULATION, V90, P2103, DOI 10.1161/01.CIR.90.4.2103; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Ryan TJ, 1999, J AM COLL CARDIOL, V34, P890, DOI 10.1016/S0735-1097(99)00351-4; Webb JG, 2001, AM HEART J, V141, P964, DOI 10.1067/mhj.2001.115294	23	447	472	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2005	294	4					448	454		10.1001/jama.294.4.448	http://dx.doi.org/10.1001/jama.294.4.448			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RM	16046651	Bronze			2022-12-28	WOS:000230733400019
J	Hedley, RN; Maxhuni, B				Hedley, RN; Maxhuni, B			Development of family medicine in Kosovo	BRITISH MEDICAL JOURNAL			English	Article									Hopwell House, Hopwell DE72 3RU, Derbyshire, England; Ctr Dev Family Med, Kosovar Family Med Programme, Pristina, Kosovo, Serbia Monteneg		Hedley, RN (corresponding author), Hopwell House, Hopwell DE72 3RU, Derbyshire, England.	rnhedley@aol.com						CARTER Y, 1998, ED GEN PRACT, V9, P182; *DEP HLTH SOC WELF, 2001, HLTH POL KOS; GROL R, 1992, CONTRIBUTION FAMILY; Nelson Eugene C, 2002, Jt Comm J Qual Improv, V28, P472; SIMAY AN, 2004, PRAXIS MED KOSOVA, V46, P135; SMITH T, 1992, BRIT MED J, V304, P1457; *UN CIV ADM HLTH S, 1999, INT HLTH POL GUID KO	7	7	7	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 23	2005	331	7510					201	203		10.1136/bmj.331.7510.201	http://dx.doi.org/10.1136/bmj.331.7510.201			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951EA	16037456	Green Published, Bronze			2022-12-28	WOS:000230910700025
J	Kerr, T; Tyndall, M; Li, K; Montaner, J; Wood, E				Kerr, T; Tyndall, M; Li, K; Montaner, J; Wood, E			Safer injection facility use and syringe sharing in injection drug users	LANCET			English	Article								Safer injection facilities provide medical supervision for illicit drug injections. We aimed to examine factors associated with syringe sharing in a community-recruited cohort of illicit injection drug users in a setting where such a facility had recently opened. Between Dec 1, 2003, and June 1, 2004, of 431 active injection drug users 49 (11.4%, 95% CI 8.5-14.3) reported syringe sharing in the past 6 months. In logistic regression analyses, use of the facility was independently associated with reduced syringe sharing (adjusted odds ratio 0.30, 0.11-0.82, p=0.02) after adjustment for relevant sociodemographic and drug-use characteristics. These findings could help inform discussions about the merits of such facilities.	St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; Univ British Columbia, Dept Med, Vancouver, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of British Columbia	Kerr, T (corresponding author), St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, 608-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	tkerr@cfenet.ubc.ca	Montaner, Julio/K-7621-2012	Tyndall, Mark/0000-0003-4450-5679				Hedrich D, 2004, EUROPEAN REPORT DRUG; Kerr T, 2004, ANTIVIR THER, V9, P407; *MED SUP INJ CTR E, 2003, FIN REP SYDN MED SUP; Wood E, 2004, CAN MED ASSOC J, V171, P731, DOI 10.1503/cmaj.1040774; Wood E, 2004, LANCET INFECT DIS, V4, P301, DOI 10.1016/S1473-3099(04)01006-0; Wood E, 2002, AIDS, V16, P941, DOI 10.1097/00002030-200204120-00021; Wood E, 2001, CAN MED ASSOC J, V165, P405; Wright NMJ, 2004, BRIT MED J, V328, P100, DOI 10.1136/bmj.328.7431.100	8	210	210	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 23	2005	366	9482					316	318		10.1016/S0140-6736(05)66475-6	http://dx.doi.org/10.1016/S0140-6736(05)66475-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RJ	16039335				2022-12-28	WOS:000230733100031
J	Oudega, R; Hoes, AW; Moons, KGM				Oudega, R; Hoes, AW; Moons, KGM			The wells rule does not adequately rule out deep venous thrombosis in primary care patients	ANNALS OF INTERNAL MEDICINE			English	Article							VEIN THROMBOSIS; D-DIMER; CLINICAL PROBABILITY; DIAGNOSTIC-TESTS; COMPRESSION ULTRASONOGRAPHY; IMPEDANCE PLETHYSMOGRAPHY; MANAGEMENT; OUTPATIENTS; PREDICTION; COMBINATION	Background: using data from secondary care outpatients, Wells and colleagues developed a diagnostic rule to estimate the probability of the presence of deep venous thrombosis (DVT). The accuracy of the Wells rule has not been properly validated for use in primary care patients in whom DVT is suspected. Objective: To validate the diagnostic accuracy of the Wells rule, with and without D-dimer testing, in a primary care setting. Design: Cross-sectional study with prospective data collection from 1 January 2002 to 1 March 2003. Setting: 110 primary care practices in a circumscribed geographic region in The Netherlands. Participants: 1295 consecutive patients who consulted their primary care physician about symptoms suggestive of DVT. Measurements: All patients underwent history-taking and physical examination to calculate the Wells rule score, and D-dimer testing. Repeated leg ultrasonography was the reference standard to determine the true presence or absence of DVT. Results: In the primary care setting, 12.0% of patients in the low-risk group had DVT; the original study by Wells and colleagues reported a rate of 3% among such patients. When combined with negative results on a D-dimer test, the Wells rule yielded a prevalence of DVT of 2.9% in the lowest-risk group, whereas the prevalence was 0.9% in the original study. Limitations: Patients with previous DVT were included, and the diagnostic reference standard was different from that used in Wells and colleagues' original study. Conclusion: The Wells rule, alone or in combination with D-dimer testing, does not guarantee accurate estimation of risk in primary care patients in whom DVT is suspected.	Univ Utrecht, Ctr Med, Julius Ctr Hlth Sci & Primary Care, NL-3508 AB Utrecht, Netherlands	Utrecht University	Oudega, R (corresponding author), Univ Utrecht, Ctr Med, Julius Ctr Hlth Sci & Primary Care, POB 85060, NL-3508 AB Utrecht, Netherlands.	r.oudega@knmg.nl						Anand SS, 1998, JAMA-J AM MED ASSOC, V279, P1094, DOI 10.1001/jama.279.14.1094; Anderson DR, 2003, J THROMB HAEMOST, V1, P645, DOI 10.1046/j.1538-7836.2003.00131.x; Bigaroni A, 2000, THROMB HAEMOSTASIS, V83, P788, DOI 10.1055/s-0037-1613912; Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; Buller H R, 2000, Ned Tijdschr Geneeskd, V144, P1531; Cogo A, 1998, BRIT MED J, V316, P17, DOI 10.1136/bmj.316.7124.17; Constans J, 2001, THROMB HAEMOSTASIS, V86, P985; Cornuz J, 2002, AM J MED, V112, P198, DOI 10.1016/S0002-9343(01)01110-X; Fancher TL, 2004, BMJ-BRIT MED J, V329, P821, DOI 10.1136/bmj.38226.719803.EB; Fraser JD, 1999, RADIOLOGY, V211, P9, DOI 10.1148/radiology.211.1.r99ap459; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; HEIJBOER H, 1993, NEW ENGL J MED, V329, P1365, DOI 10.1056/NEJM199311043291901; Hirsh J, 1996, CIRCULATION, V93, P2212, DOI 10.1161/01.CIR.93.12.2212; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Kahn SR, 1999, THROMB HAEMOSTASIS, V81, P353; Kearon C, 2001, ANN INTERN MED, V135, P108, DOI 10.7326/0003-4819-135-2-200107170-00011; Knottnerus JA, 2002, J CLIN EPIDEMIOL, V55, P1201, DOI 10.1016/S0895-4356(02)00528-0; KNOTTNERUS JA, 1992, J CLIN EPIDEMIOL, V45, P1143; Kraaijenhagen RA, 2002, ARCH INTERN MED, V162, P907, DOI 10.1001/archinte.162.8.907; LACHS MS, 1992, ANN INTERN MED, V117, P135, DOI 10.7326/0003-4819-117-2-135; LANDEFELD CS, 1990, AM J MED, V88, P382, DOI 10.1016/0002-9343(90)90493-W; LENSING AWA, 1989, NEW ENGL J MED, V320, P342, DOI 10.1056/NEJM198902093200602; LITTLE RJA, 1992, J AM STAT ASSOC, V87, P1227, DOI 10.2307/2290664; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; Moons KGM, 1999, EPIDEMIOLOGY, V10, P276, DOI 10.1097/00001648-199905000-00015; Moons KGM, 2004, CLIN CHEM, V50, P473, DOI 10.1373/clinchem.2003.024752; Oudega R, 2005, FAM PRACT, V22, P86, DOI 10.1093/fampra/cmh718; OUDEGA R, IN PRESS THROMB HAEM; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; Ruiz-Gimenez N, 2004, THROMB HAEMOSTASIS, V91, P1237, DOI 10.1160/TH03-02-0080; Schutgens REG, 2003, J THROMB HAEMOST, V1, P976, DOI 10.1046/j.1538-7836.2003.00148.x; Schutgens REG, 2003, CIRCULATION, V107, P593, DOI 10.1161/01.CIR.0000045670.12988.1E; van der Graaf F, 2000, THROMB HAEMOSTASIS, V83, P191; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; Wells PS, 1998, J INTERN MED, V243, P15; WELLS PS, 1995, LANCET, V345, P1326, DOI 10.1016/S0140-6736(95)92535-X; Wells PS, 1997, LANCET, V350, P1795, DOI 10.1016/S0140-6736(97)08140-3	39	96	105	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2005	143	2					100	107		10.7326/0003-4819-143-2-200507190-00008	http://dx.doi.org/10.7326/0003-4819-143-2-200507190-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YG	16027451				2022-12-28	WOS:000230608600002
J	Biederman, J; Faraone, SV				Biederman, J; Faraone, SV			Attention-deficit hyperactivity disorder	LANCET			English	Review							LOW-BIRTH-WEIGHT; SPONTANEOUSLY HYPERTENSIVE-RAT; STRIATAL DOPAMINE TRANSPORTER; PRENATAL ALCOHOL EXPOSURE; DSM-IV ADHD; DEFICIT/HYPERACTIVITY DISORDER; STIMULANT TREATMENT; MATERNAL SMOKING; DOUBLE-BLIND; SCHOOL-AGE	Attention-deficit hyperactivity disorder (ADHD) is a disorder of inattention, impulsivity, and hyperactivity that affects 8-12% of children worldwide. Although the rate of ADHD falls with age, at least half of children with the disorder will have impairing symptoms in adulthood. Twin, adoption, and molecular genetic studies show ADHD to be highly heritable, and other findings have recorded obstetric complications and psychosocial adversity as predisposing risk factors. Converging evidence from animal and human studies implicates the dysregulation of frontal-subcortical-cerebellar catecholaminergic circuits in the pathophysiology of ADHD, and molecular imaging studies suggest that abnormalities of the dopamine transporter lead to impaired neurotransmission. Studies during the past decade have shown the safety and effectiveness of new non-stimulant drugs and long-acting formulations of methylphenidate and amfetamine. Other investigations have also clarified the appropriate role of targeted psychosocial treatments in the context of ongoing pharmacotherapy.	Massachusetts Gen Hosp, Pediat Psychophamracol Unit, Child Psychiat Serv, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Biederman, J (corresponding author), Massachusetts Gen Hosp, Pediat Psychophamracol Unit ACC 725, Boston, MA 02114 USA.	biederman@helix.mgh.harvard.edu	Thapar, Anita/AAH-5555-2020; Faraone, Stephen/AAE-7334-2019	Thapar, Anita/0000-0002-3689-737X; Faraone, Stephen/0000-0002-9217-3982				Abikoff H, 2004, J AM ACAD CHILD PSY, V43, P820, DOI 10.1097/01.chi.0000128797.91601.1a; Adler LA, 2002, J CLIN PSYCHIAT, V63, P29; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Angold A, 2000, J AM ACAD CHILD PSY, V39, P975, DOI 10.1097/00004583-200008000-00009; Arcos-Burgos M, 2004, AM J HUM GENET, V75, P998, DOI 10.1086/426154; Autti-Ramo I, 2000, DEV MED CHILD NEUROL, V42, P406, DOI 10.1017/S0012162200000748; Bakker SC, 2003, AM J HUM GENET, V72, P1251, DOI 10.1086/375143; BARKLEY, 1997, ADHD NATURE SELF CON; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 2002, CLIN CHILD FAM PSYCH, V5, P89; Barkley RA, 2001, J ABNORM CHILD PSYCH, V29, P541, DOI 10.1023/A:1012233310098; Barkley RA, 2006, ATTENTION DEFICIT HY; Batstra L, 2003, EARLY HUM DEV, V75, P21, DOI 10.1016/j.earlhumdev.2003.09.001; Biederman J, 2004, BIOL PSYCHIAT, V55, P692, DOI 10.1016/j.biopsych.2003.12.003; Biederman J, 2004, PSYCHIAT CLIN N AM, V27, P225, DOI 10.1016/j.psc.2003.12.004; BIEDERMAN J, 1995, ARCH GEN PSYCHIAT, V52, P464; BIEDERMAN J, 1995, J AM ACAD CHILD PSY, V34, P1495, DOI 10.1097/00004583-199511000-00017; Biederman J, 2002, PEDIATRICS, V110, P258, DOI 10.1542/peds.110.2.258; Biederman J, 2002, AM J PSYCHIAT, V159, P1556, DOI 10.1176/appi.ajp.159.9.1556; Biederman J, 2004, J CONSULT CLIN PSYCH, V72, P757, DOI 10.1037/0022-006X.72.5.757; BIEDERMAN J, 1995, J CLIN PSYCHIAT, V56, P87; BIEDERMAN J, 2004, 17 ANN C EUR COLL PS, pS364; Biederman J., 1992, CHILD ADOLESCENT PSY, V1, P335, DOI DOI 10.1016/S1056-4993(18)30591-1; Biederman Joseph, 2003, Paediatr Drugs, V5, P833, DOI 10.2165/00148581-200305120-00006; BIRD HR, 1994, J CHILD FAM STUD, V3, P365, DOI DOI 10.1007/BF02233996; Boksa P, 2003, NEUROSCI BIOBEHAV R, V27, P91, DOI 10.1016/S0149-7634(03)00012-5; Botting N, 1997, J CHILD PSYCHOL PSYC, V38, P931, DOI 10.1111/j.1469-7610.1997.tb01612.x; BOYD TA, 1991, NEUROTOXICOL TERATOL, V13, P49, DOI 10.1016/0892-0362(91)90027-T; BROWN RT, 1991, NEUROTOXICOL TERATOL, V13, P369, DOI 10.1016/0892-0362(91)90085-B; Brownell MD, 2001, CAN J PSYCHIAT, V46, P264, DOI 10.1177/070674370104600307; Bussing R, 1998, AM J PUBLIC HEALTH, V88, P880, DOI 10.2105/AJPH.88.6.880; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Cheon KA, 2003, EUR J NUCL MED MOL I, V30, P306, DOI 10.1007/s00259-002-1047-3; CONNERS CK, 1980, FOOD ADDITIVES HYPER; Connor DF, 1999, J AM ACAD CHILD PSY, V38, P1551, DOI 10.1097/00004583-199912000-00017; Cox DJ, 2004, J AM BOARD FAM PRACT, V17, P235, DOI 10.3122/jabfm.17.4.235; Crosbie J, 2001, AM J PSYCHIAT, V158, P1884, DOI 10.1176/appi.ajp.158.11.1884; Daviss WB, 2001, J AM ACAD CHILD PSY, V40, P307, DOI 10.1097/00004583-200103000-00010; Dilsaver SC, 2003, J CLIN PSYCHIAT, V64, P1170, DOI 10.4088/JCP.v64n1005; DiScala C, 1998, PEDIATRICS, V102, P1415, DOI 10.1542/peds.102.6.1415; Dopfner M, 2004, EUR CHILD ADOLES PSY, V13, P130, DOI 10.1007/s00787-004-1012-8; Dougherty DD, 1999, LANCET, V354, P2132, DOI 10.1016/S0140-6736(99)04030-1; Dowson JH, 2004, ACTA PSYCHIAT SCAND, V110, P45, DOI 10.1111/j.1600-0447.2004.00292.x; DOYLE AE, IN PRESS J CHILD PSY; Doyle R, 2004, PSYCHIAT CLIN N AM, V27, P203, DOI 10.1016/j.psc.2004.01.001; Dresel S, 2000, EUR J NUCL MED, V27, P1518, DOI 10.1007/s002590000330; Durston S, 2003, BIOL PSYCHIAT, V53, P871, DOI 10.1016/S0006-3223(02)01904-2; Essau CA, 1999, FORTSCHR NEUROL PSYC, V67, P296, DOI 10.1055/s-2007-994980; FARAONE S, IN PRESS PSYCHOL MED; Faraone S. V., 2003, MEDSCAPE PSYCHIAT ME, V8; Faraone Stephen V, 2003, World Psychiatry, V2, P104; Faraone SV, 2005, J CHILD ADOL PSYCHOP, V15, P191, DOI 10.1089/cap.2005.15.191; Faraone SV, 2005, EUR CHILD ADOLES PSY, V14, P20, DOI 10.1007/s00787-005-0415-5; Faraone SV, 2004, PSYCHIAT CLIN N AM, V27, P303, DOI 10.1016/S0193-953X(03)00090-X; Faraone SV, 2003, J CLIN PSYCHIAT, V64, P9; Faraone SV, 2001, CHILD ADOL PSYCH CL, V10, P299; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Faraone SV, 2000, J AM ACAD CHILD PSY, V39, P300, DOI 10.1097/00004583-200003000-00011; Faraone SV, 1998, BIOL PSYCHIAT, V44, P951, DOI 10.1016/S0006-3223(98)00240-6; Faraone SV, 2000, AM J PSYCHIAT, V157, P1077, DOI 10.1176/appi.ajp.157.7.1077; FARAONE SV, 2004, NEUROBIOLOGY MENTAL; Fischer M, 2002, J ABNORM CHILD PSYCH, V30, P463, DOI 10.1023/A:1019864813776; Fogelman Y, 2003, CNS DRUGS, V17, P915, DOI 10.2165/00023210-200317120-00005; FUNG YK, 1989, PHARMACOL BIOCHEM BE, V33, P1, DOI 10.1016/0091-3057(89)90419-X; GADOW KD, 1995, ARCH GEN PSYCHIAT, V52, P444; GELFAND DM, 1990, CLIN PSYCHOL REV, V10, P329, DOI 10.1016/0272-7358(90)90065-I; Geurts HM, 2004, J CHILD PSYCHOL PSYC, V45, P836, DOI 10.1111/j.1469-7610.2004.00276.x; Graetz BW, 2001, J AM ACAD CHILD PSY, V40, P1410, DOI 10.1097/00004583-200112000-00011; Greene RW, 2001, J AM ACAD CHILD PSY, V40, P704, DOI 10.1097/00004583-200106000-00016; Greenhill LL, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.3.e39; Guevara J, 2001, PEDIATRICS, V108, P71, DOI 10.1542/peds.108.1.71; Hack M, 2004, PEDIATRICS, V114, P932, DOI 10.1542/peds.2003-1017-L; Hawi Z, 2003, MOL PSYCHIATR, V8, P299, DOI 10.1038/sj.mp.4001290; He Yun, 2000, Zhonghua Yufang Yixue Zazhi, V34, P290; Hurt RD, 1997, NEW ENGL J MED, V337, P1195, DOI 10.1056/NEJM199710233371703; Indredavik MS, 2004, ARCH DIS CHILD-FETAL, V89, pF445, DOI 10.1136/adc.2003.038943; Jensen PS, 2004, PEDIATRICS, V113, P762; Jensen PS, 2004, PEDIATRICS, V113, P754; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Jensen PS, 2001, J AM ACAD CHILD PSY, V40, P147, DOI 10.1097/00004583-200102000-00009; Johansen EB, 2002, BEHAV BRAIN RES, V130, P37, DOI 10.1016/S0166-4328(01)00434-X; JOHNSTON A, 1991, J CLIN PSYCHIAT, V52, P450; Kadesjo B, 2001, J CHILD PSYCHOL PSYC, V42, P487, DOI 10.1017/S0021963001007090; Katz L.J., 1998, J ATTEN DISORD, V2, P239; KLEIN RG, 1988, ARCH GEN PSYCHIAT, V45, P1127; Krause KH, 2000, NEUROSCI LETT, V285, P107, DOI 10.1016/S0304-3940(00)01040-5; Krause KH, 2002, INT J NEUROPSYCHOPH, V5, P111, DOI 10.1017/S1461145702002821; Kurlan R, 2002, NEUROLOGY, V58, P527; Lahey BB, 2002, J ABNORM PSYCHOL, V111, P556, DOI 10.1037//0021-843X.111.4.556; Lisska MC, 2003, J PEDIATR ENDOCR MET, V16, P711; Lou HC, 1996, ACTA PAEDIATR, V85, P1266, DOI 10.1111/j.1651-2227.1996.tb13909.x; Lowe N, 2004, AM J HUM GENET, V74, P348, DOI 10.1086/381561; LOWE TL, 1982, JAMA-J AM MED ASSOC, V247, P1168, DOI 10.1001/jama.247.8.1168; MARKUSSENLINNET K, 2003, AM J PSYCHIAT, V160, P1028; Michelson D, 2002, AM J PSYCHIAT, V159, P1896, DOI 10.1176/appi.ajp.159.11.1896; Michelson D, 2003, BIOL PSYCHIAT, V53, P112, DOI 10.1016/S0006-3223(02)01671-2; Mick E, 2002, J AM ACAD CHILD PSY, V41, P378, DOI 10.1097/00004583-200204000-00009; Mick E, 2002, J DEV BEHAV PEDIATR, V23, P16, DOI 10.1097/00004703-200202000-00004; Miller AR, 2001, CAN MED ASSOC J, V165, P1489; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Modestin J, 2001, EUR ARCH PSY CLIN N, V251, P42, DOI 10.1007/s004060170067; Murphy KR, 2002, J NERV MENT DIS, V190, P147, DOI 10.1097/00005053-200203000-00003; Nichols PL, 1981, MINIMAL BRAIN DYSFUN; Nigg JT, 2004, J ABNORM PSYCHOL, V113, P614, DOI 10.1037/0021-843X.113.4.614; Nigg JT, 2004, J CLIN CHILD ADOLESC, V33, P42, DOI 10.1207/S15374424JCCP3301_5; OFFORD DR, 1992, J AM ACAD CHILD PSY, V31, P916, DOI 10.1097/00004583-199209000-00021; Ogdie MN, 2003, AM J HUM GENET, V72, P1268, DOI 10.1086/375139; Olfson M, 2003, AM J PSYCHIAT, V160, P1071, DOI 10.1176/appi.ajp.160.6.1071; PALFREY JS, 1985, J DEV BEHAV PEDIATR, V6, P339; Pomerleau CS, 1996, J SUBST ABUSE, V8, P371, DOI 10.1016/S0899-3289(96)90215-1; Poulton A, 2003, J PAEDIATR CHILD H, V39, P180, DOI 10.1046/j.1440-1754.2003.00107.x; Raber J, 1997, J NEUROCHEM, V68, P176; Rapport MD, 2002, CLIN PSYCHOL REV, V22, P1107, DOI 10.1016/S0272-7358(02)00129-0; Rasmussen ER, 2004, J CHILD PSYCHOL PSYC, V45, P589, DOI 10.1111/j.1469-7610.2004.00248.x; Rasmussen P, 2000, J AM ACAD CHILD PSY, V39, P1424, DOI 10.1097/00004583-200011000-00017; Reid R, 2002, J AM ACAD CHILD PSY, V41, P906, DOI 10.1097/00004583-200208000-00008; RICHARDSON GA, 1994, J AM ACAD CHILD PSY, V33, P28, DOI 10.1097/00004583-199401000-00005; RICHTERS JE, 1992, PSYCHOL BULL, V112, P485, DOI 10.1037/0033-2909.112.3.485; Riggs PD, 1998, J AM ACAD CHILD PSY, V37, P1271, DOI 10.1097/00004583-199812000-00010; Robbins TW, 1998, J INT NEUROPSYCH SOC, V4, P474, DOI 10.1017/s1355617798455073; Rugino TA, 2001, J AM ACAD CHILD PSY, V40, P230, DOI 10.1097/00004583-200102000-00018; Russell VA, 2000, NEUROSCI BIOBEHAV R, V24, P133, DOI 10.1016/S0149-7634(99)00056-1; RUTTER M, 1975, BRIT J PSYCHIAT, V126, P493, DOI 10.1192/bjp.126.6.493; Safren SA, 2005, BEHAV RES THER, V43, P831, DOI 10.1016/j.brat.2004.07.001; Sagvolden T, 2000, NEUROSCI BIOBEHAV R, V24, P31, DOI 10.1016/S0149-7634(99)00058-5; Saigal S, 2003, PEDIATRICS, V111, P969, DOI 10.1542/peds.111.5.969; SATTERFIELD JH, 1979, ARCH GEN PSYCHIAT, V36, P212; Scahill L, 2000, CHILD ADOL PSYCH CL, V9, P541; Scahill L, 2001, AM J PSYCHIAT, V158, P1067, DOI 10.1176/appi.ajp.158.7.1067; Schmidt-Troschke SO, 2004, GESUNDHEITSWESEN, V66, P387, DOI 10.1055/s-2004-813322; SCHNEIDER JS, 1994, PHARMACOL BIOCHEM BE, V48, P235, DOI 10.1016/0091-3057(94)90522-3; SEIDMAN L, 2004, ADULT ADHD PSYCHIAT, P261; Seidman LJ, 2004, PSYCHIAT CLIN N AM, V27, P323, DOI 10.1016/j.psc.2004.01.002; Sergeant J, 2004, EUR CHILD ADOLES PSY, V13, P43, DOI 10.1007/s00787-004-1005-7; Sergeant J, 2000, NEUROSCI BIOBEHAV R, V24, P7, DOI 10.1016/S0149-7634(99)00060-3; Sergeant JA, 2003, NEUROSCI BIOBEHAV R, V27, P583, DOI 10.1016/j.neubiorev.2003.08.004; SHAYWITZ SE, 1978, J PEDIATR-US, V92, P179, DOI 10.1016/S0022-3476(78)80001-8; Sonuga-Barke EJS, 2002, DEV NEUROPSYCHOL, V21, P255, DOI 10.1207/S15326942DN2103_3; Sonuga-Barke EJS, 2005, BIOL PSYCHIAT, V57, P1231, DOI 10.1016/j.biopsych.2004.09.008; Sonuga-Barke EJS, 2003, NEUROSCI BIOBEHAV R, V27, P593, DOI 10.1016/j.neubiorev.2003.08.005; Sowell ER, 2003, LANCET, V362, P1699, DOI 10.1016/S0140-6736(03)14842-8; Spencer T, 2000, CHILD ADOL PSYCH CL, V9, P77; Spencer T, 1999, ARCH GEN PSYCHIAT, V56, P842, DOI 10.1001/archpsyc.56.9.842; Spencer T, 1998, PEDIATRICS, V102, P501; Spencer T, 2004, PSYCHIAT CLIN N AM, V27, P361, DOI 10.1016/j.psc.2003.12.002; Sprich S, 2000, J AM ACAD CHILD PSY, V39, P1432, DOI 10.1097/00004583-200011000-00018; State RC, 2004, J CLIN PSYCHIAT, V65, P1057; Stein B, 2001, J BEHAV HEALTH SER R, V28, P30, DOI 10.1007/BF02287232; Steinhausen HC, 2003, J AM ACAD CHILD PSY, V42, P1085, DOI 10.1097/01.CHI.0000070241.24125.A3; Stevens J, 2004, J DEV BEHAV PEDIATR, V25, P318, DOI 10.1097/00004703-200410000-00003; Swanson JM, 1998, LANCET, V351, P429, DOI 10.1016/S0140-6736(97)11450-7; SZATMARI P, 1989, J CHILD PSYCHOL PSYC, V30, P219, DOI 10.1111/j.1469-7610.1989.tb00236.x; TAYLOR E, 1994, CHILD ADOLESCENT PSY, V3, P209; Taylor FB, 2000, J CHILD ADOL PSYCHOP, V10, P311, DOI 10.1089/cap.2000.10.311; Thapar A, 2003, AM J PSYCHIAT, V160, P1985, DOI 10.1176/appi.ajp.160.11.1985; Todd RD, 2004, MOL PSYCHIATR, V9, P260, DOI 10.1038/sj.mp.4001406; Tripp G, 2002, AUST NZ J PSYCHIAT, V36, P771, DOI 10.1046/j.1440-1614.2002.01093.x; Turner DC, 2004, BIOL PSYCHIAT, V55, P1031, DOI 10.1016/j.biopsych.2004.02.008; van Dyck CH, 2002, AM J PSYCHIAT, V159, P309, DOI 10.1176/appi.ajp.159.2.309; VANDEKAMP JL, 1994, PHARMACOL BIOCHEM BE, V47, P889, DOI 10.1016/0091-3057(94)90293-3; Vles JSH, 2003, NEUROPEDIATRICS, V34, P77; Volkow ND, 1998, AM J PSYCHIAT, V155, P1325, DOI 10.1176/ajp.155.10.1325; Volkow ND, 2003, AM J PSYCHIAT, V160, P1909, DOI 10.1176/appi.ajp.160.11.1909; Wells KC, 2000, J ABNORM CHILD PSYCH, V28, P543, DOI 10.1023/A:1005131131159; Westgard JO, 2004, CLIN CHIM ACTA, V346, P3, DOI 10.1016/j.cccn.2003.12.034; Wigal S, 2004, J AM ACAD CHILD PSY, V43, P1406, DOI 10.1097/01.chi.0000138351.98604.92; Wilens TE, 2003, PEDIATRICS, V111, P179, DOI 10.1542/peds.111.1.179; Wilens TE, 2003, BIOL PSYCHIAT, V54, P9, DOI 10.1016/S0006-3223(02)01664-5; Wilens TE, 2001, AM J PSYCHIAT, V158, P282, DOI 10.1176/appi.ajp.158.2.282; Wilens TE, 1999, J AM ACAD CHILD PSY, V38, P614, DOI 10.1097/00004583-199905000-00025; Wilens TE, 2005, BIOL PSYCHIAT, V57, P793, DOI 10.1016/j.biopsych.2005.01.027; Willcutt EG, 1999, J AM ACAD CHILD PSY, V38, P1355, DOI 10.1097/00004583-199911000-00009; WILLCUTT EG, 2005, ATTENTIONDEFICIT HYP; Wilson MC, 2000, NEUROSCI BIOBEHAV R, V24, P51, DOI 10.1016/S0149-7634(99)00064-0; WOLRAICH ML, 1995, JAMA-J AM MED ASSOC, V274, P1617, DOI 10.1001/jama.274.20.1617; Wolraich ML, 2001, PEDIATRICS, V108, P883, DOI 10.1542/peds.108.4.883; Wolraich ML, 1998, J DEV BEHAV PEDIATR, V19, P162, DOI 10.1097/00004703-199806000-00003; Zito JM, 2000, JAMA-J AM MED ASSOC, V283, P1025, DOI 10.1001/jama.283.8.1025	179	1258	1299	13	568	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2005	366	9481					237	248		10.1016/S0140-6736(05)66915-2	http://dx.doi.org/10.1016/S0140-6736(05)66915-2			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	945RG	16023516				2022-12-28	WOS:000230519200034
J	Holden, CA; McLachlan, RI; Pitts, M; Cumming, R; Wittert, G; Agius, PA; Handelsman, DJ; de Kretser, DM				Holden, CA; McLachlan, RI; Pitts, M; Cumming, R; Wittert, G; Agius, PA; Handelsman, DJ; de Kretser, DM			Men in Australia Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older Australian men	LANCET			English	Article							URINARY-TRACT SYMPTOMS; BENIGN PROSTATIC HYPERPLASIA; ERECTILE DYSFUNCTION; WAIST CIRCUMFERENCE; POPULATION; PREVALENCE; COMMUNITY; ASSOCIATION; INDEX; RISK	Background The Men in Australia Telephone Survey (MATeS) describes the prevalence of self-reported reproductive health disorders as well as related concerns and health behaviours among middle-aged and older Australian men. Methods A representative sample population (n=5990) of Australian men (>= 40 years) was obtained by contacting a random selection of households with unbiased sampling, stratified by age and state. A 20-min computer-assisted telephone interview was done to assess reproductive health and related knowledge and beliefs, sociodemographic factors, general health, and lifestyle factors. Findings A response rate of 78% (5990/7636) was achieved. 34% (1627/4737) of men surveyed reported one or more reproductive health disorder, all of which were most common in the oldest age group. Age-standardised prevalence of significant lower urinary tract symptoms was 16%, erectile dysfunction was 21%, and prostate disease was 14%. About 50% of participants reported having had a prostate cancer test whereas only 30% (300/1012) of men with erectile dysfunction sought medical help. Willingness to seek medical help for erectile dysfunction was related to age and ethnic origin. Although men aged 40-69 years expressed a moderate or high level of concern about prostate cancer and loss of erectile function, concern about reproductive health was less in the oldest age group (>= 70 years). Interpretation The high prevalence of reproductive health disorders and associated concerns in middle-aged and older Australian men draws attention to the need to develop appropriate services and education strategies specifically directed to improving reproductive health in these men.	Monash Univ, Androl Australia, Monash Inst Med Res, Monash Med Ctr, Clayton, Vic 3168, Australia; Prince Henrys Inst Med Res, Melbourne, Vic, Australia; La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia; Univ Sydney, Concord Hosp, Ctr Educ & Res Ageing, Sydney, NSW 2006, Australia; Univ Adelaide, Adelaide, SA, Australia; Univ Sydney, Concord Hosp, Dept Androl, ANZAC Res Inst, Sydney, NSW 2006, Australia	Monash University; Prince Henry's Institute of Medical Research; La Trobe University; Concord Repatriation General Hospital; University of Sydney; University of Adelaide; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute	Holden, CA (corresponding author), Monash Univ, Androl Australia, Monash Inst Med Res, Monash Med Ctr, Clayton, Vic 3168, Australia.	carol.holden@med.monash.edu.au	Carol, Holden/A-4971-2009; wittert, gary/AAE-2398-2019; Research Institute, ANZAC/CAE-9030-2022; Handelsman, David/AAR-9580-2021	Handelsman, David/0000-0002-4200-7476; Agius, Paul/0000-0002-6075-8548; Holden, Carol/0000-0002-4011-6628				ARRIGHI HM, 1991, UROLOGY, V38, P4, DOI 10.1016/0090-4295(91)80191-9; Australian Health Technology Advisory Committee, 1996, PROST CANC SCREEN; Baldwin K, 2003, INT J IMPOT RES, V15, P87, DOI 10.1038/sj.ijir.3900948; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; Boyle P, 2003, BJU INT, V92, P719, DOI 10.1046/j.1464-410X.2003.04459.x; Dalton M, 2003, J INTERN MED, V254, P555, DOI 10.1111/j.1365-2796.2003.01229.x; *DEP EC SOC AFF UN, 2003, WORLD POP PROSP 2002; Derby CA, 2000, INT J IMPOT RES, V12, P197, DOI 10.1038/sj.ijir.3900542; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; GARRAWAY WM, 1991, LANCET, V338, P469, DOI 10.1016/0140-6736(91)90543-X; Green JSA, 2001, BJU INT, V88, P551, DOI 10.1046/j.1464-4096.2001.01274.x; Handelsman DJ, 2004, MED J AUSTRALIA, V180, P529, DOI 10.5694/j.1326-5377.2004.tb06060.x; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; McCredie M, 2001, J Epidemiol Biostat, V6, P211, DOI 10.1080/135952201753172980; Mozes B, 1997, PROSTATE, V33, P246; *NAT OFF INF EC, 2002, CURR STAT PLAY AUSTR; Pinnock C, 1998, AUST NZ J PUBL HEAL, V22, P368, DOI 10.1111/j.1467-842X.1998.tb01393.x; Pinnock CB, 1999, MED J AUSTRALIA, V171, P353, DOI 10.5694/j.1326-5377.1999.tb123691.x; Pinnock CB, 1997, MED J AUSTRALIA, V167, P72, DOI 10.5694/j.1326-5377.1997.tb138783.x; Rosen RC, 2004, CURR MED RES OPIN, V20, P607, DOI 10.1185/030079904125003467; Sanders KM, 1999, OSTEOPOROSIS INT, V10, P240, DOI 10.1007/s001980050222; Sladden MJ, 2000, AUST NZ J SURG, V70, P322, DOI 10.1046/j.1440-1622.2000.01738.x; Smith AMA, 2003, AUST NZ J PUBL HEAL, V27, P103, DOI 10.1111/j.1467-842X.2003.tb00796.x; Welch G, 2002, UROLOGY, V59, P245, DOI 10.1016/S0090-4295(01)01506-0; Weller D, 1998, AUST NZ J PUBL HEAL, V22, P400, DOI 10.1111/j.1467-842X.1998.tb01400.x; Zakaria Lara, 2001, International Urology and Nephrology, V33, P283, DOI 10.1023/A:1015292603884	26	181	188	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 16	2005	366	9481					218	224		10.1016/S0140-6736(05)66911-5	http://dx.doi.org/10.1016/S0140-6736(05)66911-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945RG	16023512				2022-12-28	WOS:000230519200030
J	Besemer, J; Harant, H; Wang, S; Oberhauser, B; Marquardt, K; Foster, CA; Schreiner, EP; de Vries, JE; Dascher-Nadel, C; Lindley, IJD				Besemer, J; Harant, H; Wang, S; Oberhauser, B; Marquardt, K; Foster, CA; Schreiner, EP; de Vries, JE; Dascher-Nadel, C; Lindley, IJD			Selective inhibition of cotranslational translocation of vascular cell adhesion molecule 1	NATURE			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; SIGNAL SEQUENCE RECOGNITION; ER MEMBRANE; PROTEIN TRANSLOCATION; EXPRESSION; COMPLEX	Increased expression of vascular cell adhesion molecule 1 (VCAM1) is associated with a variety of chronic inflammatory conditions, making its expression and function a target for therapeutic intervention(1-3). We have recently identified CAM741, a derivative of a fungus-derived cyclopeptolide that acts as a selective inhibitor of VCAM1 synthesis in endothelial cells. Here we show that the compound represses the biosynthesis of VCAM1 in cells by blocking the process of cotranslational translocation, which is dependent on the signal peptide of VCAM1. CAM741 does not inhibit targeting of the VCAM1 nascent chains to the translocon channel but prevents translocation to the luminal side of the endoplasmic reticulum ( ER), through a process that involves the translocon component Sec61 beta. Consequently, the VCAM1 precursor protein is synthesized towards the cytosolic compartment of the cells, where it is degraded. Our results indicate that the inhibition of cotranslational translocation with low-molecular-mass compounds, using specificity conferred by signal peptides, can modulate the biosynthesis of certain secreted and/or membrane proteins. In addition, they highlight cotranslational translocation at the ER membrane as a potential target for drug discovery.	Novartis Inst Biomed Res, A-1235 Vienna, Austria	Novartis	de Vries, JE (corresponding author), Novartis Inst Biomed Res, Brunner Str 59, A-1235 Vienna, Austria.	jan.devries@novartis.com	Hanna, Harant/AAA-7120-2022	Hanna, Harant/0000-0003-3842-0249				BEVILACQUA MP, 1994, ANNU REV MED, V45, P361, DOI 10.1146/annurev.med.45.1.361; Boger DL, 1999, J AM CHEM SOC, V121, P6197, DOI 10.1021/ja990918u; DeMartino GN, 1999, J BIOL CHEM, V274, P22123, DOI 10.1074/jbc.274.32.22123; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Hommel U, 1996, FEBS LETT, V379, P69, DOI 10.1016/0014-5793(95)01453-5; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Kalies KU, 1998, J CELL BIOL, V141, P887, DOI 10.1083/jcb.141.4.887; Kim SJ, 2002, DEV CELL, V2, P207, DOI 10.1016/S1534-5807(01)00120-4; Matlack KES, 1998, CELL, V92, P381, DOI 10.1016/S0092-8674(00)80930-7; MOTHES W, 1994, EMBO J, V13, P3973, DOI 10.1002/j.1460-2075.1994.tb06713.x; Rutkowski DT, 2001, P NATL ACAD SCI USA, V98, P7823, DOI 10.1073/pnas.141125098; Schreiner EP, 2003, EXPERT OPIN THER PAT, V13, P149, DOI 10.1517/13543776.13.2.149; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511	15	98	103	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					290	293		10.1038/nature03670	http://dx.doi.org/10.1038/nature03670			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015337				2022-12-28	WOS:000230459500048
J	Goodman, NW				Goodman, NW			Horizon: Does the MMR jab cause autism? We cannot win	BRITISH MEDICAL JOURNAL			English	Letter							POWER		Southmead Gen Hosp, Bristol BS10 5NB, Avon, England	Southmead Hospital	Goodman, NW (corresponding author), Southmead Gen Hosp, Bristol BS10 5NB, Avon, England.	Nev.W.Goodman@bris.ac.uk						Draper G, 2005, BRIT MED J, V330, P1290, DOI 10.1136/bmj.330.7503.1290; MACAULEY D, 2005, BRIT MED J, V330, P1335; Watts G, 2005, BMJ-BRIT MED J, V330, P1293, DOI 10.1136/bmj.330.7503.1293	3	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 9	2005	331	7508					111	111		10.1136/bmj.331.7508.111-a	http://dx.doi.org/10.1136/bmj.331.7508.111-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945XR	16002901	Green Published			2022-12-28	WOS:000230536800036
J	Langford, N; Graham-Clarke, E				Langford, N; Graham-Clarke, E			Confusing tablets	LANCET			English	Editorial Material									City Hosp, Sandwell & W Birmingham Hosp NHS Trust, Birmingham B18 7QH, W Midlands, England	University of Birmingham	Langford, N (corresponding author), City Hosp, Sandwell & W Birmingham Hosp NHS Trust, Birmingham B18 7QH, W Midlands, England.	nigel.langford@swbh.nhs.uk	Graham-Clarke, Emma/GZG-8429-2022; Graham-Clarke, Emma/U-1559-2019; Langford, Nigel/P-3308-2019	Graham-Clarke, Emma/0000-0001-5657-778X; 				Ferner RE, 2001, JAMA-J AM MED ASSOC, V286, P2091; Pathak A, 2004, LANCET, V363, P2142, DOI 10.1016/S0140-6736(04)16507-0	2	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 9	2005	366	9480					154	154		10.1016/S0140-6736(05)66873-0	http://dx.doi.org/10.1016/S0140-6736(05)66873-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	943JH	16005339				2022-12-28	WOS:000230349200035
J	Shpak, ED; McAbee, JM; Pillitteri, LJ; Torii, KU				Shpak, ED; McAbee, JM; Pillitteri, LJ; Torii, KU			Stomatal patterning and differentiation by synergistic interactions of receptor kinases	SCIENCE			English	Article							FLOWER DEVELOPMENT; ARABIDOPSIS; MOUTHS; ORGAN; TOO	Coordinated spacing and patterning of stomata allow efficient gas exchange between plants and the atmosphere. Here we report that three ERECTA (ER)family leucine-rich repeat-receptor-like kinases (LRR-RLKs) together control stomatal patterning, with specific family members regulating the specification of stomatal stem cell fate and the differentiation of guard cells. Loss-of-function mutations in all three ER-family genes cause stomatal clustering. Genetic interactions with a known stomata[ patterning mutant too many mouths (tmm) revealed stoichiometric epistasis and combination-specific neomorphism. Our findings suggest that the negative regulation of ER-family RLKs by TMM, which is an LRR receptor-like protein, is critical for proper stomatal differentiation.	Univ Washington, Dept Biol, Seattle, WA 98195 USA; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Saitama 3320012, Japan	University of Washington; University of Washington Seattle; Japan Science & Technology Agency (JST)	Torii, KU (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	ktorii@u.washington.edu	TORII, KEIKO U./A-6041-2013	TORII, KEIKO U./0000-0002-6168-427X				Berger D, 2000, GENE DEV, V14, P1119; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Carles CC, 2003, TRENDS PLANT SCI, V8, P394, DOI 10.1016/S1360-1385(03)00164-X; Geisler M, 1998, PLANTA, V205, P522, DOI 10.1007/s004250050351; Geisler M, 2000, PLANT CELL, V12, P2075, DOI 10.1105/tpc.12.11.2075; Geisler MJ, 2003, PLANTA, V216, P571; Glover BJ, 2000, J EXP BOT, V51, P497, DOI 10.1093/jexbot/51.344.497; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Nadeau JA, 2002, THE ARABIDOPSIS BOOK; REDEI GP, 1962, Z VEREBUNGSL, V93, P164; Sack FD, 2004, SCIENCE, V304, P1461, DOI 10.1126/science.1099445; Serna L, 2000, TRENDS PLANT SCI, V5, P458, DOI 10.1016/S1360-1385(00)01782-9; Serna L, 2004, NATURE, V430, P302, DOI 10.1038/430302a; Shpak ED, 2004, DEVELOPMENT, V131, P1491, DOI 10.1242/dev.01028; Shpak ED, 2003, PLANT CELL, V15, P1095, DOI 10.1105/tpc.010413; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Yang M, 1995, PLANT CELL, V7, P2227, DOI 10.1105/tpc.7.12.2227	21	413	455	1	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2005	309	5732					290	293		10.1126/science.1109710	http://dx.doi.org/10.1126/science.1109710			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002616				2022-12-28	WOS:000230449800042
J	Erwin, SC; Zu, LJ; Haftel, MI; Efros, AL; Kennedy, TA; Norris, DJ				Erwin, SC; Zu, LJ; Haftel, MI; Efros, AL; Kennedy, TA; Norris, DJ			Doping semiconductor nanocrystals	NATURE			English	Article							CDSE NANOCRYSTALS; QUANTUM DOTS; II-VI; MANGANESE; CLUSTERS; SIZE; MN	Doping-the intentional introduction of impurities into a material-is fundamental to controlling the properties of bulk semiconductors. This has stimulated similar efforts to dope semiconductor nanocrystals(1-4). Despite some successes(5-11), many of these efforts have failed, for reasons that remain unclear. For example, Mn can be incorporated into nanocrystals of CdS and ZnSe (refs 7-9), but not into CdSe (ref. 12)-despite comparable bulk solubilities of near 50 per cent. These difficulties, which have hindered development of new nanocrystalline materials(13-15), are often attributed to 'self-purification', an allegedly intrinsic mechanism whereby impurities are expelled. Here we show instead that the underlying mechanism that controls doping is the initial adsorption of impurities on the nanocrystal surface during growth. We find that adsorption-and therefore doping efficiency-is determined by three main factors: surface morphology, nanocrystal shape, and surfactants in the growth solution. Calculated Mn adsorption energies and equilibrium shapes for several nanocrystals lead to specific doping predictions. These are confirmed by measuring how the Mn concentration in ZnSe varies with nanocrystal size and shape. Finally, we use our predictions to incorporate Mn into previously undopable CdSe nanocrystals. This success establishes that earlier difficulties with doping are not intrinsic, and suggests that a variety of doped nanocrystals-for applications from solar cells(16) to spintronics(17)-can be anticipated.	USN, Res Lab, Washington, DC 20375 USA; Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA	United States Department of Defense; United States Navy; Naval Research Laboratory; University of Minnesota System; University of Minnesota Twin Cities	Erwin, SC (corresponding author), USN, Res Lab, Washington, DC 20375 USA.	Steven.Erwin@nrl.navy.mil; dnorris@umn.edu	Norris, David J/F-4022-2010; Erwin, Steven C/B-1850-2009	Norris, David J/0000-0002-3765-0678; 				Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Balet LP, 2004, NANO LETT, V4, P1485, DOI 10.1021/nl049146c; BHARGAVA RN, 1994, PHYS REV LETT, V72, P416, DOI 10.1103/PhysRevLett.72.416; BRUS LE, 1983, J CHEM PHYS, V79, P5566, DOI 10.1063/1.445676; Efros AL, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.206601; EFROS AL, 1982, SOV PHYS SEMICOND+, V16, P772; EKIMOV AI, 1981, JETP LETT+, V34, P345; Hanif KM, 2002, J AM CHEM SOC, V124, P11495, DOI 10.1021/ja0262840; Hoffman DM, 2000, SOLID STATE COMMUN, V114, P547, DOI 10.1016/S0038-1098(00)00089-2; Huynh WU, 2002, SCIENCE, V295, P2425, DOI 10.1126/science.1069156; HWANG IS, 1994, PHYS REV B, V50, P8849, DOI 10.1103/PhysRevB.50.8849; JAMIL NY, 1995, SEMICOND SCI TECH, V10, P952, DOI 10.1088/0268-1242/10/7/009; Ji TH, 2003, J AM CHEM SOC, V125, P8448, DOI 10.1021/ja0351746; Kasuya A, 2004, NAT MATER, V3, P99, DOI 10.1038/nmat1056; KAXIRAS E, 1990, PHYS REV LETT, V64, P551, DOI 10.1103/PhysRevLett.64.551; KOH AK, 1986, SOLID STATE COMMUN, V60, P217, DOI 10.1016/0038-1098(86)90449-7; KRESSE G, 1996, PHYS REV B, V54, P11116; Levy L, 1996, J PHYS CHEM-US, V100, P18322, DOI 10.1021/jp960824w; Mikulec FV, 2000, J AM CHEM SOC, V122, P2532, DOI 10.1021/ja991249n; Norris DJ, 2001, NANO LETT, V1, P3, DOI 10.1021/nl005503h; Peng XG, 2000, NATURE, V404, P59, DOI 10.1038/35003535; Peng XG, 1998, J AM CHEM SOC, V120, P5343, DOI 10.1021/ja9805425; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; SHIANG JJ, 1995, J PHYS CHEM-US, V99, P17417, DOI 10.1021/j100048a017; Shim M, 2000, NATURE, V407, P981, DOI 10.1038/35039577; Stowell CA, 2003, NANO LETT, V3, P1441, DOI 10.1021/nl034419+; Suyver JF, 2000, PHYS CHEM CHEM PHYS, V2, P5445, DOI 10.1039/b006950g; WANG Y, 1991, SOLID STATE COMMUN, V77, P33, DOI 10.1016/0038-1098(91)90421-Q; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; WORTIS M, 1988, CHEM PHYS SOLID SURF, V7, pCH13	30	1362	1389	20	804	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					91	94		10.1038/nature03832	http://dx.doi.org/10.1038/nature03832			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001066				2022-12-28	WOS:000230296600044
J	Goetz, W; Bertelsen, P; Binau, CS; Gunnlaugsson, HP; Hviid, SF; Kinch, KM; Madsen, DE; Madsen, MB; Olsen, M; Gellert, R; Klingelhofer, G; Ming, DW; Morris, RV; Rieder, R; Rodionov, DS; de Souza, PA; Schroder, C; Squyres, SW; Wdowiak, T; Yen, A				Goetz, W; Bertelsen, P; Binau, CS; Gunnlaugsson, HP; Hviid, SF; Kinch, KM; Madsen, DE; Madsen, MB; Olsen, M; Gellert, R; Klingelhofer, G; Ming, DW; Morris, RV; Rieder, R; Rodionov, DS; de Souza, PA; Schroder, C; Squyres, SW; Wdowiak, T; Yen, A			Indication of drier periods on Mars from the chemistry and mineralogy of atmospheric dust	NATURE			English	Article							MAGNETIC-PROPERTIES EXPERIMENTS; X-RAY SPECTROMETER; GUSEV CRATER; MOSSBAUER SPECTROMETER; MERIDIANI-PLANUM; SPIRIT; PATHFINDER; ROVERS; SPECTROSCOPY; OPPORTUNITY	The ubiquitous atmospheric dust on Mars is well mixed by periodic global dust storms, and such dust carries information about the environment in which it once formed and hence about the history of water on Mars(1). The Mars Exploration Rovers have permanent magnets to collect atmospheric dust for investigation by instruments on the rovers(2,3). Here we report results from Mossbauer spectroscopy and X-ray fluorescence of dust particles captured from the martian atmosphere by the magnets. The dust on the magnets contains magnetite and olivine; this indicates a basaltic origin of the dust and shows that magnetite, not maghemite, is the mineral mainly responsible for the magnetic properties of the dust. Furthermore, the dust on the magnets contains some ferric oxides, probably including nanocrystalline phases, so some alteration or oxidation of the basaltic dust seems to have occurred. The presence of olivine indicates that liquid water did not play a dominant role in the processes that formed the atmospheric dust.	Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; Aarhus Univ, Inst Phys & Astron, DK-8000 Aarhus, Denmark; Max Planck Inst Chem, D-55128 Mainz, Germany; Univ Mainz, Inst Anorgan & Analyt Chem, D-55128 Mainz, Germany; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Space Res Inst IKI, Moscow, Russia; Co Vale Rio Doce, BR-29090900 Vitoria, ES, Brazil; Cornell Univ, Ithaca, NY 14853 USA; Univ Alabama, Birmingham, AL 35203 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	Max Planck Society; University of Copenhagen; Niels Bohr Institute; Aarhus University; Max Planck Society; Johannes Gutenberg University of Mainz; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; Cornell University; University of Alabama System; University of Alabama Birmingham; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Goetz, W (corresponding author), Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany.	goetz@mps.mpg.de	de Souza, Paulo/W-2993-2019; Schröder, Christian/B-3870-2009; Kinch, Kjartan Bergeron/C-5742-2015; de Souza, Paulo/P-7294-2019; de Souza, Paulo A/B-8961-2008; Madsen, Morten Bo/D-2082-2011; Gunnlaugsson, Haraldur/L-6535-2016	de Souza, Paulo/0000-0002-0091-8925; Schröder, Christian/0000-0002-7935-6039; Kinch, Kjartan Bergeron/0000-0002-4629-8880; de Souza, Paulo A/0000-0002-0091-8925; Madsen, Morten Bo/0000-0001-8909-5111; Gunnlaugsson, Haraldur/0000-0002-8958-0245				Bertelsen P, 2004, SCIENCE, V305, P827, DOI 10.1126/science.1100112; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; HARGRAVES RB, 1979, J GEOPHYS RES, V84, P8379, DOI 10.1029/JB084iB14p08379; Hviid SF, 1997, SCIENCE, V278, P1768, DOI 10.1126/science.278.5344.1768; KINCH KM, UNPUB PLANET SPACE S; Klingelhofer G, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002138; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; KNUDSEN JM, 1991, HYPERFINE INTERACT, V68, P83; Lemmon MT, 2004, SCIENCE, V306, P1753, DOI 10.1126/science.1104474; LEVIN GV, 1976, SCIENCE, V194, P1322, DOI 10.1126/science.194.4271.1322; Madsen MB, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002029; Madsen MB, 1999, J GEOPHYS RES-PLANET, V104, P8761, DOI 10.1029/1998JE900006; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; Morris RV, 2001, J GEOPHYS RES-PLANET, V106, P5057, DOI 10.1029/2000JE001328; POLLACK JB, 1979, J GEOPHYS RES, V84, P2924; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; Schroder C, 2004, PLANET SPACE SCI, V52, P997, DOI 10.1016/j.pss.2004.07.018; SMITH P, 2004, LUNAR PLANET SCI C, V35, P2050; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; SQUYRES SW, 2003, J GEOPHYS RES, V108; Tomasko MG, 1999, J GEOPHYS RES-PLANET, V104, P8987, DOI 10.1029/1998JE900016; YEN A, 2005, LUNAR PLANET SCI C, V36, P1571	23	99	100	3	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 7	2005	436	7047					62	65		10.1038/nature03807	http://dx.doi.org/10.1038/nature03807			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001062				2022-12-28	WOS:000230296600039
J	Maskos, U; Molles, BE; Pons, S; Besson, M; Guiard, BP; Guilloux, JP; Evrard, A; Cazala, P; Cormier, A; Mameli-Engvall, M; Dufour, N; Cloez-Tayarani, I; Bemelmans, AP; Mallet, J; Gardier, AM; David, V; Faure, P; Granon, S; Changeux, JP				Maskos, U; Molles, BE; Pons, S; Besson, M; Guiard, BP; Guilloux, JP; Evrard, A; Cazala, P; Cormier, A; Mameli-Engvall, M; Dufour, N; Cloez-Tayarani, I; Bemelmans, AP; Mallet, J; Gardier, AM; David, V; Faure, P; Granon, S; Changeux, JP			Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors	NATURE			English	Article							VENTRAL TEGMENTAL AREA; ACETYLCHOLINE-RECEPTORS; PHYSIOLOGICAL DIVERSITY; NUCLEUS-ACCUMBENS; NEURONS; MICE; RAT; BEHAVIOR; IDENTIFICATION; ADDICTION	Worldwide, 100 million people are expected to die this century from the consequences of nicotine addiction(1), but nicotine is also known to enhance cognitive performance(2). Identifying the molecular mechanisms involved in nicotine reinforcement and cognition is a priority and requires the development of new in vivo experimental paradigms. The ventral tegmental area (VTA) of the midbrain is thought to mediate the reinforcement properties of many drugs of abuse. Here we specifically re-expressed the beta 2-subunit of the nicotinic acetylcholine receptor (nAChR) by stereotaxically injecting a lentiviral vector into the VTA of mice carrying beta 2-subunit deletions(3,4). We demonstrate the efficient re-expression of electrophysiologically responsive, ligand-binding nicotinic acetylcholine receptors in dopamine-containing neurons of the VTA, together with the recovery of nicotine-elicited dopamine release and nicotine self-administration. We also quantified exploratory behaviours of the mice, and showed that beta 2-subunit re-expression restored slow exploratory behaviour (a measure of cognitive function) to wild-type levels, but did not affect fast navigation behaviour. We thus demonstrate the sufficient role of the VTA in both nicotine reinforcement and endogenous cholinergic regulation of cognitive functions.	Inst Pasteur, CNRS, URA 2182, Unite Recepteurs & Cognit, F-75724 Paris, France; Univ Paris Sud, Fac Pharm, Lab Neuropharmacol EA3544, F-92296 Chatenay Malabry, France; Univ Bordeaux 1, CNRS, UMR 5106, Cognit Neurosci Lab, F-33405 Talence, France; Hop La Pitie Salpetriere, CNRS, UMR 7091, Lab Genet Mol Neurotransmiss & Proc Neurodegenera, F-75013 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Changeux, JP (corresponding author), Inst Pasteur, CNRS, URA 2182, Unite Recepteurs & Cognit, 25 Rue Dr Roux, F-75724 Paris, France.	changeux@pasteur.fr	Guilloux, Jean-Philippe/B-3726-2015; JP, Guilloux/Z-5069-2019; Bemelmans, Alexis-Pierre/H-4476-2019; Guiard, Bruno/A-3955-2016	Guilloux, Jean-Philippe/0000-0003-0982-3751; JP, Guilloux/0000-0003-0982-3751; Bemelmans, Alexis-Pierre/0000-0001-7605-5225; Faure, Philippe/0000-0003-3573-4971; Granon, sylvie/0000-0001-9384-3119; David, Vincent/0000-0003-2263-7275				Bardo MT, 1996, BEHAV BRAIN RES, V77, P23, DOI 10.1016/0166-4328(95)00203-0; Carr DB, 2000, SYNAPSE, V38, P114, DOI 10.1002/1098-2396(200011)38:2<114::AID-SYN2>3.0.CO;2-R; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; CUNNINGHAM MG, 1993, J NEUROSCI METH, V47, P105, DOI 10.1016/0165-0270(93)90026-N; David V, 2002, PSYCHOPHARMACOLOGY, V160, P307, DOI 10.1007/s00213-001-0981-2; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; Faure P, 2003, FRACTALS, V11, P233, DOI 10.1142/S0218348X03002166; GRACE AA, 1983, NEUROSCIENCE, V10, P301, DOI 10.1016/0306-4522(83)90135-5; Granon S, 2003, P NATL ACAD SCI USA, V100, P9596, DOI 10.1073/pnas.1533498100; GRENHOFF J, 1986, ACTA PHYSIOL SCAND, V128, P351, DOI 10.1111/j.1748-1716.1986.tb07988.x; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; Laviolette SR, 2004, NAT REV NEUROSCI, V5, P55, DOI 10.1038/nrn1298; Levin ED, 2002, CNS NEUROL DISORD-DR, V1, P423, DOI 10.2174/1568007023339102; Mansvelder HD, 2003, EUR J PHARMACOL, V480, P117, DOI 10.1016/j.ejphar.2003.08.099; Maskos U, 2002, P NATL ACAD SCI USA, V99, P10120, DOI 10.1073/pnas.152266799; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; MESULAM MM, 1983, NEUROSCIENCE, V10, P1185, DOI 10.1016/0306-4522(83)90108-2; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Peto R, 1996, BRIT MED BULL, V52, P12, DOI 10.1093/oxfordjournals.bmb.a011519; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; Poucet B, 1997, CRIT REV NEUROBIOL, V11, P101, DOI 10.1615/CritRevNeurobiol.v11.i2-3.10; RENNER MJ, 1990, PSYCHOBIOLOGY, V18, P16; Robbins TW, 2000, EXP BRAIN RES, V133, P130, DOI 10.1007/s002210000407; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Thinus-Blanc C., 1996, ANIMAL SPATIAL COGNI; Zoli M, 1998, J NEUROSCI, V18, P4461; Zoli M, 1999, EMBO J, V18, P1235, DOI 10.1093/emboj/18.5.1235	30	428	443	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					103	107		10.1038/nature03694	http://dx.doi.org/10.1038/nature03694			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001069				2022-12-28	WOS:000230296600047
J	Garg, V; Muth, AN; Ransom, JF; Schluterman, MK; Barnes, R; King, IN; Grossfeld, PD; Srivastava, D				Garg, V; Muth, AN; Ransom, JF; Schluterman, MK; Barnes, R; King, IN; Grossfeld, PD; Srivastava, D			Mutations in NOTCH1 cause aortic valve disease	NATURE			English	Article							NUCLEAR ACCESS; DROSOPHILA; HEART; TRANSITION; MECHANISM; CBFA1	Calcification of the aortic valve is the third leading cause of heart disease in adults(1). The incidence increases with age, and it is often associated with a bicuspid aortic valve present in 1 - 2% of the population(2). Despite the frequency, neither the mechanisms of valve calcification nor the developmental origin of a two, rather than three, leaflet aortic valve is known. Here, we show that mutations in the signalling and transcriptional regulator NOTCH1 cause a spectrum of developmental aortic valve anomalies and severe valve calcification in non-syndromic autosomal-dominant human pedigrees. Consistent with the valve calcification phenotype, Notch1 transcripts were most abundant in the developing aortic valve of mice, and Notch1 repressed the activity of Runx2, a central transcriptional regulator of osteoblast cell fate. The hairy-related family of transcriptional repressors (Hrt), which are activated by Notch1 signalling, physically interacted with Runx2 and repressed Runx2 transcriptional activity independent of histone deacetylase activity. These results suggest that NOTCH1 mutations cause an early developmental defect in the aortic valve and a later de-repression of calcium deposition that causes progressive aortic valve disease.	Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; Childrens Med Ctr, Dallas, TX 75235 USA; Univ Calif San Diego, Dept Pediat, Div Cardiol, San Diego, CA 92123 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego	Garg, V (corresponding author), Univ Texas, SW Med Ctr, Dept Pediat, 6000 Harry Hines Blvd,Room NA8-124, Dallas, TX 75390 USA.	vidu.garg@utsouthwestern.edu; dsrivastava@gladstone.ucsf.edu	Burdine, Marie Schluterman/GLU-1812-2022; Garg, Vidu/E-3101-2011; Garg, Vidu/D-8240-2012	Burdine, Marie Schluterman/0000-0002-3940-5748; Garg, Vidu/0000-0002-3778-5927; Ransom, Joshua/0000-0002-3591-0288	NHLBI NIH HHS [K08 HL079260-01, K08 HL079260] Funding Source: Medline; NICHD NIH HHS [K08 HD001382] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079260] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*AM HEART ASS, 2004, HEART DIS STROK STAT; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cripe L, 2004, J AM COLL CARDIOL, V44, P138, DOI 10.1016/j.jacc.2004.03.050; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Horne BD, 2004, CIRCULATION, V110, P3143, DOI 10.1161/01.CIR.0000147189.85636.C3; Iso T, 2001, MOL CELL BIOL, V21, P6080, DOI 10.1128/MCB.21.17.6080-6089.2001; Kathiriya IS, 2004, J BIOL CHEM, V279, P54937, DOI 10.1074/jbc.M409879200; Krebs LT, 2000, GENE DEV, V14, P1343; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Loffredo CA, 2004, AM J MED GENET A, V124A, P225, DOI 10.1002/ajmg.a.20366; McLarren KW, 2000, J BIOL CHEM, V275, P530, DOI 10.1074/jbc.275.1.530; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; OBRIEN KD, 1995, CIRCULATION, V92, P2163, DOI 10.1161/01.CIR.92.8.2163; Rajamannan NM, 2003, HEART, V89, P801, DOI 10.1136/heart.89.7.801; Rajamannan NM, 2002, CIRCULATION, V105, P2660, DOI 10.1161/01.CIR.0000017435.87463.72; Sotillos S, 1997, DEVELOPMENT, V124, P4769; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Wen CH, 1997, DEVELOPMENT, V124, P4759; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160	30	991	1052	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					270	274		10.1038/nature03940	http://dx.doi.org/10.1038/nature03940			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16025100				2022-12-28	WOS:000231696900059
J	Kimm, SYS; Glynn, NW; Obarzanek, E; Kriska, AM; Daniels, SR; Barton, BA; Liu, K				Kimm, SYS; Glynn, NW; Obarzanek, E; Kriska, AM; Daniels, SR; Barton, BA; Liu, K			Relation between the changes in physical activity and body-mass index during adolescence: a multicentre longitudinal study	LANCET			English	Article							WEIGHT CHANGE; YOUNG-ADULTS; BIRACIAL COHORT; DIETARY-INTAKE; NHLBI GROWTH; LIFE-STYLE; PREDICTORS; OBESITY; OVERWEIGHT; GAIN	Background The role of physical activity in preventing obesity during adolescence remains unknown. We examined changes in activity in relation to changes in body-mass index (BMI) and adiposity in a cohort of 1152 black and 1135 white girls from the USA, who were followed up prospectively from ages 9 or 110 to 18 or 19 years. Methods BMI and sum of skinfold thickness were assessed annually, whereas habitual activity was assessed at years 1 (baseline), 3, 5, and 7-10. Each girls' overall activity status was categorised as active, moderately active, or inactive. Longitudinal regression models examined associations between changes in activity and in overall activity status with changes in BMI and in sum of skinfold thickness. Findings Each decline in activity of 10 metabolic equivalent [MET]-times per week was associated with an increase in BMI of 0.14 kg/m(2)(SE 0.03) and in sum of skinfold thickness of 0.62 mm (0.17) for black girls, and of 0.09 kg/m(2) (0.02) and 0.63 mm (0.13) for white girls. At ages 18 or 19 years, BMI differences between active and inactive girls were 2.98 kg/m(2) (p<0.0001) for black girls and 2.10 kg/ml (p<0.0001) for white girls. Similar results were apparent for sum of skinfold thickness. For moderately active girls, changes in BMI and sum of skinfold thickness were about midway between those for active and inactive girls. Interpretation Changes in activity levels of US girls during adolescence significantly affected changes in BMI and adiposity. Thus, preventing the steep decline in activity during adolescence is an important method to reduce obesity.	Univ New Mexico, Sch Med, Dept Internal Med, Albuquerque, NM 87131 USA; Univ Pittsburgh, Sch Med, Dept Family Med, Pittsburgh, PA USA; NHLBI, Prevent Sci Res Grp, Div Epidemiol & Clin Applicat, Bethesda, MD 20892 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; Childrens Hosp, Med Ctr, Div Cardiol, Cincinnati, OH 45229 USA; Maryland Med Res Inst, Baltimore, MD USA; Northwestern Univ, Sch Med, Dept Prevent Med, Chicago, IL USA	University of New Mexico; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cincinnati Children's Hospital Medical Center; Northwestern University	Kimm, SYS (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Internal Med Epidemiol, 1 Univ New Mexico,MSC 105550, Albuquerque, NM 87131 USA.	skimm@salud.unm.edu		Kriska, Andrea/0000-0002-3522-0869; Barton, Bruce/0000-0001-7878-8895; Glynn, Nancy/0000-0003-2265-0162	NHLBI NIH HHS [U01-HL48941-44, N01-HC-55023-26] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055023] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL048941] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Berkey CS, 2003, PEDIATRICS, V111, P836, DOI 10.1542/peds.111.4.836; Berkey CS, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e56; Bild DE, 1996, INT J OBESITY, V20, P47; BURKE GL, 1990, PREV MED, V19, P476, DOI 10.1016/0091-7435(90)90045-L; BURKE GL, 1992, AM J PUBLIC HEALTH, V82, P1621, DOI 10.2105/AJPH.82.12.1621; Coakley EH, 1998, INT J OBESITY, V22, P89, DOI 10.1038/sj.ijo.0800549; CRAWFORD PB, 1994, J AM DIET ASSOC, V94, P626, DOI 10.1016/0002-8223(94)90158-9; Fogelholm M, 2000, Obes Rev, V1, P95, DOI 10.1046/j.1467-789x.2000.00016.x; Fogelholm M, 2000, OBES RES, V8, P367, DOI 10.1038/oby.2000.44; French SA, 1999, INT J OBESITY, V23, P320, DOI 10.1038/sj.ijo.0800822; FRENCH SA, 1994, INT J OBESITY, V18, P145; Gordon-Larsen P, 2002, OBES RES, V10, P141, DOI 10.1038/oby.2002.23; Guo SS, 1999, AM J CLIN NUTR, V70, P405; Haapanen N, 1997, INT J OBESITY, V21, P288, DOI 10.1038/sj.ijo.0800403; Heitmann BL, 1997, AM J CLIN NUTR, V66, P672, DOI 10.1093/ajcn/66.3.672; HIMES JH, 1994, AM J CLIN NUTR, V59, P307, DOI 10.1093/ajcn/59.2.307; Kimm S. Y. S., 2002, International Journal of Obesity, V26, pS77; Kimm SYS, 2002, NEW ENGL J MED, V347, P709, DOI 10.1056/NEJMoa003277; Kimm SYS, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e54; Kimm SYS, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e34; Kimm SYS, 2000, MED SCI SPORT EXER, V32, P1445, DOI 10.1097/00005768-200008000-00013; KLESGES RC, 1992, AM J CLIN NUTR, V55, P818, DOI 10.1093/ajcn/55.4.818; Koh-Banerjee P, 2003, AM J CLIN NUTR, V78, P719, DOI 10.1093/ajcn/78.4.719; Kronsberg SS, 2003, J AM DIET ASSOC, V103, P852, DOI 10.1016/S0002-8223(03)00384-5; Lahti-Koski M, 2002, AM J CLIN NUTR, V75, P809, DOI 10.1093/ajcn/75.5.809; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; MOORE LL, 1995, AM J EPIDEMIOL, V142, P982, DOI 10.1093/oxfordjournals.aje.a117747; MORRISON JA, 1992, AM J PUBLIC HEALTH, V82, P1613; OWENS JF, 1992, CIRCULATION, V85, P1265, DOI 10.1161/01.CIR.85.4.1265; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Proctor MH, 2003, INT J OBESITY, V27, P827, DOI 10.1038/sj.ijo.0802294; RAITAKARI OT, 1994, AM J EPIDEMIOL, V140, P195, DOI 10.1093/oxfordjournals.aje.a117239; RISSANEN AM, 1991, EUR J CLIN NUTR, V45, P419; Robinson Thomas N, 2003, Ethn Dis, V13, pS65; Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561; Rogol AD, 2002, J ADOLESCENT HEALTH, V31, P192, DOI 10.1016/S1054-139X(02)00485-8; SAS Institute Inc, 1999, SAS STAT US GUID VER; Schmitz KH, 2000, INT J OBESITY, V24, P1475, DOI 10.1038/sj.ijo.0801415; Sherwood NE, 2000, INT J OBESITY, V24, P395, DOI 10.1038/sj.ijo.0801169; TAYLOR CB, 1994, EPIDEMIOLOGY, V5, P599, DOI 10.1097/00001648-199411000-00007; WILLIAMSON DF, 1993, INT J OBESITY, V17, P279	42	258	265	1	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2005	366	9482					301	307		10.1016/S0140-6736(05)66837-7	http://dx.doi.org/10.1016/S0140-6736(05)66837-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RJ	16039332				2022-12-28	WOS:000230733100028
J	Maisel, WH; Laskey, WK				Maisel, WH; Laskey, WK			Patent foramen ovalle closure devices - Moving beyond equipoise	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CRYPTOGENIC STROKE; PERCUTANEOUS CLOSURE; MEDICAL-TREATMENT		Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Cardiovasc Div, Boston, MA 02115 USA; Univ New Mexico, Sch Med, Dept Med, Div Cardiol, Albuquerque, NM 87131 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of New Mexico	Maisel, WH (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Cardiovasc Div, 185 Pilgrim Rd, Boston, MA 02115 USA.	wmaisel@bidmc.harvard.edu						*AM HEART ASS, STROK NEWS SUMM 2004; Baker SS, 2002, CATHETER CARDIO INTE, V55, P83, DOI 10.1002/ccd.10079; Blackshear JL, 2004, J AM COLL CARDIOL, V44, P759, DOI 10.1016/j.jacc.2004.06.002; *CIMIT REG AFF, 2002, AGA MED ANT FULL PMA; Donnan GA, 2004, STROKE, V35, P806, DOI 10.1161/01.STR.0000117965.15684.D3; Homma S, 2002, CIRCULATION, V105, P2625, DOI 10.1161/01.CIR.0000017498.88393.44; Homma S, 1997, STROKE, V28, P2376, DOI 10.1161/01.STR.28.12.2376; Horton SC, 2004, MAYO CLIN PROC, V79, P79, DOI 10.4065/79.1.79; *INT STROK CTR, STROK TRIALS DIR TRI; *INT STROK CTR, STROK TRIALS DIR RES; Khairy P, 2003, ANN INTERN MED, V139, P753, DOI 10.7326/0003-4819-139-9-200311040-00010; Krumsdorf U, 2004, J AM COLL CARDIOL, V43, P302, DOI 10.1016/j.jacc.2003.10.030; Landzberg MJ, 2004, HEART, V90, P219, DOI 10.1136/hrt.2003.019315; Maisel WH, 2004, ANN INTERN MED, V140, P296, DOI 10.7326/0003-4819-140-4-200402170-00012; Meissner I, 1999, MAYO CLIN PROC, V74, P862, DOI 10.4065/74.9.862; Messe SR, 2004, NEUROLOGY, V62, P1042, DOI 10.1212/01.WNL.0000119173.15878.F3; *MINN HEART I, CARDIA STAR TRIAL US; Orgera MA, 2001, SOUTHERN MED J, V94, P699; Schwerzmann M, 2004, HEART, V90, P186, DOI 10.1136/hrt.2002.003111; Sievert H, 2004, EUR HEART J, V25, P361, DOI 10.1016/j.ehj.2004.01.012; *US DEP HHS, HUM DEV EX HDE REG Q; *US DEP HHS, H990011 CARDIOSEAL S; *US DEP HHS, H000007 AMPL PFO OCC; *US SEC EXCH COMM, ANN REP FISC YEAR EN; Williams DO, 1998, CIRCULATION, V97, P309; Windecker S, 2004, J AM COLL CARDIOL, V44, P750, DOI 10.1016/j.jacc.2004.05.044; *WINDH INF INC, START UP WINDH REV E; Wu LA, 2004, ARCH INTERN MED, V164, P950, DOI 10.1001/archinte.164.9.950; 2004, FED REG, V69, P66235	29	35	35	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2005	294	3					366	369		10.1001/jama.294.3.366	http://dx.doi.org/10.1001/jama.294.3.366			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YL	16030282				2022-12-28	WOS:000230609100022
J	Opstelten, W; Zaal, MJW				Opstelten, W; Zaal, MJW			Managing ophthalmic herpes zoster in primary care	BRITISH MEDICAL JOURNAL			English	Review							ORAL ACYCLOVIR; POSTHERPETIC NEURALGIA; MANAGEMENT; KERATITIS; SHINGLES; VIRUS; RISK		Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3500 AB Utrecht, Netherlands; VU Univ Med Ctr Amsterdam, Dept Ophthalmol, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Opstelten, W (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, POB 85060, NL-3500 AB Utrecht, Netherlands.	W.Opstelten@umcutrecht.nl						Chapman RS, 2003, VACCINE, V21, P2541, DOI 10.1016/S0264-410X(03)00034-3; COBO LM, 1986, OPHTHALMOLOGY, V93, P763; COBO M, 1987, CURR EYE RES, V6, P195, DOI 10.3109/02713688709020090; Colin J, 2000, OPHTHALMOLOGY, V107, P1507, DOI 10.1016/S0161-6420(00)00222-0; Gnann JW, 2002, NEW ENGL J MED, V347, P340, DOI 10.1056/NEJMcp1302674; Gross G, 2003, J CLIN VIROL, V26, P277, DOI 10.1016/S1386-6532(03)00005-2; Haanpaa M, 1998, NEUROLOGY, V51, P1405, DOI 10.1212/WNL.51.5.1405; HARDING SP, 1986, BRIT MED J, V292, P1428, DOI 10.1136/bmj.292.6533.1428; HARDING SP, 1991, CURR EYE RES, V10, P177, DOI 10.3109/02713689109020376; HILT DC, 1983, ANN NEUROL, V14, P543, DOI 10.1002/ana.410140509; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; Hutchinson J, 1865, ROYAL LONDON OPHTHAL, V5, P191; JOHNSON R, 1995, J INFECTION, V30, P193; Jung BF, 2004, NEUROLOGY, V62, P1545, DOI 10.1212/01.WNL.0000123261.00004.29; KATTAH JC, 1978, AM J OPHTHALMOL, V85, P378, DOI 10.1016/S0002-9394(14)77734-7; Liesegang Thomas J, 2004, Curr Opin Ophthalmol, V15, P531, DOI 10.1097/01.icu.0000143686.68103.46; LIESEGANG TJ, 1984, J AM ACAD DERMATOL, V11, P165, DOI 10.1016/S0190-9622(84)70148-4; MARSH RJ, 1977, BRIT J OPHTHALMOL, V61, P677, DOI 10.1136/bjo.61.11.677; NEOH C, 1994, EYE, V8, P688, DOI 10.1038/eye.1994.170; Opstelten W, 2004, PAIN, V107, P202, DOI 10.1016/j.pain.2003.10.021; RAGOZZINO MW, 1982, NEW ENGL J MED, V307, P393, DOI 10.1056/NEJM198208123070701; RAGOZZINO MW, 1982, MEDICINE, V61, P310, DOI 10.1097/00005792-198209000-00003; Shaikh S, 2002, AM FAM PHYSICIAN, V66, P1723; Silverstein BE, 1997, AM J OPHTHALMOL, V123, P254, DOI 10.1016/S0002-9394(14)71044-X; Tullo AB., 1983, CORNEA, V2, P115; Tyring S, 2001, BRIT J OPHTHALMOL, V85, P576, DOI 10.1136/bjo.85.5.576; Van der Lelij A, 2000, OPHTHALMOLOGY, V107, P1164, DOI 10.1016/S0161-6420(00)00115-9; Zaal MJW, 2003, ACTA OPHTHALMOL SCAN, V81, P216, DOI 10.1034/j.1600-0420.2003.00057.x; Zaal MJW, 2003, GRAEF ARCH CLIN EXP, V241, P187, DOI 10.1007/s00417-002-0609-1; Zaal MJW, 2001, AM J OPHTHALMOL, V131, P25, DOI 10.1016/S0002-9394(00)00652-8	30	37	41	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 16	2005	331	7509					147	151		10.1136/bmj.331.7509.147	http://dx.doi.org/10.1136/bmj.331.7509.147			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	947GV	16020856	Green Published, Green Submitted			2022-12-28	WOS:000230632300020
J	Chisholm, N; Gillett, G				Chisholm, N; Gillett, G			The patient's journey: Living with locked-in syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Otago, Sch Med, Dunedin Hosp, Dunedin, New Zealand; Univ Otago, Sch Med, Otago Bioeth Ctr, Dunedin, New Zealand	Dunedin Public Hospital; University of Otago; University of Otago	Gillett, G (corresponding author), Univ Otago, Sch Med, Dunedin Hosp, POB 913, Dunedin, New Zealand.	grant.gillett@stonebow.otago.ac.nz							0	34	34	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 9	2005	331	7508					94	97		10.1136/bmj.331.7508.94	http://dx.doi.org/10.1136/bmj.331.7508.94			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945XR	16002884	Green Published			2022-12-28	WOS:000230536800018
J	Van Damme-Lombaerts, R				Van Damme-Lombaerts, R			Children's growth after kidney transplantation	LANCET			English	Editorial Material							RENAL-TRANSPLANTATION; HORMONE TREATMENT		Katholieke Univ Leuven Hosp, UZ Gasthuisberg, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven	Van Damme-Lombaerts, R (corresponding author), Katholieke Univ Leuven Hosp, UZ Gasthuisberg, B-3000 Louvain, Belgium.	Rita.Lombaerts@uz.kuleuven.ac.be						Benfield M R, 1999, Pediatr Transplant, V3, P152, DOI 10.1034/j.1399-3046.1999.00011.x; Crompton CH, 2004, NEPHROLOGY, V9, P325, DOI 10.1111/j.1440-1797.2004.00318.x; Fine RN, 2002, KIDNEY INT, V62, P688, DOI 10.1046/j.1523-1755.2002.00489.x; Guest G, 1998, PEDIATR NEPHROL, V12, P437, DOI 10.1007/s004670050483; Haffner D, 2000, NEW ENGL J MED, V343, P923, DOI 10.1056/NEJM200009283431304; HOKKENKOELEGA ACS, 1994, LANCET, V343, P1313, DOI 10.1016/S0140-6736(94)92465-1; Pape L, 2005, LANCET, V366, P151, DOI 10.1016/S0140-6736(05)66872-9; Pratschke J, 2005, TRANSPLANT INT, V18, P15, DOI 10.1111/j.1432-2277.2004.00018.x; Qvist E, 2002, PEDIATR NEPHROL, V17, P438, DOI 10.1007/s00467-002-0850-1; TEJANI A, 1993, J PEDIATR-US, V122, P397, DOI 10.1016/S0022-3476(05)83423-7; Tonshoff B, 1997, KIDNEY INT, pS106	11	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2005	366	9480					103	104		10.1016/S0140-6736(05)66844-4	http://dx.doi.org/10.1016/S0140-6736(05)66844-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	943JH	16005316				2022-12-28	WOS:000230349200008
J	Johnson, CN				Johnson, CN			Anthropology - The remaking of Australia's ecology	SCIENCE			English	Editorial Material							LATE PLEISTOCENE; EXTINCTIONS		James Cook Univ N Queensland, Sch Trop Biol, Townsville, Qld 4811, Australia	James Cook University	Johnson, CN (corresponding author), James Cook Univ N Queensland, Sch Trop Biol, Townsville, Qld 4811, Australia.	christopher.johnson@jcu.edu.au	Johnson, Chris N/A-7275-2008; Johnson, Christopher/J-7894-2014	Johnson, Christopher/0000-0002-9719-3771				Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Hesse PP, 2003, QUATERNARY SCI REV, V22, P2007, DOI 10.1016/S0277-3791(03)00164-1; Johnson CN, 2004, AUSTRAL ECOL, V29, P553, DOI 10.1111/j.1442-9993.2004.01389.x; Kershaw A. P., 2002, Flammable Australia: the fire regimes and biodiversity of a continent, punknown; Miller GH, 2005, SCIENCE, V309, P287, DOI 10.1126/science.1111288; O'Connell JF, 2004, J ARCHAEOL SCI, V31, P835, DOI 10.1016/j.jas.2003.11.005; Owen-Smith R.N., 1988, MEGAHERBIVORES INFLU, DOI [10.1017/CBO9780511565441, DOI 10.1017/CBO9780511565441]; Pate F.D., 2002, AUST ARCHAEOL, V54, P53; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Roberts RG, 2001, SCIENCE, V292, P1888, DOI 10.1126/science.1060264	10	7	8	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2005	309	5732					255	256		10.1126/science.1113957	http://dx.doi.org/10.1126/science.1113957			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002607				2022-12-28	WOS:000230449800031
